Citrus Sinensis ID: 014352
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 426 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LFV3 | 436 | Probable leucine-rich rep | yes | no | 0.985 | 0.963 | 0.673 | 1e-156 | |
| O65924 | 881 | Putative leucine-rich rep | no | no | 0.631 | 0.305 | 0.407 | 1e-56 | |
| C0LGI2 | 929 | Probable LRR receptor-lik | no | no | 0.619 | 0.284 | 0.415 | 5e-56 | |
| Q9SJT0 | 871 | Probable receptor-like pr | no | no | 0.636 | 0.311 | 0.427 | 1e-55 | |
| O22187 | 834 | Probable receptor-like pr | no | no | 0.645 | 0.329 | 0.424 | 2e-55 | |
| Q9T020 | 878 | Probable receptor-like pr | no | no | 0.636 | 0.308 | 0.416 | 2e-55 | |
| Q9FLJ8 | 842 | Probable receptor-like pr | no | no | 0.819 | 0.414 | 0.344 | 2e-55 | |
| Q9ZNQ8 | 633 | Proline-rich receptor-lik | no | no | 0.633 | 0.426 | 0.414 | 3e-55 | |
| Q9FZB1 | 872 | Probable LRR receptor-lik | no | no | 0.631 | 0.308 | 0.393 | 3e-55 | |
| Q9FX99 | 663 | Probable receptor-like pr | no | no | 0.654 | 0.420 | 0.374 | 6e-55 |
| >sp|Q9LFV3|Y5157_ARATH Probable leucine-rich repeat receptor-like serine/threonine-protein kinase At5g15730 OS=Arabidopsis thaliana GN=At5g15730 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 551 bits (1421), Expect = e-156, Method: Compositional matrix adjust.
Identities = 293/435 (67%), Positives = 339/435 (77%), Gaps = 15/435 (3%)
Query: 1 MVHKSDLVIIGICVGLALGILIATLVFFGLRWYKKHDHLRRCSNERSVATHPIRINGLGT 60
MV++SDLV+IGI VGLALG+L+A L+FF ++WY HLRRC+NE++ T P+ G
Sbjct: 1 MVNRSDLVVIGISVGLALGLLLALLLFFAIKWYYGRSHLRRCANEQNSPTLPVHTAKRGV 60
Query: 61 SIDFSAPVANSVAVKASGFPQKKSQVSWWSNHSKDRFTSAPSASGIPRYAYKDIQKATQN 120
I S +G P + WW+NH+KD SA SGIPRY YKDIQKATQN
Sbjct: 61 VIPDDRANTESSQPPENGAPTQHQ--PWWNNHTKDLTVSA---SGIPRYNYKDIQKATQN 115
Query: 121 FTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIG 180
FT +LGQG+FGPVYKA MP+G +AA KV S+S QG++EFQTEVSLLGRLHHRNLVNL G
Sbjct: 116 FTTVLGQGSFGPVYKAVMPNGELAAAKVHGSNSSQGDREFQTEVSLLGRLHHRNLVNLTG 175
Query: 181 YCVDKGKYMLIYEFMSNGSLSNLIYSEE--RVLNWEERLQIALDISHGIEYLHEGAVPPV 238
YCVDK MLIYEFMSNGSL NL+Y E +VLNWEERLQIALDISHGIEYLHEGAVPPV
Sbjct: 176 YCVDKSHRMLIYEFMSNGSLENLLYGGEGMQVLNWEERLQIALDISHGIEYLHEGAVPPV 235
Query: 239 IHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSD 298
IHRDLKSANILLDH MRAKVADFGLSKE V D SGLKGT+GY+DP YISTNK+TMKSD
Sbjct: 236 IHRDLKSANILLDHSMRAKVADFGLSKEMVLDRMTSGLKGTHGYMDPTYISTNKYTMKSD 295
Query: 299 IFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGH 358
I+SFGVII ELITAIHP QNLMEY+NLASMS DG+DEILD++LVG +I+EVR LA+I +
Sbjct: 296 IYSFGVIILELITAIHPQQNLMEYINLASMSPDGIDEILDQKLVGNASIEEVRLLAKIAN 355
Query: 359 KCLHKTPRKRPSIGEVTQALLKIKQRHL--AKQDTMSFADG-----EFSRAVSRIEDQQV 411
+C+HKTPRKRPSIGEVTQ +LKIKQ +QDTMS + G + SR +SRI+DQ V
Sbjct: 356 RCVHKTPRKRPSIGEVTQFILKIKQSRSRGRRQDTMSSSFGVGYEEDLSRVMSRIKDQHV 415
Query: 412 ELSKLAEVKER-HEE 425
EL LA VKE H+E
Sbjct: 416 ELGLLAGVKEENHQE 430
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O65924|Y2921_ARATH Putative leucine-rich repeat receptor-like protein kinase At2g19210 OS=Arabidopsis thaliana GN=At2g19210 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 220 bits (561), Expect = 1e-56, Method: Compositional matrix adjust.
Identities = 115/282 (40%), Positives = 170/282 (60%), Gaps = 13/282 (4%)
Query: 109 YAYKDIQKATQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLG 168
Y Y ++ K T NF +LGQG FG VY + VA +K+L+ S QG KEF+ EV LL
Sbjct: 566 YKYSEVVKVTNNFERVLGQGGFGKVYHGVLNDDQVA-VKILSESSAQGYKEFRAEVELLL 624
Query: 169 RLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEER-VLNWEERLQIALDISHGI 227
R+HH+NL LIGYC + K LIYEFM+NG+L + + E+ VL+WEERLQI+LD + G+
Sbjct: 625 RVHHKNLTALIGYCHEGKKMALIYEFMANGTLGDYLSGEKSYVLSWEERLQISLDAAQGL 684
Query: 228 EYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRN---SGLKGTYGYID 284
EYLH G PP++ RD+K ANIL++ ++AK+ADFGLS+ DG N + + GT GY+D
Sbjct: 685 EYLHNGCKPPIVQRDVKPANILINEKLQAKIADFGLSRSVALDGNNQDTTAVAGTIGYLD 744
Query: 285 PAYISTNKFTMKSDIFSFGVIIFELITA---IHPHQNLMEYVNLAS-----MSQDGVDEI 336
P Y T K + KSDI+SFGV++ E+++ I + E +++ +S + I
Sbjct: 745 PEYHLTQKLSEKSDIYSFGVVLLEVVSGQPVIARSRTTAENIHITDRVDLMLSTGDIRGI 804
Query: 337 LDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQAL 378
+D +L + ++ + C + + RP++ V L
Sbjct: 805 VDPKLGERFDAGSAWKITEVAMACASSSSKNRPTMSHVVAEL 846
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGI2|Y1677_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g67720 OS=Arabidopsis thaliana GN=At1g67720 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 218 bits (556), Expect = 5e-56, Method: Compositional matrix adjust.
Identities = 115/277 (41%), Positives = 174/277 (62%), Gaps = 13/277 (4%)
Query: 114 IQKATQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHR 173
+++AT NF+ +G+G+FG VY M G A+K+ A S ++F TEV+LL R+HHR
Sbjct: 601 LEEATDNFSKKVGRGSFGSVYYGRMKDGKEVAVKITADPSSHLNRQFVTEVALLSRIHHR 660
Query: 174 NLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIY--SEERVLNWEERLQIALDISHGIEYLH 231
NLV LIGYC + + +L+YE+M NGSL + ++ S+ + L+W RLQIA D + G+EYLH
Sbjct: 661 NLVPLIGYCEEADRRILVYEYMHNGSLGDHLHGSSDYKPLDWLTRLQIAQDAAKGLEYLH 720
Query: 232 EGAVPPVIHRDLKSANILLDHFMRAKVADFGLSK--EEVFDGRNSGLKGTYGYIDPAYIS 289
G P +IHRD+KS+NILLD MRAKV+DFGLS+ EE +S KGT GY+DP Y +
Sbjct: 721 TGCNPSIIHRDVKSSNILLDINMRAKVSDFGLSRQTEEDLTHVSSVAKGTVGYLDPEYYA 780
Query: 290 TNKFTMKSDIFSFGVIIFELITA--------IHPHQNLMEYVNLASMSQDGVDEILDKQL 341
+ + T KSD++SFGV++FEL++ P N++ + + + + V I+D +
Sbjct: 781 SQQLTEKSDVYSFGVVLFELLSGKKPVSAEDFGPELNIVHWAR-SLIRKGDVCGIIDPCI 839
Query: 342 VGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQAL 378
I+ V +A + ++C+ + RP + EV A+
Sbjct: 840 ASNVKIESVWRVAEVANQCVEQRGHNRPRMQEVIVAI 876
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SJT0|Y2214_ARATH Probable receptor-like protein kinase At2g21480 OS=Arabidopsis thaliana GN=At2g21480 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 218 bits (554), Expect = 1e-55, Method: Compositional matrix adjust.
Identities = 123/288 (42%), Positives = 180/288 (62%), Gaps = 17/288 (5%)
Query: 102 SASGIPRY-AYKDIQKATQNF--TNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEK 158
SA G+ RY + ++Q+ T+NF + I+G G FG VY T+ G AIK S QG
Sbjct: 505 SALGLGRYFSLSELQEVTKNFDASEIIGVGGFGNVYIGTIDDGTQVAIKRGNPQSEQGIT 564
Query: 159 EFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEE-RVLNWEERL 217
EF TE+ +L +L HR+LV+LIGYC + + +L+YE+MSNG + +Y + L W++RL
Sbjct: 565 EFHTEIQMLSKLRHRHLVSLIGYCDENAEMILVYEYMSNGPFRDHLYGKNLSPLTWKQRL 624
Query: 218 QIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRN---S 274
+I + + G+ YLH G +IHRD+KS NILLD + AKVADFGLSK+ F G+N +
Sbjct: 625 EICIGAARGLHYLHTGTAQGIIHRDVKSTNILLDEALVAKVADFGLSKDVAF-GQNHVST 683
Query: 275 GLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELI---TAIHPHQNLMEYVNLASMS-- 329
+KG++GY+DP Y + T KSD++SFGV++ E + AI+P Q E VNLA +
Sbjct: 684 AVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLLEALCARPAINP-QLPREQVNLAEWAML 742
Query: 330 --QDG-VDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEV 374
Q G +++I+D LVGA N + +++ A KCL RP++G+V
Sbjct: 743 WKQKGLLEKIIDPHLVGAVNPESMKKFAEAAEKCLADYGVDRPTMGDV 790
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|O22187|Y2232_ARATH Probable receptor-like protein kinase At2g23200 OS=Arabidopsis thaliana GN=At2g23200 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 217 bits (552), Expect = 2e-55, Method: Compositional matrix adjust.
Identities = 123/290 (42%), Positives = 177/290 (61%), Gaps = 15/290 (5%)
Query: 111 YKDIQKATQNFTN--ILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLG 168
+ DI AT NF ++G+G FG VYKA +P G AAIK + S QG EFQTE+ +L
Sbjct: 478 FTDILSATNNFDEQLLIGKGGFGYVYKAILPDGTKAAIKRGKTGSGQGILEFQTEIQVLS 537
Query: 169 RLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIY-SEERVLNWEERLQIALDISHGI 227
R+ HR+LV+L GYC + + +L+YEFM G+L +Y S L W++RL+I + + G+
Sbjct: 538 RIRHRHLVSLTGYCEENSEMILVYEFMEKGTLKEHLYGSNLPSLTWKQRLEICIGAARGL 597
Query: 228 EYLH-EGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRN--SGLKGTYGYID 284
+YLH G+ +IHRD+KS NILLD AKVADFGLSK D N +KGT+GY+D
Sbjct: 598 DYLHSSGSEGAIIHRDVKSTNILLDEHNIAKVADFGLSKIHNQDESNISINIKGTFGYLD 657
Query: 285 PAYISTNKFTMKSDIFSFGVIIFELITA------IHPHQ--NLMEYVNLASMSQDGVDEI 336
P Y+ T+K T KSD+++FGV++ E++ A PH+ NL E+V + S+ +DEI
Sbjct: 658 PEYLQTHKLTEKSDVYAFGVVLLEVLFARPAIDPYLPHEEVNLSEWV-MFCKSKGTIDEI 716
Query: 337 LDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRHL 386
LD L+G +++ I KCL + +RPS+ +V L + Q +
Sbjct: 717 LDPSLIGQIETNSLKKFMEIAEKCLKEYGDERPSMRDVIWDLEYVLQLQM 766
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9T020|Y4391_ARATH Probable receptor-like protein kinase At4g39110 OS=Arabidopsis thaliana GN=At4g39110 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 217 bits (552), Expect = 2e-55, Method: Compositional matrix adjust.
Identities = 120/288 (41%), Positives = 177/288 (61%), Gaps = 17/288 (5%)
Query: 102 SASGIPRY-AYKDIQKATQNF--TNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEK 158
S G+ RY + ++Q+AT+NF + I+G G FG VY T+ G A+K S QG
Sbjct: 506 STLGLGRYFSLSELQEATKNFEASQIIGVGGFGNVYIGTLDDGTKVAVKRGNPQSEQGIT 565
Query: 159 EFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERV-LNWEERL 217
EFQTE+ +L +L HR+LV+LIGYC + + +L+YEFMSNG + +Y + L W++RL
Sbjct: 566 EFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEFMSNGPFRDHLYGKNLAPLTWKQRL 625
Query: 218 QIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRN---S 274
+I + + G+ YLH G +IHRD+KS NILLD + AKVADFGLSK+ F G+N +
Sbjct: 626 EICIGSARGLHYLHTGTAQGIIHRDVKSTNILLDEALVAKVADFGLSKDVAF-GQNHVST 684
Query: 275 GLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELI---TAIHPHQNLMEYVNLASMSQD 331
+KG++GY+DP Y + T KSD++SFGV++ E + AI+P Q E VNLA +
Sbjct: 685 AVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLLEALCARPAINP-QLPREQVNLAEWAMQ 743
Query: 332 G-----VDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEV 374
+++I+D L G N + +++ A KCL RP++G+V
Sbjct: 744 WKRKGLLEKIIDPHLAGTINPESMKKFAEAAEKCLEDYGVDRPTMGDV 791
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9FLJ8|Y5613_ARATH Probable receptor-like protein kinase At5g61350 OS=Arabidopsis thaliana GN=At5g61350 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 216 bits (551), Expect = 2e-55, Method: Compositional matrix adjust.
Identities = 135/392 (34%), Positives = 215/392 (54%), Gaps = 43/392 (10%)
Query: 7 LVIIGICVGLALGILIATLVFFGLRWYKKHDHLRRCSNERSV-----ATHPIRINGLGTS 61
L I GI +AL + +V +RW ++ ++ ++ S A+H I+ G S
Sbjct: 424 LAIAGIGFVMALTAFLGVVVLL-VRWQRRPKDWQKQNSFSSWLLPLHASHSSYISSKGGS 482
Query: 62 IDFSAPVANSVAVKASGFPQKKSQVSWWSNHSKDRFTSAPSASGIPRYAYKDIQKATQNF 121
+ S K++GF S++SN R+ + + ++Q ATQNF
Sbjct: 483 TSRRMSIFGSKKSKSNGFS------SFFSNQGLGRY-----------FPFTELQTATQNF 525
Query: 122 TN--ILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLI 179
+ G G FG VY + G AIK + S QG EFQTE+ +L +L HR+LV+LI
Sbjct: 526 DENAVCGVGGFGKVYIGEIDGGTQVAIKRGSQSSEQGINEFQTEIQMLSKLRHRHLVSLI 585
Query: 180 GYCVDKGKYMLIYEFMSNGSLSNLIYSEER-------VLNWEERLQIALDISHGIEYLHE 232
G+C + + +L+YE+MSNG L + +Y + L+W++RL+I + + G+ YLH
Sbjct: 586 GFCDENKEMILVYEYMSNGPLRDHLYGSKENDPNPIPTLSWKQRLEICIGSARGLHYLHT 645
Query: 233 GAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGR--NSGLKGTYGYIDPAYIST 290
GA +IHRD+K+ NILLD + AKV+DFGLSK+ D ++ +KG++GY+DP Y
Sbjct: 646 GAAQGIIHRDVKTTNILLDENLVAKVSDFGLSKDAPMDEGHVSTAVKGSFGYLDPEYFRR 705
Query: 291 NKFTMKSDIFSFGVIIFELITA---IHPHQNLMEYVNLASMSQD-----GVDEILDKQLV 342
+ T KSD++SFGV++FE++ A I+P Q E VNLA + + +++I+D ++V
Sbjct: 706 QQLTDKSDVYSFGVVLFEVLCARPVINP-QLPREQVNLAEYAMNLHRKGMLEKIIDPKIV 764
Query: 343 GACNIQEVRELARIGHKCLHKTPRKRPSIGEV 374
G + +R+ KCL + RP +G+V
Sbjct: 765 GTISKGSLRKFVEAAEKCLAEYGVDRPGMGDV 796
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9ZNQ8|PERK4_ARATH Proline-rich receptor-like protein kinase PERK4 OS=Arabidopsis thaliana GN=PERK4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 216 bits (550), Expect = 3e-55, Method: Compositional matrix adjust.
Identities = 118/285 (41%), Positives = 176/285 (61%), Gaps = 15/285 (5%)
Query: 109 YAYKDIQKATQNFT--NILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSL 166
+ Y+++ AT FT N+LGQG FG V+K +PSG A+K L + S QGE+EFQ EV +
Sbjct: 272 FTYQELAAATGGFTDANLLGQGGFGYVHKGVLPSGKEVAVKSLKAGSGQGEREFQAEVDI 331
Query: 167 LGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEE-RVLNWEERLQIALDISH 225
+ R+HHR LV+L+GYC+ G+ ML+YEF+ N +L ++ + V+ + RL+IAL +
Sbjct: 332 ISRVHHRYLVSLVGYCIADGQRMLVYEFVPNKTLEYHLHGKNLPVMEFSTRLRIALGAAK 391
Query: 226 GIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGR--NSGLKGTYGYI 283
G+ YLHE P +IHRD+KSANILLD A VADFGL+K + ++ + GT+GY+
Sbjct: 392 GLAYLHEDCHPRIIHRDIKSANILLDFNFDAMVADFGLAKLTSDNNTHVSTRVMGTFGYL 451
Query: 284 DPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQN-------LMEYVN--LASMSQDG-V 333
P Y S+ K T KSD+FS+GV++ ELIT P N L+++ +A +DG
Sbjct: 452 APEYASSGKLTEKSDVFSYGVMLLELITGKRPVDNSITMDDTLVDWARPLMARALEDGNF 511
Query: 334 DEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQAL 378
+E+ D +L G N QE+ + + + RKRP + ++ +AL
Sbjct: 512 NELADARLEGNYNPQEMARMVTCAAASIRHSGRKRPKMSQIVRAL 556
|
Required during abscisic acid (ABA)-mediated activation of Ca(2+) channels. Regulates ABA signaling pathways. Modulates the expression of genes related to cell elongation and ABA signaling during root growth. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FZB1|Y5188_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51880 OS=Arabidopsis thaliana GN=At1g51880 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 216 bits (549), Expect = 3e-55, Method: Compositional matrix adjust.
Identities = 111/282 (39%), Positives = 169/282 (59%), Gaps = 13/282 (4%)
Query: 108 RYAYKDIQKATQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLL 167
R Y ++ K T NF +LG+G FG VY + VA +K+L+ S QG KEF+ EV LL
Sbjct: 555 RITYPEVLKMTNNFERVLGKGGFGTVYHGNLEDTQVA-VKMLSHSSAQGYKEFKAEVELL 613
Query: 168 GRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEE--RVLNWEERLQIALDISH 225
R+HHRNLV L+GYC D LIYE+M+NG L + + VL WE R+QIA++ +
Sbjct: 614 LRVHHRNLVGLVGYCDDGDNLALIYEYMANGDLKENMSGKRGGNVLTWENRMQIAVEAAQ 673
Query: 226 GIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGR---NSGLKGTYGY 282
G+EYLH G PP++HRD+K+ NILL+ AK+ADFGLS+ DG ++ + GT GY
Sbjct: 674 GLEYLHNGCTPPMVHRDVKTTNILLNERYGAKLADFGLSRSFPVDGESHVSTVVAGTPGY 733
Query: 283 IDPAYISTNKFTMKSDIFSFGVIIFELIT------AIHPHQNLMEYVNLASMSQDGVDEI 336
+DP Y TN + KSD++SFGV++ E++T ++ E+V + +++ + I
Sbjct: 734 LDPEYYRTNWLSEKSDVYSFGVVLLEIVTNQPVTDKTRERTHINEWVG-SMLTKGDIKSI 792
Query: 337 LDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQAL 378
LD +L+G + ++ + C++ + +RP++ V L
Sbjct: 793 LDPKLMGDYDTNGAWKIVELALACVNPSSNRRPTMAHVVTEL 834
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FX99|Y1497_ARATH Probable receptor-like protein kinase At1g49730 OS=Arabidopsis thaliana GN=At1g49730 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 215 bits (547), Expect = 6e-55, Method: Compositional matrix adjust.
Identities = 109/291 (37%), Positives = 182/291 (62%), Gaps = 12/291 (4%)
Query: 102 SASGIPRYAYKDIQKATQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQ 161
S+S +++YK++ AT +F ++GQG FG VYKA G +AA+K + S Q E++F
Sbjct: 310 SSSAFRKFSYKEMTNATNDFNTVIGQGGFGTVYKAEFNDGLIAAVKKMNKVSEQAEQDFC 369
Query: 162 TEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYS-EERVLNWEERLQIA 220
E+ LL +LHHRNLV L G+C++K + L+Y++M NGSL + +++ + +W R++IA
Sbjct: 370 REIGLLAKLHHRNLVALKGFCINKKERFLVYDYMKNGSLKDHLHAIGKPPPSWGTRMKIA 429
Query: 221 LDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEE-----VFDGRNSG 275
+D+++ +EYLH PP+ HRD+KS+NILLD AK++DFGL+ F+ N+
Sbjct: 430 IDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLSDFGLAHSSRDGSVCFEPVNTD 489
Query: 276 LKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT---AIHPHQNLMEYVNLASMSQDG 332
++GT GY+DP Y+ T + T KSD++S+GV++ ELIT A+ +NL+E +++
Sbjct: 490 IRGTPGYVDPEYVVTQELTEKSDVYSYGVVLLELITGRRAVDEGRNLVEMSQRFLLAKSK 549
Query: 333 VDEILDKQLVGACNI---QEVRELARIGHKCLHKTPRKRPSIGEVTQALLK 380
E++D ++ + N +++ + + C K R RPSI +V + L +
Sbjct: 550 HLELVDPRIKDSINDAGGKQLDAVVTVVRLCTEKEGRSRPSIKQVLRLLCE 600
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 426 | ||||||
| 255569978 | 420 | Serine/threonine-protein kinase PBS1, pu | 0.978 | 0.992 | 0.781 | 0.0 | |
| 505146 | 422 | protein-serine/threonine kinase [Nicotia | 0.990 | 1.0 | 0.748 | 0.0 | |
| 359488371 | 424 | PREDICTED: probable leucine-rich repeat | 0.990 | 0.995 | 0.768 | 0.0 | |
| 224120712 | 419 | predicted protein [Populus trichocarpa] | 0.974 | 0.990 | 0.763 | 0.0 | |
| 224119236 | 417 | predicted protein [Populus trichocarpa] | 0.969 | 0.990 | 0.747 | 0.0 | |
| 356573737 | 424 | PREDICTED: probable leucine-rich repeat | 0.974 | 0.978 | 0.720 | 0.0 | |
| 356568849 | 422 | PREDICTED: probable leucine-rich repeat | 0.983 | 0.992 | 0.710 | 0.0 | |
| 147767799 | 477 | hypothetical protein VITISV_019641 [Viti | 0.990 | 0.884 | 0.666 | 1e-178 | |
| 359806620 | 426 | probable leucine-rich repeat receptor-li | 0.983 | 0.983 | 0.694 | 1e-177 | |
| 255640116 | 426 | unknown [Glycine max] | 0.983 | 0.983 | 0.687 | 1e-175 |
| >gi|255569978|ref|XP_002525952.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] gi|223534781|gb|EEF36472.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 690 bits (1781), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 330/422 (78%), Positives = 374/422 (88%), Gaps = 5/422 (1%)
Query: 1 MVHKSDLVIIGICVGLALGILIATLVFFGLRWYKKHDHLRRCSNERSVATHPIRINGLGT 60
MVH+SDLVIIG+ VGLALGILIA+LVFFG+RWYK +LRRC+NERS+ T PIR NGLGT
Sbjct: 1 MVHQSDLVIIGVSVGLALGILIASLVFFGIRWYKNRANLRRCANERSLTTLPIRTNGLGT 60
Query: 61 SIDFSAPVANSVAVKASGFPQKKSQVSWWSNHSKDRFTSAPSASGIPRYAYKDIQKATQN 120
S DFSA +A+S+ ++ S P+K S WW++HSKD+F SA SGI RY+YKDIQKATQN
Sbjct: 61 STDFSASLAHSINIQGSEKPEKSSPFFWWNHHSKDQFASA---SGILRYSYKDIQKATQN 117
Query: 121 FTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIG 180
FT ILGQG+FGPVYKA +P GGV A+KVLA++S QGEKEFQTEVSLLGRLHHRNLVNL+G
Sbjct: 118 FTTILGQGSFGPVYKAGLP-GGVVAVKVLATNSKQGEKEFQTEVSLLGRLHHRNLVNLLG 176
Query: 181 YCVDKGKYMLIYEFMSNGSLSNLIYSEER-VLNWEERLQIALDISHGIEYLHEGAVPPVI 239
YCVDKG+ MLIYEFMSNGSL+NL+Y+EE VL WEERLQIALDISHGIEYLHEGA PPVI
Sbjct: 177 YCVDKGQRMLIYEFMSNGSLANLLYNEEEIVLGWEERLQIALDISHGIEYLHEGAAPPVI 236
Query: 240 HRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDI 299
HRDLKSANILLD MRAKVADFGLSKEE +DGRNSGLKGTYGYIDP YISTN+FTMKSDI
Sbjct: 237 HRDLKSANILLDQSMRAKVADFGLSKEESYDGRNSGLKGTYGYIDPVYISTNEFTMKSDI 296
Query: 300 FSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHK 359
+SFG+IIFELITAIHP QNLMEY+NLA+MS DGVDEILD++LVG CN++EVRELA I HK
Sbjct: 297 YSFGIIIFELITAIHPQQNLMEYINLAAMSSDGVDEILDQKLVGECNMEEVRELAAIAHK 356
Query: 360 CLHKTPRKRPSIGEVTQALLKIKQRHLAKQDTMSFADGEFSRAVSRIEDQQVELSKLAEV 419
CL K+ RKRPSIGEV+QA+LKIKQRHLAK+DTMSFA FSRAVSRIE+QQVELS +A +
Sbjct: 357 CLQKSQRKRPSIGEVSQAILKIKQRHLAKEDTMSFASQAFSRAVSRIEEQQVELSSMASI 416
Query: 420 KE 421
KE
Sbjct: 417 KE 418
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|505146|dbj|BAA06538.1| protein-serine/threonine kinase [Nicotiana tabacum] | Back alignment and taxonomy information |
|---|
Score = 684 bits (1764), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 318/425 (74%), Positives = 370/425 (87%), Gaps = 3/425 (0%)
Query: 1 MVHKSDLVIIGICVGLALGILIATLVFFGLRWYKKHDHLRRCSNERSVATHPIRINGLGT 60
MVHK+DLVIIGICVG+A GILIA+LVFFG+RWYK+ L+R +NER +A PIR NGL T
Sbjct: 1 MVHKADLVIIGICVGVAFGILIASLVFFGIRWYKRRARLQRQANERCIAALPIRTNGLNT 60
Query: 61 SIDFSAPVANSVAVKASGFPQKKSQVSWWSNHSKDRFTSAPSASGIPRYAYKDIQKATQN 120
S+DFSA +++SVA+ SGFP SQ SWWS+ SK F SA SGIPRY+YKDIQKATQN
Sbjct: 61 SVDFSASLSSSVAINTSGFPATNSQPSWWSHPSKVHFASA---SGIPRYSYKDIQKATQN 117
Query: 121 FTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIG 180
FT ILGQG+FGPVYKATMP+GGV A+KVLA+DS QGEKEF TEV+LLGRLHHRNLVNL+G
Sbjct: 118 FTTILGQGSFGPVYKATMPAGGVVAVKVLATDSKQGEKEFFTEVTLLGRLHHRNLVNLVG 177
Query: 181 YCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIH 240
YCVDKG MLIYEFMSNGSL+NL+YSEE L+WE+RLQIALD+SHG+EYLH+GAVPPVIH
Sbjct: 178 YCVDKGHRMLIYEFMSNGSLANLLYSEEHTLSWEDRLQIALDVSHGVEYLHDGAVPPVIH 237
Query: 241 RDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIF 300
RDLKSANILLDH MRAKVADFGLSKEEV+DGRNSGLKGTYGYIDP YIST+KFT +SDI+
Sbjct: 238 RDLKSANILLDHSMRAKVADFGLSKEEVYDGRNSGLKGTYGYIDPVYISTSKFTTRSDIY 297
Query: 301 SFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKC 360
SFGVI+FELITAIHPHQNLMEYVNLA+MS DGVDEILDK+LVG C++++VR LA I HKC
Sbjct: 298 SFGVILFELITAIHPHQNLMEYVNLAAMSSDGVDEILDKKLVGTCSLEQVRSLAAIAHKC 357
Query: 361 LHKTPRKRPSIGEVTQALLKIKQRHLAKQDTMSFADGEFSRAVSRIEDQQVELSKLAEVK 420
+H+TPRKRPS+GE++ A+L+I+QR L K+DTMSF + SR SRIE+QQVEL +A +
Sbjct: 358 IHRTPRKRPSMGEISHAILRIRQRRLVKEDTMSFTGYDSSRMASRIENQQVELRNMASIN 417
Query: 421 ERHEE 425
ER E
Sbjct: 418 EREAE 422
|
Source: Nicotiana tabacum Species: Nicotiana tabacum Genus: Nicotiana Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359488371|ref|XP_002281983.2| PREDICTED: probable leucine-rich repeat receptor-like serine/threonine-protein kinase At5g15730-like [Vitis vinifera] gi|298204439|emb|CBI16919.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 678 bits (1749), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 328/427 (76%), Positives = 367/427 (85%), Gaps = 5/427 (1%)
Query: 1 MVHKSDLVIIGICVGLALGILIATLVFFGLRWYKKHDHLRRCSNERSVATHPIRINGLGT 60
MV+ +DLV IGI GLA+GILIA+LVF G+RWYKKH HLRRC+NER PIR NGL
Sbjct: 1 MVNSADLVTIGISAGLAIGILIASLVFCGIRWYKKHSHLRRCANERCSTALPIRTNGLDA 60
Query: 61 SIDFSAPVANSVAVKASGFPQKKSQVSWWSN-HSKDRFTSAPSASGIPRYAYKDIQKATQ 119
SID SA V+NS+A+ S FP K S + WWS+ H KD+ SA SGIPRY+YKDIQKAT
Sbjct: 61 SIDSSASVSNSIAIPGSEFPAKDSHLFWWSHRHDKDQLASA---SGIPRYSYKDIQKATH 117
Query: 120 NFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLI 179
NFT ILGQG+FGPVYKATM +GGV A+KVLAS+S QGEKEFQTEVSLLGRLHHRNLVNL+
Sbjct: 118 NFTTILGQGSFGPVYKATMATGGVVAVKVLASNSKQGEKEFQTEVSLLGRLHHRNLVNLV 177
Query: 180 GYCVDKGKYMLIYEFMSNGSLSNLIYSEE-RVLNWEERLQIALDISHGIEYLHEGAVPPV 238
GYCVDKG++MLIYEFMSNGSL NL+YSEE + L+WEERLQIALDISHGIEYLHEGAVPPV
Sbjct: 178 GYCVDKGQHMLIYEFMSNGSLENLLYSEEGQGLSWEERLQIALDISHGIEYLHEGAVPPV 237
Query: 239 IHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSD 298
IHRDLKSANILLD MRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYIS+NKFTMKSD
Sbjct: 238 IHRDLKSANILLDQSMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISSNKFTMKSD 297
Query: 299 IFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGH 358
I+SFGVIIFELITAIHPHQNLME+VNLA+MS DG DEILDKQLVG C ++EVR LA IGH
Sbjct: 298 IYSFGVIIFELITAIHPHQNLMEFVNLAAMSPDGADEILDKQLVGECKLEEVRTLASIGH 357
Query: 359 KCLHKTPRKRPSIGEVTQALLKIKQRHLAKQDTMSFADGEFSRAVSRIEDQQVELSKLAE 418
KCLHKTPRKRPSIGEV+ A+ +IKQR AK+ TMS AD + SR VSRIE+QQVEL ++A
Sbjct: 358 KCLHKTPRKRPSIGEVSLAIARIKQRRFAKEHTMSLADSDLSRMVSRIENQQVELFEIAS 417
Query: 419 VKERHEE 425
K++ E
Sbjct: 418 FKDKATE 424
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224120712|ref|XP_002330933.1| predicted protein [Populus trichocarpa] gi|222873127|gb|EEF10258.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 672 bits (1733), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 323/423 (76%), Positives = 371/423 (87%), Gaps = 8/423 (1%)
Query: 1 MVHKSDLVIIGICVGLALGILIATLVFFGLRWYKKHDHLRRCSNERSVATHPIRINGLGT 60
MV+K D V+IGI VGLALGILIA+LVFFG+RWYK+ +LRRCSN+RS+ T PIR+NGLGT
Sbjct: 1 MVYKGDFVVIGISVGLALGILIASLVFFGIRWYKRRAYLRRCSNDRSLPTLPIRMNGLGT 60
Query: 61 SIDFSAPVANSVAVKASGFPQKKSQVS-WWSNHSKDRFTSAPSASGIPRYAYKDIQKATQ 119
S DFS +ANS+ ++ + PQK SQVS WW++HSKDRF S SGI RY+YKDIQKATQ
Sbjct: 61 SNDFSDSLANSITIQGTEHPQKSSQVSSWWNHHSKDRFAST---SGILRYSYKDIQKATQ 117
Query: 120 NFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLI 179
NFT +LGQG+FGPVYKA MP+G + A+KVLAS+S QGEKEFQTEVSLLGRLHHRNLVNL+
Sbjct: 118 NFTTVLGQGSFGPVYKAVMPTGEILAVKVLASNSKQGEKEFQTEVSLLGRLHHRNLVNLL 177
Query: 180 GYCVDKGKYMLIYEFMSNGSLSNLIYS-EERVLNWEERLQIALDISHGIEYLHEGAVPPV 238
GYC+DKG +MLIYEFMSNGSL+N +Y+ EE+ L+WEER+QIALDISHGIEYLHEGAVPPV
Sbjct: 178 GYCIDKGNHMLIYEFMSNGSLANHLYNDEEQFLSWEERIQIALDISHGIEYLHEGAVPPV 237
Query: 239 IHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSD 298
IHRDLKSANILLD MRAKVADFGLSKEEVFD RNSGLKGTYGYIDP YISTNKFTMKSD
Sbjct: 238 IHRDLKSANILLDQSMRAKVADFGLSKEEVFDERNSGLKGTYGYIDPVYISTNKFTMKSD 297
Query: 299 IFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGH 358
I+SFG+I+FELITAIHPHQNLMEYVNLA MS DGVDEILDK+LVG CNI+EVR LA + H
Sbjct: 298 IYSFGIIMFELITAIHPHQNLMEYVNLAGMSPDGVDEILDKRLVGECNIEEVRGLATVAH 357
Query: 359 KCLHKTPRKRPSIGEVTQALLKIKQRHLAKQDTMSFADGEFSRAVSRIEDQQVELSKLAE 418
KCL K RKRPSIGEV+QA+LKIKQR LAK+DTMS E SR ++RI+DQQVELS++A
Sbjct: 358 KCLQKFQRKRPSIGEVSQAILKIKQRCLAKEDTMSI---EVSRVLTRIDDQQVELSRMAS 414
Query: 419 VKE 421
+K+
Sbjct: 415 IKD 417
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224119236|ref|XP_002331261.1| predicted protein [Populus trichocarpa] gi|222873686|gb|EEF10817.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 650 bits (1676), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 316/423 (74%), Positives = 364/423 (86%), Gaps = 10/423 (2%)
Query: 1 MVHKSDLVIIGICVGLALGILIATLVFFGLRWYKKHDHLRRCSNERSVATHPIRINGLGT 60
MVHK DLV+IGI VGLALGILIA+L+FFG+ WYKK +LR+CSNER + T PIR+NGLGT
Sbjct: 1 MVHKGDLVVIGISVGLALGILIASLIFFGIWWYKKRSNLRQCSNERILPTLPIRMNGLGT 60
Query: 61 SIDFSAPVANSVAVKASGFPQKKSQVS-WWSNHSKDRFTSAPSASGIPRYAYKDIQKATQ 119
S DFSA +A+S+ ++ S PQK S VS WW++HSKD+F SA SGI RY+YKDIQKATQ
Sbjct: 61 SNDFSASLASSITIRGSEHPQKSSPVSSWWNHHSKDQFASA---SGILRYSYKDIQKATQ 117
Query: 120 NFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLI 179
FT +LGQG+FGPVYKA MP+G V A+KVLAS+S QGEKEFQTE+SLLGRLHHRNLVNL+
Sbjct: 118 KFTTVLGQGSFGPVYKAVMPTGEVLAVKVLASNSKQGEKEFQTEISLLGRLHHRNLVNLL 177
Query: 180 GYCVDKGKYMLIYEFMSNGSLSNLIYSE-ERVLNWEERLQIALDISHGIEYLHEGAVPPV 238
GYC+DKG +MLIY+FMSNGSL+N +YS+ +R L+WEERLQIALDISHGIEYLHEGAVPPV
Sbjct: 178 GYCIDKGSHMLIYQFMSNGSLANHLYSKLKRFLSWEERLQIALDISHGIEYLHEGAVPPV 237
Query: 239 IHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSD 298
IHRDLKSANILLD MRAKVADFGLS EEVFD SGLKGTYGYIDP Y+STNKFT+KSD
Sbjct: 238 IHRDLKSANILLDQSMRAKVADFGLSNEEVFDEHTSGLKGTYGYIDPVYVSTNKFTVKSD 297
Query: 299 IFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGH 358
I+SFGVIIFELITAIHPHQNLMEYVNLA MS DGVDEILDK+LVG CNI+EVR+LA I H
Sbjct: 298 IYSFGVIIFELITAIHPHQNLMEYVNLAGMSPDGVDEILDKKLVGECNIEEVRDLAAIAH 357
Query: 359 KCLHKTPRKRPSIGEVTQALLKIKQRHLAKQDTMSFADGEFSRAVSRIEDQQVELSKLAE 418
KCL K RKRPSIGEV+QA+LKIKQR L ++ EFSR +SRIEDQQ+ELS++A
Sbjct: 358 KCLQKFQRKRPSIGEVSQAILKIKQRLLDRE-----MSKEFSRVLSRIEDQQMELSRMAS 412
Query: 419 VKE 421
+K+
Sbjct: 413 IKD 415
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356573737|ref|XP_003555013.1| PREDICTED: probable leucine-rich repeat receptor-like serine/threonine-protein kinase At5g15730-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 642 bits (1657), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 304/422 (72%), Positives = 361/422 (85%), Gaps = 7/422 (1%)
Query: 1 MVHKSDLVIIGICVGLALGILIATLVFFGLRWYKKHDHLRRCSNERSVATHPIRINGLGT 60
MV ++DLVIIG+ VGL LGILI+ L+FFG+RWYKK H+RR +NE S+ T PIR NGLGT
Sbjct: 1 MVRQADLVIIGVSVGLTLGILISCLIFFGIRWYKKRAHIRRSANESSLTTLPIRTNGLGT 60
Query: 61 SIDFSAPVANSVAVKASGFPQKKSQVSWWSNHSKDRFTSAPSASGIPRYAYKDIQKATQN 120
S DFSA + +S+A S ++ S SWW++ +KDRF SA SGI +Y YK+IQKATQN
Sbjct: 61 SSDFSASLDSSIASSWSENLKRNSHFSWWNHQNKDRFASA---SGILKYLYKEIQKATQN 117
Query: 121 FTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIG 180
FT LGQG+FG VYKATMP+G V A+KVLA +S QGEKEFQTEV LLGRLHHRNLVNL+G
Sbjct: 118 FTTTLGQGSFGTVYKATMPTGEVVAVKVLAPNSKQGEKEFQTEVFLLGRLHHRNLVNLVG 177
Query: 181 YCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIH 240
YCVDKG+ +L+Y++MSNGSL+NL+Y EE+ L+W++RLQIALDISHGIEYLHEGAVPPVIH
Sbjct: 178 YCVDKGQRILVYQYMSNGSLANLLYGEEKELSWDQRLQIALDISHGIEYLHEGAVPPVIH 237
Query: 241 RDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIF 300
RDLKSANILLDH MRAKVADFGLSKEE+FD RNSGLKGTYGY+DPAYIST+K T KSDI+
Sbjct: 238 RDLKSANILLDHSMRAKVADFGLSKEEIFDDRNSGLKGTYGYMDPAYISTSKLTTKSDIY 297
Query: 301 SFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKC 360
SFG+I+FELITAIHPHQNLMEYVNLA+M DGVDEILDKQLVG CN++EVR+LA+IGHKC
Sbjct: 298 SFGIIVFELITAIHPHQNLMEYVNLAAMDHDGVDEILDKQLVGKCNLEEVRQLAKIGHKC 357
Query: 361 LHKTPRKRPSIGEVTQALLKIK---QRHLAKQDTMSFADGEFSRAVSRIEDQQVELSKLA 417
LHK+PRKRPSIGEV+Q + +IK QRHL +D +SFA FSRAVSR+ED+QVELS++
Sbjct: 358 LHKSPRKRPSIGEVSQFISRIKQRRQRHLT-EDNLSFASNNFSRAVSRLEDRQVELSRMP 416
Query: 418 EV 419
+
Sbjct: 417 TI 418
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356568849|ref|XP_003552620.1| PREDICTED: probable leucine-rich repeat receptor-like serine/threonine-protein kinase At5g15730-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 641 bits (1653), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 300/422 (71%), Positives = 360/422 (85%), Gaps = 3/422 (0%)
Query: 1 MVHKSDLVIIGICVGLALGILIATLVFFGLRWYKKHDHLRRCSNERSVATHPIRINGLGT 60
MV ++DLVII + VG+ALG+LIA L++ G+R YKK HL R +NE S+ T PIR NGL T
Sbjct: 1 MVDQADLVIICVSVGVALGVLIAYLIYVGIRCYKKRAHLSRSANEPSLTTIPIRTNGLET 60
Query: 61 SIDFSAPVANSVAVKASGFPQKKSQVSWWSNHSKDRFTSAPSASGIPRYAYKDIQKATQN 120
SIDFSA + +S+A S P K S +WWS+ +KD F S SGI +Y+YK+IQKATQN
Sbjct: 61 SIDFSASLTSSIATSRSPNPHKSSHSTWWSHQNKDGFASV---SGILKYSYKEIQKATQN 117
Query: 121 FTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIG 180
FTN LG+G+FG VYKA MP+G V A+K+L +S QGEKEFQTEV LLGRLHHRNLVNL+G
Sbjct: 118 FTNTLGEGSFGTVYKAMMPTGEVVAVKMLGPNSKQGEKEFQTEVLLLGRLHHRNLVNLLG 177
Query: 181 YCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIH 240
YC+DKG++ML+YEFMSNGSL NL+Y EE+ L+W+ERLQIA+DISHGIEYLHEGAVPPV+H
Sbjct: 178 YCIDKGQFMLVYEFMSNGSLENLLYGEEKELSWDERLQIAVDISHGIEYLHEGAVPPVVH 237
Query: 241 RDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIF 300
RDLKSANILLDH MRAKV+DFGLSKEEVFDGRNSGLKGTYGY+DPAYIS++KFT+KSDI+
Sbjct: 238 RDLKSANILLDHSMRAKVSDFGLSKEEVFDGRNSGLKGTYGYMDPAYISSSKFTVKSDIY 297
Query: 301 SFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKC 360
SFG+IIFELITAIHPHQNLMEY++LA+M DGVD ILDKQLVG CN++EVR+LA+I HKC
Sbjct: 298 SFGIIIFELITAIHPHQNLMEYIHLAAMDYDGVDGILDKQLVGKCNLEEVRQLAKIAHKC 357
Query: 361 LHKTPRKRPSIGEVTQALLKIKQRHLAKQDTMSFADGEFSRAVSRIEDQQVELSKLAEVK 420
LHK+PRKRPSIGEV+Q +L+IKQR L K+DTMSFA FSR+VS+IE+QQVELSK+ +
Sbjct: 358 LHKSPRKRPSIGEVSQGILRIKQRRLMKEDTMSFASSNFSRSVSQIEEQQVELSKITTMN 417
Query: 421 ER 422
R
Sbjct: 418 HR 419
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147767799|emb|CAN76053.1| hypothetical protein VITISV_019641 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 629 bits (1622), Expect = e-178, Method: Compositional matrix adjust.
Identities = 320/480 (66%), Positives = 361/480 (75%), Gaps = 58/480 (12%)
Query: 1 MVHKSDLVIIGICVGLALGILIATLVFFGLRWYKKHDHLRRCSNERSVATHPIRINGLGT 60
MV+ +DLV IGI GLA+GILIA+LVF G+RWYKKH HLRRC+NER PIR NGL
Sbjct: 1 MVNSADLVTIGISAGLAIGILIASLVFCGIRWYKKHSHLRRCANERCSTALPIRTNGLDA 60
Query: 61 SIDFSAPVANSVAVKASGFPQKKSQVSWWSN-HSKDRFTSAPSASGIPRYAY-------- 111
SID SA V+NS+A+ S FP K S + WWS+ H KD+ SA SGIPRY+Y
Sbjct: 61 SIDSSASVSNSIAIPGSEFPAKDSHLFWWSHRHDKDQLASA---SGIPRYSYNNPCNNCT 117
Query: 112 --------------------------------------------KDIQKATQNFTNI-LG 126
K I K + + LG
Sbjct: 118 DEDGNMGINFTLEKWQSLLYRRKPHLLLVLDAEKNLRPLNKCREKGIFKKQHTISQLFLG 177
Query: 127 QGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKG 186
QG+FGPVYKATM +GGV A+KVLAS+S QGEKEFQTEVSLLGRLHHRNLVNL+GYCVDKG
Sbjct: 178 QGSFGPVYKATMATGGVVAVKVLASNSKQGEKEFQTEVSLLGRLHHRNLVNLVGYCVDKG 237
Query: 187 KYMLIYEFMSNGSLSNLIYSEE-RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKS 245
++MLIYEFMSNGSL NL+YSEE + L+WEERLQIALDISHGIEYLHEGAVPPVIHRDLKS
Sbjct: 238 QHMLIYEFMSNGSLENLLYSEEGQGLSWEERLQIALDISHGIEYLHEGAVPPVIHRDLKS 297
Query: 246 ANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVI 305
ANILLD MRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYIS+NKFTMKSDI+SFGVI
Sbjct: 298 ANILLDQSMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISSNKFTMKSDIYSFGVI 357
Query: 306 IFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTP 365
IFELITAIHPHQNLME+VNLA+MS DG DEILDKQLVG C ++EVR LA IGHKCLHKTP
Sbjct: 358 IFELITAIHPHQNLMEFVNLAAMSPDGADEILDKQLVGECKLEEVRTLASIGHKCLHKTP 417
Query: 366 RKRPSIGEVTQALLKIKQRHLAKQDTMSFADGEFSRAVSRIEDQQVELSKLAEVKERHEE 425
RKRPSIGEV+ A+ +IKQR AK+ TMS AD + SR VSRIE+QQVEL ++A K++ E
Sbjct: 418 RKRPSIGEVSLAIARIKQRRFAKEHTMSLADSDLSRMVSRIENQQVELFEIASFKDKATE 477
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359806620|ref|NP_001241274.1| probable leucine-rich repeat receptor-like serine/threonine-protein kinase At5g15730-like [Glycine max] gi|223452304|gb|ACM89480.1| protein-serine/threonine kinase [Glycine max] gi|223452562|gb|ACM89608.1| protein-serine/threonine kinase [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 628 bits (1619), Expect = e-177, Method: Compositional matrix adjust.
Identities = 296/426 (69%), Positives = 359/426 (84%), Gaps = 7/426 (1%)
Query: 1 MVHKSDLVIIGICVGLALGILIATLVFFGLRWYKKHDH-LRRCSNERSVATHPIRINGLG 59
MV ++DLVI+ + VG+ALG+LIA L++FG+RWYKK H L R +NE S+ T PIR NGL
Sbjct: 1 MVDQADLVIVCVSVGVALGVLIACLIYFGIRWYKKRAHRLSRSANEPSLTTIPIRTNGLE 60
Query: 60 TSIDFSAPVANSVAVKASGFPQ---KKSQVSWWSNHSKDRFTSAPSASGIPRYAYKDIQK 116
TSIDFSA + +S+A S P K S +WWS+ +KD F S SGI +Y+YK+IQK
Sbjct: 61 TSIDFSASLTSSIATSRSPNPHNPHKSSHSTWWSHQNKDGFASV---SGILKYSYKEIQK 117
Query: 117 ATQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLV 176
ATQNFTN LG+G+FG VYKA MP+G V A+K+L +S QGEKEFQTEV LLGRLHHRNLV
Sbjct: 118 ATQNFTNTLGEGSFGTVYKAMMPTGEVVAVKMLGPNSKQGEKEFQTEVLLLGRLHHRNLV 177
Query: 177 NLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVP 236
NL+GYC+DKG++ML+YEFMSNGSL NL+Y EE+ L+W+ERLQIA DISHGIEYLHEGAVP
Sbjct: 178 NLLGYCIDKGQFMLVYEFMSNGSLENLLYGEEKELSWDERLQIAGDISHGIEYLHEGAVP 237
Query: 237 PVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMK 296
PV+HRDLKSANILLDH MRAKV+DFG SKEEVFDGRNSGLKGTYGY+DPAYIS++KFT+K
Sbjct: 238 PVVHRDLKSANILLDHSMRAKVSDFGFSKEEVFDGRNSGLKGTYGYMDPAYISSSKFTVK 297
Query: 297 SDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARI 356
SDI+SFG+IIFELITAIHPHQNLMEY++LA+M DGVD ILDKQLVG CN++EVR+LA+I
Sbjct: 298 SDIYSFGIIIFELITAIHPHQNLMEYIHLAAMDYDGVDGILDKQLVGKCNLEEVRQLAKI 357
Query: 357 GHKCLHKTPRKRPSIGEVTQALLKIKQRHLAKQDTMSFADGEFSRAVSRIEDQQVELSKL 416
HKCLHK+PRKRPSIGEV+ +L+IKQ+ L K+D+MSFA FSR+VS+IE+QQVEL+K+
Sbjct: 358 AHKCLHKSPRKRPSIGEVSLGILRIKQKRLMKEDSMSFASSNFSRSVSQIEEQQVELTKI 417
Query: 417 AEVKER 422
+ R
Sbjct: 418 TTINHR 423
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255640116|gb|ACU20349.1| unknown [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 620 bits (1599), Expect = e-175, Method: Compositional matrix adjust.
Identities = 293/426 (68%), Positives = 356/426 (83%), Gaps = 7/426 (1%)
Query: 1 MVHKSDLVIIGICVGLALGILIATLVFFGLRWYKKHDH-LRRCSNERSVATHPIRINGLG 59
MV ++DLVI+ + VG+ALG+LIA L++FG+RWYK H L R +NE S+ T PIR NGL
Sbjct: 1 MVDQADLVIVCVSVGVALGVLIACLIYFGIRWYKMRAHRLSRSANEPSLTTIPIRTNGLE 60
Query: 60 TSIDFSAPVANSVAVKASGFPQ---KKSQVSWWSNHSKDRFTSAPSASGIPRYAYKDIQK 116
TSIDFSA + +S+A S P K +WWS+ +KD F S SGI +Y+YK+IQK
Sbjct: 61 TSIDFSASLTSSIATSRSPNPHNPHKSPHSTWWSHQNKDGFASV---SGILKYSYKEIQK 117
Query: 117 ATQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLV 176
ATQNFTN LG+G+FG VYKA MP+G V A+K+L +S QGEKEFQT V LLGRLHHRNLV
Sbjct: 118 ATQNFTNTLGEGSFGTVYKAMMPTGEVVAVKMLGPNSKQGEKEFQTGVLLLGRLHHRNLV 177
Query: 177 NLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVP 236
NL+GYC+DKG++ML+YEFMSNGSL NL+Y EE+ L+W+ERLQIA DISHGIEYLHEGAVP
Sbjct: 178 NLLGYCIDKGQFMLVYEFMSNGSLENLLYGEEKELSWDERLQIAGDISHGIEYLHEGAVP 237
Query: 237 PVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMK 296
PV+HRDLKSANILLDH MRAKV+DFG SKEEVFDGRNSGLKGTYGY+DPAYIS++KFT+K
Sbjct: 238 PVVHRDLKSANILLDHSMRAKVSDFGFSKEEVFDGRNSGLKGTYGYMDPAYISSSKFTVK 297
Query: 297 SDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARI 356
SDI+SFG+IIFELITAIHPHQNLMEY++LA+M DGVD ILDKQLVG CN++EVR+LA+I
Sbjct: 298 SDIYSFGIIIFELITAIHPHQNLMEYIHLAAMDYDGVDGILDKQLVGKCNLEEVRQLAKI 357
Query: 357 GHKCLHKTPRKRPSIGEVTQALLKIKQRHLAKQDTMSFADGEFSRAVSRIEDQQVELSKL 416
HKCLHK+PRKRPSIGEV+ +L+IKQ+ L K+D+MSFA FSR+VS+IE+QQVEL+K+
Sbjct: 358 AHKCLHKSPRKRPSIGEVSLGILRIKQKRLMKEDSMSFASSNFSRSVSQIEEQQVELTKI 417
Query: 417 AEVKER 422
+ R
Sbjct: 418 TTINHR 423
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 426 | ||||||
| TAIR|locus:2143166 | 436 | CRLK2 "calcium/calmodulin-regu | 0.985 | 0.963 | 0.673 | 1.5e-147 | |
| TAIR|locus:2172149 | 440 | CRLK1 "calcium/calmodulin-regu | 0.906 | 0.877 | 0.511 | 1.8e-101 | |
| TAIR|locus:2019863 | 971 | AT1G79620 [Arabidopsis thalian | 0.718 | 0.315 | 0.396 | 2.5e-57 | |
| TAIR|locus:2028446 | 888 | AT1G49100 [Arabidopsis thalian | 0.687 | 0.329 | 0.396 | 8.3e-57 | |
| TAIR|locus:2057991 | 934 | AT2G37050 [Arabidopsis thalian | 0.711 | 0.324 | 0.420 | 3.2e-56 | |
| TAIR|locus:2157042 | 953 | AT5G49760 [Arabidopsis thalian | 0.715 | 0.320 | 0.387 | 1.3e-55 | |
| TAIR|locus:2046268 | 633 | PERK4 "proline-rich extensin-l | 0.633 | 0.426 | 0.414 | 1.6e-55 | |
| TAIR|locus:2090634 | 663 | AT3G19300 [Arabidopsis thalian | 0.640 | 0.411 | 0.408 | 2.3e-55 | |
| TAIR|locus:2139474 | 670 | PERK5 "proline-rich extensin-l | 0.633 | 0.402 | 0.396 | 2.6e-55 | |
| TAIR|locus:2156992 | 946 | AT5G49770 [Arabidopsis thalian | 0.659 | 0.297 | 0.408 | 1.7e-54 |
| TAIR|locus:2143166 CRLK2 "calcium/calmodulin-regulated receptor-like kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1441 (512.3 bits), Expect = 1.5e-147, P = 1.5e-147
Identities = 293/435 (67%), Positives = 339/435 (77%)
Query: 1 MVHKSDLVIIGICVGLALGILIATLVFFGLRWYKKHDHLRRCSNERSVATHPIRINGLGT 60
MV++SDLV+IGI VGLALG+L+A L+FF ++WY HLRRC+NE++ T P+ G
Sbjct: 1 MVNRSDLVVIGISVGLALGLLLALLLFFAIKWYYGRSHLRRCANEQNSPTLPVHTAKRGV 60
Query: 61 SIDFSAPVANSVAVKASGFPQKKSQVSWWSNHSKDRFTSAPSASGIPRYAYKDIQKATQN 120
I S +G P + WW+NH+KD SA SGIPRY YKDIQKATQN
Sbjct: 61 VIPDDRANTESSQPPENGAPTQHQP--WWNNHTKDLTVSA---SGIPRYNYKDIQKATQN 115
Query: 121 FTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIG 180
FT +LGQG+FGPVYKA MP+G +AA KV S+S QG++EFQTEVSLLGRLHHRNLVNL G
Sbjct: 116 FTTVLGQGSFGPVYKAVMPNGELAAAKVHGSNSSQGDREFQTEVSLLGRLHHRNLVNLTG 175
Query: 181 YCVDKGKYMLIYEFMSNGSLSNLIYSEE--RVLNWEERLQIALDISHGIEYLHEGAVPPV 238
YCVDK MLIYEFMSNGSL NL+Y E +VLNWEERLQIALDISHGIEYLHEGAVPPV
Sbjct: 176 YCVDKSHRMLIYEFMSNGSLENLLYGGEGMQVLNWEERLQIALDISHGIEYLHEGAVPPV 235
Query: 239 IHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSD 298
IHRDLKSANILLDH MRAKVADFGLSKE V D SGLKGT+GY+DP YISTNK+TMKSD
Sbjct: 236 IHRDLKSANILLDHSMRAKVADFGLSKEMVLDRMTSGLKGTHGYMDPTYISTNKYTMKSD 295
Query: 299 IFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGH 358
I+SFGVII ELITAIHP QNLMEY+NLASMS DG+DEILD++LVG +I+EVR LA+I +
Sbjct: 296 IYSFGVIILELITAIHPQQNLMEYINLASMSPDGIDEILDQKLVGNASIEEVRLLAKIAN 355
Query: 359 KCLHKTPRKRPSIGEVTQALLKIKQRHLA--KQDTMSFADG-----EFSRAVSRIEDQQV 411
+C+HKTPRKRPSIGEVTQ +LKIKQ +QDTMS + G + SR +SRI+DQ V
Sbjct: 356 RCVHKTPRKRPSIGEVTQFILKIKQSRSRGRRQDTMSSSFGVGYEEDLSRVMSRIKDQHV 415
Query: 412 ELSKLAEVKER-HEE 425
EL LA VKE H+E
Sbjct: 416 ELGLLAGVKEENHQE 430
|
|
| TAIR|locus:2172149 CRLK1 "calcium/calmodulin-regulated receptor-like kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1006 (359.2 bits), Expect = 1.8e-101, P = 1.8e-101
Identities = 204/399 (51%), Positives = 282/399 (70%)
Query: 1 MVHKSDLVIIGICVGLALGILIATLVFFGLRWYKKHDHLRRCSNERSVATHPIRINGLGT 60
M +S +I+GI +GL +G+++A F R+++K + + RS AT PIR NG +
Sbjct: 1 MEGESKGLIVGISLGLVIGVVLAISALFCFRYHRKKSQIVNSGSRRS-ATIPIRENGADS 59
Query: 61 -SIDFSAPVANSVAVKASGFPQKKSQVSWWSNHSKDRFTSAPSASGIPRYAYKDIQKATQ 119
+I + + VK+S K + W SK ++ SASGI Y+Y+D+QKAT
Sbjct: 60 CNIMSDSTIGPDSPVKSS----KNGRSVWLEGFSKR--SNVISASGILEYSYRDLQKATC 113
Query: 120 NFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLI 179
NFT ++GQGAFGPVYKA M +G + A+KVLA+DS QGEKEFQTEV LLGRLHHRNLVNLI
Sbjct: 114 NFTTLIGQGAFGPVYKAQMSTGEIVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLI 173
Query: 180 GYCVDKGKYMLIYEFMSNGSLSNLIYSEERV-LNWEERLQIALDISHGIEYLHEGAVPPV 238
GYC +KG++MLIY +MS GSL++ +YSE+ L+W+ R+ IALD++ G+EYLH+GAVPPV
Sbjct: 174 GYCAEKGQHMLIYVYMSKGSLASHLYSEKHEPLSWDLRVYIALDVARGLEYLHDGAVPPV 233
Query: 239 IHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSD 298
IHRD+KS+NILLD MRA+VADFGLS+EE+ D + ++GT+GY+DP YIST FT KSD
Sbjct: 234 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRTFTKKSD 293
Query: 299 IFSFGVIIFELITAIHPHQNLMEYVNLASMSQD---GVDEILDKQLVGACNIQEVRELAR 355
++ FGV++FELI +P Q LME V LA+M+ + G +EI+D +L G ++QEV E+A
Sbjct: 294 VYGFGVLLFELIAGRNPQQGLMELVELAAMNAEEKVGWEEIVDSRLDGRYDLQEVNEVAA 353
Query: 356 IGHKCLHKTPRKRPSIGEVTQALLK-IKQRHLAKQDTMS 393
+KC+ + PRKRP++ ++ Q L + IK RH K+ S
Sbjct: 354 FAYKCISRAPRKRPNMRDIVQVLTRVIKVRHCRKRQKNS 392
|
|
| TAIR|locus:2019863 AT1G79620 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 596 (214.9 bits), Expect = 2.5e-57, P = 2.5e-57
Identities = 127/320 (39%), Positives = 194/320 (60%)
Query: 89 WSNHSKDRFTSAPSASGIPRYAYKDIQKATQNFT--NILGQGAFGPVYKATMPSGGVAAI 146
W++ KD AP G ++Y++++K T NF+ + LG G +G VYK + G + AI
Sbjct: 607 WASSGKDS-GGAPQLKGARWFSYEELKKITNNFSVSSELGYGGYGKVYKGMLQDGHMVAI 665
Query: 147 KVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYS 206
K S QG EF+TE+ LL R+HH+NLV L+G+C ++G+ +L+YE+MSNGSL + +
Sbjct: 666 KRAQQGSTQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQILVYEYMSNGSLKDSLTG 725
Query: 207 EERV-LNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSK 265
+ L+W+ RL++AL + G+ YLHE A PP+IHRD+KS NILLD + AKVADFGLSK
Sbjct: 726 RSGITLDWKRRLRVALGSARGLAYLHELADPPIIHRDVKSTNILLDENLTAKVADFGLSK 785
Query: 266 --EEVFDGR-NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQN---L 319
+ G ++ +KGT GY+DP Y +T K T KSD++SFGV++ ELITA P + +
Sbjct: 786 LVSDCTKGHVSTQVKGTLGYLDPEYYTTQKLTEKSDVYSFGVVMMELITAKQPIEKGKYI 845
Query: 320 MEYVNLASMSQD----GVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVT 375
+ + L D G+ + +D+ L + E+ + KC+ +T +RP++ EV
Sbjct: 846 VREIKLVMNKSDDDFYGLRDKMDRSLRDVGTLPELGRYMELALKCVDETADERPTMSEVV 905
Query: 376 QALLKIKQRHLAKQDTMSFA 395
+ + I Q A + + A
Sbjct: 906 KEIEIIIQNSGASSSSSASA 925
|
|
| TAIR|locus:2028446 AT1G49100 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 563 (203.2 bits), Expect = 8.3e-57, Sum P(2) = 8.3e-57
Identities = 124/313 (39%), Positives = 189/313 (60%)
Query: 81 QKKSQVSWWSNHSKDRFTSAPSASGIPRYAYKDIQKATQNFTNILGQGAFGPVYKATMPS 140
+KK+ N R + P + ++ Y ++ + T NF ++LG+G FG VY +
Sbjct: 543 RKKNPSRSKENGRTSRSSEPPRITKKKKFTYVEVTEMTNNFRSVLGKGGFGMVYHGYVNG 602
Query: 141 GGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYM-LIYEFMSNGS 199
A+KVL+ S G K+F+ EV LL R+HH+NLV+L+GYC +KGK + L+YE+M+NG
Sbjct: 603 REQVAVKVLSHASKHGHKQFKAEVELLLRVHHKNLVSLVGYC-EKGKELALVYEYMANGD 661
Query: 200 LSNLIYSEER---VLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRA 256
L +S +R VL WE RLQIA++ + G+EYLH+G PP++HRD+K+ANILLD +A
Sbjct: 662 LKEF-FSGKRGDDVLRWETRLQIAVEAAQGLEYLHKGCRPPIVHRDVKTANILLDEHFQA 720
Query: 257 KVADFGLSKEEVFDGRN---SGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-- 311
K+ADFGLS+ + +G + + + GT GY+DP Y TN T KSD++SFGV++ E+IT
Sbjct: 721 KLADFGLSRSFLNEGESHVSTVVAGTIGYLDPEYYRTNWLTEKSDVYSFGVVLLEIITNQ 780
Query: 312 -AIH-----PHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTP 365
I PH + E+VNL D + +I+D L G + V + + C++ +
Sbjct: 781 RVIERTREKPH--IAEWVNLMITKGD-IRKIVDPNLKGDYHSDSVWKFVELAMTCVNDSS 837
Query: 366 RKRPSIGEVTQAL 378
RP++ +V L
Sbjct: 838 ATRPTMTQVVTEL 850
|
|
| TAIR|locus:2057991 AT2G37050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 563 (203.2 bits), Expect = 3.2e-56, Sum P(2) = 3.2e-56
Identities = 135/321 (42%), Positives = 191/321 (59%)
Query: 113 DIQKATQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHH 172
+I++AT+ F +G G FG VY G A+KVLA++S+QG++EF EV+LL R+HH
Sbjct: 598 EIEEATKKFEKRIGSGGFGIVYYGKTREGKEIAVKVLANNSYQGKREFANEVTLLSRIHH 657
Query: 173 RNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYS---EERVLNWEERLQIALDISHGIEY 229
RNLV +GYC ++GK ML+YEFM NG+L +Y +R ++W +RL+IA D + GIEY
Sbjct: 658 RNLVQFLGYCQEEGKNMLVYEFMHNGTLKEHLYGVVPRDRRISWIKRLEIAEDAARGIEY 717
Query: 230 LHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRN---SGLKGTYGYIDPA 286
LH G VP +IHRDLK++NILLD MRAKV+DFGLSK V DG + S ++GT GY+DP
Sbjct: 718 LHTGCVPAIIHRDLKTSNILLDKHMRAKVSDFGLSKFAV-DGTSHVSSIVRGTVGYLDPE 776
Query: 287 YISTNKFTMKSDIFSFGVIIFELIT---AIHPHQ---NLMEYVNLASMSQDGVD--EILD 338
Y + + T KSD++SFGVI+ EL++ AI N V A M D D I+D
Sbjct: 777 YYISQQLTEKSDVYSFGVILLELMSGQEAISNESFGVNCRNIVQWAKMHIDNGDIRGIID 836
Query: 339 KQLV-GACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLK-IKQRHLAKQDTMSFAD 396
L ++Q + ++A C+ RPS+ EV + + I+ A +D
Sbjct: 837 PALAEDDYSLQSMWKIAEKALLCVKPHGNMRPSMSEVQKDIQDAIRIEKEALAARGGISD 896
Query: 397 GEFSRAVSRIEDQQVELSKLA 417
EFSR+ + + + LA
Sbjct: 897 -EFSRSSAHSSSLNMGMLDLA 916
|
|
| TAIR|locus:2157042 AT5G49760 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 564 (203.6 bits), Expect = 1.3e-55, Sum P(2) = 1.3e-55
Identities = 126/325 (38%), Positives = 192/325 (59%)
Query: 73 AVKASGFPQKKSQVSWWSNHSKDRFTSAPSASGIPRYAYKDIQKATQNFT--NILGQGAF 130
A +A+G Q W ++ S AP G + +++++K T NF+ N +G G +
Sbjct: 588 AERATG--QNNPFAKWDTSKSS---IDAPQLMGAKAFTFEELKKCTDNFSEANDVGGGGY 642
Query: 131 GPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYML 190
G VY+ +P+G + AIK S QG EF+TE+ LL R+HH+N+V L+G+C D+ + ML
Sbjct: 643 GKVYRGILPNGQLIAIKRAQQGSLQGGLEFKTEIELLSRVHHKNVVRLLGFCFDRNEQML 702
Query: 191 IYEFMSNGSLSNLIYSEERV-LNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANIL 249
+YE++SNGSL + + + + L+W RL+IAL G+ YLHE A PP+IHRD+KS NIL
Sbjct: 703 VYEYISNGSLKDSLSGKSGIRLDWTRRLKIALGSGKGLAYLHELADPPIIHRDIKSNNIL 762
Query: 250 LDHFMRAKVADFGLSKEEVFDGRNSGL----KGTYGYIDPAYISTNKFTMKSDIFSFGVI 305
LD + AKVADFGLSK V D + + KGT GY+DP Y TN+ T KSD++ FGV+
Sbjct: 763 LDENLTAKVADFGLSKL-VGDPEKTHVTTQVKGTMGYLDPEYYMTNQLTEKSDVYGFGVV 821
Query: 306 IFELITAIHPHQN----LMEYVNLASMSQDGVD--EILDKQLVGAC-NIQEVRELARIGH 358
+ EL+T P + + E + S+ D E+LD ++ + N++ + +
Sbjct: 822 LLELLTGRSPIERGKYVVREVKTKMNKSRSLYDLQELLDTTIIASSGNLKGFEKYVDLAL 881
Query: 359 KCLHKTPRKRPSIGEVTQALLKIKQ 383
+C+ + RPS+GEV + + I Q
Sbjct: 882 RCVEEEGVNRPSMGEVVKEIENIMQ 906
|
|
| TAIR|locus:2046268 PERK4 "proline-rich extensin-like receptor kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 545 (196.9 bits), Expect = 1.6e-55, Sum P(2) = 1.6e-55
Identities = 118/285 (41%), Positives = 175/285 (61%)
Query: 109 YAYKDIQKATQNFT--NILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSL 166
+ Y+++ AT FT N+LGQG FG V+K +PSG A+K L + S QGE+EFQ EV +
Sbjct: 272 FTYQELAAATGGFTDANLLGQGGFGYVHKGVLPSGKEVAVKSLKAGSGQGEREFQAEVDI 331
Query: 167 LGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEER-VLNWEERLQIALDISH 225
+ R+HHR LV+L+GYC+ G+ ML+YEF+ N +L ++ + V+ + RL+IAL +
Sbjct: 332 ISRVHHRYLVSLVGYCIADGQRMLVYEFVPNKTLEYHLHGKNLPVMEFSTRLRIALGAAK 391
Query: 226 GIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLK--GTYGYI 283
G+ YLHE P +IHRD+KSANILLD A VADFGL+K + + + GT+GY+
Sbjct: 392 GLAYLHEDCHPRIIHRDIKSANILLDFNFDAMVADFGLAKLTSDNNTHVSTRVMGTFGYL 451
Query: 284 DPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQN-------LMEYVN--LASMSQDG-V 333
P Y S+ K T KSD+FS+GV++ ELIT P N L+++ +A +DG
Sbjct: 452 APEYASSGKLTEKSDVFSYGVMLLELITGKRPVDNSITMDDTLVDWARPLMARALEDGNF 511
Query: 334 DEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQAL 378
+E+ D +L G N QE+ + + + RKRP + ++ +AL
Sbjct: 512 NELADARLEGNYNPQEMARMVTCAAASIRHSGRKRPKMSQIVRAL 556
|
|
| TAIR|locus:2090634 AT3G19300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 571 (206.1 bits), Expect = 2.3e-55, P = 2.3e-55
Identities = 116/284 (40%), Positives = 185/284 (65%)
Query: 105 GIPRYAYKDIQKATQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEV 164
G +++YK+I+KAT++F ++G+G FG VYKA +G VAA+K + S Q E EF E+
Sbjct: 312 GFRKFSYKEIRKATEDFNAVIGRGGFGTVYKAEFSNGLVAAVKKMNKSSEQAEDEFCREI 371
Query: 165 SLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERV-LNWEERLQIALDI 223
LL RLHHR+LV L G+C K + L+YE+M NGSL + ++S E+ L+WE R++IA+D+
Sbjct: 372 ELLARLHHRHLVALKGFCNKKNERFLVYEYMENGSLKDHLHSTEKSPLSWESRMKIAIDV 431
Query: 224 SHGIEYLHEGAVPPVIHRDLKSANILLD-HFMRAKVADFGLSKEE-----VFDGRNSGLK 277
++ +EYLH PP+ HRD+KS+NILLD HF+ AK+ADFGL+ F+ N+ ++
Sbjct: 432 ANALEYLHFYCDPPLCHRDIKSSNILLDEHFV-AKLADFGLAHASRDGSICFEPVNTDIR 490
Query: 278 GTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT---AIHPHQNLMEYVNLASMSQDGVD 334
GT GY+DP Y+ T++ T KSD++S+GV++ E+IT A+ +NL+E +S+
Sbjct: 491 GTPGYVDPEYVVTHELTEKSDVYSYGVVLLEIITGKRAVDEGRNLVELSQPLLVSESRRI 550
Query: 335 EILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQAL 378
+++D ++ + +++ + + C K RPSI +V + L
Sbjct: 551 DLVDPRIKDCIDGEQLETVVAVVRWCTEKEGVARPSIKQVLRLL 594
|
|
| TAIR|locus:2139474 PERK5 "proline-rich extensin-like receptor kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 542 (195.9 bits), Expect = 2.6e-55, Sum P(2) = 2.6e-55
Identities = 113/285 (39%), Positives = 181/285 (63%)
Query: 109 YAYKDIQKATQNF--TNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSL 166
+ Y ++ AT+ F +N+LGQG FG V+K +PSG A+K L S QGE+EFQ EV +
Sbjct: 300 FTYDELSIATEGFAQSNLLGQGGFGYVHKGVLPSGKEVAVKSLKLGSGQGEREFQAEVDI 359
Query: 167 LGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEER-VLNWEERLQIALDISH 225
+ R+HHR+LV+L+GYC+ G+ +L+YEF+ N +L ++ + R VL+W R++IAL +
Sbjct: 360 ISRVHHRHLVSLVGYCISGGQRLLVYEFIPNNTLEFHLHGKGRPVLDWPTRVKIALGSAR 419
Query: 226 GIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSK--EEVFDGRNSGLKGTYGYI 283
G+ YLHE P +IHRD+K+ANILLD KVADFGL+K ++ + ++ + GT+GY+
Sbjct: 420 GLAYLHEDCHPRIIHRDIKAANILLDFSFETKVADFGLAKLSQDNYTHVSTRVMGTFGYL 479
Query: 284 DPAYISTNKFTMKSDIFSFGVIIFELITAIHP-------HQNLMEYVNLASM--SQDG-V 333
P Y S+ K + KSD+FSFGV++ ELIT P +L+++ + +QDG
Sbjct: 480 APEYASSGKLSDKSDVFSFGVMLLELITGRPPLDLTGEMEDSLVDWARPLCLKAAQDGDY 539
Query: 334 DEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQAL 378
+++ D +L + QE+ ++A + + R+RP + ++ +AL
Sbjct: 540 NQLADPRLELNYSHQEMVQMASCAAAAIRHSARRRPKMSQIVRAL 584
|
|
| TAIR|locus:2156992 AT5G49770 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 550 (198.7 bits), Expect = 1.7e-54, Sum P(2) = 1.7e-54
Identities = 121/296 (40%), Positives = 174/296 (58%)
Query: 100 APSASGIPRYAYKDIQKATQNFT--NILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGE 157
AP G + ++++ K T NF+ N +G G +G VYK T+P+G V AIK S QG
Sbjct: 613 APQLMGTKAFTFEELSKCTNNFSDANDVGGGGYGQVYKGTLPNGQVIAIKRAQQGSMQGA 672
Query: 158 KEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERV-LNWEER 216
EF+TE+ LL R+HH+N+V L+G+C D+ + ML+YE++ NGSL + + + V L+W R
Sbjct: 673 FEFKTEIELLSRVHHKNVVKLLGFCFDQKEQMLVYEYIPNGSLRDGLSGKNGVKLDWTRR 732
Query: 217 LQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGL 276
L+IAL G+ YLHE A PP+IHRD+KS NILLD + AKVADFGLSK V D + +
Sbjct: 733 LKIALGSGKGLAYLHELADPPIIHRDVKSNNILLDEHLTAKVADFGLSKL-VGDPEKAHV 791
Query: 277 ----KGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQD- 331
KGT GY+DP Y TN+ T KSD++ FGV++ EL+T P V D
Sbjct: 792 TTQVKGTMGYLDPEYYMTNQLTEKSDVYGFGVVMLELLTGKSPIDRGSYVVKEVKKKMDK 851
Query: 332 -----GVDEILDKQLV-GACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKI 381
+ E+LD ++ + N++ + + +C+ RP++ EV Q L I
Sbjct: 852 SRNLYDLQELLDTTIIQNSGNLKGFEKYVDVALQCVEPEGVNRPTMSEVVQELESI 907
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9LFV3 | Y5157_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6735 | 0.9859 | 0.9633 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 426 | |||
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-54 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-53 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 9e-52 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 7e-51 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-49 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-49 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-48 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-42 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-37 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-33 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-33 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-33 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-32 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-32 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 9e-32 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-31 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-31 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-31 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-31 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-31 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 7e-31 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-30 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-30 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-29 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 9e-29 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-28 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-28 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-28 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-28 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 6e-28 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 9e-28 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-27 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-27 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-26 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-26 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-26 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 7e-26 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 8e-26 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-25 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-25 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 8e-25 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 9e-25 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-24 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-24 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-24 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-24 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-24 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-24 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-24 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 6e-24 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 6e-24 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 6e-24 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-23 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-23 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-23 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-23 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-23 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 7e-23 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 9e-23 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-22 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-22 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-22 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-22 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-22 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-22 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-22 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 7e-22 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 8e-22 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-21 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-21 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-21 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-21 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-21 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-21 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-21 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-21 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-21 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-21 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-21 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-21 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-21 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-21 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-20 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-20 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-20 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-20 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 7e-20 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 7e-20 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 9e-20 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-19 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-19 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-19 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-18 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-18 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-18 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-18 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-18 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-18 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-18 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-18 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-18 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-18 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-18 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-18 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-18 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 8e-18 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-17 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-17 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-17 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-17 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-17 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-17 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-17 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-17 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-17 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-17 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-17 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 8e-17 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-16 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-16 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-16 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-16 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-16 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-16 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-16 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-16 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-16 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-16 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-16 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-16 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-16 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-16 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-16 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-16 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-16 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-16 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-16 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 8e-16 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 9e-16 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-15 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-15 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-15 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-15 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-15 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-15 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-15 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-15 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-15 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-15 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-15 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-15 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-15 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 7e-15 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 7e-15 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 7e-15 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 7e-15 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-14 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-14 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-14 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-14 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-14 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-14 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-14 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-14 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-14 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-14 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-14 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-14 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-13 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-13 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-13 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-13 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-13 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-13 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 5e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 8e-13 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 9e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-12 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-12 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-12 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-12 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-12 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-12 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-12 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-12 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-12 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 6e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 9e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-11 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-11 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-11 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-11 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 6e-11 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 7e-11 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 8e-11 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-10 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-10 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-10 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 6e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 6e-10 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 9e-10 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-09 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-09 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 6e-09 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 6e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 7e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 7e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 8e-09 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 8e-09 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 9e-09 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 9e-09 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-08 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 6e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 6e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 8e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-07 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-07 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-07 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 6e-07 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 6e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 8e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-06 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-06 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 6e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 7e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 7e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 8e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 9e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-05 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 7e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-04 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 4e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 5e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 7e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.001 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 181 bits (462), Expect = 1e-54
Identities = 85/274 (31%), Positives = 137/274 (50%), Gaps = 34/274 (12%)
Query: 121 FTNILGQGAFGPVYKAT--MPSGGV---AAIKVLASDSH-QGEKEFQTEVSLLGRLHHRN 174
LG+GAFG VYK T G A+K L D+ Q +EF E ++ +L H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 175 LVNLIGYCVDKGKYMLIYEFMSNGSLSN-LIYSEERVLNWEERLQIALDISHGIEYLHEG 233
+V L+G C ++ M++ E+M G L + L + + L+ + L AL I+ G+EYL
Sbjct: 63 IVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK 122
Query: 234 AVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG---RNSGLKGTYGYIDPAYIST 290
IHRDL + N L+ + K++DFGLS+ +++D + G K ++ P +
Sbjct: 123 ---NFIHRDLAARNCLVGENLVVKISDFGLSR-DLYDDDYYKVKGGKLPIRWMAPESLKE 178
Query: 291 NKFTMKSDIFSFGVIIFELIT-AIHPH-----QNLMEYVNLASMSQDGVDEILDKQLVGA 344
KFT KSD++SFGV+++E+ T P+ ++EY+ + G L K
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYL------KKG--YRLPKPPN-- 228
Query: 345 CNIQEVRELARIGHKCLHKTPRKRPSIGEVTQAL 378
C E+ +L +C + P RP+ E+ + L
Sbjct: 229 CP-PELYKLML---QCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 179 bits (456), Expect = 1e-53
Identities = 82/273 (30%), Positives = 135/273 (49%), Gaps = 33/273 (12%)
Query: 121 FTNILGQGAFGPVYKAT--MPSGGV---AAIKVLASDSH-QGEKEFQTEVSLLGRLHHRN 174
LG+GAFG VYK G A+K L D+ Q +EF E ++ +L H N
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 175 LVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGA 234
+V L+G C ++ ++ E+M G L + + L+ + L AL I+ G+EYL
Sbjct: 63 VVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESK- 121
Query: 235 VPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG---RNSGLKGTYGYIDPAYISTN 291
IHRDL + N L+ + K++DFGLS+ +++D R G K ++ P +
Sbjct: 122 --NFIHRDLAARNCLVGENLVVKISDFGLSR-DLYDDDYYRKRGGKLPIRWMAPESLKEG 178
Query: 292 KFTMKSDIFSFGVIIFELIT-AIHPH-----QNLMEYVNLASMSQDGVDEILDKQLVGAC 345
KFT KSD++SFGV+++E+ T P+ + ++EY+ ++G L + C
Sbjct: 179 KFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYL------KNG--YRLPQPPN--C 228
Query: 346 NIQEVRELARIGHKCLHKTPRKRPSIGEVTQAL 378
E+ +L +C + P RP+ E+ + L
Sbjct: 229 P-PELYDLML---QCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 9e-52
Identities = 75/288 (26%), Positives = 122/288 (42%), Gaps = 59/288 (20%)
Query: 123 NILGQGAFGPVYKATMPSGG----VAAIKVL-ASDSHQGEKEFQTEVSLLGRLHHRNLVN 177
LG+GAFG VYK + A+K L S + K+F E ++ +L H N+V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 178 LIGYCVDKGKYMLIYEFMSNGSL--------SNLIYSEERVLNWEERLQIALDISHGIEY 229
L+G C ++ L+ E+M G L E+ L+ ++ L A+ I+ G+EY
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 230 LHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYID----- 284
L +HRDL + N L+ + K++DFGLS++ Y
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRD--------VYDDDYYRKKTGGKL 169
Query: 285 ------PAYISTNKFTMKSDIFSFGVIIFELIT-------AIHPHQNLMEYVNLASMSQD 331
P + FT KSD++SFGV+++E+ T + + ++EY+ +
Sbjct: 170 PIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE-VLEYL------RK 222
Query: 332 GVDEILDK-QLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQAL 378
G L K + EL + C P RP+ E+ + L
Sbjct: 223 G--YRLPKPEYCPD-------ELYELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 7e-51
Identities = 88/259 (33%), Positives = 123/259 (47%), Gaps = 49/259 (18%)
Query: 125 LGQGAFGPVYKAT-MPSGGVAAIKVL-ASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYC 182
LG+G FG VY A +G AIK++ DS +E E+ +L +L+H N+V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 183 VDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRD 242
D+ L+ E+ GSL +L+ E L+ +E L+I L I G+EYLH +IHRD
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHRD 117
Query: 243 LKSANILLDH-FMRAKVADFGLSKE-EVFDGRNSGLKGTYGYIDP-AYISTNKFTMKSDI 299
LK NILLD + K+ADFGLSK + GT Y+ P + ++ KSDI
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDI 177
Query: 300 FSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHK 359
+S GVI++EL E+++L R K
Sbjct: 178 WSLGVILYEL--------------------------------------PELKDLIR---K 196
Query: 360 CLHKTPRKRPSIGEVTQAL 378
L K P KRPS E+ + L
Sbjct: 197 MLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 2e-49
Identities = 78/266 (29%), Positives = 125/266 (46%), Gaps = 34/266 (12%)
Query: 121 FTNILGQGAFGPVYKATM-PSGGVA----AIKVL-ASDSHQGEKEFQTEVSLLGRLHHRN 174
LG+GAFG VYK T+ G A+K L S + +EF E S++ +L H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62
Query: 175 LVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGA 234
+V L+G C ++ E+M G L + + L ++ LQ+AL I+ G+EYL
Sbjct: 63 IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESK- 121
Query: 235 VPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYG---YIDPAYISTN 291
+HRDL + N L+ + K++DFGLS++ D G ++ P +
Sbjct: 122 --NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDG 179
Query: 292 KFTMKSDIFSFGVIIFELIT-------AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGA 344
KFT KSD++SFGV+++E+ T + + ++E + +DG L +
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE-VLELL------EDG--YRLP-RPENC 229
Query: 345 CNIQEVRELARIGHKCLHKTPRKRPS 370
E+ EL +C P RP+
Sbjct: 230 P--DELYELML---QCWAYDPEDRPT 250
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 167 bits (426), Expect = 2e-49
Identities = 77/258 (29%), Positives = 121/258 (46%), Gaps = 16/258 (6%)
Query: 123 NILGQGAFGPVYKATM-PSGGVAAIKVL-ASDSHQGEKEFQTEVSLLGRLHHRNLVNLIG 180
LG+G+FG VY A +G + AIKV+ + + E+ +L +L H N+V L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 181 YCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHE-GAVPPVI 239
D+ K L+ E+ G L +L+ + L+ +E I +EYLH G ++
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLL-KKRGRLSEDEARFYLRQILSALEYLHSKG----IV 119
Query: 240 HRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDI 299
HRDLK NILLD K+ADFGL+++ + + GT Y+ P + + DI
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDI 179
Query: 300 FSFGVIIFELITAIHPHQNLMEYVNLA-SMSQDGVDEILDKQLVGACNIQEVRELARIGH 358
+S GVI++EL+T P + + L + + + + E ++L R
Sbjct: 180 WSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDIS----PEAKDLIR--- 232
Query: 359 KCLHKTPRKRPSIGEVTQ 376
K L K P KR + E Q
Sbjct: 233 KLLVKDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 165 bits (421), Expect = 2e-48
Identities = 86/256 (33%), Positives = 131/256 (51%), Gaps = 12/256 (4%)
Query: 124 ILGQGAFGPVYKATMPSGG-VAAIKVLA--SDSHQGEKEFQTEVSLLGRLHHRNLVNLIG 180
LG G+FG VYKA G + A+K+L S+ + ++ + E+ +L RL H N+V LI
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 181 YCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIH 240
DK L+ E+ G L + + S L+ +E +IAL I G+EYLH + IH
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYL-SRGGPLSEDEAKKIALQILRGLEYLHSNGI---IH 121
Query: 241 RDLKSANILLDHFMRAKVADFGLSKE-EVFDGRNSGLKGTYGYIDP-AYISTNKFTMKSD 298
RDLK NILLD K+ADFGL+K+ + GT Y+ P + N + K D
Sbjct: 122 RDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVD 181
Query: 299 IFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGH 358
++S GVI++EL+T P L + + + + + +E ++L +
Sbjct: 182 VWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIK--- 238
Query: 359 KCLHKTPRKRPSIGEV 374
KCL+K P KRP+ E+
Sbjct: 239 KCLNKDPSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 148 bits (377), Expect = 4e-42
Identities = 80/272 (29%), Positives = 130/272 (47%), Gaps = 35/272 (12%)
Query: 123 NILGQGAFGPVYKATMP-SGGVAAIKV--LASDSHQGEKEFQTEVSLLGRLHHRNLVNLI 179
+LG+G+FG VY A +G + A+K L+ DS + + + E+ +L L H N+V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 180 GYCVDK-GKYMLIY-EFMSNGSLSNLIYSEERVLNWEERL--QIALDISHGIEYLHE-GA 234
G D+ + I+ E++S GSLS+L+ ++ E + + I G+ YLH G
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKL---PEPVIRKYTRQILEGLAYLHSNG- 121
Query: 235 VPPVIHRDLKSANILLDHFMRAKVADFGLSK---EEVFDGRNSGLKGTYGYIDPAYISTN 291
++HRD+K ANIL+D K+ADFG +K + ++GT ++ P I
Sbjct: 122 ---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE 178
Query: 292 KFTMKSDIFSFGVIIFELITAIHP---HQNLMEYVNLASMSQDGVDEILDKQLVGACNIQ 348
++ +DI+S G + E+ T P N M S EI + +
Sbjct: 179 EYGRAADIWSLGCTVIEMATGKPPWSELGNPMA-ALYKIGSSGEPPEIPE------HLSE 231
Query: 349 EVRELARIGHKCLHKTPRKRPSIGEVTQALLK 380
E ++ R KCL + P+KRP+ E LL+
Sbjct: 232 EAKDFLR---KCLRRDPKKRPTADE----LLQ 256
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 3e-37
Identities = 80/277 (28%), Positives = 131/277 (47%), Gaps = 39/277 (14%)
Query: 112 KDIQKATQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLH 171
K+++ +G+G FG V G A+K L DS + F E S++ L
Sbjct: 6 KELKLGAT-----IGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQA-FLAEASVMTTLR 58
Query: 172 HRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEER-VLNWEERLQIALDISHGIEYL 230
H NLV L+G + ++ E+M+ GSL + + S R V+ ++L ALD+ G+EYL
Sbjct: 59 HPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYL 118
Query: 231 HEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYIST 290
E +HRDL + N+L+ + AKV+DFGL+KE G++SG K + P +
Sbjct: 119 EEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQ-GQDSG-KLPVKWTAPEALRE 173
Query: 291 NKFTMKSDIFSFGVIIFELIT---AIHPHQNLMEYVNLAS----M-SQDGV-DEILDKQL 341
KF+ KSD++SFG++++E+ + +P L + V M + +G E+
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMK 233
Query: 342 VGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQAL 378
C P KRP+ ++ + L
Sbjct: 234 -----------------DCWELDPAKRPTFKQLREQL 253
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 2e-33
Identities = 79/266 (29%), Positives = 124/266 (46%), Gaps = 37/266 (13%)
Query: 125 LGQGAFGPVYKATMPSGG--VAAIKVLASDSHQGEKEF-QTEVSLLGRLHHRNLVNLIGY 181
+G+G+FG VY S G ++ S+ + E+E EV +L +L+H N++
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYES 67
Query: 182 CVDKGKYMLIYEFMSNGSLSNLI---------YSEERVLNWEERLQIALDISHGIEYLHE 232
+KGK ++ E+ G LS I + EE++L+W +Q+ L ++YLH
Sbjct: 68 FEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDW--FVQLCL----ALKYLHS 121
Query: 233 GAVPPVIHRDLKSANILLDHFMRAKVADFGLSK--EEVFDGRNSGLKGTYGYIDPAYIST 290
+ +HRD+K NI L K+ DFG+SK D + + GT Y+ P
Sbjct: 122 RKI---LHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT-VVGTPYYLSPELCQN 177
Query: 291 NKFTMKSDIFSFGVIIFELITAIHP--HQNLMEYVNLASMSQDGVDEILDKQLVGACNIQ 348
+ KSDI+S G +++EL T HP +NL+E +IL Q Q
Sbjct: 178 KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELAL----------KILKGQ-YPPIPSQ 226
Query: 349 EVRELARIGHKCLHKTPRKRPSIGEV 374
EL + L K P +RPSI ++
Sbjct: 227 YSSELRNLVSSLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 3e-33
Identities = 77/266 (28%), Positives = 126/266 (47%), Gaps = 26/266 (9%)
Query: 121 FTNI--LGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVN 177
F + +G+G FG VYKA +G AIKV+ +S + +++ E+ +L + H N+V
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 178 LIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPP 237
G + K + ++ EF S GSL +L+ S + L + + ++ G+EYLH +
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGI-- 119
Query: 238 VIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKS 297
IHRD+K+ANILL K+ DFGLS + + + GT ++ P I+ + K+
Sbjct: 120 -IHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKA 178
Query: 298 DIFSFGVIIFELITAIHPHQNL-----MEYVNLASMSQDGVDEILDKQLVGACNIQEVRE 352
DI+S G+ EL P+ L + + + +G + + + E
Sbjct: 179 DIWSLGITAIELAEGKPPYSELPPMKALFKI-----ATNGPPGLRNPEKWSD-------E 226
Query: 353 LARIGHKCLHKTPRKRPSIGEVTQAL 378
KCL K P KRP+ Q L
Sbjct: 227 FKDFLKKCLQKNPEKRPT---AEQLL 249
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 6e-33
Identities = 69/191 (36%), Positives = 104/191 (54%), Gaps = 9/191 (4%)
Query: 125 LGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVD 184
LG G FG V++ + AIK+L SD +++FQ EV L RL H++L++L C
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73
Query: 185 KGKYMLIYEFMSNGSLSNLIYS-EERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDL 243
+I E M GSL + S E +VL + +A ++ G+ YL E IHRDL
Sbjct: 74 GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDL 130
Query: 244 KSANILLDHFMRAKVADFGLS---KEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIF 300
+ NIL+ + KVADFGL+ KE+V+ + K Y + P S F+ KSD++
Sbjct: 131 AARNILVGEDLVCKVADFGLARLIKEDVYLSSDK--KIPYKWTAPEAASHGTFSTKSDVW 188
Query: 301 SFGVIIFELIT 311
SFG++++E+ T
Sbjct: 189 SFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 2e-32
Identities = 79/273 (28%), Positives = 125/273 (45%), Gaps = 31/273 (11%)
Query: 121 FTNILGQGAFGPVYKATM-PSGG----VAAIKVLASDS-HQGEKEFQTEVSLLGRLHHRN 174
F LG+G FG V P G A+K L Q +F+ E+ +L L H N
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67
Query: 175 LVNLIGYCVDKGK--YMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHE 232
+V G C G LI E++ +GSL + + +N + L + I G++YL
Sbjct: 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS 127
Query: 233 GAVPPVIHRDLKSANILLDHFMRAKVADFGLSK-----EEVFDGRNSGLKGTYGYIDPAY 287
IHRDL + NIL++ K++DFGL+K ++ + + G + Y P
Sbjct: 128 QRY---IHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APEC 183
Query: 288 ISTNKFTMKSDIFSFGVIIFELITAI----HPHQNLMEYVNLA--SMSQDGVDEILD--K 339
+ T+KF+ SD++SFGV ++EL T P + + +A M + E+L +
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGE 243
Query: 340 QLV--GACNIQEVRELARIGHKCLHKTPRKRPS 370
+L +C EV +L + C P+ RPS
Sbjct: 244 RLPRPPSCP-DEVYDLMK---LCWEAEPQDRPS 272
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 5e-32
Identities = 80/271 (29%), Positives = 118/271 (43%), Gaps = 37/271 (13%)
Query: 125 LGQGAFGPVY----KATMPSGGVAAIKVLASDS---HQGEKEFQTEVSLLGRLHHRNLVN 177
LG+G+FG V K T G + A+KVL + + TE ++L R++H +V
Sbjct: 1 LGKGSFGKVLLVRKKDT---GKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57
Query: 178 LIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHE-GAVP 236
L + K L+ E+ G L + + E R R A +I +EYLH G
Sbjct: 58 LHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAA-EIVLALEYLHSLG--- 113
Query: 237 PVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG-RNSGLKGTYGYIDPAYISTNKFTM 295
+I+RDLK NILLD K+ DFGL+KE +G R + GT Y+ P + +
Sbjct: 114 -IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGK 172
Query: 296 KSDIFSFGVIIFELITAIHP--HQNLMEYVNLASMSQDGVDEILDKQLVGACNI-QEVRE 352
D +S GV+++E++T P ++ E IL L + E R+
Sbjct: 173 AVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEK----------ILKDPLRFPEFLSPEARD 222
Query: 353 LARIGHKCLHKTPRKRPSIGEVTQALLKIKQ 383
L L K P KR G + IK
Sbjct: 223 LIS---GLLQKDPTKRLGSGGAEE----IKA 246
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 9e-32
Identities = 77/263 (29%), Positives = 119/263 (45%), Gaps = 33/263 (12%)
Query: 125 LGQGAFGPVYKAT-MPSGGVAAIKVLASDS-HQGEKEFQTEVSLLGRLHHRNLVNLIGYC 182
LGQG+ G VYK P+G + A+K + D + K+ E+ L +V G
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68
Query: 183 VDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERL--QIALDISHGIEYLHEGAVPPVIH 240
+G+ ++ E+M GSL++L+ +V E + IA I G++YLH +IH
Sbjct: 69 YKEGEISIVLEYMDGGSLADLLK---KVGKIPEPVLAYIARQILKGLDYLH--TKRHIIH 123
Query: 241 RDLKSANILLDHFMRAKVADFGLSK--EEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSD 298
RD+K +N+L++ K+ADFG+SK E D N+ + GT Y+ P I ++ +D
Sbjct: 124 RDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGESYSYAAD 182
Query: 299 IFSFGVIIFELITAIHPHQ--------NLMEYVNLASMSQDGVDEILDKQLVGACNIQEV 350
I+S G+ + E P LM+ + DG L +
Sbjct: 183 IWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC------DGPPPSLPAEEFSP------ 230
Query: 351 RELARIGHKCLHKTPRKRPSIGE 373
E CL K P+KRPS E
Sbjct: 231 -EFRDFISACLQKDPKKRPSAAE 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 1e-31
Identities = 85/286 (29%), Positives = 139/286 (48%), Gaps = 39/286 (13%)
Query: 104 SGIPRYAYKDIQKATQNFTNILGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKEFQT 162
G PR YK+++K +G+GA G VYKAT +G AIK + Q ++
Sbjct: 14 EGDPRELYKNLEK--------IGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIIN 64
Query: 163 EVSLLGRLHHRNLVNLIG-YCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIAL 221
E+ ++ H N+V+ Y V ++++ E+M GSL+++I +N + +
Sbjct: 65 EILIMKDCKHPNIVDYYDSYLVGDELWVVM-EYMDGGSLTDIITQNFVRMNEPQIAYVCR 123
Query: 222 DISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFG----LSKEEVFDGRNSGLK 277
++ G+EYLH VIHRD+KS NILL K+ADFG L+KE+ RNS +
Sbjct: 124 EVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK--SKRNS-VV 177
Query: 278 GTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASM---SQDGVD 334
GT ++ P I + K DI+S G++ E+ P+ + L ++ + G+
Sbjct: 178 GTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPY---LREPPLRALFLITTKGIP 234
Query: 335 EILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLK 380
+ + + E ++ +KCL K P KRPS + LL+
Sbjct: 235 PLKNPEKWS----PEFKDFL---NKCLVKDPEKRPS----AEELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 2e-31
Identities = 76/291 (26%), Positives = 133/291 (45%), Gaps = 36/291 (12%)
Query: 114 IQKATQNFTNILGQGAFGPVYKATMPSGG------VAAIKVLA-SDSHQGEKEFQTEVSL 166
+Q+ T LG+GAFG V+ + A+K L + S+ K+F+ E L
Sbjct: 2 VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAEL 61
Query: 167 LGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYS-------------EERVLNW 213
L H N+V G C + ++++E+M +G L+ + S L
Sbjct: 62 LTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTL 121
Query: 214 EERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRN 273
+ LQIA+ I+ G+ YL A +HRDL + N L+ + + K+ DFG+S+ +V+
Sbjct: 122 SQLLQIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR-DVYTTDY 177
Query: 274 SGLKGT----YGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMS 329
+ G ++ P I KFT +SD++SFGV+++E+ T + Q N
Sbjct: 178 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT--YGKQPWYGLSN----- 230
Query: 330 QDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLK 380
+ V E + + + E+ I C + P++R +I ++ + L K
Sbjct: 231 -EEVIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 4e-31
Identities = 72/262 (27%), Positives = 121/262 (46%), Gaps = 17/262 (6%)
Query: 113 DIQKATQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHH 172
+I + + LG G FG V++ + A+K L + K+F E ++ +L H
Sbjct: 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRH 60
Query: 173 RNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEE-RVLNWEERLQIALDISHGIEYLH 231
L+ L C + ++ E M GSL + R L + + +A ++ G+ YL
Sbjct: 61 PKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE 120
Query: 232 EGAVPPVIHRDLKSANILLDHFMRAKVADFGLS---KEEVFDGRNSGLKGTYGYIDPAYI 288
IHRDL + N+L+ KVADFGL+ KE++++ R G K + P
Sbjct: 121 AQNY---IHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAR-EGAKFPIKWTAPEAA 176
Query: 289 STNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQ 348
N+F++KSD++SFG+++ E++T M Y M+ V + +D+ C
Sbjct: 177 LYNRFSIKSDVWSFGILLTEIVT-----YGRMPY---PGMTNAEVLQQVDQGYRMPCPPG 228
Query: 349 EVRELARIGHKCLHKTPRKRPS 370
+EL I C + P RP+
Sbjct: 229 CPKELYDIMLDCWKEDPDDRPT 250
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 4e-31
Identities = 81/269 (30%), Positives = 122/269 (45%), Gaps = 28/269 (10%)
Query: 123 NILGQGAFGPVYKATMPSGG-VAAIKVLASDSHQGEKEFQ---TEVSLLGRLHHRNLVNL 178
+G+G+FG V K S G + K + + EKE Q +EV++L L H N+V
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEI-DYGNMTEKEKQQLVSEVNILRELKHPNIVRY 64
Query: 179 IGYCVDKGKYML--IYEFMSNGSLSNLI---YSEERVLNWEERLQIALDISHGIEYLHEG 233
+D+ L + E+ G L+ LI E + + E +I + + H
Sbjct: 65 YDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNR 124
Query: 234 AVPP--VIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLK---GTYGYIDPAYI 288
+ P V+HRDLK ANI LD K+ DFGL+K + +S K GT Y+ P +
Sbjct: 125 SDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK--ILGHDSSFAKTYVGTPYYMSPEQL 182
Query: 289 STNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDG-VDEILDKQLVGACNI 347
+ + KSDI+S G +I+EL A+ P + LAS ++G I
Sbjct: 183 NHMSYDEKSDIWSLGCLIYEL-CALSPPFTARNQLQLASKIKEGKFRRIPY--------- 232
Query: 348 QEVRELARIGHKCLHKTPRKRPSIGEVTQ 376
+ EL + L+ P KRPS E+ Q
Sbjct: 233 RYSSELNEVIKSMLNVDPDKRPSTEELLQ 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 122 bits (306), Expect = 4e-31
Identities = 84/308 (27%), Positives = 131/308 (42%), Gaps = 26/308 (8%)
Query: 125 LGQGAFGPVYKATMPSGGVAAIKVLASD---SHQGEKEFQTEVSLLGRL-HHRNLVNLIG 180
LG+G+FG VY A + A+KVLA + + F E+ +L L H N+V L
Sbjct: 8 LGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65
Query: 181 YCVDKGKYMLIYEFMSNGSLSNLI--YSEERVLNWEERLQIALDISHGIEYLHEGAVPPV 238
+ D+G L+ E++ GSL +L+ + L+ E L I I +EYLH +
Sbjct: 66 FFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GI 122
Query: 239 IHRDLKSANILLDHF-MRAKVADFGLSKEEVFDGRNSGLK-------GTYGYIDPAYI-- 288
IHRD+K NILLD K+ DFGL+K G S + GT GY+ P +
Sbjct: 123 IHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLG 182
Query: 289 -STNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQ---DGVDEILDKQLVGA 344
S + SDI+S G+ ++EL+T + P + + + + L L +
Sbjct: 183 LSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPS 242
Query: 345 CNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRHLAKQDTMSFADGEFSRAVS 404
+ + + K L K P+ R S L + L + D + S +
Sbjct: 243 NPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDL-LAHLKLKESDLSDLLKPDDSAPLR 301
Query: 405 RIEDQQVE 412
+E
Sbjct: 302 LSLPPSLE 309
|
Length = 384 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 7e-31
Identities = 74/261 (28%), Positives = 122/261 (46%), Gaps = 21/261 (8%)
Query: 125 LGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKE-FQTEVSLLGRLHHRNLVNLIGYCV 183
+G+G FG VYK + A+K S K F E +L + H N+V LIG CV
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 184 DKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDL 243
K ++ E + GSL + ++ L ++ LQ++LD + G+EYL IHRDL
Sbjct: 63 QKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDL 119
Query: 244 KSANILLDHFMRAKVADFGLSKEEVFDGR----NSGLKGT-YGYIDPAYISTNKFTMKSD 298
+ N L+ K++DFG+S+EE +G + GLK + P ++ ++T +SD
Sbjct: 120 AARNCLVGENNVLKISDFGMSREE--EGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESD 177
Query: 299 IFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIG 357
++S+G++++E + P+ MS E ++ E+ R+
Sbjct: 178 VWSYGILLWETFSLGDTPYPG---------MSNQQTRERIESGYRMPAPQLCPEEIYRLM 228
Query: 358 HKCLHKTPRKRPSIGEVTQAL 378
+C P RPS E+ L
Sbjct: 229 LQCWAYDPENRPSFSEIYNEL 249
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 1e-30
Identities = 84/266 (31%), Positives = 125/266 (46%), Gaps = 29/266 (10%)
Query: 123 NILGQGAFGPVYKA-TMPSGGVAAIK--VLASDSHQGEKEFQTEVSLLGRLHHRNLVNLI 179
+++G+GAFG VYK + +G AIK L + K E+ LL L H N+V I
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 180 GYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDIS---HGIEYLHEGAVP 236
G +I E+ NGSL +I ++ + E L +A+ + G+ YLHE
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQII---KKFGPFPESL-VAVYVYQVLQGLAYLHEQG-- 119
Query: 237 PVIHRDLKSANILLDHFMRAKVADFGLS-KEEVFDGRNSGLKGTYGYIDPAYISTNKFTM 295
VIHRD+K+ANIL K+ADFG++ K ++ + GT ++ P I + +
Sbjct: 120 -VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGAST 178
Query: 296 KSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEI-LDKQLVGACNIQEVRELA 354
SDI+S G + EL+T P+ +L L + QD D L + I EL
Sbjct: 179 ASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQD--DHPPLPE------GISP--ELK 228
Query: 355 RIGHKCLHKTPRKRPSIGEVTQALLK 380
+C K P RP+ + LLK
Sbjct: 229 DFLMQCFQKDPNLRPT----AKQLLK 250
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 5e-30
Identities = 81/300 (27%), Positives = 134/300 (44%), Gaps = 72/300 (24%)
Query: 125 LGQGAFGPVYKATMPSGGV--------AAIKVLASD-SHQGEKEFQTEVSLLGRLHHRNL 175
+GQGAFG V++A P G+ A+K+L + S + +FQ E +L+ H N+
Sbjct: 13 IGQGAFGRVFQARAP--GLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNI 70
Query: 176 VNLIGYCVDKGKYMLIYEFMSNGSLSNLI--------------------YSEERV-LNWE 214
V L+G C L++E+M+ G L+ + + L+
Sbjct: 71 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130
Query: 215 ERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNS 274
E+L IA ++ G+ YL E +HRDL + N L+ M K+ADFGLS RN
Sbjct: 131 EQLCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLS-------RNI 180
Query: 275 GLKGTYG----------YIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHP-----HQN 318
Y ++ P I N++T +SD++++GV+++E+ + + P H+
Sbjct: 181 YSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240
Query: 319 LMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQAL 378
++ YV +DG +L +C EL + C K P RPS + + L
Sbjct: 241 VIYYV------RDG--NVL------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRIL 286
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 4e-29
Identities = 74/261 (28%), Positives = 121/261 (46%), Gaps = 29/261 (11%)
Query: 125 LGQGAFGPVYKA-TMPSGGVAAIKV--LASDSHQGE---KEFQTEVSLLGRLHHRNLVNL 178
LG G+FG VY+ + G A+K LA D G+ K+ + E++LL +L H N+V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 179 IGYCVDKGKYMLIYEFMSNGSLSNLI-----YSEERVLNWEERLQIALDISHGIEYLHEG 233
+G ++ + E + GSL+ L+ + E + + QI L G+EYLH+
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR--QILL----GLEYLHDR 121
Query: 234 AVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYI-STNK 292
+HRD+K ANIL+D K+ADFG++K+ V KG+ ++ P I
Sbjct: 122 NT---VHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGG 178
Query: 293 FTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRE 352
+ + +DI+S G + E+ T P L + + + + L E ++
Sbjct: 179 YGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLS-----DEAKD 233
Query: 353 LARIGHKCLHKTPRKRPSIGE 373
KCL + P RP+ E
Sbjct: 234 FIL---KCLQRDPSLRPTAAE 251
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 9e-29
Identities = 77/251 (30%), Positives = 120/251 (47%), Gaps = 18/251 (7%)
Query: 124 ILGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYC 182
LG+G++G VYKA +G V AIKV+ + +E E+S+L + +V G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVKYYGSY 67
Query: 183 VDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRD 242
++ E+ GS+S+++ + L EE I G+EYLH IHRD
Sbjct: 68 FKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKK---IHRD 124
Query: 243 LKSANILLDHFMRAKVADFGLSK--EEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIF 300
+K+ NILL+ +AK+ADFG+S + RN+ + GT ++ P I + K+DI+
Sbjct: 125 IKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-VIGTPFWMAPEVIQEIGYNNKADIW 183
Query: 301 SFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEV-RELARIGHK 359
S G ITAI + Y ++ M + I +K + ++ E K
Sbjct: 184 SLG------ITAIEMAEGKPPYSDIHPMRA--IFMIPNKPPPTLSDPEKWSPEFNDFVKK 235
Query: 360 CLHKTPRKRPS 370
CL K P +RPS
Sbjct: 236 CLVKDPEERPS 246
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 1e-28
Identities = 64/200 (32%), Positives = 106/200 (53%), Gaps = 15/200 (7%)
Query: 122 TNILGQGAFGPVYKATMPSGG----VAAIKVLASDSHQGEK-EFQTEVSLLGRLHHRNLV 176
++G G FG V + + G AIK L + S ++ +F TE S++G+ H N++
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 177 NLIGYCVDKGK-YMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHE-GA 234
L G V K + M+I E+M NGSL + + + + + I+ G++YL E
Sbjct: 69 RLEG-VVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNY 127
Query: 235 VPPVIHRDLKSANILLDHFMRAKVADFGLSKE-EVFDG--RNSGLKGTYGYIDPAYISTN 291
V HRDL + NIL++ + KV+DFGLS+ E + G K + P I+
Sbjct: 128 V----HRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYR 183
Query: 292 KFTMKSDIFSFGVIIFELIT 311
KFT SD++SFG++++E+++
Sbjct: 184 KFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 1e-28
Identities = 66/210 (31%), Positives = 107/210 (50%), Gaps = 17/210 (8%)
Query: 106 IPRYAYKDIQKATQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVS 165
IPR + K +K LG G FG V+ T A+K L + E F E
Sbjct: 3 IPRESLKLERK--------LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE-AFLQEAQ 53
Query: 166 LLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEE-RVLNWEERLQIALDIS 224
++ +L H LV L C ++ ++ E+MS GSL + + S E + L + + +A I+
Sbjct: 54 IMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIA 113
Query: 225 HGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLS---KEEVFDGRNSGLKGTYG 281
G+ YL IHRDL + NIL+ + K+ADFGL+ +++ + R G K
Sbjct: 114 EGMAYLESRNY---IHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAR-EGAKFPIK 169
Query: 282 YIDPAYISTNKFTMKSDIFSFGVIIFELIT 311
+ P + +FT+KSD++SFG+++ E++T
Sbjct: 170 WTAPEAANYGRFTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 3e-28
Identities = 73/265 (27%), Positives = 121/265 (45%), Gaps = 30/265 (11%)
Query: 125 LGQGAFGPVYKATMPSGGVAAIKVLASDSHQG---EKEFQTEVSLLGRLHHRNLVNLIGY 181
LG G FG V+ AIK++ +G E +F E ++ +L H NLV L G
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMI----REGAMSEDDFIEEAKVMMKLSHPNLVQLYGV 67
Query: 182 CVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHR 241
C + ++ E+M+NG L N + + L E L + D+ +EYL IHR
Sbjct: 68 CTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHR 124
Query: 242 DLKSANILLDHFMRAKVADFGLSKEEVFDGRNS--GLKGTYGYIDPAYISTNKFTMKSDI 299
DL + N L+ KV+DFGL++ + D S G K + P ++F+ KSD+
Sbjct: 125 DLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDV 184
Query: 300 FSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEI-----LDKQLVGACNIQEVRELA 354
+SFGV+++E+ + + M Y S S+ V+ + L + + + +
Sbjct: 185 WSFGVLMWEVFS-----EGKMPYERF-SNSEV-VESVSAGYRLYRPKLAPTEVYTIM--- 234
Query: 355 RIGHKCLHKTPRKRPSIGEVTQALL 379
+ C H+ P RP+ ++ L
Sbjct: 235 ---YSCWHEKPEDRPAFKKLLSQLT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 4e-28
Identities = 83/272 (30%), Positives = 139/272 (51%), Gaps = 26/272 (9%)
Query: 113 DIQKATQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHH 172
++QK T I+G+G FG V + +G A+K + D + F E +++ +LHH
Sbjct: 4 NLQKLT--LGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHH 58
Query: 173 RNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVL-NWEERLQIALDISHGIEYLH 231
+NLV L+G + G Y ++ E MS G+L N + + R L + + LQ +LD++ G+EYL
Sbjct: 59 KNLVRLLGVILHNGLY-IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE 117
Query: 232 EGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTN 291
++HRDL + NIL+ AKV+DFGL++ NS L + P +
Sbjct: 118 S---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLP--VKWTAPEALKHK 172
Query: 292 KFTMKSDIFSFGVIIFELIT---AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQ 348
KF+ KSD++S+GV+++E+ + A +P +L E V E ++K
Sbjct: 173 KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE-----------VKECVEKGYRMEPPEG 221
Query: 349 EVRELARIGHKCLHKTPRKRPSIGEVTQALLK 380
++ + C P+KRPS ++ + L K
Sbjct: 222 CPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 6e-28
Identities = 80/273 (29%), Positives = 125/273 (45%), Gaps = 46/273 (16%)
Query: 125 LGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGE-KEFQTEVSLLGRLHHRNLVNLIGYC 182
LG G G V K P+G + A+K + + ++ K+ E+ +L + + +V G
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 183 VDKGKYMLIYEFMSNGSLSNLIYSE------ERVLNWEERLQIALDISHGIEYLHEGAVP 236
+ G + E+M GSL I E ER+L +IA+ + G+ YLHE
Sbjct: 69 YNNGDISICMEYMDGGSLDK-ILKEVQGRIPERILG-----KIAVAVLKGLTYLHE--KH 120
Query: 237 PVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLK---GTYGYIDPAYISTNKF 293
+IHRD+K +NIL++ + K+ DFG+S + V NS K GT Y+ P I N +
Sbjct: 121 KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLV----NSLAKTFVGTSSYMAPERIQGNDY 176
Query: 294 TMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQE---- 349
++KSDI+S G+ + EL T P+ D D I + L + E
Sbjct: 177 SVKSDIWSLGLSLIELATGRFPYPP----------ENDPPDGIFE-LL--QYIVNEPPPR 223
Query: 350 ------VRELARIGHKCLHKTPRKRPSIGEVTQ 376
+ + CL K PR+RPS E+ +
Sbjct: 224 LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 9e-28
Identities = 60/189 (31%), Positives = 100/189 (52%), Gaps = 6/189 (3%)
Query: 125 LGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVD 184
+G G FG V+ AIK + + E++F E ++ +L H LV L G C +
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 185 KGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLK 244
+ L++EFM +G LS+ + ++ + E L + LD+ G+ YL VIHRDL
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLA 127
Query: 245 SANILLDHFMRAKVADFGLSKEEVFDGRNS--GLKGTYGYIDPAYISTNKFTMKSDIFSF 302
+ N L+ KV+DFG+++ + D S G K + P S +K++ KSD++SF
Sbjct: 128 ARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSF 187
Query: 303 GVIIFELIT 311
GV+++E+ +
Sbjct: 188 GVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-27
Identities = 85/266 (31%), Positives = 134/266 (50%), Gaps = 28/266 (10%)
Query: 123 NILGQGAFGPVYKATMPS-GGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGY 181
+ LG G +G VY+ A+K L D+ + E EF E +++ + H NLV L+G
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 70
Query: 182 CVDKGKYMLIYEFMSNGSLSNLIYSEER-VLNWEERLQIALDISHGIEYLHEGAVPPVIH 240
C + + +I EFM+ G+L + + R +N L +A IS +EYL + IH
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIH 127
Query: 241 RDLKSANILLDHFMRAKVADFGLS---KEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKS 297
RDL + N L+ KVADFGLS + + ++G K + P ++ NKF++KS
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA-HAGAKFPIKWTAPESLAYNKFSIKS 186
Query: 298 DIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDK----QLVGACNIQEVRE 352
D+++FGV+++E+ T + P+ + +SQ V E+L+K + C +V E
Sbjct: 187 DVWAFGVLLWEIATYGMSPYPGI-------DLSQ--VYELLEKGYRMERPEGCP-PKVYE 236
Query: 353 LARIGHKCLHKTPRKRPSIGEVTQAL 378
L R C P RPS E+ QA
Sbjct: 237 LMR---ACWQWNPSDRPSFAEIHQAF 259
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 5e-27
Identities = 76/272 (27%), Positives = 133/272 (48%), Gaps = 26/272 (9%)
Query: 121 FTNILGQGAFGPVYKATM----PSGGV--AAIKVLASDSHQGEKE-FQTEVSLLGRL-HH 172
F LG GAFG V +AT S V A+K+L +H E+E +E+ ++ L +H
Sbjct: 39 FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNH 98
Query: 173 RNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSE-ERVLNWEERLQIALDISHGIEYLH 231
N+VNL+G C G ++I E+ G L N + + E L E+ L + ++ G+ +L
Sbjct: 99 ENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL- 157
Query: 232 EGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGT----YGYIDPAY 287
A IHRDL + N+LL H K+ DFGL+++ + D N +KG ++ P
Sbjct: 158 --ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDS-NYVVKGNARLPVKWMAPES 214
Query: 288 ISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACN 346
I +T +SD++S+G++++E+ + +P+ + + ++G + +
Sbjct: 215 IFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYR--MAQPEHAPAE 272
Query: 347 IQEVRELARIGHKCLHKTPRKRPSIGEVTQAL 378
I + I C P KRP+ ++ Q +
Sbjct: 273 IYD------IMKTCWDADPLKRPTFKQIVQLI 298
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-26
Identities = 78/265 (29%), Positives = 125/265 (47%), Gaps = 25/265 (9%)
Query: 125 LGQGAFGPV----YKATMP-SGGVAAIKVLASD-SHQGEKEFQTEVSLLGRLHHRNLVNL 178
LG+G FG V Y +G + A+K L + Q ++ E+++L L+H N+V
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 179 IGYCVDKGK--YMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVP 236
G C ++G LI E++ GSL + Y + LN + L A I G+ YLH
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRD--YLPKHKLNLAQLLLFAQQICEGMAYLHSQHY- 128
Query: 237 PVIHRDLKSANILLDHFMRAKVADFGLSK-----EEVFDGRNSGLKGTYGYIDPAYISTN 291
IHRDL + N+LLD+ K+ DFGL+K E + R G + Y + N
Sbjct: 129 --IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA-VECLKEN 185
Query: 292 KFTMKSDIFSFGVIIFELITAIHPHQN----LMEYVNLAS--MSQDGVDEILDKQLVGAC 345
KF+ SD++SFGV ++EL+T Q+ E + M+ + E+L++ + C
Sbjct: 186 KFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPC 245
Query: 346 NIQEVRELARIGHKCLHKTPRKRPS 370
+E+ + C + RP+
Sbjct: 246 PKNCPQEVYILMKNCWETEAKFRPT 270
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-26
Identities = 74/283 (26%), Positives = 139/283 (49%), Gaps = 40/283 (14%)
Query: 114 IQKATQNFTNILGQGAFGPVYKA--TMPSGGVAAIKVLA---SDSHQG--EKEFQTEVSL 166
I + F LG+GAFG VYK T P+ ++A V ++ + ++EF+ E L
Sbjct: 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAEL 61
Query: 167 LGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSE---------------ERVL 211
+ L H N+V L+G C + +++E++++G L + + L
Sbjct: 62 MSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSL 121
Query: 212 NWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG 271
+ + L IA+ I+ G+EYL + +HRDL + N L+ + K++DFGLS+ +++
Sbjct: 122 DCSDFLHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSR-DIYSA 177
Query: 272 RNSGLKGT----YGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLA 326
++ ++ P I KFT +SDI+SFGV+++E+ + + P+ + N
Sbjct: 178 DYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYG---FSN-- 232
Query: 327 SMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRP 369
Q+ ++ I +QL+ C + + +C ++ P +RP
Sbjct: 233 ---QEVIEMIRSRQLLP-CPEDCPARVYALMIECWNEIPARRP 271
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 5e-26
Identities = 65/203 (32%), Positives = 104/203 (51%), Gaps = 16/203 (7%)
Query: 121 FTNILGQGAFGPVYKATMP-----SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNL 175
F LG+G FG V +G V A+K L + + ++F+ E+ +L L H N+
Sbjct: 8 FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNI 67
Query: 176 VNLIGYCVDKGK--YMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEG 233
V G C G+ L+ E++ GSL + + L+ + L A I G+EYL
Sbjct: 68 VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYL--- 124
Query: 234 AVPPVIHRDLKSANILLDHFMRAKVADFGLSK-----EEVFDGRNSGLKGTYGYIDPAYI 288
+HRDL + NIL++ R K+ DFGL+K +E + R G + Y P +
Sbjct: 125 GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYA-PESL 183
Query: 289 STNKFTMKSDIFSFGVIIFELIT 311
+ +KF++ SD++SFGV+++EL T
Sbjct: 184 TESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 7e-26
Identities = 80/264 (30%), Positives = 122/264 (46%), Gaps = 26/264 (9%)
Query: 125 LGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKEF-QTEVSLLGRLHHRNLVNLIGYC 182
+G+G+FG VYKA + V AIKV+ + + E E Q E+ L + + G
Sbjct: 9 IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSF 68
Query: 183 VDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRD 242
+ K +I E+ GS +L+ + L+ I ++ G+EYLHE IHRD
Sbjct: 69 LKGSKLWIIMEYCGGGSCLDLL--KPGKLDETYIAFILREVLLGLEYLHEEGK---IHRD 123
Query: 243 LKSANILLDHFMRAKVADFGLSKE--EVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIF 300
+K+ANILL K+ADFG+S + RN+ GT ++ P I + + K+DI+
Sbjct: 124 IKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT-FVGTPFWMAPEVIKQSGYDEKADIW 182
Query: 301 SFGVIIFELITAIHPHQNL--MEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGH 358
S G+ EL P +L M + L + L G + ++
Sbjct: 183 SLGITAIELAKGEPPLSDLHPMRVLFLIPKNN-------PPSLEGNKFSKPFKDFV---S 232
Query: 359 KCLHKTPRKRPSIGEVTQALLKIK 382
CL+K P++RPS E LLK K
Sbjct: 233 LCLNKDPKERPSAKE----LLKHK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 8e-26
Identities = 74/262 (28%), Positives = 127/262 (48%), Gaps = 18/262 (6%)
Query: 121 FTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIG 180
F LG G FG V+ + AIK + ++ E++F E ++ +L H LV L G
Sbjct: 8 FMKELGSGQFGVVHLGKWRAQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYG 66
Query: 181 YCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIH 240
C + ++ EFM NG L N + + L+ + L + D+ G+EYL + IH
Sbjct: 67 VCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIH 123
Query: 241 RDLKSANILLDHFMRAKVADFGLSKEEVFDGR---NSGLKGTYGYIDPAYISTNKFTMKS 297
RDL + N L+ KV+DFG+++ V D +SG K + P + +K++ KS
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTR-YVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKS 182
Query: 298 DIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARI 356
D++SFGV+++E+ T P + Y + +S+ + +L A + +
Sbjct: 183 DVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRG--FRLYRPKL--ASMT-----VYEV 233
Query: 357 GHKCLHKTPRKRPSIGEVTQAL 378
+ C H+ P RP+ E+ +A+
Sbjct: 234 MYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 3e-25
Identities = 64/202 (31%), Positives = 99/202 (49%), Gaps = 10/202 (4%)
Query: 125 LGQGAFGPVYKATMPSGGV-AAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCV 183
LG GAFG VYKA G+ AA K++ +S + ++F E+ +L H N+V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 184 DKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDL 243
+ K ++ EF G+L +++ ER L + + + + +LH VIHRDL
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDL 129
Query: 244 KSANILLDHFMRAKVADFGLS-KEEVFDGRNSGLKGTYGYIDPAYI-----STNKFTMKS 297
K+ NILL K+ADFG+S K + + GT ++ P + N + K+
Sbjct: 130 KAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKA 189
Query: 298 DIFSFGVIIFELITAIHPHQNL 319
DI+S G+ + EL PH L
Sbjct: 190 DIWSLGITLIELAQMEPPHHEL 211
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 6e-25
Identities = 68/260 (26%), Positives = 129/260 (49%), Gaps = 18/260 (6%)
Query: 124 ILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEK-EFQTEVSLLGRLHHRNLVNLIGYC 182
+LG+G FG V+K T+ A+K D Q K +F +E +L + H N+V LIG C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 183 VDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRD 242
+ ++ E + G + + ++ L ++ ++ ALD + G+ YL IHRD
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLES---KNCIHRD 118
Query: 243 LKSANILLDHFMRAKVADFGLSKEEVFDG--RNSGLKGT-YGYIDPAYISTNKFTMKSDI 299
L + N L+ K++DFG+S++E DG +SGLK + P ++ +++ +SD+
Sbjct: 119 LAARNCLVGENNVLKISDFGMSRQED-DGIYSSSGLKQIPIKWTAPEALNYGRYSSESDV 177
Query: 300 FSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGH 358
+S+G++++E + + P+ M+ E ++K +C + ++ ++
Sbjct: 178 WSYGILLWETFSLGVCPY---------PGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQ 228
Query: 359 KCLHKTPRKRPSIGEVTQAL 378
+C P RP E+ + L
Sbjct: 229 RCWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 8e-25
Identities = 73/295 (24%), Positives = 110/295 (37%), Gaps = 64/295 (21%)
Query: 124 ILGQGAFGPVYKATMPSGG-VAAIKVLASDSH----QGEKEFQTEVSLLGRL-HHRNLVN 177
I+G+G+F V A AIK+L + K + E +L RL H ++
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKIL-DKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIK 66
Query: 178 LIGYCVDKGKYMLIYEFMSNGSLSNLI---YSEERVLNWEERLQIALDISHGIEYLHE-G 233
L D+ + E+ NG L I S L+ + A +I +EYLH G
Sbjct: 67 LYYTFQDEENLYFVLEYAPNGELLQYIRKYGS----LDEKCTRFYAAEILLALEYLHSKG 122
Query: 234 AVPPVIHRDLKSANILLDHFMRAKVADFGLSK---------------------EEVFDGR 272
+IHRDLK NILLD M K+ DFG +K E R
Sbjct: 123 ----IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRR 178
Query: 273 NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDG 332
+ GT Y+ P ++ SD+++ G II++++T P G
Sbjct: 179 FASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPF--------------RG 224
Query: 333 VDEILDKQLVGACNIQ-------EVRELARIGHKCLHKTPRKRPSIGEVTQALLK 380
+E L Q + + ++L K L P+ R + E L
Sbjct: 225 SNEYLTFQKILKLEYSFPPNFPPDAKDLIE---KLLVLDPQDRLGVNEGYDELKA 276
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 9e-25
Identities = 63/201 (31%), Positives = 108/201 (53%), Gaps = 16/201 (7%)
Query: 123 NILGQGAFGPVYKATM----PSGGVAAIKVLASDSHQGE-KEFQTEVSLLGRLHHRNLVN 177
++G+G FG VY T+ A+K L + E ++F E ++ H N+++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 178 LIGYCVDK-GKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVP 236
L+G C+ G +++ +M +G L N I SE ++ + L ++ G+EYL A
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYL---ASK 117
Query: 237 PVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG------RNSGLKGTYGYIDPAYIST 290
+HRDL + N +LD KVADFGL+++ ++D ++G K ++ + T
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLARD-IYDKEYYSVHNHTGAKLPVKWMALESLQT 176
Query: 291 NKFTMKSDIFSFGVIIFELIT 311
KFT KSD++SFGV+++EL+T
Sbjct: 177 QKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 85/298 (28%), Positives = 149/298 (50%), Gaps = 48/298 (16%)
Query: 107 PRYAYKDIQKATQNFTNILGQGAFGPVYKATMPSGGV---AAIKVLASDSHQGE-KEFQT 162
P + DI+ F +++G+G FG V KA + G+ AAIK + + + + ++F
Sbjct: 2 PVLEWNDIK-----FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAG 56
Query: 163 EVSLLGRL-HHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLI---------------YS 206
E+ +L +L HH N++NL+G C +G L E+ +G+L + + S
Sbjct: 57 ELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANS 116
Query: 207 EERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSK- 265
L+ ++ L A D++ G++YL + IHRDL + NIL+ AK+ADFGLS+
Sbjct: 117 TASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRG 173
Query: 266 EEVFDGRNSGLKGTYGYIDPAYISTNK-----FTMKSDIFSFGVIIFELITAIHPHQNLM 320
+EV+ +K T G + +++ +T SD++S+GV+++E+++ M
Sbjct: 174 QEVY------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 227
Query: 321 EYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQAL 378
L G L+K L C+ EV +L R +C + P +RPS ++ +L
Sbjct: 228 TCAELYEKLPQGYR--LEKPL--NCD-DEVYDLMR---QCWREKPYERPSFAQILVSL 277
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 68/217 (31%), Positives = 122/217 (56%), Gaps = 35/217 (16%)
Query: 121 FTNILGQGAFGPVYKATMPSGGV---AAIKVLAS-DSHQGEKEFQTEVSLLGRL-HHRNL 175
F +++G+G FG V +A + G+ AAIK+L S ++F E+ +L +L HH N+
Sbjct: 6 FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNI 65
Query: 176 VNLIGYCVDKGKYMLIYEFMSNGSLSNLI-----------YSEER----VLNWEERLQIA 220
+NL+G C ++G + E+ G+L + + +++E L ++ LQ A
Sbjct: 66 INLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125
Query: 221 LDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSK-EEVFDGRNSGLKGT 279
D++ G++YL E IHRDL + N+L+ + +K+ADFGLS+ EEV+ +K T
Sbjct: 126 SDVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLSRGEEVY------VKKT 176
Query: 280 YGYIDPAYISTNK-----FTMKSDIFSFGVIIFELIT 311
G + +++ +T KSD++SFGV+++E+++
Sbjct: 177 MGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-24
Identities = 74/282 (26%), Positives = 134/282 (47%), Gaps = 46/282 (16%)
Query: 125 LGQGAFGPVYK---ATMPSGGV---AAIKVLASDSHQGEK-EFQTEVSLLGRLHHRNLVN 177
LGQG+FG VY+ + G AIK + ++ E+ EF E S++ + ++V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 178 LIGYCVDKGKYMLIYEFMSNGSLSNLIYS---EER------VLNWEERLQIALDISHGIE 228
L+G +++ E M+ G L + + S E ++ +Q+A +I+ G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 229 YLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYG-----YI 283
YL +HRDL + N ++ + K+ DFG++++ +++ + KG G ++
Sbjct: 134 YLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRD-IYE-TDYYRKGGKGLLPVRWM 188
Query: 284 DPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNL-----MEYVNLASMSQDGVDEIL 337
P + FT KSD++SFGV+++E+ T A P+Q L +++V DG L
Sbjct: 189 APESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFV------IDG--GHL 240
Query: 338 DKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALL 379
D ++ EL R+ C P+ RP+ E+ +L
Sbjct: 241 DLP---ENCPDKLLELMRM---CWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 2e-24
Identities = 57/209 (27%), Positives = 90/209 (43%), Gaps = 41/209 (19%)
Query: 124 ILGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKE--FQT---EVSLLGRLHHRNLVN 177
LG+G +G VYKA +G + A+K + D+ E+E T E+SLL L H N+V
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDN---EEEGIPSTALREISLLKELKHPNIVK 62
Query: 178 LIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPP 237
L+ + K L++E+ L + L+ I + G+ Y H +
Sbjct: 63 LLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRI-- 119
Query: 238 VIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAY---------- 287
+HRDLK NIL++ K+ADFGL++ +G Y
Sbjct: 120 -LHRDLKPQNILINRDGVLKLADFGLAR-------------AFGIPLRTYTHEVVTLWYR 165
Query: 288 -----ISTNKFTMKSDIFSFGVIIFELIT 311
+ + ++ DI+S G I E+IT
Sbjct: 166 APEILLGSKHYSTAVDIWSVGCIFAEMIT 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 2e-24
Identities = 78/278 (28%), Positives = 130/278 (46%), Gaps = 25/278 (8%)
Query: 106 IPRYAYKDIQKATQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVS 165
+PR K ++K LG G FG V+ AIK L S E F E +
Sbjct: 3 VPRETLKLVKK--------LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEA-FLAEAN 53
Query: 166 LLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERV-LNWEERLQIALDIS 224
L+ +L H LV L V + +I E+M NGSL + + + E + L + + +A I+
Sbjct: 54 LMKQLQHPRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIA 112
Query: 225 HGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSK--EEVFDGRNSGLKGTYGY 282
G+ ++ IHRDL++ANIL+ + K+ADFGL++ E+ G K +
Sbjct: 113 EGMAFIERKNY---IHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKW 169
Query: 283 IDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLV 342
P I+ FT+KSD++SFG+++ E++T + M+ V + L++
Sbjct: 170 TAPEAINYGTFTIKSDVWSFGILLTEIVT--------YGRIPYPGMTNPEVIQNLERGYR 221
Query: 343 GACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLK 380
EL + C + P +RP+ E +++L+
Sbjct: 222 MPRPDNCPEELYELMRLCWKEKPEERPTF-EYLRSVLE 258
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-24
Identities = 63/188 (33%), Positives = 102/188 (54%), Gaps = 10/188 (5%)
Query: 124 ILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCV 183
+G+G FG V G A+K + +D+ + F E S++ +L H NLV L+G V
Sbjct: 13 TIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIV 69
Query: 184 -DKGKYMLIYEFMSNGSLSNLIYSEER-VLNWEERLQIALDISHGIEYLHEGAVPPVIHR 241
+KG ++ E+M+ GSL + + S R VL + L+ +LD+ +EYL +HR
Sbjct: 70 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNF---VHR 126
Query: 242 DLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFS 301
DL + N+L+ AKV+DFGL+KE L + P + KF+ KSD++S
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP--VKWTAPEALREKKFSTKSDVWS 184
Query: 302 FGVIIFEL 309
FG++++E+
Sbjct: 185 FGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 4e-24
Identities = 60/199 (30%), Positives = 100/199 (50%), Gaps = 17/199 (8%)
Query: 124 ILGQGAFGPVYKAT-MPSGGVA----AIKVLASDS-HQGEKEFQTEVSLLGRLHHRNLVN 177
+LG GAFG VYK +P G AIKVL ++ + KE E ++ + H ++V
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 178 LIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPP 237
L+G C+ + LI + M G L + + + + + + L + I+ G+ YL E +
Sbjct: 74 LLGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRL-- 130
Query: 238 VIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYG-----YIDPAYISTNK 292
+HRDL + N+L+ K+ DFGL+K + D G ++ I
Sbjct: 131 -VHRDLAARNVLVKTPQHVKITDFGLAK--LLDVDEKEYHAEGGKVPIKWMALESILHRI 187
Query: 293 FTMKSDIFSFGVIIFELIT 311
+T KSD++S+GV ++EL+T
Sbjct: 188 YTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 6e-24
Identities = 67/261 (25%), Positives = 118/261 (45%), Gaps = 27/261 (10%)
Query: 124 ILGQGAFGP--VYKATMPSGGVAAIKV-LASDSHQGEKEFQTEVSLLGRLHHRNLVNLIG 180
+LG+GAFG +Y+ T V +V L S + ++ E+ +L L H N++
Sbjct: 7 VLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 181 YCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIAL--DISHGIEYLHEGAVPPV 238
+ +D ++ E+ + G+L + I ++ +EE + + I + Y+H+ +
Sbjct: 67 HFMDDNTLLIEMEYANGGTLYDKI-VRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGI--- 122
Query: 239 IHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLK---GTYGYIDPAYISTNKFTM 295
+HRD+K+ NI L K+ DFG+SK + S + GT Y+ P K+
Sbjct: 123 LHRDIKTLNIFLTKAGLIKLGDFGISK--ILGSEYSMAETVVGTPYYMSPELCQGVKYNF 180
Query: 296 KSDIFSFGVIIFELIT--AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVREL 353
KSDI++ G +++EL+T N + V + Q ++ EL
Sbjct: 181 KSDIWALGCVLYELLTLKRTFDATNPLNLVV--KIVQGNYTPVVS---------VYSSEL 229
Query: 354 ARIGHKCLHKTPRKRPSIGEV 374
+ H L + P KRP+ EV
Sbjct: 230 ISLVHSLLQQDPEKRPTADEV 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 99.6 bits (248), Expect = 6e-24
Identities = 74/268 (27%), Positives = 119/268 (44%), Gaps = 38/268 (14%)
Query: 121 FTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIG 180
F LG G FG V AIK++ S E EF E ++ +L H LV L G
Sbjct: 8 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYG 66
Query: 181 YCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIH 240
C + ++ E+MSNG L N + + + L++ D+ G+ YL IH
Sbjct: 67 VCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ---FIH 123
Query: 241 RDLKSANILLDHFMRAKVADFGLSKEEVFDGRNS--GLKGTYGYIDPAYISTNKFTMKSD 298
RDL + N L+D KV+DFGLS+ + D S G K + P + +KF+ KSD
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSD 183
Query: 299 IFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVD--EILDKQLVGACNIQEVRELAR- 355
+++FGV+++E+ + L M + + E ++K + + L R
Sbjct: 184 VWAFGVLMWEVYS-------------LGKMPYERFNNSETVEK-------VSQGLRLYRP 223
Query: 356 ---------IGHKCLHKTPRKRPSIGEV 374
I + C H+ +RP+ ++
Sbjct: 224 HLASEKVYAIMYSCWHEKAEERPTFQQL 251
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 6e-24
Identities = 77/294 (26%), Positives = 144/294 (48%), Gaps = 50/294 (17%)
Query: 124 ILGQGAFGPVYKAT------MPSGGVAAIKVLASDSHQGE-KEFQTEVSLLGRLHHRNLV 176
LG+G FG V KAT A+K+L ++ E ++ +E +LL +++H +++
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 177 NLIGYCVDKGKYMLIYEFMSNGSL-----------------------SNLIYSEERVLNW 213
L G C G +LI E+ GSL S L +ER L
Sbjct: 67 KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 214 EERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRN 273
+ + A IS G++YL E + +HRDL + N+L+ + K++DFGLS+ +V++ +
Sbjct: 127 GDLISFAWQISRGMQYLAEMKL---VHRDLAARNVLVAEGRKMKISDFGLSR-DVYE-ED 181
Query: 274 SGLKGTYG-----YIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLAS 327
S +K + G ++ + + +T +SD++SFGV+++E++T +P+ + L +
Sbjct: 182 SYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE-RLFN 240
Query: 328 MSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKI 381
+ + G ++ N E E+ + C + P KRP+ ++++ L K+
Sbjct: 241 LLKTG------YRMERPENCSE--EMYNLMLTCWKQEPDKRPTFADISKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 1e-23
Identities = 81/278 (29%), Positives = 129/278 (46%), Gaps = 25/278 (8%)
Query: 106 IPRYAYKDIQKATQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVS 165
IPR + + I+K LG G FG V+ T A+K L + E F E
Sbjct: 3 IPRESLQLIKK--------LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES-FLEEAQ 53
Query: 166 LLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEE-RVLNWEERLQIALDIS 224
++ +L H LV L ++ Y ++ E+MS GSL + + E R L + +A ++
Sbjct: 54 IMKKLRHDKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVA 112
Query: 225 HGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSK--EEVFDGRNSGLKGTYGY 282
G+ Y+ IHRDL+SANIL+ + K+ADFGL++ E+ G K +
Sbjct: 113 AGMAYIERMNY---IHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKW 169
Query: 283 IDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLV 342
P +FT+KSD++SFG+++ EL+T V M+ V E +++
Sbjct: 170 TAPEAALYGRFTIKSDVWSFGILLTELVTK--------GRVPYPGMNNREVLEQVERGYR 221
Query: 343 GACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLK 380
C L + +C K P +RP+ E Q+ L+
Sbjct: 222 MPCPQDCPISLHELMLQCWKKDPEERPTF-EYLQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 2e-23
Identities = 72/272 (26%), Positives = 112/272 (41%), Gaps = 40/272 (14%)
Query: 125 LGQGAFGPVYKAT--MPSGGV--AAIKVL-ASDSHQGEKEFQTEVSLLGRLHHRNLVNLI 179
LG G FG V K M SG A+K L G+KEF E S++ +L H +V LI
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 180 GYCVDKGKYMLIYEFMSNGSL-----SNLIYSEERVLNWEERLQIALDISHGIEYLHEGA 234
G C + ML+ E G L + A ++ G+ YL
Sbjct: 63 GVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYLESKH 115
Query: 235 VPPVIHRDLKSANILL--DHFMRAKVADFGLSK-----EEVFDGRNSGLKGTYGYIDPAY 287
+HRDL + N+LL H AK++DFG+S+ + + +G + + P
Sbjct: 116 F---VHRDLAARNVLLVNRHQ--AKISDFGMSRALGAGSDYYRATTAG-RWPLKWYAPEC 169
Query: 288 ISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACN 346
I+ KF+ KSD++S+GV ++E + P+ M V +L+
Sbjct: 170 INYGKFSSKSDVWSYGVTLWEAFSYGAKPYGE---------MKGAEVIAMLESGERLPRP 220
Query: 347 IQEVRELARIGHKCLHKTPRKRPSIGEVTQAL 378
+ +E+ I C P RP+ E+
Sbjct: 221 EECPQEIYSIMLSCWKYRPEDRPTFSELESTF 252
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 2e-23
Identities = 63/224 (28%), Positives = 106/224 (47%), Gaps = 36/224 (16%)
Query: 112 KDIQKATQNFTNILGQGAFGPVYKAT---MPSGGVA---AIKVLASD-SHQGEKEFQTEV 164
++ + + LG GAFG VY+ V A+K L S Q E +F E
Sbjct: 1 PEVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEA 60
Query: 165 SLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEER-------VLNWEERL 217
++ + +H+N+V LIG ++ ++ E M+ G L + + E R L ++ L
Sbjct: 61 LIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFL-RENRPRPERPSSLTMKDLL 119
Query: 218 QIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHF---MRAKVADFGLSKE----EVFD 270
A D++ G +YL E IHRD+ + N LL AK+ADFG++++ +
Sbjct: 120 FCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYY- 175
Query: 271 GRNSG-----LKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFEL 309
R G +K ++ P FT K+D++SFGV+++E+
Sbjct: 176 -RKGGRAMLPIK----WMPPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 3e-23
Identities = 64/214 (29%), Positives = 103/214 (48%), Gaps = 25/214 (11%)
Query: 123 NILGQGAFGPVYKATMPSGGVAAIKVLA---SDSHQGEKEF---QTEVSLLGRLHHRNLV 176
+LG+GA+G VY G + A+K + S+ EKE+ Q EV LL L H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 177 NLIGYCVDKGKYMLIYEFMSNGSLSNLIYS----EERVLNWEERLQIALDISHGIEYLHE 232
+G C+D + EF+ GS+S+++ E V + I G+ YLH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK-----QILDGVAYLHN 120
Query: 233 GAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRN-------SGLKGTYGYIDP 285
V+HRD+K N++L K+ DFG ++ + G + + GT ++ P
Sbjct: 121 NC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177
Query: 286 AYISTNKFTMKSDIFSFGVIIFELITAIHPHQNL 319
I+ + + KSDI+S G +FE+ T P ++
Sbjct: 178 EVINESGYGRKSDIWSIGCTVFEMATGKPPLASM 211
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 4e-23
Identities = 81/281 (28%), Positives = 127/281 (45%), Gaps = 33/281 (11%)
Query: 107 PRYAYKDIQKATQNFTNILGQGAFGPVYKATM-PSGGVAAIKVLASDSHQGEKEFQTEVS 165
P+ Y+ IQ+ +G G +G VYKA +G + AIKV+ + + Q E+S
Sbjct: 1 PQEDYELIQR--------IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEIS 52
Query: 166 LLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIAL---D 222
+L H N+V G + + K ++ E+ GSL ++ L LQIA +
Sbjct: 53 MLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPL---SELQIAYVCRE 109
Query: 223 ISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKE--EVFDGRNSGLKGTY 280
G+ YLHE IHRD+K ANILL K+ADFG+S + R S GT
Sbjct: 110 TLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS-FIGTP 165
Query: 281 GYIDPAYISTNK---FTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVD--E 335
++ P + + + K DI++ G+ EL P +L L +S+ +
Sbjct: 166 YWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPK 225
Query: 336 ILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQ 376
+ DK+ ++ KCL K P+KRP+ ++ Q
Sbjct: 226 LKDKEKWSPVFHDFIK-------KCLTKDPKKRPTATKLLQ 259
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.1 bits (241), Expect = 7e-23
Identities = 65/215 (30%), Positives = 115/215 (53%), Gaps = 35/215 (16%)
Query: 123 NILGQGAFGPVYKATMPSGGV---AAIKVLAS-DSHQGEKEFQTEVSLLGRL-HHRNLVN 177
+++G+G FG V KA + G+ AAIK + S ++F E+ +L +L HH N++N
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 178 LIGYCVDKGKYMLIYEFMSNGSLSNLI---------------YSEERVLNWEERLQIALD 222
L+G C +G L E+ +G+L + + S L+ ++ L A D
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 223 ISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSK-EEVFDGRNSGLKGTYG 281
++ G++YL + IHRDL + NIL+ AK+ADFGLS+ +EV+ +K T G
Sbjct: 121 VARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY------VKKTMG 171
Query: 282 YIDPAYISTNK-----FTMKSDIFSFGVIIFELIT 311
+ +++ +T SD++S+GV+++E+++
Sbjct: 172 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 9e-23
Identities = 64/211 (30%), Positives = 109/211 (51%), Gaps = 19/211 (9%)
Query: 106 IPRYAYKDIQKATQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVS 165
IPR + K ++K LG G FG V+ + A+K L + + F E +
Sbjct: 3 IPRESIKLVKK--------LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA-FLEEAN 53
Query: 166 LLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEE--RVLNWEERLQIALDI 223
L+ L H LV L + +I E+M+ GSL + + S+E +VL + + + I
Sbjct: 54 LMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQI 112
Query: 224 SHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSK---EEVFDGRNSGLKGTY 280
+ G+ Y+ IHRDL++AN+L+ + K+ADFGL++ + + R G K
Sbjct: 113 AEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAR-EGAKFPI 168
Query: 281 GYIDPAYISTNKFTMKSDIFSFGVIIFELIT 311
+ P I+ FT+KSD++SFG++++E++T
Sbjct: 169 KWTAPEAINFGSFTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 1e-22
Identities = 64/218 (29%), Positives = 108/218 (49%), Gaps = 31/218 (14%)
Query: 124 ILGQGAFGPVYKA-TMPSGGVAAIK--VLASDSHQGEKE-------FQTEVSLLGRLHHR 173
++G G+FG VY SG + A+K L S S + E++LL L H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 174 NLVNLIGYCVDKGKYMLIYEFMSNGSLSNLI-----YSEERVLNWEERLQIALDISHGIE 228
N+V +G +D + E++ GS++ L+ + E V N+ + I G+
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQ------ILKGLN 120
Query: 229 YLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKE---EVFDGRNSG----LKGTYG 281
YLH + IHRD+K ANIL+D+ K++DFG+SK+ + +G L+G+
Sbjct: 121 YLHNRGI---IHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVF 177
Query: 282 YIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNL 319
++ P + +T K+DI+S G ++ E++T HP +
Sbjct: 178 WMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC 215
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 2e-22
Identities = 70/230 (30%), Positives = 110/230 (47%), Gaps = 33/230 (14%)
Query: 123 NILGQGAFGPVYKATM-----PSGGV--AAIKVLASDSHQGEK-EFQTEVSLLGRLHHRN 174
N LG GAFG VY+ T P G A+K L + EK EF E L+ +H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 175 LVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEER------VLNWEERLQIALDISHGIE 228
+V L+G C+ +I E M G L + + +L +E L I LD++ G
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 229 YLHEGAVPPVIHRDLKSANILL-----DHFMRAKVADFGLSKE----EVFDGRNSGLKGT 279
YL + IHRDL + N L+ D K+ DFGL+++ + + GL
Sbjct: 121 YLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 280 YGYIDPAYISTNKFTMKSDIFSFGVIIFELIT------AIHPHQNLMEYV 323
++ P + KFT +SD++SFGV+++E++T +Q ++++V
Sbjct: 178 R-WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHV 226
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 2e-22
Identities = 79/263 (30%), Positives = 127/263 (48%), Gaps = 25/263 (9%)
Query: 125 LGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVD 184
LGQG FG V+ T AIK L + E F E ++ +L H LV L +
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 72
Query: 185 KGKYMLIYEFMSNGSLSNLIYSE-ERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDL 243
+ Y ++ E+MS GSL + + E + L + + +A I+ G+ Y+ +HRDL
Sbjct: 73 EPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY---VHRDL 128
Query: 244 KSANILLDHFMRAKVADFGLSK---EEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIF 300
++ANIL+ + KVADFGL++ + + R G K + P +FT+KSD++
Sbjct: 129 RAANILVGENLVCKVADFGLARLIEDNEYTARQ-GAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 301 SFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVG---ACNIQEVRELARIG 357
SFG+++ EL T + + Y + + E+LD+ G C + L +
Sbjct: 188 SFGILLTELTT-----KGRVPYPGMVNR------EVLDQVERGYRMPCPPECPESLHDLM 236
Query: 358 HKCLHKTPRKRPSIGEVTQALLK 380
+C K P +RP+ E QA L+
Sbjct: 237 CQCWRKEPEERPTF-EYLQAFLE 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 2e-22
Identities = 81/298 (27%), Positives = 142/298 (47%), Gaps = 65/298 (21%)
Query: 124 ILGQGAFGPVYKAT------MPSGGVAAIKVLASDSHQGEKEFQTEVS------LLGRLH 171
LG+GAFG V KA A+K+L D+ EK+ VS ++G+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGK-- 74
Query: 172 HRNLVNLIGYCVDKGKYMLIYEFMSNGSLS---------NLIYSEERVLNWEERL----- 217
H+N++NL+G C +G ++ E+ ++G+L S + EE L
Sbjct: 75 HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134
Query: 218 -QIALDISHGIEYLHEGAVPPVIHRDLKSANILL--DHFMRAKVADFGLSKE-------- 266
A ++ G+E+L A IHRDL + N+L+ DH M K+ADFGL+++
Sbjct: 135 VSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVM--KIADFGLARDIHHIDYYR 189
Query: 267 EVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT---AIHPHQNLMEYV 323
+ +GR ++ P + +T +SD++SFGV+++E+ T + +P + E
Sbjct: 190 KTTNGRLP-----VKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE-- 242
Query: 324 NLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKI 381
L + ++G ++K C QE+ L R C H+ P +RP+ ++ + L ++
Sbjct: 243 -LFKLLKEG--YRMEKPQ--NCT-QELYHLMR---DCWHEVPSQRPTFKQLVEDLDRM 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 2e-22
Identities = 79/280 (28%), Positives = 132/280 (47%), Gaps = 39/280 (13%)
Query: 125 LGQGAFGPVYKATM----PSGG--VAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNL 178
LG+GAFG V+ A P+ + A+K L + K+FQ E LL L H ++V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 179 IGYCVDKGKYMLIYEFMSNGSLSN-----------LIYSEERVLNWE----ERLQIALDI 223
G C D ++++E+M +G L+ L+ + R E + L IA I
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 224 SHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKG----T 279
+ G+ YL A +HRDL + N L+ + K+ DFG+S+ +V+ + G
Sbjct: 133 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR-DVYSTDYYRVGGHTMLP 188
Query: 280 YGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILD 338
++ P I KFT +SD++SFGVI++E+ T P L + ++Q +L+
Sbjct: 189 IRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQ---GRVLE 245
Query: 339 KQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQAL 378
+ V +E+ I C + P++R +I E+ + L
Sbjct: 246 RPRVCP------KEVYDIMLGCWQREPQQRLNIKEIYKIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 3e-22
Identities = 59/197 (29%), Positives = 107/197 (54%), Gaps = 12/197 (6%)
Query: 124 ILGQGAFGPVYKATMPSGG----VAAIKVL-ASDSHQGEKEFQTEVSLLGRLHHRNLVNL 178
++G G FG V++ + G AIK L + + ++F +E S++G+ H N++ L
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 179 IGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPV 238
G M+I E+M NG+L + + + + + + I+ G++YL +
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNY--- 128
Query: 239 IHRDLKSANILLDHFMRAKVADFGLSK--EEVFDG--RNSGLKGTYGYIDPAYISTNKFT 294
+HRDL + NIL++ + KV+DFGLS+ E+ +G SG K + P I+ KFT
Sbjct: 129 VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFT 188
Query: 295 MKSDIFSFGVIIFELIT 311
SD++SFG++++E+++
Sbjct: 189 SASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 3e-22
Identities = 77/261 (29%), Positives = 121/261 (46%), Gaps = 29/261 (11%)
Query: 125 LGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQG-EKEFQTEVSLLGRLHHRNLVNLIGYC 182
LG G G V K +P+G V A KV+ + K+ E+ ++ +V+ G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 183 VDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRD 242
+++ + EFM GSL IY + + E +IA+ + G+ YL+ V ++HRD
Sbjct: 73 LNENNICMCMEFMDCGSLDR-IYKKGGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRD 129
Query: 243 LKSANILLDHFMRAKVADFGLSKEEVFDGRNS---GLKGTYGYIDPAYISTNKFTMKSDI 299
+K +NIL++ + K+ DFG+S E + NS GT Y+ P I K+T+KSD+
Sbjct: 130 IKPSNILVNSRGQIKLCDFGVSGELI----NSIADTFVGTSTYMSPERIQGGKYTVKSDV 185
Query: 300 FSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQE---------- 349
+S G+ I EL P + N+ QD ILD + +QE
Sbjct: 186 WSLGISIIELALGKFP----FAFSNIDDDGQDDPMGILD---LLQQIVQEPPPRLPSSDF 238
Query: 350 VRELARIGHKCLHKTPRKRPS 370
+L CL K P +RP+
Sbjct: 239 PEDLRDFVDACLLKDPTERPT 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 7e-22
Identities = 64/211 (30%), Positives = 107/211 (50%), Gaps = 28/211 (13%)
Query: 125 LGQGAFGPVYKAT----MPSGG--VAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNL 178
LG+GAFG V+ A +P + A+K L S ++FQ E LL L H+++V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 179 IGYCVDKGKYMLIYEFMSNGSLSNLIYS---EERVLNWEE-----------RLQIALDIS 224
G C + ++++E+M +G L+ + S + ++L E L IA I+
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 225 HGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKG----TY 280
G+ YL A +HRDL + N L+ + K+ DFG+S+ +++ + G
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR-DIYSTDYYRVGGRTMLPI 188
Query: 281 GYIDPAYISTNKFTMKSDIFSFGVIIFELIT 311
++ P I KFT +SDI+SFGV+++E+ T
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 8e-22
Identities = 76/260 (29%), Positives = 121/260 (46%), Gaps = 19/260 (7%)
Query: 125 LGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVD 184
LGQG FG V+ T AIK L + E F E ++ +L H LV L +
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA-FLQEAQIMKKLRHDKLVPLYAVVSE 72
Query: 185 KGKYMLIYEFMSNGSLSNLIYSEE-RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDL 243
+ Y ++ EFM GSL + + + + L + + +A I+ G+ Y+ IHRDL
Sbjct: 73 EPIY-IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNY---IHRDL 128
Query: 244 KSANILLDHFMRAKVADFGLSK---EEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIF 300
++ANIL+ + K+ADFGL++ + + R G K + P +FT+KSD++
Sbjct: 129 RAANILVGDNLVCKIADFGLARLIEDNEYTARQ-GAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 301 SFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKC 360
SFG+++ EL+T V M V E +++ C L + C
Sbjct: 188 SFGILLTELVTK--------GRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLC 239
Query: 361 LHKTPRKRPSIGEVTQALLK 380
K P +RP+ E Q+ L+
Sbjct: 240 WKKDPDERPTF-EYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 1e-21
Identities = 58/199 (29%), Positives = 105/199 (52%), Gaps = 14/199 (7%)
Query: 124 ILGQGAFGPVYKATMPSGG----VAAIKVLASD-SHQGEKEFQTEVSLLGRLHHRNLVNL 178
++G G FG V + + G AIK L S + + ++F +E S++G+ H N+++L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 179 IGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPV 238
G M+I EFM NG+L + + + + + + I+ G++YL E
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN---Y 127
Query: 239 IHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYG------YIDPAYISTNK 292
+HRDL + NIL++ + KV+DFGLS+ D + + G + P I+ K
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRK 187
Query: 293 FTMKSDIFSFGVIIFELIT 311
FT SD++S+G++++E+++
Sbjct: 188 FTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 1e-21
Identities = 66/261 (25%), Positives = 120/261 (45%), Gaps = 18/261 (6%)
Query: 125 LGQGAFGPVYKATMPSGG--VAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYC 182
+G+G FG V+ + + VA + + +F E +L + H N+V LIG C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 183 VDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRD 242
K ++ E + G + +E L +E +Q+ + + G+EYL IHRD
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRD 119
Query: 243 LKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGT----YGYIDPAYISTNKFTMKSD 298
L + N L+ K++DFG+S+EE DG + G + P ++ +++ +SD
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSREEE-DGVYASTGGMKQIPVKWTAPEALNYGRYSSESD 178
Query: 299 IFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGH 358
++SFG++++E + + V A++S E +++ + C + R+
Sbjct: 179 VWSFGILLWEAFS--------LGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLME 230
Query: 359 KCLHKTPRKRPSIGEVTQALL 379
+C P +RPS V Q L
Sbjct: 231 RCWEYDPGQRPSFSTVHQELQ 251
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 1e-21
Identities = 63/204 (30%), Positives = 95/204 (46%), Gaps = 15/204 (7%)
Query: 123 NILGQGAFGPVYKA-TMPSGGVAAIKVLA--SDSHQGEKEFQTEVSLLGRLHHRNLVNLI 179
N +G G FG VY A + +G + A+K + + + KE E+ +L L H NLV
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 180 GYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVI 239
G V + K + E+ S G+L L+ R+L+ L + G+ YLH + +
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELL-EHGRILDEHVIRVYTLQLLEGLAYLHSHGI---V 121
Query: 240 HRDLKSANILLDHFMRAKVADFGLSKE-----EVFDGRNSGLKGTYGYIDPAYISTNKFT 294
HRD+K ANI LDH K+ DFG + + L GT Y+ P I+ K
Sbjct: 122 HRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGK 181
Query: 295 MK---SDIFSFGVIIFELITAIHP 315
+DI+S G ++ E+ T P
Sbjct: 182 GHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 1e-21
Identities = 76/281 (27%), Positives = 133/281 (47%), Gaps = 40/281 (14%)
Query: 121 FTNILGQGAFGPVYKA-----TMPSGGVAAIKVLAS-DSHQGEKEFQTEVSLLGRLHHRN 174
F LG+ AFG +YK M + AIK L ++ Q EFQ E SL+ LHH N
Sbjct: 9 FMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPN 68
Query: 175 LVNLIGYCVDKGKYMLIYEFMSNGSLSNLIY-----------SEE-----RVLNWEERLQ 218
+V L+G + +++E+++ G L + S+E L+ + L
Sbjct: 69 IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128
Query: 219 IALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKE----EVFDGRNS 274
IA+ I+ G+EYL + +H+DL + NIL+ + K++D GLS+E + + +
Sbjct: 129 IAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPK 185
Query: 275 GLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGV 333
L ++ P I KF+ SDI+SFGV+++E+ + + P+ S V
Sbjct: 186 SLLPIR-WMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGF---------SNQEV 235
Query: 334 DEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEV 374
E++ K+ + C+ + + +C + P +RP ++
Sbjct: 236 IEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 1e-21
Identities = 68/209 (32%), Positives = 106/209 (50%), Gaps = 25/209 (11%)
Query: 124 ILGQGAFGPVYKATM----PSGGVAAIKVLASD--SHQGEKEFQTEVSLLGRLHHRNLVN 177
ILG+G FG V + + S A+K + D ++ +EF +E + + H N++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 178 LIGYCV---DKGKY---MLIYEFMSNGSL-SNLIYSE----ERVLNWEERLQIALDISHG 226
LIG C K M+I FM +G L S L+YS L + L+ +DI+ G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 227 IEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG---RNSGL-KGTYGY 282
+EYL + IHRDL + N +L M VADFGLSK +++ G R + K +
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSK-KIYSGDYYRQGRIAKMPVKW 181
Query: 283 IDPAYISTNKFTMKSDIFSFGVIIFELIT 311
I ++ +T KSD+++FGV ++E+ T
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 2e-21
Identities = 56/201 (27%), Positives = 99/201 (49%), Gaps = 14/201 (6%)
Query: 123 NILGQGAFGPVYKATMPSGG-VAAIKV--LASDSHQGEKEFQTEVSLLGRLHHRNLVNLI 179
N +G+G+FG V+K + V A+K L+ + + +E E +L +L ++
Sbjct: 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYY 65
Query: 180 GYCVDKGKYMLIYEFMSNGSLSNLIYSEE-RVLNWEERLQIALDISHGIEYLHEGAVPPV 238
+DKGK ++ E+ NG L L+ + R L ++ + + I G+ +LH +
Sbjct: 66 ESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKI--- 122
Query: 239 IHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLK----GTYGYIDPAYISTNKFT 294
+HRD+KS N+ LD + K+ D G++K N+ GT Y+ P +
Sbjct: 123 LHRDIKSLNLFLDAYDNVKIGDLGVAK---LLSDNTNFANTIVGTPYYLSPELCEDKPYN 179
Query: 295 MKSDIFSFGVIIFELITAIHP 315
KSD+++ GV+++E T HP
Sbjct: 180 EKSDVWALGVVLYECCTGKHP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 2e-21
Identities = 76/282 (26%), Positives = 131/282 (46%), Gaps = 45/282 (15%)
Query: 124 ILGQGAFGPVYKATMP----SGGVAAIKVLASD--SHQGEKEFQTEVSLLGRLHHRNLVN 177
+LG+G FG V +A + S A+K+L +D S +EF E + + H N++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 178 LIGYCVD---KGKY---MLIYEFMSNGSLSNL-----IYSEERVLNWEERLQIALDISHG 226
LIG + KG+ M+I FM +G L I E L + ++ +DI+ G
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 227 IEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG----RNSGLKGTYGY 282
+EYL + IHRDL + N +L+ M VADFGLSK+ ++ G + K +
Sbjct: 126 MEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKK-IYSGDYYRQGCASKLPVKW 181
Query: 283 IDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVD--EILDKQ 340
+ ++ N +T SD+++FGV ++E++T GV+ EI +
Sbjct: 182 LALESLADNVYTTHSDVWAFGVTMWEIMT-------------RGQTPYAGVENSEIYN-Y 227
Query: 341 LVGACNIQE----VRELARIGHKCLHKTPRKRPSIGEVTQAL 378
L+ +++ + ++ + +C P+ RPS + L
Sbjct: 228 LIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQL 269
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 2e-21
Identities = 63/203 (31%), Positives = 104/203 (51%), Gaps = 10/203 (4%)
Query: 113 DIQKATQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHH 172
+I + + LG G FG V+ AT A+K + S E F E +++ L H
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQH 60
Query: 173 RNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEE-RVLNWEERLQIALDISHGIEYLH 231
LV L V K +I EFM+ GSL + + S+E + + + I+ G+ ++
Sbjct: 61 DKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 119
Query: 232 EGAVPPVIHRDLKSANILLDHFMRAKVADFGLSK---EEVFDGRNSGLKGTYGYIDPAYI 288
+ IHRDL++ANIL+ + K+ADFGL++ + + R G K + P I
Sbjct: 120 QRNY---IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAR-EGAKFPIKWTAPEAI 175
Query: 289 STNKFTMKSDIFSFGVIIFELIT 311
+ FT+KSD++SFG+++ E++T
Sbjct: 176 NFGSFTIKSDVWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.0 bits (232), Expect = 2e-21
Identities = 60/203 (29%), Positives = 100/203 (49%), Gaps = 24/203 (11%)
Query: 123 NILGQGAFGPVYKA-TMPSGGVAAIKVLASDSHQGEKEF-QT---EVSLLGRLHHRNLVN 177
+G+G +G VYKA +G + A+K + ++ F T E+ LL +L H N+V
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKI--RMENEKEGFPITAIREIKLLQKLRHPNIVR 62
Query: 178 LIGYCVDKGK---YMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGA 234
L KGK YM ++E+M + L+ L+ S E + + G++YLH
Sbjct: 63 LKEIVTSKGKGSIYM-VFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG 120
Query: 235 VPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAY------I 288
+ +HRD+K +NIL+++ K+ADFGL++ + RNS T I Y +
Sbjct: 121 I---LHRDIKGSNILINNDGVLKLADFGLARP--YTKRNSA-DYTNRVITLWYRPPELLL 174
Query: 289 STNKFTMKSDIFSFGVIIFELIT 311
++ + D++S G I+ EL
Sbjct: 175 GATRYGPEVDMWSVGCILAELFL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 3e-21
Identities = 74/271 (27%), Positives = 114/271 (42%), Gaps = 31/271 (11%)
Query: 125 LGQGAFGPVYKA--TMPSGGV--AAIKVLASDSHQG-EKEFQTEVSLLGRLHHRNLVNLI 179
LG G+FG V + + G V A+K L SD +F E +++ L H NL+ L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 180 GYCVDKGKYMLIYEFMSNGSL-SNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPV 238
G + M++ E GSL L A+ I++G+ YL
Sbjct: 63 GVVLTH-PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRF--- 118
Query: 239 IHRDLKSANILLDHFMRAKVADFGLSK----EEVFDGRNSGLKGTYGYIDPAYISTNKFT 294
IHRDL + NILL + K+ DFGL + E LK + + P + T F+
Sbjct: 119 IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFS 178
Query: 295 MKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQ-----DGVDEILDKQLVGACNIQE 349
SD++ FGV ++E+ T + L S SQ D E L++ AC Q+
Sbjct: 179 HASDVWMFGVTLWEMFT-----YGEEPWAGL-SGSQILKKIDKEGERLERP--EACP-QD 229
Query: 350 VRELARIGHKCLHKTPRKRPSIGEVTQALLK 380
+ + +C P RP+ + + L +
Sbjct: 230 IYNVML---QCWAHNPADRPTFAALREFLPE 257
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 3e-21
Identities = 61/211 (28%), Positives = 111/211 (52%), Gaps = 24/211 (11%)
Query: 122 TNILGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGE-KEFQTEVSLLGRLHHRNLVNLI 179
++G+GA+G VY+ +P+G V A+K++ D+ + + Q EV+LL +L N+
Sbjct: 6 LELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNIT 65
Query: 180 GYCVDKGKYM------LIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISH---GIEYL 230
Y G Y+ +I E+ GS+ L+ + E+ I++ I ++Y+
Sbjct: 66 KY---YGSYLKGPRLWIIMEYAEGGSVRTLM----KAGPIAEKY-ISVIIREVLVALKYI 117
Query: 231 HEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD-GRNSGLKGTYGYIDPAYIS 289
H+ VIHRD+K+ANIL+ + K+ DFG++ + + S GT ++ P I+
Sbjct: 118 HKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVIT 174
Query: 290 TNK-FTMKSDIFSFGVIIFELITAIHPHQNL 319
K + K+DI+S G+ I+E+ T P+ ++
Sbjct: 175 EGKYYDTKADIWSLGITIYEMATGNPPYSDV 205
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 4e-21
Identities = 71/277 (25%), Positives = 124/277 (44%), Gaps = 37/277 (13%)
Query: 124 ILGQGAFGPVYKATMP----SGG--VAAIKVLAS-DSHQGEKEFQTEVSLLGRLHHRNLV 176
LG+G FG V+ A GG + +K L + EF+ E+ + +L H+N+V
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 177 NLIGYCVDKGKYMLIYEFMSNGSLSN-LIYSEERV-------LNWEERLQIALDISHGIE 228
L+G C + + +I E+ G L L ++ + L+ ++++ + I+ G++
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 229 YLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKE----EVFDGRNSGLKGTYGYID 284
+L +HRDL + N L+ KV+ LSK+ E + RN ++
Sbjct: 132 HLSNARF---VHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRN--ALIPLRWLA 186
Query: 285 PAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLM--EYVNLASMSQDGVDEILDKQL 341
P + + F+ KSD++SFGV+++E+ T P L E +N Q G +L
Sbjct: 187 PEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLN---RLQAG-----KLEL 238
Query: 342 VGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQAL 378
L ++ +C P+ RPS E+ AL
Sbjct: 239 PVPEGCPS--RLYKLMTRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 4e-21
Identities = 69/206 (33%), Positives = 107/206 (51%), Gaps = 21/206 (10%)
Query: 124 ILGQGAFGPVY---KATMP-SGGVAAIKVLASDSHQGEKEFQT--EVSLLGRLHHRNLVN 177
+LGQG+FG V+ K T P +G + A+KVL + + +T E +L ++H +V
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 178 LIGYCVDKGKYMLIYEFMSNGSL-----SNLIYSEERVLNWEERLQIALDISHGIEYLHE 232
L +GK LI +F+ G L ++++EE V + L +ALD H +
Sbjct: 63 LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG---- 118
Query: 233 GAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEV-FDGRNSGLKGTYGYIDPAYISTN 291
+I+RDLK NILLD K+ DFGLSKE + + + GT Y+ P ++
Sbjct: 119 -----IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRR 173
Query: 292 KFTMKSDIFSFGVIIFELITAIHPHQ 317
T +D +SFGV++FE++T P Q
Sbjct: 174 GHTQSADWWSFGVLMFEMLTGSLPFQ 199
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 6e-21
Identities = 59/209 (28%), Positives = 106/209 (50%), Gaps = 25/209 (11%)
Query: 124 ILGQGAFGPVYKAT-MPSGGVAAIKVL------ASDSHQGEKEFQTEVSLLGRLHHRNLV 176
LG GAF Y+A + +G + A+K + +S+ + + + E+ L+ RL+H +++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 177 NLIGYCVDKGKYMLIYEFMSNGSLSNLIYS----EERVLNWEERLQIALDISHGIEYLHE 232
++G + + L E+M+ GS+S+L+ +E V+ + G+ YLHE
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVII-----NYTEQLLRGLSYLHE 121
Query: 233 GAVPPVIHRDLKSANILLDHF-MRAKVADFGLSKEEVFDGRNSG-----LKGTYGYIDPA 286
+IHRD+K AN+L+D R ++ADFG + G +G L GT ++ P
Sbjct: 122 NQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178
Query: 287 YISTNKFTMKSDIFSFGVIIFELITAIHP 315
+ ++ D++S G +I E+ TA P
Sbjct: 179 VLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 1e-20
Identities = 80/279 (28%), Positives = 127/279 (45%), Gaps = 33/279 (11%)
Query: 120 NFTNILGQGAFGPVYKA-TMPSGGVAAIKVLASDSHQGE-KEFQTEVSLLGRLHHRNLVN 177
++G GA VY A +P+ AIK + + Q E + EV + + +H N+V
Sbjct: 4 ELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVK 63
Query: 178 LIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIAL---DISHGIEYLHEGA 234
V + L+ ++S GSL +++ S +E + IA ++ G+EYLH
Sbjct: 64 YYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAI-IATVLKEVLKGLEYLHSNG 122
Query: 235 VPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLK------GTYGYIDPAYI 288
IHRD+K+ NILL K+ADFG+S + DG + K GT ++ P +
Sbjct: 123 Q---IHRDIKAGNILLGEDGSVKIADFGVSAS-LADGGDRTRKVRKTFVGTPCWMAPEVM 178
Query: 289 STNK-FTMKSDIFSFGVIIFELITAIHPHQNL--MEYVNLASMSQD--GVDEILDKQLVG 343
+ K+DI+SFG+ EL T P+ M+ V + ++ D ++ D +
Sbjct: 179 EQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-VLMLTLQNDPPSLETGADYKKYS 237
Query: 344 ACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIK 382
R++ CL K P KRP+ E LLK K
Sbjct: 238 K----SFRKMIS---LCLQKDPSKRPTAEE----LLKHK 265
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 2e-20
Identities = 73/269 (27%), Positives = 120/269 (44%), Gaps = 37/269 (13%)
Query: 123 NILGQGAFGPVYKATMPSGG-VAAIKVLASDSHQG-EKEFQTEVSLLGRLHHRNLVNLIG 180
+ LG+GA G V K + + G + A+K + +D + +K+ E+ + +V G
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYG 66
Query: 181 YCVDKGKYML--IYEFMSNGSLSNLIYSE---------ERVLNWEERLQIALDISHGIEY 229
+D+ + E+ GSL + IY + E+VL +IA + G+ Y
Sbjct: 67 AFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEKVL-----GKIAESVLKGLSY 120
Query: 230 LHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLK---GTYGYIDPA 286
LH + IHRD+K +NILL + K+ DFG+S E V NS GT Y+ P
Sbjct: 121 LHSRKI---IHRDIKPSNILLTRKGQVKLCDFGVSGELV----NSLAGTFTGTSFYMAPE 173
Query: 287 YISTNKFTMKSDIFSFGVIIFELITAIHP-----HQNLMEYVNLASMSQDGVDEILDKQL 341
I +++ SD++S G+ + E+ P L L+ + E+ D+
Sbjct: 174 RIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPG 233
Query: 342 VGACNIQEVRELARIGHKCLHKTPRKRPS 370
G I+ E +CL K P +RP+
Sbjct: 234 NG---IKWSEEFKDFIKQCLEKDPTRRPT 259
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 2e-20
Identities = 64/209 (30%), Positives = 104/209 (49%), Gaps = 26/209 (12%)
Query: 125 LGQGAFGPVYKATM----PSGG--VAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNL 178
LG+GAFG V+ A P + A+K L S K+F E LL L H ++V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 179 IGYCVDKGKYMLIYEFMSNGSLSNLI--YSEERVLNWE----------ERLQIALDISHG 226
G CV+ ++++E+M +G L+ + + + VL E + L IA I+ G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 227 IEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKG----TYGY 282
+ YL A +HRDL + N L+ + K+ DFG+S+ +V+ + G +
Sbjct: 133 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR-DVYSTDYYRVGGHTMLPIRW 188
Query: 283 IDPAYISTNKFTMKSDIFSFGVIIFELIT 311
+ P I KFT +SD++S GV+++E+ T
Sbjct: 189 MPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 2e-20
Identities = 65/203 (32%), Positives = 106/203 (52%), Gaps = 12/203 (5%)
Query: 125 LGQGAFGPVYKA-TMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCV 183
LG GAFG VYKA +G +AA KV+ + S + +++ E+ +L +H +V L+G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 184 DKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDL 243
GK ++ EF G++ ++ +R L + I + ++YLH +IHRDL
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS---MKIIHRDL 136
Query: 244 KSANILLDHFMRAKVADFGLSKEEV--FDGRNSGLKGTYGYIDPAYI--STNK---FTMK 296
K+ N+LL K+ADFG+S + V R+S + GT ++ P + T K + K
Sbjct: 137 KAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-GTPYWMAPEVVMCETMKDTPYDYK 195
Query: 297 SDIFSFGVIIFELITAIHPHQNL 319
+DI+S G+ + E+ PH L
Sbjct: 196 ADIWSLGITLIEMAQIEPPHHEL 218
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 7e-20
Identities = 69/226 (30%), Positives = 109/226 (48%), Gaps = 25/226 (11%)
Query: 98 TSAPSASGIPRYAYKDIQKATQNFT-----NILGQGAFGPVYKAT-MPSGGVAAIKVLAS 151
S+ S+S A A ++ + N +G GA G VYK P+G + A+KV+
Sbjct: 50 PSSSSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYG 109
Query: 152 DSHQGEKEFQT--EVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEER 209
+ H+ Q E+ +L ++H N+V G+ ++ EFM GSL ++E+
Sbjct: 110 N-HEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQ 168
Query: 210 VLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSK--EE 267
L +A I GI YLH + +HRD+K +N+L++ K+ADFG+S+ +
Sbjct: 169 FLA-----DVARQILSGIAYLHRRHI---VHRDIKPSNLLINSAKNVKIADFGVSRILAQ 220
Query: 268 VFDGRNSGLKGTYGYIDPAYISTNKFTMK-----SDIFSFGVIIFE 308
D NS + GT Y+ P I+T+ DI+S GV I E
Sbjct: 221 TMDPCNSSV-GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILE 265
|
Length = 353 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 7e-20
Identities = 73/271 (26%), Positives = 113/271 (41%), Gaps = 38/271 (14%)
Query: 125 LGQGAFGPVYKATMPSGG-VAAIKVLASDSHQGE---KEFQTEVSLLGRLHHRNLVNLIG 180
+ +GA+G V+ A S G + AIKV+ + + TE +L + +V L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59
Query: 181 YCVDKGKYM-LIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVI 239
Y K + L+ E++ G L++L+ + L+ + +I +EYLH + I
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLENVG-SLDEDVARIYIAEIVLALEYLHSNGI---I 115
Query: 240 HRDLKSANILLDHFMRAKVADFGLSKE---------EVFDGRNSGLKGTYGYIDPAYIST 290
HRDLK NIL+D K+ DFGLSK + + + GT YI P I
Sbjct: 116 HRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG 175
Query: 291 NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEV 350
+ D +S G I++E + I P + +EI L G E
Sbjct: 176 QGHSKTVDWWSLGCILYEFLVGIPPFHG------------ETPEEIFQNILNGKIEWPED 223
Query: 351 RELAR----IGHKCLHKTPRKRP---SIGEV 374
E++ + K L P KR SI E+
Sbjct: 224 VEVSDEAIDLISKLLVPDPEKRLGAKSIEEI 254
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 9e-20
Identities = 75/279 (26%), Positives = 129/279 (46%), Gaps = 39/279 (13%)
Query: 125 LGQGAFGPVYKATMP-----SGGVAAIKVLASDSHQGE-KEFQTEVSLLGRLHHRNLVNL 178
LG+G FG V +G A+K L +S + + E+ +L L+H N+V
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 179 IGYCVDKG--KYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVP 236
G C + G LI EF+ +GSL + + +N +++L+ A+ I G++YL
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYL---GSR 128
Query: 237 PVIHRDLKSANILLDHFMRAKVADFGLSK-----EEVFDGRNSGLKGTYGYIDPAYISTN 291
+HRDL + N+L++ + K+ DFGL+K +E + ++ + Y P + +
Sbjct: 129 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYA-PECLIQS 187
Query: 292 KFTMKSDIFSFGVIIFELIT--------------AIHPHQNLMEYVNLASMSQDGVDEIL 337
KF + SD++SFGV ++EL+T I P M L + ++G
Sbjct: 188 KFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEG----- 242
Query: 338 DKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQ 376
K+L N E E+ ++ KC P KR + + +
Sbjct: 243 -KRLPRPPNCPE--EVYQLMRKCWEFQPSKRTTFQNLIE 278
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 1e-19
Identities = 62/202 (30%), Positives = 99/202 (49%), Gaps = 10/202 (4%)
Query: 125 LGQGAFGPVYKATMPSGGV-AAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCV 183
LG GAFG VYKA GV AA KV+ + S + +++ E+ +L H N+V L+
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 184 DKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDL 243
+ ++ EF + G++ ++ ER L + + + YLHE +IHRDL
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDL 129
Query: 244 KSANILLDHFMRAKVADFGLSKEEVFD-GRNSGLKGTYGYIDPAYI--STNK---FTMKS 297
K+ NIL K+ADFG+S + R GT ++ P + T+K + K+
Sbjct: 130 KAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKA 189
Query: 298 DIFSFGVIIFELITAIHPHQNL 319
D++S G+ + E+ PH L
Sbjct: 190 DVWSLGITLIEMAQIEPPHHEL 211
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 2e-19
Identities = 58/199 (29%), Positives = 104/199 (52%), Gaps = 16/199 (8%)
Query: 124 ILGQGAFGPVYKATMPSGG----VAAIKVL-ASDSHQGEKEFQTEVSLLGRLHHRNLVNL 178
++G G FG V + G AIK L A + + ++F +E S++G+ H N+++L
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 179 IGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPV 238
G M++ E+M NGSL + + + + + I+ G++YL +
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG---Y 127
Query: 239 IHRDLKSANILLDHFMRAKVADFGLSK------EEVFDGRNSGLKGTYGYIDPAYISTNK 292
+HRDL + NIL++ + KV+DFGLS+ E + R G K + P I+ K
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR--GGKIPIRWTAPEAIAYRK 185
Query: 293 FTMKSDIFSFGVIIFELIT 311
FT SD++S+G++++E+++
Sbjct: 186 FTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 3e-19
Identities = 72/280 (25%), Positives = 127/280 (45%), Gaps = 40/280 (14%)
Query: 113 DIQKATQNFTNILGQGAFGPVYKAT-MPSGGVAAIKVLA----SDSHQGEKEFQTEVSLL 167
I+K +G+G F VYKA + G V A+K + D+ + + E+ LL
Sbjct: 5 KIEKK-------IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK-EIDLL 56
Query: 168 GRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYS--------EERVLNWEERLQI 219
+L H N++ + ++ + ++ E G LS +I ER + W+ +Q+
Sbjct: 57 KQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTI-WKYFVQL 115
Query: 220 ALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNS---GL 276
+E++H + +HRD+K AN+ + K+ D GL + F + + L
Sbjct: 116 C----SALEHMHSKRI---MHRDIKPANVFITATGVVKLGDLGLGR--FFSSKTTAAHSL 166
Query: 277 KGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEI 336
GT Y+ P I N + KSDI+S G +++E+ P + +NL S+ + +++
Sbjct: 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY--GDKMNLYSLCKK-IEKC 223
Query: 337 LDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQ 376
L +E+R+L C++ P KRP I V Q
Sbjct: 224 DYPPLPADHYSEELRDLVSR---CINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 1e-18
Identities = 63/210 (30%), Positives = 107/210 (50%), Gaps = 19/210 (9%)
Query: 121 FTNILGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRL-HHRNLVNL 178
++G G +G VYK + +G +AAIKV+ + E+E + E+++L + HHRN+
Sbjct: 10 LVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIATY 68
Query: 179 IGYCVDKG------KYMLIYEFMSNGSLSNLIYSEE-RVLNWEERLQIALDISHGIEYLH 231
G + K + L+ EF GS+++LI + + L E I +I G+ +LH
Sbjct: 69 YGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH 128
Query: 232 EGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKE-EVFDGRNSGLKGTYGYIDPAYIST 290
+ V IHRD+K N+LL K+ DFG+S + + GR + GT ++ P I+
Sbjct: 129 QHKV---IHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 185
Query: 291 NK-----FTMKSDIFSFGVIIFELITAIHP 315
++ + KSD++S G+ E+ P
Sbjct: 186 DENPDATYDFKSDLWSLGITAIEMAEGAPP 215
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 1e-18
Identities = 53/195 (27%), Positives = 90/195 (46%), Gaps = 8/195 (4%)
Query: 122 TNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKE---FQTEVSLLGRLHHRNLVNL 178
++G+GAFG V+ + I + E Q E +L L H N++
Sbjct: 5 IRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEY 64
Query: 179 IGYCVDKGKYMLIYEFMSNGSLSNLIYSEER-VLNWEERLQIALDISHGIEYLHEGAVPP 237
++ M++ E+ G+L+ I +L+ + L + I + ++H +
Sbjct: 65 YENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLI-- 122
Query: 238 VIHRDLKSANILLD-HFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMK 296
+HRDLK+ NILLD H M K+ DFG+SK + + GT YI P + K
Sbjct: 123 -LHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQK 181
Query: 297 SDIFSFGVIIFELIT 311
SDI++ G +++EL +
Sbjct: 182 SDIWALGCVLYELAS 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 1e-18
Identities = 63/201 (31%), Positives = 102/201 (50%), Gaps = 21/201 (10%)
Query: 124 ILGQGAFGPVYKAT-MPSGGVA----AIKVL-ASDSHQGEKEFQTEVSLLGRLHHRNLVN 177
+LG GAFG VYK +P G AIK+L + + EF E ++ + H +LV
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 178 LIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPP 237
L+G C+ L+ + M +G L + ++ + + + L + I+ G+ YL E +
Sbjct: 74 LLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRL-- 130
Query: 238 VIHRDLKSANILLDHFMRAKVADFGLS-------KEEVFDGRNSGLKGTYGYIDPAYIST 290
+HRDL + N+L+ K+ DFGL+ KE DG +K ++ I
Sbjct: 131 -VHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK----WMALECIHY 185
Query: 291 NKFTMKSDIFSFGVIIFELIT 311
KFT +SD++S+GV I+EL+T
Sbjct: 186 RKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 2e-18
Identities = 62/206 (30%), Positives = 95/206 (46%), Gaps = 14/206 (6%)
Query: 124 ILGQGAFGPVYKA-TMPSGGVAAIKVLASDSHQGE-----KEFQTEVSLLGRLHHRNLVN 177
+LGQGAFG VY + +G A+K + D E + E+ LL L H +V
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 178 LIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPP 237
G D + E+M GS+ + + + + R + I G+EYLH +
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTR-KYTRQILEGVEYLHSNMI-- 125
Query: 238 VIHRDLKSANILLDHFMRAKVADFGLSKE-EVFDGRNSGLK---GTYGYIDPAYISTNKF 293
+HRD+K ANIL D K+ DFG SK + +G+K GT ++ P IS +
Sbjct: 126 -VHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGY 184
Query: 294 TMKSDIFSFGVIIFELITAIHPHQNL 319
K+D++S G + E++T P
Sbjct: 185 GRKADVWSVGCTVVEMLTEKPPWAEF 210
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 2e-18
Identities = 61/211 (28%), Positives = 108/211 (51%), Gaps = 31/211 (14%)
Query: 124 ILGQGAFGPVY--KATMPSGGVAAIKVLASDSHQGEKEF-QTEVSLLGRLHHRNLVNLIG 180
+G+G+FG +Y KA S ++ + EKE + EV LL ++ H N+V
Sbjct: 7 KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 181 YCVDKGKYMLIYEFMSNGSLSNLI-------YSEERVLNWEERLQIALDISHGIEYLHEG 233
+ G+ ++ E+ G L I +SE+++L+W +QI+L G++++H+
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW--FVQISL----GLKHIHDR 120
Query: 234 AVPPVIHRDLKSANILLD-HFMRAKVADFGLSKEEVFDGRNSGLK------GTYGYIDPA 286
+ +HRD+KS NI L + M AK+ DFG++++ N ++ GT Y+ P
Sbjct: 121 KI---LHRDIKSQNIFLSKNGMVAKLGDFGIARQ-----LNDSMELAYTCVGTPYYLSPE 172
Query: 287 YISTNKFTMKSDIFSFGVIIFELITAIHPHQ 317
+ K+DI+S G +++EL T HP +
Sbjct: 173 ICQNRPYNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 3e-18
Identities = 61/211 (28%), Positives = 104/211 (49%), Gaps = 35/211 (16%)
Query: 124 ILGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRL-HHRNLVNLIG- 180
++G+G +G VYKA +G + AIK++ + E+E + E ++L + +H N+ G
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKYSNHPNIATFYGA 71
Query: 181 -----YCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERL---QIAL---DISHGIEY 229
+ + L+ E GS+++L+ + + +RL IA + G+ Y
Sbjct: 72 FIKKNPPGNDDQLWLVMELCGGGSVTDLV---KGLRKKGKRLKEEWIAYILRETLRGLAY 128
Query: 230 LHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKE--EVFDGRNSGLKGTYGYIDPAY 287
LHE V IHRD+K NILL K+ DFG+S + RN+ + GT ++ P
Sbjct: 129 LHENKV---IHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-GTPYWMAPEV 184
Query: 288 ISTNK-----FTMKSDIFSFGVIIFELITAI 313
I+ ++ + +SD++S G ITAI
Sbjct: 185 IACDEQPDASYDARSDVWSLG------ITAI 209
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 3e-18
Identities = 77/307 (25%), Positives = 124/307 (40%), Gaps = 66/307 (21%)
Query: 120 NFTNILGQGAFGPVYKATM----------PSGGV-------AAIKVLASDSHQGEK-EFQ 161
NF LG+G FG V+ + A+KVL D+ + +F
Sbjct: 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67
Query: 162 TEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEE----------RVL 211
EV +L RL N+ L+G C +I E+M NG L+ + + L
Sbjct: 68 KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127
Query: 212 NWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG 271
++ L +A I+ G+ YL +HRDL + N L+ K+ADFG+S
Sbjct: 128 SFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLVGKNYTIKIADFGMS------- 177
Query: 272 RNSGLKGTYGYID---PAYIS--------TNKFTMKSDIFSFGVIIFELITAI--HPHQN 318
+ Y + P I KFT KSD+++FGV ++E++T P+++
Sbjct: 178 -RNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236
Query: 319 L-----MEYVNLASMSQD-GVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIG 372
L +E N +D G L + C +++ EL +C + RP+
Sbjct: 237 LTDQQVIE--NAGHFFRDDGRQIYLPRP--PNCP-KDIYELML---ECWRRDEEDRPTFR 288
Query: 373 EVTQALL 379
E+ L
Sbjct: 289 EIHLFLQ 295
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 3e-18
Identities = 60/201 (29%), Positives = 101/201 (50%), Gaps = 12/201 (5%)
Query: 124 ILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQ---TEVSLLGRLHHRNLVNLI 179
+LG+G+FG V A + SG + A+KVL D + + + TE +L + + +
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 180 GYCVDK-GKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQI-ALDISHGIEYLHEGAVPP 237
C + + EF++ G L I R E R + A +I+ + +LH+ +
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD--EARARFYAAEITSALMFLHDKGI-- 117
Query: 238 VIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGR-NSGLKGTYGYIDPAYISTNKFTMK 296
I+RDLK N+LLDH K+ADFG+ KE +F+G+ S GT YI P + +
Sbjct: 118 -IYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPS 176
Query: 297 SDIFSFGVIIFELITAIHPHQ 317
D ++ GV+++E++ P +
Sbjct: 177 VDWWAMGVLLYEMLCGHAPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 84.1 bits (209), Expect = 3e-18
Identities = 60/203 (29%), Positives = 90/203 (44%), Gaps = 16/203 (7%)
Query: 120 NFTNILGQGAFGPVYKA-TMPSGGVAAIKVLASDS--HQGEKE-FQTEVSLLGRLHHRNL 175
F LG G+FG V SG A+K+L+ + E E +L + H L
Sbjct: 4 EFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFL 63
Query: 176 VNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERL---QIALDISHGIEYLHE 232
VNL G D L+ E++ G L + + R R Q+ L +EYLH
Sbjct: 64 VNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVL----ALEYLHS 119
Query: 233 GAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNK 292
+ ++RDLK N+LLD K+ DFG +K GR L GT Y+ P I +
Sbjct: 120 LDI---VYRDLKPENLLLDSDGYIKITDFGFAKRV--KGRTYTLCGTPEYLAPEIILSKG 174
Query: 293 FTMKSDIFSFGVIIFELITAIHP 315
+ D ++ G++I+E++ P
Sbjct: 175 YGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 4e-18
Identities = 72/268 (26%), Positives = 123/268 (45%), Gaps = 27/268 (10%)
Query: 123 NILGQGAFGPVYKATMPSGGVAAI--KVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIG 180
N++ +G G YK G+ + ++ +S +E++ +G+L H N+V LIG
Sbjct: 696 NVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP-----SSEIADMGKLQHPNIVKLIG 750
Query: 181 YC-VDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVI 239
C +KG Y LI+E++ +LS ++ R L+WE R +IA+ I+ + +LH P V+
Sbjct: 751 LCRSEKGAY-LIHEYIEGKNLSEVL----RNLSWERRRKIAIGIAKALRFLHCRCSPAVV 805
Query: 240 HRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDI 299
+L I++D LS + + Y+ P T T KSDI
Sbjct: 806 VGNLSPEKIIID---GKDEPHLRLSLPGLLCTDTKCFISS-AYVAPETRETKDITEKSDI 861
Query: 300 FSFGVIIFELITAIHP-------HQNLMEYVNLASMSQDGVDEILDKQLVG--ACNIQEV 350
+ FG+I+ EL+T P H +++E+ S +D +D + G + N E+
Sbjct: 862 YGFGLILIELLTGKSPADAEFGVHGSIVEWARY-CYSDCHLDMWIDPSIRGDVSVNQNEI 920
Query: 351 RELARIGHKCLHKTPRKRPSIGEVTQAL 378
E+ + C P RP +V + L
Sbjct: 921 VEVMNLALHCTATDPTARPCANDVLKTL 948
|
Length = 968 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 4e-18
Identities = 60/218 (27%), Positives = 104/218 (47%), Gaps = 35/218 (16%)
Query: 125 LGQGAFGPVYKAT---------MPSG------GVAAIKVLASDSHQGEK-EFQTEVSLLG 168
LG+G FG V+ + + A+K+L +D + + +F E+ ++
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 169 RLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNL-----IYSEERVLN------WEERL 217
RL + N++ L+G CV +I E+M NG L+ I S N L
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 218 QIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLK 277
+A+ I+ G++YL A +HRDL + N L+ + K+ADFG+S+ ++ G ++
Sbjct: 133 YMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSR-NLYSGDYYRIQ 188
Query: 278 G----TYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT 311
G ++ I KFT SD+++FGV ++E+ T
Sbjct: 189 GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 5e-18
Identities = 57/193 (29%), Positives = 102/193 (52%), Gaps = 14/193 (7%)
Query: 125 LGQGAFGPVYKAT--MPSGGV-AAIKVLASDSHQGEK-EFQTEVSLLGRLHHRNLVNLIG 180
LG G FG V K M + AIKVL +++ + + E E ++ +L + +V +IG
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 181 YCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIH 240
C + ML+ E S G L+ + ++ + +++ +S G++YL +H
Sbjct: 63 VC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNF---VH 118
Query: 241 RDLKSANILLDHFMRAKVADFGLSK-----EEVFDGRNSGLKGTYGYIDPAYISTNKFTM 295
RDL + N+LL + AK++DFGLSK + + R++G K + P I+ KF+
Sbjct: 119 RDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG-KWPLKWYAPECINFRKFSS 177
Query: 296 KSDIFSFGVIIFE 308
+SD++S+G+ ++E
Sbjct: 178 RSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 6e-18
Identities = 69/262 (26%), Positives = 128/262 (48%), Gaps = 21/262 (8%)
Query: 125 LGQGAFGPVYKAT--MPSGGVAAIKVLASD--SHQGEKEFQTEVSLLGRLHHRNLVNLIG 180
+G+G F VY+AT + VA KV + + ++ E+ LL +L+H N++ +
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 181 YCVDKGKYMLIYEFMSNGSLSNLI--YSEERVLNWEERL-QIALDISHGIEYLHEGAVPP 237
++ + ++ E G LS +I + +++ L E + + + + +E++H V
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRV-- 127
Query: 238 VIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSG---LKGTYGYIDPAYISTNKFT 294
+HRD+K AN+ + K+ D GL + F + + L GT Y+ P I N +
Sbjct: 128 -MHRDIKPANVFITATGVVKLGDLGLGR--FFSSKTTAAHSLVGTPYYMSPERIHENGYN 184
Query: 295 MKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELA 354
KSDI+S G +++E+ P + +NL S+ Q +++ L +++REL
Sbjct: 185 FKSDIWSLGCLLYEMAALQSPFYG--DKMNLFSLCQK-IEQCDYPPLPTEHYSEKLRELV 241
Query: 355 RIGHKCLHKTPRKRPSIGEVTQ 376
+ C++ P +RP IG V Q
Sbjct: 242 SM---CIYPDPDQRPDIGYVHQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 8e-18
Identities = 65/207 (31%), Positives = 99/207 (47%), Gaps = 14/207 (6%)
Query: 124 ILGQGAFGPVYKATMPSGGVA-AIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYC 182
+LG+G +G VY A S V AIK + + + E++L L HRN+V +G
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 183 VDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQI--ALDISHGIEYLHEGAVPPVIH 240
+ G + + E + GSLS L+ S+ L E+ I I G++YLH+ ++H
Sbjct: 75 SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVH 131
Query: 241 RDLKSANILLDHFMRA-KVADFGLSKEEVFDGRN---SGLKGTYGYIDPAYISTNK--FT 294
RD+K N+L++ + K++DFG SK G N GT Y+ P I +
Sbjct: 132 RDIKGDNVLVNTYSGVVKISDFGTSKR--LAGINPCTETFTGTLQYMAPEVIDKGPRGYG 189
Query: 295 MKSDIFSFGVIIFELITAIHPHQNLME 321
+DI+S G I E+ T P L E
Sbjct: 190 APADIWSLGCTIVEMATGKPPFIELGE 216
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 1e-17
Identities = 74/274 (27%), Positives = 128/274 (46%), Gaps = 32/274 (11%)
Query: 125 LGQGAFGPVYKATM-------PSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVN 177
LGQG+FG VY+ P VA V + S + EF E S++ + ++V
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 178 LIGYCVDKGKYMLIYEFMSNGSLSNLIYS---------EERVLNWEERLQIALDISHGIE 228
L+G ++I E M+ G L + + S + + ++ +Q+A +I+ G+
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 229 YLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKE-EVFDGRNSGLKGTYG--YIDP 285
YL+ +HRDL + N ++ K+ DFG++++ D G KG ++ P
Sbjct: 134 YLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190
Query: 286 AYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGA 344
+ FT SD++SFGV+++E+ T A P+Q + L + + G +LDK
Sbjct: 191 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGG---LLDKP--DN 245
Query: 345 CNIQEVRELARIGHKCLHKTPRKRPSIGEVTQAL 378
C + EL R+ C P+ RPS E+ ++
Sbjct: 246 CP-DMLFELMRM---CWQYNPKMRPSFLEIISSI 275
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 82.2 bits (204), Expect = 2e-17
Identities = 57/198 (28%), Positives = 89/198 (44%), Gaps = 20/198 (10%)
Query: 125 LGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKE---FQT--EVSLLGRLHHRNLVNL 178
LG+G + VYKA +G + AIK + + K+ F E+ LL L H N++ L
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 179 IGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPV 238
+ K L++EFM L +I + VL + L G+EYLH +
Sbjct: 68 LDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWI--- 123
Query: 239 IHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYIS------TNK 292
+HRDLK N+L+ K+ADFGL++ R T+ + Y +
Sbjct: 124 LHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM----THQVVTRWYRAPELLFGARH 179
Query: 293 FTMKSDIFSFGVIIFELI 310
+ + D++S G I EL+
Sbjct: 180 YGVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 2e-17
Identities = 60/203 (29%), Positives = 102/203 (50%), Gaps = 12/203 (5%)
Query: 120 NFTNILGQGAFGPVYKATMPSGG-VAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNL 178
NF I G+G+ G V AT+ S G + A+K + Q + EV ++ H N+V +
Sbjct: 24 NFIKI-GEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEM 82
Query: 179 IGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPV 238
+ + ++ EF+ G+L++++ +N E+ + L + + LH V
Sbjct: 83 YNSYLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLKALSVLHAQGV--- 137
Query: 239 IHRDLKSANILLDHFMRAKVADFGLSKE---EVFDGRNSGLKGTYGYIDPAYISTNKFTM 295
IHRD+KS +ILL H R K++DFG + EV R L GT ++ P IS +
Sbjct: 138 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSLVGTPYWMAPELISRLPYGP 195
Query: 296 KSDIFSFGVIIFELITAIHPHQN 318
+ DI+S G+++ E++ P+ N
Sbjct: 196 EVDIWSLGIMVIEMVDGEPPYFN 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 2e-17
Identities = 74/289 (25%), Positives = 135/289 (46%), Gaps = 47/289 (16%)
Query: 125 LGQGAFGPVYKATM-------PSGGV-AAIKVLASDSHQGE-KEFQTEVSLLGRL-HHRN 174
LG+G FG V A P+ A+K+L SD+ + + + +E+ ++ + H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 175 LVNLIGYCVDKGKYMLIYEFMSNGSLS---------------NLIYSEERVLNWEERLQI 219
++NL+G C G +I E+ S G+L N E L++++ +
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 220 ALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKE----EVFDGRNSG 275
A ++ G+EYL A IHRDL + N+L+ K+ADFGL+++ + + +G
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 276 LKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT---AIHPHQNLMEYVNLASMSQDG 332
+ ++ P + +T +SD++SFGV+++E+ T + +P + E L
Sbjct: 203 -RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR- 260
Query: 333 VDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKI 381
+DK C EL + C H P +RP+ ++ + L +I
Sbjct: 261 ----MDKP--SNCT----NELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 3e-17
Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 8/204 (3%)
Query: 125 LGQGAFGPVYKATMP-SGGVAAIKVLASD---SHQGEKEFQTEVSLLGRLHHRNLVNLIG 180
LG+G FG V + +G + A K L +GE+ E +L ++ R +V+L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 181 YCVDKGKYMLIYEFMSNGSLSNLIYS-EERVLNWEERLQIALDISHGIEYLHEGAVPPVI 239
K L+ M+ G L IY+ E + A I G+E+LH+ + +
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRI---V 117
Query: 240 HRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDI 299
+RDLK N+LLD +++D GL+ E + G GT GY+ P + + D
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDW 177
Query: 300 FSFGVIIFELITAIHPHQNLMEYV 323
F+ G ++E+I P + E V
Sbjct: 178 FALGCTLYEMIAGRSPFRQRKEKV 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-17
Identities = 74/289 (25%), Positives = 136/289 (47%), Gaps = 47/289 (16%)
Query: 125 LGQGAFGPVYKATM-------PSGGVA-AIKVLASDSHQGE-KEFQTEVSLLGRL-HHRN 174
LG+G FG V A P+ V A+K+L D+ + + +E+ ++ + H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 175 LVNLIGYCVDKGKYMLIYEFMSNGSLSNLI---------YS------EERVLNWEERLQI 219
++NL+G C G ++ E+ S G+L + YS E L +++ +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 220 ALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKE----EVFDGRNSG 275
A ++ G+EYL A IHRDL + N+L+ K+ADFGL+++ + + +G
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 276 LKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT---AIHPHQNLMEYVNLASMSQDG 332
+ ++ P + +T +SD++SFGV+++E+ T + +P + E L
Sbjct: 197 -RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHR- 254
Query: 333 VDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKI 381
+DK C EL I +C H P +RP+ ++ + L ++
Sbjct: 255 ----MDKP--ANCT----HELYMIMRECWHAVPSQRPTFKQLVEDLDRV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 3e-17
Identities = 77/293 (26%), Positives = 133/293 (45%), Gaps = 55/293 (18%)
Query: 125 LGQGAFGPVYKATM-------PSGGVA-AIKVLASDSHQGEKEFQTEVS------LLGRL 170
LG+G FG V A P V A+K+L D+ EK+ VS ++G+
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGK- 79
Query: 171 HHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLI-----------YSEERV----LNWEE 215
H+N++NL+G C G +I E+ S G+L + Y RV + +++
Sbjct: 80 -HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKD 138
Query: 216 RLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKE----EVFDG 271
+ ++ G+EYL A IHRDL + N+L+ K+ADFGL+++ + +
Sbjct: 139 LVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKK 195
Query: 272 RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT---AIHPHQNLMEYVNLASM 328
+G + ++ P + +T +SD++SFGV+++E+ T + +P + E L
Sbjct: 196 TTNG-RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE 254
Query: 329 SQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKI 381
+DK C EL + C H P RP+ ++ + L +I
Sbjct: 255 GHR-----MDKP--ANCT----NELYMMMRDCWHAIPSHRPTFKQLVEDLDRI 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 3e-17
Identities = 65/288 (22%), Positives = 136/288 (47%), Gaps = 40/288 (13%)
Query: 114 IQKATQNFTNILGQGAFGPVYKATM--PSGGV---AAIKVLASDSHQGEKE-FQTEVSLL 167
I + +++L +G FG ++ + G +K + + + + E LL
Sbjct: 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLL 62
Query: 168 GRLHHRNLVNLIGYCV-DKGKYMLIYEFMSNGSLSNLI----YSEE---RVLNWEERLQI 219
L H+N++ ++ C+ D ++Y +M+ G+L + E + L+ ++ + +
Sbjct: 63 YGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHM 122
Query: 220 ALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF--------DG 271
A+ I+ G+ YLH+ V IH+D+ + N ++D ++ K+ D LS+ ++F D
Sbjct: 123 AIQIACGMSYLHKRGV---IHKDIAARNCVIDEELQVKITDNALSR-DLFPMDYHCLGDN 178
Query: 272 RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQ 330
N +K ++ + +++ SD++SFGV+++EL+T P+ + + +A+ +
Sbjct: 179 ENRPVK----WMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF-EMAAYLK 233
Query: 331 DGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQAL 378
DG +L N + EL + C P +RPS ++ Q L
Sbjct: 234 DG------YRLAQPINCPD--ELFAVMACCWALDPEERPSFSQLVQCL 273
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 4e-17
Identities = 61/207 (29%), Positives = 106/207 (51%), Gaps = 19/207 (9%)
Query: 124 ILGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRL-HHRNLVNLIGY 181
++G G +G VYK + +G +AAIKV+ + E+E + E+++L + HHRN+ G
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-EEEIKLEINMLKKYSHHRNIATYYGA 81
Query: 182 CVDKG------KYMLIYEFMSNGSLSNLIYSEE-RVLNWEERLQIALDISHGIEYLHEGA 234
+ K + L+ EF GS+++L+ + + L + I +I G+ +LH
Sbjct: 82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH--- 138
Query: 235 VPPVIHRDLKSANILLDHFMRAKVADFGLSKE-EVFDGRNSGLKGTYGYIDPAYISTNK- 292
VIHRD+K N+LL K+ DFG+S + + GR + GT ++ P I+ ++
Sbjct: 139 AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDEN 198
Query: 293 ----FTMKSDIFSFGVIIFELITAIHP 315
+ +SDI+S G+ E+ P
Sbjct: 199 PDATYDYRSDIWSLGITAIEMAEGAPP 225
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 5e-17
Identities = 72/288 (25%), Positives = 133/288 (46%), Gaps = 45/288 (15%)
Query: 125 LGQGAFGPVYKAT-----------MPSGGVAAIKVLASDSHQGEKEFQTEV-SLLGRLHH 172
LG+G FG V +A + V +K A+D + + E+ L+G+ H
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGK--H 77
Query: 173 RNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIY---------------SEERVLNWEERL 217
+N++NL+G C +G +I E+ + G+L + E L++++ +
Sbjct: 78 KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137
Query: 218 QIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD----GRN 273
A ++ G+EYL IHRDL + N+L+ K+ADFGL++ V D +
Sbjct: 138 SCAYQVARGMEYL---ESRRCIHRDLAARNVLVTEDNVMKIADFGLAR-GVHDIDYYKKT 193
Query: 274 SGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGV 333
S + ++ P + +T +SD++SFG++++E+ T + L + ++G
Sbjct: 194 SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREG- 252
Query: 334 DEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKI 381
+DK C EL + +C H P +RP+ ++ +AL K+
Sbjct: 253 -HRMDKP--SNCT----HELYMLMRECWHAVPTQRPTFKQLVEALDKV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 6e-17
Identities = 55/214 (25%), Positives = 109/214 (50%), Gaps = 24/214 (11%)
Query: 124 ILGQGAFGPVYKA-TMPSGGVAAIKVL-----ASDSHQGE-----KEFQTEVSLLGRLHH 172
++G+G +G VY A + +G + A+K + + H K ++E+ L L H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 173 RNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIAL--DISHGIEYL 230
N+V +G+ + + E++ GS+ + + + R +EE+L + G+ YL
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGR---FEEQLVRFFTEQVLEGLAYL 124
Query: 231 HEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSK--EEVFDG-RNSGLKGTYGYIDPAY 287
H + +HRDLK+ N+L+D K++DFG+SK ++++D +N ++G+ ++ P
Sbjct: 125 HSKGI---LHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEV 181
Query: 288 ISTNK--FTMKSDIFSFGVIIFELITAIHPHQNL 319
I + ++ K DI+S G ++ E+ P +
Sbjct: 182 IHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE 215
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 6e-17
Identities = 69/259 (26%), Positives = 121/259 (46%), Gaps = 21/259 (8%)
Query: 125 LGQGAFGPVYKATMPSGG-VAAIKV--LASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGY 181
LG+G++G VYK S A+K L S S + ++ E+ +L ++H N+++
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67
Query: 182 CVDKGKYMLIYEFMSNGSLSNLIYSEE---RVLNWEERLQIALDISHGIEYLHEGAVPPV 238
+D K ++ E+ G LS I + +++ +E +I + + G++ LHE +
Sbjct: 68 FLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKI--- 124
Query: 239 IHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLK-GTYGYIDPAYISTNKFTMKS 297
+HRDLKSANILL K+ D G+SK V + + GT Y+ P ++ KS
Sbjct: 125 LHRDLKSANILLVANDLVKIGDLGISK--VLKKNMAKTQIGTPHYMAPEVWKGRPYSYKS 182
Query: 298 DIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIG 357
DI+S G +++E+ T P + A QD ++ + I ++L
Sbjct: 183 DIWSLGCLLYEMATFAPPFE--------ARSMQDLRYKVQRGKYPPIPPIYS-QDLQNFI 233
Query: 358 HKCLHKTPRKRPSIGEVTQ 376
L P+ RP+ ++
Sbjct: 234 RSMLQVKPKLRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 8e-17
Identities = 64/208 (30%), Positives = 102/208 (49%), Gaps = 13/208 (6%)
Query: 125 LGQGAFGPVYKATM-PSGGVAAIKVLASDSHQGEKEFQ---TEVSLLGRLHHRNLVNLIG 180
LG+G FG V M +G + A K L + K ++ E +L ++H R +V+L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 181 YCVDKGKYMLIYEFMSNGSLSNLIYS--EERVLNWEER-LQIALDISHGIEYLHEGAVPP 237
K L+ M+ G L IY+ EE E R I G+E+LH+ +
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRI-- 118
Query: 238 VIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNS--GLKGTYGYIDPAYISTNKFTM 295
I+RDLK N+LLD+ +++D GL+ E + DG++ G GT G++ P + ++
Sbjct: 119 -IYRDLKPENVLLDNDGNVRISDLGLAVE-LKDGQSKTKGYAGTPGFMAPELLQGEEYDF 176
Query: 296 KSDIFSFGVIIFELITAIHPHQNLMEYV 323
D F+ GV ++E+I A P + E V
Sbjct: 177 SVDYFALGVTLYEMIAARGPFRARGEKV 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 1e-16
Identities = 59/194 (30%), Positives = 100/194 (51%), Gaps = 16/194 (8%)
Query: 125 LGQGAFGPVYKA---TMPSGGVAAIKVLASDSHQG--EKEFQTEVSLLGRLHHRNLVNLI 179
LG G FG V K S A+K+L +D++ + E E +++ +L + +V +I
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 180 GYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVI 239
G C + +ML+ E G L+ + + V + ++ +S G++YL E +
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQKNKHVTE-KNITELVHQVSMGMKYLEETNF---V 117
Query: 240 HRDLKSANILLDHFMRAKVADFGLSK-----EEVFDGRNSGLKGTYGYIDPAYISTNKFT 294
HRDL + N+LL AK++DFGLSK E + + G K + P ++ KF+
Sbjct: 118 HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG-KWPVKWYAPECMNYYKFS 176
Query: 295 MKSDIFSFGVIIFE 308
KSD++SFGV+++E
Sbjct: 177 SKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 1e-16
Identities = 76/263 (28%), Positives = 119/263 (45%), Gaps = 25/263 (9%)
Query: 124 ILGQGAFGPVYKATMPSGG--VAAIKV-LASDSHQGEKE---FQTEVSLLGRLHHRNLVN 177
+LGQGAFG VY G +AA +V +S + KE + E+ LL L H +V
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 178 LIGYCVDKGKYML--IYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAV 235
G D+ + L E+M GS+ + + + + R + I G+ YLH +
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTR-KYTRQILEGMSYLHSNMI 127
Query: 236 PPVIHRDLKSANILLDHFMRAKVADFGLSKE-EVFDGRNSGLK---GTYGYIDPAYISTN 291
+HRD+K ANIL D K+ DFG SK + +G++ GT ++ P IS
Sbjct: 128 ---VHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGE 184
Query: 292 KFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVR 351
+ K+D++S G + E++T P EY +A++ + + Q +
Sbjct: 185 GYGRKADVWSLGCTVVEMLTEKPP---WAEYEAMAAIFK------IATQPTNPQLPSHIS 235
Query: 352 ELARIGHKCLHKTPRKRPSIGEV 374
E AR C+ R RPS E+
Sbjct: 236 EHARDFLGCIFVEARHRPSAEEL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 1e-16
Identities = 73/263 (27%), Positives = 121/263 (46%), Gaps = 27/263 (10%)
Query: 121 FTNI--LGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKE-FQTEVSLLGRLHHRNLV 176
FT + +G+G+FG VYK + V AIK++ + + E E Q E+++L + +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 177 NLIGYCVDKGKYMLIYEFMSNGSLSNLIYS---EERVLNWEERLQIALDISHGIEYLHEG 233
G + K +I E++ GS +L+ EE + I +I G++YLH
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYI-----ATILREILKGLDYLHS- 119
Query: 234 AVPPVIHRDLKSANILLDHFMRAKVADFGLSKE--EVFDGRNSGLKGTYGYIDPAYISTN 291
IHRD+K+AN+LL K+ADFG++ + + RN+ GT ++ P I +
Sbjct: 120 --ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIKQS 176
Query: 292 KFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVR 351
+ K+DI+S G+ EL P+ +L L ++ K Q +
Sbjct: 177 AYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF---------LIPKNSPPTLEGQYSK 227
Query: 352 ELARIGHKCLHKTPRKRPSIGEV 374
CL+K PR RP+ E+
Sbjct: 228 PFKEFVEACLNKDPRFRPTAKEL 250
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 1e-16
Identities = 56/200 (28%), Positives = 89/200 (44%), Gaps = 15/200 (7%)
Query: 121 FTNI--LGQGAFGPVYKA-TMPSGGVAAIKVLASDSHQGEKEFQT--EVSLLGRLHHRNL 175
+ + +G+G +G VYKA +G + AIK + E+ LL L+H N+
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 176 VNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAV 235
+ L+ KG L++EFM L LI +R L + G+ + H +
Sbjct: 61 IKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGI 119
Query: 236 PPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLK---GTYGYIDPAYISTNK 292
+HRDLK N+L++ K+ADFGL++ F T Y P + +K
Sbjct: 120 ---LHRDLKPENLLINTEGVLKLADFGLAR--SFGSPVRPYTHYVVTRWYRAPELLLGDK 174
Query: 293 F-TMKSDIFSFGVIIFELIT 311
+ DI+S G I EL++
Sbjct: 175 GYSTPVDIWSVGCIFAELLS 194
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 1e-16
Identities = 61/211 (28%), Positives = 106/211 (50%), Gaps = 14/211 (6%)
Query: 113 DIQKATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLH 171
D ++ +F I G+G+ G V AT +G A+K + Q + EV ++ H
Sbjct: 19 DPREYLDSFIKI-GEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYH 77
Query: 172 HRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLH 231
H N+V++ + + ++ EF+ G+L++++ +N E+ + L + + YLH
Sbjct: 78 HENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLSVLRALSYLH 135
Query: 232 EGAVPPVIHRDLKSANILLDHFMRAKVADFG----LSKEEVFDGRNSGLKGTYGYIDPAY 287
V IHRD+KS +ILL R K++DFG +SKE + L GT ++ P
Sbjct: 136 NQGV---IHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV---PKRKSLVGTPYWMAPEV 189
Query: 288 ISTNKFTMKSDIFSFGVIIFELITAIHPHQN 318
IS + + DI+S G+++ E+I P+ N
Sbjct: 190 ISRLPYGTEVDIWSLGIMVIEMIDGEPPYFN 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 79.4 bits (195), Expect = 1e-16
Identities = 68/255 (26%), Positives = 120/255 (47%), Gaps = 17/255 (6%)
Query: 125 LGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGE-KEFQTEVSLLGRLHHRNLVNLIGYC 182
+G+G+FG V+K + V AIK++ + + E ++ Q E+++L + + G
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 183 VDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRD 242
+ K +I E++ GS +L+ E L+ + I +I G++YLH IHRD
Sbjct: 72 LKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLHS---EKKIHRD 126
Query: 243 LKSANILLDHFMRAKVADFGLSKEEV-FDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFS 301
+K+AN+LL K+ADFG++ + + + GT ++ P I + + K+DI+S
Sbjct: 127 IKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWS 186
Query: 302 FGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCL 361
G+ EL PH L L + ++ L G + + L CL
Sbjct: 187 LGITAIELAKGEPPHSELHPMKVLFLIPKNN-----PPTLEGNYS----KPLKEFVEACL 237
Query: 362 HKTPRKRPSIGEVTQ 376
+K P RP+ E+ +
Sbjct: 238 NKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 71/237 (29%), Positives = 102/237 (43%), Gaps = 60/237 (25%)
Query: 111 YKDIQKATQNFTNILGQGAFGPVYKATMPSGG--VAAIKVLASDSHQGEKEF----QTEV 164
Y+ + K LG+G FG VYKA G VA K+L + G F E+
Sbjct: 10 YEILGK--------LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG---FPITALREI 58
Query: 165 SLLGRLHHRNLVNLIGYCVDKGK---------YMLIYEFMS---NGSLSNLIYSEERVLN 212
+L +L H N+V LI V++ YM + +M +G L N V
Sbjct: 59 KILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYM-VTPYMDHDLSGLLEN-----PSV-K 111
Query: 213 WEERLQIA---LDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF 269
E QI L + GI YLHE + +HRD+K+ANIL+D+ K+ADFGL++ +
Sbjct: 112 LTES-QIKCYMLQLLEGINYLHENHI---LHRDIKAANILIDNQGILKIADFGLAR--PY 165
Query: 270 DGRNSGLKGTYGYIDPAYIST---------------NKFTMKSDIFSFGVIIFELIT 311
DG KG G Y + ++T DI+ G + E+ T
Sbjct: 166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFT 222
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 2e-16
Identities = 53/192 (27%), Positives = 83/192 (43%), Gaps = 10/192 (5%)
Query: 125 LGQGAFGPVYKATM-PSGGVAAIKVLASD---SHQGEKEFQTEVSLLGRLHHRNLVNLIG 180
LG G FG V + A+K + ++ +E +L +H +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 181 YCVDKGK-YMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVI 239
DK YML+ E+ G L ++ + R IA + EYLH + I
Sbjct: 61 TFKDKKYIYMLM-EYCLGGELWTILRDRGLFDEYTARFYIACVVL-AFEYLHNRGI---I 115
Query: 240 HRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDI 299
+RDLK N+LLD K+ DFG +K+ + GT Y+ P I + D
Sbjct: 116 YRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDY 175
Query: 300 FSFGVIIFELIT 311
+S G++++EL+T
Sbjct: 176 WSLGILLYELLT 187
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 2e-16
Identities = 56/225 (24%), Positives = 105/225 (46%), Gaps = 40/225 (17%)
Query: 121 FTNILGQGAFGPVY-------------------KATMPSGGVAAIKVLASDSHQGEK-EF 160
F LG+G FG V+ P + A+K+L D+++ + +F
Sbjct: 9 FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPV--LVAVKMLREDANKNARNDF 66
Query: 161 QTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEE----------RV 210
E+ ++ RL N++ L+ C+ +I E+M NG L+ + E
Sbjct: 67 LKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVT 126
Query: 211 LNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD 270
+++ + +A I+ G++YL + +HRDL + N L+ K+ADFG+S+ ++
Sbjct: 127 ISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSR-NLYS 182
Query: 271 GRNSGLKG----TYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT 311
G ++G ++ I KFT SD+++FGV ++E++T
Sbjct: 183 GDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 2e-16
Identities = 68/277 (24%), Positives = 121/277 (43%), Gaps = 46/277 (16%)
Query: 125 LGQGAFGPVYKATMPSGG--VAAIK-------VLASDSHQGEKEFQTEVSLLG----RLH 171
LG GAFG VYK + G + A+K D + +K VS + +L
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 172 HRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLI---------YSEERVLNWEERLQIALD 222
H N+V ++ + ++ + + L ++EER+ W +Q+ L
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERI--WNIFVQMVL- 124
Query: 223 ISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLK---GT 279
+ YLH+ ++HRDL NI+L + + DFGL+K++ S L GT
Sbjct: 125 ---ALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDFGLAKQK---QPESKLTSVVGT 176
Query: 280 YGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHP-HQNLMEYVNLASMSQDGVDEILD 338
Y P + + K+D+++FG I++++ T P + M ++LA+ + V E L
Sbjct: 177 ILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM--LSLATKIVEAVYEPLP 234
Query: 339 KQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVT 375
+ + ++V ++ CL RP I +V+
Sbjct: 235 EGMYS----EDVTDVIT---SCLTPDAEARPDIIQVS 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 3e-16
Identities = 55/206 (26%), Positives = 93/206 (45%), Gaps = 20/206 (9%)
Query: 123 NILGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKEFQT---EVSLLGRLHHRNLVNL 178
++G+GAFG V + + A+K + + + E +L L+H LVNL
Sbjct: 6 RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65
Query: 179 IGYCVDKGKYM-LIYEFMSNGSL-----SNLIYSEERVLNWEERLQIALDISHGIEYLHE 232
Y + M L+ + + G L + +SEE+V + I +I +EYLH
Sbjct: 66 W-YSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQV-----KFWIC-EIVLALEYLHS 118
Query: 233 GAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNK 292
+ IHRD+K NILLD + DF ++ + D + GT GY+ P +
Sbjct: 119 KGI---IHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQG 175
Query: 293 FTMKSDIFSFGVIIFELITAIHPHQN 318
+++ D +S GV +E + P++
Sbjct: 176 YSVAVDWWSLGVTAYECLRGKRPYRG 201
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 3e-16
Identities = 63/205 (30%), Positives = 105/205 (51%), Gaps = 16/205 (7%)
Query: 120 NFTNILGQGAFGPVYKATMPSGG-VAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNL 178
NF I G+G+ G V AT S G A+K + Q + EV ++ H N+V +
Sbjct: 23 NFVKI-GEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEM 81
Query: 179 IG-YCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPP 237
Y V ++++ EF+ G+L++++ + R +N E+ + L + + +LH V
Sbjct: 82 YSSYLVGDELWVVM-EFLEGGALTDIV-THTR-MNEEQIATVCLAVLKALSFLHAQGV-- 136
Query: 238 VIHRDLKSANILLDHFMRAKVADFG----LSKEEVFDGRNSGLKGTYGYIDPAYISTNKF 293
IHRD+KS +ILL R K++DFG +SKE R L GT ++ P IS +
Sbjct: 137 -IHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV---PRRKSLVGTPYWMAPEVISRLPY 192
Query: 294 TMKSDIFSFGVIIFELITAIHPHQN 318
+ DI+S G+++ E++ P+ N
Sbjct: 193 GTEVDIWSLGIMVIEMVDGEPPYFN 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 4e-16
Identities = 66/275 (24%), Positives = 128/275 (46%), Gaps = 24/275 (8%)
Query: 105 GIPRYAYKDIQKATQNFTNILGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKEFQTE 163
G P+ Y +K +GQGA G V+ A + +G AIK + ++ E
Sbjct: 15 GDPKKKYTRYEK--------IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINE 66
Query: 164 VSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDI 223
+ ++ L + N+VN + + + ++ E+++ GSL++++ E ++ + + +
Sbjct: 67 ILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVV--TETCMDEAQIAAVCREC 124
Query: 224 SHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD-GRNSGLKGTYGY 282
+E+LH V IHRD+KS N+LL K+ DFG + + + S + GT +
Sbjct: 125 LQALEFLHANQV---IHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 181
Query: 283 IDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLV 342
+ P ++ + K DI+S G++ E++ P+ N L ++ +G E+
Sbjct: 182 MAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQ----- 236
Query: 343 GACNIQEVRELAR-IGHKCLHKTPRKRPSIGEVTQ 376
N +++ + R ++CL KR S E+ Q
Sbjct: 237 ---NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 4e-16
Identities = 48/196 (24%), Positives = 91/196 (46%), Gaps = 15/196 (7%)
Query: 124 ILGQGAFGPVYKATM--PSGGV--AAIKVLASDSHQGEKE-FQTEVSLLGRLHHRNLVNL 178
+G+G FG VY+ P A+K + + +E F E ++ + H ++V L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 179 IGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPV 238
IG + + ++ E G L + + + L+ + + +S + YL
Sbjct: 73 IGVITENPVW-IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES---KRF 128
Query: 239 IHRDLKSANILLDHFMRAKVADFGLSK----EEVFDGRNSGLKGTYGYIDPAYISTNKFT 294
+HRD+ + N+L+ K+ DFGLS+ E + + S K ++ P I+ +FT
Sbjct: 129 VHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYY--KASKGKLPIKWMAPESINFRRFT 186
Query: 295 MKSDIFSFGVIIFELI 310
SD++ FGV ++E++
Sbjct: 187 SASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 4e-16
Identities = 65/260 (25%), Positives = 124/260 (47%), Gaps = 21/260 (8%)
Query: 125 LGQGAFGPVYKATMPSGGVAA----IKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIG 180
+G+G F VY+AT GV +++ + + E+ LL +L+H N++
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69
Query: 181 YCVDKGKYMLIYEFMSNGSLSNLI--YSEERVLNWEERL-QIALDISHGIEYLHEGAVPP 237
++ + ++ E G LS +I + +++ L E+ + + + + +E++H V
Sbjct: 70 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRV-- 127
Query: 238 VIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSG---LKGTYGYIDPAYISTNKFT 294
+HRD+K AN+ + K+ D GL + F + + L GT Y+ P I N +
Sbjct: 128 -MHRDIKPANVFITATGVVKLGDLGLGR--FFSSKTTAAHSLVGTPYYMSPERIHENGYN 184
Query: 295 MKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELA 354
KSDI+S G +++E+ P + +NL S+ + +++ L +E+R+L
Sbjct: 185 FKSDIWSLGCLLYEMAALQSPFYG--DKMNLYSLCKK-IEQCDYPPLPSDHYSEELRQLV 241
Query: 355 RIGHKCLHKTPRKRPSIGEV 374
+ C++ P KRP I V
Sbjct: 242 NM---CINPDPEKRPDITYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 4e-16
Identities = 60/219 (27%), Positives = 94/219 (42%), Gaps = 63/219 (28%)
Query: 125 LGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKEFQT--------EVSLLGRL-HHRN 174
LG G FG VY A +G + AIK + +K+F + EV L +L H N
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKM-------KKKFYSWEECMNLREVKSLRKLNEHPN 59
Query: 175 LVNLIGYCVDKGKYMLIYEFMSNGSLSNLI-------YSEERVLNWEERLQIALDISHGI 227
+V L + + ++E+M G+L L+ +SE + + QI G+
Sbjct: 60 IVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSI--IYQILQ----GL 112
Query: 228 EYLHE-GAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDP- 285
++H+ G HRDLK N+L+ K+ADFGL++E R+ P
Sbjct: 113 AHIHKHG----FFHRDLKPENLLVSGPEVVKIADFGLAREI----RSR---------PPY 155
Query: 286 -AYIST------------NKFTMKSDIFSFGVIIFELIT 311
Y+ST ++ DI++ G I+ EL T
Sbjct: 156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYT 194
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 4e-16
Identities = 74/294 (25%), Positives = 135/294 (45%), Gaps = 42/294 (14%)
Query: 113 DIQKATQNFTNILGQGAFGPVYKATM--PSGG----VAAIKVLASDSHQG--EKEFQTEV 164
+I +T F LG+ FG VYK + + G AIK L D +G +EF+ E
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL-KDKAEGPLREEFKHEA 59
Query: 165 SLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIY---------------SEER 209
+ RL H N+V L+G + +I+ + S+ L + + +
Sbjct: 60 MMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS 119
Query: 210 VLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF 269
L + + I I+ G+E+L V +H+DL + N+L+ + K++D GL +E V+
Sbjct: 120 TLEPADFVHIVTQIAAGMEFLSSHHV---VHKDLATRNVLVFDKLNVKISDLGLFRE-VY 175
Query: 270 DGRNSGLKGT----YGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVN 324
L G ++ P I KF++ SDI+S+GV+++E+ + + P+ Y N
Sbjct: 176 AADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG---YSN 232
Query: 325 LASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQAL 378
QD ++ I ++Q++ C + + +C ++ P +RP ++ L
Sbjct: 233 -----QDVIEMIRNRQVL-PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 5e-16
Identities = 66/236 (27%), Positives = 120/236 (50%), Gaps = 31/236 (13%)
Query: 120 NFTNILGQGAFGPVYKATMPSGG-VAAIKVLASDSHQGEKEFQ---TEVSLLGRLHHRNL 175
NF +LG+G+FG V A + AIK+L D + + + E +L
Sbjct: 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPF 62
Query: 176 VNLIGYC---VDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQI--ALDISHGIEYL 230
+ + C VD+ +++ E+++ G +L+Y ++V ++E + A +IS G+ +L
Sbjct: 63 LTQLHSCFQTVDRLYFVM--EYVNGG---DLMYHIQQVGKFKEPQAVFYAAEISVGLFFL 117
Query: 231 HEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNS-GLKGTYGYIDPAYIS 289
H + I+RDLK N++LD K+ADFG+ KE + DG + GT YI P I+
Sbjct: 118 HRRGI---IYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIA 174
Query: 290 TNKFTMKSDIFSFGVIIFELITAIHP---------HQNLMEYVNLA---SMSQDGV 333
+ D +++GV+++E++ P Q++ME+ N++ S+S++ V
Sbjct: 175 YQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEH-NVSYPKSLSKEAV 229
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 5e-16
Identities = 63/204 (30%), Positives = 96/204 (47%), Gaps = 23/204 (11%)
Query: 120 NFTNILGQGAFGPVYKA-TMPSGGVAAIKVLAS---------DSHQGEKE-FQTEVSLLG 168
+LG+G FG V A +G + AIK L +S EK F+T
Sbjct: 2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFET----AN 57
Query: 169 RLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQI-ALDISHGI 227
H LVNL + + E+ + G L I+++ V + E R A + G+
Sbjct: 58 SERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTD--VFS-EPRAVFYAACVVLGL 114
Query: 228 EYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEV-FDGRNSGLKGTYGYIDPA 286
+YLHE + ++RDLK N+LLD K+ADFGL KE + F R S GT ++ P
Sbjct: 115 QYLHENKI---VYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPE 171
Query: 287 YISTNKFTMKSDIFSFGVIIFELI 310
++ +T D + GV+I+E++
Sbjct: 172 VLTETSYTRAVDWWGLGVLIYEML 195
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 6e-16
Identities = 61/230 (26%), Positives = 110/230 (47%), Gaps = 44/230 (19%)
Query: 121 FTNILGQGAFGPVYKATMPSGG-----------------VAAIKVLASDSHQGEK-EFQT 162
F LG+G FG V+ + + + A+K+L D+++ + +F
Sbjct: 9 FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK 68
Query: 163 EVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEE-------------- 208
EV +L RL N++ L+G CVD+ +I E+M NG L+ + S
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 209 ----RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLS 264
+++ L +AL I+ G++YL + +HRDL + N L+ + K+ADFG+S
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
Query: 265 KEEVFDGRNSGLKG----TYGYIDPAYISTNKFTMKSDIFSFGVIIFELI 310
+ ++ G ++G ++ I KFT SD+++FGV ++E++
Sbjct: 186 R-NLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 6e-16
Identities = 76/269 (28%), Positives = 130/269 (48%), Gaps = 33/269 (12%)
Query: 112 KDIQKATQNFTNILGQGAFGPVYKAT-MPSGGVAAIKVLASD-SHQGEKEFQTEVSLLGR 169
+DIQ + ILG G G VYKA + + + A+KV+ D + + +K+ +E+ +L +
Sbjct: 1 QDIQ-----YQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYK 55
Query: 170 LHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEY 229
++ G + + + EFM GSL E VL +IA+ + G+ Y
Sbjct: 56 CDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYRKIPEHVLG-----RIAVAVVKGLTY 110
Query: 230 LHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLK---GTYGYIDPA 286
L ++HRD+K +N+L++ + K+ DFG+S + V NS K GT Y+ P
Sbjct: 111 LWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV----NSIAKTYVGTNAYMAPE 163
Query: 287 YISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMS-----QDGVDEILDKQL 341
IS ++ + SD++S G+ EL P+ + + N S+ Q VDE
Sbjct: 164 RISGEQYGIHSDVWSLGISFMELALGRFPYPQIQK--NQGSLMPLQLLQCIVDEDPPVLP 221
Query: 342 VGACNIQEVRELARIGHKCLHKTPRKRPS 370
VG + + V + +C+ K P++RP+
Sbjct: 222 VGQFSEKFVHFIT----QCMRKQPKERPA 246
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 8e-16
Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 30/203 (14%)
Query: 124 ILGQGAFGPV----YKATMPSGGVAAIKVLASD---------SHQGEKEFQTEVSLLGRL 170
+LG+G+FG V K T + A+KVL D EK ++L G+
Sbjct: 2 VLGKGSFGKVLLAELKGT---DELYAVKVLKKDVILQDDDVECTMTEKRV---LALAGK- 54
Query: 171 HHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQI--ALDISHGIE 228
H L L K + + E+++ G +L++ +R ++E A +I G++
Sbjct: 55 -HPFLTQLHSCFQTKDRLFFVMEYVNGG---DLMFHIQRSGRFDEPRARFYAAEIVLGLQ 110
Query: 229 YLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG-RNSGLKGTYGYIDPAY 287
+LHE + I+RDLK N+LLD K+ADFG+ KE + G S GT YI P
Sbjct: 111 FLHERGI---IYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEI 167
Query: 288 ISTNKFTMKSDIFSFGVIIFELI 310
+S + D ++ GV+++E++
Sbjct: 168 LSYQPYGPAVDWWALGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 9e-16
Identities = 63/214 (29%), Positives = 97/214 (45%), Gaps = 22/214 (10%)
Query: 124 ILGQGAFGPVY----KATMPSGGVAAIKVLASDSHQGEKEFQ---TEVSLLGRLHHRNLV 176
+LG+G FG V KAT G A+K+L + + E TE +L H L
Sbjct: 2 LLGKGTFGKVILVREKAT---GKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLT 58
Query: 177 NLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQI-ALDISHGIEYLHEGAV 235
L + + E+ + G L + S ERV + E+R + +I + YLH V
Sbjct: 59 ALKYSFQTHDRLCFVMEYANGGELFFHL-SRERVFS-EDRARFYGAEIVSALGYLHSCDV 116
Query: 236 PPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRN-SGLKGTYGYIDPAYISTNKFT 294
++RDLK N++LD K+ DFGL KE + DG GT Y+ P + N +
Sbjct: 117 ---VYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYG 173
Query: 295 MKSDIFSFGVIIFELITAIHP-----HQNLMEYV 323
D + GV+++E++ P H+ L E +
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 207
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 1e-15
Identities = 65/204 (31%), Positives = 96/204 (47%), Gaps = 16/204 (7%)
Query: 124 ILGQGAFGPVYKA-TMPSGGVAAIKVLA--SDSHQGEKE---FQTEVSLLGRLHHRNLVN 177
+LGQGAFG VY +G A+K + +S + KE + E+ LL L H +V
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 178 LIGYCVDKGKYML--IYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAV 235
G D + L E M GS+ + + S + R + I G+ YLH +
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTR-KYTRQILEGVSYLHSNMI 127
Query: 236 PPVIHRDLKSANILLDHFMRAKVADFGLSKE-EVFDGRNSGLK---GTYGYIDPAYISTN 291
+HRD+K ANIL D K+ DFG SK + +G+K GT ++ P IS
Sbjct: 128 ---VHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGE 184
Query: 292 KFTMKSDIFSFGVIIFELITAIHP 315
+ K+DI+S G + E++T P
Sbjct: 185 GYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 76.7 bits (188), Expect = 1e-15
Identities = 70/282 (24%), Positives = 131/282 (46%), Gaps = 23/282 (8%)
Query: 105 GIPRYAYKDIQKATQNFTNILGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKEFQTE 163
G P+ Y +K +GQGA G VY A + +G AI+ + ++ E
Sbjct: 16 GDPKKKYTRFEK--------IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINE 67
Query: 164 VSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDI 223
+ ++ + N+VN + + + ++ E+++ GSL++++ E ++ + + +
Sbjct: 68 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCREC 125
Query: 224 SHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD-GRNSGLKGTYGY 282
+E+LH V IHRD+KS NILL K+ DFG + + + S + GT +
Sbjct: 126 LQALEFLHSNQV---IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 182
Query: 283 IDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLV 342
+ P ++ + K DI+S G++ E+I P+ N L ++ +G E+ + + +
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKL 242
Query: 343 GACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQ-ALLKIKQ 383
A R+ ++CL KR S E+ Q LKI +
Sbjct: 243 SAI----FRDFL---NRCLDMDVEKRGSAKELLQHQFLKIAK 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 1e-15
Identities = 60/202 (29%), Positives = 99/202 (49%), Gaps = 18/202 (8%)
Query: 124 ILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGR------LHHRNLV 176
+LG+G+FG V+ A + + AIK L D + + E +++ + H L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDD--VECTMVEKRVLSLAWEHPFLT 59
Query: 177 NLIGYCVDKGKYMLIY--EFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGA 234
+L YC + K L + E+++ G L I S + + A +I G+++LH
Sbjct: 60 HL--YCTFQTKENLFFVMEYLNGGDLMFHIQSCHK-FDLPRATFYAAEIICGLQFLHSKG 116
Query: 235 VPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF-DGRNSGLKGTYGYIDPAYISTNKF 293
+ ++RDLK NILLD K+ADFG+ KE + D + GT YI P + K+
Sbjct: 117 I---VYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKY 173
Query: 294 TMKSDIFSFGVIIFELITAIHP 315
D +SFGV+++E++ P
Sbjct: 174 NTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 59/197 (29%), Positives = 98/197 (49%), Gaps = 13/197 (6%)
Query: 124 ILGQGAFGPVYKAT-MPSG-GV---AAIKVL-ASDSHQGEKEFQTEVSLLGRLHHRNLVN 177
+LG GAFG VYK +P G V AIK L + S + KE E ++ + + ++
Sbjct: 14 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 73
Query: 178 LIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPP 237
L+G C+ LI + M G L + + + + + L + I+ G+ YL E +
Sbjct: 74 LLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRL-- 130
Query: 238 VIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRN---SGLKGTYGYIDPAYISTNKFT 294
+HRDL + N+L+ K+ DFGL+K D + G K ++ I +T
Sbjct: 131 -VHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYT 189
Query: 295 MKSDIFSFGVIIFELIT 311
+SD++S+GV ++EL+T
Sbjct: 190 HQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 1e-15
Identities = 64/199 (32%), Positives = 97/199 (48%), Gaps = 12/199 (6%)
Query: 124 ILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQ---TEVSLLGRLHHRN--LVN 177
+LG+G+FG V A + G A+K L D + + + E +L L N L +
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLA-LAWENPFLTH 60
Query: 178 LIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPP 237
L K + EF++ G L I + R + A +I G+++LH +
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATF-YAAEIVCGLQFLHSKGI-- 117
Query: 238 VIHRDLKSANILLDHFMRAKVADFGLSKEEVF-DGRNSGLKGTYGYIDPAYISTNKFTMK 296
I+RDLK N++LD K+ADFG+ KE VF D R S GT YI P + K+T
Sbjct: 118 -IYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFS 176
Query: 297 SDIFSFGVIIFELITAIHP 315
D +SFGV+++E++ P
Sbjct: 177 VDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 20/211 (9%)
Query: 124 ILGQGAFGPVYKATM-PSGGVAAIKVLASD---SHQGEKEFQTEVSLLGRLHHRNLVNLI 179
+LG+G FG V + +G + A K L +GE E +L +++ + +VNL
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLA 66
Query: 180 GYCVDKGKYMLIYEFMSNGSLSNLIYS-------EERVLNWEERLQIALDISHGIEYLHE 232
K L+ M+ G L IY+ EER L + A +I G+E LH
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFY------AAEILCGLEDLHR 120
Query: 233 GAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNK 292
++RDLK NILLD + +++D GL+ + G GT GY+ P ++ +
Sbjct: 121 ENT---VYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQR 177
Query: 293 FTMKSDIFSFGVIIFELITAIHPHQNLMEYV 323
+T+ D + G +I+E+I P + E V
Sbjct: 178 YTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV 208
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 78/275 (28%), Positives = 129/275 (46%), Gaps = 34/275 (12%)
Query: 125 LGQGAFGPVYKATM-------PSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVN 177
LGQG+FG VY+ VA V S S + EF E S++ ++V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 178 LIGYCVDKGK-YMLIYEFMSNGSLSNLIYS--------EERVL-NWEERLQIALDISHGI 227
L+G V KG+ +++ E M++G L + + S R +E +Q+A +I+ G+
Sbjct: 74 LLG-VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 228 EYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKE-EVFDGRNSGLKGTY--GYID 284
YL+ +HRDL + N ++ H K+ DFG++++ D G KG ++
Sbjct: 133 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189
Query: 285 PAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVG 343
P + FT SD++SFGV+++E+ + A P+Q L L + G LD+
Sbjct: 190 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY---LDQP--D 244
Query: 344 ACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQAL 378
C + V +L R+ C P+ RP+ E+ L
Sbjct: 245 NCP-ERVTDLMRM---CWQFNPKMRPTFLEIVNLL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 2e-15
Identities = 73/272 (26%), Positives = 128/272 (47%), Gaps = 27/272 (9%)
Query: 121 FTNI--LGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKE-FQTEVSLLGRLHHRNLV 176
FT + +G+G+FG V+K + V AIK++ + + E E Q E+++L + +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 177 NLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIAL---DISHGIEYLHEG 233
G + K +I E++ GS +L+ R ++E QIA +I G++YLH
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLL----RAGPFDE-FQIATMLKEILKGLDYLHS- 119
Query: 234 AVPPVIHRDLKSANILLDHFMRAKVADFGLSKE--EVFDGRNSGLKGTYGYIDPAYISTN 291
IHRD+K+AN+LL K+ADFG++ + + RN+ GT ++ P I +
Sbjct: 120 --EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIQQS 176
Query: 292 KFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVR 351
+ K+DI+S G+ EL P+ ++ L + ++ L G + +
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNP-----PTLTG----EFSK 227
Query: 352 ELARIGHKCLHKTPRKRPSIGEVTQALLKIKQ 383
CL+K P RP+ E+ + +K
Sbjct: 228 PFKEFIDACLNKDPSFRPTAKELLKHKFIVKN 259
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 2e-15
Identities = 65/208 (31%), Positives = 105/208 (50%), Gaps = 26/208 (12%)
Query: 125 LGQGAFGPVYKATMPSG------GVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNL 178
LG+G FG V + + V +K+ + E +F +E + H N++ L
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEME-DFLSEAVCMKEFDHPNVMRL 65
Query: 179 IGYC---VDKGKY---MLIYEFMSNGSL-SNLIYS----EERVLNWEERLQIALDISHGI 227
IG C V+ Y ++I FM +G L S L+YS + L + ++ DI+ G+
Sbjct: 66 IGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGM 125
Query: 228 EYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG---RNSGL-KGTYGYI 283
EYL + IHRDL + N +L+ M VADFGLSK ++++G R + K +I
Sbjct: 126 EYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSK-KIYNGDYYRQGRIAKMPVKWI 181
Query: 284 DPAYISTNKFTMKSDIFSFGVIIFELIT 311
++ +T KSD++SFGV ++E+ T
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 3e-15
Identities = 58/197 (29%), Positives = 97/197 (49%), Gaps = 13/197 (6%)
Query: 124 ILGQGAFGPVYKAT-MPSGG----VAAIKVLASD-SHQGEKEFQTEVSLLGRLHHRNLVN 177
+LG GAFG VYK +P G AIKVL + S + KE E ++ + +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 178 LIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPP 237
L+G C+ L+ + M G L + + + + ++ L + I+ G+ YL E
Sbjct: 74 LLGICL-TSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE---VR 129
Query: 238 VIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRN---SGLKGTYGYIDPAYISTNKFT 294
++HRDL + N+L+ K+ DFGL++ D G K ++ I +FT
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFT 189
Query: 295 MKSDIFSFGVIIFELIT 311
+SD++S+GV ++EL+T
Sbjct: 190 HQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 3e-15
Identities = 76/296 (25%), Positives = 125/296 (42%), Gaps = 64/296 (21%)
Query: 124 ILGQGAFGPVYKAT-MPSGGVAAIKVL--ASDSHQGEKEFQTEVSLLGRLHHRNLVNLIG 180
++G+G++G V K +G + AIK + D +K E+ +L +L H NLVNLI
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 181 YCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNW--EERLQIAL-DISHGIEYLHEGAVPP 237
K + L++EF+ + L +L E+ N E R++ L I GIE+ H
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDL----EKYPNGLDESRVRKYLFQILRGIEFCHSHN--- 120
Query: 238 VIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTN------ 291
+IHRD+K NIL+ K+ DFG ++ G Y D Y++T
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV--------YTD--YVATRWYRAPE 170
Query: 292 ------KFTMKSDIFSFGVIIFELITA--IHP--------HQNLMEYVNLASMSQDGVDE 335
K+ DI++ G ++ E++T + P + + NL Q E
Sbjct: 171 LLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQ----E 226
Query: 336 ILDKQLVGAC----NIQEVRELAR-----------IGHKCLHKTPRKRPSIGEVTQ 376
I K + A ++E+ L + + +CL P RPS ++
Sbjct: 227 IFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 4e-15
Identities = 64/208 (30%), Positives = 96/208 (46%), Gaps = 24/208 (11%)
Query: 124 ILGQGAFGPVYKATMPSGG--VAAIKV-LASDSHQGEKE---FQTEVSLLGRLHHRNLVN 177
+LG+GAFG VY G +A +V DS + KE + E+ LL L H +V
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 178 LIGYCVD--KGKYMLIYEFMSNGSLSNLIYS----EERVLNWEERLQIALDISHGIEYLH 231
G D + K + E+M GS+ + + + E V R I G+ YLH
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTR-----QILQGVSYLH 123
Query: 232 EGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKE-EVFDGRNSGLK---GTYGYIDPAY 287
+ +HRD+K ANIL D K+ DFG SK + +G+K GT ++ P
Sbjct: 124 SNMI---VHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEV 180
Query: 288 ISTNKFTMKSDIFSFGVIIFELITAIHP 315
IS + K+D++S + E++T P
Sbjct: 181 ISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 4e-15
Identities = 65/271 (23%), Positives = 124/271 (45%), Gaps = 30/271 (11%)
Query: 124 ILGQGAFGPVYKA--TMPSGG--VAAIKVL-ASDSHQGEKEFQTEVSLLGRLHHRNLVNL 178
ILG G FG + + +PS AI L A S + + F E LG+ H N+V L
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 179 IGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPV 238
G M++ E+MSNG+L + + E L + + + ++ G++YL E
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG---Y 128
Query: 239 IHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYG--YIDPAYISTNKFTMK 296
+H+ L + +L++ + K++ F +E+ + + + G + P I + F+
Sbjct: 129 VHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSA 188
Query: 297 SDIFSFGVIIFELIT-AIHP-----HQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEV 350
SD++SFG++++E+++ P Q++++ V +DG +L N +
Sbjct: 189 SDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAV------EDGF------RLPAPRNCPNL 236
Query: 351 RELARIGHKCLHKTPRKRPSIGEVTQALLKI 381
L ++ C K +RP ++ L K+
Sbjct: 237 --LHQLMLDCWQKERGERPRFSQIHSILSKM 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 5e-15
Identities = 68/258 (26%), Positives = 117/258 (45%), Gaps = 16/258 (6%)
Query: 125 LGQGAFGPVYKA-TMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCV 183
+G G +G VYKA + +G +AAIKV+ + + Q E+ ++ H N+V G +
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 184 DKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDL 243
+ K + EF GSL + IY L+ + ++ + G+ YLH +HRD+
Sbjct: 77 RRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAYVSRETLQGLYYLHSKGK---MHRDI 132
Query: 244 KSANILLDHFMRAKVADFGLSKE-EVFDGRNSGLKGTYGYIDPAYISTNK---FTMKSDI 299
K ANILL K+ADFG+S + + GT ++ P + + + DI
Sbjct: 133 KGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDI 192
Query: 300 FSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVD-EILDKQLVGACNIQEVRELARIGH 358
++ G+ EL P +L L M++ L ++ + + ++A
Sbjct: 193 WAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMA---- 248
Query: 359 KCLHKTPRKRPSIGEVTQ 376
L K P+KRP+ ++ Q
Sbjct: 249 --LTKNPKKRPTAEKLLQ 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 5e-15
Identities = 70/257 (27%), Positives = 113/257 (43%), Gaps = 22/257 (8%)
Query: 125 LGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQ---TEVSLLGRLHHRNLVNLIG 180
+G G+FG VY AT + V A+K ++ Q +++Q EV L +L H N + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 181 YCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIH 240
+ + L+ E+ GS S+L+ ++ L E I G+ YLH + IH
Sbjct: 89 CYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM---IH 144
Query: 241 RDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYI---STNKFTMKS 297
RD+K+ NILL + K+ADFG NS GT ++ P I ++ K
Sbjct: 145 RDIKAGNILLTEPGQVKLADFG--SASKSSPANS-FVGTPYWMAPEVILAMDEGQYDGKV 201
Query: 298 DIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIG 357
D++S G+ EL P N+ L ++Q+ + + +
Sbjct: 202 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDS--------FRGFV 253
Query: 358 HKCLHKTPRKRPSIGEV 374
CL K P++RP+ E+
Sbjct: 254 DYCLQKIPQERPASAEL 270
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 74.8 bits (183), Expect = 6e-15
Identities = 65/274 (23%), Positives = 127/274 (46%), Gaps = 22/274 (8%)
Query: 105 GIPRYAYKDIQKATQNFTNILGQGAFGPVYKA-TMPSGGVAAIKVLASDSHQGEKEFQTE 163
G P+ Y +K +GQGA G VY A + +G AIK + ++ E
Sbjct: 15 GDPKKKYTRFEK--------IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINE 66
Query: 164 VSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDI 223
+ ++ + N+VN + + + ++ E+++ GSL++++ E ++ + + +
Sbjct: 67 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCREC 124
Query: 224 SHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD-GRNSGLKGTYGY 282
+++LH V IHRD+KS NILL K+ DFG + + + S + GT +
Sbjct: 125 LQALDFLHSNQV---IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 181
Query: 283 IDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLV 342
+ P ++ + K DI+S G++ E++ P+ N L ++ +G E+ + + +
Sbjct: 182 MAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERL 241
Query: 343 GACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQ 376
A R+ ++CL +R S E+ Q
Sbjct: 242 SAV----FRDFL---NRCLEMDVDRRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 7e-15
Identities = 64/203 (31%), Positives = 103/203 (50%), Gaps = 20/203 (9%)
Query: 124 ILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGR------LHHRNLV 176
+LG+G+FG V A + + AIK L D + + E +++ R H L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDD--VECTMVERRVLALAWEHPFLT 59
Query: 177 NLIGYCVDKGKYMLIY--EFMSNGSLSNLIYSEERVLNWEERLQI-ALDISHGIEYLHEG 233
+L +C + K L + E+++ G L I S R E R + A +I G+++LH+
Sbjct: 60 HL--FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFD--EARARFYAAEIICGLQFLHKK 115
Query: 234 AVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF-DGRNSGLKGTYGYIDPAYISTNK 292
+ I+RDLK N+LLD K+ADFG+ KE + +G+ S GT YI P + K
Sbjct: 116 GI---IYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQK 172
Query: 293 FTMKSDIFSFGVIIFELITAIHP 315
+ D +SFGV+++E++ P
Sbjct: 173 YNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 7e-15
Identities = 57/211 (27%), Positives = 97/211 (45%), Gaps = 41/211 (19%)
Query: 123 NILGQGAFGPVYKA-TMPSGGVAAIKVLASDSHQGEKEFQT--EVSLLGRLHHRNLVNLI 179
N +G+G +G VY+A SG + A+K + D+ + + E++LL L H N+V L
Sbjct: 13 NRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELK 72
Query: 180 GYCVDKGKYM----LIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAV 235
V GK++ L+ E+ L++L+ + + + + L + G++YLHE +
Sbjct: 73 EVVV--GKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFI 129
Query: 236 PPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAY-------- 287
IHRDLK +N+LL K+ADFGL++ TYG
Sbjct: 130 ---IHRDLKVSNLLLTDKGCLKIADFGLAR-------------TYGLPAKPMTPKVVTLW 173
Query: 288 -------ISTNKFTMKSDIFSFGVIIFELIT 311
+ +T D+++ G I+ EL+
Sbjct: 174 YRAPELLLGCTTYTTAIDMWAVGCILAELLA 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 7e-15
Identities = 73/273 (26%), Positives = 122/273 (44%), Gaps = 24/273 (8%)
Query: 121 FTNI--LGQGAFGPVYKA-TMPSGGVAAIKVLASDSHQGEKEFQ---TEVSLLGRLHHRN 174
FT++ +G G+FG VY A + + V AIK ++ Q +++Q EV L R+ H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 175 LVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGA 234
+ G + + L+ E+ GS S+L+ ++ L E I G+ YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN 145
Query: 235 VPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYI---STN 291
+ IHRD+K+ NILL + K+ADFG + NS GT ++ P I
Sbjct: 146 M---IHRDIKAGNILLTEPGQVKLADFG--SASIASPANS-FVGTPYWMAPEVILAMDEG 199
Query: 292 KFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVR 351
++ K D++S G+ EL P N+ L ++Q+ + +
Sbjct: 200 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDY------- 252
Query: 352 ELARIGHKCLHKTPRKRPSIGEVTQALLKIKQR 384
CL K P+ RP+ E+ + + +++R
Sbjct: 253 -FRNFVDSCLQKIPQDRPTSEELLKHMFVLRER 284
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 7e-15
Identities = 57/200 (28%), Positives = 102/200 (51%), Gaps = 8/200 (4%)
Query: 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVN 177
+N+ I G+G+ G V A SG A+K++ Q + EV ++ H+N+V
Sbjct: 24 ENYIKI-GEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVE 82
Query: 178 LIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPP 237
+ + + ++ EF+ G+L++++ S+ R LN E+ + + + YLH V
Sbjct: 83 MYKSYLVGEELWVLMEFLQGGALTDIV-SQTR-LNEEQIATVCESVLQALCYLHSQGV-- 138
Query: 238 VIHRDLKSANILLDHFMRAKVADFGLSKEEVFD-GRNSGLKGTYGYIDPAYISTNKFTMK 296
IHRD+KS +ILL R K++DFG + D + L GT ++ P IS + +
Sbjct: 139 -IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTE 197
Query: 297 SDIFSFGVIIFELITAIHPH 316
DI+S G+++ E++ P+
Sbjct: 198 VDIWSLGIMVIEMVDGEPPY 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 71/260 (27%), Positives = 121/260 (46%), Gaps = 35/260 (13%)
Query: 124 ILGQGAFGPVYKATM----PSGGVAAIKVLAS----DSHQGEKEFQTEVSLLGRLHHRNL 175
+LG+G +G V++ +G + A+KVL + + + E ++L + H +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 176 VNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIAL-DISHGIEYLHEGA 234
V+LI GK LI E++S G L ++ E + E+ L +IS +E+LH+
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGEL--FMHLEREGIFMEDTACFYLSEISLALEHLHQQG 120
Query: 235 VPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNS-GLKGTYGYIDPAYISTNKF 293
+ I+RDLK NILLD K+ DFGL KE + +G + GT Y+ P + +
Sbjct: 121 I---IYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGH 177
Query: 294 TMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNI-----Q 348
D +S G ++++++T P + + + +DK L G N+
Sbjct: 178 GKAVDWWSLGALMYDMLTGAPP------------FTAENRKKTIDKILKGKLNLPPYLTP 225
Query: 349 EVRELARIGHKCLHKTPRKR 368
E R+L + K L + P R
Sbjct: 226 EARDLLK---KLLKRNPSSR 242
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-14
Identities = 61/205 (29%), Positives = 96/205 (46%), Gaps = 8/205 (3%)
Query: 124 ILGQGAFGPVYKATM-PSGGVAAIKVLASD---SHQGEKEFQTEVSLLGRLHHRNLVNLI 179
+LG+G FG V + +G + A K L +GE E +L +++ R +V+L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 66
Query: 180 GYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQI-ALDISHGIEYLHEGAVPPV 238
K L+ M+ G L IY+ EER A +I+ G+E LH +
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR---ERI 123
Query: 239 IHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSD 298
++RDLK NILLD + +++D GL+ E G GT GY+ P + ++T D
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPD 183
Query: 299 IFSFGVIIFELITAIHPHQNLMEYV 323
+ G +I+E+I P + E V
Sbjct: 184 WWGLGCLIYEMIEGKSPFRQRKEKV 208
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 1e-14
Identities = 61/222 (27%), Positives = 108/222 (48%), Gaps = 34/222 (15%)
Query: 124 ILGQGAFGPVYKAT-MPSGGV----AAIKVLASDSHQGEKEFQ--TEVSL-LGRLHHRNL 175
+LG G FG V+K +P G AIK + S G + FQ T+ L +G L H +
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAYI 71
Query: 176 VNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAV 235
V L+G C L+ + GSL + + L+ + L + I+ G+ YL E +
Sbjct: 72 VRLLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRM 130
Query: 236 PPVIHRDLKSANILLDHFMRAKVADFGLS-------KEEVFDGRNSGLKGTYGYIDPAYI 288
+HR+L + NILL ++ADFG++ K+ + + +K ++ I
Sbjct: 131 ---VHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIK----WMALESI 183
Query: 289 STNKFTMKSDIFSFGVIIFELIT-------AIHPHQ--NLME 321
++T +SD++S+GV ++E+++ + PH+ +L+E
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE 225
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 1e-14
Identities = 60/220 (27%), Positives = 109/220 (49%), Gaps = 23/220 (10%)
Query: 105 GIPRYAYKDIQKATQNFTNILGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKEFQ-T 162
G P+ Y +K +GQGA G VY A + +G AIK + + Q +KE
Sbjct: 15 GDPKKKYTRFEK--------IGQGASGTVYTAIDVATGQEVAIKQM-NLQQQPKKELIIN 65
Query: 163 EVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALD 222
E+ ++ H N+VN + + + ++ E+++ GSL++++ E ++ + + +
Sbjct: 66 EILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRE 123
Query: 223 ISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFG----LSKEEVFDGRNSGLKG 278
+E+LH V IHRD+KS NILL K+ DFG ++ E+ + S + G
Sbjct: 124 CLQALEFLHSNQV---IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ---SKRSTMVG 177
Query: 279 TYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQN 318
T ++ P ++ + K DI+S G++ E++ P+ N
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 1e-14
Identities = 55/194 (28%), Positives = 89/194 (45%), Gaps = 14/194 (7%)
Query: 125 LGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKEFQT--EVSLLGRLHHRNLVNLIGY 181
+G+GA G V+KA +G A+K +A +G Q E+ L H +V L+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 182 CVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHR 241
++L+ E+M LS ++ EER L + + G+ Y+H + +HR
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGI---MHR 123
Query: 242 DLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLK----GTYGYIDPAYI-STNKFTMK 296
DLK AN+L+ K+ADFGL++ +F L T Y P + K+
Sbjct: 124 DLKPANLLISADGVLKIADFGLAR--LFSEEEPRLYSHQVATRWYRAPELLYGARKYDPG 181
Query: 297 SDIFSFGVIIFELI 310
D+++ G I EL+
Sbjct: 182 VDLWAVGCIFAELL 195
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 66/234 (28%), Positives = 118/234 (50%), Gaps = 27/234 (11%)
Query: 120 NFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQ---TEVSLLGRLHHRNL 175
NF +LG+G+FG V A + + AIK+L D + + + E +L
Sbjct: 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPF 62
Query: 176 VNLIGYCVDK-GKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQI--ALDISHGIEYLHE 232
+ + C + + E+++ G +L+Y ++V ++E + A +I+ G+ +LH
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGG---DLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHS 119
Query: 233 GAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNS-GLKGTYGYIDPAYISTN 291
+ I+RDLK N++LD K+ADFG+ KE ++DG + GT YI P I+
Sbjct: 120 KGI---IYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQ 176
Query: 292 KFTMKSDIFSFGVIIFELITAIHP---------HQNLMEYVNLA---SMSQDGV 333
+ D ++FGV+++E++ P Q++ME+ N+A SMS++ V
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH-NVAYPKSMSKEAV 229
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 2e-14
Identities = 59/210 (28%), Positives = 95/210 (45%), Gaps = 14/210 (6%)
Query: 124 ILGQGAFGPVYKA-TMPSGGVAAIKVLASDSHQGEKEFQ---TEVSLLGRLHHRNLVNLI 179
+LG+G FG V SG A+K+L + + E TE +L H L +L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 180 GYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVI 239
K + + E+++ G L S ERV + + +I ++YLH G + +
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELF-FHLSRERVFSEDRTRFYGAEIVSALDYLHSGKI---V 117
Query: 240 HRDLKSANILLDHFMRAKVADFGLSKEEVFDGRN-SGLKGTYGYIDPAYISTNKFTMKSD 298
+RDLK N++LD K+ DFGL KE + D GT Y+ P + N + D
Sbjct: 118 YRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVD 177
Query: 299 IFSFGVIIFELITAIHP-----HQNLMEYV 323
+ GV+++E++ P H+ L E +
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHEKLFELI 207
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 3e-14
Identities = 55/194 (28%), Positives = 88/194 (45%), Gaps = 12/194 (6%)
Query: 127 QGAFGPVYKA-TMPSGGVAAIKVLAS---DSHQGEKEFQTEVSLLGRLHHRNLVNLIGYC 182
+GAFG VY A +G AIKVL + + E +++ V + Y
Sbjct: 6 KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65
Query: 183 VDKGKYM-LIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHR 241
Y+ L+ E+++ G ++LI L + Q ++ G+E LH+ + IHR
Sbjct: 66 FQSKDYLYLVMEYLNGGDCASLI-KTLGGLPEDWAKQYIAEVVLGVEDLHQRGI---IHR 121
Query: 242 DLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFS 301
D+K N+L+D K+ DFGLS+ + + + GT Y+ P I SD +S
Sbjct: 122 DIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV---GTPDYLAPETILGVGDDKMSDWWS 178
Query: 302 FGVIIFELITAIHP 315
G +IFE + P
Sbjct: 179 LGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 3e-14
Identities = 57/200 (28%), Positives = 93/200 (46%), Gaps = 10/200 (5%)
Query: 124 ILGQGAFGPVYKATM-PSGGVAAIKVLASD---SHQGEKEFQTEVSLLGRLHHRNLVNLI 179
+LG+G FG V + +G + A K L +GE E +L +++ R +V+L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLA 66
Query: 180 GYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQI--ALDISHGIEYLHEGAVPP 237
K L+ M+ G L IY +EE + A +I G+E LH+
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYHMGEA-GFEEGRAVFYAAEICCGLEDLHQ---ER 122
Query: 238 VIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKS 297
+++RDLK NILLD +++D GL+ G GT GY+ P + ++T
Sbjct: 123 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSP 182
Query: 298 DIFSFGVIIFELITAIHPHQ 317
D ++ G +++E+I P Q
Sbjct: 183 DWWALGCLLYEMIAGQSPFQ 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 3e-14
Identities = 73/266 (27%), Positives = 111/266 (41%), Gaps = 23/266 (8%)
Query: 112 KDIQKATQNFTNILGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKEFQ---TEVSLL 167
D +K + I G G+FG VY A + + V AIK ++ Q +++Q EV L
Sbjct: 11 DDPEKLFTDLREI-GHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFL 69
Query: 168 GRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGI 227
+L H N + G + + L+ E+ GS S+++ ++ L E I G+
Sbjct: 70 QQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGL 128
Query: 228 EYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAY 287
YLH IHRD+K+ NILL K+ADFG + NS GT ++ P
Sbjct: 129 AYLHSHER---IHRDIKAGNILLTEPGTVKLADFG--SASLVSPANS-FVGTPYWMAPEV 182
Query: 288 I---STNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGA 344
I ++ K D++S G+ EL P N+ +MS + I
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPP------LFNMNAMS--ALYHIAQNDSPTL 234
Query: 345 CNIQEVRELARIGHKCLHKTPRKRPS 370
+ CL K P+ RPS
Sbjct: 235 SSNDWSDYFRNFVDSCLQKIPQDRPS 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 4e-14
Identities = 61/216 (28%), Positives = 95/216 (43%), Gaps = 43/216 (19%)
Query: 126 GQGAFGPVYKA---TMPSGGVAAIKVLASDSHQGEKEFQT---EVSLLGRLHHRNLVNLI 179
G+G +G VYKA G AIK D Q Q+ E++LL L H N+V+L+
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLV 68
Query: 180 GYCV---DKGKYMLI-------YEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEY 229
+ DK Y+L ++ + + + ++ + I +G+ Y
Sbjct: 69 EVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVK-----SLLWQILNGVHY 123
Query: 230 LHEGAVPPVIHRDLKSANILL--DHFMRA--KVADFGLSKEEVFDGRNSGLKG------- 278
LH V +HRDLK ANIL+ + R K+ D GL++ +F N+ LK
Sbjct: 124 LHSNWV---LHRDLKPANILVMGEGPERGVVKIGDLGLAR--LF---NAPLKPLADLDPV 175
Query: 279 --TYGYIDPAYISTNK-FTMKSDIFSFGVIIFELIT 311
T Y P + + +T DI++ G I EL+T
Sbjct: 176 VVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 5e-14
Identities = 71/273 (26%), Positives = 119/273 (43%), Gaps = 30/273 (10%)
Query: 107 PRYAYKDIQKATQNFTNILGQGAFGPVYKA-TMPSGGVAAIKVLASDSHQGEKEFQTEVS 165
P++ Y+ IQ+ +G G +G VYKA + +G +AA+K++ + Q E+
Sbjct: 7 PQHDYELIQR--------VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIF 58
Query: 166 LLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIAL---D 222
++ H N+V G + + K + E+ GSL ++ + V LQIA +
Sbjct: 59 MVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYH----VTGPLSELQIAYVCRE 114
Query: 223 ISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGL-SKEEVFDGRNSGLKGTYG 281
G+ YLH +HRD+K ANILL K+ADFG+ +K + GT
Sbjct: 115 TLQGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPY 171
Query: 282 YIDPAYISTNK---FTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVD-EIL 337
++ P + K + DI++ G+ EL P +L L MS+ L
Sbjct: 172 WMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKL 231
Query: 338 DKQLVGACNIQEVRELARIGHKCLHKTPRKRPS 370
+ + +++ L K P+KRP+
Sbjct: 232 KDKTKWSSTFHNFVKIS------LTKNPKKRPT 258
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 6e-14
Identities = 53/197 (26%), Positives = 90/197 (45%), Gaps = 14/197 (7%)
Query: 125 LGQGAFGPVYKATMPSGG-VAAIKVLASD---SHQGEKEFQTEVSLLGRLHHRNLVNLIG 180
+G G FG V+ A+KV+A + E+ E +L + H ++ L
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL-- 66
Query: 181 YCVDKGKYML--IYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPV 238
+ + + L + E++ G L + + + R N A +I +EYLH +
Sbjct: 67 FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLF-YASEIVCALEYLHSKEI--- 122
Query: 239 IHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSD 298
++RDLK NILLD K+ DFG +K ++ D R L GT Y+ P I + D
Sbjct: 123 VYRDLKPENILLDKEGHIKLTDFGFAK-KLRD-RTWTLCGTPEYLAPEVIQSKGHNKAVD 180
Query: 299 IFSFGVIIFELITAIHP 315
++ G++I+E++ P
Sbjct: 181 WWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 6e-14
Identities = 72/266 (27%), Positives = 121/266 (45%), Gaps = 42/266 (15%)
Query: 120 NFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQ---TE---VSLLGRLHH 172
NF +LG+G+FG V A + + AIK+L D + + + E ++L G+
Sbjct: 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPF 62
Query: 173 RNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQI--ALDISHGIEYL 230
L L + + E+++ G +L+Y ++V ++E + A +I+ G+ +L
Sbjct: 63 --LTQLHSCFQTMDRLYFVMEYVNGG---DLMYHIQQVGKFKEPHAVFYAAEIAIGLFFL 117
Query: 231 HEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNS-GLKGTYGYIDPAYIS 289
H + I+RDLK N++LD K+ADFG+ KE +F G+ + GT YI P I+
Sbjct: 118 HSKGI---IYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIA 174
Query: 290 TNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQE 349
+ D ++FGV+++E++ P DG DE +L +
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQPPF--------------DGEDE---DELFQSIMEHN 217
Query: 350 V-------RELARIGHKCLHKTPRKR 368
V +E I L K P KR
Sbjct: 218 VSYPKSLSKEAVSICKGLLTKHPAKR 243
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 1e-13
Identities = 60/240 (25%), Positives = 98/240 (40%), Gaps = 48/240 (20%)
Query: 125 LGQGAFGPVYKATMPSGGVAA---IKVL-ASDSHQGEKEFQTEVSLLGRLHHRNLVNLIG 180
+G G FG V G A +K L AS + + F EV L+H N++ +G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 181 YCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEER----LQIALDISHGIEYLHEGAVP 236
C++ Y+L+ EF G L N + S ++ + ++A +++ G+ +LH+
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD-- 120
Query: 237 PVIHRDLKSANILLDHFMRAKVADFGLSKE----------------------EVFDGRNS 274
IH DL N L + K+ D+GL+ E E+ + R
Sbjct: 121 -FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQ 179
Query: 275 GLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNL--MEYVNLASMSQD 331
L T KS+I+S GV ++EL T A P+ +L + + QD
Sbjct: 180 DLL------------PKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQD 227
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 75/268 (27%), Positives = 126/268 (47%), Gaps = 37/268 (13%)
Query: 125 LGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRL-HHRNLVNLIG-- 180
+G+G +G VYK T G +AA+K+L S E E + E ++L L +H N+V G
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDE-EIEAEYNILQSLPNHPNVVKFYGMF 88
Query: 181 YCVDK---GKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISH-------GIEYL 230
Y DK G+ L+ E + GS++ L+ + +L +RL A+ IS+ G+++L
Sbjct: 89 YKADKLVGGQLWLVLELCNGGSVTELV---KGLLICGQRLDEAM-ISYILYGALLGLQHL 144
Query: 231 HEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD--GRNSGLKGTYGYIDPAYI 288
H + IHRD+K NILL K+ DFG+S + RN+ + GT ++ P I
Sbjct: 145 HNNRI---IHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVI 200
Query: 289 STNK-----FTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVG 343
+ + + + D++S G+ EL P ++ L + ++ +L +
Sbjct: 201 ACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPE--- 257
Query: 344 ACNIQEVRELARIGHKCLHKTPRKRPSI 371
+ R +CL K RPS+
Sbjct: 258 ----KWCRSFNHFISQCLIKDFEARPSV 281
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (175), Expect = 1e-13
Identities = 62/213 (29%), Positives = 91/213 (42%), Gaps = 34/213 (15%)
Query: 120 NFTNILGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKEFQT---------EVSLLGR 169
+G GA+G V A +G AIK + F E+ LL
Sbjct: 3 ELLKPIGSGAYGVVCSAVDKRTGRKVAIKKI-------SNVFDDLIDAKRILREIKLLRH 55
Query: 170 LHHRNLVNL--IGYCVDKGKYMLIY---EFMSNGSLSNLIYSEERVLNWEERLQ-IALDI 223
L H N++ L I + +Y E M L +I S + L ++ +Q I
Sbjct: 56 LRHENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSP-QPLT-DDHIQYFLYQI 112
Query: 224 SHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTY--- 280
G++YLH V IHRDLK +NIL++ K+ DFGL++ D G Y
Sbjct: 113 LRGLKYLHSANV---IHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVT 169
Query: 281 -GYIDPAYI-STNKFTMKSDIFSFGVIIFELIT 311
Y P + S++++T DI+S G I EL+T
Sbjct: 170 RWYRAPELLLSSSRYTKAIDIWSVGCIFAELLT 202
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 2e-13
Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 22/212 (10%)
Query: 124 ILGQGAFGPVYKATM-PSGGVAAIKVLASD---SHQGEKEFQTEVSLLGRLHHRNLVNLI 179
+LG+G FG V + +G + A K L +GE E +L +++ R +V+L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL- 65
Query: 180 GYCVD-KGKYMLIYEFMSNGSLSNLIYS-------EERVLNWEERLQIALDISHGIEYLH 231
Y + K L+ M+ G L IY+ E+R + + A ++ G+E L
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFY------AAELCCGLEDLQ 119
Query: 232 EGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTN 291
+++RDLK NILLD +++D GL+ + G GT GY+ P I+
Sbjct: 120 R---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNE 176
Query: 292 KFTMKSDIFSFGVIIFELITAIHPHQNLMEYV 323
K+T D + G +I+E+I P + E V
Sbjct: 177 KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV 208
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 68/217 (31%), Positives = 114/217 (52%), Gaps = 40/217 (18%)
Query: 121 FTNILGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKE-FQT----EVSLLGRLHHRN 174
+G+G +G VYKA +G + A+K + D+ EKE F E+ +L +L+HRN
Sbjct: 11 IIGQIGEGTYGQVYKARDKDTGELVALKKVRLDN---EKEGFPITAIREIKILRQLNHRN 67
Query: 175 LVNL----------IGYCVDKGKYMLIYEFMSN---GSL-SNLI-YSEERVLNWEERLQI 219
+VNL + + DKG + L++E+M + G L S L+ +SE+ + ++ ++L
Sbjct: 68 IVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQL-- 125
Query: 220 ALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLS----KEEVFDGRNSG 275
L+ G+ Y H+ +HRD+K +NILL++ + K+ADFGL+ EE N
Sbjct: 126 -LE---GLNYCHKKNF---LHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKV 178
Query: 276 LKGTYGYIDPA-YISTNKFTMKSDIFSFGVIIFELIT 311
+ T Y P + ++ D++S G I+ EL T
Sbjct: 179 I--TLWYRPPELLLGEERYGPAIDVWSCGCILGELFT 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 30/206 (14%)
Query: 123 NILGQGAFGPVYKATMPSGG--VAAIKVLASDSHQGEKEFQT-EVSLLGRL---HHRNLV 176
+G+GA+G VYKA + G VA KV S +G E++LL +L H N+V
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64
Query: 177 NLIGYC----VDKG-KYMLIYE--------FMSNGSLSNLIYSEERVLNWEERLQIALDI 223
L+ C D+ K L++E ++S L E + + + +
Sbjct: 65 RLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGL--PPETIKD------LMRQL 116
Query: 224 SHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYI 283
G+++LH + +HRDLK NIL+ + K+ADFGL++ F+ + + T Y
Sbjct: 117 LRGVDFLHSHRI---VHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYR 173
Query: 284 DPAYISTNKFTMKSDIFSFGVIIFEL 309
P + + + D++S G I EL
Sbjct: 174 APEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 2e-13
Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 31/213 (14%)
Query: 125 LGQGAFGPVYKAT-MPSGGVAAIKVL-ASDSHQGEKEFQTEVSLLGR-LHHRNLVNLIGY 181
LG+GA+G V K +P+G + A+K + A+ + Q +K ++ + R + V G
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68
Query: 182 CVDKGKYMLIYEFMSNGSLSNL--------IYSEERVLNWEERLQIALDISHGIEYLHEG 233
+G + E M SL + E +L +IA+ I +EYLH
Sbjct: 69 LFREGDVWICMEVMDT-SLDKFYKKVYDKGLTIPEDILG-----KIAVSIVKALEYLHSK 122
Query: 234 AVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLK----GTYGYIDPAYI- 288
VIHRD+K +N+L++ + K+ DFG+S V +S K G Y+ P I
Sbjct: 123 L--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLV----DSVAKTIDAGCKPYMAPERIN 176
Query: 289 ---STNKFTMKSDIFSFGVIIFELITAIHPHQN 318
+ + +KSD++S G+ + EL T P+ +
Sbjct: 177 PELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 2e-13
Identities = 54/170 (31%), Positives = 84/170 (49%), Gaps = 31/170 (18%)
Query: 111 YKDIQKATQNFTNILGQGAFGPVYKATMPSGG--VAAIKVLASDSHQGEKE-FQT----E 163
Y+ + K +GQG FG V+KA VA KVL + EKE F E
Sbjct: 14 YEKLAK--------IGQGTFGEVFKARHKKTKQIVALKKVLMEN----EKEGFPITALRE 61
Query: 164 VSLLGRLHHRNLVNLIGYCV--------DKGKYMLIYEFMSNGSLSNLIYSEERVLNWEE 215
+ +L L H N+VNLI C KG + L++EF + L+ L+ ++ E
Sbjct: 62 IKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSE 120
Query: 216 RLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSK 265
++ + +G+ Y+H + +HRD+K+ANIL+ K+ADFGL++
Sbjct: 121 IKKVMKMLLNGLYYIHRNKI---LHRDMKAANILITKDGILKLADFGLAR 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 3e-13
Identities = 56/201 (27%), Positives = 90/201 (44%), Gaps = 26/201 (12%)
Query: 125 LGQGAFGPVYKA-TMPSGGVAAIKVLASDSHQGEKEFQT-EVSLLGRLHHRNLVNLIGYC 182
LG+G + VYK +G + A+K + D+ +G E+SL+ L H N+V L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 183 VDKGKYMLIYEFMSNGSLSNL-IYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHR 241
+ K ML++E+M + + L+ + GI + HE V +HR
Sbjct: 68 HTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRV---LHR 124
Query: 242 DLKSANILLDHFMRAKVADFGLSK----------EEVFDGRNSGLKGTYGYIDP-AYIST 290
DLK N+L++ K+ADFGL++ EV T Y P + +
Sbjct: 125 DLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV---------TLWYRAPDVLLGS 175
Query: 291 NKFTMKSDIFSFGVIIFELIT 311
++ DI+S G I+ E+IT
Sbjct: 176 RTYSTSIDIWSVGCIMAEMIT 196
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 3e-13
Identities = 70/264 (26%), Positives = 115/264 (43%), Gaps = 27/264 (10%)
Query: 125 LGQGAFGPVYKATM---PSGGVAAIKVLASDSHQGE-KEFQTEVSLLGRLHH-RNLVNLI 179
+G+GAFG V K M PSG + A+K + S + E K ++ ++ R +V
Sbjct: 12 IGRGAFGTVNK--MLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFY 69
Query: 180 GYCVDKGKYMLIYEFMSNGSLSNL---IYSEERVLNWEERL-QIALDISHGIEYLHEGAV 235
G +G + E M SL +Y + + EE L +IA+ + YL E
Sbjct: 70 GALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL- 127
Query: 236 PPVIHRDLKSANILLDHFMRAKVADFGLS---KEEVFDGRNSGLKGTYGYIDPAYISTN- 291
+IHRD+K +NILLD K+ DFG+S + + R++G + Y+ P I +
Sbjct: 128 -KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCR---PYMAPERIDPSA 183
Query: 292 --KFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQE 349
+ ++SD++S G+ ++E+ T P+ + + G IL +
Sbjct: 184 RDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSE----EREF 239
Query: 350 VRELARIGHKCLHKTPRKRPSIGE 373
+ CL K KRP E
Sbjct: 240 SPSFVNFINLCLIKDESKRPKYKE 263
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 4e-13
Identities = 75/259 (28%), Positives = 115/259 (44%), Gaps = 25/259 (9%)
Query: 124 ILGQGAFGPVY---KAT-MPSGGVAAIKVLAS----DSHQGEKEFQTEVSLLGRLHHRN- 174
+LG GA+G V+ K +G + A+KVL + + +TE +L +
Sbjct: 7 VLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPF 66
Query: 175 LVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGA 234
LV L K LI ++++ G L +Y E E R+ IA +I +++LH+
Sbjct: 67 LVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIA-EIVLALDHLHQLG 125
Query: 235 VPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG--RNSGLKGTYGYIDPAYISTNK 292
+ I+RD+K NILLD + DFGLSKE + + R GT Y+ P I
Sbjct: 126 I---IYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGS 182
Query: 293 FTMKS--DIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQ-E 349
D +S GV+ FEL+T P E + + +S+ IL + + E
Sbjct: 183 GGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISR----RILKSKPPFPKTMSAE 238
Query: 350 VRELARIGHKCLHKTPRKR 368
R+ K L K P+KR
Sbjct: 239 ARDFI---QKLLEKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 5e-13
Identities = 59/210 (28%), Positives = 95/210 (45%), Gaps = 23/210 (10%)
Query: 120 NFTNILGQGAFGPV----YKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNL 175
N ++G+G+FG + + + I+ L S E + E LL ++ H N+
Sbjct: 3 NVLRVVGEGSFGRALLVQHVNSDQKYAMKEIR-LPKSSSAVEDS-RKEAVLLAKMKHPNI 60
Query: 176 VNLIGYCVDKGKYMLIYEFMSNGSLSNLI-------YSEERVLNWEERLQIALDISHGIE 228
V G ++ E+ G L I + E+ +L W +Q+ L G++
Sbjct: 61 VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQW--FVQMCL----GVQ 114
Query: 229 YLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNS-GLKGTYGYIDPAY 287
++HE V +HRD+KS NI L + K+ DFG ++ G + GT Y+ P
Sbjct: 115 HIHEKRV---LHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEI 171
Query: 288 ISTNKFTMKSDIFSFGVIIFELITAIHPHQ 317
+ KSDI+S G I++EL T HP Q
Sbjct: 172 WENMPYNNKSDIWSLGCILYELCTLKHPFQ 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 5e-13
Identities = 60/222 (27%), Positives = 98/222 (44%), Gaps = 40/222 (18%)
Query: 124 ILGQGAFGPVYKATMP-SGGVAAIKVL-ASDSHQGEKE--FQTEVSLLGRLHHRNLVNLI 179
++G+GAFG V+ +G V A+KVL SD + + + E +L +V L
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLY 67
Query: 180 GYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHE-GAVPPV 238
D+ L+ E+M G L NL+ ++ R IA ++ ++ +H+ G
Sbjct: 68 YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIA-ELVLALDSVHKLG----F 122
Query: 239 IHRDLKSANILLDHFMRAKVADFGLSK--------EEVFDGRNSGLK------------- 277
IHRD+K NIL+D K+ADFGL K E + ++ L
Sbjct: 123 IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQ 182
Query: 278 ---------GTYGYIDPAYISTNKFTMKSDIFSFGVIIFELI 310
GT YI P + + ++ D +S GVI++E++
Sbjct: 183 RRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 8e-13
Identities = 59/242 (24%), Positives = 99/242 (40%), Gaps = 47/242 (19%)
Query: 102 SASGIPRYAYKDIQKATQNFTNILGQGAFGPVYKA--TMPSGGVAAIKVLASDSHQGEKE 159
S S RY K LG+G +G V KA T+ VA KV + +
Sbjct: 3 SFSISERYIQKG---------AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTK 53
Query: 160 -----------FQT--EVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYS 206
F T E+ ++ + H N++ L+ V+ L+ + M+ L ++
Sbjct: 54 DRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVV-- 110
Query: 207 EERVLNWEERLQ-IALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSK 265
+ ++ E +++ I L I +G+ LH+ +HRDL ANI ++ K+ADFGL++
Sbjct: 111 DRKIRLTESQVKCILLQILNGLNVLHKWYF---MHRDLSPANIFINSKGICKIADFGLAR 167
Query: 266 EEVFD---GRNSGLKG------------TYGYIDPAYI-STNKFTMKSDIFSFGVIIFEL 309
+ S + T Y P + K+ D++S G I EL
Sbjct: 168 RYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAEL 227
Query: 310 IT 311
+T
Sbjct: 228 LT 229
|
Length = 335 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 9e-13
Identities = 50/221 (22%), Positives = 103/221 (46%), Gaps = 19/221 (8%)
Query: 160 FQTEVSLLGRLHHRNLVNLIGYCVDKG----KYMLIYEFMSNGSLSNLIYSEERVLNWEE 215
+ E+ L R+ N++ + G+ +D + LI E+ + G L ++ E + L+++
Sbjct: 65 TENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKE-KDLSFKT 123
Query: 216 RLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSG 275
+L +A+D G+ L++ P +++L S + L+ + K+ GL E++
Sbjct: 124 KLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGL--EKILSSPPFK 179
Query: 276 LKGTYGYIDPAYIST--NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGV 333
Y ++ +++T+K DI+S GV+++E+ T P +NL +++
Sbjct: 180 NVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL--------TTKEIY 231
Query: 334 DEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEV 374
D I++K + E+ I C KRP+I E+
Sbjct: 232 DLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEI 272
|
Length = 283 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 60/207 (28%), Positives = 101/207 (48%), Gaps = 12/207 (5%)
Query: 125 LGQGAFGPVYKATMP-SGGVAAIKVLASD---SHQGEKEFQTEVSLLGRLHHRNLVNLIG 180
LG+G FG V + +G + A K L GEK E +L +++ +VNL
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-A 59
Query: 181 YCVDKGKYM-LIYEFMSNGSLSNLIYS-EERVLNWEERLQIALDISHGIEYLHEGAVPPV 238
Y + ++ L+ M+ G L IY+ ER L E + + I+ GI +LH +
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDI--- 116
Query: 239 IHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLK-GTYGYIDPAYISTNKFTMKS 297
++RD+K N+LLD +++D GL+ E+ DG+ + GT GY+ P + ++
Sbjct: 117 VYRDMKPENVLLDDQGNCRLSDLGLAV-ELKDGKTITQRAGTNGYMAPEILKEEPYSYPV 175
Query: 298 DIFSFGVIIFELITAIHPHQNLMEYVN 324
D F+ G I+E++ P ++ E V
Sbjct: 176 DWFAMGCSIYEMVAGRTPFKDHKEKVA 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 75/324 (23%), Positives = 123/324 (37%), Gaps = 78/324 (24%)
Query: 125 LGQGAFGPVYKATM------PSGGVAAIKVLASDSHQGE-KEFQTEVSLLGRL-HHRNLV 176
LG+GAFG V +A+ S A+K+L + E K TE+ +L + HH N+V
Sbjct: 15 LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVV 74
Query: 177 NLIGYCVDK-GKYMLIYEFMSNGSLSNLI------YSEERVLNWEERLQI---------- 219
NL+G C G M+I E+ G+LSN + +S R + +R
Sbjct: 75 NLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLD 134
Query: 220 -----------------ALDISHGIEYLHEGAVPPVIHRDLKS----------------- 245
+L E E P+ DL S
Sbjct: 135 SVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKC 194
Query: 246 -------ANILLDHFMRAKVADFGLSKEEVFDG---RNSGLKGTYGYIDPAYISTNKFTM 295
NILL K+ DFGL+++ D R + ++ P I +T
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTT 254
Query: 296 KSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELA 354
+SD++SFGV+++E+ + P+ + + ++ + + + A E+
Sbjct: 255 QSDVWSFGVLLWEIFSLGASPYPGV-------QIDEEFCRRLKEGTRMRAPE-YATPEIY 306
Query: 355 RIGHKCLHKTPRKRPSIGEVTQAL 378
I C H P RP+ E+ + L
Sbjct: 307 SIMLDCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 71/289 (24%), Positives = 118/289 (40%), Gaps = 40/289 (13%)
Query: 124 ILGQGAFGPVYKATMPS-GGVAAIKVLASDSHQGEKEFQTEVS----LLGRLHHRNLVNL 178
++G+G+FG V A + G A+KVL + +KE + ++ LL + H LV L
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 179 IGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPV 238
K + ++++ G L + E R A +I+ + YLH +
Sbjct: 62 HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLHS---LNI 117
Query: 239 IHRDLKSANILLDHFMRAKVADFGLSKEEV-FDGRNSGLKGTYGYIDPAYISTNKFTMKS 297
I+RDLK NILLD + DFGL KE + S GT Y+ P + +
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTV 177
Query: 298 DIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIG 357
D + G +++E++ + P S+D E+ D I
Sbjct: 178 DWWCLGAVLYEMLYGLPPF-----------YSRD-TAEMYDN----------------IL 209
Query: 358 HKCLHKTPRKRPSIGEVTQALL-KIKQRHL-AKQDTMSFADGEFSRAVS 404
+K L P S + + LL K + + L AK D + + F +++
Sbjct: 210 NKPLRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSIN 258
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 1e-12
Identities = 54/194 (27%), Positives = 96/194 (49%), Gaps = 8/194 (4%)
Query: 125 LGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQG-EKEFQTEVSLLGRLHHRNLVNLIGYC 182
LG G G V K PSG + A K++ + + E+ +L + +V G
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 183 VDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERL-QIALDISHGIEYLHEGAVPPVIHR 241
G+ + E M GSL ++ +R+ EE L ++++ + G+ YL E ++HR
Sbjct: 73 YSDGEISICMEHMDGGSLDQVLKEAKRIP--EEILGKVSIAVLRGLAYLREKH--QIMHR 128
Query: 242 DLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFS 301
D+K +NIL++ K+ DFG+S ++ D + GT Y+ P + ++++SDI+S
Sbjct: 129 DVKPSNILVNSRGEIKLCDFGVSG-QLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWS 187
Query: 302 FGVIIFELITAIHP 315
G+ + EL +P
Sbjct: 188 MGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 63/244 (25%), Positives = 111/244 (45%), Gaps = 37/244 (15%)
Query: 145 AIKVLASDSHQGEKE---FQTEVSLLGRLHHRNLVNLI--GYCVDKGKYMLIYEFMSNGS 199
AIK+L +D+ + E + F+ E +L RL+H N+V L+ G G ++E++ +
Sbjct: 7 AIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPP-GLLFAVFEYVPGRT 65
Query: 200 LSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILL---DHFMRA 256
L ++ + + L E ++ L + + H ++HRDLK NI++ A
Sbjct: 66 LREVL-AADGALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTGVRPHA 121
Query: 257 KVADFGLS--------KEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFE 308
KV DFG+ + R + + GT Y P + T SD++++G+I E
Sbjct: 122 KVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLE 181
Query: 309 LITAIHPHQNLMEYVNLASMSQDGVDEILDKQL----VGACNIQEVRELARIGHKCLHKT 364
+T Q +++ ++A EIL +QL V L ++ K L+K
Sbjct: 182 CLTG----QRVVQGASVA--------EILYQQLSPVDVSLPPWIAGHPLGQVLRKALNKD 229
Query: 365 PRKR 368
PR+R
Sbjct: 230 PRQR 233
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 1e-12
Identities = 43/141 (30%), Positives = 67/141 (47%), Gaps = 7/141 (4%)
Query: 125 LGQGAFGPVYKATMPSGG--VAAIKVLASDSHQGEKEF-QTEVSLLGRLHHRNLVNLIGY 181
+G+GA+G V K + G VA K S+ + K+ EV +L +L H N+VNL
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEA 68
Query: 182 CVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHR 241
KG+ L++E++ +L L+ + L + + I Y H +IHR
Sbjct: 69 FRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHR 124
Query: 242 DLKSANILLDHFMRAKVADFG 262
D+K NIL+ K+ DFG
Sbjct: 125 DIKPENILVSESGVLKLCDFG 145
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 63/197 (31%), Positives = 91/197 (46%), Gaps = 10/197 (5%)
Query: 123 NILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQ---TEVSLLGRLHHRNLVNL 178
LG G+FG V A +G AIK L K+ Q E S+L L H +VN+
Sbjct: 24 ETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNM 83
Query: 179 IGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPV 238
+ D+ + + EF+ G L + R N + A ++ EYLH +
Sbjct: 84 MCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHA-ELVLAFEYLHSKDI--- 139
Query: 239 IHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSD 298
I+RDLK N+LLD+ KV DFG +K +V D R L GT Y+ P I + D
Sbjct: 140 IYRDLKPENLLLDNKGHVKVTDFGFAK-KVPD-RTFTLCGTPEYLAPEVIQSKGHGKAVD 197
Query: 299 IFSFGVIIFELITAIHP 315
++ GV+++E I P
Sbjct: 198 WWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 61/213 (28%), Positives = 95/213 (44%), Gaps = 19/213 (8%)
Query: 124 ILGQGAFGPVY----KATMPSGGVAAIKVLASDSHQGEKEFQ---TEVSLLGRLHHRNLV 176
+LG+G FG V KAT G A+K+L + + E TE +L H L
Sbjct: 2 LLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 58
Query: 177 NLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVP 236
L + + E+ + G L S ERV + + +I ++YLH +
Sbjct: 59 ALKYSFQTHDRLCFVMEYANGGELF-FHLSRERVFSEDRARFYGAEIVSALDYLH--SEK 115
Query: 237 PVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRN-SGLKGTYGYIDPAYISTNKFTM 295
V++RDLK N++LD K+ DFGL KE + DG GT Y+ P + N +
Sbjct: 116 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGR 175
Query: 296 KSDIFSFGVIIFELITAIHP-----HQNLMEYV 323
D + GV+++E++ P H+ L E +
Sbjct: 176 AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 208
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 73/279 (26%), Positives = 124/279 (44%), Gaps = 35/279 (12%)
Query: 118 TQNFTNILGQGAFGPVYKA-TMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLH-HRNL 175
T +G+G +G V+K +G AA+K+L H ++E + E ++L L H N+
Sbjct: 19 TWEIIETIGKGTYGKVFKVLNKKNGSKAAVKIL-DPIHDIDEEIEAEYNILKALSDHPNV 77
Query: 176 VNLIGYCVDKG-----KYMLIYEFMSNGSLSNLIYSEERVLNWEERLQ--IALDISH--- 225
V G K + L+ E + GS+++L+ + L ER++ I I H
Sbjct: 78 VKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLV---KGFLKRGERMEEPIIAYILHEAL 134
Query: 226 -GIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKE--EVFDGRNSGLKGTYGY 282
G+++LH IHRD+K NILL K+ DFG+S + RN+ + GT +
Sbjct: 135 MGLQHLHVNKT---IHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFW 190
Query: 283 IDPAYISTNK-----FTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEIL 337
+ P I+ + + + D++S G+ EL P +L L + ++ +
Sbjct: 191 MAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLH 250
Query: 338 DKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQ 376
+L E KCL K KRP++ ++ Q
Sbjct: 251 QPELWSN-------EFNDFIRKCLTKDYEKRPTVSDLLQ 282
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 62/213 (29%), Positives = 93/213 (43%), Gaps = 20/213 (9%)
Query: 124 ILGQGAFGPVY----KATMPSGGVAAIKVLASDSHQGEKEFQ---TEVSLLGRLHHRNLV 176
+LG+G FG V KAT G A+K+L + + E TE +L H L
Sbjct: 2 LLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 58
Query: 177 NLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVP 236
L + + E+ + G L S ERV E +I +EYLH
Sbjct: 59 ALKYAFQTHDRLCFVMEYANGGELF-FHLSRERVFTEERARFYGAEIVSALEYLHS---R 114
Query: 237 PVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRN-SGLKGTYGYIDPAYISTNKFTM 295
V++RD+K N++LD K+ DFGL KE + DG GT Y+ P + N +
Sbjct: 115 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGR 174
Query: 296 KSDIFSFGVIIFELITAIHP-----HQNLMEYV 323
D + GV+++E++ P H+ L E +
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 207
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 2e-12
Identities = 73/274 (26%), Positives = 118/274 (43%), Gaps = 46/274 (16%)
Query: 121 FTNILGQGAFGPVYKATMPSGG---VAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVN 177
F ++G+G++G V + G V L + S + K + E LL +L H N+V
Sbjct: 4 FVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVA 63
Query: 178 --------------LIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDI 223
++G+C Y + E G L E +V+ W +QIA+
Sbjct: 64 YRESWEGEDGLLYIVMGFCEGGDLYHKLKE--QKGKL----LPENQVVEW--FVQIAM-- 113
Query: 224 SHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRN---SGLKGTY 280
++YLHE ++HRDLK+ N+ L KV D G+++ V + + S L GT
Sbjct: 114 --ALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIAR--VLENQCDMASTLIGTP 166
Query: 281 GYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQ 340
Y+ P S + KSD+++ G ++E+ T H N M+ V I++ +
Sbjct: 167 YYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHA-------FNAKDMNSL-VYRIIEGK 218
Query: 341 LVGACNIQEVRELARIGHKCLHKTPRKRPSIGEV 374
L EL + L K P KRPS+ +
Sbjct: 219 LPPMPK-DYSPELGELIATMLSKRPEKRPSVKSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 3e-12
Identities = 67/253 (26%), Positives = 106/253 (41%), Gaps = 22/253 (8%)
Query: 125 LGQGAFGPVYKA-TMPSGGVAAIKVLASDSHQGEKEFQ---TEVSLLGRLHHRNLVNLIG 180
+G G+FG VY A + + V AIK ++ Q +++Q EV L +L H N + G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 181 YCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIH 240
+ + L+ E+ GS S+L+ ++ L E + G+ YLH + IH
Sbjct: 83 CYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM---IH 138
Query: 241 RDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYI---STNKFTMKS 297
RD+K+ NILL K+ DFG + N GT ++ P I ++ K
Sbjct: 139 RDVKAGNILLSEPGLVKLGDFG--SASIMAPANX-FVGTPYWMAPEVILAMDEGQYDGKV 195
Query: 298 DIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIG 357
D++S G+ EL P N+ L ++Q+ L
Sbjct: 196 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE-SPALQSG-------HWSEYFRNFV 247
Query: 358 HKCLHKTPRKRPS 370
CL K P+ RP+
Sbjct: 248 DSCLQKIPQDRPT 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 4e-12
Identities = 58/201 (28%), Positives = 89/201 (44%), Gaps = 11/201 (5%)
Query: 120 NFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQ-----TEVSLLGRLHHRN 174
NF LG G+FG V AT + + + + + K+ Q +E +L ++H
Sbjct: 33 NFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPF 92
Query: 175 LVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGA 234
VNL G D+ L+ EF+ G + +R N + A I EYL
Sbjct: 93 CVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPN-DVGCFYAAQIVLIFEYLQS-- 149
Query: 235 VPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFT 294
+++RDLK N+LLD K+ DFG +K V D R L GT YI P +
Sbjct: 150 -LNIVYRDLKPENLLLDKDGFIKMTDFGFAK--VVDTRTYTLCGTPEYIAPEILLNVGHG 206
Query: 295 MKSDIFSFGVIIFELITAIHP 315
+D ++ G+ I+E++ P
Sbjct: 207 KAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 4e-12
Identities = 60/204 (29%), Positives = 96/204 (47%), Gaps = 16/204 (7%)
Query: 124 ILGQGAFGPVY---KATMP-SGGVAAIKVLAS----DSHQGEKEFQTEVSLLGRLHHRNL 175
+LG GA+G V+ K T +G + A+KVL + + +TE ++L +
Sbjct: 7 VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPF 66
Query: 176 VNLIGYCVD-KGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGA 234
+ + Y + K LI +++S G + +Y + E R +I +E+LH+
Sbjct: 67 LVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSG-EIILALEHLHKLG 125
Query: 235 VPPVIHRDLKSANILLDHFMRAKVADFGLSKE--EVFDGRNSGLKGTYGYIDPAYISTNK 292
+ ++RD+K NILLD + DFGLSKE R GT Y+ P I
Sbjct: 126 I---VYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKG 182
Query: 293 FTMKS-DIFSFGVIIFELITAIHP 315
K+ D +S G++IFEL+T P
Sbjct: 183 GHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 4e-12
Identities = 70/273 (25%), Positives = 115/273 (42%), Gaps = 45/273 (16%)
Query: 125 LGQGAFGPVY--KATMPSGGVAAIKVLASDSHQGEKEFQT-----EVSLLGRLHHRNLVN 177
LG+G+FG VY K +KVL +T E LL +L H +V
Sbjct: 8 LGKGSFGTVYLVKDKKAVAE-ERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66
Query: 178 LIGYCVDKGKYMLIYEFMSNGSL---------SNLIYSEERVLNWEERLQIALDISHGIE 228
+++ + +I E+ L + SE +V W +Q+ L G+
Sbjct: 67 FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW--FIQLLL----GVH 120
Query: 229 YLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGR---NSGLKGTYGYIDP 285
Y+H+ + +HRDLK+ NI L + + K+ DFG+S+ + G + GT Y+ P
Sbjct: 121 YMHQRRI---LHRDLKAKNIFLKNNL-LKIGDFGVSR--LLMGSCDLATTFTGTPYYMSP 174
Query: 286 AYISTNKFTMKSDIFSFGVIIFELITAIHPH--QNLMEYVNLASMSQDGVDEILDKQLVG 343
+ + KSDI+S G I++E+ H QN + V + + + +
Sbjct: 175 EALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVV--LRIVEGPTPSLPETY--- 229
Query: 344 ACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQ 376
R+L I L+K P RPS E+ +
Sbjct: 230 ------SRQLNSIMQSMLNKDPSLRPSAAEILR 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 6e-12
Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 29/207 (14%)
Query: 118 TQNFTNI--LGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKEFQT---------EVS 165
T + ++ +G GAFG V A +G AIK + K F T E+
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIM-------KPFSTPVLAKRTYRELK 61
Query: 166 LLGRLHHRNLVNLIGYCVDKGKYM-LIYEFMSNGSLSNLIYSEERVLNWEERLQIALDIS 224
LL L H N+++L + + + + E + L L+ R L + I
Sbjct: 62 LLKHLRHENIISLSDIFISPLEDIYFVTELLGT-DLHRLL--TSRPLEKQFIQYFLYQIL 118
Query: 225 HGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYID 284
G++Y+H V +HRDLK +NIL++ K+ DFGL++ + D + +G T Y
Sbjct: 119 RGLKYVHSAGV---VHRDLKPSNILINENCDLKICDFGLAR--IQDPQMTGYVSTRYYRA 173
Query: 285 PAYIST-NKFTMKSDIFSFGVIIFELI 310
P + T K+ ++ DI+S G I E++
Sbjct: 174 PEIMLTWQKYDVEVDIWSAGCIFAEML 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 9e-12
Identities = 74/259 (28%), Positives = 108/259 (41%), Gaps = 36/259 (13%)
Query: 124 ILGQGAFGPVYKATMPS-GGVAAIKVLASDSHQGEKEFQTEVS-----LLGRLHHRNLVN 177
++G+G+FG V A S G A+KVL + +KE Q + LL L H LV
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKE-QNHIMAERNVLLKNLKHPFLVG 60
Query: 178 LIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPP 237
L K + ++++ G L + E L R A +++ I YLH
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAA-EVASAIGYLHS---LN 116
Query: 238 VIHRDLKSANILLDHFMRAKVADFGLSKEEVF-DGRNSGLKGTYGYIDPAYISTNKFTMK 296
+I+RDLK NILLD + DFGL KE V + S GT Y+ P + +
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRT 176
Query: 297 SDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQL-------VGACNIQE 349
D + G +++E++ + P Y S D IL K L V AC++
Sbjct: 177 VDWWCLGAVLYEMLYGLPPF-----YSRDVSQMYDN---ILHKPLQLPGGKTVAACDLL- 227
Query: 350 VRELARIGHKCLHKTPRKR 368
LHK R+R
Sbjct: 228 --------VGLLHKDQRRR 238
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 51/195 (26%), Positives = 97/195 (49%), Gaps = 10/195 (5%)
Query: 125 LGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQG-EKEFQTEVSLLGRLHHRNLVNLIGYC 182
LG G G V+K + PSG + A K++ + + E+ +L + +V G
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 183 VDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERL--QIALDISHGIEYLHEGAVPPVIH 240
G+ + E M GSL ++ R+ E++ ++++ + G+ YL E ++H
Sbjct: 73 YSDGEISICMEHMDGGSLDQVLKKAGRI---PEQILGKVSIAVIKGLTYLREKH--KIMH 127
Query: 241 RDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIF 300
RD+K +NIL++ K+ DFG+S ++ D + GT Y+ P + ++++SDI+
Sbjct: 128 RDVKPSNILVNSRGEIKLCDFGVSG-QLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIW 186
Query: 301 SFGVIIFELITAIHP 315
S G+ + E+ +P
Sbjct: 187 SMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 1e-11
Identities = 59/200 (29%), Positives = 100/200 (50%), Gaps = 14/200 (7%)
Query: 124 ILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQ---TEVSLLG-RLHHRNLVNL 178
+LG+G+FG V A + + V AIKVL D + + TE +L H L L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 179 IGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEE-RLQI-ALDISHGIEYLHEGAVP 236
K + + E+++ G +L++ +R ++E R + A +++ + +LH V
Sbjct: 62 HCCFQTKDRLFFVMEYVNGG---DLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGV- 117
Query: 237 PVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGR-NSGLKGTYGYIDPAYISTNKFTM 295
I+RDLK NILLD K+ADFG+ KE + +G + GT YI P + ++
Sbjct: 118 --IYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGP 175
Query: 296 KSDIFSFGVIIFELITAIHP 315
D ++ GV+++E++ P
Sbjct: 176 SVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 1e-11
Identities = 55/209 (26%), Positives = 99/209 (47%), Gaps = 36/209 (17%)
Query: 125 LGQGAFGPVYKATM----PSGGVAAIKVL--ASDSHQGEKEFQTEVSLLGRLHHRNLVNL 178
+G+G+FG KA + G IK + + S + +E + EV++L + H N+V
Sbjct: 8 IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64
Query: 179 IGYCVDKGKYMLIYEFMSNGSLSNLI-------YSEERVLNWEERLQIALDISHGIEYLH 231
+ G ++ ++ G L I + E+++L+W +QI L + H +H
Sbjct: 65 QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW--FVQICLALKH----VH 118
Query: 232 EGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLK------GTYGYIDP 285
+ + +HRD+KS NI L K+ DFG+++ NS ++ GT Y+ P
Sbjct: 119 DRKI---LHRDIKSQNIFLTKDGTIKLGDFGIARV-----LNSTVELARTCIGTPYYLSP 170
Query: 286 AYISTNKFTMKSDIFSFGVIIFELITAIH 314
+ KSDI++ G +++E+ T H
Sbjct: 171 EICENRPYNNKSDIWALGCVLYEMCTLKH 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 65/230 (28%), Positives = 103/230 (44%), Gaps = 18/230 (7%)
Query: 124 ILGQGAFGPVYKATMPSGGV-AAIKVLASDS---HQGEKEFQTEVS-LLGRLHHRNLVNL 178
++G+G+FG V A + A+KVL + + EK +E + LL + H LV L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 179 IGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPV 238
K + ++++ G L + E L R A +I+ + YLH +
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAA-EIASALGYLHS---LNI 117
Query: 239 IHRDLKSANILLDHFMRAKVADFGLSKEEV-FDGRNSGLKGTYGYIDPAYISTNKFTMKS 297
++RDLK NILLD + DFGL KE + +G S GT Y+ P + +
Sbjct: 118 VYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTV 177
Query: 298 DIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNI 347
D + G +++E++ + P + N A M D IL+K L NI
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSR----NTAEM----YDNILNKPLQLKPNI 219
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 57/214 (26%), Positives = 104/214 (48%), Gaps = 47/214 (21%)
Query: 123 NILGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKE-FQT----EVSLLGRLHHRNLV 176
N + +G +G VY+A +G + A+K L + EKE F E+++L +L H N+V
Sbjct: 11 NRIEEGTYGVVYRARDKKTGEIVALKKLKMEK---EKEGFPITSLREINILLKLQHPNIV 67
Query: 177 NL----IGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHE 232
+ +G +DK YM + E++ + L +L+ + ++ E + L + G+ +LH+
Sbjct: 68 TVKEVVVGSNLDK-IYM-VMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHD 124
Query: 233 GAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAY----- 287
+ +HRDLK++N+LL++ K+ DFGL++E YG Y
Sbjct: 125 NWI---LHRDLKTSNLLLNNRGILKICDFGLARE-------------YGSPLKPYTQLVV 168
Query: 288 ----------ISTNKFTMKSDIFSFGVIIFELIT 311
+ +++ D++S G I EL+T
Sbjct: 169 TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLT 202
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-11
Identities = 69/269 (25%), Positives = 118/269 (43%), Gaps = 33/269 (12%)
Query: 125 LGQGAFGPVYKAT-MPSGGVAAIKV--LASDSHQGEKEFQTEVSLLGRLHHRN---LVNL 178
LG+G +G VYK P+G A+K L D E +F + L LH +V+
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELD----ESKFNQIIMELDILHKAVSPYIVDF 64
Query: 179 IGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERL--QIALDISHGIEYLHEGAVP 236
G +G + E+M GSL L E + +I + G+++L E
Sbjct: 65 YGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH-- 122
Query: 237 PVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTN----- 291
+IHRD+K N+L++ + K+ DFG+S V + + G Y+ P I +
Sbjct: 123 NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI-GCQSYMAPERIKSGGPNQN 181
Query: 292 -KFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQ---DGVDEILDKQLVGACNI 347
+T++SD++S G+ I E+ +P+ Y N+ + DG L
Sbjct: 182 PTYTVQSDVWSLGLSILEMALGRYPYPP-ETYANIFAQLSAIVDGDPPTLPSGYSD---- 236
Query: 348 QEVRELARIGHKCLHKTPRKRPSIGEVTQ 376
+ ++ KCL+K P +RP+ ++ +
Sbjct: 237 -DAQDFVA---KCLNKIPNRRPTYAQLLE 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 47/143 (32%), Positives = 66/143 (46%), Gaps = 26/143 (18%)
Query: 238 VIHRDLKSANILLDHFMRAKVADFGLSK---EEVFDGRNSGLKGTYGYIDPAYISTNKFT 294
+IHRD+KSANILL K+ DFG SK V D GT Y+ P ++
Sbjct: 164 MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS 223
Query: 295 MKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVD--EILDKQLVG-----ACNI 347
K+D+FS GV+++EL+T P DG + E++ K L G +I
Sbjct: 224 KKADMFSLGVLLYELLTLKRPF--------------DGENMEEVMHKTLAGRYDPLPPSI 269
Query: 348 QEVRELARIGHKCLHKTPRKRPS 370
E+ I L P++RPS
Sbjct: 270 SP--EMQEIVTALLSSDPKRRPS 290
|
Length = 496 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 56/198 (28%), Positives = 92/198 (46%), Gaps = 17/198 (8%)
Query: 125 LGQGAFGPVYKA-TMPSGG--VAAIKVLASDSHQGEKEFQT--EVSLLGRLH---HRNLV 176
+G+GA+G V+KA + +GG VA +V +G T EV++L L H N+V
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVV 67
Query: 177 NLIGYCV-----DKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLH 231
L C + K L++E + + L E + E + + G+++LH
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127
Query: 232 EGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTN 291
V +HRDLK NIL+ + K+ADFGL++ F + + T Y P + +
Sbjct: 128 SHRV---VHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQS 184
Query: 292 KFTMKSDIFSFGVIIFEL 309
+ D++S G I E+
Sbjct: 185 SYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 61/214 (28%), Positives = 95/214 (44%), Gaps = 39/214 (18%)
Query: 120 NFTNI--LGQGAFGPVYKA-TMPSGGVAAIKV--LASDSHQGEKEFQTEVSLLGRLHHRN 174
++T I +G+G +G VYK +G + A+K L S+ E+SLL L H N
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60
Query: 175 LVNLIGYCVDKGKYMLIYEFMSNG------SLSNLIYSEERVLNWEERLQIALDISHGIE 228
+V L + + + LI+EF+S SL Y + ++ I GI
Sbjct: 61 IVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVK-----SYLYQILQGIL 115
Query: 229 YLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSK----------EEVFDGRNSGLKG 278
+ H V+HRDLK N+L+D+ K+ADFGL++ EV
Sbjct: 116 FCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV--------- 163
Query: 279 TYGYIDP-AYISTNKFTMKSDIFSFGVIIFELIT 311
T Y P + + +++ DI+S G I E+ T
Sbjct: 164 TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 3e-11
Identities = 67/258 (25%), Positives = 109/258 (42%), Gaps = 28/258 (10%)
Query: 125 LGQGAFGPVYKATM-PSGGVAAIKVLASDSHQGE-KEFQTEVSLLGRLHH-RNLVNLIGY 181
+G G G VYK +G V A+K + ++ E K ++ ++ + H +V GY
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGY 82
Query: 182 CVDKGKYMLIYEFMSN--GSLSNLIYS--EERVLNWEERLQIALDISHGIEYLHEGAVPP 237
+ + E MS L I E +L ++ + I + YL E
Sbjct: 83 FITDSDVFICMELMSTCLDKLLKRIQGPIPEDILG-----KMTVAIVKALHYLKEKH--G 135
Query: 238 VIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTN----KF 293
VIHRD+K +NILLD K+ DFG+S V + G Y+ P I K+
Sbjct: 136 VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKY 195
Query: 294 TMKSDIFSFGVIIFELITAIHPHQNL-MEYVNLASMSQDGVDEI-LDKQLVGACNIQEVR 351
+++D++S G+ + EL T P++N E+ L + Q+ + ++ +
Sbjct: 196 DIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFS-----PDFC 250
Query: 352 ELARIGHKCLHKTPRKRP 369
CL K RKRP
Sbjct: 251 SFVD---LCLTKDHRKRP 265
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 60/206 (29%), Positives = 94/206 (45%), Gaps = 17/206 (8%)
Query: 121 FTNILGQGAFGPVYKAT---MPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVN 177
T ++G+ + AT P V A V+ +D Q ++E+ L H +V
Sbjct: 71 LTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYA-RSELHCLAACDHFGIVK 129
Query: 178 LIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERL-----QIALDISHGIEYLHE 232
K +LI E+ S G L+ I ++R+ +E L ++ L + L E
Sbjct: 130 HFDDFKSDDKLLLIMEYGSGGDLNKQI--KQRL---KEHLPFQEYEVGLLFYQIVLALDE 184
Query: 233 GAVPPVIHRDLKSANILLDHFMRAKVADFGLSKE---EVFDGRNSGLKGTYGYIDPAYIS 289
++HRDLKSANI L K+ DFG SK+ V S GT Y+ P
Sbjct: 185 VHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWE 244
Query: 290 TNKFTMKSDIFSFGVIIFELITAIHP 315
+++ K+D++S GVI++EL+T P
Sbjct: 245 RKRYSKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 4e-11
Identities = 41/155 (26%), Positives = 76/155 (49%), Gaps = 8/155 (5%)
Query: 163 EVSLLGRLHHRNLVNLIGYCVDKG-KYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIAL 221
E LL ++H +++ + V M++ + S+ L + R L ++ L I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSD--LYTYLTKRSRPLPIDQALIIEK 164
Query: 222 DISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYG 281
I G+ YLH + IHRD+K+ NI ++ + + D G ++ V GL GT
Sbjct: 165 QILEGLRYLHAQRI---IHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVE 221
Query: 282 YIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPH 316
P ++ +K+ K+DI+S G+++FE++ +P
Sbjct: 222 TNAPEVLARDKYNSKADIWSAGIVLFEMLA--YPS 254
|
Length = 357 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 4e-11
Identities = 56/216 (25%), Positives = 99/216 (45%), Gaps = 20/216 (9%)
Query: 124 ILGQGAFGPVYKATMPSGG-VAAIKVLASDSHQGEKEF---QTEVSLLGRL-HHRNLVNL 178
++G+G++ V + + A+KV+ + +++ QTE + +H LV L
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 179 IGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPV 238
+ + + EF+S G L +R L E + +IS + +LHE +
Sbjct: 62 HSCFQTESRLFFVIEFVSGGDLM-FHMQRQRKLPEEHARFYSAEISLALNFLHERGI--- 117
Query: 239 IHRDLKSANILLDHFMRAKVADFGLSKEEVFDG-RNSGLKGTYGYIDPAYISTNKFTMKS 297
I+RDLK N+LLD K+ D+G+ KE + G S GT YI P + +
Sbjct: 118 IYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSV 177
Query: 298 DIFSFGVIIFELIT----------AIHPHQNLMEYV 323
D ++ GV++FE++ + +P QN +Y+
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYL 213
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 4e-11
Identities = 61/214 (28%), Positives = 93/214 (43%), Gaps = 46/214 (21%)
Query: 125 LGQGAFGPVYKA-TMPSGGVAAIKVLASDSHQGEKEFQ-TEVSLLGRL-HHRNLVNLIGY 181
+G+G F V KA + +G AIK + E+ E+ L RL H N++ LI
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66
Query: 182 CVDK--GKYMLIYEFMSNGSLSNLI------YSEERVLNWEERLQIALDISHGIEYLHEG 233
D+ G+ L++E M + +L LI E+RV ++ +L +LD H
Sbjct: 67 LFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG----- 120
Query: 234 AVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYIST--- 290
+ HRD+K NIL+ K+ADFG S ++ K Y YIST
Sbjct: 121 ----IFHRDIKPENILIK-DDILKLADFG-SCRGIYS------KPPY----TEYISTRWY 164
Query: 291 ---------NKFTMKSDIFSFGVIIFELITAIHP 315
+ K DI++ G + FE I ++ P
Sbjct: 165 RAPECLLTDGYYGPKMDIWAVGCVFFE-ILSLFP 197
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 6e-11
Identities = 61/215 (28%), Positives = 98/215 (45%), Gaps = 42/215 (19%)
Query: 120 NFTNI--LGQGAFGPVYKA-TMPSGGVAAIKVLASDSHQGEKEFQT---EVSLLGRLHHR 173
NF + +G+G +G VYKA +G V A+K + D+ + E T E+SLL L+H
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELNHP 59
Query: 174 NLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDIS------HGI 227
N+V L+ + K L++EF+ + L + + + + L S G+
Sbjct: 60 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPL-----SGIPLPLIKSYLFQLLQGL 113
Query: 228 EYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSK----------EEVFDGRNSGLK 277
+ H V +HRDLK N+L++ K+ADFGL++ EV
Sbjct: 114 AFCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-------- 162
Query: 278 GTYGYIDPAYISTNKF-TMKSDIFSFGVIIFELIT 311
T Y P + K+ + DI+S G I E++T
Sbjct: 163 -TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 7e-11
Identities = 58/209 (27%), Positives = 92/209 (44%), Gaps = 17/209 (8%)
Query: 112 KDIQKATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQ---TEVSLL 167
KD Q TQ +GQG +G V+ A +G + A+K + E + TE +L
Sbjct: 1 KDFQILTQ-----VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDIL 55
Query: 168 GRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEE-RLQIALDISHG 226
LV L+ D L E++ G L+ + VL+ + R +A ++
Sbjct: 56 TTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLL-NNLGVLSEDHARFYMA-EMFEA 113
Query: 227 IEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPA 286
++ LHE IHRDLK N L+D K+ DFGLSK V + + G+ Y+ P
Sbjct: 114 VDALHELGY---IHRDLKPENFLIDASGHIKLTDFGLSKGIV--TYANSVVGSPDYMAPE 168
Query: 287 YISTNKFTMKSDIFSFGVIIFELITAIHP 315
+ + D +S G +++E + P
Sbjct: 169 VLRGKGYDFTVDYWSLGCMLYEFLCGFPP 197
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 8e-11
Identities = 57/225 (25%), Positives = 108/225 (48%), Gaps = 11/225 (4%)
Query: 124 ILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEF---QTEVSLLGRL-HHRNLVNL 178
++G+G++ V + + + A+KV+ + +++ QTE + + +H LV L
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 179 IGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPV 238
+ + + E+++ G L + + ++ R A +IS + YLHE +
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHERGI--- 117
Query: 239 IHRDLKSANILLDHFMRAKVADFGLSKEEVFDG-RNSGLKGTYGYIDPAYISTNKFTMKS 297
I+RDLK N+LLD K+ D+G+ KE + G S GT YI P + +
Sbjct: 118 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSV 177
Query: 298 DIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDE-ILDKQL 341
D ++ GV++FE++ P + N ++D + + IL+KQ+
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 222
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 58/212 (27%), Positives = 100/212 (47%), Gaps = 28/212 (13%)
Query: 111 YKDIQKATQNFTNILGQGAFGPV-YKATMPSGGVAAIKVLAS--DSHQGEKEFQTEVSLL 167
Y+D+++ +G GA+G V +G AIK L S K E+ LL
Sbjct: 17 YRDLKQ--------VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLL 68
Query: 168 GRLHHRNLVNLIGY-----CVDK-GKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQ-IA 220
+ H N++ L+ +D+ + L+ FM G+ + E++ E+R+Q +
Sbjct: 69 KHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKL--SEDRIQFLV 124
Query: 221 LDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTY 280
+ G++Y+H + IHRDLK N+ ++ K+ DFGL+++ D +G T
Sbjct: 125 YQMLKGLKYIHAAGI---IHRDLKPGNLAVNEDCELKILDFGLARQT--DSEMTGYVVTR 179
Query: 281 GYIDPAYI-STNKFTMKSDIFSFGVIIFELIT 311
Y P I + +T DI+S G I+ E++T
Sbjct: 180 WYRAPEVILNWMHYTQTVDIWSVGCIMAEMLT 211
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 58/201 (28%), Positives = 95/201 (47%), Gaps = 22/201 (10%)
Query: 125 LGQGAFGPVYKAT-MPSGGVAAIK-----VLASDSHQGEKEFQTEVSLLGRLHHRN---L 175
LG G G V K PSG + A K + + +Q +E + LH N +
Sbjct: 9 LGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKV-------LHECNSPYI 61
Query: 176 VNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERL-QIALDISHGIEYLHEGA 234
V G G+ + E M GSL ++ R+ E L +I++ + G+ YL E
Sbjct: 62 VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP--ENILGKISIAVLRGLTYLRE-- 117
Query: 235 VPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFT 294
++HRD+K +NIL++ K+ DFG+S + + NS GT Y+ P + +T
Sbjct: 118 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-FVGTRSYMSPERLQGTHYT 176
Query: 295 MKSDIFSFGVIIFELITAIHP 315
++SDI+S G+ + E+ +P
Sbjct: 177 VQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 1e-10
Identities = 56/196 (28%), Positives = 90/196 (45%), Gaps = 14/196 (7%)
Query: 125 LGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQT--EVSLLGRLH---HRNLVNL 178
+G GA+G VYKA P SG A+K + +++ T EV+LL RL H N+V L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 179 IGYCVD-----KGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEG 233
+ C + K L++E + + L L E + G+++LH
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN 127
Query: 234 AVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKF 293
+ +HRDLK NIL+ + K+ADFGL++ + + T Y P + + +
Sbjct: 128 CI---VHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQSTY 184
Query: 294 TMKSDIFSFGVIIFEL 309
D++S G I E+
Sbjct: 185 ATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 1e-10
Identities = 57/208 (27%), Positives = 97/208 (46%), Gaps = 32/208 (15%)
Query: 123 NILGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKEFQT-------EVSLLGRLHHRN 174
+ +G+GA+G V AT P+G AIK ++ HQ T E+ +L R H N
Sbjct: 11 SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQ------TFCQRTLREIKILRRFKHEN 64
Query: 175 LVNL------IGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIE 228
++ + + Y ++ E M L LI ++ L+ + I G++
Sbjct: 65 IIGILDIIRPPSFESFNDVY-IVQELMET-DLYKLIKTQH--LSNDHIQYFLYQILRGLK 120
Query: 229 YLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTY----GYID 284
Y+H V +HRDLK +N+LL+ K+ DFGL++ + ++G Y Y
Sbjct: 121 YIHSANV---LHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRA 177
Query: 285 PAYISTNKFTMKS-DIFSFGVIIFELIT 311
P + +K K+ DI+S G I+ E+++
Sbjct: 178 PEIMLNSKGYTKAIDIWSVGCILAEMLS 205
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 59/201 (29%), Positives = 96/201 (47%), Gaps = 15/201 (7%)
Query: 125 LGQGAFGPVYKA-TMPSGGVAAIKVLASDSHQGEKEFQ---TEVSLLGRLHHRNLVNLIG 180
+G+G FG VY+ + + A+KVL+ +KE E ++L R ++G
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 181 ----YCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVP 236
+ D Y L+ ++MS G L + E R + IA ++ +E+LH+
Sbjct: 61 LKFSFQTDSDLY-LVTDYMSGGELFWHLQKEGRFSEDRAKFYIA-ELVLALEHLHKY--- 115
Query: 237 PVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSG-LKGTYGYIDPAYISTNK-FT 294
+++RDLK NILLD + DFGLSK + D + + GT Y+ P + K +T
Sbjct: 116 DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYT 175
Query: 295 MKSDIFSFGVIIFELITAIHP 315
D +S GV++FE+ P
Sbjct: 176 KHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 52/196 (26%), Positives = 93/196 (47%), Gaps = 9/196 (4%)
Query: 125 LGQGAFGPVYKA-TMPSGGVAAIKVLASDSHQGEKEFQ---TEVSLLGRLHHRNLVNLIG 180
+G+G+FG V + + + A+K + E E ++L +++ +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 181 YCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIH 240
K L+ F++ G L + + E R R A ++ +E LH+ V I+
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTA-ELLCALENLHKFNV---IY 116
Query: 241 RDLKSANILLDHFMRAKVADFGLSKEEVFDG-RNSGLKGTYGYIDPAYISTNKFTMKSDI 299
RDLK NILLD+ + DFGL K + D + + GT Y+ P + + +T D
Sbjct: 117 RDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDW 176
Query: 300 FSFGVIIFELITAIHP 315
++ GV+++E++T + P
Sbjct: 177 WTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 70/247 (28%), Positives = 102/247 (41%), Gaps = 43/247 (17%)
Query: 125 LGQGAFGPVY----KATMPSGGVAAIKVLASDSHQGEKEFQT-----EVSLLGRLHHRNL 175
+G G FG V+ K T AI S++G KE + EV+++ L H+N+
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAI------SYRGLKEREKSQLVIEVNVMRELKHKNI 74
Query: 176 VNLIGYCVDKG--KYMLIYEFMSNGSLSNLIYSEERVLNWEER---LQIALDISHGIEYL 230
V I ++K K ++ EF G LS I ++ E + I + H + Y
Sbjct: 75 VRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYC 134
Query: 231 HEGAVPP----VIHRDLKSANILLDHFMR-----------------AKVADFGLSKEEVF 269
H P V+HRDLK NI L +R AK+ DFGLSK
Sbjct: 135 HNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGI 194
Query: 270 DGRNSGLKGTYGYIDPAYI--STNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLAS 327
+ GT Y P + T + KSD+++ G II+EL + P + L S
Sbjct: 195 ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLIS 254
Query: 328 MSQDGVD 334
+ G D
Sbjct: 255 ELKRGPD 261
|
Length = 1021 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 3e-10
Identities = 52/206 (25%), Positives = 97/206 (47%), Gaps = 20/206 (9%)
Query: 184 DKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDL 243
DK + + ++ S ++ +E L+ E+ L + ++ G+ +L A IHRDL
Sbjct: 184 DKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFL---ASKNCIHRDL 240
Query: 244 KSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGT----YGYIDPAYISTNKFTMKSDI 299
+ NILL H K+ DFGL+++ D N +KG ++ P I +T +SD+
Sbjct: 241 AARNILLTHGRITKICDFGLARDIRNDS-NYVVKGNARLPVKWMAPESIFNCVYTFESDV 299
Query: 300 FSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGH 358
+S+G++++E+ + P+ + M ++G + L C E+ + I
Sbjct: 300 WSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGY-----RMLSPECAPSEMYD---IMK 351
Query: 359 KCLHKTPRKRPSIGEVTQALLKIKQR 384
C P KRP+ ++ Q I+Q+
Sbjct: 352 SCWDADPLKRPTFKQIVQ---LIEQQ 374
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-10
Identities = 74/263 (28%), Positives = 118/263 (44%), Gaps = 25/263 (9%)
Query: 124 ILGQGAFGPVY----KATMPSGGVAAIKVLASDS----HQGEKEFQTEVSLLGRLHHRNL 175
+LG GA+G V+ + SG + A+KVL + + + +TE +L +
Sbjct: 7 VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 66
Query: 176 VNLIGYCVD-KGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGA 234
+ + Y K LI ++++ G L + ER E ++ +I +E+LH+
Sbjct: 67 LVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSG-EIVLALEHLHKLG 125
Query: 235 VPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG--RNSGLKGTYGYIDPAYISTNK 292
+ I+RD+K NILLD + DFGLSKE D R GT Y+ P +
Sbjct: 126 I---IYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGD 182
Query: 293 --FTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEV 350
D +S GV+++EL+T P E + A +S+ IL + QE+
Sbjct: 183 GGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISR----RILKSE---PPYPQEM 235
Query: 351 RELAR-IGHKCLHKTPRKRPSIG 372
LA+ I + L K P+KR G
Sbjct: 236 SALAKDIIQRLLMKDPKKRLGCG 258
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 61.1 bits (149), Expect = 3e-10
Identities = 63/219 (28%), Positives = 99/219 (45%), Gaps = 57/219 (26%)
Query: 125 LGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKEFQT---EVSLLGRL-HHRN---LV 176
LG+GA+G V+KA + V A+K + D+ + + Q E+ L L H N L+
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIF-DAFRNATDAQRTFREIMFLQELGDHPNIVKLL 73
Query: 177 NLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISH---------GI 227
N+I DK Y L++E+M L +I R I D+ +
Sbjct: 74 NVIKAENDKDIY-LVFEYMET-DLHAVI-----------RANILEDVHKRYIMYQLLKAL 120
Query: 228 EYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPA- 286
+Y+H G V IHRDLK +NILL+ R K+ADFGL++ S + +P
Sbjct: 121 KYIHSGNV---IHRDLKPSNILLNSDCRVKLADFGLAR--------SLSELEENPENPVL 169
Query: 287 --YIST------------NKFTMKSDIFSFGVIIFELIT 311
Y++T ++T D++S G I+ E++
Sbjct: 170 TDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLL 208
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 3e-10
Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 25/213 (11%)
Query: 120 NFTNILGQGAFGPVY----KATMPSGGVAAIKVLASDSHQGEKE---FQTEVSLLGRLHH 172
+ +++G+G FG V KAT G + A+KV+ ++ F+ E +L +
Sbjct: 4 DVKSLVGRGHFGEVQVVREKAT---GDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 173 RNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIAL-DISHGIEYLH 231
+ L DK L+ E+ G L +L+ E + E+ Q L ++ I +H
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFD-EDMAQFYLAELVLAIHSVH 119
Query: 232 E-GAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGR-NSGLK-GTYGYIDPAYI 288
+ G V HRD+K N+L+D K+ADFG + + NS L GT YI P +
Sbjct: 120 QMGYV----HRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVL 175
Query: 289 ST------NKFTMKSDIFSFGVIIFELITAIHP 315
+T + ++ D +S GVI +E+I P
Sbjct: 176 TTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 6e-10
Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 19/207 (9%)
Query: 124 ILGQGAFGPVY---KATMPSGGVAAIKVLASDS---HQGEKEFQTEVSLLGRLHHRN--L 175
I+G+G FG VY KA +G + A+K L QGE E +L + +
Sbjct: 1 IIGRGGFGEVYGCRKAD--TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 58
Query: 176 VNLIGYCVDK-GKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGA 234
+ + Y K I + M+ G L + S+ V + E A +I G+E++H
Sbjct: 59 IVCMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEAEMRFYAAEIILGLEHMHNRF 117
Query: 235 VPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLK-GTYGYIDPAYISTN-K 292
V++RDLK ANILLD +++D GL+ + F + GT+GY+ P +
Sbjct: 118 ---VVYRDLKPANILLDEHGHVRISDLGLACD--FSKKKPHASVGTHGYMAPEVLQKGVA 172
Query: 293 FTMKSDIFSFGVIIFELITAIHPHQNL 319
+ +D FS G ++F+L+ P +
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSPFRQH 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 6e-10
Identities = 61/250 (24%), Positives = 108/250 (43%), Gaps = 46/250 (18%)
Query: 120 NFTNILGQGAFGPV----YKATMPSGGVAAIKVLASDSHQGEKE---FQTEVSLLGRLHH 172
+ ++G+GAFG V +K++ V A+K+L+ + F E ++ +
Sbjct: 46 DVIKVIGRGAFGEVQLVRHKSSKQ---VYAMKLLSKFEMIKRSDSAFFWEERDIMAHANS 102
Query: 173 RNLVNLIGYCVDKGKYM-LIYEFMSNGSLSNLIYSEERVLNWEE----RLQIALDISHGI 227
+V L Y KY+ ++ E+M G L NL+ + + W + +ALD H +
Sbjct: 103 EWIVQLH-YAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSM 161
Query: 228 EYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG--RNSGLKGTYGYIDP 285
+ IHRD+K N+LLD K+ADFG + +G R GT YI P
Sbjct: 162 GF---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISP 212
Query: 286 AYIST----NKFTMKSDIFSFGVIIFELI---------------TAIHPHQNLMEYVNLA 326
+ + + + D +S GV ++E++ + I H+N + + +
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDI 272
Query: 327 SMSQDGVDEI 336
+S+ D I
Sbjct: 273 EISKQAKDLI 282
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 9e-10
Identities = 33/100 (33%), Positives = 50/100 (50%), Gaps = 8/100 (8%)
Query: 121 FTNILGQGAFGPVYKATMPSGG------VAAIKVLASDSHQGEKE-FQTEVSLLGRL-HH 172
F LG GAFG V +AT G A+K+L + +H E+E +E+ +L L H
Sbjct: 42 FGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQH 101
Query: 173 RNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLN 212
+N+VNL+G C G ++I E+ G L N + +
Sbjct: 102 KNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFL 141
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 42/190 (22%), Positives = 93/190 (48%), Gaps = 17/190 (8%)
Query: 196 SNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMR 255
S+ S + L+ ++ L+ + ++ G+++L A IHRD+ + N+LL
Sbjct: 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRV 250
Query: 256 AKVADFGLSKEEVFDGRNSGLKGT----YGYIDPAYISTNKFTMKSDIFSFGVIIFELIT 311
AK+ DFGL++ ++ + N +KG ++ P I +T++SD++S+G++++E+ +
Sbjct: 251 AKICDFGLAR-DIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
Query: 312 -AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPS 370
P+ ++ M + G Q+ + E+ I C + P +RP+
Sbjct: 310 LGKSPYPGILVNSKFYKMVKRGY------QM--SRPDFAPPEIYSIMKMCWNLEPTERPT 361
Query: 371 IGEVTQALLK 380
+++Q + +
Sbjct: 362 FSQISQLIQR 371
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 42/144 (29%), Positives = 72/144 (50%), Gaps = 7/144 (4%)
Query: 125 LGQGAFGPVYKA-TMPSGGVAAIK--VLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGY 181
+G+G++G V+K +G + AIK V + D +K E+ +L +L H NLVNLI
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 182 CVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHR 241
K K L++E+ + ++ N + R + +I + + H+ IHR
Sbjct: 69 FRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNC---IHR 124
Query: 242 DLKSANILLDHFMRAKVADFGLSK 265
D+K NIL+ + K+ DFG ++
Sbjct: 125 DVKPENILITKQGQIKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 54/198 (27%), Positives = 87/198 (43%), Gaps = 10/198 (5%)
Query: 124 ILGQGAFGPVYKATMP-SGGVAAIKVLASD---SHQGEKEFQTEVS-LLGRLHHRNLVNL 178
++G+G+FG V A G A+KVL + + +K E + LL + H LV L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 179 IGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPV 238
K + +F++ G L + E R A +I+ + YLH +
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLHS---INI 117
Query: 239 IHRDLKSANILLDHFMRAKVADFGLSKEEV-FDGRNSGLKGTYGYIDPAYISTNKFTMKS 297
++RDLK NILLD + DFGL KE + + GT Y+ P I +
Sbjct: 118 VYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTV 177
Query: 298 DIFSFGVIIFELITAIHP 315
D + G +++E++ + P
Sbjct: 178 DWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 13/200 (6%)
Query: 124 ILGQGAFGPVYKA-TMPSGGVAAIKVLASDS---HQGEKEFQTEVSLLGRLHHRN--LVN 177
I+G+G FG VY +G + A+K L QGE E +L + + +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 178 LIGYCVDK-GKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVP 236
+ Y K I + M+ G L + S+ V + +E A +I G+E++H V
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHL-SQHGVFSEKEMRFYATEIILGLEHMHNRFV- 118
Query: 237 PVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYIST-NKFTM 295
++RDLK ANILLD +++D GL+ + ++ + GT+GY+ P + +
Sbjct: 119 --VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPEVLQKGTAYDS 175
Query: 296 KSDIFSFGVIIFELITAIHP 315
+D FS G ++F+L+ P
Sbjct: 176 SADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 52/191 (27%), Positives = 89/191 (46%), Gaps = 10/191 (5%)
Query: 125 LGQGAFGPVYKA-TMPSGGVAAIKVLASDSHQGEKEFQT--EVSLLGRLHHRNLVNLIGY 181
LG+G++ VYK + +G + A+KV++ + +G F E SLL L H N+V L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEG-VPFTAIREASLLKGLKHANIVLLHDI 71
Query: 182 CVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHR 241
K ++E+M +I + + RL + G+ Y+H + +HR
Sbjct: 72 IHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRL-FMFQLLRGLAYIHGQHI---LHR 127
Query: 242 DLKSANILLDHFMRAKVADFGLSKEEVFDGRN-SGLKGTYGYIDP-AYISTNKFTMKSDI 299
DLK N+L+ + K+ADFGL++ + + S T Y P + ++ DI
Sbjct: 128 DLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDI 187
Query: 300 FSFGVIIFELI 310
+ G I E++
Sbjct: 188 WGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 39/130 (30%), Positives = 64/130 (49%), Gaps = 5/130 (3%)
Query: 187 KYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSA 246
+ L+ E+++ G L +R L E A +I + +LHE + I+RDLK
Sbjct: 70 RLFLVIEYVNGGDLM-FHMQRQRKLPEEHARFYAAEICIALNFLHERGI---IYRDLKLD 125
Query: 247 NILLDHFMRAKVADFGLSKEEVFDG-RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVI 305
N+LLD K+ D+G+ KE + G S GT YI P + ++ D ++ GV+
Sbjct: 126 NVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVL 185
Query: 306 IFELITAIHP 315
+FE++ P
Sbjct: 186 MFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 3e-09
Identities = 59/296 (19%), Positives = 103/296 (34%), Gaps = 57/296 (19%)
Query: 121 FTNILGQGAFGPVYKATMPSGGVAAIKV--LASDSHQGEKEFQTEVSLLGRLHHRNLVNL 178
+ K P+ + A+K L S S + K Q E+ +L H N++
Sbjct: 6 IGKCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPY 64
Query: 179 IGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIAL---DISHGIEYLH-EGA 234
+ + + ++ M+ GS +L+ + L IA D+ + ++Y+H +G
Sbjct: 65 VTSFIVDSELYVVSPLMAYGSCEDLL--KTHFPEGLPELAIAFILKDVLNALDYIHSKG- 121
Query: 235 VPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTN--- 291
IHR +K+++ILL + ++ S + G + + P N
Sbjct: 122 ---FIHRSVKASHILLSGDGKVVLSGLRYSVSMI----KHGKRQRVVHDFPKSSVKNLPW 174
Query: 292 -----------KFTMKSDIFSFGVIIFEL------ITAIHPHQNLMEYVN---------- 324
+ KSDI+S G+ EL + Q L+E V
Sbjct: 175 LSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKS 234
Query: 325 -----LASMSQDGVDEILDKQLVGACNIQEVRELARIGHK----CLHKTPRKRPSI 371
SMSQ + + R + H+ CL + P RPS
Sbjct: 235 TYPLYEDSMSQSR-SSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSA 289
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 4e-09
Identities = 46/157 (29%), Positives = 70/157 (44%), Gaps = 15/157 (9%)
Query: 125 LGQGAFGPVYKATMPSGGVAAIKVL----ASDSHQGEKEFQTEVSLLGRLHHRNLVNLIG 180
+G G FG V + SG A V+ S S Q + +F E L H NL+ +G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 181 YCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERL----QIALDISHGIEYLHEGAVP 236
C + Y+L+ EF G L + S + ++A +I+ G+ +LH+
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN-- 120
Query: 237 PVIHRDLKSANILLDHFMRAKVADFGLS----KEEVF 269
IH DL N LL + K+ D+GLS KE+ +
Sbjct: 121 -FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY 156
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 6e-09
Identities = 45/168 (26%), Positives = 72/168 (42%), Gaps = 30/168 (17%)
Query: 156 GEKEFQTEVSLLGRLHHRNLVNLI-GY------CVDKGKY---MLIY-EFMSNGSLSNLI 204
G K E+ +L + HR ++NLI Y C+ KY + Y + L I
Sbjct: 129 GGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAI 188
Query: 205 YSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLS 264
+ R+L + YLH + IHRD+K+ NI LD A + DFG +
Sbjct: 189 TIQRRLLE-------------ALAYLHGRGI---IHRDVKTENIFLDEPENAVLGDFGAA 232
Query: 265 ---KEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFEL 309
+ G GT P ++ + + K+DI+S G+++FE+
Sbjct: 233 CKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 6e-09
Identities = 57/211 (27%), Positives = 94/211 (44%), Gaps = 36/211 (17%)
Query: 120 NFTNILGQGAFGPVYKATMPSGGV-AAIKVLASDSHQGEKEFQT---------EVSLLGR 169
+ +G GA+G V A G AIK L+ + FQ+ E+ LL
Sbjct: 18 QNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLS-------RPFQSAIHAKRTYRELRLLKH 70
Query: 170 LHHRNLVNLIG-YCVDKG-----KYMLIYEFMSNGSLSNLIYSEERVLNWEERLQ-IALD 222
+ H N++ L+ + L+ M L+N++ + L+ ++ +Q +
Sbjct: 71 MDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC--QKLS-DDHIQFLVYQ 126
Query: 223 ISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGY 282
I G++Y+H + IHRDLK +NI ++ K+ DFGL++ D +G T Y
Sbjct: 127 ILRGLKYIHSAGI---IHRDLKPSNIAVNEDCELKILDFGLARHT--DDEMTGYVATRWY 181
Query: 283 IDPAYISTNK--FTMKSDIFSFGVIIFELIT 311
P I N + DI+S G I+ EL+T
Sbjct: 182 RAPE-IMLNWMHYNQTVDIWSVGCIMAELLT 211
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 7e-09
Identities = 43/172 (25%), Positives = 78/172 (45%), Gaps = 15/172 (8%)
Query: 211 LNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD 270
L E+ + + ++ G+E+L A IHRDL + NILL K+ DFGL+++ D
Sbjct: 171 LTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD 227
Query: 271 G---RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLA 326
R + ++ P I +T +SD++SFGV+++E+ + P+ +
Sbjct: 228 PDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFC 287
Query: 327 SMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQAL 378
+DG + + E+ RI C P++RP+ + + L
Sbjct: 288 QRLKDGT-RMRAPENATP-------EIYRIMLACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 7e-09
Identities = 51/205 (24%), Positives = 94/205 (45%), Gaps = 30/205 (14%)
Query: 194 FMSNGSLSNLIYSEE-------RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSA 246
F+ SLS++ E +VL E+ + + ++ G+E+L A IHRDL +
Sbjct: 152 FVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAAR 208
Query: 247 NILLDHFMRAKVADFGLSKEEVFDG---RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFG 303
NILL K+ DFGL+++ D R + ++ P I +T++SD++SFG
Sbjct: 209 NILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 268
Query: 304 VIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQ----EVRELARIGH 358
V+++E+ + P+ + +DE ++L ++ E+ +
Sbjct: 269 VLLWEIFSLGASPYPGVK------------IDEEFCRRLKEGTRMRAPDYTTPEMYQTML 316
Query: 359 KCLHKTPRKRPSIGEVTQALLKIKQ 383
C H P +RP+ E+ + L + Q
Sbjct: 317 DCWHGEPSQRPTFSELVEHLGNLLQ 341
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 8e-09
Identities = 72/277 (25%), Positives = 120/277 (43%), Gaps = 48/277 (17%)
Query: 120 NFTNILGQGAFGPV----YKATMPSGGVAAIKVLA-------SDSHQGEKEFQTEVSLLG 168
+ ++G+GAFG V +K+ S V A+K+L+ SDS F E ++
Sbjct: 46 DVVKVIGRGAFGEVQLVRHKS---SQKVYAMKLLSKFEMIKRSDS----AFFWEERDIMA 98
Query: 169 RLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEE----RLQIALDIS 224
+ +V L D ++ E+M G L NL+ + + W + + +ALD
Sbjct: 99 FANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAI 158
Query: 225 HGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFG--LSKEEVFDGRNSGLKGTYGY 282
H + +IHRD+K N+LLD K+ADFG + +E R GT Y
Sbjct: 159 HSMG---------LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDY 209
Query: 283 IDPAYISTNK----FTMKSDIFSFGVIIFELITAIHP---------HQNLMEYVNLASMS 329
I P + + + + D +S GV +FE++ P + +M++ N +
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFP 269
Query: 330 QDGVDEILDKQLVGA-CNIQEVRELARIGHKCLHKTP 365
+D K L+ A +EVR L R G + + + P
Sbjct: 270 EDVEISKHAKNLICAFLTDREVR-LGRNGVEEIKQHP 305
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 8e-09
Identities = 41/144 (28%), Positives = 68/144 (47%), Gaps = 7/144 (4%)
Query: 125 LGQGAFGPVYKA-TMPSGGVAAIK-VLASDSHQGEKEFQT-EVSLLGRLHHRNLVNLIGY 181
+G+G +G V+KA + + A+K V D +G E+ LL L H+N+V L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 182 CVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHR 241
K L++E+ + L S ++ E + G+ + H V+HR
Sbjct: 68 LHSDKKLTLVFEY-CDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHR 123
Query: 242 DLKSANILLDHFMRAKVADFGLSK 265
DLK N+L++ K+ADFGL++
Sbjct: 124 DLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 9e-09
Identities = 44/179 (24%), Positives = 87/179 (48%), Gaps = 26/179 (14%)
Query: 162 TEVSLLGRLHHRNLVNLIG-YCVDKGKYMLIYEFMSNGSLSNLIY---SEERVLNWEERL 217
TE +L ++H +++ L G + +K +++ + ++ +Y + +R + + L
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTD------LYCYLAAKRNIAICDIL 185
Query: 218 QIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLS--KEEVFDGRNSG 275
I + I+YLHE + IHRD+K+ NI ++H + DFG + ++ + G
Sbjct: 186 AIERSVLRAIQYLHENRI---IHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYG 242
Query: 276 LKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVD 334
GT P ++ + + DI+S G+++FE+ T H +L E +DG+D
Sbjct: 243 WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATC---HDSLFE--------KDGLD 290
|
Length = 391 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 9e-09
Identities = 48/148 (32%), Positives = 76/148 (51%), Gaps = 14/148 (9%)
Query: 125 LGQGAFGPVYKA-TMPSGGVAAIKVLASDSHQGEKEF--QT---EVSLLGRLHHRNLVNL 178
+G+G +G VYKA +G + A+K + ++ E E T E+SLL L+H N+V L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLET---EDEGVPSTAIREISLLKELNHPNIVRL 63
Query: 179 IGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIAL-DISHGIEYLHEGAVPP 237
+ + K L++EF+ + L + S ++ L + GI Y H
Sbjct: 64 LDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR--- 119
Query: 238 VIHRDLKSANILLDHFMRAKVADFGLSK 265
V+HRDLK N+L+D K+ADFGL++
Sbjct: 120 VLHRDLKPQNLLIDREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 60/228 (26%), Positives = 104/228 (45%), Gaps = 41/228 (17%)
Query: 112 KDIQKATQNF--TNILGQGAFGPV----YKATMPSGGVAAIKVLA-------SDSHQGEK 158
+D++ +++ ++G+GAFG V +K+T V A+K+L+ SDS
Sbjct: 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRK---VYAMKLLSKFEMIKRSDS----A 88
Query: 159 EFQTEVSLLGRLHHRNLVNLIGYCVDKGKYM-LIYEFMSNGSLSNLIYSEERVLNWEE-- 215
F E ++ + +V L Y +Y+ ++ E+M G L NL+ + + W
Sbjct: 89 FFWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFY 147
Query: 216 --RLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG-- 271
+ +ALD H + + IHRD+K N+LLD K+ADFG + +G
Sbjct: 148 TAEVVLALDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 198
Query: 272 RNSGLKGTYGYIDPAYISTNK----FTMKSDIFSFGVIIFELITAIHP 315
R GT YI P + + + + D +S GV ++E++ P
Sbjct: 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 55/209 (26%), Positives = 89/209 (42%), Gaps = 27/209 (12%)
Query: 121 FTNILGQGAFGPV----YKATMPSGGVAAIKVLASDSHQGEKEFQT-----EVSLLGRLH 171
LGQGA+G V T VA K+ ++ K+ E+ LL
Sbjct: 4 LIKELGQGAYGIVCSARNAETSEEETVAIKKI----TNVFSKKILAKRALRELKLLRHFR 59
Query: 172 -HRNLVNLIGY-CVDKGKY--MLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGI 227
H+N+ L V G + + +YE + L +I S + + + + I I G+
Sbjct: 60 GHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFI-YQILCGL 118
Query: 228 EYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSK-----EEVFDGRNSGLKGTYGY 282
+Y+H V +HRDLK N+L++ K+ DFGL++ G + T Y
Sbjct: 119 KYIHSANV---LHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWY 175
Query: 283 IDPA-YISTNKFTMKSDIFSFGVIIFELI 310
P +S +T D++S G I+ EL+
Sbjct: 176 RAPEIMLSFQSYTKAIDVWSVGCILAELL 204
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 46/200 (23%), Positives = 93/200 (46%), Gaps = 27/200 (13%)
Query: 192 YEFMSNGSLSNLIYSE-ERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILL 250
Y+ ++ + NL+ + L + L ++ G+E+L A +HRDL + N+LL
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLL 270
Query: 251 DHFMRAKVADFGLSKEEVFDGRNSGLKGTY---GYIDPAYISTNKFTMKSDIFSFGVIIF 307
K+ DFGL+++ + D T+ ++ P I N +T SD++S+G++++
Sbjct: 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLW 330
Query: 308 ELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQE----VRELARIGHKCLH 362
E+ + P+ ++ VD ++ + + +E+ I KC +
Sbjct: 331 EIFSLGGTPYPGMI------------VDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWN 378
Query: 363 KTPRKRPS---IGEVTQALL 379
P KRPS + ++ ++LL
Sbjct: 379 SEPEKRPSFLHLSDIVESLL 398
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 2e-08
Identities = 54/217 (24%), Positives = 98/217 (45%), Gaps = 29/217 (13%)
Query: 125 LGQGAFGPVYKA---TMPSGGVAAIKVL-ASDSHQGEKEFQTEVSLLGRLHHRNLVNLIG 180
+G G FG V + T +K L A+ S + + EF + L H N++ +G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 181 YCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQI---ALDISHGIEYLHEGAVPP 237
CV+ Y+L++E+ G L + + E+ + L + A +I+ G+ ++H+
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--- 119
Query: 238 VIHRDLKSANILLDHFMRAKVADFGLS----KE---EVFDGRNSGLKGTYGYIDPAYIS- 289
+H DL N L + KV D+G+ KE E D + L+ ++ P +
Sbjct: 120 FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR----WLAPELVGE 175
Query: 290 ------TNKFTMKSDIFSFGVIIFELI-TAIHPHQNL 319
T + T S++++ GV ++EL A P+ +L
Sbjct: 176 FHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHL 212
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 59/232 (25%), Positives = 94/232 (40%), Gaps = 44/232 (18%)
Query: 124 ILGQGAFGPVYKATMP-SGGVAAIKVL-ASDSHQGEK--EFQTEVSLLGRLHHRNLVNLI 179
++G+GAFG V +G V A+K+L +D + E+ + E +L +V +
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMF 67
Query: 180 GYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVI 239
DK LI EF+ G + L+ ++ + E + IA + I+ +H+ I
Sbjct: 68 YSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA-ETVLAIDSIHQLGF---I 123
Query: 240 HRDLKSANILLDHFMRAKVADFG--------------------LSKEEVFDGRNSGLK-- 277
HRD+K N+LLD K++DFG L + F NS K
Sbjct: 124 HRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAE 183
Query: 278 --------------GTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHP 315
GT YI P + D +S GVI++E++ P
Sbjct: 184 TWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 32/92 (34%), Positives = 48/92 (52%), Gaps = 8/92 (8%)
Query: 121 FTNILGQGAFGPVYKATM------PSGGVAAIKVLASDSHQGEKE-FQTEVSLLGRL-HH 172
F LG GAFG V +AT + A+K+L +H E+E +E+ +L L +H
Sbjct: 39 FGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 98
Query: 173 RNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLI 204
N+VNL+G C G ++I E+ G L N +
Sbjct: 99 INIVNLLGACTVGGPTLVITEYCCYGDLLNFL 130
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 30/112 (26%), Positives = 62/112 (55%), Gaps = 6/112 (5%)
Query: 203 LIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFG 262
+ +E L++ + + + +++G+E+L A +HRDL + N+L+ K+ DFG
Sbjct: 228 TLINESPALSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFG 284
Query: 263 LSKEEVFDGRNSGLKGTY---GYIDPAYISTNKFTMKSDIFSFGVIIFELIT 311
L+++ + D T+ ++ P I N +T SD++SFG++++E+ T
Sbjct: 285 LARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 3e-08
Identities = 41/151 (27%), Positives = 74/151 (49%), Gaps = 14/151 (9%)
Query: 124 ILGQGAFGPVYKAT-MPSGGVAAIKVL--ASDSHQGEKEFQTEVSLLGRLHHRNLVNLIG 180
+G GA+G V A SG AIK + A D K E+ +L H N++ +
Sbjct: 12 NIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRD 71
Query: 181 YCVDKGKYM----LIYEFMSNGSLSNLIYSEERVLNWEERLQIAL-DISHGIEYLHEGAV 235
G ++ + M + L ++I+S++ + EE ++ L + G++Y+H V
Sbjct: 72 ILRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLT--EEHIRYFLYQLLRGLKYIHSANV 128
Query: 236 PPVIHRDLKSANILLDHFMRAKVADFGLSKE 266
IHRDLK +N+L++ ++ DFG+++
Sbjct: 129 ---IHRDLKPSNLLVNEDCELRIGDFGMARG 156
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 4e-08
Identities = 49/192 (25%), Positives = 87/192 (45%), Gaps = 8/192 (4%)
Query: 125 LGQGAFGPVYKA-TMPSGGVAAIKVLASDSHQGEK-EFQTEVSLLGRLHHRNLVNLIGYC 182
LG+G + VYK + + + A+K + + +G EVSLL L H N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 183 VDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRD 242
+ L++E++ + L + +N + G+ Y H V+HRD
Sbjct: 74 HTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR---RKVLHRD 129
Query: 243 LKSANILLDHFMRAKVADFGLSKEEVFDGRN-SGLKGTYGYIDP-AYISTNKFTMKSDIF 300
LK N+L++ K+ADFGL++ + + S T Y P + + ++ + D++
Sbjct: 130 LKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMW 189
Query: 301 SFGVIIFELITA 312
G I +E+ T
Sbjct: 190 GVGCIFYEMSTG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 4e-08
Identities = 52/194 (26%), Positives = 89/194 (45%), Gaps = 10/194 (5%)
Query: 125 LGQGAFGPVYKA-TMPSGGVAAIKVLASDSHQGEKEFQT--EVSLLGRLHHRNLVNLIGY 181
LG+G++ VYK + +G + A+KV+ +G F E SLL L H N+V L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG-TPFTAIREASLLKGLKHANIVLLHDI 71
Query: 182 CVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHR 241
K L++E++ L + L+ E + G+ Y+H+ + +HR
Sbjct: 72 IHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYI---LHR 127
Query: 242 DLKSANILLDHFMRAKVADFGLSKEEVFDGRN-SGLKGTYGYIDP-AYISTNKFTMKSDI 299
DLK N+L+ K+ADFGL++ + S T Y P + + +++ D+
Sbjct: 128 DLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDM 187
Query: 300 FSFGVIIFELITAI 313
+ G I E+I +
Sbjct: 188 WGVGCIFVEMIQGV 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 6e-08
Identities = 59/240 (24%), Positives = 93/240 (38%), Gaps = 67/240 (27%)
Query: 124 ILGQGAFGPVYKATMP-SGGVAAIKVL-ASDSHQGEKEFQT-----EVSLLGRLHHRNLV 176
++G+GAFG V +G + A+K L S+ EKE Q E +L + +V
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEML--EKE-QVAHVRAERDILAEADNPWVV 64
Query: 177 NLIGYCV--DKGKYMLIYEFMSNGSLSNL-----IYSEERVLNWEERLQIALDISHGIEY 229
L Y D+ LI E++ G + L ++EE + +A+D H + Y
Sbjct: 65 KL--YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGY 122
Query: 230 LHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSK-----------------------E 266
IHRD+K N+LLD K++DFGL +
Sbjct: 123 ---------IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLD 173
Query: 267 EVFDGRNSGLK----------------GTYGYIDPAYISTNKFTMKSDIFSFGVIIFELI 310
+ +S K GT YI P + + D +S GVI++E++
Sbjct: 174 FISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 6e-08
Identities = 76/301 (25%), Positives = 123/301 (40%), Gaps = 56/301 (18%)
Query: 124 ILGQGAFGPVYKATMP--SGGVAAIKVLA--SDSHQGEKEFQTEVSLLGRLHHRNLVNLI 179
++G+G G VY A P S VA K+ S++ +K F E + L H +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 180 GYCVDKGKYMLIYEFMSNGSLSNLIYS--EERVLNWEER--------LQIALDISHGIEY 229
C D ++ +L +L+ S ++ L+ E L I I IEY
Sbjct: 69 SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEY 128
Query: 230 LHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSK-----EEV-----FDGRNSG---- 275
+H V +HRDLK NILL F + D+G + EE D RN
Sbjct: 129 VHSKGV---LHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSM 185
Query: 276 -----LKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQ 330
+ GT Y+ P + + +DI++ GVI+++++T P++ +
Sbjct: 186 TIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR-----------K 234
Query: 331 DGVDEILDKQLVGACNIQEVRE----LARIGHKCLHKTPRKR-PSIGEVTQALLKIKQRH 385
G ++ + RE L++I K L P +R S+ E+ Q L + H
Sbjct: 235 KGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDL----EPH 290
Query: 386 L 386
L
Sbjct: 291 L 291
|
Length = 932 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 8e-08
Identities = 53/200 (26%), Positives = 86/200 (43%), Gaps = 25/200 (12%)
Query: 125 LGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGE---KEFQTEVSLLGRLHHRNLVNLIG 180
+G GA+G V A +G AIK L S Q E K E++LL + H N++ L+
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKL-SRPFQSEIFAKRAYRELTLLKHMQHENVIGLLD 81
Query: 181 YCVDKGKY--------MLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHE 232
++ Y + SE++V + + G++Y+H
Sbjct: 82 VFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQ------YLVYQMLCGLKYIHS 135
Query: 233 GAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYI-STN 291
+ IHRDLK N+ ++ K+ DFGL++ D +G T Y P I +
Sbjct: 136 AGI---IHRDLKPGNLAVNEDCELKILDFGLARHA--DAEMTGYVVTRWYRAPEVILNWM 190
Query: 292 KFTMKSDIFSFGVIIFELIT 311
+ DI+S G I+ E++T
Sbjct: 191 HYNQTVDIWSVGCIMAEMLT 210
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 48/189 (25%), Positives = 88/189 (46%), Gaps = 8/189 (4%)
Query: 125 LGQGAFGPVYKA-TMPSGGVAAIKVLASDSHQGEK-EFQTEVSLLGRLHHRNLVNLIGYC 182
LG+G + V+K + + + A+K + + +G EVSLL L H N+V L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 183 VDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRD 242
L++E++ + L + +++ I G+ Y H V +HRD
Sbjct: 74 HTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKV---LHRD 129
Query: 243 LKSANILLDHFMRAKVADFGLSKEEVFDGRN-SGLKGTYGYIDP-AYISTNKFTMKSDIF 300
LK N+L++ K+ADFGL++ + + S T Y P + +++++ + D++
Sbjct: 130 LKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMW 189
Query: 301 SFGVIIFEL 309
G I FE+
Sbjct: 190 GVGCIFFEM 198
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 46/191 (24%), Positives = 91/191 (47%), Gaps = 8/191 (4%)
Query: 125 LGQGAFGPVYKA-TMPSGGVAAIKVLASDSHQGEK-EFQTEVSLLGRLHHRNLVNLIGYC 182
LG+G + V+K + + + A+K + + +G EVSLL L H N+V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 183 VDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRD 242
+ L++E++ + L + + +++ + G+ Y H+ + +HRD
Sbjct: 73 HTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKI---LHRD 128
Query: 243 LKSANILLDHFMRAKVADFGLSKEEVFDGRN-SGLKGTYGYIDP-AYISTNKFTMKSDIF 300
LK N+L++ K+ADFGL++ + + S T Y P + + +++ D++
Sbjct: 129 LKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMW 188
Query: 301 SFGVIIFELIT 311
G I++E+ T
Sbjct: 189 GVGCILYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 2e-07
Identities = 58/276 (21%), Positives = 116/276 (42%), Gaps = 59/276 (21%)
Query: 125 LGQGAFGPVYKATMPSGG--------VAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLV 176
LGQG F ++K G +KVL + F S++ +L H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 177 NLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVP 236
G CV + +++ E++ GSL + + ++N +L++A ++ + +L + +
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLT 122
Query: 237 PVIHRDLKSANILLDH----------FMRAKVADFGLS----KEEVFDGRNSGLKGTYGY 282
H ++ + N+LL F+ K++D G+S +E+ R +
Sbjct: 123 ---HGNVCAKNVLLIREEDRKTGNPPFI--KLSDPGISITVLPKEILLER-------IPW 170
Query: 283 IDPAYISTNK-FTMKSDIFSFGVIIFEL-------ITAIHPHQNLMEYVNLASMSQDGVD 334
+ P I + ++ +D +SFG ++E+ ++A+ + L Y
Sbjct: 171 VPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYE----------- 219
Query: 335 EILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPS 370
D+ + A ELA + ++C+ P RPS
Sbjct: 220 ---DRHQLPAPKWT---ELANLINQCMDYEPDFRPS 249
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 53/198 (26%), Positives = 91/198 (45%), Gaps = 18/198 (9%)
Query: 125 LGQGAFGPVYKATMP-SGGVAAIKVL--ASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGY 181
+G GAFG V+ T P G A+K + + K E+ +L H N+++ +
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67
Query: 182 C--VDKGKYMLIY---EFMSNGSLSNLIYSEERVLNWEERLQIAL-DISHGIEYLHEGAV 235
+ IY E M + L +I S + + + +++ L I G++YLH +
Sbjct: 68 LQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLS--SDHVKVFLYQILRGLKYLHSAGI 124
Query: 236 PPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKG--TYGYIDPAYISTNK- 292
+HRD+K N+L++ K+ DFGL++ E D + T Y P + ++
Sbjct: 125 ---LHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRH 181
Query: 293 FTMKSDIFSFGVIIFELI 310
+T DI+S G I EL+
Sbjct: 182 YTSAVDIWSVGCIFAELL 199
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 3e-07
Identities = 51/192 (26%), Positives = 88/192 (45%), Gaps = 11/192 (5%)
Query: 124 ILGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKEFQT---EVSLLGRLHHRNLVNLI 179
++G+GA+G V K + + AIK DS + E+ +T E+ +L L N+V L
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKF-KDSEENEEVKETTLRELKMLRTLKQENIVELK 66
Query: 180 GYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVI 239
+GK L++E++ L L E + N ++ I I+ +H ++
Sbjct: 67 EAFRRRGKLYLVFEYVEKNMLELL----EEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIV 122
Query: 240 HRDLKSANILLDHFMRAKVADFGLSK--EEVFDGRNSGLKGTYGYIDPAYISTNKFTMKS 297
HRD+K N+L+ H K+ DFG ++ E + + T Y P + +
Sbjct: 123 HRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAV 182
Query: 298 DIFSFGVIIFEL 309
D++S G I+ EL
Sbjct: 183 DMWSVGCILGEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 3e-07
Identities = 57/232 (24%), Positives = 93/232 (40%), Gaps = 44/232 (18%)
Query: 124 ILGQGAFGPVYKATMP-SGGVAAIKVL-ASDSHQGEK--EFQTEVSLLGRLHHRNLVNLI 179
++G+GAFG V +G + A+K+L +D + E+ + E +L +V +
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMF 67
Query: 180 GYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVI 239
DK LI EF+ G + L+ ++ + + IA + I+ +H+ I
Sbjct: 68 YSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIA-ETVLAIDAIHQLGF---I 123
Query: 240 HRDLKSANILLDHFMRAKVADFGL--------------------SKEEVFDGRNSGLK-- 277
HRD+K N+LLD K++DFGL + F NS K
Sbjct: 124 HRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAE 183
Query: 278 --------------GTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHP 315
GT YI P + D +S GVI++E++ P
Sbjct: 184 TWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 3e-07
Identities = 53/195 (27%), Positives = 90/195 (46%), Gaps = 16/195 (8%)
Query: 125 LGQGAFGPVYKATMPSGGV-AAIKVLAS--DSHQGEKEFQTEVSLLGRLHHRNLVNLIGY 181
+G GA G V A G+ A+K L+ + K E+ LL ++H+N+++L+
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 88
Query: 182 CVDKGKY------MLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAV 235
+ L+ E M + +L +I+ E L+ E + + GI++LH +
Sbjct: 89 FTPQKSLEEFQDVYLVMELM-DANLCQVIHME---LDHERMSYLLYQMLCGIKHLHSAGI 144
Query: 236 PPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTM 295
IHRDLK +NI++ K+ DFGL++ + + T Y P I +
Sbjct: 145 ---IHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKE 201
Query: 296 KSDIFSFGVIIFELI 310
DI+S G I+ EL+
Sbjct: 202 NVDIWSVGCIMGELV 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 4e-07
Identities = 43/145 (29%), Positives = 69/145 (47%), Gaps = 7/145 (4%)
Query: 125 LGQGAFGPVYKAT--MPSGGVAAIKVLASDSHQGEKEFQT-EVSLLGRLHHRNLVNLIGY 181
+G+G +G VYKA + + +A K+ +G E+SLL + H N+V L
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 182 CVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHR 241
+ + L++E++ ++ S + N I GI Y H V+HR
Sbjct: 70 VHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHR 126
Query: 242 DLKSANILLDHFMRA-KVADFGLSK 265
DLK N+L+D A K+ADFGL++
Sbjct: 127 DLKPQNLLIDRRTNALKLADFGLAR 151
|
Length = 294 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 5e-07
Identities = 52/204 (25%), Positives = 96/204 (47%), Gaps = 19/204 (9%)
Query: 119 QNFTNILGQGAFGPVYKA-TMPSGGVAAIKVLAS--DSHQGEKEFQTEVSLLGRLHHRNL 175
QN + + G GA+G V A +G A+K L+ S K E+ LL + H N+
Sbjct: 20 QNLSPV-GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 78
Query: 176 VNLI-----GYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIAL-DISHGIEY 229
+ L+ +++ + + + L+N++ ++ ++ +Q + I G++Y
Sbjct: 79 IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT---DDHVQFLIYQILRGLKY 135
Query: 230 LHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPA-YI 288
+H + IHRDLK +N+ ++ K+ DFGL++ D +G T Y P +
Sbjct: 136 IHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRWYRAPEIML 190
Query: 289 STNKFTMKSDIFSFGVIIFELITA 312
+ + DI+S G I+ EL+T
Sbjct: 191 NWMHYNQTVDIWSVGCIMAELLTG 214
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.7 bits (122), Expect = 6e-07
Identities = 60/238 (25%), Positives = 92/238 (38%), Gaps = 62/238 (26%)
Query: 125 LGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQ---TEVSLLGRLHHRNLVNLIG 180
LG+G G V+ + +G + A+KVL + + TE +L L H L L
Sbjct: 9 LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL-- 66
Query: 181 YCV-DKGKYM-LIYEFMSNGSLSNL-------IYSEERVLNWEERLQIALDISHGIEYLH 231
Y Y+ L+ ++ G L L SEE + + +AL EYLH
Sbjct: 67 YASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLAL------EYLH 120
Query: 232 -EGAVPPVIHRDLKSANILLD---HFMRAKVADFGLSKE-------EVFDGRNSGLK--- 277
G +++RDLK NILL H M ++DF LSK+ R +
Sbjct: 121 LLG----IVYRDLKPENILLHESGHIM---LSDFDLSKQSDVEPPPVSKALRKGSRRSSV 173
Query: 278 --------------------GTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHP 315
GT YI P IS + D ++ G++++E++ P
Sbjct: 174 NSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (121), Expect = 6e-07
Identities = 45/161 (27%), Positives = 78/161 (48%), Gaps = 11/161 (6%)
Query: 171 HHRNLVNLIGYCVDKGK-YMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEY 229
+ N + L Y V K ++LI +++ +G L +L+ E ++ E + I + +
Sbjct: 67 DNPNFIKLY-YSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKK-IIRQLVEALND 124
Query: 230 LHEGAVPPVIHRDLKSANILLDHFM-RAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYI 288
LH+ + IH D+K N+L D R + D+GL K G S GT Y P I
Sbjct: 125 LHKHNI---IHNDIKLENVLYDRAKDRIYLCDYGLCKII---GTPSCYDGTLDYFSPEKI 178
Query: 289 STNKFTMKSDIFSFGVIIFELITAIHPHQNLM-EYVNLASM 328
+ + + D ++ GV+ +EL+T HP + E ++L S+
Sbjct: 179 KGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESL 219
|
Length = 267 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 8e-07
Identities = 43/191 (22%), Positives = 90/191 (47%), Gaps = 31/191 (16%)
Query: 159 EFQTEVSLLGRLHHRNLVNL---IGYCVDKGKYML-------IYEFMSNGSLSNLIYSEE 208
+ + E+ LGRL+H N++ + + + YM+ +Y FM + + ++
Sbjct: 209 QLENEILALGRLNHENILKIEEILRS--EANTYMITQKYDFDLYSFMYDEAFD----WKD 262
Query: 209 RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFG--LSKE 266
R L + R I + +EY+H+ + IHRD+K NI L+ + + DFG + E
Sbjct: 263 RPLLKQTR-AIMKQLLCAVEYIHDKKL---IHRDIKLENIFLNCDGKIVLGDFGTAMPFE 318
Query: 267 EVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT---------AIHPHQ 317
+ + + G GT P ++ + + +DI+S G+I+ ++++ P +
Sbjct: 319 KEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK 378
Query: 318 NLMEYVNLASM 328
L++ ++ S+
Sbjct: 379 QLLKIIDSLSV 389
|
Length = 501 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 47/177 (26%), Positives = 75/177 (42%), Gaps = 40/177 (22%)
Query: 110 AYKDIQKATQNFTNILGQGAFGPVYKATMPSGG--VAAIKVLASDSHQG-EKEFQTEVSL 166
AY+ ++K +G+G +G VYKA + G VA K +G E+SL
Sbjct: 2 AYEKLEK--------IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISL 53
Query: 167 LGRLHHRN-LVNLIGYCV-----DKGKYM--LIYEFM---------SNGSLSNLIYSEER 209
L L +V L+ V GK L++E++ SNG +
Sbjct: 54 LQMLSESIYIVRLL--DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKT 111
Query: 210 VLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHF-MRAKVADFGLSK 265
+ ++ +L G+ + H+ V+HRDLK N+L+D K+AD GL +
Sbjct: 112 IKSFMYQLLK------GVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGR 159
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 1e-06
Identities = 53/209 (25%), Positives = 92/209 (44%), Gaps = 26/209 (12%)
Query: 124 ILGQGAFGPVYKATMPSGG-VAAIKVLASDSHQGEKE---FQTEVSLLGRLHHRNLVNLI 179
++G+GAFG V + + V A+K+L E F+ E +L ++ + L
Sbjct: 8 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLH 67
Query: 180 GYCVDKGKYMLIYEFMSNGSLSNLI------YSEERVLNWEERLQIALDISHGIEYLHEG 233
D+ L+ ++ G L L+ E+ + + IA+D H + Y
Sbjct: 68 YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY---- 123
Query: 234 AVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG--RNSGLKGTYGYIDPAYIST- 290
+HRD+K NIL+D ++ADFG + + DG ++S GT YI P +
Sbjct: 124 -----VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM 178
Query: 291 ----NKFTMKSDIFSFGVIIFELITAIHP 315
K+ + D +S GV ++E++ P
Sbjct: 179 EDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 57/205 (27%), Positives = 96/205 (46%), Gaps = 31/205 (15%)
Query: 125 LGQGAFGPVYKAT-MPSGGVAAIKVLAS--DSHQGEKEFQTEVSLLGRLHHRNLVNL--I 179
+G+GA+G V A + AIK +A+ D+ K E+ LL L H N++ + I
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72
Query: 180 GYCVDKGKY---MLIYEFMSNGSLSNLIYSEERVLNWEERLQIAL-DISHGIEYLHEGAV 235
+ + ++YE M L +I S + + + + Q L + G++Y+H V
Sbjct: 73 MPPPHREAFNDVYIVYELMDT-DLHQIIRSSQTLSD--DHCQYFLYQLLRGLKYIHSANV 129
Query: 236 PPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKG--------TYGYIDPAY 287
+HRDLK +N+LL+ K+ DFGL+ R + KG T Y P
Sbjct: 130 ---LHRDLKPSNLLLNANCDLKICDFGLA-------RTTSEKGDFMTEYVVTRWYRAPEL 179
Query: 288 I-STNKFTMKSDIFSFGVIIFELIT 311
+ + +++T D++S G I EL+
Sbjct: 180 LLNCSEYTTAIDVWSVGCIFAELLG 204
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 28/104 (26%), Positives = 55/104 (52%), Gaps = 5/104 (4%)
Query: 147 KVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYS 206
KVL SD F SL+ +L H++LV L G CV + + +++ E++ G L ++
Sbjct: 36 KVLGSDHRDSL-AFFETASLMSQLSHKHLVKLYGVCV-RDENIMVEEYVKFGPLDVFLHR 93
Query: 207 EERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILL 250
E+ ++ +L +A ++ + YL + ++H ++ NIL+
Sbjct: 94 EKNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILV 134
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 5e-06
Identities = 53/193 (27%), Positives = 88/193 (45%), Gaps = 12/193 (6%)
Query: 125 LGQGAFGPVYKA-TMPSGGVAAIKVLASDSHQGEKEFQT--EVSLLGRLHHRNLVNLIGY 181
LG+G++ VYK + +G + A+K + + +G F E SLL L H N+V L
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-APFTAIREASLLKDLKHANIVTLHDI 71
Query: 182 CVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHR 241
K L++E++ L + L+ + G+ Y H+ V +HR
Sbjct: 72 IHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRV---LHR 127
Query: 242 DLKSANILLDHFMRAKVADFGLSKEEVFDGRN-SGLKGTYGYIDPAYI--STNKFTMKSD 298
DLK N+L+ K+ADFGL++ + + S T Y P + ST ++ D
Sbjct: 128 DLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTE-YSTSLD 186
Query: 299 IFSFGVIIFELIT 311
++ G I +E+ T
Sbjct: 187 MWGVGCIFYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 6e-06
Identities = 59/228 (25%), Positives = 101/228 (44%), Gaps = 37/228 (16%)
Query: 125 LGQGAFGPVYKATMPSGG--VAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYC 182
LG G+ G V+ A VA K++ +D K E+ ++ RL H N+V +
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQS-VKHALREIKIIRRLDHDNIVKVYEVL 71
Query: 183 VDKG-----------KYMLIY---EFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIE 228
G + +Y E+M L+N++ E+ L+ E + G++
Sbjct: 72 GPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVL--EQGPLSEEHARLFMYQLLRGLK 128
Query: 229 YLHEGAVPPVIHRDLKSANILLD-HFMRAKVADFGLSKEEVFDGRNSGLKG-------TY 280
Y+H V +HRDLK AN+ ++ + K+ DFGL++ + D S KG T
Sbjct: 129 YIHSANV---LHRDLKPANVFINTEDLVLKIGDFGLAR--IVDPHYSH-KGYLSEGLVTK 182
Query: 281 GYIDPAYI-STNKFTMKSDIFSFGVIIFELITA--IHPHQNLMEYVNL 325
Y P + S N +T D+++ G I E++T + + +E + L
Sbjct: 183 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQL 230
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 7e-06
Identities = 60/220 (27%), Positives = 93/220 (42%), Gaps = 58/220 (26%)
Query: 123 NILGQGAFGPVYKATM--PSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIG 180
NI+G G+FG VY+A S VA KVL ++ E+ ++ L+H N++ L
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR-----ELLIMKNLNHINIIFLKD 126
Query: 181 Y----CVDKG------------------KYMLIYEFMSNGSLSNL---IYSEERVLNWEE 215
Y C K KYM Y +N +L +YS +
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYA-RNNHALPLFLVKLYSYQ------- 178
Query: 216 RLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLD---HFMRAKVADFGLSKEEVFDGR 272
+ + Y+H + HRDLK N+L+D H + K+ DFG +K + R
Sbjct: 179 -------LCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTL--KLCDFGSAKNLLAGQR 226
Query: 273 NSGLKGTYGYIDPAYI--STNKFTMKSDIFSFGVIIFELI 310
+ + Y P + +TN +T D++S G II E+I
Sbjct: 227 SVSYICSRFYRAPELMLGATN-YTTHIDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 7e-06
Identities = 45/153 (29%), Positives = 71/153 (46%), Gaps = 28/153 (18%)
Query: 127 QGAFGPVYKA-TMPSGGVAAIKVL-ASD------SHQGEKEFQTEVSLLGRLHHRNLVNL 178
+GAFG VY + + A+KV+ +D HQ Q E L +V+L
Sbjct: 14 RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQ----VQAERDALALSKSPFIVHL 69
Query: 179 IGYCVDKGKYM-LIYEFMSNGSLSNLI-----YSEERVLNWEERLQIALDISHGIEYLHE 232
Y + + L+ E++ G + +L+ + EE + + + +ALD YLH
Sbjct: 70 Y-YSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALD------YLHR 122
Query: 233 GAVPPVIHRDLKSANILLDHFMRAKVADFGLSK 265
+ IHRDLK N+L+ + K+ DFGLSK
Sbjct: 123 HGI---IHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 8e-06
Identities = 38/125 (30%), Positives = 57/125 (45%), Gaps = 13/125 (10%)
Query: 125 LGQGAFGPVYKATM------PSGGVAAIKVLASDSHQGEKE-FQTEVSLLGRLH-HRNLV 176
LG GAFG V +AT S A+K+L S + EK+ +E+ ++ L H N+V
Sbjct: 45 LGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIV 104
Query: 177 NLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVP 236
NL+G C G +I E+ G L + ++ + LQ LD + L G
Sbjct: 105 NLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTF-----LQYYLDKNRDDGSLISGGST 159
Query: 237 PVIHR 241
P+ R
Sbjct: 160 PLSQR 164
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 9e-06
Identities = 32/90 (35%), Positives = 48/90 (53%), Gaps = 9/90 (10%)
Query: 124 ILGQGAFGPVYKATM------PSGGVAAIKVLASDSHQGE-KEFQTEVSLLGRL-HHRNL 175
+LG GAFG V +A+ S A+K+L + E K +E+ +L + +H N+
Sbjct: 14 VLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNV 73
Query: 176 VNLIGYCVD-KGKYMLIYEFMSNGSLSNLI 204
VNL+G C G M+I EF G+LSN +
Sbjct: 74 VNLLGACTKPNGPLMVIVEFCKYGNLSNFL 103
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 30/105 (28%), Positives = 48/105 (45%), Gaps = 19/105 (18%)
Query: 227 IEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSK-------EEVFDGR------- 272
+EYLH + +HRDLK N+L+ K+ DFGLSK +++G
Sbjct: 114 LEYLHNYGI---VHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 273 --NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHP 315
+ + GT YI P I + D ++ G+I++E + P
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 1e-05
Identities = 76/299 (25%), Positives = 128/299 (42%), Gaps = 45/299 (15%)
Query: 125 LGQGAFGPVYKATMPSGGVAAIKVLASDSHQG-EKEFQTEVSLLGRLHHRNLVNLIGYCV 183
+G+G +G VYKA G L G E++LL L H N+++L +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 184 DKG--KYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIA--------LDISHGIEYLHEG 233
K L++++ + L ++I ++ +Q+ I GI YLH
Sbjct: 69 SHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 127
Query: 234 AVPPVIHRDLKSANILL----DHFMRAKVADFGLSKEEVFDGRNSGLKG---------TY 280
V +HRDLK ANIL+ R K+AD G ++ +F NS LK T+
Sbjct: 128 WV---LHRDLKPANILVMGEGPERGRVKIADMGFAR--LF---NSPLKPLADLDPVVVTF 179
Query: 281 GYIDPA-YISTNKFTMKSDIFSFGVIIFELITA---IHPHQNLMEYVNLASMSQDGVDEI 336
Y P + +T DI++ G I EL+T+ H Q ++ N D +D I
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN--PYHHDQLDRI 237
Query: 337 LDKQLVGACNIQEVRELARI-GHKCLHKTPRKRPSIGEVTQALLKIKQRHLAKQDTMSF 394
+ ++G ++ ++ ++ H L K R+ +L+K ++H K D+ +F
Sbjct: 238 FN--VMGFPADKDWEDIKKMPEHSTLMKDFRRNTY---TNCSLIKYMEKHKVKPDSKAF 291
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 1e-05
Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 21/208 (10%)
Query: 114 IQKATQNFTNILGQGAFGPV---YKATMPSGGVAAIKVLAS--DSHQGEKEFQTEVSLLG 168
+ K QN I G GA G V Y A + AIK L+ + K E+ L+
Sbjct: 15 VLKRYQNLKPI-GSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMK 71
Query: 169 RLHHRNLVNLIGYCVDKGKY------MLIYEFMSNGSLSNLIYSEERVLNWEERLQIALD 222
++H+N+++L+ + L+ E M + +L +I E L+ E +
Sbjct: 72 CVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQME---LDHERMSYLLYQ 127
Query: 223 ISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGY 282
+ GI++LH + IHRDLK +NI++ K+ DFGL++ + T Y
Sbjct: 128 MLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYY 184
Query: 283 IDPAYISTNKFTMKSDIFSFGVIIFELI 310
P I + DI+S G I+ E++
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 32/92 (34%), Positives = 49/92 (53%), Gaps = 9/92 (9%)
Query: 125 LGQGAFGPVYKAT------MPSGGVAAIKVLASD-SHQGEKEFQTEVSLLGRL-HHRNLV 176
LG+GAFG V +A + A+K+L +H + +E+ +L + HH N+V
Sbjct: 15 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 74
Query: 177 NLIGYCVDK-GKYMLIYEFMSNGSLSNLIYSE 207
NL+G C G M+I EF G+LSN + S+
Sbjct: 75 NLLGACTKPGGPLMVIVEFCKFGNLSNYLRSK 106
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 58/207 (28%), Positives = 92/207 (44%), Gaps = 22/207 (10%)
Query: 124 ILGQGAFGPVYKATMPSGG-VAAIKVLASDSHQGEKE---FQTEVSLLGRLHHRNLVNLI 179
++G+GAFG V M + A+K+L E F+ E ++L + + L
Sbjct: 8 VIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLH 67
Query: 180 GYCVDKGKYMLIYEFMSNGSLSNLIYS-EERVLNWEERLQIA---LDISHGIEYLHEGAV 235
D+ L+ ++ G L L+ E+R+ R IA L I H I LH
Sbjct: 68 YAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAI-HSIHQLH---- 122
Query: 236 PPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG--RNSGLKGTYGYIDPAYIST--- 290
+HRD+K N+LLD ++ADFG + DG ++S GT YI P +
Sbjct: 123 --YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMED 180
Query: 291 --NKFTMKSDIFSFGVIIFELITAIHP 315
K+ + D +S GV ++E++ P
Sbjct: 181 GMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 55/204 (26%), Positives = 92/204 (45%), Gaps = 26/204 (12%)
Query: 124 ILGQGAFGPVYKATMPSGG-VAAIKVLASDSHQGEKE---FQTEVSLLGRLHHRNLVNLI 179
++G+GAFG V M + G V A+K+L E F+ E +L R + NL
Sbjct: 8 VIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLH 67
Query: 180 GYCVDKGKYMLIYEFMSNGSLSNLIYS-EERVLNWEERLQI-----ALDISHGIEYLHEG 233
D+ L+ ++ G L L+ E+R+ R + A+D H + Y
Sbjct: 68 YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGY---- 123
Query: 234 AVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG--RNSGLKGTYGYIDPAYI--- 288
+HRD+K N+LLD ++ADFG + DG +++ GT YI P +
Sbjct: 124 -----VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAM 178
Query: 289 --STNKFTMKSDIFSFGVIIFELI 310
++ + D +S GV ++E++
Sbjct: 179 EDGKGRYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 53/211 (25%), Positives = 95/211 (45%), Gaps = 37/211 (17%)
Query: 119 QNFTNILGQGAFGPVYKA--TMPSGGVAAIKVLASDSHQGEKEFQT---------EVSLL 167
QN T + G GA+G V A T VA K+ + FQ+ E+ LL
Sbjct: 18 QNLTPV-GSGAYGSVCSAYDTRLRQKVAVKKL--------SRPFQSLIHARRTYRELRLL 68
Query: 168 GRLHHRNLVNLIGYCV------DKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIAL 221
+ H N++ L+ + + L+ M L+N++ ++ +E +Q +
Sbjct: 69 KHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMG-ADLNNIVKCQKLS---DEHVQFLI 124
Query: 222 -DISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTY 280
+ G++Y+H + IHRDLK +N+ ++ ++ DFGL+++ D +G T
Sbjct: 125 YQLLRGLKYIHSAGI---IHRDLKPSNVAVNEDCELRILDFGLARQA--DDEMTGYVATR 179
Query: 281 GYIDPA-YISTNKFTMKSDIFSFGVIIFELI 310
Y P ++ + DI+S G I+ EL+
Sbjct: 180 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 210
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 4e-05
Identities = 76/299 (25%), Positives = 124/299 (41%), Gaps = 45/299 (15%)
Query: 125 LGQGAFGPVYKATMPSGGVAAIKVLASDSHQG-EKEFQTEVSLLGRLHHRNLVNLIGYCV 183
+G+G +G VYKA G L G E++LL L H N++ L +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 184 DKG--KYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIA--------LDISHGIEYLHEG 233
K L++++ + L ++I ++ +Q+ I GI YLH
Sbjct: 69 SHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127
Query: 234 AVPPVIHRDLKSANILL----DHFMRAKVADFGLSKEEVFDGRNSGLKG---------TY 280
V +HRDLK ANIL+ R K+AD G ++ +F NS LK T+
Sbjct: 128 WV---LHRDLKPANILVMGEGPERGRVKIADMGFAR--LF---NSPLKPLADLDPVVVTF 179
Query: 281 GYIDPA-YISTNKFTMKSDIFSFGVIIFELITA---IHPHQNLMEYVNLASMSQDGVDEI 336
Y P + +T DI++ G I EL+T+ H Q ++ N D +D I
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN--PFHHDQLDRI 237
Query: 337 LDKQLVGA-CNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRHLAKQDTMSF 394
A + +++R++ + L K R+ +L+K ++H K D+ F
Sbjct: 238 FSVMGFPADKDWEDIRKMPE--YPTLQKDFRRTTY---ANSSLIKYMEKHKVKPDSKVF 291
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 4e-05
Identities = 50/174 (28%), Positives = 81/174 (46%), Gaps = 29/174 (16%)
Query: 150 ASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIY-EFMSNGSLSNLIYSEE 208
AS H E LL RL H ++ L+ V G L+ ++ S+ L + +
Sbjct: 205 ASSVH--------EARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRSD--LYTYLGARL 254
Query: 209 RVLNWEERLQIALDISHGIEYLH-EGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEE 267
R L + +A + I+Y+H EG +IHRD+K+ N+L++ + DFG +
Sbjct: 255 RPLGLAQVTAVARQLLSAIDYIHGEG----IIHRDIKTENVLVNGPEDICLGDFGAA--- 307
Query: 268 VFDGRNS-------GLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIH 314
F R S G+ GT P ++ + +T DI+S G++IFE A+H
Sbjct: 308 CF-ARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE--AAVH 358
|
Length = 461 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 7e-05
Identities = 59/230 (25%), Positives = 103/230 (44%), Gaps = 45/230 (19%)
Query: 124 ILGQGAFGPVYKAT-MPSGGVAAIKVL------ASDSHQGEKEFQTEVSLLGRLHHRNLV 176
++G+G++G V A +G AIK + SD+ + E+ LL L H ++V
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATR----ILREIKLLRLLRHPDIV 62
Query: 177 NL--IGYCVDKGKYMLIY---EFMSNGSLSNLIYSEERVLNWEERLQIAL-DISHGIEYL 230
+ I + ++ IY E M + L +I + + + E Q L + ++Y+
Sbjct: 63 EIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLT--PEHHQFFLYQLLRALKYI 119
Query: 231 HEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYIST 290
H V HRDLK NIL + + K+ DFGL++ D + D Y++T
Sbjct: 120 HTANV---FHRDLKPKNILANADCKLKICDFGLARVAFNDT-----PTAIFWTD--YVAT 169
Query: 291 -------------NKFTMKSDIFSFGVIIFELITA--IHPHQNLMEYVNL 325
+K+T DI+S G I E++T + P +N++ ++L
Sbjct: 170 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDL 219
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 31/91 (34%), Positives = 46/91 (50%), Gaps = 10/91 (10%)
Query: 124 ILGQGAFGPVYKAT-------MPSGGVAAIKVLASDSHQGEKE-FQTEVSLLGRL-HHRN 174
ILG GAFG V + T P VA +K+L + EK+ +E+ ++ L H N
Sbjct: 44 ILGSGAFGKVVEGTAYGLSRSQPVMKVA-VKMLKPTARSSEKQALMSELKIMTHLGPHLN 102
Query: 175 LVNLIGYCVDKGKYMLIYEFMSNGSLSNLIY 205
+VNL+G C G +I E+ G L N ++
Sbjct: 103 IVNLLGACTKSGPIYIITEYCFYGDLVNYLH 133
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 28/85 (32%), Positives = 42/85 (49%), Gaps = 3/85 (3%)
Query: 226 GIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDP 285
GI++LH + IHRDLK +NI++ K+ DFGL++ + T Y P
Sbjct: 130 GIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 186
Query: 286 AYISTNKFTMKSDIFSFGVIIFELI 310
I + DI+S G I+ E+I
Sbjct: 187 EVILGMGYKENVDIWSVGCIMGEMI 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 19/207 (9%)
Query: 114 IQKATQNFTNILGQGAFGPV---YKATMPSGGVAAIKVLAS--DSHQGEKEFQTEVSLLG 168
+ K QN I G GA G V Y A + AIK L+ + K E+ L+
Sbjct: 22 VLKRYQNLKPI-GSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 169 RLHHRNLVNLIGY-----CVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDI 223
++H+N++ L+ +++ + + I + + +L +I E L+ E + +
Sbjct: 79 CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME---LDHERMSYLLYQM 135
Query: 224 SHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYI 283
GI++LH + IHRDLK +NI++ K+ DFGL++ + T Y
Sbjct: 136 LCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYR 192
Query: 284 DPAYISTNKFTMKSDIFSFGVIIFELI 310
P I + DI+S G I+ E+I
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMI 219
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 1e-04
Identities = 41/143 (28%), Positives = 59/143 (41%), Gaps = 16/143 (11%)
Query: 174 NLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYS-----EERVLNWEERLQIALDISHGIE 228
N+V L Y V + L+ + G L + I EE V W + +ALD H
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALH--- 102
Query: 229 YLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYI 288
EG ++ RDL NILLD ++ F E ++ Y + I
Sbjct: 103 --REG----IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYCAPEVGGI 156
Query: 289 STNKFTMKSDIFSFGVIIFELIT 311
S + T D +S G I+FEL+T
Sbjct: 157 S--EETEACDWWSLGAILFELLT 177
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 52/246 (21%), Positives = 104/246 (42%), Gaps = 52/246 (21%)
Query: 146 IKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIY 205
+KVL F S++ ++ H+++V L G CV + +++ EF+ G L ++
Sbjct: 37 LKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH 96
Query: 206 SEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILL-------DHFMRAKV 258
+ VL + ++A ++ + YL + ++H ++ + NILL + K+
Sbjct: 97 RKSDVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKL 153
Query: 259 ADFG-----LSKEEVFDGRNSGLKGTYGYIDPAYISTNK-FTMKSDIFSFGVIIFELITA 312
+D G LS++E + +I P + +K ++ +D +SFG ++E+
Sbjct: 154 SDPGIPITVLSRQECVE--------RIPWIAPECVEDSKNLSIAADKWSFGTTLWEI--- 202
Query: 313 IHPHQNLMEYVNLASMSQDGVDEILDKQLV-------GACNI--QEVRELARIGHKCLHK 363
+G + DK L G C + +ELA + C++
Sbjct: 203 ----------------CYNGEIPLKDKTLAEKERFYEGQCMLVTPSCKELADLMTHCMNY 246
Query: 364 TPRKRP 369
P +RP
Sbjct: 247 DPNQRP 252
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 4e-04
Identities = 44/176 (25%), Positives = 68/176 (38%), Gaps = 58/176 (32%)
Query: 184 DKGKYMLIYEFMSNGSLSNL-----IYSEERVLNWEERLQIALDISHGIEYLHEGAVPPV 238
DK + +++ G + +L I+ E+ R IA +++ IE +H+
Sbjct: 72 DKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLA-----RFYIA-ELTCAIESVHKMGF--- 122
Query: 239 IHRDLKSANILLDHFMRAKVADFGL---------SK----------------EEVFDGRN 273
IHRD+K NIL+D K+ DFGL SK EE +
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182
Query: 274 SGLK-------------------GTYGYIDPAYISTNKFTMKSDIFSFGVIIFELI 310
LK GT YI P + +T D +S GVI++E++
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 65/293 (22%), Positives = 110/293 (37%), Gaps = 67/293 (22%)
Query: 139 PSGGVAAIKVLASDSHQGE--KEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMS 196
P+G + +++ ++ E K Q EV L H N++ +I FM+
Sbjct: 23 PTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82
Query: 197 NGSLSNLI--YSEERVLNWEERL--QIALDISHGIEYLHEGAVPPVIHRDLKSANILLDH 252
GS ++L+ Y E + E L I G+ YLH+ IHR++K+++IL+
Sbjct: 83 YGSANSLLKTYFPEGM---SEALIGNILFGALRGLNYLHQNGY---IHRNIKASHILISG 136
Query: 253 FMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYIST--------------NKFTMKSD 298
V+ GLS ++ +G K Y P + ++ + +KSD
Sbjct: 137 --DGLVSLSGLS--HLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSD 192
Query: 299 IFSFGVIIFELITAIHPHQNLME----------------YVNLASM-------SQDGVDE 335
I+S G+ EL T P Q+++ + SQ GVD
Sbjct: 193 IYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDS 252
Query: 336 ILDKQLVGACNIQEVR--------------ELARIGHKCLHKTPRKRPSIGEV 374
+ + +V A Q + + CL + P KRPS +
Sbjct: 253 GIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSL 305
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 5e-04
Identities = 44/154 (28%), Positives = 74/154 (48%), Gaps = 26/154 (16%)
Query: 124 ILGQGAFGPVY----KATMPSGGVAAIK-VLASDSHQGEK--EFQTEVSLLGRLHHRNLV 176
++G+GAFG V K T G + A+K +L S+ + ++ + E +L +V
Sbjct: 8 VIGKGAFGEVRLVQKKDT---GKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVV 64
Query: 177 NLIGYCVDKGKYM-LIYEFMSNGSLSNL-----IYSEERVLNWEERLQIALDISHGIEYL 230
+L Y +Y+ LI EF+ G L + +SE+ + +A++ H + +
Sbjct: 65 SLY-YSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGF- 122
Query: 231 HEGAVPPVIHRDLKSANILLDHFMRAKVADFGLS 264
IHRD+K NIL+D K++DFGLS
Sbjct: 123 --------IHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 7e-04
Identities = 40/143 (27%), Positives = 64/143 (44%), Gaps = 8/143 (5%)
Query: 125 LGQGAFGPVYKA-TMPSGGVAAIKVLASDSHQGEKEF---QTEVSLLGRLHHRNLVNLIG 180
LG GAFG V A + + + A+K L + + E +L + +V L
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 181 YCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIH 240
DK + +++ G + +L+ E R IA +++ IE +H+ IH
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA-ELTLAIESVHKMGF---IH 124
Query: 241 RDLKSANILLDHFMRAKVADFGL 263
RD+K NIL+D K+ DFGL
Sbjct: 125 RDIKPDNILIDLDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 54/248 (21%), Positives = 88/248 (35%), Gaps = 66/248 (26%)
Query: 125 LGQGAFGPVYKA-TMPSGGVAAIKVLASDS---HQGEKEFQTEVSLLGRLHHRNLVNLIG 180
LG GAFG V A + + + A+K L + E +L + +V L
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68
Query: 181 YCVDKGKYMLIYEFMSNGSLSNL-----IYSEERVLNWEERLQIALDISHGIEYLHEGAV 235
DK + +++ G + +L I+ E+ + L A++ H + +
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGF------ 122
Query: 236 PPVIHRDLKSANILLDHFMRAKVADFGLS------------------KEEVFDGRNS--- 274
IHRD+K NIL+D K+ DFGL +++ D N
Sbjct: 123 ---IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGD 179
Query: 275 ---------------------------GLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIF 307
L GT YI P + +T D +S GVI++
Sbjct: 180 PANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 239
Query: 308 ELITAIHP 315
E++ P
Sbjct: 240 EMLVGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 426 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.98 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.98 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.9 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.89 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.89 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.88 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.87 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.86 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.86 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.85 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.84 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.84 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.81 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.8 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.8 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.79 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.77 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.77 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.77 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.76 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.76 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.71 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.69 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.67 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.66 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.56 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.54 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.52 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.44 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.43 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.35 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.29 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.28 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.28 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.23 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.23 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.2 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.12 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.0 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.98 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.94 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.83 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.74 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.74 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.7 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.65 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.6 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.56 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.42 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.41 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.36 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.34 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.31 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.14 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.13 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.1 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.08 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.06 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.99 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.96 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.94 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.91 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.87 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.61 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.52 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.44 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.35 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.35 | |
| PF08693 | 40 | SKG6: Transmembrane alpha-helix domain; InterPro: | 97.2 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.2 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.18 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.1 | |
| PF01102 | 122 | Glycophorin_A: Glycophorin A; InterPro: IPR001195 | 97.04 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.99 | |
| PF02439 | 38 | Adeno_E3_CR2: Adenovirus E3 region protein CR2; In | 96.93 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.91 | |
| PLN02236 | 344 | choline kinase | 96.9 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.78 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.77 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.7 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.43 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.41 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.39 | |
| PTZ00382 | 96 | Variant-specific surface protein (VSP); Provisiona | 96.37 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.29 | |
| PF04478 | 154 | Mid2: Mid2 like cell wall stress sensor; InterPro: | 96.22 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.03 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.78 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.69 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.63 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.59 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-56 Score=428.36 Aligned_cols=278 Identities=44% Similarity=0.806 Sum_probs=240.5
Q ss_pred CCCCCChhHHHHHHhhhh--cccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEE
Q 014352 105 GIPRYAYKDIQKATQNFT--NILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYC 182 (426)
Q Consensus 105 ~~~~~~~~~l~~~~~~~~--~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~ 182 (426)
....|++.+|.++|.+|. +.||+|+||.||+|...++..||||++........++|.+|+.++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 456799999999999998 699999999999999998899999988765433155699999999999999999999999
Q ss_pred EeCC-eEEEEEEecCCCChhHHhhhccC-CCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEee
Q 014352 183 VDKG-KYMLIYEFMSNGSLSNLIYSEER-VLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVAD 260 (426)
Q Consensus 183 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 260 (426)
.+.+ +.+||||||++|+|.++|+.... +++|..|++||.++|+||+|||+...++|+||||||+|||||+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9998 59999999999999999988766 899999999999999999999998888999999999999999999999999
Q ss_pred ecCcccccc-CCCcccC-ccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCch--------HHHHHHhhccc
Q 014352 261 FGLSKEEVF-DGRNSGL-KGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNL--------MEYVNLASMSQ 330 (426)
Q Consensus 261 fgl~~~~~~-~~~~~~~-~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~--------~~~~~~~~~~~ 330 (426)
||+++.... ....... .||.+|+|||++..+..+.|+|||||||+|+||+||+.|.+.. ..|. ...+..
T Consensus 221 FGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~-~~~~~~ 299 (361)
T KOG1187|consen 221 FGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWA-KPLLEE 299 (361)
T ss_pred ccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHH-HHHHHC
Confidence 999975543 2222222 8999999999999999999999999999999999999887642 2222 223444
Q ss_pred cchhhhhhhhhc-ccCCH-HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 014352 331 DGVDEILDKQLV-GACNI-QEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQ 383 (426)
Q Consensus 331 ~~~~~~~~~~~~-~~~~~-~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 383 (426)
....+++|+.+. ...+. .....+..++.+|++.+|.+||+|.+|++.|+.+..
T Consensus 300 ~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 300 GKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred cchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 578889999986 44443 678889999999999999999999999999865543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-53 Score=400.54 Aligned_cols=257 Identities=35% Similarity=0.599 Sum_probs=216.2
Q ss_pred hhcccccCCCeeEEEEEeCCCcEEEEEEeccCCccC--hHHHHHHHHHHhcCCCCceeeEEeEEEeCC-eEEEEEEecCC
Q 014352 121 FTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQG--EKEFQTEVSLLGRLHHRNLVNLIGYCVDKG-KYMLIYEFMSN 197 (426)
Q Consensus 121 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~~~ 197 (426)
+.+.||+|+||+||+|.+.+...||||++....... .+.|.+|+.+|.+++|||||+++|+|.+.. .+++||||+++
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~ 124 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG 124 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence 445699999999999999766669999997654322 458999999999999999999999999987 79999999999
Q ss_pred CChhHHhhh-ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCC-cEEEeeecCccccccC-CCcc
Q 014352 198 GSLSNLIYS-EERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFM-RAKVADFGLSKEEVFD-GRNS 274 (426)
Q Consensus 198 gsL~~~l~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgl~~~~~~~-~~~~ 274 (426)
|+|..+++. ....+++..++.++.+||.||.|||+++. ||||||||+|||++.++ ++||+|||+++..... ...+
T Consensus 125 GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~ 202 (362)
T KOG0192|consen 125 GSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTSMT 202 (362)
T ss_pred CcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccccccc
Confidence 999999988 36789999999999999999999999873 99999999999999998 9999999999865443 3344
Q ss_pred cCccccCccCccccc--cCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHH
Q 014352 275 GLKGTYGYIDPAYIS--TNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRE 352 (426)
Q Consensus 275 ~~~gt~~y~aPE~~~--~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (426)
...||+.|||||++. ...|+.|+||||||++||||+||+.||.+......... ++....+...+......
T Consensus 203 ~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~--------v~~~~~Rp~~p~~~~~~ 274 (362)
T KOG0192|consen 203 SVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASA--------VVVGGLRPPIPKECPPH 274 (362)
T ss_pred CCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHH--------HHhcCCCCCCCccCCHH
Confidence 478999999999999 56999999999999999999999999988655222111 11122222222335578
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHhhh
Q 014352 353 LARIGHKCLHKTPRKRPSIGEVTQALLKIKQRHLA 387 (426)
Q Consensus 353 l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~~ 387 (426)
+..++.+||+.||..||++.+++..|+.+......
T Consensus 275 l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 275 LSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred HHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 99999999999999999999999999999776554
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-53 Score=400.28 Aligned_cols=258 Identities=29% Similarity=0.490 Sum_probs=228.3
Q ss_pred HHHHHHhhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEE
Q 014352 113 DIQKATQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIY 192 (426)
Q Consensus 113 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 192 (426)
++.+....+.+.||+|.||.||.|.+++...||+|.++... ...++|.+|+++|++|+|+|||+++|+|..++.+||||
T Consensus 202 ei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVt 280 (468)
T KOG0197|consen 202 EIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVT 280 (468)
T ss_pred eecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEE
Confidence 46666677788999999999999999888899999998753 45678999999999999999999999999988999999
Q ss_pred EecCCCChhHHhhh-ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC
Q 014352 193 EFMSNGSLSNLIYS-EERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG 271 (426)
Q Consensus 193 e~~~~gsL~~~l~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 271 (426)
|||+.|+|.++|.. .+..+...+.+.++.|||+||+||++++ +|||||.++||||+++..+||+|||+++....+.
T Consensus 281 E~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~ 357 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDE 357 (468)
T ss_pred EecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCc
Confidence 99999999999986 5577999999999999999999999999 9999999999999999999999999999433222
Q ss_pred --CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHH
Q 014352 272 --RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQ 348 (426)
Q Consensus 272 --~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (426)
......-...|.|||.+..+.++.|||||||||+||||+| |+.||.. +....+.+.++...+.++|..
T Consensus 358 Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~---------msn~ev~~~le~GyRlp~P~~ 428 (468)
T KOG0197|consen 358 YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPG---------MSNEEVLELLERGYRLPRPEG 428 (468)
T ss_pred eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCC---------CCHHHHHHHHhccCcCCCCCC
Confidence 2233445678999999999999999999999999999999 8899865 334455667778888888889
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 014352 349 EVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQ 383 (426)
Q Consensus 349 ~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 383 (426)
++..++++|..||..+|++||||..+...|+.+..
T Consensus 429 CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 429 CPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred CCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 99999999999999999999999999988887765
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-52 Score=380.37 Aligned_cols=257 Identities=27% Similarity=0.394 Sum_probs=212.5
Q ss_pred CCChhHHHHHHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC-ccChHHHHHHHHHHhcCCCCceeeEEeEEEeC
Q 014352 108 RYAYKDIQKATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS-HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDK 185 (426)
Q Consensus 108 ~~~~~~l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 185 (426)
..+..||++ .+.||+|..|+||+++++ ++..+|+|.+.... ....+++.+|++++++.+|||||.++|.|...
T Consensus 75 ~i~~~dle~-----~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~ 149 (364)
T KOG0581|consen 75 GISLSDLER-----LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSN 149 (364)
T ss_pred ccCHHHhhh-----hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeC
Confidence 345556554 357999999999999987 77889999995543 23457899999999999999999999999999
Q ss_pred C-eEEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeecCCCCCCEEecCCCcEEEeeecC
Q 014352 186 G-KYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHE-GAVPPVIHRDLKSANILLDHFMRAKVADFGL 263 (426)
Q Consensus 186 ~-~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 263 (426)
+ ...++||||++|||++++... +.+++..+..|+.+|++||.|||+ .+ ||||||||+|||++..|++||+|||.
T Consensus 150 ~~~isI~mEYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGV 225 (364)
T KOG0581|consen 150 GEEISICMEYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGV 225 (364)
T ss_pred CceEEeehhhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccc
Confidence 8 599999999999999998654 458999999999999999999996 66 99999999999999999999999999
Q ss_pred ccccccCCCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhc-
Q 014352 264 SKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLV- 342 (426)
Q Consensus 264 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~- 342 (426)
+...... ...+..||..|||||.+.+..|+.++||||||+.++|+.+|+.||....+ ......++++..+.
T Consensus 226 S~~lvnS-~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~-------~~~~~~~Ll~~Iv~~ 297 (364)
T KOG0581|consen 226 SGILVNS-IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP-------PYLDIFELLCAIVDE 297 (364)
T ss_pred cHHhhhh-hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC-------CCCCHHHHHHHHhcC
Confidence 9876544 55778999999999999999999999999999999999999999976310 01111222222221
Q ss_pred ---ccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 014352 343 ---GACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKI 381 (426)
Q Consensus 343 ---~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 381 (426)
..+....++++..++..||++||.+|||+.+++++-.-.
T Consensus 298 ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~ 339 (364)
T KOG0581|consen 298 PPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIK 339 (364)
T ss_pred CCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHh
Confidence 111223678899999999999999999999999875433
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-50 Score=399.98 Aligned_cols=260 Identities=28% Similarity=0.508 Sum_probs=218.9
Q ss_pred HHHHHHhhhhcccccCCCeeEEEEEeC------CCcEEEEEEeccCCcc-ChHHHHHHHHHHhcCCCCceeeEEeEEEeC
Q 014352 113 DIQKATQNFTNILGQGAFGPVYKATMP------SGGVAAIKVLASDSHQ-GEKEFQTEVSLLGRLHHRNLVNLIGYCVDK 185 (426)
Q Consensus 113 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 185 (426)
++......+.+.||+|+||+||+|... ..+.||||.++..... ...+|++|+++|+.|+|||||+++|+|.++
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~ 561 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG 561 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence 344444456678999999999999753 3457999999887655 567999999999999999999999999999
Q ss_pred CeEEEEEEecCCCChhHHhhhcc-------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecC
Q 014352 186 GKYMLIYEFMSNGSLSNLIYSEE-------------RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDH 252 (426)
Q Consensus 186 ~~~~lv~e~~~~gsL~~~l~~~~-------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~ 252 (426)
+.++||+|||..|+|.++|.... .+|+..+.+.||.|||.||.||-++. +|||||.++|+||.+
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGE 638 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceecc
Confidence 99999999999999999995421 23888999999999999999999999 999999999999999
Q ss_pred CCcEEEeeecCccccccC---CCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhc
Q 014352 253 FMRAKVADFGLSKEEVFD---GRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASM 328 (426)
Q Consensus 253 ~~~~kl~Dfgl~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~ 328 (426)
+..|||+|||+++..... .......-..+|||||.|..++|+.+||||||||+|||+++ |+.||.+......+..
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~- 717 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIEC- 717 (774)
T ss_pred ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHH-
Confidence 999999999999853322 11223345679999999999999999999999999999998 9999987655444333
Q ss_pred cccchhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHH
Q 014352 329 SQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQR 384 (426)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 384 (426)
+...-...++..++.++++||..||+.+|.+||+++||-..|+..-..
T Consensus 718 --------i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 718 --------IRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred --------HHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 233333567777889999999999999999999999999999887654
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-49 Score=364.42 Aligned_cols=197 Identities=29% Similarity=0.471 Sum_probs=178.8
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccC--CccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEec
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASD--SHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 195 (426)
|.+.+.||+|+||+||+|++. ++..||||.+... .....+.+..|+.+|+.++|||||+++++++.++.+|||||||
T Consensus 12 y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC 91 (429)
T KOG0595|consen 12 YELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYC 91 (429)
T ss_pred ceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeC
Confidence 344567999999999999976 6789999999776 3444567889999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCC------CcEEEeeecCcccccc
Q 014352 196 SNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHF------MRAKVADFGLSKEEVF 269 (426)
Q Consensus 196 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~------~~~kl~Dfgl~~~~~~ 269 (426)
.||+|.++++..+ .+++.+...++.|+|.||++||+++ ||||||||.|||++.. -.+||+|||+|+....
T Consensus 92 ~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~ 167 (429)
T KOG0595|consen 92 NGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQP 167 (429)
T ss_pred CCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhhhCCc
Confidence 9999999997665 5899999999999999999999999 9999999999999875 4589999999998877
Q ss_pred CCCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCch
Q 014352 270 DGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNL 319 (426)
Q Consensus 270 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~ 319 (426)
.......+|++-|||||++..++|+.|+|+||.|+++|++++|+.||...
T Consensus 168 ~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 168 GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 77778899999999999999999999999999999999999999999753
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-50 Score=368.10 Aligned_cols=254 Identities=25% Similarity=0.356 Sum_probs=209.7
Q ss_pred HHHHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCcc-------ChHHHHHHHHHHhcCCCCceeeEEeEEEeCC
Q 014352 115 QKATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQ-------GEKEFQTEVSLLGRLHHRNLVNLIGYCVDKG 186 (426)
Q Consensus 115 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 186 (426)
.+..|-+++.||+|+||.|-+|... +++.||||++...... ......+|+++|++|+|||||++++++..++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 4555667889999999999999854 8899999999654211 1234579999999999999999999999999
Q ss_pred eEEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCC---CcEEEeeecC
Q 014352 187 KYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHF---MRAKVADFGL 263 (426)
Q Consensus 187 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfgl 263 (426)
..||||||++||+|.+.+..++ .+.+.....++.|++.|+.|||++| |+||||||+|||++.+ ..+||+|||+
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk-~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANK-YLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred ceEEEEEEecCccHHHHHHhcc-ccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccch
Confidence 9999999999999999996554 4777777889999999999999999 9999999999999876 6799999999
Q ss_pred ccccccCCCcccCccccCccCccccccCCCC---cchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhh
Q 014352 264 SKEEVFDGRNSGLKGTYGYIDPAYISTNKFT---MKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQ 340 (426)
Q Consensus 264 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (426)
|+.........+.+||+.|.|||++.+..+. .+.|+||+||+||-+++|.+||++......+. ..+....
T Consensus 326 AK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~-------eQI~~G~ 398 (475)
T KOG0615|consen 326 AKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLK-------EQILKGR 398 (475)
T ss_pred hhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHH-------HHHhcCc
Confidence 9987767778899999999999999776543 47899999999999999999998643322111 1111112
Q ss_pred h--cccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 014352 341 L--VGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALL 379 (426)
Q Consensus 341 ~--~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 379 (426)
+ ....+...+++..+++.+||..||++|||+.|++++-.
T Consensus 399 y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW 439 (475)
T KOG0615|consen 399 YAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPW 439 (475)
T ss_pred ccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChh
Confidence 1 12334567789999999999999999999999998744
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-49 Score=378.20 Aligned_cols=249 Identities=27% Similarity=0.444 Sum_probs=213.8
Q ss_pred HHhhhhcccccCCCeeEEEEEe-CCCcEEEEEEeccCC---ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEE
Q 014352 117 ATQNFTNILGQGAFGPVYKATM-PSGGVAAIKVLASDS---HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIY 192 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 192 (426)
.+|..+++||+|||+.||+++. .+|..||+|++.... ....+.+.+|+++.++|+|||||+++++|++.++.|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4577788999999999999998 799999999997642 234567889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC-C
Q 014352 193 EFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD-G 271 (426)
Q Consensus 193 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-~ 271 (426)
|+|++++|..+++ ..+++++.++..+..||+.||.|||+++ |+|||||..|++++++.++||+|||||.....+ .
T Consensus 98 ELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E 173 (592)
T KOG0575|consen 98 ELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE 173 (592)
T ss_pred EecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCccc
Confidence 9999999999986 6678999999999999999999999999 999999999999999999999999999876654 5
Q ss_pred CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHH
Q 014352 272 RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVR 351 (426)
Q Consensus 272 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (426)
...+.+|||.|.|||++.....+..+||||+||+||-|+.|++||+...-...+..+. ...+. .|...+.
T Consensus 174 rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik--------~~~Y~--~P~~ls~ 243 (592)
T KOG0575|consen 174 RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIK--------LNEYS--MPSHLSA 243 (592)
T ss_pred ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHH--------hcCcc--cccccCH
Confidence 6678999999999999999999999999999999999999999998642222222111 11111 1123456
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 014352 352 ELARIGHKCLHKTPRKRPSIGEVTQALL 379 (426)
Q Consensus 352 ~l~~l~~~cl~~~p~~RPs~~evl~~L~ 379 (426)
+..+|+.++|+.||.+|||+.+|+.+=-
T Consensus 244 ~A~dLI~~lL~~~P~~Rpsl~~vL~h~F 271 (592)
T KOG0575|consen 244 EAKDLIRKLLRPNPSERPSLDEVLDHPF 271 (592)
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhcCHh
Confidence 7889999999999999999999997643
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-50 Score=392.32 Aligned_cols=262 Identities=26% Similarity=0.448 Sum_probs=226.8
Q ss_pred HHHHHHhhhhcccccCCCeeEEEEEeC-C---CcEEEEEEeccCC-ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCe
Q 014352 113 DIQKATQNFTNILGQGAFGPVYKATMP-S---GGVAAIKVLASDS-HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGK 187 (426)
Q Consensus 113 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 187 (426)
||.-....+.++||.|.||.|++|+++ . ...||||.++... ...+.+|..|+.||.++.||||++|.|+......
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~P 704 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKP 704 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCce
Confidence 444455556689999999999999975 2 3479999998764 3445689999999999999999999999999999
Q ss_pred EEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccc
Q 014352 188 YMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEE 267 (426)
Q Consensus 188 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 267 (426)
.++|.|||+||+|+.+|+.+++.+++.++..++.+||.||.||.+.+ +|||||.++|||++.+..+|++|||+++..
T Consensus 705 vMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvl 781 (996)
T KOG0196|consen 705 VMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 781 (996)
T ss_pred eEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeec
Confidence 99999999999999999988888999999999999999999999999 999999999999999999999999999965
Q ss_pred ccCCCc----ccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhc
Q 014352 268 VFDGRN----SGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLV 342 (426)
Q Consensus 268 ~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (426)
..+... .+..-..+|.|||.+...+++.++|||||||+|||.++ |..||-+. .+..+...++..++
T Consensus 782 edd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdm---------SNQdVIkaIe~gyR 852 (996)
T KOG0196|consen 782 EDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM---------SNQDVIKAIEQGYR 852 (996)
T ss_pred ccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccccc---------chHHHHHHHHhccC
Confidence 443311 12223579999999999999999999999999999776 99998653 44445555677788
Q ss_pred ccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHhh
Q 014352 343 GACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRHL 386 (426)
Q Consensus 343 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~ 386 (426)
.+++++++..|++||..||++|..+||.|.+|+..|+++.....
T Consensus 853 LPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~ 896 (996)
T KOG0196|consen 853 LPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPN 896 (996)
T ss_pred CCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCch
Confidence 88899999999999999999999999999999999999975543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-49 Score=342.50 Aligned_cols=254 Identities=24% Similarity=0.376 Sum_probs=203.9
Q ss_pred HHhhhhcccccCCCeeEEEEEe-CCCcEEEEEEeccCC--ccChHHHHHHHHHHhcCCCCceeeEEe-EEEeCCe-EEEE
Q 014352 117 ATQNFTNILGQGAFGPVYKATM-PSGGVAAIKVLASDS--HQGEKEFQTEVSLLGRLHHRNLVNLIG-YCVDKGK-YMLI 191 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~-~~~~~~~-~~lv 191 (426)
+.|.+.+.||+|.||+||++.. .+|..+|.|.+.-.. .....++..|+.+|++|+|||||++++ -+.+++. +++|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 3466777899999999999985 488899999887442 223457889999999999999999999 4445444 8999
Q ss_pred EEecCCCChhHHhhh---ccCCCCHHHHHHHHHHHHHHHHHHHcCCC-CCeeecCCCCCCEEecCCCcEEEeeecCcccc
Q 014352 192 YEFMSNGSLSNLIYS---EERVLNWEERLQIALDISHGIEYLHEGAV-PPVIHRDLKSANILLDHFMRAKVADFGLSKEE 267 (426)
Q Consensus 192 ~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 267 (426)
||||.+|+|...+.. ..+.+++.++++++.|++.||..+|++-. ..|.||||||.||+++.+|.+||+|||+++..
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999999853 44679999999999999999999999421 23999999999999999999999999999865
Q ss_pred ccCC-CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCC
Q 014352 268 VFDG-RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACN 346 (426)
Q Consensus 268 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (426)
.... .....+|||.||+||.+...+|+.||||||+||++|||+.-..||.+..-......+.+... ..-+.
T Consensus 179 ~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~--------~~~p~ 250 (375)
T KOG0591|consen 179 SSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDY--------PPLPD 250 (375)
T ss_pred cchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCC--------CCCcH
Confidence 4332 23567899999999999999999999999999999999999999987522222222222221 11122
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014352 347 IQEVRELARIGHKCLHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 347 ~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 378 (426)
.-.+.++..|+..|+..||+.||+...++..+
T Consensus 251 ~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 251 EHYSTDLRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred HHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence 45778999999999999999999964444443
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-48 Score=365.53 Aligned_cols=240 Identities=28% Similarity=0.427 Sum_probs=203.3
Q ss_pred ccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCCCChhHH
Q 014352 124 ILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNL 203 (426)
Q Consensus 124 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~ 203 (426)
-||+|+.|.||+|++. ++.||||+++.- -..+|+-|++|+||||+.|.|+|.....++||||||+.|-|..+
T Consensus 131 WlGSGaQGAVF~Grl~-netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~V 202 (904)
T KOG4721|consen 131 WLGSGAQGAVFLGRLH-NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEV 202 (904)
T ss_pred hhccCcccceeeeecc-CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHH
Confidence 3999999999999995 556788876532 23578899999999999999999999999999999999999999
Q ss_pred hhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCcccCccccCcc
Q 014352 204 IYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYI 283 (426)
Q Consensus 204 l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~gt~~y~ 283 (426)
|+. ++++.......+..+||.||.|||.+. |||||||.-||||+.+..+||+|||-++..........+.||..||
T Consensus 203 Lka-~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaGTVaWM 278 (904)
T KOG4721|consen 203 LKA-GRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFAGTVAWM 278 (904)
T ss_pred Hhc-cCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhhhhHhhh
Confidence 954 456888889999999999999999998 9999999999999999999999999998766666667789999999
Q ss_pred CccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHHHHHcccC
Q 014352 284 DPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHK 363 (426)
Q Consensus 284 aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~ 363 (426)
|||++++.+.+.|.||||||||||||+||..||.+...-..+..+ -...+....+..+++.+.-|+++||+.
T Consensus 279 APEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGV--------GsNsL~LpvPstcP~GfklL~Kqcw~s 350 (904)
T KOG4721|consen 279 APEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGV--------GSNSLHLPVPSTCPDGFKLLLKQCWNS 350 (904)
T ss_pred CHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEec--------cCCcccccCcccCchHHHHHHHHHHhc
Confidence 999999999999999999999999999999999775432222111 112222233344457788899999999
Q ss_pred CCCCCCCHHHHHHHHHHHHH
Q 014352 364 TPRKRPSIGEVTQALLKIKQ 383 (426)
Q Consensus 364 ~p~~RPs~~evl~~L~~~~~ 383 (426)
.|.+||+|.+++.+|+-...
T Consensus 351 KpRNRPSFrqil~HldIa~p 370 (904)
T KOG4721|consen 351 KPRNRPSFRQILLHLDIASP 370 (904)
T ss_pred CCCCCccHHHHHHHHhhcCH
Confidence 99999999999999976543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-47 Score=345.83 Aligned_cols=245 Identities=24% Similarity=0.384 Sum_probs=202.6
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCcc---ChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEe
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQ---GEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEF 194 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 194 (426)
+++.++||+|+||+||.++.. +++.+|+|++++.... ..+...+|..+|.+++||+||.++-.|.+.+.+|+|+||
T Consensus 27 F~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~ 106 (357)
T KOG0598|consen 27 FEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDY 106 (357)
T ss_pred eeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEec
Confidence 456689999999999999864 7889999999765322 345678999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC-CCc
Q 014352 195 MSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD-GRN 273 (426)
Q Consensus 195 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-~~~ 273 (426)
+.||.|..+|.+++ .+++..+.-++..|+.||.|||+++ ||||||||+|||+|++|+++|+|||+++..... ...
T Consensus 107 ~~GGeLf~hL~~eg-~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~t 182 (357)
T KOG0598|consen 107 LNGGELFYHLQREG-RFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDAT 182 (357)
T ss_pred cCCccHHHHHHhcC-CcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcccCCCcc
Confidence 99999999996554 4888888889999999999999999 999999999999999999999999999965444 345
Q ss_pred ccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHH
Q 014352 274 SGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVREL 353 (426)
Q Consensus 274 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 353 (426)
...+||+.|||||++.+..|+..+|+||+|+++|||++|.+||...........+.... ....+.-.+.+.
T Consensus 183 ~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k---------~~~~p~~ls~~a 253 (357)
T KOG0598|consen 183 RTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK---------LPLPPGYLSEEA 253 (357)
T ss_pred ccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc---------CCCCCccCCHHH
Confidence 66899999999999999999999999999999999999999997643322222221111 111122244678
Q ss_pred HHHHHHcccCCCCCCC----CHHHHHH
Q 014352 354 ARIGHKCLHKTPRKRP----SIGEVTQ 376 (426)
Q Consensus 354 ~~l~~~cl~~~p~~RP----s~~evl~ 376 (426)
.+++...+..||++|. ++.+|.+
T Consensus 254 rdll~~LL~rdp~~RLg~~~d~~~ik~ 280 (357)
T KOG0598|consen 254 RDLLKKLLKRDPRQRLGGPGDAEEIKR 280 (357)
T ss_pred HHHHHHHhccCHHHhcCCCCChHHhhc
Confidence 8999999999999995 5555544
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-47 Score=349.29 Aligned_cols=255 Identities=29% Similarity=0.448 Sum_probs=205.4
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCC--eEEEEEEec
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKG--KYMLIYEFM 195 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e~~ 195 (426)
+..++.||+|+||+||++... +|...|||.+........+.+.+|+.+|.+++|||||+++|.....+ .+++.|||+
T Consensus 19 ~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~ 98 (313)
T KOG0198|consen 19 WSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYA 98 (313)
T ss_pred hhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeecc
Confidence 445678999999999999976 48899999987653333567899999999999999999999855554 699999999
Q ss_pred CCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecC-CCcEEEeeecCcccccc----C
Q 014352 196 SNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDH-FMRAKVADFGLSKEEVF----D 270 (426)
Q Consensus 196 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgl~~~~~~----~ 270 (426)
++|||.+++...+..++...+..++.|+++||.|||+++ |+|+||||+|||++. ++.+||+|||++..... .
T Consensus 99 ~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~ 175 (313)
T KOG0198|consen 99 PGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKS 175 (313)
T ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccccccc
Confidence 999999999776657999999999999999999999999 999999999999999 79999999999886542 1
Q ss_pred CCcccCccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCch-HHHHHHhhccccchhhhhhhhhcccCCHH
Q 014352 271 GRNSGLKGTYGYIDPAYISTN-KFTMKSDIFSFGVIIFELITAIHPHQNL-MEYVNLASMSQDGVDEILDKQLVGACNIQ 348 (426)
Q Consensus 271 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (426)
.......||+.|||||++.++ ....++|||||||++.||+||+.||... .....+..+... ......+..
T Consensus 176 ~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~--------~~~P~ip~~ 247 (313)
T KOG0198|consen 176 DSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRE--------DSLPEIPDS 247 (313)
T ss_pred cccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhcc--------CCCCCCCcc
Confidence 223457899999999999863 3335999999999999999999999863 111111111110 011122333
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHH
Q 014352 349 EVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQR 384 (426)
Q Consensus 349 ~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 384 (426)
.+.+..+++..|+..||++|||+.+++++.......
T Consensus 248 ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 248 LSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred cCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 557889999999999999999999999987655443
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=357.28 Aligned_cols=262 Identities=24% Similarity=0.434 Sum_probs=211.0
Q ss_pred hHHHHHHhhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCccC--hHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEE
Q 014352 112 KDIQKATQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQG--EKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYM 189 (426)
Q Consensus 112 ~~l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 189 (426)
.+|.-....+++.||+|.||+||+|.|.+ .||||++..+.... .+.|++|+..+++-+|.||+-+.|+|..++. .
T Consensus 387 WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-A 463 (678)
T KOG0193|consen 387 WEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-A 463 (678)
T ss_pred cccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-e
Confidence 34555555677899999999999999843 48999997664433 4689999999999999999999999999876 9
Q ss_pred EEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccccc
Q 014352 190 LIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF 269 (426)
Q Consensus 190 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 269 (426)
+|+.+|+|.+|+.+|+.....+...+.+.|+.|||+||.|||.++ |||||||..||++.+++.|||+|||++.....
T Consensus 464 IiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~ 540 (678)
T KOG0193|consen 464 IITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTR 540 (678)
T ss_pred eeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeeeee
Confidence 999999999999999988888999999999999999999999999 99999999999999999999999999863221
Q ss_pred ---CCCcccCccccCccCccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcc
Q 014352 270 ---DGRNSGLKGTYGYIDPAYIS---TNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVG 343 (426)
Q Consensus 270 ---~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (426)
........|...|||||++. ..+|+..+||||||+|+|||+||..||........+..+-.+-.. .|..
T Consensus 541 w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~--pd~s--- 615 (678)
T KOG0193|consen 541 WSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLM--PDLS--- 615 (678)
T ss_pred eccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccC--ccch---
Confidence 12223456788999999985 357899999999999999999999999842222222211111000 0110
Q ss_pred cCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHH
Q 014352 344 ACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQR 384 (426)
Q Consensus 344 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 384 (426)
.......+++.+|+..||..++++||.+.+|+..|+.+...
T Consensus 616 ~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 616 KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 11223456899999999999999999999999988888764
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=350.86 Aligned_cols=264 Identities=26% Similarity=0.432 Sum_probs=216.0
Q ss_pred ChhHHHHHHhhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCccCh-HHHHHHHHHHhcCCCCceeeEEeEEEeCCeE
Q 014352 110 AYKDIQKATQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGE-KEFQTEVSLLGRLHHRNLVNLIGYCVDKGKY 188 (426)
Q Consensus 110 ~~~~l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 188 (426)
...++.+....|.++||+|-||.|..+...++..||||.++....... ++|..|+++|.+|+||||++++|+|..++.+
T Consensus 531 al~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePi 610 (807)
T KOG1094|consen 531 ALVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPL 610 (807)
T ss_pred chhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCch
Confidence 455667777778899999999999999998889999999998765554 7899999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHhhhccCC-CCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccc
Q 014352 189 MLIYEFMSNGSLSNLIYSEERV-LNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEE 267 (426)
Q Consensus 189 ~lv~e~~~~gsL~~~l~~~~~~-l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 267 (426)
++|+|||++|+|.+++.....+ +.-.....|+.||+.||+||.+.+ +|||||.+.|+|+|.++++||+|||+++..
T Consensus 611 cmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~l 687 (807)
T KOG1094|consen 611 CMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNL 687 (807)
T ss_pred HHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCccccccc
Confidence 9999999999999999665432 355566789999999999999999 999999999999999999999999999854
Q ss_pred ccCC---CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHH--hCCCCCCchHHHHHHhhccccchhhhhhh---
Q 014352 268 VFDG---RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELI--TAIHPHQNLMEYVNLASMSQDGVDEILDK--- 339 (426)
Q Consensus 268 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~--tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--- 339 (426)
.... ......-..+|||||.+..++++.++|||+||+++||++ +...||+......... ...++++.
T Consensus 688 ysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vve-----n~~~~~~~~~~ 762 (807)
T KOG1094|consen 688 YSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVE-----NAGEFFRDQGR 762 (807)
T ss_pred ccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHH-----hhhhhcCCCCc
Confidence 3222 122344578999999999999999999999999999966 4788998754433221 11112211
Q ss_pred hhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 014352 340 QLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKI 381 (426)
Q Consensus 340 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 381 (426)
......+.-++..++++|.+||+.+.++|||++++...|...
T Consensus 763 ~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 763 QVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 111223344567899999999999999999999999888754
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-47 Score=333.40 Aligned_cols=255 Identities=22% Similarity=0.321 Sum_probs=204.7
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCcc--ChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEec
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQ--GEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 195 (426)
|+...++|+|+||+||+++.+ +|+.||||++...... -.+-.++|+++|++|+|+|+|.++.+|.....++||+|||
T Consensus 4 YE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~ 83 (396)
T KOG0593|consen 4 YEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYC 83 (396)
T ss_pred HhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeec
Confidence 444568999999999999976 7899999999765322 2345789999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccc-cCCCcc
Q 014352 196 SNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEV-FDGRNS 274 (426)
Q Consensus 196 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~-~~~~~~ 274 (426)
+. ++.+-|......++.....+++.|++.|+.|+|+++ ++||||||+|||++.+|.+||+|||+|+... .....+
T Consensus 84 dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YT 159 (396)
T KOG0593|consen 84 DH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYT 159 (396)
T ss_pred ch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCCcchhh
Confidence 87 555556566666899999999999999999999999 9999999999999999999999999999766 334446
Q ss_pred cCccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccc--cc-h---hhhhh---------
Q 014352 275 GLKGTYGYIDPAYIST-NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQ--DG-V---DEILD--------- 338 (426)
Q Consensus 275 ~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~--~~-~---~~~~~--------- 338 (426)
..+.|..|.|||.+.+ .+|....|||+.||++.||++|.+-|.+.++...+..+.. +. . ..++.
T Consensus 160 DYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~ 239 (396)
T KOG0593|consen 160 DYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVR 239 (396)
T ss_pred hhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeee
Confidence 6788999999999977 6899999999999999999999999987665544433211 00 0 11111
Q ss_pred ------hhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 339 ------KQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 339 ------~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
+......-+..+.-+.++++.||+.||++|++.++++.+
T Consensus 240 lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 240 LPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred cCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 000011112234568999999999999999999999865
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-46 Score=354.67 Aligned_cols=244 Identities=26% Similarity=0.406 Sum_probs=213.9
Q ss_pred cccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCCCChh
Q 014352 123 NILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLS 201 (426)
Q Consensus 123 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 201 (426)
..||+|+.|.||.+... +++.||||++........+-+.+|+.+|+..+|+|||.+++.|...+++|+|||||+||+|.
T Consensus 279 ~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLT 358 (550)
T KOG0578|consen 279 KKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLT 358 (550)
T ss_pred hhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchh
Confidence 47999999999999854 78899999998776666677899999999999999999999999999999999999999999
Q ss_pred HHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC-CcccCcccc
Q 014352 202 NLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG-RNSGLKGTY 280 (426)
Q Consensus 202 ~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-~~~~~~gt~ 280 (426)
+.+. ...+++.++..|+.++++||+|||.++ |+|||||.+|||++.+|.+||+|||++....... ......||+
T Consensus 359 DvVt--~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~TmVGTP 433 (550)
T KOG0578|consen 359 DVVT--KTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRSTMVGTP 433 (550)
T ss_pred hhhh--cccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccCccccccCCC
Confidence 9983 344899999999999999999999999 9999999999999999999999999987654443 556788999
Q ss_pred CccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHHHHHc
Q 014352 281 GYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKC 360 (426)
Q Consensus 281 ~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c 360 (426)
.|||||++....|+.|.||||||++++||+-|.+||-+......+..+...+..++-.+ ...+..+.+++.+|
T Consensus 434 YWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~-------~klS~~~kdFL~~c 506 (550)
T KOG0578|consen 434 YWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNP-------EKLSPELKDFLDRC 506 (550)
T ss_pred CccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCc-------cccCHHHHHHHHHH
Confidence 99999999999999999999999999999999999987666666655555554444332 23456899999999
Q ss_pred ccCCCCCCCCHHHHHHHH
Q 014352 361 LHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 361 l~~~p~~RPs~~evl~~L 378 (426)
|..|+++||++.|+|++-
T Consensus 507 L~~dv~~RasA~eLL~Hp 524 (550)
T KOG0578|consen 507 LVVDVEQRASAKELLEHP 524 (550)
T ss_pred hhcchhcCCCHHHHhcCh
Confidence 999999999999999873
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=339.12 Aligned_cols=258 Identities=26% Similarity=0.377 Sum_probs=209.7
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccC-hHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEec
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQG-EKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 195 (426)
.|++.+.||.|..++||+|+.. .+..||||++..+.-.. ...+..|+..|+.++||||++++..|..+..+|+||.||
T Consensus 27 ~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfM 106 (516)
T KOG0582|consen 27 DYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFM 106 (516)
T ss_pred ceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhh
Confidence 3667789999999999999864 77999999997664333 378899999999999999999999999999999999999
Q ss_pred CCCChhHHhhhc-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCC--
Q 014352 196 SNGSLSNLIYSE-ERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGR-- 272 (426)
Q Consensus 196 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~-- 272 (426)
.+||+.++++.. ...+++..+..|+.++++||.|||.+| .||||||+.||||+.+|.+||+|||.+......+.
T Consensus 107 a~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~ 183 (516)
T KOG0582|consen 107 AGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQ 183 (516)
T ss_pred cCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccCcee
Confidence 999999999653 244899999999999999999999999 99999999999999999999999998765433221
Q ss_pred ---cccCccccCccCccccc--cCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCH
Q 014352 273 ---NSGLKGTYGYIDPAYIS--TNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNI 347 (426)
Q Consensus 273 ---~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (426)
.....||+.|||||++. ...|+.|+||||||++..||.+|..||..+.+...+-.-.+...+.............
T Consensus 184 ~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k 263 (516)
T KOG0582|consen 184 VTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDK 263 (516)
T ss_pred eEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHHhh
Confidence 14568999999999953 3579999999999999999999999999876655433222222221111111111223
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014352 348 QEVRELARIGHKCLHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 348 ~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 378 (426)
.....+.+++..||++||++|||+++++++-
T Consensus 264 ~~~ksf~e~i~~CL~kDP~kRptAskLlkh~ 294 (516)
T KOG0582|consen 264 KFSKSFREMIALCLVKDPSKRPTASKLLKHA 294 (516)
T ss_pred hhcHHHHHHHHHHhhcCcccCCCHHHHhccH
Confidence 3456899999999999999999999998753
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=351.90 Aligned_cols=258 Identities=28% Similarity=0.500 Sum_probs=202.7
Q ss_pred HHHHhhhhcccccCCCeeEEEEEe------CCCcEEEEEEeccCCcc-ChHHHHHHHHHHhcC-CCCceeeEEeEEEeC-
Q 014352 115 QKATQNFTNILGQGAFGPVYKATM------PSGGVAAIKVLASDSHQ-GEKEFQTEVSLLGRL-HHRNLVNLIGYCVDK- 185 (426)
Q Consensus 115 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~- 185 (426)
...++.+.+.||+|+||.||+|.+ .++..||+|++...... ....+.+|+.++.++ +||||++++++|...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 345677788999999999999974 23467999998754322 235688999999999 899999999988765
Q ss_pred CeEEEEEEecCCCChhHHhhhcc---------------------------------------------------------
Q 014352 186 GKYMLIYEFMSNGSLSNLIYSEE--------------------------------------------------------- 208 (426)
Q Consensus 186 ~~~~lv~e~~~~gsL~~~l~~~~--------------------------------------------------------- 208 (426)
+.++++|||+++|+|.+++....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 45899999999999999986421
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC---CcccCccccC
Q 014352 209 ----RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG---RNSGLKGTYG 281 (426)
Q Consensus 209 ----~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---~~~~~~gt~~ 281 (426)
..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...... ......++..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 24788899999999999999999998 9999999999999999999999999997542221 1123346678
Q ss_pred ccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHHHHHc
Q 014352 282 YIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKC 360 (426)
Q Consensus 282 y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c 360 (426)
|+|||++.+..++.++||||||+++|||++ |..||........... .+.+ ......+...+..+.+++.+|
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~-------~~~~-~~~~~~~~~~~~~l~~li~~c 313 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQ-------RLKD-GTRMRAPENATPEIYRIMLAC 313 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHH-------HHhc-CCCCCCCCCCCHHHHHHHHHH
Confidence 999999999999999999999999999997 9999975322111100 0000 001111223346789999999
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHH
Q 014352 361 LHKTPRKRPSIGEVTQALLKIKQ 383 (426)
Q Consensus 361 l~~~p~~RPs~~evl~~L~~~~~ 383 (426)
|+.||++|||+.++++.|+.+..
T Consensus 314 l~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 314 WQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred ccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-46 Score=380.98 Aligned_cols=259 Identities=29% Similarity=0.504 Sum_probs=216.7
Q ss_pred HHhhhhcccccCCCeeEEEEEeC--CCc----EEEEEEeccCC-ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEE
Q 014352 117 ATQNFTNILGQGAFGPVYKATMP--SGG----VAAIKVLASDS-HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYM 189 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 189 (426)
....+.+.||+|+||.||+|.+. .+. .||+|.+.... .+...+|.+|..+|++++|||||+++|+|.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 34456678999999999999864 333 48999987663 344568999999999999999999999999999999
Q ss_pred EEEEecCCCChhHHhhhc------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecC
Q 014352 190 LIYEFMSNGSLSNLIYSE------ERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGL 263 (426)
Q Consensus 190 lv~e~~~~gsL~~~l~~~------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 263 (426)
+++|||++|+|..+|+.. ...|+..+++.++.+||+|+.||++++ +|||||..+|+||+....+||+|||+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccch
Confidence 999999999999999876 567999999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCC---CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhh
Q 014352 264 SKEEVFDG---RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDK 339 (426)
Q Consensus 264 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 339 (426)
|+...... ......-..+|||||.+..+.|+.|+|||||||+|||++| |..||.+..++..+.....++
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg------- 921 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG------- 921 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-------
Confidence 99432111 1111234579999999999999999999999999999999 999998876665544222222
Q ss_pred hhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHhhh
Q 014352 340 QLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRHLA 387 (426)
Q Consensus 340 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~~ 387 (426)
+..++..+++.++++|.+||+.+|++||++..+++.+..+......
T Consensus 922 --RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~ 967 (1025)
T KOG1095|consen 922 --RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALG 967 (1025)
T ss_pred --ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhcc
Confidence 3344555668899999999999999999999999988888665443
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-46 Score=359.33 Aligned_cols=263 Identities=28% Similarity=0.487 Sum_probs=216.9
Q ss_pred HHHHHhhhhcccccCCCeeEEEEEeCC--C---cEEEEEEeccCC---ccChHHHHHHHHHHhcCCCCceeeEEeEEEeC
Q 014352 114 IQKATQNFTNILGQGAFGPVYKATMPS--G---GVAAIKVLASDS---HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDK 185 (426)
Q Consensus 114 l~~~~~~~~~~lg~G~~g~Vy~~~~~~--~---~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 185 (426)
|......+.++||+|+||.||+|++.. + ..||||..+... .....+|..|+++|++++|||||+++|++...
T Consensus 154 l~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~ 233 (474)
T KOG0194|consen 154 LSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLE 233 (474)
T ss_pred EeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCC
Confidence 334444456789999999999998652 2 238999988532 33456899999999999999999999999999
Q ss_pred CeEEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcc
Q 014352 186 GKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSK 265 (426)
Q Consensus 186 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 265 (426)
..+++|||+|+||+|.++|...+..++..+++.++.+.|.||+|||+++ ++||||.++|+|++.++.+||+|||+++
T Consensus 234 ~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 234 EPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSR 310 (474)
T ss_pred CccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCcccccc
Confidence 9999999999999999999887777999999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCCcc-cCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcc
Q 014352 266 EEVFDGRNS-GLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVG 343 (426)
Q Consensus 266 ~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (426)
......... ...-..+|+|||.+....|+.++|||||||++||+++ |..||.+......... ++...++.
T Consensus 311 ~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~k--------I~~~~~r~ 382 (474)
T KOG0194|consen 311 AGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAK--------IVKNGYRM 382 (474)
T ss_pred CCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHH--------HHhcCccC
Confidence 543111111 2245679999999999999999999999999999998 8889987554432222 21233333
Q ss_pred cCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHhhh
Q 014352 344 ACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRHLA 387 (426)
Q Consensus 344 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~~ 387 (426)
..+...+..+..++.+||..+|++||||.++.+.|+.+......
T Consensus 383 ~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 383 PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred CCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 44445567889999999999999999999999999999876554
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-45 Score=348.87 Aligned_cols=248 Identities=26% Similarity=0.383 Sum_probs=207.6
Q ss_pred HHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccC----Cc-cChHHHHHHHHHHhcCC-CCceeeEEeEEEeCCeEE
Q 014352 117 ATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASD----SH-QGEKEFQTEVSLLGRLH-HRNLVNLIGYCVDKGKYM 189 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~ 189 (426)
..|.+.+.||+|+||+|+.|... ++..||+|++... .. ...+.+.+|+.++++++ ||||++++.++.....++
T Consensus 17 g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ 96 (370)
T KOG0583|consen 17 GKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIY 96 (370)
T ss_pred CceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEE
Confidence 44667889999999999999865 7799999977653 11 22346778999999999 999999999999999999
Q ss_pred EEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCC-CcEEEeeecCcccc-
Q 014352 190 LIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHF-MRAKVADFGLSKEE- 267 (426)
Q Consensus 190 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgl~~~~- 267 (426)
+||||+.||+|.+++.. .+.+.+.+...++.|++.|++|||+++ |+||||||+|||+|.+ +++||+|||++...
T Consensus 97 ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 97 IVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred EEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 99999999999999977 566889999999999999999999999 9999999999999999 99999999999876
Q ss_pred ccCCCcccCccccCccCccccccCC-CC-cchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccC
Q 014352 268 VFDGRNSGLKGTYGYIDPAYISTNK-FT-MKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGAC 345 (426)
Q Consensus 268 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (426)
.........+||+.|+|||++.+.. |+ .++||||+||+||.|++|..||...........+.. ..+ ..
T Consensus 173 ~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~--------~~~--~~ 242 (370)
T KOG0583|consen 173 GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRK--------GEF--KI 242 (370)
T ss_pred CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhc--------CCc--cC
Confidence 4556678899999999999999987 86 789999999999999999999987332222211111 111 01
Q ss_pred CHHH-HHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014352 346 NIQE-VRELARIGHKCLHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 346 ~~~~-~~~l~~l~~~cl~~~p~~RPs~~evl~~L 378 (426)
+... +.++..++.+|+..||.+|+|+.+++.+=
T Consensus 243 p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~ 276 (370)
T KOG0583|consen 243 PSYLLSPEARSLIEKMLVPDPSTRITLLEILEHP 276 (370)
T ss_pred CCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhCh
Confidence 1112 57899999999999999999999999543
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-46 Score=346.50 Aligned_cols=260 Identities=25% Similarity=0.332 Sum_probs=216.5
Q ss_pred HHHHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChH-HHHHHHHHHhcCC-CCceeeEEeEEEeCC-eEEE
Q 014352 115 QKATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEK-EFQTEVSLLGRLH-HRNLVNLIGYCVDKG-KYML 190 (426)
Q Consensus 115 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~-~~~~e~~~l~~l~-h~niv~~~~~~~~~~-~~~l 190 (426)
...+|.+.+.||.|+||.||+|+.. ++..||||.++......++ .=.+|+..|++|+ |||||++..++.+.+ .+++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 3457888899999999999999854 7889999999876443332 2358999999999 999999999999887 9999
Q ss_pred EEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC
Q 014352 191 IYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD 270 (426)
Q Consensus 191 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 270 (426)
|||||+. +|+++++..++.++...+..|+.||++||+|+|.+| +.|||+||+|||+..+..+||+|||+||.....
T Consensus 88 VfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk 163 (538)
T KOG0661|consen 88 VFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRSK 163 (538)
T ss_pred eHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccccC
Confidence 9999954 999999988999999999999999999999999999 999999999999999999999999999988777
Q ss_pred CCcccCccccCccCcccc-ccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccc----cchhhh-----hhhh
Q 014352 271 GRNSGLKGTYGYIDPAYI-STNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQ----DGVDEI-----LDKQ 340 (426)
Q Consensus 271 ~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~----~~~~~~-----~~~~ 340 (426)
...+..+.|..|+|||++ +.+-|+.+.|+|++||+++|+.+-++-|.+..+...+..+.. .....+ +...
T Consensus 164 pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~ 243 (538)
T KOG0661|consen 164 PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASA 243 (538)
T ss_pred CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHH
Confidence 788889999999999987 556789999999999999999999999998777666554321 100000 0000
Q ss_pred -------hcc----cCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014352 341 -------LVG----ACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 341 -------~~~----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 378 (426)
..+ ...+..+.+..+++.+|++.||.+|||+.+++++-
T Consensus 244 mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 244 MNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred hccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 000 01112557899999999999999999999999864
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=346.63 Aligned_cols=246 Identities=26% Similarity=0.373 Sum_probs=208.1
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC---ccChHHHHHHHHHHhcC-CCCceeeEEeEEEeCCeEEEEEE
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS---HQGEKEFQTEVSLLGRL-HHRNLVNLIGYCVDKGKYMLIYE 193 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 193 (426)
+.|++.||.|+|++|++|+.. ++..+|||++.+.- ....+....|-..|.+| .||.|++|+-.|.+...+|+|+|
T Consensus 75 F~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe 154 (604)
T KOG0592|consen 75 FKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLE 154 (604)
T ss_pred cchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEE
Confidence 567899999999999999864 78899999986542 22234577899999999 89999999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC--
Q 014352 194 FMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG-- 271 (426)
Q Consensus 194 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-- 271 (426)
|+++|+|.++|.+.+ .+++.....++.+|+.||+|||++| ||||||||+|||+|.++++||+|||-++......
T Consensus 155 ~A~nGdll~~i~K~G-sfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~ 230 (604)
T KOG0592|consen 155 YAPNGDLLDLIKKYG-SFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKS 230 (604)
T ss_pred ecCCCcHHHHHHHhC-cchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCChhhcc
Confidence 999999999997664 5898888999999999999999999 9999999999999999999999999887432211
Q ss_pred ----------Cc--ccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhh
Q 014352 272 ----------RN--SGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDK 339 (426)
Q Consensus 272 ----------~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 339 (426)
.. ..++||..|.+||++.....+..+|+|+|||+||+|+.|.+||....++.....+. +.
T Consensus 231 ~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~--------~l 302 (604)
T KOG0592|consen 231 QENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQ--------AL 302 (604)
T ss_pred ccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHH--------Hh
Confidence 11 45789999999999999999999999999999999999999999887776554332 22
Q ss_pred hhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014352 340 QLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 340 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 378 (426)
.+ ..+...++...+|+++.|..||.+|+|..+|.++.
T Consensus 303 ~y--~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 303 DY--EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred cc--cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 21 12233346788999999999999999999988764
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-45 Score=351.94 Aligned_cols=248 Identities=26% Similarity=0.361 Sum_probs=214.0
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc---cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEe
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH---QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEF 194 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 194 (426)
|.+++.||.|+-|.|-.|++. +|+.+|||++..... .....+.+|+.+|+-+.||||+++++++.+..++|+|.||
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy 93 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY 93 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence 446678999999999999975 899999999976522 2234578999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCcc
Q 014352 195 MSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNS 274 (426)
Q Consensus 195 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 274 (426)
+++|.|.+++..++ +++..+..+++.||+.|+.|+|..+ |+||||||+|+|+|..+++||+|||+|.....+....
T Consensus 94 v~gGELFdylv~kG-~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLe 169 (786)
T KOG0588|consen 94 VPGGELFDYLVRKG-PLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLE 169 (786)
T ss_pred cCCchhHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCCcccc
Confidence 99999999996554 5888999999999999999999999 9999999999999999999999999999888788888
Q ss_pred cCccccCccCccccccCCCC-cchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccC--CHHHHH
Q 014352 275 GLKGTYGYIDPAYISTNKFT-MKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGAC--NIQEVR 351 (426)
Q Consensus 275 ~~~gt~~y~aPE~~~~~~~~-~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 351 (426)
+.+|++.|.+||++.+.+|+ .++||||+|||||.|+||+.||++..-...+..+ ..+.. +...+.
T Consensus 170 TSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV------------~~G~f~MPs~Is~ 237 (786)
T KOG0588|consen 170 TSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKV------------QRGVFEMPSNISS 237 (786)
T ss_pred ccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHH------------HcCcccCCCcCCH
Confidence 99999999999999999996 7899999999999999999999864333322222 22222 233557
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 014352 352 ELARIGHKCLHKTPRKRPSIGEVTQALLKIK 382 (426)
Q Consensus 352 ~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 382 (426)
+..+|+.+|+..||+.|.|++||++|-....
T Consensus 238 eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g 268 (786)
T KOG0588|consen 238 EAQDLLRRMLDVDPSTRITTEEILKHPFLSG 268 (786)
T ss_pred HHHHHHHHHhccCccccccHHHHhhCchhhc
Confidence 8899999999999999999999999876553
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=336.83 Aligned_cols=259 Identities=22% Similarity=0.303 Sum_probs=206.4
Q ss_pred CCCChhHHHHHHhhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCccC---hHHHHHHHHHHhcCCCCceeeEEeEEE
Q 014352 107 PRYAYKDIQKATQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQG---EKEFQTEVSLLGRLHHRNLVNLIGYCV 183 (426)
Q Consensus 107 ~~~~~~~l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~ 183 (426)
..++.++|..... ..||+|++|.||+|.+ +|+.||+|.+....... .+.|.+|+.+|.+++||||+++++++.
T Consensus 13 ~~i~~~~i~~~~~---~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~ 88 (283)
T PHA02988 13 KCIESDDIDKYTS---VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFII 88 (283)
T ss_pred eecCHHHcCCCCC---eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEE
Confidence 3445555543221 3699999999999998 67889999987654333 356789999999999999999999987
Q ss_pred e----CCeEEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCeeecCCCCCCEEecCCCcEEE
Q 014352 184 D----KGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEG-AVPPVIHRDLKSANILLDHFMRAKV 258 (426)
Q Consensus 184 ~----~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~ivH~dlk~~Nill~~~~~~kl 258 (426)
+ ....++||||+++|+|.+++... ..+++...+.++.+++.||.|||+. + ++||||||+|||+++++.+||
T Consensus 89 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl 164 (283)
T PHA02988 89 DIVDDLPRLSLILEYCTRGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKI 164 (283)
T ss_pred ecccCCCceEEEEEeCCCCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEE
Confidence 7 34689999999999999999654 4689999999999999999999984 6 789999999999999999999
Q ss_pred eeecCccccccCCCcccCccccCccCcccccc--CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhh
Q 014352 259 ADFGLSKEEVFDGRNSGLKGTYGYIDPAYIST--NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEI 336 (426)
Q Consensus 259 ~Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 336 (426)
+|||+++.... ......++..|+|||++.+ ..++.++|||||||++|||++|..||...........+.
T Consensus 165 ~dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~------- 235 (283)
T PHA02988 165 ICHGLEKILSS--PPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLII------- 235 (283)
T ss_pred cccchHhhhcc--ccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHH-------
Confidence 99999875322 2234568899999999976 689999999999999999999999998643322111111
Q ss_pred hhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 014352 337 LDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQ 383 (426)
Q Consensus 337 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 383 (426)
........+...+..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 236 -~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 236 -NKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred -hcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 1111111122345679999999999999999999999999988753
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-46 Score=342.74 Aligned_cols=243 Identities=30% Similarity=0.451 Sum_probs=206.2
Q ss_pred hcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccC-hHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCCCC
Q 014352 122 TNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQG-EKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGS 199 (426)
Q Consensus 122 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 199 (426)
.+.||+|+||.||+|... +++.||+|++..+.... .+++++|+.+|.+++++||.++++.+..+..++++||||.||+
T Consensus 18 ~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGs 97 (467)
T KOG0201|consen 18 LELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGS 97 (467)
T ss_pred chhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcc
Confidence 358999999999999875 78899999998765443 4688999999999999999999999999999999999999999
Q ss_pred hhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC-CCcccCcc
Q 014352 200 LSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD-GRNSGLKG 278 (426)
Q Consensus 200 L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-~~~~~~~g 278 (426)
+.+.|... ..+++..+.-++.++..||.|||+++ .+|||||+.|||+..+|.+|++|||++-..... .....+.|
T Consensus 98 v~~lL~~~-~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~tfvG 173 (467)
T KOG0201|consen 98 VLDLLKSG-NILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKTFVG 173 (467)
T ss_pred hhhhhccC-CCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhhccccccc
Confidence 99999543 34577788889999999999999999 999999999999999999999999998754433 33477899
Q ss_pred ccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHHHH
Q 014352 279 TYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGH 358 (426)
Q Consensus 279 t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 358 (426)
|+.|||||++....|+.|+||||||++.+||++|.+|+....+...+..+ .+..+.......++.+.+++.
T Consensus 174 TPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI---------pk~~PP~L~~~~S~~~kEFV~ 244 (467)
T KOG0201|consen 174 TPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI---------PKSAPPRLDGDFSPPFKEFVE 244 (467)
T ss_pred cccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec---------cCCCCCccccccCHHHHHHHH
Confidence 99999999999889999999999999999999999999875543222222 222222223355677999999
Q ss_pred HcccCCCCCCCCHHHHHHH
Q 014352 359 KCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 359 ~cl~~~p~~RPs~~evl~~ 377 (426)
.||++||+.|||+.+++++
T Consensus 245 ~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 245 ACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred HHhhcCcccCcCHHHHhhh
Confidence 9999999999999999875
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=332.44 Aligned_cols=256 Identities=21% Similarity=0.383 Sum_probs=207.3
Q ss_pred HHHHHhhhhcccccCCCeeEEEEEeC----CCcEEEEEEeccCCc-cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeE
Q 014352 114 IQKATQNFTNILGQGAFGPVYKATMP----SGGVAAIKVLASDSH-QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKY 188 (426)
Q Consensus 114 l~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 188 (426)
|....+.+.+.||+|+||.||+|.+. .+..||+|.++.... .....|.+|+..+++++||||+++++++..++..
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 34556778889999999999999753 356899999876532 2235788999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccc
Q 014352 189 MLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEV 268 (426)
Q Consensus 189 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 268 (426)
++||||+++|+|.+++......+++..++.++.|++.||+|||+++ ++||||||+||+++.++.++++|||.+....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 9999999999999999766667899999999999999999999998 9999999999999999999999999876432
Q ss_pred cCCCc--ccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccC
Q 014352 269 FDGRN--SGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGAC 345 (426)
Q Consensus 269 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (426)
..... ....++..|+|||.+.+..++.++||||||+++||+++ |..||...........+... .....
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~---------~~~~~ 229 (266)
T cd05064 159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDG---------FRLPA 229 (266)
T ss_pred ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC---------CCCCC
Confidence 22111 12335678999999999999999999999999999775 99999765433222222111 11112
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 014352 346 NIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKI 381 (426)
Q Consensus 346 ~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 381 (426)
+...+..+.+++.+||+.+|++|||+.++++.|.++
T Consensus 230 ~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 230 PRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 233456789999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-44 Score=335.32 Aligned_cols=259 Identities=25% Similarity=0.326 Sum_probs=207.7
Q ss_pred HHHHhhhhcccccCCCeeEEEEEe-CCCcEEEEEEeccCCc--cChHHHHHHHHHHhcCCCCceeeEEeEEEeC--CeEE
Q 014352 115 QKATQNFTNILGQGAFGPVYKATM-PSGGVAAIKVLASDSH--QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDK--GKYM 189 (426)
Q Consensus 115 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~ 189 (426)
....|+..++||+|+||.||+|+. .+|..||+|+++.+.. .......+||.+|++|+||||+++.+...+. ..+|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 334455567899999999999986 4889999999987652 3335678999999999999999999999887 6899
Q ss_pred EEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccccc
Q 014352 190 LIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF 269 (426)
Q Consensus 190 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 269 (426)
||+|||+. +|..++...+-.++..++..++.|++.||+|||+++ |+|||||.+|||||.+|.+||+|||||+....
T Consensus 195 lVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred EEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccC
Confidence 99999987 999999777778999999999999999999999999 99999999999999999999999999995544
Q ss_pred CC--CcccCccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccc------cchhhhhh--
Q 014352 270 DG--RNSGLKGTYGYIDPAYISTN-KFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQ------DGVDEILD-- 338 (426)
Q Consensus 270 ~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~------~~~~~~~~-- 338 (426)
.. ..+..+-|..|.|||.+.+. .|+.+.|+||.||||.||++|++.|.+..+...+..+.. +..-...+
T Consensus 271 ~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP 350 (560)
T KOG0600|consen 271 SGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLP 350 (560)
T ss_pred CCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCC
Confidence 33 34667789999999998775 699999999999999999999999988665544433211 10000000
Q ss_pred --hhhcccCC---------HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 339 --KQLVGACN---------IQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 339 --~~~~~~~~---------~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
..+....+ ...+....+|+..+|..||++|.|+.++++.
T Consensus 351 ~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 351 HATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred cccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 00000000 1123567899999999999999999998864
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=315.72 Aligned_cols=233 Identities=27% Similarity=0.379 Sum_probs=197.3
Q ss_pred hhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccC---hHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEec
Q 014352 120 NFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQG---EKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 120 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 195 (426)
++...||.|+||.|.+.+.+ +|..+|+|++....-.. .+...+|..+|+.+.||+++++.+.|.+.+.+||||||.
T Consensus 47 e~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv 126 (355)
T KOG0616|consen 47 ERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYV 126 (355)
T ss_pred hheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEecc
Confidence 34568999999999999976 78899999997654332 345678999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCccc
Q 014352 196 SNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSG 275 (426)
Q Consensus 196 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 275 (426)
+||.|..+|++.++ ++.+...-++.+|+.||+|||+.+ |++|||||+|||+|.+|.+||+|||+|+... ..+.+
T Consensus 127 ~GGElFS~Lrk~~r-F~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~--~rT~T 200 (355)
T KOG0616|consen 127 PGGELFSYLRKSGR-FSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVS--GRTWT 200 (355)
T ss_pred CCccHHHHHHhcCC-CCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEec--CcEEE
Confidence 99999999966554 899999999999999999999999 9999999999999999999999999998653 33677
Q ss_pred CccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHH
Q 014352 276 LKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELAR 355 (426)
Q Consensus 276 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 355 (426)
.+||+.|+|||.+...+|..++|.|||||++|||+.|.+||...........+... .+ ..+.-...++.+
T Consensus 201 lCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~--------~v--~fP~~fs~~~kd 270 (355)
T KOG0616|consen 201 LCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEG--------KV--KFPSYFSSDAKD 270 (355)
T ss_pred ecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhC--------cc--cCCcccCHHHHH
Confidence 89999999999999999999999999999999999999999875443332222211 11 112233457888
Q ss_pred HHHHcccCCCCCC
Q 014352 356 IGHKCLHKTPRKR 368 (426)
Q Consensus 356 l~~~cl~~~p~~R 368 (426)
|+...|+.|-.+|
T Consensus 271 Ll~~LL~vD~t~R 283 (355)
T KOG0616|consen 271 LLKKLLQVDLTKR 283 (355)
T ss_pred HHHHHHhhhhHhh
Confidence 8999999999998
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=330.98 Aligned_cols=278 Identities=24% Similarity=0.421 Sum_probs=210.0
Q ss_pred CCCCCCCCCCCChhHHHHHHhhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhc--CCCCcee
Q 014352 99 SAPSASGIPRYAYKDIQKATQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGR--LHHRNLV 176 (426)
Q Consensus 99 ~~~~~~~~~~~~~~~l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv 176 (426)
.+.+.+|+|.+-...+.+ +..+.+.||+|.||.||+|.| .|+.||||++.. .+++.+.+|.++.+. |+|+||+
T Consensus 194 tSGSGSGlplLVQRTiar-qI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENIL 268 (513)
T KOG2052|consen 194 TSGSGSGLPLLVQRTIAR-QIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENIL 268 (513)
T ss_pred cCCCCCCchhHhHHhhhh-eeEEEEEecCccccceeeccc-cCCceEEEEecc---cchhhhhhHHHHHHHHHhccchhh
Confidence 344567778765555543 355778999999999999999 566789999865 356677788887765 5999999
Q ss_pred eEEeEEEeCC----eEEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHc-----CCCCCeeecCCCCCC
Q 014352 177 NLIGYCVDKG----KYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHE-----GAVPPVIHRDLKSAN 247 (426)
Q Consensus 177 ~~~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~-----~~~~~ivH~dlk~~N 247 (426)
.+++.-..++ .++||++|.+.|||+++|.. ..++-...++++..+|.||++||. +++|.|.|||||+.|
T Consensus 269 gFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKN 346 (513)
T KOG2052|consen 269 GFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKN 346 (513)
T ss_pred hhhhccccCCCceEEEEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcccccccc
Confidence 9998765442 68999999999999999954 568999999999999999999995 678999999999999
Q ss_pred EEecCCCcEEEeeecCccccccC-----CCcccCccccCccCccccccCC----CC--cchhhHHHHHHHHHHHhC----
Q 014352 248 ILLDHFMRAKVADFGLSKEEVFD-----GRNSGLKGTYGYIDPAYISTNK----FT--MKSDIFSFGVIIFELITA---- 312 (426)
Q Consensus 248 ill~~~~~~kl~Dfgl~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~----~~--~~~Dv~S~Gvvl~el~tg---- 312 (426)
|||..++.+.|+|+|||-..... ...+..+||.+|||||++...- +. ..+||||||.|+||+...
T Consensus 347 ILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~g 426 (513)
T KOG2052|consen 347 ILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESG 426 (513)
T ss_pred EEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcC
Confidence 99999999999999999643322 2345678999999999985432 21 469999999999998864
Q ss_pred ------CCCCCchHHHHH-Hhhccccchhhhhhhhhc-ccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 014352 313 ------IHPHQNLMEYVN-LASMSQDGVDEILDKQLV-GACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQ 383 (426)
Q Consensus 313 ------~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 383 (426)
..||.+..+... ...+..-.-.+-+.+..+ .....+....+.++|+.||..||.-|-|+-.+.+.|.++.+
T Consensus 427 gi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 427 GIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 356544322110 111111111111111111 12234677899999999999999999999999999988764
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=333.97 Aligned_cols=250 Identities=26% Similarity=0.388 Sum_probs=200.6
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc---cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEe
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH---QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEF 194 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 194 (426)
|...+.||+|+||.||++... ++..||+|.+..... .....+.+|+.++.+++|+||+++++++.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 344578999999999999864 788999999865421 2234578899999999999999999999999999999999
Q ss_pred cCCCChhHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCc
Q 014352 195 MSNGSLSNLIYSEE-RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRN 273 (426)
Q Consensus 195 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 273 (426)
+++|+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.........
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETV 158 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCee
Confidence 99999998875433 46899999999999999999999998 999999999999999999999999999764333333
Q ss_pred ccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHH
Q 014352 274 SGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVREL 353 (426)
Q Consensus 274 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 353 (426)
....||..|+|||++.+..++.++|||||||++|||++|+.||............ ...+ .......+...+..+
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~-----~~~~-~~~~~~~~~~~s~~~ 232 (285)
T cd05631 159 RGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEV-----DRRV-KEDQEEYSEKFSEDA 232 (285)
T ss_pred cCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHH-----HHHh-hcccccCCccCCHHH
Confidence 4567899999999999999999999999999999999999999753321110000 0000 000111222345678
Q ss_pred HHHHHHcccCCCCCCCC-----HHHHHHH
Q 014352 354 ARIGHKCLHKTPRKRPS-----IGEVTQA 377 (426)
Q Consensus 354 ~~l~~~cl~~~p~~RPs-----~~evl~~ 377 (426)
.+++.+||+.||.+||+ +++++++
T Consensus 233 ~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 233 KSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred HHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 99999999999999997 7888765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=334.96 Aligned_cols=259 Identities=27% Similarity=0.458 Sum_probs=199.7
Q ss_pred HHHhhhhcccccCCCeeEEEEEeCC-----------------CcEEEEEEeccCCc-cChHHHHHHHHHHhcCCCCceee
Q 014352 116 KATQNFTNILGQGAFGPVYKATMPS-----------------GGVAAIKVLASDSH-QGEKEFQTEVSLLGRLHHRNLVN 177 (426)
Q Consensus 116 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~ 177 (426)
...+.+.+.||+|+||.||++.+.+ +..||+|.+..... ....+|.+|++++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3456677899999999999997532 23699999876532 23457899999999999999999
Q ss_pred EEeEEEeCCeEEEEEEecCCCChhHHhhhcc------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCee
Q 014352 178 LIGYCVDKGKYMLIYEFMSNGSLSNLIYSEE------------------RVLNWEERLQIALDISHGIEYLHEGAVPPVI 239 (426)
Q Consensus 178 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iv 239 (426)
+++++.+.+..++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 9999999999999999999999999885421 24788899999999999999999998 99
Q ss_pred ecCCCCCCEEecCCCcEEEeeecCccccccCC---CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh--CCC
Q 014352 240 HRDLKSANILLDHFMRAKVADFGLSKEEVFDG---RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT--AIH 314 (426)
Q Consensus 240 H~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t--g~~ 314 (426)
||||||+|||++.++.+||+|||+++...... ......++..|+|||++.+..++.++||||||+++|||++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 99999999999999999999999987532221 1123345788999999998899999999999999999987 567
Q ss_pred CCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 014352 315 PHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALL 379 (426)
Q Consensus 315 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 379 (426)
||.............. ..... ........+...+..+.+++.+||+.||++|||+.+|.+.|+
T Consensus 241 p~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 241 PYGELTDEQVIENAGE-FFRDQ-GRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCcCCHHHHHHHHHH-Hhhhc-cccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 7765433221111000 00000 000001112233467999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=340.59 Aligned_cols=245 Identities=25% Similarity=0.380 Sum_probs=206.0
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCcc--ChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEec
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQ--GEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 195 (426)
|.+.+.||+|+||.||||+.+ +.+.||+|.+.+.... ..+.+.+|++++++++|||||.++++|+...++++|.||+
T Consensus 4 yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a 83 (808)
T KOG0597|consen 4 YHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYA 83 (808)
T ss_pred hhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhh
Confidence 445678999999999999865 7789999999765433 2356899999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC-Ccc
Q 014352 196 SNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG-RNS 274 (426)
Q Consensus 196 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-~~~ 274 (426)
.| +|..+|... ..++++.+..++.+++.||.|||+.+ |+|||+||.|||++..+.+|++|||+++-..... ..+
T Consensus 84 ~g-~L~~il~~d-~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vlt 158 (808)
T KOG0597|consen 84 VG-DLFTILEQD-GKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLT 158 (808)
T ss_pred hh-hHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCceeee
Confidence 76 999999554 55999999999999999999999999 9999999999999999999999999998654332 235
Q ss_pred cCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHH
Q 014352 275 GLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELA 354 (426)
Q Consensus 275 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 354 (426)
...||+-|||||...+++|+..+|.||+||++||+++|++||....-..-...+..+. ..++...+..+.
T Consensus 159 sikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~----------v~~p~~~S~~f~ 228 (808)
T KOG0597|consen 159 SIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDP----------VKPPSTASSSFV 228 (808)
T ss_pred eccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCC----------CCCcccccHHHH
Confidence 6789999999999999999999999999999999999999996432222111121111 112335667899
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHH
Q 014352 355 RIGHKCLHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 355 ~l~~~cl~~~p~~RPs~~evl~~L 378 (426)
.++...|.+||..|.|..+++.+-
T Consensus 229 nfl~gLL~kdP~~RltW~~Ll~Hp 252 (808)
T KOG0597|consen 229 NFLQGLLIKDPAQRLTWTDLLGHP 252 (808)
T ss_pred HHHHHHhhcChhhcccHHHHhcCh
Confidence 999999999999999999998764
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=343.83 Aligned_cols=256 Identities=27% Similarity=0.473 Sum_probs=202.2
Q ss_pred HHHHHhhhhcccccCCCeeEEEEEe------CCCcEEEEEEeccCCc-cChHHHHHHHHHHhcC-CCCceeeEEeEEEeC
Q 014352 114 IQKATQNFTNILGQGAFGPVYKATM------PSGGVAAIKVLASDSH-QGEKEFQTEVSLLGRL-HHRNLVNLIGYCVDK 185 (426)
Q Consensus 114 l~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 185 (426)
+....+.+.+.||+|+||.||+|++ .++..||+|+++.... ...+.+.+|+.++..+ +||||++++++|.+.
T Consensus 32 ~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 32 FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred cchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 3344577788999999999999973 2455899999875432 2345688999999999 899999999999999
Q ss_pred CeEEEEEEecCCCChhHHhhhcc---------------------------------------------------------
Q 014352 186 GKYMLIYEFMSNGSLSNLIYSEE--------------------------------------------------------- 208 (426)
Q Consensus 186 ~~~~lv~e~~~~gsL~~~l~~~~--------------------------------------------------------- 208 (426)
+..++||||+++|+|.+++....
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 99999999999999999885421
Q ss_pred -----------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC
Q 014352 209 -----------------RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG 271 (426)
Q Consensus 209 -----------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 271 (426)
..+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 24788899999999999999999998 9999999999999999999999999987543222
Q ss_pred C---cccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCCH
Q 014352 272 R---NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNI 347 (426)
Q Consensus 272 ~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (426)
. .....++..|+|||.+.+..++.++||||||+++|||++ |..||........... .+........+.
T Consensus 269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~--------~~~~~~~~~~~~ 340 (375)
T cd05104 269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYK--------MIKEGYRMLSPE 340 (375)
T ss_pred cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHH--------HHHhCccCCCCC
Confidence 1 112335668999999999999999999999999999998 8889865422211111 111111111111
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 014352 348 QEVRELARIGHKCLHKTPRKRPSIGEVTQALLK 380 (426)
Q Consensus 348 ~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 380 (426)
..+.++.+++.+||+.||++|||+.++++.|++
T Consensus 341 ~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 341 CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 234578999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=343.24 Aligned_cols=258 Identities=25% Similarity=0.481 Sum_probs=203.8
Q ss_pred HHHHHhhhhcccccCCCeeEEEEEeC------CCcEEEEEEeccCCcc-ChHHHHHHHHHHhcC-CCCceeeEEeEEEeC
Q 014352 114 IQKATQNFTNILGQGAFGPVYKATMP------SGGVAAIKVLASDSHQ-GEKEFQTEVSLLGRL-HHRNLVNLIGYCVDK 185 (426)
Q Consensus 114 l~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 185 (426)
+....+.+.+.||+|+||.||+|+.. ++..||+|.+...... ....+.+|+.+++.+ +||||++++++|...
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 44456777889999999999998742 3347999999754322 235688999999999 899999999999999
Q ss_pred CeEEEEEEecCCCChhHHhhhcc---------------------------------------------------------
Q 014352 186 GKYMLIYEFMSNGSLSNLIYSEE--------------------------------------------------------- 208 (426)
Q Consensus 186 ~~~~lv~e~~~~gsL~~~l~~~~--------------------------------------------------------- 208 (426)
+..++||||+++|+|.+++....
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 99999999999999999885421
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCC---c
Q 014352 209 ------------RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGR---N 273 (426)
Q Consensus 209 ------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~---~ 273 (426)
..+++..++.++.|++.||.|||+++ |+||||||+|||+++++.+||+|||+++....... .
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence 24788889999999999999999998 99999999999999999999999999875432211 1
Q ss_pred ccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHH
Q 014352 274 SGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRE 352 (426)
Q Consensus 274 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (426)
....++..|+|||++.+..++.++||||||+++|||++ |+.||.......... ...........+...+.+
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~ 343 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFY--------KMVKRGYQMSRPDFAPPE 343 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHH--------HHHHcccCccCCCCCCHH
Confidence 12335678999999998899999999999999999997 999997543211111 111111111112223467
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 014352 353 LARIGHKCLHKTPRKRPSIGEVTQALLKIK 382 (426)
Q Consensus 353 l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 382 (426)
+.+++.+||+.||++|||+.++++.|+++.
T Consensus 344 l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 344 IYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=331.35 Aligned_cols=246 Identities=30% Similarity=0.573 Sum_probs=194.6
Q ss_pred hhcccccCCCeeEEEEEeC-----CCcEEEEEEeccCCcc-ChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEe
Q 014352 121 FTNILGQGAFGPVYKATMP-----SGGVAAIKVLASDSHQ-GEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEF 194 (426)
Q Consensus 121 ~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 194 (426)
+.+.||.|.||.||+|.+. .+..|+||.+...... ..+.|.+|++.+++++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4568999999999999976 3467999999654322 357899999999999999999999999988889999999
Q ss_pred cCCCChhHHhhhc-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC--
Q 014352 195 MSNGSLSNLIYSE-ERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG-- 271 (426)
Q Consensus 195 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-- 271 (426)
+++|+|.++|... ...+++..++.|+.|++.||.|||+++ ++|+||+++||++++++.+||+|||++.......
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred ccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 9999999999776 567999999999999999999999998 9999999999999999999999999987542211
Q ss_pred -CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHH
Q 014352 272 -RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQE 349 (426)
Q Consensus 272 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (426)
..........|+|||.+.+..++.++||||||+++||+++ |..||.+.........+ ........+...
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~---------~~~~~~~~~~~~ 230 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL---------KQGQRLPIPDNC 230 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH---------HTTEETTSBTTS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---------cccccceeccch
Confidence 1233456789999999999889999999999999999999 78998765333222221 111111122234
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014352 350 VRELARIGHKCLHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 350 ~~~l~~l~~~cl~~~p~~RPs~~evl~~L 378 (426)
+..+.+++.+||+.||++|||+.++++.|
T Consensus 231 ~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 231 PKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp BHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred hHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 56799999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=338.72 Aligned_cols=261 Identities=26% Similarity=0.456 Sum_probs=223.2
Q ss_pred hHHHHHHhhhhcccccCCCeeEEEEEeCC---Cc--EEEEEEeccC-CccChHHHHHHHHHHhcCCCCceeeEEeEEEeC
Q 014352 112 KDIQKATQNFTNILGQGAFGPVYKATMPS---GG--VAAIKVLASD-SHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDK 185 (426)
Q Consensus 112 ~~l~~~~~~~~~~lg~G~~g~Vy~~~~~~---~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 185 (426)
.+|.++...+.++||.|-||.||+|.+.+ |. .||||..+.+ ...+.+.|.+|..+|++++|||||+++|+|.+.
T Consensus 384 yel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~ 463 (974)
T KOG4257|consen 384 YELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ 463 (974)
T ss_pred ceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc
Confidence 35667777788899999999999998743 22 5899998875 344567899999999999999999999999875
Q ss_pred CeEEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcc
Q 014352 186 GKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSK 265 (426)
Q Consensus 186 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 265 (426)
..++|||.++-|.|..+|..+...|+......++.|++.||+|||+.+ +|||||..+|||+.....+|++|||+++
T Consensus 464 -P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR 539 (974)
T KOG4257|consen 464 -PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSR 539 (974)
T ss_pred -ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhh
Confidence 689999999999999999888888999999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCc--ccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhc
Q 014352 266 EEVFDGRN--SGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLV 342 (426)
Q Consensus 266 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (426)
......-. +...-...|||||.+...+++.++|||.|||.+||++. |..||.+..+ ..+...+...-+
T Consensus 540 ~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN---------sDVI~~iEnGeR 610 (974)
T KOG4257|consen 540 YLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN---------SDVIGHIENGER 610 (974)
T ss_pred hccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc---------cceEEEecCCCC
Confidence 76544322 23344678999999999999999999999999999887 9999987433 333333444445
Q ss_pred ccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHh
Q 014352 343 GACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRH 385 (426)
Q Consensus 343 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~ 385 (426)
.++++.++..|+.|+.+||+.+|.+||.+.++...|..+.+++
T Consensus 611 lP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qee 653 (974)
T KOG4257|consen 611 LPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEE 653 (974)
T ss_pred CCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHh
Confidence 6677788899999999999999999999999999999987644
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-44 Score=324.61 Aligned_cols=251 Identities=25% Similarity=0.378 Sum_probs=215.3
Q ss_pred HHHHHHhhhhcccccCCCeeEEEEEe-CCCcEEEEEEeccCCccChHH---HHHHHHHHhcCCCCceeeEEeEEEeCCeE
Q 014352 113 DIQKATQNFTNILGQGAFGPVYKATM-PSGGVAAIKVLASDSHQGEKE---FQTEVSLLGRLHHRNLVNLIGYCVDKGKY 188 (426)
Q Consensus 113 ~l~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~---~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 188 (426)
--.+-+|++.+.||+|.||.|-++.. ..|+.||||.++++...++.+ +.+|+++|..|+||||+.++.+|...+..
T Consensus 49 hnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKI 128 (668)
T KOG0611|consen 49 HNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKI 128 (668)
T ss_pred cchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceE
Confidence 34566788999999999999999985 689999999998876666554 67899999999999999999999999999
Q ss_pred EEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccc
Q 014352 189 MLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEV 268 (426)
Q Consensus 189 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 268 (426)
.+||||..+|.|++++.. .+.|+..+...++.||..|+.|+|.++ ++|||||.+|||+|.|+++||+|||++....
T Consensus 129 vivMEYaS~GeLYDYiSe-r~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 129 VIVMEYASGGELYDYISE-RGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEEEEecCCccHHHHHHH-hccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhc
Confidence 999999999999999954 456999999999999999999999998 9999999999999999999999999999877
Q ss_pred cCCCcccCccccCccCccccccCCCC-cchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCH
Q 014352 269 FDGRNSGLKGTYGYIDPAYISTNKFT-MKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNI 347 (426)
Q Consensus 269 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (426)
......+++|++-|.+||.+.+.+|. +..|-|||||+||-|+.|..||++..-......+..+... . +
T Consensus 205 ~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYr--------E---P 273 (668)
T KOG0611|consen 205 DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYR--------E---P 273 (668)
T ss_pred cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccccc--------C---C
Confidence 77778899999999999999999985 7899999999999999999999874332222222222211 1 1
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014352 348 QEVRELARIGHKCLHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 348 ~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 378 (426)
+.+....-|+.+||..||++|.|+.+|..+-
T Consensus 274 ~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 274 ETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred CCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 2223567888999999999999999998765
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=307.15 Aligned_cols=255 Identities=24% Similarity=0.324 Sum_probs=205.4
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccC--hHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEec
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQG--EKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 195 (426)
|.-.+.||+|.||.||+|+.. +|+.||||+++.....+ .....+|++.|+.++|+||+.++++|...+.+.+|+|||
T Consensus 4 Y~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm 83 (318)
T KOG0659|consen 4 YEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFM 83 (318)
T ss_pred hhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEec
Confidence 444568999999999999864 88999999997653322 346789999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCc-c
Q 014352 196 SNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRN-S 274 (426)
Q Consensus 196 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~-~ 274 (426)
+. +|...++++...++..++..++.++.+|++|||++. |+||||||.|+|++++|.+||+|||+++........ .
T Consensus 84 ~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~ 159 (318)
T KOG0659|consen 84 PT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQT 159 (318)
T ss_pred cc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCCcccc
Confidence 76 999999988889999999999999999999999999 999999999999999999999999999965543332 3
Q ss_pred cCccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccc----cc------h---hhhhhhh
Q 014352 275 GLKGTYGYIDPAYIST-NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQ----DG------V---DEILDKQ 340 (426)
Q Consensus 275 ~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~----~~------~---~~~~~~~ 340 (426)
..+-|..|.|||.+-+ ..|+...|+||.||++.||+.|.+-|.+..+...+..+-. .. + .+...-.
T Consensus 160 ~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~ 239 (318)
T KOG0659|consen 160 HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQ 239 (318)
T ss_pred cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHh
Confidence 3468899999998755 5799999999999999999999888877554433332110 00 0 1111101
Q ss_pred hccc-----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 341 LVGA-----CNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 341 ~~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
.... .-...+.+..+++..+|..||.+|+|+.|++++
T Consensus 240 ~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 240 QFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 0000 112244677999999999999999999999976
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=335.38 Aligned_cols=259 Identities=23% Similarity=0.328 Sum_probs=203.6
Q ss_pred HHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc-cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEe
Q 014352 117 ATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH-QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEF 194 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 194 (426)
..|++.+.||+|+||.||+++.. ++..+|+|.+..... .....+.+|++++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence 34566778999999999999976 677899999875432 2235789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCcc
Q 014352 195 MSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNS 274 (426)
Q Consensus 195 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 274 (426)
+++|+|.+++... ..+++..+..++.|++.||.|||+++ +|+||||||+|||++.++.+||+|||++..... ....
T Consensus 85 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-~~~~ 160 (331)
T cd06649 85 MDGGSLDQVLKEA-KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMAN 160 (331)
T ss_pred CCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccc-cccc
Confidence 9999999998554 45899999999999999999999853 299999999999999999999999999875432 2334
Q ss_pred cCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhcccc-----------------------
Q 014352 275 GLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQD----------------------- 331 (426)
Q Consensus 275 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~----------------------- 331 (426)
...||..|+|||++.+..++.++|||||||++|||++|+.||...............
T Consensus 161 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (331)
T cd06649 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPV 240 (331)
T ss_pred cCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccccc
Confidence 457899999999999999999999999999999999999999653221110000000
Q ss_pred -----------chhhhhhh----hhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 014352 332 -----------GVDEILDK----QLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALL 379 (426)
Q Consensus 332 -----------~~~~~~~~----~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 379 (426)
......+. ............++.+++.+||+.||++|||+.+++++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~ 303 (331)
T cd06649 241 SGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTF 303 (331)
T ss_pred cccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChH
Confidence 00000000 0001111124567999999999999999999999998754
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=337.16 Aligned_cols=240 Identities=24% Similarity=0.335 Sum_probs=197.3
Q ss_pred ccccCCCeeEEEEEeC-CCcEEEEEEeccCCc---cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCCCC
Q 014352 124 ILGQGAFGPVYKATMP-SGGVAAIKVLASDSH---QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGS 199 (426)
Q Consensus 124 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 199 (426)
.||+|+||.||+++.. +++.+|+|++..... .....+..|+.++++++||||+++++++...+..++||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 81 (323)
T cd05571 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCc
Confidence 6999999999999875 788999999875421 223457789999999999999999999999999999999999999
Q ss_pred hhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccccc-CCCcccCcc
Q 014352 200 LSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF-DGRNSGLKG 278 (426)
Q Consensus 200 L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~-~~~~~~~~g 278 (426)
|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.... ........|
T Consensus 82 L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~g 157 (323)
T cd05571 82 LFFHLSRE-RVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG 157 (323)
T ss_pred HHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceec
Confidence 99998644 46899999999999999999999998 99999999999999999999999999875322 222345679
Q ss_pred ccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHHHH
Q 014352 279 TYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGH 358 (426)
Q Consensus 279 t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 358 (426)
|+.|+|||++.+..++.++|||||||++|||++|..||...........+.... ...+......+.+++.
T Consensus 158 t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~----------~~~p~~~~~~~~~li~ 227 (323)
T cd05571 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE----------IRFPRTLSPEAKSLLA 227 (323)
T ss_pred CccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC----------CCCCCCCCHHHHHHHH
Confidence 999999999999999999999999999999999999996533222111111110 0112234467899999
Q ss_pred HcccCCCCCCC-----CHHHHHHH
Q 014352 359 KCLHKTPRKRP-----SIGEVTQA 377 (426)
Q Consensus 359 ~cl~~~p~~RP-----s~~evl~~ 377 (426)
+||+.||++|| ++.+++++
T Consensus 228 ~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 228 GLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred HHccCCHHHcCCCCCCCHHHHHcC
Confidence 99999999999 78888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=320.71 Aligned_cols=248 Identities=29% Similarity=0.458 Sum_probs=203.7
Q ss_pred HhhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCC
Q 014352 118 TQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSN 197 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 197 (426)
.+.+.+.||+|+||.||++.+.++..+|+|.+.... ....++.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (256)
T cd05114 5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN 83 (256)
T ss_pred HcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence 355677899999999999998888889999876433 3456789999999999999999999999999999999999999
Q ss_pred CChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCC--ccc
Q 014352 198 GSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGR--NSG 275 (426)
Q Consensus 198 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~--~~~ 275 (426)
|+|.+++......+++..+..++.+++.||.|||+++ ++|+||||+||+++.++.+||+|||+++....... ...
T Consensus 84 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05114 84 GCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSG 160 (256)
T ss_pred CcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCC
Confidence 9999998765556899999999999999999999998 99999999999999999999999999875432211 122
Q ss_pred CccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHH
Q 014352 276 LKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELA 354 (426)
Q Consensus 276 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 354 (426)
..++..|+|||++.+..++.++||||||+++|||++ |+.||...........+..... ...+...+..+.
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~---------~~~~~~~~~~~~ 231 (256)
T cd05114 161 AKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFR---------LYRPKLASMTVY 231 (256)
T ss_pred CCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC---------CCCCCCCCHHHH
Confidence 345668999999998899999999999999999999 8999976544333222221110 001112335789
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHH
Q 014352 355 RIGHKCLHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 355 ~l~~~cl~~~p~~RPs~~evl~~L 378 (426)
+++.+||+.+|++|||+.++++.|
T Consensus 232 ~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 232 EVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HHHHHHccCCcccCcCHHHHHHhh
Confidence 999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=340.59 Aligned_cols=240 Identities=28% Similarity=0.411 Sum_probs=204.1
Q ss_pred HHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc---cChHHHHHHHHHHhcCC-CCceeeEEeEEEeCCeEEEE
Q 014352 117 ATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH---QGEKEFQTEVSLLGRLH-HRNLVNLIGYCVDKGKYMLI 191 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv 191 (426)
..+.+..+||+|+||+|+++..+ +++.+|||++++... .+.+..+.|.+++...+ ||.+++++.+|...+++|+|
T Consensus 368 ~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fv 447 (694)
T KOG0694|consen 368 DDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFV 447 (694)
T ss_pred cceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEE
Confidence 34567789999999999999976 778999999988743 33467888999987774 99999999999999999999
Q ss_pred EEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccc-cC
Q 014352 192 YEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEV-FD 270 (426)
Q Consensus 192 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~-~~ 270 (426)
|||+.||++..+. ....++...+.-++..|+.||.|||+++ ||+||||.+|||||.+|.+||+|||+++... ..
T Consensus 448 mey~~Ggdm~~~~--~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g 522 (694)
T KOG0694|consen 448 MEYVAGGDLMHHI--HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQG 522 (694)
T ss_pred EEecCCCcEEEEE--ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccccCCCC
Confidence 9999999954443 4456999999999999999999999999 9999999999999999999999999999766 45
Q ss_pred CCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHH
Q 014352 271 GRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEV 350 (426)
Q Consensus 271 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (426)
..+++++||+.|||||++.+..|+...|+|||||+||||+.|..||.+..+......+..+. ..++...+
T Consensus 523 ~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~----------~~yP~~ls 592 (694)
T KOG0694|consen 523 DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDE----------VRYPRFLS 592 (694)
T ss_pred CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC----------CCCCCccc
Confidence 56788999999999999999999999999999999999999999998755544433332221 12344556
Q ss_pred HHHHHHHHHcccCCCCCCCCH
Q 014352 351 RELARIGHKCLHKTPRKRPSI 371 (426)
Q Consensus 351 ~~l~~l~~~cl~~~p~~RPs~ 371 (426)
.+...+++++|.+||++|.-+
T Consensus 593 ~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 593 KEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHHHHHHHHhccCcccccCC
Confidence 789999999999999999654
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=325.62 Aligned_cols=251 Identities=28% Similarity=0.524 Sum_probs=202.9
Q ss_pred HhhhhcccccCCCeeEEEEEeCCC------cEEEEEEeccCCc-cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEE
Q 014352 118 TQNFTNILGQGAFGPVYKATMPSG------GVAAIKVLASDSH-QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYML 190 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~~~------~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 190 (426)
.+.+.+.||+|+||.||+|...+. ..+|+|.+..... .....|.+|+.++.+++||||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 85 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM 85 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence 455678899999999999986432 4789998865432 223568999999999999999999999999889999
Q ss_pred EEEecCCCChhHHhhhcc---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCc
Q 014352 191 IYEFMSNGSLSNLIYSEE---------------RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMR 255 (426)
Q Consensus 191 v~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~ 255 (426)
+|||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.
T Consensus 86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLT 162 (283)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCCc
Confidence 999999999999986431 45788999999999999999999998 999999999999999999
Q ss_pred EEEeeecCccccccCC---CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhcccc
Q 014352 256 AKVADFGLSKEEVFDG---RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQD 331 (426)
Q Consensus 256 ~kl~Dfgl~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~ 331 (426)
++|+|||+++...... ......+++.|+|||.+.+..++.++||||||+++|||++ |..||.+.........
T Consensus 163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~---- 238 (283)
T cd05048 163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM---- 238 (283)
T ss_pred EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH----
Confidence 9999999987432211 1233456788999999998899999999999999999998 9999876433221111
Q ss_pred chhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 014352 332 GVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLK 380 (426)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 380 (426)
+........+...+.++.+++.+||+.||++||++.+|+++|+.
T Consensus 239 -----i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 239 -----IRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred -----HHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11111112233455789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=338.43 Aligned_cols=263 Identities=29% Similarity=0.457 Sum_probs=226.6
Q ss_pred CCCChhHHHHHHhhhhcccccCCCeeEEEEEeCC-CcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeC
Q 014352 107 PRYAYKDIQKATQNFTNILGQGAFGPVYKATMPS-GGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDK 185 (426)
Q Consensus 107 ~~~~~~~l~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 185 (426)
|.....++++......++||-|-||.||.|.|+. .-.||||.++.+. ...++|..|..+|+.++|||+|+++|+|..+
T Consensus 257 Pn~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~E 335 (1157)
T KOG4278|consen 257 PNADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE 335 (1157)
T ss_pred CCcchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccC
Confidence 3344556666666677899999999999999974 4579999998765 3467899999999999999999999999999
Q ss_pred CeEEEEEEecCCCChhHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCc
Q 014352 186 GKYMLIYEFMSNGSLSNLIYSEE-RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLS 264 (426)
Q Consensus 186 ~~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 264 (426)
..+|||+|||.+|+|.++|+..+ .-++...++.++.||+.||+||..++ +|||||..+|+|+.++..+||+|||++
T Consensus 336 pPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLs 412 (1157)
T KOG4278|consen 336 PPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLS 412 (1157)
T ss_pred CCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchh
Confidence 99999999999999999997765 34667778899999999999999999 999999999999999999999999999
Q ss_pred cccccCCC--cccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhh
Q 014352 265 KEEVFDGR--NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQL 341 (426)
Q Consensus 265 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (426)
+....+.- .........|.|||-+....++.|+|||+|||+||||.| |..||.+. ....+-+++...+
T Consensus 413 RlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi---------dlSqVY~LLEkgy 483 (1157)
T KOG4278|consen 413 RLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI---------DLSQVYGLLEKGY 483 (1157)
T ss_pred hhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc---------cHHHHHHHHhccc
Confidence 97543321 223445678999999999999999999999999999998 89998763 2334456677778
Q ss_pred cccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 014352 342 VGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIK 382 (426)
Q Consensus 342 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 382 (426)
+...+..++..+++||..||+.+|.+||++.|+-+.++.+.
T Consensus 484 RM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 484 RMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred cccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 77788888899999999999999999999999999998874
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=320.85 Aligned_cols=254 Identities=27% Similarity=0.448 Sum_probs=208.4
Q ss_pred HHHHHhhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEE
Q 014352 114 IQKATQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYE 193 (426)
Q Consensus 114 l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 193 (426)
+...++++.+.||+|+||.||+|.+.++..||+|.+.... ...+++.+|+.++++++||||+++++++...+..+++||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 3445677888999999999999998777889999987543 345679999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCC
Q 014352 194 FMSNGSLSNLIYSEE-RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGR 272 (426)
Q Consensus 194 ~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 272 (426)
|+++++|.+++.... ..+++..+..++.+++.||.|||+.+ ++||||||+||+++.++.++|+|||+++.......
T Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 82 LMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred cccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 999999999996543 56899999999999999999999998 99999999999999999999999999875432211
Q ss_pred --cccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHH
Q 014352 273 --NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQE 349 (426)
Q Consensus 273 --~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (426)
......+..|+|||++.+..++.++||||||+++|||++ |..||...........+.. ......+...
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~---------~~~~~~~~~~ 229 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQ---------GYRMPCPPGC 229 (261)
T ss_pred cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc---------CCCCCCCCcC
Confidence 112223457999999999999999999999999999999 9999976443322221111 1111122334
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 014352 350 VRELARIGHKCLHKTPRKRPSIGEVTQALLK 380 (426)
Q Consensus 350 ~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 380 (426)
+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 230 ~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 230 PKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 5679999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=331.91 Aligned_cols=257 Identities=26% Similarity=0.394 Sum_probs=204.4
Q ss_pred HHHhhhhcccccCCCeeEEEEEeC-CCc----EEEEEEeccCC-ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEE
Q 014352 116 KATQNFTNILGQGAFGPVYKATMP-SGG----VAAIKVLASDS-HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYM 189 (426)
Q Consensus 116 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 189 (426)
...+...+.||+|+||.||+|++. ++. .||+|.+.... ....+.+.+|+.+++.++||||++++++|... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 344666778999999999999864 333 38999986543 23346788999999999999999999999875 578
Q ss_pred EEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccccc
Q 014352 190 LIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF 269 (426)
Q Consensus 190 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 269 (426)
+++||+++|+|.+++......+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 85 ~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 85 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccccC
Confidence 999999999999999776667899999999999999999999998 99999999999999999999999999985433
Q ss_pred CCCc---ccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccC
Q 014352 270 DGRN---SGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGAC 345 (426)
Q Consensus 270 ~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (426)
.... ....++..|+|||++.+..++.++||||||+++|||++ |..||.+........ .+........
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~---------~~~~~~~~~~ 232 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS---------ILEKGERLPQ 232 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH---------HHhCCCCCCC
Confidence 2221 22334678999999999999999999999999999998 999997643221111 1111111111
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHh
Q 014352 346 NIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRH 385 (426)
Q Consensus 346 ~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~ 385 (426)
+......+.+++.+||+.+|++|||+.+++..|..+....
T Consensus 233 ~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 233 PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 1223457899999999999999999999999999886544
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=333.10 Aligned_cols=240 Identities=25% Similarity=0.358 Sum_probs=196.5
Q ss_pred ccccCCCeeEEEEEeC-CCcEEEEEEeccCCc---cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCCCC
Q 014352 124 ILGQGAFGPVYKATMP-SGGVAAIKVLASDSH---QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGS 199 (426)
Q Consensus 124 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 199 (426)
.||+|+||.||++... ++..||+|++..... .....+.+|+.++++++||||+++++++...+..++||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (323)
T cd05595 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCc
Confidence 6999999999999875 788999999875421 223457789999999999999999999999999999999999999
Q ss_pred hhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC-CCcccCcc
Q 014352 200 LSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD-GRNSGLKG 278 (426)
Q Consensus 200 L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-~~~~~~~g 278 (426)
|..++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..... .......|
T Consensus 82 L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 157 (323)
T cd05595 82 LFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG 157 (323)
T ss_pred HHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccC
Confidence 99888544 46899999999999999999999998 999999999999999999999999998753222 22334679
Q ss_pred ccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHHHH
Q 014352 279 TYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGH 358 (426)
Q Consensus 279 t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 358 (426)
|+.|+|||++.+..++.++|||||||++|||++|..||...........+.... . ..+...+..+.+++.
T Consensus 158 t~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~--------~--~~p~~~~~~~~~li~ 227 (323)
T cd05595 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE--------I--RFPRTLSPEAKSLLA 227 (323)
T ss_pred CcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--------C--CCCCCCCHHHHHHHH
Confidence 999999999999999999999999999999999999996543222111111100 0 111233467889999
Q ss_pred HcccCCCCCCC-----CHHHHHHH
Q 014352 359 KCLHKTPRKRP-----SIGEVTQA 377 (426)
Q Consensus 359 ~cl~~~p~~RP-----s~~evl~~ 377 (426)
+||+.||++|| ++.+++++
T Consensus 228 ~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 228 GLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred HHccCCHHHhCCCCCCCHHHHHcC
Confidence 99999999998 88888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=335.48 Aligned_cols=243 Identities=25% Similarity=0.337 Sum_probs=200.6
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC---ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEe
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS---HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEF 194 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 194 (426)
|.+.+.||+|+||.||+|+.. +++.+|+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 20 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 99 (329)
T PTZ00263 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEF 99 (329)
T ss_pred eEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcC
Confidence 567789999999999999976 67899999986532 12335688999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCcc
Q 014352 195 MSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNS 274 (426)
Q Consensus 195 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 274 (426)
+++|+|.+++... ..+++.....++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.... ...
T Consensus 100 ~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~--~~~ 173 (329)
T PTZ00263 100 VVGGELFTHLRKA-GRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD--RTF 173 (329)
T ss_pred CCCChHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCC--Ccc
Confidence 9999999998654 45888999999999999999999998 99999999999999999999999999975422 223
Q ss_pred cCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHH
Q 014352 275 GLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELA 354 (426)
Q Consensus 275 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 354 (426)
...||+.|+|||++.+..++.++|||||||++|||++|..||.+.........+.... . ..+......+.
T Consensus 174 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~--------~--~~p~~~~~~~~ 243 (329)
T PTZ00263 174 TLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR--------L--KFPNWFDGRAR 243 (329)
T ss_pred eecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC--------c--CCCCCCCHHHH
Confidence 4578999999999999999999999999999999999999997644332222211111 0 01111335688
Q ss_pred HHHHHcccCCCCCCCC-----HHHHHHH
Q 014352 355 RIGHKCLHKTPRKRPS-----IGEVTQA 377 (426)
Q Consensus 355 ~l~~~cl~~~p~~RPs-----~~evl~~ 377 (426)
+++.+||+.||.+||+ +.+++.+
T Consensus 244 ~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 244 DLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred HHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 9999999999999987 6888766
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=331.56 Aligned_cols=259 Identities=22% Similarity=0.325 Sum_probs=202.6
Q ss_pred HHHHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc-cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEE
Q 014352 115 QKATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH-QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIY 192 (426)
Q Consensus 115 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 192 (426)
....|++.+.||.|+||.||++... ++..+|+|.+..... .....+.+|++++++++||||+++++++.+.+..++||
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 3455777889999999999999976 677889998875432 22356889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC
Q 014352 193 EFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEG-AVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG 271 (426)
Q Consensus 193 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 271 (426)
||+++|+|.+++... ..+++.....++.+++.||.|||+. + ++|+||||+|||++.++.+||+|||++..... .
T Consensus 83 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~-~ 157 (333)
T cd06650 83 EHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-S 157 (333)
T ss_pred ecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhh-h
Confidence 999999999998654 4588999999999999999999974 5 99999999999999999999999999875422 2
Q ss_pred CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhcc---cc-----------------
Q 014352 272 RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMS---QD----------------- 331 (426)
Q Consensus 272 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~---~~----------------- 331 (426)
......|+..|+|||++.+..++.++|||||||++|||++|+.||............. ..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (333)
T cd06650 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRP 237 (333)
T ss_pred ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccch
Confidence 2334568999999999999899999999999999999999999997533211110000 00
Q ss_pred ------------chhhhhhhhhcc----cCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014352 332 ------------GVDEILDKQLVG----ACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 332 ------------~~~~~~~~~~~~----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 378 (426)
......+..... ........++.+++.+||+.||++|||+.+++++-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~ 300 (333)
T cd06650 238 LSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHA 300 (333)
T ss_pred hhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCH
Confidence 000000000000 00011345789999999999999999999998763
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=330.14 Aligned_cols=244 Identities=23% Similarity=0.305 Sum_probs=200.4
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc---cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEe
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH---QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEF 194 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 194 (426)
|.+.+.||+|+||.||+|... +++.+|+|++..... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 82 (291)
T cd05612 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEY 82 (291)
T ss_pred ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeC
Confidence 456678999999999999976 688999999864321 2335688999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCcc
Q 014352 195 MSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNS 274 (426)
Q Consensus 195 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 274 (426)
+++|+|.+++... +.+++.....++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.... ...
T Consensus 83 ~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~--~~~ 156 (291)
T cd05612 83 VPGGELFSYLRNS-GRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD--RTW 156 (291)
T ss_pred CCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccC--Ccc
Confidence 9999999998654 45899999999999999999999998 99999999999999999999999999875432 223
Q ss_pred cCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHH
Q 014352 275 GLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELA 354 (426)
Q Consensus 275 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 354 (426)
...||+.|+|||++.+..++.++|||||||++|||++|..||...........+... .. ..+......+.
T Consensus 157 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~--------~~--~~~~~~~~~~~ 226 (291)
T cd05612 157 TLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG--------KL--EFPRHLDLYAK 226 (291)
T ss_pred cccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------Cc--CCCccCCHHHH
Confidence 456899999999999999999999999999999999999999764332221111111 00 11122345788
Q ss_pred HHHHHcccCCCCCCCC-----HHHHHHHH
Q 014352 355 RIGHKCLHKTPRKRPS-----IGEVTQAL 378 (426)
Q Consensus 355 ~l~~~cl~~~p~~RPs-----~~evl~~L 378 (426)
+++.+||+.||.+||+ +.+++++-
T Consensus 227 ~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 255 (291)
T cd05612 227 DLIKKLLVVDRTRRLGNMKNGADDVKNHR 255 (291)
T ss_pred HHHHHHcCCCHHHccCCccCCHHHHhcCc
Confidence 9999999999999995 88888663
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=308.33 Aligned_cols=261 Identities=22% Similarity=0.336 Sum_probs=213.5
Q ss_pred HHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccC--CccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEE
Q 014352 117 ATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASD--SHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYE 193 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 193 (426)
..|++.+.||+|.|+.||++... +|+.+|+|++... ...+.+++.+|+++.+.|+|||||++...+.+....|+|+|
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe 90 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 90 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence 34566778999999999999764 7888888887543 22355788999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecC---CCcEEEeeecCccccccC
Q 014352 194 FMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDH---FMRAKVADFGLSKEEVFD 270 (426)
Q Consensus 194 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfgl~~~~~~~ 270 (426)
+|.|++|..-+-.. -..++......+.||+++|.|+|.++ |||||+||+|+|+.+ ..-+||+|||++......
T Consensus 91 ~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g 166 (355)
T KOG0033|consen 91 LVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG 166 (355)
T ss_pred cccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEeCCc
Confidence 99999998766443 44677788889999999999999999 999999999999964 345899999999987755
Q ss_pred CCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHH
Q 014352 271 GRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEV 350 (426)
Q Consensus 271 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (426)
....+..|||+|||||+++..+|+..+|||+.||+||-|+.|.+||.+..+......+.... -.+.+.......
T Consensus 167 ~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~------yd~~~~~w~~is 240 (355)
T KOG0033|consen 167 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGA------YDYPSPEWDTVT 240 (355)
T ss_pred cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccc------cCCCCcccCcCC
Confidence 55567889999999999999999999999999999999999999998743333222222211 112233344556
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHhhh
Q 014352 351 RELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRHLA 387 (426)
Q Consensus 351 ~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~~ 387 (426)
++..+|+.+||..||.+|.|+.|.+++-.-..++..+
T Consensus 241 ~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~~~A 277 (355)
T KOG0033|consen 241 PEAKSLIRRMLTVNPKKRITADEALKHPWICNRERVA 277 (355)
T ss_pred HHHHHHHHHHhccChhhhccHHHHhCCchhcchHHHH
Confidence 7889999999999999999999999887766665555
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=320.47 Aligned_cols=253 Identities=26% Similarity=0.446 Sum_probs=204.9
Q ss_pred HHhhhhcccccCCCeeEEEEEeCC----CcEEEEEEeccCCcc-ChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEE
Q 014352 117 ATQNFTNILGQGAFGPVYKATMPS----GGVAAIKVLASDSHQ-GEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLI 191 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 191 (426)
..+.+.+.||+|+||.||+|.+.. ...||+|.+...... ....|..|+.++++++||||+++++++...+..+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 345677899999999999998742 347899988754322 335788999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC-
Q 014352 192 YEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD- 270 (426)
Q Consensus 192 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~- 270 (426)
|||+++++|.+++......+++..++.++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||+++.....
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 9999999999999776667999999999999999999999988 999999999999999999999999999854311
Q ss_pred CC--cccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCCH
Q 014352 271 GR--NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNI 347 (426)
Q Consensus 271 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (426)
.. .....++..|+|||.+.+..++.++||||||+++||+++ |..||...........+.. ......+.
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~---------~~~~~~~~ 231 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVED---------GYRLPPPM 231 (266)
T ss_pred cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHc---------CCCCCCCC
Confidence 11 112334678999999999999999999999999999998 9999865332221111111 11111122
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 014352 348 QEVRELARIGHKCLHKTPRKRPSIGEVTQALLKI 381 (426)
Q Consensus 348 ~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 381 (426)
..+..+.+++.+||+.+|++||++.+++++|+.+
T Consensus 232 ~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 232 DCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 3456789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=337.98 Aligned_cols=256 Identities=25% Similarity=0.427 Sum_probs=202.6
Q ss_pred HHHhhhhcccccCCCeeEEEEEeC------CCcEEEEEEeccCCcc-ChHHHHHHHHHHhcCC-CCceeeEEeEEEeCCe
Q 014352 116 KATQNFTNILGQGAFGPVYKATMP------SGGVAAIKVLASDSHQ-GEKEFQTEVSLLGRLH-HRNLVNLIGYCVDKGK 187 (426)
Q Consensus 116 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~ 187 (426)
...+.+.+.||+|+||.||+|+.. .+..||+|++...... ..+.+.+|+++++++. ||||++++++|.+.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 334667789999999999999853 1236999999754332 2357899999999996 9999999999999999
Q ss_pred EEEEEEecCCCChhHHhhhcc-----------------------------------------------------------
Q 014352 188 YMLIYEFMSNGSLSNLIYSEE----------------------------------------------------------- 208 (426)
Q Consensus 188 ~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------- 208 (426)
.++||||+++|+|.+++....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 999999999999999885421
Q ss_pred ------------------------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecC
Q 014352 209 ------------------------------------RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDH 252 (426)
Q Consensus 209 ------------------------------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~ 252 (426)
..+++..+..++.|++.||.|||+.+ |+||||||+|||++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence 24788888999999999999999998 999999999999999
Q ss_pred CCcEEEeeecCccccccCCC---cccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhc
Q 014352 253 FMRAKVADFGLSKEEVFDGR---NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASM 328 (426)
Q Consensus 253 ~~~~kl~Dfgl~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~ 328 (426)
++.+||+|||+++....... .....++..|+|||.+.+..++.++||||||+++|||++ |..||..........
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~-- 350 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY-- 350 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH--
Confidence 99999999999875432211 123346788999999999999999999999999999997 999986532211111
Q ss_pred cccchhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 014352 329 SQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIK 382 (426)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 382 (426)
..+........+...+..+.+++.+||+.||++|||+.++.+.|+++.
T Consensus 351 ------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 351 ------NKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred ------HHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 011111111122234567999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=332.69 Aligned_cols=240 Identities=25% Similarity=0.361 Sum_probs=197.2
Q ss_pred ccccCCCeeEEEEEeC-CCcEEEEEEeccCCc---cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCCCC
Q 014352 124 ILGQGAFGPVYKATMP-SGGVAAIKVLASDSH---QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGS 199 (426)
Q Consensus 124 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 199 (426)
.||+|+||.||++... ++..+|+|++..... .....+.+|+.+++.++||||+++++++...+..++||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~ 81 (328)
T cd05593 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGE 81 (328)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCC
Confidence 6999999999999875 788999999875421 223467889999999999999999999999999999999999999
Q ss_pred hhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccccc-CCCcccCcc
Q 014352 200 LSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF-DGRNSGLKG 278 (426)
Q Consensus 200 L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~-~~~~~~~~g 278 (426)
|..++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.... ........|
T Consensus 82 L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~g 157 (328)
T cd05593 82 LFFHLSRE-RVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCG 157 (328)
T ss_pred HHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccC
Confidence 99888544 46899999999999999999999998 99999999999999999999999999875322 222334679
Q ss_pred ccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHHHH
Q 014352 279 TYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGH 358 (426)
Q Consensus 279 t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 358 (426)
|+.|+|||++.+..++.++|||||||++|||++|..||...........+.... . ..+......+.+++.
T Consensus 158 t~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~------~----~~p~~~~~~~~~li~ 227 (328)
T cd05593 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED------I----KFPRTLSADAKSLLS 227 (328)
T ss_pred CcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCC------c----cCCCCCCHHHHHHHH
Confidence 999999999999999999999999999999999999997543222111111100 0 111223467889999
Q ss_pred HcccCCCCCCC-----CHHHHHHH
Q 014352 359 KCLHKTPRKRP-----SIGEVTQA 377 (426)
Q Consensus 359 ~cl~~~p~~RP-----s~~evl~~ 377 (426)
+||+.||++|| ++.+++++
T Consensus 228 ~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 228 GLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred HHcCCCHHHcCCCCCCCHHHHhcC
Confidence 99999999997 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=330.84 Aligned_cols=239 Identities=23% Similarity=0.319 Sum_probs=194.3
Q ss_pred cccCCCeeEEEEEeC-CCcEEEEEEeccCC---ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCCCCh
Q 014352 125 LGQGAFGPVYKATMP-SGGVAAIKVLASDS---HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSL 200 (426)
Q Consensus 125 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 200 (426)
||+|+||.||++... ++..+|+|.+.... ......+..|+.++++++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999975 67889999986432 22335678899999999999999999999999999999999999999
Q ss_pred hHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC-CCcccCccc
Q 014352 201 SNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD-GRNSGLKGT 279 (426)
Q Consensus 201 ~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-~~~~~~~gt 279 (426)
.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..... .......||
T Consensus 81 ~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 156 (312)
T cd05585 81 FHHLQRE-GRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGT 156 (312)
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCC
Confidence 9998654 45899999999999999999999998 999999999999999999999999998753222 223345799
Q ss_pred cCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHHHHH
Q 014352 280 YGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHK 359 (426)
Q Consensus 280 ~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 359 (426)
+.|+|||++.+..++.++|||||||++|||++|..||...........+.. .. ...+......+.+++.+
T Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~--------~~--~~~~~~~~~~~~~li~~ 226 (312)
T cd05585 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQ--------EP--LRFPDGFDRDAKDLLIG 226 (312)
T ss_pred cccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHc--------CC--CCCCCcCCHHHHHHHHH
Confidence 999999999999999999999999999999999999975332221111111 00 01122344678899999
Q ss_pred cccCCCCCCCC---HHHHHHH
Q 014352 360 CLHKTPRKRPS---IGEVTQA 377 (426)
Q Consensus 360 cl~~~p~~RPs---~~evl~~ 377 (426)
||+.||++||+ +.+++.+
T Consensus 227 ~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 227 LLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred HcCCCHHHcCCCCCHHHHHcC
Confidence 99999999985 5666554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=319.00 Aligned_cols=249 Identities=28% Similarity=0.428 Sum_probs=203.2
Q ss_pred HhhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCC
Q 014352 118 TQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSN 197 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 197 (426)
.+.+.+.||+|+||.||+|.+.++..+|+|.+.... .....+.+|+.++++++||||+++++++.+.+..+++|||+++
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 356778899999999999998777779999887543 3456799999999999999999999999988889999999999
Q ss_pred CChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCC--ccc
Q 014352 198 GSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGR--NSG 275 (426)
Q Consensus 198 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~--~~~ 275 (426)
|+|.+++......+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||.++....... ...
T Consensus 84 ~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05113 84 GCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVG 160 (256)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceeecCC
Confidence 9999999765557899999999999999999999998 99999999999999999999999999875432221 112
Q ss_pred CccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHH
Q 014352 276 LKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELA 354 (426)
Q Consensus 276 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 354 (426)
..++..|+|||.+.+..++.++||||||+++|||++ |..||................ ....+...+..+.
T Consensus 161 ~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~ 231 (256)
T cd05113 161 SKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGL---------RLYRPHLASEKVY 231 (256)
T ss_pred CccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCC---------CCCCCCCCCHHHH
Confidence 335678999999998889999999999999999998 999987543322111111110 0111112346799
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHHH
Q 014352 355 RIGHKCLHKTPRKRPSIGEVTQALL 379 (426)
Q Consensus 355 ~l~~~cl~~~p~~RPs~~evl~~L~ 379 (426)
+++.+||+.+|.+||++.++++.|+
T Consensus 232 ~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 232 AIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred HHHHHHcCCCcccCCCHHHHHHhhC
Confidence 9999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=319.35 Aligned_cols=252 Identities=31% Similarity=0.475 Sum_probs=209.1
Q ss_pred HHhhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecC
Q 014352 117 ATQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMS 196 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 196 (426)
..|.+.+.||.|+||.||+|...++..+++|.+..........+..|+.+++.++||||+++++++.+.+..++||||++
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 85 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELME 85 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecc
Confidence 34667789999999999999988888999999887655456688999999999999999999999999999999999999
Q ss_pred CCChhHHhhhc-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCC-cc
Q 014352 197 NGSLSNLIYSE-ERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGR-NS 274 (426)
Q Consensus 197 ~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~-~~ 274 (426)
+++|.+++... +..+++..+..++.+++.||.|||+++ ++|+||||+||+++.++.+||+|||++........ ..
T Consensus 86 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~ 162 (261)
T cd05148 86 KGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSS 162 (261)
T ss_pred cCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcccccc
Confidence 99999999653 356899999999999999999999998 99999999999999999999999999875432211 12
Q ss_pred cCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHH
Q 014352 275 GLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVREL 353 (426)
Q Consensus 275 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 353 (426)
...++..|+|||.+....++.++||||||+++|+|++ |..||...........+ ........+...+..+
T Consensus 163 ~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~ 233 (261)
T cd05148 163 DKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI---------TAGYRMPCPAKCPQEI 233 (261)
T ss_pred CCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH---------HhCCcCCCCCCCCHHH
Confidence 3345678999999998899999999999999999998 89999754322221111 1111112233445678
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHHHH
Q 014352 354 ARIGHKCLHKTPRKRPSIGEVTQALLK 380 (426)
Q Consensus 354 ~~l~~~cl~~~p~~RPs~~evl~~L~~ 380 (426)
.+++.+||+.||++|||+.++++.|+.
T Consensus 234 ~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 234 YKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred HHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=334.69 Aligned_cols=251 Identities=22% Similarity=0.339 Sum_probs=202.8
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc---cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEe
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH---QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEF 194 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 194 (426)
|.+.+.||+|+||.||+|+.. +++.||+|++..... .....+..|+.++.+++||||+++++++.+.+..++||||
T Consensus 3 y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 82 (333)
T cd05600 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEY 82 (333)
T ss_pred cEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeC
Confidence 456788999999999999976 678999999875421 2235688899999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCcc
Q 014352 195 MSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNS 274 (426)
Q Consensus 195 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 274 (426)
+++|+|.+++... ..+++.....++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++..... ...
T Consensus 83 ~~g~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--~~~ 156 (333)
T cd05600 83 VPGGDFRTLLNNL-GVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--YAN 156 (333)
T ss_pred CCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc--ccC
Confidence 9999999999544 45899999999999999999999998 99999999999999999999999999975432 334
Q ss_pred cCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHH
Q 014352 275 GLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELA 354 (426)
Q Consensus 275 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 354 (426)
...||+.|+|||++.+..++.++|||||||++|||++|..||...........+.... ..+............+.++.
T Consensus 157 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~~s~~~~ 234 (333)
T cd05600 157 SVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWK--ETLQRPVYDDPRFNLSDEAW 234 (333)
T ss_pred CcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcc--ccccCCCCCccccccCHHHH
Confidence 5679999999999999999999999999999999999999997643322211111000 00000000000113356789
Q ss_pred HHHHHcccCCCCCCCCHHHHHHH
Q 014352 355 RIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 355 ~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
+++.+||..+|.+||++.+++++
T Consensus 235 ~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 235 DLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred HHHHHHhhChhhhcCCHHHHHhC
Confidence 99999999999999999999977
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=319.67 Aligned_cols=252 Identities=25% Similarity=0.431 Sum_probs=205.7
Q ss_pred HHHhhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEec
Q 014352 116 KATQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 116 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 195 (426)
...+.+.+.||+|+||.||+|...++..+|+|.+.... ...+.+.+|+.++++++|+||+++++++.+.+..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 44566778999999999999998888889999876543 23568899999999999999999999999999999999999
Q ss_pred CCCChhHHhhhc-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC--C
Q 014352 196 SNGSLSNLIYSE-ERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG--R 272 (426)
Q Consensus 196 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~--~ 272 (426)
++++|.+++... ...+++..++.++.+++.||+|||+.+ ++||||||+||+++.++.++|+|||++....... .
T Consensus 84 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05072 84 AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA 160 (261)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCceec
Confidence 999999998654 356899999999999999999999988 9999999999999999999999999997543221 1
Q ss_pred cccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHH
Q 014352 273 NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVR 351 (426)
Q Consensus 273 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (426)
.....++..|+|||++.+..++.++||||||+++|+|++ |..||...........+... .........+.
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~---------~~~~~~~~~~~ 231 (261)
T cd05072 161 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG---------YRMPRMENCPD 231 (261)
T ss_pred cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcC---------CCCCCCCCCCH
Confidence 122345678999999998899999999999999999998 99999654332222111111 11111122346
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 014352 352 ELARIGHKCLHKTPRKRPSIGEVTQALLK 380 (426)
Q Consensus 352 ~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 380 (426)
.+.+++.+||..+|++|||+.++.+.|+.
T Consensus 232 ~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 232 ELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 78999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=322.74 Aligned_cols=252 Identities=27% Similarity=0.472 Sum_probs=204.6
Q ss_pred HHHhhhhcccccCCCeeEEEEEeCC------CcEEEEEEeccCCcc-ChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeE
Q 014352 116 KATQNFTNILGQGAFGPVYKATMPS------GGVAAIKVLASDSHQ-GEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKY 188 (426)
Q Consensus 116 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 188 (426)
..++.+.+.||+|+||.||+|...+ +..+|+|.+...... ..+.+.+|++++++++||||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 4557778899999999999998633 468999998765433 346899999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHhhhcc-------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCc
Q 014352 189 MLIYEFMSNGSLSNLIYSEE-------------RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMR 255 (426)
Q Consensus 189 ~lv~e~~~~gsL~~~l~~~~-------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~ 255 (426)
++||||+++++|.+++...+ ..+++..+..++.|++.||.|||+++ ++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 99999999999999996432 34788899999999999999999998 999999999999999999
Q ss_pred EEEeeecCccccccCC---CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhcccc
Q 014352 256 AKVADFGLSKEEVFDG---RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQD 331 (426)
Q Consensus 256 ~kl~Dfgl~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~ 331 (426)
+||+|||+++...... ......++..|+|||++.+..++.++||||||+++|||++ |..||...........+..
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~- 239 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQ- 239 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-
Confidence 9999999987432211 1223345788999999999999999999999999999998 9999865433222221111
Q ss_pred chhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 014352 332 GVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALL 379 (426)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 379 (426)
......+...+..+.+++.+||+.||++||++.|+++.|+
T Consensus 240 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 240 --------GRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred --------CCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 1111112234467999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=346.75 Aligned_cols=257 Identities=25% Similarity=0.388 Sum_probs=214.7
Q ss_pred hhhhcccccCCCeeEEEEEeCCC-cEEEEEEeccCCccChHHHHHHHHHHhcCC-CCceeeEEe-EEEeC------CeEE
Q 014352 119 QNFTNILGQGAFGPVYKATMPSG-GVAAIKVLASDSHQGEKEFQTEVSLLGRLH-HRNLVNLIG-YCVDK------GKYM 189 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~-~~~~~------~~~~ 189 (426)
..+.+.|.+|||+.||.+....+ ..+|+|++........+.+.+|+.+|++|+ |+|||.+++ ..... -+++
T Consensus 39 v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Evl 118 (738)
T KOG1989|consen 39 VTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVL 118 (738)
T ss_pred EEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEE
Confidence 45667899999999999998755 899999987766666778999999999997 999999999 33221 3679
Q ss_pred EEEEecCCCChhHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccc
Q 014352 190 LIYEFMSNGSLSNLIYSEE-RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEV 268 (426)
Q Consensus 190 lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 268 (426)
|.||||.||+|-+++...- ..|++.++++|+.++++|+++||... +||||||||-+||||+.+++.||||||.+....
T Consensus 119 lLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~ 197 (738)
T KOG1989|consen 119 LLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSATTKI 197 (738)
T ss_pred eehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCccccccccc
Confidence 9999999999999996432 44999999999999999999999987 889999999999999999999999999886432
Q ss_pred cCCCc----------ccCccccCccCcccc---ccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhh
Q 014352 269 FDGRN----------SGLKGTYGYIDPAYI---STNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDE 335 (426)
Q Consensus 269 ~~~~~----------~~~~gt~~y~aPE~~---~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 335 (426)
..... -....|+.|+|||++ .+.++++|+|||+|||+||-|+....||.. .+...
T Consensus 198 ~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~------------sg~la 265 (738)
T KOG1989|consen 198 LSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEE------------SGKLA 265 (738)
T ss_pred CCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCc------------Cccee
Confidence 22211 123478999999987 677899999999999999999999999975 22334
Q ss_pred hhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHhhhc
Q 014352 336 ILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRHLAK 388 (426)
Q Consensus 336 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~ 388 (426)
+++..+.-+..+.++..|.+||..||+.||++||++.+++..+.++.......
T Consensus 266 Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~ 318 (738)
T KOG1989|consen 266 ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPI 318 (738)
T ss_pred EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCc
Confidence 55555555555678899999999999999999999999999999998765543
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=322.86 Aligned_cols=255 Identities=20% Similarity=0.266 Sum_probs=198.6
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc-cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecC
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH-QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMS 196 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 196 (426)
|.+.+.||.|+||.||+|... ++..||+|.+..... .....+.+|+.++++++||||+++++++...+..++||||++
T Consensus 7 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 86 (288)
T cd07871 7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD 86 (288)
T ss_pred ceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC
Confidence 556778999999999999875 778999999875432 233467899999999999999999999999999999999997
Q ss_pred CCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC-CCccc
Q 014352 197 NGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD-GRNSG 275 (426)
Q Consensus 197 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-~~~~~ 275 (426)
+ +|.+++...+..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..... .....
T Consensus 87 ~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~~ 162 (288)
T cd07871 87 S-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSN 162 (288)
T ss_pred c-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCccccC
Confidence 5 999988766666899999999999999999999998 999999999999999999999999998753322 22234
Q ss_pred CccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhcc---ccch----hh---------hhh
Q 014352 276 LKGTYGYIDPAYIST-NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMS---QDGV----DE---------ILD 338 (426)
Q Consensus 276 ~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~---~~~~----~~---------~~~ 338 (426)
..+++.|+|||.+.+ ..++.++|||||||++|||++|..||........+..+. .... .. ...
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (288)
T cd07871 163 EVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLF 242 (288)
T ss_pred ceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhcccc
Confidence 568999999998865 568999999999999999999999997643222111110 0000 00 000
Q ss_pred hhhcccC----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 339 KQLVGAC----NIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 339 ~~~~~~~----~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
+...... ......++.+++.+||+.||.+|||+.|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 243 PQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred CccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000 01123568899999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=315.68 Aligned_cols=245 Identities=25% Similarity=0.441 Sum_probs=198.3
Q ss_pred cccccCCCeeEEEEEeC-CCcEEEEEEeccCCc-cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCCCCh
Q 014352 123 NILGQGAFGPVYKATMP-SGGVAAIKVLASDSH-QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSL 200 (426)
Q Consensus 123 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 200 (426)
+.||+|+||.||+|+.. +++.+|+|.+..... .....+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36999999999999875 788899998765432 2345789999999999999999999999999999999999999999
Q ss_pred hHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCc---ccCc
Q 014352 201 SNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRN---SGLK 277 (426)
Q Consensus 201 ~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~---~~~~ 277 (426)
.+++......+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++......... ....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 9999765566899999999999999999999998 999999999999999999999999998743221111 1112
Q ss_pred cccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHH
Q 014352 278 GTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARI 356 (426)
Q Consensus 278 gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 356 (426)
.+..|+|||.+.+..++.++||||||+++||+++ |..||........... +........+...+..+.++
T Consensus 158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~l 228 (252)
T cd05084 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREA---------IEQGVRLPCPELCPDAVYRL 228 (252)
T ss_pred CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHH---------HHcCCCCCCcccCCHHHHHH
Confidence 3457999999999999999999999999999998 8888865433221111 11111112223345679999
Q ss_pred HHHcccCCCCCCCCHHHHHHHHH
Q 014352 357 GHKCLHKTPRKRPSIGEVTQALL 379 (426)
Q Consensus 357 ~~~cl~~~p~~RPs~~evl~~L~ 379 (426)
+.+||+.+|++|||+.++++.|.
T Consensus 229 i~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 229 MERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHcCCChhhCcCHHHHHHHHh
Confidence 99999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=318.23 Aligned_cols=252 Identities=29% Similarity=0.457 Sum_probs=204.0
Q ss_pred HHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEec
Q 014352 117 ATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 195 (426)
..+.+.+.||+|+||.||+|.+. ++..+|+|.+.... .....+.+|++++++++||||+++++++...+..+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 34556778999999999999875 57789999987543 33567899999999999999999999999999999999999
Q ss_pred CCCChhHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCc-
Q 014352 196 SNGSLSNLIYSEE-RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRN- 273 (426)
Q Consensus 196 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~- 273 (426)
++++|.+++.... ..+++..++.++.|++.||+|||+++ ++||||||+||++++++.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~ 161 (263)
T cd05052 85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 161 (263)
T ss_pred CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence 9999999986543 45899999999999999999999998 999999999999999999999999998754322111
Q ss_pred -ccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHH
Q 014352 274 -SGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVR 351 (426)
Q Consensus 274 -~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (426)
....++..|+|||.+.+..++.++||||||+++|||++ |..||............ ........+...+.
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~---------~~~~~~~~~~~~~~ 232 (263)
T cd05052 162 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL---------EKGYRMERPEGCPP 232 (263)
T ss_pred cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH---------HCCCCCCCCCCCCH
Confidence 12234568999999999999999999999999999998 89998653222111111 11111112223446
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 014352 352 ELARIGHKCLHKTPRKRPSIGEVTQALLKI 381 (426)
Q Consensus 352 ~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 381 (426)
.+.+++.+||+.||++|||+.++++.|+.+
T Consensus 233 ~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 233 KVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 799999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=344.63 Aligned_cols=247 Identities=23% Similarity=0.297 Sum_probs=201.0
Q ss_pred hhhhcccccCCCeeEEEEEeC-C-CcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecC
Q 014352 119 QNFTNILGQGAFGPVYKATMP-S-GGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMS 196 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 196 (426)
|.+.+.||+|+||.||+|... + +..||+|.+..........+..|+.+++.++||||+++++++...+..++||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 667789999999999999864 3 56788887755444444567889999999999999999999999999999999999
Q ss_pred CCChhHHhhhc---cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC--
Q 014352 197 NGSLSNLIYSE---ERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG-- 271 (426)
Q Consensus 197 ~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-- 271 (426)
+|+|.+++... ..++++.....++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 99999988542 346889999999999999999999998 9999999999999999999999999997543221
Q ss_pred -CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHH
Q 014352 272 -RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEV 350 (426)
Q Consensus 272 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (426)
......||+.|+|||++.+..++.++|||||||++|||++|..||........+..+... .. ...+...+
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~--------~~-~~~~~~~s 296 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYG--------KY-DPFPCPVS 296 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------CC-CCCCccCC
Confidence 133456999999999999999999999999999999999999999764332211111111 00 01122344
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 351 RELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 351 ~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
..+.+++.+||+.||++||++.+++.+
T Consensus 297 ~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 297 SGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 679999999999999999999998764
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=320.01 Aligned_cols=252 Identities=25% Similarity=0.372 Sum_probs=199.0
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCc----EEEEEEeccCCcc-ChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEE
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGG----VAAIKVLASDSHQ-GEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIY 192 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 192 (426)
+.+.+.||+|+||+||+|.+. ++. .+++|.+...... ...++..|+..+++++||||+++++++.. ...++++
T Consensus 9 ~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~ 87 (279)
T cd05111 9 LRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVT 87 (279)
T ss_pred ceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEE
Confidence 445678999999999999874 344 3677777543222 23567788889999999999999998864 4578899
Q ss_pred EecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC-
Q 014352 193 EFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG- 271 (426)
Q Consensus 193 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~- 271 (426)
||+++|+|.+++......+++..+..++.|++.||.|||+++ ++||||||+||++++++.+||+|||+++......
T Consensus 88 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T cd05111 88 QLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDK 164 (279)
T ss_pred EeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccCCCc
Confidence 999999999999776777999999999999999999999988 9999999999999999999999999997543221
Q ss_pred --CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHH
Q 014352 272 --RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQ 348 (426)
Q Consensus 272 --~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (426)
......++..|+|||++.+..++.++||||||+++||+++ |..||......... ..+........+..
T Consensus 165 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~---------~~~~~~~~~~~~~~ 235 (279)
T cd05111 165 KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVP---------DLLEKGERLAQPQI 235 (279)
T ss_pred ccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH---------HHHHCCCcCCCCCC
Confidence 1223456778999999998899999999999999999998 99999764322111 11111111111111
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 014352 349 EVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQ 383 (426)
Q Consensus 349 ~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 383 (426)
....+.+++.+||..||++|||+.++++.|..+.+
T Consensus 236 ~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 236 CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 23567889999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=322.49 Aligned_cols=255 Identities=26% Similarity=0.380 Sum_probs=205.0
Q ss_pred HHHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc--------------cChHHHHHHHHHHhcCCCCceeeEEe
Q 014352 116 KATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH--------------QGEKEFQTEVSLLGRLHHRNLVNLIG 180 (426)
Q Consensus 116 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------------~~~~~~~~e~~~l~~l~h~niv~~~~ 180 (426)
-.+|.+...||+|.||.|-+|... ++..||||++.+... ...+...+|+.+|++++|||||+++.
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 345777788999999999999975 788999999854321 11246889999999999999999999
Q ss_pred EEEeC--CeEEEEEEecCCCChhHHhhhccCC-CCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEE
Q 014352 181 YCVDK--GKYMLIYEFMSNGSLSNLIYSEERV-LNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAK 257 (426)
Q Consensus 181 ~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~-l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 257 (426)
+..+. +.+|||+|||..|.+...= ..++ ++..+...++.++..||+|||.++ |+||||||+|+||+++|++|
T Consensus 176 vLDDP~s~~~YlVley~s~G~v~w~p--~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~VK 250 (576)
T KOG0585|consen 176 VLDDPESDKLYLVLEYCSKGEVKWCP--PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGTVK 250 (576)
T ss_pred eecCcccCceEEEEEeccCCccccCC--CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCcEE
Confidence 98875 6799999999998876542 3345 899999999999999999999999 99999999999999999999
Q ss_pred EeeecCccccc------cCCCcccCccccCccCccccccCC----CCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhh
Q 014352 258 VADFGLSKEEV------FDGRNSGLKGTYGYIDPAYISTNK----FTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLAS 327 (426)
Q Consensus 258 l~Dfgl~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~ 327 (426)
|+|||.+.... .+.......||+.|+|||...++. .+.+.||||+||+||.|+.|+.||-+.........
T Consensus 251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~K 330 (576)
T KOG0585|consen 251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDK 330 (576)
T ss_pred eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHH
Confidence 99999987431 112223478999999999987633 34688999999999999999999987555444333
Q ss_pred ccccchhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 014352 328 MSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQ 383 (426)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 383 (426)
+ +...+.-+..++....+.+|++++|.+||+.|.+..+|..+......
T Consensus 331 I--------vn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 331 I--------VNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred H--------hcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 3 22222222333456789999999999999999999999988765543
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=320.83 Aligned_cols=257 Identities=27% Similarity=0.464 Sum_probs=207.1
Q ss_pred HHHhhhhcccccCCCeeEEEEEeC------CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEE
Q 014352 116 KATQNFTNILGQGAFGPVYKATMP------SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYM 189 (426)
Q Consensus 116 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 189 (426)
+..+.+.+.||+|+||.||++... ++..+|+|.+..........+.+|+.++++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 344567789999999999999742 34568999887655444567999999999999999999999999999999
Q ss_pred EEEEecCCCChhHHhhhcc------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEE
Q 014352 190 LIYEFMSNGSLSNLIYSEE------------RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAK 257 (426)
Q Consensus 190 lv~e~~~~gsL~~~l~~~~------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 257 (426)
+||||+++++|.+++.... ..+++..++.++.|++.||+|||+++ ++||||||+||++++++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence 9999999999999986432 24899999999999999999999998 99999999999999999999
Q ss_pred EeeecCccccccCC---CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccch
Q 014352 258 VADFGLSKEEVFDG---RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGV 333 (426)
Q Consensus 258 l~Dfgl~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~ 333 (426)
|+|||+++...... ......++..|+|||++.+..++.++||||||+++|||++ |..||...........+.....
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~ 240 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV 240 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCc
Confidence 99999987542221 1123345778999999999999999999999999999998 8999875433222222211111
Q ss_pred hhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHH
Q 014352 334 DEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQR 384 (426)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 384 (426)
. ..+...+..+.+++.+||+.||.+|||+.+++..|+.+.+.
T Consensus 241 ~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 241 L---------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred C---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 0 01112335799999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=315.82 Aligned_cols=247 Identities=29% Similarity=0.442 Sum_probs=202.2
Q ss_pred hhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCCC
Q 014352 119 QNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNG 198 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 198 (426)
+.+.+.||+|+||.||++.+.++..+|+|.+.... .....+.+|++++++++||||+++++++...+..++||||++++
T Consensus 6 ~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd05059 6 LTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANG 84 (256)
T ss_pred cchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCC
Confidence 55678899999999999998777789999886433 34557889999999999999999999999999999999999999
Q ss_pred ChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCc--ccC
Q 014352 199 SLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRN--SGL 276 (426)
Q Consensus 199 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~--~~~ 276 (426)
+|.+++......+++...+.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++........ ...
T Consensus 85 ~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 161 (256)
T cd05059 85 CLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGT 161 (256)
T ss_pred CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccccCCC
Confidence 999999766667899999999999999999999998 999999999999999999999999998754322111 122
Q ss_pred ccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHH
Q 014352 277 KGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELAR 355 (426)
Q Consensus 277 ~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 355 (426)
.++..|+|||.+.+..++.++||||||+++||+++ |..||.............. ......+...+..+.+
T Consensus 162 ~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~ 232 (256)
T cd05059 162 KFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSA---------GYRLYRPKLAPTEVYT 232 (256)
T ss_pred CCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHc---------CCcCCCCCCCCHHHHH
Confidence 34467999999999999999999999999999999 8999875433222211111 1111112224567999
Q ss_pred HHHHcccCCCCCCCCHHHHHHHH
Q 014352 356 IGHKCLHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 356 l~~~cl~~~p~~RPs~~evl~~L 378 (426)
++.+||..+|++|||+.++++.|
T Consensus 233 li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 233 IMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHHHHhcCChhhCcCHHHHHHHh
Confidence 99999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=326.41 Aligned_cols=246 Identities=24% Similarity=0.334 Sum_probs=199.2
Q ss_pred hhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCcc---ChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecC
Q 014352 121 FTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQ---GEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMS 196 (426)
Q Consensus 121 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 196 (426)
+...||+|+||.||.|+-+ +|..+|+|++++.... ..+.+..|-.+|....+|+||+++-.|.+.+.+||||||+|
T Consensus 145 ~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylP 224 (550)
T KOG0605|consen 145 LLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLP 224 (550)
T ss_pred hheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecC
Confidence 3467999999999999864 8899999999876433 33567889999999999999999999999999999999999
Q ss_pred CCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccccc-------
Q 014352 197 NGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF------- 269 (426)
Q Consensus 197 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~------- 269 (426)
||++..+|...+ .|+......++.+++.|+.-+|+.| +|||||||+|+|||..|++||+||||+.-...
T Consensus 225 GGD~mTLL~~~~-~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~ 300 (550)
T KOG0605|consen 225 GGDMMTLLMRKD-TLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESY 300 (550)
T ss_pred CccHHHHHHhcC-cCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhhhhhhhhhh
Confidence 999999996554 5899988999999999999999999 99999999999999999999999999841100
Q ss_pred ------------------CC----Cc-------------------ccCccccCccCccccccCCCCcchhhHHHHHHHHH
Q 014352 270 ------------------DG----RN-------------------SGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFE 308 (426)
Q Consensus 270 ------------------~~----~~-------------------~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~e 308 (426)
.. .. ...+|||-|||||++.+..|+..+|+||||||+||
T Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyE 380 (550)
T KOG0605|consen 301 RLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYE 380 (550)
T ss_pred cchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHH
Confidence 00 00 12469999999999999999999999999999999
Q ss_pred HHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCC---CHHHHHHH
Q 014352 309 LITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRP---SIGEVTQA 377 (426)
Q Consensus 309 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP---s~~evl~~ 377 (426)
|+.|.+||...........+..-. ..+..+.....+.+..+||.+|+. ||++|. .+.||.++
T Consensus 381 mLvGyPPF~s~tp~~T~rkI~nwr------~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~H 445 (550)
T KOG0605|consen 381 MLVGYPPFCSETPQETYRKIVNWR------ETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKH 445 (550)
T ss_pred HHhCCCCCCCCCHHHHHHHHHHHh------hhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcC
Confidence 999999998754443333222111 112222233344788999999999 999995 57777655
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-43 Score=298.92 Aligned_cols=247 Identities=26% Similarity=0.393 Sum_probs=209.4
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC---ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEe
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS---HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEF 194 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 194 (426)
+++++.||+|.||.||.|+.+ ++-.||+|++.+.. ....+++.+|+++-+.|+||||++++++|.+....||++||
T Consensus 24 feigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEy 103 (281)
T KOG0580|consen 24 FEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEY 103 (281)
T ss_pred ccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEe
Confidence 456789999999999999975 67789999986552 23457899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCc
Q 014352 195 MSNGSLSNLIYSEE-RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRN 273 (426)
Q Consensus 195 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 273 (426)
.++|+|...|.... ..++......++.|+|.||.|+|.++ ++||||||+|+|++..+..|++|||-+-... .+..
T Consensus 104 a~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-~~kR 179 (281)
T KOG0580|consen 104 APRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP-SNKR 179 (281)
T ss_pred cCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC-CCCc
Confidence 99999999996433 55888888999999999999999998 9999999999999999999999999987554 5566
Q ss_pred ccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHH
Q 014352 274 SGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVREL 353 (426)
Q Consensus 274 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 353 (426)
...+||.-|.+||+..+..++...|+|++|++.||++.|.+||...........+.. -.+ ..+...+...
T Consensus 180 ~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k--------~~~--~~p~~is~~a 249 (281)
T KOG0580|consen 180 KTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRK--------VDL--KFPSTISGGA 249 (281)
T ss_pred eeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHH--------ccc--cCCcccChhH
Confidence 788999999999999999999999999999999999999999986543322222211 111 1123344678
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHHH
Q 014352 354 ARIGHKCLHKTPRKRPSIGEVTQALL 379 (426)
Q Consensus 354 ~~l~~~cl~~~p~~RPs~~evl~~L~ 379 (426)
.+++.+|+..+|.+|.+..|++++-.
T Consensus 250 ~dlI~~ll~~~p~~r~~l~~v~~hpw 275 (281)
T KOG0580|consen 250 ADLISRLLVKNPIERLALTEVMDHPW 275 (281)
T ss_pred HHHHHHHhccCccccccHHHHhhhHH
Confidence 99999999999999999999998743
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=332.31 Aligned_cols=246 Identities=24% Similarity=0.291 Sum_probs=201.2
Q ss_pred HHHhhhhcccccCCCeeEEEEEeCC--CcEEEEEEeccCC---ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEE
Q 014352 116 KATQNFTNILGQGAFGPVYKATMPS--GGVAAIKVLASDS---HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYML 190 (426)
Q Consensus 116 ~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 190 (426)
...|.+.+.||+|+||.||+|.+.+ +..||+|.+.... ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3446778899999999999998643 3589999986432 1233568889999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC
Q 014352 191 IYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD 270 (426)
Q Consensus 191 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 270 (426)
||||+++|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 109 v~Ey~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~-- 182 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRN-KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD-- 182 (340)
T ss_pred EEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC--
Confidence 99999999999999654 45899999999999999999999998 9999999999999999999999999997542
Q ss_pred CCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHH
Q 014352 271 GRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEV 350 (426)
Q Consensus 271 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (426)
.......||+.|+|||++.+..++.++|||||||++|||++|..||...........+.... . ..+....
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~--------~--~~p~~~~ 252 (340)
T PTZ00426 183 TRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI--------I--YFPKFLD 252 (340)
T ss_pred CCcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC--------C--CCCCCCC
Confidence 22345679999999999999889999999999999999999999997644332222111111 0 1122233
Q ss_pred HHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 014352 351 RELARIGHKCLHKTPRKRP-----SIGEVTQA 377 (426)
Q Consensus 351 ~~l~~l~~~cl~~~p~~RP-----s~~evl~~ 377 (426)
..+.+++.+||+.||++|+ ++++++++
T Consensus 253 ~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 253 NNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred HHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 5688999999999999995 89988876
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=322.57 Aligned_cols=255 Identities=20% Similarity=0.258 Sum_probs=198.7
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc--cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEec
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH--QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 195 (426)
|.+.+.||+|+||.||+++.. +++.+|+|++..... ...+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (287)
T cd07848 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYV 82 (287)
T ss_pred ceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecC
Confidence 556788999999999999986 678899999875422 23456789999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC--Cc
Q 014352 196 SNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG--RN 273 (426)
Q Consensus 196 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~--~~ 273 (426)
+++++..+. .....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....... ..
T Consensus 83 ~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (287)
T cd07848 83 EKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY 158 (287)
T ss_pred CCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccccccc
Confidence 987776544 34456899999999999999999999998 9999999999999999999999999997543221 22
Q ss_pred ccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhc---cccchhhhh-----h-------
Q 014352 274 SGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASM---SQDGVDEIL-----D------- 338 (426)
Q Consensus 274 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~---~~~~~~~~~-----~------- 338 (426)
....|++.|+|||++.+..++.++|||||||++|||++|+.||........+..+ ......... +
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (287)
T cd07848 159 TEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLR 238 (287)
T ss_pred cccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccc
Confidence 3456899999999999989999999999999999999999999764332211110 000000000 0
Q ss_pred -hhhcc------cCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 339 -KQLVG------ACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 339 -~~~~~------~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
+.... ......+..+.+++.+||+.||++|||+.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 239 FPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred cCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000 0011134579999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=320.90 Aligned_cols=256 Identities=28% Similarity=0.463 Sum_probs=207.6
Q ss_pred HHhhhhcccccCCCeeEEEEEeC------CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEE
Q 014352 117 ATQNFTNILGQGAFGPVYKATMP------SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYML 190 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 190 (426)
..+.+.+.||+|+||.||+|... ++..+++|.+........+.+.+|+.++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 34556678999999999999742 345688998876554455679999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhcc---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCc
Q 014352 191 IYEFMSNGSLSNLIYSEE---------------RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMR 255 (426)
Q Consensus 191 v~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~ 255 (426)
||||+++++|.+++.... ..+++..++.++.|++.||+|||+++ ++||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999986432 34889999999999999999999998 999999999999999999
Q ss_pred EEEeeecCccccccCC---CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhcccc
Q 014352 256 AKVADFGLSKEEVFDG---RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQD 331 (426)
Q Consensus 256 ~kl~Dfgl~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~ 331 (426)
++|+|||++....... ......++..|+|||++.+..++.++||||||+++|||+| |..||...........+...
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~ 241 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQG 241 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCC
Confidence 9999999987433221 1233456788999999999999999999999999999999 99998654433222211111
Q ss_pred chhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHH
Q 014352 332 GVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQR 384 (426)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 384 (426)
... ..+...+..+.+++.+||+.+|.+|||+.++++.|+.+...
T Consensus 242 ~~~---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 242 RVL---------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred CCC---------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 111 11122346789999999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=314.32 Aligned_cols=245 Identities=26% Similarity=0.417 Sum_probs=196.9
Q ss_pred ccccCCCeeEEEEEeC---CCcEEEEEEeccCCc-cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCCCC
Q 014352 124 ILGQGAFGPVYKATMP---SGGVAAIKVLASDSH-QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGS 199 (426)
Q Consensus 124 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 199 (426)
.||+|+||.||+|.+. ++..||+|.+..... ...+.+.+|+.++++++||||+++++++.. +..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 3899999999999764 344689999876532 223568899999999999999999998854 57899999999999
Q ss_pred hhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCC----ccc
Q 014352 200 LSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGR----NSG 275 (426)
Q Consensus 200 L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~----~~~ 275 (426)
|.+++......+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++........ ...
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 99999766667999999999999999999999998 99999999999999999999999999874332211 112
Q ss_pred CccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHH
Q 014352 276 LKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELA 354 (426)
Q Consensus 276 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 354 (426)
..++..|+|||++.+..++.++||||||+++||+++ |..||...........+ ........+...+.++.
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~l~ 228 (257)
T cd05115 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFI---------EQGKRLDCPAECPPEMY 228 (257)
T ss_pred CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH---------HCCCCCCCCCCCCHHHH
Confidence 233578999999988889999999999999999996 99999764432221111 11111122333457889
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHHHHH
Q 014352 355 RIGHKCLHKTPRKRPSIGEVTQALLKI 381 (426)
Q Consensus 355 ~l~~~cl~~~p~~RPs~~evl~~L~~~ 381 (426)
+++.+||..+|++||++.+|.+.|..+
T Consensus 229 ~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 229 ALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=327.34 Aligned_cols=256 Identities=30% Similarity=0.486 Sum_probs=201.8
Q ss_pred HHhhhhcccccCCCeeEEEEEeC------CCcEEEEEEeccCCcc-ChHHHHHHHHHHhcC-CCCceeeEEeEEEeC-Ce
Q 014352 117 ATQNFTNILGQGAFGPVYKATMP------SGGVAAIKVLASDSHQ-GEKEFQTEVSLLGRL-HHRNLVNLIGYCVDK-GK 187 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-~~ 187 (426)
.++.+.+.||.|+||.||+|... +++.||+|++...... ..+.+..|+.++.++ +|+||++++++|... ..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 45777889999999999999642 3468999998754322 234677899999999 899999999988754 56
Q ss_pred EEEEEEecCCCChhHHhhhcc-----------------------------------------------------------
Q 014352 188 YMLIYEFMSNGSLSNLIYSEE----------------------------------------------------------- 208 (426)
Q Consensus 188 ~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------- 208 (426)
+++++||+++++|.+++....
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 889999999999999885421
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC---CcccCccccCccC
Q 014352 209 -RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG---RNSGLKGTYGYID 284 (426)
Q Consensus 209 -~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---~~~~~~gt~~y~a 284 (426)
..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||+++...... ......++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 25889999999999999999999998 9999999999999999999999999997543221 1223445678999
Q ss_pred ccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHHHHHcccC
Q 014352 285 PAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHK 363 (426)
Q Consensus 285 PE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~ 363 (426)
||++.+..++.++|||||||++|||++ |..||........+.. .+........+......+.+++.+||+.
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~l~~~cl~~ 315 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCR--------RLKEGTRMRAPEYATPEIYSIMLDCWHN 315 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHH--------HHhccCCCCCCccCCHHHHHHHHHHccC
Confidence 999999999999999999999999998 9999865322111111 1111111111223446789999999999
Q ss_pred CCCCCCCHHHHHHHHHHHHH
Q 014352 364 TPRKRPSIGEVTQALLKIKQ 383 (426)
Q Consensus 364 ~p~~RPs~~evl~~L~~~~~ 383 (426)
+|++||++.+++++|.++.+
T Consensus 316 ~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 316 NPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred ChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=322.07 Aligned_cols=257 Identities=27% Similarity=0.480 Sum_probs=202.7
Q ss_pred hhhhcccccCCCeeEEEEEeCC-Cc--EEEEEEeccCC-ccChHHHHHHHHHHhcC-CCCceeeEEeEEEeCCeEEEEEE
Q 014352 119 QNFTNILGQGAFGPVYKATMPS-GG--VAAIKVLASDS-HQGEKEFQTEVSLLGRL-HHRNLVNLIGYCVDKGKYMLIYE 193 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 193 (426)
+.+.+.||+|+||.||+|...+ +. .+++|.++... ....+.+.+|+.+++++ +||||+++++++...+..++++|
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 83 (297)
T cd05089 4 IKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIE 83 (297)
T ss_pred ceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEE
Confidence 4566789999999999998753 32 46888876432 22345788999999999 79999999999999999999999
Q ss_pred ecCCCChhHHhhhcc---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEE
Q 014352 194 FMSNGSLSNLIYSEE---------------RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKV 258 (426)
Q Consensus 194 ~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 258 (426)
|+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.+||
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl 160 (297)
T cd05089 84 YAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLASKI 160 (297)
T ss_pred ecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeEEE
Confidence 999999999985432 34888999999999999999999988 999999999999999999999
Q ss_pred eeecCccccccCCCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhh
Q 014352 259 ADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEIL 337 (426)
Q Consensus 259 ~Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 337 (426)
+|||++..............+..|+|||++.+..++.++|||||||++|||++ |..||............
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~--------- 231 (297)
T cd05089 161 ADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL--------- 231 (297)
T ss_pred CCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH---------
Confidence 99999864322111222233567999999998899999999999999999997 99999654322211111
Q ss_pred hhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHhhh
Q 014352 338 DKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRHLA 387 (426)
Q Consensus 338 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~~ 387 (426)
........+...+..+.+++.+||+.+|.+|||+.++++.|..+......
T Consensus 232 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~ 281 (297)
T cd05089 232 PQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281 (297)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 11111111223446789999999999999999999999999988765544
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=319.75 Aligned_cols=252 Identities=27% Similarity=0.502 Sum_probs=200.4
Q ss_pred HHhhhhcccccCCCeeEEEEEe-----CCCcEEEEEEeccCCc-cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEE
Q 014352 117 ATQNFTNILGQGAFGPVYKATM-----PSGGVAAIKVLASDSH-QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYML 190 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 190 (426)
..+.+.+.||+|+||.||+|.+ .++..+++|.+..... .....+.+|+.++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 3456678999999999999984 2456899999875432 223578899999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhcc----------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCC
Q 014352 191 IYEFMSNGSLSNLIYSEE----------------RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFM 254 (426)
Q Consensus 191 v~e~~~~gsL~~~l~~~~----------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~ 254 (426)
+|||+++++|.+++.... ..+++...+.++.+++.||.|||+++ ++||||||+||+++.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 999999999999985321 24788899999999999999999998 99999999999999999
Q ss_pred cEEEeeecCccccccCC---CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccc
Q 014352 255 RAKVADFGLSKEEVFDG---RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQ 330 (426)
Q Consensus 255 ~~kl~Dfgl~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~ 330 (426)
.+||+|||+++...... ......++..|+|||++.+..++.++||||||+++|||++ |..||..............
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 241 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK 241 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 99999999997543221 1223445678999999988889999999999999999998 9899865332211111111
Q ss_pred cchhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 014352 331 DGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLK 380 (426)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 380 (426)
......+...+..+.+++.+||+.||++||++.++.++|..
T Consensus 242 ---------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 242 ---------RQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred ---------CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11111222334678999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=318.50 Aligned_cols=245 Identities=27% Similarity=0.383 Sum_probs=194.4
Q ss_pred cccCCCeeEEEEEeC-CCcEEEEEEeccCCc---cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCCCCh
Q 014352 125 LGQGAFGPVYKATMP-SGGVAAIKVLASDSH---QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSL 200 (426)
Q Consensus 125 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 200 (426)
||+|+||.||++... +++.+|+|.+..... .....+..|++++++++||||+++++++.++...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999875 688999999864321 1234556799999999999999999999999999999999999999
Q ss_pred hHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCcccCccc
Q 014352 201 SNLIYSEE-RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGT 279 (426)
Q Consensus 201 ~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~gt 279 (426)
.+++.... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.............|+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 157 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGT 157 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCC
Confidence 98885543 45899999999999999999999998 999999999999999999999999998754433333445689
Q ss_pred cCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHHHHH
Q 014352 280 YGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHK 359 (426)
Q Consensus 280 ~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 359 (426)
..|+|||++.+..++.++|||||||++|||++|..||............. ......... ......+.++.+++.+
T Consensus 158 ~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~----~~~~~~~~~-~~~~~~~~~~~~li~~ 232 (277)
T cd05607 158 NGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELK----RRTLEDEVK-FEHQNFTEESKDICRL 232 (277)
T ss_pred CCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHH----HHhhccccc-cccccCCHHHHHHHHH
Confidence 99999999999899999999999999999999999996532211100000 001111110 0111245678999999
Q ss_pred cccCCCCCCCCHHHHHHH
Q 014352 360 CLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 360 cl~~~p~~RPs~~evl~~ 377 (426)
||+.||++||++.|+++.
T Consensus 233 ~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 233 FLAKKPEDRLGSREKNDD 250 (277)
T ss_pred HhccCHhhCCCCccchhh
Confidence 999999999999776643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=321.97 Aligned_cols=250 Identities=26% Similarity=0.392 Sum_probs=201.5
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc---cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEe
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH---QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEF 194 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 194 (426)
|+..+.||+|+||.||++... ++..||+|.+..... .....+.+|+.++++++||||+++++++..++..++||||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 445678999999999999875 688999999865422 1234577899999999999999999999999999999999
Q ss_pred cCCCChhHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCc
Q 014352 195 MSNGSLSNLIYSEE-RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRN 273 (426)
Q Consensus 195 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 273 (426)
+++|+|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 158 (285)
T cd05605 82 MNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETI 158 (285)
T ss_pred cCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcc
Confidence 99999998886543 46899999999999999999999998 999999999999999999999999998764333333
Q ss_pred ccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHH
Q 014352 274 SGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVREL 353 (426)
Q Consensus 274 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 353 (426)
....|+..|+|||++.+..++.++||||||+++||+++|..||.+.........+ ...+.. .....+...+..+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~-----~~~~~~-~~~~~~~~~~~~~ 232 (285)
T cd05605 159 RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEV-----ERRVKE-DQEEYSEKFSEAA 232 (285)
T ss_pred ccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHH-----HHHhhh-cccccCcccCHHH
Confidence 4457899999999999889999999999999999999999999764322111111 000111 0111223345678
Q ss_pred HHHHHHcccCCCCCCC-----CHHHHHHH
Q 014352 354 ARIGHKCLHKTPRKRP-----SIGEVTQA 377 (426)
Q Consensus 354 ~~l~~~cl~~~p~~RP-----s~~evl~~ 377 (426)
.+++.+||+.||++|| ++.+++++
T Consensus 233 ~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 233 RSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred HHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 9999999999999999 78788765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=327.17 Aligned_cols=241 Identities=27% Similarity=0.413 Sum_probs=196.0
Q ss_pred cccccCCCeeEEEEEe----CCCcEEEEEEeccCC----ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEe
Q 014352 123 NILGQGAFGPVYKATM----PSGGVAAIKVLASDS----HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEF 194 (426)
Q Consensus 123 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 194 (426)
+.||+|+||.||+++. .+++.+|+|++.... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 4799999999999975 357789999987532 12234578899999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC-CCc
Q 014352 195 MSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD-GRN 273 (426)
Q Consensus 195 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-~~~ 273 (426)
+++|+|.+++... ..+.+..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (323)
T cd05584 82 LSGGELFMHLERE-GIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVT 157 (323)
T ss_pred CCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcc
Confidence 9999999998554 45788888899999999999999998 999999999999999999999999998743222 223
Q ss_pred ccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHH
Q 014352 274 SGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVREL 353 (426)
Q Consensus 274 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 353 (426)
....||+.|+|||++.+..++.++||||||+++|||++|..||...........+... .. ..+......+
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~--------~~--~~~~~~~~~~ 227 (323)
T cd05584 158 HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG--------KL--NLPPYLTPEA 227 (323)
T ss_pred cccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcC--------CC--CCCCCCCHHH
Confidence 3457999999999999989999999999999999999999999764332222211111 10 1122234678
Q ss_pred HHHHHHcccCCCCCCC-----CHHHHHHH
Q 014352 354 ARIGHKCLHKTPRKRP-----SIGEVTQA 377 (426)
Q Consensus 354 ~~l~~~cl~~~p~~RP-----s~~evl~~ 377 (426)
.+++.+||+.||++|| ++.+++++
T Consensus 228 ~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 228 RDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred HHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 9999999999999999 78888765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=323.49 Aligned_cols=255 Identities=23% Similarity=0.345 Sum_probs=196.5
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc-cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecC
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH-QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMS 196 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 196 (426)
|.+.+.||+|+||.||+|... ++..+|+|++..... .....+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 86 (303)
T cd07869 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH 86 (303)
T ss_pred ceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC
Confidence 566789999999999999976 788999999875432 223467889999999999999999999999999999999995
Q ss_pred CCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC-CCccc
Q 014352 197 NGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD-GRNSG 275 (426)
Q Consensus 197 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-~~~~~ 275 (426)
++|.+++......++...+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..... .....
T Consensus 87 -~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 162 (303)
T cd07869 87 -TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSN 162 (303)
T ss_pred -cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCCC
Confidence 6888888666667899999999999999999999998 999999999999999999999999998743221 22234
Q ss_pred CccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHH-Hhhc----cccc---hhh-----hhhh-h
Q 014352 276 LKGTYGYIDPAYIST-NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVN-LASM----SQDG---VDE-----ILDK-Q 340 (426)
Q Consensus 276 ~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~-~~~~----~~~~---~~~-----~~~~-~ 340 (426)
..+|+.|+|||.+.+ ..++.++|||||||++|||++|..||.+...... +..+ .... ... ...+ .
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (303)
T cd07869 163 EVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPER 242 (303)
T ss_pred CcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccccccc
Confidence 568999999998865 4588999999999999999999999976422111 0000 0000 000 0000 0
Q ss_pred hc--ccCC-------HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 341 LV--GACN-------IQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 341 ~~--~~~~-------~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
.. .... ...+..+.+++.+||+.||++|||+.+++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 243 FTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred ccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 00 0000 0122467899999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=321.72 Aligned_cols=255 Identities=24% Similarity=0.310 Sum_probs=194.6
Q ss_pred hhhhcccccCCCeeEEEEEeC--CCcEEEEEEeccCCcc--ChHHHHHHHHHHhcC---CCCceeeEEeEEEe-----CC
Q 014352 119 QNFTNILGQGAFGPVYKATMP--SGGVAAIKVLASDSHQ--GEKEFQTEVSLLGRL---HHRNLVNLIGYCVD-----KG 186 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l---~h~niv~~~~~~~~-----~~ 186 (426)
|.+.+.||+|+||.||+|+.. ++..||+|.+...... ....+.+|+.+++.+ +||||++++++|.. ..
T Consensus 3 Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~ 82 (290)
T cd07862 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 82 (290)
T ss_pred cceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCC
Confidence 566788999999999999863 4678999988654322 234566777777665 69999999999853 35
Q ss_pred eEEEEEEecCCCChhHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcc
Q 014352 187 KYMLIYEFMSNGSLSNLIYSEE-RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSK 265 (426)
Q Consensus 187 ~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 265 (426)
..++||||++ ++|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 83 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 83 KLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred cEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 6899999996 59999886533 45899999999999999999999998 9999999999999999999999999997
Q ss_pred ccccCCCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhcccc-------chhhh--
Q 014352 266 EEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQD-------GVDEI-- 336 (426)
Q Consensus 266 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~-------~~~~~-- 336 (426)
............||+.|+|||.+.+..++.++|||||||++|||++|.+||........+..+... .....
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (290)
T cd07862 159 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 238 (290)
T ss_pred eccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhc
Confidence 654444445567899999999999889999999999999999999999999765433222111100 00000
Q ss_pred -hhhhhc--cc-----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 337 -LDKQLV--GA-----CNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 337 -~~~~~~--~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
....+. .. ........+.+++.+||+.||++|||+.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 239 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred ccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 000000 00 001233567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=323.43 Aligned_cols=257 Identities=26% Similarity=0.474 Sum_probs=202.0
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCc--EEEEEEeccCC-ccChHHHHHHHHHHhcC-CCCceeeEEeEEEeCCeEEEEE
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGG--VAAIKVLASDS-HQGEKEFQTEVSLLGRL-HHRNLVNLIGYCVDKGKYMLIY 192 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 192 (426)
.+.+.+.||+|+||.||+|.+. ++. .+++|.+.... ......+.+|+.++.++ +||||+++++++...+..++||
T Consensus 8 ~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 87 (303)
T cd05088 8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI 87 (303)
T ss_pred hceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEE
Confidence 3566789999999999999875 443 45777765432 22345788999999999 8999999999999999999999
Q ss_pred EecCCCChhHHhhhcc---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEE
Q 014352 193 EFMSNGSLSNLIYSEE---------------RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAK 257 (426)
Q Consensus 193 e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 257 (426)
||+++++|.+++.... ..+++.+++.++.|++.||+|||+++ ++||||||+|||++.++.+|
T Consensus 88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~k 164 (303)
T cd05088 88 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAK 164 (303)
T ss_pred EeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcEE
Confidence 9999999999986432 25789999999999999999999998 99999999999999999999
Q ss_pred EeeecCccccccCCCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhh
Q 014352 258 VADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEI 336 (426)
Q Consensus 258 l~Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 336 (426)
|+|||+++............++..|+|||++.+..++.++||||||+++|||+| |..||.............
T Consensus 165 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~------- 237 (303)
T cd05088 165 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP------- 237 (303)
T ss_pred eCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHh-------
Confidence 999999864321111222334678999999988889999999999999999998 999986533221111111
Q ss_pred hhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHhh
Q 014352 337 LDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRHL 386 (426)
Q Consensus 337 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~ 386 (426)
.......+...+..+.+++.+||+.+|++||++.++++.|..+.....
T Consensus 238 --~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 238 --QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred --cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 111111122234578999999999999999999999999988765443
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=318.57 Aligned_cols=260 Identities=28% Similarity=0.449 Sum_probs=201.5
Q ss_pred HhhhhcccccCCCeeEEEEEe-----CCCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeC--CeEEE
Q 014352 118 TQNFTNILGQGAFGPVYKATM-----PSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDK--GKYML 190 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l 190 (426)
.+.+.+.||+|+||.||++.. .++..+|+|.+........+.+.+|++++++++||||+++++++... ...++
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 84 (284)
T cd05081 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRL 84 (284)
T ss_pred cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEE
Confidence 345667899999999999974 25778999998766555556789999999999999999999987543 46899
Q ss_pred EEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC
Q 014352 191 IYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD 270 (426)
Q Consensus 191 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 270 (426)
|+||+++|+|.+++......+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++.....
T Consensus 85 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 161 (284)
T cd05081 85 VMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVLPQD 161 (284)
T ss_pred EEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccccCC
Confidence 99999999999999766566899999999999999999999998 999999999999999999999999998754322
Q ss_pred CCc----ccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccc--------hhhhhh
Q 014352 271 GRN----SGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDG--------VDEILD 338 (426)
Q Consensus 271 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~--------~~~~~~ 338 (426)
... ....++..|+|||++.+..++.++||||||+++|||++|..|+........ ..+.... ..+.+.
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05081 162 KEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFM-RMMGNDKQGQMIVYHLIELLK 240 (284)
T ss_pred CcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhh-hhcccccccccchHHHHHHHh
Confidence 111 112234569999999988999999999999999999998877543322110 0000000 011111
Q ss_pred hhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 014352 339 KQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKI 381 (426)
Q Consensus 339 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 381 (426)
.......+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 241 NNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 1111112223456799999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=330.51 Aligned_cols=240 Identities=25% Similarity=0.357 Sum_probs=195.7
Q ss_pred ccccCCCeeEEEEEeC-CCcEEEEEEeccCCc---cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCCCC
Q 014352 124 ILGQGAFGPVYKATMP-SGGVAAIKVLASDSH---QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGS 199 (426)
Q Consensus 124 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 199 (426)
.||+|+||.||++... ++..+|+|++..... .....+..|++++..++||||+++++++...+..++||||+++|+
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (325)
T cd05594 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (325)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCc
Confidence 6999999999999865 788999999875421 223467789999999999999999999999999999999999999
Q ss_pred hhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC-CCcccCc
Q 014352 200 LSNLIYSEERVLNWEERLQIALDISHGIEYLHE-GAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD-GRNSGLK 277 (426)
Q Consensus 200 L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-~~~~~~~ 277 (426)
|..++... ..+++..+..++.|++.||.|||+ .+ |+||||||+|||++.++.+||+|||+++..... .......
T Consensus 82 L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (325)
T cd05594 82 LFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC 157 (325)
T ss_pred HHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccccccc
Confidence 99888543 468999999999999999999997 67 999999999999999999999999998743222 2233456
Q ss_pred cccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHHH
Q 014352 278 GTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIG 357 (426)
Q Consensus 278 gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 357 (426)
||+.|+|||++.+..++.++|||||||++|||++|..||...........+.... . ..+......+.+++
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~--------~--~~p~~~~~~~~~li 227 (325)
T cd05594 158 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE--------I--RFPRTLSPEAKSLL 227 (325)
T ss_pred CCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCC--------C--CCCCCCCHHHHHHH
Confidence 9999999999999999999999999999999999999997543222111111100 0 11122345788999
Q ss_pred HHcccCCCCCCC-----CHHHHHHH
Q 014352 358 HKCLHKTPRKRP-----SIGEVTQA 377 (426)
Q Consensus 358 ~~cl~~~p~~RP-----s~~evl~~ 377 (426)
.+||+.||++|+ ++.+++++
T Consensus 228 ~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 228 SGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred HHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 999999999996 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=313.41 Aligned_cols=252 Identities=28% Similarity=0.451 Sum_probs=204.0
Q ss_pred HHHhhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEec
Q 014352 116 KATQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 116 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 195 (426)
..++.+.+.||+|+||.||+|++.++..||+|.+.... ...+.+.+|++++++++||||+++++++.+ +..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence 34577888999999999999998777789999987533 345678999999999999999999998754 5679999999
Q ss_pred CCCChhHHhhhc-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCC--
Q 014352 196 SNGSLSNLIYSE-ERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGR-- 272 (426)
Q Consensus 196 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~-- 272 (426)
++|+|.+++... ...+++..+..++.+++.||+|||+.+ ++|+||||+||+++.++.++|+|||.++.......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~ 159 (262)
T cd05071 83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 159 (262)
T ss_pred CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence 999999999653 345899999999999999999999988 99999999999999999999999999875432221
Q ss_pred cccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHH
Q 014352 273 NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVR 351 (426)
Q Consensus 273 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (426)
.....++..|+|||+..+..++.++||||||+++|||++ |..||............. ...........+.
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~---------~~~~~~~~~~~~~ 230 (262)
T cd05071 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE---------RGYRMPCPPECPE 230 (262)
T ss_pred ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHh---------cCCCCCCccccCH
Confidence 123346678999999998899999999999999999999 888887543322211111 1111122334556
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 014352 352 ELARIGHKCLHKTPRKRPSIGEVTQALLKI 381 (426)
Q Consensus 352 ~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 381 (426)
.+.+++.+||+.+|++||++.++++.|+..
T Consensus 231 ~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 231 SLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred HHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=317.73 Aligned_cols=255 Identities=25% Similarity=0.415 Sum_probs=203.0
Q ss_pred HHhhhhcccccCCCeeEEEEEeC-CCc----EEEEEEeccCCc-cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEE
Q 014352 117 ATQNFTNILGQGAFGPVYKATMP-SGG----VAAIKVLASDSH-QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYML 190 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 190 (426)
..+++.+.||+|+||+||+|++. ++. .||+|.+..... .....+.+|+.++..++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEE
Confidence 34556788999999999999864 444 479999865432 2345788999999999999999999998764 5789
Q ss_pred EEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC
Q 014352 191 IYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD 270 (426)
Q Consensus 191 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 270 (426)
++||+++|+|.+++......+++..++.++.|++.||.|||+++ ++||||||+|||+++++.+||+|||+++.....
T Consensus 86 ~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~ 162 (279)
T cd05109 86 VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDID 162 (279)
T ss_pred EEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecccc
Confidence 99999999999999766667999999999999999999999998 999999999999999999999999998754322
Q ss_pred CCc---ccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCC
Q 014352 271 GRN---SGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACN 346 (426)
Q Consensus 271 ~~~---~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (426)
... ....++..|+|||.+.+..++.++||||||+++|||++ |..||.......... .+........+
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~---------~~~~~~~~~~~ 233 (279)
T cd05109 163 ETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPD---------LLEKGERLPQP 233 (279)
T ss_pred cceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH---------HHHCCCcCCCC
Confidence 221 12335678999999999999999999999999999998 899987543221111 11111111112
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHH
Q 014352 347 IQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQR 384 (426)
Q Consensus 347 ~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 384 (426)
...+..+.+++.+||+.||++||++.++++.|..+...
T Consensus 234 ~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 234 PICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 23456789999999999999999999999998877653
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=326.52 Aligned_cols=240 Identities=28% Similarity=0.407 Sum_probs=194.4
Q ss_pred ccccCCCeeEEEEEeC-CCcEEEEEEeccCC---ccChHHHHHHHHHHhcC-CCCceeeEEeEEEeCCeEEEEEEecCCC
Q 014352 124 ILGQGAFGPVYKATMP-SGGVAAIKVLASDS---HQGEKEFQTEVSLLGRL-HHRNLVNLIGYCVDKGKYMLIYEFMSNG 198 (426)
Q Consensus 124 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g 198 (426)
.||+|+||.||+|+.. +++.||+|++.... ....+.+..|..++..+ +||||+++++++...+.+++||||+++|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g 81 (320)
T cd05590 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGG 81 (320)
T ss_pred eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCc
Confidence 6999999999999975 67899999987532 22334567888888876 6999999999999999999999999999
Q ss_pred ChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccccc-CCCcccCc
Q 014352 199 SLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF-DGRNSGLK 277 (426)
Q Consensus 199 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~-~~~~~~~~ 277 (426)
+|..++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.... ........
T Consensus 82 ~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (320)
T cd05590 82 DLMFHIQKS-RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC 157 (320)
T ss_pred hHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccc
Confidence 999988554 45899999999999999999999998 99999999999999999999999999875322 22234467
Q ss_pred cccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHHH
Q 014352 278 GTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIG 357 (426)
Q Consensus 278 gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 357 (426)
||+.|+|||++.+..++.++|||||||++|||++|..||...........+..... ..+...+..+.+++
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~----------~~~~~~~~~~~~li 227 (320)
T cd05590 158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV----------VYPTWLSQDAVDIL 227 (320)
T ss_pred cCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC----------CCCCCCCHHHHHHH
Confidence 99999999999999999999999999999999999999976443322222111110 01112346788999
Q ss_pred HHcccCCCCCCCCH------HHHHHH
Q 014352 358 HKCLHKTPRKRPSI------GEVTQA 377 (426)
Q Consensus 358 ~~cl~~~p~~RPs~------~evl~~ 377 (426)
.+||+.||++||++ .+++.+
T Consensus 228 ~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 228 KAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred HHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 99999999999998 555544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=312.58 Aligned_cols=251 Identities=27% Similarity=0.456 Sum_probs=203.5
Q ss_pred HHHhhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEec
Q 014352 116 KATQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 116 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 195 (426)
...+++.+.||+|+||.||+|...++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++. .+..+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 345677889999999999999988888899999876443 4567999999999999999999999875 45689999999
Q ss_pred CCCChhHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCC--
Q 014352 196 SNGSLSNLIYSEE-RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGR-- 272 (426)
Q Consensus 196 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~-- 272 (426)
++++|.+++.... ..+++..+..++.+++.||.|||+.+ ++||||||+||++++++.++|+|||++........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05070 83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence 9999999986543 45899999999999999999999998 99999999999999999999999999875332211
Q ss_pred cccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHH
Q 014352 273 NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVR 351 (426)
Q Consensus 273 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (426)
.....++..|+|||.+.+..++.++|+||||+++|||++ |..||...........+ ........+...+.
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~---------~~~~~~~~~~~~~~ 230 (260)
T cd05070 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQV---------ERGYRMPCPQDCPI 230 (260)
T ss_pred ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH---------HcCCCCCCCCcCCH
Confidence 122335668999999988899999999999999999999 88998653322211111 11111122334456
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 014352 352 ELARIGHKCLHKTPRKRPSIGEVTQALLK 380 (426)
Q Consensus 352 ~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 380 (426)
.+.+++.+||..+|++|||+.++.+.|+.
T Consensus 231 ~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 231 SLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 79999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=315.75 Aligned_cols=258 Identities=27% Similarity=0.437 Sum_probs=201.1
Q ss_pred hhhcccccCCCeeEEEEEe-----CCCcEEEEEEeccCCc-cChHHHHHHHHHHhcCCCCceeeEEeEEEeC--CeEEEE
Q 014352 120 NFTNILGQGAFGPVYKATM-----PSGGVAAIKVLASDSH-QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDK--GKYMLI 191 (426)
Q Consensus 120 ~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv 191 (426)
.+.+.||+|+||+||++.+ .++..+|+|.+..... .....+.+|++++++++||||+++++++... ...+++
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 5677899999999988653 3567899999876532 2346788999999999999999999988764 458999
Q ss_pred EEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC
Q 014352 192 YEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG 271 (426)
Q Consensus 192 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 271 (426)
|||+++++|.+++... .+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||+++......
T Consensus 87 ~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 161 (283)
T cd05080 87 MEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 161 (283)
T ss_pred ecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCCcc
Confidence 9999999999998543 4899999999999999999999998 9999999999999999999999999987543221
Q ss_pred C----cccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHH-HHhhcc-----ccchhhhhhhhh
Q 014352 272 R----NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYV-NLASMS-----QDGVDEILDKQL 341 (426)
Q Consensus 272 ~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~-~~~~~~-----~~~~~~~~~~~~ 341 (426)
. .....++..|+|||.+.+..++.++||||||+++|||++|..|+....... ...... ........+...
T Consensus 162 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (283)
T cd05080 162 EYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGM 241 (283)
T ss_pred hhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCC
Confidence 1 122345667999999998899999999999999999999999986532211 100000 011111122222
Q ss_pred cccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 014352 342 VGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIK 382 (426)
Q Consensus 342 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 382 (426)
....+...+..+.+++.+||+.+|++|||+.++++.|+.+.
T Consensus 242 ~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 242 RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 22223334578999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=312.44 Aligned_cols=244 Identities=27% Similarity=0.421 Sum_probs=195.9
Q ss_pred ccccCCCeeEEEEEeC---CCcEEEEEEeccCCcc--ChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCCC
Q 014352 124 ILGQGAFGPVYKATMP---SGGVAAIKVLASDSHQ--GEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNG 198 (426)
Q Consensus 124 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 198 (426)
.||+|+||.||+|.+. ++..+|+|++...... ..+.+.+|+.+++++.||||+++++++.. +..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 5899999999999753 5678999998654322 24578899999999999999999998854 5678999999999
Q ss_pred ChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCC----cc
Q 014352 199 SLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGR----NS 274 (426)
Q Consensus 199 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~----~~ 274 (426)
+|.+++... ..+++.....++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++....... ..
T Consensus 81 ~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05116 81 PLNKFLQKN-KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT 156 (257)
T ss_pred cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence 999998543 46899999999999999999999998 99999999999999999999999999875432221 12
Q ss_pred cCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHH
Q 014352 275 GLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVREL 353 (426)
Q Consensus 275 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 353 (426)
...++..|+|||.+.+..++.++|+||||+++|||++ |..||...........+. .......+...+.++
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~---------~~~~~~~~~~~~~~l 227 (257)
T cd05116 157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE---------SGERMECPQRCPPEM 227 (257)
T ss_pred CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---------CCCCCCCCCCCCHHH
Confidence 2234578999999988889999999999999999998 999997643322222111 111112223345678
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 014352 354 ARIGHKCLHKTPRKRPSIGEVTQALLKI 381 (426)
Q Consensus 354 ~~l~~~cl~~~p~~RPs~~evl~~L~~~ 381 (426)
.+++.+||+.||++||++.+|.+.|+..
T Consensus 228 ~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 228 YDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred HHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 9999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=318.77 Aligned_cols=252 Identities=25% Similarity=0.428 Sum_probs=201.5
Q ss_pred HHhhhhcccccCCCeeEEEEEeCC------CcEEEEEEeccCCcc-ChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEE
Q 014352 117 ATQNFTNILGQGAFGPVYKATMPS------GGVAAIKVLASDSHQ-GEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYM 189 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 189 (426)
..+.+.+.||.|+||.||+|...+ +..||+|.+...... ..+.+.+|+.++.+++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 345667889999999999998642 467999998755322 2356889999999999999999999999999999
Q ss_pred EEEEecCCCChhHHhhhc---------------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCC
Q 014352 190 LIYEFMSNGSLSNLIYSE---------------ERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFM 254 (426)
Q Consensus 190 lv~e~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~ 254 (426)
+++||+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence 999999999999998422 134788889999999999999999998 99999999999999999
Q ss_pred cEEEeeecCccccccCC---CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccc
Q 014352 255 RAKVADFGLSKEEVFDG---RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQ 330 (426)
Q Consensus 255 ~~kl~Dfgl~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~ 330 (426)
.+||+|||+++...... ......+++.|+|||.+.+..++.++||||||+++|||++ |..||...........+..
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~ 241 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRN 241 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 99999999987532221 1123445779999999988889999999999999999998 8888876433222211111
Q ss_pred cchhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 014352 331 DGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLK 380 (426)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 380 (426)
.. ....+...+..+.+++.+||+.+|++||++.+|+..|+.
T Consensus 242 ~~---------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 242 RQ---------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred CC---------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 11 111223345678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=313.41 Aligned_cols=253 Identities=27% Similarity=0.447 Sum_probs=206.2
Q ss_pred HHHHHhhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEE
Q 014352 114 IQKATQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYE 193 (426)
Q Consensus 114 l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 193 (426)
+...++++.+.||+|+||.||+|...+++.+|+|.+.... .....+.+|+.++++++||||+++++++. .+..+++||
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 4566788889999999999999998888999999987544 34567899999999999999999999874 456899999
Q ss_pred ecCCCChhHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC-
Q 014352 194 FMSNGSLSNLIYSEE-RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG- 271 (426)
Q Consensus 194 ~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~- 271 (426)
|+++++|.+++.... ..+++.+++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 81 YMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred cCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 999999999986543 56899999999999999999999988 9999999999999999999999999987543221
Q ss_pred -CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHH
Q 014352 272 -RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQE 349 (426)
Q Consensus 272 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (426)
......++..|+|||++....++.++||||||+++||+++ |..||...........+ ........+...
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~---------~~~~~~~~~~~~ 228 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL---------ERGYRMPRPDNC 228 (260)
T ss_pred ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHH---------HcCCCCCCCCCC
Confidence 1123345678999999998899999999999999999999 99999754332221111 111111122223
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 014352 350 VRELARIGHKCLHKTPRKRPSIGEVTQALLK 380 (426)
Q Consensus 350 ~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 380 (426)
+.++.+++.+||+.+|++|||+.+++..|+.
T Consensus 229 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 229 PEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 4679999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=327.51 Aligned_cols=254 Identities=23% Similarity=0.320 Sum_probs=194.2
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC--ccChHHHHHHHHHHhcCCCCceeeEEeEEEeC-----CeEEE
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS--HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDK-----GKYML 190 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~l 190 (426)
|.+.+.||+|+||.||+|+.. ++..||+|.+.... ......+.+|+.++++++||||+++++++... ...++
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l 81 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 81 (338)
T ss_pred eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence 556789999999999999965 78899999986432 22334688999999999999999999988653 24799
Q ss_pred EEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC
Q 014352 191 IYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD 270 (426)
Q Consensus 191 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 270 (426)
||||++ ++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 82 v~e~~~-~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 82 VFELME-SDLHQVIKAN-DDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFND 156 (338)
T ss_pred EEecCC-CCHHHHHHhc-ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence 999995 6899888544 45899999999999999999999998 999999999999999999999999998743222
Q ss_pred CC----cccCccccCccCcccccc--CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhh---------------cc
Q 014352 271 GR----NSGLKGTYGYIDPAYIST--NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLAS---------------MS 329 (426)
Q Consensus 271 ~~----~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~---------------~~ 329 (426)
.. .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||........+.. +.
T Consensus 157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (338)
T cd07859 157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVR 236 (338)
T ss_pred cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 11 134568999999999865 6789999999999999999999999965332111100 00
Q ss_pred ccchhhhhhhhhccc-C-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 330 QDGVDEILDKQLVGA-C-----NIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 330 ~~~~~~~~~~~~~~~-~-----~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
.......+....... . .......+.+++.+||+.||++|||+.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 237 NEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000000000000000 0 01123567899999999999999999999987
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=330.18 Aligned_cols=258 Identities=25% Similarity=0.440 Sum_probs=204.3
Q ss_pred HHHHHHhhhhcccccCCCeeEEEEEeC------CCcEEEEEEeccCCccC-hHHHHHHHHHHhcCC-CCceeeEEeEEEe
Q 014352 113 DIQKATQNFTNILGQGAFGPVYKATMP------SGGVAAIKVLASDSHQG-EKEFQTEVSLLGRLH-HRNLVNLIGYCVD 184 (426)
Q Consensus 113 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~-h~niv~~~~~~~~ 184 (426)
++....+.+.+.||+|+||.||+|++. .+..||+|++....... .+.+..|+++|.++. ||||++++++|..
T Consensus 33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~ 112 (401)
T cd05107 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK 112 (401)
T ss_pred eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence 344455667789999999999999863 33579999997653322 346889999999997 9999999999999
Q ss_pred CCeEEEEEEecCCCChhHHhhhcc--------------------------------------------------------
Q 014352 185 KGKYMLIYEFMSNGSLSNLIYSEE-------------------------------------------------------- 208 (426)
Q Consensus 185 ~~~~~lv~e~~~~gsL~~~l~~~~-------------------------------------------------------- 208 (426)
.+..++||||+++|+|.++++...
T Consensus 113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 999999999999999999986431
Q ss_pred -----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCC
Q 014352 209 -----------------------------------------RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSAN 247 (426)
Q Consensus 209 -----------------------------------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~N 247 (426)
..+++...+.++.|++.||.|||+.+ ++||||||+|
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~N 269 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARN 269 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcce
Confidence 23677888999999999999999988 9999999999
Q ss_pred EEecCCCcEEEeeecCccccccCC---CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHH
Q 014352 248 ILLDHFMRAKVADFGLSKEEVFDG---RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYV 323 (426)
Q Consensus 248 ill~~~~~~kl~Dfgl~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~ 323 (426)
||+++++.+||+|||+++...... ......++..|+|||.+.+..++.++||||||+++|||++ |..||.......
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~ 349 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE 349 (401)
T ss_pred EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence 999999999999999987532211 1123456788999999998899999999999999999998 889986532221
Q ss_pred HHhhccccchhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 014352 324 NLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKI 381 (426)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 381 (426)
... ..+........+...+..+.+++.+||..+|++||++.++++.|+.+
T Consensus 350 ~~~--------~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 350 QFY--------NAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred HHH--------HHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 111 11111111112223446799999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=314.52 Aligned_cols=252 Identities=25% Similarity=0.459 Sum_probs=202.7
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CC---cEEEEEEeccCC-ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEE
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SG---GVAAIKVLASDS-HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIY 192 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 192 (426)
.++..+.||+|+||.||+|+.. ++ ..+|+|.+.... ....+.+..|++++++++|||++++++++...+..++||
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (268)
T cd05063 6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIIT 85 (268)
T ss_pred HceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEE
Confidence 4556678999999999999875 33 278999886543 223457889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCC
Q 014352 193 EFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGR 272 (426)
Q Consensus 193 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 272 (426)
||+++++|.+++......+++..+..++.+++.||.|||+.+ ++|+||||+||+++.++.+|++|||++........
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 162 (268)
T cd05063 86 EYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPE 162 (268)
T ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecccccc
Confidence 999999999999766667899999999999999999999998 99999999999999999999999999875432211
Q ss_pred c----ccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCCH
Q 014352 273 N----SGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNI 347 (426)
Q Consensus 273 ~----~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (426)
. .....+..|+|||++.+..++.++||||||+++||+++ |..||...........+.. ........
T Consensus 163 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~---------~~~~~~~~ 233 (268)
T cd05063 163 GTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIND---------GFRLPAPM 233 (268)
T ss_pred cceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhc---------CCCCCCCC
Confidence 1 11223457999999998889999999999999999997 9999865333222111111 11111222
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 014352 348 QEVRELARIGHKCLHKTPRKRPSIGEVTQALLKI 381 (426)
Q Consensus 348 ~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 381 (426)
..+..+.+++.+||+.+|++||++.++++.|+++
T Consensus 234 ~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 234 DCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 3446789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=334.88 Aligned_cols=249 Identities=27% Similarity=0.454 Sum_probs=212.5
Q ss_pred hhhhcccccCCCeeEEEEEeCC-CcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCC
Q 014352 119 QNFTNILGQGAFGPVYKATMPS-GGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSN 197 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 197 (426)
+++..-||.|+||.||++..+. +-..|-|++........+++.-|++||+.+.||+||++++.|+..+.+++..|||+|
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 4566679999999999999764 445677888766666667899999999999999999999999999999999999999
Q ss_pred CChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccccc-CCCcccC
Q 014352 198 GSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF-DGRNSGL 276 (426)
Q Consensus 198 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~-~~~~~~~ 276 (426)
|-.+.++-.-+++|+..++..++.+++.||.|||+++ |||||||+.|||++-+|.++|+|||++..... ......+
T Consensus 114 GAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDsF 190 (1187)
T KOG0579|consen 114 GAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDSF 190 (1187)
T ss_pred chHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhHHhhhccc
Confidence 9999999888889999999999999999999999999 99999999999999999999999999864332 2344678
Q ss_pred ccccCccCcccc-----ccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHH
Q 014352 277 KGTYGYIDPAYI-----STNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVR 351 (426)
Q Consensus 277 ~gt~~y~aPE~~-----~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (426)
.||+.|||||+. ...+|+.++||||||++|.||..+.+|.........+-.+.....+.++ .+...+.
T Consensus 191 IGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLl-------qPS~Ws~ 263 (1187)
T KOG0579|consen 191 IGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLL-------QPSHWSR 263 (1187)
T ss_pred cCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCccc-------Ccchhhh
Confidence 999999999976 5678999999999999999999999999887666555444443333222 2334567
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 352 ELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 352 ~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
.+.+++.+||.+||+.||++++++++
T Consensus 264 ~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 264 SFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred HHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 89999999999999999999999876
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=310.16 Aligned_cols=244 Identities=24% Similarity=0.464 Sum_probs=199.4
Q ss_pred ccccCCCeeEEEEEeCCCcEEEEEEeccCCcc-ChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCCCChhH
Q 014352 124 ILGQGAFGPVYKATMPSGGVAAIKVLASDSHQ-GEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSN 202 (426)
Q Consensus 124 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~ 202 (426)
+||+|+||.||+|...++..+|+|.+...... ....+.+|++++++++||||+++++++...+..++||||+++++|.+
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 81 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS 81 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHH
Confidence 69999999999999888889999998755322 23468899999999999999999999999999999999999999999
Q ss_pred HhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCC--cccCcccc
Q 014352 203 LIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGR--NSGLKGTY 280 (426)
Q Consensus 203 ~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~--~~~~~gt~ 280 (426)
++......+++..++.++.+++.||.|||+++ ++|+||||+||+++.++.+||+|||++........ .....++.
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~ 158 (250)
T cd05085 82 FLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPI 158 (250)
T ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCcc
Confidence 98766666899999999999999999999998 99999999999999999999999999864322111 11223456
Q ss_pred CccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHHHHH
Q 014352 281 GYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHK 359 (426)
Q Consensus 281 ~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 359 (426)
.|+|||++.+..++.++||||||+++|++++ |..||.............. ......+...+..+.+++.+
T Consensus 159 ~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~li~~ 229 (250)
T cd05085 159 KWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEK---------GYRMSCPQKCPDDVYKVMQR 229 (250)
T ss_pred cccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHc---------CCCCCCCCCCCHHHHHHHHH
Confidence 7999999998899999999999999999998 9999875433222111111 11111222345689999999
Q ss_pred cccCCCCCCCCHHHHHHHHH
Q 014352 360 CLHKTPRKRPSIGEVTQALL 379 (426)
Q Consensus 360 cl~~~p~~RPs~~evl~~L~ 379 (426)
||+.+|++||++.++++.|.
T Consensus 230 ~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 230 CWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HcccCcccCCCHHHHHHHhc
Confidence 99999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=324.69 Aligned_cols=242 Identities=28% Similarity=0.406 Sum_probs=190.8
Q ss_pred hhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc-cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCC
Q 014352 120 NFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH-QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSN 197 (426)
Q Consensus 120 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 197 (426)
++.+.||+|+||.||+|+.. +++.||+|++..... .....+.+|++++++++|+||+++++++...+.+++||||+++
T Consensus 77 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 156 (353)
T PLN00034 77 ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDG 156 (353)
T ss_pred hhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCC
Confidence 34568999999999999875 688999999865432 2235788999999999999999999999999999999999999
Q ss_pred CChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC-CCcccC
Q 014352 198 GSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD-GRNSGL 276 (426)
Q Consensus 198 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-~~~~~~ 276 (426)
|+|.+.. ..+...+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..... ......
T Consensus 157 ~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~ 228 (353)
T PLN00034 157 GSLEGTH-----IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS 228 (353)
T ss_pred Ccccccc-----cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccccccccc
Confidence 9986532 3566778889999999999999998 999999999999999999999999998754322 122345
Q ss_pred ccccCccCcccccc-----CCCCcchhhHHHHHHHHHHHhCCCCCCchHH--HHHHhhccccchhhhhhhhhcccCCHHH
Q 014352 277 KGTYGYIDPAYIST-----NKFTMKSDIFSFGVIIFELITAIHPHQNLME--YVNLASMSQDGVDEILDKQLVGACNIQE 349 (426)
Q Consensus 277 ~gt~~y~aPE~~~~-----~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (426)
.||..|+|||++.. ...+.++|||||||++|||++|+.||..... +..... .+........+...
T Consensus 229 ~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~--------~~~~~~~~~~~~~~ 300 (353)
T PLN00034 229 VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMC--------AICMSQPPEAPATA 300 (353)
T ss_pred ccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH--------HHhccCCCCCCCcc
Confidence 78999999998843 2335689999999999999999999963211 110000 00000011112234
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 350 VRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 350 ~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
..++.+++.+||+.||++|||+.|++++
T Consensus 301 ~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 301 SREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 5679999999999999999999999986
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=304.52 Aligned_cols=255 Identities=23% Similarity=0.303 Sum_probs=203.8
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccC--hHHHHHHHHHHhcCCCCceeeEEeEEEeC--CeEEEEEE
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQG--EKEFQTEVSLLGRLHHRNLVNLIGYCVDK--GKYMLIYE 193 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e 193 (426)
|+..+.|++|+||.||+|+++ +++.||+|+++.+.... .-.-.+|+.+|.+++|||||.+-.+.... +..|||||
T Consensus 78 fe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe 157 (419)
T KOG0663|consen 78 FEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVME 157 (419)
T ss_pred HHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHH
Confidence 344568999999999999976 78899999998654221 12357899999999999999999988764 57999999
Q ss_pred ecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC-CC
Q 014352 194 FMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD-GR 272 (426)
Q Consensus 194 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-~~ 272 (426)
||+. +|..++..-..++...+...+..|+++|+.|||++. |+||||||+|+|+++.|.+||+|||+|+..... ..
T Consensus 158 ~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~ 233 (419)
T KOG0663|consen 158 YVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKP 233 (419)
T ss_pred HHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcCCccc
Confidence 9977 999999887788999999999999999999999999 999999999999999999999999999976544 34
Q ss_pred cccCccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccc--cchhhhhhhhh--------
Q 014352 273 NSGLKGTYGYIDPAYISTN-KFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQ--DGVDEILDKQL-------- 341 (426)
Q Consensus 273 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~-------- 341 (426)
.+..+-|..|.|||.+.+. .|+...|+||+|||+.|++++++-|.+..+...+..+.. +...+.+.+.+
T Consensus 234 ~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~ 313 (419)
T KOG0663|consen 234 YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKK 313 (419)
T ss_pred CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhc
Confidence 5667889999999998765 699999999999999999999999988666544433211 00001011110
Q ss_pred ---cc--------cCC-HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 342 ---VG--------ACN-IQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 342 ---~~--------~~~-~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
.. ... ....+.-++|+...|..||.+|.|+.+.+++
T Consensus 314 ~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 314 MTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred cccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 00 000 0123567889999999999999999999876
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=314.56 Aligned_cols=253 Identities=25% Similarity=0.375 Sum_probs=202.3
Q ss_pred HHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEec
Q 014352 117 ATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 195 (426)
..|.+.+.||+|+||.||+|+.. ++..+|+|++..........+.+|+.++++++||||+++++++...+..++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 34667789999999999999974 77889999987654444567889999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC-Ccc
Q 014352 196 SNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG-RNS 274 (426)
Q Consensus 196 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-~~~ 274 (426)
++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++....... ...
T Consensus 89 ~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~ 164 (267)
T cd06646 89 GGGSLQDIYHVT-GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRK 164 (267)
T ss_pred CCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccccccC
Confidence 999999988544 46899999999999999999999988 9999999999999999999999999987543221 223
Q ss_pred cCccccCccCccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHH
Q 014352 275 GLKGTYGYIDPAYIS---TNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVR 351 (426)
Q Consensus 275 ~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (426)
...++..|+|||.+. ...++.++||||||+++|||++|..||...........+...... .+... .....+.
T Consensus 165 ~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~--~~~~~~~ 239 (267)
T cd06646 165 SFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQ---PPKLK--DKTKWSS 239 (267)
T ss_pred ccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCC---CCCCc--cccccCH
Confidence 456889999999884 445788999999999999999999998654332221111111100 00000 0112346
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014352 352 ELARIGHKCLHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 352 ~l~~l~~~cl~~~p~~RPs~~evl~~L 378 (426)
.+.+++.+||+.+|++|||+.+++++|
T Consensus 240 ~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 240 TFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred HHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 789999999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=314.16 Aligned_cols=247 Identities=27% Similarity=0.481 Sum_probs=195.7
Q ss_pred ccccCCCeeEEEEEeCC-Cc--EEEEEEeccCC-ccChHHHHHHHHHHhcC-CCCceeeEEeEEEeCCeEEEEEEecCCC
Q 014352 124 ILGQGAFGPVYKATMPS-GG--VAAIKVLASDS-HQGEKEFQTEVSLLGRL-HHRNLVNLIGYCVDKGKYMLIYEFMSNG 198 (426)
Q Consensus 124 ~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g 198 (426)
.||+|+||.||+|.+.+ +. .+++|.+.... ......+.+|++++.++ +||||+++++++...+..+++|||+++|
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 81 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence 69999999999999753 33 46888876432 23345788999999999 7999999999999999999999999999
Q ss_pred ChhHHhhhcc---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecC
Q 014352 199 SLSNLIYSEE---------------RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGL 263 (426)
Q Consensus 199 sL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 263 (426)
+|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+
T Consensus 82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCCC
Confidence 9999986432 24789999999999999999999988 99999999999999999999999999
Q ss_pred ccccccCCCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhc
Q 014352 264 SKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLV 342 (426)
Q Consensus 264 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (426)
+..............+..|+|||++....++.++||||||+++|||++ |..||...........+. ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~---------~~~~ 229 (270)
T cd05047 159 SRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP---------QGYR 229 (270)
T ss_pred ccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHh---------CCCC
Confidence 863221111222234567999999988899999999999999999997 999986532221111111 1111
Q ss_pred ccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 014352 343 GACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIK 382 (426)
Q Consensus 343 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 382 (426)
...+......+.+++.+||+.||.+|||+.++++.|..+.
T Consensus 230 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 230 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 1112223457899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=313.04 Aligned_cols=253 Identities=23% Similarity=0.398 Sum_probs=203.3
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc---cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEe
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH---QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEF 194 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 194 (426)
|.+.+.||+|+||.||+|+.. ++..+|+|.+..... .....+.+|+.++++++||||+++++++.+.+..++++||
T Consensus 4 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 83 (267)
T cd08228 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLEL 83 (267)
T ss_pred eeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEe
Confidence 556778999999999999875 788999998764322 2234688999999999999999999999999999999999
Q ss_pred cCCCChhHHhhh---ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC
Q 014352 195 MSNGSLSNLIYS---EERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG 271 (426)
Q Consensus 195 ~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 271 (426)
+++|+|.+++.. ....++...+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~ 160 (267)
T cd08228 84 ADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred cCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence 999999988843 2345888999999999999999999998 9999999999999999999999999987543221
Q ss_pred -CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHH-HHHhhccccchhhhhhh-hhcccCCHH
Q 014352 272 -RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEY-VNLASMSQDGVDEILDK-QLVGACNIQ 348 (426)
Q Consensus 272 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~ 348 (426)
......++..|+|||.+.+..++.++|+||||+++|||++|..||...... .... ..+.. .........
T Consensus 161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~--------~~~~~~~~~~~~~~~ 232 (267)
T cd08228 161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLC--------QKIEQCDYPPLPTEH 232 (267)
T ss_pred HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHH--------HHHhcCCCCCCChhh
Confidence 122356888999999998888999999999999999999999998542211 0000 00000 111111223
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 014352 349 EVRELARIGHKCLHKTPRKRPSIGEVTQALLKIK 382 (426)
Q Consensus 349 ~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 382 (426)
....+.+++.+||+.+|++||++.++++.|+.++
T Consensus 233 ~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 233 YSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred cCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 4567999999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=326.10 Aligned_cols=240 Identities=28% Similarity=0.395 Sum_probs=195.5
Q ss_pred ccccCCCeeEEEEEeC-CCcEEEEEEeccCC---ccChHHHHHHHHHHhcC-CCCceeeEEeEEEeCCeEEEEEEecCCC
Q 014352 124 ILGQGAFGPVYKATMP-SGGVAAIKVLASDS---HQGEKEFQTEVSLLGRL-HHRNLVNLIGYCVDKGKYMLIYEFMSNG 198 (426)
Q Consensus 124 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g 198 (426)
.||+|+||.||+|+.. +++.+|+|++.... ....+.+..|.+++..+ +||||+++++++.+.+..++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 81 (321)
T cd05591 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG 81 (321)
T ss_pred ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCC
Confidence 6999999999999875 57899999987542 12234577888888866 7999999999999999999999999999
Q ss_pred ChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccccc-CCCcccCc
Q 014352 199 SLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF-DGRNSGLK 277 (426)
Q Consensus 199 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~-~~~~~~~~ 277 (426)
+|...+... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++..... ........
T Consensus 82 ~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (321)
T cd05591 82 DLMFQIQRS-RKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFC 157 (321)
T ss_pred cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCccccccc
Confidence 999988544 45899999999999999999999998 99999999999999999999999999874322 22234456
Q ss_pred cccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHHH
Q 014352 278 GTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIG 357 (426)
Q Consensus 278 gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 357 (426)
||+.|+|||++.+..++.++|||||||++|||++|..||...........+.... . ..+...+.++.+++
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~--------~--~~p~~~~~~~~~ll 227 (321)
T cd05591 158 GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDD--------V--LYPVWLSKEAVSIL 227 (321)
T ss_pred cCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--------C--CCCCCCCHHHHHHH
Confidence 8999999999999999999999999999999999999997654333222221111 0 01112346788999
Q ss_pred HHcccCCCCCCC-------CHHHHHHH
Q 014352 358 HKCLHKTPRKRP-------SIGEVTQA 377 (426)
Q Consensus 358 ~~cl~~~p~~RP-------s~~evl~~ 377 (426)
.+||+.||++|| ++.+++++
T Consensus 228 ~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 228 KAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred HHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 999999999999 77888765
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=326.98 Aligned_cols=249 Identities=27% Similarity=0.379 Sum_probs=211.4
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCcc--ChHHHHHHHHHHhcCCCCceeeEEeEEEeCCe-EEEEEE
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQ--GEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGK-YMLIYE 193 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~lv~e 193 (426)
.|.+.+++|+|+||.++..+.+ ++..+++|.+...... .++...+|+.++++++|||||.+.+.|..++. +++||+
T Consensus 5 ~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~ 84 (426)
T KOG0589|consen 5 NYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVME 84 (426)
T ss_pred hhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEe
Confidence 4667789999999999999865 6678899988765322 23467899999999999999999999999888 999999
Q ss_pred ecCCCChhHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC-
Q 014352 194 FMSNGSLSNLIYSEE-RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG- 271 (426)
Q Consensus 194 ~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~- 271 (426)
||+||+|.+.+.... ..++.+.+..++.|++.|+.|||++. |+|||||+.||+++.++.+||.|||+|+......
T Consensus 85 Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~ 161 (426)
T KOG0589|consen 85 YCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS 161 (426)
T ss_pred ecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCchh
Confidence 999999999997655 67889999999999999999999888 9999999999999999999999999999776655
Q ss_pred CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHH
Q 014352 272 RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVR 351 (426)
Q Consensus 272 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (426)
......||+.||.||.+.+.+|..|+|+|||||++|||++-+.+|....-...... +.+....+.+...+.
T Consensus 162 ~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~k---------i~~~~~~Plp~~ys~ 232 (426)
T KOG0589|consen 162 LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILK---------INRGLYSPLPSMYSS 232 (426)
T ss_pred hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHH---------HhhccCCCCCccccH
Confidence 66778999999999999999999999999999999999999999975322111111 111122334556778
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014352 352 ELARIGHKCLHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 352 ~l~~l~~~cl~~~p~~RPs~~evl~~L 378 (426)
++..++..|++.+|+.||++.+++.+.
T Consensus 233 el~~lv~~~l~~~P~~RPsa~~LL~~P 259 (426)
T KOG0589|consen 233 ELRSLVKSMLRKNPEHRPSALELLRRP 259 (426)
T ss_pred HHHHHHHHHhhcCCccCCCHHHHhhCh
Confidence 999999999999999999999999873
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=318.92 Aligned_cols=244 Identities=27% Similarity=0.394 Sum_probs=194.1
Q ss_pred cccCCCeeEEEEEeC-CCcEEEEEEeccCCcc---ChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCCCCh
Q 014352 125 LGQGAFGPVYKATMP-SGGVAAIKVLASDSHQ---GEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSL 200 (426)
Q Consensus 125 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 200 (426)
||+|+||+||++... +++.+|+|.+...... ..+.+..|++++++++||||+++.+++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999875 7789999998654222 224577899999999999999999999999999999999999999
Q ss_pred hHHhhh---ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC-CcccC
Q 014352 201 SNLIYS---EERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG-RNSGL 276 (426)
Q Consensus 201 ~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-~~~~~ 276 (426)
..++.. ....+++..+..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 157 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY 157 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccccc
Confidence 988753 2356899999999999999999999998 9999999999999999999999999987533221 22345
Q ss_pred ccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHH
Q 014352 277 KGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARI 356 (426)
Q Consensus 277 ~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 356 (426)
.||+.|+|||.+.+..++.++||||||+++|||++|+.||............. ....... ...+...+..+.++
T Consensus 158 ~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~----~~~~~~~--~~~~~~~~~~~~~l 231 (280)
T cd05608 158 AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK----QRILNDS--VTYPDKFSPASKSF 231 (280)
T ss_pred CCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHH----HhhcccC--CCCcccCCHHHHHH
Confidence 78999999999999999999999999999999999999997532211100000 0000000 11122345678999
Q ss_pred HHHcccCCCCCCC-----CHHHHHHH
Q 014352 357 GHKCLHKTPRKRP-----SIGEVTQA 377 (426)
Q Consensus 357 ~~~cl~~~p~~RP-----s~~evl~~ 377 (426)
+.+||+.||++|| ++.+++++
T Consensus 232 i~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 232 CEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred HHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 9999999999999 66777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=361.47 Aligned_cols=263 Identities=26% Similarity=0.447 Sum_probs=204.6
Q ss_pred CChhHHHHHHhhhhcccccCCCeeEEEEEe-CCCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCe
Q 014352 109 YAYKDIQKATQNFTNILGQGAFGPVYKATM-PSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGK 187 (426)
Q Consensus 109 ~~~~~l~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 187 (426)
+..+++... +...+.||+|+||.||+|.. .++..||+|.+...... ...|++.+++++|||||+++++|.+.+.
T Consensus 683 ~~~~~~~~~-~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~ 757 (968)
T PLN00113 683 ITINDILSS-LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKG 757 (968)
T ss_pred hhHHHHHhh-CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCC
Confidence 344555443 34456899999999999997 47889999988643321 2356889999999999999999999999
Q ss_pred EEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccc
Q 014352 188 YMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEE 267 (426)
Q Consensus 188 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 267 (426)
.++||||+++|+|.++++ .++|..+..++.|+++||+|||+...++|+||||||+||+++.++..++. ||.....
T Consensus 758 ~~lv~Ey~~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~ 832 (968)
T PLN00113 758 AYLIHEYIEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL 832 (968)
T ss_pred CEEEEeCCCCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccc
Confidence 999999999999999994 38999999999999999999996644559999999999999999888875 6665432
Q ss_pred ccCCCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchH-------HHHHHhhccccchhhhhhhh
Q 014352 268 VFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLM-------EYVNLASMSQDGVDEILDKQ 340 (426)
Q Consensus 268 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~-------~~~~~~~~~~~~~~~~~~~~ 340 (426)
. ......+|+.|+|||++.+..++.++|||||||++|||+||+.||.... .+... .........++++.
T Consensus 833 ~---~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 908 (968)
T PLN00113 833 C---TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARY-CYSDCHLDMWIDPS 908 (968)
T ss_pred c---cCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHH-hcCccchhheeCcc
Confidence 1 1223367899999999999999999999999999999999999985321 11111 01111223334444
Q ss_pred hcc--cCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHh
Q 014352 341 LVG--ACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRH 385 (426)
Q Consensus 341 ~~~--~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~ 385 (426)
+.. ..+.....++.+++.+||+.||++||||.++++.|+.+.+..
T Consensus 909 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~ 955 (968)
T PLN00113 909 IRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS 955 (968)
T ss_pred ccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence 322 223456678899999999999999999999999999886533
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=328.24 Aligned_cols=248 Identities=25% Similarity=0.381 Sum_probs=194.3
Q ss_pred ccccCCCeeEEEEEeC-CCcEEEEEEeccCCc---cChHHHHHHHHHHhcC-CCCceeeEEeEEEeCCeEEEEEEecCCC
Q 014352 124 ILGQGAFGPVYKATMP-SGGVAAIKVLASDSH---QGEKEFQTEVSLLGRL-HHRNLVNLIGYCVDKGKYMLIYEFMSNG 198 (426)
Q Consensus 124 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g 198 (426)
.||+|+||.||++... ++..||+|+++.... .....+..|..++.++ +||||+++++++.+.+.+++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g 81 (329)
T cd05588 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGG 81 (329)
T ss_pred eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 6999999999999875 678999999975422 2234578899999988 7999999999999999999999999999
Q ss_pred ChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccccc-CCCcccCc
Q 014352 199 SLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF-DGRNSGLK 277 (426)
Q Consensus 199 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~-~~~~~~~~ 277 (426)
+|..++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.... ........
T Consensus 82 ~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (329)
T cd05588 82 DLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFC 157 (329)
T ss_pred CHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCCCcccccc
Confidence 999888544 46999999999999999999999998 99999999999999999999999999874222 22334567
Q ss_pred cccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchh-hhhhhhhcccCCHHHHHHHHHH
Q 014352 278 GTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVD-EILDKQLVGACNIQEVRELARI 356 (426)
Q Consensus 278 gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~l 356 (426)
||+.|+|||++.+..++.++|+|||||++|||++|+.||.................. .+..... ..+...+..+.++
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~p~~~~~~~~~l 235 (329)
T cd05588 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI--RIPRSLSVKASSV 235 (329)
T ss_pred CCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC--CCCCCCCHHHHHH
Confidence 999999999999999999999999999999999999999632110000000000000 0111111 1122344678999
Q ss_pred HHHcccCCCCCCCC------HHHHHHH
Q 014352 357 GHKCLHKTPRKRPS------IGEVTQA 377 (426)
Q Consensus 357 ~~~cl~~~p~~RPs------~~evl~~ 377 (426)
+.+||+.||.+||+ +.+++++
T Consensus 236 i~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 236 LKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred HHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 99999999999997 5677654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=312.59 Aligned_cols=238 Identities=20% Similarity=0.368 Sum_probs=190.3
Q ss_pred ccccCCCeeEEEEEeCCC-------------cEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEE
Q 014352 124 ILGQGAFGPVYKATMPSG-------------GVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYML 190 (426)
Q Consensus 124 ~lg~G~~g~Vy~~~~~~~-------------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 190 (426)
.||+|+||.||+|++.+. ..+++|.+..........|.+|+.+++.++||||+++++++......++
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l 81 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM 81 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence 689999999999985321 2588888766544444578889999999999999999999999989999
Q ss_pred EEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCc-------EEEeeecC
Q 014352 191 IYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMR-------AKVADFGL 263 (426)
Q Consensus 191 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~-------~kl~Dfgl 263 (426)
||||+++|+|..++......+++..++.++.|++.||.|||+++ |+||||||+|||++.++. ++++|||+
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~ 158 (262)
T cd05077 82 VEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSDPGI 158 (262)
T ss_pred EEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCCCCC
Confidence 99999999999998766667999999999999999999999998 999999999999987664 89999999
Q ss_pred ccccccCCCcccCccccCccCccccc-cCCCCcchhhHHHHHHHHHHH-hCCCCCCchHHHHHHhhccccchhhhhhhhh
Q 014352 264 SKEEVFDGRNSGLKGTYGYIDPAYIS-TNKFTMKSDIFSFGVIIFELI-TAIHPHQNLMEYVNLASMSQDGVDEILDKQL 341 (426)
Q Consensus 264 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~S~Gvvl~el~-tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (426)
+.... ......++..|+|||.+. +..++.++||||||+++|||+ +|..|+......... .......
T Consensus 159 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~---------~~~~~~~ 226 (262)
T cd05077 159 PITVL---SRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE---------RFYEGQC 226 (262)
T ss_pred Ccccc---CcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH---------HHHhcCc
Confidence 86432 223345788999999986 567899999999999999997 588887643211100 0001111
Q ss_pred cccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014352 342 VGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 342 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 378 (426)
. ........+.+++.+||+.||++||++.++++.+
T Consensus 227 ~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 227 M--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred c--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 0 0111235789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=325.48 Aligned_cols=243 Identities=28% Similarity=0.404 Sum_probs=194.2
Q ss_pred hhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC---ccChHHHHHHHHHH---hcCCCCceeeEEeEEEeCCeEEEEE
Q 014352 120 NFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS---HQGEKEFQTEVSLL---GRLHHRNLVNLIGYCVDKGKYMLIY 192 (426)
Q Consensus 120 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l---~~l~h~niv~~~~~~~~~~~~~lv~ 192 (426)
.+.+.||+|+||.||+|... +++.||+|++.... ....+.+..|++++ ++++||||+++++++...+..|+||
T Consensus 2 ~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~ 81 (324)
T cd05589 2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVM 81 (324)
T ss_pred eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEE
Confidence 45678999999999999875 68899999987542 12234566666654 5678999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccccc-CC
Q 014352 193 EFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF-DG 271 (426)
Q Consensus 193 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~-~~ 271 (426)
||+++|+|...+.. ..+++.....++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++.... ..
T Consensus 82 E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05589 82 EYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD 156 (324)
T ss_pred cCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC
Confidence 99999999988743 45899999999999999999999998 99999999999999999999999999874322 22
Q ss_pred CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHH
Q 014352 272 RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVR 351 (426)
Q Consensus 272 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (426)
......|++.|+|||.+.+..++.++|||||||++|||++|..||...........+... . ...+...+.
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~--------~--~~~p~~~~~ 226 (324)
T cd05589 157 RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND--------E--VRYPRFLSR 226 (324)
T ss_pred cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------C--CCCCCCCCH
Confidence 234567999999999999999999999999999999999999999764332221111110 0 011222346
Q ss_pred HHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 014352 352 ELARIGHKCLHKTPRKRP-----SIGEVTQA 377 (426)
Q Consensus 352 ~l~~l~~~cl~~~p~~RP-----s~~evl~~ 377 (426)
.+.+++.+||+.||.+|| ++.+++++
T Consensus 227 ~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 227 EAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred HHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 788999999999999999 56666654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=313.00 Aligned_cols=248 Identities=25% Similarity=0.379 Sum_probs=213.2
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCC
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSN 197 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 197 (426)
+++.++||+|+||.||++.++ +|+++|||.+..+ .+.+++..|+.+|+++..|++|+++|.+.....+++|||||..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 345678999999999999875 8999999998654 4567899999999999999999999999999999999999999
Q ss_pred CChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC-CCcccC
Q 014352 198 GSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD-GRNSGL 276 (426)
Q Consensus 198 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-~~~~~~ 276 (426)
||+.+.++..+++|+..++..++...++||+|||... -+|||||..|||++.+|.+||+|||.+-..... ...+..
T Consensus 113 GSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNTV 189 (502)
T KOG0574|consen 113 GSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNTV 189 (502)
T ss_pred CcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCcc
Confidence 9999999988899999999999999999999999987 799999999999999999999999999765433 344678
Q ss_pred ccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHH
Q 014352 277 KGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARI 356 (426)
Q Consensus 277 ~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 356 (426)
.||+-|||||++..-.|+.++||||||++..||..|++||.+..+...+..+.....+ . -..+...+.++.++
T Consensus 190 IGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPP-----T--F~KPE~WS~~F~DF 262 (502)
T KOG0574|consen 190 IGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPP-----T--FKKPEEWSSEFNDF 262 (502)
T ss_pred ccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCC-----C--CCChHhhhhHHHHH
Confidence 8999999999999999999999999999999999999999876554433332222111 1 12244567889999
Q ss_pred HHHcccCCCCCCCCHHHHHHHH
Q 014352 357 GHKCLHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 357 ~~~cl~~~p~~RPs~~evl~~L 378 (426)
++.||-++|++|-|+.+++++-
T Consensus 263 i~~CLiK~PE~R~TA~~L~~H~ 284 (502)
T KOG0574|consen 263 IRSCLIKKPEERKTALRLCEHT 284 (502)
T ss_pred HHHHhcCCHHHHHHHHHHhhhh
Confidence 9999999999999999987763
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=316.78 Aligned_cols=252 Identities=27% Similarity=0.471 Sum_probs=201.5
Q ss_pred hhhcccccCCCeeEEEEEeC------CCcEEEEEEeccCCc-cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEE
Q 014352 120 NFTNILGQGAFGPVYKATMP------SGGVAAIKVLASDSH-QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIY 192 (426)
Q Consensus 120 ~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 192 (426)
.+.+.||+|+||.||+|... +...+++|.+..... .....+.+|+.+++.++||||+++++.+...+..++++
T Consensus 3 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (290)
T cd05045 3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIV 82 (290)
T ss_pred cccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEE
Confidence 45678999999999999853 224688888865432 22357889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhc-----------------------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEE
Q 014352 193 EFMSNGSLSNLIYSE-----------------------ERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANIL 249 (426)
Q Consensus 193 e~~~~gsL~~~l~~~-----------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil 249 (426)
||+++|+|.+++... ...+++..++.++.|++.||.|||+.+ ++||||||+||+
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~nil 159 (290)
T cd05045 83 EYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARNVL 159 (290)
T ss_pred EecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhheEE
Confidence 999999999988532 134789999999999999999999988 999999999999
Q ss_pred ecCCCcEEEeeecCccccccCC---CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHH
Q 014352 250 LDHFMRAKVADFGLSKEEVFDG---RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNL 325 (426)
Q Consensus 250 l~~~~~~kl~Dfgl~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~ 325 (426)
+++++.+||+|||+++...... ......++..|+|||++.+..++.++||||||+++|||++ |..||.........
T Consensus 160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~ 239 (290)
T cd05045 160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLF 239 (290)
T ss_pred EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 9999999999999987432221 1223345678999999988889999999999999999998 99998754322211
Q ss_pred hhccccchhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 014352 326 ASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQ 383 (426)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 383 (426)
. ..........+...+..+.+++.+||+.+|++||++.++++.|+++..
T Consensus 240 ~---------~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 240 N---------LLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred H---------HHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 1 111111111222344679999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=337.62 Aligned_cols=248 Identities=25% Similarity=0.326 Sum_probs=199.6
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc--cChHHHHHHHHHHhcCCCCceeeEEeEEEeCC--------
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH--QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKG-------- 186 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-------- 186 (426)
+|.+.+.||+|+||+||+++.. +++.||+|++..... .....+.+|+.++..++|+|+++++..+...+
T Consensus 33 rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~ 112 (496)
T PTZ00283 33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVL 112 (496)
T ss_pred CEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccce
Confidence 5777889999999999999864 788999999865432 22346788999999999999999988775432
Q ss_pred eEEEEEEecCCCChhHHhhhc---cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecC
Q 014352 187 KYMLIYEFMSNGSLSNLIYSE---ERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGL 263 (426)
Q Consensus 187 ~~~lv~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 263 (426)
.+++||||+++|+|.+++... ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 113 ~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~DFGl 189 (496)
T PTZ00283 113 MIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLGDFGF 189 (496)
T ss_pred EEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEEeccc
Confidence 368999999999999998643 356899999999999999999999998 99999999999999999999999999
Q ss_pred ccccccC---CCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhh
Q 014352 264 SKEEVFD---GRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQ 340 (426)
Q Consensus 264 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (426)
++..... .......||+.|+|||++.+..++.++|||||||++|||++|..||........+...... .
T Consensus 190 s~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~--------~ 261 (496)
T PTZ00283 190 SKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAG--------R 261 (496)
T ss_pred CeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC--------C
Confidence 8753321 1223467999999999999999999999999999999999999999753322111111110 0
Q ss_pred hcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 341 LVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 341 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
....+...+..+.+++.+||+.||.+||++.+++++
T Consensus 262 -~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 262 -YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred -CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 011122345679999999999999999999999876
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=316.86 Aligned_cols=253 Identities=25% Similarity=0.405 Sum_probs=200.3
Q ss_pred HHHHhhhhcccccCCCeeEEEEEeC------CCcEEEEEEeccCCc-cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCe
Q 014352 115 QKATQNFTNILGQGAFGPVYKATMP------SGGVAAIKVLASDSH-QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGK 187 (426)
Q Consensus 115 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 187 (426)
....+++.+.||+|+||.||+|... .+..+|+|.+..... ....++.+|+.+++.++||||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3455777889999999999999753 245799998864322 233468899999999999999999999999999
Q ss_pred EEEEEEecCCCChhHHhhhcc---------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEE
Q 014352 188 YMLIYEFMSNGSLSNLIYSEE---------RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKV 258 (426)
Q Consensus 188 ~~lv~e~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 258 (426)
.++||||+++|+|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 999999999999999986432 23678889999999999999999988 999999999999999999999
Q ss_pred eeecCccccccCC---CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchh
Q 014352 259 ADFGLSKEEVFDG---RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVD 334 (426)
Q Consensus 259 ~Dfgl~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 334 (426)
+|||+++...... ......++..|+|||++.+..++.++||||||+++|||++ |..||.................
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~- 239 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGL- 239 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc-
Confidence 9999987432211 1112345778999999998899999999999999999999 7888876433322211111111
Q ss_pred hhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 014352 335 EILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALL 379 (426)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 379 (426)
...+...+..+.+++.+||+.||++|||+.++++.|+
T Consensus 240 --------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 240 --------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred --------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 0112223457899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=327.62 Aligned_cols=248 Identities=25% Similarity=0.383 Sum_probs=192.8
Q ss_pred ccccCCCeeEEEEEeC-CCcEEEEEEeccCCc---cChHHHHHHHHHHhcC-CCCceeeEEeEEEeCCeEEEEEEecCCC
Q 014352 124 ILGQGAFGPVYKATMP-SGGVAAIKVLASDSH---QGEKEFQTEVSLLGRL-HHRNLVNLIGYCVDKGKYMLIYEFMSNG 198 (426)
Q Consensus 124 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g 198 (426)
.||+|+||.||++... +++.+|+|++..... .....+..|+.++.++ +||||+++++++...+..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~ 81 (329)
T cd05618 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG 81 (329)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCC
Confidence 6999999999999975 678999999875422 2234577888888776 7999999999999999999999999999
Q ss_pred ChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccccc-CCCcccCc
Q 014352 199 SLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF-DGRNSGLK 277 (426)
Q Consensus 199 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~-~~~~~~~~ 277 (426)
+|..++... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++.... ........
T Consensus 82 ~L~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (329)
T cd05618 82 DLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC 157 (329)
T ss_pred CHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcccccc
Confidence 999888544 45899999999999999999999998 99999999999999999999999999874322 22234467
Q ss_pred cccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhh-hhhhhhcccCCHHHHHHHHHH
Q 014352 278 GTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDE-ILDKQLVGACNIQEVRELARI 356 (426)
Q Consensus 278 gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~l 356 (426)
||..|+|||++.+..++.++||||||+++|||++|..||................... +.... ...+...+..+.++
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~l 235 (329)
T cd05618 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--IRIPRSLSVKAASV 235 (329)
T ss_pred CCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC--CCCCCCCCHHHHHH
Confidence 8999999999999999999999999999999999999995311100000000000000 00110 11122344678899
Q ss_pred HHHcccCCCCCCCC------HHHHHHH
Q 014352 357 GHKCLHKTPRKRPS------IGEVTQA 377 (426)
Q Consensus 357 ~~~cl~~~p~~RPs------~~evl~~ 377 (426)
+.+||+.||++||+ +.+++++
T Consensus 236 l~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 236 LKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred HHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 99999999999998 4676655
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=313.89 Aligned_cols=259 Identities=24% Similarity=0.468 Sum_probs=194.9
Q ss_pred hhcccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhc--CCCCceeeEEeEEEeCC----eEEEEEEe
Q 014352 121 FTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGR--LHHRNLVNLIGYCVDKG----KYMLIYEF 194 (426)
Q Consensus 121 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~----~~~lv~e~ 194 (426)
+.+++|+|.||.||+|.+ +++.||||++.. .....|.+|.++.+. ++|+||+++++.-.... +++||++|
T Consensus 214 l~eli~~Grfg~V~KaqL-~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~f 289 (534)
T KOG3653|consen 214 LLELIGRGRFGCVWKAQL-DNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEF 289 (534)
T ss_pred hHHHhhcCccceeehhhc-cCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeee
Confidence 456899999999999999 458899999865 345678888888765 58999999999876555 89999999
Q ss_pred cCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcC------CCCCeeecCCCCCCEEecCCCcEEEeeecCccccc
Q 014352 195 MSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEG------AVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEV 268 (426)
Q Consensus 195 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~------~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 268 (426)
.++|||.++|.. ..++|....+|+..+++||+|||+. .+|+|+|||||+.||||.+++++.|+|||+|....
T Consensus 290 h~kGsL~dyL~~--ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~ 367 (534)
T KOG3653|consen 290 HPKGSLCDYLKA--NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLE 367 (534)
T ss_pred ccCCcHHHHHHh--ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEec
Confidence 999999999954 4589999999999999999999974 35789999999999999999999999999997654
Q ss_pred cCC---CcccCccccCccCccccccCC-CC-----cchhhHHHHHHHHHHHhCCCCCC--chHHHHH-Hh-hc-cccchh
Q 014352 269 FDG---RNSGLKGTYGYIDPAYISTNK-FT-----MKSDIFSFGVIIFELITAIHPHQ--NLMEYVN-LA-SM-SQDGVD 334 (426)
Q Consensus 269 ~~~---~~~~~~gt~~y~aPE~~~~~~-~~-----~~~Dv~S~Gvvl~el~tg~~p~~--~~~~~~~-~~-~~-~~~~~~ 334 (426)
... .....+||.+|||||++.+.. +. .+.||||+|.||||+++...-+. ...++.. .. .+ ....+.
T Consensus 368 p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e 447 (534)
T KOG3653|consen 368 PGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLE 447 (534)
T ss_pred CCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHH
Confidence 332 334578999999999986532 22 47899999999999998754331 1111000 00 00 011111
Q ss_pred ---h-hhhhhhcccCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHh
Q 014352 335 ---E-ILDKQLVGACN-----IQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRH 385 (426)
Q Consensus 335 ---~-~~~~~~~~~~~-----~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~ 385 (426)
+ ++....+...+ ...+..+.+.+..||+.||+-|.|+.=+-+.+..+....
T Consensus 448 ~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 448 EMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred HHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 1 11111111111 124567899999999999999999988888888776543
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=332.85 Aligned_cols=248 Identities=25% Similarity=0.351 Sum_probs=202.6
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC---ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEe
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS---HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEF 194 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 194 (426)
|.+.+.||+|+||+||+|... +++.||+|++.... ......+.+|+.++..++||||+++++++.+.+..++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (350)
T cd05573 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEY 82 (350)
T ss_pred ceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcC
Confidence 556789999999999999976 78899999987542 12345688999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC---
Q 014352 195 MSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG--- 271 (426)
Q Consensus 195 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~--- 271 (426)
+++++|.+++... ..++...+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 83 MPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred CCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence 9999999999655 56899999999999999999999988 9999999999999999999999999987543322
Q ss_pred ---------------------------CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHH
Q 014352 272 ---------------------------RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVN 324 (426)
Q Consensus 272 ---------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~ 324 (426)
......||+.|+|||++.+..++.++|||||||++|||++|..||........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 238 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQET 238 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHH
Confidence 22345689999999999999999999999999999999999999976543322
Q ss_pred HhhccccchhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCC-HHHHHHH
Q 014352 325 LASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPS-IGEVTQA 377 (426)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-~~evl~~ 377 (426)
...+.... ...........+..+.+++.+|+. ||.+||+ +.+++++
T Consensus 239 ~~~i~~~~------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 239 YNKIINWK------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHHhccC------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 21111100 011111111135678899999997 9999999 9999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=323.94 Aligned_cols=240 Identities=28% Similarity=0.402 Sum_probs=195.4
Q ss_pred ccccCCCeeEEEEEeC-CCcEEEEEEeccCC---ccChHHHHHHHHHHhcC-CCCceeeEEeEEEeCCeEEEEEEecCCC
Q 014352 124 ILGQGAFGPVYKATMP-SGGVAAIKVLASDS---HQGEKEFQTEVSLLGRL-HHRNLVNLIGYCVDKGKYMLIYEFMSNG 198 (426)
Q Consensus 124 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g 198 (426)
.||+|+||.||++... ++..+|+|++.... ......+..|..++..+ +||||+++++++.+.+.+++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (318)
T cd05570 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGG 81 (318)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 6999999999999876 57789999987542 22234577888898887 6999999999999999999999999999
Q ss_pred ChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC-CCcccCc
Q 014352 199 SLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD-GRNSGLK 277 (426)
Q Consensus 199 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-~~~~~~~ 277 (426)
+|..++... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++..... .......
T Consensus 82 ~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (318)
T cd05570 82 DLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC 157 (318)
T ss_pred CHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCCccccee
Confidence 999988544 45899999999999999999999998 999999999999999999999999998743222 2233456
Q ss_pred cccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHHH
Q 014352 278 GTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIG 357 (426)
Q Consensus 278 gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 357 (426)
||..|+|||++.+..++.++|||||||++|+|++|..||...........+.... . ..+...+..+.+++
T Consensus 158 g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~--------~--~~~~~~~~~~~~li 227 (318)
T cd05570 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDE--------V--RYPRWLSKEAKSIL 227 (318)
T ss_pred cCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC--------C--CCCCcCCHHHHHHH
Confidence 8999999999999999999999999999999999999997543322211111110 0 11122346789999
Q ss_pred HHcccCCCCCCCCH-----HHHHHH
Q 014352 358 HKCLHKTPRKRPSI-----GEVTQA 377 (426)
Q Consensus 358 ~~cl~~~p~~RPs~-----~evl~~ 377 (426)
.+||+.||.+|||+ .+++++
T Consensus 228 ~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 228 KSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred HHHccCCHHHcCCCCCCCHHHHhcC
Confidence 99999999999999 777764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=314.13 Aligned_cols=252 Identities=27% Similarity=0.480 Sum_probs=201.9
Q ss_pred HhhhhcccccCCCeeEEEEEeCC-C---cEEEEEEeccCC-ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEE
Q 014352 118 TQNFTNILGQGAFGPVYKATMPS-G---GVAAIKVLASDS-HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIY 192 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 192 (426)
.+.+.+.||+|+||.||+|.... + ..||+|.+.... ......|..|+.++++++||||+++++++.+++..++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 45677899999999999998752 3 369999987542 223457999999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCC
Q 014352 193 EFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGR 272 (426)
Q Consensus 193 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 272 (426)
||+++++|.+++......+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++........
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~ 161 (269)
T cd05065 85 EFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 161 (269)
T ss_pred ecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence 999999999999766667899999999999999999999998 99999999999999999999999999864332211
Q ss_pred c---c-cC--ccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccC
Q 014352 273 N---S-GL--KGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGAC 345 (426)
Q Consensus 273 ~---~-~~--~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (426)
. . .. ..+..|+|||++.+..++.++||||||+++||+++ |..||...........+.. ......
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~---------~~~~~~ 232 (269)
T cd05065 162 DPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQ---------DYRLPP 232 (269)
T ss_pred ccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHc---------CCcCCC
Confidence 1 1 11 12457999999999999999999999999999886 9999865433222111111 011111
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 014352 346 NIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKI 381 (426)
Q Consensus 346 ~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 381 (426)
+.+.+..+.+++.+||+.+|++||++.+++..|+.+
T Consensus 233 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 233 PMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 223346788999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=327.74 Aligned_cols=242 Identities=28% Similarity=0.406 Sum_probs=208.5
Q ss_pred cccccCCCeeEEEEEeC-CCcEEEEEEeccCCccCh---HHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCCC
Q 014352 123 NILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGE---KEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNG 198 (426)
Q Consensus 123 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 198 (426)
+-||.|+||.||.+++. +..+||||.+.....+.. .++..|+.+|++++|||+|.+-|+|......||||||| -|
T Consensus 32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC-lG 110 (948)
T KOG0577|consen 32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC-LG 110 (948)
T ss_pred HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH-hc
Confidence 46999999999999865 788999999976654443 46788999999999999999999999999999999999 45
Q ss_pred ChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCcccCcc
Q 014352 199 SLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKG 278 (426)
Q Consensus 199 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~g 278 (426)
|-.+++.-..+++-..++..|..+.+.||+|||+.+ .||||||+.|||+++.|.|||+|||.+... .....++|
T Consensus 111 SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~---~PAnsFvG 184 (948)
T KOG0577|consen 111 SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIM---APANSFVG 184 (948)
T ss_pred cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhc---CchhcccC
Confidence 999999888888999999999999999999999999 999999999999999999999999988643 34567889
Q ss_pred ccCccCccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHH
Q 014352 279 TYGYIDPAYIS---TNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELAR 355 (426)
Q Consensus 279 t~~y~aPE~~~---~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 355 (426)
||.|||||++. .+.|+-|+||||||++..||.-.++|+-+......+..+.....+. -...+.++.+.+
T Consensus 185 TPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPt--------Lqs~eWS~~F~~ 256 (948)
T KOG0577|consen 185 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT--------LQSNEWSDYFRN 256 (948)
T ss_pred CccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCC--------CCCchhHHHHHH
Confidence 99999999984 5789999999999999999999999987766655555443332221 124567788999
Q ss_pred HHHHcccCCCCCCCCHHHHHHHHH
Q 014352 356 IGHKCLHKTPRKRPSIGEVTQALL 379 (426)
Q Consensus 356 l~~~cl~~~p~~RPs~~evl~~L~ 379 (426)
++..||++-|.+|||..+++.+--
T Consensus 257 Fvd~CLqKipqeRptse~ll~H~f 280 (948)
T KOG0577|consen 257 FVDSCLQKIPQERPTSEELLKHRF 280 (948)
T ss_pred HHHHHHhhCcccCCcHHHHhhcch
Confidence 999999999999999999988743
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=310.36 Aligned_cols=247 Identities=29% Similarity=0.487 Sum_probs=203.6
Q ss_pred HhhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCC
Q 014352 118 TQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSN 197 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 197 (426)
.+.+.+.||.|+||.||+|... ++.+|+|.+..... ..+.+.+|+.++++++|+||+++++++.+.+..++||||+++
T Consensus 7 ~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 84 (256)
T cd05039 7 ELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAK 84 (256)
T ss_pred hccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCC
Confidence 4566789999999999999874 78899999976644 456789999999999999999999999988899999999999
Q ss_pred CChhHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCcccC
Q 014352 198 GSLSNLIYSEE-RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGL 276 (426)
Q Consensus 198 gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~ 276 (426)
++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||.++..... ....
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~--~~~~ 159 (256)
T cd05039 85 GSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG--QDSG 159 (256)
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccc--cccC
Confidence 99999986544 36899999999999999999999998 999999999999999999999999999865322 1233
Q ss_pred ccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHH
Q 014352 277 KGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELAR 355 (426)
Q Consensus 277 ~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 355 (426)
..+..|+|||++....++.++||||||+++||+++ |..||.............. ......+...+..+.+
T Consensus 160 ~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~ 230 (256)
T cd05039 160 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK---------GYRMEAPEGCPPEVYK 230 (256)
T ss_pred CCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc---------CCCCCCccCCCHHHHH
Confidence 45678999999988889999999999999999997 9999865432221111111 1111112233467899
Q ss_pred HHHHcccCCCCCCCCHHHHHHHHHH
Q 014352 356 IGHKCLHKTPRKRPSIGEVTQALLK 380 (426)
Q Consensus 356 l~~~cl~~~p~~RPs~~evl~~L~~ 380 (426)
++.+||..+|++|||+.++++.|+.
T Consensus 231 li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 231 VMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred HHHHHhccChhhCcCHHHHHHHHhc
Confidence 9999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=318.49 Aligned_cols=260 Identities=25% Similarity=0.435 Sum_probs=205.8
Q ss_pred HHHHHhhhhcccccCCCeeEEEEEeC--------CCcEEEEEEeccCC-ccChHHHHHHHHHHhcC-CCCceeeEEeEEE
Q 014352 114 IQKATQNFTNILGQGAFGPVYKATMP--------SGGVAAIKVLASDS-HQGEKEFQTEVSLLGRL-HHRNLVNLIGYCV 183 (426)
Q Consensus 114 l~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 183 (426)
+....+.+.+.||+|+||.||++... +...+|+|.+.... ......+..|+.+++++ +||||+++++++.
T Consensus 15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (307)
T cd05098 15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 94 (307)
T ss_pred eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 33456788899999999999999752 22469999987542 22335688899999999 7999999999999
Q ss_pred eCCeEEEEEEecCCCChhHHhhhcc---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCE
Q 014352 184 DKGKYMLIYEFMSNGSLSNLIYSEE---------------RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANI 248 (426)
Q Consensus 184 ~~~~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Ni 248 (426)
..+..++||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+.+ ++||||||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Ni 171 (307)
T cd05098 95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV 171 (307)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHhe
Confidence 9999999999999999999996532 24889999999999999999999988 99999999999
Q ss_pred EecCCCcEEEeeecCccccccCC---CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHH
Q 014352 249 LLDHFMRAKVADFGLSKEEVFDG---RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVN 324 (426)
Q Consensus 249 ll~~~~~~kl~Dfgl~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~ 324 (426)
+++.++.+||+|||+++...... ......++..|+|||.+.+..++.++||||||+++|||++ |..||........
T Consensus 172 ll~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~ 251 (307)
T cd05098 172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 251 (307)
T ss_pred EEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH
Confidence 99999999999999987443211 1122234568999999998889999999999999999998 8888865322111
Q ss_pred HhhccccchhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHh
Q 014352 325 LASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRH 385 (426)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~ 385 (426)
.... ........+...+..+.+++.+||..+|++|||+.++++.|.++....
T Consensus 252 ~~~~---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 252 FKLL---------KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred HHHH---------HcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 1111 111111122234468889999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=313.06 Aligned_cols=249 Identities=27% Similarity=0.422 Sum_probs=201.2
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCC
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSN 197 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 197 (426)
|++.+.||.|+||.||+|... ++..+++|.+........+.+.+|+++++.++||||+++++++...+..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 456678999999999999976 5678899988665544456788999999999999999999999999999999999999
Q ss_pred CChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC-CCcccC
Q 014352 198 GSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD-GRNSGL 276 (426)
Q Consensus 198 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-~~~~~~ 276 (426)
++|..++......+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++...... ......
T Consensus 87 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 163 (282)
T cd06643 87 GAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF 163 (282)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccccccccc
Confidence 9999988765667999999999999999999999998 999999999999999999999999998753222 122345
Q ss_pred ccccCccCccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHH
Q 014352 277 KGTYGYIDPAYIS-----TNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVR 351 (426)
Q Consensus 277 ~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (426)
.++..|+|||++. +..++.++|||||||++|||++|..||.................. ....+...+.
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~ 236 (282)
T cd06643 164 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP-------TLAQPSRWSS 236 (282)
T ss_pred cccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCC-------CCCCccccCH
Confidence 6899999999983 455788999999999999999999998764332221111111000 0011222346
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 352 ELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 352 ~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
.+.+++.+||+.||.+||++.+++++
T Consensus 237 ~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 237 EFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 78999999999999999999998865
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=321.75 Aligned_cols=239 Identities=28% Similarity=0.435 Sum_probs=192.4
Q ss_pred ccccCCCeeEEEEEeC-CCcEEEEEEeccCC---ccChHHHHHHHHHHhc-CCCCceeeEEeEEEeCCeEEEEEEecCCC
Q 014352 124 ILGQGAFGPVYKATMP-SGGVAAIKVLASDS---HQGEKEFQTEVSLLGR-LHHRNLVNLIGYCVDKGKYMLIYEFMSNG 198 (426)
Q Consensus 124 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~g 198 (426)
.||+|+||.||+|... ++..||+|.+.... ......+..|..++.. ++||||+++++++.+.+.+++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g 81 (316)
T cd05619 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence 6999999999999976 57789999987542 1223456677778775 48999999999999999999999999999
Q ss_pred ChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccccc-CCCcccCc
Q 014352 199 SLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF-DGRNSGLK 277 (426)
Q Consensus 199 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~-~~~~~~~~ 277 (426)
+|.+++... ..+++.+...++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.... ........
T Consensus 82 ~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05619 82 DLMFHIQSC-HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC 157 (316)
T ss_pred cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeec
Confidence 999998543 45899999999999999999999998 99999999999999999999999999874322 22234557
Q ss_pred cccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHHH
Q 014352 278 GTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIG 357 (426)
Q Consensus 278 gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 357 (426)
||..|+|||++.+..++.++|||||||++|||++|..||...........+... .+ ..+......+.+++
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~------~~----~~~~~~~~~~~~li 227 (316)
T cd05619 158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD------NP----CYPRWLTREAKDIL 227 (316)
T ss_pred CCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------CC----CCCccCCHHHHHHH
Confidence 899999999999999999999999999999999999999754332211111000 00 11122345788999
Q ss_pred HHcccCCCCCCCCHH-HHHH
Q 014352 358 HKCLHKTPRKRPSIG-EVTQ 376 (426)
Q Consensus 358 ~~cl~~~p~~RPs~~-evl~ 376 (426)
.+||+.||++||++. ++++
T Consensus 228 ~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 228 VKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred HHHhccCHhhcCCChHHHHc
Confidence 999999999999997 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=309.88 Aligned_cols=250 Identities=28% Similarity=0.450 Sum_probs=202.4
Q ss_pred HHhhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecC
Q 014352 117 ATQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMS 196 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 196 (426)
.++.+.+.||+|+||.||++.+.++..+|+|.+.... ...+.+.+|++++++++|||++++++++.. +..+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCC
Confidence 4466778999999999999998777789999876543 345678899999999999999999998754 56889999999
Q ss_pred CCChhHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC--Cc
Q 014352 197 NGSLSNLIYSEE-RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG--RN 273 (426)
Q Consensus 197 ~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~--~~ 273 (426)
+++|.+++.... ..+++..+..++.+++.||.|||+.+ ++|+||||+||++++++.++|+|||++....... ..
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05069 84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccccc
Confidence 999999996543 45899999999999999999999988 9999999999999999999999999987542221 11
Q ss_pred ccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHH
Q 014352 274 SGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRE 352 (426)
Q Consensus 274 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (426)
....++..|+|||...+..++.++||||||+++|||++ |..||.+.........+.. ......+...+..
T Consensus 161 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~ 231 (260)
T cd05069 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVER---------GYRMPCPQGCPES 231 (260)
T ss_pred CCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc---------CCCCCCCcccCHH
Confidence 22345678999999998899999999999999999999 8999976433222111111 1111222344567
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 014352 353 LARIGHKCLHKTPRKRPSIGEVTQALLK 380 (426)
Q Consensus 353 l~~l~~~cl~~~p~~RPs~~evl~~L~~ 380 (426)
+.+++.+||+.||++||++.++++.|+.
T Consensus 232 ~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 232 LHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 9999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=323.15 Aligned_cols=251 Identities=27% Similarity=0.384 Sum_probs=216.3
Q ss_pred HHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccC---hHHHHHHHHHHhcCC-CCceeeEEeEEEeCCeEEEE
Q 014352 117 ATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQG---EKEFQTEVSLLGRLH-HRNLVNLIGYCVDKGKYMLI 191 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv 191 (426)
..|.+.+.||+|.||.||+++.. +|+.+|+|.+....... ...+.+|+.+|+++. |||||.+.+.+.+...+++|
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv 114 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV 114 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence 44677789999999999999976 58999999997764433 358999999999998 99999999999999999999
Q ss_pred EEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCC----CcEEEeeecCcccc
Q 014352 192 YEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHF----MRAKVADFGLSKEE 267 (426)
Q Consensus 192 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfgl~~~~ 267 (426)
||++.||.|.+.+... .++......++.|++.++.|||+.+ ++||||||+|+|+... +.+|++|||++...
T Consensus 115 mEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 115 MELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred EEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 9999999999999666 3899999999999999999999998 9999999999999653 47999999999977
Q ss_pred ccCCCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCH
Q 014352 268 VFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNI 347 (426)
Q Consensus 268 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (426)
.........+||+.|+|||++....|+..+||||+|+++|.|++|.+||....+......+..... .+......
T Consensus 190 ~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~------~f~~~~w~ 263 (382)
T KOG0032|consen 190 KPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDF------DFTSEPWD 263 (382)
T ss_pred cCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCC------CCCCCCcc
Confidence 665567788999999999999999999999999999999999999999987654433332222211 33444555
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014352 348 QEVRELARIGHKCLHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 348 ~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 378 (426)
..+..+.+++..|+..||..|+|+.+++++-
T Consensus 264 ~is~~akd~i~~ll~~dp~~R~ta~~~L~Hp 294 (382)
T KOG0032|consen 264 DISESAKDFIRKLLEFDPRKRLTAAQALQHP 294 (382)
T ss_pred ccCHHHHHHHHHhcccCcccCCCHHHHhcCc
Confidence 6678899999999999999999999999973
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=318.07 Aligned_cols=257 Identities=24% Similarity=0.473 Sum_probs=204.2
Q ss_pred HHHHHhhhhcccccCCCeeEEEEEeC------CCcEEEEEEeccCCc-cChHHHHHHHHHHhcC-CCCceeeEEeEEEeC
Q 014352 114 IQKATQNFTNILGQGAFGPVYKATMP------SGGVAAIKVLASDSH-QGEKEFQTEVSLLGRL-HHRNLVNLIGYCVDK 185 (426)
Q Consensus 114 l~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 185 (426)
+....+++.+.||+|+||.||++... +...+|+|.+..... .....+.+|+.++.++ +||||+++++++...
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 34455667789999999999999864 235789998875422 2234688999999999 799999999999999
Q ss_pred CeEEEEEEecCCCChhHHhhhc---------------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEe
Q 014352 186 GKYMLIYEFMSNGSLSNLIYSE---------------ERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILL 250 (426)
Q Consensus 186 ~~~~lv~e~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill 250 (426)
+..+++|||+++|+|..++... ...+++..++.++.|++.||.|||+.+ |+||||||+||++
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEE
Confidence 9999999999999999998532 346899999999999999999999988 9999999999999
Q ss_pred cCCCcEEEeeecCccccccCC---CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHh
Q 014352 251 DHFMRAKVADFGLSKEEVFDG---RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLA 326 (426)
Q Consensus 251 ~~~~~~kl~Dfgl~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~ 326 (426)
+.++.+||+|||+++...... ......++..|+|||.+.+..++.++|||||||++||+++ |..||..........
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 245 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 245 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHH
Confidence 999999999999987543221 1122335678999999998999999999999999999998 999987543221111
Q ss_pred hccccchhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 014352 327 SMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIK 382 (426)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 382 (426)
.+ ........+......+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 246 ~~---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 246 LL---------KEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HH---------HcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 11 111111122233467899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=323.69 Aligned_cols=245 Identities=26% Similarity=0.378 Sum_probs=196.6
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC---ccChHHHHHHHHHHhcCCCC-ceeeEEeEEEeCCeEEEEEE
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS---HQGEKEFQTEVSLLGRLHHR-NLVNLIGYCVDKGKYMLIYE 193 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e 193 (426)
|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+..|..++..++|+ +|+++++++.+.+.+|+|||
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (324)
T cd05587 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 81 (324)
T ss_pred ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence 456678999999999999876 56789999987542 22345678899999999765 58889999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccccc-CCC
Q 014352 194 FMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF-DGR 272 (426)
Q Consensus 194 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~-~~~ 272 (426)
|+++|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++..... ...
T Consensus 82 ~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05587 82 YVNGGDLMYHIQQV-GKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT 157 (324)
T ss_pred CCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCc
Confidence 99999999988544 45899999999999999999999998 99999999999999999999999999874322 222
Q ss_pred cccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHH
Q 014352 273 NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRE 352 (426)
Q Consensus 273 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (426)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.... ...+...+..
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~----------~~~~~~~~~~ 227 (324)
T cd05587 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN----------VSYPKSLSKE 227 (324)
T ss_pred eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC----------CCCCCCCCHH
Confidence 334578999999999999999999999999999999999999997644332222111110 1112223467
Q ss_pred HHHHHHHcccCCCCCCCCH-----HHHHHH
Q 014352 353 LARIGHKCLHKTPRKRPSI-----GEVTQA 377 (426)
Q Consensus 353 l~~l~~~cl~~~p~~RPs~-----~evl~~ 377 (426)
+.+++.+||+.||.+|++. .+++++
T Consensus 228 ~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 228 AVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred HHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 8899999999999999986 566554
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=321.59 Aligned_cols=239 Identities=28% Similarity=0.416 Sum_probs=191.0
Q ss_pred ccccCCCeeEEEEEeC-CCcEEEEEEeccCC---ccChHHHHHHHHHHhc-CCCCceeeEEeEEEeCCeEEEEEEecCCC
Q 014352 124 ILGQGAFGPVYKATMP-SGGVAAIKVLASDS---HQGEKEFQTEVSLLGR-LHHRNLVNLIGYCVDKGKYMLIYEFMSNG 198 (426)
Q Consensus 124 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~g 198 (426)
.||+|+||.||+|... ++..||+|++.... ....+.+..|..++.. .+||||+++++++...+..++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg 81 (316)
T cd05592 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 6999999999999975 67789999987542 1223345566677665 48999999999999999999999999999
Q ss_pred ChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccccc-CCCcccCc
Q 014352 199 SLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF-DGRNSGLK 277 (426)
Q Consensus 199 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~-~~~~~~~~ 277 (426)
+|..++... ..++......++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.... ........
T Consensus 82 ~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 157 (316)
T cd05592 82 DLMFHIQSS-GRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC 157 (316)
T ss_pred cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcccccc
Confidence 999988554 45899999999999999999999998 99999999999999999999999999975322 22334567
Q ss_pred cccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHHH
Q 014352 278 GTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIG 357 (426)
Q Consensus 278 gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 357 (426)
||+.|+|||++.+..++.++|||||||++|||++|..||...........+... ....+......+.+++
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~----------~~~~~~~~~~~~~~ll 227 (316)
T cd05592 158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND----------RPHFPRWISKEAKDCL 227 (316)
T ss_pred CCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC----------CCCCCCCCCHHHHHHH
Confidence 999999999999999999999999999999999999999764332221111110 0111222345788999
Q ss_pred HHcccCCCCCCCCHH-HHHH
Q 014352 358 HKCLHKTPRKRPSIG-EVTQ 376 (426)
Q Consensus 358 ~~cl~~~p~~RPs~~-evl~ 376 (426)
.+||+.||++||++. ++++
T Consensus 228 ~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 228 SKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred HHHccCCHHHcCCChHHHHc
Confidence 999999999999875 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=315.00 Aligned_cols=251 Identities=25% Similarity=0.417 Sum_probs=199.0
Q ss_pred HHhhhhcccccCCCeeEEEEEeCC------CcEEEEEEeccCCc-cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEE
Q 014352 117 ATQNFTNILGQGAFGPVYKATMPS------GGVAAIKVLASDSH-QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYM 189 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 189 (426)
..+.+.+.||+|+||.||+|.+.+ +..|++|.+..... .....|..|+.++++++|+||+++++++.+.+..+
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRF 85 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcE
Confidence 345567889999999999998753 45788998764432 23456899999999999999999999999988999
Q ss_pred EEEEecCCCChhHHhhhcc------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCC---cEEEee
Q 014352 190 LIYEFMSNGSLSNLIYSEE------RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFM---RAKVAD 260 (426)
Q Consensus 190 lv~e~~~~gsL~~~l~~~~------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~D 260 (426)
+||||+++++|.+++.... ..+++..++.++.|++.||.|||+++ ++||||||+||+++.++ .+||+|
T Consensus 86 lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~d 162 (277)
T cd05036 86 ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIAD 162 (277)
T ss_pred EEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEecc
Confidence 9999999999999986543 25899999999999999999999998 99999999999998765 599999
Q ss_pred ecCccccccCCC---cccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhh
Q 014352 261 FGLSKEEVFDGR---NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEI 336 (426)
Q Consensus 261 fgl~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 336 (426)
||+++....... ......+..|+|||++.+..++.++|||||||++|||++ |..||...........+
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~-------- 234 (277)
T cd05036 163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV-------- 234 (277)
T ss_pred CccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH--------
Confidence 999875422111 112233568999999998999999999999999999997 99999764322211111
Q ss_pred hhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 014352 337 LDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALL 379 (426)
Q Consensus 337 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 379 (426)
........+...+..+.+++.+||+.+|++|||+.+++++|.
T Consensus 235 -~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 235 -TGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred -HcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 111111122334467899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=312.45 Aligned_cols=249 Identities=27% Similarity=0.404 Sum_probs=195.8
Q ss_pred hhcccccCCCeeEEEEEeCCC-c--EEEEEEeccCC--ccChHHHHHHHHHHhcCCCCceeeEEeEEEeC------CeEE
Q 014352 121 FTNILGQGAFGPVYKATMPSG-G--VAAIKVLASDS--HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDK------GKYM 189 (426)
Q Consensus 121 ~~~~lg~G~~g~Vy~~~~~~~-~--~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~~ 189 (426)
+.+.||+|+||.||+|.+.++ . .+|+|.++... ....+.+..|+.+++.++||||+++++++... ...+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 457899999999999997643 3 58999886542 22345788999999999999999999987542 2468
Q ss_pred EEEEecCCCChhHHhhh-----ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCc
Q 014352 190 LIYEFMSNGSLSNLIYS-----EERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLS 264 (426)
Q Consensus 190 lv~e~~~~gsL~~~l~~-----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 264 (426)
++|||+++|+|.+++.. ....+++.....++.|++.||.|||+++ |+||||||+|||+++++.+||+|||++
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCcc
Confidence 99999999999988742 2245899999999999999999999988 999999999999999999999999998
Q ss_pred cccccCCC---cccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhh
Q 014352 265 KEEVFDGR---NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQ 340 (426)
Q Consensus 265 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (426)
+....... .....+++.|+|||++.+..++.++||||||+++|||++ |..||...........+.....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~------- 232 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNR------- 232 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC-------
Confidence 75432211 122345678999999999999999999999999999999 8899875433222111111110
Q ss_pred hcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 014352 341 LVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKI 381 (426)
Q Consensus 341 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 381 (426)
...+...+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 233 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 233 --LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred --CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 011123346789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=328.75 Aligned_cols=249 Identities=22% Similarity=0.297 Sum_probs=193.2
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC---ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEe
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS---HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEF 194 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 194 (426)
+++.+.||+|+||+||++... +++.+|+|++.... ......+..|+.++.+++||||+++++.+.+...+++||||
T Consensus 3 y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~ 82 (363)
T cd05628 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEF 82 (363)
T ss_pred ceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcC
Confidence 455678999999999999865 67899999986532 12234678899999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC---
Q 014352 195 MSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG--- 271 (426)
Q Consensus 195 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~--- 271 (426)
+++|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 83 LPGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred CCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence 9999999999654 46899999999999999999999998 9999999999999999999999999986422110
Q ss_pred ---------------------------------CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 014352 272 ---------------------------------RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQN 318 (426)
Q Consensus 272 ---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~ 318 (426)
......||+.|+|||++.+..++.++|||||||++|||++|..||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~ 238 (363)
T cd05628 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (363)
T ss_pred ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence 01235799999999999999999999999999999999999999976
Q ss_pred hHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHHHHHccc--CCCCCCCCHHHHHHH
Q 014352 319 LMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLH--KTPRKRPSIGEVTQA 377 (426)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~--~~p~~RPs~~evl~~ 377 (426)
.........+..... .+.-......+..+.+++.+++. .++..||++.+++++
T Consensus 239 ~~~~~~~~~i~~~~~------~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 239 ETPQETYKKVMNWKE------TLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCHHHHHHHHHcCcC------cccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 433322221111000 00001111123456666666433 344457999999987
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=314.65 Aligned_cols=257 Identities=21% Similarity=0.396 Sum_probs=205.6
Q ss_pred HHHHhhhhcccccCCCeeEEEEEeCC-----CcEEEEEEeccCCc-cChHHHHHHHHHHhcCCCCceeeEEeEEEe-CCe
Q 014352 115 QKATQNFTNILGQGAFGPVYKATMPS-----GGVAAIKVLASDSH-QGEKEFQTEVSLLGRLHHRNLVNLIGYCVD-KGK 187 (426)
Q Consensus 115 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~ 187 (426)
...++.+.+.||+|+||.||+|.+.. +..|++|.+..... .....+.+|+.++++++||||+++++++.. ...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 45567778899999999999999765 67899998875432 224568899999999999999999998876 467
Q ss_pred EEEEEEecCCCChhHHhhhcc-------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEee
Q 014352 188 YMLIYEFMSNGSLSNLIYSEE-------RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVAD 260 (426)
Q Consensus 188 ~~lv~e~~~~gsL~~~l~~~~-------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 260 (426)
.++++||+++++|.+++.... ..+++..++.++.+++.||.|||+.+ ++|+||||+||+++.++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 899999999999999985532 45899999999999999999999988 99999999999999999999999
Q ss_pred ecCccccccCC---CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhh
Q 014352 261 FGLSKEEVFDG---RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEI 336 (426)
Q Consensus 261 fgl~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 336 (426)
||+++...... ......++..|+|||++.+..++.++||||||+++||+++ |..||..............
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~------ 234 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKD------ 234 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHc------
Confidence 99997532221 1122345778999999998899999999999999999999 9999976433221111111
Q ss_pred hhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 014352 337 LDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQ 383 (426)
Q Consensus 337 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 383 (426)
......+...+..+.+++.+||+.||++|||+.++++.|..+..
T Consensus 235 ---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 235 ---GYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred ---CCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 11111112234678999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=312.33 Aligned_cols=253 Identities=25% Similarity=0.446 Sum_probs=203.3
Q ss_pred HHhhhhcccccCCCeeEEEEEeC-C---CcEEEEEEeccCCc-cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEE
Q 014352 117 ATQNFTNILGQGAFGPVYKATMP-S---GGVAAIKVLASDSH-QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLI 191 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 191 (426)
..+.+.+.||+|+||.||+|... + +..+|+|.+..... ...+.+..|+.++++++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 34667789999999999999863 2 23789998865432 2245789999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC
Q 014352 192 YEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG 271 (426)
Q Consensus 192 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 271 (426)
|||+++++|.+++......+++.+++.++.|++.||.|||+++ ++||||||+||+++.++.++++|||++.......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 9999999999999776667899999999999999999999998 9999999999999999999999999987543221
Q ss_pred C----cccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCC
Q 014352 272 R----NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACN 346 (426)
Q Consensus 272 ~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (426)
. .....++..|+|||++.+..++.++|+||||+++||+++ |..||...........+... .....+
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~---------~~~~~~ 231 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG---------YRLPAP 231 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCC---------CcCCCC
Confidence 1 112223568999999998899999999999999999886 99998764332221111111 001112
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 014352 347 IQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKI 381 (426)
Q Consensus 347 ~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 381 (426)
...+..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus 232 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 232 MDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 23346789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=318.47 Aligned_cols=259 Identities=24% Similarity=0.413 Sum_probs=199.1
Q ss_pred HHHhhhhcccccCCCeeEEEEEeCC---------------CcEEEEEEeccCCcc-ChHHHHHHHHHHhcCCCCceeeEE
Q 014352 116 KATQNFTNILGQGAFGPVYKATMPS---------------GGVAAIKVLASDSHQ-GEKEFQTEVSLLGRLHHRNLVNLI 179 (426)
Q Consensus 116 ~~~~~~~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~ 179 (426)
+.++.+.+.||+|+||.||++...+ ...||+|.+...... ....|.+|++++++++|||+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 4557778899999999999987532 125899998765322 235689999999999999999999
Q ss_pred eEEEeCCeEEEEEEecCCCChhHHhhhcc-----------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCE
Q 014352 180 GYCVDKGKYMLIYEFMSNGSLSNLIYSEE-----------RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANI 248 (426)
Q Consensus 180 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Ni 248 (426)
+++...+..++||||+++++|.+++.... ..+++..++.++.+++.||.|||+.+ ++|+||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 99999999999999999999999985432 23688899999999999999999998 99999999999
Q ss_pred EecCCCcEEEeeecCccccccCCC---cccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh--CCCCCCchHHHH
Q 014352 249 LLDHFMRAKVADFGLSKEEVFDGR---NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT--AIHPHQNLMEYV 323 (426)
Q Consensus 249 ll~~~~~~kl~Dfgl~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t--g~~p~~~~~~~~ 323 (426)
+++.++.+||+|||++........ .....++..|+|||++.+..++.++||||||+++|||++ |..||.......
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 999999999999999875322211 122345678999999998899999999999999999998 667776533222
Q ss_pred HHhhccccchhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 014352 324 NLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALL 379 (426)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 379 (426)
........ ............+...+..+.+++.+||+.||++|||+.+|++.|.
T Consensus 241 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 241 VIENTGEF--FRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHHHh--hhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 11111000 0000000001111223467999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=330.93 Aligned_cols=250 Identities=23% Similarity=0.289 Sum_probs=195.3
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc---cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEe
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH---QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEF 194 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 194 (426)
+.+.+.||+|+||+||+|+.. ++..+|+|++..... .....+.+|+.++++++||||+++++++.+.+.+++||||
T Consensus 3 f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~ 82 (381)
T cd05626 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (381)
T ss_pred ceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEec
Confidence 345678999999999999865 678999999865421 2234688999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC---
Q 014352 195 MSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG--- 271 (426)
Q Consensus 195 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~--- 271 (426)
+++|+|.+++... ..+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 83 IPGGDMMSLLIRM-EVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred CCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence 9999999998654 45888888999999999999999998 9999999999999999999999999875211000
Q ss_pred ---------------------------------------------CcccCccccCccCccccccCCCCcchhhHHHHHHH
Q 014352 272 ---------------------------------------------RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVII 306 (426)
Q Consensus 272 ---------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl 306 (426)
......||+.|+|||.+.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il 238 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHH
Confidence 01234699999999999999999999999999999
Q ss_pred HHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHHHHH--cccCCCCCCCCHHHHHHHH
Q 014352 307 FELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHK--CLHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 307 ~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--cl~~~p~~RPs~~evl~~L 378 (426)
|||++|..||...........+... ............+.++.+++.+ |+..+|..||++.+++.+-
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~------~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp 306 (381)
T cd05626 239 FEMLVGQPPFLAPTPTETQLKVINW------ENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHP 306 (381)
T ss_pred HHHHhCCCCCcCCCHHHHHHHHHcc------ccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCc
Confidence 9999999999754332211111100 0001111111234567778877 5667777799999998863
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=317.25 Aligned_cols=260 Identities=23% Similarity=0.436 Sum_probs=206.1
Q ss_pred HHHHHhhhhcccccCCCeeEEEEEeC--------CCcEEEEEEeccCC-ccChHHHHHHHHHHhcC-CCCceeeEEeEEE
Q 014352 114 IQKATQNFTNILGQGAFGPVYKATMP--------SGGVAAIKVLASDS-HQGEKEFQTEVSLLGRL-HHRNLVNLIGYCV 183 (426)
Q Consensus 114 l~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 183 (426)
+....+.+.+.||+|+||.||+++.. ++..+|+|.+.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 44566778889999999999999741 23478999886543 23345788999999999 8999999999999
Q ss_pred eCCeEEEEEEecCCCChhHHhhhcc---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCE
Q 014352 184 DKGKYMLIYEFMSNGSLSNLIYSEE---------------RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANI 248 (426)
Q Consensus 184 ~~~~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Ni 248 (426)
..+..+++|||+++|+|.+++.... ..+++..++.++.|++.||.|||+++ ++||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceE
Confidence 9999999999999999999986532 34788899999999999999999998 99999999999
Q ss_pred EecCCCcEEEeeecCccccccCC---CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHH
Q 014352 249 LLDHFMRAKVADFGLSKEEVFDG---RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVN 324 (426)
Q Consensus 249 ll~~~~~~kl~Dfgl~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~ 324 (426)
+++.++.+||+|||+++...... ......++..|+|||++.+..++.++||||||+++||+++ |..||........
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~ 248 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 248 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence 99999999999999987543221 1223345678999999988889999999999999999998 7888765322211
Q ss_pred HhhccccchhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHh
Q 014352 325 LASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRH 385 (426)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~ 385 (426)
...... ......+...+..+.+++.+||+.+|.+|||+.++++.|.++....
T Consensus 249 ~~~~~~---------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~ 300 (304)
T cd05101 249 FKLLKE---------GHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300 (304)
T ss_pred HHHHHc---------CCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence 111111 1111112234467899999999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=297.07 Aligned_cols=260 Identities=23% Similarity=0.354 Sum_probs=211.1
Q ss_pred HHHHHhhhhcccccCCCeeEEEEE-eCCCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeC-----Ce
Q 014352 114 IQKATQNFTNILGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDK-----GK 187 (426)
Q Consensus 114 l~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~ 187 (426)
|...+|.+.+.||.|||+-||.++ ..++..+|+|++......+.+..++|++..++++||||++++++...+ ..
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 445668888999999999999998 457889999999887767778899999999999999999999987644 35
Q ss_pred EEEEEEecCCCChhHHhhh---ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCc
Q 014352 188 YMLIYEFMSNGSLSNLIYS---EERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLS 264 (426)
Q Consensus 188 ~~lv~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 264 (426)
.|++++|+..|||.+.+.. ++..++..+.+.|+.++++||.+||+.. +++.||||||.|||+++.+.+++.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCc
Confidence 8999999999999998854 3457999999999999999999999987 78999999999999999999999999988
Q ss_pred cccccCCCc----------ccCccccCccCccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhcccc
Q 014352 265 KEEVFDGRN----------SGLKGTYGYIDPAYIS---TNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQD 331 (426)
Q Consensus 265 ~~~~~~~~~----------~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~ 331 (426)
+...-.... .....|..|.|||.+. +...+.++|||||||+||+|+.|..||....+. .+
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~-------Gg 249 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ-------GG 249 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc-------CC
Confidence 642211111 1234688999999884 456789999999999999999999999753321 11
Q ss_pred ch-hhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 014352 332 GV-DEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKI 381 (426)
Q Consensus 332 ~~-~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 381 (426)
.+ -.+....+.-+.....++.+.+++++|++.||.+||++.+++..++.+
T Consensus 250 SlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 250 SLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred eEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 11 122222333333344778999999999999999999999999998765
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=313.23 Aligned_cols=238 Identities=22% Similarity=0.365 Sum_probs=188.6
Q ss_pred ccccCCCeeEEEEEeCC-------------------------CcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeE
Q 014352 124 ILGQGAFGPVYKATMPS-------------------------GGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNL 178 (426)
Q Consensus 124 ~lg~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~ 178 (426)
.||+|+||.||+|.+.. ...|++|.+..........|.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999997521 12578888865443334578889999999999999999
Q ss_pred EeEEEeCCeEEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCC----
Q 014352 179 IGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFM---- 254 (426)
Q Consensus 179 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---- 254 (426)
++++.+.+..++||||+++|+|..++......+++..++.++.|++.||.|||+++ |+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcccC
Confidence 99999999999999999999999998766667899999999999999999999998 99999999999998644
Q ss_pred ---cEEEeeecCccccccCCCcccCccccCccCcccccc-CCCCcchhhHHHHHHHHHHH-hCCCCCCchHHHHHHhhcc
Q 014352 255 ---RAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYIST-NKFTMKSDIFSFGVIIFELI-TAIHPHQNLMEYVNLASMS 329 (426)
Q Consensus 255 ---~~kl~Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~-tg~~p~~~~~~~~~~~~~~ 329 (426)
.+|++|||++..... .....++..|+|||.+.+ ..++.++||||||+++||++ +|..||.........
T Consensus 159 ~~~~~kl~d~g~~~~~~~---~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~---- 231 (274)
T cd05076 159 TSPFIKLSDPGVSFTALS---REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE---- 231 (274)
T ss_pred ccceeeecCCcccccccc---ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH----
Confidence 379999998764321 123357788999998865 56899999999999999985 689998653222110
Q ss_pred ccchhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014352 330 QDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 378 (426)
....... ..+......+.+++.+||+.+|++|||+.++++.|
T Consensus 232 -----~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 232 -----RFYEKKH--RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred -----HHHHhcc--CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 1111111 01111234689999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=335.50 Aligned_cols=253 Identities=23% Similarity=0.315 Sum_probs=192.9
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeC--------CeE
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDK--------GKY 188 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--------~~~ 188 (426)
.|.+.+.||+|+||.||+|... +++.||+|.+.... ....+|+.+|++++||||+++++++... ..+
T Consensus 67 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 142 (440)
T PTZ00036 67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFL 142 (440)
T ss_pred eEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEE
Confidence 4667889999999999999875 67899999885432 2345799999999999999999887542 246
Q ss_pred EEEEEecCCCChhHHhhh---ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCC-cEEEeeecCc
Q 014352 189 MLIYEFMSNGSLSNLIYS---EERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFM-RAKVADFGLS 264 (426)
Q Consensus 189 ~lv~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgl~ 264 (426)
++||||+++ +|.+++.. ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++ .+||+|||++
T Consensus 143 ~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFGla 218 (440)
T PTZ00036 143 NVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSA 218 (440)
T ss_pred EEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccccc
Confidence 799999975 77776643 3456899999999999999999999998 99999999999999765 6999999999
Q ss_pred cccccCCCcccCccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhcc----ccchhhh--h
Q 014352 265 KEEVFDGRNSGLKGTYGYIDPAYIST-NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMS----QDGVDEI--L 337 (426)
Q Consensus 265 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~----~~~~~~~--~ 337 (426)
+............||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+......+..+. ....... .
T Consensus 219 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~ 298 (440)
T PTZ00036 219 KNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEM 298 (440)
T ss_pred hhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 86544444445678999999999865 468999999999999999999999997643322211110 0000000 0
Q ss_pred h-------------hhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014352 338 D-------------KQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 338 ~-------------~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 378 (426)
. ..+....+...+.++.+|+.+||+.||.+|||+.+++++-
T Consensus 299 ~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp 352 (440)
T PTZ00036 299 NPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADP 352 (440)
T ss_pred chhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCCh
Confidence 0 0000011112346789999999999999999999999764
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=314.71 Aligned_cols=250 Identities=28% Similarity=0.456 Sum_probs=200.8
Q ss_pred HhhhhcccccCCCeeEEEEEeC------CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEE
Q 014352 118 TQNFTNILGQGAFGPVYKATMP------SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLI 191 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 191 (426)
.+.+.+.||+|+||.||++... ++..+++|.+..........+.+|++++++++|+||+++++++...+..+++
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (280)
T cd05092 6 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMV 85 (280)
T ss_pred hceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEE
Confidence 3455678999999999999642 3457899988765545556899999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhcc--------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEE
Q 014352 192 YEFMSNGSLSNLIYSEE--------------RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAK 257 (426)
Q Consensus 192 ~e~~~~gsL~~~l~~~~--------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 257 (426)
|||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+|
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~k 162 (280)
T cd05092 86 FEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVVK 162 (280)
T ss_pred EecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCEE
Confidence 99999999999986532 24889999999999999999999998 99999999999999999999
Q ss_pred EeeecCccccccCC---CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccch
Q 014352 258 VADFGLSKEEVFDG---RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGV 333 (426)
Q Consensus 258 l~Dfgl~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~ 333 (426)
|+|||++....... ......+++.|+|||.+.+..++.++||||||+++|||++ |..||................
T Consensus 163 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~- 241 (280)
T cd05092 163 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGR- 241 (280)
T ss_pred ECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCc-
Confidence 99999986432211 1122335678999999999999999999999999999998 899986543332221111110
Q ss_pred hhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 014352 334 DEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALL 379 (426)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 379 (426)
....+...+..+.+++.+||+.||++||++.++++.|+
T Consensus 242 --------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 242 --------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred --------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 01111223467899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=326.86 Aligned_cols=237 Identities=27% Similarity=0.404 Sum_probs=193.4
Q ss_pred cccccCCCeeEEEEEe----CCCcEEEEEEeccCCc--cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecC
Q 014352 123 NILGQGAFGPVYKATM----PSGGVAAIKVLASDSH--QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMS 196 (426)
Q Consensus 123 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 196 (426)
+.||+|+||.||++.. .++..+|+|++..... .....+..|++++++++||||+++++++.+.+..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 4699999999999875 3678999999875422 223456789999999999999999999999999999999999
Q ss_pred CCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC-CCccc
Q 014352 197 NGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD-GRNSG 275 (426)
Q Consensus 197 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-~~~~~ 275 (426)
+|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++..... .....
T Consensus 82 ~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~ 157 (318)
T cd05582 82 GGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS 157 (318)
T ss_pred CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceec
Confidence 99999998543 45899999999999999999999998 999999999999999999999999998754332 22334
Q ss_pred CccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHH
Q 014352 276 LKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELAR 355 (426)
Q Consensus 276 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 355 (426)
..||+.|+|||.+.+..++.++||||||+++|||++|+.||...........+.... ...+...+..+.+
T Consensus 158 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~----------~~~p~~~~~~~~~ 227 (318)
T cd05582 158 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK----------LGMPQFLSPEAQS 227 (318)
T ss_pred ccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC----------CCCCCCCCHHHHH
Confidence 678999999999998889999999999999999999999997643322221111110 0111223467889
Q ss_pred HHHHcccCCCCCCCCHHH
Q 014352 356 IGHKCLHKTPRKRPSIGE 373 (426)
Q Consensus 356 l~~~cl~~~p~~RPs~~e 373 (426)
++.+||+.||++||++.+
T Consensus 228 li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 228 LLRALFKRNPANRLGAGP 245 (318)
T ss_pred HHHHHhhcCHhHcCCCCC
Confidence 999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=311.54 Aligned_cols=250 Identities=28% Similarity=0.444 Sum_probs=198.6
Q ss_pred hhhcccccCCCeeEEEEEeCC----CcEEEEEEeccCCcc--ChHHHHHHHHHHhcCCCCceeeEEeEEEeCCe------
Q 014352 120 NFTNILGQGAFGPVYKATMPS----GGVAAIKVLASDSHQ--GEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGK------ 187 (426)
Q Consensus 120 ~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~------ 187 (426)
.+.+.||+|+||.||+|.... +..+|+|.+...... ....+.+|+..++.++||||+++++++...+.
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 81 (273)
T cd05035 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK 81 (273)
T ss_pred ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence 356789999999999998642 357999998754322 23578899999999999999999998876554
Q ss_pred EEEEEEecCCCChhHHhhhc-----cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeec
Q 014352 188 YMLIYEFMSNGSLSNLIYSE-----ERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFG 262 (426)
Q Consensus 188 ~~lv~e~~~~gsL~~~l~~~-----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 262 (426)
.++++||+++|+|..++... ...+++.....++.|++.||.|||+++ ++||||||+||++++++.+||+|||
T Consensus 82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg 158 (273)
T cd05035 82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADFG 158 (273)
T ss_pred cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCcc
Confidence 79999999999999988543 235899999999999999999999998 9999999999999999999999999
Q ss_pred CccccccCCC---cccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhh
Q 014352 263 LSKEEVFDGR---NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILD 338 (426)
Q Consensus 263 l~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 338 (426)
+++....... .....++..|+|||.+.+..++.++||||||+++|||++ |..||................
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~------ 232 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN------ 232 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC------
Confidence 9875432211 122335678999999998899999999999999999999 889987643322211111111
Q ss_pred hhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 014352 339 KQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKI 381 (426)
Q Consensus 339 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 381 (426)
....+...+..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 233 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 233 ---RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred ---CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1111223456899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=331.81 Aligned_cols=248 Identities=22% Similarity=0.298 Sum_probs=197.5
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC---ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEe
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS---HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEF 194 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 194 (426)
|.+.+.||+|+||.||+++.. +++.||+|++.... ......+.+|+.++..++||||+++++++.+++..++||||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (364)
T cd05599 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEY 82 (364)
T ss_pred ceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECC
Confidence 455678999999999999975 68899999987532 12234578899999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC---
Q 014352 195 MSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG--- 271 (426)
Q Consensus 195 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~--- 271 (426)
+++|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++.......
T Consensus 83 ~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 83 LPGGDMMTLLMKK-DTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred CCCcHHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence 9999999998654 45899999999999999999999998 9999999999999999999999999986422110
Q ss_pred ------------------------------------CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCC
Q 014352 272 ------------------------------------RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHP 315 (426)
Q Consensus 272 ------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p 315 (426)
......||+.|+|||++.+..++.++|||||||++|||++|..|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~P 238 (364)
T cd05599 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP 238 (364)
T ss_pred ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCC
Confidence 00124689999999999999999999999999999999999999
Q ss_pred CCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCC---HHHHHHH
Q 014352 316 HQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPS---IGEVTQA 377 (426)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs---~~evl~~ 377 (426)
|...........+.... ..+........+..+.+++.+|+. +|.+|++ +.+++++
T Consensus 239 f~~~~~~~~~~~i~~~~------~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 239 FCSDNPQETYRKIINWK------ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCHHHHHHHHHcCC------CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 97644332221111100 000001111234578889999996 8999997 8888875
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=321.84 Aligned_cols=239 Identities=29% Similarity=0.427 Sum_probs=192.1
Q ss_pred ccccCCCeeEEEEEeC-CCcEEEEEEeccCC---ccChHHHHHHHHHHhcC-CCCceeeEEeEEEeCCeEEEEEEecCCC
Q 014352 124 ILGQGAFGPVYKATMP-SGGVAAIKVLASDS---HQGEKEFQTEVSLLGRL-HHRNLVNLIGYCVDKGKYMLIYEFMSNG 198 (426)
Q Consensus 124 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g 198 (426)
.||+|+||.||+|... ++..||+|.+.... ......+..|..++..+ +||||+++++++.+.+..++||||+++|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g 81 (316)
T cd05620 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCC
Confidence 6999999999999976 67899999987542 12334566778887654 8999999999999999999999999999
Q ss_pred ChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccccc-CCCcccCc
Q 014352 199 SLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF-DGRNSGLK 277 (426)
Q Consensus 199 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~-~~~~~~~~ 277 (426)
+|..++... ..+++.....++.|++.||+|||+++ |+||||||+|||++.++.++|+|||+++.... ........
T Consensus 82 ~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05620 82 DLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC 157 (316)
T ss_pred cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccC
Confidence 999988554 45899999999999999999999998 99999999999999999999999999874322 22234567
Q ss_pred cccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHHH
Q 014352 278 GTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIG 357 (426)
Q Consensus 278 gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 357 (426)
||+.|+|||++.+..++.++|||||||++|||++|..||...........+... .+ ..+......+.+++
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~------~~----~~~~~~~~~~~~li 227 (316)
T cd05620 158 GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD------TP----HYPRWITKESKDIL 227 (316)
T ss_pred CCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------CC----CCCCCCCHHHHHHH
Confidence 899999999999999999999999999999999999999754332211111100 00 11112345788999
Q ss_pred HHcccCCCCCCCCHH-HHHH
Q 014352 358 HKCLHKTPRKRPSIG-EVTQ 376 (426)
Q Consensus 358 ~~cl~~~p~~RPs~~-evl~ 376 (426)
.+||+.||++||++. ++++
T Consensus 228 ~~~l~~dP~~R~~~~~~~~~ 247 (316)
T cd05620 228 EKLFERDPTRRLGVVGNIRG 247 (316)
T ss_pred HHHccCCHHHcCCChHHHHc
Confidence 999999999999984 5553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=322.81 Aligned_cols=245 Identities=26% Similarity=0.376 Sum_probs=196.5
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc---cChHHHHHHHHHHhcC-CCCceeeEEeEEEeCCeEEEEEE
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH---QGEKEFQTEVSLLGRL-HHRNLVNLIGYCVDKGKYMLIYE 193 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 193 (426)
+++.+.||+|+||.||+|... ++..+|+|.+..... ...+.+..|..++..+ +|++|+++++++.+.+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05616 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME 81 (323)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence 445678999999999999876 567899999875422 2223566788888777 58999999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC-CC
Q 014352 194 FMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD-GR 272 (426)
Q Consensus 194 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-~~ 272 (426)
|+++|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..... ..
T Consensus 82 ~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~ 157 (323)
T cd05616 82 YVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT 157 (323)
T ss_pred CCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCCCCc
Confidence 99999999988554 45899999999999999999999998 999999999999999999999999998753322 22
Q ss_pred cccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHH
Q 014352 273 NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRE 352 (426)
Q Consensus 273 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (426)
.....||+.|+|||++.+..++.++|||||||++|||++|..||...........+... . ...+...+.+
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~--------~--~~~p~~~s~~ 227 (323)
T cd05616 158 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH--------N--VAYPKSMSKE 227 (323)
T ss_pred cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------C--CCCCCcCCHH
Confidence 34567899999999999999999999999999999999999999764433222211111 1 1112234567
Q ss_pred HHHHHHHcccCCCCCCCCH-----HHHHHH
Q 014352 353 LARIGHKCLHKTPRKRPSI-----GEVTQA 377 (426)
Q Consensus 353 l~~l~~~cl~~~p~~RPs~-----~evl~~ 377 (426)
+.+++.+||+.||++|++. .++.++
T Consensus 228 ~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 228 AVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred HHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 8999999999999999985 555543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=329.10 Aligned_cols=249 Identities=20% Similarity=0.282 Sum_probs=200.4
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc---cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEe
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH---QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEF 194 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 194 (426)
|.+.+.||+|+||+||++... ++..+|+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (330)
T cd05601 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEY 82 (330)
T ss_pred ceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECC
Confidence 456788999999999999875 788999999875422 2335688999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCC--
Q 014352 195 MSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGR-- 272 (426)
Q Consensus 195 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~-- 272 (426)
+++|+|.+++......+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 83 ~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~ 159 (330)
T cd05601 83 QPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVN 159 (330)
T ss_pred CCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCCcee
Confidence 9999999999776567999999999999999999999998 99999999999999999999999999975433222
Q ss_pred cccCccccCccCccccc------cCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCC
Q 014352 273 NSGLKGTYGYIDPAYIS------TNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACN 346 (426)
Q Consensus 273 ~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (426)
.....||+.|+|||++. ...++.++|||||||++|||++|..||...........+.... ........
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~------~~~~~~~~ 233 (330)
T cd05601 160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQ------RFLKFPED 233 (330)
T ss_pred eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCC------CccCCCCC
Confidence 22346899999999986 4567899999999999999999999997643322221111100 00000111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 347 IQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 347 ~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
...+..+.+++..||+ +|++|||+.+++.+
T Consensus 234 ~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 234 PKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred CCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 2234678899999998 99999999999865
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=309.81 Aligned_cols=254 Identities=28% Similarity=0.461 Sum_probs=207.3
Q ss_pred HHHHHhhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEE
Q 014352 114 IQKATQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYE 193 (426)
Q Consensus 114 l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 193 (426)
+.+..+.+.+.||+|+||.||+|..+++..+|+|.+.... ...+++.+|+.++++++||||+++++++......++|||
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 3445567788999999999999998888889999987543 345689999999999999999999999998889999999
Q ss_pred ecCCCChhHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC-
Q 014352 194 FMSNGSLSNLIYSEE-RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG- 271 (426)
Q Consensus 194 ~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~- 271 (426)
|+++++|.+++.... ..+++..+..++.+++.||.|||+++ ++|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 999999999996644 56899999999999999999999998 9999999999999999999999999987543211
Q ss_pred -CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHH
Q 014352 272 -RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQE 349 (426)
Q Consensus 272 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (426)
......++..|+|||.+.+..++.++|+||||+++|++++ |+.||........+..+.. ......+...
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~---------~~~~~~~~~~ 229 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVER---------GYRMPRPPNC 229 (261)
T ss_pred hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc---------CCCCCCCCCC
Confidence 1122334568999999998899999999999999999998 9999976433222221111 1111112223
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 014352 350 VRELARIGHKCLHKTPRKRPSIGEVTQALLK 380 (426)
Q Consensus 350 ~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 380 (426)
+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus 230 ~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 230 PEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 4678999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=307.82 Aligned_cols=245 Identities=30% Similarity=0.524 Sum_probs=203.5
Q ss_pred cccccCCCeeEEEEEeCC----CcEEEEEEeccCCccC-hHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCC
Q 014352 123 NILGQGAFGPVYKATMPS----GGVAAIKVLASDSHQG-EKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSN 197 (426)
Q Consensus 123 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 197 (426)
+.||+|+||.||+|.... +..+++|.+....... .+.+.+|++.+..++|+||+++++++......+++|||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 369999999999998763 7789999987664333 56889999999999999999999999999999999999999
Q ss_pred CChhHHhhhc--------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccccc
Q 014352 198 GSLSNLIYSE--------ERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF 269 (426)
Q Consensus 198 gsL~~~l~~~--------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 269 (426)
++|.+++... ...+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999765 467999999999999999999999998 99999999999999999999999999975443
Q ss_pred C---CCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccC
Q 014352 270 D---GRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGAC 345 (426)
Q Consensus 270 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (426)
. .......++..|+|||.+....++.++||||||+++|||++ |..||...........+.. ......
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~---------~~~~~~ 228 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK---------GYRLPK 228 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc---------CCCCCC
Confidence 2 12334567889999999988899999999999999999999 6999976533222211111 111112
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 014352 346 NIQEVRELARIGHKCLHKTPRKRPSIGEVTQALL 379 (426)
Q Consensus 346 ~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 379 (426)
+...+.++.+++.+||+.+|++|||+.+++++|+
T Consensus 229 ~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 229 PEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 2333568999999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=309.15 Aligned_cols=248 Identities=26% Similarity=0.383 Sum_probs=190.3
Q ss_pred ccccCCCeeEEEEEeCC---CcEEEEEEeccCCc-cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCCCC
Q 014352 124 ILGQGAFGPVYKATMPS---GGVAAIKVLASDSH-QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGS 199 (426)
Q Consensus 124 ~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 199 (426)
.||+|+||.||+|.+.+ +..+|+|.+..... .....+.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 59999999999998643 34689998865532 223478889999999999999999999999889999999999999
Q ss_pred hhHHhhhcc----CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC---C
Q 014352 200 LSNLIYSEE----RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG---R 272 (426)
Q Consensus 200 L~~~l~~~~----~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---~ 272 (426)
|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++....... .
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 999996532 34677788899999999999999998 9999999999999999999999999986432221 1
Q ss_pred cccCccccCccCccccccC-------CCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhccc
Q 014352 273 NSGLKGTYGYIDPAYISTN-------KFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGA 344 (426)
Q Consensus 273 ~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (426)
.....++..|+|||++.+. .++.++|+||||+++|||++ |..||.....................++..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--- 235 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRL--- 235 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCcc---
Confidence 2234567889999998542 35789999999999999996 999997643332211111111111111111
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 014352 345 CNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALL 379 (426)
Q Consensus 345 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 379 (426)
.......+.+++..|| .+|++|||+.+|+..|+
T Consensus 236 -~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 236 -KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred -CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1123356888999999 58999999999998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=309.25 Aligned_cols=253 Identities=24% Similarity=0.391 Sum_probs=203.6
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc---cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEe
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH---QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEF 194 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 194 (426)
|.+.+.||+|+||.||++... ++..+++|.+..... .....+.+|+.+++.++||||+++++++.+++..+++|||
T Consensus 4 y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 83 (267)
T cd08229 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLEL 83 (267)
T ss_pred hhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEe
Confidence 556778999999999999964 788999998764322 2235788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhh---ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC
Q 014352 195 MSNGSLSNLIYS---EERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG 271 (426)
Q Consensus 195 ~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 271 (426)
+++++|.+++.. ....+++..++.++.+++.||.|||+++ ++|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd08229 84 ADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred cCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence 999999998853 2346899999999999999999999998 9999999999999999999999999987543222
Q ss_pred -CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHH-HHHhhccccchhhhhhhhhcccCCHHH
Q 014352 272 -RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEY-VNLASMSQDGVDEILDKQLVGACNIQE 349 (426)
Q Consensus 272 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (426)
......++..|+|||++.+..++.++|+||||+++|+|++|..||...... .... ..+.............
T Consensus 161 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~ 233 (267)
T cd08229 161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLC-------KKIEQCDYPPLPSDHY 233 (267)
T ss_pred cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHh-------hhhhcCCCCCCCcccc
Confidence 123456889999999999888999999999999999999999998642211 0000 0000001111112234
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 014352 350 VRELARIGHKCLHKTPRKRPSIGEVTQALLKI 381 (426)
Q Consensus 350 ~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 381 (426)
+..+.+++.+||+.||++|||+.+|++.+.++
T Consensus 234 ~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 234 SEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred cHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 56899999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=311.48 Aligned_cols=257 Identities=23% Similarity=0.375 Sum_probs=205.6
Q ss_pred HHHHhhhhcccccCCCeeEEEEEeCC----CcEEEEEEeccCC-ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEE
Q 014352 115 QKATQNFTNILGQGAFGPVYKATMPS----GGVAAIKVLASDS-HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYM 189 (426)
Q Consensus 115 ~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 189 (426)
.+..+.+.+.||.|+||.||+|.+.+ ...+++|...... ....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~ 82 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW 82 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence 34556677899999999999998643 2468999887654 3344678999999999999999999998876 4578
Q ss_pred EEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccccc
Q 014352 190 LIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF 269 (426)
Q Consensus 190 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 269 (426)
+||||+++|+|.+++......+++..++.++.+++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++....
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 83 IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence 999999999999999765566899999999999999999999988 99999999999999999999999999875432
Q ss_pred CCC--cccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCC
Q 014352 270 DGR--NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACN 346 (426)
Q Consensus 270 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (426)
... .....++..|+|||.+....++.++||||||+++||+++ |..||...........+.... ....+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~---------~~~~~ 230 (270)
T cd05056 160 ESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE---------RLPMP 230 (270)
T ss_pred ccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC---------cCCCC
Confidence 211 122334568999999988889999999999999999986 999997654332222111111 00112
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHH
Q 014352 347 IQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQR 384 (426)
Q Consensus 347 ~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 384 (426)
...+..+.+++.+||..+|++|||+.+++..|+.+..+
T Consensus 231 ~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 231 PNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 23346799999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=308.54 Aligned_cols=246 Identities=28% Similarity=0.459 Sum_probs=198.7
Q ss_pred HhhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEE-eCCeEEEEEEecC
Q 014352 118 TQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCV-DKGKYMLIYEFMS 196 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~ 196 (426)
.+.+.+.||+|+||.||++... +..+|+|.+.... ..+.+.+|+.++++++|+|++++++++. ..+..++++||++
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~ 83 (256)
T cd05082 7 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 83 (256)
T ss_pred hCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCC
Confidence 4567789999999999999874 6778999886543 3457899999999999999999999765 4467899999999
Q ss_pred CCChhHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCccc
Q 014352 197 NGSLSNLIYSEE-RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSG 275 (426)
Q Consensus 197 ~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 275 (426)
+++|.+++.... ..+++..++.++.+++.||+|||+++ ++||||||+||+++.++.+||+|||+++..... ...
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~--~~~ 158 (256)
T cd05082 84 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--QDT 158 (256)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceecccc--CCC
Confidence 999999986544 35889999999999999999999998 999999999999999999999999998753322 223
Q ss_pred CccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHH
Q 014352 276 LKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELA 354 (426)
Q Consensus 276 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 354 (426)
..++..|+|||++.+..++.++||||||+++|||++ |+.||...........+.. ......+...+..+.
T Consensus 159 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~ 229 (256)
T cd05082 159 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK---------GYKMDAPDGCPPVVY 229 (256)
T ss_pred CccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc---------CCCCCCCCCCCHHHH
Confidence 345678999999998899999999999999999998 9999864322111111111 111112223446789
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHHHH
Q 014352 355 RIGHKCLHKTPRKRPSIGEVTQALLK 380 (426)
Q Consensus 355 ~l~~~cl~~~p~~RPs~~evl~~L~~ 380 (426)
+++.+||+.+|++|||+.++++.|+.
T Consensus 230 ~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 230 DVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred HHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 99999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=315.91 Aligned_cols=256 Identities=27% Similarity=0.483 Sum_probs=203.4
Q ss_pred HHHHhhhhcccccCCCeeEEEEEeC------CCcEEEEEEeccCCc-cChHHHHHHHHHHhcC-CCCceeeEEeEEEeCC
Q 014352 115 QKATQNFTNILGQGAFGPVYKATMP------SGGVAAIKVLASDSH-QGEKEFQTEVSLLGRL-HHRNLVNLIGYCVDKG 186 (426)
Q Consensus 115 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 186 (426)
....+.+.+.||+|+||.||++... .+..+|+|.+..... ...+.+.+|+.+++++ +||||+++++++...+
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 3445667789999999999999742 234789998875432 2235688999999999 7999999999999999
Q ss_pred eEEEEEEecCCCChhHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcc
Q 014352 187 KYMLIYEFMSNGSLSNLIYSEE-RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSK 265 (426)
Q Consensus 187 ~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 265 (426)
..+++|||+++|+|.+++.... ..+++.++..++.+++.||.|||+++ |+|+||||+|||++.++.++++|||+++
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence 9999999999999999996543 34899999999999999999999998 9999999999999999999999999987
Q ss_pred ccccCCC---cccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhh
Q 014352 266 EEVFDGR---NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQL 341 (426)
Q Consensus 266 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (426)
....... .....++..|+|||.+.+..++.++||||||+++|||++ |..||.......... ..++...
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~--------~~~~~~~ 261 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFY--------KLIKEGY 261 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHH--------HHHHcCC
Confidence 5432221 122345778999999999999999999999999999998 999986533221111 1111111
Q ss_pred cccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 014352 342 VGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKI 381 (426)
Q Consensus 342 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 381 (426)
....+...+..+.+++.+||+.+|++|||+.++++.|.++
T Consensus 262 ~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 262 RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 1111122346799999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=313.41 Aligned_cols=262 Identities=27% Similarity=0.443 Sum_probs=202.0
Q ss_pred HHhhhhcccccCCCeeEEEEEe-----CCCcEEEEEEeccCC-ccChHHHHHHHHHHhcCCCCceeeEEeEEEeC--CeE
Q 014352 117 ATQNFTNILGQGAFGPVYKATM-----PSGGVAAIKVLASDS-HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDK--GKY 188 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~ 188 (426)
..+.+.+.||+|+||.||++++ .++..+|+|.+.... ......+.+|+.++++++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3456677899999999999974 356789999987553 22335789999999999999999999998875 568
Q ss_pred EEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccc
Q 014352 189 MLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEV 268 (426)
Q Consensus 189 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 268 (426)
++||||+++++|.+++......+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||+++...
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccccc
Confidence 9999999999999999665556899999999999999999999998 9999999999999999999999999987543
Q ss_pred cCCC----cccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHH-HHh--hccccch---hhhhh
Q 014352 269 FDGR----NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYV-NLA--SMSQDGV---DEILD 338 (426)
Q Consensus 269 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~-~~~--~~~~~~~---~~~~~ 338 (426)
.... .....++..|+|||++.+..++.++||||||+++|||+++..|+....... ... ....... ...+.
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLE 240 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHH
Confidence 2211 123456778999999988889999999999999999999877653211100 000 0000000 00111
Q ss_pred hhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 014352 339 KQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKI 381 (426)
Q Consensus 339 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 381 (426)
.......+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 241 EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred cCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 1111111223457899999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=327.56 Aligned_cols=252 Identities=22% Similarity=0.301 Sum_probs=200.2
Q ss_pred HHHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC---ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEE
Q 014352 116 KATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS---HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLI 191 (426)
Q Consensus 116 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 191 (426)
...+.+.+.||+|+||.||+++.. ++..+|+|.+.... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 345667789999999999999875 67899999986431 12334578899999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC
Q 014352 192 YEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG 271 (426)
Q Consensus 192 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 271 (426)
|||+++|+|.+++.. ..++......++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 122 ~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~ 196 (370)
T cd05596 122 MEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG 196 (370)
T ss_pred EcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccCCC
Confidence 999999999998854 34788888889999999999999998 9999999999999999999999999987543222
Q ss_pred --CcccCccccCccCccccccC----CCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccC
Q 014352 272 --RNSGLKGTYGYIDPAYISTN----KFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGAC 345 (426)
Q Consensus 272 --~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (426)
......||+.|+|||.+.+. .++.++|||||||++|||++|..||...........+.... ..+.-..
T Consensus 197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~------~~~~~~~ 270 (370)
T cd05596 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHK------NSLTFPD 270 (370)
T ss_pred cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCC------CcCCCCC
Confidence 22346799999999998653 47899999999999999999999997643322221111100 0010011
Q ss_pred CHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHHH
Q 014352 346 NIQEVRELARIGHKCLHKTPRK--RPSIGEVTQAL 378 (426)
Q Consensus 346 ~~~~~~~l~~l~~~cl~~~p~~--RPs~~evl~~L 378 (426)
....+..+.+++.+||+.+|.+ |||+.+++++-
T Consensus 271 ~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~ 305 (370)
T cd05596 271 DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHP 305 (370)
T ss_pred cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence 1234567899999999999988 99999998773
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=307.53 Aligned_cols=252 Identities=27% Similarity=0.401 Sum_probs=205.4
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecC
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMS 196 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 196 (426)
.+.+.+.||.|+||.||++... ++..+++|.+........+.+.+|+.++++++||||+++++++.+.+.++++|||++
T Consensus 4 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~ 83 (262)
T cd06613 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCG 83 (262)
T ss_pred ceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCC
Confidence 3556788999999999999875 677899999986655556789999999999999999999999999999999999999
Q ss_pred CCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC-Cccc
Q 014352 197 NGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG-RNSG 275 (426)
Q Consensus 197 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-~~~~ 275 (426)
+++|.+++......++...+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 84 ~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 160 (262)
T cd06613 84 GGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS 160 (262)
T ss_pred CCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhhcccc
Confidence 99999998766567999999999999999999999998 9999999999999999999999999987543221 2334
Q ss_pred CccccCccCccccccC---CCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHH
Q 014352 276 LKGTYGYIDPAYISTN---KFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRE 352 (426)
Q Consensus 276 ~~gt~~y~aPE~~~~~---~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (426)
..++..|+|||.+.+. .++.++|+||||+++|||++|..||.................. .. ........+.+
T Consensus 161 ~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~----~~-~~~~~~~~~~~ 235 (262)
T cd06613 161 FIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFP----PP-KLKDKEKWSPV 235 (262)
T ss_pred ccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC----Cc-cccchhhhhHH
Confidence 5688899999999777 8899999999999999999999999764432222111111000 00 00112234567
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 353 LARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 353 l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
+.+++.+||..+|.+|||+.+++.+
T Consensus 236 ~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 236 FHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred HHHHHHHHcCCChhhCCCHHHHhcC
Confidence 9999999999999999999999853
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=307.00 Aligned_cols=245 Identities=27% Similarity=0.428 Sum_probs=196.8
Q ss_pred cccccCCCeeEEEEEeC-CC---cEEEEEEeccCCcc-ChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCC
Q 014352 123 NILGQGAFGPVYKATMP-SG---GVAAIKVLASDSHQ-GEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSN 197 (426)
Q Consensus 123 ~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 197 (426)
+.||+|+||.||+|.+. .+ ..+|+|.+...... ..+.+.+|+.+++++.||||+++++++.. +..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCC
Confidence 36999999999999753 22 57999998765432 34578999999999999999999998764 568999999999
Q ss_pred CChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCc----
Q 014352 198 GSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRN---- 273 (426)
Q Consensus 198 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~---- 273 (426)
|+|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++........
T Consensus 80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 99999996544 6899999999999999999999998 999999999999999999999999998754332211
Q ss_pred ccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHH
Q 014352 274 SGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRE 352 (426)
Q Consensus 274 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (426)
....++..|+|||.+.+..++.++||||||+++||+++ |..||...........+... .....+...+..
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~ 226 (257)
T cd05060 156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESG---------ERLPRPEECPQE 226 (257)
T ss_pred cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC---------CcCCCCCCCCHH
Confidence 11223567999999999999999999999999999998 99999754332211111111 111122334467
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 014352 353 LARIGHKCLHKTPRKRPSIGEVTQALLKI 381 (426)
Q Consensus 353 l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 381 (426)
+.+++.+||..+|++|||+.++++.|+.+
T Consensus 227 l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 227 IYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred HHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 89999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=322.47 Aligned_cols=235 Identities=26% Similarity=0.360 Sum_probs=188.6
Q ss_pred ccccCCCeeEEEEEeC-CCcEEEEEEeccCCc---cChHHHHHHHH-HHhcCCCCceeeEEeEEEeCCeEEEEEEecCCC
Q 014352 124 ILGQGAFGPVYKATMP-SGGVAAIKVLASDSH---QGEKEFQTEVS-LLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNG 198 (426)
Q Consensus 124 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 198 (426)
.||+|+||+||+|... +++.||+|++..... .....+..|.. +++.++||||+++++++.+.+..++||||+++|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g 81 (323)
T cd05575 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGG 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCC
Confidence 6999999999999975 788999999865321 12234445544 567899999999999999999999999999999
Q ss_pred ChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccccc-CCCcccCc
Q 014352 199 SLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF-DGRNSGLK 277 (426)
Q Consensus 199 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~-~~~~~~~~ 277 (426)
+|..++... ..+++.....++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.... ........
T Consensus 82 ~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (323)
T cd05575 82 ELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC 157 (323)
T ss_pred CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcccccc
Confidence 999988544 46889999999999999999999998 99999999999999999999999999875322 22234457
Q ss_pred cccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHHH
Q 014352 278 GTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIG 357 (426)
Q Consensus 278 gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 357 (426)
||+.|+|||++.+..++.++|||||||++|||++|..||...........+.. ... ......+..+.+++
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~--------~~~--~~~~~~~~~~~~li 227 (323)
T cd05575 158 GTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILN--------KPL--RLKPNISVSARHLL 227 (323)
T ss_pred CChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHc--------CCC--CCCCCCCHHHHHHH
Confidence 99999999999999999999999999999999999999975432221111111 100 11122346789999
Q ss_pred HHcccCCCCCCCCHH
Q 014352 358 HKCLHKTPRKRPSIG 372 (426)
Q Consensus 358 ~~cl~~~p~~RPs~~ 372 (426)
.+||+.||.+||++.
T Consensus 228 ~~~l~~~p~~R~~~~ 242 (323)
T cd05575 228 EGLLQKDRTKRLGAK 242 (323)
T ss_pred HHHhhcCHHhCCCCC
Confidence 999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=306.87 Aligned_cols=248 Identities=28% Similarity=0.425 Sum_probs=204.3
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecC
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMS 196 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 196 (426)
.|.+.+.||+|+||.||+|... ++..+++|.+..... ..++.+|++++++++||||+++++++.+....++++||++
T Consensus 4 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 81 (256)
T cd06612 4 VFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG 81 (256)
T ss_pred cchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence 3556678999999999999986 478899999865432 6689999999999999999999999999999999999999
Q ss_pred CCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC-Cccc
Q 014352 197 NGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG-RNSG 275 (426)
Q Consensus 197 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-~~~~ 275 (426)
+++|.+++......+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 82 ~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 158 (256)
T cd06612 82 AGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT 158 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcccccc
Confidence 99999999766677999999999999999999999998 9999999999999999999999999987543322 2234
Q ss_pred CccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHH
Q 014352 276 LKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELAR 355 (426)
Q Consensus 276 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 355 (426)
..++..|+|||++.+..++.++||||||+++|+|++|..||.................. ....+......+.+
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~ 231 (256)
T cd06612 159 VIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPP-------TLSDPEKWSPEFND 231 (256)
T ss_pred ccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCC-------CCCchhhcCHHHHH
Confidence 45788999999999989999999999999999999999999764333221111110000 00111223457899
Q ss_pred HHHHcccCCCCCCCCHHHHHHH
Q 014352 356 IGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 356 l~~~cl~~~p~~RPs~~evl~~ 377 (426)
++.+||+.||++|||+.+++++
T Consensus 232 ~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 232 FVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred HHHHHHhcChhhCcCHHHHhcC
Confidence 9999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=306.77 Aligned_cols=247 Identities=25% Similarity=0.424 Sum_probs=202.6
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC--ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEec
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS--HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 195 (426)
+.+.+.||+|+||.||++... ++..+++|.+.... ......+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYA 81 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeC
Confidence 345678999999999999875 67889999886532 233467889999999999999999999999999999999999
Q ss_pred CCCChhHHhhhc-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC-Cc
Q 014352 196 SNGSLSNLIYSE-ERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG-RN 273 (426)
Q Consensus 196 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-~~ 273 (426)
++++|.+++... ...+++..++.++.+++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++...... ..
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~ 158 (256)
T cd08529 82 ENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFA 158 (256)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccchh
Confidence 999999999764 456899999999999999999999988 9999999999999999999999999987543222 22
Q ss_pred ccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHH
Q 014352 274 SGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVREL 353 (426)
Q Consensus 274 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 353 (426)
....|++.|+|||++.+..++.++|+||||+++|+|++|..||............... .....+......+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~ 229 (256)
T cd08529 159 NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRG---------VFPPVSQMYSQQL 229 (256)
T ss_pred hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC---------CCCCCccccCHHH
Confidence 3456889999999999999999999999999999999999999765432221111111 1111112344679
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHH
Q 014352 354 ARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 354 ~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
.+++.+||+.+|++||++.+++++
T Consensus 230 ~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 230 AQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred HHHHHHHccCCcccCcCHHHHhhC
Confidence 999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=306.63 Aligned_cols=247 Identities=26% Similarity=0.392 Sum_probs=199.8
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCcc-----ChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEE
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQ-----GEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIY 192 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 192 (426)
+...+.||+|+||.||++... ++..+|+|.+...... ....+.+|++++++++||||+++++++.+.+..++|+
T Consensus 4 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 83 (263)
T cd06625 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFM 83 (263)
T ss_pred ccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEE
Confidence 455678999999999999864 6889999988644211 1246888999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCC
Q 014352 193 EFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGR 272 (426)
Q Consensus 193 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 272 (426)
||+++++|.+++... ..++......++.+++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++.......
T Consensus 84 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~ 159 (263)
T cd06625 84 EYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS 159 (263)
T ss_pred EECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecccccc
Confidence 999999999998544 45889999999999999999999998 99999999999999999999999999874322111
Q ss_pred c----ccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHH
Q 014352 273 N----SGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQ 348 (426)
Q Consensus 273 ~----~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (426)
. ....++..|+|||.+.+..++.++||||||+++||+++|+.||............... ......+..
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~ 231 (263)
T cd06625 160 SGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQ--------PTNPQLPSH 231 (263)
T ss_pred ccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhcc--------CCCCCCCcc
Confidence 1 2345788999999999999999999999999999999999999764332221111110 011112223
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 349 EVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 349 ~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
....+.+++.+||..+|.+|||+.+++++
T Consensus 232 ~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 232 VSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred CCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 44678999999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=311.28 Aligned_cols=250 Identities=28% Similarity=0.446 Sum_probs=202.0
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecC
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMS 196 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 196 (426)
.|++.+.||.|+||.||+|... ++..+++|.+........+.+.+|+.++++++||||+++++++..++..++||||++
T Consensus 13 ~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 92 (292)
T cd06644 13 VWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCP 92 (292)
T ss_pred hhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCC
Confidence 4667778999999999999976 578899999876654455678899999999999999999999999999999999999
Q ss_pred CCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC-CCccc
Q 014352 197 NGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD-GRNSG 275 (426)
Q Consensus 197 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-~~~~~ 275 (426)
+++|..++......+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++...... .....
T Consensus 93 ~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 169 (292)
T cd06644 93 GGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS 169 (292)
T ss_pred CCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccccccce
Confidence 99999888666667999999999999999999999998 999999999999999999999999998643221 12234
Q ss_pred CccccCccCccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHH
Q 014352 276 LKGTYGYIDPAYIS-----TNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEV 350 (426)
Q Consensus 276 ~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (426)
..++..|+|||++. ...++.++||||||+++|||++|..||.................. ....+...+
T Consensus 170 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~ 242 (292)
T cd06644 170 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP-------TLSQPSKWS 242 (292)
T ss_pred ecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCc-------cCCCCcccC
Confidence 56888999999984 345788999999999999999999998654322211111111000 001122334
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 351 RELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 351 ~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
.++.+++.+||+.+|++||++.+++++
T Consensus 243 ~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 243 MEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred HHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 578899999999999999999999864
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=321.59 Aligned_cols=257 Identities=28% Similarity=0.492 Sum_probs=199.8
Q ss_pred HHHhhhhcccccCCCeeEEEEEe------CCCcEEEEEEeccCCcc-ChHHHHHHHHHHhcC-CCCceeeEEeEEEeC-C
Q 014352 116 KATQNFTNILGQGAFGPVYKATM------PSGGVAAIKVLASDSHQ-GEKEFQTEVSLLGRL-HHRNLVNLIGYCVDK-G 186 (426)
Q Consensus 116 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-~ 186 (426)
..++.+.+.||+|+||.||+|.. .+++.||||.++..... ....+..|+.++.++ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 44577888999999999999973 24678999999754322 234688899999999 689999999988654 4
Q ss_pred eEEEEEEecCCCChhHHhhhcc----------------------------------------------------------
Q 014352 187 KYMLIYEFMSNGSLSNLIYSEE---------------------------------------------------------- 208 (426)
Q Consensus 187 ~~~lv~e~~~~gsL~~~l~~~~---------------------------------------------------------- 208 (426)
..+++|||+++|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 6799999999999999985421
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCC---cccCc
Q 014352 209 --------RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGR---NSGLK 277 (426)
Q Consensus 209 --------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~---~~~~~ 277 (426)
..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++........ .....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 23678888999999999999999998 99999999999999999999999999875322211 12234
Q ss_pred cccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHH
Q 014352 278 GTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARI 356 (426)
Q Consensus 278 gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 356 (426)
++..|+|||.+.+..++.++||||||+++|||++ |..||........... .+........+......+.++
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~ 314 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR--------RLKEGTRMRAPDYTTPEMYQT 314 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHH--------HHhccCCCCCCCCCCHHHHHH
Confidence 5678999999988899999999999999999997 8999865321111100 000000001111123568999
Q ss_pred HHHcccCCCCCCCCHHHHHHHHHHHHH
Q 014352 357 GHKCLHKTPRKRPSIGEVTQALLKIKQ 383 (426)
Q Consensus 357 ~~~cl~~~p~~RPs~~evl~~L~~~~~ 383 (426)
+.+||+.||++|||+.+++++|+.+.+
T Consensus 315 ~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 315 MLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=314.01 Aligned_cols=249 Identities=24% Similarity=0.388 Sum_probs=198.6
Q ss_pred hhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccC---hHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEec
Q 014352 120 NFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQG---EKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 120 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 195 (426)
...+.||+|+||.||++... +++.+|+|.+....... ...+..|+.++++++|+|++++++.+.+.+..++||||+
T Consensus 3 ~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05630 3 RQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLM 82 (285)
T ss_pred eeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEec
Confidence 34568999999999999875 67899999886543222 245778999999999999999999999999999999999
Q ss_pred CCCChhHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCcc
Q 014352 196 SNGSLSNLIYSEE-RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNS 274 (426)
Q Consensus 196 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 274 (426)
++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++..........
T Consensus 83 ~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 159 (285)
T cd05630 83 NGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK 159 (285)
T ss_pred CCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcccc
Confidence 9999999885533 45899999999999999999999988 9999999999999999999999999987543333333
Q ss_pred cCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHH
Q 014352 275 GLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELA 354 (426)
Q Consensus 275 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 354 (426)
...|+..|+|||.+.+..++.++||||||+++|+|++|..||.......... ....... ......+......+.
T Consensus 160 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~-----~~~~~~~-~~~~~~~~~~~~~~~ 233 (285)
T cd05630 160 GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE-----EVERLVK-EVQEEYSEKFSPDAR 233 (285)
T ss_pred CCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHH-----HHHhhhh-hhhhhcCccCCHHHH
Confidence 4578999999999999999999999999999999999999997532110000 0000000 000111222345688
Q ss_pred HHHHHcccCCCCCCCC-----HHHHHHH
Q 014352 355 RIGHKCLHKTPRKRPS-----IGEVTQA 377 (426)
Q Consensus 355 ~l~~~cl~~~p~~RPs-----~~evl~~ 377 (426)
+++.+||+.||++||| +.+++++
T Consensus 234 ~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 234 SLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred HHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 9999999999999999 7888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=306.50 Aligned_cols=247 Identities=27% Similarity=0.474 Sum_probs=201.5
Q ss_pred hhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCCC
Q 014352 119 QNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNG 198 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 198 (426)
+++.+.||.|+||.||++.+.++..+|+|.+.... .....|.+|++++++++|||++++++++......++||||++++
T Consensus 6 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (256)
T cd05112 6 LTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHG 84 (256)
T ss_pred eEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCC
Confidence 45667899999999999998778889999886543 34567899999999999999999999999999999999999999
Q ss_pred ChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCC--cccC
Q 014352 199 SLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGR--NSGL 276 (426)
Q Consensus 199 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~--~~~~ 276 (426)
+|.+++......+++..+..++.+++.||+|||+.+ ++|+||||+||+++.++.++|+|||+++....... ....
T Consensus 85 ~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 161 (256)
T cd05112 85 CLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGT 161 (256)
T ss_pred cHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccccCCC
Confidence 999999766667899999999999999999999998 99999999999999999999999999875432211 1223
Q ss_pred ccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHH
Q 014352 277 KGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELAR 355 (426)
Q Consensus 277 ~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 355 (426)
.++.+|+|||.+.+..++.++||||||+++|||++ |..||...........+... .....+...+..+.+
T Consensus 162 ~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~ 232 (256)
T cd05112 162 KFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAG---------FRLYKPRLASQSVYE 232 (256)
T ss_pred ccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCC---------CCCCCCCCCCHHHHH
Confidence 35678999999998899999999999999999998 99998653322211111110 000011113467999
Q ss_pred HHHHcccCCCCCCCCHHHHHHHH
Q 014352 356 IGHKCLHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 356 l~~~cl~~~p~~RPs~~evl~~L 378 (426)
++.+||+.+|++|||+.++++.|
T Consensus 233 l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 233 LMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred HHHHHcccChhhCCCHHHHHHhh
Confidence 99999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=304.84 Aligned_cols=245 Identities=27% Similarity=0.451 Sum_probs=200.2
Q ss_pred cccccCCCeeEEEEEeCCCcEEEEEEeccCCcc-ChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCCCChh
Q 014352 123 NILGQGAFGPVYKATMPSGGVAAIKVLASDSHQ-GEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLS 201 (426)
Q Consensus 123 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 201 (426)
+.||.|+||.||++...+++.+++|.+...... ....+.+|++++++++||||+++++++.+.+..++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 369999999999999877899999988765433 3467899999999999999999999999999999999999999999
Q ss_pred HHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCc---ccCcc
Q 014352 202 NLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRN---SGLKG 278 (426)
Q Consensus 202 ~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~---~~~~g 278 (426)
+++......+++..++.++.+++.||.|||+++ ++||||||+||+++.++.++|+|||++......... .....
T Consensus 81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 999766667899999999999999999999998 999999999999999999999999998753311111 12233
Q ss_pred ccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHHH
Q 014352 279 TYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIG 357 (426)
Q Consensus 279 t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 357 (426)
+..|+|||.+.+..++.++|+||||+++|||++ |..||............ ........+...+..+.+++
T Consensus 158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~li 228 (251)
T cd05041 158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERI---------ESGYRMPAPQLCPEEIYRLM 228 (251)
T ss_pred eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHH---------hcCCCCCCCccCCHHHHHHH
Confidence 567999999998899999999999999999999 88888654322211111 11111112223446799999
Q ss_pred HHcccCCCCCCCCHHHHHHHHH
Q 014352 358 HKCLHKTPRKRPSIGEVTQALL 379 (426)
Q Consensus 358 ~~cl~~~p~~RPs~~evl~~L~ 379 (426)
.+||..+|.+|||+.++++.|+
T Consensus 229 ~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 229 LQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHhccChhhCcCHHHHHHHhh
Confidence 9999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=313.73 Aligned_cols=249 Identities=28% Similarity=0.427 Sum_probs=199.0
Q ss_pred hhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCcc---ChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEec
Q 014352 120 NFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQ---GEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 120 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 195 (426)
...+.||+|+||+||++... +++.+|+|.+...... ....+.+|++++++++|+||+++.+++..++..+++|||+
T Consensus 3 ~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05632 3 RQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIM 82 (285)
T ss_pred eEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEec
Confidence 34568999999999999875 6789999998654222 2345778999999999999999999999999999999999
Q ss_pred CCCChhHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCcc
Q 014352 196 SNGSLSNLIYSEE-RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNS 274 (426)
Q Consensus 196 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 274 (426)
++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++..........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 159 (285)
T cd05632 83 NGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIR 159 (285)
T ss_pred cCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCCccc
Confidence 9999998886543 46999999999999999999999998 9999999999999999999999999987543333334
Q ss_pred cCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHH
Q 014352 275 GLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELA 354 (426)
Q Consensus 275 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 354 (426)
...|+..|+|||++.+..++.++|+||||+++|||++|..||...........+... +... ...........+.
T Consensus 160 ~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~----~~~~--~~~~~~~~~~~~~ 233 (285)
T cd05632 160 GRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRR----VLET--EEVYSAKFSEEAK 233 (285)
T ss_pred CCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh----hhcc--ccccCccCCHHHH
Confidence 457899999999999999999999999999999999999999764332211111000 0000 0011223345788
Q ss_pred HHHHHcccCCCCCCCC-----HHHHHHH
Q 014352 355 RIGHKCLHKTPRKRPS-----IGEVTQA 377 (426)
Q Consensus 355 ~l~~~cl~~~p~~RPs-----~~evl~~ 377 (426)
+++..||+.||++||+ +.+++.+
T Consensus 234 ~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 234 SICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred HHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 9999999999999999 6666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=296.48 Aligned_cols=253 Identities=25% Similarity=0.376 Sum_probs=211.5
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCcc----Ch----HHHHHHHHHHhcC-CCCceeeEEeEEEeCCeE
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQ----GE----KEFQTEVSLLGRL-HHRNLVNLIGYCVDKGKY 188 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~----~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 188 (426)
|.-.+.||.|..++|-++..+ ++...|+|++...... .. +.-..|+.+|+++ .||||+.+.+++.++.-+
T Consensus 19 y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~ 98 (411)
T KOG0599|consen 19 YEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFV 98 (411)
T ss_pred cChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchh
Confidence 444578999999999999865 7778888888643211 11 2346799999998 599999999999999999
Q ss_pred EEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccc
Q 014352 189 MLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEV 268 (426)
Q Consensus 189 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 268 (426)
++|+|.|+.|.|.++|.. ...++......|+.|+.+|++|||.++ ||||||||+|||+|++.++||+|||++....
T Consensus 99 FlVFdl~prGELFDyLts-~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 99 FLVFDLMPRGELFDYLTS-KVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFACQLE 174 (411)
T ss_pred hhhhhhcccchHHHHhhh-heeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccceeeccC
Confidence 999999999999999943 456899999999999999999999999 9999999999999999999999999999888
Q ss_pred cCCCcccCccccCccCcccccc------CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhc
Q 014352 269 FDGRNSGLKGTYGYIDPAYIST------NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLV 342 (426)
Q Consensus 269 ~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (426)
........+||++|+|||.+.. ..|+...|.|++||+||-|+.|.+||-...+...+..+..+.. .+.
T Consensus 175 ~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGky------qF~ 248 (411)
T KOG0599|consen 175 PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKY------QFR 248 (411)
T ss_pred CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhccc------ccC
Confidence 7788888999999999998853 3578889999999999999999999987666555444333221 223
Q ss_pred ccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 014352 343 GACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKI 381 (426)
Q Consensus 343 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 381 (426)
++...+.+....+|+.+||+.||.+|.|++|++.+-.-+
T Consensus 249 speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~ 287 (411)
T KOG0599|consen 249 SPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFI 287 (411)
T ss_pred CcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHH
Confidence 444556677899999999999999999999999875443
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=311.61 Aligned_cols=249 Identities=25% Similarity=0.391 Sum_probs=196.7
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC-ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecC
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS-HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMS 196 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 196 (426)
+++.+.||+|+||.||+|... ++..+|+|.+.... ......+.+|++++++++||||+++++++...+..++||||++
T Consensus 3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 82 (279)
T cd06619 3 IQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMD 82 (279)
T ss_pred chheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCC
Confidence 345678999999999999864 77889999986542 2234578899999999999999999999999999999999999
Q ss_pred CCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCcccC
Q 014352 197 NGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGL 276 (426)
Q Consensus 197 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~ 276 (426)
+++|..+. .+++.....++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.... .......
T Consensus 83 ~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~-~~~~~~~ 153 (279)
T cd06619 83 GGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV-NSIAKTY 153 (279)
T ss_pred CCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecc-cccccCC
Confidence 99997543 3678888999999999999999998 9999999999999999999999999987543 2233446
Q ss_pred ccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHH
Q 014352 277 KGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARI 356 (426)
Q Consensus 277 ~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 356 (426)
.++..|+|||++.+..++.++||||||+++|+|++|..||.......... ..........+.............++.++
T Consensus 154 ~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 232 (279)
T cd06619 154 VGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL-MPLQLLQCIVDEDPPVLPVGQFSEKFVHF 232 (279)
T ss_pred CCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc-chHHHHHHHhccCCCCCCCCcCCHHHHHH
Confidence 78999999999999999999999999999999999999986532111000 00000011111111111112234578999
Q ss_pred HHHcccCCCCCCCCHHHHHHH
Q 014352 357 GHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 357 ~~~cl~~~p~~RPs~~evl~~ 377 (426)
+.+||+.+|++||++.+++++
T Consensus 233 i~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 233 ITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred HHHHhhCChhhCCCHHHHhcC
Confidence 999999999999999999976
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=306.26 Aligned_cols=253 Identities=25% Similarity=0.406 Sum_probs=204.6
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC---ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEe
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS---HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEF 194 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 194 (426)
|.+.+.||+|+||.||+|... +++.+|+|.+.... ....+.+.+|++++++++|+|++++++++...+..++||||
T Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (267)
T cd08224 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLEL 83 (267)
T ss_pred eeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEec
Confidence 566788999999999999986 78899999886432 22245788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhh---ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC
Q 014352 195 MSNGSLSNLIYS---EERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG 271 (426)
Q Consensus 195 ~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 271 (426)
+++++|.+++.. ....+++..+..++.+++.||.|||+.+ ++||||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~ 160 (267)
T cd08224 84 ADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred CCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccCCC
Confidence 999999998854 2355899999999999999999999998 9999999999999999999999999987533221
Q ss_pred -CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHH-HHHHhhccccchhhhhhhhhcccCC-HH
Q 014352 272 -RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLME-YVNLASMSQDGVDEILDKQLVGACN-IQ 348 (426)
Q Consensus 272 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 348 (426)
......++..|+|||.+.+..++.++||||||+++|+|++|..||..... .... ...+........+ ..
T Consensus 161 ~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--------~~~~~~~~~~~~~~~~ 232 (267)
T cd08224 161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL--------CKKIEKCDYPPLPADH 232 (267)
T ss_pred cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHH--------HhhhhcCCCCCCChhh
Confidence 22335688899999999988999999999999999999999999854211 0000 0000011111111 23
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 014352 349 EVRELARIGHKCLHKTPRKRPSIGEVTQALLKIK 382 (426)
Q Consensus 349 ~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 382 (426)
....+.+++.+||..+|++|||+.++++.|..+.
T Consensus 233 ~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 233 YSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred cCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 4567899999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=307.29 Aligned_cols=248 Identities=28% Similarity=0.470 Sum_probs=193.8
Q ss_pred cccccCCCeeEEEEEeC----CCcEEEEEEeccCC-ccChHHHHHHHHHHhcCCCCceeeEEeEEEe-CCeEEEEEEecC
Q 014352 123 NILGQGAFGPVYKATMP----SGGVAAIKVLASDS-HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVD-KGKYMLIYEFMS 196 (426)
Q Consensus 123 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~ 196 (426)
+.||+|+||.||+|.+. +...+|+|.+.... ....+.+.+|+.+++.++||||+++++++.. ++..++++||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 36899999999999853 23478999875432 2234578899999999999999999998764 456899999999
Q ss_pred CCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC-----
Q 014352 197 NGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG----- 271 (426)
Q Consensus 197 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~----- 271 (426)
+|+|.+++......+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++......
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 99999999766566788888999999999999999988 9999999999999999999999999987432211
Q ss_pred CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhC-CCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHH
Q 014352 272 RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITA-IHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEV 350 (426)
Q Consensus 272 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (426)
......++..|+|||++.+..++.++||||||+++|||++| .+||............... .....+...+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~ 228 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQG---------RRLLQPEYCP 228 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC---------CCCCCCCcCC
Confidence 11233457789999999888999999999999999999995 5566543222111111000 0011111234
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 014352 351 RELARIGHKCLHKTPRKRPSIGEVTQALLKIK 382 (426)
Q Consensus 351 ~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 382 (426)
..+.+++.+||+.+|++||++.++++.|+.+.
T Consensus 229 ~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 229 DPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 57899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=306.70 Aligned_cols=245 Identities=27% Similarity=0.433 Sum_probs=198.9
Q ss_pred cccccCCCeeEEEEEeCC--Cc--EEEEEEeccCCc-cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCC
Q 014352 123 NILGQGAFGPVYKATMPS--GG--VAAIKVLASDSH-QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSN 197 (426)
Q Consensus 123 ~~lg~G~~g~Vy~~~~~~--~~--~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 197 (426)
+.||+|++|.||+|.+.+ +. .+|+|.+..... ...+.+..|+.++++++||||+++++++.. ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 368999999999998643 32 589999987655 445678999999999999999999999988 889999999999
Q ss_pred CChhHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC----C
Q 014352 198 GSLSNLIYSEE-RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG----R 272 (426)
Q Consensus 198 gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~----~ 272 (426)
++|.+++.... ..+++...+.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||+++...... .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 99999997655 56899999999999999999999998 9999999999999999999999999987543211 1
Q ss_pred cccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHH
Q 014352 273 NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVR 351 (426)
Q Consensus 273 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (426)
.....++..|+|||++.+..++.++||||||+++|||++ |..||...........+.... .....+...+.
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~ 228 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEG--------ERLERPEACPQ 228 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC--------CcCCCCccCCH
Confidence 123456788999999999999999999999999999999 999986543322211111100 00011122346
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 014352 352 ELARIGHKCLHKTPRKRPSIGEVTQALL 379 (426)
Q Consensus 352 ~l~~l~~~cl~~~p~~RPs~~evl~~L~ 379 (426)
.+.+++.+||+.+|++|||+.++++.|.
T Consensus 229 ~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 229 DIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 7999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=310.03 Aligned_cols=252 Identities=31% Similarity=0.484 Sum_probs=200.5
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChH--HHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEec
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEK--EFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~--~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 195 (426)
|++.+.||+|+||+||+++.. +++.+|+|.+......... ....|+.++++++||||+++++++...+..++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 356788999999999999986 5568999999876433322 3456999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccc-ccCCCcc
Q 014352 196 SNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEE-VFDGRNS 274 (426)
Q Consensus 196 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~-~~~~~~~ 274 (426)
++++|.+++. ....+++..+..++.|++.||.+||+.+ ++|+||||+||+++.++.++|+|||.+... .......
T Consensus 81 ~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~ 156 (260)
T PF00069_consen 81 PGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFN 156 (260)
T ss_dssp TTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBS
T ss_pred cccccccccc-cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccc
Confidence 9999999996 4456899999999999999999999998 999999999999999999999999998742 2233345
Q ss_pred cCccccCccCccccc-cCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHH
Q 014352 275 GLKGTYGYIDPAYIS-TNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVREL 353 (426)
Q Consensus 275 ~~~gt~~y~aPE~~~-~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 353 (426)
...++..|+|||++. +..++.++||||||+++|+|++|..||................... ..... .........+
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~l 233 (260)
T PF00069_consen 157 PFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRP-LPSSS--QQSREKSEEL 233 (260)
T ss_dssp SSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTH-HHHHT--TSHTTSHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccc-ccccc--cccchhHHHH
Confidence 567899999999998 8889999999999999999999999998751111111110000000 00000 0001112689
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHH
Q 014352 354 ARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 354 ~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
.+++.+||+.||++|||+.+++++
T Consensus 234 ~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 234 RDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp HHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred HHHHHHHccCChhHCcCHHHHhcC
Confidence 999999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=336.17 Aligned_cols=250 Identities=28% Similarity=0.462 Sum_probs=215.3
Q ss_pred hcccccCCCeeEEEEEeC-CCc----EEEEEEeccCCc-cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEec
Q 014352 122 TNILGQGAFGPVYKATMP-SGG----VAAIKVLASDSH-QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 122 ~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 195 (426)
..+||+|+||+||+|.+- .|. +||+|++..... ....++.+|+-+|.+++|||+++++|+|.... +.||++||
T Consensus 701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m 779 (1177)
T KOG1025|consen 701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM 779 (1177)
T ss_pred hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence 358999999999999863 333 689999876543 34578999999999999999999999999876 88999999
Q ss_pred CCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCc--
Q 014352 196 SNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRN-- 273 (426)
Q Consensus 196 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~-- 273 (426)
+.|+|.++++.+...+-....+.|..|||+||.|||.+. ++||||.++||||.+-..+||+|||+++....+...
T Consensus 780 P~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~ 856 (1177)
T KOG1025|consen 780 PLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYS 856 (1177)
T ss_pred ccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCccccccc
Confidence 999999999888888999999999999999999999998 999999999999999999999999999876544332
Q ss_pred -ccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHH
Q 014352 274 -SGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVR 351 (426)
Q Consensus 274 -~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (426)
....-.+.|||=|.+....|+.++|||||||++||++| |..||.+. ..+.+..++...-+..+++-...
T Consensus 857 ~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi---------~~~eI~dlle~geRLsqPpiCti 927 (1177)
T KOG1025|consen 857 APGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGI---------PAEEIPDLLEKGERLSQPPICTI 927 (1177)
T ss_pred ccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCC---------CHHHhhHHHhccccCCCCCCccH
Confidence 22334678999999999999999999999999999998 99999763 33445555665556677777888
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHH
Q 014352 352 ELARIGHKCLHKTPRKRPSIGEVTQALLKIKQR 384 (426)
Q Consensus 352 ~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 384 (426)
+++.++.+||..|+..||+|+++...+.+..+.
T Consensus 928 DVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 928 DVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred HHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 999999999999999999999999999887643
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=329.35 Aligned_cols=249 Identities=22% Similarity=0.273 Sum_probs=195.2
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC---ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEe
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS---HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEF 194 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 194 (426)
|.+.+.||+|+||.||++... ++..||+|++.... ......+.+|++++++++||||+++++++.+.+..|+||||
T Consensus 3 y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~ 82 (377)
T cd05629 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEF 82 (377)
T ss_pred ceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeC
Confidence 455678999999999999865 78899999986432 12234678899999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC---
Q 014352 195 MSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG--- 271 (426)
Q Consensus 195 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~--- 271 (426)
+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~gg~L~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 83 LPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred CCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 9999999998644 45889999999999999999999998 9999999999999999999999999985211000
Q ss_pred ---------------------------------------------CcccCccccCccCccccccCCCCcchhhHHHHHHH
Q 014352 272 ---------------------------------------------RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVII 306 (426)
Q Consensus 272 ---------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl 306 (426)
......||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 238 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM 238 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhh
Confidence 00124689999999999999999999999999999
Q ss_pred HHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCC---CCHHHHHHHH
Q 014352 307 FELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKR---PSIGEVTQAL 378 (426)
Q Consensus 307 ~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R---Ps~~evl~~L 378 (426)
|||++|..||...........+.... ..+.-......+..+.+++.+|+. +|.+| +++.+++.+-
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~------~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp 306 (377)
T cd05629 239 FECLIGWPPFCSENSHETYRKIINWR------ETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHP 306 (377)
T ss_pred hhhhcCCCCCCCCCHHHHHHHHHccC------CccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCC
Confidence 99999999997543322221111100 000000111234578899999997 66665 6999988863
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=310.40 Aligned_cols=250 Identities=28% Similarity=0.436 Sum_probs=203.8
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecC
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMS 196 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 196 (426)
.|.+.+.||.|+||.||++... ++..+|+|.+........+.+..|++++++++||||+++++++..++..++||||++
T Consensus 6 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (280)
T cd06611 6 IWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCD 85 (280)
T ss_pred HHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccC
Confidence 3667778999999999999975 678999999876654455678899999999999999999999999999999999999
Q ss_pred CCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC-CCccc
Q 014352 197 NGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD-GRNSG 275 (426)
Q Consensus 197 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-~~~~~ 275 (426)
+++|.+++......+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++...... .....
T Consensus 86 ~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 162 (280)
T cd06611 86 GGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT 162 (280)
T ss_pred CCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccccccce
Confidence 99999999776677999999999999999999999998 999999999999999999999999988643222 12234
Q ss_pred CccccCccCccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHH
Q 014352 276 LKGTYGYIDPAYIS-----TNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEV 350 (426)
Q Consensus 276 ~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (426)
..++..|+|||.+. ...++.++|+||||+++|||++|..||...........+...... ....+...+
T Consensus 163 ~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~ 235 (280)
T cd06611 163 FIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPP-------TLDQPSKWS 235 (280)
T ss_pred eecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCC-------CcCCcccCC
Confidence 56889999999874 345778999999999999999999999764332222111111000 001122344
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 351 RELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 351 ~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
..+.+++.+||+.+|++||++.+++++
T Consensus 236 ~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 236 SSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 678899999999999999999999876
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=302.60 Aligned_cols=255 Identities=25% Similarity=0.285 Sum_probs=202.9
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCcc--ChHHHHHHHHHHhcCCCCc-eeeEEeEEEeCC------eE
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQ--GEKEFQTEVSLLGRLHHRN-LVNLIGYCVDKG------KY 188 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~------~~ 188 (426)
+...++||+|+||+||+|+.. +|+.||+|++...... ......+|+.+|++|+|+| |+++++++.+.+ .+
T Consensus 13 ~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l 92 (323)
T KOG0594|consen 13 YEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKL 92 (323)
T ss_pred HHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceE
Confidence 444567999999999999865 7889999999866432 3356789999999999999 999999999877 78
Q ss_pred EEEEEecCCCChhHHhhhcc---CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcc
Q 014352 189 MLIYEFMSNGSLSNLIYSEE---RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSK 265 (426)
Q Consensus 189 ~lv~e~~~~gsL~~~l~~~~---~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 265 (426)
++|+||+.. +|..++.... ..++...+..++.|++.||+|||+++ |+||||||.|||++++|.+||+|||+|+
T Consensus 93 ~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 93 YLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGLAR 168 (323)
T ss_pred EEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccchHH
Confidence 999999955 9999997655 35777889999999999999999999 9999999999999999999999999998
Q ss_pred cccc-CCCcccCccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccc----c---chhh-
Q 014352 266 EEVF-DGRNSGLKGTYGYIDPAYISTN-KFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQ----D---GVDE- 335 (426)
Q Consensus 266 ~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~----~---~~~~- 335 (426)
.... ....+...+|..|.|||++.+. .|+...|+||+||++.||++++.-|.+..+...+..+-. . ..+.
T Consensus 169 a~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v 248 (323)
T KOG0594|consen 169 AFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGV 248 (323)
T ss_pred HhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCc
Confidence 5442 2335667789999999999876 799999999999999999999999988666544332210 0 0000
Q ss_pred --hhhh--hhcccC-CH-------HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 336 --ILDK--QLVGAC-NI-------QEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 336 --~~~~--~~~~~~-~~-------~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
..+- .+.... +. .......+++.+|++.+|.+|.|++.++.+
T Consensus 249 ~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 249 SSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred cccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 0010 111111 11 111368899999999999999999999987
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=314.60 Aligned_cols=258 Identities=24% Similarity=0.440 Sum_probs=203.4
Q ss_pred HHHhhhhcccccCCCeeEEEEEeC--------CCcEEEEEEeccCCc-cChHHHHHHHHHHhcC-CCCceeeEEeEEEeC
Q 014352 116 KATQNFTNILGQGAFGPVYKATMP--------SGGVAAIKVLASDSH-QGEKEFQTEVSLLGRL-HHRNLVNLIGYCVDK 185 (426)
Q Consensus 116 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 185 (426)
..++.+.+.||+|+||.||+++.. ....+|+|.+..... .....+..|+.+++++ +||||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 455667889999999999999742 234689998875432 2235688999999999 699999999999998
Q ss_pred CeEEEEEEecCCCChhHHhhhcc---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEe
Q 014352 186 GKYMLIYEFMSNGSLSNLIYSEE---------------RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILL 250 (426)
Q Consensus 186 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill 250 (426)
+..+++|||+++|+|.+++.... ..+++.++..++.|++.||.|||+++ ++||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence 89999999999999999985431 35889999999999999999999998 9999999999999
Q ss_pred cCCCcEEEeeecCccccccCC---CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHh
Q 014352 251 DHFMRAKVADFGLSKEEVFDG---RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLA 326 (426)
Q Consensus 251 ~~~~~~kl~Dfgl~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~ 326 (426)
+.++.+||+|||+++...... ......++..|+|||.+.+..++.++||||||+++|||++ |..||..........
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~ 247 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK 247 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 999999999999997542211 1112234567999999998899999999999999999999 888986543222111
Q ss_pred hccccchhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHh
Q 014352 327 SMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRH 385 (426)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~ 385 (426)
..... .....+...+.++.+++.+||+.+|++|||+.++++.|..+....
T Consensus 248 ~~~~~---------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 248 LLREG---------HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred HHHcC---------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 11111 011112233457889999999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=307.49 Aligned_cols=248 Identities=28% Similarity=0.472 Sum_probs=197.2
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcC-CCCceeeEEeEEEeC------CeEE
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRL-HHRNLVNLIGYCVDK------GKYM 189 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~------~~~~ 189 (426)
.|++.+.||+|+||.||+|... +++.+|+|.+.... .....+..|+.++.++ +||||+++++++... ...+
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 85 (272)
T cd06637 7 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW 85 (272)
T ss_pred hhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEE
Confidence 3556678999999999999875 67889999986543 3456788999999998 699999999998753 4589
Q ss_pred EEEEecCCCChhHHhhhc-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccc
Q 014352 190 LIYEFMSNGSLSNLIYSE-ERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEV 268 (426)
Q Consensus 190 lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 268 (426)
++|||+++++|.+++... ...+++..+..++.|++.||.|||+++ |+|+||||+||++++++.++|+|||++....
T Consensus 86 iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~ 162 (272)
T cd06637 86 LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 162 (272)
T ss_pred EEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCceecc
Confidence 999999999999998653 356899999999999999999999998 9999999999999999999999999987532
Q ss_pred cC-CCcccCccccCccCccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhc
Q 014352 269 FD-GRNSGLKGTYGYIDPAYIS-----TNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLV 342 (426)
Q Consensus 269 ~~-~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (426)
.. .......|+..|+|||++. +..++.++|||||||++|||++|..||................ ..
T Consensus 163 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~--------~~ 234 (272)
T cd06637 163 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP--------AP 234 (272)
T ss_pred cccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCC--------CC
Confidence 21 2234456899999999986 3467889999999999999999999996543322211111100 01
Q ss_pred ccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 343 GACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 343 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
.......+..+.+++.+||..+|.+|||+.+++++
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 235 RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 11112234578999999999999999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=326.82 Aligned_cols=252 Identities=23% Similarity=0.264 Sum_probs=195.3
Q ss_pred HHHHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEE
Q 014352 115 QKATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYE 193 (426)
Q Consensus 115 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 193 (426)
.+..|.+.+.||+|+||.||++... +++.||+|... ...+.+|++++++++||||+++++++......++|+|
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence 3455777889999999999999875 77899999643 2356789999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC--C
Q 014352 194 FMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD--G 271 (426)
Q Consensus 194 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~--~ 271 (426)
++. ++|..++... ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..... .
T Consensus 164 ~~~-~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 164 RYK-TDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238 (391)
T ss_pred cCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence 995 6888888544 45899999999999999999999998 999999999999999999999999998643221 2
Q ss_pred CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHH-------HHHHhhcc--------------c
Q 014352 272 RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLME-------YVNLASMS--------------Q 330 (426)
Q Consensus 272 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~-------~~~~~~~~--------------~ 330 (426)
......||+.|+|||++.+..++.++|||||||++|||++|..||..... ...+..+. .
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 23346799999999999999999999999999999999999987643110 00000000 0
Q ss_pred cchhhhh-h--hh-hcc---cC----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 331 DGVDEIL-D--KQ-LVG---AC----NIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 331 ~~~~~~~-~--~~-~~~---~~----~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
....... . .. ... .. ....+.++.+++.+||+.||++|||+.|++++
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0000000 0 00 000 00 01234578999999999999999999999975
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=311.32 Aligned_cols=240 Identities=23% Similarity=0.406 Sum_probs=191.0
Q ss_pred cccccCCCeeEEEEEeCC-C-------cEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEe
Q 014352 123 NILGQGAFGPVYKATMPS-G-------GVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEF 194 (426)
Q Consensus 123 ~~lg~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 194 (426)
+.||+|+||.||+|.... + ..+++|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 369999999999998642 2 24788887654434446788999999999999999999999998899999999
Q ss_pred cCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCc--------EEEeeecCccc
Q 014352 195 MSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMR--------AKVADFGLSKE 266 (426)
Q Consensus 195 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~--------~kl~Dfgl~~~ 266 (426)
+++|+|..++......+++..++.++.|++.||.|||+++ |+||||||+||+++.++. ++++|||++..
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 9999999999776667899999999999999999999998 999999999999987765 69999998864
Q ss_pred cccCCCcccCccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCC-CCCCchHHHHHHhhccccchhhhhhhhhccc
Q 014352 267 EVFDGRNSGLKGTYGYIDPAYIST-NKFTMKSDIFSFGVIIFELITAI-HPHQNLMEYVNLASMSQDGVDEILDKQLVGA 344 (426)
Q Consensus 267 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (426)
.. ......++..|+|||++.+ ..++.++||||||+++|||++|. .|+.......... .... ...
T Consensus 158 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~---------~~~~--~~~ 223 (258)
T cd05078 158 VL---PKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ---------FYED--RHQ 223 (258)
T ss_pred cC---CchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH---------HHHc--ccc
Confidence 32 2234567889999999976 45789999999999999999985 5554432221111 0000 011
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 014352 345 CNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALL 379 (426)
Q Consensus 345 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 379 (426)
.+.....++.+++.+||+.||++|||+.++++.|+
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 224 LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 12223357899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=314.12 Aligned_cols=258 Identities=26% Similarity=0.424 Sum_probs=201.0
Q ss_pred HHhhhhcccccCCCeeEEEEEeCC-----------------CcEEEEEEeccCCc-cChHHHHHHHHHHhcCCCCceeeE
Q 014352 117 ATQNFTNILGQGAFGPVYKATMPS-----------------GGVAAIKVLASDSH-QGEKEFQTEVSLLGRLHHRNLVNL 178 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~ 178 (426)
..+.+.+.||+|+||.||++.... +..+|+|.+..... .....+.+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 346677899999999999987642 23589999875532 234578899999999999999999
Q ss_pred EeEEEeCCeEEEEEEecCCCChhHHhhhcc----------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCE
Q 014352 179 IGYCVDKGKYMLIYEFMSNGSLSNLIYSEE----------RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANI 248 (426)
Q Consensus 179 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Ni 248 (426)
++++..++..++++||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~Ni 161 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhce
Confidence 999999999999999999999999986543 25899999999999999999999998 99999999999
Q ss_pred EecCCCcEEEeeecCccccccCC---CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh--CCCCCCchHHHH
Q 014352 249 LLDHFMRAKVADFGLSKEEVFDG---RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT--AIHPHQNLMEYV 323 (426)
Q Consensus 249 ll~~~~~~kl~Dfgl~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t--g~~p~~~~~~~~ 323 (426)
+++.++.++|+|||+++...... ......++..|+|||++.+..++.++||||||+++|||++ |..||.......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ 241 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH
Confidence 99999999999999987532221 1223456778999999988889999999999999999998 677876543222
Q ss_pred HHhhccccchhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 014352 324 NLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALL 379 (426)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 379 (426)
.+....... . ..........+...+.++.+++.+||+.||++|||+.++++.|+
T Consensus 242 ~~~~~~~~~-~-~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 242 VIENAGHFF-R-DDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HHHHHHhcc-c-cccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 211110000 0 00000001112223468999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=312.30 Aligned_cols=248 Identities=24% Similarity=0.352 Sum_probs=202.0
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecC
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMS 196 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 196 (426)
+|.+.+.||+|+||.||+|... +++.+++|.+..........+.+|+.+++.++||||+++++.+......++||||++
T Consensus 21 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~ 100 (296)
T cd06654 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (296)
T ss_pred ceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccC
Confidence 3556678999999999999864 778999999876655555678899999999999999999999999999999999999
Q ss_pred CCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC-Cccc
Q 014352 197 NGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG-RNSG 275 (426)
Q Consensus 197 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-~~~~ 275 (426)
+++|.+++.. ..+++.++..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++....... ....
T Consensus 101 ~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~ 175 (296)
T cd06654 101 GGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175 (296)
T ss_pred CCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccccccCc
Confidence 9999999843 35889999999999999999999998 9999999999999999999999999987432221 2234
Q ss_pred CccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHH
Q 014352 276 LKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELAR 355 (426)
Q Consensus 276 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 355 (426)
..+++.|+|||.+.+..++.++|||||||++|+|++|+.||................ ......+......+.+
T Consensus 176 ~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~~ 248 (296)
T cd06654 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-------TPELQNPEKLSAIFRD 248 (296)
T ss_pred ccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCC-------CCCCCCccccCHHHHH
Confidence 568899999999998889999999999999999999999997543322111111100 0001112234467889
Q ss_pred HHHHcccCCCCCCCCHHHHHHH
Q 014352 356 IGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 356 l~~~cl~~~p~~RPs~~evl~~ 377 (426)
++.+||..+|++||++.+++++
T Consensus 249 li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 249 FLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred HHHHHCcCCcccCcCHHHHhhC
Confidence 9999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=307.00 Aligned_cols=237 Identities=25% Similarity=0.456 Sum_probs=190.5
Q ss_pred cccccCCCeeEEEEEeCCCc-----------EEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEE
Q 014352 123 NILGQGAFGPVYKATMPSGG-----------VAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLI 191 (426)
Q Consensus 123 ~~lg~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 191 (426)
+.||+|+||.||+|.+.+.. .+++|.+...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 36999999999999976433 4777877654332 6788999999999999999999999988 778999
Q ss_pred EEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCC-------cEEEeeecCc
Q 014352 192 YEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFM-------RAKVADFGLS 264 (426)
Q Consensus 192 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-------~~kl~Dfgl~ 264 (426)
|||+++|+|.+++......+++..++.++.|++.||.|||+++ |+||||||+||+++.++ .+||+|||++
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 9999999999999766657899999999999999999999998 99999999999999888 7999999998
Q ss_pred cccccCCCcccCccccCccCccccccC--CCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhh
Q 014352 265 KEEVFDGRNSGLKGTYGYIDPAYISTN--KFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQL 341 (426)
Q Consensus 265 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (426)
..... .....++..|+|||++.+. .++.++||||||+++|||++ |..||............. ...
T Consensus 156 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~--------~~~- 223 (259)
T cd05037 156 ITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ--------DQH- 223 (259)
T ss_pred ccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh--------cCC-
Confidence 75432 2334567789999999776 78999999999999999999 577775532111100000 000
Q ss_pred cccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014352 342 VGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 342 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 378 (426)
..+......+.+++.+||..+|++|||+.++++.|
T Consensus 224 --~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 224 --RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred --CCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 01111126789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=323.42 Aligned_cols=249 Identities=28% Similarity=0.372 Sum_probs=194.8
Q ss_pred hhhhcccccCCCeeEEEEEe----CCCcEEEEEEeccCC----ccChHHHHHHHHHHhcC-CCCceeeEEeEEEeCCeEE
Q 014352 119 QNFTNILGQGAFGPVYKATM----PSGGVAAIKVLASDS----HQGEKEFQTEVSLLGRL-HHRNLVNLIGYCVDKGKYM 189 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 189 (426)
|.+.+.||+|+||.||+++. .++..+|+|++.... ....+.+..|+.++.++ +||||+++++++...+.++
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (332)
T cd05614 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH 81 (332)
T ss_pred ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence 45677899999999999875 357899999986432 12234678899999999 5999999999999999999
Q ss_pred EEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccccc
Q 014352 190 LIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF 269 (426)
Q Consensus 190 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 269 (426)
+||||+++|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 82 lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 82 LILDYVSGGEMFTHLYQR-DNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence 999999999999998654 45899999999999999999999998 99999999999999999999999999875322
Q ss_pred CC--CcccCccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCC
Q 014352 270 DG--RNSGLKGTYGYIDPAYISTN-KFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACN 346 (426)
Q Consensus 270 ~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (426)
.. ......||+.|+|||++.+. .++.++|||||||++|||++|..||...........+ ...+.. .....+
T Consensus 158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~----~~~~~~--~~~~~~ 231 (332)
T cd05614 158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV----SRRILK--CDPPFP 231 (332)
T ss_pred cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHH----HHHHhc--CCCCCC
Confidence 21 22345799999999999765 4788999999999999999999999642111000000 000000 001112
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 014352 347 IQEVRELARIGHKCLHKTPRKRP-----SIGEVTQA 377 (426)
Q Consensus 347 ~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~~ 377 (426)
......+.+++.+||+.||++|| ++.+++++
T Consensus 232 ~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 232 SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 23446788999999999999999 67788765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=329.19 Aligned_cols=248 Identities=22% Similarity=0.298 Sum_probs=193.4
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC---ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEe
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS---HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEF 194 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 194 (426)
+.+.+.||+|+||.||+|+.. +++.+|+|++.... ......+.+|+.++++++||||+++++.+.+.+.+++||||
T Consensus 3 f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~ 82 (382)
T cd05625 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 82 (382)
T ss_pred cEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeC
Confidence 445678999999999999875 67889999986532 12234688999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC----
Q 014352 195 MSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD---- 270 (426)
Q Consensus 195 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~---- 270 (426)
+++|+|.+++... ..++......++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 83 ~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 83 IPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred CCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence 9999999998654 45888888999999999999999998 999999999999999999999999997421100
Q ss_pred --------------------------------------------CCcccCccccCccCccccccCCCCcchhhHHHHHHH
Q 014352 271 --------------------------------------------GRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVII 306 (426)
Q Consensus 271 --------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl 306 (426)
.......||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil 238 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence 001234689999999999999999999999999999
Q ss_pred HHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCC---HHHHHHH
Q 014352 307 FELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPS---IGEVTQA 377 (426)
Q Consensus 307 ~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs---~~evl~~ 377 (426)
|||++|..||...........+... ............+.++.+++.+++ .+|.+|++ +.+++++
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~------~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 305 (382)
T cd05625 239 YEMLVGQPPFLAQTPLETQMKVINW------QTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAH 305 (382)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHcc------CCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcC
Confidence 9999999999764332221111110 000111111223456777777765 49999987 8887765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=318.20 Aligned_cols=261 Identities=24% Similarity=0.444 Sum_probs=206.4
Q ss_pred HHHHHHhhhhcccccCCCeeEEEEEeC--------CCcEEEEEEeccCCc-cChHHHHHHHHHHhcC-CCCceeeEEeEE
Q 014352 113 DIQKATQNFTNILGQGAFGPVYKATMP--------SGGVAAIKVLASDSH-QGEKEFQTEVSLLGRL-HHRNLVNLIGYC 182 (426)
Q Consensus 113 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~ 182 (426)
++...++.+.+.||+|+||.||++... ....+|+|.+..... ...+.+.+|+++++++ +||||+++++++
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 445566888899999999999999742 123689998875432 2345788999999999 799999999999
Q ss_pred EeCCeEEEEEEecCCCChhHHhhhcc---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCC
Q 014352 183 VDKGKYMLIYEFMSNGSLSNLIYSEE---------------RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSAN 247 (426)
Q Consensus 183 ~~~~~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~N 247 (426)
...+..++++||+++|+|.+++.... ..+++.+++.++.|++.||.|||+++ ++||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~N 164 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARN 164 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccce
Confidence 99999999999999999999986421 34788999999999999999999998 9999999999
Q ss_pred EEecCCCcEEEeeecCccccccCC---CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHH
Q 014352 248 ILLDHFMRAKVADFGLSKEEVFDG---RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYV 323 (426)
Q Consensus 248 ill~~~~~~kl~Dfgl~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~ 323 (426)
|+++.++.+||+|||+++...... ......++..|+|||.+.+..++.++||||||+++|||++ |..||.......
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 244 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 244 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 999999999999999987533211 1122334567999999999999999999999999999998 888886543222
Q ss_pred HHhhccccchhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHh
Q 014352 324 NLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRH 385 (426)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~ 385 (426)
....+... .....+...+..+.+++.+||+.+|++|||+.++++.|..+....
T Consensus 245 ~~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 245 LFKLLKEG---------HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred HHHHHHcC---------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 21111111 111112233467899999999999999999999999999987544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=313.62 Aligned_cols=256 Identities=25% Similarity=0.456 Sum_probs=199.1
Q ss_pred HHHhhhhcccccCCCeeEEEEEeC-----------------CCcEEEEEEeccCCc-cChHHHHHHHHHHhcCCCCceee
Q 014352 116 KATQNFTNILGQGAFGPVYKATMP-----------------SGGVAAIKVLASDSH-QGEKEFQTEVSLLGRLHHRNLVN 177 (426)
Q Consensus 116 ~~~~~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~ 177 (426)
+..+.+.+.||+|+||.||++... +...+|+|.+..... .....+.+|+.++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 345677889999999999998532 234689999875432 23457899999999999999999
Q ss_pred EEeEEEeCCeEEEEEEecCCCChhHHhhhcc----------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCC
Q 014352 178 LIGYCVDKGKYMLIYEFMSNGSLSNLIYSEE----------RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSAN 247 (426)
Q Consensus 178 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~N 247 (426)
+++++...+..+++|||+++|+|.+++.... ..+++.++..++.|++.||+|||+.+ ++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 9999999999999999999999999986532 24778899999999999999999998 9999999999
Q ss_pred EEecCCCcEEEeeecCccccccCCC---cccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh--CCCCCCchHHH
Q 014352 248 ILLDHFMRAKVADFGLSKEEVFDGR---NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT--AIHPHQNLMEY 322 (426)
Q Consensus 248 ill~~~~~~kl~Dfgl~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t--g~~p~~~~~~~ 322 (426)
|+++.++.++|+|||+++....... .....++..|++||...++.++.++||||||+++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 9999999999999999875322211 122334678999999888899999999999999999998 77888654322
Q ss_pred HHHhhccccchhhhhhh---hhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 014352 323 VNLASMSQDGVDEILDK---QLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALL 379 (426)
Q Consensus 323 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 379 (426)
...... ...... ......+...+..+.+++.+||+.||.+||++.++++.|+
T Consensus 241 ~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 241 QVIENT-----GEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHHHH-----HHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 211110 000000 0001111223467999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=321.35 Aligned_cols=236 Identities=25% Similarity=0.360 Sum_probs=188.7
Q ss_pred ccccCCCeeEEEEEeC-CCcEEEEEEeccCCc---cChHHHHHHH-HHHhcCCCCceeeEEeEEEeCCeEEEEEEecCCC
Q 014352 124 ILGQGAFGPVYKATMP-SGGVAAIKVLASDSH---QGEKEFQTEV-SLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNG 198 (426)
Q Consensus 124 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~-~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 198 (426)
.||+|+||+||+++.. +++.+|+|++..... .....+..|. .+++.++||||+++++++...+..++||||+++|
T Consensus 2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05602 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG 81 (325)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCC
Confidence 6999999999999976 667899999865321 1223344444 4567899999999999999999999999999999
Q ss_pred ChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccccc-CCCcccCc
Q 014352 199 SLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF-DGRNSGLK 277 (426)
Q Consensus 199 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~-~~~~~~~~ 277 (426)
+|.+++... ..++......++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.... ........
T Consensus 82 ~L~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 157 (325)
T cd05602 82 ELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC 157 (325)
T ss_pred cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCccccc
Confidence 999998654 45788888889999999999999998 99999999999999999999999999875322 22334567
Q ss_pred cccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHHH
Q 014352 278 GTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIG 357 (426)
Q Consensus 278 gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 357 (426)
||+.|+|||++.+..++.++|||||||++|||++|..||...........+.. .. .......+..+.+++
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~--------~~--~~~~~~~~~~~~~li 227 (325)
T cd05602 158 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN--------KP--LQLKPNITNSARHLL 227 (325)
T ss_pred CCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHh--------CC--cCCCCCCCHHHHHHH
Confidence 99999999999999999999999999999999999999976433222111111 10 011223446789999
Q ss_pred HHcccCCCCCCCCHHH
Q 014352 358 HKCLHKTPRKRPSIGE 373 (426)
Q Consensus 358 ~~cl~~~p~~RPs~~e 373 (426)
.+||+.||.+||++.+
T Consensus 228 ~~~l~~~p~~R~~~~~ 243 (325)
T cd05602 228 EGLLQKDRTKRLGAKD 243 (325)
T ss_pred HHHcccCHHHCCCCCC
Confidence 9999999999998864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=317.14 Aligned_cols=254 Identities=18% Similarity=0.278 Sum_probs=194.8
Q ss_pred hhcccccC--CCeeEEEEEeC-CCcEEEEEEeccCCc--cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEec
Q 014352 121 FTNILGQG--AFGPVYKATMP-SGGVAAIKVLASDSH--QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 121 ~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 195 (426)
+.++||+| +||+||++... ++..||+|.+..... ...+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45689999 78999999875 788999999875432 22346778999999999999999999999999999999999
Q ss_pred CCCChhHHhhhc-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC---
Q 014352 196 SNGSLSNLIYSE-ERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG--- 271 (426)
Q Consensus 196 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~--- 271 (426)
++|+|.+++... ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++++||+.........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 999999998653 345899999999999999999999998 9999999999999999999999998654221111
Q ss_pred -----CcccCccccCccCcccccc--CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhh----
Q 014352 272 -----RNSGLKGTYGYIDPAYIST--NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQ---- 340 (426)
Q Consensus 272 -----~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---- 340 (426)
......++..|+|||++.+ ..++.++|||||||++|||++|..||....................++..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPA 238 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhh
Confidence 1122346778999999975 46899999999999999999999999754332211111111111000000
Q ss_pred --------------------------------hcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 341 --------------------------------LVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 341 --------------------------------~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
............+.+++.+||+.||++|||+.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 0000111234578999999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=306.95 Aligned_cols=247 Identities=25% Similarity=0.414 Sum_probs=188.7
Q ss_pred ccccCCCeeEEEEEeCC---CcEEEEEEeccCCc-cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCCCC
Q 014352 124 ILGQGAFGPVYKATMPS---GGVAAIKVLASDSH-QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGS 199 (426)
Q Consensus 124 ~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 199 (426)
.||+|+||.||+|...+ ...+++|.+..... .....|.+|+..++.++||||+++++.+......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 59999999999997543 34678887764432 223568899999999999999999999999999999999999999
Q ss_pred hhHHhhhcc----CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC---C
Q 014352 200 LSNLIYSEE----RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG---R 272 (426)
Q Consensus 200 L~~~l~~~~----~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---~ 272 (426)
|.+++.... ...++.....++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++....... .
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 999996543 23467788899999999999999998 9999999999999999999999999986432211 1
Q ss_pred cccCccccCccCccccc-------cCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhccc
Q 014352 273 NSGLKGTYGYIDPAYIS-------TNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGA 344 (426)
Q Consensus 273 ~~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (426)
.....++..|+|||++. ...++.++||||||+++|||++ |..||....+...+.............+..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--- 235 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQL--- 235 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcc---
Confidence 22334567899999874 3456889999999999999999 788887654333222221111111111111
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014352 345 CNIQEVRELARIGHKCLHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 345 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 378 (426)
+......+.+++..|| .||++|||+++|++.|
T Consensus 236 -~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 236 -DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred -cccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 1223456778888998 5999999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=324.74 Aligned_cols=251 Identities=22% Similarity=0.303 Sum_probs=197.4
Q ss_pred HHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC---ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEE
Q 014352 117 ATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS---HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIY 192 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 192 (426)
..|++.+.||+|+||.||+++.. ++..+|+|++.... ......+.+|+.+++.++||||+++++++.+++..++||
T Consensus 43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05621 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVM 122 (370)
T ss_pred HHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 44666788999999999999976 67889999986421 122346789999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC-
Q 014352 193 EFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG- 271 (426)
Q Consensus 193 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~- 271 (426)
||+++|+|.+++... .++......++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 123 Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~ 197 (370)
T cd05621 123 EYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM 197 (370)
T ss_pred cCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecccCCc
Confidence 999999999998543 4788899999999999999999998 9999999999999999999999999997543222
Q ss_pred -CcccCccccCccCccccccCC----CCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCC
Q 014352 272 -RNSGLKGTYGYIDPAYISTNK----FTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACN 346 (426)
Q Consensus 272 -~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (426)
......||+.|+|||++.+.. ++.++|||||||++|||++|..||...........+.... ..+.....
T Consensus 198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~------~~~~~p~~ 271 (370)
T cd05621 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHK------NSLNFPED 271 (370)
T ss_pred eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCC------cccCCCCc
Confidence 123567999999999986543 7889999999999999999999997643322221111100 00111111
Q ss_pred HHHHHHHHHHHHHcccCCCCC--CCCHHHHHHHH
Q 014352 347 IQEVRELARIGHKCLHKTPRK--RPSIGEVTQAL 378 (426)
Q Consensus 347 ~~~~~~l~~l~~~cl~~~p~~--RPs~~evl~~L 378 (426)
...+..+.+++..|+..++.+ ||++.+++++-
T Consensus 272 ~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp 305 (370)
T cd05621 272 VEISKHAKNLICAFLTDREVRLGRNGVEEIKQHP 305 (370)
T ss_pred ccCCHHHHHHHHHHccCchhccCCCCHHHHhcCc
Confidence 234567888899999865544 89999999873
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=307.93 Aligned_cols=245 Identities=27% Similarity=0.386 Sum_probs=195.4
Q ss_pred cccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCCCChh
Q 014352 123 NILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLS 201 (426)
Q Consensus 123 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 201 (426)
..||+|+||.||+|... ++..+++|.+........+.+.+|+.++++++|+||+++++++..++..++|+||+++++|.
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 93 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS 93 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHH
Confidence 47999999999999865 67789999887665555668999999999999999999999999999999999999999999
Q ss_pred HHhhhccCCC--CHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecC-CCcEEEeeecCccccccC-CCcccCc
Q 014352 202 NLIYSEERVL--NWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDH-FMRAKVADFGLSKEEVFD-GRNSGLK 277 (426)
Q Consensus 202 ~~l~~~~~~l--~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgl~~~~~~~-~~~~~~~ 277 (426)
+++......+ ++..+..++.|++.||.|||+.+ |+||||||+||+++. ++.++|+|||++...... .......
T Consensus 94 ~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 170 (268)
T cd06624 94 ALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT 170 (268)
T ss_pred HHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecccCCCccccCC
Confidence 9997654445 78888999999999999999988 999999999999986 678999999998643221 1223345
Q ss_pred cccCccCccccccCC--CCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHH
Q 014352 278 GTYGYIDPAYISTNK--FTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELAR 355 (426)
Q Consensus 278 gt~~y~aPE~~~~~~--~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 355 (426)
++..|+|||++.+.. ++.++||||||+++|+|++|..||.......... ............+......+.+
T Consensus 171 ~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~ 243 (268)
T cd06624 171 GTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM-------FKVGMFKIHPEIPESLSAEAKN 243 (268)
T ss_pred CCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH-------hhhhhhccCCCCCcccCHHHHH
Confidence 789999999986643 7899999999999999999999986432111000 0000000011112234467899
Q ss_pred HHHHcccCCCCCCCCHHHHHHH
Q 014352 356 IGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 356 l~~~cl~~~p~~RPs~~evl~~ 377 (426)
++.+||+.+|.+|||+.+++.+
T Consensus 244 li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 244 FILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred HHHHHcCCCchhCCCHHHHHhC
Confidence 9999999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=320.21 Aligned_cols=247 Identities=22% Similarity=0.361 Sum_probs=193.3
Q ss_pred ccccCCCeeEEEEEeC-CCcEEEEEEeccCCc---cChHHHHHHHHHHhcC-CCCceeeEEeEEEeCCeEEEEEEecCCC
Q 014352 124 ILGQGAFGPVYKATMP-SGGVAAIKVLASDSH---QGEKEFQTEVSLLGRL-HHRNLVNLIGYCVDKGKYMLIYEFMSNG 198 (426)
Q Consensus 124 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g 198 (426)
.||+|+||.||++... +++.+|+|++..... ...+.+..|+.++.++ +||||+++++++.+.+.+++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (327)
T cd05617 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGG 81 (327)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCC
Confidence 6999999999999875 678899999976432 2234578899999888 6999999999999999999999999999
Q ss_pred ChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccccc-CCCcccCc
Q 014352 199 SLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF-DGRNSGLK 277 (426)
Q Consensus 199 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~-~~~~~~~~ 277 (426)
+|..++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.... ........
T Consensus 82 ~L~~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (327)
T cd05617 82 DLMFHMQRQ-RKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC 157 (327)
T ss_pred cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceeccc
Confidence 999888544 45999999999999999999999998 99999999999999999999999999874322 22334567
Q ss_pred cccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHHH
Q 014352 278 GTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIG 357 (426)
Q Consensus 278 gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 357 (426)
||+.|+|||++.+..++.++|||||||++|||++|..||.......... ........+... ....+...+..+.+++
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~--~~~~~~~~~~~~-~~~~p~~~~~~~~~li 234 (327)
T cd05617 158 GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN--TEDYLFQVILEK-PIRIPRFLSVKASHVL 234 (327)
T ss_pred CCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccc--cHHHHHHHHHhC-CCCCCCCCCHHHHHHH
Confidence 9999999999999999999999999999999999999995321100000 000000000000 0112223346788999
Q ss_pred HHcccCCCCCCCCH------HHHHHH
Q 014352 358 HKCLHKTPRKRPSI------GEVTQA 377 (426)
Q Consensus 358 ~~cl~~~p~~RPs~------~evl~~ 377 (426)
.+||+.||++||++ .+++++
T Consensus 235 ~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 235 KGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred HHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 99999999999985 466554
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=309.53 Aligned_cols=254 Identities=25% Similarity=0.419 Sum_probs=202.5
Q ss_pred HHHHHhhhhcccccCCCeeEEEEEeCC------CcEEEEEEeccCCc-cChHHHHHHHHHHhcCCCCceeeEEeEEEeCC
Q 014352 114 IQKATQNFTNILGQGAFGPVYKATMPS------GGVAAIKVLASDSH-QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKG 186 (426)
Q Consensus 114 l~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 186 (426)
|....+.+.+.||+|+||.||+|...+ +..+|+|.+..... .....+.+|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 82 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ 82 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence 344566777899999999999998642 35799999865432 22356889999999999999999999999999
Q ss_pred eEEEEEEecCCCChhHHhhhcc---------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEE
Q 014352 187 KYMLIYEFMSNGSLSNLIYSEE---------RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAK 257 (426)
Q Consensus 187 ~~~lv~e~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 257 (426)
..++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEE
Confidence 9999999999999999985422 24788999999999999999999988 99999999999999999999
Q ss_pred EeeecCccccccCC---CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccch
Q 014352 258 VADFGLSKEEVFDG---RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGV 333 (426)
Q Consensus 258 l~Dfgl~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~ 333 (426)
|+|||+++...... ......++..|+|||.+.+..++.++||||||+++||+++ |..||................
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~- 238 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGG- 238 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCC-
Confidence 99999987433221 1223446789999999988889999999999999999998 999986533322211111111
Q ss_pred hhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 014352 334 DEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALL 379 (426)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 379 (426)
....+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 239 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 239 --------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred --------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 01112223568999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=320.28 Aligned_cols=235 Identities=26% Similarity=0.357 Sum_probs=187.7
Q ss_pred ccccCCCeeEEEEEeC-CCcEEEEEEeccCCc---cChHHHHHHH-HHHhcCCCCceeeEEeEEEeCCeEEEEEEecCCC
Q 014352 124 ILGQGAFGPVYKATMP-SGGVAAIKVLASDSH---QGEKEFQTEV-SLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNG 198 (426)
Q Consensus 124 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~-~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 198 (426)
.||+|+||.||+|+.. ++..+|+|++..... .....+..|. .+++.++||||+++++++.+.+..++||||+++|
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (321)
T cd05603 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGG 81 (321)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 6999999999999975 678899999864321 1223444554 4678899999999999999999999999999999
Q ss_pred ChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccccc-CCCcccCc
Q 014352 199 SLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF-DGRNSGLK 277 (426)
Q Consensus 199 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~-~~~~~~~~ 277 (426)
+|...+... ..++......++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.... ........
T Consensus 82 ~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (321)
T cd05603 82 ELFFHLQRE-RCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC 157 (321)
T ss_pred CHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcccccc
Confidence 999888543 45888888999999999999999998 99999999999999999999999999874322 22234457
Q ss_pred cccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHHH
Q 014352 278 GTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIG 357 (426)
Q Consensus 278 gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 357 (426)
||+.|+|||.+.+..++.++|||||||++|||++|..||...........+. ... ...+......+.+++
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~--------~~~--~~~~~~~~~~~~~li 227 (321)
T cd05603 158 GTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNIL--------HKP--LQLPGGKTVAACDLL 227 (321)
T ss_pred CCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHh--------cCC--CCCCCCCCHHHHHHH
Confidence 8999999999999999999999999999999999999997643221111111 110 111223446789999
Q ss_pred HHcccCCCCCCCCHH
Q 014352 358 HKCLHKTPRKRPSIG 372 (426)
Q Consensus 358 ~~cl~~~p~~RPs~~ 372 (426)
.+||+.||.+||+..
T Consensus 228 ~~~l~~~p~~R~~~~ 242 (321)
T cd05603 228 VGLLHKDQRRRLGAK 242 (321)
T ss_pred HHHccCCHhhcCCCC
Confidence 999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=307.63 Aligned_cols=253 Identities=26% Similarity=0.439 Sum_probs=204.3
Q ss_pred HHHHHhhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEE
Q 014352 114 IQKATQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYE 193 (426)
Q Consensus 114 l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 193 (426)
+..+++.+.+.||+|+||.||++...++..+|+|.+.... ...+.+.+|++++++++|+||+++++++.+ ...+++||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 3455677888999999999999998777889999886542 234678899999999999999999999887 67899999
Q ss_pred ecCCCChhHHhhhc-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC-
Q 014352 194 FMSNGSLSNLIYSE-ERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG- 271 (426)
Q Consensus 194 ~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~- 271 (426)
|+++++|.+++... ...+++..++.++.+++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 81 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred eCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 99999999999653 355789999999999999999999988 9999999999999999999999999986432211
Q ss_pred -CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHH
Q 014352 272 -RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQE 349 (426)
Q Consensus 272 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (426)
......++..|+|||++....++.++|+||||+++|++++ |..||............... .........
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~---------~~~~~~~~~ 228 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG---------YRMPRPENC 228 (260)
T ss_pred ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC---------CCCCCcccC
Confidence 1122345678999999998889999999999999999999 99999764332221111111 111112234
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 014352 350 VRELARIGHKCLHKTPRKRPSIGEVTQALLK 380 (426)
Q Consensus 350 ~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 380 (426)
+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus 229 ~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 229 PEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 4679999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=307.41 Aligned_cols=246 Identities=28% Similarity=0.431 Sum_probs=201.6
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC-ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecC
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS-HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMS 196 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 196 (426)
|.+.+.||.|+||.||+|... +++.+|+|.+.... ......+.+|+.++++++||||+++++++.+....++|+||++
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (274)
T cd06609 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCG 82 (274)
T ss_pred hhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeC
Confidence 456678999999999999975 67899999987553 2334578899999999999999999999999999999999999
Q ss_pred CCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC-CCccc
Q 014352 197 NGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD-GRNSG 275 (426)
Q Consensus 197 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-~~~~~ 275 (426)
+++|.+++... .+++..+..++.|++.||.|||+++ ++|+||+|+||++++++.++|+|||+++..... .....
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (274)
T cd06609 83 GGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT 157 (274)
T ss_pred CCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccccccc
Confidence 99999998644 6899999999999999999999998 999999999999999999999999998765433 22334
Q ss_pred CccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHH
Q 014352 276 LKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELAR 355 (426)
Q Consensus 276 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 355 (426)
..++..|+|||++.+..++.++||||||+++|+|++|..||...........+....... . .....+..+.+
T Consensus 158 ~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-----~---~~~~~~~~~~~ 229 (274)
T cd06609 158 FVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPS-----L---EGNKFSKPFKD 229 (274)
T ss_pred ccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCC-----C---cccccCHHHHH
Confidence 568889999999998889999999999999999999999997543222111111111000 0 01113457889
Q ss_pred HHHHcccCCCCCCCCHHHHHHH
Q 014352 356 IGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 356 l~~~cl~~~p~~RPs~~evl~~ 377 (426)
++.+||..+|++|||+++++++
T Consensus 230 ~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 230 FVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred HHHHHhhCChhhCcCHHHHhhC
Confidence 9999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=321.67 Aligned_cols=236 Identities=26% Similarity=0.359 Sum_probs=188.9
Q ss_pred ccccCCCeeEEEEEeC-CCcEEEEEEeccCCc---cChHHHHHHHH-HHhcCCCCceeeEEeEEEeCCeEEEEEEecCCC
Q 014352 124 ILGQGAFGPVYKATMP-SGGVAAIKVLASDSH---QGEKEFQTEVS-LLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNG 198 (426)
Q Consensus 124 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 198 (426)
.||+|+||.||+++.. +++.+|+|++..... .....+..|.. +++.++||||+++++++...+..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05604 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGG 81 (325)
T ss_pred ceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCC
Confidence 6999999999999875 788999999865421 22234555554 567799999999999999999999999999999
Q ss_pred ChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccccc-CCCcccCc
Q 014352 199 SLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF-DGRNSGLK 277 (426)
Q Consensus 199 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~-~~~~~~~~ 277 (426)
+|..++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.... ........
T Consensus 82 ~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (325)
T cd05604 82 ELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFC 157 (325)
T ss_pred CHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCccccc
Confidence 99988854 346899999999999999999999998 99999999999999999999999999874322 22334567
Q ss_pred cccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHHH
Q 014352 278 GTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIG 357 (426)
Q Consensus 278 gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 357 (426)
||+.|+|||++.+..++.++|||||||++|||++|..||...........+.. ... ......+..+.+++
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~--------~~~--~~~~~~~~~~~~ll 227 (325)
T cd05604 158 GTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILH--------KPL--VLRPGASLTAWSIL 227 (325)
T ss_pred CChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHc--------CCc--cCCCCCCHHHHHHH
Confidence 99999999999999999999999999999999999999975432221111111 110 11122345788999
Q ss_pred HHcccCCCCCCCCHHH
Q 014352 358 HKCLHKTPRKRPSIGE 373 (426)
Q Consensus 358 ~~cl~~~p~~RPs~~e 373 (426)
.+|++.+|.+||++.+
T Consensus 228 ~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 228 EELLEKDRQRRLGAKE 243 (325)
T ss_pred HHHhccCHHhcCCCCC
Confidence 9999999999998853
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=322.10 Aligned_cols=256 Identities=25% Similarity=0.281 Sum_probs=196.6
Q ss_pred HHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC--ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCC------e
Q 014352 117 ATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS--HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKG------K 187 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~ 187 (426)
..|.+.+.||+|+||.||++... ++..+|+|.+.... ......+.+|+.+++.++||||+++++++...+ .
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 100 (359)
T cd07876 21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQD 100 (359)
T ss_pred hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccce
Confidence 44667789999999999999875 68899999986542 223456789999999999999999999986543 5
Q ss_pred EEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccc
Q 014352 188 YMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEE 267 (426)
Q Consensus 188 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 267 (426)
.++||||+++ +|...+. ..++...+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 101 ~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 101 VYLVMELMDA-NLCQVIH---MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred eEEEEeCCCc-CHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 7999999965 6666653 23788889999999999999999998 999999999999999999999999999754
Q ss_pred ccCCCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhcc---ccchhh---------
Q 014352 268 VFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMS---QDGVDE--------- 335 (426)
Q Consensus 268 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~---~~~~~~--------- 335 (426)
..........||..|+|||.+.+..++.++||||||+++|+|++|..||........+.... ......
T Consensus 174 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (359)
T cd07876 174 CTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTV 253 (359)
T ss_pred ccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHH
Confidence 33333445678999999999999999999999999999999999999997543221111100 000000
Q ss_pred --hhhh--hhcc----------------cCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 014352 336 --ILDK--QLVG----------------ACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALL 379 (426)
Q Consensus 336 --~~~~--~~~~----------------~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 379 (426)
.... .... .........+.+++.+||+.||++|||+.|++++-.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 317 (359)
T cd07876 254 RNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPY 317 (359)
T ss_pred HHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCch
Confidence 0000 0000 000112356889999999999999999999998753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=318.81 Aligned_cols=239 Identities=27% Similarity=0.394 Sum_probs=192.9
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC---ccChHHHHHHHHHHhcCC-CCceeeEEeEEEeCCeEEEEEE
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS---HQGEKEFQTEVSLLGRLH-HRNLVNLIGYCVDKGKYMLIYE 193 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e 193 (426)
+++.+.||+|+||.||++... ++..||+|++.... ....+.+..|..++..+. |++|+++++++.+.+.+++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 456678999999999999875 68899999987542 122345778888988885 5778889999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC-C
Q 014352 194 FMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG-R 272 (426)
Q Consensus 194 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-~ 272 (426)
|+++|+|.+++... ..+++.++..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 82 y~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~ 157 (323)
T cd05615 82 YVNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT 157 (323)
T ss_pred CCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCCcc
Confidence 99999999998544 45899999999999999999999998 9999999999999999999999999987532222 2
Q ss_pred cccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHH
Q 014352 273 NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRE 352 (426)
Q Consensus 273 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (426)
.....||+.|+|||++.+..++.++|||||||++|||++|..||...........+.. ... ..+...+..
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~--------~~~--~~p~~~~~~ 227 (323)
T cd05615 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME--------HNV--SYPKSLSKE 227 (323)
T ss_pred ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------CCC--CCCccCCHH
Confidence 3345689999999999999999999999999999999999999976443222211111 110 112223467
Q ss_pred HHHHHHHcccCCCCCCCCH
Q 014352 353 LARIGHKCLHKTPRKRPSI 371 (426)
Q Consensus 353 l~~l~~~cl~~~p~~RPs~ 371 (426)
+.+++.+||+.+|.+|++.
T Consensus 228 ~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 228 AVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred HHHHHHHHcccCHhhCCCC
Confidence 8899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=308.96 Aligned_cols=255 Identities=27% Similarity=0.427 Sum_probs=203.8
Q ss_pred HHhhhhcccccCCCeeEEEEEeC-CCc----EEEEEEeccCCc-cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEE
Q 014352 117 ATQNFTNILGQGAFGPVYKATMP-SGG----VAAIKVLASDSH-QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYML 190 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 190 (426)
..+.+.+.||+|+||.||+|.+. ++. .+|+|.+..... .....+.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 34566789999999999999864 333 588998765543 234578899999999999999999999987 68899
Q ss_pred EEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC
Q 014352 191 IYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD 270 (426)
Q Consensus 191 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 270 (426)
|+||+++|+|.+++......+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.+||+|||+++.....
T Consensus 86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 99999999999999776667999999999999999999999988 999999999999999999999999999754322
Q ss_pred CCc---ccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCC
Q 014352 271 GRN---SGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACN 346 (426)
Q Consensus 271 ~~~---~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (426)
... ....++..|+|||.+....++.++|+||||+++||+++ |..||...........+ ........+
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~---------~~~~~~~~~ 233 (279)
T cd05057 163 EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLL---------EKGERLPQP 233 (279)
T ss_pred ccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH---------hCCCCCCCC
Confidence 211 12223568999999988899999999999999999998 99998764322111111 111011111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHH
Q 014352 347 IQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQR 384 (426)
Q Consensus 347 ~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 384 (426)
......+.+++.+||..+|.+||++.++++.|..+.+.
T Consensus 234 ~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 234 PICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 22335688999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=312.55 Aligned_cols=255 Identities=25% Similarity=0.319 Sum_probs=193.6
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCcc--ChHHHHHHHHHHhcC---CCCceeeEEeEEEeC-----Ce
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQ--GEKEFQTEVSLLGRL---HHRNLVNLIGYCVDK-----GK 187 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~-----~~ 187 (426)
|.+.+.||+|+||+||+|... +++.+|+|.+...... ....+.+|+.+++.+ +||||+++++++... ..
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~ 81 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK 81 (288)
T ss_pred ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence 456678999999999999875 6889999998754222 223556777777665 799999999988652 45
Q ss_pred EEEEEEecCCCChhHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccc
Q 014352 188 YMLIYEFMSNGSLSNLIYSEE-RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKE 266 (426)
Q Consensus 188 ~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 266 (426)
.+++|||+++ +|.+++.... ..+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++.
T Consensus 82 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~~ 157 (288)
T cd07863 82 VTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARI 157 (288)
T ss_pred EEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcccc
Confidence 7999999975 8988886543 45899999999999999999999998 99999999999999999999999999976
Q ss_pred cccCCCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccc-------cchhhhh--
Q 014352 267 EVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQ-------DGVDEIL-- 337 (426)
Q Consensus 267 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~-------~~~~~~~-- 337 (426)
...........+|..|+|||++.+..++.++|||||||++|||++|.+||........+..+.. .......
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07863 158 YSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTL 237 (288)
T ss_pred ccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccc
Confidence 5433333456789999999999989999999999999999999999999965433221111100 0000000
Q ss_pred -hhhhc-------ccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 338 -DKQLV-------GACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 338 -~~~~~-------~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
...+. ..........+.+++.+||+.||++|||+.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 238 PRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred cccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000 00111234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=325.24 Aligned_cols=248 Identities=26% Similarity=0.420 Sum_probs=208.3
Q ss_pred hhhhcccccCCCeeEEEEEeC--CCc--EEEEEEeccCCcc-ChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEE
Q 014352 119 QNFTNILGQGAFGPVYKATMP--SGG--VAAIKVLASDSHQ-GEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYE 193 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 193 (426)
..+.++||+|.||.|++|.|. +|. .||||+++.+... ...+|.+|+.+|.+|+|||++++||+..+ ....||+|
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E 190 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE 190 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence 445678999999999999985 343 5899999887654 45789999999999999999999999987 67899999
Q ss_pred ecCCCChhHHhhh-ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCC
Q 014352 194 FMSNGSLSNLIYS-EERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGR 272 (426)
Q Consensus 194 ~~~~gsL~~~l~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 272 (426)
.++.|||.+.|++ ....|-...+..++.|||.||.||.+++ +|||||..+|+|+.....+||+||||.+.......
T Consensus 191 LaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred hcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 9999999999987 3456778888999999999999999999 99999999999999999999999999985443322
Q ss_pred c----ccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCCH
Q 014352 273 N----SGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNI 347 (426)
Q Consensus 273 ~----~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (426)
. ....-...|.|||.++...++.++|||+|||++|||+| |..||-+......+..+. ..-+...+.
T Consensus 268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD---------~~erLpRPk 338 (1039)
T KOG0199|consen 268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID---------AGERLPRPK 338 (1039)
T ss_pred ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc---------ccccCCCCC
Confidence 1 12234568999999999999999999999999999998 889998877666554443 222333455
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 014352 348 QEVRELARIGHKCLHKTPRKRPSIGEVTQALL 379 (426)
Q Consensus 348 ~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 379 (426)
.++++++++|++||..+|++||||..|.+.+-
T Consensus 339 ~csedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 339 YCSEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred CChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 67789999999999999999999999985443
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=305.78 Aligned_cols=251 Identities=26% Similarity=0.406 Sum_probs=199.9
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecC
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMS 196 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 196 (426)
.+.+.+.||+|+||.||+|... ++..+|+|.++.........+.+|+.+++.++||||+++++++...+..++|+||++
T Consensus 10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 89 (267)
T cd06645 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCG 89 (267)
T ss_pred HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccC
Confidence 4566778999999999999865 678999999876654444568899999999999999999999999999999999999
Q ss_pred CCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC-CCccc
Q 014352 197 NGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD-GRNSG 275 (426)
Q Consensus 197 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-~~~~~ 275 (426)
+++|.+++... ..+++.+.+.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++...... .....
T Consensus 90 ~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 165 (267)
T cd06645 90 GGSLQDIYHVT-GPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS 165 (267)
T ss_pred CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCccccccc
Confidence 99999988544 45899999999999999999999998 999999999999999999999999998643322 12234
Q ss_pred CccccCccCccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHH
Q 014352 276 LKGTYGYIDPAYIS---TNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRE 352 (426)
Q Consensus 276 ~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (426)
..|+..|+|||++. ...++.++|+|||||++|+|++|..||....+............. .+.. ......+..
T Consensus 166 ~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~---~~~~--~~~~~~~~~ 240 (267)
T cd06645 166 FIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQ---PPKL--KDKMKWSNS 240 (267)
T ss_pred ccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCC---CCcc--cccCCCCHH
Confidence 56899999999974 456889999999999999999999998653322211111111000 0000 001123356
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 353 LARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 353 l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
+.+++.+||+.+|++|||+.+++++
T Consensus 241 ~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 241 FHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred HHHHHHHHccCCchhCcCHHHHhcC
Confidence 8899999999999999999998864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=310.59 Aligned_cols=263 Identities=25% Similarity=0.347 Sum_probs=206.4
Q ss_pred HHHHHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC-ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEE
Q 014352 114 IQKATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS-HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLI 191 (426)
Q Consensus 114 l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 191 (426)
|....+++.+.||+|+||+||++... ++..+|+|++.... ....+.+.+|+++++.++||||+++++++...+.+++|
T Consensus 2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence 33455777889999999999999875 67889999876543 23346789999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC
Q 014352 192 YEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHE-GAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD 270 (426)
Q Consensus 192 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 270 (426)
|||+++++|.+++... +.+++.....++.+++.||.|||+ .+ ++||||||+||+++.++.++|+|||++.....
T Consensus 82 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~- 156 (284)
T cd06620 82 MEFMDCGSLDRIYKKG-GPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELIN- 156 (284)
T ss_pred EecCCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhh-
Confidence 9999999999988543 468999999999999999999997 46 99999999999999999999999999864322
Q ss_pred CCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhh----hhcccCC
Q 014352 271 GRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDK----QLVGACN 346 (426)
Q Consensus 271 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~ 346 (426)
.......|+..|+|||++.+..++.++|+|||||++|++++|..||.......... .........+.. .......
T Consensus 157 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd06620 157 SIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQ-DDPMGILDLLQQIVQEPPPRLPS 235 (284)
T ss_pred hccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhh-hhhhHHHHHHHHHhhccCCCCCc
Confidence 22234578999999999988899999999999999999999999997543211000 000001111111 1111111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 014352 347 IQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIK 382 (426)
Q Consensus 347 ~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 382 (426)
...+..+.+++.+||+.||++|||+.|++++..-+.
T Consensus 236 ~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 236 SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 224567899999999999999999999998754443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=327.97 Aligned_cols=248 Identities=21% Similarity=0.285 Sum_probs=195.3
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC---ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEe
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS---HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEF 194 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 194 (426)
|.+.+.||+|+||.||+++.. +++.+|+|++.... ......+.+|+++|++++||||+++++.+.+++.+++||||
T Consensus 3 y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (376)
T cd05598 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (376)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeC
Confidence 456678999999999999865 68899999986432 12235688999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC----
Q 014352 195 MSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD---- 270 (426)
Q Consensus 195 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~---- 270 (426)
+++|+|.+++... ..++......++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 83 ~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~ 158 (376)
T cd05598 83 IPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (376)
T ss_pred CCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence 9999999999654 45888888899999999999999998 999999999999999999999999997421000
Q ss_pred ----------------------------------------CCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHH
Q 014352 271 ----------------------------------------GRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELI 310 (426)
Q Consensus 271 ----------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~ 310 (426)
.......||+.|+|||++.+..++.++|||||||++|||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell 238 (376)
T cd05598 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238 (376)
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehh
Confidence 0011346999999999999999999999999999999999
Q ss_pred hCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCC---CHHHHHHH
Q 014352 311 TAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRP---SIGEVTQA 377 (426)
Q Consensus 311 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP---s~~evl~~ 377 (426)
+|+.||...........+.... ...........+..+.+++.+|+ .+|.+|+ ++.+++++
T Consensus 239 ~G~~Pf~~~~~~~~~~~i~~~~------~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 239 VGQPPFLADTPAETQLKVINWE------TTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hCCCCCCCCCHHHHHHHHhccC------ccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 9999997654332211111100 00011111223456777787876 4999999 89999877
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=305.85 Aligned_cols=246 Identities=26% Similarity=0.446 Sum_probs=199.6
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccCh---------HHHHHHHHHHhcCCCCceeeEEeEEEeCCeE
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGE---------KEFQTEVSLLGRLHHRNLVNLIGYCVDKGKY 188 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~---------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 188 (426)
+.+...||.|+||.||+|... ++..+|+|.+........ +.+.+|+.++++++||||+++++++.+.+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 456678999999999999865 678899998865432211 4578899999999999999999999999999
Q ss_pred EEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccc
Q 014352 189 MLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEV 268 (426)
Q Consensus 189 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 268 (426)
++++||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||+++...
T Consensus 82 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLE 157 (267)
T ss_pred EEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence 9999999999999999544 45889999999999999999999998 9999999999999999999999999987543
Q ss_pred cCC-------CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhh
Q 014352 269 FDG-------RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQL 341 (426)
Q Consensus 269 ~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (426)
... ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||.............. ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---------~~ 228 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE---------NA 228 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc---------cC
Confidence 211 11234578899999999988899999999999999999999999976543322211111 11
Q ss_pred cccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 342 VGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 342 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
....+...+..+.+++.+||+.||.+||++.+++++
T Consensus 229 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 229 SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 111222344678999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=312.00 Aligned_cols=257 Identities=24% Similarity=0.331 Sum_probs=200.8
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc-cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecC
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH-QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMS 196 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 196 (426)
+++.+.||+|+||.||++... ++..+|+|.+..... .....+.+|++++.+++||||+++++++.+++..++||||++
T Consensus 3 ~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~ 82 (308)
T cd06615 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMD 82 (308)
T ss_pred ceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccC
Confidence 456678999999999999875 677889998865422 223568899999999999999999999999999999999999
Q ss_pred CCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCccc
Q 014352 197 NGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHE-GAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSG 275 (426)
Q Consensus 197 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 275 (426)
+++|.+++... ..+++..+..++.|+++||.|||+ .+ ++|+||||+||+++.++.++|+|||++..... .....
T Consensus 83 ~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-~~~~~ 157 (308)
T cd06615 83 GGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMANS 157 (308)
T ss_pred CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCcccccc-ccccc
Confidence 99999999654 558999999999999999999997 46 99999999999999999999999999875422 22344
Q ss_pred CccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccc-----------------------
Q 014352 276 LKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDG----------------------- 332 (426)
Q Consensus 276 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~----------------------- 332 (426)
..++..|+|||.+.+..++.++|+||||+++|+|++|..||................
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (308)
T cd06615 158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPM 237 (308)
T ss_pred CCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchh
Confidence 578899999999988889999999999999999999999986432211111000000
Q ss_pred -hhhhhhhhhc----ccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 014352 333 -VDEILDKQLV----GACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLK 380 (426)
Q Consensus 333 -~~~~~~~~~~----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 380 (426)
..+..+.... ..+.......+.+++.+||..+|++|||+.+++++..-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~ 290 (308)
T cd06615 238 AIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFI 290 (308)
T ss_pred hHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence 0000000000 00111234578999999999999999999999987543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=311.98 Aligned_cols=251 Identities=28% Similarity=0.508 Sum_probs=199.8
Q ss_pred HHhhhhcccccCCCeeEEEEEeC------CCcEEEEEEeccCCc-cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEE
Q 014352 117 ATQNFTNILGQGAFGPVYKATMP------SGGVAAIKVLASDSH-QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYM 189 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 189 (426)
..+.+.+.||+|+||.||++... ++..+|+|.+..... .....+.+|+.++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMC 84 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccE
Confidence 34556678999999999999863 456899999875432 23457889999999999999999999999999999
Q ss_pred EEEEecCCCChhHHhhhcc---------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCE
Q 014352 190 LIYEFMSNGSLSNLIYSEE---------------------RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANI 248 (426)
Q Consensus 190 lv~e~~~~gsL~~~l~~~~---------------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Ni 248 (426)
++|||+++|+|.+++.... ..+++..++.++.|++.||.|||+++ ++||||||+||
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~ni 161 (288)
T cd05050 85 LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRNC 161 (288)
T ss_pred EEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhhe
Confidence 9999999999999986321 24788889999999999999999998 99999999999
Q ss_pred EecCCCcEEEeeecCccccccCC---CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHH
Q 014352 249 LLDHFMRAKVADFGLSKEEVFDG---RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVN 324 (426)
Q Consensus 249 ll~~~~~~kl~Dfgl~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~ 324 (426)
+++.++.++|+|||++....... .......+..|+|||.+.+..++.++|||||||++|||++ |..||........
T Consensus 162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~ 241 (288)
T cd05050 162 LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEV 241 (288)
T ss_pred EecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 99999999999999987432221 1122334667999999998999999999999999999998 8888865332221
Q ss_pred HhhccccchhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 014352 325 LASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALL 379 (426)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 379 (426)
...+... .. ...+...+.++.+++.+||+.+|++|||+.|+++.|+
T Consensus 242 ~~~~~~~--------~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 242 IYYVRDG--------NV-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred HHHHhcC--------CC-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 1111111 11 1112234467999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=314.68 Aligned_cols=256 Identities=22% Similarity=0.293 Sum_probs=198.2
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc-cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecC
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH-QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMS 196 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 196 (426)
|.+.+.||+|+||.||+|+.. ++..+|+|.+..... .....+.+|+.++++++||||+++++++..++..++||||++
T Consensus 8 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 87 (309)
T cd07872 8 YIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLD 87 (309)
T ss_pred eEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCC
Confidence 556678999999999999875 677899999875432 223467889999999999999999999999999999999997
Q ss_pred CCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC-Cccc
Q 014352 197 NGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG-RNSG 275 (426)
Q Consensus 197 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-~~~~ 275 (426)
+ +|.+++......+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++...... ....
T Consensus 88 ~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 163 (309)
T cd07872 88 K-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSN 163 (309)
T ss_pred C-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcccccc
Confidence 5 888888666666899999999999999999999998 9999999999999999999999999987532221 2234
Q ss_pred CccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhcc---ccchh----------hhhhhhh
Q 014352 276 LKGTYGYIDPAYIST-NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMS---QDGVD----------EILDKQL 341 (426)
Q Consensus 276 ~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~---~~~~~----------~~~~~~~ 341 (426)
..++..|+|||.+.+ ..++.++||||||+++|||+||+.||........+..+. ..... ...+...
T Consensus 164 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (309)
T cd07872 164 EVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNF 243 (309)
T ss_pred ccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhc
Confidence 567899999998865 468899999999999999999999997543221111100 00000 0000000
Q ss_pred ccc-------CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014352 342 VGA-------CNIQEVRELARIGHKCLHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 342 ~~~-------~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 378 (426)
... .....+..+.+++.+||+.||++|||+.|++++-
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 287 (309)
T cd07872 244 PKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHA 287 (309)
T ss_pred CccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcCh
Confidence 000 0012345688999999999999999999999753
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=308.42 Aligned_cols=247 Identities=26% Similarity=0.409 Sum_probs=200.8
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc-cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEec
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH-QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 195 (426)
.|...+.||+|+||.||+|... ++..||+|.+..... ...+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 3455678999999999999865 677899998875432 23357889999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC-Ccc
Q 014352 196 SNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG-RNS 274 (426)
Q Consensus 196 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-~~~ 274 (426)
++++|.+++.. ..+++..+..++.+++.|+.|||+++ ++|+||+|+||++++++.++++|||++....... ...
T Consensus 85 ~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06642 85 GGGSALDLLKP--GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred CCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcchhhh
Confidence 99999998843 45899999999999999999999988 9999999999999999999999999987543222 122
Q ss_pred cCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHH
Q 014352 275 GLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELA 354 (426)
Q Consensus 275 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 354 (426)
...++..|+|||++.+..++.++||||||+++|||++|..|+.............. ..........+..+.
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~ 230 (277)
T cd06642 160 TFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPK---------NSPPTLEGQYSKPFK 230 (277)
T ss_pred cccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhc---------CCCCCCCcccCHHHH
Confidence 34678899999999998999999999999999999999999875433222111111 111111223446789
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHH
Q 014352 355 RIGHKCLHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 355 ~l~~~cl~~~p~~RPs~~evl~~L 378 (426)
+++.+||+.+|++||++.+++++-
T Consensus 231 ~li~~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06642 231 EFVEACLNKDPRFRPTAKELLKHK 254 (277)
T ss_pred HHHHHHccCCcccCcCHHHHHHhH
Confidence 999999999999999999999864
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=312.86 Aligned_cols=254 Identities=27% Similarity=0.426 Sum_probs=199.6
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCc----EEEEEEeccCCcc-ChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEE
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGG----VAAIKVLASDSHQ-GEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIY 192 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 192 (426)
+...+.||+|+||.||+|.+. ++. .+|+|.+...... ....+.+|+.++++++||||+++++++... ..++++
T Consensus 9 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~ 87 (303)
T cd05110 9 LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVT 87 (303)
T ss_pred ceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeee
Confidence 344568999999999999864 443 4788887654322 234688999999999999999999998765 467999
Q ss_pred EecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCC
Q 014352 193 EFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGR 272 (426)
Q Consensus 193 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 272 (426)
||+++|+|.+++......+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||+++.......
T Consensus 88 e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 164 (303)
T cd05110 88 QLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK 164 (303)
T ss_pred hhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccccCccc
Confidence 999999999999766667899999999999999999999998 99999999999999999999999999975432221
Q ss_pred ---cccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHH
Q 014352 273 ---NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQ 348 (426)
Q Consensus 273 ---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (426)
.....++..|+|||++.+..++.++||||||+++||+++ |..||.+........ .+........+..
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~---------~~~~~~~~~~~~~ 235 (303)
T cd05110 165 EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPD---------LLEKGERLPQPPI 235 (303)
T ss_pred ccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH---------HHHCCCCCCCCCC
Confidence 122345678999999999999999999999999999997 899987532211111 1111100111112
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHh
Q 014352 349 EVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRH 385 (426)
Q Consensus 349 ~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~ 385 (426)
....+.+++..||..+|++||++.++++.|..+....
T Consensus 236 ~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 236 CTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 3357889999999999999999999999999886544
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=310.28 Aligned_cols=248 Identities=23% Similarity=0.364 Sum_probs=202.8
Q ss_pred hhhhcccccCCCeeEEEEEe-CCCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCC
Q 014352 119 QNFTNILGQGAFGPVYKATM-PSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSN 197 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 197 (426)
|.+.+.||.|+||.||+|.. .+++.+++|.+........+.+.+|+.+++.++||||+++++++...+..++|+||+++
T Consensus 21 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 100 (296)
T cd06655 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAG 100 (296)
T ss_pred EEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCC
Confidence 45667899999999999986 47889999998765545566788999999999999999999999999999999999999
Q ss_pred CChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC-CcccC
Q 014352 198 GSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG-RNSGL 276 (426)
Q Consensus 198 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-~~~~~ 276 (426)
++|..++.. ..+++.++..++.+++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....... .....
T Consensus 101 ~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 175 (296)
T cd06655 101 GSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTM 175 (296)
T ss_pred CcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccccCCCc
Confidence 999998843 35899999999999999999999998 9999999999999999999999999987533222 22345
Q ss_pred ccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHH
Q 014352 277 KGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARI 356 (426)
Q Consensus 277 ~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 356 (426)
.++..|+|||.+.+..++.++|||||||++|++++|..||...........+...... ....+......+.++
T Consensus 176 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~l 248 (296)
T cd06655 176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP-------ELQNPEKLSPIFRDF 248 (296)
T ss_pred CCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCc-------ccCCcccCCHHHHHH
Confidence 6888999999999888999999999999999999999999764433222111111000 001122234578899
Q ss_pred HHHcccCCCCCCCCHHHHHHHH
Q 014352 357 GHKCLHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 357 ~~~cl~~~p~~RPs~~evl~~L 378 (426)
+.+||..||++|||+.+++.+=
T Consensus 249 i~~~l~~dp~~Rpt~~~il~~~ 270 (296)
T cd06655 249 LNRCLEMDVEKRGSAKELLQHP 270 (296)
T ss_pred HHHHhhcChhhCCCHHHHhhCh
Confidence 9999999999999999998653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=309.39 Aligned_cols=255 Identities=24% Similarity=0.402 Sum_probs=199.8
Q ss_pred HHHhhhhcccccCCCeeEEEEEeC------CCcEEEEEEeccCCc-cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeE
Q 014352 116 KATQNFTNILGQGAFGPVYKATMP------SGGVAAIKVLASDSH-QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKY 188 (426)
Q Consensus 116 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 188 (426)
..++.+.+.||+|+||.||+|... .+..||+|.+..... .....+.+|+.+++.++||||+++++++.+.+..
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPT 84 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 456777889999999999999753 234789998764432 2234678899999999999999999999999999
Q ss_pred EEEEEecCCCChhHHhhhcc---------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEe
Q 014352 189 MLIYEFMSNGSLSNLIYSEE---------RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVA 259 (426)
Q Consensus 189 ~lv~e~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 259 (426)
++||||+++|+|.+++.... ..+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEEC
Confidence 99999999999999996421 23567788899999999999999998 9999999999999999999999
Q ss_pred eecCccccccCC---CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhh
Q 014352 260 DFGLSKEEVFDG---RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDE 335 (426)
Q Consensus 260 Dfgl~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 335 (426)
|||+++...... ......++..|+|||.+.+..++.++||||||+++|||++ |..||...........+....
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~--- 238 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG--- 238 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC---
Confidence 999987432211 1122335678999999998899999999999999999998 788886533222111111110
Q ss_pred hhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 014352 336 ILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIK 382 (426)
Q Consensus 336 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 382 (426)
. ...+...+..+.+++.+||+.||++|||+.++++.|....
T Consensus 239 -----~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 239 -----Y-LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred -----C-CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 0 0111223467999999999999999999999998887653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=339.73 Aligned_cols=256 Identities=26% Similarity=0.345 Sum_probs=201.8
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCcc---ChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEe
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQ---GEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEF 194 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 194 (426)
|.+.+.||+|+||.||+|... +++.||+|++...... ..+.|.+|++++++++||||+++++++.+.+..+++|||
T Consensus 4 YeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY 83 (932)
T PRK13184 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPY 83 (932)
T ss_pred eEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEc
Confidence 566789999999999999875 6889999998754322 235688999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhc----------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCc
Q 014352 195 MSNGSLSNLIYSE----------ERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLS 264 (426)
Q Consensus 195 ~~~gsL~~~l~~~----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 264 (426)
++||+|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.++|+|||++
T Consensus 84 ~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 84 IEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred CCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecCcc
Confidence 9999999988531 123567788999999999999999998 999999999999999999999999998
Q ss_pred cccccCC-------------------CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHH
Q 014352 265 KEEVFDG-------------------RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNL 325 (426)
Q Consensus 265 ~~~~~~~-------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~ 325 (426)
+...... ......||+.|+|||++.+..++.++|||||||++|||+||..||.........
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~ 240 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKIS 240 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhh
Confidence 7541100 011246899999999999999999999999999999999999999753221110
Q ss_pred hhccccchhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHHHHHHH
Q 014352 326 ASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRP-SIGEVTQALLKIKQR 384 (426)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-s~~evl~~L~~~~~~ 384 (426)
.. ....++.. .......+..+.+++.+||+.||++|| ++.++++.|+...+.
T Consensus 241 ~~------~~i~~P~~-~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 241 YR------DVILSPIE-VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred hh------hhccChhh-ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 00 00000000 001123346788999999999999995 677788888877553
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=302.34 Aligned_cols=249 Identities=24% Similarity=0.327 Sum_probs=204.5
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccCh---HHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEE
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGE---KEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYE 193 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 193 (426)
..++.+.||.|.-|+||++... ++..+|+|++.+...... .....|-+||+.++||.+..+++.+..+...+++||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 3445678999999999999986 458999999987643333 356789999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccc----
Q 014352 194 FMSNGSLSNLIYSEE-RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEV---- 268 (426)
Q Consensus 194 ~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~---- 268 (426)
||+||+|..+++.+. +.++...+.-++..|+-||+|||-.| ||+|||||+||||-++|++.|+||.|+....
T Consensus 158 yCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt 234 (459)
T KOG0610|consen 158 YCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT 234 (459)
T ss_pred cCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence 999999999986654 67999999999999999999999999 9999999999999999999999999863100
Q ss_pred ------------------------------c-C----------------------CCcccCccccCccCccccccCCCCc
Q 014352 269 ------------------------------F-D----------------------GRNSGLKGTYGYIDPAYISTNKFTM 295 (426)
Q Consensus 269 ------------------------------~-~----------------------~~~~~~~gt~~y~aPE~~~~~~~~~ 295 (426)
. . .....++||-.|+|||++.+...+.
T Consensus 235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgs 314 (459)
T KOG0610|consen 235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGS 314 (459)
T ss_pred eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCc
Confidence 0 0 0112356999999999999999999
Q ss_pred chhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCC----H
Q 014352 296 KSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPS----I 371 (426)
Q Consensus 296 ~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs----~ 371 (426)
+.|+|+|||++|||+.|.+||.+......+.. ++-..+.-+..+..+..+.+||++.|.+||.+|.- +
T Consensus 315 AVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~N--------Iv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA 386 (459)
T KOG0610|consen 315 AVDWWTFGIFLYEMLYGTTPFKGSNNKETLRN--------IVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGA 386 (459)
T ss_pred hhhHHHHHHHHHHHHhCCCCcCCCCchhhHHH--------HhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccch
Confidence 99999999999999999999987554433332 22222222222355678999999999999999987 7
Q ss_pred HHHHHH
Q 014352 372 GEVTQA 377 (426)
Q Consensus 372 ~evl~~ 377 (426)
.||.++
T Consensus 387 ~eIK~H 392 (459)
T KOG0610|consen 387 AEIKRH 392 (459)
T ss_pred HHhhcC
Confidence 787765
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=309.24 Aligned_cols=261 Identities=27% Similarity=0.409 Sum_probs=204.5
Q ss_pred HhhhhcccccCCCeeEEEEEeC-----CCcEEEEEEeccCCcc-ChHHHHHHHHHHhcCCCCceeeEEeEEEe--CCeEE
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-----SGGVAAIKVLASDSHQ-GEKEFQTEVSLLGRLHHRNLVNLIGYCVD--KGKYM 189 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~ 189 (426)
.+.+.+.||+|+||.||++.+. ++..+|+|.+...... ....|.+|++++++++||||+++++++.. ....+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 3456678999999999999864 3578999998765433 35679999999999999999999999887 55789
Q ss_pred EEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccccc
Q 014352 190 LIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF 269 (426)
Q Consensus 190 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 269 (426)
++|||+++++|.+++......+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 85 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred EEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 999999999999999766656999999999999999999999998 99999999999999999999999999875432
Q ss_pred CCC----cccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHH-hh--c---cccchhhhhhh
Q 014352 270 DGR----NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNL-AS--M---SQDGVDEILDK 339 (426)
Q Consensus 270 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~-~~--~---~~~~~~~~~~~ 339 (426)
... .....++..|+|||.+.+..++.++||||||+++|||++|..|+......... .. . ........+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE 241 (284)
T ss_pred CCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHc
Confidence 211 11233456799999998889999999999999999999999998653221100 00 0 00001111111
Q ss_pred hhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 014352 340 QLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKI 381 (426)
Q Consensus 340 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 381 (426)
......+...+.++.+++.+||+.+|++|||+.+++++|+.+
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 242 GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred CCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 111112223446799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=303.47 Aligned_cols=247 Identities=26% Similarity=0.375 Sum_probs=200.9
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC-ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecC
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS-HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMS 196 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 196 (426)
|++.+.||.|+||.||++... ++..+|+|.+.... ....+.+..|+.++++++||||+++++.+.+.+.++++|||++
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (255)
T cd08219 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCD 81 (255)
T ss_pred ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCC
Confidence 456678999999999999875 67889999886432 2334678889999999999999999999999999999999999
Q ss_pred CCChhHHhhhc-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC-Ccc
Q 014352 197 NGSLSNLIYSE-ERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG-RNS 274 (426)
Q Consensus 197 ~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-~~~ 274 (426)
+|+|.+++... ...++....+.++.+++.||.|||+++ ++|+||||+||++++++.++++|||++....... ...
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (255)
T cd08219 82 GGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYAC 158 (255)
T ss_pred CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccccccc
Confidence 99999988643 356889999999999999999999998 9999999999999999999999999987543222 223
Q ss_pred cCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHH
Q 014352 275 GLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELA 354 (426)
Q Consensus 275 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 354 (426)
...+++.|+|||++.+..++.++|+||||+++|+|++|..||................. ...+...+..+.
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~ 229 (255)
T cd08219 159 TYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSY---------KPLPSHYSYELR 229 (255)
T ss_pred cccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCC---------CCCCcccCHHHH
Confidence 45688999999999988999999999999999999999999975432222111111111 111222345688
Q ss_pred HHHHHcccCCCCCCCCHHHHHHH
Q 014352 355 RIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 355 ~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
+++.+||+.||++|||+.+++..
T Consensus 230 ~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 230 SLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHHHHhCCcccCCCHHHHhhc
Confidence 99999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=306.37 Aligned_cols=254 Identities=24% Similarity=0.318 Sum_probs=198.4
Q ss_pred hcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCC-----eEEEEEEec
Q 014352 122 TNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKG-----KYMLIYEFM 195 (426)
Q Consensus 122 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~e~~ 195 (426)
.+++|+|+||.||+|... +++.||||+.-.+.. .-..|+++|+++.|||||++.-+|.... ...+|||||
T Consensus 29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym 104 (364)
T KOG0658|consen 29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM 104 (364)
T ss_pred eEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence 468999999999999975 568999998765432 2346899999999999999999887642 346899999
Q ss_pred CCCChhHHhhh---ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCC-CcEEEeeecCccccccCC
Q 014352 196 SNGSLSNLIYS---EERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHF-MRAKVADFGLSKEEVFDG 271 (426)
Q Consensus 196 ~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgl~~~~~~~~ 271 (426)
|. +|.+.++. .+..++...+.-+..|+++||.|||+.+ |+||||||.|+|+|.+ |.+||||||.|+......
T Consensus 105 P~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e 180 (364)
T KOG0658|consen 105 PE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE 180 (364)
T ss_pred hH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceeeccCC
Confidence 87 99999864 2455777777889999999999999988 9999999999999976 899999999999887777
Q ss_pred CcccCccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccc----cch----------hhh
Q 014352 272 RNSGLKGTYGYIDPAYIST-NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQ----DGV----------DEI 336 (426)
Q Consensus 272 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~----~~~----------~~~ 336 (426)
.+.....|..|+|||.+.+ ..|+.+.||||.|||+.||+-|++-|.+......+..+.. ... .+.
T Consensus 181 pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~ 260 (364)
T KOG0658|consen 181 PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEF 260 (364)
T ss_pred CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccc
Confidence 7778888999999998865 5799999999999999999999999987544333322110 000 011
Q ss_pred hhhhhccc-----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHHHH
Q 014352 337 LDKQLVGA-----CNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA--LLKIKQ 383 (426)
Q Consensus 337 ~~~~~~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~--L~~~~~ 383 (426)
..+.+... .......+..+++.++|+.+|.+|.++.|++.+ ++.++.
T Consensus 261 ~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~ 314 (364)
T KOG0658|consen 261 KFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD 314 (364)
T ss_pred cCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence 11111111 112244679999999999999999999999865 344443
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=303.90 Aligned_cols=248 Identities=24% Similarity=0.389 Sum_probs=202.6
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC-ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEec
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS-HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 195 (426)
.|+..+.||.|+||.||+|... ++..+|+|.+.... ......+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 3455668999999999999875 67889999987543 233457889999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC-Ccc
Q 014352 196 SNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG-RNS 274 (426)
Q Consensus 196 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-~~~ 274 (426)
++++|.+++.. ..+++.....++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 85 ~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06640 85 GGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred CCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCccccc
Confidence 99999998853 45889999999999999999999988 9999999999999999999999999987543222 223
Q ss_pred cCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHH
Q 014352 275 GLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELA 354 (426)
Q Consensus 275 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 354 (426)
...++..|+|||++.+..++.++|+||||+++|||++|..||...........+ ............+..+.
T Consensus 160 ~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~ 230 (277)
T cd06640 160 TFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI---------PKNNPPTLTGEFSKPFK 230 (277)
T ss_pred cccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh---------hcCCCCCCchhhhHHHH
Confidence 346788999999998888999999999999999999999998754332211111 11111122334567799
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHHH
Q 014352 355 RIGHKCLHKTPRKRPSIGEVTQALL 379 (426)
Q Consensus 355 ~l~~~cl~~~p~~RPs~~evl~~L~ 379 (426)
+++.+||+.+|++||++.+++.+-.
T Consensus 231 ~li~~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06640 231 EFIDACLNKDPSFRPTAKELLKHKF 255 (277)
T ss_pred HHHHHHcccCcccCcCHHHHHhChH
Confidence 9999999999999999999988744
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=309.72 Aligned_cols=249 Identities=23% Similarity=0.349 Sum_probs=202.6
Q ss_pred HHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEec
Q 014352 117 ATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 195 (426)
..|.+.+.||.|+||.||++... +++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 34566788999999999999864 78899999987655455567889999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC-Ccc
Q 014352 196 SNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG-RNS 274 (426)
Q Consensus 196 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-~~~ 274 (426)
++++|.+++.. ..+++..+..++.+++.||.|||+.+ ++||||||+||+++.++.++|+|||++....... ...
T Consensus 99 ~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 173 (297)
T cd06656 99 AGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 173 (297)
T ss_pred CCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCccCcC
Confidence 99999999843 45889999999999999999999998 9999999999999999999999999987533222 123
Q ss_pred cCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHH
Q 014352 275 GLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELA 354 (426)
Q Consensus 275 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 354 (426)
...+++.|+|||.+.+..++.++|+||||+++|++++|..||.................. ....+......+.
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~ 246 (297)
T cd06656 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP-------ELQNPERLSAVFR 246 (297)
T ss_pred cccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCC-------CCCCccccCHHHH
Confidence 456888999999999989999999999999999999999999653322111111110000 0011122345688
Q ss_pred HHHHHcccCCCCCCCCHHHHHHH
Q 014352 355 RIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 355 ~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
+++.+||+.+|++||++.+++++
T Consensus 247 ~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 247 DFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred HHHHHHccCChhhCcCHHHHhcC
Confidence 99999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=303.69 Aligned_cols=248 Identities=26% Similarity=0.422 Sum_probs=199.6
Q ss_pred hhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCcc------ChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEE
Q 014352 119 QNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQ------GEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIY 192 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 192 (426)
|.+.+.||.|+||.||+|...+++.+|+|.+...... ....+.+|++++++++|+||+++++++.+.+..++++
T Consensus 2 ~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (265)
T cd06631 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFM 81 (265)
T ss_pred ccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEE
Confidence 3456789999999999999888899999988654321 1245888999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccccc---
Q 014352 193 EFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF--- 269 (426)
Q Consensus 193 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~--- 269 (426)
||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 82 EFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred ecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 999999999999554 45889999999999999999999988 99999999999999999999999998864321
Q ss_pred ----CCCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccC
Q 014352 270 ----DGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGAC 345 (426)
Q Consensus 270 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (426)
........++..|+|||++.+..++.++||||||+++|++++|..||................ ......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-------~~~~~~ 230 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHR-------GLMPRL 230 (265)
T ss_pred cccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhcc-------CCCCCC
Confidence 111233568899999999999899999999999999999999999997543322211110000 000111
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 346 NIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 346 ~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
+......+.+++.+||+.+|++||++.+++.+
T Consensus 231 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 231 PDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred CCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 22344678999999999999999999998863
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=316.75 Aligned_cols=251 Identities=22% Similarity=0.312 Sum_probs=194.9
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccC---CccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEe
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASD---SHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEF 194 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 194 (426)
|.+.+.||+|+||.||+++.. +++.+|+|++... .....+.+.+|+.++..++|+||+++++++.+.+..++||||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (331)
T cd05597 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDY 82 (331)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEec
Confidence 556788999999999999975 6889999998642 112234688999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCC--
Q 014352 195 MSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGR-- 272 (426)
Q Consensus 195 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~-- 272 (426)
+++|+|.+++......++...+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 83 ~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 159 (331)
T cd05597 83 YVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ 159 (331)
T ss_pred CCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCCCcc
Confidence 9999999999765667899999999999999999999998 99999999999999999999999999865332221
Q ss_pred cccCccccCccCcccccc-----CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCH
Q 014352 273 NSGLKGTYGYIDPAYIST-----NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNI 347 (426)
Q Consensus 273 ~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (426)
.....||+.|+|||++.. ..++.++|||||||++|||++|+.||...........+...... . .+. ....
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~--~--~~~-~~~~ 234 (331)
T cd05597 160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEH--F--QFP-PDVT 234 (331)
T ss_pred ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCc--c--cCC-CccC
Confidence 223468999999999863 45788999999999999999999999764322221111110000 0 000 0111
Q ss_pred HHHHHHHHHHHHcccC--CCCCCCCHHHHHHH
Q 014352 348 QEVRELARIGHKCLHK--TPRKRPSIGEVTQA 377 (426)
Q Consensus 348 ~~~~~l~~l~~~cl~~--~p~~RPs~~evl~~ 377 (426)
..+..+.+++.+|+.. ++..||++.+++++
T Consensus 235 ~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 235 DVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 2345678888887754 33447899999887
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=319.71 Aligned_cols=190 Identities=25% Similarity=0.388 Sum_probs=165.6
Q ss_pred HHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEec
Q 014352 117 ATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 195 (426)
..|.+.+.||+|+||.||+|+.. ++..||+|..... ....|+.++++++||||+++++++...+..++|+||+
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 139 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY 139 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc
Confidence 34677889999999999999976 5678999974332 2356899999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCccc
Q 014352 196 SNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSG 275 (426)
Q Consensus 196 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 275 (426)
. ++|.+++......+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..........
T Consensus 140 ~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 215 (357)
T PHA03209 140 S-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG 215 (357)
T ss_pred C-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccCccccc
Confidence 5 6899988776777999999999999999999999998 99999999999999999999999999975433333445
Q ss_pred CccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCC
Q 014352 276 LKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPH 316 (426)
Q Consensus 276 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~ 316 (426)
..||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 216 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 216 LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 67999999999999999999999999999999999865554
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=301.64 Aligned_cols=248 Identities=24% Similarity=0.370 Sum_probs=202.4
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC--ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEec
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS--HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 195 (426)
|++.+.||.|+||.||.++.. ++..+++|.+.... ......+.+|++++++++|+||+++++++.+.+..+++|||+
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~ 81 (256)
T cd08221 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYA 81 (256)
T ss_pred ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEec
Confidence 456678999999999998864 67889999876542 233457889999999999999999999999999999999999
Q ss_pred CCCChhHHhhhc-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC-Cc
Q 014352 196 SNGSLSNLIYSE-ERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG-RN 273 (426)
Q Consensus 196 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-~~ 273 (426)
++++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++....... ..
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~ 158 (256)
T cd08221 82 NGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMA 158 (256)
T ss_pred CCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccccc
Confidence 999999999664 356899999999999999999999998 9999999999999999999999999987543322 22
Q ss_pred ccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHH
Q 014352 274 SGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVREL 353 (426)
Q Consensus 274 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 353 (426)
....+++.|+|||.+.+..++.++||||||+++|||++|..||...........+... .. .......+..+
T Consensus 159 ~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~--------~~-~~~~~~~~~~~ 229 (256)
T cd08221 159 ETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQG--------NY-TPVVSVYSSEL 229 (256)
T ss_pred cccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--------CC-CCCccccCHHH
Confidence 3456899999999998888999999999999999999999998753322211111111 11 11112344678
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHH
Q 014352 354 ARIGHKCLHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 354 ~~l~~~cl~~~p~~RPs~~evl~~L 378 (426)
.+++.+||..+|++||++.++++++
T Consensus 230 ~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 230 ISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred HHHHHHHcccCcccCCCHHHHhhCc
Confidence 9999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=321.80 Aligned_cols=252 Identities=22% Similarity=0.299 Sum_probs=197.8
Q ss_pred HHHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC---ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEE
Q 014352 116 KATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS---HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLI 191 (426)
Q Consensus 116 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 191 (426)
...|.+.+.||+|+||.||++... +++.+|+|++.... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV 121 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 355777889999999999999976 67889999986421 12234578899999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC
Q 014352 192 YEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG 271 (426)
Q Consensus 192 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 271 (426)
|||+++|+|.+++.. ..++...+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 122 ~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~ 196 (371)
T cd05622 122 MEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 196 (371)
T ss_pred EcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCC
Confidence 999999999999854 34788888899999999999999998 9999999999999999999999999997543222
Q ss_pred --CcccCccccCccCccccccCC----CCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccC
Q 014352 272 --RNSGLKGTYGYIDPAYISTNK----FTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGAC 345 (426)
Q Consensus 272 --~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (426)
......||+.|+|||++.+.. ++.++|||||||++|||++|..||...........+.... ..+....
T Consensus 197 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~------~~~~~~~ 270 (371)
T cd05622 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK------NSLTFPD 270 (371)
T ss_pred cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC------CcccCCC
Confidence 223567999999999986543 7899999999999999999999997643322221111100 0011111
Q ss_pred CHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHHH
Q 014352 346 NIQEVRELARIGHKCLHKTPRK--RPSIGEVTQAL 378 (426)
Q Consensus 346 ~~~~~~~l~~l~~~cl~~~p~~--RPs~~evl~~L 378 (426)
....+..+.+++..|+..++.+ ||++.+++++.
T Consensus 271 ~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 271 DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 2234567889999999844443 78999999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=320.13 Aligned_cols=255 Identities=23% Similarity=0.258 Sum_probs=196.4
Q ss_pred HHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC--ccChHHHHHHHHHHhcCCCCceeeEEeEEEeC------Ce
Q 014352 117 ATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS--HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDK------GK 187 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~ 187 (426)
.+|.+.+.||+|+||.||++... .++.+|||++.... ......+.+|+.+++.++||||+++++++... ..
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~ 103 (364)
T cd07875 24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 103 (364)
T ss_pred cceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCe
Confidence 34667789999999999999865 67889999987542 22335678899999999999999999987543 35
Q ss_pred EEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccc
Q 014352 188 YMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEE 267 (426)
Q Consensus 188 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 267 (426)
.|+||||+++ +|.+.+. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 104 ~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 176 (364)
T cd07875 104 VYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 176 (364)
T ss_pred EEEEEeCCCC-CHHHHHH---hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence 7999999965 7777763 24788899999999999999999998 999999999999999999999999999865
Q ss_pred ccCCCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccc---cchhh---------
Q 014352 268 VFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQ---DGVDE--------- 335 (426)
Q Consensus 268 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~---~~~~~--------- 335 (426)
..........+|..|+|||++.+..++.++|||||||++|||++|+.||........+..+.. ....+
T Consensus 177 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (364)
T cd07875 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 256 (364)
T ss_pred CCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHH
Confidence 433334456789999999999999999999999999999999999999976433222111100 00000
Q ss_pred --hhhh--------------hhc----ccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014352 336 --ILDK--------------QLV----GACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 336 --~~~~--------------~~~----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 378 (426)
.... ... ..........+.+++.+||+.||.+|||+.+++++-
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp 319 (364)
T cd07875 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319 (364)
T ss_pred HHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCc
Confidence 0000 000 000011235688999999999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=343.37 Aligned_cols=255 Identities=25% Similarity=0.351 Sum_probs=198.7
Q ss_pred HHHHHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc--cChHHHHHHHHHHhcCCCCceeeEEeEEEeC--CeE
Q 014352 114 IQKATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH--QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDK--GKY 188 (426)
Q Consensus 114 l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~ 188 (426)
.....|.+.+.||.|+||+||++... ++..+|+|.+..... .....|..|+.++++|+|||||+++++|... ..+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 34445778889999999999999975 667889998865422 2235688999999999999999999988653 568
Q ss_pred EEEEEecCCCChhHHhhhc---cCCCCHHHHHHHHHHHHHHHHHHHcCCC----CCeeecCCCCCCEEecC---------
Q 014352 189 MLIYEFMSNGSLSNLIYSE---ERVLNWEERLQIALDISHGIEYLHEGAV----PPVIHRDLKSANILLDH--------- 252 (426)
Q Consensus 189 ~lv~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~----~~ivH~dlk~~Nill~~--------- 252 (426)
|+||||+++|+|.++|... ...+++..++.|+.||+.||.|||+.+. .+|+||||||+||||+.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 9999999999999998642 2469999999999999999999998531 23999999999999964
Q ss_pred --------CCcEEEeeecCccccccCCCcccCccccCccCcccccc--CCCCcchhhHHHHHHHHHHHhCCCCCCchHHH
Q 014352 253 --------FMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYIST--NKFTMKSDIFSFGVIIFELITAIHPHQNLMEY 322 (426)
Q Consensus 253 --------~~~~kl~Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~ 322 (426)
.+.+||+|||++.............||+.|+|||++.+ ..++.++|||||||+||||++|..||......
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~ 249 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNF 249 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcH
Confidence 33489999999986543333445679999999999854 45889999999999999999999999753322
Q ss_pred HHHhhccccchhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 323 VNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
..+...... . ........+..+.+|+..||+.+|.+||++.+++.+
T Consensus 250 ~qli~~lk~--------~-p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 250 SQLISELKR--------G-PDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred HHHHHHHhc--------C-CCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 211110000 0 001112234679999999999999999999999853
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=303.12 Aligned_cols=248 Identities=23% Similarity=0.391 Sum_probs=188.3
Q ss_pred ccccCCCeeEEEEEeCCCc---EEEEEEeccCC-ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCCCC
Q 014352 124 ILGQGAFGPVYKATMPSGG---VAAIKVLASDS-HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGS 199 (426)
Q Consensus 124 ~lg~G~~g~Vy~~~~~~~~---~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 199 (426)
.||+|+||.||+|...++. .+++|.+.... ....+.+.+|+.+++.++||||+++++.+.+....++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 5999999999999754332 45667665443 2334678999999999999999999999999999999999999999
Q ss_pred hhHHhhhcc---CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC---CCc
Q 014352 200 LSNLIYSEE---RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD---GRN 273 (426)
Q Consensus 200 L~~~l~~~~---~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~---~~~ 273 (426)
|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++...... ...
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 999996532 34566778889999999999999988 999999999999999999999999997632211 122
Q ss_pred ccCccccCccCcccccc-------CCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccC
Q 014352 274 SGLKGTYGYIDPAYIST-------NKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGAC 345 (426)
Q Consensus 274 ~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (426)
....++..|+|||++.. ..++.++||||||+++|||++ |..||........+............++...
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 235 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLE--- 235 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccC---
Confidence 34567889999998743 245789999999999999997 5678865433322222111211222222221
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 014352 346 NIQEVRELARIGHKCLHKTPRKRPSIGEVTQALL 379 (426)
Q Consensus 346 ~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 379 (426)
......+.+++..|| .+|++||++.++++.|.
T Consensus 236 -~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 236 -LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred -CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 123467888999999 67999999999998774
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=301.15 Aligned_cols=246 Identities=31% Similarity=0.530 Sum_probs=200.0
Q ss_pred hhcccccCCCeeEEEEEeCC-----CcEEEEEEeccCCcc-ChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEe
Q 014352 121 FTNILGQGAFGPVYKATMPS-----GGVAAIKVLASDSHQ-GEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEF 194 (426)
Q Consensus 121 ~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 194 (426)
+.+.||.|+||.||++.... +..+|+|.+...... ..+.+..|+.++.+++|+||+++++++.+.+..+++|||
T Consensus 3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~ 82 (258)
T smart00219 3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY 82 (258)
T ss_pred ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence 55789999999999998753 378999999765433 456899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCC-CCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCc
Q 014352 195 MSNGSLSNLIYSEERV-LNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRN 273 (426)
Q Consensus 195 ~~~gsL~~~l~~~~~~-l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 273 (426)
+++++|.+++...... +++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.........
T Consensus 83 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (258)
T smart00219 83 MEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY 159 (258)
T ss_pred cCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence 9999999999665444 899999999999999999999998 999999999999999999999999998754332111
Q ss_pred c--cCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHH
Q 014352 274 S--GLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEV 350 (426)
Q Consensus 274 ~--~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (426)
. ...++..|+|||.+.+..++.++||||||+++++|++ |..||................ ....+...+
T Consensus 160 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~---------~~~~~~~~~ 230 (258)
T smart00219 160 KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGY---------RLPKPENCP 230 (258)
T ss_pred ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC---------CCCCCCcCC
Confidence 1 2336789999999988889999999999999999998 788886532222111111111 111122245
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014352 351 RELARIGHKCLHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 351 ~~l~~l~~~cl~~~p~~RPs~~evl~~L 378 (426)
.++.+++.+||..+|++|||+.++++.|
T Consensus 231 ~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 231 PEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 6799999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=321.76 Aligned_cols=254 Identities=24% Similarity=0.310 Sum_probs=195.5
Q ss_pred hhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC--ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCC-----eEEEE
Q 014352 120 NFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS--HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKG-----KYMLI 191 (426)
Q Consensus 120 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~lv 191 (426)
++.+.||+|+||.||++... ++..||+|.+.... ....+.+.+|+.+++.++||||+++++++...+ ..|+|
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 82 (372)
T cd07853 3 EPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVV 82 (372)
T ss_pred cccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEE
Confidence 45678999999999999864 78899999986532 223456889999999999999999999998776 78999
Q ss_pred EEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC
Q 014352 192 YEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG 271 (426)
Q Consensus 192 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 271 (426)
+||+. ++|.+.+.. ...+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||+++......
T Consensus 83 ~e~~~-~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~ 157 (372)
T cd07853 83 TELMQ-SDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE 157 (372)
T ss_pred eeccc-cCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeecccCc
Confidence 99996 588887744 346899999999999999999999998 9999999999999999999999999987533221
Q ss_pred --CcccCccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccc----cchhh---------
Q 014352 272 --RNSGLKGTYGYIDPAYISTN-KFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQ----DGVDE--------- 335 (426)
Q Consensus 272 --~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~----~~~~~--------- 335 (426)
......++..|+|||.+.+. .++.++|||||||++|||++|+.||........+..+.. .....
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 237 (372)
T cd07853 158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGAR 237 (372)
T ss_pred cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHH
Confidence 22334678999999998764 478999999999999999999999976443322211100 00000
Q ss_pred -hhhhhhcc--------cCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014352 336 -ILDKQLVG--------ACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 336 -~~~~~~~~--------~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 378 (426)
.+...... .........+.+++.+||+.||++|||+.+++++-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 289 (372)
T cd07853 238 AHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHP 289 (372)
T ss_pred HHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCH
Confidence 00000000 00112245788999999999999999999999763
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=301.34 Aligned_cols=250 Identities=21% Similarity=0.380 Sum_probs=199.1
Q ss_pred hhhhcccccCCCeeEEEEEeCC--CcEEEEEEeccCCc----------cChHHHHHHHHHHhc-CCCCceeeEEeEEEeC
Q 014352 119 QNFTNILGQGAFGPVYKATMPS--GGVAAIKVLASDSH----------QGEKEFQTEVSLLGR-LHHRNLVNLIGYCVDK 185 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~----------~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~ 185 (426)
|.+.+.||+|+||.||+|.... +..+|+|.+..... ....++.+|+.++.+ ++||||+++++++.+.
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 3456789999999999999764 67899998754321 112356778888865 7999999999999999
Q ss_pred CeEEEEEEecCCCChhHHhhh---ccCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeecCCCCCCEEecCCCcEEEeee
Q 014352 186 GKYMLIYEFMSNGSLSNLIYS---EERVLNWEERLQIALDISHGIEYLHE-GAVPPVIHRDLKSANILLDHFMRAKVADF 261 (426)
Q Consensus 186 ~~~~lv~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Df 261 (426)
+..+++|||+++++|.+++.. ....+++..++.++.|++.||.|||+ .+ ++|+||+|+||+++.++.++|+||
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEecc
Confidence 999999999999999988743 34568999999999999999999996 56 999999999999999999999999
Q ss_pred cCccccccCCCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhh
Q 014352 262 GLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQL 341 (426)
Q Consensus 262 gl~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (426)
|++.............++..|+|||.+.+..++.++||||||+++|||++|..||.............. ...
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~--------~~~ 230 (269)
T cd08528 159 GLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVE--------AVY 230 (269)
T ss_pred cceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhh--------ccC
Confidence 998764443333456688999999999988899999999999999999999999865432221111111 111
Q ss_pred cccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 014352 342 VGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALL 379 (426)
Q Consensus 342 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 379 (426)
........+..+.+++.+||+.||++||++.|+..++.
T Consensus 231 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 231 EPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred CcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 11111123467899999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=324.76 Aligned_cols=243 Identities=28% Similarity=0.435 Sum_probs=202.3
Q ss_pred ccccCCCeeEEEEEeCC-CcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCCCChhH
Q 014352 124 ILGQGAFGPVYKATMPS-GGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSN 202 (426)
Q Consensus 124 ~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~ 202 (426)
+||+|.||+||-|++.+ ...+|||.+........+.+.+|+.+-++|+|.|||+++|.+.+++.+-+.||-+|||||.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 69999999999999764 45689999877665566778999999999999999999999999999999999999999999
Q ss_pred HhhhccCCC--CHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecC-CCcEEEeeecCcccccc-CCCcccCcc
Q 014352 203 LIYSEERVL--NWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDH-FMRAKVADFGLSKEEVF-DGRNSGLKG 278 (426)
Q Consensus 203 ~l~~~~~~l--~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgl~~~~~~-~~~~~~~~g 278 (426)
+|...=+++ ++.+.-.+..||++||.|||++. |||||||-+|||++. .|.+||+|||-++.... ...+.++.|
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTG 738 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTG 738 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCCcccccccc
Confidence 998776777 77788889999999999999999 999999999999975 78999999999876443 334567889
Q ss_pred ccCccCccccccC--CCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHH
Q 014352 279 TYGYIDPAYISTN--KFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARI 356 (426)
Q Consensus 279 t~~y~aPE~~~~~--~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 356 (426)
|..|||||++..+ .|..++|||||||++.||.||++||-....... .+-.-+. -......+.+.+.+...+
T Consensus 739 TLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA--AMFkVGm-----yKvHP~iPeelsaeak~F 811 (1226)
T KOG4279|consen 739 TLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA--AMFKVGM-----YKVHPPIPEELSAEAKNF 811 (1226)
T ss_pred chhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH--hhhhhcc-----eecCCCCcHHHHHHHHHH
Confidence 9999999999765 588999999999999999999999965322110 1111110 111233456677889999
Q ss_pred HHHcccCCCCCCCCHHHHHH
Q 014352 357 GHKCLHKTPRKRPSIGEVTQ 376 (426)
Q Consensus 357 ~~~cl~~~p~~RPs~~evl~ 376 (426)
+.+|+.+||..||++.++++
T Consensus 812 ilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 812 ILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHcCCCcccCccHHHhcc
Confidence 99999999999999999875
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=304.19 Aligned_cols=244 Identities=29% Similarity=0.474 Sum_probs=195.3
Q ss_pred ccccCCCeeEEEEEeCC-------CcEEEEEEeccCC-ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEec
Q 014352 124 ILGQGAFGPVYKATMPS-------GGVAAIKVLASDS-HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 124 ~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 195 (426)
.||+|+||.||+|+..+ +..+|+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 69999999999998642 2478999876543 233467889999999999999999999999999999999999
Q ss_pred CCCChhHHhhhc------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCC-----cEEEeeecCc
Q 014352 196 SNGSLSNLIYSE------ERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFM-----RAKVADFGLS 264 (426)
Q Consensus 196 ~~gsL~~~l~~~------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-----~~kl~Dfgl~ 264 (426)
++++|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++ .++++|||++
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999999642 234788999999999999999999988 99999999999999887 8999999998
Q ss_pred cccccCC---CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhh
Q 014352 265 KEEVFDG---RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQ 340 (426)
Q Consensus 265 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (426)
....... ......++..|+|||++.+..++.++||||||+++|||++ |..||...........+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~--------- 229 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG--------- 229 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcC---------
Confidence 7432211 1122345678999999999999999999999999999998 99998654332221111111
Q ss_pred hcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 014352 341 LVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALL 379 (426)
Q Consensus 341 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 379 (426)
.....+...+..+.+++.+||+.+|.+||++.++++.|+
T Consensus 230 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 230 GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 111112234567899999999999999999999999885
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=301.67 Aligned_cols=245 Identities=28% Similarity=0.482 Sum_probs=198.4
Q ss_pred HHhhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecC
Q 014352 117 ATQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMS 196 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 196 (426)
..+.+.+.||+|+||.||++.. ++..+|+|.+.... ....+.+|+.++++++|||++++++++... ..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 3466778999999999999986 66778999886542 345788999999999999999999998765 4799999999
Q ss_pred CCChhHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCccc
Q 014352 197 NGSLSNLIYSEE-RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSG 275 (426)
Q Consensus 197 ~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 275 (426)
+++|.+++.... ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++..... ....
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~--~~~~ 156 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSM--GVDN 156 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccc--cCCC
Confidence 999999996544 45899999999999999999999988 99999999999999999999999999875322 1223
Q ss_pred CccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHH
Q 014352 276 LKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELA 354 (426)
Q Consensus 276 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 354 (426)
...+..|+|||++.+..++.++|+||||+++|||++ |..||............ ........+...+..+.
T Consensus 157 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~ 227 (254)
T cd05083 157 SKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECV---------EKGYRMEPPEGCPADVY 227 (254)
T ss_pred CCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH---------hCCCCCCCCCcCCHHHH
Confidence 344578999999998899999999999999999998 99998754332211111 11111112223456789
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHHH
Q 014352 355 RIGHKCLHKTPRKRPSIGEVTQALL 379 (426)
Q Consensus 355 ~l~~~cl~~~p~~RPs~~evl~~L~ 379 (426)
+++.+||+.+|++||++.++++.|+
T Consensus 228 ~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 228 VLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHc
Confidence 9999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=319.03 Aligned_cols=254 Identities=24% Similarity=0.267 Sum_probs=195.6
Q ss_pred HHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc--cChHHHHHHHHHHhcCCCCceeeEEeEEEeC------Ce
Q 014352 117 ATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH--QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDK------GK 187 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~ 187 (426)
.+|.+.+.||+|+||.||++... .+..+|+|.+..... .....+.+|+.+++.++||||+++++++... ..
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 96 (355)
T cd07874 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQD 96 (355)
T ss_pred hceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccce
Confidence 34667789999999999999865 678899999875422 2235677899999999999999999988643 35
Q ss_pred EEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccc
Q 014352 188 YMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEE 267 (426)
Q Consensus 188 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 267 (426)
.++||||+++ +|.+.+. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 97 ~~lv~e~~~~-~l~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~~~~ 169 (355)
T cd07874 97 VYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_pred eEEEhhhhcc-cHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcccccC
Confidence 7999999965 6766663 24788899999999999999999998 999999999999999999999999999865
Q ss_pred ccCCCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhcc---cc-----------ch
Q 014352 268 VFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMS---QD-----------GV 333 (426)
Q Consensus 268 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~---~~-----------~~ 333 (426)
..........||..|+|||++.+..++.++|||||||++|||++|+.||............. .. ..
T Consensus 170 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (355)
T cd07874 170 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249 (355)
T ss_pred CCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHH
Confidence 43333445678999999999999999999999999999999999999997543221111000 00 00
Q ss_pred hhhhhh---------------hhc---ccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 334 DEILDK---------------QLV---GACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 334 ~~~~~~---------------~~~---~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
...++. ... ..........+.+++.+||+.||++|||+.|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000000 000 00011123568899999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=325.33 Aligned_cols=249 Identities=20% Similarity=0.263 Sum_probs=191.1
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCC
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSN 197 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 197 (426)
|.+.+.||+|+||.||++... .++.||+|... ...+.+|+++|++++|+|||++++++...+..++|||++.
T Consensus 171 y~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~- 243 (461)
T PHA03211 171 FAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR- 243 (461)
T ss_pred eEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-
Confidence 455678999999999999976 57789999632 2346789999999999999999999999999999999995
Q ss_pred CChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC---Ccc
Q 014352 198 GSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG---RNS 274 (426)
Q Consensus 198 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---~~~ 274 (426)
++|.+++......+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 244 ~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 320 (461)
T PHA03211 244 SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHY 320 (461)
T ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccccccccc
Confidence 6999888666567999999999999999999999998 9999999999999999999999999987532221 122
Q ss_pred cCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHH----------HHHH-hh--ccccchhh-----h
Q 014352 275 GLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLME----------YVNL-AS--MSQDGVDE-----I 336 (426)
Q Consensus 275 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~----------~~~~-~~--~~~~~~~~-----~ 336 (426)
...||..|+|||++.+..++.++|||||||++|||++|..|+-.... .... .. ........ +
T Consensus 321 ~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l 400 (461)
T PHA03211 321 GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRL 400 (461)
T ss_pred ccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHH
Confidence 45699999999999999999999999999999999998765422110 0000 00 00000000 0
Q ss_pred hhh-----------hhcccCCH---HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 337 LDK-----------QLVGACNI---QEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 337 ~~~-----------~~~~~~~~---~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
... ........ .....+.+|+.+||+.||.+|||+.|++++
T Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 401 VSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000 00000000 122368899999999999999999999976
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=300.93 Aligned_cols=247 Identities=27% Similarity=0.436 Sum_probs=200.6
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc-----cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEE
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH-----QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIY 192 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 192 (426)
|...+.||+|+||.||+|... ++..+++|.+..... ...+.+.+|+.++++++||||+++++++.+....++++
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL 81 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence 345578999999999999976 788999998865431 12357889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCC
Q 014352 193 EFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGR 272 (426)
Q Consensus 193 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 272 (426)
||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 82 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~ 157 (258)
T cd06632 82 ELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF 157 (258)
T ss_pred EecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceecccccc
Confidence 999999999998654 45889999999999999999999998 99999999999999999999999999875443333
Q ss_pred cccCccccCccCccccccCC-CCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHH
Q 014352 273 NSGLKGTYGYIDPAYISTNK-FTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVR 351 (426)
Q Consensus 273 ~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (426)
.....++..|++||.+.... ++.++|+||||+++|+|++|..||............... ......+.....
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~--------~~~~~~~~~~~~ 229 (258)
T cd06632 158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRS--------KELPPIPDHLSD 229 (258)
T ss_pred ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhc--------ccCCCcCCCcCH
Confidence 34566889999999997776 899999999999999999999999764322211111100 000111222346
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 352 ELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 352 ~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
.+.+++.+||+.+|.+||++.+++.+
T Consensus 230 ~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 230 EAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred HHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 78899999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=321.75 Aligned_cols=248 Identities=22% Similarity=0.305 Sum_probs=194.4
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC---ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEe
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS---HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEF 194 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 194 (426)
+++.+.||+|+||.||++... ++..+|+|++.... ......+..|+.++.+++||||+++++.+.+.+.+++||||
T Consensus 3 f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~ 82 (360)
T cd05627 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEF 82 (360)
T ss_pred ceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence 345678999999999999875 68899999986432 22235678899999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC---
Q 014352 195 MSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG--- 271 (426)
Q Consensus 195 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~--- 271 (426)
+++|+|.+++... ..++...+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.......
T Consensus 83 ~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 83 LPGGDMMTLLMKK-DTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred CCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence 9999999998644 45899999999999999999999998 9999999999999999999999999986321110
Q ss_pred ---------------------------------CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 014352 272 ---------------------------------RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQN 318 (426)
Q Consensus 272 ---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~ 318 (426)
......||+.|+|||++.+..++.++|||||||++|||++|..||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~ 238 (360)
T cd05627 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (360)
T ss_pred cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCC
Confidence 01134699999999999999999999999999999999999999976
Q ss_pred hHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCC---HHHHHHH
Q 014352 319 LMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPS---IGEVTQA 377 (426)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs---~~evl~~ 377 (426)
.........+.... ..+.-......+..+.+++.+++. ||.+|++ +.+++++
T Consensus 239 ~~~~~~~~~i~~~~------~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 239 ETPQETYRKVMNWK------ETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCHHHHHHHHHcCC------CceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence 43332221111100 000001111234567778878764 9999985 6777766
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=310.00 Aligned_cols=191 Identities=28% Similarity=0.367 Sum_probs=158.3
Q ss_pred hcccccCCCeeEEEEEeC---CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEe--CCeEEEEEEecC
Q 014352 122 TNILGQGAFGPVYKATMP---SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVD--KGKYMLIYEFMS 196 (426)
Q Consensus 122 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~ 196 (426)
+..||+|+||+||+|+.. ++..+|+|.+.... ....+.+|+.++++++||||+++++++.. ....+++|||++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 357999999999999864 45789999986542 23467889999999999999999998865 356899999995
Q ss_pred CCChhHHhhhc--------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEe----cCCCcEEEeeecCc
Q 014352 197 NGSLSNLIYSE--------ERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILL----DHFMRAKVADFGLS 264 (426)
Q Consensus 197 ~gsL~~~l~~~--------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfgl~ 264 (426)
++|.+++... ...++...+..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5888877422 135888999999999999999999998 9999999999999 45678999999999
Q ss_pred cccccCC----CcccCccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 014352 265 KEEVFDG----RNSGLKGTYGYIDPAYIST-NKFTMKSDIFSFGVIIFELITAIHPHQN 318 (426)
Q Consensus 265 ~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~ 318 (426)
+...... ......||+.|+|||++.+ ..++.++|||||||++|||++|.+||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 7543221 2234678999999999876 4589999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=309.33 Aligned_cols=255 Identities=23% Similarity=0.309 Sum_probs=197.7
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc-cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecC
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH-QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMS 196 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 196 (426)
|.+.+.||.|+||.||+|... ++..||+|.+..... .....+.+|+.++++++||||+++++++...+..++||||++
T Consensus 8 y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~ 87 (301)
T cd07873 8 YIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD 87 (301)
T ss_pred eEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc
Confidence 556678999999999999875 678899999865432 233467889999999999999999999999999999999997
Q ss_pred CCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC-Cccc
Q 014352 197 NGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG-RNSG 275 (426)
Q Consensus 197 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-~~~~ 275 (426)
++|.+++......+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....... ....
T Consensus 88 -~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 163 (301)
T cd07873 88 -KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSN 163 (301)
T ss_pred -cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcccc
Confidence 5999988766667899999999999999999999998 9999999999999999999999999987533221 2233
Q ss_pred CccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhc---c----ccchhhhhh---------
Q 014352 276 LKGTYGYIDPAYIST-NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASM---S----QDGVDEILD--------- 338 (426)
Q Consensus 276 ~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~---~----~~~~~~~~~--------- 338 (426)
..+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...........+ . .........
T Consensus 164 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (301)
T cd07873 164 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNY 243 (301)
T ss_pred cceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccccccc
Confidence 457889999998865 45788999999999999999999999754321111100 0 000000000
Q ss_pred hhhccc----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 339 KQLVGA----CNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 339 ~~~~~~----~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
+..... .....+..+.+++.+||+.||.+|||+.+++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 244 PKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred CccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000000 011234568899999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=314.66 Aligned_cols=251 Identities=22% Similarity=0.288 Sum_probs=196.2
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC---ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEe
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS---HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEF 194 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 194 (426)
|.+.+.||+|+||.||+++.. ++..+|+|++.... ......+.+|+.++..++|+||+++++++.+.+.+++||||
T Consensus 3 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey 82 (332)
T cd05623 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDY 82 (332)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEec
Confidence 456688999999999999976 56789999985421 12234578899999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCC--
Q 014352 195 MSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGR-- 272 (426)
Q Consensus 195 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~-- 272 (426)
+++|+|.+++......+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 83 ~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~ 159 (332)
T cd05623 83 YVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ 159 (332)
T ss_pred cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCCcce
Confidence 9999999999765667899999999999999999999998 99999999999999999999999999875332221
Q ss_pred cccCccccCccCccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCH
Q 014352 273 NSGLKGTYGYIDPAYIS-----TNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNI 347 (426)
Q Consensus 273 ~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (426)
.....||+.|+|||++. ...++.++|||||||++|||++|+.||...........+....... .. .....
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~----~~-p~~~~ 234 (332)
T cd05623 160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF----QF-PAQVT 234 (332)
T ss_pred ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccc----cC-CCccc
Confidence 22356999999999986 3468899999999999999999999997643332222211110000 00 01112
Q ss_pred HHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 014352 348 QEVRELARIGHKCLHKTPRK--RPSIGEVTQA 377 (426)
Q Consensus 348 ~~~~~l~~l~~~cl~~~p~~--RPs~~evl~~ 377 (426)
..+..+.+++.+|+..++.+ |+++.+++++
T Consensus 235 ~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 235 DVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred cCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 23467888888888654444 6899999887
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=305.35 Aligned_cols=255 Identities=23% Similarity=0.309 Sum_probs=197.4
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc--cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEec
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH--QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 195 (426)
|++...||+|+||.||+|+.. +++.+|+|++..... ...+.+.+|+.++++++|||++++++++...+..++||||+
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~ 82 (286)
T cd07847 3 YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYC 82 (286)
T ss_pred eeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEecc
Confidence 556678999999999999976 688999998864422 22356789999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC-Ccc
Q 014352 196 SNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG-RNS 274 (426)
Q Consensus 196 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-~~~ 274 (426)
++++|..++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++....... ...
T Consensus 83 ~~~~l~~~~~~-~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (286)
T cd07847 83 DHTVLNELEKN-PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYT 158 (286)
T ss_pred CccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCccccc
Confidence 99888877643 345899999999999999999999988 9999999999999999999999999987543322 223
Q ss_pred cCccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhcc---ccch---hhhh----------
Q 014352 275 GLKGTYGYIDPAYIST-NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMS---QDGV---DEIL---------- 337 (426)
Q Consensus 275 ~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~---~~~~---~~~~---------- 337 (426)
...++..|+|||.+.+ ..++.++||||||+++|||++|..||.+.........+. .... ....
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd07847 159 DYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLS 238 (286)
T ss_pred CcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccccc
Confidence 4457889999999866 557899999999999999999999997543322111100 0000 0000
Q ss_pred hhhhcccC-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 338 DKQLVGAC-----NIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 338 ~~~~~~~~-----~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
.+...... ....+..+.+++.+||+.+|++|||+.+++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 239 IPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred CCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 00000000 01234678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=304.25 Aligned_cols=249 Identities=25% Similarity=0.390 Sum_probs=194.8
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcC-CCCceeeEEeEEE-----eCCeEEEE
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRL-HHRNLVNLIGYCV-----DKGKYMLI 191 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~-----~~~~~~lv 191 (426)
|++.+.||+|+||.||++... ++..+|+|.+.... .....+.+|+.+++++ +||||+++++++. .++..++|
T Consensus 20 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv 98 (286)
T cd06638 20 WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLV 98 (286)
T ss_pred eeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEE
Confidence 456678999999999999875 67789999876432 2245688899999999 6999999999885 34568999
Q ss_pred EEecCCCChhHHhhh---ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccc
Q 014352 192 YEFMSNGSLSNLIYS---EERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEV 268 (426)
Q Consensus 192 ~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 268 (426)
|||+++++|.+++.. ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||+++...
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~ 175 (286)
T cd06638 99 LELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 175 (286)
T ss_pred EeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEccCCceeecc
Confidence 999999999998753 2345888999999999999999999988 9999999999999999999999999987543
Q ss_pred cCC-CcccCccccCccCcccccc-----CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhc
Q 014352 269 FDG-RNSGLKGTYGYIDPAYIST-----NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLV 342 (426)
Q Consensus 269 ~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (426)
... ......|+..|+|||++.. ..++.++|||||||++|||++|..||........+............
T Consensus 176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~----- 250 (286)
T cd06638 176 STRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLH----- 250 (286)
T ss_pred cCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCccc-----
Confidence 221 2234568999999999853 45788999999999999999999998765433222211111000000
Q ss_pred ccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014352 343 GACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 343 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 378 (426)
.+......+.+++.+||+.||++|||+.|+++++
T Consensus 251 --~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 251 --QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred --CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 0111235689999999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=314.50 Aligned_cols=251 Identities=22% Similarity=0.287 Sum_probs=196.3
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC---ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEe
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS---HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEF 194 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 194 (426)
|.+.+.||+|+||.||+++.. ++..+|+|.+.... ......+.+|..++..++|+||+++++++.+.+..|+||||
T Consensus 3 y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey 82 (331)
T cd05624 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDY 82 (331)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence 456788999999999999975 67889999986421 12234578899999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCC--
Q 014352 195 MSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGR-- 272 (426)
Q Consensus 195 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~-- 272 (426)
+++|+|.+++......+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 83 ~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 159 (331)
T cd05624 83 YVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ 159 (331)
T ss_pred CCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCCcee
Confidence 9999999999765567899999999999999999999998 99999999999999999999999999875433222
Q ss_pred cccCccccCccCcccccc-----CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCH
Q 014352 273 NSGLKGTYGYIDPAYIST-----NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNI 347 (426)
Q Consensus 273 ~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (426)
.....||+.|+|||++.+ ..++.++||||||+++|||++|+.||...........+....... .+ .....
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~----~~-p~~~~ 234 (331)
T cd05624 160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERF----QF-PSHIT 234 (331)
T ss_pred eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcc----cC-CCccc
Confidence 123569999999999875 567899999999999999999999997543322222111110000 00 00111
Q ss_pred HHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 014352 348 QEVRELARIGHKCLHKTPRK--RPSIGEVTQA 377 (426)
Q Consensus 348 ~~~~~l~~l~~~cl~~~p~~--RPs~~evl~~ 377 (426)
..+..+.+++.+|+..++++ |+++.+++++
T Consensus 235 ~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 235 DVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred cCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 23467888999998866544 4688888776
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=298.39 Aligned_cols=247 Identities=23% Similarity=0.375 Sum_probs=201.0
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc--cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEec
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH--QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 195 (426)
|++.+.||+|+||.||++... +++.+|+|.+..... .....+.+|++++++++||||+++++.+...+..++||||+
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08220 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA 81 (256)
T ss_pred ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecC
Confidence 456678999999999999874 778899999865432 23457889999999999999999999999999999999999
Q ss_pred CCCChhHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCC-CcEEEeeecCccccccCCCc
Q 014352 196 SNGSLSNLIYSEE-RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHF-MRAKVADFGLSKEEVFDGRN 273 (426)
Q Consensus 196 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgl~~~~~~~~~~ 273 (426)
++++|.+++.... ..+++..+..++.+++.||.|||+++ ++|+||+|+||+++.+ +.+||+|||++.........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~ 158 (256)
T cd08220 82 PGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKA 158 (256)
T ss_pred CCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccc
Confidence 9999999996643 45899999999999999999999998 9999999999999865 45899999999865444444
Q ss_pred ccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHH
Q 014352 274 SGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVREL 353 (426)
Q Consensus 274 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 353 (426)
....++..|+|||.+.+..++.++||||||+++|+|++|..||.............. . .....+...+..+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~--------~-~~~~~~~~~~~~l 229 (256)
T cd08220 159 YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMS--------G-TFAPISDRYSPDL 229 (256)
T ss_pred cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHh--------c-CCCCCCCCcCHHH
Confidence 456688999999999988899999999999999999999999875432211111100 0 0111122345678
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHH
Q 014352 354 ARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 354 ~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
.+++.+||+.+|++|||+.+++++
T Consensus 230 ~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 230 RQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred HHHHHHHccCChhhCCCHHHHhhC
Confidence 999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=301.12 Aligned_cols=250 Identities=22% Similarity=0.385 Sum_probs=197.0
Q ss_pred hhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCcc----------ChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeE
Q 014352 120 NFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQ----------GEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKY 188 (426)
Q Consensus 120 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 188 (426)
...+.||.|+||.||+|... +++.+|+|.+...... ..+.+..|+.++++++|||++++++++...+..
T Consensus 4 ~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (272)
T cd06629 4 VKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYL 83 (272)
T ss_pred eecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCce
Confidence 34568999999999999864 6889999987542111 013578899999999999999999999999999
Q ss_pred EEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccc
Q 014352 189 MLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEV 268 (426)
Q Consensus 189 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 268 (426)
++||||+++++|.+++... ..+++..+..++.|++.||.|||+++ ++||||+|+||+++.++.++++|||+++...
T Consensus 84 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~ 159 (272)
T cd06629 84 SIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSD 159 (272)
T ss_pred EEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccccccc
Confidence 9999999999999998655 46899999999999999999999998 9999999999999999999999999987532
Q ss_pred cCC---CcccCccccCccCccccccCC--CCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcc
Q 014352 269 FDG---RNSGLKGTYGYIDPAYISTNK--FTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVG 343 (426)
Q Consensus 269 ~~~---~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (426)
... ......++..|+|||.+.... ++.++|+||||+++||+++|..||....................+. .
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~ 235 (272)
T cd06629 160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIP----P 235 (272)
T ss_pred ccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCC----c
Confidence 211 123356888999999987654 7899999999999999999999986543322221111111111111 1
Q ss_pred cCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 344 ACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 344 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
......+..+.+++.+||+.+|++|||+.+++++
T Consensus 236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 236 DVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 1112335689999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=299.62 Aligned_cols=247 Identities=27% Similarity=0.391 Sum_probs=199.7
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc--cChHHHHHHHHHHhcCCCCceeeEEeEEEe--CCeEEEEEE
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH--QGEKEFQTEVSLLGRLHHRNLVNLIGYCVD--KGKYMLIYE 193 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e 193 (426)
|++.+.||.|+||.||++... ++..+|+|.+..... ...+.+..|++++++++||||+++++++.. ....+++||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e 81 (265)
T cd08217 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME 81 (265)
T ss_pred ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence 455678999999999999865 678899998865432 223568889999999999999999998764 356799999
Q ss_pred ecCCCChhHHhhhc---cCCCCHHHHHHHHHHHHHHHHHHH-----cCCCCCeeecCCCCCCEEecCCCcEEEeeecCcc
Q 014352 194 FMSNGSLSNLIYSE---ERVLNWEERLQIALDISHGIEYLH-----EGAVPPVIHRDLKSANILLDHFMRAKVADFGLSK 265 (426)
Q Consensus 194 ~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~LH-----~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 265 (426)
|+++++|.+++... ...+++..++.++.+++.||.||| +.+ ++|+||+|+||+++.++.+||+|||++.
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~~ 158 (265)
T cd08217 82 YCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLAK 158 (265)
T ss_pred hccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEecccccc
Confidence 99999999998653 457899999999999999999999 666 9999999999999999999999999988
Q ss_pred ccccCCC-cccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhccc
Q 014352 266 EEVFDGR-NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGA 344 (426)
Q Consensus 266 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (426)
....... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...........+ .......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~---------~~~~~~~ 229 (265)
T cd08217 159 ILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKI---------KEGKFRR 229 (265)
T ss_pred cccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHH---------hcCCCCC
Confidence 6543332 33456899999999999888999999999999999999999999764322111111 1111112
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 345 CNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 345 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
.+...+..+.+++.+||+.+|++||++.+|+++
T Consensus 230 ~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 230 IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred CccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 223445689999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=290.01 Aligned_cols=248 Identities=24% Similarity=0.397 Sum_probs=199.2
Q ss_pred hhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCcc-ChHHHHHHHHHHhcCC-CCceeeEEeEEEeCCeEEEEEEecCC
Q 014352 121 FTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQ-GEKEFQTEVSLLGRLH-HRNLVNLIGYCVDKGKYMLIYEFMSN 197 (426)
Q Consensus 121 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~ 197 (426)
+...||.|+.|.||++++. +|...|||.+...... ..+.+...+.++.+-+ .|+||+.+|||..+...++.||.|.
T Consensus 96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs- 174 (391)
T KOG0983|consen 96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS- 174 (391)
T ss_pred hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-
Confidence 3456999999999999976 6788999999766432 2345666677666554 8999999999999999999999994
Q ss_pred CChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCcccCc
Q 014352 198 GSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLK 277 (426)
Q Consensus 198 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 277 (426)
.-+..++..-.+++++..+-++...+.+||.||.++. +|+|||+||+|||+|+.|++|++|||++-........+...
T Consensus 175 ~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAhtrsA 252 (391)
T KOG0983|consen 175 TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHTRSA 252 (391)
T ss_pred HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccccccccc
Confidence 3666677666677888888899999999999999865 59999999999999999999999999998777777777788
Q ss_pred cccCccCcccccc---CCCCcchhhHHHHHHHHHHHhCCCCCCchHH-HHHHhhccccchhhhhhhhhcccCCHHHHHHH
Q 014352 278 GTYGYIDPAYIST---NKFTMKSDIFSFGVIIFELITAIHPHQNLME-YVNLASMSQDGVDEILDKQLVGACNIQEVREL 353 (426)
Q Consensus 278 gt~~y~aPE~~~~---~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 353 (426)
|-+.|||||.+.. ..|+.++||||||+.|+||.||..||.+... +..+..+.+... .. + ......+..+
T Consensus 253 GC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~eP-P~----L--~~~~gFSp~F 325 (391)
T KOG0983|consen 253 GCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEP-PL----L--PGHMGFSPDF 325 (391)
T ss_pred CCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCC-CC----C--CcccCcCHHH
Confidence 9999999999954 4789999999999999999999999987432 222222222111 11 1 1112266789
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHH
Q 014352 354 ARIGHKCLHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 354 ~~l~~~cl~~~p~~RPs~~evl~~L 378 (426)
.+++..||++|+.+||.+.+++++-
T Consensus 326 ~~fv~~CL~kd~r~RP~Y~~Ll~h~ 350 (391)
T KOG0983|consen 326 QSFVKDCLTKDHRKRPKYNKLLEHP 350 (391)
T ss_pred HHHHHHHhhcCcccCcchHHHhcCc
Confidence 9999999999999999999998764
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=297.80 Aligned_cols=247 Identities=25% Similarity=0.384 Sum_probs=199.0
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc--cChHHHHHHHHHHhcCCCCceeeEEeEEEe-CCeEEEEEEe
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH--QGEKEFQTEVSLLGRLHHRNLVNLIGYCVD-KGKYMLIYEF 194 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~ 194 (426)
|.+.+.||+|++|.||++... ++..+|+|.+..... ...+.+.+|++++++++|||++++++.+.. ...++++|||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF 81 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence 456788999999999999875 567899999865432 233568899999999999999999998764 4467999999
Q ss_pred cCCCChhHHhhhc-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC-CC
Q 014352 195 MSNGSLSNLIYSE-ERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD-GR 272 (426)
Q Consensus 195 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-~~ 272 (426)
+++++|.+++... ...+++.++..++.+++.|+.|||+.+ ++||||||+||+++.++.++|+|||++...... ..
T Consensus 82 ~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 158 (257)
T cd08223 82 CEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDM 158 (257)
T ss_pred cCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccCCc
Confidence 9999999998653 356899999999999999999999998 999999999999999999999999998754322 22
Q ss_pred cccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHH
Q 014352 273 NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRE 352 (426)
Q Consensus 273 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (426)
.....+++.|+|||++.+..++.++||||||++++++++|..||.............. ......+...+..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~ 229 (257)
T cd08223 159 ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIE---------GKLPPMPKDYSPE 229 (257)
T ss_pred cccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh---------cCCCCCccccCHH
Confidence 2345688999999999999999999999999999999999999865322111111111 1111122345568
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 353 LARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 353 l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
+.+++.+||+.||++|||+.+++++
T Consensus 230 ~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 230 LGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred HHHHHHHHhccCcccCCCHHHHhcC
Confidence 9999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=304.11 Aligned_cols=255 Identities=26% Similarity=0.314 Sum_probs=195.0
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc--cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEec
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH--QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 195 (426)
|.+.+.||+|+||.||+|... ++..||+|.+..... ...+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (285)
T cd07861 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL 81 (285)
T ss_pred ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecC
Confidence 345678999999999999975 688999999865422 22356889999999999999999999999999999999999
Q ss_pred CCCChhHHhhhcc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC-C
Q 014352 196 SNGSLSNLIYSEE--RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG-R 272 (426)
Q Consensus 196 ~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-~ 272 (426)
+ ++|.+++.... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++....... .
T Consensus 82 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 157 (285)
T cd07861 82 S-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRV 157 (285)
T ss_pred C-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCccc
Confidence 7 68888875432 56899999999999999999999998 9999999999999999999999999987432221 1
Q ss_pred cccCccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhcc----cc------chhhhh--hh
Q 014352 273 NSGLKGTYGYIDPAYIST-NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMS----QD------GVDEIL--DK 339 (426)
Q Consensus 273 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~----~~------~~~~~~--~~ 339 (426)
.....+++.|+|||.+.+ ..++.++||||||+++|+|+||+.||....+........ .. ...... ..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN 237 (285)
T ss_pred ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHh
Confidence 223456889999998865 457899999999999999999999997543322111100 00 000000 00
Q ss_pred hhcc-------cCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 340 QLVG-------ACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 340 ~~~~-------~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
.... ......+.++.+++.+||+.||++|||+.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 238 TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0000 0011134678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=302.91 Aligned_cols=251 Identities=27% Similarity=0.401 Sum_probs=201.8
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCcc---ChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEe
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQ---GEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEF 194 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 194 (426)
+...+.||+|+||.||+++.. ++..+|+|.+...... ....+..|++++++++|||++++++++.+++..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 455678999999999999865 6789999998654222 224688899999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCcc
Q 014352 195 MSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNS 274 (426)
Q Consensus 195 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 274 (426)
++ |+|.+.+......+++..+..++.+++.||.|||+.+ ++||||+|+||+++.++.++|+|||++.... ...
T Consensus 107 ~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~---~~~ 179 (317)
T cd06635 107 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIAS---PAN 179 (317)
T ss_pred CC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccC---Ccc
Confidence 96 5888887666677999999999999999999999998 9999999999999999999999999986432 233
Q ss_pred cCccccCccCccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHH
Q 014352 275 GLKGTYGYIDPAYIS---TNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVR 351 (426)
Q Consensus 275 ~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (426)
...++..|+|||++. .+.++.++||||||+++|||++|..||...........+.. ...........+.
T Consensus 180 ~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~ 251 (317)
T cd06635 180 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--------NESPTLQSNEWSD 251 (317)
T ss_pred cccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh--------ccCCCCCCccccH
Confidence 456888999999973 45688999999999999999999999865432222111111 1111111223446
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHH
Q 014352 352 ELARIGHKCLHKTPRKRPSIGEVTQALLKIKQR 384 (426)
Q Consensus 352 ~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 384 (426)
.+.+++.+||+.+|.+||++.++++++..+...
T Consensus 252 ~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 252 YFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence 789999999999999999999999987765543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=301.98 Aligned_cols=252 Identities=25% Similarity=0.427 Sum_probs=199.9
Q ss_pred HHhhhhcccccCCCeeEEEEEeC------CCcEEEEEEeccCCcc-ChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEE
Q 014352 117 ATQNFTNILGQGAFGPVYKATMP------SGGVAAIKVLASDSHQ-GEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYM 189 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 189 (426)
..+.....||.|+||.||+|+.. +...+++|.+...... ....+.+|++++++++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 34455678999999999999864 2457899988654332 2457899999999999999999999999988999
Q ss_pred EEEEecCCCChhHHhhhcc--------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeee
Q 014352 190 LIYEFMSNGSLSNLIYSEE--------RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADF 261 (426)
Q Consensus 190 lv~e~~~~gsL~~~l~~~~--------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 261 (426)
+||||+++|+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999986543 15899999999999999999999998 999999999999999999999999
Q ss_pred cCccccccCC--CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhh
Q 014352 262 GLSKEEVFDG--RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILD 338 (426)
Q Consensus 262 gl~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 338 (426)
|++....... ......++..|+|||.+.+..++.++||||||+++|++++ |..||................
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~------ 235 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGK------ 235 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCC------
Confidence 9986432211 1223456778999999988888999999999999999999 788886533322111111111
Q ss_pred hhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 014352 339 KQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALL 379 (426)
Q Consensus 339 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 379 (426)
.....+...+..+.+++.+||+.+|++|||+.+++..|.
T Consensus 236 --~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 236 --LELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred --cCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 011111233467999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=316.96 Aligned_cols=240 Identities=23% Similarity=0.310 Sum_probs=187.4
Q ss_pred cccCCCeeEEEEEeC-CCcEEEEEEeccCCcc---ChHHHHHHHHHHhcC---CCCceeeEEeEEEeCCeEEEEEEecCC
Q 014352 125 LGQGAFGPVYKATMP-SGGVAAIKVLASDSHQ---GEKEFQTEVSLLGRL---HHRNLVNLIGYCVDKGKYMLIYEFMSN 197 (426)
Q Consensus 125 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~ 197 (426)
||+|+||+||+|+.. ++..||+|++...... ....+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999875 6889999998643211 122345566776655 699999999999999999999999999
Q ss_pred CChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccccc-CCCcccC
Q 014352 198 GSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF-DGRNSGL 276 (426)
Q Consensus 198 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~-~~~~~~~ 276 (426)
|+|..++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||+++.... .......
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 156 (330)
T cd05586 81 GELFWHLQKE-GRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTF 156 (330)
T ss_pred ChHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCc
Confidence 9999988544 45899999999999999999999998 99999999999999999999999999874322 2233456
Q ss_pred ccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHH
Q 014352 277 KGTYGYIDPAYISTN-KFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELAR 355 (426)
Q Consensus 277 ~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 355 (426)
.||..|+|||++.+. .++.++|||||||++|||++|..||...........+.... . ..........+.+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~--------~-~~~~~~~~~~~~~ 227 (330)
T cd05586 157 CGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGK--------V-RFPKNVLSDEGRQ 227 (330)
T ss_pred cCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCC--------C-CCCCccCCHHHHH
Confidence 799999999998754 48899999999999999999999996533222111111110 0 0011123457889
Q ss_pred HHHHcccCCCCCCC----CHHHHHHH
Q 014352 356 IGHKCLHKTPRKRP----SIGEVTQA 377 (426)
Q Consensus 356 l~~~cl~~~p~~RP----s~~evl~~ 377 (426)
++.+||+.||.+|| ++.+++++
T Consensus 228 li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 228 FVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred HHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 99999999999998 56666653
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=322.28 Aligned_cols=255 Identities=20% Similarity=0.306 Sum_probs=190.5
Q ss_pred HHHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCCC------CceeeEEeEEEeC-Ce
Q 014352 116 KATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHH------RNLVNLIGYCVDK-GK 187 (426)
Q Consensus 116 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h------~niv~~~~~~~~~-~~ 187 (426)
..+|.+.+.||+|+||+||+|... ++..||||+++... ...+.+..|+.++.+++| ++++.+++++... ..
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~ 206 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGH 206 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCce
Confidence 345777789999999999999875 67889999986532 223455667777776654 5688999988765 57
Q ss_pred EEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCeeecCCCCCCEEecCCC------------
Q 014352 188 YMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEG-AVPPVIHRDLKSANILLDHFM------------ 254 (426)
Q Consensus 188 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~ivH~dlk~~Nill~~~~------------ 254 (426)
+++|||++ +++|.+++... ..+++..+..++.|++.||.|||++ + |+||||||+|||++.++
T Consensus 207 ~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~~~~~~ 281 (467)
T PTZ00284 207 MCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVTNRALP 281 (467)
T ss_pred EEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccccccccC
Confidence 89999988 67898888554 4689999999999999999999984 7 99999999999998765
Q ss_pred ----cEEEeeecCccccccCCCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccc
Q 014352 255 ----RAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQ 330 (426)
Q Consensus 255 ----~~kl~Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~ 330 (426)
.+||+|||.+... ........||+.|+|||++.+..++.++|||||||++|||++|+.||........+..+..
T Consensus 282 ~~~~~vkl~DfG~~~~~--~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~ 359 (467)
T PTZ00284 282 PDPCRVRICDLGGCCDE--RHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEK 359 (467)
T ss_pred CCCceEEECCCCccccC--ccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 4999999987642 2233456799999999999999999999999999999999999999976433221111000
Q ss_pred --cch-------------hhhhhhh--hc------------ccC---CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014352 331 --DGV-------------DEILDKQ--LV------------GAC---NIQEVRELARIGHKCLHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 331 --~~~-------------~~~~~~~--~~------------~~~---~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 378 (426)
... ..+++.. +. ... .......+.+|+.+||+.||++|||+.|++++-
T Consensus 360 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp 439 (467)
T PTZ00284 360 TLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHP 439 (467)
T ss_pred HcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCc
Confidence 000 0000000 00 000 001134578999999999999999999999864
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=305.62 Aligned_cols=243 Identities=24% Similarity=0.362 Sum_probs=198.4
Q ss_pred cccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCCCChh
Q 014352 123 NILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLS 201 (426)
Q Consensus 123 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 201 (426)
..||.|+||.||++... ++..+|+|.+........+.+.+|+.++..++||||+++++++..++..++++||+++++|.
T Consensus 27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~ 106 (297)
T cd06659 27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT 106 (297)
T ss_pred hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHH
Confidence 36999999999999875 68899999987654445567889999999999999999999999999999999999999999
Q ss_pred HHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC-CcccCcccc
Q 014352 202 NLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG-RNSGLKGTY 280 (426)
Q Consensus 202 ~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-~~~~~~gt~ 280 (426)
.++.. ..+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++....... ......++.
T Consensus 107 ~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~ 181 (297)
T cd06659 107 DIVSQ--TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTP 181 (297)
T ss_pred HHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccccccceecCc
Confidence 97743 45899999999999999999999998 9999999999999999999999999986432221 223456889
Q ss_pred CccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHHHHHc
Q 014352 281 GYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKC 360 (426)
Q Consensus 281 ~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c 360 (426)
.|+|||++.+..++.++||||||+++|||++|..||........+..+....... ..........+.+++.+|
T Consensus 182 ~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~l~~~i~~~ 254 (297)
T cd06659 182 YWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPK-------LKNAHKISPVLRDFLERM 254 (297)
T ss_pred cccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCC-------ccccCCCCHHHHHHHHHH
Confidence 9999999998899999999999999999999999986543332222111110000 000112335688999999
Q ss_pred ccCCCCCCCCHHHHHHH
Q 014352 361 LHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 361 l~~~p~~RPs~~evl~~ 377 (426)
|+.+|++||++.+++++
T Consensus 255 l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 255 LTREPQERATAQELLDH 271 (297)
T ss_pred hcCCcccCcCHHHHhhC
Confidence 99999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=304.89 Aligned_cols=245 Identities=27% Similarity=0.378 Sum_probs=198.1
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCcc---ChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEe
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQ---GEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEF 194 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 194 (426)
|.+.+.||+|+||.||+|... +++.||+|.+...... ....+.+|+.+++.++||||+++++++.+.+..++|+||
T Consensus 17 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 96 (307)
T cd06607 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEY 96 (307)
T ss_pred hhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHh
Confidence 556678999999999999875 6889999988644322 224688999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCcc
Q 014352 195 MSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNS 274 (426)
Q Consensus 195 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 274 (426)
++ |+|.+++......+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.... ...
T Consensus 97 ~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~---~~~ 169 (307)
T cd06607 97 CL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVS---PAN 169 (307)
T ss_pred hC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecC---CCC
Confidence 96 5888877655567999999999999999999999998 9999999999999999999999999987432 223
Q ss_pred cCccccCccCccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHH
Q 014352 275 GLKGTYGYIDPAYIS---TNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVR 351 (426)
Q Consensus 275 ~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (426)
...++..|+|||.+. ...++.++||||||+++|||++|..||................ .........+.
T Consensus 170 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~ 241 (307)
T cd06607 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND--------SPTLSSNDWSD 241 (307)
T ss_pred CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCC--------CCCCCchhhCH
Confidence 456788999999874 4568899999999999999999999987643322211111110 01111223456
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014352 352 ELARIGHKCLHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 352 ~l~~l~~~cl~~~p~~RPs~~evl~~L 378 (426)
.+.+++.+||+.+|++||++.+++.+.
T Consensus 242 ~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 242 YFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred HHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 799999999999999999999999764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=297.03 Aligned_cols=260 Identities=20% Similarity=0.340 Sum_probs=211.2
Q ss_pred hHHHHHHhhhhcccccCCCeeEEEEEeC------CCcEEEEEEeccCCc-cChHHHHHHHHHHhcCCCCceeeEEeEEEe
Q 014352 112 KDIQKATQNFTNILGQGAFGPVYKATMP------SGGVAAIKVLASDSH-QGEKEFQTEVSLLGRLHHRNLVNLIGYCVD 184 (426)
Q Consensus 112 ~~l~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 184 (426)
-.+.+.+..+..++-+|.||.||+|.+. +.+.|.+|.++.... -....+..|.-++..+.|||+.++.+++.+
T Consensus 279 l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie 358 (563)
T KOG1024|consen 279 LTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE 358 (563)
T ss_pred hhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence 3455666777788999999999999654 334566777765432 223467888889999999999999999877
Q ss_pred C-CeEEEEEEecCCCChhHHhhh-------ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcE
Q 014352 185 K-GKYMLIYEFMSNGSLSNLIYS-------EERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRA 256 (426)
Q Consensus 185 ~-~~~~lv~e~~~~gsL~~~l~~-------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 256 (426)
. ...+++|.++.-|+|..+|.. ..+.++-.+...++.|++.||+|||+++ +||.||..+|+++|+...+
T Consensus 359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqV 435 (563)
T KOG1024|consen 359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQV 435 (563)
T ss_pred ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeE
Confidence 5 567889999999999999962 1245777888999999999999999999 9999999999999999999
Q ss_pred EEeeecCccccccCC---CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccc
Q 014352 257 KVADFGLSKEEVFDG---RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDG 332 (426)
Q Consensus 257 kl~Dfgl~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~ 332 (426)
||+|=.+++...... ..........||+||.+.+..|+.++|||||||+||||+| |+.||....++..
T Consensus 436 kltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm-------- 507 (563)
T KOG1024|consen 436 KLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM-------- 507 (563)
T ss_pred EeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH--------
Confidence 999999998643221 1123345678999999999999999999999999999998 9999976554432
Q ss_pred hhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 014352 333 VDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQ 383 (426)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 383 (426)
...+...++..++.+++++++.+|..||+..|++||++++++.-|.+...
T Consensus 508 -~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ 557 (563)
T KOG1024|consen 508 -EHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHT 557 (563)
T ss_pred -HHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence 23344455667788888999999999999999999999999999887654
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=306.60 Aligned_cols=243 Identities=26% Similarity=0.390 Sum_probs=197.4
Q ss_pred cccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCCCChh
Q 014352 123 NILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLS 201 (426)
Q Consensus 123 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 201 (426)
..||.|+||.||++... ++..+|+|.+........+.+.+|+.++++++||||+++++.+...+..++||||+++++|.
T Consensus 28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (292)
T cd06658 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT 107 (292)
T ss_pred hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHH
Confidence 46999999999999875 67899999987654444567889999999999999999999999999999999999999999
Q ss_pred HHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC-CCcccCcccc
Q 014352 202 NLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD-GRNSGLKGTY 280 (426)
Q Consensus 202 ~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-~~~~~~~gt~ 280 (426)
+++.. ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++...... .......++.
T Consensus 108 ~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~ 182 (292)
T cd06658 108 DIVTH--TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTP 182 (292)
T ss_pred HHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCceeecCc
Confidence 98843 35899999999999999999999998 999999999999999999999999998643221 1223356889
Q ss_pred CccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHHHHHc
Q 014352 281 GYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKC 360 (426)
Q Consensus 281 ~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c 360 (426)
.|+|||.+.+..++.++||||||+++||+++|..||...........+.. .+..... ........+.+++.+|
T Consensus 183 ~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~--~~~~~~~~~~~li~~~ 255 (292)
T cd06658 183 YWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRD-----NLPPRVK--DSHKVSSVLRGFLDLM 255 (292)
T ss_pred cccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-----cCCCccc--cccccCHHHHHHHHHH
Confidence 99999999988999999999999999999999999875433222111100 0011110 0112345688999999
Q ss_pred ccCCCCCCCCHHHHHHH
Q 014352 361 LHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 361 l~~~p~~RPs~~evl~~ 377 (426)
|..||.+|||+.+++++
T Consensus 256 l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 256 LVREPSQRATAQELLQH 272 (292)
T ss_pred ccCChhHCcCHHHHhhC
Confidence 99999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=306.38 Aligned_cols=246 Identities=26% Similarity=0.381 Sum_probs=211.2
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccC--hHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEec
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQG--EKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 195 (426)
|++.+.||+|.|..|-++++- +|..||||++.+..... ...+.+|++.|+-++|||||++|.+......+|||+|.=
T Consensus 20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELG 99 (864)
T KOG4717|consen 20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELG 99 (864)
T ss_pred ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEec
Confidence 445568999999999999854 89999999998764332 346889999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEec-CCCcEEEeeecCccccccCCCcc
Q 014352 196 SNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLD-HFMRAKVADFGLSKEEVFDGRNS 274 (426)
Q Consensus 196 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfgl~~~~~~~~~~~ 274 (426)
.+|+|+++|.+....+++....+++.||..|+.|+|+.. +|||||||+||.+- .-|-+||+|||++..........
T Consensus 100 D~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~ 176 (864)
T KOG4717|consen 100 DGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLT 176 (864)
T ss_pred CCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCcchhh
Confidence 999999999888878999999999999999999999998 99999999999875 56889999999998877777888
Q ss_pred cCccccCccCccccccCCCC-cchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHH
Q 014352 275 GLKGTYGYIDPAYISTNKFT-MKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVREL 353 (426)
Q Consensus 275 ~~~gt~~y~aPE~~~~~~~~-~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 353 (426)
..+|+..|-|||++.+..|+ ++.|||||||+||-|++|++||+....-..+.. ++|-.+ ..+...+.+.
T Consensus 177 TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTm--------ImDCKY--tvPshvS~eC 246 (864)
T KOG4717|consen 177 TSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTM--------IMDCKY--TVPSHVSKEC 246 (864)
T ss_pred cccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhh--------hhcccc--cCchhhhHHH
Confidence 99999999999999999997 578999999999999999999986544333322 222222 2234456789
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHH
Q 014352 354 ARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 354 ~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
.+||..||..||.+|.|.+||...
T Consensus 247 rdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 247 RDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred HHHHHHHHhcCchhhccHHHHhcc
Confidence 999999999999999999998754
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=298.85 Aligned_cols=246 Identities=26% Similarity=0.382 Sum_probs=192.5
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc-----cChHHHHHHHHHHhcCCCCceeeEEeEEEe--CCeEEE
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH-----QGEKEFQTEVSLLGRLHHRNLVNLIGYCVD--KGKYML 190 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~l 190 (426)
|...+.||+|+||.||++... ++..+++|.+..... .....+.+|+.++++++||||+++++++.+ ....++
T Consensus 4 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 83 (266)
T cd06651 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTI 83 (266)
T ss_pred ccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEE
Confidence 345678999999999999864 688999998864321 122458889999999999999999998875 357899
Q ss_pred EEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC
Q 014352 191 IYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD 270 (426)
Q Consensus 191 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 270 (426)
++||+++++|.+++... ..+++...+.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||+++.....
T Consensus 84 ~~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd06651 84 FMEYMPGGSVKDQLKAY-GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 159 (266)
T ss_pred EEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccccccc
Confidence 99999999999998654 35899999999999999999999988 999999999999999999999999998743221
Q ss_pred ----CCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCC
Q 014352 271 ----GRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACN 346 (426)
Q Consensus 271 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (426)
.......++..|+|||++.+..++.++||||||+++|||++|..||................ .....+
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~--------~~~~~~ 231 (266)
T cd06651 160 CMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQP--------TNPQLP 231 (266)
T ss_pred cccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCC--------CCCCCc
Confidence 11123458889999999999899999999999999999999999997643322211111000 001111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 347 IQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 347 ~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
......+..++ +||..+|++||++.+++++
T Consensus 232 ~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 232 SHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred hhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 22334566666 6888999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=301.67 Aligned_cols=252 Identities=27% Similarity=0.396 Sum_probs=201.1
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc-cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecC
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH-QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMS 196 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 196 (426)
+++.+.||.|+||.||++... +++.+++|.+..... ...+.+.+|++++++++||||+++++++...+..++++||++
T Consensus 3 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (265)
T cd06605 3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMD 82 (265)
T ss_pred chHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecC
Confidence 345678999999999999976 688899999876532 334578899999999999999999999999999999999999
Q ss_pred CCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCccc
Q 014352 197 NGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHE-GAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSG 275 (426)
Q Consensus 197 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 275 (426)
+++|.+++......++......++.|++.||.|||+ .+ ++|+||||+||+++.++.++|+|||.+........ ..
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~ 158 (265)
T cd06605 83 GGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-KT 158 (265)
T ss_pred CCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-hc
Confidence 999999997655678999999999999999999999 88 99999999999999999999999999875432221 22
Q ss_pred CccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHH
Q 014352 276 LKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELAR 355 (426)
Q Consensus 276 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 355 (426)
..++..|+|||++.+..++.++||||||+++|+|++|..||........ ......................+..+.+
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (265)
T cd06605 159 FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD---GIFELLQYIVNEPPPRLPSGKFSPDFQD 235 (265)
T ss_pred ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc---cHHHHHHHHhcCCCCCCChhhcCHHHHH
Confidence 6688899999999999999999999999999999999999865311000 0000000111111001111114567999
Q ss_pred HHHHcccCCCCCCCCHHHHHHH
Q 014352 356 IGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 356 l~~~cl~~~p~~RPs~~evl~~ 377 (426)
++.+||..||++|||+.+++.+
T Consensus 236 li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 236 FVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred HHHHHcCCCchhCcCHHHHhhC
Confidence 9999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=299.08 Aligned_cols=246 Identities=26% Similarity=0.418 Sum_probs=200.4
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc-cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEec
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH-QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 195 (426)
.+.+.+.||.|+||.||+|... ++..+|+|.+..... .....+.+|+.++.+++||||+++++++..++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 3456678999999999999865 678999998764432 22356889999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC-Ccc
Q 014352 196 SNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG-RNS 274 (426)
Q Consensus 196 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-~~~ 274 (426)
++++|.+++.. ..+++.....++.+++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 85 ~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06641 85 GGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred CCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchhhhc
Confidence 99999998843 45899999999999999999999988 9999999999999999999999999986543221 123
Q ss_pred cCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHH
Q 014352 275 GLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELA 354 (426)
Q Consensus 275 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 354 (426)
...++..|+|||.+.+..++.++|+||||+++|++++|..||...........+... .........+..+.
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~ 230 (277)
T cd06641 160 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN---------NPPTLEGNYSKPLK 230 (277)
T ss_pred cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC---------CCCCCCcccCHHHH
Confidence 346788999999998888999999999999999999999999754332221111111 01111223346788
Q ss_pred HHHHHcccCCCCCCCCHHHHHHH
Q 014352 355 RIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 355 ~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
+++.+||+.+|.+||++.+++++
T Consensus 231 ~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 231 EFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred HHHHHHccCChhhCcCHHHHHhC
Confidence 99999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=302.44 Aligned_cols=250 Identities=24% Similarity=0.377 Sum_probs=198.6
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc-cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecC
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH-QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMS 196 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 196 (426)
+++.+.||+|+||.||++... ++..+|+|.+..... .....+.+|+.++++++||||+++++++...+..++||||++
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (286)
T cd06622 3 IEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMD 82 (286)
T ss_pred hhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecC
Confidence 567788999999999999976 788999998865422 223578899999999999999999999999999999999999
Q ss_pred CCChhHHhhhc--cCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCc
Q 014352 197 NGSLSNLIYSE--ERVLNWEERLQIALDISHGIEYLHEG-AVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRN 273 (426)
Q Consensus 197 ~gsL~~~l~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 273 (426)
+++|..++... ...+++..+..++.+++.||.|||++ + ++|+||||+||+++.++.++|+|||++..... ...
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-~~~ 158 (286)
T cd06622 83 AGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA-SLA 158 (286)
T ss_pred CCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccC-Ccc
Confidence 99999988653 23689999999999999999999974 6 99999999999999999999999999875422 223
Q ss_pred ccCccccCccCccccccC------CCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCH
Q 014352 274 SGLKGTYGYIDPAYISTN------KFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNI 347 (426)
Q Consensus 274 ~~~~gt~~y~aPE~~~~~------~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (426)
....++..|+|||.+.+. .++.++|+|||||++|+|++|..||........... .....+. .....+.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~-----~~~~~~~-~~~~~~~ 232 (286)
T cd06622 159 KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQ-----LSAIVDG-DPPTLPS 232 (286)
T ss_pred ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHH-----HHHHhhc-CCCCCCc
Confidence 344678899999998554 357899999999999999999999964321111000 0011111 1112223
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014352 348 QEVRELARIGHKCLHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 348 ~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 378 (426)
.....+.+++.+||+.+|++||++.+++.+-
T Consensus 233 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~ 263 (286)
T cd06622 233 GYSDDAQDFVAKCLNKIPNRRPTYAQLLEHP 263 (286)
T ss_pred ccCHHHHHHHHHHcccCcccCCCHHHHhcCh
Confidence 3557789999999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=299.35 Aligned_cols=251 Identities=26% Similarity=0.348 Sum_probs=198.0
Q ss_pred hcccccCCCeeEEEEEeC-CCcEEEEEEeccC--CccChHHHHHHHHHHhcCCCCceeeEEeEEEe-----CCeEEEEEE
Q 014352 122 TNILGQGAFGPVYKATMP-SGGVAAIKVLASD--SHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVD-----KGKYMLIYE 193 (426)
Q Consensus 122 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-----~~~~~lv~e 193 (426)
.+.||+|+||.|..+... +|..||||.+... .....+.-.+|+++|+.++|+||+.+++++.. -+..|+|+|
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e 106 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE 106 (359)
T ss_pred cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence 357999999999999875 7889999998743 33344667899999999999999999998865 357899999
Q ss_pred ecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccccc---C
Q 014352 194 FMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF---D 270 (426)
Q Consensus 194 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~---~ 270 (426)
+| +.+|...++.+ +.|+......+..|++.||.|+|+.+ ++||||||+|+|++.+...||+|||+|+.... .
T Consensus 107 lM-etDL~~iik~~-~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~ 181 (359)
T KOG0660|consen 107 LM-ETDLHQIIKSQ-QDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFED 181 (359)
T ss_pred HH-hhHHHHHHHcC-ccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceeeccccCcc
Confidence 99 55999988544 44899999999999999999999999 99999999999999999999999999996643 3
Q ss_pred CCcccCccccCccCcccc-ccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhc---------------cccchh
Q 014352 271 GRNSGLKGTYGYIDPAYI-STNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASM---------------SQDGVD 334 (426)
Q Consensus 271 ~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~---------------~~~~~~ 334 (426)
...+....|..|.|||.+ ....|+...||||.||++.||++|++-|.+......+..+ ......
T Consensus 182 ~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar 261 (359)
T KOG0660|consen 182 GFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKAR 261 (359)
T ss_pred cchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHH
Confidence 445667889999999987 4568999999999999999999999998764332222111 101111
Q ss_pred hhhhhhhccc--CC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014352 335 EILDKQLVGA--CN-----IQEVRELARIGHKCLHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 335 ~~~~~~~~~~--~~-----~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 378 (426)
..+. .+... .+ +.......+|+.+||..||.+|+|++|.+++-
T Consensus 262 ~yi~-slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hP 311 (359)
T KOG0660|consen 262 PYIK-SLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHP 311 (359)
T ss_pred HHHH-hCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcCh
Confidence 1111 00000 01 12335688999999999999999999999874
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=305.10 Aligned_cols=255 Identities=24% Similarity=0.272 Sum_probs=194.6
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc--cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEec
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH--QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 195 (426)
|.+.+.||+|+||.||+|+.. +|..+|+|.+..... .....+.+|+.++++++||||+++++++.+.+..++|+||+
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC 81 (284)
T ss_pred ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence 455678999999999999975 688999999865422 22346788999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC-CCcc
Q 014352 196 SNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD-GRNS 274 (426)
Q Consensus 196 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-~~~~ 274 (426)
+ ++|.+++......+++..+..++.|+++||.|||+++ ++||||||+||+++.++.++|+|||+++..... ....
T Consensus 82 ~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (284)
T cd07839 82 D-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYS 157 (284)
T ss_pred C-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcC
Confidence 6 5888888665667999999999999999999999998 999999999999999999999999998753322 1223
Q ss_pred cCccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCchHH-HHHHhhc----cccc------hhhhhhhhhc
Q 014352 275 GLKGTYGYIDPAYISTN-KFTMKSDIFSFGVIIFELITAIHPHQNLME-YVNLASM----SQDG------VDEILDKQLV 342 (426)
Q Consensus 275 ~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~----~~~~------~~~~~~~~~~ 342 (426)
...++..|+|||++.+. .++.++||||||+++|||++|..|+..... ...+..+ .... .....+....
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07839 158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPY 237 (284)
T ss_pred CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccccc
Confidence 34578899999998664 478999999999999999999988533211 1111000 0000 0000000000
Q ss_pred ---------ccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 343 ---------GACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 343 ---------~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
.......+..+.+++.+||+.||.+|||+.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 238 PMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred CCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 00011234678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=297.68 Aligned_cols=251 Identities=27% Similarity=0.402 Sum_probs=201.6
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC-ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecC
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS-HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMS 196 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 196 (426)
|++.+.||.|+||+||+|... ++..+++|++.... ......+.+|++.++.++|+||+++++.+...+..++++||++
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~ 82 (267)
T cd06610 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLS 82 (267)
T ss_pred ceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccC
Confidence 556788999999999999865 67789999986543 2244678999999999999999999999999999999999999
Q ss_pred CCChhHHhhhcc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCC--
Q 014352 197 NGSLSNLIYSEE--RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGR-- 272 (426)
Q Consensus 197 ~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~-- 272 (426)
+++|.+++.... ..+++.....++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 159 (267)
T cd06610 83 GGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT 159 (267)
T ss_pred CCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc
Confidence 999999996532 46899999999999999999999998 99999999999999999999999999865433221
Q ss_pred ---cccCccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccC-CH
Q 014352 273 ---NSGLKGTYGYIDPAYISTN-KFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGAC-NI 347 (426)
Q Consensus 273 ---~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 347 (426)
.....|+..|+|||++... .++.++|+||||+++|||++|..||................. +.+.... ..
T Consensus 160 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~ 234 (267)
T cd06610 160 RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDP-----PSLETGADYK 234 (267)
T ss_pred ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCC-----CCcCCccccc
Confidence 1334688999999998776 789999999999999999999999976433222211111100 0111000 12
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 348 QEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 348 ~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
..+..+.+++.+||+.||++|||+.+++++
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 235 KYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred cccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 345678999999999999999999999864
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=306.73 Aligned_cols=190 Identities=28% Similarity=0.375 Sum_probs=157.1
Q ss_pred cccccCCCeeEEEEEeC---CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEe--CCeEEEEEEecCC
Q 014352 123 NILGQGAFGPVYKATMP---SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVD--KGKYMLIYEFMSN 197 (426)
Q Consensus 123 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~ 197 (426)
..||+|+||.||+|+.. ++..+|+|.+.... ....+.+|+.++++++||||+++++++.. ....++|+||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 57999999999999864 34679999886542 23467889999999999999999998854 4578999999965
Q ss_pred CChhHHhhhc--------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEe----cCCCcEEEeeecCcc
Q 014352 198 GSLSNLIYSE--------ERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILL----DHFMRAKVADFGLSK 265 (426)
Q Consensus 198 gsL~~~l~~~--------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfgl~~ 265 (426)
+|.+++... ...+++..+..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 787776421 135888999999999999999999998 9999999999999 566789999999997
Q ss_pred ccccCC----CcccCccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 014352 266 EEVFDG----RNSGLKGTYGYIDPAYIST-NKFTMKSDIFSFGVIIFELITAIHPHQN 318 (426)
Q Consensus 266 ~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~ 318 (426)
...... ......+|..|+|||++.+ ..++.++|||||||++|||+||..||..
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 543221 1234568999999999876 4588999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=294.04 Aligned_cols=248 Identities=30% Similarity=0.495 Sum_probs=204.4
Q ss_pred hhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCCC
Q 014352 120 NFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNG 198 (426)
Q Consensus 120 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 198 (426)
...+.||+|++|.||++... ++..+++|++..........+.+|++++++++|||++++++++...+..++++||++++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~ 82 (253)
T cd05122 3 EILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGG 82 (253)
T ss_pred eeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCC
Confidence 44578999999999999986 67889999987765445578999999999999999999999999999999999999999
Q ss_pred ChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCcccCcc
Q 014352 199 SLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKG 278 (426)
Q Consensus 199 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~g 278 (426)
+|.+++......+++..+..++.+++.||.|||+.+ ++||||+|+||+++.++.++|+|||.+.............+
T Consensus 83 ~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 159 (253)
T cd05122 83 SLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVG 159 (253)
T ss_pred cHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeeccccccccccccccceec
Confidence 999998766567999999999999999999999988 99999999999999999999999999875543322345678
Q ss_pred ccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHHHH
Q 014352 279 TYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGH 358 (426)
Q Consensus 279 t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 358 (426)
+..|+|||.+.+..++.++||||||+++|+|++|..||..................... ........+.+++.
T Consensus 160 ~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~i~ 232 (253)
T cd05122 160 TPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLR-------NPEKWSDEFKDFLK 232 (253)
T ss_pred CCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcC-------cccccCHHHHHHHH
Confidence 89999999998888999999999999999999999999764322221111111111100 01112467999999
Q ss_pred HcccCCCCCCCCHHHHHHH
Q 014352 359 KCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 359 ~cl~~~p~~RPs~~evl~~ 377 (426)
+||+.||++|||+.+++++
T Consensus 233 ~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 233 KCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred HHccCChhhCCCHHHHhcC
Confidence 9999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=305.05 Aligned_cols=255 Identities=24% Similarity=0.312 Sum_probs=197.7
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCcc-----ChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEE
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQ-----GEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIY 192 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 192 (426)
|++.+.||+|+||.||+|... +++.||+|.+...... ....+..|++++++++|+||+++++++.+.+..++||
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF 81 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence 445678999999999999975 6889999999765432 2345678999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC-
Q 014352 193 EFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG- 271 (426)
Q Consensus 193 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~- 271 (426)
||+ +|+|.+++......+++..+..++.|+++||.|||+++ ++|+||||+||+++.++.++|+|||+++......
T Consensus 82 e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 82 EFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR 157 (298)
T ss_pred ccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence 999 88999999665546999999999999999999999998 9999999999999999999999999987543321
Q ss_pred CcccCccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccc----cc---------hhhhh
Q 014352 272 RNSGLKGTYGYIDPAYIST-NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQ----DG---------VDEIL 337 (426)
Q Consensus 272 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~----~~---------~~~~~ 337 (426)
......++..|+|||.+.+ ..++.++||||||+++|||++|.+||........+..... .. .....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence 2233456788999998854 4678999999999999999999888765332221111100 00 00000
Q ss_pred hhhhcccC-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 338 DKQLVGAC-----NIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 338 ~~~~~~~~-----~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
........ ....+..+.+++.+||+.+|++|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000001 11234678999999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=296.68 Aligned_cols=247 Identities=21% Similarity=0.343 Sum_probs=200.2
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC--ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEec
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS--HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 195 (426)
|.+.+.||+|+||.||++... +++.+|+|.+.... .....++.+|+.++++++||||+++++++.+.+..++|+||+
T Consensus 2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08218 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYC 81 (256)
T ss_pred ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecC
Confidence 456678999999999999865 67889999986532 223357889999999999999999999999999999999999
Q ss_pred CCCChhHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC-Cc
Q 014352 196 SNGSLSNLIYSEE-RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG-RN 273 (426)
Q Consensus 196 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-~~ 273 (426)
++++|.+++.... ..+++...+.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 158 (256)
T cd08218 82 EGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELA 158 (256)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhh
Confidence 9999999886543 35789999999999999999999998 9999999999999999999999999987543221 12
Q ss_pred ccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHH
Q 014352 274 SGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVREL 353 (426)
Q Consensus 274 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 353 (426)
....|++.|+|||++.+..++.++|+||||++++++++|..||.............. .. ....+......+
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--------~~-~~~~~~~~~~~~ 229 (256)
T cd08218 159 RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR--------GS-YPPVSSHYSYDL 229 (256)
T ss_pred hhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhc--------CC-CCCCcccCCHHH
Confidence 234578899999999988999999999999999999999999865322211111111 11 011122345679
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHH
Q 014352 354 ARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 354 ~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
.+++.+||+.+|++||++.+++++
T Consensus 230 ~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 230 RNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred HHHHHHHhhCChhhCcCHHHHhhC
Confidence 999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=317.22 Aligned_cols=259 Identities=26% Similarity=0.349 Sum_probs=203.6
Q ss_pred HHHHHHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCC-C-----CceeeEEeEEEeC
Q 014352 113 DIQKATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLH-H-----RNLVNLIGYCVDK 185 (426)
Q Consensus 113 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~~~~~~~~~ 185 (426)
|....+|.+.+.||+|+||.|.+|... +++.||||++++... -..+-..|+.+|..|+ | -|+|+++++|...
T Consensus 182 d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr 260 (586)
T KOG0667|consen 182 DHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR 260 (586)
T ss_pred ceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc
Confidence 333346777899999999999999865 789999999987542 3456678999999997 4 4999999999999
Q ss_pred CeEEEEEEecCCCChhHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecC--CCcEEEeeec
Q 014352 186 GKYMLIYEFMSNGSLSNLIYSEE-RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDH--FMRAKVADFG 262 (426)
Q Consensus 186 ~~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~--~~~~kl~Dfg 262 (426)
+++|||+|.+. .+|.++|+.+. ..++...+..++.||+.||.+||+.+ |||+||||+||||.+ ...+||+|||
T Consensus 261 ~HlciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFG 336 (586)
T KOG0667|consen 261 NHLCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFG 336 (586)
T ss_pred cceeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecc
Confidence 99999999995 59999997655 66999999999999999999999998 999999999999976 3469999999
Q ss_pred CccccccCCCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccc------------
Q 014352 263 LSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQ------------ 330 (426)
Q Consensus 263 l~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~------------ 330 (426)
.|...... .-...-+..|+|||++.+.+|+.+.||||||||+.||++|.+.|.+..+...+..+..
T Consensus 337 SSc~~~q~--vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~ 414 (586)
T KOG0667|consen 337 SSCFESQR--VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDT 414 (586)
T ss_pred cccccCCc--ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 99754322 2255667899999999999999999999999999999999988887555444332211
Q ss_pred -cchhhhhhh---------------------------------hhc-cc------CCHHHHHHHHHHHHHcccCCCCCCC
Q 014352 331 -DGVDEILDK---------------------------------QLV-GA------CNIQEVRELARIGHKCLHKTPRKRP 369 (426)
Q Consensus 331 -~~~~~~~~~---------------------------------~~~-~~------~~~~~~~~l~~l~~~cl~~~p~~RP 369 (426)
......++. ..+ .. .....-..+.+++++||..||.+|+
T Consensus 415 ~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~ 494 (586)
T KOG0667|consen 415 AKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERI 494 (586)
T ss_pred ccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcC
Confidence 000000000 000 00 0012235689999999999999999
Q ss_pred CHHHHHHHH
Q 014352 370 SIGEVTQAL 378 (426)
Q Consensus 370 s~~evl~~L 378 (426)
|..+++++-
T Consensus 495 tp~qal~Hp 503 (586)
T KOG0667|consen 495 TPAQALNHP 503 (586)
T ss_pred CHHHHhcCc
Confidence 999999874
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=301.77 Aligned_cols=256 Identities=23% Similarity=0.303 Sum_probs=197.4
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCcc--ChHHHHHHHHHHhcCCCCceeeEEeEEEeC--CeEEEEE
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQ--GEKEFQTEVSLLGRLHHRNLVNLIGYCVDK--GKYMLIY 192 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~ 192 (426)
.|.+.+.||.|+||.||+|... ++..+++|.++..... ....+.+|+.++++++||||+++++++... +..++|+
T Consensus 6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~ 85 (293)
T cd07843 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVM 85 (293)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEe
Confidence 3556678999999999999986 6788999998754322 223567899999999999999999999887 8899999
Q ss_pred EecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC-C
Q 014352 193 EFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD-G 271 (426)
Q Consensus 193 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-~ 271 (426)
||++ ++|.+++......+++.....++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++...... .
T Consensus 86 e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 161 (293)
T cd07843 86 EYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK 161 (293)
T ss_pred hhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence 9997 4999988765567999999999999999999999998 999999999999999999999999998754432 2
Q ss_pred CcccCccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccc--------------------
Q 014352 272 RNSGLKGTYGYIDPAYISTN-KFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQ-------------------- 330 (426)
Q Consensus 272 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~-------------------- 330 (426)
......++..|+|||.+.+. .++.++|+||||+++|||++|..||...........+..
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (293)
T cd07843 162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAK 241 (293)
T ss_pred ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhc
Confidence 23345578899999998654 468999999999999999999999975432211111000
Q ss_pred -cchhhhhhhhhcccCCHH-HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 331 -DGVDEILDKQLVGACNIQ-EVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 331 -~~~~~~~~~~~~~~~~~~-~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
..........+....+.. ....+.+++.+||+.+|++|||+.|++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 242 KKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred ccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000000000000111111 35678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=297.03 Aligned_cols=246 Identities=26% Similarity=0.378 Sum_probs=194.8
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc-----cChHHHHHHHHHHhcCCCCceeeEEeEEEeC--CeEEE
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH-----QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDK--GKYML 190 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l 190 (426)
+.+.+.||+|+||.||+|... ++..||+|.+..... ...+.+.+|+.++++++||||+++++++.+. ..+++
T Consensus 4 ~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (265)
T cd06652 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSI 83 (265)
T ss_pred ceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEE
Confidence 445678999999999999875 678999998854321 1124678899999999999999999988764 46789
Q ss_pred EEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC
Q 014352 191 IYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD 270 (426)
Q Consensus 191 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 270 (426)
+|||+++++|.+++... ..+++...+.++.+++.||.|||+++ ++|+||||+||+++.++.++|+|||+++.....
T Consensus 84 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~ 159 (265)
T cd06652 84 FMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTI 159 (265)
T ss_pred EEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccccccc
Confidence 99999999999998644 45788899999999999999999998 999999999999999999999999998743211
Q ss_pred ----CCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCC
Q 014352 271 ----GRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACN 346 (426)
Q Consensus 271 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (426)
.......++..|+|||.+.+..++.++||||||+++|||++|..||............... ......+
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~ 231 (265)
T cd06652 160 CLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQ--------PTNPVLP 231 (265)
T ss_pred cccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcC--------CCCCCCc
Confidence 1123356888999999998888999999999999999999999999754322221111100 0011123
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 347 IQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 347 ~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
......+.+++.+||. +|++||++.+++++
T Consensus 232 ~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 232 PHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred hhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 3445678889999995 89999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=301.88 Aligned_cols=255 Identities=25% Similarity=0.298 Sum_probs=200.1
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc--cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEec
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH--QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 195 (426)
|.+.+.||.|+||.||+|... ++..+|+|.+..... .....+.+|+.++++++||||+++++++...+..++|+||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (286)
T cd07832 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM 81 (286)
T ss_pred ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence 456778999999999999975 788999999876542 23457899999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC--Cc
Q 014352 196 SNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG--RN 273 (426)
Q Consensus 196 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~--~~ 273 (426)
+++|.+++......+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....... ..
T Consensus 82 -~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (286)
T cd07832 82 -PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLY 157 (286)
T ss_pred -CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcc
Confidence 99999999766677999999999999999999999998 9999999999999999999999999987543322 13
Q ss_pred ccCccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhcc----ccch---h---hhhh--h-
Q 014352 274 SGLKGTYGYIDPAYISTN-KFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMS----QDGV---D---EILD--K- 339 (426)
Q Consensus 274 ~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~----~~~~---~---~~~~--~- 339 (426)
....++..|+|||.+.+. .++.++||||||+++|||++|.+||........+.... .... . +..+ .
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI 237 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence 345688999999998654 46899999999999999999988886533221111100 0000 0 0000 0
Q ss_pred hhcc-------cCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 340 QLVG-------ACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 340 ~~~~-------~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
.... ....+....+.+++.+||+.+|++|||+++++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000 0001234788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=300.36 Aligned_cols=249 Identities=27% Similarity=0.451 Sum_probs=195.9
Q ss_pred HHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcC-CCCceeeEEeEEEe------CCeE
Q 014352 117 ATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRL-HHRNLVNLIGYCVD------KGKY 188 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~------~~~~ 188 (426)
..+.+.+.||.|+||.||+|... +++.+|+|.+.... .....+..|+.++.++ +||||+++++++.. .+..
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 94 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQL 94 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEE
Confidence 34566678999999999999974 67889999886543 2345688899999998 69999999999853 4578
Q ss_pred EEEEEecCCCChhHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccc
Q 014352 189 MLIYEFMSNGSLSNLIYSEE-RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEE 267 (426)
Q Consensus 189 ~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 267 (426)
+++|||+++|+|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++...
T Consensus 95 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~dfg~~~~~ 171 (282)
T cd06636 95 WLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQL 171 (282)
T ss_pred EEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCcchhhh
Confidence 99999999999999986533 45888888999999999999999998 999999999999999999999999998743
Q ss_pred ccC-CCcccCccccCccCccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhh
Q 014352 268 VFD-GRNSGLKGTYGYIDPAYIS-----TNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQL 341 (426)
Q Consensus 268 ~~~-~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (426)
... .......|+..|+|||.+. ...++.++||||||+++|||++|..||.............. ...
T Consensus 172 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~--------~~~ 243 (282)
T cd06636 172 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPR--------NPP 243 (282)
T ss_pred hccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhh--------CCC
Confidence 221 2233456889999999885 35678899999999999999999999965433222111100 001
Q ss_pred cccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 342 VGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 342 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
........+..+.+++.+||+.||.+|||+.+++++
T Consensus 244 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 244 PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 111112244679999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=301.81 Aligned_cols=247 Identities=26% Similarity=0.396 Sum_probs=191.8
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc-cChHHHHHHHHH-HhcCCCCceeeEEeEEEeCCeEEEEEEec
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH-QGEKEFQTEVSL-LGRLHHRNLVNLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 195 (426)
+.+.+.||+|+||.||++... ++..||+|.+..... .....+..|+.. ++.++||||+++++++...+..+++|||+
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~ 82 (283)
T cd06617 3 LEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVM 82 (283)
T ss_pred ceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhh
Confidence 445678999999999999976 688999999875432 223455556665 56678999999999999999999999999
Q ss_pred CCCChhHHhhh---ccCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC
Q 014352 196 SNGSLSNLIYS---EERVLNWEERLQIALDISHGIEYLHEG-AVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG 271 (426)
Q Consensus 196 ~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 271 (426)
+ |+|.+++.. ....+++..++.++.|++.||.|||++ + ++||||||+||+++.++.+||+|||++.......
T Consensus 83 ~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 158 (283)
T cd06617 83 D-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV 158 (283)
T ss_pred c-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 6 688887754 234689999999999999999999986 6 9999999999999999999999999987543333
Q ss_pred CcccCccccCccCcccccc----CCCCcchhhHHHHHHHHHHHhCCCCCCchHH-HHHHhhccccchhhhhhhhhcccCC
Q 014352 272 RNSGLKGTYGYIDPAYIST----NKFTMKSDIFSFGVIIFELITAIHPHQNLME-YVNLASMSQDGVDEILDKQLVGACN 346 (426)
Q Consensus 272 ~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (426)
......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||..... ...+. ............
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~--------~~~~~~~~~~~~ 230 (283)
T cd06617 159 AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLK--------QVVEEPSPQLPA 230 (283)
T ss_pred ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHH--------HHHhcCCCCCCc
Confidence 3334568889999998864 4568899999999999999999999864221 11111 111110011111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 347 IQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 347 ~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
...+..+.+++.+||..+|++||++.+++++
T Consensus 231 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 231 EKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1234679999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=313.91 Aligned_cols=257 Identities=22% Similarity=0.293 Sum_probs=197.5
Q ss_pred hHHHHHHhhhhcccccCCCeeEEEEEeC---CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeE
Q 014352 112 KDIQKATQNFTNILGQGAFGPVYKATMP---SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKY 188 (426)
Q Consensus 112 ~~l~~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 188 (426)
..+...+|.+.+.||.|+||.||++... .+..||+|.+... ..+.+|++++++++||||+++++++...+..
T Consensus 87 ~~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~ 161 (392)
T PHA03207 87 ASVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTV 161 (392)
T ss_pred chhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence 3444556888899999999999999753 3467899987542 2456899999999999999999999999999
Q ss_pred EEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccc
Q 014352 189 MLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEV 268 (426)
Q Consensus 189 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 268 (426)
+++||++. ++|.+++ .....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++....
T Consensus 162 ~lv~e~~~-~~l~~~l-~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~ 236 (392)
T PHA03207 162 CMVMPKYK-CDLFTYV-DRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLD 236 (392)
T ss_pred EEEehhcC-CCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence 99999995 6888888 34456999999999999999999999998 9999999999999999999999999987533
Q ss_pred cCC---CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHH------HHHhh-c-------ccc
Q 014352 269 FDG---RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEY------VNLAS-M-------SQD 331 (426)
Q Consensus 269 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~------~~~~~-~-------~~~ 331 (426)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.... ..... . ...
T Consensus 237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~ 316 (392)
T PHA03207 237 AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQN 316 (392)
T ss_pred cccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCc
Confidence 221 123457999999999999999999999999999999999999998643210 00000 0 000
Q ss_pred chhhh---h---hhhhcccCC-------HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014352 332 GVDEI---L---DKQLVGACN-------IQEVRELARIGHKCLHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 332 ~~~~~---~---~~~~~~~~~-------~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 378 (426)
....+ + ......... .....++.+++.+||..||++|||+.+++.+-
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p 376 (392)
T PHA03207 317 GSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLP 376 (392)
T ss_pred cchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 00000 0 000000000 01234688899999999999999999999873
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=302.81 Aligned_cols=255 Identities=23% Similarity=0.320 Sum_probs=198.3
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC--ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEec
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS--HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 195 (426)
|++.+.||+|+||.||+|... ++..||+|.+.... ......+.+|++++++++|+||+++++++..++..+++|||+
T Consensus 3 y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 82 (288)
T cd07833 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYV 82 (288)
T ss_pred eeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecC
Confidence 566788999999999999876 67899999886542 223467899999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC--Cc
Q 014352 196 SNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG--RN 273 (426)
Q Consensus 196 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~--~~ 273 (426)
+++.+..+. .....+++..+..++.+++.||.|||+++ ++|+||+|+||++++++.+||+|||++....... ..
T Consensus 83 ~~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (288)
T cd07833 83 ERTLLELLE-ASPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL 158 (288)
T ss_pred CCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCccccc
Confidence 987666555 34455899999999999999999999998 9999999999999999999999999987544332 22
Q ss_pred ccCccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhcc---cc------------------
Q 014352 274 SGLKGTYGYIDPAYISTN-KFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMS---QD------------------ 331 (426)
Q Consensus 274 ~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~---~~------------------ 331 (426)
....++..|+|||++.+. .++.++||||||+++|+|++|..||........+.... ..
T Consensus 159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07833 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV 238 (288)
T ss_pred cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccc
Confidence 345678899999999887 88999999999999999999999987543221111100 00
Q ss_pred chhhhhhhh-hcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 332 GVDEILDKQ-LVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 332 ~~~~~~~~~-~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
......+.. .....+...+..+.+++.+||..+|++|||+.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 000000000 0000111225779999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=299.91 Aligned_cols=248 Identities=26% Similarity=0.409 Sum_probs=195.8
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcC-CCCceeeEEeEEEeC-----CeEEEE
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRL-HHRNLVNLIGYCVDK-----GKYMLI 191 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-----~~~~lv 191 (426)
+.+.+.||+|+||.||++... ++..+|+|.+.... .....+.+|+.+++++ +|||++++++++... +..++|
T Consensus 24 y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv 102 (291)
T cd06639 24 WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLV 102 (291)
T ss_pred eEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEE
Confidence 556678999999999999875 67889999986532 2345678899999999 799999999998754 358999
Q ss_pred EEecCCCChhHHhhh---ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccc
Q 014352 192 YEFMSNGSLSNLIYS---EERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEV 268 (426)
Q Consensus 192 ~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 268 (426)
+||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++....
T Consensus 103 ~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl~dfg~~~~~~ 179 (291)
T cd06639 103 LELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 179 (291)
T ss_pred EEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEeecccchhcc
Confidence 999999999998853 3356899999999999999999999988 9999999999999999999999999987543
Q ss_pred cCC-CcccCccccCccCccccccC-----CCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhc
Q 014352 269 FDG-RNSGLKGTYGYIDPAYISTN-----KFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLV 342 (426)
Q Consensus 269 ~~~-~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (426)
... ......++..|+|||.+... .++.++||||||+++|||++|+.||........+..+........
T Consensus 180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~------ 253 (291)
T cd06639 180 STRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTL------ 253 (291)
T ss_pred cccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCC------
Confidence 222 22345688999999998543 368899999999999999999999976433322222111111110
Q ss_pred ccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 343 GACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 343 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
..+......+.+++.+||+.+|++||++.+++++
T Consensus 254 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 254 -LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred -CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 0112234578999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=296.61 Aligned_cols=248 Identities=30% Similarity=0.471 Sum_probs=198.9
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCcc--ChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEec
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQ--GEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 195 (426)
|...+.||+|+||.||+|... ++..+++|.+...... ..+.+.+|+.++++++|+||+++++++...+..++|+||+
T Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06626 2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC 81 (264)
T ss_pred ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence 456678999999999999865 7789999998765443 4567899999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCC---
Q 014352 196 SNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGR--- 272 (426)
Q Consensus 196 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~--- 272 (426)
++++|.+++... ..+++..+..++.+++.||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 82 ~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~ 157 (264)
T cd06626 82 SGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG 157 (264)
T ss_pred CCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence 999999998654 45889999999999999999999998 99999999999999999999999999875432221
Q ss_pred --cccCccccCccCccccccCC---CCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHh-hccccchhhhhhhhhcccCC
Q 014352 273 --NSGLKGTYGYIDPAYISTNK---FTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLA-SMSQDGVDEILDKQLVGACN 346 (426)
Q Consensus 273 --~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 346 (426)
.....++..|+|||++.+.. ++.++||||||+++|++++|..||.......... ...... .+.+ ...
T Consensus 158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-----~~~~--~~~ 230 (264)
T cd06626 158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGH-----KPPI--PDS 230 (264)
T ss_pred ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCC-----CCCC--Ccc
Confidence 11346788999999998766 8899999999999999999999997542211111 000000 0000 011
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 347 IQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 347 ~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
......+.+++.+||+.+|.+|||+.+++.+
T Consensus 231 ~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 231 LQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred cccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 1224678899999999999999999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=310.77 Aligned_cols=253 Identities=22% Similarity=0.290 Sum_probs=193.0
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc--cChHHHHHHHHHHhcCCCCceeeEEeEEEeC------CeE
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH--QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDK------GKY 188 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~ 188 (426)
+|.+.+.||+|+||.||+|... ++..||+|.+..... .....+.+|+.++++++||||+++++++... ...
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 95 (343)
T cd07878 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEV 95 (343)
T ss_pred hhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcE
Confidence 4666788999999999999864 678899999865422 2234677899999999999999999987543 357
Q ss_pred EEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccc
Q 014352 189 MLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEV 268 (426)
Q Consensus 189 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 268 (426)
+++++++ +++|.+++. ...+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++...
T Consensus 96 ~~~~~~~-~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 169 (343)
T cd07878 96 YLVTNLM-GADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQAD 169 (343)
T ss_pred EEEeecC-CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCccceecC
Confidence 8999988 779988874 345899999999999999999999998 9999999999999999999999999997543
Q ss_pred cCCCcccCccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhc---cccchhhhhh------
Q 014352 269 FDGRNSGLKGTYGYIDPAYIST-NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASM---SQDGVDEILD------ 338 (426)
Q Consensus 269 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~---~~~~~~~~~~------ 338 (426)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|..||........+..+ ..........
T Consensus 170 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (343)
T cd07878 170 --DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEH 247 (343)
T ss_pred --CCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhh
Confidence 23345578999999999876 56889999999999999999999999753222111110 0000000000
Q ss_pred -----hhhcccCC-------HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014352 339 -----KQLVGACN-------IQEVRELARIGHKCLHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 339 -----~~~~~~~~-------~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 378 (426)
..+..... ......+.+++.+||+.||.+|||+.+++++-
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp 299 (343)
T cd07878 248 ARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHP 299 (343)
T ss_pred HHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 00000000 01123578999999999999999999999773
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=298.31 Aligned_cols=249 Identities=28% Similarity=0.406 Sum_probs=203.3
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCC
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSN 197 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 197 (426)
+.+.+.||.|+||.||++... ++..+++|.+..... ....+.+|++++++++|+|++++++++...+..++++||+++
T Consensus 21 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 99 (286)
T cd06614 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDG 99 (286)
T ss_pred chHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCC
Confidence 445568999999999999986 678899999876543 456788999999999999999999999999999999999999
Q ss_pred CChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC-CcccC
Q 014352 198 GSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG-RNSGL 276 (426)
Q Consensus 198 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-~~~~~ 276 (426)
++|.+++......+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 100 ~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 176 (286)
T cd06614 100 GSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSV 176 (286)
T ss_pred CcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhccc
Confidence 9999999765547999999999999999999999988 9999999999999999999999999876433221 22334
Q ss_pred ccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHH
Q 014352 277 KGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARI 356 (426)
Q Consensus 277 ~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 356 (426)
.++..|++||.+.+..++.++|+||||+++|+|++|..||................... ..........+.++
T Consensus 177 ~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~l~~l 249 (286)
T cd06614 177 VGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPP-------LKNPEKWSPEFKDF 249 (286)
T ss_pred cCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-------CcchhhCCHHHHHH
Confidence 57889999999998889999999999999999999999987644332222111111100 00111134678999
Q ss_pred HHHcccCCCCCCCCHHHHHHHH
Q 014352 357 GHKCLHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 357 ~~~cl~~~p~~RPs~~evl~~L 378 (426)
+.+||+.+|.+|||+.+++++-
T Consensus 250 i~~~l~~~p~~Rpt~~~il~~~ 271 (286)
T cd06614 250 LNKCLVKDPEKRPSAEELLQHP 271 (286)
T ss_pred HHHHhccChhhCcCHHHHhhCh
Confidence 9999999999999999998753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=296.03 Aligned_cols=247 Identities=28% Similarity=0.430 Sum_probs=203.5
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc-cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecC
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH-QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMS 196 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 196 (426)
+++.+.||.|++|.||+++.. ++..+++|.+..... .....+..|+..+.+++|+|++++++++...+..++|+||++
T Consensus 3 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (264)
T cd06623 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMD 82 (264)
T ss_pred ceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecC
Confidence 445678999999999999976 588999999876543 335679999999999999999999999999999999999999
Q ss_pred CCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCc-c
Q 014352 197 NGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHE-GAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRN-S 274 (426)
Q Consensus 197 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~-~ 274 (426)
+++|.+++... ..++....+.++.|++.||.|||+ .+ ++|+||+|+||+++.++.++|+|||++......... .
T Consensus 83 ~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 158 (264)
T cd06623 83 GGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN 158 (264)
T ss_pred CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCCccc
Confidence 99999999654 568999999999999999999999 88 999999999999999999999999998754332222 2
Q ss_pred cCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchH--HHHHHhhccccchhhhhhhhhcccCCHH-HHH
Q 014352 275 GLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLM--EYVNLASMSQDGVDEILDKQLVGACNIQ-EVR 351 (426)
Q Consensus 275 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 351 (426)
...++..|+|||.+.+..++.++|+||||+++|+|++|..||.... ....... .+.. ......+.. .+.
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~-------~~~~-~~~~~~~~~~~~~ 230 (264)
T cd06623 159 TFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQ-------AICD-GPPPSLPAEEFSP 230 (264)
T ss_pred ceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHH-------HHhc-CCCCCCCcccCCH
Confidence 4568899999999999999999999999999999999999997653 1111110 0000 011111222 456
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 352 ELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 352 ~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
.+.+++.+||..+|++|||+.+++++
T Consensus 231 ~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 231 EFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred HHHHHHHHHccCChhhCCCHHHHHhC
Confidence 89999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=298.62 Aligned_cols=243 Identities=24% Similarity=0.379 Sum_probs=198.0
Q ss_pred cccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCCCChh
Q 014352 123 NILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLS 201 (426)
Q Consensus 123 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 201 (426)
+.||+|++|.||++... ++..+++|.+........+.+.+|+.+++.++||||+++++++...+..++++||+++++|.
T Consensus 25 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~ 104 (285)
T cd06648 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALT 104 (285)
T ss_pred eEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHH
Confidence 58999999999999864 77889999886554444567889999999999999999999999999999999999999999
Q ss_pred HHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC-CcccCcccc
Q 014352 202 NLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG-RNSGLKGTY 280 (426)
Q Consensus 202 ~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-~~~~~~gt~ 280 (426)
+++.. ..+++..+..++.|++.||+|||+++ ++||||+|+||+++.++.++|+|||++....... ......|+.
T Consensus 105 ~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 179 (285)
T cd06648 105 DIVTH--TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTP 179 (285)
T ss_pred HHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccccCCc
Confidence 99865 45899999999999999999999998 9999999999999999999999999876433221 223346889
Q ss_pred CccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHHHHHc
Q 014352 281 GYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKC 360 (426)
Q Consensus 281 ~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c 360 (426)
.|+|||.+.+..++.++||||||+++|||++|..||................. +.. ......+..+.+++.+|
T Consensus 180 ~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~-----~~~--~~~~~~~~~l~~li~~~ 252 (285)
T cd06648 180 YWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLP-----PKL--KNLHKVSPRLRSFLDRM 252 (285)
T ss_pred cccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCC-----CCC--cccccCCHHHHHHHHHH
Confidence 99999999988899999999999999999999999865332222111111100 000 01112346799999999
Q ss_pred ccCCCCCCCCHHHHHHH
Q 014352 361 LHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 361 l~~~p~~RPs~~evl~~ 377 (426)
|+.+|++|||+.+++++
T Consensus 253 l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 253 LVRDPAQRATAAELLNH 269 (285)
T ss_pred cccChhhCcCHHHHccC
Confidence 99999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=297.07 Aligned_cols=246 Identities=26% Similarity=0.449 Sum_probs=197.7
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC-ccChHHHHHHHHHHhcCC---CCceeeEEeEEEeCCeEEEEEE
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS-HQGEKEFQTEVSLLGRLH---HRNLVNLIGYCVDKGKYMLIYE 193 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e 193 (426)
|++.+.||.|+||.||+|... ++..+|+|.+.... ......+.+|+.++++++ |||++++++++......++|||
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e 82 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIME 82 (277)
T ss_pred hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEe
Confidence 445678999999999999974 78899999986543 233457889999999996 9999999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC-C
Q 014352 194 FMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG-R 272 (426)
Q Consensus 194 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-~ 272 (426)
|+++++|.+++.. ..+++...+.++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .
T Consensus 83 ~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06917 83 YAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK 157 (277)
T ss_pred cCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCccc
Confidence 9999999998854 36899999999999999999999998 9999999999999999999999999987543322 2
Q ss_pred cccCccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHH
Q 014352 273 NSGLKGTYGYIDPAYIST-NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVR 351 (426)
Q Consensus 273 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (426)
.....|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||................ .+.+. ....+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~-----~~~~~---~~~~~~ 229 (277)
T cd06917 158 RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSK-----PPRLE---DNGYSK 229 (277)
T ss_pred cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCC-----CCCCC---cccCCH
Confidence 234568889999999865 456899999999999999999999997643322211111110 01111 111446
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 352 ELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 352 ~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
.+.+++.+||+.||++||++.+++.+
T Consensus 230 ~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 230 LLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 78999999999999999999999874
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=301.82 Aligned_cols=249 Identities=24% Similarity=0.354 Sum_probs=201.3
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecC
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMS 196 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 196 (426)
++.+.+.||+|+||.||++... ++..+++|.+........+.+.+|+.++++++||||+++++++...+..++|+||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~ 99 (293)
T cd06647 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLA 99 (293)
T ss_pred hceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCC
Confidence 4566778999999999999864 678899999865544445678899999999999999999999999999999999999
Q ss_pred CCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC-Cccc
Q 014352 197 NGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG-RNSG 275 (426)
Q Consensus 197 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-~~~~ 275 (426)
+++|.+++.. ..+++..+..++.+++.||.|||+++ ++|+||||+||+++.++.++|+|||++....... ....
T Consensus 100 ~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~ 174 (293)
T cd06647 100 GGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 174 (293)
T ss_pred CCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccccccc
Confidence 9999999854 34789999999999999999999998 9999999999999999999999999876433222 2233
Q ss_pred CccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHH
Q 014352 276 LKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELAR 355 (426)
Q Consensus 276 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 355 (426)
..+++.|+|||.+....++.++||||||+++|++++|..||................ ......+......+.+
T Consensus 175 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~~ 247 (293)
T cd06647 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-------TPELQNPEKLSAIFRD 247 (293)
T ss_pred ccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCC-------CCCCCCccccCHHHHH
Confidence 468889999999988889999999999999999999999997543322111111000 0001112223456889
Q ss_pred HHHHcccCCCCCCCCHHHHHHHH
Q 014352 356 IGHKCLHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 356 l~~~cl~~~p~~RPs~~evl~~L 378 (426)
++.+||+.+|++||++.+++.+-
T Consensus 248 li~~~l~~~p~~Rp~~~~il~h~ 270 (293)
T cd06647 248 FLNRCLEMDVEKRGSAKELLQHP 270 (293)
T ss_pred HHHHHccCChhhCcCHHHHhcCH
Confidence 99999999999999999999773
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=304.26 Aligned_cols=255 Identities=25% Similarity=0.377 Sum_probs=196.6
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCcc--ChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEec
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQ--GEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 195 (426)
|++.+.||+|+||.||+|... ++..+|+|.+...... ..+.+.+|+++++.++||||+++++++..++..++|+||+
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 82 (286)
T cd07846 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFV 82 (286)
T ss_pred eeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecC
Confidence 456678999999999999986 6789999987654322 2456889999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC-Ccc
Q 014352 196 SNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG-RNS 274 (426)
Q Consensus 196 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-~~~ 274 (426)
++++|..+... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++....... ...
T Consensus 83 ~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (286)
T cd07846 83 DHTVLDDLEKY-PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYT 158 (286)
T ss_pred CccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccC
Confidence 99988887643 345899999999999999999999998 9999999999999999999999999987543222 223
Q ss_pred cCccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhcc---cc---chhhhhh---------
Q 014352 275 GLKGTYGYIDPAYIST-NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMS---QD---GVDEILD--------- 338 (426)
Q Consensus 275 ~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~---~~---~~~~~~~--------- 338 (426)
...++..|+|||++.+ ..++.++||||||+++|||++|.+||............. .. ......+
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd07846 159 DYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMR 238 (286)
T ss_pred cccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccc
Confidence 3557889999999865 457889999999999999999999986433211111000 00 0000000
Q ss_pred -hhhc-----ccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 339 -KQLV-----GACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 339 -~~~~-----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
+... .......+..+.+++.+||+.+|++||++.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 239 LPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred cccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0000 00011234679999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=304.27 Aligned_cols=248 Identities=25% Similarity=0.360 Sum_probs=200.0
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCcc---ChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEe
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQ---GEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEF 194 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 194 (426)
|++.+.||+|+||.||++... ++..+|+|.+...... ..+.+..|+++++.++||||+++++.+.+.+..++||||
T Consensus 3 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 82 (316)
T cd05574 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDY 82 (316)
T ss_pred eEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEe
Confidence 455678999999999999876 5889999998765332 335688999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhc-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC--
Q 014352 195 MSNGSLSNLIYSE-ERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG-- 271 (426)
Q Consensus 195 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-- 271 (426)
+.+++|.+++... ...+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (316)
T cd05574 83 CPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPP 159 (316)
T ss_pred cCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccccccc
Confidence 9999999998653 356899999999999999999999998 9999999999999999999999999876432111
Q ss_pred ----------------------------CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHH
Q 014352 272 ----------------------------RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYV 323 (426)
Q Consensus 272 ----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~ 323 (426)
......|+..|+|||++.+..++.++||||||+++|+|++|..||.......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 239 (316)
T cd05574 160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239 (316)
T ss_pred cccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence 0112357889999999999899999999999999999999999997654332
Q ss_pred HHhhccccchhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCC----HHHHHHH
Q 014352 324 NLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPS----IGEVTQA 377 (426)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs----~~evl~~ 377 (426)
.+..+. ............+..+.+++.+||..||++||| +.+++.+
T Consensus 240 ~~~~~~--------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 240 TFSNIL--------KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred HHHHHh--------cCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 222111 111111111124578999999999999999999 6676664
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=297.11 Aligned_cols=250 Identities=27% Similarity=0.428 Sum_probs=195.5
Q ss_pred hhhcccccCCCeeEEEEEeC----CCcEEEEEEeccCCc--cChHHHHHHHHHHhcCCCCceeeEEeEEEeCC------e
Q 014352 120 NFTNILGQGAFGPVYKATMP----SGGVAAIKVLASDSH--QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKG------K 187 (426)
Q Consensus 120 ~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~ 187 (426)
.+.+.||+|+||.||+|.+. ++..+|+|++..... ...+++.+|++++++++||||+++++++...+ .
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 81 (273)
T cd05074 2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPI 81 (273)
T ss_pred cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccc
Confidence 34568999999999999853 357899999875432 23456889999999999999999999886542 2
Q ss_pred EEEEEEecCCCChhHHhhhc-----cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeec
Q 014352 188 YMLIYEFMSNGSLSNLIYSE-----ERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFG 262 (426)
Q Consensus 188 ~~lv~e~~~~gsL~~~l~~~-----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 262 (426)
.++++||+++|+|.+++... ...+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 82 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 158 (273)
T cd05074 82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADFG 158 (273)
T ss_pred eEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECccc
Confidence 47889999999999887432 134788999999999999999999998 9999999999999999999999999
Q ss_pred CccccccCC---CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhh
Q 014352 263 LSKEEVFDG---RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILD 338 (426)
Q Consensus 263 l~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 338 (426)
+++...... ......++..|++||.+.+..++.++||||||+++|||++ |..||...........+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~------ 232 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN------ 232 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC------
Confidence 987543221 1123345678999999998899999999999999999999 888886543322111111100
Q ss_pred hhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 014352 339 KQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKI 381 (426)
Q Consensus 339 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 381 (426)
....+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 233 ---~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 233 ---RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred ---cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0011123446899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=300.92 Aligned_cols=255 Identities=23% Similarity=0.358 Sum_probs=195.2
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCcc-ChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecC
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQ-GEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMS 196 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 196 (426)
|.+.+.||.|+||.||+|... ++..||+|.+...... ....+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 7 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (291)
T cd07844 7 YKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD 86 (291)
T ss_pred eeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC
Confidence 556678999999999999976 6789999998754322 23457789999999999999999999999999999999997
Q ss_pred CCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC-Cccc
Q 014352 197 NGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG-RNSG 275 (426)
Q Consensus 197 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-~~~~ 275 (426)
+ +|.+++......+++.....++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++...... ....
T Consensus 87 ~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 162 (291)
T cd07844 87 T-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSN 162 (291)
T ss_pred C-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCccccc
Confidence 5 999988766667899999999999999999999998 9999999999999999999999999987432211 1122
Q ss_pred CccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHH-HHh---hccccchhhhh-------------
Q 014352 276 LKGTYGYIDPAYIST-NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYV-NLA---SMSQDGVDEIL------------- 337 (426)
Q Consensus 276 ~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~-~~~---~~~~~~~~~~~------------- 337 (426)
..++..|+|||.+.+ ..++.++||||||+++|+|++|..||....... .+. ...........
T Consensus 163 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (291)
T cd07844 163 EVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYS 242 (291)
T ss_pred cccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccccc
Confidence 346789999999865 458899999999999999999999996543111 100 00000000000
Q ss_pred -----hhhhccc-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 338 -----DKQLVGA-CNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 338 -----~~~~~~~-~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
...+... ........+.+++.+||+.+|++|||+.+++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 243 FPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred ccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 0000000 001112567899999999999999999998864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=299.55 Aligned_cols=248 Identities=26% Similarity=0.390 Sum_probs=193.5
Q ss_pred hhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc-cChHHHHHHHHHHhcCC-CCceeeEEeEEEeCCeEEEEEEecCC
Q 014352 121 FTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH-QGEKEFQTEVSLLGRLH-HRNLVNLIGYCVDKGKYMLIYEFMSN 197 (426)
Q Consensus 121 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~ 197 (426)
+.+.||+|+||.||++... +++.+|+|.+..... .....+..|+.++.++. ||||+++++++..++..+++|||++.
T Consensus 8 ~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~ 87 (288)
T cd06616 8 DLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI 87 (288)
T ss_pred HHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC
Confidence 4467999999999999875 678999999875432 23456889999999996 99999999999999899999999864
Q ss_pred CChhHHh---hh-ccCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCC
Q 014352 198 GSLSNLI---YS-EERVLNWEERLQIALDISHGIEYLHEG-AVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGR 272 (426)
Q Consensus 198 gsL~~~l---~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 272 (426)
+|.++. .. ....+++.....++.+++.||+|||+. + ++||||||+||+++.++.++|+|||+++.......
T Consensus 88 -~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 163 (288)
T cd06616 88 -SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA 163 (288)
T ss_pred -CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhccCCc
Confidence 665543 22 235689999999999999999999975 6 99999999999999999999999999875443333
Q ss_pred cccCccccCccCccccccC---CCCcchhhHHHHHHHHHHHhCCCCCCchHHHH-HHhhccccchhhhhhhhhcccCCHH
Q 014352 273 NSGLKGTYGYIDPAYISTN---KFTMKSDIFSFGVIIFELITAIHPHQNLMEYV-NLASMSQDGVDEILDKQLVGACNIQ 348 (426)
Q Consensus 273 ~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (426)
.....|+..|+|||.+.+. .++.++||||||+++|||++|+.||....... .......... +.+.......
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~ 238 (288)
T cd06616 164 KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDP-----PILSNSEERE 238 (288)
T ss_pred cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCC-----CcCCCcCCCc
Confidence 3445688999999999766 68999999999999999999999997543211 1111111100 1111111123
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 349 EVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 349 ~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
.+..+.+++.+||+.+|++|||+.+++.+
T Consensus 239 ~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 239 FSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 45679999999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=300.90 Aligned_cols=250 Identities=20% Similarity=0.296 Sum_probs=195.6
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc---cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEe
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH---QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEF 194 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 194 (426)
|.+.+.||+|+||.||++... +++.|++|.+..... .....+.+|+++++.++||||+++++.+..++..++||||
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (305)
T cd05609 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEY 82 (305)
T ss_pred ceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEec
Confidence 445678999999999999875 667899998875432 2234678999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC---
Q 014352 195 MSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG--- 271 (426)
Q Consensus 195 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~--- 271 (426)
+++++|.+++... ..+++.....++.+++.||.|||+.+ ++||||||+||+++.++.++|+|||+++......
T Consensus 83 ~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 83 VEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred CCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence 9999999999654 45899999999999999999999988 9999999999999999999999999886311100
Q ss_pred -------------CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhh
Q 014352 272 -------------RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILD 338 (426)
Q Consensus 272 -------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 338 (426)
......++..|+|||.+.+..++.++|+||||+++||+++|..||.+...............
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~----- 233 (305)
T cd05609 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI----- 233 (305)
T ss_pred ccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc-----
Confidence 01124578899999999888999999999999999999999999975322211111100000
Q ss_pred hhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 014352 339 KQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALL 379 (426)
Q Consensus 339 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 379 (426)
.. .......+..+.+++.+||+.+|++||++.++.+.|+
T Consensus 234 -~~-~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 234 -EW-PEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred -CC-CCccccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 00 0011123467899999999999999999655554443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=299.54 Aligned_cols=243 Identities=23% Similarity=0.329 Sum_probs=199.2
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc---cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEe
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH---QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEF 194 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 194 (426)
|.+.+.||+|+||.||++... +++.+|+|.+..... .....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 3 y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (290)
T cd05580 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEY 82 (290)
T ss_pred eEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEec
Confidence 456678999999999999875 678999999865321 2235688999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCcc
Q 014352 195 MSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNS 274 (426)
Q Consensus 195 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 274 (426)
+++++|.+++... ..++...+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++...... ..
T Consensus 83 ~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--~~ 156 (290)
T cd05580 83 VPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--TY 156 (290)
T ss_pred CCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC--CC
Confidence 9999999998655 56899999999999999999999988 999999999999999999999999998754332 34
Q ss_pred cCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHH
Q 014352 275 GLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELA 354 (426)
Q Consensus 275 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 354 (426)
...+++.|+|||.+.+..++.++||||||+++|+|++|..||............... . ...+......+.
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--------~--~~~~~~~~~~l~ 226 (290)
T cd05580 157 TLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG--------K--VRFPSFFSPDAK 226 (290)
T ss_pred CCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--------C--ccCCccCCHHHH
Confidence 456889999999998888999999999999999999999999754322211111110 0 011122346788
Q ss_pred HHHHHcccCCCCCCC-----CHHHHHHH
Q 014352 355 RIGHKCLHKTPRKRP-----SIGEVTQA 377 (426)
Q Consensus 355 ~l~~~cl~~~p~~RP-----s~~evl~~ 377 (426)
+++.+||..||.+|| ++++++++
T Consensus 227 ~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 227 DLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred HHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 999999999999998 77777654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=295.11 Aligned_cols=241 Identities=22% Similarity=0.314 Sum_probs=196.5
Q ss_pred cccCCCeeEEEEEeC-CCcEEEEEEeccCCc---cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCCCCh
Q 014352 125 LGQGAFGPVYKATMP-SGGVAAIKVLASDSH---QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSL 200 (426)
Q Consensus 125 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 200 (426)
||.|+||.||+++.. ++..+|+|.+..... ...+.+.+|+.++++++||||+++++++.+++..++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999986 578999999875432 2335789999999999999999999999999999999999999999
Q ss_pred hHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCcccCcccc
Q 014352 201 SNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTY 280 (426)
Q Consensus 201 ~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~gt~ 280 (426)
.+++... ..+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++.............++.
T Consensus 81 ~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~ 156 (262)
T cd05572 81 WTILRDR-GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTP 156 (262)
T ss_pred HHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCc
Confidence 9999654 45899999999999999999999988 9999999999999999999999999987654333333456889
Q ss_pred CccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchH--HHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHHHH
Q 014352 281 GYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLM--EYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGH 358 (426)
Q Consensus 281 ~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 358 (426)
.|++||.+.+..++.++|+||||+++|++++|..||.... ...... ...+.......+......+.+++.
T Consensus 157 ~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~i~ 228 (262)
T cd05572 157 EYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYN--------DILKGNGKLEFPNYIDKAAKDLIK 228 (262)
T ss_pred CccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHH--------HHhccCCCCCCCcccCHHHHHHHH
Confidence 9999999988889999999999999999999999997643 111111 111101111122223568999999
Q ss_pred HcccCCCCCCCC-----HHHHHHH
Q 014352 359 KCLHKTPRKRPS-----IGEVTQA 377 (426)
Q Consensus 359 ~cl~~~p~~RPs-----~~evl~~ 377 (426)
+||+.+|++||+ +.|++++
T Consensus 229 ~~l~~~p~~R~~~~~~~~~~l~~~ 252 (262)
T cd05572 229 QLLRRNPEERLGNLKGGIKDIKKH 252 (262)
T ss_pred HHccCChhhCcCCcccCHHHHhcC
Confidence 999999999999 6777653
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=328.01 Aligned_cols=261 Identities=27% Similarity=0.452 Sum_probs=212.2
Q ss_pred hHHHHHHhhhhcccccCCCeeEEEEEeC----C----CcEEEEEEeccCCcc-ChHHHHHHHHHHhcC-CCCceeeEEeE
Q 014352 112 KDIQKATQNFTNILGQGAFGPVYKATMP----S----GGVAAIKVLASDSHQ-GEKEFQTEVSLLGRL-HHRNLVNLIGY 181 (426)
Q Consensus 112 ~~l~~~~~~~~~~lg~G~~g~Vy~~~~~----~----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~ 181 (426)
-++......+.+.||+|.||.|++|... . ...||||.++..... ..+.+..|+++|+.+ +||||+.++|+
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 3444444456679999999999999742 1 347999999876443 346799999999998 59999999999
Q ss_pred EEeCCeEEEEEEecCCCChhHHhhhcc---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCC
Q 014352 182 CVDKGKYMLIYEFMSNGSLSNLIYSEE---------------RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSA 246 (426)
Q Consensus 182 ~~~~~~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~ 246 (426)
|..++.+++|+||+..|+|.++|+... ..++..+++.++.|||.||+||++.. ++||||..+
T Consensus 371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaR 447 (609)
T KOG0200|consen 371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAAR 447 (609)
T ss_pred eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhh
Confidence 999999999999999999999997765 34899999999999999999999998 999999999
Q ss_pred CEEecCCCcEEEeeecCccccccCCCc--ccCc--cccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHH
Q 014352 247 NILLDHFMRAKVADFGLSKEEVFDGRN--SGLK--GTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLME 321 (426)
Q Consensus 247 Nill~~~~~~kl~Dfgl~~~~~~~~~~--~~~~--gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~ 321 (426)
|||++.+..+||+|||+++........ .... -...|||||.+....|+.++|||||||+||||+| |..||.+...
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~ 527 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP 527 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence 999999999999999999854332221 1112 3456999999999999999999999999999998 8999976321
Q ss_pred HHHHhhccccchhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 014352 322 YVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQ 383 (426)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 383 (426)
.. .+.+.+....+...+..+..+++++|+.||+.+|++||++.++++.++....
T Consensus 528 ~~--------~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 528 TE--------ELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred HH--------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 11 1122333444444555567889999999999999999999999999998543
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=295.40 Aligned_cols=250 Identities=27% Similarity=0.444 Sum_probs=198.3
Q ss_pred HHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcC-CCCceeeEEeEEEeCC------eE
Q 014352 117 ATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRL-HHRNLVNLIGYCVDKG------KY 188 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~------~~ 188 (426)
.+|.+.+.||.|+||.||+|... +++.+++|.+..... ....+.+|+.+++++ +|+||+++++++.... .+
T Consensus 6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (275)
T cd06608 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQL 84 (275)
T ss_pred hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEE
Confidence 34667789999999999999975 677899999876543 346789999999999 7999999999997654 48
Q ss_pred EEEEEecCCCChhHHhhhc---cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcc
Q 014352 189 MLIYEFMSNGSLSNLIYSE---ERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSK 265 (426)
Q Consensus 189 ~lv~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 265 (426)
++||||+++++|.+++... +..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~~~ 161 (275)
T cd06608 85 WLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSA 161 (275)
T ss_pred EEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCccce
Confidence 9999999999999988543 356899999999999999999999998 9999999999999999999999999986
Q ss_pred ccccC-CCcccCccccCccCcccccc-----CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhh
Q 014352 266 EEVFD-GRNSGLKGTYGYIDPAYIST-----NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDK 339 (426)
Q Consensus 266 ~~~~~-~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 339 (426)
..... .......++..|+|||.+.. ..++.++||||||+++|++++|..||...........+.......
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---- 237 (275)
T cd06608 162 QLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPT---- 237 (275)
T ss_pred ecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCC----
Confidence 43221 22234568899999998753 346789999999999999999999997543322222211111100
Q ss_pred hhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 340 QLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 340 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
...+......+.+++.+||..||++|||+.+++++
T Consensus 238 ---~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 238 ---LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred ---CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 01112245678999999999999999999999864
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=296.46 Aligned_cols=253 Identities=23% Similarity=0.325 Sum_probs=194.1
Q ss_pred hhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc-cChHHHHHHHHHHhcCC-CCceeeEEeEEEeC--CeEEEEEEe
Q 014352 120 NFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH-QGEKEFQTEVSLLGRLH-HRNLVNLIGYCVDK--GKYMLIYEF 194 (426)
Q Consensus 120 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~e~ 194 (426)
.+.+.||+|+||.||+|... ++..+|+|.+..... ........|+.++.++. |||++++++++.+. +..++|+||
T Consensus 2 ~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~ 81 (282)
T cd07831 2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFEL 81 (282)
T ss_pred ceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEec
Confidence 45678999999999999865 678899999875422 22234457888898885 99999999999987 889999999
Q ss_pred cCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCcc
Q 014352 195 MSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNS 274 (426)
Q Consensus 195 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 274 (426)
++ ++|.+.+......+++..+..++.|++.||.|||+.+ ++||||+|+||+++. +.+||+|||+++.........
T Consensus 82 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~ 156 (282)
T cd07831 82 MD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYT 156 (282)
T ss_pred CC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCCCcC
Confidence 96 5888888665567899999999999999999999998 999999999999999 999999999997654433334
Q ss_pred cCccccCccCccccc-cCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhc---cccchhhh---hhhh------h
Q 014352 275 GLKGTYGYIDPAYIS-TNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASM---SQDGVDEI---LDKQ------L 341 (426)
Q Consensus 275 ~~~gt~~y~aPE~~~-~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~---~~~~~~~~---~~~~------~ 341 (426)
...++..|+|||++. +..++.++|||||||++|||++|..||............ .......+ .... .
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07831 157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF 236 (282)
T ss_pred CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccC
Confidence 456889999999764 455788999999999999999999999754322111110 00000000 0000 0
Q ss_pred c-------ccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 342 V-------GACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 342 ~-------~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
. .......+..+.+++.+||+.+|++||++.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 237 PSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0 00011345789999999999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=297.19 Aligned_cols=244 Identities=27% Similarity=0.403 Sum_probs=194.0
Q ss_pred cccCCCeeEEEEEeC-CCcEEEEEEeccCC---ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCCCCh
Q 014352 125 LGQGAFGPVYKATMP-SGGVAAIKVLASDS---HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSL 200 (426)
Q Consensus 125 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 200 (426)
||+|+||+||++... ++..+|+|.+.... ......+..|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999865 67899999886432 12234567899999999999999999999999999999999999999
Q ss_pred hHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCcccCccc
Q 014352 201 SNLIYSEE-RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGT 279 (426)
Q Consensus 201 ~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~gt 279 (426)
.+++.... ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++.............++
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 157 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGT 157 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCC
Confidence 99986544 36899999999999999999999998 999999999999999999999999998754333333445678
Q ss_pred cCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHHHHH
Q 014352 280 YGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHK 359 (426)
Q Consensus 280 ~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 359 (426)
..|+|||++.+..++.++||||||+++|+|++|+.||...........+...... .....+......+.+++.+
T Consensus 158 ~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~li~~ 231 (277)
T cd05577 158 PGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE------MAVEYPDKFSPEAKDLCEA 231 (277)
T ss_pred CCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc------ccccCCccCCHHHHHHHHH
Confidence 8999999998888999999999999999999999999654321111110000000 0111122235678999999
Q ss_pred cccCCCCCCC-----CHHHHHHH
Q 014352 360 CLHKTPRKRP-----SIGEVTQA 377 (426)
Q Consensus 360 cl~~~p~~RP-----s~~evl~~ 377 (426)
||+.||++|| ++.+++.+
T Consensus 232 ~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 232 LLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred HccCChhHccCCCcccHHHHHhC
Confidence 9999999999 55556543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=296.19 Aligned_cols=250 Identities=26% Similarity=0.439 Sum_probs=197.6
Q ss_pred hhhhcccccCCCeeEEEEEe-CCCcEEEEEEeccCCcc------ChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEE
Q 014352 119 QNFTNILGQGAFGPVYKATM-PSGGVAAIKVLASDSHQ------GEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLI 191 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 191 (426)
|...+.||+|+||.||++.. .++..+|+|.+...... ..+.+..|++++++++||||+++++++.+.+..++|
T Consensus 2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 81 (268)
T cd06630 2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLF 81 (268)
T ss_pred ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEE
Confidence 34557899999999999986 47889999998643211 235688999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCC-cEEEeeecCccccccC
Q 014352 192 YEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFM-RAKVADFGLSKEEVFD 270 (426)
Q Consensus 192 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgl~~~~~~~ 270 (426)
+||+++++|.+++... .++++..+..++.|++.||.|||+++ ++|+||+|+||+++.++ .++|+|||++......
T Consensus 82 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 82 VEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EeccCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 9999999999998543 46899999999999999999999998 99999999999998876 5999999998754322
Q ss_pred C-----CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccC
Q 014352 271 G-----RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGAC 345 (426)
Q Consensus 271 ~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (426)
. ......++..|+|||.+.+..++.++||||||+++|+|++|..||........... .............
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~ 232 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL-----IFKIASATTAPSI 232 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHH-----HHHHhccCCCCCC
Confidence 1 11234578899999999888899999999999999999999999864211100000 0000001111122
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 346 NIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 346 ~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
+......+.+++.+||+.+|++|||+.+++++
T Consensus 233 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 233 PEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred chhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 23345678999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=297.99 Aligned_cols=251 Identities=25% Similarity=0.379 Sum_probs=197.1
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc-cChHHHHHHHHHHhcCCCCceeeEEeEEEeC--CeEEEEEEe
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH-QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDK--GKYMLIYEF 194 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~ 194 (426)
+.+.+.||.|++|.||++... +++.+|+|.+..... .....+.+|++++++++||||+++++++.+. +.+++||||
T Consensus 3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 82 (287)
T cd06621 3 IVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEY 82 (287)
T ss_pred eEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEe
Confidence 345678999999999999975 678899999875432 2345788999999999999999999998654 468999999
Q ss_pred cCCCChhHHhhh---ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC
Q 014352 195 MSNGSLSNLIYS---EERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG 271 (426)
Q Consensus 195 ~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 271 (426)
+++++|.+++.. ....++......++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~- 158 (287)
T cd06621 83 CEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS- 158 (287)
T ss_pred cCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccccc-
Confidence 999999988743 2355888999999999999999999998 999999999999999999999999998654322
Q ss_pred CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHH----HHHH-hhccccchhhhhhhhhcccC-
Q 014352 272 RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLME----YVNL-ASMSQDGVDEILDKQLVGAC- 345 (426)
Q Consensus 272 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~----~~~~-~~~~~~~~~~~~~~~~~~~~- 345 (426)
......++..|+|||.+.+..++.++||||||+++|+|++|..||..... .... ........ +.+....
T Consensus 159 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~ 233 (287)
T cd06621 159 LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPN-----PELKDEPG 233 (287)
T ss_pred ccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCc-----hhhccCCC
Confidence 22244578899999999999999999999999999999999999875411 0000 00000000 0010011
Q ss_pred -CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014352 346 -NIQEVRELARIGHKCLHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 346 -~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 378 (426)
....+..+.+++.+||+.+|++|||+.|++++-
T Consensus 234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~ 267 (287)
T cd06621 234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHP 267 (287)
T ss_pred CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCc
Confidence 122356789999999999999999999999853
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=297.19 Aligned_cols=245 Identities=23% Similarity=0.333 Sum_probs=201.3
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc---cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEe
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH---QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEF 194 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 194 (426)
|++.+.||.|+||.||++... ++..+|+|.+..... ...+.+.+|++++++++||||+++++++.+.+..++|+||
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (258)
T cd05578 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL 81 (258)
T ss_pred ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence 456678999999999999976 688999999875432 2346789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCcc
Q 014352 195 MSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNS 274 (426)
Q Consensus 195 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 274 (426)
+++++|.+++... ..++...+..++.|+++||.|||+++ ++|+||+|+||++++++.++|+|||++..........
T Consensus 82 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 157 (258)
T cd05578 82 LLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTT 157 (258)
T ss_pred CCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCcccc
Confidence 9999999998654 56899999999999999999999998 9999999999999999999999999987654433344
Q ss_pred cCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHH--HHHHhhccccchhhhhhhhhcccCCHHHHHH
Q 014352 275 GLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLME--YVNLASMSQDGVDEILDKQLVGACNIQEVRE 352 (426)
Q Consensus 275 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (426)
...|+..|+|||.+.+..++.++|+||||+++|+|++|..||..... ...... .... .....+...+..
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--------~~~~-~~~~~~~~~~~~ 228 (258)
T cd05578 158 STSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRA--------KQET-ADVLYPATWSTE 228 (258)
T ss_pred ccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHH--------Hhcc-ccccCcccCcHH
Confidence 56688899999999988899999999999999999999999976432 111100 0000 111122234478
Q ss_pred HHHHHHHcccCCCCCCCCH--HHHHH
Q 014352 353 LARIGHKCLHKTPRKRPSI--GEVTQ 376 (426)
Q Consensus 353 l~~l~~~cl~~~p~~RPs~--~evl~ 376 (426)
+.+++.+||+.||.+||++ +++++
T Consensus 229 ~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 229 AIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred HHHHHHHHccCChhHcCCccHHHHhc
Confidence 9999999999999999999 66553
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=312.35 Aligned_cols=244 Identities=26% Similarity=0.406 Sum_probs=195.1
Q ss_pred hhcccccCCCeeEEEEEeC-CCcEEEEEEeccC----CccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCe--EEEEEE
Q 014352 121 FTNILGQGAFGPVYKATMP-SGGVAAIKVLASD----SHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGK--YMLIYE 193 (426)
Q Consensus 121 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~--~~lv~e 193 (426)
|.+.||+|+|-+||+|.+. +|-.||--.++.. .....+.|..|+.+|+.|+||||++++.+|.+... ..+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 4568999999999999875 5555654333211 12223679999999999999999999999988654 889999
Q ss_pred ecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecC-CCcEEEeeecCccccccCCC
Q 014352 194 FMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDH-FMRAKVADFGLSKEEVFDGR 272 (426)
Q Consensus 194 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgl~~~~~~~~~ 272 (426)
.+..|+|..|+.+.+ .++...+..|+.||++||.|||++. |||+|||||.+||+|+. .|.|||+|.|||..... ..
T Consensus 124 L~TSGtLr~Y~kk~~-~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~-s~ 200 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHR-RVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK-SH 200 (632)
T ss_pred cccCCcHHHHHHHhc-cCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhc-cc
Confidence 999999999996554 4888999999999999999999987 88999999999999985 68999999999986433 33
Q ss_pred cccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhh-ccccchhhhhhhhhcccCCHHHHH
Q 014352 273 NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLAS-MSQDGVDEILDKQLVGACNIQEVR 351 (426)
Q Consensus 273 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 351 (426)
.....|||.|||||+.. ..|+...||||||..++||+|+..||+.......+.. +..+..+..+.+. . ..
T Consensus 201 aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV----~----dP 271 (632)
T KOG0584|consen 201 AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKV----K----DP 271 (632)
T ss_pred cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhcc----C----CH
Confidence 34478999999999997 8899999999999999999999999987655433322 2222222222211 1 14
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 352 ELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 352 ~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
++.++|.+|+.. ..+|||+.|+++.
T Consensus 272 evr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 272 EVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred HHHHHHHHHhcC-chhccCHHHHhhC
Confidence 688999999999 9999999999864
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=292.64 Aligned_cols=247 Identities=25% Similarity=0.415 Sum_probs=199.0
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC--ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEec
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS--HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 195 (426)
+.+.+.||+|+||.||++... ++..+|+|.+.... ....+.+.+|+.++++++|+||+++++.+.+.+..++|+||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (257)
T cd08225 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYC 81 (257)
T ss_pred ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecC
Confidence 445678999999999999976 67889999986542 123457889999999999999999999999999999999999
Q ss_pred CCCChhHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCc-EEEeeecCccccccCCC-
Q 014352 196 SNGSLSNLIYSEE-RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMR-AKVADFGLSKEEVFDGR- 272 (426)
Q Consensus 196 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~-~kl~Dfgl~~~~~~~~~- 272 (426)
++++|.+++.... ..+++..+..++.+++.||.|||+.+ ++|+||||+||++++++. +||+|||.+........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~ 158 (257)
T cd08225 82 DGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMEL 158 (257)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCccc
Confidence 9999999986543 35799999999999999999999998 999999999999998864 69999999875432221
Q ss_pred cccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHH
Q 014352 273 NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRE 352 (426)
Q Consensus 273 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (426)
.....|++.|+|||++.+..++.++|+||||+++||+++|..||................ ...........
T Consensus 159 ~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~ 229 (257)
T cd08225 159 AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGY---------FAPISPNFSRD 229 (257)
T ss_pred ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccc---------CCCCCCCCCHH
Confidence 223458889999999988889999999999999999999999987543222111111111 01112233467
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 353 LARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 353 l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
+.+++.+||+.+|++|||+.+++++
T Consensus 230 ~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 230 LRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred HHHHHHHHhccChhhCcCHHHHhhC
Confidence 9999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=296.00 Aligned_cols=255 Identities=22% Similarity=0.327 Sum_probs=193.9
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccC-hHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecC
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQG-EKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMS 196 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 196 (426)
|.+.+.||+|+||.||+|... ++..+|+|.+....... ...+.+|+.+++.++|+||+++++++..++..++|+||++
T Consensus 7 y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~ 86 (291)
T cd07870 7 YLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH 86 (291)
T ss_pred eEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc
Confidence 456678999999999999865 68899999987553222 3467889999999999999999999999999999999995
Q ss_pred CCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC-CCccc
Q 014352 197 NGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD-GRNSG 275 (426)
Q Consensus 197 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-~~~~~ 275 (426)
++|.+.+......+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||+++..... .....
T Consensus 87 -~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 162 (291)
T cd07870 87 -TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSS 162 (291)
T ss_pred -CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCCC
Confidence 6887777555556888889999999999999999998 999999999999999999999999998743221 12233
Q ss_pred CccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCchHHHHH-Hhhc------cccc-----------hhhh
Q 014352 276 LKGTYGYIDPAYISTN-KFTMKSDIFSFGVIIFELITAIHPHQNLMEYVN-LASM------SQDG-----------VDEI 336 (426)
Q Consensus 276 ~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~-~~~~------~~~~-----------~~~~ 336 (426)
..++..|+|||++.+. .++.++||||||+++|||++|..||........ +... .... ....
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (291)
T cd07870 163 EVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEW 242 (291)
T ss_pred ccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchh
Confidence 4578899999998754 578899999999999999999999975432111 0000 0000 0000
Q ss_pred hhhhhccc-----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 337 LDKQLVGA-----CNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 337 ~~~~~~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
........ ........+.+++.+|++.||.+|||+.+++.+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 243 FLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred ccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 00000000 000123578899999999999999999998754
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=296.08 Aligned_cols=254 Identities=25% Similarity=0.356 Sum_probs=196.7
Q ss_pred hhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC--ccChHHHHHHHHHHhcCCCCceeeEEeEEEeC--CeEEEEEEe
Q 014352 120 NFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS--HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDK--GKYMLIYEF 194 (426)
Q Consensus 120 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~ 194 (426)
++.+.||.|+||.||+|+.. ++..+|+|.+.... ......+.+|+.++++++|||++++++++... +..++|+||
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07840 2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEY 81 (287)
T ss_pred eeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecc
Confidence 35578999999999999976 57889999997653 22345688999999999999999999999988 889999999
Q ss_pred cCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC--C
Q 014352 195 MSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG--R 272 (426)
Q Consensus 195 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~--~ 272 (426)
+++ +|.+++......+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++....... .
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~ 157 (287)
T cd07840 82 MDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD 157 (287)
T ss_pred ccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCCccc
Confidence 975 899888665567999999999999999999999998 9999999999999999999999999987543332 1
Q ss_pred cccCccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccc-------cchhhh--------
Q 014352 273 NSGLKGTYGYIDPAYIST-NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQ-------DGVDEI-------- 336 (426)
Q Consensus 273 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~-------~~~~~~-------- 336 (426)
.....++..|+|||.+.+ ..++.++||||||+++|||++|..||........+..+.. ......
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN 237 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence 233456888999998764 4678999999999999999999999975433221111100 000000
Q ss_pred ------hhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 337 ------LDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 337 ------~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
....+........+..+.+++.+||+.+|++||++.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00000000000025678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=294.80 Aligned_cols=242 Identities=26% Similarity=0.356 Sum_probs=186.6
Q ss_pred ccccCCCeeEEEEEeC-CCcEEEEEEeccCCcc---ChHHHHHHHHHH---hcCCCCceeeEEeEEEeCCeEEEEEEecC
Q 014352 124 ILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQ---GEKEFQTEVSLL---GRLHHRNLVNLIGYCVDKGKYMLIYEFMS 196 (426)
Q Consensus 124 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l---~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 196 (426)
.||+|+||.||++... +++.+|+|.+...... ....+.+|..++ ...+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999875 6789999988654221 122344444433 33479999999999999999999999999
Q ss_pred CCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCcccC
Q 014352 197 NGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGL 276 (426)
Q Consensus 197 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~ 276 (426)
+|+|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++...... .....
T Consensus 81 ~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~ 155 (279)
T cd05633 81 GGDLHYHLSQH-GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHAS 155 (279)
T ss_pred CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceecccc-CccCc
Confidence 99999988544 45899999999999999999999998 999999999999999999999999998643322 22345
Q ss_pred ccccCccCccccc-cCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHH
Q 014352 277 KGTYGYIDPAYIS-TNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELAR 355 (426)
Q Consensus 277 ~gt~~y~aPE~~~-~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 355 (426)
.|+..|+|||.+. +..++.++||||||+++|||++|..||........ .. .... ........+...+..+.+
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~-----~~~~-~~~~~~~~~~~~~~~~~~ 228 (279)
T cd05633 156 VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HE-----IDRM-TLTVNVELPDSFSPELKS 228 (279)
T ss_pred CCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-HH-----HHHH-hhcCCcCCccccCHHHHH
Confidence 6899999999986 45689999999999999999999999964211000 00 0000 000111122334567899
Q ss_pred HHHHcccCCCCCCC-----CHHHHHHH
Q 014352 356 IGHKCLHKTPRKRP-----SIGEVTQA 377 (426)
Q Consensus 356 l~~~cl~~~p~~RP-----s~~evl~~ 377 (426)
++.+||+.||++|| |+++++++
T Consensus 229 li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 229 LLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred HHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 99999999999999 58888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=299.17 Aligned_cols=251 Identities=25% Similarity=0.361 Sum_probs=199.5
Q ss_pred HHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc---cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEE
Q 014352 117 ATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH---QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIY 192 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 192 (426)
.++...+.||.|+||.||+|+.. ++..+|+|.+..... ....++.+|+++++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 33555568999999999999975 677899998864322 22346788999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCC
Q 014352 193 EFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGR 272 (426)
Q Consensus 193 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 272 (426)
||+. |+|.+.+......+++..+..++.+++.||.|||+.+ ++||||+|+||+++.++.++|+|||++.... .
T Consensus 95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~---~ 167 (308)
T cd06634 95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA---P 167 (308)
T ss_pred EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeec---C
Confidence 9996 5888887665667899999999999999999999988 9999999999999999999999999987532 2
Q ss_pred cccCccccCccCccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHH
Q 014352 273 NSGLKGTYGYIDPAYIS---TNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQE 349 (426)
Q Consensus 273 ~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (426)
.....++..|+|||.+. ...++.++||||||+++|+|++|..||................ .........
T Consensus 168 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~ 239 (308)
T cd06634 168 ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE--------SPALQSGHW 239 (308)
T ss_pred cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcC--------CCCcCcccc
Confidence 23456888999999974 3567889999999999999999999986543322211111111 111112234
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 014352 350 VRELARIGHKCLHKTPRKRPSIGEVTQALLKIK 382 (426)
Q Consensus 350 ~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 382 (426)
...+.+++.+||+.+|++||++.+++.+.....
T Consensus 240 ~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 240 SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred cHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 467899999999999999999999998755444
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=306.05 Aligned_cols=255 Identities=25% Similarity=0.290 Sum_probs=196.0
Q ss_pred HHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC--ccChHHHHHHHHHHhcCCCCceeeEEeEEEeC------Ce
Q 014352 117 ATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS--HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDK------GK 187 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~ 187 (426)
.+|...+.||+|+||.||+|... ++..+|+|.+.... ......+.+|+.++++++||||+++++++... ..
T Consensus 16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 95 (353)
T cd07850 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQD 95 (353)
T ss_pred cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCc
Confidence 44666788999999999999875 78899999986432 22234677899999999999999999988643 35
Q ss_pred EEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccc
Q 014352 188 YMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEE 267 (426)
Q Consensus 188 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 267 (426)
.++||||+. ++|.+.+... ++...+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++..
T Consensus 96 ~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 168 (353)
T cd07850 96 VYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 168 (353)
T ss_pred EEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence 799999996 5888877432 888999999999999999999998 999999999999999999999999999865
Q ss_pred ccCCCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhc---cccchh----------
Q 014352 268 VFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASM---SQDGVD---------- 334 (426)
Q Consensus 268 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~---~~~~~~---------- 334 (426)
..........++..|+|||.+.+..++.++||||||+++|+|++|+.||........+..+ ......
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (353)
T cd07850 169 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTV 248 (353)
T ss_pred CCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhh
Confidence 4333334456889999999999999999999999999999999999999753321111110 000000
Q ss_pred ----------------hhhhhhh----cccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014352 335 ----------------EILDKQL----VGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 335 ----------------~~~~~~~----~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 378 (426)
....... ...........+.+++.+||+.||++|||+.+++++-
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~ 312 (353)
T cd07850 249 RNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHP 312 (353)
T ss_pred hHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcCh
Confidence 0000000 0000112355688999999999999999999999763
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=297.93 Aligned_cols=258 Identities=17% Similarity=0.226 Sum_probs=185.4
Q ss_pred HHHHHHhhhhcccccCCCeeEEEEEeCC----CcEEEEEEeccCCccC--h---------HHHHHHHHHHhcCCCCceee
Q 014352 113 DIQKATQNFTNILGQGAFGPVYKATMPS----GGVAAIKVLASDSHQG--E---------KEFQTEVSLLGRLHHRNLVN 177 (426)
Q Consensus 113 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~--~---------~~~~~e~~~l~~l~h~niv~ 177 (426)
++...+|.+.+.||+|+||.||+|...+ +..+|+|......... + .....+...+..+.|+|+++
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~ 87 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK 87 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence 4444567788899999999999999754 3456666543322111 0 11223344556778999999
Q ss_pred EEeEEEeCC----eEEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCC
Q 014352 178 LIGYCVDKG----KYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHF 253 (426)
Q Consensus 178 ~~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~ 253 (426)
+++++.... ..++++|++.. ++.+.+... ...++..+..++.|++.||.|||+.+ |+||||||+|||++.+
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGN 162 (294)
T ss_pred EEEeeeEecCCceEEEEEEehhcc-CHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCC
Confidence 999776543 34678887743 676666432 34678888999999999999999998 9999999999999999
Q ss_pred CcEEEeeecCccccccCC--------CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHH
Q 014352 254 MRAKVADFGLSKEEVFDG--------RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNL 325 (426)
Q Consensus 254 ~~~kl~Dfgl~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~ 325 (426)
+.++|+|||+++...... ......||+.|+|||+..+..++.++|||||||++|||++|..||.........
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~ 242 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL 242 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence 999999999987542211 112346999999999999999999999999999999999999999765221111
Q ss_pred hhc-cccchhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014352 326 ASM-SQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 326 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 378 (426)
... ..+....+..... .....++.+.+++..||+.+|++||++.++++.|
T Consensus 243 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 243 IHAAKCDFIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHhHHHHHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 110 0111111111111 1112346799999999999999999999999876
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=296.11 Aligned_cols=254 Identities=25% Similarity=0.303 Sum_probs=195.2
Q ss_pred hhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc--cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecC
Q 014352 120 NFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH--QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMS 196 (426)
Q Consensus 120 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 196 (426)
++.+.||.|++|.||+|... ++..||+|++..... .....+.+|++++++++|||++++++++.+.+..+++|||++
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~ 81 (283)
T cd07835 2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD 81 (283)
T ss_pred chheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC
Confidence 35578999999999999875 788999999875432 223568889999999999999999999999999999999995
Q ss_pred CCChhHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC-CCcc
Q 014352 197 NGSLSNLIYSEE-RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD-GRNS 274 (426)
Q Consensus 197 ~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-~~~~ 274 (426)
++|.+++.... ..+++..++.++.|++.||.|||+++ ++||||+|+||+++.++.++|+|||++...... ....
T Consensus 82 -~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~ 157 (283)
T cd07835 82 -LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYT 157 (283)
T ss_pred -cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccC
Confidence 69999886544 36899999999999999999999988 999999999999999999999999998743222 1122
Q ss_pred cCccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhcccc---ch----------hhhhhh-
Q 014352 275 GLKGTYGYIDPAYISTN-KFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQD---GV----------DEILDK- 339 (426)
Q Consensus 275 ~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~---~~----------~~~~~~- 339 (426)
...++..|+|||++.+. .++.++|+||||+++|+|++|..||........+..+... .. .+....
T Consensus 158 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd07835 158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTF 237 (283)
T ss_pred ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhc
Confidence 33568899999988654 5789999999999999999999999754332211110000 00 000000
Q ss_pred -----hhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 340 -----QLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 340 -----~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
..........+..+.+++.+||+.+|++|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 238 PKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred ccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00001112233678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=295.84 Aligned_cols=241 Identities=28% Similarity=0.425 Sum_probs=194.6
Q ss_pred hcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccC---hHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCC
Q 014352 122 TNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQG---EKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSN 197 (426)
Q Consensus 122 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 197 (426)
.+.||+|+||.||+|+.. ++..+++|.+....... ...+.+|+.++++++|||++++++++.+.+..++||||+.
T Consensus 26 ~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 104 (313)
T cd06633 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL- 104 (313)
T ss_pred ceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-
Confidence 457999999999999875 67889999986543222 2467889999999999999999999999999999999996
Q ss_pred CChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCcccCc
Q 014352 198 GSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLK 277 (426)
Q Consensus 198 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 277 (426)
|+|.+++......+++.++..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++... .......
T Consensus 105 ~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~---~~~~~~~ 178 (313)
T cd06633 105 GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKS---SPANSFV 178 (313)
T ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCccc---CCCCCcc
Confidence 5888888666667999999999999999999999998 999999999999999999999999998642 2233456
Q ss_pred cccCccCccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHH
Q 014352 278 GTYGYIDPAYIS---TNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELA 354 (426)
Q Consensus 278 gt~~y~aPE~~~---~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 354 (426)
|+..|+|||++. ...++.++||||||+++|||++|..||................. ...........+.
T Consensus 179 ~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~l~ 250 (313)
T cd06633 179 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS--------PTLQSNEWTDSFR 250 (313)
T ss_pred ccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC--------CCCCccccCHHHH
Confidence 889999999984 46688999999999999999999999876433222221111111 1111122335688
Q ss_pred HHHHHcccCCCCCCCCHHHHHHH
Q 014352 355 RIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 355 ~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
+++.+||+.+|.+||++.+++.+
T Consensus 251 ~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 251 GFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred HHHHHHccCChhhCcCHHHHhcC
Confidence 99999999999999999999965
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=296.49 Aligned_cols=254 Identities=24% Similarity=0.319 Sum_probs=194.1
Q ss_pred hhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc--cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecC
Q 014352 120 NFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH--QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMS 196 (426)
Q Consensus 120 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 196 (426)
+..+.||.|+||.||+|+.. ++..+|+|.+..... .....+.+|++++++++||||+++++++.+.+..++||||+.
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (284)
T cd07860 3 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH 82 (284)
T ss_pred eeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc
Confidence 45568999999999999875 688999998865432 223568899999999999999999999999999999999995
Q ss_pred CCChhHHhhhc-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC-CCcc
Q 014352 197 NGSLSNLIYSE-ERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD-GRNS 274 (426)
Q Consensus 197 ~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-~~~~ 274 (426)
++|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++...... ....
T Consensus 83 -~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (284)
T cd07860 83 -QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT 158 (284)
T ss_pred -cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCccccc
Confidence 6898888553 356899999999999999999999998 999999999999999999999999998743322 1223
Q ss_pred cCccccCccCccccccCC-CCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccc---cchh-------hhhh--hhh
Q 014352 275 GLKGTYGYIDPAYISTNK-FTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQ---DGVD-------EILD--KQL 341 (426)
Q Consensus 275 ~~~gt~~y~aPE~~~~~~-~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~---~~~~-------~~~~--~~~ 341 (426)
...++..|+|||.+.+.. ++.++||||||+++|||+||+.||....+......... .... .... ..+
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd07860 159 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSF 238 (284)
T ss_pred cccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhc
Confidence 345688999999886644 58899999999999999999999965433222111000 0000 0000 000
Q ss_pred cc-------cCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 342 VG-------ACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 342 ~~-------~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
.. .........+.+++.+||+.||++|||+.+++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 239 PKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred ccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 00 0001123567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=289.12 Aligned_cols=246 Identities=28% Similarity=0.429 Sum_probs=202.4
Q ss_pred hhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc--cChHHHHHHHHHHhcCCCCceeeEEeEEEeC--CeEEEEEEe
Q 014352 120 NFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH--QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDK--GKYMLIYEF 194 (426)
Q Consensus 120 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~ 194 (426)
...+.||+|++|.||+|... ++..+++|++..... ...+.+.+|+.++++++||||+++++.+... +..++++||
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 82 (260)
T cd06606 3 TRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEY 82 (260)
T ss_pred eeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEe
Confidence 34578999999999999986 688899999876542 3356789999999999999999999999988 889999999
Q ss_pred cCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCC--
Q 014352 195 MSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGR-- 272 (426)
Q Consensus 195 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~-- 272 (426)
+++++|.+++.... .+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 83 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 158 (260)
T cd06606 83 VSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGE 158 (260)
T ss_pred cCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccccccc
Confidence 99999999986554 7999999999999999999999988 99999999999999999999999999875543332
Q ss_pred -cccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHH-HhhccccchhhhhhhhhcccCCHHHH
Q 014352 273 -NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVN-LASMSQDGVDEILDKQLVGACNIQEV 350 (426)
Q Consensus 273 -~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (426)
.....++..|+|||.+....++.++||||||+++++|++|..||........ ...... .......+....
T Consensus 159 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~ 230 (260)
T cd06606 159 GTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGS--------SGEPPEIPEHLS 230 (260)
T ss_pred cccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccc--------cCCCcCCCcccC
Confidence 3456688999999999888899999999999999999999999976431111 111100 011111222335
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 351 RELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 351 ~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
..+.+++.+|++.+|++||++.+++.+
T Consensus 231 ~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 231 EEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred HHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 689999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=294.86 Aligned_cols=243 Identities=26% Similarity=0.398 Sum_probs=196.6
Q ss_pred cccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCCCChh
Q 014352 123 NILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLS 201 (426)
Q Consensus 123 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 201 (426)
..||+|+||.||++... ++..+|+|.+..........+.+|+.++++++|+|++++++++...+..+++|||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 46999999999999875 78899999886544444567889999999999999999999999999999999999999999
Q ss_pred HHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC-CcccCcccc
Q 014352 202 NLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG-RNSGLKGTY 280 (426)
Q Consensus 202 ~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-~~~~~~gt~ 280 (426)
+++.. ..+++.....++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... ......++.
T Consensus 106 ~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 180 (292)
T cd06657 106 DIVTH--TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTP 180 (292)
T ss_pred HHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccccccccccCc
Confidence 98743 35889999999999999999999998 9999999999999999999999999886433221 223356889
Q ss_pred CccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHHHHHc
Q 014352 281 GYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKC 360 (426)
Q Consensus 281 ~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c 360 (426)
.|+|||.+.+..++.++|+||||+++|+|++|..||............... ...... ........+.+++.+|
T Consensus 181 ~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~-----~~~~~~--~~~~~~~~l~~li~~~ 253 (292)
T cd06657 181 YWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN-----LPPKLK--NLHKVSPSLKGFLDRL 253 (292)
T ss_pred cccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhh-----CCcccC--CcccCCHHHHHHHHHH
Confidence 999999998888999999999999999999999998754332221111100 000000 0112345688999999
Q ss_pred ccCCCCCCCCHHHHHHH
Q 014352 361 LHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 361 l~~~p~~RPs~~evl~~ 377 (426)
|+.+|.+||++.+++.+
T Consensus 254 l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 254 LVRDPAQRATAAELLKH 270 (292)
T ss_pred HhCCcccCcCHHHHhcC
Confidence 99999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=293.23 Aligned_cols=254 Identities=25% Similarity=0.331 Sum_probs=195.4
Q ss_pred hhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccC--hHHHHHHHHHHhcC---CCCceeeEEeEEEeCCe-----E
Q 014352 120 NFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQG--EKEFQTEVSLLGRL---HHRNLVNLIGYCVDKGK-----Y 188 (426)
Q Consensus 120 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~-----~ 188 (426)
++.+.||+|+||.||+|+.. ++..+|+|.+....... ...+.+|+.+++++ +|||++++++++...+. .
T Consensus 2 ~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~ 81 (287)
T cd07838 2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKL 81 (287)
T ss_pred eEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCcee
Confidence 45678999999999999986 58899999987543221 23566787777665 69999999999988776 8
Q ss_pred EEEEEecCCCChhHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccc
Q 014352 189 MLIYEFMSNGSLSNLIYSEE-RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEE 267 (426)
Q Consensus 189 ~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 267 (426)
+++|||+++ +|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 82 ~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~~ 157 (287)
T cd07838 82 TLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIY 157 (287)
T ss_pred EEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcceec
Confidence 999999974 8988886543 35899999999999999999999998 999999999999999999999999998765
Q ss_pred ccCCCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccc----cchhh--------
Q 014352 268 VFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQ----DGVDE-------- 335 (426)
Q Consensus 268 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~----~~~~~-------- 335 (426)
..........++..|+|||.+.+..++.++|+||||+++|||++|..||...........+.. .....
T Consensus 158 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07838 158 SFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLP 237 (287)
T ss_pred cCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccc
Confidence 444333445678899999999999999999999999999999999999876433222111100 00000
Q ss_pred --hhhhhh---cccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 336 --ILDKQL---VGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 336 --~~~~~~---~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
...... ...........+.+++.+||+.||.+||++.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 238 RSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred hhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 000000 001112334678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=288.91 Aligned_cols=247 Identities=27% Similarity=0.423 Sum_probs=202.9
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc--cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEec
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH--QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 195 (426)
|.+.+.||.|+||.||++... ++..+++|.+..... .....+.+|++++++++|||++++++.+...+..++|+||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd08215 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYA 81 (258)
T ss_pred ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEec
Confidence 345678999999999999976 688999999876543 34467889999999999999999999999999999999999
Q ss_pred CCCChhHHhhhc---cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC-
Q 014352 196 SNGSLSNLIYSE---ERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG- 271 (426)
Q Consensus 196 ~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~- 271 (426)
++++|.+++... ...+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 158 (258)
T cd08215 82 DGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD 158 (258)
T ss_pred CCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCcc
Confidence 999999998664 367999999999999999999999998 9999999999999999999999999987543332
Q ss_pred CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHH
Q 014352 272 RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVR 351 (426)
Q Consensus 272 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (426)
......|++.|+|||...+..++.++|+||||+++++|++|..||................ ....+.....
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~---------~~~~~~~~~~ 229 (258)
T cd08215 159 LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ---------YPPIPSQYSS 229 (258)
T ss_pred eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC---------CCCCCCCCCH
Confidence 2234568889999999998889999999999999999999999986543221111111111 1111223446
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 352 ELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 352 ~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
.+.+++.+||..+|++|||+.+++++
T Consensus 230 ~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 230 ELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 78999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=298.81 Aligned_cols=254 Identities=21% Similarity=0.308 Sum_probs=193.1
Q ss_pred ccccC--CCeeEEEEEeC-CCcEEEEEEeccCCcc--ChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCCC
Q 014352 124 ILGQG--AFGPVYKATMP-SGGVAAIKVLASDSHQ--GEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNG 198 (426)
Q Consensus 124 ~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 198 (426)
.||+| +||+||++... +++.||+|++...... ..+.+.+|+.+++.++||||+++++++..++..++|+||++++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 46666 99999999875 7899999998754322 2356889999999999999999999999999999999999999
Q ss_pred ChhHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCC-----
Q 014352 199 SLSNLIYSEE-RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGR----- 272 (426)
Q Consensus 199 sL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~----- 272 (426)
+|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++++||+.+........
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (328)
T cd08226 85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV 161 (328)
T ss_pred CHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence 9999886543 45889999999999999999999988 99999999999999999999999985432111110
Q ss_pred ---cccCccccCccCccccccC--CCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhcccc-ch------------h
Q 014352 273 ---NSGLKGTYGYIDPAYISTN--KFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQD-GV------------D 334 (426)
Q Consensus 273 ---~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~-~~------------~ 334 (426)
.....++..|+|||++.+. .++.++||||||+++|||++|..||............... .. .
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (328)
T cd08226 162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEES 241 (328)
T ss_pred ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhh
Confidence 1112346679999999763 5789999999999999999999999764332221110000 00 0
Q ss_pred ------------------------hhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 014352 335 ------------------------EILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLK 380 (426)
Q Consensus 335 ------------------------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 380 (426)
...+..............+.+++.+||+.||++|||+.+++++-.-
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~ 311 (328)
T cd08226 242 RMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFF 311 (328)
T ss_pred hhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHH
Confidence 0000111111223456789999999999999999999999876543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=298.78 Aligned_cols=255 Identities=26% Similarity=0.341 Sum_probs=195.3
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccC--hHHHHHHHHHHhcCCCCceeeEEeEEEeC--CeEEEEEE
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQG--EKEFQTEVSLLGRLHHRNLVNLIGYCVDK--GKYMLIYE 193 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e 193 (426)
|++.+.||.|+||.||+|... ++..||+|.+....... ...+.+|+.++++++|+||+++++++... +..++|||
T Consensus 9 y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 88 (309)
T cd07845 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVME 88 (309)
T ss_pred eeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEe
Confidence 556678999999999999975 68899999986543221 23466899999999999999999998765 56899999
Q ss_pred ecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC-CC
Q 014352 194 FMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD-GR 272 (426)
Q Consensus 194 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-~~ 272 (426)
|+.+ +|.+++......+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++...... ..
T Consensus 89 ~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~ 164 (309)
T cd07845 89 YCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP 164 (309)
T ss_pred cCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCCccCC
Confidence 9964 898888665567999999999999999999999998 999999999999999999999999998754332 12
Q ss_pred cccCccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccc---cchhhhh----h----hh
Q 014352 273 NSGLKGTYGYIDPAYIST-NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQ---DGVDEIL----D----KQ 340 (426)
Q Consensus 273 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~---~~~~~~~----~----~~ 340 (426)
.....++..|+|||.+.+ ..++.++||||||+++|||++|..||........+..+.. ....... + ..
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (309)
T cd07845 165 MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGK 244 (309)
T ss_pred CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccccccc
Confidence 233346788999999865 5678999999999999999999999976443322211110 0000000 0 00
Q ss_pred hc-ccC--------CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 341 LV-GAC--------NIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 341 ~~-~~~--------~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
.. ... .......+.+++.+||+.||++|||+.+++.+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 245 FTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred ccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00 000 01124678899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=298.71 Aligned_cols=255 Identities=19% Similarity=0.269 Sum_probs=193.4
Q ss_pred hhcccccCCCeeEEEEEeCCCcEEEEEEeccC--CccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCCC
Q 014352 121 FTNILGQGAFGPVYKATMPSGGVAAIKVLASD--SHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNG 198 (426)
Q Consensus 121 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 198 (426)
+++.+|.|+++.||+++. ++..+|+|++... .....+.+..|+.++++++||||+++++++...+..+++|||+++|
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 344556666666666655 7889999998754 2233467899999999999999999999999999999999999999
Q ss_pred ChhHHhhhc-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC------
Q 014352 199 SLSNLIYSE-ERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG------ 271 (426)
Q Consensus 199 sL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~------ 271 (426)
+|.+++... ...+++.....++.|++.||.|||+++ |+||||||+||+++.++.+||+|||.+.......
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 85 SCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred CHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 999999653 345889999999999999999999998 9999999999999999999999999876432211
Q ss_pred --CcccCccccCccCcccccc--CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhh----------
Q 014352 272 --RNSGLKGTYGYIDPAYIST--NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEIL---------- 337 (426)
Q Consensus 272 --~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---------- 337 (426)
......++..|+|||++.. ..++.++|+||||+++|||++|..||....................+
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYED 241 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcC
Confidence 1123456788999999865 45889999999999999999999999764332221110000000000
Q ss_pred ----------hh----hhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 014352 338 ----------DK----QLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALL 379 (426)
Q Consensus 338 ----------~~----~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 379 (426)
++ ............++.+++.+||+.||++|||+.+++++-.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~ 297 (314)
T cd08216 242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSF 297 (314)
T ss_pred CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCch
Confidence 00 0011112234567899999999999999999999998643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=291.95 Aligned_cols=242 Identities=26% Similarity=0.392 Sum_probs=194.8
Q ss_pred cccCCCeeEEEEEeC-CCcEEEEEEeccCCc---cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCCCCh
Q 014352 125 LGQGAFGPVYKATMP-SGGVAAIKVLASDSH---QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSL 200 (426)
Q Consensus 125 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 200 (426)
||.|+||.||++... +++.+++|.+..... ...+.+.+|++++++++||||+++++.+...+..++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999986 588999999875533 2345788999999999999999999999999999999999999999
Q ss_pred hHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC---------
Q 014352 201 SNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG--------- 271 (426)
Q Consensus 201 ~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~--------- 271 (426)
.+++.... .+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 81 ASLLENVG-SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence 99996544 6899999999999999999999998 9999999999999999999999999987533221
Q ss_pred CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHH
Q 014352 272 RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVR 351 (426)
Q Consensus 272 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (426)
......++..|+|||......++.++||||||+++|++++|..||.............. ...........+.
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~ 228 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN--------GKIEWPEDVEVSD 228 (265)
T ss_pred cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--------CCcCCCccccCCH
Confidence 12334678899999999888899999999999999999999999975432221111111 0000011111256
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014352 352 ELARIGHKCLHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 352 ~l~~l~~~cl~~~p~~RPs~~evl~~L 378 (426)
.+.+++.+||+.+|++|||+..+.+.|
T Consensus 229 ~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 229 EAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred HHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 789999999999999999995555443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=296.13 Aligned_cols=250 Identities=26% Similarity=0.406 Sum_probs=194.9
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc-cChHHHHHHHHHHhcCC-CCceeeEEeEEEeCCeEEEEEEec
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH-QGEKEFQTEVSLLGRLH-HRNLVNLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~ 195 (426)
+.+.+.||+|+||.||+|... ++..+|+|.+..... .....+..|+.++.+.. ||||+++++++.+....+++|||+
T Consensus 17 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 96 (296)
T cd06618 17 LENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM 96 (296)
T ss_pred heeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeecc
Confidence 456789999999999999986 488999999875432 22345666777776664 999999999999999999999998
Q ss_pred CCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCcc
Q 014352 196 SNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHE-GAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNS 274 (426)
Q Consensus 196 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 274 (426)
+ ++|.+++......+++..+..++.+++.||.|||+ .+ |+||||+|+||++++++.+||+|||++..........
T Consensus 97 ~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~~ 172 (296)
T cd06618 97 S-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKT 172 (296)
T ss_pred C-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCCCccc
Confidence 5 47888776655679999999999999999999997 46 9999999999999999999999999987543333334
Q ss_pred cCccccCccCccccccCC----CCcchhhHHHHHHHHHHHhCCCCCCchHHH-HHHhhccccchhhhhhhhhcccCCHHH
Q 014352 275 GLKGTYGYIDPAYISTNK----FTMKSDIFSFGVIIFELITAIHPHQNLMEY-VNLASMSQDGVDEILDKQLVGACNIQE 349 (426)
Q Consensus 275 ~~~gt~~y~aPE~~~~~~----~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (426)
...++..|+|||.+.+.. ++.++||||||+++|+|++|+.||...... ..+.......... . ......
T Consensus 173 ~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-----~--~~~~~~ 245 (296)
T cd06618 173 RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPS-----L--PPNEGF 245 (296)
T ss_pred CCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCC-----C--CCCCCC
Confidence 445788999999987554 788999999999999999999999753221 1111111111000 0 001123
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 014352 350 VRELARIGHKCLHKTPRKRPSIGEVTQALL 379 (426)
Q Consensus 350 ~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 379 (426)
..++.+++.+||+.||.+||++.+++++..
T Consensus 246 ~~~l~~li~~~l~~~p~~Rp~~~~il~~~~ 275 (296)
T cd06618 246 SPDFCSFVDLCLTKDHRKRPKYRELLQHPF 275 (296)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 467899999999999999999999997743
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=288.24 Aligned_cols=246 Identities=24% Similarity=0.356 Sum_probs=195.9
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC-----ccChHHHHHHHHHHhcCCCCceeeEEeEEEeC--CeEEE
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS-----HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDK--GKYML 190 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l 190 (426)
|.+.+.||+|+||.||+|... ++..+|+|.+.... ......+.+|++++++++||||+++++++.+. +.+++
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (264)
T cd06653 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSI 83 (264)
T ss_pred eeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEE
Confidence 456789999999999999865 68899999875321 12234688999999999999999999998764 46889
Q ss_pred EEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC
Q 014352 191 IYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD 270 (426)
Q Consensus 191 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 270 (426)
++||+++++|.+++... ..+++.....++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||+++.....
T Consensus 84 v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 159 (264)
T cd06653 84 FVEYMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTI 159 (264)
T ss_pred EEEeCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccccccc
Confidence 99999999999998644 34889999999999999999999998 999999999999999999999999998753221
Q ss_pred ----CCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCC
Q 014352 271 ----GRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACN 346 (426)
Q Consensus 271 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (426)
.......++..|+|||++.+..++.++|+||||+++|++++|..||............ .........+
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--------~~~~~~~~~p 231 (264)
T cd06653 160 CMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKI--------ATQPTKPMLP 231 (264)
T ss_pred cccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHH--------HcCCCCCCCC
Confidence 1122356889999999999888999999999999999999999999764332221111 1111111223
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 347 IQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 347 ~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
....+.+.+++.+||+ +|..||+..+++.+
T Consensus 232 ~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 232 DGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred cccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 3455779999999999 57999999988764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=296.35 Aligned_cols=255 Identities=25% Similarity=0.348 Sum_probs=191.7
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCcc--ChHHHHHHHHHHhcCCCCceeeEEeEEEeCC--------e
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQ--GEKEFQTEVSLLGRLHHRNLVNLIGYCVDKG--------K 187 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--------~ 187 (426)
|.+.+.||+|+||.||+|... ++..+|+|.+...... ....+.+|++++++++||||+++++++...+ .
T Consensus 14 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 93 (310)
T cd07865 14 YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGS 93 (310)
T ss_pred eEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCce
Confidence 566788999999999999975 6889999988654222 2335678999999999999999999987654 4
Q ss_pred EEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccc
Q 014352 188 YMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEE 267 (426)
Q Consensus 188 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 267 (426)
.++||||+. ++|.+.+......+++.++..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++...
T Consensus 94 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 169 (310)
T cd07865 94 FYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAF 169 (310)
T ss_pred EEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCCcccc
Confidence 599999996 4888888665557899999999999999999999998 999999999999999999999999998743
Q ss_pred ccCC-----CcccCccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHh---hccccchhhh--
Q 014352 268 VFDG-----RNSGLKGTYGYIDPAYISTN-KFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLA---SMSQDGVDEI-- 336 (426)
Q Consensus 268 ~~~~-----~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~---~~~~~~~~~~-- 336 (426)
.... ......++..|+|||.+.+. .++.++||||||+++|||++|..||.......... .+......++
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (310)
T cd07865 170 SLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWP 249 (310)
T ss_pred cCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence 2221 11234577889999988664 47889999999999999999999987543221111 1000000000
Q ss_pred -------hhh-hhcccC---------CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 337 -------LDK-QLVGAC---------NIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 337 -------~~~-~~~~~~---------~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
.+. ...... .......+.+++.+||..||++|||+.+++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 250 GVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred cccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 000 000000 00012457789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=287.88 Aligned_cols=241 Identities=25% Similarity=0.329 Sum_probs=187.3
Q ss_pred cccccCCCeeEEEEEeC-CCcEEEEEEeccCCccC---hHHHHHHHHH-HhcCCCCceeeEEeEEEeCCeEEEEEEecCC
Q 014352 123 NILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQG---EKEFQTEVSL-LGRLHHRNLVNLIGYCVDKGKYMLIYEFMSN 197 (426)
Q Consensus 123 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 197 (426)
+.||.|+||.||+|... +++.+|+|.+....... ...+..|..+ ....+|||++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 36999999999999875 67899999986543211 1234445444 4455899999999999999999999999999
Q ss_pred CChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCcccCc
Q 014352 198 GSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLK 277 (426)
Q Consensus 198 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 277 (426)
++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+++.... .....
T Consensus 82 ~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~~~~~ 154 (260)
T cd05611 82 GDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NKKFV 154 (260)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc---cccCC
Confidence 9999998544 45899999999999999999999998 99999999999999999999999999875332 33456
Q ss_pred cccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHHH
Q 014352 278 GTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIG 357 (426)
Q Consensus 278 gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 357 (426)
++..|+|||.+.+..++.++||||||+++|+|++|..||...........+..... ..........+..+.+++
T Consensus 155 ~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~i 228 (260)
T cd05611 155 GTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRI------NWPEEVKEFCSPEAVDLI 228 (260)
T ss_pred CCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccc------CCCCcccccCCHHHHHHH
Confidence 88899999999888899999999999999999999999965432221111100000 000011112346799999
Q ss_pred HHcccCCCCCCCCHHHHHH
Q 014352 358 HKCLHKTPRKRPSIGEVTQ 376 (426)
Q Consensus 358 ~~cl~~~p~~RPs~~evl~ 376 (426)
.+||+.+|++||++.++.+
T Consensus 229 ~~~l~~~p~~R~~~~~~~~ 247 (260)
T cd05611 229 NRLLCMDPAKRLGANGYQE 247 (260)
T ss_pred HHHccCCHHHccCCCcHHH
Confidence 9999999999997754443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=288.25 Aligned_cols=246 Identities=25% Similarity=0.369 Sum_probs=201.6
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc--cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEec
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH--QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 195 (426)
|.+.+.||.|+||.||+++.. ++..+++|.+..... .....+.+|++++++++|+||+++++++.+....++|+||+
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd08530 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYA 81 (256)
T ss_pred ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhc
Confidence 445678999999999999865 678899999875432 22346788999999999999999999999999999999999
Q ss_pred CCCChhHHhhhc---cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCC
Q 014352 196 SNGSLSNLIYSE---ERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGR 272 (426)
Q Consensus 196 ~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 272 (426)
++++|.+++... ...+++..++.++.+++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++...... .
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-~ 157 (256)
T cd08530 82 PFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN-M 157 (256)
T ss_pred CCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-C
Confidence 999999998552 256899999999999999999999998 999999999999999999999999998765433 3
Q ss_pred cccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHH
Q 014352 273 NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRE 352 (426)
Q Consensus 273 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (426)
.....++..|+|||.+.+..++.++|+||||+++|+|++|+.||............ ........+.....+
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~ 228 (256)
T cd08530 158 AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKV---------QRGKYPPIPPIYSQD 228 (256)
T ss_pred cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---------hcCCCCCCchhhCHH
Confidence 33456889999999999999999999999999999999999999754332111111 111111122345567
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 353 LARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 353 l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
+.+++.+||+.+|++|||+.+++++
T Consensus 229 ~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 229 LQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred HHHHHHHHcCCCcccCCCHHHHhcC
Confidence 9999999999999999999999865
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=285.08 Aligned_cols=245 Identities=30% Similarity=0.436 Sum_probs=201.4
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc--cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEec
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH--QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 195 (426)
|.+.+.||+|++|.||++... ++..+++|.+..... .....+.+|++++++++|||++++++++.+.+..++++||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (254)
T cd06627 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA 81 (254)
T ss_pred ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence 445678999999999999875 677899999876643 23457899999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCC-cc
Q 014352 196 SNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGR-NS 274 (426)
Q Consensus 196 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~-~~ 274 (426)
++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++........ ..
T Consensus 82 ~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 157 (254)
T cd06627 82 ENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDA 157 (254)
T ss_pred CCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCccccc
Confidence 999999998654 56899999999999999999999998 99999999999999999999999999875433222 23
Q ss_pred cCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHH
Q 014352 275 GLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELA 354 (426)
Q Consensus 275 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 354 (426)
...++..|+|||...+..++.++||||||+++|+|++|..||................ ....+......+.
T Consensus 158 ~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~ 228 (254)
T cd06627 158 SVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDD---------HPPLPEGISPELK 228 (254)
T ss_pred ccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccC---------CCCCCCCCCHHHH
Confidence 4568889999999988888999999999999999999999987644322222111111 0111222346788
Q ss_pred HHHHHcccCCCCCCCCHHHHHH
Q 014352 355 RIGHKCLHKTPRKRPSIGEVTQ 376 (426)
Q Consensus 355 ~l~~~cl~~~p~~RPs~~evl~ 376 (426)
+++.+||..+|++|||+.+++.
T Consensus 229 ~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 229 DFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred HHHHHHHhCChhhCcCHHHHhc
Confidence 9999999999999999999885
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=294.60 Aligned_cols=255 Identities=24% Similarity=0.273 Sum_probs=192.7
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc--cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEec
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH--QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 195 (426)
|.+.+.||+|+||.||+|... +++.+|+|.+..... ...+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (294)
T PLN00009 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYL 83 (294)
T ss_pred eEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEecc
Confidence 456678999999999999976 678999998865432 22356889999999999999999999999999999999999
Q ss_pred CCCChhHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecC-CCcEEEeeecCccccccC-CC
Q 014352 196 SNGSLSNLIYSEE-RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDH-FMRAKVADFGLSKEEVFD-GR 272 (426)
Q Consensus 196 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgl~~~~~~~-~~ 272 (426)
+ ++|.+++.... ..+++.....++.|++.||.|||+++ ++|+||+|+||+++. ++.+||+|||++...... ..
T Consensus 84 ~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~ 159 (294)
T PLN00009 84 D-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (294)
T ss_pred c-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCCccc
Confidence 6 58887774433 33678888899999999999999998 999999999999985 557999999998753222 12
Q ss_pred cccCccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhcc---ccchhhhh-------h---
Q 014352 273 NSGLKGTYGYIDPAYIST-NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMS---QDGVDEIL-------D--- 338 (426)
Q Consensus 273 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~---~~~~~~~~-------~--- 338 (426)
.....+++.|+|||++.+ ..++.++||||||+++|+|+||..||....+......+. ........ +
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (294)
T PLN00009 160 FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKS 239 (294)
T ss_pred cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhh
Confidence 233457889999998865 457899999999999999999999997543322211100 00000000 0
Q ss_pred --hhhcc----cCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 339 --KQLVG----ACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 339 --~~~~~----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
+.... ......+..+.+++.+|++.+|++||++.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 240 AFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 0011234568899999999999999999999974
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=304.02 Aligned_cols=245 Identities=26% Similarity=0.395 Sum_probs=206.5
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccC--hHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEec
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQG--EKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 195 (426)
|.+...||+|.|++|..++.. ++..||||.+.+..... ...+.+|+++|..++|||||+++.+......+|+||||+
T Consensus 58 y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya 137 (596)
T KOG0586|consen 58 YVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYA 137 (596)
T ss_pred eeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEec
Confidence 445678999999999999865 78899999998764332 245889999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCccc
Q 014352 196 SNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSG 275 (426)
Q Consensus 196 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 275 (426)
.+|.+++++...++. .......++.|+..|++|||+++ |+|||||++||||+.+.++||+|||++...........
T Consensus 138 ~~ge~~~yl~~~gr~-~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~lqt 213 (596)
T KOG0586|consen 138 SGGELFDYLVKHGRM-KEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDYGLMLQT 213 (596)
T ss_pred cCchhHHHHHhcccc-hhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecccccccc
Confidence 999999999877764 44788889999999999999999 99999999999999999999999999998777777889
Q ss_pred CccccCccCccccccCCCC-cchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccC--CHHHHHH
Q 014352 276 LKGTYGYIDPAYISTNKFT-MKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGAC--NIQEVRE 352 (426)
Q Consensus 276 ~~gt~~y~aPE~~~~~~~~-~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 352 (426)
.+|++.|.|||.+.+..|+ +.+|+||+|+++|-|+.|..||.+.. +.++-++.+.+.. +...+.+
T Consensus 214 ~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~------------lk~Lr~rvl~gk~rIp~~ms~d 281 (596)
T KOG0586|consen 214 FCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN------------LKELRPRVLRGKYRIPFYMSCD 281 (596)
T ss_pred cCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc------------cccccchheeeeecccceeech
Confidence 9999999999999998875 78999999999999999999998521 1111122222211 1223346
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHHHH
Q 014352 353 LARIGHKCLHKTPRKRPSIGEVTQALL 379 (426)
Q Consensus 353 l~~l~~~cl~~~p~~RPs~~evl~~L~ 379 (426)
.-+++++++-.+|.+|++++++.+.-.
T Consensus 282 ce~lLrk~lvl~Pskr~~~dqim~~~W 308 (596)
T KOG0586|consen 282 CEDLLRKFLVLNPSKRGPCDQIMKDRW 308 (596)
T ss_pred hHHHHHHhhccCccccCCHHHhhhhcc
Confidence 778899999999999999999877643
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=292.50 Aligned_cols=253 Identities=25% Similarity=0.310 Sum_probs=198.4
Q ss_pred hhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCcc--ChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCC
Q 014352 121 FTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQ--GEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSN 197 (426)
Q Consensus 121 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 197 (426)
+.+.||.|++|.||++... ++..+++|.+...... ....+..|+.++++++|+||+++++++..++..++|+||+++
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 82 (283)
T cd05118 3 KLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT 82 (283)
T ss_pred cceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC
Confidence 4567999999999999875 7888999998755332 345788899999999999999999999999999999999975
Q ss_pred CChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC-CcccC
Q 014352 198 GSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG-RNSGL 276 (426)
Q Consensus 198 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-~~~~~ 276 (426)
+|.+++......+++..+..++.+++.||.|||+.+ ++|+||||+||+++.++.++|+|||.+....... .....
T Consensus 83 -~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~ 158 (283)
T cd05118 83 -DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHY 158 (283)
T ss_pred -CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCc
Confidence 888888665567999999999999999999999998 9999999999999999999999999987543322 22335
Q ss_pred ccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhcc---cc----chhhhhh------hhhc
Q 014352 277 KGTYGYIDPAYISTN-KFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMS---QD----GVDEILD------KQLV 342 (426)
Q Consensus 277 ~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~---~~----~~~~~~~------~~~~ 342 (426)
.++..|+|||.+.+. .++.++|+||||+++|+|++|+.||............. .. ......+ ....
T Consensus 159 ~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05118 159 VVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFP 238 (283)
T ss_pred cCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhc
Confidence 578899999998776 78999999999999999999999996543322111100 00 0000000 0000
Q ss_pred -------ccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 343 -------GACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 343 -------~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
.......+..+.+++.+||+.||.+||++.+++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 239 KKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred cccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 00112345689999999999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=291.69 Aligned_cols=255 Identities=25% Similarity=0.325 Sum_probs=195.5
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCcc-ChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecC
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQ-GEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMS 196 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 196 (426)
|++.+.||.|++|.||+|+.. ++..+|+|.+...... ....+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (284)
T cd07836 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD 81 (284)
T ss_pred ceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC
Confidence 445678999999999999975 6888999998765322 34567789999999999999999999999999999999998
Q ss_pred CCChhHHhhhcc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC-CCc
Q 014352 197 NGSLSNLIYSEE--RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD-GRN 273 (426)
Q Consensus 197 ~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-~~~ 273 (426)
+ +|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++...... ...
T Consensus 82 ~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~ 157 (284)
T cd07836 82 K-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTF 157 (284)
T ss_pred c-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcccc
Confidence 5 8888875543 46899999999999999999999998 999999999999999999999999998743222 122
Q ss_pred ccCccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhcc-------ccchhhhh-----hhh
Q 014352 274 SGLKGTYGYIDPAYIST-NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMS-------QDGVDEIL-----DKQ 340 (426)
Q Consensus 274 ~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~-------~~~~~~~~-----~~~ 340 (426)
....++..|++||++.+ ..++.++||||||+++|++++|..||............. ......+. ...
T Consensus 158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07836 158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPT 237 (284)
T ss_pred ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccc
Confidence 33457889999998865 457889999999999999999999997533211111000 00000000 000
Q ss_pred hc-------ccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 341 LV-------GACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 341 ~~-------~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
.. .......+..+.+++.+||+.||++||++.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 238 FPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred ccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00 00011234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=297.37 Aligned_cols=255 Identities=24% Similarity=0.309 Sum_probs=192.1
Q ss_pred hhhhcccccCCCeeEEEEEeC---CCcEEEEEEeccCC---ccChHHHHHHHHHHhcCCCCceeeEEeEEEeC--CeEEE
Q 014352 119 QNFTNILGQGAFGPVYKATMP---SGGVAAIKVLASDS---HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDK--GKYML 190 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l 190 (426)
|.+.+.||+|+||.||+|... ++..+|+|.+.... ......+.+|+.++++++||||+++++++.+. +.+++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 456678999999999999975 46899999987643 23345678899999999999999999999988 78999
Q ss_pred EEEecCCCChhHHhhhc----cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecC----CCcEEEeeec
Q 014352 191 IYEFMSNGSLSNLIYSE----ERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDH----FMRAKVADFG 262 (426)
Q Consensus 191 v~e~~~~gsL~~~l~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~----~~~~kl~Dfg 262 (426)
||||+++ +|.+++... ...++...+..++.|++.||.|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 9999975 677666322 136889999999999999999999998 999999999999999 9999999999
Q ss_pred CccccccCC----CcccCccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHH---------HHhh-
Q 014352 263 LSKEEVFDG----RNSGLKGTYGYIDPAYIST-NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYV---------NLAS- 327 (426)
Q Consensus 263 l~~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~---------~~~~- 327 (426)
++....... ......++..|+|||.+.+ ..++.++||||||+++++|++|..||....... .+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence 987533221 1234567889999998866 457899999999999999999999986432211 0000
Q ss_pred ---cccc------------chhhhhhhhhcccCC-----------HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 328 ---MSQD------------GVDEILDKQLVGACN-----------IQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 328 ---~~~~------------~~~~~~~~~~~~~~~-----------~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
+... ......+.......+ ......+.+++.+||+.||++|||+.+++++
T Consensus 238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0000 000000000000000 0233568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=292.22 Aligned_cols=254 Identities=25% Similarity=0.343 Sum_probs=196.0
Q ss_pred hhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCcc-ChHHHHHHHHHHhcCC-CCceeeEEeEEEeCCeEEEEEEecC
Q 014352 120 NFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQ-GEKEFQTEVSLLGRLH-HRNLVNLIGYCVDKGKYMLIYEFMS 196 (426)
Q Consensus 120 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~ 196 (426)
.+.+.||.|+||+||+|+.. +++.+++|.+...... ......+|+..+++++ |||++++++++.+++..++||||+
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~- 80 (283)
T cd07830 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM- 80 (283)
T ss_pred eeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-
Confidence 45678999999999999986 5778999998654322 2234567899999999 999999999999999999999999
Q ss_pred CCChhHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCccc
Q 014352 197 NGSLSNLIYSEE-RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSG 275 (426)
Q Consensus 197 ~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 275 (426)
+|+|.+++.... ..+++..+..++.|++.+|.|||+++ ++|+||+|+||+++.++.++|+|||++...........
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 157 (283)
T cd07830 81 EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTD 157 (283)
T ss_pred CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCC
Confidence 789999886654 56899999999999999999999998 99999999999999999999999999976544333445
Q ss_pred CccccCccCccccc-cCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhcc---ccchh----------hhhhhhh
Q 014352 276 LKGTYGYIDPAYIS-TNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMS---QDGVD----------EILDKQL 341 (426)
Q Consensus 276 ~~gt~~y~aPE~~~-~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~---~~~~~----------~~~~~~~ 341 (426)
..++..|+|||++. +..++.++|+||||+++|||++|..||............. ..... ..++...
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd07830 158 YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRF 237 (283)
T ss_pred CCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccc
Confidence 56888999999884 4557899999999999999999999986543221111000 00000 0000000
Q ss_pred cc-------cCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 342 VG-------ACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 342 ~~-------~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
.. .........+.+++.+||+.+|++|||+.|++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 238 PQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred cccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 00 0001123678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=297.65 Aligned_cols=251 Identities=23% Similarity=0.367 Sum_probs=199.4
Q ss_pred HHHHhhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCC--ccChHHHHHHHHHHhcCC-CCceeeEEeEEEeCCeEEEE
Q 014352 115 QKATQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDS--HQGEKEFQTEVSLLGRLH-HRNLVNLIGYCVDKGKYMLI 191 (426)
Q Consensus 115 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv 191 (426)
....|++.++||+||.+.||++...+.+.+|+|++.... .+...-|.+|+..|.+|+ |.+||++++|-..++.+|||
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 344567778999999999999998888888888775443 223457999999999995 99999999999999999999
Q ss_pred EEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC
Q 014352 192 YEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG 271 (426)
Q Consensus 192 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 271 (426)
|||= .-+|..+|.+....++...+..+..|++.|+.++|..+ |||.||||.|+|+-. |.+||+|||+|.....+.
T Consensus 439 mE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 439 MECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDT 513 (677)
T ss_pred eecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCccc
Confidence 9975 56999999877665554477789999999999999999 999999999999987 899999999998654433
Q ss_pred C---cccCccccCccCccccccCC-----------CCcchhhHHHHHHHHHHHhCCCCCCchHH-HHHHhhccccchhhh
Q 014352 272 R---NSGLKGTYGYIDPAYISTNK-----------FTMKSDIFSFGVIIFELITAIHPHQNLME-YVNLASMSQDGVDEI 336 (426)
Q Consensus 272 ~---~~~~~gt~~y~aPE~~~~~~-----------~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~ 336 (426)
. ....+||+.||+||.+.... .+.++|||||||+||+|+.|++||..... +..+..+...+..-
T Consensus 514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~I- 592 (677)
T KOG0596|consen 514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEI- 592 (677)
T ss_pred cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccc-
Confidence 2 24578999999999884332 56789999999999999999999987663 33333333222110
Q ss_pred hhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 337 LDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 337 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
..+......++.++|+.||+.||.+|||..+++++
T Consensus 593 ------efp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 593 ------EFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ------cccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 11111122349999999999999999999999875
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=293.50 Aligned_cols=255 Identities=24% Similarity=0.280 Sum_probs=192.7
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCcc--ChHHHHHHHHHHhcCC-CCceeeEEeEEEeCCe-----EE
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQ--GEKEFQTEVSLLGRLH-HRNLVNLIGYCVDKGK-----YM 189 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~-----~~ 189 (426)
|.+.+.||+|+||.||+|... ++..||+|.+...... ....+.+|+.++++++ ||||+++++++...+. .+
T Consensus 3 y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~ 82 (295)
T cd07837 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLY 82 (295)
T ss_pred ceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEE
Confidence 455678999999999999975 6889999987654322 2356888999999995 6999999999887665 89
Q ss_pred EEEEecCCCChhHHhhhc----cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecC-CCcEEEeeecCc
Q 014352 190 LIYEFMSNGSLSNLIYSE----ERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDH-FMRAKVADFGLS 264 (426)
Q Consensus 190 lv~e~~~~gsL~~~l~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgl~ 264 (426)
+||||+++ +|.+++... ...+++..++.++.|++.||.|||+++ ++||||||+||+++. ++.+||+|||++
T Consensus 83 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 83 LVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred EEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecccc
Confidence 99999985 898887543 245899999999999999999999998 999999999999998 889999999998
Q ss_pred cccccC-CCcccCccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccc---cchhhh---
Q 014352 265 KEEVFD-GRNSGLKGTYGYIDPAYIST-NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQ---DGVDEI--- 336 (426)
Q Consensus 265 ~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~---~~~~~~--- 336 (426)
...... .......+++.|+|||++.+ ..++.++||||||+++|+|++|..||....+...+..+.. ......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (295)
T cd07837 159 RAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPG 238 (295)
T ss_pred eecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence 743222 22223456888999998865 4578999999999999999999999975433222111100 000000
Q ss_pred ----hh----h----hhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 337 ----LD----K----QLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 337 ----~~----~----~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
.+ + .............+.+++.+||+.||.+||++.+++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 239 VSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00 0 00000011244678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=297.59 Aligned_cols=241 Identities=26% Similarity=0.388 Sum_probs=200.7
Q ss_pred hcccccCCCeeEEEEEeC-CCcEEEEEEeccCC---ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCC
Q 014352 122 TNILGQGAFGPVYKATMP-SGGVAAIKVLASDS---HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSN 197 (426)
Q Consensus 122 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 197 (426)
-++||+||||.||-++.. +|..+|.|.+.+.. ...+.-..+|..+|.+++.+.||.+--.|.+.+.+++|+..|.|
T Consensus 190 ~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNG 269 (591)
T KOG0986|consen 190 YRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNG 269 (591)
T ss_pred eEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecC
Confidence 368999999999999865 78889988875432 23344577899999999999999999999999999999999999
Q ss_pred CChhHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCcccC
Q 014352 198 GSLSNLIYSEE-RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGL 276 (426)
Q Consensus 198 gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~ 276 (426)
|+|.-+|++.+ ..+++....-++.+|+.||++||+.+ ||.|||||+|||+|+.|+++|+|.|+|............
T Consensus 270 GDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~~~r 346 (591)
T KOG0986|consen 270 GDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPIRGR 346 (591)
T ss_pred CceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCCCccccc
Confidence 99999997655 56899999999999999999999999 999999999999999999999999999877766666777
Q ss_pred ccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHH
Q 014352 277 KGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARI 356 (426)
Q Consensus 277 ~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 356 (426)
.||.+|||||++.++.|+...|.|||||++|||+.|+.||....+.+....+...... .....+...+++..++
T Consensus 347 vGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~------~~~ey~~kFS~eaksl 420 (591)
T KOG0986|consen 347 VGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLE------DPEEYSDKFSEEAKSL 420 (591)
T ss_pred cCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhc------chhhcccccCHHHHHH
Confidence 9999999999999999999999999999999999999999765443332221111100 0112334556778888
Q ss_pred HHHcccCCCCCCCCH
Q 014352 357 GHKCLHKTPRKRPSI 371 (426)
Q Consensus 357 ~~~cl~~~p~~RPs~ 371 (426)
....|.+||.+|.-.
T Consensus 421 c~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 421 CEGLLTKDPEKRLGC 435 (591)
T ss_pred HHHHHccCHHHhccC
Confidence 889999999999543
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=293.53 Aligned_cols=258 Identities=25% Similarity=0.336 Sum_probs=195.8
Q ss_pred HHHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc--cChHHHHHHHHHHhcCCCCceeeEEeEEEeCC------
Q 014352 116 KATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH--QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKG------ 186 (426)
Q Consensus 116 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------ 186 (426)
...|.+.+.||.|+||.||+|... ++..||+|.+..... .....+.+|+.++++++||||+++++++.+..
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~ 85 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK 85 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence 344667789999999999999986 678899999875432 22346778999999999999999999987654
Q ss_pred ----eEEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeec
Q 014352 187 ----KYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFG 262 (426)
Q Consensus 187 ----~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 262 (426)
.+++|+||+++ ++...+......+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||
T Consensus 86 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~dfg 161 (302)
T cd07864 86 KDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFG 161 (302)
T ss_pred ccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeCccc
Confidence 78999999976 777777655556899999999999999999999998 9999999999999999999999999
Q ss_pred CccccccCC--CcccCccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccc---cchh--
Q 014352 263 LSKEEVFDG--RNSGLKGTYGYIDPAYIST-NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQ---DGVD-- 334 (426)
Q Consensus 263 l~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~---~~~~-- 334 (426)
++....... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||........+..+.. ....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (302)
T cd07864 162 LARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAV 241 (302)
T ss_pred ccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence 987543222 1223346788999998864 4578999999999999999999999975433222111100 0000
Q ss_pred --hhhhhhhc-------------ccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 335 --EILDKQLV-------------GACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 335 --~~~~~~~~-------------~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
.+...... .......+..+.+++.+||+.||++|||+.+++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 242 WPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred cccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00000000 00001124678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=312.97 Aligned_cols=261 Identities=20% Similarity=0.272 Sum_probs=184.8
Q ss_pred HHHHHHhhhhcccccCCCeeEEEEEeCC--CcEEEEEE--------------ecc---CCccChHHHHHHHHHHhcCCCC
Q 014352 113 DIQKATQNFTNILGQGAFGPVYKATMPS--GGVAAIKV--------------LAS---DSHQGEKEFQTEVSLLGRLHHR 173 (426)
Q Consensus 113 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~--------------~~~---~~~~~~~~~~~e~~~l~~l~h~ 173 (426)
+.....|.+.+.||+|+||+||++.... +...++|. +.. ........+.+|+.+|++++||
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence 3344668888999999999999987532 22222221 100 0111234678999999999999
Q ss_pred ceeeEEeEEEeCCeEEEEEEecCCCChhHHhhhcc----CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEE
Q 014352 174 NLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEE----RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANIL 249 (426)
Q Consensus 174 niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil 249 (426)
||+++++++...+..|+|++++. ++|.+++.... ..........++.|++.||.|||+++ |+||||||+|||
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NIL 299 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIF 299 (501)
T ss_pred CcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEE
Confidence 99999999999999999999995 57777764432 22345667789999999999999998 999999999999
Q ss_pred ecCCCcEEEeeecCccccccCC--CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCC-CCch--HHHHH
Q 014352 250 LDHFMRAKVADFGLSKEEVFDG--RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHP-HQNL--MEYVN 324 (426)
Q Consensus 250 l~~~~~~kl~Dfgl~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p-~~~~--~~~~~ 324 (426)
++.++.+||+|||+++...... ......||..|+|||++.+..++.++|||||||++|||++|..+ +... .....
T Consensus 300 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~ 379 (501)
T PHA03210 300 LNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379 (501)
T ss_pred ECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence 9999999999999997543222 22345799999999999999999999999999999999998754 4321 11111
Q ss_pred Hhhc------cccch-------hhhhhhhhcccC---------CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 325 LASM------SQDGV-------DEILDKQLVGAC---------NIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 325 ~~~~------~~~~~-------~~~~~~~~~~~~---------~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
+..+ ..... ...++....... .......+.+++.+||+.||.+|||+.|++.+
T Consensus 380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 1000 00000 000000000000 00122457788999999999999999999875
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=287.86 Aligned_cols=242 Identities=25% Similarity=0.352 Sum_probs=187.1
Q ss_pred ccccCCCeeEEEEEeC-CCcEEEEEEeccCCcc---ChHHHHHHHH---HHhcCCCCceeeEEeEEEeCCeEEEEEEecC
Q 014352 124 ILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQ---GEKEFQTEVS---LLGRLHHRNLVNLIGYCVDKGKYMLIYEFMS 196 (426)
Q Consensus 124 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~---~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 196 (426)
.||+|+||.||++... +++.||+|.+...... ....+..|.. .++...||||+++++++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999865 6789999998654221 1222344433 4445689999999999999999999999999
Q ss_pred CCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCcccC
Q 014352 197 NGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGL 276 (426)
Q Consensus 197 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~ 276 (426)
+|+|..++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++..... ......
T Consensus 81 g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~-~~~~~~ 155 (278)
T cd05606 81 GGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHAS 155 (278)
T ss_pred CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCc-cCCcCc
Confidence 9999998854 356999999999999999999999988 99999999999999999999999999874322 222345
Q ss_pred ccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHH
Q 014352 277 KGTYGYIDPAYISTN-KFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELAR 355 (426)
Q Consensus 277 ~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 355 (426)
.|+..|+|||.+.++ .++.++||||||+++|||++|..||......... ..... ........+...+..+.+
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~------~~~~~-~~~~~~~~~~~~s~~~~~ 228 (278)
T cd05606 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH------EIDRM-TLTMAVELPDSFSPELRS 228 (278)
T ss_pred CCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH------HHHHH-hhccCCCCCCcCCHHHHH
Confidence 689999999999754 6899999999999999999999999753111000 00000 000011112223567999
Q ss_pred HHHHcccCCCCCCC-----CHHHHHHH
Q 014352 356 IGHKCLHKTPRKRP-----SIGEVTQA 377 (426)
Q Consensus 356 l~~~cl~~~p~~RP-----s~~evl~~ 377 (426)
++.+||..+|.+|| ++.+++++
T Consensus 229 li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 229 LLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred HHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 99999999999999 88898854
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=299.32 Aligned_cols=254 Identities=23% Similarity=0.307 Sum_probs=192.4
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC-ccChHHHHHHHHHHhcCCCCceeeEEeEEEeC-----CeEEE
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS-HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDK-----GKYML 190 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~l 190 (426)
.|.+.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++... ...++
T Consensus 6 ~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 85 (336)
T cd07849 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYI 85 (336)
T ss_pred ceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEE
Confidence 3566789999999999999865 78899999986432 22335678899999999999999999987654 35799
Q ss_pred EEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC
Q 014352 191 IYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD 270 (426)
Q Consensus 191 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 270 (426)
++||+++ +|..++. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 86 v~e~~~~-~l~~~~~--~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 86 VQELMET-DLYKLIK--TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred Eehhccc-CHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 9999964 8888773 345899999999999999999999998 999999999999999999999999998754322
Q ss_pred CC----cccCccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhc---ccc----chhhhhh
Q 014352 271 GR----NSGLKGTYGYIDPAYIST-NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASM---SQD----GVDEILD 338 (426)
Q Consensus 271 ~~----~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~---~~~----~~~~~~~ 338 (426)
.. .....|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||...........+ ... ....+.+
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (336)
T cd07849 160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIIS 239 (336)
T ss_pred ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhc
Confidence 11 123467899999998754 56889999999999999999999999653221111100 000 0000000
Q ss_pred hh-------hccc-------CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 339 KQ-------LVGA-------CNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 339 ~~-------~~~~-------~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
.. .... ........+.+++.+||+.+|++|||+.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred hhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 0000 001234578999999999999999999999987
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=296.36 Aligned_cols=255 Identities=25% Similarity=0.344 Sum_probs=193.9
Q ss_pred HHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccC--CccChHHHHHHHHHHhcC-CCCceeeEEeEEEeC--CeEEE
Q 014352 117 ATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASD--SHQGEKEFQTEVSLLGRL-HHRNLVNLIGYCVDK--GKYML 190 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~--~~~~l 190 (426)
..|.+.+.||+|+||.||+|... ++..+|+|.+... .......+..|+.+++++ +||||+++++++... ...++
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l 86 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL 86 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence 45667789999999999999975 6788999988543 122334577899999999 999999999998654 46899
Q ss_pred EEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC
Q 014352 191 IYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD 270 (426)
Q Consensus 191 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 270 (426)
||||++ ++|..++... .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 87 v~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 87 VFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred Eecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 999997 5999888543 6889999999999999999999988 999999999999999999999999998754322
Q ss_pred C------CcccCccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccc-------------
Q 014352 271 G------RNSGLKGTYGYIDPAYIST-NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQ------------- 330 (426)
Q Consensus 271 ~------~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~------------- 330 (426)
. ......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||...........+..
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240 (337)
T ss_pred cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHH
Confidence 1 1223468889999998754 5678899999999999999999999965332221111000
Q ss_pred --cchhhhhhhhhc------ccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 331 --DGVDEILDKQLV------GACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 331 --~~~~~~~~~~~~------~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
......++.... .......+..+.+++.+||+.||++|||+.+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000001100000 00001134678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=297.53 Aligned_cols=260 Identities=26% Similarity=0.319 Sum_probs=202.0
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC--ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCC-----eEEE
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS--HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKG-----KYML 190 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~l 190 (426)
|.+.+.||.|+||.||+|+.. ++..+|+|.+.... ....+.+.+|+.++++++||||+++++++...+ ..++
T Consensus 2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 81 (330)
T cd07834 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI 81 (330)
T ss_pred ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence 456778999999999999975 58899999987643 233467889999999999999999999988775 7899
Q ss_pred EEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC
Q 014352 191 IYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD 270 (426)
Q Consensus 191 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 270 (426)
+|||++ ++|.+++.... .+++..+..++.+++.||.|||+.+ |+||||||+||+++.++.++|+|||++......
T Consensus 82 v~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 82 VTELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156 (330)
T ss_pred Eecchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence 999997 48988885443 7999999999999999999999998 999999999999999999999999998864433
Q ss_pred C----CcccCccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhcc---------------c
Q 014352 271 G----RNSGLKGTYGYIDPAYISTN-KFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMS---------------Q 330 (426)
Q Consensus 271 ~----~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~---------------~ 330 (426)
. ......++..|+|||.+.+. .++.++|+||||+++|+|++|..||...........+. .
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 236 (330)
T cd07834 157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITS 236 (330)
T ss_pred ccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccc
Confidence 2 23345678899999999887 88999999999999999999999997543221111100 0
Q ss_pred cchhhhhhhhh-c-----ccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHHHH
Q 014352 331 DGVDEILDKQL-V-----GACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA--LLKIKQ 383 (426)
Q Consensus 331 ~~~~~~~~~~~-~-----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~--L~~~~~ 383 (426)
......+.... . .......+..+.+++.+||+.+|++|||+.+++.+ +..+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 237 EKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred cchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 00000000000 0 00011234678999999999999999999999986 555544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=284.34 Aligned_cols=239 Identities=22% Similarity=0.305 Sum_probs=185.2
Q ss_pred hhhcc--cccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcC-CCCceeeEEeEEEeCCeEEEEEEec
Q 014352 120 NFTNI--LGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRL-HHRNLVNLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 120 ~~~~~--lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~ 195 (426)
.+.+. ||.|+||.||++... ++..+|+|.+....... . |+.....+ +||||+++++++...+..++||||+
T Consensus 17 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---~--e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~ 91 (267)
T PHA03390 17 EIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---I--EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYI 91 (267)
T ss_pred ccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch---h--hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcC
Confidence 34444 599999999999865 67889999886542211 1 22222212 7999999999999999999999999
Q ss_pred CCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCC-cEEEeeecCccccccCCCcc
Q 014352 196 SNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFM-RAKVADFGLSKEEVFDGRNS 274 (426)
Q Consensus 196 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgl~~~~~~~~~~~ 274 (426)
++++|.+++.... .+++.++..++.|+++||.|||+.+ ++||||||+||+++.++ .++|+|||+++... ...
T Consensus 92 ~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~---~~~ 164 (267)
T PHA03390 92 KDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG---TPS 164 (267)
T ss_pred CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceecC---CCc
Confidence 9999999996553 7999999999999999999999998 99999999999999988 99999999987542 223
Q ss_pred cCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHH-HHhhccccchhhhhhhhhcccCCHHHHHHH
Q 014352 275 GLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYV-NLASMSQDGVDEILDKQLVGACNIQEVREL 353 (426)
Q Consensus 275 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 353 (426)
...++..|+|||++.+..++.++||||||+++|||++|..||....... ..... ...... ........+..+
T Consensus 165 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~-----~~~~~~--~~~~~~~~~~~~ 237 (267)
T PHA03390 165 CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESL-----LKRQQK--KLPFIKNVSKNA 237 (267)
T ss_pred cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHH-----HHhhcc--cCCcccccCHHH
Confidence 3468899999999999999999999999999999999999997432111 00000 000000 001112345679
Q ss_pred HHHHHHcccCCCCCCCC-HHHHHHH
Q 014352 354 ARIGHKCLHKTPRKRPS-IGEVTQA 377 (426)
Q Consensus 354 ~~l~~~cl~~~p~~RPs-~~evl~~ 377 (426)
.+++.+||+.+|.+||+ +++++++
T Consensus 238 ~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 238 NDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred HHHHHHHhccChhhCCchHHHHhcC
Confidence 99999999999999995 6888854
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=295.75 Aligned_cols=253 Identities=23% Similarity=0.287 Sum_probs=192.6
Q ss_pred hhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccC--------------hHHHHHHHHHHhcCCCCceeeEEeEEEeC
Q 014352 121 FTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQG--------------EKEFQTEVSLLGRLHHRNLVNLIGYCVDK 185 (426)
Q Consensus 121 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 185 (426)
+.+.||.|+||+||+|... +++.||+|.+....... ...+.+|++++++++||||+++++++...
T Consensus 13 ~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 92 (335)
T PTZ00024 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG 92 (335)
T ss_pred hhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC
Confidence 3467999999999999865 68899999986543221 12477899999999999999999999999
Q ss_pred CeEEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcc
Q 014352 186 GKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSK 265 (426)
Q Consensus 186 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 265 (426)
+..++||||++ |+|.+++.. ...+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 93 ~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~dfg~~~ 167 (335)
T PTZ00024 93 DFINLVMDIMA-SDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLAR 167 (335)
T ss_pred CcEEEEEeccc-cCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEECCcccee
Confidence 99999999996 599998854 345899999999999999999999998 9999999999999999999999999987
Q ss_pred cccc---------------CCCcccCccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhcc
Q 014352 266 EEVF---------------DGRNSGLKGTYGYIDPAYISTN-KFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMS 329 (426)
Q Consensus 266 ~~~~---------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~ 329 (426)
.... ........++..|+|||++.+. .++.++||||||+++|||++|..||....+...+..+.
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~ 247 (335)
T PTZ00024 168 RYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIF 247 (335)
T ss_pred ecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 5331 0111223467889999998764 46899999999999999999999997644322211110
Q ss_pred c---cchhh----hhh-hh---hcc-------cCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014352 330 Q---DGVDE----ILD-KQ---LVG-------ACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 330 ~---~~~~~----~~~-~~---~~~-------~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 378 (426)
. ..... ..+ +. ... .........+.+++.+||+.+|++|||+.+++.+-
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~ 314 (335)
T PTZ00024 248 ELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHE 314 (335)
T ss_pred HHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence 0 00000 000 00 000 00112246788999999999999999999999753
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=288.41 Aligned_cols=253 Identities=26% Similarity=0.318 Sum_probs=196.8
Q ss_pred hhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC--ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCC
Q 014352 121 FTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS--HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSN 197 (426)
Q Consensus 121 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 197 (426)
+.+.||+|+||.||+|+.. +++.+|+|.+.... ......+..|+.++++++|+|++++++++.+.+..++|+||++
T Consensus 3 ~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~- 81 (282)
T cd07829 3 KLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD- 81 (282)
T ss_pred eehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-
Confidence 4467999999999999976 58899999987653 2233567889999999999999999999999999999999997
Q ss_pred CChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC-CcccC
Q 014352 198 GSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG-RNSGL 276 (426)
Q Consensus 198 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-~~~~~ 276 (426)
++|.+++......+++..+..++.+++.||.|||+++ |+||||+|+||++++++.++|+|||+++...... .....
T Consensus 82 ~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~ 158 (282)
T cd07829 82 MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE 158 (282)
T ss_pred cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCccccCcc
Confidence 5999999766456999999999999999999999998 9999999999999999999999999987543322 22334
Q ss_pred ccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccc---cchhh----h-----hhhhhcc
Q 014352 277 KGTYGYIDPAYISTN-KFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQ---DGVDE----I-----LDKQLVG 343 (426)
Q Consensus 277 ~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~---~~~~~----~-----~~~~~~~ 343 (426)
.++..|+|||.+.+. .++.++||||||+++||+++|..||........+..+.. ..... . .+.....
T Consensus 159 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (282)
T cd07829 159 VVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPK 238 (282)
T ss_pred ccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccc
Confidence 467789999998766 789999999999999999999999975432211111000 00000 0 0000000
Q ss_pred -------cCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 344 -------ACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 344 -------~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
...+.....+.+++.+||+.||++||++.+++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 239 FPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 0011124679999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=305.59 Aligned_cols=261 Identities=28% Similarity=0.384 Sum_probs=203.1
Q ss_pred hcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc-cChHHHHHHHHHHhcCCCCceeeEEeEEEeCC------eEEEEEE
Q 014352 122 TNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH-QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKG------KYMLIYE 193 (426)
Q Consensus 122 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~~~lv~e 193 (426)
.+.||+|+||.||+|+++ +|+.||||.+..... ...+....|+++|++|+|||||+++++-.+.. ...+|||
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE 97 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME 97 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence 457999999999999965 899999999987643 33456789999999999999999999865543 5689999
Q ss_pred ecCCCChhHHhhhcc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEec--CCCc--EEEeeecCcccc
Q 014352 194 FMSNGSLSNLIYSEE--RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLD--HFMR--AKVADFGLSKEE 267 (426)
Q Consensus 194 ~~~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~--~~~~--~kl~Dfgl~~~~ 267 (426)
||.+|||...|.+.. ..|+..+.+.+..+++.||.|||+++ |+||||||.||++- .+|. .||+|||.|+..
T Consensus 98 yC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel 174 (732)
T KOG4250|consen 98 YCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL 174 (732)
T ss_pred ecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence 999999999996543 56999999999999999999999999 99999999999994 3333 799999999988
Q ss_pred ccCCCcccCccccCccCccccc-cCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHH-----HHhhcc--ccchhh----
Q 014352 268 VFDGRNSGLKGTYGYIDPAYIS-TNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYV-----NLASMS--QDGVDE---- 335 (426)
Q Consensus 268 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~-----~~~~~~--~~~~~~---- 335 (426)
..+.......||..|.+||... ...|+...|.|||||++|+.+||..||-...... .+.... ...+.-
T Consensus 175 ~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~ 254 (732)
T KOG4250|consen 175 DDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQE 254 (732)
T ss_pred CCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeec
Confidence 7777888899999999999998 5889999999999999999999999986432221 111100 001000
Q ss_pred ----hhhh--hhccc--CCHHHHHHHHHHHHHcccCCCCCCC--CHHHHHHHHHHHHHHh
Q 014352 336 ----ILDK--QLVGA--CNIQEVRELARIGHKCLHKTPRKRP--SIGEVTQALLKIKQRH 385 (426)
Q Consensus 336 ----~~~~--~~~~~--~~~~~~~~l~~l~~~cl~~~p~~RP--s~~evl~~L~~~~~~~ 385 (426)
-+.. .++-+ ........+-..+..+|..+|++|- .+.+.-..+..+....
T Consensus 255 ~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~ 314 (732)
T KOG4250|consen 255 EENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLK 314 (732)
T ss_pred ccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhh
Confidence 0000 01111 1123445677788888999999998 7777777777776543
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=279.31 Aligned_cols=260 Identities=24% Similarity=0.376 Sum_probs=198.4
Q ss_pred CCCCChhHHHHHHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc-cChHHHHHHHHHHhc-CCCCceeeEEeEE
Q 014352 106 IPRYAYKDIQKATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH-QGEKEFQTEVSLLGR-LHHRNLVNLIGYC 182 (426)
Q Consensus 106 ~~~~~~~~l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~-l~h~niv~~~~~~ 182 (426)
+..|+-++|+.- ..||.|+||+|++-.++ .|...|||+++.... ....++..|.+...+ -+.||||+++|.+
T Consensus 58 ~~~F~~~~Lqdl-----g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~ 132 (361)
T KOG1006|consen 58 LHTFTSDNLQDL-----GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGAL 132 (361)
T ss_pred ccccccchHHHH-----HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhh
Confidence 334555555532 35999999999999875 889999999987654 334567777776544 4799999999999
Q ss_pred EeCCeEEEEEEecCCCChhHHhh---h-ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEE
Q 014352 183 VDKGKYMLIYEFMSNGSLSNLIY---S-EERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKV 258 (426)
Q Consensus 183 ~~~~~~~lv~e~~~~gsL~~~l~---~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 258 (426)
..++..|+.||.|. .||+.+-. . ....+++.-+-.|+.....||.||...- .|+|||+||+|||+|..|.+||
T Consensus 133 F~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKL 209 (361)
T KOG1006|consen 133 FSEGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKL 209 (361)
T ss_pred hcCCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEee
Confidence 99999999999994 47765532 1 2355888888899999999999998764 3999999999999999999999
Q ss_pred eeecCccccccCCCcccCccccCccCcccccc--CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHH-HHhhccccchhh
Q 014352 259 ADFGLSKEEVFDGRNSGLKGTYGYIDPAYIST--NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYV-NLASMSQDGVDE 335 (426)
Q Consensus 259 ~Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~-~~~~~~~~~~~~ 335 (426)
+|||++-.....-..+.-.|-..|||||.+.. ..|+.+|||||||++|||+.||..||....... .+..+..+..+.
T Consensus 210 CDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~ 289 (361)
T KOG1006|consen 210 CDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPI 289 (361)
T ss_pred ecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCe
Confidence 99999876555444455568889999999954 358999999999999999999999997644322 122222222111
Q ss_pred hhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 336 ILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 336 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
+.. .......+..+..++..|+.+|...||++.+++++
T Consensus 290 l~~----~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 290 LLF----DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ecC----cccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 111 11123456789999999999999999999998865
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=294.25 Aligned_cols=257 Identities=21% Similarity=0.300 Sum_probs=195.8
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc--cChHHHHHHHHHHhcCCCCceeeEEeEEEe----CCeEEE
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH--QGEKEFQTEVSLLGRLHHRNLVNLIGYCVD----KGKYML 190 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~l 190 (426)
.|.+.+.||.|+||.||+|... ++..||+|++..... .....+.+|+.++++++||||+++++++.. ....++
T Consensus 6 ~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 85 (334)
T cd07855 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYV 85 (334)
T ss_pred ceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEE
Confidence 3556678999999999999865 688999999875422 234567789999999999999999998763 346899
Q ss_pred EEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC
Q 014352 191 IYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD 270 (426)
Q Consensus 191 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 270 (426)
||||+. ++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 86 v~e~~~-~~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 86 VMDLME-SDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred EEehhh-hhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 999995 6899888544 45899999999999999999999998 999999999999999999999999998754322
Q ss_pred CC-----cccCccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhh---------------cc
Q 014352 271 GR-----NSGLKGTYGYIDPAYIST-NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLAS---------------MS 329 (426)
Q Consensus 271 ~~-----~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~---------------~~ 329 (426)
.. .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||........+.. ..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~ 240 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIG 240 (334)
T ss_pred CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhc
Confidence 21 123468889999999865 4688999999999999999999999965322111100 00
Q ss_pred ccchhhhhhhhhccc--C-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 014352 330 QDGVDEILDKQLVGA--C-----NIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLK 380 (426)
Q Consensus 330 ~~~~~~~~~~~~~~~--~-----~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 380 (426)
........+ ..... . ....+..+.+++.+||+.+|++|||+.+++.+-.-
T Consensus 241 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~ 297 (334)
T cd07855 241 SDRVRKYIQ-NLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFL 297 (334)
T ss_pred hhhHHHHHh-hcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhh
Confidence 000111111 00000 0 11235679999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=289.88 Aligned_cols=256 Identities=26% Similarity=0.332 Sum_probs=191.6
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccC--hHHHHHHHHHHhcCCCCceeeEEeEEEeCC--------
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQG--EKEFQTEVSLLGRLHHRNLVNLIGYCVDKG-------- 186 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-------- 186 (426)
.|.+.+.||.|+||.||+|... +++.+|+|.+....... ...+.+|++++++++||||+++++++.+..
T Consensus 9 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 88 (311)
T cd07866 9 DYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRG 88 (311)
T ss_pred cEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCc
Confidence 4667788999999999999975 67889999886543222 245778999999999999999999875533
Q ss_pred eEEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccc
Q 014352 187 KYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKE 266 (426)
Q Consensus 187 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 266 (426)
.+++|+||+.+ +|...+......+++..+..++.|+++||.|||+++ ++|+||||+||++++++.++|+|||+++.
T Consensus 89 ~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 164 (311)
T cd07866 89 SVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARP 164 (311)
T ss_pred eEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCccchh
Confidence 46999999965 788777665667999999999999999999999998 99999999999999999999999999874
Q ss_pred cccCCC------------cccCccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhcc---c
Q 014352 267 EVFDGR------------NSGLKGTYGYIDPAYIST-NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMS---Q 330 (426)
Q Consensus 267 ~~~~~~------------~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~---~ 330 (426)
...... .....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...........+. .
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~ 244 (311)
T cd07866 165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCG 244 (311)
T ss_pred ccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 322111 122356788999998765 457899999999999999999999987543322111100 0
Q ss_pred -c---c------hhhhhhhhhcccCC-------HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 331 -D---G------VDEILDKQLVGACN-------IQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 331 -~---~------~~~~~~~~~~~~~~-------~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
. . .....+.......+ ......+.+++.+||+.||++|||+.+++.+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 245 TPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred CCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 0 0 00000000000000 1122568899999999999999999998864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=328.17 Aligned_cols=243 Identities=28% Similarity=0.417 Sum_probs=196.3
Q ss_pred hcccccCCCeeEEEEEe-CCCcEEEEEEeccCCc--cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCCC
Q 014352 122 TNILGQGAFGPVYKATM-PSGGVAAIKVLASDSH--QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNG 198 (426)
Q Consensus 122 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 198 (426)
+..||.|.||.||-|.. ++|...|+|-+..... .....+.+|+.++..++|||+|+++|+-...+..+|.||||.+|
T Consensus 1240 g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~G 1319 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGG 1319 (1509)
T ss_pred ccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccC
Confidence 46899999999999985 4788889998765432 23356889999999999999999999999999999999999999
Q ss_pred ChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC-----CCc
Q 014352 199 SLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD-----GRN 273 (426)
Q Consensus 199 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-----~~~ 273 (426)
+|.+++.. ++..++.....+..|++.|+.|||+++ ||||||||.||+++.+|.+|+.|||.|...... +..
T Consensus 1320 sLa~ll~~-gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el 1395 (1509)
T KOG4645|consen 1320 SLASLLEH-GRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGEL 1395 (1509)
T ss_pred cHHHHHHh-cchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHH
Confidence 99999843 444666666678899999999999999 999999999999999999999999999754332 223
Q ss_pred ccCccccCccCccccccCC---CCcchhhHHHHHHHHHHHhCCCCCCchHH-HHHHhhccccchhhhhhhhhcccCCHHH
Q 014352 274 SGLKGTYGYIDPAYISTNK---FTMKSDIFSFGVIIFELITAIHPHQNLME-YVNLASMSQDGVDEILDKQLVGACNIQE 349 (426)
Q Consensus 274 ~~~~gt~~y~aPE~~~~~~---~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (426)
....||+.|||||++.+.. ...++||||+|||++||+||+.||..... |..+..+..+. .+..+...
T Consensus 1396 ~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh---------~Pq~P~~l 1466 (1509)
T KOG4645|consen 1396 QSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGH---------KPQIPERL 1466 (1509)
T ss_pred HhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccC---------CCCCchhh
Confidence 4567999999999996543 45789999999999999999999987543 33222221111 12223335
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 350 VRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 350 ~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
+.+-.+++.+||..||..|.++.+++++
T Consensus 1467 s~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1467 SSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred hHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 5677899999999999999998877765
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=294.55 Aligned_cols=259 Identities=23% Similarity=0.302 Sum_probs=196.2
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC--ccChHHHHHHHHHHhcCCCCceeeEEeEEEeC-----CeEEE
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS--HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDK-----GKYML 190 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~l 190 (426)
|.+.+.||+|+||+||++... ++..||+|.+.... ......+.+|+.+++.++||||+++++++... ...++
T Consensus 7 y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~l 86 (337)
T cd07858 7 YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYI 86 (337)
T ss_pred eeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEE
Confidence 556678999999999999865 78899999986532 22344677899999999999999999987654 35799
Q ss_pred EEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC
Q 014352 191 IYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD 270 (426)
Q Consensus 191 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 270 (426)
++||+. ++|.+++... ..++......++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++......
T Consensus 87 v~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 161 (337)
T cd07858 87 VYELMD-TDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEK 161 (337)
T ss_pred EEeCCC-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence 999995 6898888544 45899999999999999999999998 999999999999999999999999998754332
Q ss_pred -CCcccCccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHH---hh------------ccccch
Q 014352 271 -GRNSGLKGTYGYIDPAYIST-NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNL---AS------------MSQDGV 333 (426)
Q Consensus 271 -~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~---~~------------~~~~~~ 333 (426)
.......++..|+|||.+.+ ..++.++||||||+++|+|++|..||......... .. +.....
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (337)
T cd07858 162 GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKA 241 (337)
T ss_pred cccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhh
Confidence 12234467889999998865 46889999999999999999999999653211000 00 000000
Q ss_pred hhhhhhhhc------ccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHHH
Q 014352 334 DEILDKQLV------GACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA--LLKIK 382 (426)
Q Consensus 334 ~~~~~~~~~------~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~--L~~~~ 382 (426)
...+..... .......+..+.+++.+||+.+|++|||+.+++++ +..+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 242 RRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred hHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 000000000 00011245678999999999999999999999988 55543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=287.49 Aligned_cols=245 Identities=28% Similarity=0.407 Sum_probs=199.9
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC---ccChHHHHHHHHHHhcCC-CCceeeEEeEEEeCCeEEEEEE
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS---HQGEKEFQTEVSLLGRLH-HRNLVNLIGYCVDKGKYMLIYE 193 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e 193 (426)
|.+.+.||+|+||.||++... ++..+|+|++.... ....+.+..|..++++++ ||||+++++++...+..++|||
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd05581 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLE 82 (280)
T ss_pred ceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEc
Confidence 456678999999999999875 78899999986532 122356888999999998 9999999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC--
Q 014352 194 FMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG-- 271 (426)
Q Consensus 194 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-- 271 (426)
|+++++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++++|||++.......
T Consensus 83 ~~~~~~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 83 YAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158 (280)
T ss_pred CCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence 99999999999654 36999999999999999999999998 9999999999999999999999999987433211
Q ss_pred -------------------CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccc
Q 014352 272 -------------------RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDG 332 (426)
Q Consensus 272 -------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~ 332 (426)
......++..|+|||.+....++.++|+||||++++++++|..||.............
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--- 235 (280)
T cd05581 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL--- 235 (280)
T ss_pred ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH---
Confidence 1123457889999999988889999999999999999999999998654332221111
Q ss_pred hhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCH----HHHHHH
Q 014352 333 VDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSI----GEVTQA 377 (426)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~----~evl~~ 377 (426)
. .....+...+..+.+++.+||+.+|.+|||+ .+++++
T Consensus 236 -----~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 236 -----K--LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred -----h--cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 0 0111122334678999999999999999999 777654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=286.84 Aligned_cols=247 Identities=28% Similarity=0.351 Sum_probs=192.2
Q ss_pred hhhhcccccCCCeeEEEEEe----CCCcEEEEEEeccCCc----cChHHHHHHHHHHhcC-CCCceeeEEeEEEeCCeEE
Q 014352 119 QNFTNILGQGAFGPVYKATM----PSGGVAAIKVLASDSH----QGEKEFQTEVSLLGRL-HHRNLVNLIGYCVDKGKYM 189 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 189 (426)
|++.+.||.|+||.||++.. .+|..+|+|++..... ...+.+.+|+.++.++ +|+||+++++++..+...+
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH 81 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence 34567899999999999986 3678899999875321 2235678899999999 5999999999999988999
Q ss_pred EEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccccc
Q 014352 190 LIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF 269 (426)
Q Consensus 190 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 269 (426)
+|+||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+|||++.++.+||+|||++.....
T Consensus 82 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 82 LILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred EEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence 999999999999998654 45889999999999999999999998 99999999999999999999999999875432
Q ss_pred CC--CcccCccccCccCccccccC--CCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhh--cc
Q 014352 270 DG--RNSGLKGTYGYIDPAYISTN--KFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQL--VG 343 (426)
Q Consensus 270 ~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 343 (426)
.. ......|+..|+|||.+... .++.++||||||+++|+|++|..||........ ...+..... ..
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--------~~~~~~~~~~~~~ 229 (290)
T cd05613 158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS--------QAEISRRILKSEP 229 (290)
T ss_pred ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc--------HHHHHHHhhccCC
Confidence 21 12235688999999998653 467899999999999999999999863211100 011111000 01
Q ss_pred cCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 014352 344 ACNIQEVRELARIGHKCLHKTPRKRP-----SIGEVTQA 377 (426)
Q Consensus 344 ~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~~ 377 (426)
..+......+.+++.+||+.||++|| ++.+++.+
T Consensus 230 ~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 230 PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 11222446788999999999999997 66666554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=283.09 Aligned_cols=246 Identities=24% Similarity=0.381 Sum_probs=193.1
Q ss_pred hhhhcccccCCCeeEEEEEeCC-CcEEEEEEeccCC-----ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEE
Q 014352 119 QNFTNILGQGAFGPVYKATMPS-GGVAAIKVLASDS-----HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIY 192 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 192 (426)
|.+.+.||+|+||.||++.... +..+++|.++... ......+..|+.++++++||||+++++++.+.+..++|+
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT 81 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence 5566789999999999998753 3445555554321 122335678999999999999999999999988999999
Q ss_pred EecCCCChhHHhhh---ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccccc
Q 014352 193 EFMSNGSLSNLIYS---EERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF 269 (426)
Q Consensus 193 e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 269 (426)
||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++. +.++|+|||++.....
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecCC
Confidence 99999999998854 2356899999999999999999999998 999999999999986 5699999999875432
Q ss_pred CC-CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHH
Q 014352 270 DG-RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQ 348 (426)
Q Consensus 270 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (426)
.. ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.............. ......+..
T Consensus 158 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~ 228 (260)
T cd08222 158 SCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE---------GPTPSLPET 228 (260)
T ss_pred CcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc---------CCCCCCcch
Confidence 22 22345688899999999888899999999999999999999999865332221111111 011112234
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 349 EVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 349 ~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
.+..+.+++.+||+.+|++||++.+++++
T Consensus 229 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 229 YSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred hcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 45689999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=278.33 Aligned_cols=245 Identities=27% Similarity=0.383 Sum_probs=199.6
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHH---HHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEe
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKE---FQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEF 194 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~---~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 194 (426)
++|.++||+|.||.|-+++-+ ++..+|+|++++.......+ -..|-++|+..+||.+..+--.|...+.+++||||
T Consensus 170 FdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMey 249 (516)
T KOG0690|consen 170 FDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEY 249 (516)
T ss_pred hhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEE
Confidence 456789999999999999865 88899999998875444433 35688999999999999999899999999999999
Q ss_pred cCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccccc-CCCc
Q 014352 195 MSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF-DGRN 273 (426)
Q Consensus 195 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~-~~~~ 273 (426)
..||.|.-+|.+ .+.++......+...|+.||.|||+++ ||.||||.+|.|+|.+|++||+|||+++.... ....
T Consensus 250 anGGeLf~HLsr-er~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t~ 325 (516)
T KOG0690|consen 250 ANGGELFFHLSR-ERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDTT 325 (516)
T ss_pred ccCceEeeehhh-hhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhccccccee
Confidence 999999999854 455888887888999999999999999 99999999999999999999999999986543 4456
Q ss_pred ccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHH
Q 014352 274 SGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVREL 353 (426)
Q Consensus 274 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 353 (426)
..++||+.|+|||++....|....|.|.+||++|||++|+.||.+......... ++...+ ..+...+.+.
T Consensus 326 kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeL--------Il~ed~--kFPr~ls~eA 395 (516)
T KOG0690|consen 326 KTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFEL--------ILMEDL--KFPRTLSPEA 395 (516)
T ss_pred ccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHH--------HHhhhc--cCCccCCHHH
Confidence 789999999999999999999999999999999999999999976322211111 111111 1122334567
Q ss_pred HHHHHHcccCCCCCCC-----CHHHHHHH
Q 014352 354 ARIGHKCLHKTPRKRP-----SIGEVTQA 377 (426)
Q Consensus 354 ~~l~~~cl~~~p~~RP-----s~~evl~~ 377 (426)
..|+...|.+||.+|. ++.||.++
T Consensus 396 ktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 396 KTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred HHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 7888899999999993 45666544
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=278.10 Aligned_cols=235 Identities=29% Similarity=0.359 Sum_probs=192.8
Q ss_pred cccCCCeeEEEEEeC-CCcEEEEEEeccCCcc---ChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCCCCh
Q 014352 125 LGQGAFGPVYKATMP-SGGVAAIKVLASDSHQ---GEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSL 200 (426)
Q Consensus 125 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 200 (426)
||.|+||.||++... +++.+|+|.+...... ....+..|+.++++++||||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999976 5789999998765322 234788999999999999999999999999999999999999999
Q ss_pred hHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC-CCcccCccc
Q 014352 201 SNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD-GRNSGLKGT 279 (426)
Q Consensus 201 ~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-~~~~~~~gt 279 (426)
.+++... ..+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++...... .......++
T Consensus 81 ~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05123 81 FSHLSKE-GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGT 156 (250)
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCC
Confidence 9999654 35899999999999999999999988 999999999999999999999999998754332 223455688
Q ss_pred cCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHHHHH
Q 014352 280 YGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHK 359 (426)
Q Consensus 280 ~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 359 (426)
..|+|||...+..++.++|+||||+++|++++|..||.............. . ....+...+..+.+++.+
T Consensus 157 ~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--------~--~~~~~~~~~~~l~~~i~~ 226 (250)
T cd05123 157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--------D--PLRFPEFLSPEARDLISG 226 (250)
T ss_pred ccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--------C--CCCCCCCCCHHHHHHHHH
Confidence 899999999888899999999999999999999999965432111111111 0 011122224678999999
Q ss_pred cccCCCCCCCCHHH
Q 014352 360 CLHKTPRKRPSIGE 373 (426)
Q Consensus 360 cl~~~p~~RPs~~e 373 (426)
||..||++||++.+
T Consensus 227 ~l~~~p~~R~~~~~ 240 (250)
T cd05123 227 LLQKDPTKRLGSGG 240 (250)
T ss_pred HhcCCHhhCCCccc
Confidence 99999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=287.14 Aligned_cols=252 Identities=27% Similarity=0.343 Sum_probs=194.9
Q ss_pred hhhhcccccCCCeeEEEEEe----CCCcEEEEEEeccCCc----cChHHHHHHHHHHhcC-CCCceeeEEeEEEeCCeEE
Q 014352 119 QNFTNILGQGAFGPVYKATM----PSGGVAAIKVLASDSH----QGEKEFQTEVSLLGRL-HHRNLVNLIGYCVDKGKYM 189 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 189 (426)
+.+.+.||+|+||.||++.. .++..+|+|.+..... .....+.+|+.++.++ +||||+++++.+......+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 34567899999999999874 2567899999864321 2234678899999999 5999999999999999999
Q ss_pred EEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccccc
Q 014352 190 LIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF 269 (426)
Q Consensus 190 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 269 (426)
+||||+++|+|.+++... ..+++.....++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||+++....
T Consensus 82 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 82 LILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence 999999999999998544 45889999999999999999999988 99999999999999999999999999875432
Q ss_pred CCC--cccCccccCccCccccccCC--CCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccC
Q 014352 270 DGR--NSGLKGTYGYIDPAYISTNK--FTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGAC 345 (426)
Q Consensus 270 ~~~--~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (426)
... .....|+..|+|||.+.+.. .+.++||||||+++|||++|..||...........+. ...... ....
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~----~~~~~~--~~~~ 231 (288)
T cd05583 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEIS----RRILKS--KPPF 231 (288)
T ss_pred ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHH----HHHHcc--CCCC
Confidence 221 22345889999999987655 7889999999999999999999985321110000000 000000 0111
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 014352 346 NIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLK 380 (426)
Q Consensus 346 ~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 380 (426)
+......+.+++.+||+.||++|||+.++.+.|+.
T Consensus 232 ~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 232 PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 22234578899999999999999998877766543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=275.31 Aligned_cols=246 Identities=25% Similarity=0.310 Sum_probs=199.2
Q ss_pred cccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcC-CCCceeeEEeEEEe----CCeEEEEEEecC
Q 014352 123 NILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRL-HHRNLVNLIGYCVD----KGKYMLIYEFMS 196 (426)
Q Consensus 123 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~----~~~~~lv~e~~~ 196 (426)
++||-|-.|.|..+..+ +++.+|+|++... ...++|+++--.. .|||||+++++|.. ...+.+|||+|+
T Consensus 68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~me 142 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECME 142 (400)
T ss_pred hhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeeccc
Confidence 57999999999999875 7889999998643 2446777776555 59999999998865 356899999999
Q ss_pred CCChhHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecC---CCcEEEeeecCccccccCCC
Q 014352 197 NGSLSNLIYSEE-RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDH---FMRAKVADFGLSKEEVFDGR 272 (426)
Q Consensus 197 ~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfgl~~~~~~~~~ 272 (426)
||.|.+.+...+ ..+++.+...|..||+.|+.|||+.+ |.||||||+|+|.+. |..+||+|||+++.......
T Consensus 143 GGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~ 219 (400)
T KOG0604|consen 143 GGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGD 219 (400)
T ss_pred chHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccccccccCCCcc
Confidence 999999997655 67999999999999999999999999 999999999999975 55689999999997766667
Q ss_pred cccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhh--hcccCCHHHH
Q 014352 273 NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQ--LVGACNIQEV 350 (426)
Q Consensus 273 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 350 (426)
..+.+.|+.|.|||++...+|+...|+||+||++|-|++|.+||....... +..+-...+.... ++.+.+...+
T Consensus 220 L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a----ispgMk~rI~~gqy~FP~pEWs~VS 295 (400)
T KOG0604|consen 220 LMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA----ISPGMKRRIRTGQYEFPEPEWSCVS 295 (400)
T ss_pred ccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc----CChhHHhHhhccCccCCChhHhHHH
Confidence 778899999999999999999999999999999999999999996532211 1111111111111 1222234467
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 014352 351 RELARIGHKCLHKTPRKRPSIGEVTQALLK 380 (426)
Q Consensus 351 ~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 380 (426)
+...++++.+|..+|.+|.|+.+++.+-.-
T Consensus 296 e~aKdlIR~LLkt~PteRlTI~~~m~hpwi 325 (400)
T KOG0604|consen 296 EAAKDLIRKLLKTEPTERLTIEEVMDHPWI 325 (400)
T ss_pred HHHHHHHHHHhcCCchhheeHHHhhcCchh
Confidence 788999999999999999999999887543
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=292.76 Aligned_cols=256 Identities=23% Similarity=0.321 Sum_probs=193.1
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc--cChHHHHHHHHHHhcCCCCceeeEEeEEEeC------CeEE
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH--QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDK------GKYM 189 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~~ 189 (426)
|.+.+.||+|+||.||+|... ++..+|+|.+..... .....+.+|+.++++++||||+++++++... ..++
T Consensus 17 y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 96 (342)
T cd07879 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFY 96 (342)
T ss_pred eEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEE
Confidence 445578999999999999864 688999999865321 2234678999999999999999999998754 3469
Q ss_pred EEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccccc
Q 014352 190 LIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF 269 (426)
Q Consensus 190 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 269 (426)
+|+||+.. +|..++ +..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||+++...
T Consensus 97 lv~e~~~~-~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~- 168 (342)
T cd07879 97 LVMPYMQT-DLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHAD- 168 (342)
T ss_pred EEeccccc-CHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCcCCC-
Confidence 99999964 777665 235889999999999999999999998 9999999999999999999999999987532
Q ss_pred CCCcccCccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccc---cchhhhhh-------
Q 014352 270 DGRNSGLKGTYGYIDPAYIST-NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQ---DGVDEILD------- 338 (426)
Q Consensus 270 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~---~~~~~~~~------- 338 (426)
.......++..|+|||.+.+ ..++.++||||||+++|||++|+.||........+..+.. .......+
T Consensus 169 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (342)
T cd07879 169 -AEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAA 247 (342)
T ss_pred -CCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccch
Confidence 22334567889999999866 4688999999999999999999999976432211111000 00000000
Q ss_pred ----hhhcccC-------CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHHHH
Q 014352 339 ----KQLVGAC-------NIQEVRELARIGHKCLHKTPRKRPSIGEVTQA--LLKIKQ 383 (426)
Q Consensus 339 ----~~~~~~~-------~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~--L~~~~~ 383 (426)
....... .......+.+++.+||+.||.+||++.+++.+ ++.++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 248 KSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred HHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 0000000 01123568899999999999999999999966 666643
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=291.28 Aligned_cols=252 Identities=24% Similarity=0.316 Sum_probs=192.2
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc--cChHHHHHHHHHHhcCCCCceeeEEeEEEeCC------eE
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH--QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKG------KY 188 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~~ 188 (426)
+|.+.+.||+|+||.||++... ++..||+|.+..... .....+.+|+.++++++||||+++++++.... ..
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 95 (343)
T cd07880 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDF 95 (343)
T ss_pred ceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceE
Confidence 3556678999999999999864 788999999864321 12346789999999999999999999987643 45
Q ss_pred EEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccc
Q 014352 189 MLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEV 268 (426)
Q Consensus 189 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 268 (426)
++||||+ +++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++....
T Consensus 96 ~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~ 169 (343)
T cd07880 96 YLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTD 169 (343)
T ss_pred EEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence 8999999 7799888743 45899999999999999999999998 9999999999999999999999999987532
Q ss_pred cCCCcccCccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhc---cccchhhhhh------
Q 014352 269 FDGRNSGLKGTYGYIDPAYIST-NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASM---SQDGVDEILD------ 338 (426)
Q Consensus 269 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~---~~~~~~~~~~------ 338 (426)
. ......++..|+|||.+.+ ..++.++|+||||+++|++++|..||...........+ .......+..
T Consensus 170 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (343)
T cd07880 170 S--EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSED 247 (343)
T ss_pred c--CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchh
Confidence 2 2234567889999999876 45889999999999999999999999754322111110 0000000000
Q ss_pred -----hhhcc-------cCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 339 -----KQLVG-------ACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 339 -----~~~~~-------~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
..+.. .........+.+++.+|++.||++|||+.+++.+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 248 AKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred HHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 0011233568899999999999999999999954
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=293.54 Aligned_cols=254 Identities=22% Similarity=0.253 Sum_probs=191.4
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeC-----------
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDK----------- 185 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~----------- 185 (426)
+|.+.+.||.|+||.||+|... ++..||+|.+........+.+.+|++++++++||||+++++++...
T Consensus 6 ~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 85 (342)
T cd07854 6 RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSL 85 (342)
T ss_pred ceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccc
Confidence 4566788999999999999875 6789999998766555566788999999999999999999876543
Q ss_pred ---CeEEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecC-CCcEEEeee
Q 014352 186 ---GKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDH-FMRAKVADF 261 (426)
Q Consensus 186 ---~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Df 261 (426)
...++|+||++ ++|.+++.. ..+++.....++.|++.||.|||+.+ ++||||||+||+++. ++.++++||
T Consensus 86 ~~~~~~~lv~e~~~-~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl~df 159 (342)
T cd07854 86 TELNSVYIVQEYME-TDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDF 159 (342)
T ss_pred cccceEEEEeeccc-ccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEECCc
Confidence 35789999997 589888743 35889999999999999999999998 999999999999984 567899999
Q ss_pred cCccccccCC----CcccCccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhcccc-----
Q 014352 262 GLSKEEVFDG----RNSGLKGTYGYIDPAYIST-NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQD----- 331 (426)
Q Consensus 262 gl~~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~----- 331 (426)
|+++...... ......++..|+|||.+.. ..++.++|||||||++|+|++|..||...............
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (342)
T cd07854 160 GLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVR 239 (342)
T ss_pred ccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 9987532211 1123357889999998754 56788999999999999999999999754332221111000
Q ss_pred --chhhh-------hh-hhhcccC-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 332 --GVDEI-------LD-KQLVGAC-----NIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 332 --~~~~~-------~~-~~~~~~~-----~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
..... .. ....... ......++.+++.+||+.||++|||+.+++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 240 EEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred hHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 00000 00 0000000 11234578899999999999999999999865
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=284.71 Aligned_cols=252 Identities=25% Similarity=0.311 Sum_probs=192.5
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC--ccChHHHHHHHHHHhcCCCCceeeEEeEEEe-CCeEEEEEE
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS--HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVD-KGKYMLIYE 193 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e 193 (426)
.|.+.+.||.|+||.||++... ++..+|+|.+.... ....+.+..|+.++++++||||+++++++.. .+..++++|
T Consensus 11 ~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e 90 (328)
T cd07856 11 RYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTE 90 (328)
T ss_pred ceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEee
Confidence 3556789999999999999865 78899999876432 2234578899999999999999999999876 467899999
Q ss_pred ecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCc
Q 014352 194 FMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRN 273 (426)
Q Consensus 194 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 273 (426)
|+ +++|..++.. ..+++.....++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++.... ...
T Consensus 91 ~~-~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~--~~~ 162 (328)
T cd07856 91 LL-GTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQD--PQM 162 (328)
T ss_pred hh-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccccC--CCc
Confidence 99 5689888743 34788888899999999999999998 9999999999999999999999999987432 222
Q ss_pred ccCccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHH---hhcc------------ccchhhhh
Q 014352 274 SGLKGTYGYIDPAYIST-NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNL---ASMS------------QDGVDEIL 337 (426)
Q Consensus 274 ~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~---~~~~------------~~~~~~~~ 337 (426)
....++..|+|||.+.+ ..++.++||||||+++|+|++|..||......... .... .......+
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (328)
T cd07856 163 TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFV 242 (328)
T ss_pred CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHH
Confidence 34567889999998865 56899999999999999999999999653221110 0000 00000010
Q ss_pred hhh-hcccCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 338 DKQ-LVGACN-----IQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 338 ~~~-~~~~~~-----~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
... .....+ ......+.+++.+||+.+|++|||+.+++.+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 243 QSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 000111 1134679999999999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=289.05 Aligned_cols=253 Identities=23% Similarity=0.304 Sum_probs=191.6
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC--ccChHHHHHHHHHHhcCCCCceeeEEeEEEeC------CeEE
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS--HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDK------GKYM 189 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~~ 189 (426)
|.+.+.||+|+||.||+|... ++..||+|++.... ....+.+.+|+.++++++||||+++++++... +..+
T Consensus 19 y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 98 (345)
T cd07877 19 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 98 (345)
T ss_pred eEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEE
Confidence 555678999999999999864 78899999986532 12245678899999999999999999988643 3467
Q ss_pred EEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccccc
Q 014352 190 LIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF 269 (426)
Q Consensus 190 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 269 (426)
++++++ +++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 99 lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~- 171 (345)
T cd07877 99 LVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTD- 171 (345)
T ss_pred EEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEeccccccccc-
Confidence 888887 7899888743 35899999999999999999999998 9999999999999999999999999987532
Q ss_pred CCCcccCccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhc---cccchhhhh--------
Q 014352 270 DGRNSGLKGTYGYIDPAYIST-NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASM---SQDGVDEIL-------- 337 (426)
Q Consensus 270 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~---~~~~~~~~~-------- 337 (426)
.......++..|+|||.+.+ ..++.++||||||+++|||++|..||........+..+ .......+.
T Consensus 172 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (345)
T cd07877 172 -DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 250 (345)
T ss_pred -ccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhH
Confidence 22334567889999998866 56889999999999999999999999643222111110 000000000
Q ss_pred ---hhhhcc--cC-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 014352 338 ---DKQLVG--AC-----NIQEVRELARIGHKCLHKTPRKRPSIGEVTQALL 379 (426)
Q Consensus 338 ---~~~~~~--~~-----~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 379 (426)
...+.. .. .......+.+++.+|++.||.+||++.+++.+-.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 302 (345)
T cd07877 251 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 302 (345)
T ss_pred HHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChh
Confidence 000000 00 0012456889999999999999999999998753
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=286.54 Aligned_cols=255 Identities=24% Similarity=0.272 Sum_probs=190.0
Q ss_pred hhhhcccccCCCeeEEEEEeC-C--CcEEEEEEeccCCc--cChHHHHHHHHHHhcC-CCCceeeEEeEEEeC----CeE
Q 014352 119 QNFTNILGQGAFGPVYKATMP-S--GGVAAIKVLASDSH--QGEKEFQTEVSLLGRL-HHRNLVNLIGYCVDK----GKY 188 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~--~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~----~~~ 188 (426)
|.+.+.||+|+||.||++... . +..+|+|.+..... ...+.+.+|+.+++++ +||||+++++++... ...
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 81 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL 81 (332)
T ss_pred ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence 456678999999999999975 3 67899999865322 2245678899999999 599999999875432 457
Q ss_pred EEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccc
Q 014352 189 MLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEV 268 (426)
Q Consensus 189 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 268 (426)
++++||+. ++|.+++.. ...+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++...
T Consensus 82 ~~~~e~~~-~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 82 YLYEELME-ADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFS 156 (332)
T ss_pred EEEEeccc-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence 88899885 689988854 456899999999999999999999998 9999999999999999999999999987533
Q ss_pred cCC-----CcccCccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhh---------------
Q 014352 269 FDG-----RNSGLKGTYGYIDPAYIST-NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLAS--------------- 327 (426)
Q Consensus 269 ~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~--------------- 327 (426)
... ......|+..|+|||.+.+ ..++.++|+||||+++|++++|..||........+..
T Consensus 157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (332)
T cd07857 157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR 236 (332)
T ss_pred cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 211 1233568999999998765 5689999999999999999999999875332111110
Q ss_pred ccccchhhhhhhh-hc-----ccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014352 328 MSQDGVDEILDKQ-LV-----GACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 328 ~~~~~~~~~~~~~-~~-----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 378 (426)
+............ .. ..........+.+++.+||+.||++|||+.+++.+=
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~ 293 (332)
T cd07857 237 IGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHP 293 (332)
T ss_pred hhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 0000000000000 00 000111245789999999999999999999998663
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=306.71 Aligned_cols=243 Identities=29% Similarity=0.453 Sum_probs=184.6
Q ss_pred hcccccCCCeeEEEEEeC-CCcEEEEEEeccCC-ccChHHHHHHHHHHhcCCCCceeeEEeEEEe---------------
Q 014352 122 TNILGQGAFGPVYKATMP-SGGVAAIKVLASDS-HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVD--------------- 184 (426)
Q Consensus 122 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--------------- 184 (426)
..+||+||||.||+++++ +|+.+|||++.... ......+.+|+..|++|+|||||+++..|.+
T Consensus 484 L~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~ 563 (1351)
T KOG1035|consen 484 LELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDS 563 (1351)
T ss_pred HHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccch
Confidence 357999999999999987 99999999997664 2223467889999999999999999965420
Q ss_pred ----------------------------------------C---------------------------------------
Q 014352 185 ----------------------------------------K--------------------------------------- 185 (426)
Q Consensus 185 ----------------------------------------~--------------------------------------- 185 (426)
.
T Consensus 564 ~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d 643 (1351)
T KOG1035|consen 564 ESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILD 643 (1351)
T ss_pred hhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccC
Confidence 0
Q ss_pred -------------------------CeEEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeee
Q 014352 186 -------------------------GKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIH 240 (426)
Q Consensus 186 -------------------------~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH 240 (426)
..+||-||||+...|.+++..+...-.....++++.+|++||.|+|+++ |||
T Consensus 644 ~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g---iIH 720 (1351)
T KOG1035|consen 644 DTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG---IIH 720 (1351)
T ss_pred cchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc---eee
Confidence 1257889999987777777544321146678899999999999999999 999
Q ss_pred cCCCCCCEEecCCCcEEEeeecCccccc-------------------cCCCcccCccccCccCccccccCC---CCcchh
Q 014352 241 RDLKSANILLDHFMRAKVADFGLSKEEV-------------------FDGRNSGLKGTYGYIDPAYISTNK---FTMKSD 298 (426)
Q Consensus 241 ~dlk~~Nill~~~~~~kl~Dfgl~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~D 298 (426)
|||||.||++|+++.|||+|||++.... .....+...||.-|+|||.+.+.. |+.|+|
T Consensus 721 RDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiD 800 (1351)
T KOG1035|consen 721 RDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKID 800 (1351)
T ss_pred ccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhh
Confidence 9999999999999999999999997511 011234567999999999997654 999999
Q ss_pred hHHHHHHHHHHHhCCCCCCchHHHHH-HhhccccchhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014352 299 IFSFGVIIFELITAIHPHQNLMEYVN-LASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQ 376 (426)
Q Consensus 299 v~S~Gvvl~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 376 (426)
+||+|||++||+. ||...-+... +..+....++.- .....+....=.+++.++++.||.+|||+.|++.
T Consensus 801 mYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 801 MYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEP------ADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred hHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCC------cccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 9999999999986 5765444332 222222222111 0112223345678899999999999999999875
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=289.51 Aligned_cols=251 Identities=24% Similarity=0.301 Sum_probs=192.8
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC--ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCe------EE
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS--HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGK------YM 189 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~------~~ 189 (426)
|.+.+.||+|+||.||+|... ++..+|+|.+.... ......+.+|+.++++++|||++++++++...+. .+
T Consensus 17 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 96 (343)
T cd07851 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVY 96 (343)
T ss_pred eEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEE
Confidence 556678999999999999976 67889999886432 1223567789999999999999999998766554 89
Q ss_pred EEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccccc
Q 014352 190 LIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF 269 (426)
Q Consensus 190 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 269 (426)
+|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.....
T Consensus 97 lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~ 170 (343)
T cd07851 97 LVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDD 170 (343)
T ss_pred EEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccccccccc
Confidence 999999 6699998854 45899999999999999999999998 99999999999999999999999999875432
Q ss_pred CCCcccCccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhc---cccchhh----------
Q 014352 270 DGRNSGLKGTYGYIDPAYIST-NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASM---SQDGVDE---------- 335 (426)
Q Consensus 270 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~---~~~~~~~---------- 335 (426)
......++..|+|||.+.+ ..++.++||||||+++||+++|..||........+..+ .......
T Consensus 171 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 248 (343)
T cd07851 171 --EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESA 248 (343)
T ss_pred --cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhH
Confidence 2334567889999999865 36789999999999999999999999654332211110 0000000
Q ss_pred --hhhhhhcc-cC-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 336 --ILDKQLVG-AC-----NIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 336 --~~~~~~~~-~~-----~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
.+...... .. ....+..+.+++.+||+.+|++|||+.+++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 249 RNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 00000000 00 01125679999999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=279.29 Aligned_cols=242 Identities=28% Similarity=0.399 Sum_probs=199.8
Q ss_pred HHHHHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccC---hHHHHHHHHHHhcC-CCCceeeEEeEEEeCCeE
Q 014352 114 IQKATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQG---EKEFQTEVSLLGRL-HHRNLVNLIGYCVDKGKY 188 (426)
Q Consensus 114 l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 188 (426)
|....++|..+||+|+||.|.++..+ +.+.+|||+++++..-. .+--+.|.++|+-. +-|.+++++.++..-+.+
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL 425 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL 425 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence 33445788899999999999999865 56789999998774322 23345677777665 578999999999999999
Q ss_pred EEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccc
Q 014352 189 MLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEV 268 (426)
Q Consensus 189 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 268 (426)
|+||||+.||+|-..+.+-++ +.++.+.-++..||-||-|||+++ |+.||||..||++|.+|++||+|||+++...
T Consensus 426 yFVMEyvnGGDLMyhiQQ~Gk-FKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQVGK-FKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred eeEEEEecCchhhhHHHHhcc-cCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccc
Confidence 999999999999998865554 778888889999999999999999 9999999999999999999999999998765
Q ss_pred cCC-CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCH
Q 014352 269 FDG-RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNI 347 (426)
Q Consensus 269 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (426)
... .+.+.+||+.|+|||.+..++|+...|.|||||+||||+.|.+||.+..+......+.... -.++.
T Consensus 502 ~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehn----------vsyPK 571 (683)
T KOG0696|consen 502 FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHN----------VSYPK 571 (683)
T ss_pred cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcc----------CcCcc
Confidence 544 4567899999999999999999999999999999999999999998865544333222211 12344
Q ss_pred HHHHHHHHHHHHcccCCCCCCC
Q 014352 348 QEVRELARIGHKCLHKTPRKRP 369 (426)
Q Consensus 348 ~~~~~l~~l~~~cl~~~p~~RP 369 (426)
..+.+...+.+..+.+.|.+|.
T Consensus 572 slSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 572 SLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred cccHHHHHHHHHHhhcCCcccc
Confidence 5567788899999999999993
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=276.94 Aligned_cols=268 Identities=21% Similarity=0.283 Sum_probs=210.6
Q ss_pred CCCCCCCChhHHHHHHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCCC--C----ce
Q 014352 103 ASGIPRYAYKDIQKATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHH--R----NL 175 (426)
Q Consensus 103 ~~~~~~~~~~~l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~----ni 175 (426)
..|...|...|....+|.+...+|+|.||.|-.+... .+..||+|+++.-.. -.+..+-|+++|+++.+ | -+
T Consensus 75 ~dGH~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rc 153 (415)
T KOG0671|consen 75 KDGHYVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRC 153 (415)
T ss_pred CCceEEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEE
Confidence 4455567788888899999999999999999999865 568999999976432 34556779999999942 2 36
Q ss_pred eeEEeEEEeCCeEEEEEEecCCCChhHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecC--
Q 014352 176 VNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEE-RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDH-- 252 (426)
Q Consensus 176 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~-- 252 (426)
|.+.++|.-.++.++|+|.+ |-|+.++|..++ .+++...+..|+.|++++++|||+.+ ++|.||||+|||+.+
T Consensus 154 v~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~ 229 (415)
T KOG0671|consen 154 VQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSE 229 (415)
T ss_pred EeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccc
Confidence 78888899999999999998 669999997654 67889999999999999999999998 999999999999932
Q ss_pred ------------------CCcEEEeeecCccccccCCCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCC
Q 014352 253 ------------------FMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIH 314 (426)
Q Consensus 253 ------------------~~~~kl~Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~ 314 (426)
+..+||+|||.|+... ...+..+.|..|.|||++.+-.++.++||||+||||.|+.||..
T Consensus 230 ~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~--e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~ 307 (415)
T KOG0671|consen 230 YFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDH--EHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGET 307 (415)
T ss_pred eEEEeccCCccceeccCCCcceEEEecCCcceec--cCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccce
Confidence 3458999999998543 33467789999999999999999999999999999999999999
Q ss_pred CCCchHHHHHHhhc---cccchhhhhhhh------------------------h---------cccCCHHHHHHHHHHHH
Q 014352 315 PHQNLMEYVNLASM---SQDGVDEILDKQ------------------------L---------VGACNIQEVRELARIGH 358 (426)
Q Consensus 315 p~~~~~~~~~~~~~---~~~~~~~~~~~~------------------------~---------~~~~~~~~~~~l~~l~~ 358 (426)
.|+...+...+..| ..+....++.+. . ...+...+..+|.+|++
T Consensus 308 LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~ 387 (415)
T KOG0671|consen 308 LFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLR 387 (415)
T ss_pred ecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHH
Confidence 88764433322211 111111111111 0 01122334567999999
Q ss_pred HcccCCCCCCCCHHHHHHH
Q 014352 359 KCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 359 ~cl~~~p~~RPs~~evl~~ 377 (426)
++|..||.+|+|+.|++.+
T Consensus 388 ~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 388 RMLEFDPARRITLREALSH 406 (415)
T ss_pred HHHccCccccccHHHHhcC
Confidence 9999999999999999875
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=270.93 Aligned_cols=219 Identities=21% Similarity=0.181 Sum_probs=176.6
Q ss_pred CCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCCCChhHHhhh
Q 014352 128 GAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYS 206 (426)
Q Consensus 128 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 206 (426)
|.||.||++... +++.+|+|.+.... .+..|...+....||||+++++++.+.+..+++|||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999875 77889999986543 233455555666799999999999999999999999999999999855
Q ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCcccCccccCccCcc
Q 014352 207 EERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPA 286 (426)
Q Consensus 207 ~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~gt~~y~aPE 286 (426)
. ..+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++++|||.+..... ......++..|+|||
T Consensus 79 ~-~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~--~~~~~~~~~~y~aPE 152 (237)
T cd05576 79 F-LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVED--SCDGEAVENMYCAPE 152 (237)
T ss_pred h-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccc--ccccCCcCccccCCc
Confidence 4 35899999999999999999999988 99999999999999999999999998764322 223345677899999
Q ss_pred ccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCC
Q 014352 287 YISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPR 366 (426)
Q Consensus 287 ~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~ 366 (426)
.+.+..++.++||||+|+++||+++|..|+........ . ......+......+.+++.+||+.||+
T Consensus 153 ~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~----------~----~~~~~~~~~~~~~~~~li~~~l~~dp~ 218 (237)
T cd05576 153 VGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN----------T----HTTLNIPEWVSEEARSLLQQLLQFNPT 218 (237)
T ss_pred ccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc----------c----ccccCCcccCCHHHHHHHHHHccCCHH
Confidence 99888899999999999999999999988653211100 0 000011122346789999999999999
Q ss_pred CCCCH
Q 014352 367 KRPSI 371 (426)
Q Consensus 367 ~RPs~ 371 (426)
+||++
T Consensus 219 ~R~~~ 223 (237)
T cd05576 219 ERLGA 223 (237)
T ss_pred HhcCC
Confidence 99997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=287.01 Aligned_cols=242 Identities=24% Similarity=0.347 Sum_probs=202.5
Q ss_pred cccccCCCeeEEEEEeC-CCcEEEEEEeccC--CccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCCCC
Q 014352 123 NILGQGAFGPVYKATMP-SGGVAAIKVLASD--SHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGS 199 (426)
Q Consensus 123 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 199 (426)
++||+|-||+||-|+.+ +|+.||||++.+. ....+.++++|+.||++++||.||.+.-.|+..+..++|||-+.|.=
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDM 649 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDM 649 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchH
Confidence 68999999999999875 8999999999765 33456789999999999999999999999999999999999996544
Q ss_pred hhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCC---CcEEEeeecCccccccCCCcccC
Q 014352 200 LSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHF---MRAKVADFGLSKEEVFDGRNSGL 276 (426)
Q Consensus 200 L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfgl~~~~~~~~~~~~~ 276 (426)
|.-.|.++.+.|+......++.||+.||.|||.++ |+|.||||+|||+.+. -++||+|||+++...........
T Consensus 650 LEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsV 726 (888)
T KOG4236|consen 650 LEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSV 726 (888)
T ss_pred HHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhh
Confidence 44455555567888887888999999999999999 9999999999999753 46999999999988777777889
Q ss_pred ccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhh---hcccCCHHHHHHH
Q 014352 277 KGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQ---LVGACNIQEVREL 353 (426)
Q Consensus 277 ~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l 353 (426)
.||+.|+|||++.++.|...-|+||.||++|--++|..||....+.. +.+... ++..+..+.+...
T Consensus 727 VGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn-----------dQIQNAaFMyPp~PW~eis~~A 795 (888)
T KOG4236|consen 727 VGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN-----------DQIQNAAFMYPPNPWSEISPEA 795 (888)
T ss_pred cCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchh-----------HHhhccccccCCCchhhcCHHH
Confidence 99999999999999999999999999999999999999997532221 111111 1223345566788
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHH
Q 014352 354 ARIGHKCLHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 354 ~~l~~~cl~~~p~~RPs~~evl~~L 378 (426)
++++...|+..=++|-|....+.+.
T Consensus 796 idlIn~LLqVkm~kRysvdk~lsh~ 820 (888)
T KOG4236|consen 796 IDLINNLLQVKMRKRYSVDKSLSHP 820 (888)
T ss_pred HHHHHHHHHHHHHHhcchHhhccch
Confidence 9999999999999999988876654
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=294.23 Aligned_cols=248 Identities=27% Similarity=0.444 Sum_probs=207.4
Q ss_pred hhhhcccccCCCeeEEEEEe-CCCcEEEEEEeccCCccChHHHHHHHHHHhcC-CCCceeeEEeEEEe-----CCeEEEE
Q 014352 119 QNFTNILGQGAFGPVYKATM-PSGGVAAIKVLASDSHQGEKEFQTEVSLLGRL-HHRNLVNLIGYCVD-----KGKYMLI 191 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~-----~~~~~lv 191 (426)
+.|.+.||.|.+|.||+++. ++++.+|+|++..+.. ..++...|.++|+.. .|||++.++|++.. ++.+|||
T Consensus 21 ~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLV 99 (953)
T KOG0587|consen 21 FEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLV 99 (953)
T ss_pred cEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEE
Confidence 45678999999999999985 4888899999876643 345778899999887 69999999999874 4689999
Q ss_pred EEecCCCChhHHhhhc-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC
Q 014352 192 YEFMSNGSLSNLIYSE-ERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD 270 (426)
Q Consensus 192 ~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 270 (426)
||||.+||..++++.- +..+.|..+..|+..++.||.+||.+. ++|||+|-.|||++.++.+|+.|||++......
T Consensus 100 MEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGvSaQldsT 176 (953)
T KOG0587|consen 100 MEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDST 176 (953)
T ss_pred eeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeeeeeeeecc
Confidence 9999999999998643 466899999999999999999999998 999999999999999999999999999865443
Q ss_pred -CCcccCccccCccCcccccc-----CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhccc
Q 014352 271 -GRNSGLKGTYGYIDPAYIST-----NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGA 344 (426)
Q Consensus 271 -~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (426)
....+..||+.|||||++.. ..|+.++|+||||++..||.-|.+|+.+..+...+..+....... ..
T Consensus 177 ~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPk-------Lk 249 (953)
T KOG0587|consen 177 VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPK-------LK 249 (953)
T ss_pred cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCcc-------cc
Confidence 34567889999999999954 357889999999999999999999998876655554443332222 22
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 345 CNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 345 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
.+...+.++.+++..||.+|-+.||++.+++++
T Consensus 250 rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 250 RPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred chhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 344567889999999999999999999998875
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=269.54 Aligned_cols=261 Identities=22% Similarity=0.399 Sum_probs=203.2
Q ss_pred ChhHHHHHHhhhhcccccCCCeeEEEEE-eCCCcEEEEEEeccCCccChHHHHHHHHHHhcCC-CCceeeEEeEEEeCCe
Q 014352 110 AYKDIQKATQNFTNILGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLH-HRNLVNLIGYCVDKGK 187 (426)
Q Consensus 110 ~~~~l~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~ 187 (426)
.+.|+-+-+. +.||+|+|+.|--++ ..+|..+|||++.+...-.+....+|++++.+.+ |+||+.++.+|.++..
T Consensus 74 ~F~d~YkLt~---e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~ 150 (463)
T KOG0607|consen 74 KFEDMYKLTS---ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTR 150 (463)
T ss_pred hHHHHHHhHH---HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccce
Confidence 3556655444 579999999999987 4588999999998876666678889999999985 9999999999999999
Q ss_pred EEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCc---EEEeeecCc
Q 014352 188 YMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMR---AKVADFGLS 264 (426)
Q Consensus 188 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfgl~ 264 (426)
+|||||-|.||+|..+|.+ .+.++..+..++..+|+.||.|||.++ |.||||||+|||-.+... +||+||.+.
T Consensus 151 FYLVfEKm~GGplLshI~~-~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLg 226 (463)
T KOG0607|consen 151 FYLVFEKMRGGPLLSHIQK-RKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLG 226 (463)
T ss_pred EEEEEecccCchHHHHHHH-hhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccc
Confidence 9999999999999999954 456999999999999999999999999 999999999999976544 899999887
Q ss_pred cccccCC--------CcccCccccCccCccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCchHH----HHH--H
Q 014352 265 KEEVFDG--------RNSGLKGTYGYIDPAYIS-----TNKFTMKSDIFSFGVIIFELITAIHPHQNLME----YVN--L 325 (426)
Q Consensus 265 ~~~~~~~--------~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~----~~~--~ 325 (426)
....... ...+.+|+..|||||+.. ...|+.+.|.||||||||-|++|.+||.+.-. |.. .
T Consensus 227 Sg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~ 306 (463)
T KOG0607|consen 227 SGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEV 306 (463)
T ss_pred cccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCc
Confidence 5322221 123467899999999762 34689999999999999999999999976322 100 0
Q ss_pred hhccccchhhhhhhhhcccCC---HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 326 ASMSQDGVDEILDKQLVGACN---IQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
....+..+.+.+.......++ ...+.+..+++...+..|+.+|.++..++++
T Consensus 307 Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 307 CRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred cHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence 001111122222222222222 3356778889999999999999999998873
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=304.30 Aligned_cols=143 Identities=26% Similarity=0.389 Sum_probs=127.4
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccC---hHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEe
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQG---EKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEF 194 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 194 (426)
|.+.+.||.|+||.||+|.+. +++.||+|++....... ...+..|+.++..++||||+++++++...+..|+||||
T Consensus 6 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy 85 (669)
T cd05610 6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEY 85 (669)
T ss_pred EEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeC
Confidence 556788999999999999976 68899999987543222 25688999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcc
Q 014352 195 MSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSK 265 (426)
Q Consensus 195 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 265 (426)
+++++|.+++... ..+++...+.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 86 ~~g~~L~~li~~~-~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 86 LIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999998544 45889999999999999999999998 9999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=288.46 Aligned_cols=241 Identities=23% Similarity=0.327 Sum_probs=195.2
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcC-CCCceeeEEeEEEeCCeEEEEEEec
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRL-HHRNLVNLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~ 195 (426)
.|.+...+|.|+|+.|-++... +++..++|++.... .+-.+|+.++... +||||+++.+.+.+..+.|+|||.+
T Consensus 323 ~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l 398 (612)
T KOG0603|consen 323 SYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELL 398 (612)
T ss_pred hhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeehhc
Confidence 4566677999999999999865 77888999987652 2334566555544 7999999999999999999999999
Q ss_pred CCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEe-cCCCcEEEeeecCccccccCCCcc
Q 014352 196 SNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILL-DHFMRAKVADFGLSKEEVFDGRNS 274 (426)
Q Consensus 196 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill-~~~~~~kl~Dfgl~~~~~~~~~~~ 274 (426)
.++-|.+.+..... . ...+..|+.+++.|+.|||+++ ++||||||+|||+ ++.++++|+|||.++..... ..
T Consensus 399 ~g~ell~ri~~~~~-~-~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--~~ 471 (612)
T KOG0603|consen 399 DGGELLRRIRSKPE-F-CSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--CD 471 (612)
T ss_pred cccHHHHHHHhcch-h-HHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh--hc
Confidence 99988888855443 2 2677789999999999999999 9999999999999 68999999999999865433 44
Q ss_pred cCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHH
Q 014352 275 GLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELA 354 (426)
Q Consensus 275 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 354 (426)
..+-|..|.|||++....|++++|+||||++||+|++|+.||........ +......+......++...
T Consensus 472 tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~e-----------i~~~i~~~~~s~~vS~~AK 540 (612)
T KOG0603|consen 472 TPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIE-----------IHTRIQMPKFSECVSDEAK 540 (612)
T ss_pred ccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHH-----------HHHhhcCCccccccCHHHH
Confidence 55678999999999999999999999999999999999999976433311 1111112222244567889
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHHHH
Q 014352 355 RIGHKCLHKTPRKRPSIGEVTQALLK 380 (426)
Q Consensus 355 ~l~~~cl~~~p~~RPs~~evl~~L~~ 380 (426)
+|+.+||+.||.+||++.++..+-..
T Consensus 541 dLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 541 DLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HHHHHhccCChhhCcChhhhccCcch
Confidence 99999999999999999999987555
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=264.86 Aligned_cols=236 Identities=32% Similarity=0.453 Sum_probs=194.6
Q ss_pred CCeeEEEEEeC-CCcEEEEEEeccCCccC-hHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCCCChhHHhhh
Q 014352 129 AFGPVYKATMP-SGGVAAIKVLASDSHQG-EKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYS 206 (426)
Q Consensus 129 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 206 (426)
+||.||+|... ++..+++|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999986 58899999997665444 67899999999999999999999999999999999999999999999865
Q ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCcccCccccCccCcc
Q 014352 207 EERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPA 286 (426)
Q Consensus 207 ~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~gt~~y~aPE 286 (426)
... +++..++.++.+++.++.|||+.+ ++|+||+|+||+++.++.++++|||.+.............++..|++||
T Consensus 81 ~~~-~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE 156 (244)
T smart00220 81 RGR-LSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPE 156 (244)
T ss_pred ccC-CCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHH
Confidence 443 899999999999999999999998 9999999999999999999999999998655443445667889999999
Q ss_pred ccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHH--HHHHHHHHHHHcccCC
Q 014352 287 YISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQ--EVRELARIGHKCLHKT 364 (426)
Q Consensus 287 ~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~l~~~cl~~~ 364 (426)
.+.+..++.++||||||++++++++|..||........... ............. ....+.+++.+||..+
T Consensus 157 ~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 228 (244)
T smart00220 157 VLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFK--------KIGKPKPPFPPPEWKISPEAKDLIRKLLVKD 228 (244)
T ss_pred HHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH--------HHhccCCCCccccccCCHHHHHHHHHHccCC
Confidence 99988899999999999999999999999865211111111 0111110000111 4467999999999999
Q ss_pred CCCCCCHHHHHH
Q 014352 365 PRKRPSIGEVTQ 376 (426)
Q Consensus 365 p~~RPs~~evl~ 376 (426)
|++||++.++++
T Consensus 229 p~~Rp~~~~~~~ 240 (244)
T smart00220 229 PEKRLTAEEALQ 240 (244)
T ss_pred chhccCHHHHhh
Confidence 999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=300.91 Aligned_cols=250 Identities=23% Similarity=0.288 Sum_probs=201.4
Q ss_pred HHHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccC---CccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEE
Q 014352 116 KATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASD---SHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLI 191 (426)
Q Consensus 116 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 191 (426)
...+.+..+||+|+||.|...+.. +++++|+|++.+. .......|++|-.+|..-+.+=|+.++-.|.+++++|+|
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlV 153 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLV 153 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEE
Confidence 344566789999999999999975 7889999998762 233456799999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC
Q 014352 192 YEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG 271 (426)
Q Consensus 192 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 271 (426)
||||+||+|-.++.+.+ .++..-+..++..++.||.-||+.| +|||||||+|||+|.+|++||+|||.+-....++
T Consensus 154 MdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsClkm~~dG 229 (1317)
T KOG0612|consen 154 MDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADG 229 (1317)
T ss_pred EecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHHhcCCCC
Confidence 99999999999997666 6888888889999999999999999 9999999999999999999999999876554443
Q ss_pred C--cccCccccCccCccccc----c-CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhh--hhc
Q 014352 272 R--NSGLKGTYGYIDPAYIS----T-NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDK--QLV 342 (426)
Q Consensus 272 ~--~~~~~gt~~y~aPE~~~----~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 342 (426)
. +...+|||-|.+||++. + +.|+.-+|+||+||++|||+.|.+||....-...+.. +++- .+.
T Consensus 230 ~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~K--------Im~hk~~l~ 301 (1317)
T KOG0612|consen 230 TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGK--------IMNHKESLS 301 (1317)
T ss_pred cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHH--------HhchhhhcC
Confidence 3 45678999999999984 2 5688999999999999999999999965332222222 2221 111
Q ss_pred ccCCHHHHHHHHHHHHHcccCCCCCCCC---HHHHHHHH
Q 014352 343 GACNIQEVRELARIGHKCLHKTPRKRPS---IGEVTQAL 378 (426)
Q Consensus 343 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs---~~evl~~L 378 (426)
-+.....+.+..+||.+.+. +|+.|.. +.++..|.
T Consensus 302 FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~Hp 339 (1317)
T KOG0612|consen 302 FPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHP 339 (1317)
T ss_pred CCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCc
Confidence 11223466778888887776 5888877 88887664
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=283.03 Aligned_cols=244 Identities=21% Similarity=0.286 Sum_probs=204.2
Q ss_pred cccccCCCeeEEEEEeCCCc-EEEEEEeccCC---ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCCC
Q 014352 123 NILGQGAFGPVYKATMPSGG-VAAIKVLASDS---HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNG 198 (426)
Q Consensus 123 ~~lg~G~~g~Vy~~~~~~~~-~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 198 (426)
..||-|+||.|=+...++.. .+|+|++++.. ....+....|-++|.+.+.|.||++|..|.+....|+.||-|-||
T Consensus 426 aTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGG 505 (732)
T KOG0614|consen 426 ATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGG 505 (732)
T ss_pred hhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCc
Confidence 46999999999999876444 37888886543 233455778999999999999999999999999999999999999
Q ss_pred ChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCcccCcc
Q 014352 199 SLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKG 278 (426)
Q Consensus 199 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~g 278 (426)
.|+..|.+.+ .++..+...++..+.+|++|||+++ ||.|||||+|.++|.+|-+||.|||+++.......+.+++|
T Consensus 506 ElWTiLrdRg-~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KTwTFcG 581 (732)
T KOG0614|consen 506 ELWTILRDRG-SFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKTWTFCG 581 (732)
T ss_pred hhhhhhhhcC-CcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccCCceeeecC
Confidence 9999996554 4777888889999999999999999 99999999999999999999999999998888888899999
Q ss_pred ccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHHHH
Q 014352 279 TYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGH 358 (426)
Q Consensus 279 t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 358 (426)
|+.|.|||.+.+...+.++|.||||+++|||++|.+||++..+...+..+..+. .. -..+....+...++++
T Consensus 582 TpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGi-d~-------i~~Pr~I~k~a~~Lik 653 (732)
T KOG0614|consen 582 TPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGI-DK-------IEFPRRITKTATDLIK 653 (732)
T ss_pred CcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhh-hh-------hhcccccchhHHHHHH
Confidence 999999999999999999999999999999999999999876654433222111 11 1122334466788999
Q ss_pred HcccCCCCCCCC-----HHHHHHHH
Q 014352 359 KCLHKTPRKRPS-----IGEVTQAL 378 (426)
Q Consensus 359 ~cl~~~p~~RPs-----~~evl~~L 378 (426)
+.+..+|.+|.- +.+|.++-
T Consensus 654 ~LCr~~P~ERLG~~~~gI~DIkkH~ 678 (732)
T KOG0614|consen 654 KLCRDNPTERLGYQKGGINDIKKHR 678 (732)
T ss_pred HHHhcCcHhhhccccCChHHHHhhh
Confidence 999999999965 56676654
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=257.34 Aligned_cols=257 Identities=24% Similarity=0.310 Sum_probs=191.6
Q ss_pred hhhhcccccCCCeeEEEEEeC-C----CcEEEEEEeccCCcc--ChHHHHHHHHHHhcCCCCceeeEEeEEEe-CCeEEE
Q 014352 119 QNFTNILGQGAFGPVYKATMP-S----GGVAAIKVLASDSHQ--GEKEFQTEVSLLGRLHHRNLVNLIGYCVD-KGKYML 190 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~l 190 (426)
|+....||+|+||.||+|... + +..+|+|.++..... -....-+|+.+++.++||||+.+..++.+ +..+++
T Consensus 26 ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l 105 (438)
T KOG0666|consen 26 YEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWL 105 (438)
T ss_pred hhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEE
Confidence 666778999999999999643 2 226899998765322 12456789999999999999999999887 778999
Q ss_pred EEEecCCCChhHHhhhc----cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCC----CcEEEeeec
Q 014352 191 IYEFMSNGSLSNLIYSE----ERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHF----MRAKVADFG 262 (426)
Q Consensus 191 v~e~~~~gsL~~~l~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfg 262 (426)
++||.+. +|...++.. .+.++...+..|+.||+.|+.|||++- |+||||||.|||+..+ |.+||+|||
T Consensus 106 ~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaDlG 181 (438)
T KOG0666|consen 106 LFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIADLG 181 (438)
T ss_pred Eehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeeccc
Confidence 9999977 899988543 256888999999999999999999999 9999999999999877 899999999
Q ss_pred CccccccC----CCcccCccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCchHHHH--------------
Q 014352 263 LSKEEVFD----GRNSGLKGTYGYIDPAYISTN-KFTMKSDIFSFGVIIFELITAIHPHQNLMEYV-------------- 323 (426)
Q Consensus 263 l~~~~~~~----~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~-------------- 323 (426)
+++..... .....++-|..|.|||.+.+. .|+.+.|||+.||++.||+|-.+-|.+..+..
T Consensus 182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rI 261 (438)
T KOG0666|consen 182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRI 261 (438)
T ss_pred HHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHH
Confidence 99864332 233456789999999998765 68999999999999999999877665422110
Q ss_pred -------------HHhhcccc-chhhhhhhhhcccCCH-H-------HHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 014352 324 -------------NLASMSQD-GVDEILDKQLVGACNI-Q-------EVRELARIGHKCLHKTPRKRPSIGEVTQALL 379 (426)
Q Consensus 324 -------------~~~~~~~~-~~~~~~~~~~~~~~~~-~-------~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 379 (426)
.+..+..- ....-+.......+.. . ..+..++|+..+|..||-+|.|+++.+++.-
T Consensus 262 f~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y 339 (438)
T KOG0666|consen 262 FEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY 339 (438)
T ss_pred HHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence 00000000 0000000000000000 0 1124788999999999999999999988753
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=268.69 Aligned_cols=258 Identities=25% Similarity=0.366 Sum_probs=196.6
Q ss_pred HHHHHHhhhhcccccCCCeeEEEEEe-CCCcEEEEEEeccCC-ccCh------HHHHHHHHHHhcCCCCceeeEEeEEEe
Q 014352 113 DIQKATQNFTNILGQGAFGPVYKATM-PSGGVAAIKVLASDS-HQGE------KEFQTEVSLLGRLHHRNLVNLIGYCVD 184 (426)
Q Consensus 113 ~l~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~ 184 (426)
-+...+|-+.++||+|||+.||++.+ ...+.||+|+-.... +.++ +...+|.+|-+.|.||.||++++++.-
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL 538 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence 35566677778999999999999975 467789999865432 1111 235689999999999999999999865
Q ss_pred -CCeEEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEec---CCCcEEEee
Q 014352 185 -KGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLD---HFMRAKVAD 260 (426)
Q Consensus 185 -~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~D 260 (426)
.+.++-|+|||+|.+|+-+|.. .+.++..+...|+.||+.||.||.... +||||.||||.|||+- ..|.+||+|
T Consensus 539 DtdsFCTVLEYceGNDLDFYLKQ-hklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 539 DTDSFCTVLEYCEGNDLDFYLKQ-HKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred ccccceeeeeecCCCchhHHHHh-hhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeee
Confidence 4678999999999999999854 456899999999999999999999976 8899999999999995 457899999
Q ss_pred ecCccccccCCC--------cccCccccCccCccccccC----CCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhc
Q 014352 261 FGLSKEEVFDGR--------NSGLKGTYGYIDPAYISTN----KFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASM 328 (426)
Q Consensus 261 fgl~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~ 328 (426)
||+++....+.. ++...||..|++||++.-+ +.+.|.||||.||++|..+.|+.||........+-.
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILq- 695 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQ- 695 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHh-
Confidence 999986433221 2346799999999998433 578899999999999999999999986433222110
Q ss_pred cccchhhhhhhh-hcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 329 SQDGVDEILDKQ-LVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 329 ~~~~~~~~~~~~-~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
... ++... +.-+.-+..+.+...++.+||+..-++|.+..++...
T Consensus 696 -eNT---IlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d 741 (775)
T KOG1151|consen 696 -ENT---ILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD 741 (775)
T ss_pred -hhc---hhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence 000 11110 1111112334567889999999999999988877643
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=279.05 Aligned_cols=259 Identities=16% Similarity=0.226 Sum_probs=179.0
Q ss_pred HHHhhhhcccccCCCeeEEEEEe-----------------CCCcEEEEEEeccCCccChH--------------HHHHHH
Q 014352 116 KATQNFTNILGQGAFGPVYKATM-----------------PSGGVAAIKVLASDSHQGEK--------------EFQTEV 164 (426)
Q Consensus 116 ~~~~~~~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~--------------~~~~e~ 164 (426)
...+.+.++||+|+||+||+|.. ..++.||||.+........+ .+..|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 33456678999999999999964 23457999998654322222 234577
Q ss_pred HHHhcCCCCce-----eeEEeEEEe--------CCeEEEEEEecCCCChhHHhhhcc-----------------------
Q 014352 165 SLLGRLHHRNL-----VNLIGYCVD--------KGKYMLIYEFMSNGSLSNLIYSEE----------------------- 208 (426)
Q Consensus 165 ~~l~~l~h~ni-----v~~~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~----------------------- 208 (426)
.++.+++|.++ ++++++|.. .+..++||||+++++|.++++...
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77788876654 677777753 356899999999999999986421
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCcc--cCccccCccCcc
Q 014352 209 RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNS--GLKGTYGYIDPA 286 (426)
Q Consensus 209 ~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~--~~~gt~~y~aPE 286 (426)
..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......... ...+|+.|+|||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 12467778889999999999999998 9999999999999999999999999986533222222 223478999999
Q ss_pred ccccCC--------------------C--CcchhhHHHHHHHHHHHhCCC-CCCchHHHHHHhhccccchhhh---hhhh
Q 014352 287 YISTNK--------------------F--TMKSDIFSFGVIIFELITAIH-PHQNLMEYVNLASMSQDGVDEI---LDKQ 340 (426)
Q Consensus 287 ~~~~~~--------------------~--~~~~Dv~S~Gvvl~el~tg~~-p~~~~~~~~~~~~~~~~~~~~~---~~~~ 340 (426)
.+.... + ..+.||||+||++++|++|.. |+.+.................+ ....
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~ 460 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK 460 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC
Confidence 875432 1 134799999999999999875 7754322211110000110000 0001
Q ss_pred hcccCCHHHHHHHHHHHHHcccCCC---CCCCCHHHHHHH
Q 014352 341 LVGACNIQEVRELARIGHKCLHKTP---RKRPSIGEVTQA 377 (426)
Q Consensus 341 ~~~~~~~~~~~~l~~l~~~cl~~~p---~~RPs~~evl~~ 377 (426)
..-...........+++.++|..+| .+|+|+.|+++|
T Consensus 461 ~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 461 YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 1011112234678889999998766 789999999976
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=286.56 Aligned_cols=252 Identities=17% Similarity=0.192 Sum_probs=165.1
Q ss_pred HhhhhcccccCCCeeEEEEEeC-C----CcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeE------EEeCC
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-S----GGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGY------CVDKG 186 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~------~~~~~ 186 (426)
.|.+.+.||+|+||.||+|++. + +..||+|.+..... .+.+..+ .+....+.++..++.. +....
T Consensus 133 ~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (566)
T PLN03225 133 DFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKED 208 (566)
T ss_pred CeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccccCC
Confidence 4667789999999999999975 4 68899998764321 1111111 1222222223222211 23456
Q ss_pred eEEEEEEecCCCChhHHhhhccCCC-------------------CHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCC
Q 014352 187 KYMLIYEFMSNGSLSNLIYSEERVL-------------------NWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSAN 247 (426)
Q Consensus 187 ~~~lv~e~~~~gsL~~~l~~~~~~l-------------------~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~N 247 (426)
..++|+||+++++|.+++....... ....+..++.|++.||.|||+++ |+||||||+|
T Consensus 209 ~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLKP~N 285 (566)
T PLN03225 209 EYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQN 285 (566)
T ss_pred ceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCCHHH
Confidence 7899999999999999986433111 12335578999999999999998 9999999999
Q ss_pred EEecC-CCcEEEeeecCccccccC--CCcccCccccCccCccccccC----------------------CCCcchhhHHH
Q 014352 248 ILLDH-FMRAKVADFGLSKEEVFD--GRNSGLKGTYGYIDPAYISTN----------------------KFTMKSDIFSF 302 (426)
Q Consensus 248 ill~~-~~~~kl~Dfgl~~~~~~~--~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~Dv~S~ 302 (426)
||++. ++.+||+|||+++..... .......+++.|+|||.+... .++.++|||||
T Consensus 286 ILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl 365 (566)
T PLN03225 286 IIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 365 (566)
T ss_pred EEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence 99996 578999999999753221 123456789999999965322 23456799999
Q ss_pred HHHHHHHHhCCCCCCchHHHH-HHhhccccchhhhhhhhhcccCCHH----------HHHHHHHHHHHcccCCCCCCCCH
Q 014352 303 GVIIFELITAIHPHQNLMEYV-NLASMSQDGVDEILDKQLVGACNIQ----------EVRELARIGHKCLHKTPRKRPSI 371 (426)
Q Consensus 303 Gvvl~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~l~~l~~~cl~~~p~~RPs~ 371 (426)
||+||||+++..|+....... ............+.. ........+ ......+|+.+||+.||++|||+
T Consensus 366 GviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta 444 (566)
T PLN03225 366 GLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRK-LVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISA 444 (566)
T ss_pred HHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHH-hhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCH
Confidence 999999999877765421111 000000001111100 000000000 11235589999999999999999
Q ss_pred HHHHHH
Q 014352 372 GEVTQA 377 (426)
Q Consensus 372 ~evl~~ 377 (426)
.+++++
T Consensus 445 ~e~L~H 450 (566)
T PLN03225 445 KAALAH 450 (566)
T ss_pred HHHhCC
Confidence 999986
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=240.62 Aligned_cols=194 Identities=27% Similarity=0.423 Sum_probs=163.2
Q ss_pred cccccCCCeeEEEEEeC-CCcEEEEEEeccCCc-cChHHHHHHHHHHhcC-CCCceeeEEeEEEeCCeEEEEEEecCCCC
Q 014352 123 NILGQGAFGPVYKATMP-SGGVAAIKVLASDSH-QGEKEFQTEVSLLGRL-HHRNLVNLIGYCVDKGKYMLIYEFMSNGS 199 (426)
Q Consensus 123 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gs 199 (426)
..||+|++|.|=+-++. +|...|+|.+..... +..+....|+.+..+. .+|.+|.++|........++.||.|. .|
T Consensus 52 ~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~-tS 130 (282)
T KOG0984|consen 52 EELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD-TS 130 (282)
T ss_pred hhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh-hh
Confidence 46999999999888754 899999999976543 2335677788876655 69999999999999999999999995 48
Q ss_pred hhHHhh---hccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCcccC
Q 014352 200 LSNLIY---SEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGL 276 (426)
Q Consensus 200 L~~~l~---~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~ 276 (426)
|+.+-. ..+..+++..+-+|+..+.+||.|||++- .++|||+||+|||++.+|++|++|||++-.....-..+..
T Consensus 131 ldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAkt~d 208 (282)
T KOG0984|consen 131 LDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAKTMD 208 (282)
T ss_pred HHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhhhHHHHh
Confidence 876642 35677899999999999999999999974 4999999999999999999999999999866554444446
Q ss_pred ccccCccCccccc----cCCCCcchhhHHHHHHHHHHHhCCCCCCch
Q 014352 277 KGTYGYIDPAYIS----TNKFTMKSDIFSFGVIIFELITAIHPHQNL 319 (426)
Q Consensus 277 ~gt~~y~aPE~~~----~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~ 319 (426)
.|-..|||||.+. +..|+.|+||||||+++.||.+++.||.+.
T Consensus 209 aGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 209 AGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred cCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 6888999999884 347999999999999999999999999764
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=232.21 Aligned_cols=252 Identities=25% Similarity=0.296 Sum_probs=191.2
Q ss_pred hcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc--cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCCC
Q 014352 122 TNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH--QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNG 198 (426)
Q Consensus 122 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 198 (426)
.++||+|.||+||+|+.. +++.||+|.++.+.. .-.....+|+-+|+.++|.|||+++++.-++..+-+|+|||..
T Consensus 7 mekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq- 85 (292)
T KOG0662|consen 7 MEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ- 85 (292)
T ss_pred HHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH-
Confidence 457999999999999864 788999999876532 2235678999999999999999999999999999999999954
Q ss_pred ChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC-CcccCc
Q 014352 199 SLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG-RNSGLK 277 (426)
Q Consensus 199 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-~~~~~~ 277 (426)
+|..+..+.++.++.+....++.|+.+||.|+|+++ +.|||+||.|.|++.+|..|++|||+++-..-.- ..+...
T Consensus 86 dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvrcysaev 162 (292)
T KOG0662|consen 86 DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEV 162 (292)
T ss_pred HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceEeeecee
Confidence 899988777788999999999999999999999999 9999999999999999999999999998533222 234456
Q ss_pred cccCccCccccccC-CCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhc-------cccc---hhhhhhhhhcccC
Q 014352 278 GTYGYIDPAYISTN-KFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASM-------SQDG---VDEILDKQLVGAC 345 (426)
Q Consensus 278 gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~-------~~~~---~~~~~~~~~~~~~ 345 (426)
-|..|.+|.++-+. -|+...|+||-||++.|+.. |++.|.+..-...+..+ ..+. +..+.|-......
T Consensus 163 vtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~y 242 (292)
T KOG0662|consen 163 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIY 242 (292)
T ss_pred eeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCc
Confidence 78999999998765 47899999999999999997 55556553222222111 1111 1111111111111
Q ss_pred C-----HHHH----HHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 346 N-----IQEV----RELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 346 ~-----~~~~----~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
+ .+.. ..=.++++..+.-+|..|.++++.+++
T Consensus 243 pattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 243 PATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred cccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 1 1111 123466777788899999999988764
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=248.39 Aligned_cols=254 Identities=25% Similarity=0.350 Sum_probs=191.5
Q ss_pred hcccccCCCeeEEEEEeC-CCcEEEEEEeccCC--ccChHHHHHHHHHHhcCCCCceeeEEeEEEeC--------CeEEE
Q 014352 122 TNILGQGAFGPVYKATMP-SGGVAAIKVLASDS--HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDK--------GKYML 190 (426)
Q Consensus 122 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--------~~~~l 190 (426)
..+||+|.||.||+|+.. +|+.||+|++..+. ..-.....+|+++|..|+|+|++.++..|... ..+|+
T Consensus 22 ~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~yl 101 (376)
T KOG0669|consen 22 LAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYL 101 (376)
T ss_pred HHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeee
Confidence 457999999999999865 66678887654322 22234567899999999999999999888642 35899
Q ss_pred EEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC
Q 014352 191 IYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD 270 (426)
Q Consensus 191 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 270 (426)
||++|+. +|..+|......++..++.++..++..||.|+|... |+|||+||.|+|++.++.+||+|||+++.....
T Consensus 102 Vf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGlar~fs~~ 177 (376)
T KOG0669|consen 102 VFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLARAFSTS 177 (376)
T ss_pred eHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccccceecc
Confidence 9999976 999999666567999999999999999999999998 999999999999999999999999999743221
Q ss_pred C-----CcccCccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhcc-------ccchhhhh
Q 014352 271 G-----RNSGLKGTYGYIDPAYISTN-KFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMS-------QDGVDEIL 337 (426)
Q Consensus 271 ~-----~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~-------~~~~~~~~ 337 (426)
. ..+...-|..|.+||.+.+. .|+++.|+|.-||++.||.||.+-+++..+...+..+. .+..+.+.
T Consensus 178 ~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d 257 (376)
T KOG0669|consen 178 KNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVD 257 (376)
T ss_pred cccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcc
Confidence 1 12334568999999988764 68999999999999999999999887755443322211 11111100
Q ss_pred h----hhhccc-C-------CHHH------HHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 014352 338 D----KQLVGA-C-------NIQE------VRELARIGHKCLHKTPRKRPSIGEVTQALL 379 (426)
Q Consensus 338 ~----~~~~~~-~-------~~~~------~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 379 (426)
. ..+..+ . ..+. .+...+|+..++..||.+|+++.+++.+--
T Consensus 258 ~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~ 317 (376)
T KOG0669|consen 258 NLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDF 317 (376)
T ss_pred cchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhh
Confidence 0 000000 0 0011 136788999999999999999999987643
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=272.52 Aligned_cols=238 Identities=29% Similarity=0.386 Sum_probs=182.8
Q ss_pred cccccCCCee-EEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcC-CCCceeeEEeEEEeCCeEEEEEEecCCCCh
Q 014352 123 NILGQGAFGP-VYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRL-HHRNLVNLIGYCVDKGKYMLIYEFMSNGSL 200 (426)
Q Consensus 123 ~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 200 (426)
+++|.|+-|+ ||+|.+ +++.||||++.... ..-..+|+..|+.- +|||||++++.-.+.+..|+..|.|. .+|
T Consensus 515 eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~sL 589 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGVY-EGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-CSL 589 (903)
T ss_pred HHcccCCCCcEEEEEee-CCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-hhH
Confidence 4789998754 699999 67899999986532 23457899999888 59999999999888899999999994 599
Q ss_pred hHHhhhccC---CCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecC---C--CcEEEeeecCccccccCC-
Q 014352 201 SNLIYSEER---VLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDH---F--MRAKVADFGLSKEEVFDG- 271 (426)
Q Consensus 201 ~~~l~~~~~---~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~---~--~~~kl~Dfgl~~~~~~~~- 271 (426)
.+++..... ...-...+.+..|+++||++||+.+ ||||||||.||||+. + ..++|+|||+++....+.
T Consensus 590 ~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~s 666 (903)
T KOG1027|consen 590 QDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKS 666 (903)
T ss_pred HHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccCCCcc
Confidence 999976311 1111334667889999999999988 999999999999976 3 458999999998654432
Q ss_pred ---CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhC-CCCCCchHHHHHHhhccccchhhhhhhhhcccCCH
Q 014352 272 ---RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITA-IHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNI 347 (426)
Q Consensus 272 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (426)
...+..||.+|+|||++....-+.+.|+||+||++|+.++| ..||....+...- +.... ..+.. ..+..
T Consensus 667 S~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~N--Il~~~-~~L~~----L~~~~ 739 (903)
T KOG1027|consen 667 SFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQAN--ILTGN-YTLVH----LEPLP 739 (903)
T ss_pred hhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhh--hhcCc-cceee----eccCc
Confidence 23567899999999999998888899999999999998885 8999875443211 11111 00000 01111
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 348 QEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 348 ~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
+. +..+||.+|++.+|..||++.+|+.+
T Consensus 740 d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 740 DC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred hH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 11 67899999999999999999999765
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=247.01 Aligned_cols=242 Identities=24% Similarity=0.387 Sum_probs=190.5
Q ss_pred hhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccC---hHHHHHHHHHHhcC-CCCceeeEEeEEEeCCeEEEEEEe
Q 014352 120 NFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQG---EKEFQTEVSLLGRL-HHRNLVNLIGYCVDKGKYMLIYEF 194 (426)
Q Consensus 120 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 194 (426)
.+.++||+|+|..|..+++. +.+.+|+|++++....+ ..-.+.|..+..+. +||.+|.+..+|.....+++|.||
T Consensus 253 ~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffviey 332 (593)
T KOG0695|consen 253 DLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEY 332 (593)
T ss_pred eeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEE
Confidence 45578999999999999875 77889999987653222 23456777777665 799999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC-CCc
Q 014352 195 MSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD-GRN 273 (426)
Q Consensus 195 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-~~~ 273 (426)
++||+|--++.+. +.|+.+....+...|+.||.|||+++ |+.||||..|+|+|..|++|++|||+++....+ ..+
T Consensus 333 v~ggdlmfhmqrq-rklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l~~gd~t 408 (593)
T KOG0695|consen 333 VNGGDLMFHMQRQ-RKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDTT 408 (593)
T ss_pred ecCcceeeehhhh-hcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCCCCCccc
Confidence 9999998777444 45899998889999999999999999 999999999999999999999999999865443 455
Q ss_pred ccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccc-cc-hhhhhhhhhcccCCHHHHH
Q 014352 274 SGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQ-DG-VDEILDKQLVGACNIQEVR 351 (426)
Q Consensus 274 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~ 351 (426)
++++||+.|.|||.+.+..|....|.|++||+++||+.|+.||.-.-.. . +.... +- ..-++.+.++ .+...+.
T Consensus 409 stfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~-n-~d~ntedylfqvilekqir--iprslsv 484 (593)
T KOG0695|consen 409 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMD-N-PDMNTEDYLFQVILEKQIR--IPRSLSV 484 (593)
T ss_pred ccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCC-C-cccchhHHHHHHHhhhccc--ccceeeh
Confidence 7889999999999999999999999999999999999999999632100 0 00000 00 1112222221 1222334
Q ss_pred HHHHHHHHcccCCCCCCC
Q 014352 352 ELARIGHKCLHKTPRKRP 369 (426)
Q Consensus 352 ~l~~l~~~cl~~~p~~RP 369 (426)
....+++.-|++||.+|.
T Consensus 485 kas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 485 KASHVLKGFLNKDPKERL 502 (593)
T ss_pred hhHHHHHHhhcCCcHHhc
Confidence 567788889999999994
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.6e-31 Score=233.27 Aligned_cols=209 Identities=41% Similarity=0.629 Sum_probs=183.2
Q ss_pred cccCCCeeEEEEEeCC-CcEEEEEEeccCCcc-ChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCCCChhH
Q 014352 125 LGQGAFGPVYKATMPS-GGVAAIKVLASDSHQ-GEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSN 202 (426)
Q Consensus 125 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~ 202 (426)
||+|.+|.||++...+ +..+++|.+...... ....+.+|++.++.+.|++++++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999863 888999998765432 24678999999999999999999999999899999999999999999
Q ss_pred HhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecC-CCcEEEeeecCccccccCC-CcccCcccc
Q 014352 203 LIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDH-FMRAKVADFGLSKEEVFDG-RNSGLKGTY 280 (426)
Q Consensus 203 ~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgl~~~~~~~~-~~~~~~gt~ 280 (426)
++......+++..+..++.+++.++.+||+.+ ++|+||+|.||+++. ++.++|+|||.+....... ......+..
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 157 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTP 157 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCC
Confidence 98655346899999999999999999999998 999999999999999 8999999999987543221 133456788
Q ss_pred CccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHHHHH
Q 014352 281 GYIDPAYISTN-KFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHK 359 (426)
Q Consensus 281 ~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 359 (426)
.|++||.+... .++.++|+|++|++++++ ..+.+++..
T Consensus 158 ~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------------~~~~~~l~~ 196 (215)
T cd00180 158 AYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------------PELKDLIRK 196 (215)
T ss_pred CccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------HHHHHHHHH
Confidence 99999999877 788999999999999999 468899999
Q ss_pred cccCCCCCCCCHHHHHHH
Q 014352 360 CLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 360 cl~~~p~~RPs~~evl~~ 377 (426)
|++.+|++||++.+++++
T Consensus 197 ~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 197 MLQKDPEKRPSAKEILEH 214 (215)
T ss_pred HhhCCcccCcCHHHHhhC
Confidence 999999999999999865
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-32 Score=265.53 Aligned_cols=249 Identities=27% Similarity=0.395 Sum_probs=205.5
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCC
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSN 197 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 197 (426)
|++...+|+|+||.|||+++. ++..+|+|+++.....+..-.++|+-+++..+||||+.++|.+...+.+++.||||.+
T Consensus 17 yellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgg 96 (829)
T KOG0576|consen 17 YELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGG 96 (829)
T ss_pred hhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCC
Confidence 345568999999999999965 7889999999988777777788999999999999999999999999999999999999
Q ss_pred CChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccccc-CCCcccC
Q 014352 198 GSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF-DGRNSGL 276 (426)
Q Consensus 198 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~-~~~~~~~ 276 (426)
|+|.+.-+ -..+++..++..+.....+||.|||+++ =+|||||-.|||+++.|.+|++|||.+-.... -.+...+
T Consensus 97 gslQdiy~-~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati~Krksf 172 (829)
T KOG0576|consen 97 GSLQDIYH-VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKSF 172 (829)
T ss_pred Ccccceee-ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhhhhhhcc
Confidence 99999764 4456999999999999999999999998 78999999999999999999999999865432 3445678
Q ss_pred ccccCccCcccc---ccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHH
Q 014352 277 KGTYGYIDPAYI---STNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVREL 353 (426)
Q Consensus 277 ~gt~~y~aPE~~---~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 353 (426)
.||+.|||||+. +.+.|..++|||++|+...|+---.+|.....+...+..+........ .+ .........+
T Consensus 173 iGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp---~l--kDk~kws~~f 247 (829)
T KOG0576|consen 173 IGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPP---TL--KDKTKWSEFF 247 (829)
T ss_pred cCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCC---cc--cCCccchHHH
Confidence 899999999987 567899999999999999999888888666555555444433322110 00 1112344678
Q ss_pred HHHHHHcccCCCCCCCCHHHHHH
Q 014352 354 ARIGHKCLHKTPRKRPSIGEVTQ 376 (426)
Q Consensus 354 ~~l~~~cl~~~p~~RPs~~evl~ 376 (426)
.++++.|+.++|.+||+++.+++
T Consensus 248 h~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred HHHHHHHhcCCCccCCChhhhee
Confidence 89999999999999999987654
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-32 Score=256.28 Aligned_cols=269 Identities=20% Similarity=0.243 Sum_probs=208.8
Q ss_pred CCCCCCCChhHHHHHHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCC------CCce
Q 014352 103 ASGIPRYAYKDIQKATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLH------HRNL 175 (426)
Q Consensus 103 ~~~~~~~~~~~l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------h~ni 175 (426)
..|..++.+.++...+|.+....|+|-|++|.+|... .|+.||||++.+.... .+.=..|+++|.+|+ --|+
T Consensus 418 aEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hc 496 (752)
T KOG0670|consen 418 AEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHC 496 (752)
T ss_pred ccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHH
Confidence 4455667788999999999999999999999999865 6779999999875322 234568999999995 3489
Q ss_pred eeEEeEEEeCCeEEEEEEecCCCChhHHhhhcc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCC
Q 014352 176 VNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEE--RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHF 253 (426)
Q Consensus 176 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~ 253 (426)
++++..|...+++|||+|.+ ..+|.++|..-+ ..|....+..++.|+.-||..|-..+ |+|.||||.||||++.
T Consensus 497 lrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~ 572 (752)
T KOG0670|consen 497 LRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNES 572 (752)
T ss_pred HHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccC
Confidence 99999999999999999998 559999997654 45778888999999999999999998 9999999999999985
Q ss_pred C-cEEEeeecCccccccCCCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhcc---
Q 014352 254 M-RAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMS--- 329 (426)
Q Consensus 254 ~-~~kl~Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~--- 329 (426)
. ..||||||.|.... ....+...-+.-|.|||++.+.+|+...|+||.||+||||.||+..|.+..+...+..+.
T Consensus 573 k~iLKLCDfGSA~~~~-eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~K 651 (752)
T KOG0670|consen 573 KNILKLCDFGSASFAS-ENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELK 651 (752)
T ss_pred cceeeeccCccccccc-cccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhc
Confidence 4 57999999886543 233344455668999999999999999999999999999999998887633222111000
Q ss_pred c----------------------------cch--------hhhhhh------hhc-----ccCCHHHHHHHHHHHHHccc
Q 014352 330 Q----------------------------DGV--------DEILDK------QLV-----GACNIQEVRELARIGHKCLH 362 (426)
Q Consensus 330 ~----------------------------~~~--------~~~~~~------~~~-----~~~~~~~~~~l~~l~~~cl~ 362 (426)
. +.+ ...+.+ .+. ....+....+|.+|+..|+.
T Consensus 652 Gk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~ 731 (752)
T KOG0670|consen 652 GKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLI 731 (752)
T ss_pred CCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhc
Confidence 0 000 000000 111 11123355689999999999
Q ss_pred CCCCCCCCHHHHHHH
Q 014352 363 KTPRKRPSIGEVTQA 377 (426)
Q Consensus 363 ~~p~~RPs~~evl~~ 377 (426)
.||++|.|..+.+.+
T Consensus 732 LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 732 LDPEKRITVNQALKH 746 (752)
T ss_pred cChhhcCCHHHHhcC
Confidence 999999999998875
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=252.72 Aligned_cols=193 Identities=25% Similarity=0.380 Sum_probs=163.5
Q ss_pred cccccCCCeeEEEEEe-CCCcEEEEEEeccCCc---cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCCC
Q 014352 123 NILGQGAFGPVYKATM-PSGGVAAIKVLASDSH---QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNG 198 (426)
Q Consensus 123 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 198 (426)
+.||-|+||.|.++.. ++...+|.|.+++..- ......+.|-.||+.-..+-||+|+-.|.+++.+|+||||++||
T Consensus 635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGG 714 (1034)
T KOG0608|consen 635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGG 714 (1034)
T ss_pred eeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCc
Confidence 4599999999999874 4666889998876532 22335778999999999999999999999999999999999999
Q ss_pred ChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccc---------cc
Q 014352 199 SLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEE---------VF 269 (426)
Q Consensus 199 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~---------~~ 269 (426)
++-.+|.+.+- +.+.....++..+..|+++.|..| +|||||||+|||||.+|++||+||||+.-. ..
T Consensus 715 DmMSLLIrmgI-FeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~ 790 (1034)
T KOG0608|consen 715 DMMSLLIRMGI-FEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQE 790 (1034)
T ss_pred cHHHHHHHhcc-CHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceeccccccccC
Confidence 99999977654 677777778889999999999999 999999999999999999999999997510 00
Q ss_pred CCC----------------------------------cccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCC
Q 014352 270 DGR----------------------------------NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHP 315 (426)
Q Consensus 270 ~~~----------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p 315 (426)
... ....+||+.|+|||++....|+..+|.||.|||||||+.|+.|
T Consensus 791 gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~p 870 (1034)
T KOG0608|consen 791 GDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPP 870 (1034)
T ss_pred CCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCC
Confidence 000 0124699999999999999999999999999999999999999
Q ss_pred CCch
Q 014352 316 HQNL 319 (426)
Q Consensus 316 ~~~~ 319 (426)
|...
T Consensus 871 f~~~ 874 (1034)
T KOG0608|consen 871 FLAD 874 (1034)
T ss_pred ccCC
Confidence 9653
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-30 Score=230.90 Aligned_cols=196 Identities=34% Similarity=0.506 Sum_probs=171.5
Q ss_pred hhhcccccCCCeeEEEEEeCC-CcEEEEEEeccCCcc-ChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCC
Q 014352 120 NFTNILGQGAFGPVYKATMPS-GGVAAIKVLASDSHQ-GEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSN 197 (426)
Q Consensus 120 ~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 197 (426)
.+.+.||.|++|.||++...+ +..+++|.+...... ..+.+.+|++.+++++|+|++++++++......++++||+++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~ 81 (225)
T smart00221 2 ELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEG 81 (225)
T ss_pred ceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCC
Confidence 345789999999999999864 788999999866544 567889999999999999999999999998999999999999
Q ss_pred CChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC--Cccc
Q 014352 198 GSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG--RNSG 275 (426)
Q Consensus 198 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~--~~~~ 275 (426)
++|.+++......+++.....++.+++.++.|||+.+ ++|+|++|+||+++.++.++|+|||.+....... ....
T Consensus 82 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~ 158 (225)
T smart00221 82 GDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKT 158 (225)
T ss_pred CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccc
Confidence 9999998654433889999999999999999999998 9999999999999999999999999987654332 2344
Q ss_pred CccccCccCcccc-ccCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 014352 276 LKGTYGYIDPAYI-STNKFTMKSDIFSFGVIIFELITAIHPHQN 318 (426)
Q Consensus 276 ~~gt~~y~aPE~~-~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~ 318 (426)
..++..|++||.. ....++.++|+|+||++++||++|+.||..
T Consensus 159 ~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 159 VKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred eeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 5678899999998 777788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=223.00 Aligned_cols=250 Identities=19% Similarity=0.303 Sum_probs=190.7
Q ss_pred hhhhcccccCCCeeEEEEEe-CCCcEEEEEEeccCCccChHHHHHHHHHHhcCC-CCceeeEEeEEEeC--CeEEEEEEe
Q 014352 119 QNFTNILGQGAFGPVYKATM-PSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLH-HRNLVNLIGYCVDK--GKYMLIYEF 194 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~e~ 194 (426)
|++.+++|+|.++.||.|.. .+++.++||++++. ..+.+.+|+.+|..|. ||||++++++..++ ....||+||
T Consensus 40 Yeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~ 116 (338)
T KOG0668|consen 40 YEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEY 116 (338)
T ss_pred HHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhh
Confidence 56677899999999999984 47788999999763 4567899999999997 99999999998875 457899999
Q ss_pred cCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCC-CcEEEeeecCccccccCCCc
Q 014352 195 MSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHF-MRAKVADFGLSKEEVFDGRN 273 (426)
Q Consensus 195 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgl~~~~~~~~~~ 273 (426)
+.+.+...+. ..|+...+...+.++++||.|+|+.| |.|||+||.|+++|.. ...+|+|+|+|........-
T Consensus 117 v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eY 189 (338)
T KOG0668|consen 117 VNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 189 (338)
T ss_pred hccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCCCcee
Confidence 9887776654 44778888899999999999999999 9999999999999974 56999999999876555455
Q ss_pred ccCccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCc----hHHHHHHhhccc-cchhh-------hhhhh
Q 014352 274 SGLKGTYGYIDPAYIST-NKFTMKSDIFSFGVIIFELITAIHPHQN----LMEYVNLASMSQ-DGVDE-------ILDKQ 340 (426)
Q Consensus 274 ~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~----~~~~~~~~~~~~-~~~~~-------~~~~~ 340 (426)
+-...+..|--||.+-. ..|+..-|+|||||++..|+..+.||-. ..+.+.+..+.. ..+.. .+++.
T Consensus 190 nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~ 269 (338)
T KOG0668|consen 190 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQ 269 (338)
T ss_pred eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChh
Confidence 55566778889998854 5688999999999999999999999742 222222111100 00000 01111
Q ss_pred hcc---------------cC-CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014352 341 LVG---------------AC-NIQEVRELARIGHKCLHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 341 ~~~---------------~~-~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 378 (426)
+.. .. ..-..++..+++.+.|..|-.+|||++|...+-
T Consensus 270 ~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~Hp 323 (338)
T KOG0668|consen 270 FEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHP 323 (338)
T ss_pred HhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCc
Confidence 100 00 011236788999999999999999999988763
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-32 Score=238.41 Aligned_cols=253 Identities=26% Similarity=0.343 Sum_probs=188.4
Q ss_pred cccccCCCeeEEEEEeC-CCcEEEEEEeccCC--ccChHHHHHHHHHHhcCCCCceeeEEeEEEeC-----CeEEEEEEe
Q 014352 123 NILGQGAFGPVYKATMP-SGGVAAIKVLASDS--HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDK-----GKYMLIYEF 194 (426)
Q Consensus 123 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~ 194 (426)
+.||-|+||.||..++. +|+.||.|++.+-. ....+.+-+|+++|..++|.|++..+++.... +++|+++|.
T Consensus 59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TEL 138 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTEL 138 (449)
T ss_pred CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHH
Confidence 57999999999999865 88899999886542 23446788999999999999999999887654 357888998
Q ss_pred cCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC--C
Q 014352 195 MSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG--R 272 (426)
Q Consensus 195 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~--~ 272 (426)
|.. +|...+- ....++...+.-+..||++||.|||+.+ |.||||||.|.|++.|...||+|||+++....+. .
T Consensus 139 mQS-DLHKIIV-SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~h 213 (449)
T KOG0664|consen 139 MQS-DLHKIIV-SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLN 213 (449)
T ss_pred HHh-hhhheec-cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchhhhhh
Confidence 854 8887773 4566888888889999999999999999 9999999999999999999999999998543332 2
Q ss_pred cccCccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhcc----ccch-----------hhh
Q 014352 273 NSGLKGTYGYIDPAYISTN-KFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMS----QDGV-----------DEI 336 (426)
Q Consensus 273 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~----~~~~-----------~~~ 336 (426)
.+...-|..|.|||.+.+. .|+.+.||||.||++.||+..+..|+...+...+..+. .... .-+
T Consensus 214 MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~ 293 (449)
T KOG0664|consen 214 MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHV 293 (449)
T ss_pred hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHh
Confidence 2334568899999998764 68999999999999999999888876433322221110 0000 001
Q ss_pred hhhhhcc---------cCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 014352 337 LDKQLVG---------ACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLK 380 (426)
Q Consensus 337 ~~~~~~~---------~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 380 (426)
+...... ..+...-.+...+...++..||+.|.+..+.+.++..
T Consensus 294 LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~ 346 (449)
T KOG0664|consen 294 LRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL 346 (449)
T ss_pred hccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence 1110000 0001112345677778999999999999998887643
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-30 Score=229.33 Aligned_cols=248 Identities=25% Similarity=0.307 Sum_probs=187.3
Q ss_pred cccccCCCeeEEEEEeC-CCcEEEEEEeccC--CccChHHHHHHHHHHhcCCCCceeeEEeEEEeC------CeEEEEEE
Q 014352 123 NILGQGAFGPVYKATMP-SGGVAAIKVLASD--SHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDK------GKYMLIYE 193 (426)
Q Consensus 123 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~~lv~e 193 (426)
..+|.|.- .|-.+-+. .++.||+|.+... .....+...+|..++..++|+||++++.++.-. .+.|+|||
T Consensus 23 ~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e 101 (369)
T KOG0665|consen 23 KPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVME 101 (369)
T ss_pred cccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHH
Confidence 35788877 55555443 7888999987544 223345677899999999999999999998654 36799999
Q ss_pred ecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCc
Q 014352 194 FMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRN 273 (426)
Q Consensus 194 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 273 (426)
+|. .+|...+.- .++-.++..|..|++.|+.|||+.+ |+||||||+||++..+...||.|||+++.....-..
T Consensus 102 ~m~-~nl~~vi~~---elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~~~m 174 (369)
T KOG0665|consen 102 LMD-ANLCQVILM---ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTEDTDFMM 174 (369)
T ss_pred hhh-hHHHHHHHH---hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhcccCccccc
Confidence 995 599988852 2566778889999999999999999 999999999999999999999999999976655556
Q ss_pred ccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchH---HHHHHhhcccc-------------------
Q 014352 274 SGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLM---EYVNLASMSQD------------------- 331 (426)
Q Consensus 274 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~---~~~~~~~~~~~------------------- 331 (426)
+....|..|.|||++.+..+.+.+||||.||++.||++|..-|.+.. +|.........
T Consensus 175 tpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~ 254 (369)
T KOG0665|consen 175 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVEN 254 (369)
T ss_pred CchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhc
Confidence 77889999999999999999999999999999999999998776522 22111110000
Q ss_pred -------chhhhh-hhhhcc--cCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014352 332 -------GVDEIL-DKQLVG--ACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 332 -------~~~~~~-~~~~~~--~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 378 (426)
...+.+ |..+.. ..+.-....+.+++.+||-.||++|.|+.+++.+-
T Consensus 255 ~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HP 311 (369)
T KOG0665|consen 255 RPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHP 311 (369)
T ss_pred ChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCC
Confidence 000000 000000 01112234578899999999999999999999873
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-30 Score=246.92 Aligned_cols=195 Identities=25% Similarity=0.406 Sum_probs=165.8
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCcc-----Ch---HHHHHHHHHHhcCC---CCceeeEEeEEEeCC
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQ-----GE---KEFQTEVSLLGRLH---HRNLVNLIGYCVDKG 186 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~---~~~~~e~~~l~~l~---h~niv~~~~~~~~~~ 186 (426)
|.....+|.|+||.|+.|.++ +.-.|+||.+.+...- .. -..-.|+.||..++ |+||++++++|++++
T Consensus 563 yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd 642 (772)
T KOG1152|consen 563 YTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDD 642 (772)
T ss_pred ceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCC
Confidence 444568999999999999987 4557888988654211 11 13457999999997 999999999999999
Q ss_pred eEEEEEEec-CCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcc
Q 014352 187 KYMLIYEFM-SNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSK 265 (426)
Q Consensus 187 ~~~lv~e~~-~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 265 (426)
.+||+||-. ++-+|.+++..+. .+++.+...|+.||+.|+++||+++ |||||||-+||.++.+|-+||+|||.+.
T Consensus 643 ~yyl~te~hg~gIDLFd~IE~kp-~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfgsaa 718 (772)
T KOG1152|consen 643 YYYLETEVHGEGIDLFDFIEFKP-RMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFGSAA 718 (772)
T ss_pred eeEEEecCCCCCcchhhhhhccC-ccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeeccchh
Confidence 999999975 4678899985444 4899999999999999999999999 9999999999999999999999999887
Q ss_pred ccccCCCcccCccccCccCccccccCCCC-cchhhHHHHHHHHHHHhCCCCCCc
Q 014352 266 EEVFDGRNSGLKGTYGYIDPAYISTNKFT-MKSDIFSFGVIIFELITAIHPHQN 318 (426)
Q Consensus 266 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~S~Gvvl~el~tg~~p~~~ 318 (426)
... .+....+.||..|.|||++.+.+|- ..-|||++|++||.++....||.+
T Consensus 719 ~~k-sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 719 YTK-SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhc-CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 543 4566778999999999999999885 568999999999999999998854
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=230.02 Aligned_cols=142 Identities=26% Similarity=0.379 Sum_probs=117.5
Q ss_pred CCCCCChhHHHH-HHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCC-----C---Cc
Q 014352 105 GIPRYAYKDIQK-ATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLH-----H---RN 174 (426)
Q Consensus 105 ~~~~~~~~~l~~-~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h---~n 174 (426)
|.......|..+ ++|-+.++||=|.|++||++.+. +.+.||+|+.+.... -.+....||++|++++ | .+
T Consensus 65 GYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh-YtEaAlDEIklL~~v~~~Dp~~~~~~~ 143 (590)
T KOG1290|consen 65 GYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH-YTEAALDEIKLLQQVREGDPNDPGKKC 143 (590)
T ss_pred CCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH-HHHHHHHHHHHHHHHHhcCCCCCCCce
Confidence 333455667776 88989999999999999999865 678899999876542 2346778999999883 3 47
Q ss_pred eeeEEeEEEe----CCeEEEEEEecCCCChhHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEE
Q 014352 175 LVNLIGYCVD----KGKYMLIYEFMSNGSLSNLIYSEE-RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANIL 249 (426)
Q Consensus 175 iv~~~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil 249 (426)
||+|+++|.. +.+++||+|++ |-+|..+|.... +.++...+..|+.||+.||.|||.+. +|||.||||+|||
T Consensus 144 VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvL 220 (590)
T KOG1290|consen 144 VVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVL 220 (590)
T ss_pred eeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceee
Confidence 9999999975 45899999999 558888776544 67999999999999999999999975 5999999999999
Q ss_pred e
Q 014352 250 L 250 (426)
Q Consensus 250 l 250 (426)
+
T Consensus 221 l 221 (590)
T KOG1290|consen 221 L 221 (590)
T ss_pred e
Confidence 9
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=269.11 Aligned_cols=196 Identities=19% Similarity=0.266 Sum_probs=143.5
Q ss_pred cCCC-CceeeEEeEE-------EeCCeEEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeee
Q 014352 169 RLHH-RNLVNLIGYC-------VDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIH 240 (426)
Q Consensus 169 ~l~h-~niv~~~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH 240 (426)
.++| +||+++++++ .....++.++||+ +++|.++|......+++.+++.++.||+.||.|||+++ |+|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---IvH 103 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG---IVV 103 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC---eee
Confidence 4556 6888888877 2334678889988 56999999765667999999999999999999999999 999
Q ss_pred cCCCCCCEEecC-------------------CCcEEEeeecCccccccCC-----------------CcccCccccCccC
Q 014352 241 RDLKSANILLDH-------------------FMRAKVADFGLSKEEVFDG-----------------RNSGLKGTYGYID 284 (426)
Q Consensus 241 ~dlk~~Nill~~-------------------~~~~kl~Dfgl~~~~~~~~-----------------~~~~~~gt~~y~a 284 (426)
|||||+||||+. ++.+|++|||+++...... ......||+.|||
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 999999999964 4456666666665321000 0011357888999
Q ss_pred ccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHHHHHcccCC
Q 014352 285 PAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKT 364 (426)
Q Consensus 285 PE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~ 364 (426)
||++.+..++.++|||||||+||||++|..|+........ .... ....+. ..........++.+||+.+
T Consensus 184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~--~~~~----~~~~~~-----~~~~~~~~~~~~~~~L~~~ 252 (793)
T PLN00181 184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMS--SLRH----RVLPPQ-----ILLNWPKEASFCLWLLHPE 252 (793)
T ss_pred hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHH--HHHH----hhcChh-----hhhcCHHHHHHHHHhCCCC
Confidence 9999999999999999999999999999888754221110 0000 001111 1112234668888999999
Q ss_pred CCCCCCHHHHHHHHH
Q 014352 365 PRKRPSIGEVTQALL 379 (426)
Q Consensus 365 p~~RPs~~evl~~L~ 379 (426)
|.+||++.+++++-.
T Consensus 253 P~~Rps~~eil~h~~ 267 (793)
T PLN00181 253 PSCRPSMSELLQSEF 267 (793)
T ss_pred hhhCcChHHHhhchh
Confidence 999999999987643
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-29 Score=216.18 Aligned_cols=170 Identities=20% Similarity=0.221 Sum_probs=129.8
Q ss_pred CChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCcccCc
Q 014352 198 GSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLK 277 (426)
Q Consensus 198 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 277 (426)
|+|.+++...+..+++.+++.++.|++.||.|||+++ ||+|||++.++.+|+ ||++...... ...
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~----~~~ 65 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE----QSR 65 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc----cCC
Confidence 6899999776677999999999999999999999975 999999999999999 9998754321 236
Q ss_pred cccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcc-cCCHHHHH--HHH
Q 014352 278 GTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVG-ACNIQEVR--ELA 354 (426)
Q Consensus 278 gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~--~l~ 354 (426)
||+.|||||++.+..++.++|||||||++|||++|..||.............. .......... ........ .+.
T Consensus 66 g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 142 (176)
T smart00750 66 VDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILL---NGMPADDPRDRSNLESVSAARSFA 142 (176)
T ss_pred CcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHH---HHhccCCccccccHHHHHhhhhHH
Confidence 88999999999999999999999999999999999999965432211100000 0000000000 01112222 699
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHHHHHHHHh
Q 014352 355 RIGHKCLHKTPRKRPSIGEVTQALLKIKQRH 385 (426)
Q Consensus 355 ~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~ 385 (426)
+++.+||+.+|++||++.++++++..+..+.
T Consensus 143 ~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~~ 173 (176)
T smart00750 143 DFMRVCASRLPQRREAANHYLAHCRALFAET 173 (176)
T ss_pred HHHHHHHhcccccccCHHHHHHHHHHHHHHH
Confidence 9999999999999999999999998876543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-29 Score=219.07 Aligned_cols=249 Identities=21% Similarity=0.375 Sum_probs=196.4
Q ss_pred HhhhhcccccCCCeeEEEEEeCCCcEEEEEEeccC--CccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEec
Q 014352 118 TQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASD--SHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 195 (426)
..++..+|.....|..|+|+++++..| .|++... ...-.++|.+|.-.|+-+.||||++++|.|.++.++.++..||
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwqgndiv-akil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m 269 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQGNDIV-AKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM 269 (448)
T ss_pred hhhhhhhhccCCCcccccccccCcchh-hhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence 345666899999999999999877654 4666433 2223468999999999999999999999999999999999999
Q ss_pred CCCChhHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEe--eecCccccccCCC
Q 014352 196 SNGSLSNLIYSEE-RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVA--DFGLSKEEVFDGR 272 (426)
Q Consensus 196 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~--Dfgl~~~~~~~~~ 272 (426)
+.|||+++|+... -..+-.+..+++.++|+|++|||+.. |-|.---|.+..+++|++.+++|+ |--++..
T Consensus 270 p~gslynvlhe~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsfq------ 342 (448)
T KOG0195|consen 270 PFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ------ 342 (448)
T ss_pred cchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeeee------
Confidence 9999999997654 34677788999999999999999976 446666899999999999988765 3222211
Q ss_pred cccCccccCccCccccccCCCC---cchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHH
Q 014352 273 NSGLKGTYGYIDPAYISTNKFT---MKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQE 349 (426)
Q Consensus 273 ~~~~~gt~~y~aPE~~~~~~~~---~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (426)
..+..-.+.||+||.+...+-+ .++|+|||.+++|||.|...||.+..+..--..+ .-..++...++..
T Consensus 343 e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki--------aleglrv~ippgi 414 (448)
T KOG0195|consen 343 EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI--------ALEGLRVHIPPGI 414 (448)
T ss_pred ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh--------hhccccccCCCCc
Confidence 1233457899999999776544 4799999999999999999999876543221111 1223344556677
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 014352 350 VRELARIGHKCLHKTPRKRPSIGEVTQALLKIK 382 (426)
Q Consensus 350 ~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 382 (426)
+..+.+++.-|+..||.+||.+..|+-.|+++.
T Consensus 415 s~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 415 SRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred cHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 789999999999999999999999999998763
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-28 Score=211.69 Aligned_cols=245 Identities=22% Similarity=0.315 Sum_probs=176.8
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcC-CCCceeeEEeE-EEeCCeEEEEEEe
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRL-HHRNLVNLIGY-CVDKGKYMLIYEF 194 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~-~~~~~~~~lv~e~ 194 (426)
.|++.+.||+|.||.+-++.++ +.+.+++|.+.... ...++|.+|..---.| .|.||+.-++. |...+.+++++||
T Consensus 25 ~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~ 103 (378)
T KOG1345|consen 25 VYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEF 103 (378)
T ss_pred hhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeecc
Confidence 3667788999999999999986 66788899876543 4567888887755555 48999987764 5667788999999
Q ss_pred cCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEec--CCCcEEEeeecCccccccCCC
Q 014352 195 MSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLD--HFMRAKVADFGLSKEEVFDGR 272 (426)
Q Consensus 195 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~--~~~~~kl~Dfgl~~~~~~~~~ 272 (426)
+|.|+|..-+.. ..+.+.....++.|++.|+.|+|+++ +||||||.+|||+- +...+||+|||+++... ..
T Consensus 104 aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g--~t 176 (378)
T KOG1345|consen 104 APRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG--TT 176 (378)
T ss_pred CccchhhhhcCc--ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC--ce
Confidence 999999998844 33677778889999999999999999 99999999999994 34479999999987432 22
Q ss_pred cccCccccCccCccccc---cC--CCCcchhhHHHHHHHHHHHhCCCCCCchH----HHHHHhhccccchhhhhhhhhcc
Q 014352 273 NSGLKGTYGYIDPAYIS---TN--KFTMKSDIFSFGVIIFELITAIHPHQNLM----EYVNLASMSQDGVDEILDKQLVG 343 (426)
Q Consensus 273 ~~~~~gt~~y~aPE~~~---~~--~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 343 (426)
......+..|.+||... ++ ...+.+|+|.||++++.++||+.||+... .+..+.....+....+.+
T Consensus 177 V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~----- 251 (378)
T KOG1345|consen 177 VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPK----- 251 (378)
T ss_pred ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCch-----
Confidence 23344567899998663 22 34678999999999999999999997321 111111111111111000
Q ss_pred cCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014352 344 ACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQ 376 (426)
Q Consensus 344 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 376 (426)
.-...+..+.++.++-+..+|.+|--..++.+
T Consensus 252 -~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk 283 (378)
T KOG1345|consen 252 -KFNPFSEKALRLFKKSLTPRFKDRCKIWTAKK 283 (378)
T ss_pred -hhcccCHHHHHHHHHhcCCcccccchhHHHHH
Confidence 01123356778888889999999944444333
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.5e-27 Score=218.13 Aligned_cols=190 Identities=26% Similarity=0.418 Sum_probs=158.0
Q ss_pred hhhhcccccCCCeeEEEEEeC----CCcEEEEEEeccCCccChHHHHHHHHHHhcCC-CCceeeEEeEEEeCCeEEEEEE
Q 014352 119 QNFTNILGQGAFGPVYKATMP----SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLH-HRNLVNLIGYCVDKGKYMLIYE 193 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e 193 (426)
+...++||.|.|++||++.+. ....||+|.+...+. ...+.+|+++|..+. +.||+++.+++..++...+|+|
T Consensus 38 ~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp 115 (418)
T KOG1167|consen 38 YKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLP 115 (418)
T ss_pred hhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEec
Confidence 344578999999999999854 456899999876643 346889999999995 9999999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecC-CCcEEEeeecCcccc-----
Q 014352 194 FMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDH-FMRAKVADFGLSKEE----- 267 (426)
Q Consensus 194 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgl~~~~----- 267 (426)
|++.....++.. .++..++..++..+..||.++|++| ||||||||+|+|.+. .+.-.|.|||++...
T Consensus 116 ~~~H~~f~~l~~----~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~ 188 (418)
T KOG1167|consen 116 YFEHDRFRDLYR----SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQ 188 (418)
T ss_pred ccCccCHHHHHh----cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHHHHHhhhh
Confidence 999988888873 3778899999999999999999999 999999999999986 466889999998610
Q ss_pred ------------cc-CC---------------------------CcccCccccCccCcccccc-CCCCcchhhHHHHHHH
Q 014352 268 ------------VF-DG---------------------------RNSGLKGTYGYIDPAYIST-NKFTMKSDIFSFGVII 306 (426)
Q Consensus 268 ------------~~-~~---------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl 306 (426)
.. .+ ......||++|.|||++.. ..-+.+.||||.||++
T Consensus 189 ~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~ 268 (418)
T KOG1167|consen 189 TEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVIL 268 (418)
T ss_pred hhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecccee
Confidence 00 00 0012359999999999854 4567899999999999
Q ss_pred HHHHhCCCCCC
Q 014352 307 FELITAIHPHQ 317 (426)
Q Consensus 307 ~el~tg~~p~~ 317 (426)
+-+++++.||-
T Consensus 269 Lslls~~~PFf 279 (418)
T KOG1167|consen 269 LSLLSRRYPFF 279 (418)
T ss_pred ehhhccccccc
Confidence 99999999984
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-25 Score=213.36 Aligned_cols=259 Identities=19% Similarity=0.249 Sum_probs=196.1
Q ss_pred HhhhhcccccCCCeeEEEEEeCCC--cEEEEEEeccCCccChHHHHHHHHHHhcCCC----CceeeEEeEE-EeCCeEEE
Q 014352 118 TQNFTNILGQGAFGPVYKATMPSG--GVAAIKVLASDSHQGEKEFQTEVSLLGRLHH----RNLVNLIGYC-VDKGKYML 190 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~~~~~~-~~~~~~~l 190 (426)
.|.+...||+|+||.||.+..... ..+|+|............+..|..++..+.. +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 466778999999999999997653 4788888776543333368889999988863 6888999888 46677899
Q ss_pred EEEecCCCChhHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCC-----CcEEEeeecCc
Q 014352 191 IYEFMSNGSLSNLIYSEE-RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHF-----MRAKVADFGLS 264 (426)
Q Consensus 191 v~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~-----~~~kl~Dfgl~ 264 (426)
||+.+ |.+|.++..... +.++..+.+.|+.|++.+|.+||+.+ ++||||||.|+++... ..+.|.|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99988 779999885554 77999999999999999999999999 9999999999999865 45899999999
Q ss_pred c--ccccCC--------C-cccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccch
Q 014352 265 K--EEVFDG--------R-NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGV 333 (426)
Q Consensus 265 ~--~~~~~~--------~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~ 333 (426)
+ ...... . .....||.+|.++....+...+.+.|+||++.++.|++.|..||.................
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~ 254 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR 254 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence 8 311111 1 2345699999999999999999999999999999999999999976442211111111111
Q ss_pred hhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHh
Q 014352 334 DEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRH 385 (426)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~ 385 (426)
...... .....+..+.++...+-..+...+|....+...|.......
T Consensus 255 ~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 255 KLLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred hhcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 111110 11112245666666666689999999999999988776654
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-25 Score=212.10 Aligned_cols=159 Identities=19% Similarity=0.152 Sum_probs=123.1
Q ss_pred hhhhcccccCCCeeEEEEEeC--CCcEEEEEEeccCC-----ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEE
Q 014352 119 QNFTNILGQGAFGPVYKATMP--SGGVAAIKVLASDS-----HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLI 191 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 191 (426)
|.+.+.||+|+||+||+|.+. +++.+|||++.... ....+.|.+|+++|++++|+|+++.+.. .+..++|
T Consensus 20 Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~LV 96 (365)
T PRK09188 20 FVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDGLV 96 (365)
T ss_pred ceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcEEE
Confidence 667789999999999999864 57778999875331 1124568999999999999999853322 2457999
Q ss_pred EEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCC-CCCCEEecCCCcEEEeeecCccccccC
Q 014352 192 YEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDL-KSANILLDHFMRAKVADFGLSKEEVFD 270 (426)
Q Consensus 192 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl-k~~Nill~~~~~~kl~Dfgl~~~~~~~ 270 (426)
|||++|++|... . .. . ...++.+++++|.|||+++ |+|||| ||+|||++.++.+||+|||+++.....
T Consensus 97 mE~~~G~~L~~~-~-~~---~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~ 165 (365)
T PRK09188 97 RGWTEGVPLHLA-R-PH---G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRR 165 (365)
T ss_pred EEccCCCCHHHh-C-cc---c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECccceecccC
Confidence 999999999632 1 11 1 1457889999999999998 999999 999999999999999999999854332
Q ss_pred CC---------cccCccccCccCccccccC
Q 014352 271 GR---------NSGLKGTYGYIDPAYISTN 291 (426)
Q Consensus 271 ~~---------~~~~~gt~~y~aPE~~~~~ 291 (426)
.. .....++..|+|||++...
T Consensus 166 ~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 166 GALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 21 1345678889999998543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4e-24 Score=192.09 Aligned_cols=256 Identities=18% Similarity=0.221 Sum_probs=199.6
Q ss_pred hhhhcccccCCCeeEEEEEe-CCCcEEEEEEeccCCccChHHHHHHHHHHhcCC-CCceeeEEeEEEeCCeEEEEEEecC
Q 014352 119 QNFTNILGQGAFGPVYKATM-PSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLH-HRNLVNLIGYCVDKGKYMLIYEFMS 196 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~ 196 (426)
|.++++||.|+||..+.|+. -+++.||||.-...+ ..-++..|.+..+.|. .++|..++-|-.++-+-.||+|.+
T Consensus 30 yrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL- 106 (449)
T KOG1165|consen 30 YRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL- 106 (449)
T ss_pred ceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-
Confidence 56788999999999999984 489999999854432 3347888888888885 689988888777777778999999
Q ss_pred CCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecC-----CCcEEEeeecCccccccCC
Q 014352 197 NGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDH-----FMRAKVADFGLSKEEVFDG 271 (426)
Q Consensus 197 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~-----~~~~kl~Dfgl~~~~~~~~ 271 (426)
|-||.++..-.++.++..+++.+|.|++.-++|+|++. +|.|||||+|+||.. ...+.++|||+++......
T Consensus 107 GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~ 183 (449)
T KOG1165|consen 107 GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPK 183 (449)
T ss_pred CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhhcCcc
Confidence 77999999888899999999999999999999999999 999999999999964 3458999999998654332
Q ss_pred --------CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHH---Hhhccccchhhhhhhh
Q 014352 272 --------RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVN---LASMSQDGVDEILDKQ 340 (426)
Q Consensus 272 --------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~ 340 (426)
......||.+||+-....+..-+.+.|.-|||-++++++.|..||+++..... ...+-.......+..-
T Consensus 184 TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~L 263 (449)
T KOG1165|consen 184 TKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEVL 263 (449)
T ss_pred ccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHHHH
Confidence 22456799999999999999999999999999999999999999998643221 1111111000000000
Q ss_pred hcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHh
Q 014352 341 LVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRH 385 (426)
Q Consensus 341 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~ 385 (426)
....+.++..-+.-.-..+=++-|+.+-+...+..+..+.
T Consensus 264 -----c~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~ 303 (449)
T KOG1165|consen 264 -----CEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRL 303 (449)
T ss_pred -----HhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhc
Confidence 1123456777776777778889999988888888776654
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.6e-23 Score=195.35 Aligned_cols=252 Identities=31% Similarity=0.434 Sum_probs=193.5
Q ss_pred hhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCccC---hHHHHHHHHHHhcCCCC-ceeeEEeEEEeCCeEEEEEEec
Q 014352 120 NFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQG---EKEFQTEVSLLGRLHHR-NLVNLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 120 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e~~ 195 (426)
.+...||.|+||.||++... ..+++|.+....... ...+.+|+.+++.+.|+ +++++.+++......+++++++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 3 RILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred eeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 34567999999999999986 778899887654332 56789999999999988 7999999997777789999999
Q ss_pred CCCChhHHhhhcc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCC-cEEEeeecCccccccCC-
Q 014352 196 SNGSLSNLIYSEE--RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFM-RAKVADFGLSKEEVFDG- 271 (426)
Q Consensus 196 ~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgl~~~~~~~~- 271 (426)
.++++.+++.... ..+.......+..+++.++.|+|+.+ ++|||+||+||+++..+ .++++|||.++......
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence 9999997765443 26888999999999999999999999 99999999999999988 79999999987433222
Q ss_pred ------CcccCccccCccCcccccc---CCCCcchhhHHHHHHHHHHHhCCCCCCchHH----HHHHhhccccchhhhhh
Q 014352 272 ------RNSGLKGTYGYIDPAYIST---NKFTMKSDIFSFGVIIFELITAIHPHQNLME----YVNLASMSQDGVDEILD 338 (426)
Q Consensus 272 ------~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~----~~~~~~~~~~~~~~~~~ 338 (426)
......|+..|++||.+.+ ..+....|+||+|++++++++|..||..... ......+...... ...
T Consensus 158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~ 236 (384)
T COG0515 158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-SLA 236 (384)
T ss_pred cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-ccc
Confidence 2356789999999999987 5788999999999999999999999765432 1111111000000 000
Q ss_pred hhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 339 KQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 339 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
..............+.+++..|+..+|..|.+..+....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 237 SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000001122568899999999999999999887765
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=180.79 Aligned_cols=256 Identities=23% Similarity=0.270 Sum_probs=198.4
Q ss_pred HHHHHhhhhcccccCCCeeEEEEEe-CCCcEEEEEEeccCCccChHHHHHHHHHHhcCCC-CceeeEEeEEEeCCeEEEE
Q 014352 114 IQKATQNFTNILGQGAFGPVYKATM-PSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHH-RNLVNLIGYCVDKGKYMLI 191 (426)
Q Consensus 114 l~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv 191 (426)
|....|.+.+.||+|+||.+|.|.. .+|..||||.-.... ...++.-|.++...|++ ..|..+..+..+...-.+|
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV 89 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV 89 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence 3345577788999999999999985 589999999876543 23467788888888875 5677777788888888999
Q ss_pred EEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecC---CCcEEEeeecCccccc
Q 014352 192 YEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDH---FMRAKVADFGLSKEEV 268 (426)
Q Consensus 192 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfgl~~~~~ 268 (426)
||.+ |-||.+++.-..+.++..+.+.++-|++.-++|+|.++ ++||||||+|+|+.- ...+.++|||+|+...
T Consensus 90 MdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 90 MDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred eecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence 9999 77999999877888999999999999999999999999 999999999999964 4568899999998543
Q ss_pred cCC--------CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHh---hccc---cchh
Q 014352 269 FDG--------RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLA---SMSQ---DGVD 334 (426)
Q Consensus 269 ~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~---~~~~---~~~~ 334 (426)
... ......||.+|.+-....+-.-+.+.|+-|+|.+|..+..|..||++........ .+.. ....
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~i 245 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPI 245 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCH
Confidence 221 2245679999999888777777889999999999999999999999865433211 1111 1111
Q ss_pred hhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 014352 335 EILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQ 383 (426)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 383 (426)
+.+.. ..+.++.-.+.-|-..-=++-|+..-+.+.+.-+..
T Consensus 246 e~LC~--------G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr 286 (341)
T KOG1163|consen 246 EVLCK--------GFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFR 286 (341)
T ss_pred HHHhC--------CCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHh
Confidence 11111 233567777888988888899998777766665544
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.7e-24 Score=205.56 Aligned_cols=214 Identities=29% Similarity=0.436 Sum_probs=163.6
Q ss_pred HhcCCCCceeeEEeEEEeCCeEEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCC
Q 014352 167 LGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSA 246 (426)
Q Consensus 167 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~ 246 (426)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+......++|.....+..++++||.|||+... ..|+.+++.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i--~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPI--GYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcc--eeeeeeccc
Confidence 467899999999999999999999999999999999998877789999999999999999999998651 399999999
Q ss_pred CEEecCCCcEEEeeecCcccccc---CCCcccCccccCccCccccccCC-------CCcchhhHHHHHHHHHHHhCCCCC
Q 014352 247 NILLDHFMRAKVADFGLSKEEVF---DGRNSGLKGTYGYIDPAYISTNK-------FTMKSDIFSFGVIIFELITAIHPH 316 (426)
Q Consensus 247 Nill~~~~~~kl~Dfgl~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~Dv~S~Gvvl~el~tg~~p~ 316 (426)
|+++|..+.+|++|||+...... ...........-|.|||.+.+.. .+.++||||||++++|+++...||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 99999999999999999865421 11112223456799999987642 467799999999999999999999
Q ss_pred CchHHHHH---H-hhccccchhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHh
Q 014352 317 QNLMEYVN---L-ASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRH 385 (426)
Q Consensus 317 ~~~~~~~~---~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~ 385 (426)
........ + ..+.. .-...+.+.+... .+..+.+..++.+||..+|++||++..+...++.+....
T Consensus 159 ~~~~~~~~~~eii~~~~~-~~~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~ 228 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRVKK-GGSNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG 228 (484)
T ss_pred ccccccCChHHHHHHHHh-cCCCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence 75221110 0 00000 0011111111100 123347999999999999999999999999998887644
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-23 Score=185.60 Aligned_cols=176 Identities=14% Similarity=0.212 Sum_probs=136.8
Q ss_pred hhHHHHHHhhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHH---------HHHHHHHHhcCCCCceeeEEeE
Q 014352 111 YKDIQKATQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKE---------FQTEVSLLGRLHHRNLVNLIGY 181 (426)
Q Consensus 111 ~~~l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~---------~~~e~~~l~~l~h~niv~~~~~ 181 (426)
.+++...++...+++|.|+||.||.... ++..+|+|.+.......... +.+|+..+.+++||+|..+..+
T Consensus 25 ~~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~ 103 (232)
T PRK10359 25 FDDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDF 103 (232)
T ss_pred HHHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEe
Confidence 4567777888889999999999999766 56689999997654333332 6889999999999999999988
Q ss_pred EEeC--------CeEEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCC
Q 014352 182 CVDK--------GKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHF 253 (426)
Q Consensus 182 ~~~~--------~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~ 253 (426)
+... +..+++|||++|.+|.++.. ++. ....+++.+|..+|+.+ ++|||+||+||+++.+
T Consensus 104 ~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~ 171 (232)
T PRK10359 104 YLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKN 171 (232)
T ss_pred eeecccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCC
Confidence 6643 35789999999999988741 222 24558999999999999 9999999999999998
Q ss_pred CcEEEeeecCccccccCCCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh
Q 014352 254 MRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT 311 (426)
Q Consensus 254 ~~~kl~Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t 311 (426)
+ ++++|||............ .++....|+.++|+||||+++.-+..
T Consensus 172 g-i~liDfg~~~~~~e~~a~d-----------~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 172 G-LRIIDLSGKRCTAQRKAKD-----------RIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred C-EEEEECCCcccccchhhHH-----------HHHHHhHhcccccccceeEeehHHHH
Confidence 8 9999999876432211111 13444557789999999999876543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.7e-24 Score=215.82 Aligned_cols=249 Identities=22% Similarity=0.290 Sum_probs=180.7
Q ss_pred hhcccccCCCeeEEEEEeC-CCcEEEEEEeccC--CccChH----HHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEE
Q 014352 121 FTNILGQGAFGPVYKATMP-SGGVAAIKVLASD--SHQGEK----EFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYE 193 (426)
Q Consensus 121 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 193 (426)
...++|.|++|.|+..... .....+.|..... .....+ .+..|..+-..++|||++..+..+.+....+-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 3467999999977777543 3333344433210 111221 25567777788999999888877777666666699
Q ss_pred ecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC---
Q 014352 194 FMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD--- 270 (426)
Q Consensus 194 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~--- 270 (426)
||++ +|..++... ..++..++..++.|+..|+.|+|+.+ |.|||+|++|++++.+|.+||+|||.+......
T Consensus 402 ~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~ 476 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK 476 (601)
T ss_pred cccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence 9999 999998544 35888889999999999999999999 999999999999999999999999988643222
Q ss_pred --CCcccCccccCccCccccccCCCCc-chhhHHHHHHHHHHHhCCCCCCchHHHHHH-hhccccchhhhhhhhhcccCC
Q 014352 271 --GRNSGLKGTYGYIDPAYISTNKFTM-KSDIFSFGVIIFELITAIHPHQNLMEYVNL-ASMSQDGVDEILDKQLVGACN 346 (426)
Q Consensus 271 --~~~~~~~gt~~y~aPE~~~~~~~~~-~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 346 (426)
.......|+..|+|||.+.+..|++ ..||||.|+++..|.+|+.||......... .............. .....
T Consensus 477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~--~~~~~ 554 (601)
T KOG0590|consen 477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEG--PNRLL 554 (601)
T ss_pred hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccC--hHHHH
Confidence 2345678999999999999999986 589999999999999999999654332221 01000000000000 00111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014352 347 IQEVRELARIGHKCLHKTPRKRPSIGEVTQ 376 (426)
Q Consensus 347 ~~~~~~l~~l~~~cl~~~p~~RPs~~evl~ 376 (426)
...+.....++.++|+.||.+|.|+.+|++
T Consensus 555 ~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 555 SLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred HhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 234456788899999999999999999986
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-22 Score=178.18 Aligned_cols=137 Identities=20% Similarity=0.236 Sum_probs=107.6
Q ss_pred cccccCCCeeEEEEEeCCCcEEEEEEeccCCcc--C-------hHH-----------------HHHHHHHHhcCCCCcee
Q 014352 123 NILGQGAFGPVYKATMPSGGVAAIKVLASDSHQ--G-------EKE-----------------FQTEVSLLGRLHHRNLV 176 (426)
Q Consensus 123 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~-------~~~-----------------~~~e~~~l~~l~h~niv 176 (426)
..||+|+||.||+|...+|+.||+|+++..... . ... ...|++++.++.++++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 579999999999999878999999999754211 1 011 23499999999887764
Q ss_pred eEEeEEEeCCeEEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHH-HcCCCCCeeecCCCCCCEEecCCCc
Q 014352 177 NLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYL-HEGAVPPVIHRDLKSANILLDHFMR 255 (426)
Q Consensus 177 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~ivH~dlk~~Nill~~~~~ 255 (426)
....+.. ...++||||++++++...... ...++......++.|++.+|.|+ |+.+ |+||||||+|||++ ++.
T Consensus 83 ~p~~~~~--~~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 83 CPEPILL--KSHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCcEEEe--cCCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-CCc
Confidence 3333222 224899999998877655322 35689999999999999999999 6888 99999999999998 478
Q ss_pred EEEeeecCccc
Q 014352 256 AKVADFGLSKE 266 (426)
Q Consensus 256 ~kl~Dfgl~~~ 266 (426)
++|+|||++..
T Consensus 156 v~LiDFG~a~~ 166 (190)
T cd05147 156 LYIIDVSQSVE 166 (190)
T ss_pred EEEEEcccccc
Confidence 99999999874
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.9e-21 Score=171.30 Aligned_cols=138 Identities=20% Similarity=0.191 Sum_probs=109.8
Q ss_pred cccccCCCeeEEEEEeCCCcEEEEEEeccCCccC--------------------------hHHHHHHHHHHhcCCCCcee
Q 014352 123 NILGQGAFGPVYKATMPSGGVAAIKVLASDSHQG--------------------------EKEFQTEVSLLGRLHHRNLV 176 (426)
Q Consensus 123 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~e~~~l~~l~h~niv 176 (426)
..||+|+||.||+|...+|+.||||++....... ...+..|.+.+.++.|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (190)
T cd05145 3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVP 82 (190)
T ss_pred ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 5799999999999998789999999987653110 11235789999999999875
Q ss_pred eEEeEEEeCCeEEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeecCCCCCCEEecCCCc
Q 014352 177 NLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHE-GAVPPVIHRDLKSANILLDHFMR 255 (426)
Q Consensus 177 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~ 255 (426)
....+.... .++||||++++++...... ...++......++.+++.++.++|+ .+ |+||||||+||+++ ++.
T Consensus 83 ~p~~~~~~~--~~lVmE~~~g~~~~~~~l~-~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~~~ 155 (190)
T cd05145 83 VPEPILLKK--NVLVMEFIGDDGSPAPRLK-DVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-DGK 155 (190)
T ss_pred CceEEEecC--CEEEEEEecCCCchhhhhh-hccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-CCC
Confidence 444443332 4899999998865443222 2457888899999999999999999 88 99999999999999 789
Q ss_pred EEEeeecCcccc
Q 014352 256 AKVADFGLSKEE 267 (426)
Q Consensus 256 ~kl~Dfgl~~~~ 267 (426)
++|+|||++...
T Consensus 156 ~~liDFG~a~~~ 167 (190)
T cd05145 156 PYIIDVSQAVEL 167 (190)
T ss_pred EEEEEcccceec
Confidence 999999998753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.4e-21 Score=166.41 Aligned_cols=180 Identities=17% Similarity=0.111 Sum_probs=136.3
Q ss_pred hcccccCCCeeEEEEEeCCCcEEEEEEeccCCccCh----HHHHHHHHHHhcCC-CCceeeEEeEEEeCCeEEEEEEecC
Q 014352 122 TNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGE----KEFQTEVSLLGRLH-HRNLVNLIGYCVDKGKYMLIYEFMS 196 (426)
Q Consensus 122 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~----~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~ 196 (426)
...|++|+||+||.+.. .+..++.+.+........ ..+.+|+++|++|. |+++.+++++ +..+++|||+.
T Consensus 7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 35799999999997765 677777777765543211 24789999999995 5889999886 34699999999
Q ss_pred CCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCC-CCCCEEecCCCcEEEeeecCccccccCCCc--
Q 014352 197 NGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDL-KSANILLDHFMRAKVADFGLSKEEVFDGRN-- 273 (426)
Q Consensus 197 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl-k~~Nill~~~~~~kl~Dfgl~~~~~~~~~~-- 273 (426)
|.+|...+.. ....++.+++.+|.++|+++ |+|||| ||+|||++.++.++|+|||++.........
T Consensus 82 G~~L~~~~~~--------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r 150 (218)
T PRK12274 82 GAAMYQRPPR--------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR 150 (218)
T ss_pred CccHHhhhhh--------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence 9998754311 11346789999999999999 999999 799999999999999999999743322210
Q ss_pred ------------ccCccccCccCccccccC-CCC-cchhhHHHHHHHHHHHhCCCCCC
Q 014352 274 ------------SGLKGTYGYIDPAYISTN-KFT-MKSDIFSFGVIIFELITAIHPHQ 317 (426)
Q Consensus 274 ------------~~~~gt~~y~aPE~~~~~-~~~-~~~Dv~S~Gvvl~el~tg~~p~~ 317 (426)
.....++.|++|+...-. ..+ .+.+.++-|.-+|.++|+..|+-
T Consensus 151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 012257788888754322 223 67889999999999999998864
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.5e-22 Score=196.65 Aligned_cols=225 Identities=28% Similarity=0.383 Sum_probs=173.2
Q ss_pred ccccCCCeeEEEEE----eCCCcEEEEEEeccCCccCh--HHHHHHHHHHhcCC-CCceeeEEeEEEeCCeEEEEEEecC
Q 014352 124 ILGQGAFGPVYKAT----MPSGGVAAIKVLASDSHQGE--KEFQTEVSLLGRLH-HRNLVNLIGYCVDKGKYMLIYEFMS 196 (426)
Q Consensus 124 ~lg~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~~~--~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~ 196 (426)
.+|.|+||.|+..+ .+.+..+|.|+++....... .....|..++...+ ||.+|++.-.+..+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999764 23566788888765432211 13456777888886 9999999999999999999999999
Q ss_pred CCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCcccC
Q 014352 197 NGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGL 276 (426)
Q Consensus 197 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~ 276 (426)
+|.|...+.... .+...........++-+++++|+.+ |+|||+|++||+++.+|++++.|||+++........
T Consensus 81 gg~lft~l~~~~-~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~--- 153 (612)
T KOG0603|consen 81 GGDLFTRLSKEV-MFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA--- 153 (612)
T ss_pred cchhhhccccCC-chHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhhc---
Confidence 999999885443 4566666667788999999999999 999999999999999999999999999865433322
Q ss_pred ccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHH
Q 014352 277 KGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARI 356 (426)
Q Consensus 277 ~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 356 (426)
+||..|||||++. .....+|.||||++++||+||..||.... . ..+.... ...+.+......++
T Consensus 154 cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~~----~--------~~Il~~~--~~~p~~l~~~a~~~ 217 (612)
T KOG0603|consen 154 CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGDT----M--------KRILKAE--LEMPRELSAEARSL 217 (612)
T ss_pred ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchHH----H--------HHHhhhc--cCCchhhhHHHHHH
Confidence 8999999999998 56789999999999999999999997610 0 0111101 11233444566777
Q ss_pred HHHcccCCCCCCCCH
Q 014352 357 GHKCLHKTPRKRPSI 371 (426)
Q Consensus 357 ~~~cl~~~p~~RPs~ 371 (426)
+..++..+|.+|--.
T Consensus 218 ~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 218 FRQLFKRNPENRLGA 232 (612)
T ss_pred HHHHHhhCHHHHhcc
Confidence 778888888888543
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.8e-21 Score=173.33 Aligned_cols=228 Identities=18% Similarity=0.250 Sum_probs=146.3
Q ss_pred hhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCcc---ChHHHHHHHHHHhcCCC----------CceeeEEeEEE---
Q 014352 121 FTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQ---GEKEFQTEVSLLGRLHH----------RNLVNLIGYCV--- 183 (426)
Q Consensus 121 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h----------~niv~~~~~~~--- 183 (426)
.++.||.|+++.||.+++. +++.+|+|++...... ..+++.+|.-....+.+ -.++-.++...
T Consensus 16 ~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~ 95 (288)
T PF14531_consen 16 RGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPG 95 (288)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETT
T ss_pred EccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcC
Confidence 3568999999999999986 6889999988654322 23456666555444322 12222222211
Q ss_pred ------eC---C-----eEEEEEEecCCCChhHHhh---hcc---CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCC
Q 014352 184 ------DK---G-----KYMLIYEFMSNGSLSNLIY---SEE---RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDL 243 (426)
Q Consensus 184 ------~~---~-----~~~lv~e~~~~gsL~~~l~---~~~---~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl 243 (426)
.. + +.+++|+-+ .++|.+++. ... ..+....++.+..|+++.+++||+.+ ++|+||
T Consensus 96 ~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgdi 171 (288)
T PF14531_consen 96 KPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGDI 171 (288)
T ss_dssp S-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST-
T ss_pred CCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEeccc
Confidence 11 1 246778877 458888753 222 22445667778899999999999999 999999
Q ss_pred CCCCEEecCCCcEEEeeecCccccccCCCcccCccccCccCcccccc--------CCCCcchhhHHHHHHHHHHHhCCCC
Q 014352 244 KSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYIST--------NKFTMKSDIFSFGVIIFELITAIHP 315 (426)
Q Consensus 244 k~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~S~Gvvl~el~tg~~p 315 (426)
+|+|++++.+|.+.|+||+........... ...+..|.+||.... -.++.+.|.|++|+++|.|.+|..|
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lP 249 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLP 249 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-S
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCC
Confidence 999999999999999999876543221111 334578999997633 2478899999999999999999999
Q ss_pred CCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCC
Q 014352 316 HQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKR 368 (426)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R 368 (426)
|....... .+......|. +.++.+..|+..+|+.||++|
T Consensus 250 f~~~~~~~-------------~~~~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 250 FGLSSPEA-------------DPEWDFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp TCCCGGGS-------------TSGGGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCccc-------------cccccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 97432211 0111234566 778889999999999999987
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.9e-21 Score=198.24 Aligned_cols=243 Identities=21% Similarity=0.274 Sum_probs=176.2
Q ss_pred hhhcccccCCCeeEEEEEeCCCcEEEEEEeccCC-ccChHHHHHHHHH--HhcCCCCceeeEEeEEEeCCeEEEEEEecC
Q 014352 120 NFTNILGQGAFGPVYKATMPSGGVAAIKVLASDS-HQGEKEFQTEVSL--LGRLHHRNLVNLIGYCVDKGKYMLIYEFMS 196 (426)
Q Consensus 120 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~--l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 196 (426)
.+.+.||++.|=+|.+|+.+.|. |+||++-+.. .-..+.|.++++- ...++|||++++.-+-......|||-+|..
T Consensus 26 ~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyvk 104 (1431)
T KOG1240|consen 26 HYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYVK 104 (1431)
T ss_pred eeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHHh
Confidence 34568999999999999987776 7788875543 3344455444333 445689999999888777777789999996
Q ss_pred CCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccc--ccCCCc-
Q 014352 197 NGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEE--VFDGRN- 273 (426)
Q Consensus 197 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~--~~~~~~- 273 (426)
+ +|++.|. .+..+...+...|+.|+..||.-+|..+ |+|||||.+|||++.-+-+.|+||..-+.. ..+...
T Consensus 105 h-nLyDRlS-TRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPad 179 (1431)
T KOG1240|consen 105 H-NLYDRLS-TRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPAD 179 (1431)
T ss_pred h-hhhhhhc-cchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCCccc
Confidence 5 9999983 3445777788889999999999999999 999999999999999888999999865421 111111
Q ss_pred -----ccCccccCccCccccccC----------C-CCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhh
Q 014352 274 -----SGLKGTYGYIDPAYISTN----------K-FTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEI 336 (426)
Q Consensus 274 -----~~~~gt~~y~aPE~~~~~----------~-~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 336 (426)
.+...-..|.|||.+... . .+++.||||+||++.||++ |++||. +.+...+...........
T Consensus 180 f~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~-LSQL~aYr~~~~~~~e~~ 258 (1431)
T KOG1240|consen 180 FTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT-LSQLLAYRSGNADDPEQL 258 (1431)
T ss_pred ceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc-HHHHHhHhccCccCHHHH
Confidence 122334579999987431 1 5678999999999999998 566664 333333332221111111
Q ss_pred hhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 337 LDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 337 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
+. .+. ...+..++..|++.||+.|.|+++.++.
T Consensus 259 Le-~Ie-------d~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 259 LE-KIE-------DVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HH-hCc-------CccHHHHHHHHHccCchhccCHHHHHHh
Confidence 11 111 1258899999999999999999999887
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.8e-20 Score=163.41 Aligned_cols=133 Identities=20% Similarity=0.273 Sum_probs=104.2
Q ss_pred cccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcC-----CCCceeeEEeEEEeCC---e-EEEEEE
Q 014352 123 NILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRL-----HHRNLVNLIGYCVDKG---K-YMLIYE 193 (426)
Q Consensus 123 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~~~~~~~~~~---~-~~lv~e 193 (426)
..||+|+||.||. +......+||++........+.+.+|+.+++++ .||||++++|++.++. . +.+|+|
T Consensus 8 ~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e 85 (210)
T PRK10345 8 SPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIAD 85 (210)
T ss_pred ceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEec
Confidence 4799999999996 433333468988765444567899999999999 5799999999998863 3 337899
Q ss_pred e--cCCCChhHHhhhccCCCCHHHHHHHHHHHHHHH-HHHHcCCCCCeeecCCCCCCEEecC----CCcEEEeeecCc
Q 014352 194 F--MSNGSLSNLIYSEERVLNWEERLQIALDISHGI-EYLHEGAVPPVIHRDLKSANILLDH----FMRAKVADFGLS 264 (426)
Q Consensus 194 ~--~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l-~~LH~~~~~~ivH~dlk~~Nill~~----~~~~kl~Dfgl~ 264 (426)
| +++|+|.+++... .++.. ..++.+++.++ +|||+++ |+||||||+|||++. ++.++|+||+.+
T Consensus 86 ~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 86 FDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred CCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 9 5589999999543 35544 35577788777 9999999 999999999999974 347999995544
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.7e-19 Score=187.11 Aligned_cols=252 Identities=18% Similarity=0.242 Sum_probs=178.8
Q ss_pred HHHHHhhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCC---CCceeeEEeEEEeCCeEEE
Q 014352 114 IQKATQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLH---HRNLVNLIGYCVDKGKYML 190 (426)
Q Consensus 114 l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~l 190 (426)
+-...+.+...||+|+||+||+|...+|..||+|+-+...... |---.+++.+|+ -+.|..+...+.-.+..++
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l 771 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNASVL 771 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence 3344455667899999999999998889999999977654321 111122333444 2334444444455667799
Q ss_pred EEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEec-------CCCcEEEeeecC
Q 014352 191 IYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLD-------HFMRAKVADFGL 263 (426)
Q Consensus 191 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~-------~~~~~kl~Dfgl 263 (426)
|+||.+.|+|.+++. ..+.++|...+.++.|++..+..||..+ |||+||||+|+||. .+..++|+|||.
T Consensus 772 v~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~ 847 (974)
T KOG1166|consen 772 VSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDFGR 847 (974)
T ss_pred eeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEeccc
Confidence 999999999999996 4566899999999999999999999999 99999999999994 244589999999
Q ss_pred ccccccC---CCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhh
Q 014352 264 SKEEVFD---GRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQ 340 (426)
Q Consensus 264 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (426)
+-....- .......+|-.+--+|+..|.+++.+.|-|.|..+++-|+.|+..- . ..+....++..
T Consensus 848 siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-----------~-~~g~~~~~~~~ 915 (974)
T KOG1166|consen 848 SIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-----------V-KNGSSWMVKTN 915 (974)
T ss_pred ceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-----------h-cCCcceecccc
Confidence 8643322 2345667888999999999999999999999999999999986531 1 11111111111
Q ss_pred hcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHhhh
Q 014352 341 LVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRHLA 387 (426)
Q Consensus 341 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~~ 387 (426)
++.....+. ..++...+|+.|-..=|...++...++.....+..
T Consensus 916 ~~Ry~~~~~---W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~~~ 959 (974)
T KOG1166|consen 916 FPRYWKRDM---WNKFFDLLLNPDCDTLPNLQELRTELEEVLAEHFT 959 (974)
T ss_pred chhhhhHHH---HHHHHHHHhCcCcccchhHHHHHHHHHHHHHHHHH
Confidence 222222223 33444455665555558888888888887766544
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.7e-19 Score=162.58 Aligned_cols=195 Identities=22% Similarity=0.290 Sum_probs=137.2
Q ss_pred CCCceeeEEeEEEe---------------------------CCeEEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHH
Q 014352 171 HHRNLVNLIGYCVD---------------------------KGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDI 223 (426)
Q Consensus 171 ~h~niv~~~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i 223 (426)
+|||||+++++|.+ +..+|+||..++. +|..++..+. .+......++.|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~--~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH--RSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC--CchHHHHHHHHHH
Confidence 69999999998753 2368999998865 9999996544 5666667789999
Q ss_pred HHHHHHHHcCCCCCeeecCCCCCCEEec--CCC--cEEEeeecCccccc-------cCCCcccCccccCccCccccccCC
Q 014352 224 SHGIEYLHEGAVPPVIHRDLKSANILLD--HFM--RAKVADFGLSKEEV-------FDGRNSGLKGTYGYIDPAYISTNK 292 (426)
Q Consensus 224 ~~~l~~LH~~~~~~ivH~dlk~~Nill~--~~~--~~kl~Dfgl~~~~~-------~~~~~~~~~gt~~y~aPE~~~~~~ 292 (426)
++|+.|||.++ |.|||+|++|||+. +++ ...|+|||.+--.. .........|...-||||+....+
T Consensus 351 LEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 351 LEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 99999999999 99999999999993 333 36899999764211 112223455788899999885432
Q ss_pred C------CcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCC
Q 014352 293 F------TMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPR 366 (426)
Q Consensus 293 ~------~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~ 366 (426)
- -.|+|.|+.|.+.||+++...||...-+. .+ ......+---+.+ +...+..+.+++...|+.||.
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem-~L---~~r~Yqe~qLPal----p~~vpp~~rqlV~~lL~r~ps 499 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM-LL---DTRTYQESQLPAL----PSRVPPVARQLVFDLLKRDPS 499 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccchh-ee---chhhhhhhhCCCC----cccCChHHHHHHHHHhcCCcc
Confidence 1 25899999999999999999998651111 00 0111111111112 222335678888899999999
Q ss_pred CCCCHHHHHHHHH
Q 014352 367 KRPSIGEVTQALL 379 (426)
Q Consensus 367 ~RPs~~evl~~L~ 379 (426)
+|++..-....|.
T Consensus 500 kRvsp~iAANvl~ 512 (598)
T KOG4158|consen 500 KRVSPNIAANVLN 512 (598)
T ss_pred ccCCccHHHhHHH
Confidence 9998755544443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.2e-19 Score=158.08 Aligned_cols=134 Identities=24% Similarity=0.397 Sum_probs=112.2
Q ss_pred cccccCCCeeEEEEEeCCCcEEEEEEeccCCccC--------hHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEe
Q 014352 123 NILGQGAFGPVYKATMPSGGVAAIKVLASDSHQG--------EKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEF 194 (426)
Q Consensus 123 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 194 (426)
+.||+|++|.||+|.+ .+..+++|......... ...+.+|+.++..+.|+++.....++...+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 4699999999999998 56678888765432211 13577899999999999998777777777788999999
Q ss_pred cCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccc
Q 014352 195 MSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKE 266 (426)
Q Consensus 195 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 266 (426)
++|++|.+++.... + .+..++.+++.+|.++|+.+ ++|+|++|.||+++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999884322 2 77889999999999999998 99999999999999 78999999998863
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.7e-19 Score=155.36 Aligned_cols=130 Identities=24% Similarity=0.377 Sum_probs=105.7
Q ss_pred ccccCCCeeEEEEEeCCCcEEEEEEeccCCccC--------hHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEec
Q 014352 124 ILGQGAFGPVYKATMPSGGVAAIKVLASDSHQG--------EKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 124 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 195 (426)
.||+|+||.||+|.+ ++..+++|......... ...+.+|++++..+.|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999996 56678888865432111 245678999999999887665555556666779999999
Q ss_pred CCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccc
Q 014352 196 SNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKE 266 (426)
Q Consensus 196 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 266 (426)
+|++|.+++..... .++.+++.+|.+||+.+ ++|+|++|.||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND--------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH--------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999998743221 78899999999999998 99999999999999 79999999999864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.5e-18 Score=151.62 Aligned_cols=134 Identities=22% Similarity=0.264 Sum_probs=106.3
Q ss_pred hhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCcc----------------------ChHHHHHHHHHHhcCCCCc--
Q 014352 119 QNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQ----------------------GEKEFQTEVSLLGRLHHRN-- 174 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~e~~~l~~l~h~n-- 174 (426)
+.+.+.||+|+||.||++...+|+.+|||++...... ....+..|..++.++.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 5566789999999999999888999999987643210 0123567888999988774
Q ss_pred eeeEEeEEEeCCeEEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCC
Q 014352 175 LVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFM 254 (426)
Q Consensus 175 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~ 254 (426)
+...++. ...++||||+++++|...... .....++.+++.++.++|+.+ ++||||||+||++++++
T Consensus 97 v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~~~~ 162 (198)
T cd05144 97 VPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVDDDE 162 (198)
T ss_pred CCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEcCCC
Confidence 4444432 346899999999999776421 234568889999999999988 99999999999999999
Q ss_pred cEEEeeecCccc
Q 014352 255 RAKVADFGLSKE 266 (426)
Q Consensus 255 ~~kl~Dfgl~~~ 266 (426)
.++|+|||++..
T Consensus 163 ~~~liDfg~~~~ 174 (198)
T cd05144 163 KIYIIDWPQMVS 174 (198)
T ss_pred cEEEEECCcccc
Confidence 999999999863
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.4e-18 Score=155.24 Aligned_cols=140 Identities=22% Similarity=0.260 Sum_probs=108.6
Q ss_pred hhhhcccccCCCeeEEEEE--eCCCcEEEEEEeccCCcc--C----------------------hHHHHHHHHHHhcCCC
Q 014352 119 QNFTNILGQGAFGPVYKAT--MPSGGVAAIKVLASDSHQ--G----------------------EKEFQTEVSLLGRLHH 172 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~--~----------------------~~~~~~e~~~l~~l~h 172 (426)
+.+.+.||+|+||.||+|. ..+|+.||+|++...... . ...+..|+.++.++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 5567899999999999998 458899999998754210 0 0235689999999975
Q ss_pred Cc--eeeEEeEEEeCCeEEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEe
Q 014352 173 RN--LVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILL 250 (426)
Q Consensus 173 ~n--iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill 250 (426)
.+ +.+++++ ...++||||+++++|....... ..+...+...++.|++.++.+||+++ .++||||||+||++
T Consensus 110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~NIli 182 (237)
T smart00090 110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYNILV 182 (237)
T ss_pred cCCCCCeeeEe----cCceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhhEEE
Confidence 33 3444443 2358999999998887655322 34566667889999999999999976 39999999999999
Q ss_pred cCCCcEEEeeecCccc
Q 014352 251 DHFMRAKVADFGLSKE 266 (426)
Q Consensus 251 ~~~~~~kl~Dfgl~~~ 266 (426)
+ ++.++|+|||.+..
T Consensus 183 ~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 183 H-DGKVVIIDVSQSVE 197 (237)
T ss_pred E-CCCEEEEEChhhhc
Confidence 9 88999999998864
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.4e-18 Score=174.17 Aligned_cols=132 Identities=18% Similarity=0.317 Sum_probs=108.1
Q ss_pred hcccccCCCeeEEEEEeCCCcEEEEEEeccCCc-------cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEe
Q 014352 122 TNILGQGAFGPVYKATMPSGGVAAIKVLASDSH-------QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEF 194 (426)
Q Consensus 122 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 194 (426)
.+.||+|+||+||+|.+.+...++.+....... ...+.+.+|++++.+++|++++....++...+..++||||
T Consensus 338 ~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~ 417 (535)
T PRK09605 338 DHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEY 417 (535)
T ss_pred cceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEe
Confidence 568999999999999986555443333322111 1124578999999999999999888888877788999999
Q ss_pred cCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccc
Q 014352 195 MSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKE 266 (426)
Q Consensus 195 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 266 (426)
+++++|.+++. ....++.+++.+|.|||+.+ ++||||||+|||+ .++.++|+|||+++.
T Consensus 418 ~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 418 IGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred cCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999884 34678999999999999998 9999999999999 578899999999874
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.4e-19 Score=172.93 Aligned_cols=170 Identities=24% Similarity=0.384 Sum_probs=127.8
Q ss_pred eEEEEEEecCCCChhHHhhhcc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCc
Q 014352 187 KYMLIYEFMSNGSLSNLIYSEE--RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLS 264 (426)
Q Consensus 187 ~~~lv~e~~~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 264 (426)
.+|+.|++|...+|.++|.+.. ...++...+.++.|++.|+.| ++ .+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 5789999999999999996433 457788889999999999999 66 899999999999999999999999998
Q ss_pred cccccCC-------CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhh
Q 014352 265 KEEVFDG-------RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEI 336 (426)
Q Consensus 265 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 336 (426)
....... ..+...||..||+||.+.+..|+.|+||||||++|+|++. =..++..... +..+....+
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t---~~d~r~g~i--- 477 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIAT---LTDIRDGII--- 477 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHh---hhhhhcCCC---
Confidence 7544333 3456789999999999999999999999999999999998 2222221111 111111111
Q ss_pred hhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 014352 337 LDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEV 374 (426)
Q Consensus 337 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev 374 (426)
++...... +.=+.++.+++.+.|.+||++.+.
T Consensus 478 -p~~~~~d~-----p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 478 -PPEFLQDY-----PEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred -ChHHhhcC-----cHHHHHHHHhcCCCcccCchHHHH
Confidence 11111111 234578889999999999955443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.76 E-value=8.6e-19 Score=178.84 Aligned_cols=199 Identities=24% Similarity=0.347 Sum_probs=137.1
Q ss_pred hcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCCCCh
Q 014352 122 TNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSL 200 (426)
Q Consensus 122 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 200 (426)
.+.+-.|+||.||..+++ +.+.+|+|+-+.. .+.+- ++.....|.+| |+.
T Consensus 88 IklisngAygavylvrh~~trqrfa~kiNkq~------lilRn--ilt~a~npfvv---------------------gDc 138 (1205)
T KOG0606|consen 88 IKLISNGAYGAVYLVRHKETRQRFAMKINKQN------LILRN--ILTFAGNPFVV---------------------GDC 138 (1205)
T ss_pred eEeeccCCCCceeeeeccccccchhhcccccc------hhhhc--cccccCCccee---------------------chh
Confidence 457999999999999876 4567787542211 11110 22222333333 566
Q ss_pred hHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC---------
Q 014352 201 SNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG--------- 271 (426)
Q Consensus 201 ~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~--------- 271 (426)
...+..- ++++... +.+++|||+.+ |+|||+||+|.+|+.-|.+|++|||+++......
T Consensus 139 ~tllk~~-g~lPvdm--------vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I 206 (1205)
T KOG0606|consen 139 ATLLKNI-GPLPVDM--------VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHI 206 (1205)
T ss_pred hhhcccC-CCCcchh--------hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcch
Confidence 6666432 3344322 77899999998 9999999999999999999999999986321110
Q ss_pred -------CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhccc
Q 014352 272 -------RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGA 344 (426)
Q Consensus 272 -------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (426)
.....+||+.|.|||++..+.|....|+|++|+++||++-|+.||.+......+.....+. ..+ .+
T Consensus 207 ~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~-i~w------pE 279 (1205)
T KOG0606|consen 207 EKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD-IEW------PE 279 (1205)
T ss_pred HHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhh-ccc------cc
Confidence 0134689999999999999999999999999999999999999997643222221111110 000 11
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCC
Q 014352 345 CNIQEVRELARIGHKCLHKTPRKR 368 (426)
Q Consensus 345 ~~~~~~~~l~~l~~~cl~~~p~~R 368 (426)
.+.....+..+++.+.|+.+|.+|
T Consensus 280 ~dea~p~Ea~dli~~LL~qnp~~R 303 (1205)
T KOG0606|consen 280 EDEALPPEAQDLIEQLLRQNPLCR 303 (1205)
T ss_pred cCcCCCHHHHHHHHHHHHhChHhh
Confidence 122334578889999999999999
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=8.2e-17 Score=141.46 Aligned_cols=135 Identities=23% Similarity=0.272 Sum_probs=97.3
Q ss_pred hcccccCCCeeEEEEEeCCCcEEEEEEeccCCccCh--HH----------------------HHHHHHHHhcCCCCc--e
Q 014352 122 TNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGE--KE----------------------FQTEVSLLGRLHHRN--L 175 (426)
Q Consensus 122 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~--~~----------------------~~~e~~~l~~l~h~n--i 175 (426)
.+.||+|+||.||+|...+++.||||++........ .. ...|...+.++.+.+ +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 457999999999999988899999999875432111 11 134566666664432 4
Q ss_pred eeEEeEEEeCCeEEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeecCCCCCCEEecCCC
Q 014352 176 VNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHE-GAVPPVIHRDLKSANILLDHFM 254 (426)
Q Consensus 176 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~ 254 (426)
.+.+++ ...++||||++++++......... .. .....++.+++.++.++|+ .+ |+|+||||+||+++ ++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-DG 151 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh-hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-CC
Confidence 444443 246899999998544321111100 11 5667899999999999999 87 99999999999999 89
Q ss_pred cEEEeeecCccc
Q 014352 255 RAKVADFGLSKE 266 (426)
Q Consensus 255 ~~kl~Dfgl~~~ 266 (426)
.++++|||.+..
T Consensus 152 ~~~liDfg~a~~ 163 (187)
T cd05119 152 KVYIIDVPQAVE 163 (187)
T ss_pred cEEEEECccccc
Confidence 999999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.69 E-value=3e-16 Score=132.31 Aligned_cols=132 Identities=21% Similarity=0.266 Sum_probs=112.4
Q ss_pred cccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCCC--CceeeEEeEEEeCCeEEEEEEecCCCCh
Q 014352 123 NILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHH--RNLVNLIGYCVDKGKYMLIYEFMSNGSL 200 (426)
Q Consensus 123 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~gsL 200 (426)
+.||.|.++.||++...+ ..+++|....... ...+..|+.++..++| .++.+++++....+..++++||++++++
T Consensus 4 ~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~ 80 (155)
T cd05120 4 KLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL 80 (155)
T ss_pred eecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence 569999999999999855 6789998865433 4578899999999976 5899999988887889999999998877
Q ss_pred hHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcc
Q 014352 201 SNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSK 265 (426)
Q Consensus 201 ~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 265 (426)
..+ +......++.+++.++.++|.....+++|+|++|.||+++..+.+++.|||.+.
T Consensus 81 ~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~ 137 (155)
T cd05120 81 DEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG 137 (155)
T ss_pred ccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence 654 456667789999999999998644459999999999999999999999999886
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.67 E-value=9.4e-16 Score=139.52 Aligned_cols=134 Identities=22% Similarity=0.231 Sum_probs=103.6
Q ss_pred cccc-cCCCeeEEEEEeCCCcEEEEEEeccCC-------------ccChHHHHHHHHHHhcCCCCce--eeEEeEEEeCC
Q 014352 123 NILG-QGAFGPVYKATMPSGGVAAIKVLASDS-------------HQGEKEFQTEVSLLGRLHHRNL--VNLIGYCVDKG 186 (426)
Q Consensus 123 ~~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~~~ 186 (426)
..|| .||.|+||..... +..+++|.+.... ......+.+|++++.+|+|+++ +..+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4688 8999999999875 5667888774321 1122457889999999998875 67777654432
Q ss_pred ----eEEEEEEecCC-CChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeee
Q 014352 187 ----KYMLIYEFMSN-GSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADF 261 (426)
Q Consensus 187 ----~~~lv~e~~~~-gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 261 (426)
..++|+||++| .+|.+++.. ..++.. .+.+++.+|.+||+.+ |+||||||.|||++.++.++|+||
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LIDf 186 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE--APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLIDF 186 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc--CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEEEC
Confidence 23599999997 689888743 235543 3568999999999999 999999999999999999999999
Q ss_pred cCccc
Q 014352 262 GLSKE 266 (426)
Q Consensus 262 gl~~~ 266 (426)
|.+..
T Consensus 187 g~~~~ 191 (239)
T PRK01723 187 DRGEL 191 (239)
T ss_pred CCccc
Confidence 98864
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.66 E-value=6.8e-18 Score=171.66 Aligned_cols=248 Identities=23% Similarity=0.300 Sum_probs=183.6
Q ss_pred hhhcccccCCCeeEEEEEeC--CCcEEEEEEeccCC--ccChHHHHHHHHHHhcCC-CCceeeEEeEEEeCCeEEEEEEe
Q 014352 120 NFTNILGQGAFGPVYKATMP--SGGVAAIKVLASDS--HQGEKEFQTEVSLLGRLH-HRNLVNLIGYCVDKGKYMLIYEF 194 (426)
Q Consensus 120 ~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~ 194 (426)
.+.+.||+|+|+.|-..... ....+|+|.+.... .........|..+-..+. |+|++.+++...+.+..+++++|
T Consensus 23 ~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~ 102 (601)
T KOG0590|consen 23 KLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSY 102 (601)
T ss_pred cccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCc
Confidence 34556999999999888753 33456666665443 111223344677767776 99999999999999999999999
Q ss_pred cCCCChhHHh-hhccCCCCHHHHHHHHHHHHHHHHHHH-cCCCCCeeecCCCCCCEEecCCC-cEEEeeecCcccccc-C
Q 014352 195 MSNGSLSNLI-YSEERVLNWEERLQIALDISHGIEYLH-EGAVPPVIHRDLKSANILLDHFM-RAKVADFGLSKEEVF-D 270 (426)
Q Consensus 195 ~~~gsL~~~l-~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgl~~~~~~-~ 270 (426)
..++++...+ .......+....-.++.|+..++.|+| ..+ +.|+|+||+|.+++.++ ..+++|||++..... .
T Consensus 103 s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~ 179 (601)
T KOG0590|consen 103 SDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAYRNKN 179 (601)
T ss_pred ccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccccccC
Confidence 9999999988 443325566677788999999999999 777 99999999999999999 999999999975444 2
Q ss_pred C---CcccCcc-ccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhh--cc
Q 014352 271 G---RNSGLKG-TYGYIDPAYISTN-KFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQL--VG 343 (426)
Q Consensus 271 ~---~~~~~~g-t~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 343 (426)
+ .....+| ++.|+|||...+. -..+..|+||.|+++.-+++|..|+........ ....+..... ..
T Consensus 180 g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-------~~~~~~~~~~~~~~ 252 (601)
T KOG0590|consen 180 GAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-------RYSSWKSNKGRFTQ 252 (601)
T ss_pred CcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc-------cceeeccccccccc
Confidence 2 2234567 9999999999874 446789999999999999999999876433221 1111111110 11
Q ss_pred cCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 344 ACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 344 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
...........++..+++..+|..|.+.+++...
T Consensus 253 ~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 253 LPWNSISDQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred CccccCChhhhhcccccccCCchhcccccccccc
Confidence 1223344567888889999999999998887543
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.7e-14 Score=142.53 Aligned_cols=138 Identities=20% Similarity=0.260 Sum_probs=98.4
Q ss_pred cccccCCCeeEEEEEeCCCcEEEEEEeccCCccC----------------------------------------hHHHHH
Q 014352 123 NILGQGAFGPVYKATMPSGGVAAIKVLASDSHQG----------------------------------------EKEFQT 162 (426)
Q Consensus 123 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~~~ 162 (426)
+.||+|++|.||+|++.+|+.||||+.+...... +-+|..
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 4699999999999999999999999986542110 002445
Q ss_pred HHHHHhcC----CCCceeeEEeEEE-eCCeEEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHH-HHHHHHcCCCC
Q 014352 163 EVSLLGRL----HHRNLVNLIGYCV-DKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISH-GIEYLHEGAVP 236 (426)
Q Consensus 163 e~~~l~~l----~h~niv~~~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~-~l~~LH~~~~~ 236 (426)
|.+.+.++ +|.+-+.+-.++. ..+..++||||++|++|.+.........+ ...++..++. .+..+|..+
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g-- 277 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDG-- 277 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCC--
Confidence 66655555 2333333333332 23457999999999999987643222222 3446666665 467889888
Q ss_pred CeeecCCCCCCEEecCCCcEEEeeecCccc
Q 014352 237 PVIHRDLKSANILLDHFMRAKVADFGLSKE 266 (426)
Q Consensus 237 ~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 266 (426)
++|+|++|.||+++.++.++++|||++..
T Consensus 278 -~~H~D~hPgNilv~~~g~i~liDfG~~~~ 306 (437)
T TIGR01982 278 -FFHADLHPGNIFVLKDGKIIALDFGIVGR 306 (437)
T ss_pred -ceeCCCCcccEEECCCCcEEEEeCCCeeE
Confidence 99999999999999999999999999864
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.54 E-value=1e-14 Score=131.83 Aligned_cols=202 Identities=25% Similarity=0.336 Sum_probs=141.2
Q ss_pred HHHHhcCCCCceeeEEeEEEeC-----CeEEEEEEecCCCChhHHhhhc---cCCCCHHHHHHHHHHHHHHHHHHHcCCC
Q 014352 164 VSLLGRLHHRNLVNLIGYCVDK-----GKYMLIYEFMSNGSLSNLIYSE---ERVLNWEERLQIALDISHGIEYLHEGAV 235 (426)
Q Consensus 164 ~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~ 235 (426)
...|-++-|.|||+++.|+.+. ....++.|||..|+|..+|+.. ...+....+.+++.||..||.|||+..
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~- 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD- 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-
Confidence 4445667899999999998764 3578999999999999999653 356788888999999999999999976
Q ss_pred CCeeecCCCCCCEEecCCCcEEEeeecCcccc-----ccCCCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHH
Q 014352 236 PPVIHRDLKSANILLDHFMRAKVADFGLSKEE-----VFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELI 310 (426)
Q Consensus 236 ~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~-----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~ 310 (426)
|+|+|+++..+.|++..+|-+|+.----.... ..........+-++|.+||+-.....+.++|||+||...+||.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 88999999999999999999887532111100 0001112234678999999887777888999999999999998
Q ss_pred hCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014352 311 TAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 311 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 378 (426)
.+..--.+.... -...+.+.....+..+ ..=..++..|++..|..||+|.+++.+.
T Consensus 277 ilEiq~tnseS~--------~~~ee~ia~~i~~len----~lqr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 277 ILEIQSTNSESK--------VEVEENIANVIIGLEN----GLQRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred HheeccCCCcce--------eehhhhhhhheeeccC----ccccCcCcccccCCCCCCcchhhhhcCc
Confidence 875432211000 0001111111110000 0123556689999999999999987654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.5e-14 Score=141.24 Aligned_cols=255 Identities=22% Similarity=0.208 Sum_probs=183.0
Q ss_pred hhHHHHHHhhhhccccc--CCCeeEEEEEe--C-CCcEEEEEEeccCCc--cChHHHHHHHHHHhcC-CCCceeeEEeEE
Q 014352 111 YKDIQKATQNFTNILGQ--GAFGPVYKATM--P-SGGVAAIKVLASDSH--QGEKEFQTEVSLLGRL-HHRNLVNLIGYC 182 (426)
Q Consensus 111 ~~~l~~~~~~~~~~lg~--G~~g~Vy~~~~--~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~~~~~~ 182 (426)
..+......++...+|. |.+|.||.+.. . ++..+|+|.-+.... .....-.+|+.-..++ .|+|.++.+..+
T Consensus 108 ~~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~ 187 (524)
T KOG0601|consen 108 FDSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW 187 (524)
T ss_pred ccchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc
Confidence 34455556667788999 99999999987 3 566788887433221 2222334555556666 499999999999
Q ss_pred EeCCeEEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHH----HHHHHHcCCCCCeeecCCCCCCEEecCC-CcEE
Q 014352 183 VDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISH----GIEYLHEGAVPPVIHRDLKSANILLDHF-MRAK 257 (426)
Q Consensus 183 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~----~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~k 257 (426)
.+.+.+++-+|++. .+|..+.+.....++....+.+..+... ||.++|+.. ++|-|+||.||++..+ ..++
T Consensus 188 e~~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~ 263 (524)
T KOG0601|consen 188 EGSGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCK 263 (524)
T ss_pred ccCCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceee
Confidence 99999999999995 6888888666566777777778888888 999999998 9999999999999999 8899
Q ss_pred EeeecCccccccCCCc------ccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCch--HHHHHHhhcc
Q 014352 258 VADFGLSKEEVFDGRN------SGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNL--MEYVNLASMS 329 (426)
Q Consensus 258 l~Dfgl~~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~--~~~~~~~~~~ 329 (426)
++|||+.......... ....|...|++||... +.++..+|+|++|.+..+..+|..+.... ..|..+..+.
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 9999988754433211 1225778999999885 45688999999999999999887765443 2232221110
Q ss_pred ccchhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 014352 330 QDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIK 382 (426)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 382 (426)
+...+ ......++...+..+++.+|..|++.+.+. .+.-+.
T Consensus 343 -------ip~e~----~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~-~l~~i~ 383 (524)
T KOG0601|consen 343 -------IPLEF----CEGGSSSLRSVTSQMLDEDPRLRLTAQILT-ALNVIH 383 (524)
T ss_pred -------Cchhh----hcCcchhhhhHHHHhcCcchhhhhHHHHHh-cccccc
Confidence 11111 111223455588899999999999986554 444443
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.44 E-value=3.3e-12 Score=126.18 Aligned_cols=165 Identities=17% Similarity=0.237 Sum_probs=124.5
Q ss_pred eCCCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCCCChhHHhhhccCCCCHHHHH
Q 014352 138 MPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERL 217 (426)
Q Consensus 138 ~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~ 217 (426)
..++..|.|...+...........+-++.|+.++||||++++..+...+..|+|+|-+. .|..++...+ .....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~----~~~v~ 107 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG----KEEVC 107 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH----HHHHH
Confidence 34778888888876655334556778889999999999999999999999999999984 7777775433 44555
Q ss_pred HHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCC-cccCccccCccCccccccCCCCcc
Q 014352 218 QIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGR-NSGLKGTYGYIDPAYISTNKFTMK 296 (426)
Q Consensus 218 ~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~ 296 (426)
..+.||+.||.|||+.+ .++|++|.-..|+++..|..||.+|.+......... .....--..|..|+.+.... -.
T Consensus 108 ~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--~s 183 (690)
T KOG1243|consen 108 LGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE--WS 183 (690)
T ss_pred HHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--cc
Confidence 67889999999998654 299999999999999999999999988753221111 11111223456666553322 35
Q ss_pred hhhHHHHHHHHHHHhC
Q 014352 297 SDIFSFGVIIFELITA 312 (426)
Q Consensus 297 ~Dv~S~Gvvl~el~tg 312 (426)
.|.|.||++++|++.|
T Consensus 184 ~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 184 IDSWGLGCLIEELFNG 199 (690)
T ss_pred hhhhhHHHHHHHHhCc
Confidence 6999999999999999
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.43 E-value=8e-13 Score=114.04 Aligned_cols=129 Identities=17% Similarity=0.128 Sum_probs=95.8
Q ss_pred cccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCcee-eEEeEEEeCCeEEEEEEecCCCChh
Q 014352 123 NILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLV-NLIGYCVDKGKYMLIYEFMSNGSLS 201 (426)
Q Consensus 123 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~gsL~ 201 (426)
+.|+.|.++.||++... +..+++|....... ....+..|+.++..+.+.+++ +++.+. ....++||||++|.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence 36899999999999874 66789998755432 233567899999988765554 444433 33458999999998876
Q ss_pred HHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCC--CCCeeecCCCCCCEEecCCCcEEEeeecCcc
Q 014352 202 NLIYSEERVLNWEERLQIALDISHGIEYLHEGA--VPPVIHRDLKSANILLDHFMRAKVADFGLSK 265 (426)
Q Consensus 202 ~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 265 (426)
..- . ....++.+++++|+.||+.+ ...++|+|++|.||+++ ++.++++|||.+.
T Consensus 80 ~~~------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 80 TED------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred ccc------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 531 1 11235678999999999986 22369999999999999 6789999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.35 E-value=6.7e-12 Score=125.65 Aligned_cols=139 Identities=17% Similarity=0.181 Sum_probs=90.0
Q ss_pred cccccCCCeeEEEEEeCC-CcEEEEEEeccCCcc--------------------------C--------h------HHHH
Q 014352 123 NILGQGAFGPVYKATMPS-GGVAAIKVLASDSHQ--------------------------G--------E------KEFQ 161 (426)
Q Consensus 123 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~--------------------------~--------~------~~~~ 161 (426)
+.||+|++|.||+|++.+ |+.||||+.++.... + . -+|.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 479999999999999876 999999999754210 0 0 1244
Q ss_pred HHHHHHhcC----CCCceeeEEeEEEe-CCeEEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCC
Q 014352 162 TEVSLLGRL----HHRNLVNLIGYCVD-KGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVP 236 (426)
Q Consensus 162 ~e~~~l~~l----~h~niv~~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ 236 (426)
.|+..+.++ .+.+.+.+-.++.+ ....+|||||++|+++.++-.-.....+........ +..-+.-+...+
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~--v~~~~~Qif~~G-- 280 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERG--VEVFFTQVFRDG-- 280 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHH--HHHHHHHHHhCC--
Confidence 555555554 24444444444443 456789999999999987532111112222211111 111122234456
Q ss_pred CeeecCCCCCCEEecCCC----cEEEeeecCccc
Q 014352 237 PVIHRDLKSANILLDHFM----RAKVADFGLSKE 266 (426)
Q Consensus 237 ~ivH~dlk~~Nill~~~~----~~kl~Dfgl~~~ 266 (426)
++|+|+||.||+++.++ .+++.|||+...
T Consensus 281 -ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~ 313 (537)
T PRK04750 281 -FFHADMHPGNIFVSYDPPENPRYIALDFGIVGS 313 (537)
T ss_pred -eeeCCCChHHeEEecCCCCCCeEEEEecceEEE
Confidence 99999999999999988 999999998764
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.29 E-value=2.2e-12 Score=126.16 Aligned_cols=242 Identities=20% Similarity=0.207 Sum_probs=171.6
Q ss_pred hcccccCCCeeEEEEEeC--CCcEEEEEEeccCCccChHH--HHHHHHHHhcC-CCCceeeEEeEEEeCCeEEEEEEecC
Q 014352 122 TNILGQGAFGPVYKATMP--SGGVAAIKVLASDSHQGEKE--FQTEVSLLGRL-HHRNLVNLIGYCVDKGKYMLIYEFMS 196 (426)
Q Consensus 122 ~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~--~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~ 196 (426)
...||.|.|+.|+....+ ++..+++|.+.+.......+ -..|+-+...+ .|.++++.+..+......|+-.|||.
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~ 349 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCE 349 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhc
Confidence 457999999999988644 67789999887654333222 23455555555 58899998887777777889999999
Q ss_pred CCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCC-CcEEEeeecCccccccCCCccc
Q 014352 197 NGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHF-MRAKVADFGLSKEEVFDGRNSG 275 (426)
Q Consensus 197 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgl~~~~~~~~~~~~ 275 (426)
++++...+ .-...+....++.+..+++.++.++|+.. ++|+|+||+||++..+ +..++.|||........ ...
T Consensus 350 ~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~--~~~ 423 (524)
T KOG0601|consen 350 GGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS--SGV 423 (524)
T ss_pred Ccchhhhh-HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccccccee--ccc
Confidence 99988776 33345777788899999999999999988 9999999999999986 77899999988642111 111
Q ss_pred CccccCcc--CccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHH
Q 014352 276 LKGTYGYI--DPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVREL 353 (426)
Q Consensus 276 ~~gt~~y~--aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 353 (426)
....-++. +|.......+..+.|++|||.-+.|.++|..--....++.. + ....+... .....++
T Consensus 424 ~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~---i--------~~~~~p~~--~~~~~~~ 490 (524)
T KOG0601|consen 424 FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLT---I--------RSGDTPNL--PGLKLQL 490 (524)
T ss_pred ccccccccccchhhccccccccccccccccccccccccCcccCccccccee---e--------ecccccCC--CchHHhh
Confidence 22233344 55566677788999999999999999998654322222111 1 11111111 1122567
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 014352 354 ARIGHKCLHKTPRKRPSIGEVTQALLKIK 382 (426)
Q Consensus 354 ~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 382 (426)
..+.+.+...++..||.+.++..+...+.
T Consensus 491 q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 491 QVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred hhhhhhhcCCccccchhhhhhcccchhhh
Confidence 77888899999999999988877655443
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.28 E-value=5e-11 Score=107.39 Aligned_cols=141 Identities=20% Similarity=0.277 Sum_probs=108.8
Q ss_pred cccccCCCeeEEEEEeCCCcEEEEEEeccCCc-cChHHHHHHHHHHhcCCCC--ceeeEEeEEEeC---CeEEEEEEecC
Q 014352 123 NILGQGAFGPVYKATMPSGGVAAIKVLASDSH-QGEKEFQTEVSLLGRLHHR--NLVNLIGYCVDK---GKYMLIYEFMS 196 (426)
Q Consensus 123 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~--niv~~~~~~~~~---~~~~lv~e~~~ 196 (426)
+.|+.|.++.||++...+|..+++|....... .....+..|.+++..+.+. ++.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 36899999999999987667889998755432 1345788999999999753 456777776654 25689999999
Q ss_pred CCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCC------------------------------------------
Q 014352 197 NGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGA------------------------------------------ 234 (426)
Q Consensus 197 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------------------------------------------ 234 (426)
|.++...+.. ..++......++.+++++|.+||+..
T Consensus 84 G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (223)
T cd05154 84 GRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL 161 (223)
T ss_pred CEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence 9988776532 34677777788888888888888531
Q ss_pred -----------CCCeeecCCCCCCEEecC--CCcEEEeeecCcc
Q 014352 235 -----------VPPVIHRDLKSANILLDH--FMRAKVADFGLSK 265 (426)
Q Consensus 235 -----------~~~ivH~dlk~~Nill~~--~~~~kl~Dfgl~~ 265 (426)
...++|+|+.|.||+++. ++.+.|+||+.+.
T Consensus 162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 134799999999999998 5678999999875
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.28 E-value=9.1e-11 Score=102.36 Aligned_cols=134 Identities=22% Similarity=0.234 Sum_probs=96.6
Q ss_pred cccccCCCeeEEEEEeCC-------CcEEEEEEeccCCc----------------------cChHHH----HHHHHHHhc
Q 014352 123 NILGQGAFGPVYKATMPS-------GGVAAIKVLASDSH----------------------QGEKEF----QTEVSLLGR 169 (426)
Q Consensus 123 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~----------------------~~~~~~----~~e~~~l~~ 169 (426)
..||.|-=+.||.|...+ +..+|||+.+.... ...+.+ ..|.+.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 479999999999998543 46899998743210 001222 379999998
Q ss_pred CCC--CceeeEEeEEEeCCeEEEEEEecCCCChhH-HhhhccCCCCHHHHHHHHHHHHHHHHHH-HcCCCCCeeecCCCC
Q 014352 170 LHH--RNLVNLIGYCVDKGKYMLIYEFMSNGSLSN-LIYSEERVLNWEERLQIALDISHGIEYL-HEGAVPPVIHRDLKS 245 (426)
Q Consensus 170 l~h--~niv~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~ivH~dlk~ 245 (426)
+.. -++..++++ ...++||||+.+..+.. .+. ...++......+..+++.+|..| |..+ ++|+||++
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk--d~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs~ 153 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK--DAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLSE 153 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh--ccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCCH
Confidence 853 355566654 35689999997654432 221 12345556677889999999998 8888 99999999
Q ss_pred CCEEecCCCcEEEeeecCccc
Q 014352 246 ANILLDHFMRAKVADFGLSKE 266 (426)
Q Consensus 246 ~Nill~~~~~~kl~Dfgl~~~ 266 (426)
.||++++ +.+.|+|||.+-.
T Consensus 154 ~NIL~~~-~~v~iIDF~qav~ 173 (197)
T cd05146 154 YNMLWHD-GKVWFIDVSQSVE 173 (197)
T ss_pred HHEEEEC-CcEEEEECCCcee
Confidence 9999974 7899999998764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.4e-10 Score=97.84 Aligned_cols=130 Identities=21% Similarity=0.309 Sum_probs=98.6
Q ss_pred ccccCCCeeEEEEEeCCCcEEEEEEeccCCc--c------ChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEec
Q 014352 124 ILGQGAFGPVYKATMPSGGVAAIKVLASDSH--Q------GEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 124 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 195 (426)
.+++|+=+.+|.+.+.+.. +++|.-....- . ..+.-.+|++++.+++--.|....=+..+.+...++|||+
T Consensus 3 ~i~~GAEa~i~~~~~~g~~-av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGLP-AVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeeccCcc-eEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 5789999999999874444 45554322211 1 1123567999999987666666566677777889999999
Q ss_pred CCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccc
Q 014352 196 SNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKE 266 (426)
Q Consensus 196 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 266 (426)
+|-.|.+.+... ...++..+-.-+.-||..+ |+|+||.++||++...+ +.++|||++..
T Consensus 82 ~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 82 EGELLKDALEEA--------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CChhHHHHHHhc--------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 999998888544 2456677778888999999 99999999999999865 99999999873
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.23 E-value=9.2e-11 Score=98.50 Aligned_cols=140 Identities=26% Similarity=0.297 Sum_probs=101.7
Q ss_pred cccccCCCeeEEEEEeCCCcEEEEEEe-ccC-------CccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEe
Q 014352 123 NILGQGAFGPVYKATMPSGGVAAIKVL-ASD-------SHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEF 194 (426)
Q Consensus 123 ~~lg~G~~g~Vy~~~~~~~~~vavK~~-~~~-------~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 194 (426)
.++-+|+=+.|+++.+ .|+...||.- .+. ..-..+...+|+++|.++.--.|.-..-++.+.+.-.++|||
T Consensus 13 ~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~ 91 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF 91 (229)
T ss_pred eeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence 4688999999999998 4555555542 211 111234567899999998766665555566666677899999
Q ss_pred cCC-CChhHHhhhccCCCCH-HHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCc---EEEeeecCccc
Q 014352 195 MSN-GSLSNLIYSEERVLNW-EERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMR---AKVADFGLSKE 266 (426)
Q Consensus 195 ~~~-gsL~~~l~~~~~~l~~-~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfgl~~~ 266 (426)
++| -++.+++......-.. .....++..+-+.+.-||.++ |+|+||.++||++..++. +.++|||++..
T Consensus 92 ~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 92 IDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred ccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 976 4777777554322222 333678889999999999999 999999999999976543 58999999863
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.20 E-value=6.9e-10 Score=106.80 Aligned_cols=213 Identities=17% Similarity=0.223 Sum_probs=149.5
Q ss_pred eeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEe----CCeEEEEEEecCC-CChhHHh
Q 014352 131 GPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVD----KGKYMLIYEFMSN-GSLSNLI 204 (426)
Q Consensus 131 g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~-gsL~~~l 204 (426)
.+.|++... +|..+++|++..+..........-+++++++.|+|+|++..++.. +..+++||+|+|+ ++|.++-
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 567888754 788899999954443333334456788999999999999998763 4578999999986 5676654
Q ss_pred hh--------------ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC
Q 014352 205 YS--------------EERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD 270 (426)
Q Consensus 205 ~~--------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 270 (426)
+. .+...++..+|.++.|+..||.++|+.| +.-+-|.+.+||++.+..++|+..|.......+
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 32 1234677899999999999999999999 888999999999999989999988876544332
Q ss_pred CCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHH
Q 014352 271 GRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEV 350 (426)
Q Consensus 271 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (426)
. . +.+. --.+-|.=-||.+++.|.||..--.. .+..... -........+
T Consensus 447 ~-----------~--~~le---~~Qq~D~~~lG~ll~aLAt~~~ns~~-----------~d~~~~s----~~~~I~~~yS 495 (655)
T KOG3741|consen 447 P-----------T--EPLE---SQQQNDLRDLGLLLLALATGTENSNR-----------TDSTQSS----HLTRITTTYS 495 (655)
T ss_pred C-----------C--cchh---HHhhhhHHHHHHHHHHHhhccccccc-----------ccchHHH----HHHHhhhhhh
Confidence 2 0 1111 12467899999999999998653110 0000000 0011122344
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014352 351 RELARIGHKCLHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 351 ~~l~~l~~~cl~~~p~~RPs~~evl~~L 378 (426)
.++.+++.-....++++ -++.+++.++
T Consensus 496 ~D~rn~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 496 TDLRNVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred HHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence 66778888888888886 5677766654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.12 E-value=1.8e-11 Score=126.07 Aligned_cols=237 Identities=19% Similarity=0.232 Sum_probs=158.8
Q ss_pred ccccCCCeeEEEEEeC-CCcEEEEEEeccCC---ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCCCC
Q 014352 124 ILGQGAFGPVYKATMP-SGGVAAIKVLASDS---HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGS 199 (426)
Q Consensus 124 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 199 (426)
-+-+|.+|.++.+.-. .+...++|...... ..+.+....+-.++-.-++|-+++..--+......+|+++|+.+++
T Consensus 811 p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~ 890 (1205)
T KOG0606|consen 811 PSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGGD 890 (1205)
T ss_pred cccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccCC
Confidence 5778888888877643 23223333322211 1112222333333333456777766666556678899999999999
Q ss_pred hhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccc-------c---
Q 014352 200 LSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEV-------F--- 269 (426)
Q Consensus 200 L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~-------~--- 269 (426)
|...|+..+ ..+.+.....+..+..+++|||+.. +.|+|++|.|.+...++..+++|||...... .
T Consensus 891 ~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~ 966 (1205)
T KOG0606|consen 891 LPSKLHNSG-CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGP 966 (1205)
T ss_pred chhhhhcCC-CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccccccCcCCcccc
Confidence 999997655 3444444455667888999999987 8999999999999999999999998322100 0
Q ss_pred ------------------C----CCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhh
Q 014352 270 ------------------D----GRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLAS 327 (426)
Q Consensus 270 ------------------~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~ 327 (426)
. .......||+.|.+||...+......+|+|++|++++|.++|.+||...........
T Consensus 967 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~n 1046 (1205)
T KOG0606|consen 967 SSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFEN 1046 (1205)
T ss_pred cccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhc
Confidence 0 001234689999999999999999999999999999999999999976443322221
Q ss_pred ccccchhhhhhhhhcc-cCCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 014352 328 MSQDGVDEILDKQLVG-ACNIQEVRELARIGHKCLHKTPRKRPSIG 372 (426)
Q Consensus 328 ~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ 372 (426)
+... .... .-+........+++...+..+|.+|-.+.
T Consensus 1047 i~~~--------~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1047 ILNR--------DIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred cccC--------CCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 1111 1111 11223345677788888899999996665
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.00 E-value=7.7e-09 Score=95.31 Aligned_cols=139 Identities=13% Similarity=0.109 Sum_probs=98.6
Q ss_pred cccccCCCeeEEEEEeCCCcEEEEEEeccCCcc-----------ChHHHHHHHHHHhcCCCCce--eeEEeEEEe-----
Q 014352 123 NILGQGAFGPVYKATMPSGGVAAIKVLASDSHQ-----------GEKEFQTEVSLLGRLHHRNL--VNLIGYCVD----- 184 (426)
Q Consensus 123 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~----- 184 (426)
+.+-......|++..+ +|+.+.||........ ....+.+|...+.+|..-+| ..++++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3444444455777766 6678899976433211 11247788888888743333 344555443
Q ss_pred CCeEEEEEEecCCC-ChhHHhhhc-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecC-------CCc
Q 014352 185 KGKYMLIYEFMSNG-SLSNLIYSE-ERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDH-------FMR 255 (426)
Q Consensus 185 ~~~~~lv~e~~~~g-sL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~-------~~~ 255 (426)
....++|+|++++. +|.+++... ....+......++.+++..+.-||..+ |+|+|++++|||++. +..
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCce
Confidence 23568999999886 798887431 233556677789999999999999999 999999999999985 467
Q ss_pred EEEeeecCcc
Q 014352 256 AKVADFGLSK 265 (426)
Q Consensus 256 ~kl~Dfgl~~ 265 (426)
+.++||+.+.
T Consensus 184 ~~LIDl~r~~ 193 (268)
T PRK15123 184 LSVIDLHRAQ 193 (268)
T ss_pred EEEEECCccc
Confidence 9999999875
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.98 E-value=1.5e-08 Score=95.54 Aligned_cols=257 Identities=16% Similarity=0.190 Sum_probs=157.7
Q ss_pred hcccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcC-CCCceeeEEeEE----E--eCC-eEEEEEE
Q 014352 122 TNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRL-HHRNLVNLIGYC----V--DKG-KYMLIYE 193 (426)
Q Consensus 122 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~----~--~~~-~~~lv~e 193 (426)
+..||+|+-+.+|-.---.+ .|| |+..........+ .+..|.+. .||-+-.-+.+= . +.+ ..-+.|.
T Consensus 16 gr~LgqGgea~ly~l~e~~d-~VA-KIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP 90 (637)
T COG4248 16 GRPLGQGGEADLYTLGEVRD-QVA-KIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP 90 (637)
T ss_pred CccccCCccceeeecchhhc-hhh-eeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence 45799999999985432122 344 5554433222222 23334443 466443312211 0 112 2567777
Q ss_pred ecCCCC-hhHHhhh-----ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccc
Q 014352 194 FMSNGS-LSNLIYS-----EERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEE 267 (426)
Q Consensus 194 ~~~~gs-L~~~l~~-----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 267 (426)
.+++.. ...++.- .-....|...++.+..++.+.+-||..| .+-+|+.++|+|+++++.+.|.|-..-...
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceeec
Confidence 776542 2222211 1145789999999999999999999999 899999999999999999999984432222
Q ss_pred ccCCCcccCccccCccCccccc-----cCCCCcchhhHHHHHHHHHHHhC-CCCCCchHHHHH----Hh-hccccchhhh
Q 014352 268 VFDGRNSGLKGTYGYIDPAYIS-----TNKFTMKSDIFSFGVIIFELITA-IHPHQNLMEYVN----LA-SMSQDGVDEI 336 (426)
Q Consensus 268 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gvvl~el~tg-~~p~~~~~~~~~----~~-~~~~~~~~~~ 336 (426)
..+.......|...|.+||.-. +..-+...|-|.||+++++++.| +.||++...... +. .+........
T Consensus 168 ~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya 247 (637)
T COG4248 168 ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYA 247 (637)
T ss_pred cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeec
Confidence 2233344567899999999654 33456789999999999998876 999987432111 00 0100100000
Q ss_pred hhhh--h---cccCCH-HHHHHHHHHHHHcccC--CCCCCCCHHHHHHHHHHHHHHhh
Q 014352 337 LDKQ--L---VGACNI-QEVRELARIGHKCLHK--TPRKRPSIGEVTQALLKIKQRHL 386 (426)
Q Consensus 337 ~~~~--~---~~~~~~-~~~~~l~~l~~~cl~~--~p~~RPs~~evl~~L~~~~~~~~ 386 (426)
.+.. + ....+. -....+..+..+|+.. ++.-|||++..+..|..+.+...
T Consensus 248 ~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~ 305 (637)
T COG4248 248 SDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLK 305 (637)
T ss_pred hhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhh
Confidence 0100 0 111121 2335677777889864 36789999999999988876543
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.94 E-value=1e-08 Score=89.14 Aligned_cols=124 Identities=26% Similarity=0.391 Sum_probs=80.0
Q ss_pred eEEEEEeCCCcEEEEEEeccCCc---------------------cC-----hHHHHHHHHHHhcCCCC--ceeeEEeEEE
Q 014352 132 PVYKATMPSGGVAAIKVLASDSH---------------------QG-----EKEFQTEVSLLGRLHHR--NLVNLIGYCV 183 (426)
Q Consensus 132 ~Vy~~~~~~~~~vavK~~~~~~~---------------------~~-----~~~~~~e~~~l~~l~h~--niv~~~~~~~ 183 (426)
.||.|...+|..+|+|+.+.... .. ......|.+.|.++..- ++.+++++
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 38999988899999999743210 00 12356799999999766 45566544
Q ss_pred eCCeEEEEEEecC--CCChhHHhhhccCCCCHHHHHHHHHHHHHHHHH-HHcCCCCCeeecCCCCCCEEecCCCcEEEee
Q 014352 184 DKGKYMLIYEFMS--NGSLSNLIYSEERVLNWEERLQIALDISHGIEY-LHEGAVPPVIHRDLKSANILLDHFMRAKVAD 260 (426)
Q Consensus 184 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~-LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 260 (426)
. ..++||||++ |..+..+.... ++......++.+++..+.. +|..+ |+|+||.+.||+++++ .+.++|
T Consensus 79 ~--~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iID 149 (188)
T PF01163_consen 79 N--RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYIID 149 (188)
T ss_dssp E--TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE--
T ss_pred e--CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEEe
Confidence 2 3479999998 65554433211 1123345566777775555 57888 9999999999999987 999999
Q ss_pred ecCccc
Q 014352 261 FGLSKE 266 (426)
Q Consensus 261 fgl~~~ 266 (426)
||.+..
T Consensus 150 f~qav~ 155 (188)
T PF01163_consen 150 FGQAVD 155 (188)
T ss_dssp GTTEEE
T ss_pred cCccee
Confidence 998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.83 E-value=2.6e-08 Score=89.30 Aligned_cols=144 Identities=23% Similarity=0.258 Sum_probs=99.9
Q ss_pred CChhHHHHHH--hhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCC-----------------c-----cChHHHHHHH
Q 014352 109 YAYKDIQKAT--QNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDS-----------------H-----QGEKEFQTEV 164 (426)
Q Consensus 109 ~~~~~l~~~~--~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-----------------~-----~~~~~~~~e~ 164 (426)
..+..+.+.. +.+++.||.|-=+.||.|....|..+|||.-+... . .+.....+|.
T Consensus 81 LAL~~l~~r~~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf 160 (304)
T COG0478 81 LALHALVKRGIVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREF 160 (304)
T ss_pred HHHHHHHHcChHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHH
Confidence 3444444322 45678999999999999999999999999753211 0 0122457899
Q ss_pred HHHhcCCCC--ceeeEEeEEEeCCeEEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecC
Q 014352 165 SLLGRLHHR--NLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRD 242 (426)
Q Consensus 165 ~~l~~l~h~--niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~d 242 (426)
++|.+|.-. .|.+.+++ +...+||||++|-.|...-- ..-+... ++..|+.-+.-+-..+ +||+|
T Consensus 161 ~~L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r~---~~en~~~---il~~il~~~~~~~~~G---iVHGD 227 (304)
T COG0478 161 EALQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLRL---DVENPDE---ILDKILEEVRKAYRRG---IVHGD 227 (304)
T ss_pred HHHHHhhhcCCCCCCcccc----ccceeeeehcccceeecccC---cccCHHH---HHHHHHHHHHHHHHcC---ccccC
Confidence 999999655 67777665 45689999999876655321 1122333 3344444444444566 99999
Q ss_pred CCCCCEEecCCCcEEEeeecCcc
Q 014352 243 LKSANILLDHFMRAKVADFGLSK 265 (426)
Q Consensus 243 lk~~Nill~~~~~~kl~Dfgl~~ 265 (426)
+.+-||+++++|.+.++||--+.
T Consensus 228 lSefNIlV~~dg~~~vIDwPQ~v 250 (304)
T COG0478 228 LSEFNILVTEDGDIVVIDWPQAV 250 (304)
T ss_pred CchheEEEecCCCEEEEeCcccc
Confidence 99999999999999999997654
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.74 E-value=3.6e-07 Score=80.06 Aligned_cols=138 Identities=14% Similarity=0.072 Sum_probs=101.5
Q ss_pred cccCCCeeEEEEEeCCCcEEEEEEeccCC------ccChHHHHHHHHHHhcCCCC--ceeeEEeEEEeC----CeEEEEE
Q 014352 125 LGQGAFGPVYKATMPSGGVAAIKVLASDS------HQGEKEFQTEVSLLGRLHHR--NLVNLIGYCVDK----GKYMLIY 192 (426)
Q Consensus 125 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~--niv~~~~~~~~~----~~~~lv~ 192 (426)
-|+||-+.|++-.+.+. .+-+|.-.+.. ......|.+|...|.+|..- .+.+........ ..-+||+
T Consensus 26 ~~rgG~SgV~r~~~~g~-~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERNGK-KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeCCc-EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 57788888999887444 67888765221 22456899999999988532 244444222121 2468999
Q ss_pred EecCC-CChhHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCc--EEEeeecCccc
Q 014352 193 EFMSN-GSLSNLIYSEE-RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMR--AKVADFGLSKE 266 (426)
Q Consensus 193 e~~~~-gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~--~kl~Dfgl~~~ 266 (426)
|-++| -+|.+++.... ...+...+..++.+++..+.-||+.+ +.|+|+.+.||+++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 98753 58888874432 34567777899999999999999999 999999999999986667 99999987764
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.74 E-value=7.7e-08 Score=96.03 Aligned_cols=138 Identities=17% Similarity=0.221 Sum_probs=93.4
Q ss_pred cccccCCCeeEEEEEeCCCcEEEEEEeccCCccC----------------------------------------hHHHHH
Q 014352 123 NILGQGAFGPVYKATMPSGGVAAIKVLASDSHQG----------------------------------------EKEFQT 162 (426)
Q Consensus 123 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~~~ 162 (426)
+.|+.++-|.||+|++.+|+.||||+.++..... +-++..
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 5799999999999999999999999985442110 012344
Q ss_pred HHHHHhcC-----CCCceeeEEeEEE-eCCeEEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCC
Q 014352 163 EVSLLGRL-----HHRNLVNLIGYCV-DKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVP 236 (426)
Q Consensus 163 e~~~l~~l-----~h~niv~~~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ 236 (426)
|...+.++ +.+++. +=.+++ -.+..+|+|||++|-.+.+.........+...+.....++.--.-+ ..+
T Consensus 211 EA~n~~~~~~nf~~~~~v~-VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~--~dg-- 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVY-VPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLL--RDG-- 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeE-eceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHHH--hcC--
Confidence 55555554 234432 223333 3456799999999999998853333445644444333333222222 235
Q ss_pred CeeecCCCCCCEEecCCCcEEEeeecCccc
Q 014352 237 PVIHRDLKSANILLDHFMRAKVADFGLSKE 266 (426)
Q Consensus 237 ~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 266 (426)
++|.|..|.||+++.++.+.+.|||+...
T Consensus 286 -ffHaDpHpGNi~v~~~g~i~~lDfGi~g~ 314 (517)
T COG0661 286 -FFHADPHPGNILVRSDGRIVLLDFGIVGR 314 (517)
T ss_pred -ccccCCCccceEEecCCcEEEEcCcceec
Confidence 99999999999999999999999998754
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.9e-07 Score=83.10 Aligned_cols=105 Identities=24% Similarity=0.281 Sum_probs=82.2
Q ss_pred HHHHHHHHHHhcCCCC--ceeeEEeEEEeC----CeEEEEEEecCCC-ChhHHhhhccCCCCHHHHHHHHHHHHHHHHHH
Q 014352 158 KEFQTEVSLLGRLHHR--NLVNLIGYCVDK----GKYMLIYEFMSNG-SLSNLIYSEERVLNWEERLQIALDISHGIEYL 230 (426)
Q Consensus 158 ~~~~~e~~~l~~l~h~--niv~~~~~~~~~----~~~~lv~e~~~~g-sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L 230 (426)
....+|...+..|... .+...+++.... ...++|+|++++. +|.+++..... .+......++.+++..+.-|
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKL 134 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHH
Confidence 3567788887777433 345566666553 2458999999874 79998855333 56667788999999999999
Q ss_pred HcCCCCCeeecCCCCCCEEecCCC---cEEEeeecCccc
Q 014352 231 HEGAVPPVIHRDLKSANILLDHFM---RAKVADFGLSKE 266 (426)
Q Consensus 231 H~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfgl~~~ 266 (426)
|..+ |+|+|+++.|||++.++ .+.++||+.++.
T Consensus 135 H~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 135 HDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999 99999999999999887 799999997764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.65 E-value=8.5e-09 Score=102.79 Aligned_cols=148 Identities=20% Similarity=0.261 Sum_probs=98.7
Q ss_pred HHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC----------CcccCccccCccCcccccc
Q 014352 221 LDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG----------RNSGLKGTYGYIDPAYIST 290 (426)
Q Consensus 221 ~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~----------~~~~~~gt~~y~aPE~~~~ 290 (426)
.+++.||.|+|... ++||++|.|++|.++.++..||+.|+.+-...... ......-...|.|||++.+
T Consensus 106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 34559999999864 59999999999999999999999999865322210 0111234568999999999
Q ss_pred CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCC
Q 014352 291 NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPS 370 (426)
Q Consensus 291 ~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs 370 (426)
...+.++|+||+|+++|-+..|..+--............ ....+.. ........+.++.+-+.+.+..++.-||+
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~----~~~~~~~-~~~~s~~~p~el~~~l~k~l~~~~~~rp~ 258 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFS----RNLLNAG-AFGYSNNLPSELRESLKKLLNGDSAVRPT 258 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhh----hcccccc-cccccccCcHHHHHHHHHHhcCCcccCcc
Confidence 888999999999999999996555422111100000000 0000000 01111334467888888899999999998
Q ss_pred HHHHH
Q 014352 371 IGEVT 375 (426)
Q Consensus 371 ~~evl 375 (426)
+.++.
T Consensus 259 ~~~l~ 263 (700)
T KOG2137|consen 259 LDLLL 263 (700)
T ss_pred hhhhh
Confidence 76653
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.60 E-value=7.1e-09 Score=102.29 Aligned_cols=183 Identities=17% Similarity=0.157 Sum_probs=135.6
Q ss_pred cccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCc-eeeEEeEEEeCCeEEEEEEecCCC-Ch
Q 014352 123 NILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRN-LVNLIGYCVDKGKYMLIYEFMSNG-SL 200 (426)
Q Consensus 123 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~~~~g-sL 200 (426)
+-+++|+++++||.+.........+.+... ....-++++|.+++||| .++.++-+..+...++.++++.++ +-
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~ 322 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSS 322 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccc
Confidence 457899999999998654444445555432 34566899999999999 777777777777889999999877 22
Q ss_pred hHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCcccCcccc
Q 014352 201 SNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTY 280 (426)
Q Consensus 201 ~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~gt~ 280 (426)
..........+...+...+...-.++++++|+.- =+|+| ||+..+ +..+..||+...............+++
T Consensus 323 ~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~~~t~~~~~ 394 (829)
T KOG0576|consen 323 ALEMTVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTMKPRTAIGTP 394 (829)
T ss_pred cccCChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCcccccccCCCCC
Confidence 2222112222333444555666778899999854 48998 777776 788999999987665544566778999
Q ss_pred CccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCc
Q 014352 281 GYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQN 318 (426)
Q Consensus 281 ~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~ 318 (426)
.|+|||+.....+..+.|+|++|+-..++.-|.+|-..
T Consensus 395 ~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 395 EPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred CCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 99999999999999999999999877788778777554
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.56 E-value=1.6e-06 Score=78.19 Aligned_cols=137 Identities=18% Similarity=0.251 Sum_probs=84.1
Q ss_pred cccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCc--eeeEEeEEEeCCeEEEEEEecCCCC-
Q 014352 123 NILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRN--LVNLIGYCVDKGKYMLIYEFMSNGS- 199 (426)
Q Consensus 123 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~gs- 199 (426)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..-+ +.+.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 36999999999984 24456778775432 3456788999998886433 4677777777777889999998863
Q ss_pred hhHHh---------------------hhcc-CCCCHHHHHH-HHH----------HHHH-HHHHHHcC-CCCCeeecCCC
Q 014352 200 LSNLI---------------------YSEE-RVLNWEERLQ-IAL----------DISH-GIEYLHEG-AVPPVIHRDLK 244 (426)
Q Consensus 200 L~~~l---------------------~~~~-~~l~~~~~~~-i~~----------~i~~-~l~~LH~~-~~~~ivH~dlk 244 (426)
+...+ +.-. .......... +.. .+.. ...+|... ..+.++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 21111 1100 0111111110 000 0111 12222211 12447899999
Q ss_pred CCCEEecCCCcEEEeeecCcc
Q 014352 245 SANILLDHFMRAKVADFGLSK 265 (426)
Q Consensus 245 ~~Nill~~~~~~kl~Dfgl~~ 265 (426)
|.||++++++ +.++||+.+.
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCcEEEcCCC-cEEEechhcC
Confidence 9999999988 9999999775
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.42 E-value=3.3e-06 Score=74.39 Aligned_cols=138 Identities=14% Similarity=0.205 Sum_probs=85.1
Q ss_pred HHHHHhhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHH---------HHHHHHHhcCC---CCceeeEEeE
Q 014352 114 IQKATQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEF---------QTEVSLLGRLH---HRNLVNLIGY 181 (426)
Q Consensus 114 l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~---------~~e~~~l~~l~---h~niv~~~~~ 181 (426)
+....+...+++-......|.+-.. +|..+++|..+......++.| .+.+..+.+++ .-....++.+
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 3444444444555555555555554 566778888766543333322 23344343432 2222232222
Q ss_pred EE-----eCCeEEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcE
Q 014352 182 CV-----DKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRA 256 (426)
Q Consensus 182 ~~-----~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 256 (426)
.. -....+++|||++|..|.+... ++. .++..+.+++.-||+.| ++|+|..|.|++++.+ .+
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-~i 173 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-GI 173 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-cE
Confidence 22 1235679999999988877541 221 24456778899999999 9999999999999965 49
Q ss_pred EEeeecCcc
Q 014352 257 KVADFGLSK 265 (426)
Q Consensus 257 kl~Dfgl~~ 265 (426)
++.||+..+
T Consensus 174 ~iID~~~k~ 182 (229)
T PF06176_consen 174 RIIDTQGKR 182 (229)
T ss_pred EEEECcccc
Confidence 999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.41 E-value=1.7e-06 Score=86.33 Aligned_cols=139 Identities=19% Similarity=0.206 Sum_probs=93.3
Q ss_pred cccccCCCeeEEEEEeCCCcEEEEEEeccCCccC-------------------------------------hHHHHHHHH
Q 014352 123 NILGQGAFGPVYKATMPSGGVAAIKVLASDSHQG-------------------------------------EKEFQTEVS 165 (426)
Q Consensus 123 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------------------------------------~~~~~~e~~ 165 (426)
+.||.-+.|.||+|+..+|+.||||+-++..... +-+|..|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 4699999999999999999999999965432110 112444554
Q ss_pred HHhcC----CCCce---eeEEeEEEe-CCeEEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCC
Q 014352 166 LLGRL----HHRNL---VNLIGYCVD-KGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPP 237 (426)
Q Consensus 166 ~l~~l----~h~ni---v~~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ 237 (426)
...++ .|-+. |.+=.++++ .....|+||||+|..+.+.-.-....++...+..-+.++..-+-+.| |
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~qIf~~--G--- 321 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQIFKT--G--- 321 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHHHHhc--C---
Confidence 44333 44441 112222332 24679999999999888775444455777665555554443333333 4
Q ss_pred eeecCCCCCCEEecC----CCcEEEeeecCccc
Q 014352 238 VIHRDLKSANILLDH----FMRAKVADFGLSKE 266 (426)
Q Consensus 238 ivH~dlk~~Nill~~----~~~~kl~Dfgl~~~ 266 (426)
++|.|=.|.||+++. ++.+.+.|||+...
T Consensus 322 ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~ 354 (538)
T KOG1235|consen 322 FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAV 354 (538)
T ss_pred CccCCCCCCcEEEecCCCCCccEEEEccccccc
Confidence 999999999999994 66799999999764
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.36 E-value=8.2e-06 Score=74.68 Aligned_cols=137 Identities=20% Similarity=0.167 Sum_probs=83.8
Q ss_pred cccCCC-eeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCC-CCceeeEEeEEEeCCeEEEEEEecCCCChhH
Q 014352 125 LGQGAF-GPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLH-HRNLVNLIGYCVDKGKYMLIYEFMSNGSLSN 202 (426)
Q Consensus 125 lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~ 202 (426)
|-.|.. ..||+....+ ..+.+|+..... ...+..|++++..+. +--+.+++++....+..++|||+++|.+|..
T Consensus 6 ~~~g~~~~~v~~~~~~~-~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGKN-PGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCCC-CcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 444544 8899997644 677888875432 335678888888774 3445577777766667799999999987764
Q ss_pred Hh-------------------hhcc---CCCC--HHHHHHHHH--------------------HHHHHHHHHHc----CC
Q 014352 203 LI-------------------YSEE---RVLN--WEERLQIAL--------------------DISHGIEYLHE----GA 234 (426)
Q Consensus 203 ~l-------------------~~~~---~~l~--~~~~~~i~~--------------------~i~~~l~~LH~----~~ 234 (426)
.. +.-. .+.. ....+.... .+...+..|-. ..
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 32 1100 0111 001110000 01111222211 12
Q ss_pred CCCeeecCCCCCCEEecCCCcEEEeeecCcc
Q 014352 235 VPPVIHRDLKSANILLDHFMRAKVADFGLSK 265 (426)
Q Consensus 235 ~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 265 (426)
.+.++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 2458999999999999998778899998764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.34 E-value=4.7e-06 Score=74.23 Aligned_cols=134 Identities=20% Similarity=0.288 Sum_probs=92.8
Q ss_pred cccccCCCeeEEEEEeCCCcEEEEEEeccCCcc-------------------ChHH-----HHHHHHHHhcCC--CCcee
Q 014352 123 NILGQGAFGPVYKATMPSGGVAAIKVLASDSHQ-------------------GEKE-----FQTEVSLLGRLH--HRNLV 176 (426)
Q Consensus 123 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------------------~~~~-----~~~e~~~l~~l~--h~niv 176 (426)
..|.+|.-+.||+|.-.++..+|+|+.+..... +.++ ...|...|.++. +-.+.
T Consensus 54 g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 54 GCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 357789999999999878899999998643211 1111 245777777774 33444
Q ss_pred eEEeEEEeCCeEEEEEEecCCCCh-hHHhhhccCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeecCCCCCCEEecCCC
Q 014352 177 NLIGYCVDKGKYMLIYEFMSNGSL-SNLIYSEERVLNWEERLQIALDISHGIEYLHE-GAVPPVIHRDLKSANILLDHFM 254 (426)
Q Consensus 177 ~~~~~~~~~~~~~lv~e~~~~gsL-~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~ 254 (426)
+.+++. .-.|||||++.... .-.| ....+...+...+..++++.+.-|-. .+ +||+||+.=|||+. ++
T Consensus 134 ~Pi~~~----~nVLvMEfIg~~g~pAP~L--kDv~~e~~e~~~~~~~~v~~~~~l~~~a~---LVHgDLSEyNiL~~-~~ 203 (268)
T COG1718 134 EPIAFR----NNVLVMEFIGDDGLPAPRL--KDVPLELEEAEGLYEDVVEYMRRLYKEAG---LVHGDLSEYNILVH-DG 203 (268)
T ss_pred Cceeec----CCeEEEEeccCCCCCCCCc--ccCCcCchhHHHHHHHHHHHHHHHHHhcC---cccccchhhheEEE-CC
Confidence 555543 34799999965411 1122 11223333566677888888888877 55 99999999999999 78
Q ss_pred cEEEeeecCccc
Q 014352 255 RAKVADFGLSKE 266 (426)
Q Consensus 255 ~~kl~Dfgl~~~ 266 (426)
.+.|+|||-+..
T Consensus 204 ~p~iID~~QaV~ 215 (268)
T COG1718 204 EPYIIDVSQAVT 215 (268)
T ss_pred eEEEEECccccc
Confidence 999999998753
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.31 E-value=9.1e-06 Score=73.48 Aligned_cols=140 Identities=19% Similarity=0.259 Sum_probs=82.6
Q ss_pred cccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCCCC--ceeeEEeEEEe---CCeEEEEEEecCC
Q 014352 123 NILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHR--NLVNLIGYCVD---KGKYMLIYEFMSN 197 (426)
Q Consensus 123 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~~~~~---~~~~~lv~e~~~~ 197 (426)
+.|+.|..+.||+....+ +.+++|..... .....+..|..+++.+... .+.+++.+... ....+++|+++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 468999999999999877 57889986543 3446778888888887533 34566664433 2357899999999
Q ss_pred CChhH----------------Hh---hhcc---CCCCHHH---------HHHH------------HHHHHH-HHHHHHc-
Q 014352 198 GSLSN----------------LI---YSEE---RVLNWEE---------RLQI------------ALDISH-GIEYLHE- 232 (426)
Q Consensus 198 gsL~~----------------~l---~~~~---~~l~~~~---------~~~i------------~~~i~~-~l~~LH~- 232 (426)
.++.. .+ +... ....+.. .... ...+.. .+..+++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 88877 11 1110 1111100 0000 011222 2333332
Q ss_pred ---CCCCCeeecCCCCCCEEec-CCCcEEEeeecCcc
Q 014352 233 ---GAVPPVIHRDLKSANILLD-HFMRAKVADFGLSK 265 (426)
Q Consensus 233 ---~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfgl~~ 265 (426)
.....++|+|+.|.||+++ +++.+.|.||+.+.
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 2334599999999999999 66667899998765
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.14 E-value=4.1e-05 Score=82.34 Aligned_cols=78 Identities=18% Similarity=0.364 Sum_probs=56.3
Q ss_pred cccccCCCeeEEEEEeCCC---cEEEEEEeccCC-ccChHHHHHHHHHHhcCC-CCce--eeEEeEEEeC---CeEEEEE
Q 014352 123 NILGQGAFGPVYKATMPSG---GVAAIKVLASDS-HQGEKEFQTEVSLLGRLH-HRNL--VNLIGYCVDK---GKYMLIY 192 (426)
Q Consensus 123 ~~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~ni--v~~~~~~~~~---~~~~lv~ 192 (426)
+.++.|.+..+|+....++ ..+++|+..... ......+.+|.++|+.+. |+++ .+++.+|.+. +..++||
T Consensus 44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVM 123 (822)
T PLN02876 44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIM 123 (822)
T ss_pred EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEE
Confidence 4688999999999887553 356667654322 223457889999999995 6665 7888887764 4578999
Q ss_pred EecCCCCh
Q 014352 193 EFMSNGSL 200 (426)
Q Consensus 193 e~~~~gsL 200 (426)
||++|..+
T Consensus 124 E~v~G~~~ 131 (822)
T PLN02876 124 EYLEGRIF 131 (822)
T ss_pred EecCCccc
Confidence 99988643
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.13 E-value=1e-05 Score=85.61 Aligned_cols=197 Identities=19% Similarity=0.173 Sum_probs=137.4
Q ss_pred HHHHHHHhcCCCCceeeEEeEEEeCCeE----EEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCC
Q 014352 161 QTEVSLLGRLHHRNLVNLIGYCVDKGKY----MLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVP 236 (426)
Q Consensus 161 ~~e~~~l~~l~h~niv~~~~~~~~~~~~----~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ 236 (426)
.-|...+.++.|+|+++++.|-...... .+..+++..-++...+..- ..++..+.+.+..+..+||.|+|+..
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v-~~i~~~~~r~~~~~~~~GL~~~h~~~-- 306 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV-GSIPLETLRILHQKLLEGLAYLHSLS-- 306 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc-cccCHHHHHHHHHHHhhhHHHHHHhc--
Confidence 4467778888999999999987765332 2345778888888877443 45788888889999999999999986
Q ss_pred CeeecCCCCC---CEEecCCCcEEEe--eecCccccccCCCcccCccccCccCccccccCCCCc--chhhHHHHHHHHHH
Q 014352 237 PVIHRDLKSA---NILLDHFMRAKVA--DFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTM--KSDIFSFGVIIFEL 309 (426)
Q Consensus 237 ~ivH~dlk~~---Nill~~~~~~kl~--Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~Dv~S~Gvvl~el 309 (426)
..|.-+..+ +.-.+..+.+.++ ||+.+..............+..|.+||......++. ..|+|.+|..+..+
T Consensus 307 -l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~ 385 (1351)
T KOG1035|consen 307 -LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQL 385 (1351)
T ss_pred -cceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhh
Confidence 666655555 5555666777777 888877554444444444566778888887666554 47999999999999
Q ss_pred HhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 014352 310 ITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLK 380 (426)
Q Consensus 310 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 380 (426)
..|..+-..... ...+++... . ..+.+....|+..++++|++..+++.+.-.
T Consensus 386 ~~~~~i~~~~~~-----------~~~~l~~~~----~----~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~ 437 (1351)
T KOG1035|consen 386 SQGEDISEKSAV-----------PVSLLDVLS----T----SELLDALPKCLDEDSEERLSALELLTHPFL 437 (1351)
T ss_pred hhcCcccccccc-----------hhhhhcccc----c----hhhhhhhhhhcchhhhhccchhhhhhchhc
Confidence 987665321100 011111110 0 146677789999999999999999987643
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.10 E-value=1.7e-05 Score=69.24 Aligned_cols=101 Identities=26% Similarity=0.323 Sum_probs=80.5
Q ss_pred HHHHHHHhcCCC-CceeeEEeEEEeCCeEEEEEEecCCCChhHHhh--hccCCCCHHHHHHHHHHHHHHHHHHHcCCCCC
Q 014352 161 QTEVSLLGRLHH-RNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIY--SEERVLNWEERLQIALDISHGIEYLHEGAVPP 237 (426)
Q Consensus 161 ~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ 237 (426)
..|.-+++.+.+ +++.+++|+|-. +++.||.+.+++...-. ..-...+|..+.+|+.++++.+.+|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 357788888876 699999999943 67999998776643200 01123689999999999999999999865555
Q ss_pred eeecCCCCCCEEecCCCcEEEeeecCcc
Q 014352 238 VIHRDLKSANILLDHFMRAKVADFGLSK 265 (426)
Q Consensus 238 ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 265 (426)
+.-.|++++|+.+++++.+|+.|.....
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~ 110 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVF 110 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcc
Confidence 8889999999999999999999998654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.08 E-value=9.8e-05 Score=69.61 Aligned_cols=75 Identities=15% Similarity=0.140 Sum_probs=55.4
Q ss_pred cccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCCC---CceeeEEeEEEe---CCeEEEEEEecC
Q 014352 123 NILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHH---RNLVNLIGYCVD---KGKYMLIYEFMS 196 (426)
Q Consensus 123 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~~~~~~~~---~~~~~lv~e~~~ 196 (426)
+.||.|..+.||+....++. +++|..+.. .....|..|...|+.|.- -.+.++++++.. .+..++|||+++
T Consensus 20 ~~i~~G~~~~vy~~~~~~~~-~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~ 96 (297)
T PRK10593 20 ECISEQPYAALWALYDSQGN-PMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLR 96 (297)
T ss_pred eecCCccceeEEEEEcCCCC-EEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccC
Confidence 46999999999999865564 566774331 133578899999988853 357788887754 356899999999
Q ss_pred CCCh
Q 014352 197 NGSL 200 (426)
Q Consensus 197 ~gsL 200 (426)
++++
T Consensus 97 G~~~ 100 (297)
T PRK10593 97 GVSV 100 (297)
T ss_pred CEec
Confidence 8765
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.06 E-value=4.5e-05 Score=64.43 Aligned_cols=128 Identities=18% Similarity=0.225 Sum_probs=87.1
Q ss_pred hhcccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCCCCh
Q 014352 121 FTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSL 200 (426)
Q Consensus 121 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 200 (426)
....||+|++|.||+|.+.++ .+|+|+-+.++ ....+..|+++|..+.-.++.+=+-.+.. -.+.|||+.|-+|
T Consensus 26 v~~~L~KG~~s~Vyl~~~~~~-~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg~---~~i~me~i~G~~L 99 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWRGG-EVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYGE---DFIRMEYIDGRPL 99 (201)
T ss_pred hhhhhhcccccEEEEeeccCc-eEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEech---hhhhhhhhcCcch
Confidence 345799999999999999544 67888766543 45689999999999987777643322222 2455999998888
Q ss_pred hHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCC-CCCEEecCCCcEEEeeecCcc
Q 014352 201 SNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLK-SANILLDHFMRAKVADFGLSK 265 (426)
Q Consensus 201 ~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk-~~Nill~~~~~~kl~Dfgl~~ 265 (426)
...-... +..+ ...+++.---|...+ |-|+.|. |...++..++.+.|+||.-|+
T Consensus 100 ~~~~~~~----~rk~----l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At 154 (201)
T COG2112 100 GKLEIGG----DRKH----LLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSAT 154 (201)
T ss_pred hhhhhcc----cHHH----HHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchh
Confidence 7765321 2222 234445544455556 8999887 444444444599999999876
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.99 E-value=5.6e-05 Score=68.78 Aligned_cols=73 Identities=10% Similarity=0.153 Sum_probs=44.5
Q ss_pred cccccCCCe-eEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCCCC---ceeeEEeEEEeC---CeEEEEEEec
Q 014352 123 NILGQGAFG-PVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHR---NLVNLIGYCVDK---GKYMLIYEFM 195 (426)
Q Consensus 123 ~~lg~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~~~---~~~~lv~e~~ 195 (426)
+.|+.|+.. .||+. + ..+++|..... .....+..|.+++..+... .+..+++..... ...+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~---~-~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL---G-DDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc---C-CceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 357777776 48875 2 23567764432 2345788999999877531 233444433322 2347899999
Q ss_pred CCCChh
Q 014352 196 SNGSLS 201 (426)
Q Consensus 196 ~~gsL~ 201 (426)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 987764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.96 E-value=0.00025 Score=62.34 Aligned_cols=131 Identities=19% Similarity=0.282 Sum_probs=89.2
Q ss_pred cccccCCCeeEEEEEeCCCcEEEEEEeccCC----------------ccChHHHHHHHHHHhcCC------CCceeeEEe
Q 014352 123 NILGQGAFGPVYKATMPSGGVAAIKVLASDS----------------HQGEKEFQTEVSLLGRLH------HRNLVNLIG 180 (426)
Q Consensus 123 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~e~~~l~~l~------h~niv~~~~ 180 (426)
..||+|+.-.||.-- ++....||+..... ....++..+|+.-...+. +.+|.+++|
T Consensus 7 ~~i~~G~~R~cy~HP--~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 7 DLIAQGGERDCYQHP--DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred cccccCCCceEEECC--CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 479999999999654 34445688876654 122345666666555554 889999999
Q ss_pred EEEeCCeEEEEEEecCC------CChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCC
Q 014352 181 YCVDKGKYMLIYEFMSN------GSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFM 254 (426)
Q Consensus 181 ~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~ 254 (426)
+..++.-..+|+|.+.+ -+|.+++... .++. ... ..+-+-..||-+.+ |+.+|++|.||++..+.
T Consensus 85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~--~~~~-~~~---~~L~~f~~~l~~~~---Iv~~dl~~~NIv~~~~~ 155 (199)
T PF10707_consen 85 FVETNLGLGLVVELIRDADGNISPTLEDYLKEG--GLTE-ELR---QALDEFKRYLLDHH---IVIRDLNPHNIVVQRRD 155 (199)
T ss_pred EEecCCceEEEEEEEECCCCCcCccHHHHHHcC--CccH-HHH---HHHHHHHHHHHHcC---CeecCCCcccEEEEecC
Confidence 99999888999997643 3577777333 2444 333 33334456677777 99999999999996432
Q ss_pred ----cEEEee-ecCc
Q 014352 255 ----RAKVAD-FGLS 264 (426)
Q Consensus 255 ----~~kl~D-fgl~ 264 (426)
.+.|.| ||-.
T Consensus 156 ~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 156 SGEFRLVLIDGLGEK 170 (199)
T ss_pred CCceEEEEEeCCCCc
Confidence 466776 5543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.94 E-value=0.00012 Score=63.76 Aligned_cols=125 Identities=25% Similarity=0.420 Sum_probs=88.5
Q ss_pred HHhhhhcccccCCC-eeEEEEEeCCCcEEEEEEecc---CC--------c----------cChHHHHHHHHHHhcCC---
Q 014352 117 ATQNFTNILGQGAF-GPVYKATMPSGGVAAIKVLAS---DS--------H----------QGEKEFQTEVSLLGRLH--- 171 (426)
Q Consensus 117 ~~~~~~~~lg~G~~-g~Vy~~~~~~~~~vavK~~~~---~~--------~----------~~~~~~~~e~~~l~~l~--- 171 (426)
...++.+.||.|.- |.||+.+. +|..+|+|.++. .. . .-...|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 55677889999999 99999998 667999999321 10 0 01135888999888774
Q ss_pred CCce--eeEEeEEEeC------------------CeEEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHH
Q 014352 172 HRNL--VNLIGYCVDK------------------GKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLH 231 (426)
Q Consensus 172 h~ni--v~~~~~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH 231 (426)
+.++ |+.+||..-. ....||.||.+... .+.. .-+.++.+-|..+|
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~----~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQI----RDIPQMLRDLKILH 181 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccch----hHHHHHHHHHHHHH
Confidence 5566 8999987432 12356777776543 1222 23446667788999
Q ss_pred cCCCCCeeecCCCCCCEEecCCCcEEEeeecCc
Q 014352 232 EGAVPPVIHRDLKSANILLDHFMRAKVADFGLS 264 (426)
Q Consensus 232 ~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 264 (426)
..+ |+-+|+++.|.. .-+|+|||.+
T Consensus 182 k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HCC---eeeccCcccccc-----CCEEEecccC
Confidence 988 999999999986 3479999864
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.0001 Score=68.00 Aligned_cols=136 Identities=15% Similarity=0.112 Sum_probs=77.6
Q ss_pred ccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCcee-eEEeEEEeCCeEEEEEEecCCCChhH
Q 014352 124 ILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLV-NLIGYCVDKGKYMLIYEFMSNGSLSN 202 (426)
Q Consensus 124 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~gsL~~ 202 (426)
.+..|-.+.+|+... ++..+++|........-.-+..+|..+++.+...+++ +++... . -++|+||++|..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCccccc
Confidence 356677889999874 5566778875433221112457788898888644333 334332 2 368999999876542
Q ss_pred H-----------------hhhcc---CCCCHHHH-HHHHHH---------HHHHHHHHHcC-----CCCCeeecCCCCCC
Q 014352 203 L-----------------IYSEE---RVLNWEER-LQIALD---------ISHGIEYLHEG-----AVPPVIHRDLKSAN 247 (426)
Q Consensus 203 ~-----------------l~~~~---~~l~~~~~-~~i~~~---------i~~~l~~LH~~-----~~~~ivH~dlk~~N 247 (426)
. |+... .+++.... .....+ +...+..+-.. ..+.++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 11111 11222211 111111 11112222211 12348999999999
Q ss_pred EEecCCCcEEEeeecCcc
Q 014352 248 ILLDHFMRAKVADFGLSK 265 (426)
Q Consensus 248 ill~~~~~~kl~Dfgl~~ 265 (426)
|++++++ +.++||..+.
T Consensus 158 il~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred EEEeCCC-CEEEeccccC
Confidence 9999877 7899999775
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00023 Score=64.67 Aligned_cols=72 Identities=18% Similarity=0.236 Sum_probs=46.6
Q ss_pred ccccCCCeeEEEEEeCC--CcEEEEEEeccCCccChHHHHHHHHHHhcCCCCcee-eEEeEEEeCCeEEEEEEecCCCCh
Q 014352 124 ILGQGAFGPVYKATMPS--GGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLV-NLIGYCVDKGKYMLIYEFMSNGSL 200 (426)
Q Consensus 124 ~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~gsL 200 (426)
.|..|-...+|+....+ +..+++|+...... ..-+...|+.++..+...+++ ++++.+. + .++|||++|.++
T Consensus 5 ~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~G~~l 79 (235)
T cd05157 5 RFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIPGRTL 79 (235)
T ss_pred EcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeCCCcC
Confidence 57778888999998654 56788887654321 112335788888888543443 4444332 2 479999998766
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.0012 Score=64.38 Aligned_cols=75 Identities=15% Similarity=0.152 Sum_probs=52.4
Q ss_pred cccccCCCeeEEEEEeCCC-cEEEEEEeccCC-------ccChHHHHHHHHHHhcCC---CCceeeEEeEEEeCCeEEEE
Q 014352 123 NILGQGAFGPVYKATMPSG-GVAAIKVLASDS-------HQGEKEFQTEVSLLGRLH---HRNLVNLIGYCVDKGKYMLI 191 (426)
Q Consensus 123 ~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~-------~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv 191 (426)
+.||.|.+..||+....+| +.++||.-.... ....+.+..|.+.|..+. -.++.+++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 3699999999999998766 478899854221 123345677888887763 2456667766 34557899
Q ss_pred EEecCCCC
Q 014352 192 YEFMSNGS 199 (426)
Q Consensus 192 ~e~~~~gs 199 (426)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998643
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.00083 Score=63.53 Aligned_cols=137 Identities=25% Similarity=0.317 Sum_probs=80.5
Q ss_pred ccccCCCeeEEEEEeCC-------CcEEEEEEeccCCccChHHHHHHHHHHhcCCCCcee-eEEeEEEeCCeEEEEEEec
Q 014352 124 ILGQGAFGPVYKATMPS-------GGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLV-NLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 124 ~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~ 195 (426)
.+..|-...+|+....+ +..+++|+..... ....+...|.+++..+...++. ++++++. + .+|+||+
T Consensus 5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~i 79 (302)
T cd05156 5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEFI 79 (302)
T ss_pred EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhhee
Confidence 45666667899888654 4678889865533 2223557788888887543333 4455443 2 3589999
Q ss_pred CCCChhHH-h----------------hhccCC--------CC--HHHHHH--------------------------HHHH
Q 014352 196 SNGSLSNL-I----------------YSEERV--------LN--WEERLQ--------------------------IALD 222 (426)
Q Consensus 196 ~~gsL~~~-l----------------~~~~~~--------l~--~~~~~~--------------------------i~~~ 222 (426)
+|.++... + +..... .+ +..+.. +...
T Consensus 80 ~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (302)
T cd05156 80 PSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLED 159 (302)
T ss_pred CCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHH
Confidence 88776431 0 111100 00 101100 0112
Q ss_pred HHHHHHHHHc------CCCCCeeecCCCCCCEEecCC----CcEEEeeecCcc
Q 014352 223 ISHGIEYLHE------GAVPPVIHRDLKSANILLDHF----MRAKVADFGLSK 265 (426)
Q Consensus 223 i~~~l~~LH~------~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfgl~~ 265 (426)
+..-+.+|-. .....++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 160 ~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 160 EAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 2222334432 123458999999999999985 889999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.0018 Score=60.96 Aligned_cols=138 Identities=22% Similarity=0.219 Sum_probs=83.0
Q ss_pred ccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCc--eeeEEeE------EEeCCeEEEEEEec
Q 014352 124 ILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRN--LVNLIGY------CVDKGKYMLIYEFM 195 (426)
Q Consensus 124 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~------~~~~~~~~lv~e~~ 195 (426)
.+..|....+|+....++ .+++|+... ........|++++..+.+.+ +.+++.. ....+..+++++|+
T Consensus 21 ~i~~G~~n~~y~v~~~~~-~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i 96 (296)
T cd05153 21 GISAGIENTNYFVTTDSG-RYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFL 96 (296)
T ss_pred cccCccccceEEEEeCCC-cEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeC
Confidence 577787789999876444 577888754 23445667888877774322 4444432 12345678999999
Q ss_pred CCCChhH----Hh----------hhcc----------CCCCHHHHH----------HHHHHHHHHHHHHHcC----CCCC
Q 014352 196 SNGSLSN----LI----------YSEE----------RVLNWEERL----------QIALDISHGIEYLHEG----AVPP 237 (426)
Q Consensus 196 ~~gsL~~----~l----------~~~~----------~~l~~~~~~----------~i~~~i~~~l~~LH~~----~~~~ 237 (426)
+|..+.. .. +... ....|.... .....+..++.++... ....
T Consensus 97 ~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~ 176 (296)
T cd05153 97 AGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRG 176 (296)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCc
Confidence 9876532 11 1100 011222111 0111233444555431 1234
Q ss_pred eeecCCCCCCEEecCCCcEEEeeecCcc
Q 014352 238 VIHRDLKSANILLDHFMRAKVADFGLSK 265 (426)
Q Consensus 238 ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 265 (426)
++|+|+.|.||++++++.+.|.||+.+.
T Consensus 177 l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 177 VIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CCccCcCcccEEEeCCceEEEeehhhhc
Confidence 9999999999999998778999998765
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.0066 Score=57.85 Aligned_cols=138 Identities=17% Similarity=0.221 Sum_probs=75.2
Q ss_pred ccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCCCC--ceeeEEe------EEEeCCeEEEEEEec
Q 014352 124 ILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHR--NLVNLIG------YCVDKGKYMLIYEFM 195 (426)
Q Consensus 124 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~------~~~~~~~~~lv~e~~ 195 (426)
.++.|....+|+....+| .+++|+... .....+..|..++..|... .+.+.+. +....+..+++++|+
T Consensus 29 ~l~~G~~n~~y~v~t~~g-~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~l 104 (319)
T PRK05231 29 GIAEGIENSNFFLTTTQG-EYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTFL 104 (319)
T ss_pred hhccccccceEEEEeCCC-cEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEec
Confidence 466777789999886555 577887652 2233444455555555211 1233332 112245678999999
Q ss_pred CCCChhH-----------Hh---hhcc----------CCCCH-HHHHH------------HH-HHHHHHHHHHHcC----
Q 014352 196 SNGSLSN-----------LI---YSEE----------RVLNW-EERLQ------------IA-LDISHGIEYLHEG---- 233 (426)
Q Consensus 196 ~~gsL~~-----------~l---~~~~----------~~l~~-~~~~~------------i~-~~i~~~l~~LH~~---- 233 (426)
+|..+.. .| +... ..+.| ..... .. ..+...+..+.+.
T Consensus 105 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 184 (319)
T PRK05231 105 EGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWPA 184 (319)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccccc
Confidence 8865421 11 1100 01112 11111 11 1111222333211
Q ss_pred CCCCeeecCCCCCCEEecCCCcEEEeeecCcc
Q 014352 234 AVPPVIHRDLKSANILLDHFMRAKVADFGLSK 265 (426)
Q Consensus 234 ~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 265 (426)
-..+++|+|+.|.||+++.+...-|+||+.+.
T Consensus 185 lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 185 LPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred CCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 22359999999999999976666899999775
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.0026 Score=59.86 Aligned_cols=127 Identities=15% Similarity=0.255 Sum_probs=76.1
Q ss_pred eEEEEEeCCCcEEEEEEecc--CCccChHHHHHHHHHHhcCCC--CceeeEEeEEEeCC--eEEEEEEecCCCChhHHhh
Q 014352 132 PVYKATMPSGGVAAIKVLAS--DSHQGEKEFQTEVSLLGRLHH--RNLVNLIGYCVDKG--KYMLIYEFMSNGSLSNLIY 205 (426)
Q Consensus 132 ~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~--~~~lv~e~~~~gsL~~~l~ 205 (426)
.+|.... +++..+++ ... ..........+|..+++.+.- --+...+++|.++. ..+.||+|++|..+.+.+.
T Consensus 40 ~t~~~~~-~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~ 117 (321)
T COG3173 40 DTFRLGD-TGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALP 117 (321)
T ss_pred ceEEEec-CCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCC
Confidence 3344433 36677777 321 122234556778888887743 23456677777765 6799999998843332221
Q ss_pred hccCCCCHHHHHHHH-HHHHHHHH--------------------------------------------------HHHcC-
Q 014352 206 SEERVLNWEERLQIA-LDISHGIE--------------------------------------------------YLHEG- 233 (426)
Q Consensus 206 ~~~~~l~~~~~~~i~-~~i~~~l~--------------------------------------------------~LH~~- 233 (426)
... .. -+++ ..++..|. +|+.+
T Consensus 118 ~~~----~~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~ 191 (321)
T COG3173 118 PES----LG--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANR 191 (321)
T ss_pred ccc----ch--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcC
Confidence 100 00 0111 13333333 33332
Q ss_pred ----CCCCeeecCCCCCCEEecCCCcEEEeeecCccc
Q 014352 234 ----AVPPVIHRDLKSANILLDHFMRAKVADFGLSKE 266 (426)
Q Consensus 234 ----~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 266 (426)
+.+.++|+|+.+.|++++.++.+-|.||+++..
T Consensus 192 p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 192 PPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred CCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 235699999999999999998899999999864
|
|
| >PF08693 SKG6: Transmembrane alpha-helix domain; InterPro: IPR014805 SKG6 and AXL2 are membrane proteins that show polarised intracellular localisation [, ] | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.00025 Score=43.76 Aligned_cols=34 Identities=29% Similarity=0.583 Sum_probs=22.6
Q ss_pred CCCCeEEEEeehHHHHHHHHHHHHHHHhhhhhcc
Q 014352 3 HKSDLVIIGICVGLALGILIATLVFFGLRWYKKH 36 (426)
Q Consensus 3 ~~~~~~ii~i~~g~~~~~~~~~~~~~~~~~~r~~ 36 (426)
+.+..+.|++++++-++++++++.+++++||||+
T Consensus 6 ~~~~~vaIa~~VvVPV~vI~~vl~~~l~~~~rR~ 39 (40)
T PF08693_consen 6 SNSNTVAIAVGVVVPVGVIIIVLGAFLFFWYRRK 39 (40)
T ss_pred CCCceEEEEEEEEechHHHHHHHHHHhheEEecc
Confidence 3566667777777777777766666666666654
|
This entry represents the highly conserved transmembrane alpha-helical domain found in these proteins [, ]. The full-length AXL2 protein has a negative regulatory function in cytokinesis []. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.0072 Score=57.28 Aligned_cols=139 Identities=19% Similarity=0.220 Sum_probs=79.8
Q ss_pred ccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCCCC--ceeeEEeEE------EeCCeEEEEEEec
Q 014352 124 ILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHR--NLVNLIGYC------VDKGKYMLIYEFM 195 (426)
Q Consensus 124 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~~~------~~~~~~~lv~e~~ 195 (426)
.++.|....+|+....++ .+++|...... .......|.+++..|... .+.+++... ...+..+++++|+
T Consensus 29 ~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~i 105 (307)
T TIGR00938 29 GIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEFL 105 (307)
T ss_pred ccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEeC
Confidence 567777789999876555 46678764421 234555677777666322 234444321 1235678999999
Q ss_pred CCCChhH----H----------hhhccCC-----------CCHHHHH------------HHHHHHHHHHHHHHc----CC
Q 014352 196 SNGSLSN----L----------IYSEERV-----------LNWEERL------------QIALDISHGIEYLHE----GA 234 (426)
Q Consensus 196 ~~gsL~~----~----------l~~~~~~-----------l~~~~~~------------~i~~~i~~~l~~LH~----~~ 234 (426)
+|.++.. . ++..... -.|.... .....+...++++.. ..
T Consensus 106 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~~ 185 (307)
T TIGR00938 106 QGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRDL 185 (307)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 8855421 1 1110000 1111110 001123334555543 12
Q ss_pred CCCeeecCCCCCCEEecCCCcEEEeeecCcc
Q 014352 235 VPPVIHRDLKSANILLDHFMRAKVADFGLSK 265 (426)
Q Consensus 235 ~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 265 (426)
...++|+|+.+.||+++.++...|.||+.+.
T Consensus 186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 2459999999999999998877899999764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.003 Score=58.98 Aligned_cols=136 Identities=22% Similarity=0.307 Sum_probs=71.6
Q ss_pred cccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCC---CCceeeEEeEEEeCCeEEEEEEecCCCC
Q 014352 123 NILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLH---HRNLVNLIGYCVDKGKYMLIYEFMSNGS 199 (426)
Q Consensus 123 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~gs 199 (426)
+.++.|....+|+.. .+++.+.+|.-.. .....|..|.+-|+.|. --.+.+++++....+..+|++||++.+.
T Consensus 23 ~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~~ 98 (288)
T PF03881_consen 23 EPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMGS 98 (288)
T ss_dssp EEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE------
T ss_pred EecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCCC
Confidence 468889999999988 5677788898652 23456888888888873 4457788888877777799999997761
Q ss_pred h--------hH---Hhhh-cc-C-------------------CCCHHHHH-----HHHH--------------HHHHHHH
Q 014352 200 L--------SN---LIYS-EE-R-------------------VLNWEERL-----QIAL--------------DISHGIE 228 (426)
Q Consensus 200 L--------~~---~l~~-~~-~-------------------~l~~~~~~-----~i~~--------------~i~~~l~ 228 (426)
. -. .|+. .. . .-+|.+.. .... .+.+.+.
T Consensus 99 ~~~~~~~~lg~~LA~LH~~~~~~~FGf~~~~~~G~~~q~N~w~~~W~~Ff~~~RL~~~l~~~~~~~~~~~~~~~l~~~~~ 178 (288)
T PF03881_consen 99 PSPPDWEELGRQLAALHQWSPAGKFGFPVDTYIGSLPQPNTWTDSWEEFFAEQRLRPQLELAREKGGLDAELERLVERLP 178 (288)
T ss_dssp --CCHHHHHHHHHHHHHH-T--SSBB-SS-EEETTEEE----BS-HHHHHHHHCCHHHHHHHHHCTSS-CHHHHHHHHHH
T ss_pred CCchhHHHHHHHHHHHhhhcCCCCcCCCcCCcccCcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCchhHHHHHHHHHH
Confidence 1 11 1222 10 0 12332211 1111 1111111
Q ss_pred -HHHcC-CCCCeeecCCCCCCEEecCCCcEEEeeec
Q 014352 229 -YLHEG-AVPPVIHRDLKSANILLDHFMRAKVADFG 262 (426)
Q Consensus 229 -~LH~~-~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 262 (426)
.|+.. -.|.++||||.+.|++.+.+|.+.|.|-.
T Consensus 179 ~~l~~~~~~PsLlHGDLW~GN~~~~~~g~p~l~DPa 214 (288)
T PF03881_consen 179 SLLPGREPKPSLLHGDLWSGNVGFDADGEPVLFDPA 214 (288)
T ss_dssp HCCTTS----EEE-SS-SGGGEEEETTE-EEE-S--
T ss_pred HHhcCCCCCceeeEcCccccceeecCCCCceeeccc
Confidence 12221 24679999999999999999989999854
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.00055 Score=63.52 Aligned_cols=132 Identities=17% Similarity=0.173 Sum_probs=90.3
Q ss_pred hhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCC-----------------cc-----ChHHHHHHHHHHhcCC-CC-c
Q 014352 119 QNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDS-----------------HQ-----GEKEFQTEVSLLGRLH-HR-N 174 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-----------------~~-----~~~~~~~e~~~l~~l~-h~-n 174 (426)
+.+++.||-|.=+.||.+...+|.+.++|.-+... .. ++-....|...|+.|. |. -
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 45678999999999999999889888888532110 00 0112456888888774 22 2
Q ss_pred eeeEEeEEEeCCeEEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCC
Q 014352 175 LVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFM 254 (426)
Q Consensus 175 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~ 254 (426)
+.+.+++ +..++|||++.+-.|...-+.. +.+++ ...+..-+.-|..+| +||+|..-=||++++++
T Consensus 174 VPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~----d~~~l---y~~lm~~Iv~la~~G---lIHgDFNEFNimv~dd~ 239 (465)
T KOG2268|consen 174 VPKPIDH----NRHCVVMELVDGYPLRQVRHVE----DPPTL---YDDLMGLIVRLANHG---LIHGDFNEFNIMVKDDD 239 (465)
T ss_pred CCCcccc----cceeeHHHhhcccceeeeeecC----ChHHH---HHHHHHHHHHHHHcC---ceecccchheeEEecCC
Confidence 3444444 4578999999998887654222 22222 223333344556667 99999999999999999
Q ss_pred cEEEeeecCc
Q 014352 255 RAKVADFGLS 264 (426)
Q Consensus 255 ~~kl~Dfgl~ 264 (426)
.++++||--.
T Consensus 240 ~i~vIDFPQm 249 (465)
T KOG2268|consen 240 KIVVIDFPQM 249 (465)
T ss_pred CEEEeechHh
Confidence 9999999743
|
|
| >PF01102 Glycophorin_A: Glycophorin A; InterPro: IPR001195 Proteins in this group are responsible for the molecular basis of the blood group antigens, surface markers on the outside of the red blood cell membrane | Back alignment and domain information |
|---|
Probab=97.04 E-value=0.00021 Score=56.70 Aligned_cols=34 Identities=24% Similarity=0.243 Sum_probs=23.7
Q ss_pred CCCCeEEEEeehHHHHHHHHHHHHHHHhhhhhcc
Q 014352 3 HKSDLVIIGICVGLALGILIATLVFFGLRWYKKH 36 (426)
Q Consensus 3 ~~~~~~ii~i~~g~~~~~~~~~~~~~~~~~~r~~ 36 (426)
+.+.++|++|++|+++|+++++++++++++|+||
T Consensus 60 ~fs~~~i~~Ii~gv~aGvIg~Illi~y~irR~~K 93 (122)
T PF01102_consen 60 RFSEPAIIGIIFGVMAGVIGIILLISYCIRRLRK 93 (122)
T ss_dssp SSS-TCHHHHHHHHHHHHHHHHHHHHHHHHHHS-
T ss_pred CccccceeehhHHHHHHHHHHHHHHHHHHHHHhc
Confidence 4678889999999999988777655555444443
|
Most of these markers are proteins, but some are carbohydrates attached to lipids or proteins [Reid M.E., Lomas-Francis C. The Blood Group Antigen FactsBook Academic Press, London / San Diego, (1997)]. Glycophorin A (PAS-2) and glycophorin B (PAS-3) belong to the MNS blood group system and are associated with antigens that include M/N, S/s, U, He, Mi(a), M(c), Vw, Mur, M(g), Vr, M(e), Mt(a), St(a), Ri(a), Cl(a), Ny(a), Hut, Hil, M(v), Far, Mit, Dantu, Hop, Nob, En(a), ENKT, amongst others. Glycophorin A is the major sialoglycoprotein of the erythrocyte membrane []. Structurally, glycophorin A consists of an N-terminal extracellular domain, heavily glycosylated on serine and threonine residues, followed by a transmembrane region and a C-terminal cytoplasmic domain. Other glycophorins in this entry such as Glycophorin B and Glycophorin E represent minor sialoglycoproteins in the erythrocyte membrane.; GO: 0016021 integral to membrane; PDB: 2KPF_B 1AFO_B 2KPE_A. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.0052 Score=58.17 Aligned_cols=138 Identities=20% Similarity=0.254 Sum_probs=94.2
Q ss_pred hcccccCCCeeEEEEEeCCCcEEEEEEeccCC----------------------ccChH----HHHHHHHHHhcCCCCce
Q 014352 122 TNILGQGAFGPVYKATMPSGGVAAIKVLASDS----------------------HQGEK----EFQTEVSLLGRLHHRNL 175 (426)
Q Consensus 122 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------------~~~~~----~~~~e~~~l~~l~h~ni 175 (426)
...|..|-=+.||.+.-.+|..+|||+.+... ...++ -...|++.|.+++...|
T Consensus 149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI 228 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI 228 (520)
T ss_pred ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence 34678898999999999899999999875321 00111 13457888888865554
Q ss_pred eeEEeEEEeCCeEEEEEEecCCCChh-HHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCC
Q 014352 176 VNLIGYCVDKGKYMLIYEFMSNGSLS-NLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFM 254 (426)
Q Consensus 176 v~~~~~~~~~~~~~lv~e~~~~gsL~-~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~ 254 (426)
...--+... ..+|||+|+....-. -.| ....++...+..+-.+++.-|.-|.... .+||.||.-=|+|+-+ |
T Consensus 229 P~PePIlLk--~hVLVM~FlGrdgw~aPkL--Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyhd-G 301 (520)
T KOG2270|consen 229 PCPEPILLK--NHVLVMEFLGRDGWAAPKL--KDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYHD-G 301 (520)
T ss_pred CCCCceeee--cceEeeeeccCCCCcCccc--ccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEEC-C
Confidence 322111111 347999999532211 122 2344676777778888888888887765 3999999999999876 8
Q ss_pred cEEEeeecCccc
Q 014352 255 RAKVADFGLSKE 266 (426)
Q Consensus 255 ~~kl~Dfgl~~~ 266 (426)
.+.|+|-+-+-.
T Consensus 302 ~lyiIDVSQSVE 313 (520)
T KOG2270|consen 302 KLYIIDVSQSVE 313 (520)
T ss_pred EEEEEEcccccc
Confidence 899999887653
|
|
| >PF02439 Adeno_E3_CR2: Adenovirus E3 region protein CR2; InterPro: IPR003470 Early region 3 (E3) of human adenoviruses (Ads) codes for proteins that appear to control viral interactions with the host [] | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.00085 Score=40.55 Aligned_cols=28 Identities=25% Similarity=0.362 Sum_probs=20.4
Q ss_pred EEEEeehHHHHHHHHHHHHHHHhhhhhc
Q 014352 8 VIIGICVGLALGILIATLVFFGLRWYKK 35 (426)
Q Consensus 8 ~ii~i~~g~~~~~~~~~~~~~~~~~~r~ 35 (426)
..++|++|+++++++++++++++.+++|
T Consensus 4 s~IaIIv~V~vg~~iiii~~~~YaCcyk 31 (38)
T PF02439_consen 4 STIAIIVAVVVGMAIIIICMFYYACCYK 31 (38)
T ss_pred chhhHHHHHHHHHHHHHHHHHHHHHHHc
Confidence 4578999999988888877766444333
|
This region called CR1 (conserved region 1) [] is found three times in Human adenovirus 19 (a subgroup D adenovirus) 49 kDa protein in the E3 region. CR1 is also found in the 20.1 Kd protein of subgroup B adenoviruses. The function of this 80 amino acid region is unknown. This region is probably a divergent immunoglobulin domain. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.0028 Score=62.36 Aligned_cols=180 Identities=24% Similarity=0.325 Sum_probs=97.2
Q ss_pred EEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeC-CeEEEEEEecCCCChhHHhhhccCCC
Q 014352 133 VYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDK-GKYMLIYEFMSNGSLSNLIYSEERVL 211 (426)
Q Consensus 133 Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~l 211 (426)
.+.|....|.+. ..-+.. .....++.-...+++.+.|+|+..++.+.... ....+|+|++ +.||.+.+.... +
T Consensus 5 ~~~a~~~~~~~c-~nglpl--t~~s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~--l 78 (725)
T KOG1093|consen 5 TFFAQEKPGDVC-SNGLPL--TPNSIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN--L 78 (725)
T ss_pred EEehhcCCCccc-cCCCcC--CCcHHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc--c
Confidence 355555455443 222211 12344566778889999999999999987654 4578899999 669999885433 2
Q ss_pred CHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCcccCccccCccCccccccC
Q 014352 212 NWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTN 291 (426)
Q Consensus 212 ~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 291 (426)
.... ..+.+ +.|- +..+.+| .+... | |-
T Consensus 79 ~~~s------~~~~~-----------~~~~------------~~~~~td-~~~t~---------------~--~~----- 106 (725)
T KOG1093|consen 79 KDES------LLAHG-----------VLHL------------NIIYITD-HFLTK---------------Y--PS----- 106 (725)
T ss_pred chhh------hcccc-----------ccee------------hhhhccc-ccccc---------------C--CC-----
Confidence 1111 11111 2221 1123333 11100 0 10
Q ss_pred CCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhcc---c-cc-hhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCC
Q 014352 292 KFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMS---Q-DG-VDEILDKQLVGACNIQEVRELARIGHKCLHKTPR 366 (426)
Q Consensus 292 ~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~---~-~~-~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~ 366 (426)
+..+|+||||+|.++.|+.-|..-+.....-..+..+. . +. ........ ....+....+.++...|+-..|.
T Consensus 107 ~~~pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~---~~~~~~d~~~~~~~~~c~~~~~~ 183 (725)
T KOG1093|consen 107 PIGPKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYYTDDQELLSTAMEH---LIQLLADKKRLPLLKKCLWLEPI 183 (725)
T ss_pred CCCcchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHH---HHHHhhhHhHHHHhccCCccccc
Confidence 11249999999999999999877665433222111110 0 00 00000000 11122335678888999999998
Q ss_pred CCCCHHH
Q 014352 367 KRPSIGE 373 (426)
Q Consensus 367 ~RPs~~e 373 (426)
.||...+
T Consensus 184 ir~l~~~ 190 (725)
T KOG1093|consen 184 IRPLPME 190 (725)
T ss_pred cccchhH
Confidence 8875433
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.013 Score=56.58 Aligned_cols=137 Identities=18% Similarity=0.263 Sum_probs=77.7
Q ss_pred ccccCCCeeEEEEEeCC-----CcEEEEEEeccCCccChHHHHHHHHHHhcCCCCcee-eEEeEEEeCCeEEEEEEecCC
Q 014352 124 ILGQGAFGPVYKATMPS-----GGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLV-NLIGYCVDKGKYMLIYEFMSN 197 (426)
Q Consensus 124 ~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~ 197 (426)
.+-.|-.-.+|+....+ +..+++|+....... .-+..+|..++..+..-++. ++++++... .|++|+++
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~-~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g 117 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVEL-FFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA 117 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCe-eechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence 45457778899987532 357888877554321 11236788888888644443 455555332 58999987
Q ss_pred CChhHH-----------------hhhcc----C-CCCHHHHHHHHHHH-----------------HHHHHH----HHc-C
Q 014352 198 GSLSNL-----------------IYSEE----R-VLNWEERLQIALDI-----------------SHGIEY----LHE-G 233 (426)
Q Consensus 198 gsL~~~-----------------l~~~~----~-~l~~~~~~~i~~~i-----------------~~~l~~----LH~-~ 233 (426)
.+|... +|... . ...+.....+..++ ...+.. +.. .
T Consensus 118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~ 197 (344)
T PLN02236 118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD 197 (344)
T ss_pred CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence 776421 11111 0 11122222222111 111112 222 1
Q ss_pred CCCCeeecCCCCCCEEecC-CCcEEEeeecCcc
Q 014352 234 AVPPVIHRDLKSANILLDH-FMRAKVADFGLSK 265 (426)
Q Consensus 234 ~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgl~~ 265 (426)
....++|+|+++.||++++ ++.+.++||..+.
T Consensus 198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred CCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 1234899999999999986 4679999998775
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.028 Score=54.78 Aligned_cols=72 Identities=13% Similarity=0.131 Sum_probs=47.0
Q ss_pred cccccCCCeeEEEEEeCCCcEEEEEEeccCCc-------cChHHHHHHHHHHhcCC---CCceeeEEeEEEeCCeEEEEE
Q 014352 123 NILGQGAFGPVYKATMPSGGVAAIKVLASDSH-------QGEKEFQTEVSLLGRLH---HRNLVNLIGYCVDKGKYMLIY 192 (426)
Q Consensus 123 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~ 192 (426)
+.||.|....||+.... ++.++||.-..... -....-..|...|+.+. ..++.+++.++.+ ..+++|
T Consensus 38 ~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vlvM 114 (418)
T PLN02756 38 KEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALIGM 114 (418)
T ss_pred EEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEEEE
Confidence 36899999999998864 44578887642211 01222233466665553 3477788888774 467899
Q ss_pred EecCC
Q 014352 193 EFMSN 197 (426)
Q Consensus 193 e~~~~ 197 (426)
||+++
T Consensus 115 E~L~~ 119 (418)
T PLN02756 115 RYLEP 119 (418)
T ss_pred eecCC
Confidence 99976
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.00019 Score=78.28 Aligned_cols=158 Identities=13% Similarity=-0.065 Sum_probs=112.5
Q ss_pred HHHHHHHHhcCCCCceeeEEeEEEe--CCeEEEEEEecCCCChhHHhhhcc---CCCCHHHHHHHHHHHHHHHHHHHcC-
Q 014352 160 FQTEVSLLGRLHHRNLVNLIGYCVD--KGKYMLIYEFMSNGSLSNLIYSEE---RVLNWEERLQIALDISHGIEYLHEG- 233 (426)
Q Consensus 160 ~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~---~~l~~~~~~~i~~~i~~~l~~LH~~- 233 (426)
...|..-++.+.|+++.....-... ..+.+.+++|+.+|.+.+.|.+.. ..+........-.+...+..-+|+.
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 3445556667789988876654443 245688999999999999985532 2233222222222324444444443
Q ss_pred -CCCCeeecCCCCCCEEecCCCcEEEeeecCccccc-cCCCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh
Q 014352 234 -AVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEV-FDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT 311 (426)
Q Consensus 234 -~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t 311 (426)
+...-+|+++|+-|.++..+..+|+.++|+.+... .........+++.|+.|+....-.++.++|+|+.|+-+|+...
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~ 1435 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSD 1435 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhc
Confidence 22447999999999999999999999999998322 2223344567888999999988889999999999999999998
Q ss_pred CCCCCC
Q 014352 312 AIHPHQ 317 (426)
Q Consensus 312 g~~p~~ 317 (426)
|..+|-
T Consensus 1436 ~n~~fi 1441 (2724)
T KOG1826|consen 1436 GNAYFI 1441 (2724)
T ss_pred ccHHHH
Confidence 887764
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.70 E-value=0.017 Score=53.88 Aligned_cols=30 Identities=30% Similarity=0.492 Sum_probs=25.3
Q ss_pred CCeeecCCCCCCEEecCCCc-EEEeeecCcc
Q 014352 236 PPVIHRDLKSANILLDHFMR-AKVADFGLSK 265 (426)
Q Consensus 236 ~~ivH~dlk~~Nill~~~~~-~kl~Dfgl~~ 265 (426)
+.++|+|+.+.||+++.++. .-|.||+.+.
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~ 215 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAK 215 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence 45899999999999997555 5699999875
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.43 E-value=0.058 Score=51.75 Aligned_cols=72 Identities=18% Similarity=0.170 Sum_probs=45.3
Q ss_pred ccccCCCeeEEEEEeCCC-cEEEEEEeccCC-------ccChHHHHHHHHHHhcCC--CCc-eeeEEeEEEeCCeEEEEE
Q 014352 124 ILGQGAFGPVYKATMPSG-GVAAIKVLASDS-------HQGEKEFQTEVSLLGRLH--HRN-LVNLIGYCVDKGKYMLIY 192 (426)
Q Consensus 124 ~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~-------~~~~~~~~~e~~~l~~l~--h~n-iv~~~~~~~~~~~~~lv~ 192 (426)
.||.|....||++...++ +.++||.-.... ........-|...|+... -|. +.+++.+ +++...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 479999999999997654 478888753211 122233445667776553 343 4444443 445567999
Q ss_pred EecCC
Q 014352 193 EFMSN 197 (426)
Q Consensus 193 e~~~~ 197 (426)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99965
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.015 Score=54.99 Aligned_cols=101 Identities=21% Similarity=0.228 Sum_probs=69.0
Q ss_pred eEEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccc
Q 014352 187 KYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKE 266 (426)
Q Consensus 187 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 266 (426)
..|++|++. |++|... ..-.+.+.+.++.+.+..+.-+..+- +.-|||+.-.|||++ +|++.|+||-+++.
T Consensus 300 y~yl~~kdh-gt~is~i-----k~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 300 YLYLHFKDH-GTPISII-----KADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred EEEEEEecC-Cceeeee-----ecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeeeec
Confidence 456777765 5555332 23568899999999888887777653 589999999999999 89999999999984
Q ss_pred cccCCCcccCccccCccCccccccCCCCcchhhHH
Q 014352 267 EVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFS 301 (426)
Q Consensus 267 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S 301 (426)
..... .....+.--|-.+.|. -+.+-|||-
T Consensus 371 ~~~q~----~isy~rldhp~lF~G~-dd~QFeIYr 400 (488)
T COG5072 371 SYSQG----IISYNRLDHPDLFNGV-DDYQFEIYR 400 (488)
T ss_pred ccCCc----eeeccccCchhhhcCc-cceeeeHHH
Confidence 33221 1122233345445433 366667764
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.39 E-value=0.082 Score=50.05 Aligned_cols=29 Identities=31% Similarity=0.382 Sum_probs=25.1
Q ss_pred CCeeecCCCCCCEEecCCCcEEEeeecCcc
Q 014352 236 PPVIHRDLKSANILLDHFMRAKVADFGLSK 265 (426)
Q Consensus 236 ~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 265 (426)
.+++|+|+.+.||+++. +.+.|.||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 45899999999999998 678999998654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PTZ00382 Variant-specific surface protein (VSP); Provisional | Back alignment and domain information |
|---|
Probab=96.37 E-value=0.0021 Score=49.06 Aligned_cols=22 Identities=23% Similarity=0.042 Sum_probs=16.6
Q ss_pred CCCCeEEEEeehHHHHHHHHHH
Q 014352 3 HKSDLVIIGICVGLALGILIAT 24 (426)
Q Consensus 3 ~~~~~~ii~i~~g~~~~~~~~~ 24 (426)
.+|.++|+||++|+++++.+++
T Consensus 62 ~ls~gaiagi~vg~~~~v~~lv 83 (96)
T PTZ00382 62 GLSTGAIAGISVAVVAVVGGLV 83 (96)
T ss_pred CcccccEEEEEeehhhHHHHHH
Confidence 4678899999999886664443
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.29 E-value=0.04 Score=52.77 Aligned_cols=137 Identities=15% Similarity=0.217 Sum_probs=76.0
Q ss_pred ccccCCCeeEEEEEeCC----CcEEEEEEeccCCccChHHHHHHHHHHhcCCCCcee-eEEeEEEeCCeEEEEEEecCCC
Q 014352 124 ILGQGAFGPVYKATMPS----GGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLV-NLIGYCVDKGKYMLIYEFMSNG 198 (426)
Q Consensus 124 ~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~g 198 (426)
.|..|=...+|+....+ +..+++|+...... ..-+-.+|..+++.+..-++- ++++++. .+ +|.+|+++.
T Consensus 21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g~ 95 (330)
T PLN02421 21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINAR 95 (330)
T ss_pred EeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcCC
Confidence 45456667788887543 23678887754322 112335788888888655553 4555542 22 589999876
Q ss_pred ChhHH-------h----------hhcc----C-CCCHHHHHHHHHHH----------------------HH---HHH-HH
Q 014352 199 SLSNL-------I----------YSEE----R-VLNWEERLQIALDI----------------------SH---GIE-YL 230 (426)
Q Consensus 199 sL~~~-------l----------~~~~----~-~l~~~~~~~i~~~i----------------------~~---~l~-~L 230 (426)
.|... + |... . +--|..+..+..++ .. .+. ++
T Consensus 96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~ 175 (330)
T PLN02421 96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT 175 (330)
T ss_pred CCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence 65321 1 1111 0 11122222222111 11 111 22
Q ss_pred HcCC-CCCeeecCCCCCCEEecC-CCcEEEeeecCcc
Q 014352 231 HEGA-VPPVIHRDLKSANILLDH-FMRAKVADFGLSK 265 (426)
Q Consensus 231 H~~~-~~~ivH~dlk~~Nill~~-~~~~kl~Dfgl~~ 265 (426)
.+.+ ..-++|.|+.+.|||+++ ++.++++||..+-
T Consensus 176 ~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 176 DSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred ccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 2211 123799999999999975 5789999999874
|
|
| >PF04478 Mid2: Mid2 like cell wall stress sensor; InterPro: IPR007567 This family represents a region near the C terminus of Mid2, which contains a transmembrane region | Back alignment and domain information |
|---|
Probab=96.22 E-value=0.0026 Score=51.96 Aligned_cols=30 Identities=23% Similarity=0.432 Sum_probs=19.5
Q ss_pred eEEEEeehHHHHHHHHHHHHHHHhhhhhcc
Q 014352 7 LVIIGICVGLALGILIATLVFFGLRWYKKH 36 (426)
Q Consensus 7 ~~ii~i~~g~~~~~~~~~~~~~~~~~~r~~ 36 (426)
.+|||++||+-+.++++++++++++|+|++
T Consensus 49 nIVIGvVVGVGg~ill~il~lvf~~c~r~k 78 (154)
T PF04478_consen 49 NIVIGVVVGVGGPILLGILALVFIFCIRRK 78 (154)
T ss_pred cEEEEEEecccHHHHHHHHHhheeEEEecc
Confidence 579999999877666655555544444443
|
The remainder of the protein sequence is serine-rich and of low complexity, and is therefore impossible to align accurately. Mid2 is thought to act as a mechanosensor of cell wall stress. The C-terminal cytoplasmic region of Mid2 is known to interact with Rom2, a guanine nucleotide exchange factor (GEF) for Rho1, which is part of the cell wall integrity signalling pathway []. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.03 E-value=0.097 Score=46.61 Aligned_cols=73 Identities=15% Similarity=0.230 Sum_probs=49.3
Q ss_pred cccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCC---CCceeeEEeEEEeCCeEEEEEEecCCCChh
Q 014352 125 LGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLH---HRNLVNLIGYCVDKGKYMLIYEFMSNGSLS 201 (426)
Q Consensus 125 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 201 (426)
+--|.--..|.... +...+.+|+-. ......|..|+.-|..+. --++.+++.+-.+.++.|+|+||++-|.+.
T Consensus 24 v~gG~inea~~v~d-g~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 24 VSGGDINEAWRLRD-GTDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred cCCccccceeEeec-CCcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence 44444444555544 55667788632 223456888887776663 355777888888888999999999987765
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.78 E-value=0.03 Score=49.81 Aligned_cols=28 Identities=32% Similarity=0.485 Sum_probs=20.4
Q ss_pred eeecCCCCCCEEe-cCCCcEEEeeecCcc
Q 014352 238 VIHRDLKSANILL-DHFMRAKVADFGLSK 265 (426)
Q Consensus 238 ivH~dlk~~Nill-~~~~~~kl~Dfgl~~ 265 (426)
+.|+|+.+.||++ +.++.++++||..+.
T Consensus 145 ~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 145 FCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred EeeccCccccEEeccCCCeEEEecHHHHh
Confidence 7999999999999 888999999999875
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.69 E-value=0.18 Score=48.10 Aligned_cols=137 Identities=19% Similarity=0.277 Sum_probs=81.4
Q ss_pred cccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCCC---Cc---eeeEEe----EEEeCCeEEEEEEe
Q 014352 125 LGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHH---RN---LVNLIG----YCVDKGKYMLIYEF 194 (426)
Q Consensus 125 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h---~n---iv~~~~----~~~~~~~~~lv~e~ 194 (426)
|.+ .-..+|+....+|+. ++|+.... ....++..|...|..|.- += +.+.=| ....+...+-+++|
T Consensus 34 l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~ 109 (331)
T COG2334 34 LNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEY 109 (331)
T ss_pred ccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEe
Confidence 444 446789888877776 78887665 455677778888877732 11 222212 11111367889999
Q ss_pred cCCCChhH-H--------------hhh--------cc---CCCCHHH-------------HHHHHHHHHHHHHHHHcCC-
Q 014352 195 MSNGSLSN-L--------------IYS--------EE---RVLNWEE-------------RLQIALDISHGIEYLHEGA- 234 (426)
Q Consensus 195 ~~~gsL~~-~--------------l~~--------~~---~~l~~~~-------------~~~i~~~i~~~l~~LH~~~- 234 (426)
++|..+.. . ++. .. ....|.. .......+...+..+.+.-
T Consensus 110 l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~ 189 (331)
T COG2334 110 LPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLP 189 (331)
T ss_pred cCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhch
Confidence 99988772 1 111 00 1123320 0112233444444444421
Q ss_pred ---C---CCeeecCCCCCCEEecCCCc-EEEeeecCcc
Q 014352 235 ---V---PPVIHRDLKSANILLDHFMR-AKVADFGLSK 265 (426)
Q Consensus 235 ---~---~~ivH~dlk~~Nill~~~~~-~kl~Dfgl~~ 265 (426)
. ..+||+|+.|.||+++.+.. +.+.||+-+.
T Consensus 190 ~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 190 AHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 1 12899999999999999885 8999999765
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.63 E-value=0.087 Score=46.63 Aligned_cols=134 Identities=16% Similarity=0.180 Sum_probs=81.2
Q ss_pred EEEEeccCCcc-ChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHH
Q 014352 145 AIKVLASDSHQ-GEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDI 223 (426)
Q Consensus 145 avK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i 223 (426)
.+|++....-. ...-|..+.+++++++ .|+++..- ....+-++.|+|-.- +... ..++..=
T Consensus 89 ~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~----------~i~~----~N~i~ag 150 (308)
T PF07387_consen 89 FLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKI----------KINF----SNFITAG 150 (308)
T ss_pred hhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCc----------ccch----hHHHHHh
Confidence 44554433322 3456778888887763 56776632 334677899988321 1011 1112112
Q ss_pred HHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCcccCccccCccCccccccCCCCcchhhHHHH
Q 014352 224 SHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFG 303 (426)
Q Consensus 224 ~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~G 303 (426)
.++|.-.|+.. ...+|||..|+||+-|..|.+||.|-+.--.. +..|.--| ....+.++.+-+|=
T Consensus 151 i~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~~-----------~V~~vN~~---Y~~lT~~aE~~~fv 215 (308)
T PF07387_consen 151 IKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCLLEN-----------QVNMVNIE---YESLTQEAEVKVFV 215 (308)
T ss_pred HHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhhhhh-----------eeeEEeee---ccccChHHHHHHHH
Confidence 46788889654 44999999999999999999999997743210 01121111 13356778887777
Q ss_pred HHHHHHHh
Q 014352 304 VIIFELIT 311 (426)
Q Consensus 304 vvl~el~t 311 (426)
.-++++..
T Consensus 216 ~s~l~~v~ 223 (308)
T PF07387_consen 216 KSCLKLVE 223 (308)
T ss_pred HHHHHHHH
Confidence 77777665
|
The function of this family is unknown. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.59 E-value=0.21 Score=47.36 Aligned_cols=30 Identities=17% Similarity=0.262 Sum_probs=27.2
Q ss_pred CCeeecCCCCCCEEecCCCcEEEeeecCcc
Q 014352 236 PPVIHRDLKSANILLDHFMRAKVADFGLSK 265 (426)
Q Consensus 236 ~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 265 (426)
..++|+|+.+.|+|++.++.+-++||..+.
T Consensus 196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 359999999999999999999999998775
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 426 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-47 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-46 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-43 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-42 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-33 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-33 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-33 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 8e-31 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-29 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-29 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-26 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-26 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-26 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-26 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-26 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-26 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 8e-26 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 8e-26 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 9e-26 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 9e-26 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 9e-26 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 9e-26 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 9e-26 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-25 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-25 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-25 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-25 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-25 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-25 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-25 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-25 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-25 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-25 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-25 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-25 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-24 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-24 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-24 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 9e-24 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 9e-24 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-23 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-23 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-23 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-23 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-23 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-23 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-23 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-23 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-23 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-22 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-22 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-22 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-22 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-22 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-22 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-22 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 5e-22 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 6e-22 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 6e-22 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 7e-22 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 7e-22 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 8e-22 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 8e-22 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 8e-22 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 8e-22 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 8e-22 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 8e-22 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 8e-22 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 8e-22 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 8e-22 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 8e-22 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 9e-22 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-22 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-21 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-21 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-21 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-21 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-21 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-21 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-21 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-21 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-21 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-21 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-21 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-21 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-21 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-21 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-21 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-21 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-21 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-21 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-21 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-21 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-21 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-21 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-21 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-21 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-21 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-21 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-21 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-21 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-21 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-21 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-21 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-21 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-21 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-21 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-21 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-21 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-21 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-21 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-21 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-21 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-21 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-21 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-21 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-21 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-21 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 6e-21 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 6e-21 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-21 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 8e-21 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 8e-21 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 8e-21 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 8e-21 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-21 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 9e-21 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-20 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-20 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-20 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-20 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-20 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-20 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-20 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-20 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-20 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-20 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-20 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-20 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-20 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-20 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-20 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-20 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-20 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-20 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-20 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-20 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-20 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-20 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-20 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-20 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 8e-20 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 8e-20 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 9e-20 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 9e-20 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 9e-20 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 9e-20 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-19 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-19 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-19 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-19 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-19 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-19 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-19 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-19 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-19 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-19 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-19 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-19 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-19 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-19 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-19 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-19 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-19 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-19 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 5e-19 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 6e-19 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 8e-19 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 8e-19 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 9e-19 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-18 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-18 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-18 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-18 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-18 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-18 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-18 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-18 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-18 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-18 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-18 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-18 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-18 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-18 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-18 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-18 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-18 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-18 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-18 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-18 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-18 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-18 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-18 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-18 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-18 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-18 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-18 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-18 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 5e-18 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-18 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-18 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-18 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-18 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-18 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-18 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 6e-18 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-18 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 7e-18 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 7e-18 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 8e-18 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 8e-18 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 8e-18 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-18 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 8e-18 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-18 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-17 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-17 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-17 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-17 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-17 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-17 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-17 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-17 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-17 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-17 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-17 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-17 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-17 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-17 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-17 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-17 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-17 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-17 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-17 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-17 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-17 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-17 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-17 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-17 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 5e-17 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-17 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-17 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 6e-17 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 6e-17 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-17 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-17 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 7e-17 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-17 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-17 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-17 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-17 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-16 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-16 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-16 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-16 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-16 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-16 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-16 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-16 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-16 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-16 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-16 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-16 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-16 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-16 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-16 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-16 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-16 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-16 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-16 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-16 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-16 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-16 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-16 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-16 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-16 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-16 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-16 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-16 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-16 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-16 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 5e-16 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 5e-16 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-16 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-16 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 8e-16 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-16 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-15 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-15 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-15 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-15 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-15 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-15 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-15 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-15 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-15 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-15 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-15 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-15 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-15 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-15 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-15 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-15 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-15 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-15 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-15 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-15 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-15 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-15 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-15 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-15 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-15 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-15 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-15 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-15 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-15 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-15 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-15 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-15 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-15 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-15 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-15 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-15 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 5e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-15 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 8e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 8e-15 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-15 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-14 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-14 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-14 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-14 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-14 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-14 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-14 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-14 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-14 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-14 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-14 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-14 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-14 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-14 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-14 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-14 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-14 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-14 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-14 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-14 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-14 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-14 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-14 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-14 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-14 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-14 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-14 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-14 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-14 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-14 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-14 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-14 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 6e-14 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 6e-14 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-14 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 6e-14 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 7e-14 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-14 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-14 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-14 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-14 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 8e-14 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-14 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 8e-14 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 8e-14 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 8e-14 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 8e-14 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 8e-14 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 8e-14 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-14 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 8e-14 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-14 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 9e-14 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 9e-14 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 9e-14 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-14 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 9e-14 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 9e-14 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 9e-14 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 9e-14 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 9e-14 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 9e-14 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 9e-14 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 9e-14 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 9e-14 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-14 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-13 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-13 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-13 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-13 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-13 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-13 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-13 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-13 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-13 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-13 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-13 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-13 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-13 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-13 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-13 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-13 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-13 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-13 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-13 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-13 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-13 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-13 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-13 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-13 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-13 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-13 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-13 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-13 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-13 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-13 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-13 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-13 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-13 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-13 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 5e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-13 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 5e-13 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 5e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-13 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 5e-13 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 5e-13 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 6e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 6e-13 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 6e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 6e-13 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-13 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 8e-13 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 8e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-12 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-12 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-12 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-12 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-12 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-12 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-12 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-12 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-12 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-12 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-12 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-12 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-12 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-12 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-12 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-12 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-12 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-12 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-12 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-12 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-12 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-12 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-12 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-12 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-12 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-12 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 6e-12 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 7e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 7e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 8e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 8e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 8e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 8e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 9e-12 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-11 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-11 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-11 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-11 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-11 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-11 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 5e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 5e-11 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 6e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 6e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 6e-11 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-11 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 8e-11 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 8e-11 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 9e-11 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 9e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-11 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 9e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 9e-11 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-10 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-10 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-10 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-10 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-10 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-10 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-10 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-10 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 6e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 7e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 7e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 7e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 7e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 8e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 8e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 8e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 9e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 9e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-09 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-09 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-09 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-09 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-09 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-09 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-09 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-09 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-09 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-09 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-09 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-09 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-09 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-09 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-09 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-09 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-09 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-09 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-09 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 6e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 6e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 6e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 6e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 6e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 7e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 7e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 7e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 7e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 8e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 8e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 9e-09 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 9e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 9e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-08 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-08 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-08 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-08 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-08 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-08 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 5e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 5e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 5e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 5e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 6e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 6e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 6e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 6e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 6e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 6e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 7e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 7e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 7e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 7e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 7e-08 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 8e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 8e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 9e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 9e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 9e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-07 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 5e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 5e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 6e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 6e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 8e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-06 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-06 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 4e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 5e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 5e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 5e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 5e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 5e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 5e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 5e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 6e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 6e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 6e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 6e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 6e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 6e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 6e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 6e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 6e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 6e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 6e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 6e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 6e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 7e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 7e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 7e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 7e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 7e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 7e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 7e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 7e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 7e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 7e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 7e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 7e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 8e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 8e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 9e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 9e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 9e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 9e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-05 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-05 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-05 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-05 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-05 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-05 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 6e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 334 bits (858), Expect = e-113
Identities = 108/311 (34%), Positives = 169/311 (54%), Gaps = 19/311 (6%)
Query: 84 SQVSWWSNHSKDRFTSAPSASGIPR-YAYKDIQKATQNF--TNILGQGAFGPVYKATMPS 140
S+ S +N D +S+ D+++AT NF ++G G FG VYK +
Sbjct: 3 SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62
Query: 141 GGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSL 200
G A+K +S QG +EF+TE+ L H +LV+LIG+C ++ + +LIY++M NG+L
Sbjct: 63 GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL 122
Query: 201 SNLIYSEER---VLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAK 257
+Y + ++WE+RL+I + + G+ YLH +IHRD+KS NILLD K
Sbjct: 123 KRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPK 179
Query: 258 VADFGLSKEEVFDGR---NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIH 314
+ DFG+SK+ + ++ +KGT GYIDP Y + T KSD++SFGV++FE++ A
Sbjct: 180 ITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARS 239
Query: 315 P--HQNLMEYVNLA----SMSQDG-VDEILDKQLVGACNIQEVRELARIGHKCLHKTPRK 367
E VNLA +G +++I+D L + +R+ KCL +
Sbjct: 240 AIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSED 299
Query: 368 RPSIGEVTQAL 378
RPS+G+V L
Sbjct: 300 RPSMGDVLWKL 310
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 314 bits (806), Expect = e-105
Identities = 104/290 (35%), Positives = 172/290 (59%), Gaps = 21/290 (7%)
Query: 108 RYAYKDIQKATQNF--TNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQG-EKEFQTEV 164
R++ +++Q A+ NF NILG+G FG VYK + G + A+K L + QG E +FQTEV
Sbjct: 19 RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEV 78
Query: 165 SLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIY---SEERVLNWEERLQIAL 221
++ HRNL+ L G+C+ + +L+Y +M+NGS+++ + + L+W +R +IAL
Sbjct: 79 EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIAL 138
Query: 222 DISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGL----K 277
+ G+ YLH+ P +IHRD+K+ANILLD A V DFGL+K + D +++ + +
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK--LMDYKDTHVTTAVR 196
Query: 278 GTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT---AIHPHQNLME-YVNLAS----MS 329
GT G+I P Y+ST K + K+D+F +GV++ ELIT A + + V L +
Sbjct: 197 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256
Query: 330 QDG-VDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQAL 378
++ ++ ++D L G +EV +L ++ C +P +RP + EV + L
Sbjct: 257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 307 bits (790), Expect = e-103
Identities = 93/300 (31%), Positives = 156/300 (52%), Gaps = 29/300 (9%)
Query: 102 SASGIPRYAYKDIQKATQNF--------TNILGQGAFGPVYKATMPSGGVAAIKVLAS-- 151
S + +++ +++ T NF N +G+G FG VYK + A+K LA+
Sbjct: 8 SDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMV 66
Query: 152 --DSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEER 209
+ + +++F E+ ++ + H NLV L+G+ D L+Y +M NGSL + + +
Sbjct: 67 DITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG 126
Query: 210 --VLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEE 267
L+W R +IA ++GI +LHE IHRD+KSANILLD AK++DFGL++
Sbjct: 127 TPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGLARAS 183
Query: 268 VFDGRN---SGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT---AI---HPHQN 318
+ S + GT Y+ P + + T KSDI+SFGV++ E+IT A+ Q
Sbjct: 184 EKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQL 242
Query: 319 LMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQAL 378
L++ + +++ +DK++ + V + + +CLH+ KRP I +V Q L
Sbjct: 243 LLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 226 bits (578), Expect = 3e-71
Identities = 70/309 (22%), Positives = 127/309 (41%), Gaps = 42/309 (13%)
Query: 111 YKDIQKATQNFT--NILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLG 168
+++ + + +G FG V+KA + + VA +K+ Q + + EV L
Sbjct: 16 TENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVA-VKIFPIQDKQSW-QNEYEVYSLP 73
Query: 169 RLHHRNLVNLIGYCV----DKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDIS 224
+ H N++ IG LI F GSLS+ + + V++W E IA ++
Sbjct: 74 GMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA--NVVSWNELCHIAETMA 131
Query: 225 HGIEYLHEGAV-------PPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD-----GR 272
G+ YLHE P + HRD+KS N+LL + + A +ADFGL+ F+ G
Sbjct: 132 RGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLAL--KFEAGKSAGD 189
Query: 273 NSGLKGTYGYIDPAYIS-----TNKFTMKSDIFSFGVIIFELITAIHPHQN--------- 318
G GT Y+ P + ++ D+++ G++++EL +
Sbjct: 190 THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249
Query: 319 ---LMEYVNLASMSQDGVDEILDKQLVGACNIQEV-RELARIGHKCLHKTPRKRPSIGEV 374
+ ++ +L M + V + L L +C R S G V
Sbjct: 250 EEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCV 309
Query: 375 TQALLKIKQ 383
+ + ++++
Sbjct: 310 GERITQMQR 318
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 6e-70
Identities = 74/279 (26%), Positives = 131/279 (46%), Gaps = 28/279 (10%)
Query: 111 YKDIQKATQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRL 170
YK+I+ ++G+GAFG V KA AIK + S+S K F E+ L R+
Sbjct: 7 YKEIE-----VEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESE--RKAFIVELRQLSRV 58
Query: 171 HHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERV--LNWEERLQIALDISHGIE 228
+H N+V L G C++ L+ E+ GSL N+++ E + + L S G+
Sbjct: 59 NHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVA 116
Query: 229 YLHEGAVPPVIHRDLKSANILLD-HFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAY 287
YLH +IHRDLK N+LL K+ DFG + + + KG+ ++ P
Sbjct: 117 YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI--QTHMTNNKGSAAWMAPEV 174
Query: 288 ISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQ---LVGA 344
+ ++ K D+FS+G+I++E+IT P + + + + + + L+
Sbjct: 175 FEGSNYSEKCDVFSWGIILWEVITRRKP------FDEIGGPAFRIMWAVHNGTRPPLIKN 228
Query: 345 CNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQ 383
+ + + +C K P +RPS+ E+ + + + +
Sbjct: 229 LP----KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 4e-69
Identities = 84/284 (29%), Positives = 131/284 (46%), Gaps = 33/284 (11%)
Query: 121 FTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGE--KEFQTEVSLLGRLHHRNLVNL 178
+G G+FG V++A G A+K+L E EF EV+++ RL H N+V
Sbjct: 41 IKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99
Query: 179 IGYCVDKGKYMLIYEFMSNGSLSNLIYSEE--RVLNWEERLQIALDISHGIEYLHEGAVP 236
+G ++ E++S GSL L++ L+ RL +A D++ G+ YLH P
Sbjct: 100 MGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-P 158
Query: 237 PVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNS-GLKGTYGYIDPAYISTNKFTM 295
P++HR+LKS N+L+D KV DFGLS+ + +S GT ++ P +
Sbjct: 159 PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNE 218
Query: 296 KSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVR---- 351
KSD++SFGVI++EL T P + NL Q+V A + R
Sbjct: 219 KSDVYSFGVILWELATLQQP------WGNLNPA-----------QVVAAVGFKCKRLEIP 261
Query: 352 -----ELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRHLAKQD 390
++A I C P KRPS + L + + + +
Sbjct: 262 RNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPN 305
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 1e-68
Identities = 81/306 (26%), Positives = 134/306 (43%), Gaps = 44/306 (14%)
Query: 100 APSASGIPRYAYKDIQKATQNFTNILGQGAFGPVYKATMPSGGVA-AIKVLASDSHQGE- 157
A S P+ + + +G+G FG V+K + AIK L +GE
Sbjct: 2 AMGGSEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGET 61
Query: 158 ------KEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVL 211
+EFQ EV ++ L+H N+V L G + ++ EF+ G L + + + +
Sbjct: 62 EMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPI 119
Query: 212 NWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHF-----MRAKVADFGLSKE 266
W +L++ LDI+ GIEY+ PP++HRDL+S NI L + AKVADFGLS++
Sbjct: 120 KWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ 178
Query: 267 EVFDGRNSGLKGTYGYIDPAYISTN--KFTMKSDIFSFGVIIFELITAIHPHQNLMEYVN 324
V SGL G + ++ P I +T K+D +SF +I++ ++T P
Sbjct: 179 SVHS--VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY----- 231
Query: 325 LASMSQDGVDEILDKQLVGACNIQEVR---------ELARIGHKCLHKTPRKRPSIGEVT 375
+ + + +R L + C P+KRP +
Sbjct: 232 ----------SYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIV 281
Query: 376 QALLKI 381
+ L ++
Sbjct: 282 KELSEL 287
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 2e-67
Identities = 72/282 (25%), Positives = 117/282 (41%), Gaps = 34/282 (12%)
Query: 123 NILGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGY 181
+LG+G FG K T +G V +K L + ++ F EV ++ L H N++ IG
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 182 CVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHR 241
+ I E++ G+L +I S + W +R+ A DI+ G+ YLH +IHR
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS---MNIIHR 132
Query: 242 DLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLK---------------GTYGYIDPA 286
DL S N L+ VADFGL++ V + G ++ P
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192
Query: 287 YISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQD----GVDEILDKQLV 342
I+ + K D+FSFG+++ E+I ++ + + V LD+
Sbjct: 193 MINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYL-------PRTMDFGLNVRGFLDRYCP 245
Query: 343 GACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQR 384
C I +C P KRPS ++ L ++
Sbjct: 246 PNCP----PSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 2e-66
Identities = 73/313 (23%), Positives = 126/313 (40%), Gaps = 39/313 (12%)
Query: 98 TSAPSASGIPRYAYK--------DIQKATQNFTNILGQGAFGPVYKATMPSGGVAAIKVL 149
S SA PR A + DI ++G+G FG VY G VA I+++
Sbjct: 6 LSLLSARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRW-HGEVA-IRLI 63
Query: 150 --ASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSE 207
D+ K F+ EV + H N+V +G C+ +I +L +++
Sbjct: 64 DIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDA 123
Query: 208 ERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEE 267
+ VL+ + QIA +I G+ YLH ++H+DLKS N+ D+ + + DFGL
Sbjct: 124 KIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYDN-GKVVITDFGLFSIS 179
Query: 268 VF------DGRNSGLKGTYGYIDPAYISTNK---------FTMKSDIFSFGVIIFELITA 312
+ + G ++ P I F+ SD+F+ G I +EL
Sbjct: 180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAR 239
Query: 313 IHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIG 372
P + + G+ K + + + E++ I C +RP+
Sbjct: 240 EWPFKT-QPAEAIIWQMGTGM-----KPNLSQIGMGK--EISDILLFCWAFEQEERPTFT 291
Query: 373 EVTQALLKIKQRH 385
++ L K+ +R+
Sbjct: 292 KLMDMLEKLPKRN 304
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 210 bits (538), Expect = 6e-66
Identities = 73/282 (25%), Positives = 125/282 (44%), Gaps = 42/282 (14%)
Query: 121 FTNILGQGAFGPVYKATMPSGGVAAIKVL----ASDSHQGEKEFQTEVSLLGRLHHRNLV 176
I+G G FG VY+A VA +K D Q + + E L L H N++
Sbjct: 11 LEEIIGIGGFGKVYRAFWIGDEVA-VKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 177 NLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVP 236
L G C+ + L+ EF G L+ ++ + + + + A+ I+ G+ YLH+ A+
Sbjct: 70 ALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR--IPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 237 PVIHRDLKSANILLDHFMR--------AKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYI 288
P+IHRDLKS+NIL+ + K+ DFGL++E + S G Y ++ P I
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA-AGAYAWMAPEVI 186
Query: 289 STNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQ 348
+ F+ SD++S+GV+++EL+T P + + + + +
Sbjct: 187 RASMFSKGSDVWSYGVLLWELLTGEVP------FRGIDGL-----------AVAYGVAMN 229
Query: 349 EVR---------ELARIGHKCLHKTPRKRPSIGEVTQALLKI 381
++ A++ C + P RPS + L I
Sbjct: 230 KLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 1e-63
Identities = 57/282 (20%), Positives = 122/282 (43%), Gaps = 40/282 (14%)
Query: 120 NFTNILGQGAFGPVYKATMPSGGVAAIKVLASD--SHQGEKEFQTEVSLLGRLHHRNLVN 177
NF L + G ++K G +KVL S + ++F E L H N++
Sbjct: 13 NFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLP 71
Query: 178 LIGYCVD--KGKYMLIYEFMSNGSLSNLIYSEE-RVLNWEERLQIALDISHGIEYLHEGA 234
++G C LI +M GSL N+++ V++ + ++ ALD++ G+ +LH
Sbjct: 72 VLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE 131
Query: 235 VPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYI---STN 291
P + L S ++++D M A+++ + + G ++ P + +
Sbjct: 132 -PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ----SPGRMYAPAWVAPEALQKKPED 186
Query: 292 KFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVR 351
+D++SF V+++EL+T P + +L++M ++ ++ +R
Sbjct: 187 TNRRSADMWSFAVLLWELVTREVP------FADLSNM-----------EIGMKVALEGLR 229
Query: 352 ---------ELARIGHKCLHKTPRKRPSIGEVTQALLKIKQR 384
++++ C+++ P KRP + L K++ +
Sbjct: 230 PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQDK 271
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 2e-63
Identities = 69/269 (25%), Positives = 131/269 (48%), Gaps = 22/269 (8%)
Query: 125 LGQGAFGPVYKATMPSGGVAAIKVL--ASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYC 182
+G G+FG VYK G VA +K+L + + Q + F+ EV +L + H N++ +GY
Sbjct: 32 IGSGSFGTVYKGKW-HGDVA-VKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 183 VDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRD 242
+ ++ ++ SL + +++ E ++ + IA + G++YLH +IHRD
Sbjct: 90 T-APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA---KSIIHRD 145
Query: 243 LKSANILLDHFMRAKVADFGLSKEEVFDGRNS---GLKGTYGYIDP---AYISTNKFTMK 296
LKS NI L K+ DFGL+ E+ + L G+ ++ P +N ++ +
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205
Query: 297 SDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQ--DGVDEILDKQLVGACNIQEVRELA 354
SD+++FG++++EL+T P Y N+ + Q + V + + +
Sbjct: 206 SDVYAFGIVLYELMTGQLP------YSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMK 259
Query: 355 RIGHKCLHKTPRKRPSIGEVTQALLKIKQ 383
R+ +CL K +RPS + + ++ +
Sbjct: 260 RLMAECLKKKRDERPSFPRILAEIEELAR 288
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 1e-58
Identities = 61/319 (19%), Positives = 115/319 (36%), Gaps = 56/319 (17%)
Query: 110 AYKDIQKATQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTE--VSLL 167
+++ ++G+G +G VYK ++ A+KV S + F E + +
Sbjct: 11 DLDNLK-----LLELIGRGRYGAVYKGSL-DERPVAVKVF---SFANRQNFINEKNIYRV 61
Query: 168 GRLHHRNLVNLIGYCV-----DKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALD 222
+ H N+ I + +Y+L+ E+ NGSL + +W ++A
Sbjct: 62 PLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS--LHTSDWVSSCRLAHS 119
Query: 223 ISHGIEYLHE------GAVPPVIHRDLKSANILLDHFMRAKVADFGLSK---------EE 267
++ G+ YLH P + HRDL S N+L+ + ++DFGLS
Sbjct: 120 VTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPG 179
Query: 268 VFDGRNSGLKGTYGYIDPAYI-------STNKFTMKSDIFSFGVIIFELI---TAIHPHQ 317
D GT Y+ P + + D+++ G+I +E+ T + P +
Sbjct: 180 EEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239
Query: 318 NLMEY-----------VNLASMSQDGVDEILDKQLVGACNIQEV--RELARIGHKCLHKT 364
++ EY M E + A + R L C +
Sbjct: 240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQD 299
Query: 365 PRKRPSIGEVTQALLKIKQ 383
R + + + ++
Sbjct: 300 AEARLTAQXAEERMAELMM 318
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 1e-58
Identities = 73/343 (21%), Positives = 131/343 (38%), Gaps = 51/343 (14%)
Query: 78 GFPQKKSQVSWWSNHSKDRFTSAPSASGIP----RYAYKDIQKATQNFTNILGQGAFGPV 133
+ + S S+ S SG+P R K IQ +G+G +G V
Sbjct: 3 TYIPPGESLRDLIEQS----QSSGSGSGLPLLVQRTIAKQIQ-----MVKQIGKGRYGEV 53
Query: 134 YKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKG----KYM 189
+ VA +KV + + +TE+ + H N++ I + +
Sbjct: 54 WMGKWRGEKVA-VKVF-FTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLY 111
Query: 190 LIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAV-----PPVIHRDLK 244
LI ++ NGSL + + S L+ + L++A G+ +LH P + HRDLK
Sbjct: 112 LITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLK 169
Query: 245 SANILLDHFMRAKVADFGLSKEE-----VFDGRNSGLKGTYGYIDP------AYISTNKF 293
S NIL+ +AD GL+ + D + GT Y+ P + +
Sbjct: 170 SKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQS 229
Query: 294 TMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQE---- 349
+ +D++SFG+I++E+ + EY L D + C +
Sbjct: 230 YIMADMYSFGLILWEVARRCVSGGIVEEY-QLPYHDLVPSDPSYEDMREIVCIKKLRPSF 288
Query: 350 ---------VRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQ 383
+R++ ++ +C P R + V + L K+ +
Sbjct: 289 PNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 2e-57
Identities = 69/308 (22%), Positives = 126/308 (40%), Gaps = 45/308 (14%)
Query: 108 RYAYKDIQKATQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQ--TEVS 165
R +DI +G+G +G V++ + VA +K+ +S + EK + TE+
Sbjct: 4 RTVARDIT-----LLECVGKGRYGEVWRGSWQGENVA-VKIFSS---RDEKSWFRETELY 54
Query: 166 LLGRLHHRNLVNLIGYCV----DKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIAL 221
L H N++ I + + LI + GSL + + L+ L+I L
Sbjct: 55 NTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVL 112
Query: 222 DISHGIEYLHEGAV-----PPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF-----DG 271
I+ G+ +LH P + HRDLKS NIL+ + +AD GL+ D
Sbjct: 113 SIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDV 172
Query: 272 RNSGLKGTYGYIDP------AYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEY--- 322
N+ GT Y+ P + + DI++FG++++E+ + + + +Y
Sbjct: 173 GNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP 232
Query: 323 ----VNLASMSQDGVDEILDKQL-----VGACNIQEVRELARIGHKCLHKTPRKRPSIGE 373
V +D + Q + + LA++ +C ++ P R +
Sbjct: 233 FYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALR 292
Query: 374 VTQALLKI 381
+ + L KI
Sbjct: 293 IKKTLTKI 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 1e-56
Identities = 66/325 (20%), Positives = 134/325 (41%), Gaps = 41/325 (12%)
Query: 98 TSAPSASGIPRYAYKDIQKATQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGE 157
T++ S SG+P + I + +G+G FG V++ G A+K+ +S + E
Sbjct: 24 TTSGSGSGLPLLVQRTIARTIV-LQESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REE 78
Query: 158 KEFQTE--VSLLGRLHHRNLVNLIGYCVDKG----KYMLIYEFMSNGSLSNLIYSEERVL 211
+ + E + L H N++ I + L+ ++ +GSL + + +
Sbjct: 79 RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTV 136
Query: 212 NWEERLQIALDISHGIEYLHEGAV-----PPVIHRDLKSANILLDHFMRAKVADFGLSKE 266
E +++AL + G+ +LH V P + HRDLKS NIL+ +AD GL+
Sbjct: 137 TVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 196
Query: 267 E-----VFDGRNSGLKGTYGYIDP------AYISTNKFTMKSDIFSFGVIIFELITAIHP 315
D + GT Y+ P + + ++DI++ G++ +E+
Sbjct: 197 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 256
Query: 316 HQNLMEY-------VNLASMSQDGVDEILDKQL-----VGACNIQEVRELARIGHKCLHK 363
+Y V ++ + +++L + + +R +A+I +C +
Sbjct: 257 GGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYA 316
Query: 364 TPRKRPSIGEVTQALLKIKQRHLAK 388
R + + + L ++ Q+ K
Sbjct: 317 NGAARLTALRIKKTLSQLSQQEGIK 341
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 5e-47
Identities = 67/280 (23%), Positives = 119/280 (42%), Gaps = 36/280 (12%)
Query: 121 FTNILGQGAFGPVYKATMPSGGVA-AIKVLASD-SHQGEKEFQTEVSLLGRLHHRNLVNL 178
+G+G FG V+ + + A+K + +F E +L + H N+V L
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 179 IGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPV 238
IG C K ++ E + G + +E L + LQ+ D + G+EYL
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES---KCC 234
Query: 239 IHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYI-----DPAYISTNKF 293
IHRDL + N L+ K++DFG+S+EE + G + P ++ ++
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA--SGGLRQVPVKWTAPEALNYGRY 292
Query: 294 TMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVG-------AC 345
+ +SD++SFG++++E + P+ N +S + + G C
Sbjct: 293 SSESDVWSFGILLWETFSLGASPYPN---------LS---NQQTREFVEKGGRLPCPELC 340
Query: 346 NIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRH 385
+ R+ +C P +RPS + Q L I++RH
Sbjct: 341 P----DAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH 376
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 6e-44
Identities = 63/268 (23%), Positives = 111/268 (41%), Gaps = 23/268 (8%)
Query: 121 FTNILGQGAFGPVYKATMPSGGVA-AIKV--LASDSHQGEKEFQTEVSLLGRLHHRNLVN 177
F +G+G+F VYK V A + + F+ E +L L H N+V
Sbjct: 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89
Query: 178 LIGYCVD----KGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEG 233
K +L+ E M++G+L + +V+ + I G+++LH
Sbjct: 90 FYDSWESTVKGKKCIVLVTELMTSGTLKTYL-KRFKVMKIKVLRSWCRQILKGLQFLHTR 148
Query: 234 AVPPVIHRDLKSANILLDHFM-RAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNK 292
PP+IHRDLK NI + K+ D GL+ + + + GT ++ P K
Sbjct: 149 T-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA-VIGTPEFMAPEMY-EEK 205
Query: 293 FTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRE 352
+ D+++FG+ + E+ T+ +P+ E N A + + + EV+E
Sbjct: 206 YDESVDVYAFGMCMLEMATSEYPYS---ECQNAAQIYRRVTSGVKPASFDKVAI-PEVKE 261
Query: 353 LARIGHKCLHKTPRKRPSIGEVTQALLK 380
+ C+ + +R SI + LL
Sbjct: 262 IIE---GCIRQNKDERYSIKD----LLN 282
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 3e-42
Identities = 74/308 (24%), Positives = 121/308 (39%), Gaps = 59/308 (19%)
Query: 109 YAYKD---IQKATQNFTNILGQGAFGPVYKATMPSGGVA-----AIKVLASDSHQGEKEF 160
YA +D ++ + + LG+G FG V G A+K L +++F
Sbjct: 12 YACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDF 71
Query: 161 QTEVSLLGRLHHRNLVNLIGYCVDKGK--YMLIYEFMSNGSLSNLIYSEERVLNWEERLQ 218
Q E+ +L LH +V G G+ L+ E++ +G L + + L+ L
Sbjct: 72 QREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLL 131
Query: 219 IALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKG 278
+ I G+EYL +HRDL + NIL++ K+ADFGL+K D K
Sbjct: 132 YSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLD------KD 182
Query: 279 TYGYIDPAY----------ISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLAS 327
Y +P +S N F+ +SD++SFGV+++EL T E++ +
Sbjct: 183 YYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMG 242
Query: 328 MSQDGVDEILDKQLVGACNIQEVRELARIGH-----------------KCLHKTPRKRPS 370
+D + + EL G C +P+ RPS
Sbjct: 243 CERDVP------------ALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPS 290
Query: 371 IGEVTQAL 378
+ L
Sbjct: 291 FSALGPQL 298
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 3e-42
Identities = 73/295 (24%), Positives = 127/295 (43%), Gaps = 49/295 (16%)
Query: 121 FTNILGQGAFGPVYKATMPSGG-----VAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNL 175
F LG+G FG V V A+K L + + ++F+ E+ +L L H N+
Sbjct: 14 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 176 VNLIGYCVDKGKY--MLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEG 233
V G C G+ LI E++ GSL + + + ++ + LQ I G+EYL
Sbjct: 74 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 133
Query: 234 AVPPVIHRDLKSANILLDHFMRAKVADFGLSK-----EEVFDGRNSG---LKGTYGYIDP 285
IHRDL + NIL+++ R K+ DFGL+K +E F + G + P
Sbjct: 134 R---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY----AP 186
Query: 286 AYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGAC 345
++ +KF++ SD++SFGV+++EL T Y+ + ++ G
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFT----------YIEKSKSPPAEFMRMIGNDKQGQM 236
Query: 346 NIQEVRELARIGH-----------------KCLHKTPRKRPSIGEVTQALLKIKQ 383
+ + EL + +C + +RPS ++ + +I+
Sbjct: 237 IVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 4e-42
Identities = 72/316 (22%), Positives = 131/316 (41%), Gaps = 46/316 (14%)
Query: 101 PSASGIPRYAYKD---IQKATQNFTNILGQGAFGPVYKATMPSGG-----VAAIKVLASD 152
+ + +D ++ F LG+G FG V V A+K L
Sbjct: 22 FQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS 81
Query: 153 SHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKY--MLIYEFMSNGSLSNLIYSEERV 210
+ + ++F+ E+ +L L H N+V G C G+ LI E++ GSL + + +
Sbjct: 82 TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER 141
Query: 211 LNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD 270
++ + LQ I G+EYL IHRDL + NIL+++ R K+ DFGL+K +
Sbjct: 142 IDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK-VLPQ 197
Query: 271 GRNSGLKGTYGYI-----DPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNL 325
+ G P ++ +KF++ SD++SFGV+++EL T Y+
Sbjct: 198 DKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT----------YIEK 247
Query: 326 ASMSQDGVDEILDKQLVGACNIQEVRELARIGH-----------------KCLHKTPRKR 368
+ ++ G + + EL + +C + +R
Sbjct: 248 SKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQR 307
Query: 369 PSIGEVTQALLKIKQR 384
PS ++ + +I+ +
Sbjct: 308 PSFRDLALRVDQIRDQ 323
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-41
Identities = 78/275 (28%), Positives = 131/275 (47%), Gaps = 32/275 (11%)
Query: 121 FTNILGQGAFGPVYKATMPSGGVA-AIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLI 179
+ LG G +G VY+ + A+K L D+ + +EF E +++ + H NLV L+
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLL 282
Query: 180 GYCVDKGKYMLIYEFMSNGSLSN-LIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPV 238
G C + + +I EFM+ G+L + L + ++ L +A IS +EYL +
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---F 339
Query: 239 IHRDLKSANILLDHFMRAKVADFGLSKEEVFDG--RNSGLKGTYGYIDPAYISTNKFTMK 296
IHR+L + N L+ KVADFGLS+ D ++G K + P ++ NKF++K
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 399
Query: 297 SDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVG-------ACNIQ 348
SD+++FGV+++E+ T + P+ + V E+L+K C
Sbjct: 400 SDVWAFGVLLWEIATYGMSPYPG---------IDLSQVYELLEK---DYRMERPEGC--- 444
Query: 349 EVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQ 383
++ + C P RPS E+ QA + Q
Sbjct: 445 -PEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-41
Identities = 84/364 (23%), Positives = 143/364 (39%), Gaps = 35/364 (9%)
Query: 35 KHDHLRRCSNERSVATHPIRINGLGTSIDFSAPVANSVAVKASGFPQKKSQVSWWSNHSK 94
H H SVA + G + S ++ + +
Sbjct: 8 GHHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKK-AGSENLYFQGANTVHI 66
Query: 95 DRFTSAPSASGIPRYAYKDIQKATQNFTNILGQGAFGPVYKATMPSGG----VAAIKVLA 150
D P ++ +F ++G+G FG VY T+ A+K L
Sbjct: 67 DLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN 126
Query: 151 SDSHQGEK-EFQTEVSLLGRLHHRNLVNLIGYCVDK-GKYMLIYEFMSNGSLSNLIYSEE 208
+ GE +F TE ++ H N+++L+G C+ G +++ +M +G L N I +E
Sbjct: 127 RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET 186
Query: 209 RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEV 268
++ + L ++ G+++L +HRDL + N +LD KVADFGL+++
Sbjct: 187 HNPTVKDLIGFGLQVAKGMKFLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMY 243
Query: 269 FDGRNSGLKGTYGYI-----DPAYISTNKFTMKSDIFSFGVIIFELIT-AIHP-----HQ 317
+S T + + T KFT KSD++SFGV+++EL+T P
Sbjct: 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 303
Query: 318 NLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377
++ Y+ G L + C L + KC H RPS E+
Sbjct: 304 DITVYL------LQG--RRLLQPE--YCP----DPLYEVMLKCWHPKAEMRPSFSELVSR 349
Query: 378 LLKI 381
+ I
Sbjct: 350 ISAI 353
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 3e-41
Identities = 71/305 (23%), Positives = 126/305 (41%), Gaps = 56/305 (18%)
Query: 121 FTNILGQGAFGPVYKAT----MPSGGVA--AIKVLASDSHQGEK-EFQTEVSLLGRL-HH 172
F LG GAFG V +AT V A+K+L S +H EK +E+ ++ L H
Sbjct: 50 FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 173 RNLVNLIGYCVDKGKYMLIYEFMSNGSLSN-------------LIYSEERVLNWEERLQI 219
N+VNL+G C G ++I E+ G L N + + L
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 220 ALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLS----KEEVFDGRNSG 275
+ ++ G+ +L A IHRD+ + N+LL + AK+ DFGL+ + + + +
Sbjct: 170 SSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 226
Query: 276 L---KGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-------AIHPHQNLMEYVNL 325
K P I +T++SD++S+G++++E+ + I + + V
Sbjct: 227 RLPVKWM----APESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLV-- 280
Query: 326 ASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRH 385
+DG + + + + I C P RP+ ++ L + Q
Sbjct: 281 ----KDG--YQMAQPA--FAP----KNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED 328
Query: 386 LAKQD 390
++D
Sbjct: 329 RRERD 333
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 4e-41
Identities = 73/274 (26%), Positives = 123/274 (44%), Gaps = 34/274 (12%)
Query: 121 FTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIG 180
+G+G FG V VA +K + +D+ + F E S++ +L H NLV L+G
Sbjct: 197 LLQTIGKGEFGDVMLGDYRGNKVA-VKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLG 253
Query: 181 YCV-DKGKYMLIYEFMSNGSLSN-LIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPV 238
V +KG ++ E+M+ GSL + L VL + L+ +LD+ +EYL
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF--- 310
Query: 239 IHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSD 298
+HRDL + N+L+ AKV+DFGL+KE K + P + KF+ KSD
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTKEA--SSTQDTGKLPVKWTAPEALREKKFSTKSD 368
Query: 299 IFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVG-------ACNIQEV 350
++SFG++++E+ + P+ + V ++K G C
Sbjct: 369 VWSFGILLWEIYSFGRVPYPR---------IPLKDVVPRVEK---GYKMDAPDGCP---- 412
Query: 351 RELARIGHKCLHKTPRKRPSIGEVTQALLKIKQR 384
+ + C H RP+ ++ + L I+
Sbjct: 413 PAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 4e-41
Identities = 60/193 (31%), Positives = 104/193 (53%), Gaps = 6/193 (3%)
Query: 121 FTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIG 180
F +G G FG V+ + AIK + + E++F E ++ +L H LV L G
Sbjct: 12 FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYG 70
Query: 181 YCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIH 240
C+++ L+ EFM +G LS+ + ++ + E L + LD+ G+ YL E VIH
Sbjct: 71 VCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 127
Query: 241 RDLKSANILLDHFMRAKVADFGLSKEEVFDG--RNSGLKGTYGYIDPAYISTNKFTMKSD 298
RDL + N L+ KV+DFG+++ + D ++G K + P S ++++ KSD
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 187
Query: 299 IFSFGVIIFELIT 311
++SFGV+++E+ +
Sbjct: 188 VWSFGVLMWEVFS 200
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 4e-41
Identities = 71/300 (23%), Positives = 126/300 (42%), Gaps = 60/300 (20%)
Query: 121 FTNILGQGAFGPVYKAT----MPSGGVA--AIKVLASDSHQGEK-EFQTEVSLLGRL-HH 172
F LG GAFG V +AT + S A+K+L +H E+ +E+ +L L +H
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 173 RNLVNLIGYCVDKGKYMLIYEFMSNGSL-----------------SNLIYSEERVLNWEE 215
N+VNL+G C G ++I E+ G L ++ +E L+ E+
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 216 RLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLS----KEEVFDG 271
L + ++ G+ +L IHRDL + NILL H K+ DFGL+ + +
Sbjct: 147 LLSFSYQVAKGMAFLASKNC---IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 272 RNSGL---KGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-------AIHPHQNLME 321
+ + K P I +T +SD++S+G+ ++EL + + +
Sbjct: 204 KGNARLPVKWM----APESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259
Query: 322 YVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKI 381
+ ++G + E+ ++ + C P KRP+ ++ Q + K
Sbjct: 260 MI------KEG--FRMLSPE--HAP-AEMYDIMK---TCWDADPLKRPTFKQIVQLIEKQ 305
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-40
Identities = 68/321 (21%), Positives = 124/321 (38%), Gaps = 56/321 (17%)
Query: 100 APSASGIPRYAYKD---IQKATQNFTNILGQGAFGPVYKATMPSGGVA-----AIKVLAS 151
S D +K LG+G FG V G A+K L
Sbjct: 1 GDIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKP 60
Query: 152 DSHQGE-KEFQTEVSLLGRLHHRNLVNLIGYCVDKGKY--MLIYEFMSNGSLSNLIYSEE 208
+S + + E+ +L L+H N+V G C + G LI EF+ +GSL + +
Sbjct: 61 ESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK 120
Query: 209 RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSK--- 265
+N +++L+ A+ I G++YL +HRDL + N+L++ + K+ DFGL+K
Sbjct: 121 NKINLKQQLKYAVQICKGMDYLGSRQY---VHRDLAARNVLVESEHQVKIGDFGLTKAIE 177
Query: 266 --EEVFDGRNSG---LKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNL 319
+E + ++ + P + +KF + SD++SFGV + EL+T +
Sbjct: 178 TDKEYYTVKDDRDSPVFWY----APECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPM 233
Query: 320 MEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGH-----------------KCLH 362
++ + + + + + + G KC
Sbjct: 234 ALFLKMIGPTHGQM------------TVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWE 281
Query: 363 KTPRKRPSIGEVTQALLKIKQ 383
P R S + + + +
Sbjct: 282 FQPSNRTSFQNLIEGFEALLK 302
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-40
Identities = 71/278 (25%), Positives = 122/278 (43%), Gaps = 34/278 (12%)
Query: 121 FTNILGQGAFGPVYKATMPSGGVA----AIKVLASDSHQGEK-EFQTEVSLLGRLHHRNL 175
++G+G FG VY AIK L+ + + F E L+ L+H N+
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 176 VNLIGYCVDK-GKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGA 234
+ LIG + G ++ +M +G L I S +R ++ + L ++ G+EYL A
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL---A 141
Query: 235 VPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYI-----DPAYIS 289
+HRDL + N +LD KVADFGL+++ + S + + + +
Sbjct: 142 EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQ 201
Query: 290 TNKFTMKSDIFSFGVIIFELIT-AIHP-----HQNLMEYVNLASMSQDGVDEILDKQLVG 343
T +FT KSD++SFGV+++EL+T P +L ++ G L +
Sbjct: 202 TYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFL------AQG--RRLPQPE-- 251
Query: 344 ACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKI 381
C L ++ +C P RP+ + + +I
Sbjct: 252 YCP----DSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-40
Identities = 69/291 (23%), Positives = 127/291 (43%), Gaps = 52/291 (17%)
Query: 121 FTNILGQGAFGPVYKAT---MPSGGVA---AIKVLASDSHQGEK-EFQTEVSLLGRLHHR 173
+ LGQG+FG VY+ + AIK + + E+ EF E S++ +
Sbjct: 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 174 NLVNLIGYCVDKGKYMLIYEFMSNGSL---------SNLIYSEERVLNWEERLQIALDIS 224
++V L+G ++I E M+ G L + + + +Q+A +I+
Sbjct: 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 225 HGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG---RNSGLKGTYG 281
G+ YL+ +HRDL + N ++ K+ DFG+++ ++++ R KG G
Sbjct: 149 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR-DIYETDYYR----KGGKG 200
Query: 282 YI-----DPAYISTNKFTMKSDIFSFGVIIFELIT-AIHP-----HQNLMEYVNLASMSQ 330
+ P + FT SD++SFGV+++E+ T A P ++ ++ +V
Sbjct: 201 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV------M 254
Query: 331 DGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKI 381
+G +LDK C L + C P+ RPS E+ ++ +
Sbjct: 255 EG--GLLDKPD--NCP----DMLFELMRMCWQYNPKMRPSFLEIISSIKEE 297
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-40
Identities = 70/296 (23%), Positives = 114/296 (38%), Gaps = 49/296 (16%)
Query: 121 FTNILGQGAFGPVYKATMPSGGVA-----AIKVLASDSHQGE-KEFQTEVSLLGRLHHRN 174
LG+G FG V A+K L +D+ ++ E+ +L L+H +
Sbjct: 35 KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEH 94
Query: 175 LVNLIGYCVDKGK--YMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHE 232
++ G C D G L+ E++ GSL Y + + L A I G+ YLH
Sbjct: 95 IIKYKGCCEDAGAASLQLVMEYVPLGSL--RDYLPRHSIGLAQLLLFAQQICEGMAYLHA 152
Query: 233 GAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYI-----DPAY 287
IHRDL + N+LLD+ K+ DFGL+K V +G G P
Sbjct: 153 QHY---IHRDLAARNVLLDNDRLVKIGDFGLAK-AVPEGHEYYRVREDGDSPVFWYAPEC 208
Query: 288 ISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACN 346
+ KF SD++SFGV ++EL+T +++ L ++Q +
Sbjct: 209 LKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQM------------T 256
Query: 347 IQEVRELARIGH-----------------KCLHKTPRKRPSIGEVTQALLKIKQRH 385
+ + EL G C RP+ + L + +++
Sbjct: 257 VLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-40
Identities = 76/287 (26%), Positives = 126/287 (43%), Gaps = 34/287 (11%)
Query: 112 KDIQKATQNFTNILGQGAFGPVYKATMPSGG----VAAIKVLASDSHQGEK-EFQTEVSL 166
+F ++G+G FG VY T+ A+K L + GE +F TE +
Sbjct: 20 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII 79
Query: 167 LGRLHHRNLVNLIGYCVD-KGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISH 225
+ H N+++L+G C+ +G +++ +M +G L N I +E ++ + L ++
Sbjct: 80 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 139
Query: 226 GIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYI-- 283
G++YL +HRDL + N +LD KVADFGL+++ S T +
Sbjct: 140 GMKYLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 196
Query: 284 ---DPAYISTNKFTMKSDIFSFGVIIFELIT-AIHP-----HQNLMEYVNLASMSQDGVD 334
+ T KFT KSD++SFGV+++EL+T P ++ Y+ G
Sbjct: 197 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL------LQG-- 248
Query: 335 EILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKI 381
L + C L + KC H RPS E+ + I
Sbjct: 249 RRLLQPE--YCP----DPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 3e-40
Identities = 82/319 (25%), Positives = 150/319 (47%), Gaps = 53/319 (16%)
Query: 121 FTNILGQGAFGPVYKATMPSGGV---AAIKVLASDSHQGEK-EFQTEVSLLGRL-HHRNL 175
F +++G+G FG V KA + G+ AAIK + + + + +F E+ +L +L HH N+
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 176 VNLIGYCVDKGKYMLIYEFMSNGSL---------------SNLIYSEERVLNWEERLQIA 220
+NL+G C +G L E+ +G+L + S L+ ++ L A
Sbjct: 89 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 221 LDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTY 280
D++ G++YL + IHRDL + NIL+ AK+ADFGLS+ + +K T
Sbjct: 149 ADVARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGLSRGQ-----EVYVKKTM 200
Query: 281 GYI-----DPAYISTNKFTMKSDIFSFGVIIFELIT------AIHPHQNLMEYVNLASMS 329
G + ++ + +T SD++S+GV+++E+++ L E +
Sbjct: 201 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL------ 254
Query: 330 QDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRHLAKQ 389
G L+K L C+ EV +L R +C + P +RPS ++ +L ++ +
Sbjct: 255 PQG--YRLEKPL--NCD-DEVYDLMR---QCWREKPYERPSFAQILVSLNRMLEERKTYV 306
Query: 390 DTMSFADGEFSRAVSRIED 408
+T + ++ E+
Sbjct: 307 NTTLYEKFTYAGIDCSAEE 325
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 3e-40
Identities = 64/208 (30%), Positives = 99/208 (47%), Gaps = 14/208 (6%)
Query: 106 IPRYAYKDIQKATQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVS 165
I KD+ F LG G FG V AIK++ S E EF E
Sbjct: 21 IDP---KDLT-----FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAK 71
Query: 166 LLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISH 225
++ L H LV L G C + +I E+M+NG L N + ++ L++ D+
Sbjct: 72 VMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCE 131
Query: 226 GIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG--RNSGLKGTYGYI 283
+EYL +HRDL + N L++ KV+DFGLS+ + D + G K +
Sbjct: 132 AMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS 188
Query: 284 DPAYISTNKFTMKSDIFSFGVIIFELIT 311
P + +KF+ KSDI++FGV+++E+ +
Sbjct: 189 PPEVLMYSKFSSKSDIWAFGVLMWEIYS 216
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 3e-40
Identities = 79/324 (24%), Positives = 136/324 (41%), Gaps = 54/324 (16%)
Query: 92 HSKDRFTSAPSASGIPRYAYKD--IQKATQNFTNILGQGAFGPVYKATMPSGGVA----A 145
H P S + +D I + ILG+G FG V + + A
Sbjct: 7 HHHHSSGLVPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVA 66
Query: 146 IKVLASD--SHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKG-----KYMLIYEFMSNG 198
+K + D S + +EF +E + + H N++ L+G C++ K M+I FM G
Sbjct: 67 VKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYG 126
Query: 199 SL-----SNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHF 253
L + + + + + + L+ +DI+ G+EYL +HRDL + N +L
Sbjct: 127 DLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNF---LHRDLAARNCMLRDD 183
Query: 254 MRAKVADFGLSKEEVFDG---RNSGLKGTYGYI-----DPAYISTNKFTMKSDIFSFGVI 305
M VADFGLSK +++ G R +G + ++ +T KSD+++FGV
Sbjct: 184 MTVCVADFGLSK-KIYSGDYYR----QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVT 238
Query: 306 IFELIT-AIHP-----HQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHK 359
++E+ T + P + + +Y+ G L + C EL I +
Sbjct: 239 MWEIATRGMTPYPGVQNHEMYDYL------LHG--HRLKQPE--DCL----DELYEIMYS 284
Query: 360 CLHKTPRKRPSIGEVTQALLKIKQ 383
C P RP+ + L K+ +
Sbjct: 285 CWRTDPLDRPTFSVLRLQLEKLLE 308
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 3e-40
Identities = 65/195 (33%), Positives = 104/195 (53%), Gaps = 14/195 (7%)
Query: 121 FTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIG 180
+G+G FG V VA +K + +D+ + F E S++ +L H NLV L+G
Sbjct: 25 LLQTIGKGEFGDVMLGDYRGNKVA-VKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLG 81
Query: 181 YCV-DKGKYMLIYEFMSNGSLSNLIYSEER-VLNWEERLQIALDISHGIEYLHEGAVPPV 238
V +KG ++ E+M+ GSL + + S R VL + L+ +LD+ +EYL
Sbjct: 82 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF--- 138
Query: 239 IHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGL--KGTYGYIDPAYISTNKFTMK 296
+HRDL + N+L+ AKV+DFGL+KE L K T P + KF+ K
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFSTK 194
Query: 297 SDIFSFGVIIFELIT 311
SD++SFG++++E+ +
Sbjct: 195 SDVWSFGILLWEIYS 209
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 4e-40
Identities = 65/275 (23%), Positives = 122/275 (44%), Gaps = 30/275 (10%)
Query: 121 FTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIG 180
LG G FG V A+K++ S E EF E + +L H LV G
Sbjct: 12 LLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYG 70
Query: 181 YCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIH 240
C + ++ E++SNG L N + S + L + L++ D+ G+ +L IH
Sbjct: 71 VCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIH 127
Query: 241 RDLKSANILLDHFMRAKVADFGLSKEEVFDG--RNSGLKGTYGYIDPAYISTNKFTMKSD 298
RDL + N L+D + KV+DFG+++ + D + G K + P K++ KSD
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSD 187
Query: 299 IFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVG-------ACNIQEV 350
+++FG++++E+ + P+ + V + + G +
Sbjct: 188 VWAFGILMWEVFSLGKMPYDL---------YTNSEVVLKVSQ---GHRLYRPHLAS---- 231
Query: 351 RELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRH 385
+ +I + C H+ P KRP+ ++ ++ ++++
Sbjct: 232 DTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD 266
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-40
Identities = 81/302 (26%), Positives = 124/302 (41%), Gaps = 61/302 (20%)
Query: 119 QNFTNI--LGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNL 175
+F I +G G FG V+KA G IK + + EK + EV L +L H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV---KYNNEKAER-EVKALAKLDHVNI 66
Query: 176 VNLIGYCVD---------------KGKYMLIY-EFMSNGSLSNLI-------YSEERVLN 212
V+ G K K + I EF G+L I + L
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 213 WEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGR 272
QI G++Y+H +I+RDLK +NI L + K+ DFGL DG+
Sbjct: 127 L--FEQITK----GVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK 177
Query: 273 NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDG 332
+ KGT Y+ P IS+ + + D+++ G+I+ EL+ E + +DG
Sbjct: 178 RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA---FETSKFFTDLRDG 234
Query: 333 V-DEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGE------VTQALLKIKQRH 385
+ +I DK+ + L + K L K P RP+ E V + + +RH
Sbjct: 235 IISDIFDKKE---------KTLLQ---KLLSKKPEDRPNTSEILRTLTVWKKSPEKNERH 282
Query: 386 LA 387
A
Sbjct: 283 TA 284
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 8e-40
Identities = 68/305 (22%), Positives = 122/305 (40%), Gaps = 43/305 (14%)
Query: 98 TSAPSASGIPRYAYKDIQKATQNFTNI--LGQGAFGPVYKAT-MPSGGVAAIKVLASDSH 154
P + P Y + F +G+G F VY+A + G A+K +
Sbjct: 15 QFQPQKALRPDMGYNTLAN----FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDL 70
Query: 155 QGEKE---FQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLI------- 204
K E+ LL +L+H N++ ++ + ++ E G LS +I
Sbjct: 71 MDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQK 130
Query: 205 --YSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFG 262
E V + +Q+ +E++H V +HRD+K AN+ + K+ D G
Sbjct: 131 RLIPERTVWKY--FVQLCS----ALEHMHSRRV---MHRDIKPANVFITATGVVKLGDLG 181
Query: 263 LSKEEVFDGRNSGLK---GTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNL 319
L + F + + GT Y+ P I N + KSDI+S G +++E+ P
Sbjct: 182 LGR--FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY-- 237
Query: 320 MEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALL 379
+ +NL S+ + + +E+R+L C++ P KRP + +
Sbjct: 238 GDKMNLYSLCKKIEQCDYPPLPSDHYS-EELRQLVN---MCINPDPEKRPDVTY----VY 289
Query: 380 KIKQR 384
+ +R
Sbjct: 290 DVAKR 294
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 1e-39
Identities = 58/237 (24%), Positives = 106/237 (44%), Gaps = 32/237 (13%)
Query: 96 RFTSAPSASGIPRYA----YKDIQKATQNFTNILGQGAFGPVYKATMPSGGVA----AIK 147
+F + P P A ++I+ + + I+G G G V + G AIK
Sbjct: 24 QFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIK 83
Query: 148 VLASDSHQGEK-EFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYS 206
L + + ++ +F +E S++G+ H N++ L G M++ E+M NGSL + +
Sbjct: 84 ALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRT 143
Query: 207 EERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKE 266
+ + + + + G+ YL + +HRDL + N+L+D + KV+DFGLS+
Sbjct: 144 HDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRV 200
Query: 267 EVFDGRNSGLKGTYGYID------------PAYISTNKFTMKSDIFSFGVIIFELIT 311
D P I+ F+ SD++SFGV+++E++
Sbjct: 201 LEDD--------PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-39
Identities = 70/279 (25%), Positives = 110/279 (39%), Gaps = 51/279 (18%)
Query: 124 ILGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYC 182
+LG+G +G VY + + AIK + + + E++L L H+N+V +G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 183 VDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERL--QIALDISHGIEYLHEGAVPPVIH 240
+ G + E + GSLS L+ S+ L E+ I G++YLH+ ++H
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVH 145
Query: 241 RDLKSANILLDHFM-RAKVADFGLSK--EEVFDGRNSGLKGTYGYIDPAYI--STNKFTM 295
RD+K N+L++ + K++DFG SK + + GT Y+ P I +
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPRGYGK 204
Query: 296 KSDIFSFGVIIFELITAIHPHQNLMEYVNL--------------ASMSQDGVDEILDKQL 341
+DI+S G I E+ T P L E SMS + IL
Sbjct: 205 AADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFIL---- 260
Query: 342 VGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLK 380
KC P KR + LL
Sbjct: 261 -----------------KCFEPDPDKRACAND----LLV 278
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-39
Identities = 63/199 (31%), Positives = 103/199 (51%), Gaps = 16/199 (8%)
Query: 121 FTNILGQGAFGPVYKATMPSGGVA-AIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLI 179
+ LG G +G VY+ + A+K L D+ + +EF E +++ + H NLV L+
Sbjct: 17 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLL 75
Query: 180 GYCVDKGKYMLIYEFMSNGSLSN-LIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPV 238
G C + + +I EFM+ G+L + L + ++ L +A IS +EYL +
Sbjct: 76 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---F 132
Query: 239 IHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKG------TYGYIDPAYISTNK 292
IHRDL + N L+ KVADFGLS+ D + T P ++ NK
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAYNK 188
Query: 293 FTMKSDIFSFGVIIFELIT 311
F++KSD+++FGV+++E+ T
Sbjct: 189 FSIKSDVWAFGVLLWEIAT 207
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-39
Identities = 60/302 (19%), Positives = 111/302 (36%), Gaps = 59/302 (19%)
Query: 106 IPRYAYKDIQKATQNFTNILGQGAFGPVYKATMPSGGVA--------AIKVLASDSHQGE 157
I +D+ F LGQG F ++K G +KVL
Sbjct: 5 IRN---EDLI-----FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYS 56
Query: 158 KEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERL 217
+ F S++ +L H++LV G CV + +L+ EF+ GSL + + +N +L
Sbjct: 57 ESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKL 116
Query: 218 QIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMR--------AKVADFGLSKEEVF 269
++A ++ + +L E +IH ++ + NILL K++D G+S
Sbjct: 117 EVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT--- 170
Query: 270 DGRNSGLKGTYGYIDP-------AYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLME 321
+ + + + +D +SFG ++E+ + P
Sbjct: 171 ------VLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSA--- 221
Query: 322 YVNLASMSQDGVDEILDK--QLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALL 379
+ + + QL ELA + + C+ P RPS + + L
Sbjct: 222 ------LDSQRKLQFYEDRHQLPAPKAA----ELANLINNCMDYEPDHRPSFRAIIRDLN 271
Query: 380 KI 381
+
Sbjct: 272 SL 273
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-39
Identities = 76/298 (25%), Positives = 127/298 (42%), Gaps = 57/298 (19%)
Query: 121 FTNILGQGAFGPVYKAT---MPSGGVA---AIKVLASDSHQGEKEFQTEVSLLGRLHHRN 174
LG+GAFG V+ A + A+K L + K+FQ E LL L H +
Sbjct: 19 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 175 LVNLIGYCVDKGKYMLIYEFMSNGSL---------------SNLIYSEERVLNWEERLQI 219
+V G C D ++++E+M +G L + L + L I
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 220 ALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG---RNSGL 276
A I+ G+ YL +HRDL + N L+ + K+ DFG+S+ +V+ R
Sbjct: 139 ASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSR-DVYSTDYYR---- 190
Query: 277 KGTYGYI-----DPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNL-----MEYVNL 325
G + + P I KFT +SD++SFGVI++E+ T P L +E +
Sbjct: 191 VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI-- 248
Query: 326 ASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQ 383
G +L++ C +E+ + C + P++R +I E+ + L + +
Sbjct: 249 ----TQG--RVLERP--RVCP----KEVYDVMLGCWQREPQQRLNIKEIYKILHALGK 294
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 3e-39
Identities = 72/293 (24%), Positives = 123/293 (41%), Gaps = 52/293 (17%)
Query: 121 FTNILGQGAFGPVYKAT---MPSGGVA---AIKVLASDSHQGEK-EFQTEVSLLGRLHHR 173
LG GAFG VY+ MP+ A+K L + ++ +F E ++ + +H+
Sbjct: 34 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 93
Query: 174 NLVNLIGYCVDKGKYMLIYEFMSNGSL------SNLIYSEERVLNWEERLQIALDISHGI 227
N+V IG + ++ E M+ G L + S+ L + L +A DI+ G
Sbjct: 94 NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 228 EYLHEGAVPPVIHRDLKSANILLDHF---MRAKVADFGLSKEEVFDG---RNSGLKGTYG 281
+YL E IHRD+ + N LL AK+ DFG+++ +++ R KG
Sbjct: 154 QYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-DIYRASYYR----KGGCA 205
Query: 282 YI-----DPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNL-----MEYVNLASMSQ 330
+ P FT K+D +SFGV+++E+ + P+ + +E+V
Sbjct: 206 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV------T 259
Query: 331 DGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQ 383
G +D C + RI +C P RP+ + + + Q
Sbjct: 260 SG--GRMDPPK--NC----PGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 3e-39
Identities = 77/305 (25%), Positives = 129/305 (42%), Gaps = 65/305 (21%)
Query: 121 FTNILGQGAFGPVYKAT---MPSGGVA---AIKVLASDSHQGEK-EFQTEVSLLGRL-HH 172
F +LG GAFG V AT + GV+ A+K+L + E+ +E+ ++ +L H
Sbjct: 49 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 108
Query: 173 RNLVNLIGYCVDKGKYMLIYEFMSNGSLSN----------------------LIYSEERV 210
N+VNL+G C G LI+E+ G L N + V
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 211 LNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLS----KE 266
L +E+ L A ++ G+E+L + +HRDL + N+L+ H K+ DFGL+ +
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 225
Query: 267 EVFDGRNSGL---KGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-------AIHPH 316
+ R + K P + +T+KSD++S+G++++E+ + I
Sbjct: 226 SNYVVRGNARLPVKWM----APESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 281
Query: 317 QNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQ 376
N + + Q+G +D+ E+ I C RKRPS +T
Sbjct: 282 ANFYKLI------QNG--FKMDQP--FYAT----EEIYIIMQSCWAFDSRKRPSFPNLTS 327
Query: 377 ALLKI 381
L
Sbjct: 328 FLGCQ 332
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 4e-39
Identities = 71/309 (22%), Positives = 118/309 (38%), Gaps = 80/309 (25%)
Query: 121 FTNILGQGAFGPVYKAT----MPSGGVA--AIKVLASDSHQGEKEFQTEVSLLGRLHHRN 174
LG+GAFG V+ A +P A+K L S ++FQ E LL L H++
Sbjct: 45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 104
Query: 175 LVNLIGYCVDKGKYMLIYEFMSNGSL--------------SNLIYSEERVLNWEERLQIA 220
+V G C + ++++E+M +G L + L + L +A
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 221 LDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG---RNSGLK 277
++ G+ YL +HRDL + N L+ + K+ DFG+S+ +++ R
Sbjct: 165 SQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSR-DIYSTDYYR----V 216
Query: 278 GTYGYI-----DPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQD 331
G + P I KFT +SD++SFGV+++E+ T P L
Sbjct: 217 GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQL------------ 264
Query: 332 GVDEILDKQLVGACNIQEVRELARIGH-----------------KCLHKTPRKRPSIGEV 374
+ E + G C + P++R SI +V
Sbjct: 265 --------------SNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDV 310
Query: 375 TQALLKIKQ 383
L + Q
Sbjct: 311 HARLQALAQ 319
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 4e-39
Identities = 73/274 (26%), Positives = 117/274 (42%), Gaps = 32/274 (11%)
Query: 121 FTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIG 180
LGQG FG V+ T AIK L + E F E ++ +L H LV L
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYA 329
Query: 181 YCVDKGKYMLIYEFMSNGSLSN-LIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVI 239
++ ++ E+MS GSL + L + L + + +A I+ G+ Y+ +
Sbjct: 330 VVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY---V 385
Query: 240 HRDLKSANILLDHFMRAKVADFGLSKEEVFD--GRNSGLKGTYGYIDPAYISTNKFTMKS 297
HRDL++ANIL+ + KVADFGL++ + G K + P +FT+KS
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 445
Query: 298 DIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVG-------ACNIQE 349
D++SFG+++ EL T P+ M V + +++ G C
Sbjct: 446 DVWSFGILLTELTTKGRVPYPG---------MVNREVLDQVER---GYRMPCPPECP--- 490
Query: 350 VRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQ 383
L + +C K P +RP+ + L
Sbjct: 491 -ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 4e-39
Identities = 73/274 (26%), Positives = 117/274 (42%), Gaps = 32/274 (11%)
Query: 121 FTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIG 180
LGQG FG V+ T AIK L + E F E ++ +L H LV L
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYA 246
Query: 181 YCVDKGKYMLIYEFMSNGSLSN-LIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVI 239
++ ++ E+MS GSL + L + L + + +A I+ G+ Y+ +
Sbjct: 247 VVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY---V 302
Query: 240 HRDLKSANILLDHFMRAKVADFGLSKEEVFDG--RNSGLKGTYGYIDPAYISTNKFTMKS 297
HRDL++ANIL+ + KVADFGL++ + G K + P +FT+KS
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362
Query: 298 DIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVG-------ACNIQE 349
D++SFG+++ EL T P+ M V + +++ G C
Sbjct: 363 DVWSFGILLTELTTKGRVPYPG---------MVNREVLDQVER---GYRMPCPPECP--- 407
Query: 350 VRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQ 383
L + +C K P +RP+ + L
Sbjct: 408 -ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 6e-39
Identities = 65/231 (28%), Positives = 109/231 (47%), Gaps = 17/231 (7%)
Query: 95 DRFTSAPSASGIPRYAY----KDIQKATQNFTNILGQGAFGPVYKAT--MPSGGVA---A 145
+ + P A +I + ++G G FG VYK SG A
Sbjct: 18 ENLYFQGAMGSDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVA 77
Query: 146 IKVL-ASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLI 204
IK L A + + +F E ++G+ H N++ L G M+I E+M NG+L +
Sbjct: 78 IKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFL 137
Query: 205 YSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLS 264
++ + + + + I+ G++YL +HRDL + NIL++ + KV+DFGLS
Sbjct: 138 REKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLS 194
Query: 265 K----EEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT 311
+ + SG K + P IS KFT SD++SFG++++E++T
Sbjct: 195 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMT 245
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 7e-39
Identities = 71/295 (24%), Positives = 127/295 (43%), Gaps = 53/295 (17%)
Query: 121 FTNILGQGAFGPVYKATMPSGGVA----AIKVLASD--SHQGEKEFQTEVSLLGRLHHRN 174
+LG+G FG V +A + + A+K+L +D + +EF E + + H +
Sbjct: 27 LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPH 86
Query: 175 LVNLIGYCVDKG------KYMLIYEFMSNGSL-----SNLIYSEERVLNWEERLQIALDI 223
+ L+G + M+I FM +G L ++ I L + ++ +DI
Sbjct: 87 VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146
Query: 224 SHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG---RNSGLKGTY 280
+ G+EYL IHRDL + N +L M VADFGLS+ +++ G R +G
Sbjct: 147 ACGMEYLSSRNF---IHRDLAARNCMLAEDMTVCVADFGLSR-KIYSGDYYR----QGCA 198
Query: 281 GYI-----DPAYISTNKFTMKSDIFSFGVIIFELIT-AIHP-----HQNLMEYVNLASMS 329
+ ++ N +T+ SD+++FGV ++E++T P + + Y+
Sbjct: 199 SKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL------ 252
Query: 330 QDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQR 384
G L + C E+ + ++C P++RPS + L I
Sbjct: 253 IGG--NRLKQPP--ECM----EEVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-38
Identities = 70/307 (22%), Positives = 130/307 (42%), Gaps = 40/307 (13%)
Query: 121 FTNILGQGAFGPVYKATMPSGGVA----AIKVLASD-SHQGEKEFQTEVSLLGRLHHRNL 175
++G G FG V + AIK L + + ++F E S++G+ H N+
Sbjct: 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI 108
Query: 176 VNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAV 235
+ L G M++ E+M NGSL + + + + + + I+ G++YL +
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG- 167
Query: 236 PPVIHRDLKSANILLDHFMRAKVADFGLSK----EEVFDGRNSGLKGTYGYIDPAYISTN 291
+HRDL + NIL++ + KV+DFGL + + G K + P I+
Sbjct: 168 --YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 292 KFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVG------- 343
KFT SD++S+G++++E+++ P+ MS V + +D+ G
Sbjct: 226 KFTSASDVWSYGIVLWEVMSYGERPYWE---------MSNQDVIKAVDE---GYRLPPPM 273
Query: 344 ACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRHLAKQDTMSFADGEFSRAV 403
C L ++ C K RP ++ L K+ + ++ +R
Sbjct: 274 DCP----AALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR----NPGSLKIITSAAARPS 325
Query: 404 SRIEDQQ 410
+ + DQ
Sbjct: 326 NLLLDQS 332
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-38
Identities = 68/288 (23%), Positives = 111/288 (38%), Gaps = 47/288 (16%)
Query: 119 QNFTNI--LGQGAFGPVYKAT-MPSGGVAAIKVLA-SDSHQGEKEFQTEVSLLGRLHHRN 174
+F I LG+G FG V++A AIK + + ++ EV L +L H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 175 LVNLIGYCVDKGKYM---------LIY---EFMSNGSLSNLIYSEERVLNWEER--LQIA 220
+V ++K +Y + +L + + + E L I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 221 LDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSK-------------EE 267
L I+ +E+LH + +HRDLK +NI KV DFGL
Sbjct: 125 LQIAEAVEFLHSKGL---MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 268 VFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLAS 327
R++G GT Y+ P I N ++ K DIFS G+I+FEL ++P ME V +
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL---LYPFSTQMERVRTLT 238
Query: 328 MSQDG-VDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEV 374
++ + ++ + L +P +RP +
Sbjct: 239 DVRNLKFPPLFTQKY---------PCEYVMVQDMLSPSPMERPEAINI 277
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-38
Identities = 70/299 (23%), Positives = 120/299 (40%), Gaps = 59/299 (19%)
Query: 121 FTNILGQGAFGPVYKAT---MPSGGVA---AIKVLASDSHQGEK-EFQTEVSLLGRL-HH 172
LG+GAFG V +A + A+K+L + E +E+ +L + HH
Sbjct: 31 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 173 RNLVNLIGYCVDKGK-YMLIYEFMSNGSL---------------SNLIYSEERVLNWEER 216
N+VNL+G C G M+I EF G+L + L E
Sbjct: 91 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 217 LQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLS----KEEVFDGR 272
+ + ++ G+E+L A IHRDL + NILL K+ DFGL+ K+ + +
Sbjct: 151 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 207
Query: 273 NSGL---KGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-------AIHPHQNLMEY 322
K P I +T++SD++SFGV+++E+ + + +
Sbjct: 208 GDARLPLKWM----APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 263
Query: 323 VNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKI 381
+ ++G + E+ + C H P +RP+ E+ + L +
Sbjct: 264 L------KEG--TRMRAPD--YTT----PEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-38
Identities = 72/293 (24%), Positives = 123/293 (41%), Gaps = 52/293 (17%)
Query: 121 FTNILGQGAFGPVYKAT---MPSGGVA---AIKVLASDSHQGEK-EFQTEVSLLGRLHHR 173
LG GAFG VY+ MP+ A+K L + ++ +F E ++ + +H+
Sbjct: 75 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 134
Query: 174 NLVNLIGYCVDKGKYMLIYEFMSNGSL------SNLIYSEERVLNWEERLQIALDISHGI 227
N+V IG + ++ E M+ G L + S+ L + L +A DI+ G
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194
Query: 228 EYLHEGAVPPVIHRDLKSANILLDHF---MRAKVADFGLSKEEVFDG---RNSGLKGTYG 281
+YL E IHRD+ + N LL AK+ DFG+++ +++ R KG
Sbjct: 195 QYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-DIYRAGYYR----KGGCA 246
Query: 282 YI-----DPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNL-----MEYVNLASMSQ 330
+ P FT K+D +SFGV+++E+ + P+ + +E+V
Sbjct: 247 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV------T 300
Query: 331 DGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQ 383
G +D C + RI +C P RP+ + + + Q
Sbjct: 301 SG--GRMDPPK--NC----PGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-38
Identities = 56/302 (18%), Positives = 122/302 (40%), Gaps = 31/302 (10%)
Query: 91 NHSKDRFTSAPSASGIPRYAYKDIQKATQNFTNILGQGAFGPVYKATMPSGGVAAIKV-- 148
+H + + + ++ + +G G V++ + AIK
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVN 61
Query: 149 LASDSHQGEKEFQTEVSLLGRLHHRNL--VNLIGYCVDKGKYMLIYEFMSNGSLSNLIYS 206
L +Q ++ E++ L +L + + L Y + ++ E N L++ +
Sbjct: 62 LEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKK 120
Query: 207 EERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKE 266
++ ++ ER ++ + +H+ ++H DLK AN L+ K+ DFG++ +
Sbjct: 121 KKS-IDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQ 175
Query: 267 EVFDGRNSGLK---GTYGYIDP-----------AYISTNKFTMKSDIFSFGVIIFELITA 312
D + GT Y+ P S +K + KSD++S G I++ +
Sbjct: 176 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 235
Query: 313 IHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIG 372
P Q ++ ++ D EI + ++++++ + CL + P++R SI
Sbjct: 236 KTPFQQIINQISKLHAIIDPNHEIEFPDIPE----KDLQDVLK---CCLKRDPKQRISIP 288
Query: 373 EV 374
E+
Sbjct: 289 EL 290
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-38
Identities = 59/271 (21%), Positives = 116/271 (42%), Gaps = 47/271 (17%)
Query: 124 ILGQGAFGPVYKAT-MPSGGVAAIKV--LASDSHQGEKEFQTEVSLLGRLHHRNLVNLIG 180
+G+G+FG G IK ++ S + +E + EV++L + H N+V
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 181 YCVDKGKYMLIYEFMSNGSLSNLI-------YSEERVLNWEERLQIALDISHGIEYLHEG 233
+ G ++ ++ G L I + E+++L+W +QI L ++++H+
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW--FVQICL----ALKHVHD- 143
Query: 234 AVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLK---GTYGYIDPAYIST 290
++HRD+KS NI L ++ DFG+++ V + + GT Y+ P
Sbjct: 144 --RKILHRDIKSQNIFLTKDGTVQLGDFGIAR--VLNSTVELARACIGTPYYLSPEICEN 199
Query: 291 NKFTMKSDIFSFGVIIFELITAIHPHQ--NLMEYVNLASMSQDGVDEILDKQLVGACNIQ 348
+ KSDI++ G +++EL T H + ++ V + + +
Sbjct: 200 KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLV----------------LKIISGSFP 243
Query: 349 EV-----RELARIGHKCLHKTPRKRPSIGEV 374
V +L + + + PR RPS+ +
Sbjct: 244 PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSI 274
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-38
Identities = 74/299 (24%), Positives = 133/299 (44%), Gaps = 59/299 (19%)
Query: 121 FTNILGQGAFGPVYKATMPSGGVA--------AIKVLASDSHQGEK-EFQTEVSLLGRL- 170
LG+GAFG V A A+K+L D+ + + + +E+ ++ +
Sbjct: 39 LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 171 HHRNLVNLIGYCVDKGKYMLIYEFMSNGSL---------------SNLIYSEERVLNWEE 215
H+N++NL+G C G +I E+ S G+L ++ E + +++
Sbjct: 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 216 RLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSG 275
+ ++ G+EYL A IHRDL + N+L+ K+ADFGL++ D N
Sbjct: 159 LVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR----DINNID 211
Query: 276 --LKGTYGYI-----DPAYISTNKFTMKSDIFSFGVIIFELIT-AIHP-----HQNLMEY 322
K T G + P + +T +SD++SFGV+++E+ T P + L +
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271
Query: 323 VNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKI 381
+ ++G +DK C E+ + R C H P +RP+ ++ + L +I
Sbjct: 272 L------KEG--HRMDKPA--NCT-NELYMMMR---DCWHAVPSQRPTFKQLVEDLDRI 316
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 3e-38
Identities = 68/290 (23%), Positives = 111/290 (38%), Gaps = 46/290 (15%)
Query: 118 TQNFTNI--LGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRN 174
+F I LGQGAFG V KA AIK + + +EV LL L+H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 175 LVNLIGYCVDKGKYML----------IY---EFMSNGSLSNLIYSEERVLNWEERLQIAL 221
+V +++ ++ ++ E+ NG+L +LI+SE +E ++
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 222 DISHGIEYLHE-GAVPPVIHRDLKSANILLDHFMRAKVADFGLSK--------------- 265
I + Y+H G +IHRDLK NI +D K+ DFGL+K
Sbjct: 124 QILEALSYIHSQG----IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 266 EEVFDGRNSGLKGTYGYIDPAYIS-TNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVN 324
+ GT Y+ + T + K D++S G+I FE+I + +
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILK 239
Query: 325 LASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEV 374
D +++ +I + P KRP +
Sbjct: 240 KLRSVSIEFPPDFDD--------NKMKVEKKIIRLLIDHDPNKRPGARTL 281
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 4e-38
Identities = 63/198 (31%), Positives = 97/198 (48%), Gaps = 16/198 (8%)
Query: 121 FTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIG 180
LG G FG V+ A+K L S F E +L+ +L H+ LV L
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYA 75
Query: 181 YCVDKGKYMLIYEFMSNGSLSN-LIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVI 239
+ Y +I E+M NGSL + L L + L +A I+ G+ ++ E I
Sbjct: 76 VVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY---I 131
Query: 240 HRDLKSANILLDHFMRAKVADFGLS---KEEVFDGRNSGL---KGTYGYIDPAYISTNKF 293
HRDL++ANIL+ + K+ADFGL+ ++ + R K T P I+ F
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT----APEAINYGTF 187
Query: 294 TMKSDIFSFGVIIFELIT 311
T+KSD++SFG+++ E++T
Sbjct: 188 TIKSDVWSFGILLTEIVT 205
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 4e-38
Identities = 78/308 (25%), Positives = 142/308 (46%), Gaps = 64/308 (20%)
Query: 121 FTNILGQGAFGPVYKAT----MPSGGVA--AIKVLASDSHQGEK-EFQTEVSLLGRLHHR 173
LG+G FG V KAT G A+K+L ++ E + +E ++L +++H
Sbjct: 27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 174 NLVNLIGYCVDKGKYMLIYEFMSNGSL-----------------------SNLIYSEERV 210
+++ L G C G +LI E+ GSL S+L + +ER
Sbjct: 87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 211 LNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLS----KE 266
L + + A IS G++YL A ++HRDL + NIL+ + K++DFGLS +E
Sbjct: 147 LTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203
Query: 267 EVFDGRNSGL---KGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHP-----HQ 317
+ + R+ G K + + +T +SD++SFGV+++E++T +P +
Sbjct: 204 DSYVKRSQGRIPVKWM----AIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE 259
Query: 318 NLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377
L + + G +++ C+ E+ R+ +C + P KRP ++++
Sbjct: 260 RLFNLL------KTG--HRMERPD--NCS----EEMYRLMLQCWKQEPDKRPVFADISKD 305
Query: 378 LLKIKQRH 385
L K+ +
Sbjct: 306 LEKMMVKR 313
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 4e-38
Identities = 64/275 (23%), Positives = 111/275 (40%), Gaps = 46/275 (16%)
Query: 124 ILGQGAFGPVYKAT-MPSGGVAAIKV--LASDSHQGEKEFQTEVSLLGRLHHRNLVNLIG 180
+G G++G K G + K S + ++ +EV+LL L H N+V
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 181 YCVDK--GKYMLIYEFMSNGSLSNLI---------YSEERVLNWEERLQIALDISHGIEY 229
+D+ ++ E+ G L+++I EE VL Q+ L ++
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRV--MTQLTL----ALKE 126
Query: 230 LHEGAVPP--VIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLK---GTYGYID 284
H + V+HRDLK AN+ LD K+ DFGL++ + + S K GT Y+
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR--ILNHDTSFAKTFVGTPYYMS 184
Query: 285 PAYISTNKFTMKSDIFSFGVIIFELITAIHP-----HQNLMEYVNLASMSQDGVDEILDK 339
P ++ + KSDI+S G +++EL + P + L + + +
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR--IPYRYSD 242
Query: 340 QLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEV 374
+L + L+ RPS+ E+
Sbjct: 243 ELNEIIT------------RMLNLKDYHRPSVEEI 265
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 5e-38
Identities = 53/201 (26%), Positives = 91/201 (45%), Gaps = 15/201 (7%)
Query: 121 FTNILGQGAFGPVYKATMPSGGVA-----AIKVLASDSHQGEK-EFQTEVSLLGRLHHRN 174
+LG GAFG VYK G AIK L + E E ++ + + +
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78
Query: 175 LVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGA 234
+ L+G C+ LI + M G L + + + + + L + I+ G+ YL +
Sbjct: 79 VCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 235 VPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG----RNSGLKGTYGYIDPAYIST 290
+ +HRDL + N+L+ K+ DFGL+K + G K ++ I
Sbjct: 138 L---VHRDLAARNVLVKTPQHVKITDFGLAK-LLGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 291 NKFTMKSDIFSFGVIIFELIT 311
+T +SD++S+GV ++EL+T
Sbjct: 194 RIYTHQSDVWSYGVTVWELMT 214
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 6e-38
Identities = 66/314 (21%), Positives = 105/314 (33%), Gaps = 38/314 (12%)
Query: 79 FPQKKSQVSWWSNHSKDRFTSAPSASGI---PRYAYKDIQKAT-QNFTNI--LGQGAFGP 132
+ R + AS P Y + Q+F + LG G++G
Sbjct: 13 LGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGE 72
Query: 133 VYKAT-MPSGGVAAIKVLASDSHQGEKEFQ---TEVSLLGRL-HHRNLVNLIGYCVDKGK 187
V+K G + A+K S +G K+ EV ++ H V L + G
Sbjct: 73 VFKVRSKEDGRLYAVKRSMSP-FRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGI 131
Query: 188 YMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSAN 247
L E SL + L + D + +LH + +H D+K AN
Sbjct: 132 LYLQTEL-CGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGL---VHLDVKPAN 187
Query: 248 ILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYIS----TNKFTMKSDIFSFG 303
I L R K+ DFGL E G +G P Y++ + +D+FS G
Sbjct: 188 IFLGPRGRCKLGDFGLLVELGTAGAGEVQEGD-----PRYMAPELLQGSYGTAADVFSLG 242
Query: 304 VIIFELITAI-HPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLH 362
+ I E+ + PH +G ++ L EL + L
Sbjct: 243 LTILEVACNMELPHGG------------EGWQQLRQGYLPPEFTAGLSSELRSVLVMMLE 290
Query: 363 KTPRKRPSIGEVTQ 376
P+ R + +
Sbjct: 291 PDPKLRATAEALLA 304
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 8e-38
Identities = 78/309 (25%), Positives = 137/309 (44%), Gaps = 66/309 (21%)
Query: 121 FTNILGQGAFGPVYKATMPSGG------VAAIKVLASDSHQGEK-EFQTEVSLLGRLHHR 173
+ +G+GAFG V++A P + A+K+L ++ + +FQ E +L+ +
Sbjct: 51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110
Query: 174 NLVNLIGYCVDKGKYMLIYEFMSNGSL-----------------------SNLIYSEERV 210
N+V L+G C L++E+M+ G L + +
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 211 LNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD 270
L+ E+L IA ++ G+ YL E +HRDL + N L+ M K+ADFGLS+ ++
Sbjct: 171 LSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSR-NIYS 226
Query: 271 G---RNSGLKGTYGYI-----DPAYISTNKFTMKSDIFSFGVIIFELIT-AIHP-----H 316
+ I P I N++T +SD++++GV+++E+ + + P H
Sbjct: 227 ADYYK----ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 282
Query: 317 QNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQ 376
+ ++ YV +DG IL C E+ L R C K P RPS + +
Sbjct: 283 EEVIYYV------RDG--NILACPE--NCP-LELYNLMR---LCWSKLPADRPSFCSIHR 328
Query: 377 ALLKIKQRH 385
L ++ +R
Sbjct: 329 ILQRMCERA 337
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 9e-38
Identities = 72/301 (23%), Positives = 131/301 (43%), Gaps = 59/301 (19%)
Query: 121 FTNILGQGAFGPVYKAT--------MPSGGVAAIKVLASDSHQGEK-EFQTEVSLLGRL- 170
LG+G FG V A A+K+L D+ + + + +E+ ++ +
Sbjct: 85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 144
Query: 171 HHRNLVNLIGYCVDKGKYMLIYEFMSNGSL---------------SNLIYSEERVLNWEE 215
H+N++NL+G C G +I E+ S G+L ++ E + +++
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 216 RLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSG 275
+ ++ G+EYL IHRDL + N+L+ K+ADFGL++ D N
Sbjct: 205 LVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLAR----DINNID 257
Query: 276 --LKGTYGYI-----DPAYISTNKFTMKSDIFSFGVIIFELIT-AIHP-----HQNLMEY 322
K T G + P + +T +SD++SFGV+++E+ T P + L +
Sbjct: 258 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 317
Query: 323 VNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIK 382
+ ++G +DK C E+ + R C H P +RP+ ++ + L +I
Sbjct: 318 L------KEG--HRMDKPA--NCT-NELYMMMR---DCWHAVPSQRPTFKQLVEDLDRIL 363
Query: 383 Q 383
Sbjct: 364 T 364
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 1e-37
Identities = 58/194 (29%), Positives = 95/194 (48%), Gaps = 8/194 (4%)
Query: 121 FTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIG 180
LG G FG V+ AT A+K + S + F E +++ L H LV L
Sbjct: 192 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHA 250
Query: 181 YCVDKGKYMLIYEFMSNGSLSN-LIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVI 239
+ +I EFM+ GSL + L E + + + I+ G+ ++ + I
Sbjct: 251 VVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY---I 306
Query: 240 HRDLKSANILLDHFMRAKVADFGLSKEEVFDG--RNSGLKGTYGYIDPAYISTNKFTMKS 297
HRDL++ANIL+ + K+ADFGL++ + G K + P I+ FT+KS
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 366
Query: 298 DIFSFGVIIFELIT 311
D++SFG+++ E++T
Sbjct: 367 DVWSFGILLMEIVT 380
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-37
Identities = 75/299 (25%), Positives = 135/299 (45%), Gaps = 59/299 (19%)
Query: 121 FTNILGQGAFGPVYKATMPSGGVA--------AIKVLASDSHQGEK-EFQTEVSLLGRL- 170
LG+GAFG V A A+K+L SD+ + + + +E+ ++ +
Sbjct: 73 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 132
Query: 171 HHRNLVNLIGYCVDKGKYMLIYEFMSNGSL---------------SNLIYSEERVLNWEE 215
H+N++NL+G C G +I E+ S G+L N ++ E L+ ++
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 216 RLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSK----EEVFDG 271
+ A ++ G+EYL A IHRDL + N+L+ K+ADFGL++ + +
Sbjct: 193 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 249
Query: 272 RNSGL---KGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHP-----HQNLMEY 322
+G K P + +T +SD++SFGV+++E+ T P + L +
Sbjct: 250 TTNGRLPVKWM----APEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 305
Query: 323 VNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKI 381
+ ++G +DK C E+ + R C H P +RP+ ++ + L +I
Sbjct: 306 L------KEG--HRMDKPS--NCT-NELYMMMR---DCWHAVPSQRPTFKQLVEDLDRI 350
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 2e-37
Identities = 55/208 (26%), Positives = 90/208 (43%), Gaps = 38/208 (18%)
Query: 125 LGQGAFGPVYKATMPSGGVA---AIKVLASDSHQGEK-EFQTEVSLLGRLHHRNLVNLIG 180
LG G FG V + AIKVL + + + E E ++ +L + +V LIG
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 181 YCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIH 240
C + ML+ E G L + + + ++ +S G++YL E +H
Sbjct: 78 VCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF---VH 133
Query: 241 RDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYIST---------- 290
RDL + N+LL + AK++DFGLSK D D Y +
Sbjct: 134 RDLAARNVLLVNRHYAKISDFGLSKALGAD-------------DSYYTARSAGKWPLKWY 180
Query: 291 -------NKFTMKSDIFSFGVIIFELIT 311
KF+ +SD++S+GV ++E ++
Sbjct: 181 APECINFRKFSSRSDVWSYGVTMWEALS 208
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-37
Identities = 62/330 (18%), Positives = 132/330 (40%), Gaps = 39/330 (11%)
Query: 65 SAPVANSVAVKASGFPQKKSQVSWWSNHSKDRFTSAPSASGIPRYAYKDIQKATQNFT-- 122
S V +K + + + Q + D A S++ + I + ++
Sbjct: 8 SGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSAN------ECISVKGRIYSIL 61
Query: 123 NILGQGAFGPVYKATMPSGGVAAIKV--LASDSHQGEKEFQTEVSLLGRLHHRNL--VNL 178
+G G V++ + AIK L +Q ++ E++ L +L + + L
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 179 IGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPV 238
Y + ++ E N L++ + ++ ++ ER ++ + +H+ +
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKS-IDPWERKSYWKNMLEAVHTIHQHG---I 176
Query: 239 IHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLK---GTYGYIDP---------- 285
+H DLK AN L+ K+ DFG++ + D + G Y+ P
Sbjct: 177 VHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSR 235
Query: 286 -AYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGA 344
S +K + KSD++S G I++ + P Q ++ ++ D EI +
Sbjct: 236 ENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPE- 294
Query: 345 CNIQEVRELARIGHKCLHKTPRKRPSIGEV 374
++++++ + CL + P++R SI E+
Sbjct: 295 ---KDLQDVLK---CCLKRDPKQRISIPEL 318
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 3e-37
Identities = 61/302 (20%), Positives = 106/302 (35%), Gaps = 57/302 (18%)
Query: 125 LGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCV 183
LG+G F V + G A+K + Q +E Q E + +H N++ L+ YC+
Sbjct: 37 LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCL 96
Query: 184 D----KGKYMLIYEFMSNGSLSNLI---------YSEERVLNWEERLQIALDISHGIEYL 230
K + L+ F G+L N I +E+++L L I G+E +
Sbjct: 97 RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWL------LLGICRGLEAI 150
Query: 231 HEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNS----------GLKGTY 280
H HRDLK NILL + + D G + S + T
Sbjct: 151 HA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207
Query: 281 GYIDPAYISTNK---FTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEIL 337
Y P S ++D++S G +++ ++ P + V S +
Sbjct: 208 SYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP----YDMVFQKGDS-------V 256
Query: 338 DKQLVGACNI-------QEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRHLAKQD 390
+ +I + +L + P +RP I + L ++ +
Sbjct: 257 ALAVQNQLSIPQSPRHSSALWQLLN---SMMTVDPHQRPHIPLLLSQLEALQPPAPGQHT 313
Query: 391 TM 392
T
Sbjct: 314 TQ 315
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 4e-37
Identities = 56/270 (20%), Positives = 115/270 (42%), Gaps = 31/270 (11%)
Query: 123 NILGQGAFGPVYKATMPSGGVAAIKV--LASDSHQGEKEFQTEVSLLGRL--HHRNLVNL 178
+G G V++ + AIK L +Q ++ E++ L +L H ++ L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 179 IGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPV 238
Y + ++ E N L++ + ++ ++ ER ++ + +H+ +
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKS-IDPWERKSYWKNMLEAVHTIHQHG---I 129
Query: 239 IHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLK---GTYGYIDP---------- 285
+H DLK AN L+ K+ DFG++ + D + GT Y+ P
Sbjct: 130 VHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 188
Query: 286 -AYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGA 344
S +K + KSD++S G I++ + P Q ++ ++ D EI +
Sbjct: 189 ENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPE- 247
Query: 345 CNIQEVRELARIGHKCLHKTPRKRPSIGEV 374
++++++ + CL + P++R SI E+
Sbjct: 248 ---KDLQDVLK---CCLKRDPKQRISIPEL 271
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 4e-37
Identities = 65/293 (22%), Positives = 123/293 (41%), Gaps = 56/293 (19%)
Query: 121 FTNILGQGAFGPVYKATMPSGGVA------AIKVLASD-SHQGEKEFQTEVSLLGRLHHR 173
F LG+ FG VYK + AIK L +EF+ E L RL H
Sbjct: 13 FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72
Query: 174 NLVNLIGYCVDKGKYMLIYEFMSNGSL---------------SNLIYSEERVLNWEERLQ 218
N+V L+G +I+ + S+G L ++ + + L + +
Sbjct: 73 NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 219 IALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLS----KEEVFDGRNS 274
+ I+ G+EYL V+H+DL + N+L+ + K++D GL + + +
Sbjct: 133 LVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 189
Query: 275 GL---KGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHP-----HQNLMEYVNL 325
L + P I KF++ SDI+S+GV+++E+ + + P +Q+++E +
Sbjct: 190 SLLPIRWM----APEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI-- 243
Query: 326 ASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQAL 378
++ ++L C + + +C ++ P +RP ++ L
Sbjct: 244 ----RNR--QVLPCP--DDCP----AWVYALMIECWNEFPSRRPRFKDIHSRL 284
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 5e-37
Identities = 53/202 (26%), Positives = 93/202 (46%), Gaps = 17/202 (8%)
Query: 121 FTNILGQGAFGPVYKATMPSGGVA-----AIKVL-ASDSHQGEKEFQTEVSLLGRLHHRN 174
+LG G FG V+K G + IKV+ Q + + +G L H +
Sbjct: 17 KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAH 76
Query: 175 LVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGA 234
+V L+G C L+ +++ GSL + + L + L + I+ G+ YL E
Sbjct: 77 IVRLLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG 135
Query: 235 VPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYI-----DPAYIS 289
+ +HR+L + N+LL + +VADFG++ + + L + I
Sbjct: 136 M---VHRNLAARNVLLKSPSQVQVADFGVAD--LLPPDDKQLLYSEAKTPIKWMALESIH 190
Query: 290 TNKFTMKSDIFSFGVIIFELIT 311
K+T +SD++S+GV ++EL+T
Sbjct: 191 FGKYTHQSDVWSYGVTVWELMT 212
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 5e-37
Identities = 54/203 (26%), Positives = 87/203 (42%), Gaps = 17/203 (8%)
Query: 121 FTNILGQGAFGPVYKAT--MPSGGVA--AIKVL---ASDSHQGEKEFQTEVSLLGRLHHR 173
LG G+FG V + PSG A+K L + +F EV+ + L HR
Sbjct: 22 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 81
Query: 174 NLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEG 233
NL+ L G + ++ E GSL + + + + A+ ++ G+ YL
Sbjct: 82 NLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK 140
Query: 234 AVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRN-----SGLKGTYGYIDPAYI 288
IHRDL + N+LL K+ DFGL + + + K + + P +
Sbjct: 141 RF---IHRDLAARNLLLATRDLVKIGDFGLMR-ALPQNDDHYVMQEHRKVPFAWCAPESL 196
Query: 289 STNKFTMKSDIFSFGVIIFELIT 311
T F+ SD + FGV ++E+ T
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFT 219
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 9e-37
Identities = 75/301 (24%), Positives = 114/301 (37%), Gaps = 53/301 (17%)
Query: 98 TSAPSASGIPRYAYKDIQKATQNFTNILGQGAFGPVYKAT-MPSGGVAAIKVLA----SD 152
+AP A IP + LG+G F ++ + + V A K++
Sbjct: 22 AAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK 81
Query: 153 SHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLN 212
HQ EK E+S+ L H+++V G+ D ++ E SL L + +
Sbjct: 82 PHQREK-MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTE 140
Query: 213 WEER---LQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF 269
E R QI G +YLH V IHRDLK N+ L+ + K+ DFGL+ + +
Sbjct: 141 PEARYYLRQIV----LGCQYLHRNRV---IHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193
Query: 270 DGRNSGLK---GTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHP--HQNLME--- 321
DG K GT YI P +S + + D++S G I++ L+ P L E
Sbjct: 194 DG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL 251
Query: 322 ------YVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVT 375
Y ++ I K L P RP+I E+
Sbjct: 252 RIKKNEYSIPKHINPVAASLI---------------------QKMLQTDPTARPTINELL 290
Query: 376 Q 376
Sbjct: 291 N 291
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 9e-37
Identities = 51/202 (25%), Positives = 90/202 (44%), Gaps = 19/202 (9%)
Query: 121 FTNILGQGAFGPVYKATMPSGGVA----AIKVLASD-SHQGEKEFQTEVSLLGRLHHRNL 175
ILG+G FG VY+ + A+K D + +++F +E ++ L H ++
Sbjct: 16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75
Query: 176 VNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAV 235
V LIG ++ +I E G L + + + L + +L I + YL
Sbjct: 76 VKLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINC 134
Query: 236 PPVIHRDLKSANILLDHFMRAKVADFGLSK---EEVFDGRNSGL---KGTYGYIDPAYIS 289
+HRD+ NIL+ K+ DFGLS+ +E + + K P I+
Sbjct: 135 ---VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM----SPESIN 187
Query: 290 TNKFTMKSDIFSFGVIIFELIT 311
+FT SD++ F V ++E+++
Sbjct: 188 FRRFTTASDVWMFAVCMWEILS 209
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-36
Identities = 59/198 (29%), Positives = 100/198 (50%), Gaps = 16/198 (8%)
Query: 124 ILGQGAFGPVYKATMPSGGVA---AIKVL--ASDSHQGEKEFQTEVSLLGRLHHRNLVNL 178
LG G FG V K V A+K+L ++ + E E +++ +L + +V +
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 179 IGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPV 238
IG C + +ML+ E G L+ + + R + + +++ +S G++YL E
Sbjct: 84 IGIC-EAESWMLVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLEESNF--- 138
Query: 239 IHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYI-----DPAYISTNKF 293
+HRDL + N+LL AK++DFGLSK + N T+G P I+ KF
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECINYYKF 197
Query: 294 TMKSDIFSFGVIIFELIT 311
+ KSD++SFGV+++E +
Sbjct: 198 SSKSDVWSFGVLMWEAFS 215
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-36
Identities = 53/200 (26%), Positives = 91/200 (45%), Gaps = 13/200 (6%)
Query: 121 FTNILGQGAFGPVYKATMPSGGVA-----AIKVLASDSHQGEK-EFQTEVSLLGRLHHRN 174
+LG GAFG VYK G AIK L + E E ++ + + +
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78
Query: 175 LVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGA 234
+ L+G C+ LI + M G L + + + + + L + I+ G+ YL +
Sbjct: 79 VCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 235 VPPVIHRDLKSANILLDHFMRAKVADFGLSKE-EVFDG--RNSGLKGTYGYIDPAYISTN 291
+ +HRDL + N+L+ K+ DFGL+K + G K ++ I
Sbjct: 138 L---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 292 KFTMKSDIFSFGVIIFELIT 311
+T +SD++S+GV ++EL+T
Sbjct: 195 IYTHQSDVWSYGVTVWELMT 214
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 3e-36
Identities = 70/274 (25%), Positives = 107/274 (39%), Gaps = 53/274 (19%)
Query: 125 LGQGAFGPVYKAT-MPSGGVAAIKVLA----SDSHQGEKEFQTEVSLLGRLHHRNLVNLI 179
LG+G F ++ + + V A K++ HQ EK E+S+ L H+++V
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFH 81
Query: 180 GYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEER---LQIALDISHGIEYLHEGAVP 236
G+ D ++ E SL L + + E R QI G +YLH V
Sbjct: 82 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIV----LGCQYLHRNRV- 136
Query: 237 PVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLK---GTYGYIDPAYISTNKF 293
IHRDLK N+ L+ + K+ DFGL+ + +DG K GT YI P +S
Sbjct: 137 --IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG--ERKKVLCGTPNYIAPEVLSKKGH 192
Query: 294 TMKSDIFSFGVIIFELITAIHP--HQNLME---------YVNLASMSQDGVDEILDKQLV 342
+ + D++S G I++ L+ P L E Y ++ I
Sbjct: 193 SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLI------ 246
Query: 343 GACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQ 376
K L P RP+I E+
Sbjct: 247 ---------------QKMLQTDPTARPTINELLN 265
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-36
Identities = 49/199 (24%), Positives = 90/199 (45%), Gaps = 13/199 (6%)
Query: 121 FTNILGQGAFGPVYKATMPSGGVA----AIKVLASDSHQGEK-EFQTEVSLLGRLHHRNL 175
+G+G FG V++ S AIK + + + +F E + + H ++
Sbjct: 19 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 78
Query: 176 VNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAV 235
V LIG + +I E + G L + + + L+ + A +S + YL
Sbjct: 79 VKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF 137
Query: 236 PPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG---RNSGLKGTYGYIDPAYISTNK 292
+HRD+ + N+L+ K+ DFGLS+ + D + S K ++ P I+ +
Sbjct: 138 ---VHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRR 193
Query: 293 FTMKSDIFSFGVIIFELIT 311
FT SD++ FGV ++E++
Sbjct: 194 FTSASDVWMFGVCMWEILM 212
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 5e-36
Identities = 55/214 (25%), Positives = 95/214 (44%), Gaps = 12/214 (5%)
Query: 106 IPRYAYKDIQKATQNFTNILGQGAFGPVYKATMPSGGVA---AIKVLASD-SHQGEKEFQ 161
+ + LG G FG V + AIKVL +E
Sbjct: 325 LKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMM 384
Query: 162 TEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIAL 221
E ++ +L + +V LIG C + ML+ E G L + + + ++
Sbjct: 385 REAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLH 443
Query: 222 DISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSK----EEVFDGRNSGLK 277
+S G++YL E +HR+L + N+LL + AK++DFGLSK ++ + S K
Sbjct: 444 QVSMGMKYLEEKNF---VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 500
Query: 278 GTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT 311
+ P I+ KF+ +SD++S+GV ++E ++
Sbjct: 501 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 534
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 9e-36
Identities = 57/191 (29%), Positives = 86/191 (45%), Gaps = 9/191 (4%)
Query: 125 LGQGAFGPVYKAT-MPSGGVAAIKVLASD---SHQGEKEFQTEVSLLGRLHHRNLVNLIG 180
LG+G FG VY A S + A+KVL E + + EV + L H N++ L G
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 181 YCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIH 240
Y D + LI E+ G++ + + ++++ + Y H V IH
Sbjct: 77 YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-TYITELANALSYCHSKRV---IH 132
Query: 241 RDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIF 300
RD+K N+LL K+ADFG S R + L GT Y+ P I K D++
Sbjct: 133 RDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLW 191
Query: 301 SFGVIIFELIT 311
S GV+ +E +
Sbjct: 192 SLGVLCYEFLV 202
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-35
Identities = 57/309 (18%), Positives = 103/309 (33%), Gaps = 39/309 (12%)
Query: 75 KASGFPQKKSQVSWWSNHSKDRFTSAPSASGIPRYAYKDIQKATQNFTNILGQGAFGPVY 134
+ ++ N R + +G+G+FG V+
Sbjct: 21 SSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQ-----PRVGRGSFGEVH 75
Query: 135 KAT-MPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYE 193
+ +G A+K + + + E+ L +V L G + + E
Sbjct: 76 RMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVNIFME 130
Query: 194 FMSNGSLSNLI-----YSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANI 248
+ GSL LI E+R L G+EYLH ++H D+K+ N+
Sbjct: 131 LLEGGSLGQLIKQMGCLPEDRALY------YLGQALEGLEYLHTRR---ILHGDVKADNV 181
Query: 249 LLDHF-MRAKVADFGLSKEEVFDGRNSG------LKGTYGYIDPAYISTNKFTMKSDIFS 301
LL RA + DFG + DG + GT ++ P + K DI+S
Sbjct: 182 LLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWS 241
Query: 302 FGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCL 361
++ ++ HP + + +++ +C + + + L
Sbjct: 242 SCCMMLHMLNGCHPWTQYFR---GPLCLKIASEPPPIREIPPSCA-PLTAQAIQ---EGL 294
Query: 362 HKTPRKRPS 370
K P R S
Sbjct: 295 RKEPVHRAS 303
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 7e-35
Identities = 54/288 (18%), Positives = 107/288 (37%), Gaps = 47/288 (16%)
Query: 118 TQNFTNI--LGQGAFGPVYKAT-MPSGGVAAIKV--LASDSHQGEKEFQTEVSLLGRL-H 171
T F + +G G FG V+K G + AIK E+ EV L
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 172 HRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNW--EERLQ-IALDISHGIE 228
H ++V + ++ E+ + GSL++ I R++++ E L+ + L + G+
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 229 YLHEGAVPPVIHRDLKSANILLDH-------------------FMRAKVADFGLSKEEVF 269
Y+H ++ +H D+K +NI + + K+ D G
Sbjct: 130 YIHSMSL---VHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR--I 184
Query: 270 DGRNSGLKGTYGYIDPAYISTNK-FTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASM 328
+G ++ + N K+DIF+ + + A +N ++ +
Sbjct: 185 SSPQV-EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQG 243
Query: 329 SQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQ 376
+ ++L ++ EL + +H P +RPS + +
Sbjct: 244 RLPRIPQVLSQEF---------TELLK---VMIHPDPERRPSAMALVK 279
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 9e-35
Identities = 67/300 (22%), Positives = 117/300 (39%), Gaps = 39/300 (13%)
Query: 101 PSASGIPRYAYKDIQKATQNFTNILGQGAFGPVYKAT--MPSGGVA--AIKVLASD-SHQ 155
+P +IQ+ +G+G FG V++ P AIK + S
Sbjct: 374 EDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDS 433
Query: 156 GEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEE 215
++F E + + H ++V LIG + +I E + G L + + + L+
Sbjct: 434 VREKFLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKFSLDLAS 492
Query: 216 RLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSK----EEVFDG 271
+ A +S + YL +HRD+ + N+L+ K+ DFGLS+ +
Sbjct: 493 LILYAYQLSTALAYLESKRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA 549
Query: 272 RNSGL--KGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNL-----MEYV 323
L K P I+ +FT SD++ FGV ++E++ + P Q + + +
Sbjct: 550 SKGKLPIKWM----APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 605
Query: 324 NLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQ 383
++G E L C L + KC P +RP E+ L I +
Sbjct: 606 ------ENG--ERLPMPP--NCP----PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-34
Identities = 63/286 (22%), Positives = 114/286 (39%), Gaps = 46/286 (16%)
Query: 112 KDIQKATQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRL- 170
+ K + ++LG GA G + M A+K + + EV LL
Sbjct: 19 VIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESD 75
Query: 171 HHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYL 230
H N++ D+ + E + +L + ++ E + + + G+ +L
Sbjct: 76 EHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHL 134
Query: 231 HE-GAVPPVIHRDLKSANILL-----DHFMRAKVADFGLSKEEVFD----GRNSGLKGTY 280
H ++HRDLK NIL+ ++A ++DFGL K+ R SG+ GT
Sbjct: 135 HSLN----IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTE 190
Query: 281 GYIDPAYISTN---KFTMKSDIFSFGVIIFELITA-IHP--HQNLMEY------VNLASM 328
G+I P +S + T DIFS G + + +I+ HP + +L +
Sbjct: 191 GWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCL 250
Query: 329 SQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEV 374
+ ++++ ++L+ K + P+KRPS V
Sbjct: 251 HPEKHEDVIARELIE---------------KMIAMDPQKRPSAKHV 281
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-34
Identities = 65/268 (24%), Positives = 114/268 (42%), Gaps = 40/268 (14%)
Query: 125 LGQGAFGPVYKAT-MPSGGVAAIKVLASD---SHQGEKEFQTEVSLLGRLHHRNLVNLIG 180
LG+G+F VY+A + +G AIK++ + Q EV + +L H +++ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 181 YCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIH 240
Y D L+ E NG ++ + + + + E I G+ YLH + +H
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGI---LH 135
Query: 241 RDLKSANILLDHFMRAKVADFGLS-KEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDI 299
RDL +N+LL M K+ADFGL+ + ++ ++ L GT YI P + + ++SD+
Sbjct: 136 RDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDV 195
Query: 300 FSFGVIIFELITAIHP--HQNLM---------EYVNLASMSQDGVDEILDKQLVGACNIQ 348
+S G + + L+ P + +Y + +S + D I
Sbjct: 196 WSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLI------------ 243
Query: 349 EVRELARIGHKCLHKTPRKRPSIGEVTQ 376
H+ L + P R S+ V
Sbjct: 244 ---------HQLLRRNPADRLSLSSVLD 262
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-34
Identities = 69/346 (19%), Positives = 122/346 (35%), Gaps = 42/346 (12%)
Query: 120 NFTNILGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKE-FQTEVSLLGRLHHRNLVN 177
++ILGQGA V++ +G + AIKV + S + E +L +L+H+N+V
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 178 LIGY--CVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEER--LQIALDISHGIEYLHEG 233
L +LI EF GSL ++ E L + D+ G+ +L E
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN 131
Query: 234 AVPPVIHRDLKSANILL----DHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYIS 289
+ +HR++K NI+ D K+ DFG ++E D + L GT Y+ P
Sbjct: 132 GI---VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYE 188
Query: 290 TN--------KFTMKSDIFSFGVIIFELITAIHP---------HQNLME------YVNLA 326
K+ D++S GV + T P ++ +M
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAI 248
Query: 327 SMSQDGVDEILDKQLVGACNIQEVRELARIGH----KCLHKTPRKRPSIGEVTQALLKIK 382
S Q + +D + R L + L K + I
Sbjct: 249 SGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308
Query: 383 QRHLAKQDTMSFADGE--FSRAVSRIEDQQVELSKLAEVKERHEEC 426
R + ++ + + + + K ++ ++E
Sbjct: 309 HRMVIHVFSLQQMTAHKIYIHSYNTATIFHELVYKQTKIISSNQEL 354
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 4e-34
Identities = 55/203 (27%), Positives = 89/203 (43%), Gaps = 11/203 (5%)
Query: 125 LGQGAFGPVYKA-TMPSGGVAAIKVLASD---SHQGEKEFQTEVSLLGRLHHRNLVNLIG 180
LG+G FG VY A + + A+KVL E + + E+ + L H N++ +
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 181 YCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIH 240
Y D+ + L+ EF G L + R + +++ + Y HE V IH
Sbjct: 82 YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFME-ELADALHYCHERKV---IH 137
Query: 241 RDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIF 300
RD+K N+L+ + K+ADFG S R + GT Y+ P I K D++
Sbjct: 138 RDIKPENLLMGYKGELKIADFGWSV-HAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLW 196
Query: 301 SFGVIIFELITAIHP--HQNLME 321
GV+ +E + + P + E
Sbjct: 197 CAGVLCYEFLVGMPPFDSPSHTE 219
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 8e-34
Identities = 69/315 (21%), Positives = 129/315 (40%), Gaps = 31/315 (9%)
Query: 69 ANSVAVKASGFPQKKSQVSWWSNHSKDRFTSAPSASGIPRYAYKDIQKATQNFTNILGQG 128
++ V + + V+ K G PR K +G+G
Sbjct: 8 SSGVDLGTENLYFQSGVVT--HEQFKAALRMVVD-QGDPRLLLDSYVK--------IGEG 56
Query: 129 AFGPVYKAT-MPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGK 187
+ G V A SG A+K++ Q + EV ++ H N+V + + +
Sbjct: 57 STGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEE 116
Query: 188 YMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSAN 247
++ EF+ G+L++++ + LN E+ + + + YLH VIHRD+KS +
Sbjct: 117 LWVLMEFLQGGALTDIV--SQVRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDS 171
Query: 248 ILLDHFMRAKVADFGLSKE--EVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVI 305
ILL R K++DFG + + R S L GT ++ P IS + + + DI+S G++
Sbjct: 172 ILLTLDGRVKLSDFGFCAQISKDVPKRKS-LVGTPYWMAPEVISRSLYATEVDIWSLGIM 230
Query: 306 IFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTP 365
+ E++ P+ + + + ++ + V L + L + P
Sbjct: 231 VIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVS-------PVLRDFLERMLVRDP 283
Query: 366 RKRPSIGEVTQALLK 380
++R + Q LL
Sbjct: 284 QERAT----AQELLD 294
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 9e-34
Identities = 68/280 (24%), Positives = 126/280 (45%), Gaps = 34/280 (12%)
Query: 107 PRYAYKDIQKATQNFTNILGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKEFQTEVS 165
P+ Y +K +GQGA G VY A + +G AI+ + ++ E+
Sbjct: 18 PKKKYTRFEK--------IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEIL 69
Query: 166 LLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIAL---D 222
++ + N+VN + + + ++ E+++ GSL++++ E ++ E QIA +
Sbjct: 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMD-EG--QIAAVCRE 124
Query: 223 ISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKE--EVFDGRNSGLKGTY 280
+E+LH VIHRD+KS NILL K+ DFG + R++ + GT
Sbjct: 125 CLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTP 180
Query: 281 GYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQ 340
++ P ++ + K DI+S G++ E+I P+ N L ++ +G E+ + +
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPE 240
Query: 341 LVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLK 380
+ ++CL KR S + LL+
Sbjct: 241 KLS-------AIFRDFLNRCLEMDVEKRGS----AKELLQ 269
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-33
Identities = 64/241 (26%), Positives = 110/241 (45%), Gaps = 28/241 (11%)
Query: 91 NHSKDRFTSAPSASGIPRYAYKDIQKATQNFTNILGQGAFGPVYKAT-MPSGGVAAIKVL 149
+ K R P ++ + + LG GAFG VYKA +G +AA KV+
Sbjct: 1 SMRKSREYEHVRRDLDPNEVWEIVGE--------LGDGAFGKVYKAKNKETGALAAAKVI 52
Query: 150 ASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEER 209
+ S + +++ E+ +L H +V L+G GK ++ EF G++ ++ +R
Sbjct: 53 ETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDR 112
Query: 210 VLNWEERLQIAL---DISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKE 266
L E QI + + + +LH +IHRDLK+ N+L+ ++ADFG+S +
Sbjct: 113 GLT-EP--QIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAK 166
Query: 267 --EVFDGRNSGLKGTYGY------IDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQN 318
+ R+S GT Y + + + K+DI+S G+ + E+ PH
Sbjct: 167 NLKTLQKRDS-FIGT-PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE 224
Query: 319 L 319
L
Sbjct: 225 L 225
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-33
Identities = 67/302 (22%), Positives = 115/302 (38%), Gaps = 40/302 (13%)
Query: 120 NFTNILGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKE-FQTEVSLLGRLHHRNLVN 177
++ILGQGA V++ +G + AIKV + S + E +L +L+H+N+V
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 178 LIGY--CVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEER--LQIALDISHGIEYLHEG 233
L +LI EF GSL ++ E L + D+ G+ +L E
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN 131
Query: 234 AVPPVIHRDLKSANILL----DHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYIS 289
+ +HR++K NI+ D K+ DFG ++E D + L GT Y+ P
Sbjct: 132 GI---VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYE 188
Query: 290 TN--------KFTMKSDIFSFGVIIFELITAIHP---------HQNLME------YVNLA 326
K+ D++S GV + T P ++ +M
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAI 248
Query: 327 SMSQDGVDEILD--KQLVGACNI-QEVRELAR-IGHKCLHKTPRKRPSIGEVTQALLKIK 382
S Q + +D + +C++ + ++ L + L K + I
Sbjct: 249 SGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308
Query: 383 QR 384
R
Sbjct: 309 HR 310
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-33
Identities = 65/237 (27%), Positives = 111/237 (46%), Gaps = 24/237 (10%)
Query: 90 SNHSKDRFTSAPSASGIPRYAYKDIQKATQNFTNILGQGAFGPVYKAT-MPSGGVAAIKV 148
+ + + P + ++K +G+G+FG V+K + V AIK+
Sbjct: 3 HSPVQSGLPGMQNLKADPEELFTKLEK--------IGKGSFGEVFKGIDNRTQKVVAIKI 54
Query: 149 LASDSHQGEKE-FQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSE 207
+ + + E E Q E+++L + + G + K +I E++ GS +L+ E
Sbjct: 55 IDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL--E 112
Query: 208 ERVLNWEERLQIAL---DISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLS 264
L+ E QIA +I G++YLH IHRD+K+AN+LL K+ADFG++
Sbjct: 113 PGPLD-ET--QIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVA 166
Query: 265 KE--EVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNL 319
+ + RN+ GT ++ P I + + K+DI+S G+ EL PH L
Sbjct: 167 GQLTDTQIKRNT-FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 222
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 6e-33
Identities = 72/300 (24%), Positives = 121/300 (40%), Gaps = 33/300 (11%)
Query: 98 TSAPSASGIPRYAYKDIQKATQNFTNILGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQG 156
S+ I R Y+ + +G GA V A P AIK + + Q
Sbjct: 4 DSSALPWSINRDDYELQEV--------IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQT 55
Query: 157 EKE-FQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEE 215
+ E+ + + HH N+V+ V K + L+ + +S GS+ ++I +
Sbjct: 56 SMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKS 115
Query: 216 RL----QIAL---DISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEV 268
+ IA ++ G+EYLH+ IHRD+K+ NILL ++ADFG+S +
Sbjct: 116 GVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSA-FL 171
Query: 269 FDGRNSGLK-------GTYGYIDPAYISTNK-FTMKSDIFSFGVIIFELITAIHPHQNLM 320
G + GT ++ P + + + K+DI+SFG+ EL T P+
Sbjct: 172 ATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYP 231
Query: 321 EYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLK 380
L Q+ + + + ++ CL K P KRP+ LL+
Sbjct: 232 PMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPT----AAELLR 287
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 8e-33
Identities = 68/280 (24%), Positives = 123/280 (43%), Gaps = 34/280 (12%)
Query: 107 PRYAYKDIQKATQNFTNILGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKEFQTEVS 165
P + ++K LG+G++G VYKA +G + AIK + +E E+S
Sbjct: 27 PEEVFDVLEK--------LGEGSYGSVYKAIHKETGQIVAIKQV--PVESDLQEIIKEIS 76
Query: 166 LLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIAL---D 222
++ + ++V G ++ E+ GS+S++I + L E+ +IA
Sbjct: 77 IMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLT-ED--EIATILQS 133
Query: 223 ISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKE--EVFDGRNSGLKGTY 280
G+EYLH IHRD+K+ NILL+ AK+ADFG++ + + RN+ + GT
Sbjct: 134 TLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT-VIGTP 189
Query: 281 GYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQ 340
++ P I + +DI+S G+ E+ P+ ++ + + + +
Sbjct: 190 FWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPE 249
Query: 341 LVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLK 380
L +CL K+P +R + LL+
Sbjct: 250 LWS-------DNFTDFVKQCLVKSPEQRAT----ATQLLQ 278
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-32
Identities = 63/285 (22%), Positives = 106/285 (37%), Gaps = 40/285 (14%)
Query: 125 LGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRL-HHRNLVNLIGYC 182
L +G F VY+A + SG A+K L S+ + + EV + +L H N+V
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 183 V-------DKGKYMLIYEFMSNGSLSNLIYSEERV--LNWEERLQIALDISHGIEYLHEG 233
L+ + G L + E L+ + L+I ++++H
Sbjct: 96 SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR- 154
Query: 234 AVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYID--------P 285
PP+IHRDLK N+LL + K+ DFG + S ++ P
Sbjct: 155 QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTP 214
Query: 286 AYIS-------TNK-FTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEIL 337
Y + +N K DI++ G I++ L HP ++ I+
Sbjct: 215 MYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED------------GAKLRIV 262
Query: 338 DKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIK 382
+ + + + + L P +R SI EV L +I
Sbjct: 263 NGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA 307
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 6e-32
Identities = 52/287 (18%), Positives = 100/287 (34%), Gaps = 42/287 (14%)
Query: 125 LGQGAFGPVYKATMPSGGVAAIKVL-----------------ASDSHQGEKEFQTEVSLL 167
L QG F + A+K +F+ E+ ++
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 168 GRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERV-------LNWEERLQIA 220
+ + + G + + +IYE+M N S+ + + + I
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 221 LDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTY 280
+ + Y+H + HRD+K +NIL+D R K++DFG S+ V D + G +GTY
Sbjct: 158 KSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV-DKKIKGSRGTY 214
Query: 281 GYIDPAYISTNKFT--MKSDIFSFGVIIFELITAIHP------HQNLMEYVNLASMS--- 329
++ P + S K DI+S G+ ++ + + P L + ++
Sbjct: 215 EFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPL 274
Query: 330 QDGVDEILDKQLVGACNIQEVRELAR--IGHKCLHKTPRKRPSIGEV 374
C+ + + L K P +R + +
Sbjct: 275 DRNHFLYPLTNKKSTCSNNFLSNEDIDFL-KLFLRKNPAERITSEDA 320
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-31
Identities = 65/283 (22%), Positives = 105/283 (37%), Gaps = 30/283 (10%)
Query: 121 FTNILGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKE-FQTEVSLLGRLHHRNLVNL 178
LG G FG V + +G AIK + +E + E+ ++ +L+H N+V+
Sbjct: 18 MKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSA 77
Query: 179 I------GYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEER--LQIALDISHGIEYL 230
+L E+ G L + E +E + DIS + YL
Sbjct: 78 REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL 137
Query: 231 HEGAVPPVIHRDLKSANILLD---HFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAY 287
HE + IHRDLK NI+L + K+ D G +KE + GT Y+ P
Sbjct: 138 HENRI---IHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPEL 194
Query: 288 ISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNI 347
+ K+T+ D +SFG + FE IT P + V ++ +E + +
Sbjct: 195 LEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAV 254
Query: 348 QEVRELARIGHKC--------------LHKTPRKRPSIGEVTQ 376
+ L H L R+R + +
Sbjct: 255 KFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPN 297
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-31
Identities = 44/233 (18%), Positives = 87/233 (37%), Gaps = 35/233 (15%)
Query: 112 KDIQKATQNFT--NILGQGAFGPVYKAT------MPSGGVAAIKVLASDSHQGEKEFQTE 163
+ Q ++ ++LG+GAF VY+AT + +KV + EF
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIG 114
Query: 164 VSLLGRL---HHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLI----YSEERVLNWEER 216
L+ RL + + + +L+ E S G+L N I + E+V+
Sbjct: 115 TQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLV 174
Query: 217 LQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRA-----------KVADFGLSK 265
+ A+ + + IE +H+ +IH D+K N +L + + D G S
Sbjct: 175 ISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231
Query: 266 EEVFDGRNSGLK---GTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHP 315
+ + + T G+ +S + + D F ++ ++ +
Sbjct: 232 DMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-31
Identities = 68/301 (22%), Positives = 112/301 (37%), Gaps = 53/301 (17%)
Query: 111 YKDIQKATQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRL 170
++ K ILG G+ G V G A+K + D E+ LL
Sbjct: 9 FEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFC---DIALMEIKLLTES 65
Query: 171 -HHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLI----YSEERVLNWEER--LQIALDI 223
H N++ + E N +L +L+ S+E + +E + + I
Sbjct: 66 DDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQI 124
Query: 224 SHGIEYLHE-GAVPPVIHRDLKSANILLDH-------------FMRAKVADFGLSK---- 265
+ G+ +LH +IHRDLK NIL+ +R ++DFGL K
Sbjct: 125 ASGVAHLHSLK----IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180
Query: 266 -EEVFDGRNSGLKGTYGYIDPAYIS-------TNKFTMKSDIFSFGVIIFELITA-IHP- 315
+ F + GT G+ P + + T DIFS G + + +++ HP
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240
Query: 316 HQNLMEYVNL--ASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGE 373
N+ S D + + D+ L I E +L + + P KRP+ +
Sbjct: 241 GDKYSRESNIIRGIFSLDEMKCLHDRSL-----IAEATDLIS---QMIDHDPLKRPTAMK 292
Query: 374 V 374
V
Sbjct: 293 V 293
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-30
Identities = 78/332 (23%), Positives = 130/332 (39%), Gaps = 51/332 (15%)
Query: 63 DFSAPVANSVAVKASGFPQKKSQVSWWSNHSKDRFTSAPSASGIPRYAYKDIQKATQNFT 122
D+ P ++ + + P + KD + P + D+++
Sbjct: 11 DYDIPTTENLYFQGAMDPMPAGGRA---GSLKDPDVAELFFKDDPEKLFSDLRE------ 61
Query: 123 NILGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGE---KEFQTEVSLLGRLHHRNLVNL 178
+G G+FG VY A + + V AIK ++ Q ++ EV L +L H N +
Sbjct: 62 --IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 179 IGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIAL---DISHGIEYLHEGAV 235
G + + L+ E+ GS S+L+ ++ L E +IA G+ YLH +
Sbjct: 120 RGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQ-EV--EIAAVTHGALQGLAYLHSHNM 175
Query: 236 PPVIHRDLKSANILLDHFMRAKVADFG----LSKEEVFDGRNSGLKGTYGYIDPAYISTN 291
IHRD+K+ NILL K+ DFG ++ NS GT ++ P I
Sbjct: 176 ---IHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANS-FVGTPYWMAPEVILAM 225
Query: 292 K---FTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQ 348
+ K D++S G+ EL P N+ L ++Q+ +
Sbjct: 226 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW------- 278
Query: 349 EVRELARIGHKCLHKTPRKRPSIGEVTQALLK 380
CL K P+ RP+ ++ LLK
Sbjct: 279 -SEYFRNFVDSCLQKIPQDRPT----SEVLLK 305
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 6e-30
Identities = 60/286 (20%), Positives = 112/286 (39%), Gaps = 42/286 (14%)
Query: 125 LGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGE-KEFQTEVSLLGRLHHRNLVNLIGYC 182
LG G G V+K + PSG V A K++ + + E+ +L + +V G
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 100
Query: 183 VDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERL-QIALDISHGIEYLHEGAVPPVIHR 241
G+ + E M GSL ++ R+ E+ L ++++ + G+ YL E ++HR
Sbjct: 101 YSDGEISICMEHMDGGSLDQVLKKAGRIP--EQILGKVSIAVIKGLTYLRE--KHKIMHR 156
Query: 242 DLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFS 301
D+K +NIL++ K+ DFG+S + + NS + GT Y+ P + ++++SDI+S
Sbjct: 157 DVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-GTRSYMSPERLQGTHYSVQSDIWS 215
Query: 302 FGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGH--- 358
G+ + E+ +P + + + + +
Sbjct: 216 MGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPM 275
Query: 359 -------------------------------KCLHKTPRKRPSIGE 373
KCL K P +R + +
Sbjct: 276 AIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 321
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 7e-30
Identities = 56/382 (14%), Positives = 99/382 (25%), Gaps = 81/382 (21%)
Query: 51 HPIRINGLGTSIDFSAPVANSVAVKASGFPQKKSQVSWWSNHSKDRFTSAPSASGIPRYA 110
H + ++ F P + + PQ + + S S S S
Sbjct: 3 HHHHHSSGRENLYFQGPGDVVIEELFNRIPQANVRTTSEYMQS--AADSLVSTSLWNTGQ 60
Query: 111 YKDIQKATQNFTN------ILGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKE---- 159
++ +LGQ +AT +G + V
Sbjct: 61 PFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQM 120
Query: 160 ------------------------FQTEVSLLGRLHHRNLVNLIGYCVDKG--KYMLIYE 193
F L+ + ++ + D +Y
Sbjct: 121 KEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYP 180
Query: 194 FMSNGSLSNLI------YSEERVLNWEERLQIALDISHGIEYLHE-GAVPPVIHRDLKSA 246
M +L S + L RLQ+ L + + LH G ++H L+
Sbjct: 181 RMQ-SNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPV 235
Query: 247 NILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTN-----------KFTM 295
+I+LD + F DG + G+ P + T
Sbjct: 236 DIVLDQRGGVFLTGFEHLVR---DGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTF 292
Query: 296 KSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNI-QEVRELA 354
D ++ G++I+ + A P +D + NI Q VR L
Sbjct: 293 SFDAWALGLVIYWIWCADLPIT------------KDAALGGSEWIFRSCKNIPQPVRALL 340
Query: 355 RIGHKCLHKTPRKRPSIGEVTQ 376
L R + +
Sbjct: 341 E---GFLRYPKEDRLLPLQAME 359
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 7e-30
Identities = 38/330 (11%), Positives = 71/330 (21%), Gaps = 53/330 (16%)
Query: 90 SNHSKDRFTSAPSASGIPRYAYKDIQKATQNFT--NILGQGAFGPVYKAT-MPSGGVAAI 146
+ T+ + + + L G V+ + A+
Sbjct: 33 PAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFAL 92
Query: 147 KVLASDSHQGEKE---FQTEVSLLGRLHHRNLVNLIGYC--------------------- 182
KV + E RL +
Sbjct: 93 KVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLS 152
Query: 183 -----VDKGKYMLIYEFMSNGSLSNLI------YSEERVLNWEERLQIALDISHGIEYLH 231
Y+L+ S L L Y + + L
Sbjct: 153 PGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ 211
Query: 232 E-GAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYI-- 288
G ++H N+ + R + D + R Y ++
Sbjct: 212 SKG----LVHGHFTPDNLFIMPDGRLMLGDVSALWKV--GTRGPASSVPVTYAPREFLNA 265
Query: 289 STNKFTMKSDIFSFGVIIFELITAIHP-HQNLMEYVNLASMSQDGVDEILDKQLVGACNI 347
ST FT + + G+ I+ + P V +
Sbjct: 266 STATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPL 325
Query: 348 -QEVRELARIGHKCLHKTPRKRPSIGEVTQ 376
V+ L + L+ R+R E +
Sbjct: 326 PDFVKTLIG---RFLNFDRRRRLLPLEAME 352
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-29
Identities = 72/287 (25%), Positives = 110/287 (38%), Gaps = 51/287 (17%)
Query: 114 IQKATQNFTN------ILGQGAFGPVYKATMPSGGVA-AIKVL--ASDSHQGEKEFQTEV 164
I + + LG GA+G V V AIK++ S S + EV
Sbjct: 28 ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEV 87
Query: 165 SLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLI-----YSEERVLNWEERLQI 219
++L L H N++ L + DK Y L+ E G L + I ++E I
Sbjct: 88 AVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAV------I 141
Query: 220 ALDISHGIEYLHEGAVPPVIHRDLKSANILL---DHFMRAKVADFGLSKEEVFDGRNSGL 276
+ G+ YLH+ ++HRDLK N+LL + K+ DFGLS +
Sbjct: 142 IKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKER 198
Query: 277 KGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEI 336
GT YI P + K+ K D++S GVI+F L+ P EI
Sbjct: 199 LGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGG------------QTDQEI 245
Query: 337 LDKQLVGACNI---------QEVRELARIGHKCLHKTPRKRPSIGEV 374
L K G + ++L + + L ++R S +
Sbjct: 246 LRKVEKGKYTFDSPEWKNVSEGAKDLIK---QMLQFDSQRRISAQQA 289
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 7e-29
Identities = 64/269 (23%), Positives = 110/269 (40%), Gaps = 31/269 (11%)
Query: 125 LGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGE-KEFQTEVSLLGRLH-HRNLVNLIGY 181
+G G G V+K +G V A+K + ++ E K ++ ++ + H +V G
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 182 CVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERL-QIALDISHGIEYLHEGAVPPVIH 240
+ + E M L + + E L ++ + I + YL E VIH
Sbjct: 93 FITNTDVFIAMELM-GTCAEKLKKRMQGPIP-ERILGKMTVAIVKALYYLKE--KHGVIH 148
Query: 241 RDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLK----GTYGY-----IDPAYISTN 291
RD+K +NILLD + K+ DFG+S V + K G Y IDP +
Sbjct: 149 RDVKPSNILLDERGQIKLCDFGISGRLV----DDKAKDRSAGCAAYMAPERIDPPDPTKP 204
Query: 292 KFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVR 351
+ +++D++S G+ + EL T P++N + + +L ++
Sbjct: 205 DYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPG------HMGFSG 258
Query: 352 ELARIGHKCLHKTPRKRPSIGEVTQALLK 380
+ CL K RKRP + LL+
Sbjct: 259 DFQSFVKDCLTKDHRKRPKYNK----LLE 283
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-28
Identities = 63/355 (17%), Positives = 115/355 (32%), Gaps = 81/355 (22%)
Query: 92 HSKDRFTSAPSASGIPRYA-----YKDIQKATQNFTNILGQGA--FGPVYKAT-MPSGGV 143
H G+ + Y+ + +G+G V A P+G
Sbjct: 3 HHHHHHMENLYFQGMSSFLPEGGCYELLTV--------IGKGFEDLMTVNLARYKPTGEY 54
Query: 144 AAIKV--LASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLS 201
++ L + S++ Q E+ + +H N+V + + ++ FM+ GS
Sbjct: 55 VTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAK 114
Query: 202 NLI-YSEERVLNWEERLQIAL---DISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAK 257
+LI +N E IA + ++Y+H +HR +K+++IL+ +
Sbjct: 115 DLICTHFMDGMN-EL--AIAYILQGVLKALDYIHHMGY---VHRSVKASHILISVDGKVY 168
Query: 258 VADFGLS--------KEEVFDGRNSGLKGTYGYIDPAYISTNK--FTMKSDIFSFGVIIF 307
++ + ++ V ++ P + N + KSDI+S G+
Sbjct: 169 LSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITAC 228
Query: 308 ELITA------IHPHQNLMEYVN-----LASMSQDGVDEILDKQLVGACNIQEVRELARI 356
EL + Q L+E +N L S +E+ N L
Sbjct: 229 ELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTS 288
Query: 357 GH-------------------------KCLHKTPRKRPSIGEVTQALLK---IKQ 383
+CL + P RPS LL KQ
Sbjct: 289 TPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSAST----LLNHSFFKQ 339
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-28
Identities = 66/272 (24%), Positives = 117/272 (43%), Gaps = 36/272 (13%)
Query: 125 LGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGE-KEFQTEVS-LLGRLHHRNLVNLIGY 181
LG+GA+G V K +PSG + A+K + + + E K ++ + + V G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 182 CVDKGKYMLIYEFMSNGSLSNL---IYSEERVLNWEERL-QIALDISHGIEYLHEGAVPP 237
+G + E M + SL + + + + E+ L +IA+ I +E+LH
Sbjct: 75 LFREGDVWICMELM-DTSLDKFYKQVIDKGQTIP-EDILGKIAVSIVKALEHLHS--KLS 130
Query: 238 VIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLK----GTYGY-----IDPAYI 288
VIHRD+K +N+L++ + K+ DFG+S V + K G Y I+P +
Sbjct: 131 VIHRDVKPSNVLINALGQVKMCDFGISGYLV----DDVAKDIDAGCKPYMAPERINPE-L 185
Query: 289 STNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQ 348
+ +++KSDI+S G+ + EL P+ + + L
Sbjct: 186 NQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFS----- 240
Query: 349 EVRELARIGHKCLHKTPRKRPSIGEVTQALLK 380
E +CL K ++RP+ E L++
Sbjct: 241 --AEFVDFTSQCLKKNSKERPTYPE----LMQ 266
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 74/288 (25%), Positives = 118/288 (40%), Gaps = 52/288 (18%)
Query: 114 IQKATQNFTN------ILGQGAFGPVYKATM-PSGGVAAIKVLA---SDSHQGEKEFQTE 163
+Q +T F++ +LG+G+FG V +G A+KV++ ++ E
Sbjct: 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76
Query: 164 VSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLI-----YSEERVLNWEERLQ 218
V LL +L H N++ L + DKG + L+ E + G L + I +SE
Sbjct: 77 VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR------ 130
Query: 219 IALDISHGIEYLHEGAVPPVIHRDLKSANILL---DHFMRAKVADFGLSKEEVFDGRNSG 275
I + GI Y+H+ ++HRDLK N+LL ++ DFGLS +
Sbjct: 131 IIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD 187
Query: 276 LKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDE 335
GT YI P + + K D++S GVI++ L++ P E +
Sbjct: 188 KIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPPFNGANE------------YD 234
Query: 336 ILDKQLVGACNI---------QEVRELARIGHKCLHKTPRKRPSIGEV 374
IL K G + ++L R K L P R S +
Sbjct: 235 ILKKVEKGKYTFELPQWKKVSESAKDLIR---KMLTYVPSMRISARDA 279
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 54/328 (16%), Positives = 94/328 (28%), Gaps = 71/328 (21%)
Query: 124 ILGQGAFGPVYKATMPSGG-VAAIKVLASDSHQGE---KEFQTEVSLLGRL--------- 170
+LGQ +AT G + V K+ + EV L L
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 171 -------------HHRNLVNLIGYCVDKGKYMLIYEFM----SNGSLSNLI------YSE 207
+I +D+ ++ F +L S
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 208 ERVLNWEERLQIALDISHGIEYLHE-GAVPPVIHRDLKSANILLDHFMRAKVADFGLSKE 266
+ L RLQ+ L + + LH G ++H L+ +I+LD + F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260
Query: 267 EVFDGRNSGLKGTYGYIDPAYIS----------TNKFTMKSDIFSFGVIIFELITAIHPH 316
+ G ++ G+ P + T D ++ G+ I+ + A P+
Sbjct: 261 D---GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPN 317
Query: 317 QNLMEYVNLASMSQDGVDEILDKQLVGACNI-QEVRELARIGHKCLHKTPRKRPSIGEVT 375
D + NI Q VR L L R +
Sbjct: 318 T------------DDAALGGSEWIFRSCKNIPQPVRALLE---GFLRYPKEDRLLPLQAM 362
Query: 376 Q-ALLKIKQRHLAKQDTMSFADGEFSRA 402
+ + + L+ + DGE +R
Sbjct: 363 ETPEYEQLRTELSAALPLYQTDGEPTRE 390
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-28
Identities = 72/354 (20%), Positives = 140/354 (39%), Gaps = 34/354 (9%)
Query: 38 HLRRCSNERSVATHPIRINGLGTSIDFSAPVANSVAVKASGFPQKKSQVSWWSNHSKDRF 97
H S+ + T + + S D + ++ A + ++ S +
Sbjct: 4 HHHHHSSGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALA 63
Query: 98 TSAPSASGIPRYAYKDIQKATQNFTN--------ILGQGAFGPVYKATMPSGGVA-AIKV 148
P+ + ++ + + ILG G FG V+K + G+ A K+
Sbjct: 64 VDIPAPPAP--FDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKI 121
Query: 149 LASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEE 208
+ + + ++E + E+S++ +L H NL+ L K +L+ E++ G L + I E
Sbjct: 122 IKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDES 181
Query: 209 RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRA--KVADFGLSKE 266
L + + I GI ++H+ ++H DLK NIL + K+ DFGL++
Sbjct: 182 YNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARR 238
Query: 267 EVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHP-----HQNLME 321
+ GT ++ P ++ + + +D++S GVI + L++ + P +
Sbjct: 239 YKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLN 298
Query: 322 YVNLASMSQDGVDEILDKQLVGACNI-QEVRELARIGHKCLHKTPRKRPSIGEV 374
+ + DE +I +E +E K L K R S E
Sbjct: 299 NILACRWDLE--DEEFQ-------DISEEAKEFIS---KLLIKEKSWRISASEA 340
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 9e-28
Identities = 63/329 (19%), Positives = 105/329 (31%), Gaps = 92/329 (27%)
Query: 124 ILGQGAFGPVYKAT-MPSGGVAAIK-VLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGY 181
+G+G FG V++A AIK + + ++ EV L +L H +V
Sbjct: 13 CMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 72
Query: 182 CV-----------------------------------------DKGKYMLIYEFMSNGSL 200
+ D + S
Sbjct: 73 WLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSP 132
Query: 201 SNLIY--------------SEERVLNWEERLQIALDISH----GIEYLHE-GAVPPVIHR 241
+Y R + + L I +E+LH G ++HR
Sbjct: 133 KVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG----LMHR 188
Query: 242 DLKSANILLDHFMRAKVADFGLSK-------------EEVFDGRNSGLKGTYGYIDPAYI 288
DLK +NI KV DFGL ++G GT Y+ P I
Sbjct: 189 DLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQI 248
Query: 289 STNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGV-DEILDKQLVGACNI 347
N ++ K DIFS G+I+FEL ++ ME V + + ++ +
Sbjct: 249 HGNNYSHKVDIFSLGLILFEL---LYSFSTQMERVRIITDVRNLKFPLLFT--------- 296
Query: 348 QEVRELARIGHKCLHKTPRKRPSIGEVTQ 376
Q+ + + L +P +RP ++ +
Sbjct: 297 QKYPQEHMMVQDMLSPSPTERPEATDIIE 325
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 61/283 (21%), Positives = 125/283 (44%), Gaps = 30/283 (10%)
Query: 107 PRYAYKDIQKATQNFTNI------LGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKE 159
+Y + ++ + + LG GAFG V++ +G V K + + +
Sbjct: 35 KKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYT 94
Query: 160 FQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQI 219
+ E+S++ +LHH L+NL DK + +LI EF+S G L + I +E+ ++ E +
Sbjct: 95 VKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINY 154
Query: 220 ALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRA--KVADFGLSKEEVFDGRNSGLK 277
G++++HE + ++H D+K NI+ + + K+ DFGL+ + D
Sbjct: 155 MRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT 211
Query: 278 GTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHP-----HQNLMEYVNLASMSQDG 332
T + P + +D+++ GV+ + L++ + P ++ V D
Sbjct: 212 ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD- 270
Query: 333 VDEILDKQLVGACNI-QEVRELARIGHKCLHKTPRKRPSIGEV 374
++ ++ E ++ + L K PRKR ++ +
Sbjct: 271 -EDAFS-------SVSPEAKDFIK---NLLQKEPRKRLTVHDA 302
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-27
Identities = 62/284 (21%), Positives = 112/284 (39%), Gaps = 32/284 (11%)
Query: 107 PRYAYKDIQKATQNFTNI------LGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKE 159
+Y + ++ + + LG GAFG V++ T +G A K + + ++
Sbjct: 141 KQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKET 200
Query: 160 FQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQI 219
+ E+ + L H LVNL D + ++IYEFMS G L + E ++ +E ++
Sbjct: 201 VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY 260
Query: 220 ALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRA--KVADFGLSKEEVFDGRNSGLK 277
+ G+ ++HE +H DLK NI+ K+ DFGL+
Sbjct: 261 MRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT 317
Query: 278 GTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHP-----HQNLMEYVNLA--SMSQ 330
GT + P +D++S GV+ + L++ + P + V +M
Sbjct: 318 GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD 377
Query: 331 DGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEV 374
I + + ++ R K L P R +I +
Sbjct: 378 SAFSGISE----------DGKDFIR---KLLLADPNTRMTIHQA 408
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 77/299 (25%), Positives = 111/299 (37%), Gaps = 64/299 (21%)
Query: 114 IQKATQNFTN------ILGQGAFGPVYKATMPSGGVA-AIKVLA-------------SDS 153
++K LG GA+G V +G AIKV+ +
Sbjct: 27 VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86
Query: 154 HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLI-----YSEE 208
+ +E E+SLL L H N++ L DK + L+ EF G L I + E
Sbjct: 87 EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDEC 146
Query: 209 RVLNWEERLQIALDISHGIEYLHE-GAVPPVIHRDLKSANILL---DHFMRAKVADFGLS 264
N I I GI YLH+ ++HRD+K NILL + + K+ DFGLS
Sbjct: 147 DAAN------IMKQILSGICYLHKHN----IVHRDIKPENILLENKNSLLNIKIVDFGLS 196
Query: 265 KEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVN 324
D + GT YI P + K+ K D++S GVI++ L+ P
Sbjct: 197 SFFSKDYKLRDRLGTAYYIAPEVL-KKKYNEKCDVWSCGVIMYILLCGYPPFGG------ 249
Query: 325 LASMSQDGVDEILDKQLVGACNI---------QEVRELARIGHKCLHKTPRKRPSIGEV 374
+I+ K G E +EL + L KR + E
Sbjct: 250 ------QNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIK---LMLTYDYNKRCTAEEA 299
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 64/214 (29%), Positives = 105/214 (49%), Gaps = 27/214 (12%)
Query: 125 LGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRL-HHRNLVNLIG-- 180
+G G +G VYK + +G +AAIKV+ E+E + E+++L + HHRN+ G
Sbjct: 32 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAF 90
Query: 181 ----YCVDKGKYMLIYEFMSNGSLSNLI-YSEERVLNWEERLQIAL---DISHGIEYLHE 232
+ L+ EF GS+++LI ++ L EE IA +I G+ +LH+
Sbjct: 91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLK-EE--WIAYICREILRGLSHLHQ 147
Query: 233 GAVPPVIHRDLKSANILLDHFMRAKVADFGLSKE--EVFDGRNSGLKGTYGYIDPAYIST 290
V IHRD+K N+LL K+ DFG+S + RN+ GT ++ P I+
Sbjct: 148 HKV---IHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMAPEVIAC 203
Query: 291 NKFT-----MKSDIFSFGVIIFELITAIHPHQNL 319
++ KSD++S G+ E+ P ++
Sbjct: 204 DENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 237
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-27
Identities = 60/203 (29%), Positives = 86/203 (42%), Gaps = 11/203 (5%)
Query: 120 NFTNILGQGAFGPVYKATM-PSGGVAAIKVLASDSHQGEKEFQ---TEVSLLGRLHHRNL 175
F ILG+G+F V A + AIK+L E + E ++ RL H
Sbjct: 33 KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 176 VNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAV 235
V L D K + NG L I R A +I +EYLH +
Sbjct: 93 VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLHGKGI 151
Query: 236 PPVIHRDLKSANILLDHFMRAKVADFGLSKE---EVFDGRNSGLKGTYGYIDPAYISTNK 292
IHRDLK NILL+ M ++ DFG +K E R + GT Y+ P ++
Sbjct: 152 ---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 208
Query: 293 FTMKSDIFSFGVIIFELITAIHP 315
SD+++ G II++L+ + P
Sbjct: 209 ACKSSDLWALGCIIYQLVAGLPP 231
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 75/279 (26%), Positives = 119/279 (42%), Gaps = 46/279 (16%)
Query: 125 LGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGE-KEFQTEVSLLGRL-HHRNLVNLIGY 181
+G+GA+G V K PSG + A+K + S + E K+ ++ ++ R +V G
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 182 CVDKGKYMLIYEFMSNGSLSNLIYSEERVLNW---EERL-QIALDISHGIEYLHEGAVPP 237
+G + E M + S VL+ EE L +I L + +L E
Sbjct: 90 LFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE--NLK 146
Query: 238 VIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLK----GTYGY-----IDPAYI 288
+IHRD+K +NILLD K+ DFG+S + V +S K G Y IDP+
Sbjct: 147 IIHRDIKPSNILLDRSGNIKLCDFGISGQLV----DSIAKTRDAGCRPYMAPERIDPS-A 201
Query: 289 STNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDK-------QL 341
S + ++SD++S G+ ++EL T P+ + V + L + QL
Sbjct: 202 SRQGYDVRSDVWSLGITLYELATGRFPYPKW-----------NSVFDQLTQVVKGDPPQL 250
Query: 342 VGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLK 380
+ + + CL K KRP + LLK
Sbjct: 251 SNSEEREFSPSFINFVNLCLTKDESKRPK----YKELLK 285
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 69/275 (25%), Positives = 110/275 (40%), Gaps = 45/275 (16%)
Query: 120 NFTNILGQGAFGPVYKATM-PSGGVAAIKVLASDSHQGE--KEFQTEVSLLGRLHHRNLV 176
N +LG+G+FG V K + A+KV+ S + + EV LL +L H N++
Sbjct: 25 NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 177 NLIGYCVDKGKYMLIYEFMSNGSLSNLI-----YSEERVLNWEERLQIALDISHGIEYLH 231
L D + ++ E + G L + I +SE I + GI Y+H
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR------IIKQVFSGITYMH 138
Query: 232 EGAVPPVIHRDLKSANILL---DHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYI 288
+ ++HRDLK NILL + K+ DFGLS + + GT YI P +
Sbjct: 139 KHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL 195
Query: 289 STNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNI- 347
+ K D++S GVI++ L++ P +IL + G
Sbjct: 196 R-GTYDEKCDVWSAGVILYILLSGTPP------------FYGKNEYDILKRVETGKYAFD 242
Query: 348 --------QEVRELARIGHKCLHKTPRKRPSIGEV 374
+ ++L R K L P R + +
Sbjct: 243 LPQWRTISDDAKDLIR---KMLTFHPSLRITATQC 274
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-27
Identities = 50/196 (25%), Positives = 91/196 (46%), Gaps = 16/196 (8%)
Query: 125 LGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKE-FQTEVSLLGRLHHRNLVNLIGYC 182
LG+GA+G V A + A+K++ E + E+ + L+H N+V G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 183 VDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEER---LQIALDISHGIEYLHEGAVPPVI 239
+ L E+ S G L + I + + + + Q+ ++ G+ YLH +
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL---MA-GVVYLHGIGI---T 127
Query: 240 HRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLK---GTYGYIDPAYISTNKFT-M 295
HRD+K N+LLD K++DFGL+ ++ R L GT Y+ P + +F
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187
Query: 296 KSDIFSFGVIIFELIT 311
D++S G+++ ++
Sbjct: 188 PVDVWSCGIVLTAMLA 203
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 9e-27
Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 21/200 (10%)
Query: 120 NFTNILGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNL 178
F +LG GAF V+ +G + A+K + + + E+++L ++ H N+V L
Sbjct: 12 IFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTL 71
Query: 179 IGYCVDKGKYMLIYEFMSNGSLSNLI-----YSEERVLNWEERLQIALDISHGIEYLHE- 232
Y L+ + +S G L + I Y+E ++ + + ++YLHE
Sbjct: 72 EDIYESTTHYYLVMQLVSGGELFDRILERGVYTE------KDASLVIQQVLSAVKYLHEN 125
Query: 233 GAVPPVIHRDLKSANILL---DHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYIS 289
G ++HRDLK N+L + + + DFGLSK E +G S GT GY+ P ++
Sbjct: 126 G----IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ-NGIMSTACGTPGYVAPEVLA 180
Query: 290 TNKFTMKSDIFSFGVIIFEL 309
++ D +S GVI + L
Sbjct: 181 QKPYSKAVDCWSIGVITYIL 200
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 64/256 (25%), Positives = 109/256 (42%), Gaps = 18/256 (7%)
Query: 120 NFTNILGQGAFGPVYKATM-PSGGVAAIKVLASD---SHQGEKEFQTEVSLLGRLHHRNL 175
+LG+G FG V + +G + A K L +GE E +L +++ R +
Sbjct: 187 RQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFV 246
Query: 176 VNLIGYCVD-KGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQI-ALDISHGIEYLHEG 233
V+L Y + K L+ M+ G L IY + E R A +I G+E LH
Sbjct: 247 VSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE 305
Query: 234 AVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKF 293
+ ++RDLK NILLD +++D GL+ G GT GY+ P + ++
Sbjct: 306 RI---VYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERY 362
Query: 294 TMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNI-QEVRE 352
T D ++ G +++E+I P Q + + + + + + + + R
Sbjct: 363 TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER----LVKEVPEEYSERFSPQARS 418
Query: 353 LARIGHKCLHKTPRKR 368
L + L K P +R
Sbjct: 419 LCS---QLLCKDPAER 431
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-26
Identities = 50/196 (25%), Positives = 91/196 (46%), Gaps = 16/196 (8%)
Query: 125 LGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKE-FQTEVSLLGRLHHRNLVNLIGYC 182
LG+GA+G V A + A+K++ E + E+ + L+H N+V G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 183 VDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEER---LQIALDISHGIEYLHEGAVPPVI 239
+ L E+ S G L + I + + + + Q+ ++ G+ YLH +
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL---MA-GVVYLHGIGI---T 127
Query: 240 HRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLK---GTYGYIDPAYISTNKFT-M 295
HRD+K N+LLD K++DFGL+ ++ R L GT Y+ P + +F
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187
Query: 296 KSDIFSFGVIIFELIT 311
D++S G+++ ++
Sbjct: 188 PVDVWSCGIVLTAMLA 203
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 6e-26
Identities = 69/272 (25%), Positives = 110/272 (40%), Gaps = 43/272 (15%)
Query: 125 LGQGAFGPVYKAT-MPSGGVAAIKVL------ASDSHQGEKEFQTEVSLLGRLHHRNLVN 177
LG G F V K +G A K + AS +E + EVS+L ++ H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 178 LIGYCVDKGKYMLIYEFMSNGSLSNLI-----YSEERVLNWEERLQIALDISHGIEYLHE 232
L ++ +LI E +S G L + + SEE + I G+ YLH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS------FIKQILDGVNYLHT 133
Query: 233 GAVPPVIHRDLKSANILL----DHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYI 288
+ H DLK NI+L K+ DFGL+ E + GT ++ P +
Sbjct: 134 KK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 289 STNKFTMKSDIFSFGVIIFELITAIHP-----HQNLMEYVNLASMSQDGVDEILDKQLVG 343
+ +++D++S GVI + L++ P Q + + S D +E
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFD--EEFFS----- 243
Query: 344 ACNI-QEVRELARIGHKCLHKTPRKRPSIGEV 374
+ ++ R K L K RKR +I E
Sbjct: 244 --QTSELAKDFIR---KLLVKETRKRLTIQEA 270
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 9e-26
Identities = 54/271 (19%), Positives = 99/271 (36%), Gaps = 39/271 (14%)
Query: 120 NFTNILGQGAFGPVYKATM-PSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNL 178
N +G+G++G V A + A K + + F+ E+ ++ L H N++ L
Sbjct: 12 TLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRL 71
Query: 179 IGYCVDKGKYMLIYEFMSNGSLSNLI-----YSEERVLNWEERLQIALDISHGIEYLHEG 233
D L+ E + G L + + E + +I D+ + Y H+
Sbjct: 72 YETFEDNTDIYLVMELCTGGELFERVVHKRVFRE------SDAARIMKDVLSAVAYCHKL 125
Query: 234 AVPPVIHRDLKSANILL---DHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYIST 290
V HRDLK N L K+ DFGL+ GT Y+ P +
Sbjct: 126 N---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLE- 181
Query: 291 NKFTMKSDIFSFGVIIFELITAIHP-----HQNLMEYVNLASMSQDGV--DEILDKQLVG 343
+ + D +S GV+++ L+ P +M + + + +
Sbjct: 182 GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSP----- 236
Query: 344 ACNIQEVRELARIGHKCLHKTPRKRPSIGEV 374
+ L R + L K+P++R + +
Sbjct: 237 -----QAESLIR---RLLTKSPKQRITSLQA 259
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 64/293 (21%), Positives = 114/293 (38%), Gaps = 58/293 (19%)
Query: 112 KDIQKATQNFT------NILGQGAFGPVYKATM-PSGGVAAIKVLASDSHQGEKEFQTEV 164
+ + + + FT +G G++ + + A+K++ +E +
Sbjct: 11 QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE----I 66
Query: 165 SLLGRL-HHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLI-----YSEERVLNWEERLQ 218
+L R H N++ L D ++ E M G L + I +SE E
Sbjct: 67 EILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSER------EASA 120
Query: 219 IALDISHGIEYLHE-GAVPPVIHRDLKSANILL----DHFMRAKVADFGLSKEEVFDGRN 273
+ I+ +EYLH G V+HRDLK +NIL + ++ DFG +K+ N
Sbjct: 121 VLFTITKTVEYLHAQG----VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ--LRAEN 174
Query: 274 SGLK---GTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQ 330
L T ++ P + + DI+S GV+++ ++T P A+
Sbjct: 175 GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP---------FANGPD 225
Query: 331 DGVDEILDKQLVGA--------CNI-QEVRELARIGHKCLHKTPRKRPSIGEV 374
D +EIL + G ++ ++L K LH P +R + V
Sbjct: 226 DTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVS---KMLHVDPHQRLTAALV 275
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 65/261 (24%), Positives = 115/261 (44%), Gaps = 28/261 (10%)
Query: 125 LGQGAFGPVYKAT-MPSGGVAAIKVLASD--SHQGEKEFQTEVSLLGRLHHRNLVNLIGY 181
+G+G F V A + +G AIK++ + ++ EV ++ L+H N+V L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 182 CVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHR 241
+ LI E+ S G + + + + R + +E I ++Y H+ + +HR
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVAHGR-MKEKEARSKFRQIVSAVQYCHQKRI---VHR 138
Query: 242 DLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFT-MKSDIF 300
DLK+ N+LLD M K+ADFG S E G+ G Y P K+ + D++
Sbjct: 139 DLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVW 198
Query: 301 SFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNI-----QEVRELAR 355
S GVI++ L++ P + NL + ++ L G I + L +
Sbjct: 199 SLGVILYTLVSGSLP----FDGQNLKEL--------RERVLRGKYRIPFYMSTDCENLLK 246
Query: 356 IGHKCLHKTPRKRPSIGEVTQ 376
+ L P KR ++ ++ +
Sbjct: 247 ---RFLVLNPIKRGTLEQIMK 264
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-25
Identities = 54/199 (27%), Positives = 91/199 (45%), Gaps = 10/199 (5%)
Query: 125 LGQGAFGPVYKATMPS-GGVAAIKVLASDSHQGE---KEFQTEVSLLGRLHHRNLVNLIG 180
LG G VY A AIK + + E K F+ EV +L H+N+V++I
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78
Query: 181 YCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIH 240
+ Y L+ E++ +LS I L+ + + I GI++ H+ + +H
Sbjct: 79 VDEEDDCYYLVMEYIEGPTLSEYI-ESHGPLSVDTAINFTNQILDGIKHAHDMRI---VH 134
Query: 241 RDLKSANILLDHFMRAKVADFGLSK--EEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSD 298
RD+K NIL+D K+ DFG++K E + + + GT Y P +D
Sbjct: 135 RDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTD 194
Query: 299 IFSFGVIIFELITAIHPHQ 317
I+S G++++E++ P
Sbjct: 195 IYSIGIVLYEMLVGEPPFN 213
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 64/276 (23%), Positives = 105/276 (38%), Gaps = 49/276 (17%)
Query: 124 ILGQGAFGPVYKAT-MPSGGVAAIKV-----LASDSHQGEKE-FQTEVSLLGRLHHRNLV 176
LG G F V K +G A K + +E + EVS+L ++ H N++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 177 NLIGYCVDKGKYMLIYEFMSNGSLSNLI-----YSEERVLNWEERLQIALDISHGIEYLH 231
L ++ +LI E +S G L + + SEE + I G+ YLH
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS------FIKQILDGVNYLH 132
Query: 232 EGAVPPVIHRDLKSANILL----DHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAY 287
+ H DLK NI+L K+ DFGL+ E + GT ++ P
Sbjct: 133 TKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 288 ISTNKFTMKSDIFSFGVIIFELITAIHP-----HQNLMEYVNLA--SMSQDGVDEILD-- 338
++ +++D++S GVI + L++ P Q + + ++ +
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELA 249
Query: 339 KQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEV 374
K + K L K RKR +I E
Sbjct: 250 KDFI---------------RKLLVKETRKRLTIQEA 270
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-25
Identities = 54/224 (24%), Positives = 93/224 (41%), Gaps = 39/224 (17%)
Query: 115 QKATQNFTN------ILGQGAFGPVYKAT-MPSGGVAAIKVL---------ASDSHQGEK 158
+T F ILG+G V + P+ A+K++ A + + +
Sbjct: 9 SHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELRE 68
Query: 159 EFQTEVSLLGRL-HHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLI-----YSEERVLN 212
EV +L ++ H N++ L + L+++ M G L + + SE+
Sbjct: 69 ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEK---- 124
Query: 213 WEERLQIALDISHGIEYLHE-GAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG 271
E +I + I LH+ ++HRDLK NILLD M K+ DFG S +
Sbjct: 125 --ETRKIMRALLEVICALHKLN----IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE 178
Query: 272 RNSGLKGTYGYIDP------AYISTNKFTMKSDIFSFGVIIFEL 309
+ + GT Y+ P + + + D++S GVI++ L
Sbjct: 179 KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTL 222
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-25
Identities = 58/287 (20%), Positives = 112/287 (39%), Gaps = 49/287 (17%)
Query: 124 ILGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRL-HHRNLVNLIGY 181
+LG+GA V + + A+K++ EV +L + HRN++ LI +
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 182 CVDKGKYMLIYEFMSNGSLSNLI-----YSEERVLNWEERLQIALDISHGIEYLHE-GAV 235
++ ++ L++E M GS+ + I ++E E + D++ +++LH G
Sbjct: 80 FEEEDRFYLVFEKMRGGSILSHIHKRRHFNEL------EASVVVQDVASALDFLHNKG-- 131
Query: 236 PPVIHRDLKSANILL---DHFMRAKVADFGLSK-----EEVFDGRNSGLK---GTYGYID 284
+ HRDLK NIL + K+ DF L + L G+ Y+
Sbjct: 132 --IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 285 P-----AYISTNKFTMKSDIFSFGVIIFELITAIHP---HQNLMEYVNLASMSQDGVDEI 336
P + + + D++S GVI++ L++ P + + +
Sbjct: 190 PEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNML 249
Query: 337 LDKQLVGA--------CNI-QEVRELARIGHKCLHKTPRKRPSIGEV 374
+ G +I ++L K L + ++R S +V
Sbjct: 250 FESIQEGKYEFPDKDWAHISCAAKDLIS---KLLVRDAKQRLSAAQV 293
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-25
Identities = 53/276 (19%), Positives = 98/276 (35%), Gaps = 36/276 (13%)
Query: 125 LGQGAFGPVYKA--TMPSGGVAAIKVLASDSHQGEKE-FQTEVSLLGRLHHRNLVNL--I 179
+ G G +Y A +G +K L + E L + H ++V +
Sbjct: 88 IAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNF 147
Query: 180 GYCVDKGKYMLIY---EFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVP 236
D+ + Y E++ SL + L E + L+I + YLH
Sbjct: 148 VEHTDRHGDPVGYIVMEYVGGQSLKRSK---GQKLPVAEAIAYLLEILPALSYLHS---I 201
Query: 237 PVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMK 296
+++ DLK NI+L + K+ D G L GT G+ P I T+
Sbjct: 202 GLVYNDLKPENIMLTE-EQLKLIDLGAVSRI---NSFGYLYGTPGFQAPE-IVRTGPTVA 256
Query: 297 SDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARI 356
+DI++ G + L + VD + + V ++ R+
Sbjct: 257 TDIYTVGRTLAALTLDLPTRNG------------RYVDGLPEDDPV----LKTYDSYGRL 300
Query: 357 GHKCLHKTPRKRP-SIGEVTQALLKIKQRHLAKQDT 391
+ + PR+R + E++ L + + +A+
Sbjct: 301 LRRAIDPDPRQRFTTAEEMSAQLTGVLREVVAQDTG 336
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 6e-25
Identities = 59/301 (19%), Positives = 111/301 (36%), Gaps = 36/301 (11%)
Query: 33 YKKHDHLRRCSNERSVATHPIR----INGLGTSIDFSAPVANSVAVKASGFPQKKSQVSW 88
+ + + ER A IR +N + + KK +
Sbjct: 6 HHSSGVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQ 65
Query: 89 WSNHSKDRFTSAPSASGIPRYAYKDIQKATQNFTNILGQGAFGPVYKAT-MPSGGVAAIK 147
F S +P +A + +++G+G V + +G A+K
Sbjct: 66 PKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVK 125
Query: 148 VLA--------SDSHQGEKEFQTEVSLLGRLH-HRNLVNLIGYCVDKGKYMLIYEFMSNG 198
++ + + + E +L ++ H +++ LI L+++ M G
Sbjct: 126 IMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKG 185
Query: 199 SLSNLI-----YSEERVLNWEERLQIALDISHGIEYLHE-GAVPPVIHRDLKSANILLDH 252
L + + SE+ E I + + +LH ++HRDLK NILLD
Sbjct: 186 ELFDYLTEKVALSEK------ETRSIMRSLLEAVSFLHANN----IVHRDLKPENILLDD 235
Query: 253 FMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDP------AYISTNKFTMKSDIFSFGVII 306
M+ +++DFG S + L GT GY+ P + + + D+++ GVI+
Sbjct: 236 NMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
Query: 307 F 307
F
Sbjct: 296 F 296
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-25
Identities = 50/204 (24%), Positives = 84/204 (41%), Gaps = 25/204 (12%)
Query: 120 NFTNILGQGAFGPVYKAT-MPSGGVAAIKV-----LASDSHQGEKE-FQTEVSLLGRLHH 172
LG G F V K +G A K L+S +E + EV++L + H
Sbjct: 8 EMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRH 67
Query: 173 RNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLI-----YSEERVLNWEERLQIALDISHGI 227
N++ L +K +LI E +S G L + + +E+ I G+
Sbjct: 68 PNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQ------FLKQILDGV 121
Query: 228 EYLHEGAVPPVIHRDLKSANILLDHFMRA----KVADFGLSKEEVFDGRNSGLKGTYGYI 283
YLH + H DLK NI+L K+ DFG++ + + GT ++
Sbjct: 122 HYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFV 178
Query: 284 DPAYISTNKFTMKSDIFSFGVIIF 307
P ++ +++D++S GVI +
Sbjct: 179 APEIVNYEPLGLEADMWSIGVITY 202
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 6e-25
Identities = 67/260 (25%), Positives = 111/260 (42%), Gaps = 23/260 (8%)
Query: 120 NFTNILGQGAFGPVYKATM-PSGGVAAIKVLASD---SHQGEKEFQTEVSLLGRLHHRNL 175
+LG+G FG V+ M +G + A K L +G + E +L ++H R +
Sbjct: 188 LDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFI 247
Query: 176 VNLIGYC-VDKGKYMLIYEFMSNGSLSNLIY---SEERVLNWEERLQI-ALDISHGIEYL 230
V+L Y K L+ M+ G + IY + E R I G+E+L
Sbjct: 248 VSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ-EPRAIFYTAQIVSGLEHL 305
Query: 231 HEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG-RNSGLKGTYGYIDPAYIS 289
H+ + I+RDLK N+LLD +++D GL+ E + G GT G++ P +
Sbjct: 306 HQRNI---IYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLL 362
Query: 290 TNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNI-Q 348
++ D F+ GV ++E+I A P + E V + Q +L++ +
Sbjct: 363 GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ----RVLEQAVTYPDKFSP 418
Query: 349 EVRELARIGHKCLHKTPRKR 368
++ L K P KR
Sbjct: 419 ASKDFCE---ALLQKDPEKR 435
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-25
Identities = 59/201 (29%), Positives = 93/201 (46%), Gaps = 21/201 (10%)
Query: 120 NFTNILGQGAFGPVYKATM-PSGGVAAIKVLASDSHQGEKE--FQTEVSLLGRLHHRNLV 176
N +LG+G+FG V K + A+KV+ S + + EV LL +L H N++
Sbjct: 25 NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 177 NLIGYCVDKGKYMLIYEFMSNGSLSNLI-----YSEERVLNWEERLQIALDISHGIEYLH 231
L D + ++ E + G L + I +SE + +I + GI Y+H
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE------HDAARIIKQVFSGITYMH 138
Query: 232 EGAVPPVIHRDLKSANILL---DHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYI 288
+ ++HRDLK NILL + K+ DFGLS + + GT YI P +
Sbjct: 139 KHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPE-V 194
Query: 289 STNKFTMKSDIFSFGVIIFEL 309
+ K D++S GVI++ L
Sbjct: 195 LRGTYDEKCDVWSAGVILYIL 215
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 7e-25
Identities = 41/194 (21%), Positives = 85/194 (43%), Gaps = 7/194 (3%)
Query: 125 LGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCV 183
LG+G FG V++ S K + + + E+S+L HRN+++L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 184 DKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDL 243
+ ++I+EF+S + I + LN E + + +++LH + H D+
Sbjct: 72 SMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDI 128
Query: 244 KSANILLDHFMRA--KVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFS 301
+ NI+ + K+ +FG +++ L Y P + + +D++S
Sbjct: 129 RPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWS 188
Query: 302 FGVIIFELITAIHP 315
G +++ L++ I+P
Sbjct: 189 LGTLVYVLLSGINP 202
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-24
Identities = 52/199 (26%), Positives = 90/199 (45%), Gaps = 20/199 (10%)
Query: 120 NFTNILGQGAFGPVYKAT-MPSGGVAAIKVLA--SDSHQGEKEFQTEVSLLGRLHHRNLV 176
+ LG+GAF V + +G A K++ S + ++ + E + +L H N+V
Sbjct: 9 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 68
Query: 177 NLIGYCVDKGKYMLIYEFMSNGSLSNLI-----YSEERVLNWEERLQIALDISHGIEYLH 231
L ++ + L+++ ++ G L I YSE + I I Y H
Sbjct: 69 RLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEA------DASHCIQQILESIAYCH 122
Query: 232 EGAVPPVIHRDLKSANILLDHFMRA---KVADFGLSKEEVFDGRNSGLKGTYGYIDPAYI 288
+ +HR+LK N+LL + K+ADFGL+ E G GT GY+ P +
Sbjct: 123 SNGI---VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL 179
Query: 289 STNKFTMKSDIFSFGVIIF 307
+ ++ DI++ GVI++
Sbjct: 180 KKDPYSKPVDIWACGVILY 198
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 52/208 (25%), Positives = 86/208 (41%), Gaps = 36/208 (17%)
Query: 125 LGQGAFGPVYKAT-MPSGGVAAIKVLA--------SDSHQGEKEFQTEVSLLGRLHHRNL 175
LG GA G V A + AI++++ + +TE+ +L +L+H +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 176 VNLIGYCVDKGKYMLIYEFMSNGSLSNLI-----YSEERVLNWEERLQIALDISHGIEYL 230
+ + + + Y ++ E M G L + + E + ++YL
Sbjct: 203 IKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEA------TCKLYFYQMLLAVQYL 255
Query: 231 HEGAVPPVIHRDLKSANILL---DHFMRAKVADFGLSKEEVFDGRNSGLK---GTYGYID 284
HE + IHRDLK N+LL + K+ DFG SK G S ++ GT Y+
Sbjct: 256 HENGI---IHRDLKPENVLLSSQEEDCLIKITDFGHSK---ILGETSLMRTLCGTPTYLA 309
Query: 285 P---AYISTNKFTMKSDIFSFGVIIFEL 309
P + T + D +S GVI+F
Sbjct: 310 PEVLVSVGTAGYNRAVDCWSLGVILFIC 337
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 58/279 (20%), Positives = 105/279 (37%), Gaps = 53/279 (18%)
Query: 124 ILGQGAFGPVYKAT-MPSGGVAAIKV-----LASDSHQGEKEFQTEVSLLGRLHHRNLVN 177
++G+G F V + +G A+K+ S ++ + E S+ L H ++V
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 178 LIGYCVDKGKYMLIYEFMSNGSL---------SNLIYSEERVLNWEERLQIALDISHGIE 228
L+ G +++EFM L + +YSE I +
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSE------AVASHYMRQILEALR 144
Query: 229 YLHE-GAVPPVIHRDLKSANILL---DHFMRAKVADFGLSKEEVFDG-RNSGLKGTYGYI 283
Y H+ +IHRD+K +LL ++ K+ FG++ + G G GT ++
Sbjct: 145 YCHDNN----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFM 200
Query: 284 DPAYISTNKFTMKSDIFSFGVIIFELITAIHP----HQNLMEYVNLA--SMSQDGVDEIL 337
P + + D++ GVI+F L++ P + L E + M+ I
Sbjct: 201 APEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWSHIS 260
Query: 338 D--KQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEV 374
+ K LV + L P +R ++ E
Sbjct: 261 ESAKDLVR---------------RMLMLDPAERITVYEA 284
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-24
Identities = 67/272 (24%), Positives = 106/272 (38%), Gaps = 37/272 (13%)
Query: 120 NFTNILGQGAFGPVYKATM-PSGGVAAIKVLASDSHQGEKE-FQTEVSLLGRLHHRNLVN 177
F LG GAFG V+ SG IK + D Q E + E+ +L L H N++
Sbjct: 25 IFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIK 84
Query: 178 LIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVL-NWEER--LQIALDISHGIEYLHE-G 233
+ D ++ E G L I S + E ++ + + + Y H
Sbjct: 85 IFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH 144
Query: 234 AVPPVIHRDLKSANILL---DHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYIST 290
V+H+DLK NIL K+ DFGL++ D ++ GT Y+ P
Sbjct: 145 ----VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK- 199
Query: 291 NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGAC----- 345
T K DI+S GV+++ L+T P ++E+ K
Sbjct: 200 RDVTFKCDIWSAGVVMYFLLTGCLPFTG------------TSLEEVQQKATYKEPNYAVE 247
Query: 346 --NI-QEVRELARIGHKCLHKTPRKRPSIGEV 374
+ + +L + + L K P +RPS +V
Sbjct: 248 CRPLTPQAVDLLK---QMLTKDPERRPSAAQV 276
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 51/271 (18%), Positives = 107/271 (39%), Gaps = 38/271 (14%)
Query: 125 LGQGAFGPVYKATMPSGG-VAAIKVLASDSHQGEKEFQT----EVSLLGRLHHRNLVNLI 179
+G+G G VY+A + A+K+++ + F+T E GRL ++V +
Sbjct: 42 VGRGGMGDVYEAEDTVRERIVALKLMSET-LSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 180 GYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVI 239
+ G+ + ++ L+ ++ + L + I I ++ H
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAML-RRQGPLAPPRAVAIVRQIGSALDAAHAAGA---T 156
Query: 240 HRDLKSANILLDHFMRAKVADFGLSKEEVFDG--RNSGLKGTYGYIDPAYISTNKFTMKS 297
HRD+K NIL+ A + DFG++ + + GT Y+ P S + T ++
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRA 216
Query: 298 DIFSFGVIIFELITAIHPH---------QNLMEYVNLASMSQDGVDEILDKQLVGACNIQ 348
DI++ +++E +T P+ ++ + + S + G+ D
Sbjct: 217 DIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFD---------- 266
Query: 349 EVRELARIGHKCLHKTPRKR-PSIGEVTQAL 378
+ + + K P R + G+++ A
Sbjct: 267 ------AVIARGMAKNPEDRYVTCGDLSAAA 291
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 55/229 (24%), Positives = 98/229 (42%), Gaps = 27/229 (11%)
Query: 96 RFTSAPSASGIPRYAYKDIQKATQNFTN------ILGQGAFGPVYKAT-MPSGGVAAIKV 148
S + R + + + A+ F++ LG+GAF V + +G A K+
Sbjct: 3 HMASMTGGQQMGRGS-EFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKI 61
Query: 149 LASDSHQGE--KEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLI-- 204
+ + ++ + E + +L H N+V L ++ + L+++ ++ G L I
Sbjct: 62 INTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA 121
Query: 205 ---YSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILL---DHFMRAKV 258
YSE + I I Y H + +HR+LK N+LL K+
Sbjct: 122 REFYSEA------DASHCIQQILESIAYCHSNGI---VHRNLKPENLLLASKAKGAAVKL 172
Query: 259 ADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIF 307
ADFGL+ E G GT GY+ P + + ++ DI++ GVI++
Sbjct: 173 ADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILY 221
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-24
Identities = 52/215 (24%), Positives = 96/215 (44%), Gaps = 25/215 (11%)
Query: 125 LGQGAFGPVYKAT-MPSGGVAAIKVLA----SDSHQGEKEFQTEVSLLGRLHHRNLVNL- 178
LG+G++G V + + A+K+L GE + E+ LL RL H+N++ L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 179 -IGYCVDKGKYMLIYEFMSNGSLSNLIY-SEERVLNWEER---LQIALDISHGIEYLHEG 233
+ Y +K K ++ E+ G L E+R + Q+ I G+EYLH
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQL---ID-GLEYLHSQ 128
Query: 234 AVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLK---GTYGYIDPAYIST 290
+ +H+D+K N+LL K++ G+++ + + G+ + P +
Sbjct: 129 GI---VHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANG 185
Query: 291 NKF--TMKSDIFSFGVIIFELITAIHP--HQNLME 321
K DI+S GV ++ + T ++P N+ +
Sbjct: 186 LDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK 220
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 5e-24
Identities = 66/274 (24%), Positives = 113/274 (41%), Gaps = 46/274 (16%)
Query: 124 ILGQGAFGPVYKATM-PSGGVAAIKVLASDSHQGEKEFQTEVSLLGRL-HHRNLVNLIGY 181
LG+G+F K S A+K+++ E Q E++ L H N+V L
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLHEV 74
Query: 182 CVDKGKYMLIYEFMSNGSLSNLI-----YSEERVLNWEERLQIALDISHGIEYLHE-GAV 235
D+ L+ E ++ G L I +SE E I + + ++H+ G
Sbjct: 75 FHDQLHTFLVMELLNGGELFERIKKKKHFSET------EASYIMRKLVSAVSHMHDVG-- 126
Query: 236 PPVIHRDLKSANILL---DHFMRAKVADFGLSKEEVFDGRNSGLK---GTYGYIDPAYIS 289
V+HRDLK N+L + + K+ DFG ++ + N LK T Y P ++
Sbjct: 127 --VVHRDLKPENLLFTDENDNLEIKIIDFGFAR--LKPPDNQPLKTPCFTLHYAAPELLN 182
Query: 290 TNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGA----- 344
N + D++S GVI++ +++ P + S++ EI+ K G
Sbjct: 183 QNGYDESCDLWSLGVILYTMLSGQVPF-----QSHDRSLTCTSAVEIMKKIKKGDFSFEG 237
Query: 345 ---CNI-QEVRELARIGHKCLHKTPRKRPSIGEV 374
N+ QE ++L + L P KR + +
Sbjct: 238 EAWKNVSQEAKDLIQ---GLLTVDPNKRLKMSGL 268
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 6e-24
Identities = 53/236 (22%), Positives = 98/236 (41%), Gaps = 48/236 (20%)
Query: 125 LGQGAFGPVYKAT-MPSGGVAAIKVL------------------------ASDSHQGEKE 159
+G+G++G V A A+KVL
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 160 FQT--EVSLLGRLHHRNLVNLIGYCV----DKGKYMLIYEFMSNGSLSNLIYSEERVLNW 213
Q E+++L +L H N+V L V ++ +++E ++ G + + + L+
Sbjct: 81 EQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVMEVP--TLKPLSE 136
Query: 214 EERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRN 273
++ D+ GIEYLH + IHRD+K +N+L+ K+ADFG+S F G +
Sbjct: 137 DQARFYFQDLIKGIEYLHYQKI---IHRDIKPSNLLVGEDGHIKIADFGVS--NEFKGSD 191
Query: 274 SGLK---GTYGYIDPAYISTNKFT---MKSDIFSFGVIIFELITAIHP--HQNLME 321
+ L GT ++ P +S + D+++ GV ++ + P + +M
Sbjct: 192 ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC 247
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 52/202 (25%), Positives = 90/202 (44%), Gaps = 27/202 (13%)
Query: 121 FTNILGQGAFGPVYKAT-MPSGGVAAIKVL--ASDSHQGEKEFQTEVSLLGRLHHRNLVN 177
LG+GAF V + + +G A ++ S + ++ + E + L H N+V
Sbjct: 15 LFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVR 74
Query: 178 LIGYCVDKGKYMLIYEFMSNGSLSNLI-----YSEERVLNWEERLQIALDISHGIEYLHE 232
L ++G + LI++ ++ G L I YSE + I + + H+
Sbjct: 75 LHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSE------ADASHCIQQILEAVLHCHQ 128
Query: 233 -GAVPPVIHRDLKSANILL---DHFMRAKVADFGLSKEEVFDGRNSGLK---GTYGYIDP 285
G V+HR+LK N+LL K+ADFGL+ E +G GT GY+ P
Sbjct: 129 MG----VVHRNLKPENLLLASKLKGAAVKLADFGLAIE--VEGEQQAWFGFAGTPGYLSP 182
Query: 286 AYISTNKFTMKSDIFSFGVIIF 307
+ + + D+++ GVI++
Sbjct: 183 EVLRKDPYGKPVDLWACGVILY 204
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 7e-24
Identities = 69/275 (25%), Positives = 108/275 (39%), Gaps = 49/275 (17%)
Query: 125 LGQGAFGPVYKAT-MPSGGVAAIKV-----LASDSHQGEKE-FQTEVSLLGRLHHRNLVN 177
LG G F V K +G A K S +E + EVS+L + H N++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 178 LIGYCVDKGKYMLIYEFMSNGSLSNLI-----YSEERVLNWEERLQIALDISHGIEYLHE 232
L +K +LI E ++ G L + + +EE I +G+ YLH
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE------FLKQILNGVYYLHS 132
Query: 233 GAVPPVIHRDLKSANILLDHFMRA----KVADFGLSKEEVFDGRNSGLKGTYGYIDPAYI 288
+ H DLK NI+L K+ DFGL+ + F + GT ++ P +
Sbjct: 133 LQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV 189
Query: 289 STNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNI- 347
+ +++D++S GVI + L++ P D E L V A N
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPFLG------------DTKQETLAN--VSAVNYE 235
Query: 348 ------QEVRELAR--IGHKCLHKTPRKRPSIGEV 374
LA+ I + L K P+KR +I +
Sbjct: 236 FEDEYFSNTSALAKDFI-RRLLVKDPKKRMTIQDS 269
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 7e-24
Identities = 65/248 (26%), Positives = 103/248 (41%), Gaps = 28/248 (11%)
Query: 75 KASGFPQKKSQVSWWSNHSKDRFTSAPSASGIPRYA-----YKDIQKATQNFTNILGQGA 129
+SG + + S S + +AS +P Y + + + LG+GA
Sbjct: 7 HSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFE-VESELGRGA 65
Query: 130 FGPVYKAT-MPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKY 188
VY+ + A+KVL +K +TE+ +L RL H N++ L +
Sbjct: 66 TSIVYRCKQKGTQKPYALKVL--KKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEI 123
Query: 189 MLIYEFMSNGSLSNLI-----YSEERVLNWEERLQIALDISHGIEYLHE-GAVPPVIHRD 242
L+ E ++ G L + I YSE + I + YLHE G ++HRD
Sbjct: 124 SLVLELVTGGELFDRIVEKGYYSER------DAADAVKQILEAVAYLHENG----IVHRD 173
Query: 243 LKSANILL---DHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDI 299
LK N+L K+ADFGLSK + GT GY P + + + D+
Sbjct: 174 LKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDM 233
Query: 300 FSFGVIIF 307
+S G+I +
Sbjct: 234 WSVGIITY 241
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 8e-24
Identities = 58/314 (18%), Positives = 99/314 (31%), Gaps = 83/314 (26%)
Query: 125 LGQGAFGPVYKATMPSGGVA-AIKV-----LASDSHQGEKEFQTEVSLLGRLHHRNLVNL 178
+GQG++G V A AIK+ + + + + +TEV L+ +LHH N+ L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 179 IGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERL--------------------- 217
D+ L+ E G L + + + +
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 218 ------------------QIALDISHGIEYLHE-GAVPPVIHRDLKSANILL--DHFMRA 256
I I + YLH G + HRD+K N L +
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG----ICHRDIKPENFLFSTNKSFEI 209
Query: 257 KVADFGLSKEEVFDGRNSGLK-----GTYGYIDPAYISTN--KFTMKSDIFSFGVIIFEL 309
K+ DFGLSKE GT ++ P ++T + K D +S GV++ L
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLL 269
Query: 310 ITAIHP-----HQNLMEYVNLA--SMSQDGVDEILD--KQLVGACNIQEVRELARIGHKC 360
+ P + + V + + + L+
Sbjct: 270 LMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLL---------------SNL 314
Query: 361 LHKTPRKRPSIGEV 374
L++ +R
Sbjct: 315 LNRNVDERFDAMRA 328
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 9e-24
Identities = 49/232 (21%), Positives = 92/232 (39%), Gaps = 24/232 (10%)
Query: 91 NHSKDRFTSAP-SASGIPRYAYKDIQKATQNFTNILGQGAFGPVYKAT-MPSGGVAAIKV 148
+H + + + ++ + LG+G F V + +G A K
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKF 61
Query: 149 LA--SDSHQGEKEFQTEVSLLGRL-HHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLI- 204
L E E+++L ++NL + + +LI E+ + G + +L
Sbjct: 62 LKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCL 121
Query: 205 ------YSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILL---DHFMR 255
SE V+ + I G+ YLH+ + +H DLK NILL
Sbjct: 122 PELAEMVSENDVIR------LIKQILEGVYYLHQNNI---VHLDLKPQNILLSSIYPLGD 172
Query: 256 AKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIF 307
K+ DFG+S++ + GT Y+ P ++ + T +D+++ G+I +
Sbjct: 173 IKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAY 224
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 1e-23
Identities = 64/212 (30%), Positives = 96/212 (45%), Gaps = 27/212 (12%)
Query: 125 LGQGAFGPVYKAT-MPSGGVAAIKVL---ASDSHQGEKEFQTEVSLLGRLHHRNLVNLIG 180
LG G FG V +G A+K+L S + + E+ L H +++ L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL-- 76
Query: 181 YCV--DKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERL---QIALDISHGIEYLHEGAV 235
Y V + ++ E++S G L + I RV E R QI +S ++Y H V
Sbjct: 77 YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQI---LS-AVDYCHRHMV 132
Query: 236 PPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLK---GTYGYIDPAYISTNK 292
+HRDLK N+LLD M AK+ADFGLS L+ G+ Y P IS
Sbjct: 133 ---VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGSPNYAAPEVISGRL 186
Query: 293 FT-MKSDIFSFGVIIFELITAIHP--HQNLME 321
+ + DI+S GVI++ L+ P +++
Sbjct: 187 YAGPEVDIWSCGVILYALLCGTLPFDDEHVPT 218
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-23
Identities = 58/280 (20%), Positives = 113/280 (40%), Gaps = 43/280 (15%)
Query: 125 LGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGE---KEFQTEVSLLGRLHHRNLVNLIG 180
LG G V+ A + A+KVL +D + F+ E L+H +V +
Sbjct: 20 LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 181 YCVDKGKYMLIY----EFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVP 236
+ + E++ +L +++ E + + +++ D + + H+ +
Sbjct: 80 TGEAETPAGPLPYIVMEYVDGVTLRDIV-HTEGPMTPKRAIEVIADACQALNFSHQNGI- 137
Query: 237 PVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG----RNSGLKGTYGYIDPAYISTNK 292
IHRD+K ANI++ KV DFG+++ G + + + GT Y+ P +
Sbjct: 138 --IHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS 195
Query: 293 FTMKSDIFSFGVIIFELITAIHPH----------QNLMEYVNLASMSQDGVDEILDKQLV 342
+SD++S G +++E++T P Q++ E S +G+ LD
Sbjct: 196 VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLD---- 251
Query: 343 GACNIQEVRELARIGHKCLHKTPRKRP-SIGEVTQALLKI 381
+ K L K P R + E+ L+++
Sbjct: 252 ------------AVVLKALAKNPENRYQTAAEMRADLVRV 279
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 54/204 (26%), Positives = 89/204 (43%), Gaps = 13/204 (6%)
Query: 120 NFTNILGQGAFGPVYKATM-PSGGVAAIKVLASD---SHQGEKEFQTEVSLLGRLH---H 172
+ I+G+G FG VY +G + A+K L QGE E +L +
Sbjct: 192 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 251
Query: 173 RNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHE 232
+V + K I + M+ G L + + R A +I G+E++H
Sbjct: 252 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA-EIILGLEHMHN 310
Query: 233 GAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNK 292
V ++RDLK ANILLD +++D GL+ + + GT+GY+ P +
Sbjct: 311 RFV---VYRDLKPANILLDEHGHVRISDLGLAC-DFSKKKPHASVGTHGYMAPEVLQKGV 366
Query: 293 -FTMKSDIFSFGVIIFELITAIHP 315
+ +D FS G ++F+L+ P
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGHSP 390
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 2e-23
Identities = 51/267 (19%), Positives = 100/267 (37%), Gaps = 39/267 (14%)
Query: 125 LGQGAFGPVYKAT-MPSGGVAAIKVL--------ASDSHQGEKEFQTEVSLLGRLHHRNL 175
LG GAFG V+ A +K + + E+++L R+ H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 176 VNLIGYCVDKGKYMLIYEFMSNGS-LSNLIYSEERVLNWEERL---QIALDISHGIEYLH 231
+ ++ ++G + L+ E +G L I R+ Q+ + YL
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLV----SAVGYLR 147
Query: 232 EGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTN 291
+ IHRD+K NI++ K+ DFG + GT Y P + N
Sbjct: 148 LKDI---IHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGN 204
Query: 292 KFT-MKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNI-QE 349
+ + +++S GV ++ L+ +P ++E ++ + + +E
Sbjct: 205 PYRGPELEMWSLGVTLYTLVFEENPF--------------CELEETVEAAIHPPYLVSKE 250
Query: 350 VRELARIGHKCLHKTPRKRPSIGEVTQ 376
+ L L P +R ++ ++
Sbjct: 251 LMSLVS---GLLQPVPERRTTLEKLVT 274
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 3e-23
Identities = 65/265 (24%), Positives = 97/265 (36%), Gaps = 31/265 (11%)
Query: 125 LGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCV 183
+G G FG + + A+K + + E Q E+ L H N+V +
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN-VQREIINHRSLRHPNIVRFKEVIL 86
Query: 184 DKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERL---QIALDISHGIEYLHEGAVPPVIH 240
+I E+ S G L I + R E R Q+ +S G+ Y H + H
Sbjct: 87 TPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQL---LS-GVSYCHSMQI---CH 139
Query: 241 RDLKSANILLDH--FMRAKVADFGLSKEEVFDGRNSGLK---GTYGYIDPAYISTNKFT- 294
RDLK N LLD R K+ DFG SK V + K GT YI P + ++
Sbjct: 140 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRQEYDG 196
Query: 295 MKSDIFSFGVIIFELITAIHP--HQNLME-YVNLASMSQDGVDEILDKQLVGACNIQEVR 351
+D++S GV ++ ++ +P Y I D + E
Sbjct: 197 KIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRIS----PECC 252
Query: 352 ELARIGHKCLHKTPRKRPSIGEVTQ 376
L + P R SI E+
Sbjct: 253 HLIS---RIFVADPATRISIPEIKT 274
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 8e-23
Identities = 53/211 (25%), Positives = 87/211 (41%), Gaps = 36/211 (17%)
Query: 120 NFTNILGQGAFGPVYKAT-MPSGGVAAIKVLA--------SDSHQGEKEFQTEVSLLGRL 170
+ LG GA G V A + AIK+++ + +TE+ +L +L
Sbjct: 13 IMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL 72
Query: 171 HHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLI-----YSEERVLNWEERLQIALDISH 225
+H ++ + + + Y ++ E M G L + + E +
Sbjct: 73 NHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEA------TCKLYFYQMLL 125
Query: 226 GIEYLHEGAVPPVIHRDLKSANILL---DHFMRAKVADFGLSKEEVFDGRNSGLK---GT 279
++YLHE + IHRDLK N+LL + K+ DFG SK G S ++ GT
Sbjct: 126 AVQYLHENGI---IHRDLKPENVLLSSQEEDCLIKITDFGHSK---ILGETSLMRTLCGT 179
Query: 280 YGYIDP---AYISTNKFTMKSDIFSFGVIIF 307
Y+ P + T + D +S GVI+F
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILF 210
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 2e-22
Identities = 45/148 (30%), Positives = 74/148 (50%), Gaps = 12/148 (8%)
Query: 123 NILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKE---FQT--EVSLLGRLHHRNLVN 177
+G+G +G VYKA G + A+K + D+ E E E+SLL LHH N+V+
Sbjct: 27 EKVGEGTYGVVYKAKDSQGRIVALKRIRLDA---EDEGIPSTAIREISLLKELHHPNIVS 83
Query: 178 LIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPP 237
LI + L++EFM L ++ + L + + G+ + H+ +
Sbjct: 84 LIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRI-- 140
Query: 238 VIHRDLKSANILLDHFMRAKVADFGLSK 265
+HRDLK N+L++ K+ADFGL++
Sbjct: 141 -LHRDLKPQNLLINSDGALKLADFGLAR 167
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 2e-22
Identities = 58/311 (18%), Positives = 106/311 (34%), Gaps = 49/311 (15%)
Query: 90 SNHSKDRFTSAPSASGIPRYAYKDIQKATQNFTNI--------LGQGAFGPVYKAT-MPS 140
+HS + + + LG G FG VY +
Sbjct: 8 HHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSD 67
Query: 141 GGVAAIKVL------ASDSHQGEKEFQTEVSLLGRLHHR--NLVNLIGYCVDKGKYMLIY 192
AIK + EV LL ++ ++ L+ + ++LI
Sbjct: 68 NLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL 127
Query: 193 EFMSN-GSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLD 251
E L + I L E + + + H V +HRD+K NIL+D
Sbjct: 128 ERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHNCGV---LHRDIKDENILID 183
Query: 252 -HFMRAKVADFGLSKEEVFDGRNSGLK---GTYGYIDPAYISTNKFT-MKSDIFSFGVII 306
+ K+ DFG +++ GT Y P +I +++ + ++S G+++
Sbjct: 184 LNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 239
Query: 307 FELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNI-QEVRELARIGHKCLHKTP 365
++++ P + +EI+ Q+ + E + L R CL P
Sbjct: 240 YDMVCGDIPF--------------EHDEEIIRGQVFFRQRVSSECQHLIR---WCLALRP 282
Query: 366 RKRPSIGEVTQ 376
RP+ E+
Sbjct: 283 SDRPTFEEIQN 293
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 2e-22
Identities = 73/272 (26%), Positives = 110/272 (40%), Gaps = 49/272 (18%)
Query: 125 LGQGAFGPVYKAT-MPSGGVAAIKVL---ASDSHQGEKEFQTEVSLLGRLHHRNLVNLIG 180
LG G FG V +G A+K+L S + + E+ L H +++ L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL-- 81
Query: 181 YCV--DKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERL---QIALDISHGIEYLHEGAV 235
Y V ++ E++S G L + I R+ E R QI +S G++Y H V
Sbjct: 82 YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQI---LS-GVDYCHRHMV 137
Query: 236 PPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLK---GTYGYIDPAYISTNK 292
+HRDLK N+LLD M AK+ADFGLS L+ G+ Y P IS
Sbjct: 138 ---VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGSPNYAAPEVISGRL 191
Query: 293 FT-MKSDIFSFGVIIFELITAIHP--HQNLMEYVNLASMSQDGVDEILDKQLVGACNI-- 347
+ + DI+S GVI++ L+ P ++ + K G
Sbjct: 192 YAGPEVDIWSSGVILYALLCGTLPFDDDHVP--------------TLFKKICDGIFYTPQ 237
Query: 348 ---QEVRELARIGHKCLHKTPRKRPSIGEVTQ 376
V L + L P KR +I ++ +
Sbjct: 238 YLNPSVISLLK---HMLQVDPMKRATIKDIRE 266
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 2e-22
Identities = 76/308 (24%), Positives = 124/308 (40%), Gaps = 43/308 (13%)
Query: 80 PQKKSQVSWWSNHSKDRFTSAPSASGIPRYAYKDIQKATQ---NFTNILGQGAFGPVY-- 134
K Q + + + A + K + T + +LG+G FG V
Sbjct: 108 DGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILV 167
Query: 135 --KATMPSGGVAAIKVLASDSHQGEKEF---QTEVSLLGRLHHRNLVNLIGYCV-DKGKY 188
KAT G A+K+L + + E TE +L H L L Y +
Sbjct: 168 KEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTHDRL 223
Query: 189 MLIYEFMSNGSLSNLIYSEERVLNWEERLQI-ALDISHGIEYLHEGAVPPVIHRDLKSAN 247
+ E+ + G L + S ERV + E+R + +I ++YLH V++RDLK N
Sbjct: 224 CFVMEYANGGELFFHL-SRERVFS-EDRARFYGAEIVSALDYLHSEK--NVVYRDLKLEN 279
Query: 248 ILLDHFMRAKVADFGLSKEEVFDG-RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVII 306
++LD K+ DFGL KE + DG GT Y+ P + N + D + GV++
Sbjct: 280 LMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVM 339
Query: 307 FELITAIHP-----HQNLMEYVNLASMSQDGVDEILDKQLVGACNI-QEVRELARIGHKC 360
+E++ P H+ L + IL +++ + E + L
Sbjct: 340 YEMMCGRLPFYNQDHEKLF-------------ELILMEEIRFPRTLGPEAKSLLS---GL 383
Query: 361 LHKTPRKR 368
L K P++R
Sbjct: 384 LKKDPKQR 391
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 3e-22
Identities = 66/303 (21%), Positives = 119/303 (39%), Gaps = 57/303 (18%)
Query: 100 APSASGIPRYAYKDIQKATQNFT--NILGQGAFGPVYKAT-MPSGGVAAIKVL------A 150
AP + P KD + + +LG+G FG V+ + AIKV+
Sbjct: 12 APPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLG 71
Query: 151 SDSHQGEKEFQTEVSLLGRLH----HRNLVNLIGYCVDKGKYMLIYEFMSNGS-LSNLIY 205
EV+LL ++ H ++ L+ + + +ML+ E L + I
Sbjct: 72 WSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYIT 131
Query: 206 SEERVLNWEERL------QIALDISHGIEYLHEGAVPPVIHRDLKSANILLD-HFMRAKV 258
+ + E Q+ I++ H V +HRD+K NIL+D AK+
Sbjct: 132 EKGPL---GEGPSRCFFGQVV----AAIQHCHSRGV---VHRDIKDENILIDLRRGCAKL 181
Query: 259 ADFGLSKEEVFDGRNSGLK---GTYGYIDPAYISTNKFT-MKSDIFSFGVIIFELITAIH 314
DFG + GT Y P +IS +++ + + ++S G+++++++
Sbjct: 182 IDFGSGALL----HDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDI 237
Query: 315 PHQNLMEYVNLASMSQDGVDEILDKQLVGACNI-QEVRELARIGHKCLHKTPRKRPSIGE 373
P + EIL+ +L ++ + L R +CL P RPS+ E
Sbjct: 238 PF--------------ERDQEILEAELHFPAHVSPDCCALIR---RCLAPKPSSRPSLEE 280
Query: 374 VTQ 376
+
Sbjct: 281 ILL 283
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 94.5 bits (236), Expect = 4e-22
Identities = 47/148 (31%), Positives = 72/148 (48%), Gaps = 12/148 (8%)
Query: 123 NILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKE---FQT--EVSLLGRLHHRNLVN 177
+G+G +G VYKA G A+K + + E E T E+S+L L H N+V
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEK---EDEGIPSTTIREISILKELKHSNIVK 64
Query: 178 LIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPP 237
L K + +L++E + L L+ E L L + +GI Y H+ V
Sbjct: 65 LYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRV-- 121
Query: 238 VIHRDLKSANILLDHFMRAKVADFGLSK 265
+HRDLK N+L++ K+ADFGL++
Sbjct: 122 -LHRDLKPQNLLINREGELKIADFGLAR 148
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 5e-22
Identities = 60/201 (29%), Positives = 100/201 (49%), Gaps = 15/201 (7%)
Query: 120 NFTNILGQGAFGPVY----KATMPSGGVAAIKVLASDS--HQGEKEFQTEVSLLGRLHHR 173
+LGQG+FG V+ + + + A+KVL + + + E +L ++H
Sbjct: 27 ELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHP 86
Query: 174 NLVNLIGYCV-DKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQI-ALDISHGIEYLH 231
+V L Y +GK LI +F+ G L + E EE ++ +++ +++LH
Sbjct: 87 FIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFT--EEDVKFYLAELALALDHLH 143
Query: 232 EGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG-RNSGLKGTYGYIDPAYIST 290
+ I+RDLK NILLD K+ DFGLSKE + + GT Y+ P ++
Sbjct: 144 SLGI---IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR 200
Query: 291 NKFTMKSDIFSFGVIIFELIT 311
T +D +SFGV++FE++T
Sbjct: 201 RGHTQSADWWSFGVLMFEMLT 221
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 5e-22
Identities = 57/257 (22%), Positives = 104/257 (40%), Gaps = 20/257 (7%)
Query: 120 NFTNILGQGAFGPVYKATM-PSGGVAAIKVLASDSHQGEKEFQ---TEVSLLGRLHHRNL 175
+G+G+FG V + + A+K + E + E+ ++ L H L
Sbjct: 18 EILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFL 77
Query: 176 VNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAV 235
VNL D+ ++ + + G L + +L I ++ ++YL +
Sbjct: 78 VNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFIC-ELVMALDYLQNQRI 136
Query: 236 PPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTM 295
IHRD+K NILLD + DF ++ + + + + GT Y+ P S+ K
Sbjct: 137 ---IHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAG 193
Query: 296 KS---DIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNI-QEVR 351
S D +S GV +EL+ P+ ++ ++ S++ V + QE+
Sbjct: 194 YSFAVDWWSLGVTAYELLRGRRPY-----HIRSSTSSKEIVHTFETTVVTYPSAWSQEMV 248
Query: 352 ELARIGHKCLHKTPRKR 368
L + K L P +R
Sbjct: 249 SLLK---KLLEPNPDQR 262
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 6e-22
Identities = 52/211 (24%), Positives = 85/211 (40%), Gaps = 20/211 (9%)
Query: 120 NFTNILGQGAFGPVYKATM-PSGGVAAIKVLASDSHQGEKE---FQTEVSLLGRLHHRNL 175
++G+GAF V M +G V A+K++ E F+ E +L R +
Sbjct: 64 EILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWI 123
Query: 176 VNLIGYCV-DKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQI-ALDISHGIEYLHEG 233
L + D+ L+ E+ G L L+ + E + +I I+ +H
Sbjct: 124 TQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIP-AEMARFYLAEIVMAIDSVHRL 181
Query: 234 AVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG--RNSGLKGTYGYIDP------ 285
+HRD+K NILLD ++ADFG + DG R+ GT Y+ P
Sbjct: 182 GY---VHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAV 238
Query: 286 -AYISTNKFTMKSDIFSFGVIIFELITAIHP 315
T + + D ++ GV +E+ P
Sbjct: 239 GGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 1e-21
Identities = 52/208 (25%), Positives = 89/208 (42%), Gaps = 16/208 (7%)
Query: 120 NFTNILGQGAFGPVYKATM-PSGGVAAIKVLASDSHQGEKE---FQTEVSLLGRLHHRNL 175
++G+GAFG V + + V A+K+L E F+ E +L + +
Sbjct: 77 EILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWI 136
Query: 176 VNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQI-ALDISHGIEYLHEGA 234
L D L+ ++ G L L+ E L EE + ++ I+ +H+
Sbjct: 137 TTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLP-EEMARFYLAEMVIAIDSVHQLH 195
Query: 235 VPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG--RNSGLKGTYGYIDPAYISTNK 292
+HRD+K NIL+D ++ADFG + + DG ++S GT YI P + +
Sbjct: 196 Y---VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAME 252
Query: 293 FTMKS-----DIFSFGVIIFELITAIHP 315
D +S GV ++E++ P
Sbjct: 253 GGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 1e-21
Identities = 41/149 (27%), Positives = 67/149 (44%), Gaps = 13/149 (8%)
Query: 123 NILGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKE---FQT--EVSLLGRLHHRNLV 176
+G+G +G V+KA + + A+K + D + E E+ LL L H+N+V
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDD---DDEGVPSSALREICLLKELKHKNIV 64
Query: 177 NLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVP 236
L K L++EF L S L+ E + G+ + H V
Sbjct: 65 RLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNV- 122
Query: 237 PVIHRDLKSANILLDHFMRAKVADFGLSK 265
+HRDLK N+L++ K+A+FGL++
Sbjct: 123 --LHRDLKPQNLLINRNGELKLANFGLAR 149
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 3e-21
Identities = 56/203 (27%), Positives = 90/203 (44%), Gaps = 13/203 (6%)
Query: 120 NFTNILGQGAFGPVYKATM-PSGGVAAIKVLASDSHQGEKEF---QTEVSLLGRLHHRNL 175
++ +LG+G FG V +G A+K+L + + E TE +L H L
Sbjct: 8 DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 176 VNLIGYCV-DKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQI-ALDISHGIEYLHEG 233
L Y + + E+ + G L + E EER + +I +EYLH
Sbjct: 68 TALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFT--EERARFYGAEIVSALEYLHSR 124
Query: 234 AVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG-RNSGLKGTYGYIDPAYISTNK 292
V ++RD+K N++LD K+ DFGL KE + DG GT Y+ P + N
Sbjct: 125 DV---VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 181
Query: 293 FTMKSDIFSFGVIIFELITAIHP 315
+ D + GV+++E++ P
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLP 204
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 5e-21
Identities = 60/277 (21%), Positives = 108/277 (38%), Gaps = 53/277 (19%)
Query: 124 ILGQGAFGPVYKATM-PSGGVAAIKVLASDSHQGEKEFQTEVSLLGRL-HHRNLVNLIGY 181
+LG G G V + +G A+K+L DS + + EV + ++V ++
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLL-YDS----PKARQEVDHHWQASGGPHIVCILDV 90
Query: 182 CVD----KGKYMLIYEFMSNGSLSNLI-------YSEERVLNWEERLQIALDISHGIEYL 230
+ K ++I E M G L + I ++E E +I DI I++L
Sbjct: 91 YENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTER------EAAEIMRDIGTAIQFL 144
Query: 231 HE-GAVPPVIHRDLKSANILL---DHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPA 286
H + HRD+K N+L + K+ DFG +K E T Y+ P
Sbjct: 145 HSHN----IAHRDVKPENLLYTSKEKDAVLKLTDFGFAK-ETTQNALQTPCYTPYYVAPE 199
Query: 287 YISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGA-- 344
+ K+ D++S GVI++ L+ P ++ Q + + +G
Sbjct: 200 VLGPEKYDKSCDMWSLGVIMYILLCGFPPFY--------SNTGQAISPGMKRRIRLGQYG 251
Query: 345 ------CNI-QEVRELARIGHKCLHKTPRKRPSIGEV 374
+ ++ ++L R L P +R +I +
Sbjct: 252 FPNPEWSEVSEDAKQLIR---LLLKTDPTERLTITQF 285
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 6e-21
Identities = 64/336 (19%), Positives = 115/336 (34%), Gaps = 53/336 (15%)
Query: 65 SAPVANSVAVKASGFPQKKSQVSWWSNHSKDRFTSAPSASGIPRYAYKDIQKATQNFTNI 124
P P + +F SG+ I + + +
Sbjct: 11 PVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDD-YKVTSQV 69
Query: 125 LGQGAFGPVYKATM-PSGGVAAIKVLASDSHQGEKEFQTEVSLLGRL-HHRNLVNLIGYC 182
LG G G V + + A+K+L D + + EV L R ++V ++
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKML-QDC----PKARREVELHWRASQCPHIVRIVDVY 124
Query: 183 VD----KGKYMLIYEFMSNGSL-------SNLIYSEERVLNWEERLQIALDISHGIEYLH 231
+ + +++ E + G L + ++E E +I I I+YLH
Sbjct: 125 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER------EASEIMKSIGEAIQYLH 178
Query: 232 E-GAVPPVIHRDLKSANILL---DHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAY 287
+ HRD+K N+L K+ DFG +KE + T Y+ P
Sbjct: 179 SIN----IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV 234
Query: 288 ISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGA--- 344
+ K+ D++S GVI++ L+ P ++ + + +G
Sbjct: 235 LGPEKYDKSCDMWSLGVIMYILLCGYPPFY--------SNHGLAISPGMKTRIRMGQYEF 286
Query: 345 -----CNI-QEVRELARIGHKCLHKTPRKRPSIGEV 374
+ +EV+ L R L P +R +I E
Sbjct: 287 PNPEWSEVSEEVKMLIR---NLLKTEPTQRMTITEF 319
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 6e-21
Identities = 50/161 (31%), Positives = 75/161 (46%), Gaps = 12/161 (7%)
Query: 113 DIQKATQNFTNI--LGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKE---FQT--EV 164
D++ + + + LG+G F VYKA + + AIK + K+ E+
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 165 SLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDIS 224
LL L H N++ L+ K L+++FM L +I VL L
Sbjct: 64 KLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTL 122
Query: 225 HGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSK 265
G+EYLH+ + +HRDLK N+LLD K+ADFGL+K
Sbjct: 123 QGLEYLHQHWI---LHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 6e-21
Identities = 62/259 (23%), Positives = 123/259 (47%), Gaps = 19/259 (7%)
Query: 120 NFTNILGQGAFGPVYKATM-PSGGVAAIKVLASDSHQGEKEF---QTEVSLLGR-LHHRN 174
+ ++G+G++ V + + + A+KV+ + +++ QTE + + +H
Sbjct: 12 DLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPF 71
Query: 175 LVNLIGYCV-DKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQI-ALDISHGIEYLHE 232
LV L C + + + E+++ G L + + ++ EE + + +IS + YLHE
Sbjct: 72 LVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP--EEHARFYSAEISLALNYLHE 128
Query: 233 GAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG-RNSGLKGTYGYIDPAYISTN 291
+ I+RDLK N+LLD K+ D+G+ KE + G S GT YI P +
Sbjct: 129 RGI---IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE 185
Query: 292 KFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGV-DEILDKQLVGACNI-QE 349
+ D ++ GV++FE++ P + N ++D + IL+KQ+ ++ +
Sbjct: 186 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVK 245
Query: 350 VRELARIGHKCLHKTPRKR 368
+ + L+K P++R
Sbjct: 246 AASVLK---SFLNKDPKER 261
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 7e-21
Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 28/212 (13%)
Query: 125 LGQGAFGPVYKAT-MPSGGVAAIKVL---ASDSHQGEKEFQTEVSLLGRLHHRNLVNLIG 180
LG+G+FG V AT + A+K + + E+S L L H +++ L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL-- 74
Query: 181 YCV--DKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERL---QIALDISHGIEYLHEGAV 235
Y V +++ E+ + G L + I ++R+ E R QI I IEY H +
Sbjct: 75 YDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQI---IC-AIEYCHRHKI 129
Query: 236 PPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLK---GTYGYIDPAYISTNK 292
+HRDLK N+LLD + K+ADFGLS LK G+ Y P I+
Sbjct: 130 ---VHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF---LKTSCGSPNYAAPEVINGKL 183
Query: 293 FT-MKSDIFSFGVIIFELITAIHP--HQNLME 321
+ + D++S G++++ ++ P + +
Sbjct: 184 YAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN 215
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 91.8 bits (229), Expect = 8e-21
Identities = 59/203 (29%), Positives = 99/203 (48%), Gaps = 17/203 (8%)
Query: 120 NFTNILGQGAFGPVY---KATMP-SGGVAAIKVLASDS---HQGEKEF-QTEVSLLGRLH 171
+LG+G +G V+ K T +G + A+KVL + + + E ++L +
Sbjct: 20 ELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK 79
Query: 172 HRNLVNLIGYCV-DKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQI-ALDISHGIEY 229
H +V+LI Y GK LI E++S G L + E + E+ +IS + +
Sbjct: 80 HPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFM--EDTACFYLAEISMALGH 136
Query: 230 LHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG-RNSGLKGTYGYIDPAYI 288
LH+ + I+RDLK NI+L+H K+ DFGL KE + DG GT Y+ P +
Sbjct: 137 LHQKGI---IYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEIL 193
Query: 289 STNKFTMKSDIFSFGVIIFELIT 311
+ D +S G ++++++T
Sbjct: 194 MRSGHNRAVDWWSLGALMYDMLT 216
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 8e-21
Identities = 60/227 (26%), Positives = 94/227 (41%), Gaps = 15/227 (6%)
Query: 93 SKDRFTSAPSASGIPRYAYKDIQKAT-QNFTNI--LGQGAFGPVYKATM-PSGGVAAIKV 148
S F + + ++ A F I LG G+FG V SG A+K+
Sbjct: 14 SVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKI 73
Query: 149 LASDSHQGEKEFQ---TEVSLLGRLHHRNLVNLIGYCVDKGK-YMLIYEFMSNGSLSNLI 204
L K+ + E +L ++ LV L D YM++ E+++ G + + +
Sbjct: 74 LDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM-EYVAGGEMFSHL 132
Query: 205 YSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLS 264
R R A I EYLH + I+RDLK N+L+D +V DFG +
Sbjct: 133 RRIGRFSEPHARFYAA-QIVLTFEYLHSLDL---IYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 265 KEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT 311
K GR L GT + P I + + D ++ GV+I+E+
Sbjct: 189 KR--VKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAA 233
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 1e-20
Identities = 44/150 (29%), Positives = 72/150 (48%), Gaps = 14/150 (9%)
Query: 123 NILGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKE---FQT--EVSLLGRLHHRNLV 176
+G+G +G VYKA +G V A+K + D+ E E E+SLL L+H N+V
Sbjct: 9 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDT---ETEGVPSTAIREISLLKELNHPNIV 65
Query: 177 NLIGYCVDKGKYMLIYEFMSNGSLSNLIYS-EERVLNWEERLQIALDISHGIEYLHEGAV 235
L+ + K L++EF+ L + + + + G+ + H V
Sbjct: 66 KLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 124
Query: 236 PPVIHRDLKSANILLDHFMRAKVADFGLSK 265
+HRDLK N+L++ K+ADFGL++
Sbjct: 125 ---LHRDLKPQNLLINTEGAIKLADFGLAR 151
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 1e-20
Identities = 57/199 (28%), Positives = 93/199 (46%), Gaps = 16/199 (8%)
Query: 120 NFTNILGQGAFGPVYKATM-PSGGVAAIKVLASDSHQGEKEFQ---TEVSLLGRLHHRNL 175
LG G+FG V+ +G A+KVL + K+ + E +L + H +
Sbjct: 9 QILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFI 68
Query: 176 VNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERL---QIALDISHGIEYLHE 232
+ + G D + +I +++ G L +L+ +R N + ++ L +EYLH
Sbjct: 69 IRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCL----ALEYLHS 124
Query: 233 GAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNK 292
+ I+RDLK NILLD K+ DFG +K L GT YI P +ST
Sbjct: 125 KDI---IYRDLKPENILLDKNGHIKITDFGFAKYV--PDVTYTLCGTPDYIAPEVVSTKP 179
Query: 293 FTMKSDIFSFGVIIFELIT 311
+ D +SFG++I+E++
Sbjct: 180 YNKSIDWWSFGILIYEMLA 198
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 2e-20
Identities = 45/147 (30%), Positives = 78/147 (53%), Gaps = 11/147 (7%)
Query: 123 NILGQGAFGPVYKAT-MPSGGVAAIK-VLASDSHQGEKEFQT---EVSLLGRLHHRNLVN 177
++G+G++G V K +G + AIK L SD + K+ E+ LL +L H NLVN
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKK--IAMREIKLLKQLRHENLVN 88
Query: 178 LIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPP 237
L+ C K ++ L++EF+ + ++ + + L+++ + I +GI + H +
Sbjct: 89 LLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNI-- 145
Query: 238 VIHRDLKSANILLDHFMRAKVADFGLS 264
IHRD+K NIL+ K+ DFG +
Sbjct: 146 -IHRDIKPENILVSQSGVVKLCDFGFA 171
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 61/259 (23%), Positives = 123/259 (47%), Gaps = 19/259 (7%)
Query: 120 NFTNILGQGAFGPVYKATM-PSGGVAAIKVLASDSHQGEKEF---QTEVSLLGR-LHHRN 174
+ ++G+G++ V + + + A++V+ + +++ QTE + + +H
Sbjct: 55 DLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPF 114
Query: 175 LVNLIGYCV-DKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQI-ALDISHGIEYLHE 232
LV L C + + + E+++ G L + + ++ EE + + +IS + YLHE
Sbjct: 115 LVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP--EEHARFYSAEISLALNYLHE 171
Query: 233 GAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG-RNSGLKGTYGYIDPAYISTN 291
+ I+RDLK N+LLD K+ D+G+ KE + G S GT YI P +
Sbjct: 172 RGI---IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE 228
Query: 292 KFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGV-DEILDKQLVGACNI-QE 349
+ D ++ GV++FE++ P + N ++D + IL+KQ+ ++ +
Sbjct: 229 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVK 288
Query: 350 VRELARIGHKCLHKTPRKR 368
+ + L+K P++R
Sbjct: 289 AASVLK---SFLNKDPKER 304
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 6e-20
Identities = 38/144 (26%), Positives = 69/144 (47%), Gaps = 7/144 (4%)
Query: 123 NILGQGAFGPVYKAT-MPSGGVAAIK--VLASDSHQGEKEFQTEVSLLGRLHHRNLVNLI 179
+G+G++G V+K +G + AIK + + D +K E+ +L +L H NLVNL+
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLL 68
Query: 180 GYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVI 239
K + L++E+ + ++ + + +R + I + + H+ I
Sbjct: 69 EVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNC---I 124
Query: 240 HRDLKSANILLDHFMRAKVADFGL 263
HRD+K NIL+ K+ DFG
Sbjct: 125 HRDVKPENILITKHSVIKLCDFGF 148
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 6e-20
Identities = 49/155 (31%), Positives = 79/155 (50%), Gaps = 21/155 (13%)
Query: 123 NILGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKE-F-QT---EVSLLGRLHHRNLV 176
+GQG FG V+KA +G A+K + ++ EKE F T E+ +L L H N+V
Sbjct: 23 AKIGQGTFGEVFKARHRKTGQKVALKKVLMEN---EKEGFPITALREIKILQLLKHENVV 79
Query: 177 NLIGYCVDK--------GKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIE 228
NLI C K G L+++F + L+ L+ + E ++ + +G+
Sbjct: 80 NLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLY 138
Query: 229 YLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGL 263
Y+H + +HRD+K+AN+L+ K+ADFGL
Sbjct: 139 YIHRNKI---LHRDMKAANVLITRDGVLKLADFGL 170
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 6e-20
Identities = 41/147 (27%), Positives = 68/147 (46%), Gaps = 10/147 (6%)
Query: 123 NILGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKEFQT---EVSLLGRLHHRNLVNL 178
+ LG+G + VYK + + A+K + + +G T EVSLL L H N+V L
Sbjct: 8 DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAP--CTAIREVSLLKDLKHANIVTL 65
Query: 179 IGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPV 238
+ L++E++ L + ++N + G+ Y H V
Sbjct: 66 HDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHR---QKV 121
Query: 239 IHRDLKSANILLDHFMRAKVADFGLSK 265
+HRDLK N+L++ K+ADFGL++
Sbjct: 122 LHRDLKPQNLLINERGELKLADFGLAR 148
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 9e-20
Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 14/204 (6%)
Query: 120 NFTNILGQGAFGPVYKATM-PSGGVAAIKVLASDSHQGEKEF---QTEVSLLGR-LHHRN 174
+LG+G+FG V+ A + AIK L D + + E +L H
Sbjct: 20 ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPF 79
Query: 175 LVNLIGYCV-DKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQI-ALDISHGIEYLHE 232
L ++ K + E+++ G L I S + R A +I G+++LH
Sbjct: 80 LTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFD--LSRATFYAAEIILGLQFLHS 136
Query: 233 GAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG-RNSGLKGTYGYIDPAYISTN 291
+ ++RDLK NILLD K+ADFG+ KE + + + GT YI P +
Sbjct: 137 KGI---VYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQ 193
Query: 292 KFTMKSDIFSFGVIIFELITAIHP 315
K+ D +SFGV+++E++ P
Sbjct: 194 KYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 1e-19
Identities = 45/157 (28%), Positives = 70/157 (44%), Gaps = 27/157 (17%)
Query: 123 NILGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKEF-QT---EVSLLGRLHHRNLVN 177
LG G + VYK +G A+K + DS +G T E+SL+ L H N+V
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG---TPSTAIREISLMKELKHENIVR 67
Query: 178 LIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISH----------GI 227
L + K L++EFM N L + S L+++ G+
Sbjct: 68 LYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNT-----PRGLELNLVKYFQWQLLQGL 121
Query: 228 EYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLS 264
+ HE + +HRDLK N+L++ + K+ DFGL+
Sbjct: 122 AFCHENKI---LHRDLKPQNLLINKRGQLKLGDFGLA 155
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 2e-19
Identities = 25/251 (9%), Positives = 70/251 (27%), Gaps = 41/251 (16%)
Query: 125 LGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGE---KEFQTEVSLLGRLHHRNLVNLIG 180
G ++A A+ + + +E + L R+ + ++
Sbjct: 39 HGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLD 98
Query: 181 YCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHE-GAVPPVI 239
+ +++ E++ GSL + + + ++ ++ + H G V
Sbjct: 99 VVHTRAGGLVVAEWIRGGSLQEVA---DTSPSPVGAIRAMQSLAAAADAAHRAG----VA 151
Query: 240 HRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDI 299
+ + + +A + A + DI
Sbjct: 152 LSIDHPSRVRVSIDGDVVLAYP-------------------ATMPDA-------NPQDDI 185
Query: 300 FSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHK 359
G ++ L+ P LA +D + ++ + ++ +A +
Sbjct: 186 RGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAA---R 242
Query: 360 CLHKTPRKRPS 370
+ R +
Sbjct: 243 SVQGDGGIRSA 253
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-19
Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 14/204 (6%)
Query: 120 NFTNILGQGAFGPVYKATM-PSGGVAAIKVLASDSHQGEKEF---QTEVSLLGR-LHHRN 174
F +LG+G+FG V A + +G + A+KVL D + + TE +L +H
Sbjct: 26 EFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPF 85
Query: 175 LVNLIGYCV-DKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQI-ALDISHGIEYLHE 232
L L C + + EF++ G L I R E R + A +I + +LH+
Sbjct: 86 LTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD--EARARFYAAEIISALMFLHD 142
Query: 233 GAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG-RNSGLKGTYGYIDPAYISTN 291
+ I+RDLK N+LLDH K+ADFG+ KE + +G + GT YI P +
Sbjct: 143 KGI---IYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEM 199
Query: 292 KFTMKSDIFSFGVIIFELITAIHP 315
+ D ++ GV+++E++ P
Sbjct: 200 LYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 53/206 (25%), Positives = 88/206 (42%), Gaps = 15/206 (7%)
Query: 120 NFTNILGQGAFGPVYKATM-PSGGVAAIKVLASDSHQGEKE---FQTEVSLLGRLHHRNL 175
++G+GAFG V + V A+K+L+ + F E ++ + +
Sbjct: 72 EVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWV 131
Query: 176 VNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAV 235
V L D ++ E+M G L NL+ S V R A ++ ++ +H
Sbjct: 132 VQLFYAFQDDRYLYMVMEYMPGGDLVNLM-SNYDVPEKWARFYTA-EVVLALDAIHSMGF 189
Query: 236 PPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG--RNSGLKGTYGYIDPAYIST--- 290
IHRD+K N+LLD K+ADFG + +G R GT YI P + +
Sbjct: 190 ---IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGG 246
Query: 291 -NKFTMKSDIFSFGVIIFELITAIHP 315
+ + D +S GV ++E++ P
Sbjct: 247 DGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 3e-19
Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 14/204 (6%)
Query: 120 NFTNILGQGAFGPVYKATM-PSGGVAAIKVLASDSHQGEKEF---QTEVSLLGR-LHHRN 174
NF +LG+G+FG V + + + A+K+L D + + E +L
Sbjct: 23 NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPF 82
Query: 175 LVNLIGYCV-DKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQI-ALDISHGIEYLHE 232
L L C + + E+++ G L I R E A +I+ G+ +L
Sbjct: 83 LTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK--EPHAVFYAAEIAIGLFFLQS 139
Query: 233 GAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG-RNSGLKGTYGYIDPAYISTN 291
+ I+RDLK N++LD K+ADFG+ KE ++DG GT YI P I+
Sbjct: 140 KGI---IYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQ 196
Query: 292 KFTMKSDIFSFGVIIFELITAIHP 315
+ D ++FGV+++E++ P
Sbjct: 197 PYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 4e-19
Identities = 54/200 (27%), Positives = 92/200 (46%), Gaps = 14/200 (7%)
Query: 120 NFTNILGQGAFGPVYKATM-PSGGVAAIKVLASDSHQGEKEF---QTEVSLLGR-LHHRN 174
+F ++G+G+FG V A A+KVL + +KE +E ++L + + H
Sbjct: 41 HFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPF 100
Query: 175 LVNLIGYCV-DKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQI-ALDISHGIEYLHE 232
LV L + K + ++++ G L + E L E R + A +I+ + YLH
Sbjct: 101 LVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFL--EPRARFYAAEIASALGYLHS 157
Query: 233 GAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG-RNSGLKGTYGYIDPAYISTN 291
+ ++RDLK NILLD + DFGL KE + S GT Y+ P +
Sbjct: 158 LNI---VYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQ 214
Query: 292 KFTMKSDIFSFGVIIFELIT 311
+ D + G +++E++
Sbjct: 215 PYDRTVDWWCLGAVLYEMLY 234
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 6e-19
Identities = 46/192 (23%), Positives = 78/192 (40%), Gaps = 24/192 (12%)
Query: 90 SNHSKDRFTSAPSASGIPRYAYKDIQKATQ---NFTNI--LGQGAFGPVYKAT-MPSGGV 143
++H + + + P + + I LG+G +G VYKA +
Sbjct: 2 AHHHHHHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNET 61
Query: 144 AAIKVLASDSHQGEKE---FQT--EVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNG 198
AIK + + E+E EVSLL L HRN++ L + LI+E+ N
Sbjct: 62 VAIKRIRLEH---EEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN- 117
Query: 199 SLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRA-- 256
L + + ++ + +G+ + H +HRDLK N+LL +
Sbjct: 118 DLKKYM-DKNPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASET 173
Query: 257 ---KVADFGLSK 265
K+ DFGL++
Sbjct: 174 PVLKIGDFGLAR 185
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 87.8 bits (217), Expect = 9e-19
Identities = 66/261 (25%), Positives = 109/261 (41%), Gaps = 15/261 (5%)
Query: 64 FSAPVANSVAVKASGFPQKKSQVSWWSNHSKDRFTSAPSASGIPRYAYKDIQKATQ-NFT 122
F+ PV + QK + +A + S +D K T NF
Sbjct: 287 FNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFL 346
Query: 123 NILGQGAFGPVYKATM-PSGGVAAIKVLASDSHQGEKEF---QTEVSLLGR-LHHRNLVN 177
+LG+G+FG V + + + A+K+L D + + E +L L
Sbjct: 347 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 406
Query: 178 LIGYCV-DKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQI-ALDISHGIEYLHEGAV 235
L C + + E+++ G L I R E A +I+ G+ +L +
Sbjct: 407 LH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK--EPHAVFYAAEIAIGLFFLQSKGI 463
Query: 236 PPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG-RNSGLKGTYGYIDPAYISTNKFT 294
I+RDLK N++LD K+ADFG+ KE ++DG GT YI P I+ +
Sbjct: 464 ---IYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYG 520
Query: 295 MKSDIFSFGVIIFELITAIHP 315
D ++FGV+++E++ P
Sbjct: 521 KSVDWWAFGVLLYEMLAGQAP 541
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 1e-18
Identities = 74/265 (27%), Positives = 119/265 (44%), Gaps = 29/265 (10%)
Query: 120 NFTNILGQGAFGPVY----KATMPSGGVAAIKVLASDSHQGEKEF----QTEVSLLGRL- 170
+LG GA+G V+ + +G + A+KVL + + + +TE +L +
Sbjct: 57 ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR 116
Query: 171 HHRNLVNLIGYCV-DKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQI-ALDISHGIE 228
LV L Y + K LI ++++ G L + ER E +QI +I +E
Sbjct: 117 QSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFT--EHEVQIYVGEIVLALE 173
Query: 229 YLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG--RNSGLKGTYGYIDPA 286
+LH+ + I+RD+K NILLD + DFGLSKE V D R GT Y+ P
Sbjct: 174 HLHKLGI---IYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 230
Query: 287 YISTNK--FTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGA 344
+ D +S GV+++EL+T P E + A +S+ IL +
Sbjct: 231 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR----RILKSEPPYP 286
Query: 345 CNI-QEVRELARIGHKCLHKTPRKR 368
+ ++L + + L K P+KR
Sbjct: 287 QEMSALAKDLIQ---RLLMKDPKKR 308
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 1e-18
Identities = 57/300 (19%), Positives = 101/300 (33%), Gaps = 73/300 (24%)
Query: 101 PSASGIPRYAYKDIQKATQNFTNILGQGAFGPVYKATMPSGGVA-AIKVLASDSHQGEKE 159
P + I + + +LG G G V + A+K+L D +
Sbjct: 2 PHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-QDC----PK 56
Query: 160 FQTEVSLLGRL-HHRNLVNLIGYCVD----KGKYMLIYEFMSNGSL-------SNLIYSE 207
+ EV L R ++V ++ + + +++ E + G L + ++E
Sbjct: 57 ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTE 116
Query: 208 ERVLNWEERLQIALDISHGIEYLHE-GAVPPVIHRDLKSANILLDHF---MRAKVADFGL 263
E +I I I+YLH + HRD+K N+L K+ DFG
Sbjct: 117 R------EASEIMKSIGEAIQYLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGF 166
Query: 264 SKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYV 323
+K E Y D++S GVI++ L+ P
Sbjct: 167 AK-ET-------TGEKYD-------------KSCDMWSLGVIMYILLCGYPPFY------ 199
Query: 324 NLASMSQDGVDEILDKQLVGA--------CNI-QEVRELARIGHKCLHKTPRKRPSIGEV 374
++ + + +G + +EV+ L R L P +R +I E
Sbjct: 200 --SNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIR---NLLKTEPTQRMTITEF 254
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 85.8 bits (212), Expect = 1e-18
Identities = 64/344 (18%), Positives = 118/344 (34%), Gaps = 105/344 (30%)
Query: 121 FTNILGQGAFGPVYKAT------MPSGGVAAIKVLASDSHQGE-KEFQTE---------- 163
LG+GAFG V +A + A+K+L + E + +E
Sbjct: 26 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 85
Query: 164 ---VSLLG--------------------------------------RLHHRNLVNLIGYC 182
V+LLG R + +G
Sbjct: 86 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAI 145
Query: 183 VDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEER----------------LQIALDISHG 226
K L S S S+ E+ + + EE + + ++ G
Sbjct: 146 PVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKG 205
Query: 227 IEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYID-- 284
+E+L A IHRDL + NILL K+ DFGL++ +++ + ++ +
Sbjct: 206 MEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-DIYKDPDY-VRKGDARLPLK 260
Query: 285 ---PAYISTNKFTMKSDIFSFGVIIFELIT-------AIHPHQNLMEYVNLASMSQDGVD 334
P I +T++SD++SFGV+++E+ + + + + ++G
Sbjct: 261 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL------KEG-- 312
Query: 335 EILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQAL 378
+ E+ + C H P +RP+ E+ + L
Sbjct: 313 TRMRAPD--YTT----PEMYQTMLDCWHGEPSQRPTFSELVEHL 350
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 2e-18
Identities = 48/220 (21%), Positives = 86/220 (39%), Gaps = 57/220 (25%)
Query: 122 TNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQT-EVSLLGRLHHRNLVNLI- 179
++G G+FG V++A + AIK + D K F+ E+ ++ + H N+V+L
Sbjct: 45 CKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIVKHPNVVDLKA 99
Query: 180 -----GYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISH--------- 225
G D+ L+ E++ + R +L+ + +
Sbjct: 100 FFYSNGDKKDEVFLNLVLEYVP----ETV----YRASRHYAKLKQTMPMLLIKLYMYQLL 151
Query: 226 -GIEYLHEGAVPPVIHRDLKSANILLD-HFMRAKVADFGLSKEEVFDGRNSGLKGTYGYI 283
+ Y+H + HRD+K N+LLD K+ DFG +K + N
Sbjct: 152 RSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNV--------- 199
Query: 284 DPAYIST------------NKFTMKSDIFSFGVIIFELIT 311
+YI + +T DI+S G ++ EL+
Sbjct: 200 --SYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQ 237
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 3e-18
Identities = 53/221 (23%), Positives = 91/221 (41%), Gaps = 58/221 (26%)
Query: 122 TNILGQGAFGPVYKAT-MPSGGVAAIK-VLASDSHQGEKEFQTEVSLLGRLHHRNLVNLI 179
T ++G G+FG VY+A SG + AIK VL Q ++ E+ ++ +L H N+V L
Sbjct: 59 TKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNRELQIMRKLDHCNIVRLR 113
Query: 180 GY------CVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISH-------- 225
+ D+ L+ +++ + RV R + L + +
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVP----ETV----YRVARHYSRAKQTLPVIYVKLYMYQL 165
Query: 226 --GIEYLHEGAVPPVIHRDLKSANILLD-HFMRAKVADFGLSKEEVFDGRNSGLKGTYGY 282
+ Y+H + HRD+K N+LLD K+ DFG +K+ V N
Sbjct: 166 FRSLAYIHSFGI---CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV-------- 214
Query: 283 IDPAYIST------------NKFTMKSDIFSFGVIIFELIT 311
+YI + +T D++S G ++ EL+
Sbjct: 215 ---SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLL 252
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 1e-17
Identities = 49/207 (23%), Positives = 78/207 (37%), Gaps = 25/207 (12%)
Query: 124 ILGQGAFGPVYKATMPSGGVAAIK--VLASDSHQGEKEFQT---------EVSLLGRLHH 172
+ G++G V G AIK + E+ LL HH
Sbjct: 29 FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 173 RNLVNLI------GYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQ-IALDISH 225
N++ L Y L+ E M L+ +I+ + V++ + +Q I
Sbjct: 89 PNILGLRDIFVHFEEPAMHKLY-LVTELMRT-DLAQVIHDQRIVIS-PQHIQYFMYHILL 145
Query: 226 GIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDP 285
G+ LHE V +HRDL NILL + DF L++E+ D + Y P
Sbjct: 146 GLHVLHEAGV---VHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAP 202
Query: 286 AYI-STNKFTMKSDIFSFGVIIFELIT 311
+ FT D++S G ++ E+
Sbjct: 203 ELVMQFKGFTKLVDMWSAGCVMAEMFN 229
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 4e-17
Identities = 45/161 (27%), Positives = 69/161 (42%), Gaps = 25/161 (15%)
Query: 123 NILGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKEFQT--------EVSLLGRLH-- 171
+G GA+G VYKA SG A+K + + EV+LL RL
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSVRVPN---GGGGGGGLPISTVREVALLRRLEAF 71
Query: 172 -HRNLVNLIGYCVDKG-----KYMLIYEFMSNGSLSNLIYSEERVLNWEERLQ-IALDIS 224
H N+V L+ C K L++E + L + E ++ +
Sbjct: 72 EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFL 130
Query: 225 HGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSK 265
G+++LH + +HRDLK NIL+ K+ADFGL++
Sbjct: 131 RGLDFLHANCI---VHRDLKPENILVTSGGTVKLADFGLAR 168
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 1e-16
Identities = 51/221 (23%), Positives = 85/221 (38%), Gaps = 55/221 (24%)
Query: 123 NILGQGAFGPVYKA--TMPSGGVAAIKVLASDSHQGEKE---FQT--EVSLLGRLH---H 172
+G+GA+G V+KA G A+K + + +E T EV++L L H
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT---GEEGMPLSTIREVAVLRHLETFEH 73
Query: 173 RNLVNLIGYCV-----DKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQ-IALDISHG 226
N+V L C + K L++E + L+ + E ++ + + G
Sbjct: 74 PNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRG 132
Query: 227 IEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPA 286
+++LH V +HRDLK NIL+ + K+ADFGL R +
Sbjct: 133 LDFLHSHRV---VHRDLKPQNILVTSSGQIKLADFGL-------ARIYSFQMAL------ 176
Query: 287 YISTN----------------KFTMKSDIFSFGVIIFELIT 311
T+ + D++S G I E+
Sbjct: 177 ---TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR 214
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 1e-16
Identities = 42/156 (26%), Positives = 67/156 (42%), Gaps = 23/156 (14%)
Query: 125 LGQGAFGPVYKA---TMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGY 181
+G+G +G VYKA A+K + E++LL L H N+++L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKV 86
Query: 182 CVDKG--KYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALD--------ISHGIEYLH 231
+ K L++++ + L ++I ++ +Q+ I GI YLH
Sbjct: 87 FLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 232 EGAVPPVIHRDLKSANILL----DHFMRAKVADFGL 263
V +HRDLK ANIL+ R K+AD G
Sbjct: 146 ANWV---LHRDLKPANILVMGEGPERGRVKIADMGF 178
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 57/230 (24%), Positives = 83/230 (36%), Gaps = 54/230 (23%)
Query: 115 QKATQNFTNI--LGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLH 171
+K F GQG FG V +G AIK + D +E Q + L LH
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLAVLH 77
Query: 172 HRNLVNLI------GYCVDKGKYM-LIYEFMSNGSLSNLIYSEERVLNWEERLQIALDIS 224
H N+V L G + Y+ ++ E++ L R R Q+A
Sbjct: 78 HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP----DTL----HRCCRNYYRRQVAPPPI 129
Query: 225 H----------GIEYLHEGAVPPVIHRDLKSANILLDHFM-RAKVADFGLSKEEVFDGRN 273
I LH +V V HRD+K N+L++ K+ DFG +K+ N
Sbjct: 130 LIKVFLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN 188
Query: 274 SGLKGTYGYIDPAYIST------------NKFTMKSDIFSFGVIIFELIT 311
AYI + +T DI+S G I E++
Sbjct: 189 V-----------AYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMML 227
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 4e-15
Identities = 48/235 (20%), Positives = 87/235 (37%), Gaps = 61/235 (25%)
Query: 59 GTSIDFSAPVANSVAVKASGFPQKKSQVSWWSNHSKDRFTSAPSAS---GIPRYAYKDIQ 115
G+S + +A ++ + + ++ +HS S P IP Y+
Sbjct: 1 GSSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDR-YEIRH 59
Query: 116 KATQNFTNILGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKEFQT---------EVS 165
+G G++G V +A V AIK + + F+ E++
Sbjct: 60 L--------IGTGSYGHVCEAYDKLEKRVVAIKKIL-------RVFEDLIDCKRILREIA 104
Query: 166 LLGRLHHRNLVNLI------GYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQI 219
+L RL+H ++V ++ Y ++ E + L + +
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELY-VVLEIADS-DFKKLFRT-----------PV 151
Query: 220 ALDISH----------GIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLS 264
L H G++Y+H + +HRDLK AN L++ KV DFGL+
Sbjct: 152 YLTELHIKTLLYNLLVGVKYVHSAGI---LHRDLKPANCLVNQDCSVKVCDFGLA 203
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 72.6 bits (177), Expect = 2e-14
Identities = 36/251 (14%), Positives = 68/251 (27%), Gaps = 72/251 (28%)
Query: 106 IPRYAYKDIQKATQNFTNILGQGAFGPVYKATMPSGGVAAIKVLA--------SDSHQGE 157
+P + +K +G+G FG V++ V AIK++A +
Sbjct: 17 LPTEKLQRCEK--------IGEGVFGEVFQTIADHTPV-AIKIIAIEGPDLVNGSHQKTF 67
Query: 158 KEFQTEVSLLGRLH---------HRNLVNLIGYCVDKGKYM------------------- 189
+E E+ + L + L +G Y
Sbjct: 68 EEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSAND 127
Query: 190 -----------LIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPV 238
++ EF G L ++ + I ++ +
Sbjct: 128 RPDFFKDDQLFIVLEFEFGGID--LEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRF 183
Query: 239 IHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSD 298
HRDL N+LL K+ K + G +S +T+
Sbjct: 184 EHRDLHWGNVLLKKTSLKKLHYTLNGKSSTI--------PSCGLQ----VSIIDYTLSRL 231
Query: 299 IFSFGVIIFEL 309
V+ ++
Sbjct: 232 ERDGIVVFCDV 242
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 4e-14
Identities = 56/206 (27%), Positives = 88/206 (42%), Gaps = 32/206 (15%)
Query: 123 NILGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKEFQT---------EVSLLGRLHH 172
+G GA G V A AIK L+ + FQ E+ L+ ++H
Sbjct: 31 KPIGSGAQGIVCAAYDAILERNVAIKKLS-------RPFQNQTHAKRAYRELVLMKCVNH 83
Query: 173 RN---LVNLIGYCVDKGKYMLIY---EFMSNGSLSNLIYSEERVLNWEERLQIAL-DISH 225
+N L+N+ ++ +Y E M +L +I E L+ ER+ L +
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQME---LD-HERMSYLLYQMLC 138
Query: 226 GIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDP 285
GI++LH + IHRDLK +NI++ K+ DFGL++ + T Y P
Sbjct: 139 GIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 195
Query: 286 AYISTNKFTMKSDIFSFGVIIFELIT 311
I + DI+S G I+ E+I
Sbjct: 196 EVILGMGYKENVDIWSVGCIMGEMIK 221
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 1e-13
Identities = 55/214 (25%), Positives = 92/214 (42%), Gaps = 36/214 (16%)
Query: 118 TQNFTNI--LGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKEFQT---------EVS 165
+ + N+ +G GA G V A AIK L+ + FQ E+
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-------RPFQNQTHAKRAYRELV 113
Query: 166 LLGRLHHRNLVNLI-------GYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQ 218
L+ ++H+N+++L+ + Y L+ E M + +L +I E ER+
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVY-LVMELM-DANLCQVIQMEL----DHERMS 167
Query: 219 IAL-DISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLK 277
L + GI++LH + IHRDLK +NI++ K+ DFGL++ +
Sbjct: 168 YLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV 224
Query: 278 GTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT 311
T Y P I + DI+S G I+ E++
Sbjct: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR 258
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 54/236 (22%), Positives = 92/236 (38%), Gaps = 55/236 (23%)
Query: 124 ILGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKEFQT---------EVSLLGRLHHR 173
++G+G++G VY A + AIK + + F+ E+++L RL
Sbjct: 33 LIGRGSYGYVYLAYDKNTEKNVAIKKVN-------RMFEDLIDCKRILREITILNRLKSD 85
Query: 174 NLVNLI------GYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQ-IALDISHG 226
++ L Y ++ E + L L + L EE ++ I ++ G
Sbjct: 86 YIIRLYDLIIPDDLLKFDELY-IVLEIADS-DLKKLFKTPIF-LT-EEHIKTILYNLLLG 141
Query: 227 IEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPA 286
++HE + IHRDLK AN LL+ KV DFGL++ + + + +P
Sbjct: 142 ENFIHESGI---IHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPG 198
Query: 287 ------------YIST------------NKFTMKSDIFSFGVIIFELITAIHPHQN 318
++ T +T DI+S G I EL+ + H N
Sbjct: 199 PHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIN 254
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 4e-13
Identities = 55/223 (24%), Positives = 91/223 (40%), Gaps = 37/223 (16%)
Query: 111 YKDIQKATQNFTNILGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKEFQTEVSLLGR 169
Y D++ LG G G V+ A AIK + Q K E+ ++ R
Sbjct: 13 YMDLKP--------LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRR 64
Query: 170 LHHRNLVNLI--------GYCVDKGKYM------LIYEFMSNGSLSNLIYSEERVLNWEE 215
L H N+V + D G ++ E+M L+N++ L EE
Sbjct: 65 LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGP--LL-EE 120
Query: 216 RLQ-IALDISHGIEYLHEGAVPPVIHRDLKSANILLDHF-MRAKVADFGLSKEEVFDGRN 273
+ + G++Y+H V +HRDLK AN+ ++ + K+ DFGL++ +
Sbjct: 121 HARLFMYQLLRGLKYIHSANV---LHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSH 177
Query: 274 SGLKGTY----GYIDPAYI-STNKFTMKSDIFSFGVIIFELIT 311
G Y P + S N +T D+++ G I E++T
Sbjct: 178 KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLT 220
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 6e-13
Identities = 51/209 (24%), Positives = 89/209 (42%), Gaps = 29/209 (13%)
Query: 124 ILGQGAFGPVYKAT-MPSGGVAAIK-VLASDSHQGEKEFQTEVSLLGRLHHRNLVNLI-- 179
+LG+GA+G V AT P+G + AIK + D E+ +L H N++ +
Sbjct: 18 LLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNI 77
Query: 180 ----GYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQ-IALDISHGIEYLHEGA 234
+ Y +I E M L +I ++ L+ ++ +Q ++ LH
Sbjct: 78 QRPDSFENFNEVY-IIQELMQT-DLHRVISTQM--LS-DDHIQYFIYQTLRAVKVLHGSN 132
Query: 235 VPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYIST---- 290
V IHRDLK +N+L++ KV DFGL++ ++ +++T
Sbjct: 133 V---IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYR 189
Query: 291 --------NKFTMKSDIFSFGVIIFELIT 311
K++ D++S G I+ EL
Sbjct: 190 APEVMLTSAKYSRAMDVWSCGCILAELFL 218
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 46/243 (18%), Positives = 86/243 (35%), Gaps = 74/243 (30%)
Query: 124 ILGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKEFQT-EVSLLGRLHHRNLVNL--I 179
LG G+FG V + + SG A+K + D ++ E+ ++ L H N++ L
Sbjct: 14 TLGTGSFGIVCEVFDIESGKRFALKKVLQD-----PRYKNRELDIMKVLDHVNIIKLVDY 68
Query: 180 GYCVDKGKYMLIYEFMSNGSLS-----------------------NLI--YSEE---RVL 211
Y + + L N+I Y + +VL
Sbjct: 69 FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVL 128
Query: 212 NWEERLQIALDISH----------GIEYLHEGAVPPVIHRDLKSANILLD-HFMRAKVAD 260
R ++ ++ + ++H + HRD+K N+L++ K+ D
Sbjct: 129 KSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGI---CHRDIKPQNLLVNSKDNTLKLCD 185
Query: 261 FGLSKEEVFDGRNSGLKGTYGYIDPAYIST------------NKFTMKSDIFSFGVIIFE 308
FG +K+ + + AYI + ++T D++S G + E
Sbjct: 186 FGSAKKLIPSEPSV-----------AYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGE 234
Query: 309 LIT 311
LI
Sbjct: 235 LIL 237
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 52/210 (24%), Positives = 96/210 (45%), Gaps = 24/210 (11%)
Query: 118 TQNFTNI--LGQGAFGPVYKAT-MPSGGVAAIK-VLASDSHQGEKEFQTEVSLLGRLHHR 173
+TN+ +G+GA+G V A + AIK + + + E+ +L R H
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 85
Query: 174 NLVNLI------GYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQ-IALDISHG 226
N++ + K Y ++ + M L L+ ++ L+ + + I G
Sbjct: 86 NIIGINDIIRAPTIEQMKDVY-IVQDLMET-DLYKLLKTQH--LS-NDHICYFLYQILRG 140
Query: 227 IEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTY----GY 282
++Y+H V +HRDLK +N+LL+ K+ DFGL++ D ++G Y Y
Sbjct: 141 LKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197
Query: 283 IDPAYI-STNKFTMKSDIFSFGVIIFELIT 311
P + ++ +T DI+S G I+ E+++
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLS 227
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 2e-12
Identities = 57/208 (27%), Positives = 92/208 (44%), Gaps = 37/208 (17%)
Query: 123 NILGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKEFQT---------EVSLLGRLHH 172
+G GA+G V A SG AIK L+ + FQ+ E+ LL + H
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLS-------RPFQSEIFAKRAYRELLLLKHMQH 82
Query: 173 RNLVNLI-------GYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQ-IALDIS 224
N++ L+ Y L+ FM L ++ + + EE++Q + +
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFY-LVMPFM-QTDLQKIMGLK---FS-EEKIQYLVYQML 136
Query: 225 HGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYID 284
G++Y+H V +HRDLK N+ ++ K+ DFGL++ D +G T Y
Sbjct: 137 KGLKYIHSAGV---VHRDLKPGNLAVNEDCELKILDFGLAR--HADAEMTGYVVTRWYRA 191
Query: 285 PAYI-STNKFTMKSDIFSFGVIIFELIT 311
P I S + DI+S G I+ E++T
Sbjct: 192 PEVILSWMHYNQTVDIWSVGCIMAEMLT 219
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 2e-12
Identities = 33/170 (19%), Positives = 68/170 (40%), Gaps = 47/170 (27%)
Query: 111 YKDIQKATQNFTNILGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKEFQTEVSLLGR 169
Y+ ++K LG+G + V++A + + +K+L +K+ + E+ +L
Sbjct: 38 YQLVRK--------LGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILEN 86
Query: 170 L-HHRNLVNLIGYCV----DKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDIS 224
L N++ L + L++E ++N L + L
Sbjct: 87 LRGGPNIITL--ADIVKDPVSRTPALVFEHVNNTDFKQLYQT--------------LTDY 130
Query: 225 H----------GIEYLHEGAVPPVIHRDLKSANILLDHFMRA-KVADFGL 263
++Y H + +HRD+K N+++DH R ++ D+GL
Sbjct: 131 DIRFYMYEILKALDYCHSMGI---MHRDVKPHNVMIDHEHRKLRLIDWGL 177
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 7e-12
Identities = 61/227 (26%), Positives = 99/227 (43%), Gaps = 53/227 (23%)
Query: 123 NILGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKEFQT---------EVSLLGRLH- 171
LG+GA+G V+K+ +G V A+K + FQ E+ +L L
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIF-------DAFQNSTDAQRTFREIMILTELSG 67
Query: 172 HRNLVNLIGYCV---DKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQ-IALDISHGI 227
H N+VNL+ D+ Y L++++M L +I + +L Q + + I
Sbjct: 68 HENIVNLLNVLRADNDRDVY-LVFDYMET-DLHAVIRAN--ILE-PVHKQYVVYQLIKVI 122
Query: 228 EYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPA- 286
+YLH G + +HRD+K +NILL+ KVADFGLS+ V R + +
Sbjct: 123 KYLHSGGL---LHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTEN 179
Query: 287 ----------YIST------------NKFTMKSDIFSFGVIIFELIT 311
Y++T K+T D++S G I+ E++
Sbjct: 180 FDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILC 226
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 7e-12
Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 34/205 (16%)
Query: 125 LGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKEFQT---------EVSLLGRLHHRN 174
+G GA+G V A +G AIK L + FQ+ E+ LL + H N
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLY-------RPFQSELFAKRAYRELRLLKHMRHEN 85
Query: 175 LVNLIGYCVDKGKYM------LIYEFMSNGSLSNLIYSEERVLNWEERLQ-IALDISHGI 227
++ L+ L+ FM L L+ E+ L E+R+Q + + G+
Sbjct: 86 VIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEK--LG-EDRIQFLVYQMLKGL 141
Query: 228 EYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAY 287
Y+H + IHRDLK N+ ++ K+ DFGL++ D +G T Y P
Sbjct: 142 RYIHAAGI---IHRDLKPGNLAVNEDCELKILDFGLAR--QADSEMTGYVVTRWYRAPEV 196
Query: 288 I-STNKFTMKSDIFSFGVIIFELIT 311
I + ++T DI+S G I+ E+IT
Sbjct: 197 ILNWMRYTQTVDIWSVGCIMAEMIT 221
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 8e-12
Identities = 53/206 (25%), Positives = 93/206 (45%), Gaps = 36/206 (17%)
Query: 125 LGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKEFQT---------EVSLLGRLHHRN 174
+G GA+G V A +G A+K L+ + FQ+ E+ LL + H N
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 89
Query: 175 LVNLI-------GYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQ-IALDISHG 226
++ L+ Y L+ M L+N++ ++ L ++ +Q + I G
Sbjct: 90 VIGLLDVFTPARSLEEFNDVY-LVTHLM-GADLNNIVKCQK--LT-DDHVQFLIYQILRG 144
Query: 227 IEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPA 286
++Y+H + IHRDLK +N+ ++ K+ DFGL++ +G T Y P
Sbjct: 145 LKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLAR--HTADEMTGYVATRWYRAPE 199
Query: 287 YI-STNKFTMKSDIFSFGVIIFELIT 311
+ + + DI+S G I+ EL+T
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLT 225
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 52/207 (25%), Positives = 93/207 (44%), Gaps = 35/207 (16%)
Query: 124 ILGQGAFGPVYKAT-MPSGGVAAIKVLASDS---HQGEKEFQTEVSLLGRLHHR------ 173
++G+G+FG V KA A+K++ ++ Q E+ +L L +
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA----AEEIRILEHLRKQDKDNTM 159
Query: 174 NLVNLIGYCVDKGKYMLIYEFMSNGSLSNLI-YSEERVLNWEERLQIALDISHGIEYLHE 232
N+++++ + + +E +S +L LI ++ + + + A I ++ LH+
Sbjct: 160 NVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK 218
Query: 233 GAVPPVIHRDLKSANILLDHFMRA--KVADFGLSKEEVFDGRNSGLKGTYGYID------ 284
+IH DLK NILL R+ KV DFG S ++ + Y YI
Sbjct: 219 ---NRIIHCDLKPENILLKQQGRSGIKVIDFGSS---CYEHQR-----VYTYIQSRFYRA 267
Query: 285 PAYISTNKFTMKSDIFSFGVIIFELIT 311
P I ++ M D++S G I+ EL+T
Sbjct: 268 PEVILGARYGMPIDMWSLGCILAELLT 294
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 4e-11
Identities = 51/211 (24%), Positives = 91/211 (43%), Gaps = 29/211 (13%)
Query: 124 ILGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLH----------- 171
LG G F V+ A M + A+K++ D E + E+ LL R++
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE-AAEDEIKLLQRVNDADNTKEDSMG 84
Query: 172 HRNLVNLIG---YCVDKGKYM-LIYEFMSNGSLSNLI-YSEERVLNWEERLQIALDISHG 226
+++ L+ + G ++ +++E + +L LI E R + QI+ + G
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRGIPLIYVKQISKQLLLG 143
Query: 227 IEYLHEGAVPPVIHRDLKSANILLDHFMRA------KVADFGLSKEEVFDGRNSGLKGTY 280
++Y+H +IH D+K N+L++ K+AD G + D + T
Sbjct: 144 LDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY--DEHYTNSIQTR 199
Query: 281 GYIDPAYISTNKFTMKSDIFSFGVIIFELIT 311
Y P + + +DI+S +IFELIT
Sbjct: 200 EYRSPEVLLGAPWGCGADIWSTACLIFELIT 230
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 8e-11
Identities = 41/198 (20%), Positives = 80/198 (40%), Gaps = 40/198 (20%)
Query: 125 LGQGAFGPVYKATMPSGGVA---------AIKVLASDSHQ-GEKEF------QTEVSLLG 168
+ G +Y+A S ++K+ A D E+ F +V+
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 169 RLHHRNLV---NLIGYCVDKGKY-MLIYEFMSNGSLSNLI-YSEERVLNWEERLQIALDI 223
+L+ L+ +G+ V + KY L+ + SL + + S + VL+ LQ+A +
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSALDVSPKHVLSERSVLQVACRL 168
Query: 224 SHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKV--ADFGLSKE--------EVFDGRN 273
+E+LHE +H ++ + NI +D +++V A +G + +G
Sbjct: 169 LDALEFLHENEY---VHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSR 225
Query: 274 SGLKGTYGYIDPAYISTN 291
S +G +IS +
Sbjct: 226 SPHEGD-----LEFISMD 238
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 3e-10
Identities = 53/215 (24%), Positives = 91/215 (42%), Gaps = 45/215 (20%)
Query: 122 TNILGQGAFGPVYKAT-MPSGGVAAIKVLASDS---HQGEKEFQTEVSLLGRLHHR---- 173
+++G+G+FG V KA AIK++ + +Q Q EV LL ++
Sbjct: 59 DSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA----QIEVRLLELMNKHDTEM 114
Query: 174 --NLVNLIGYCVDKGKYMLIYEFMSNGSLSNLI-------YSEERVLNWEERLQIALDIS 224
+V+L + + + L++E +S +L +L+ S + +++ AL
Sbjct: 115 KYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFL 173
Query: 225 HGIEYLHEGAVPPVIHRDLKSANILLDHFMRA--KVADFGLSKEEVFDGRNSGLKGTYGY 282
E +IH DLK NILL + R+ K+ DFG S G+ Y Y
Sbjct: 174 ATPE-------LSIIHCDLKPENILLCNPKRSAIKIVDFGSS---CQLGQR-----IYQY 218
Query: 283 ID------PAYISTNKFTMKSDIFSFGVIIFELIT 311
I P + + + D++S G I+ E+ T
Sbjct: 219 IQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHT 253
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 3e-09
Identities = 34/150 (22%), Positives = 68/150 (45%), Gaps = 15/150 (10%)
Query: 125 LGQGAFGPVYKAT-MPSGGVAAIKV--LASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGY 181
+G+G+FG +++ T + + AIK SD+ Q E++T L G + N+ +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTG---IPNVYYF 74
Query: 182 CVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHR 241
+ +L+ + + SL +L+ R + + A + ++ +HE ++ ++R
Sbjct: 75 GQEGLHNVLVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSL---VYR 130
Query: 242 DLKSANILLDHFMRAK-----VADFGLSKE 266
D+K N L+ V DFG+ K
Sbjct: 131 DIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 8e-09
Identities = 37/164 (22%), Positives = 63/164 (38%), Gaps = 25/164 (15%)
Query: 125 LGQGAFGPVYKATMPSGG------VAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNL 178
+GQG FG +Y A M S +KV SD+ E + + +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 179 IG----------YCVDKGKYMLIYEFMS----NGSLSNLIYSEERVLNWEERLQIALDIS 224
K Y FM L + + + + + LQ++L I
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRIL 162
Query: 225 HGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKV--ADFGLSKE 266
+EY+HE +H D+K++N+LL++ +V D+GL+
Sbjct: 163 DILEYIHEHEY---VHGDIKASNLLLNYKNPDQVYLVDYGLAYR 203
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 8e-09
Identities = 36/148 (24%), Positives = 66/148 (44%), Gaps = 13/148 (8%)
Query: 125 LGQGAFGPVYKAT-MPSGGVAAIKV--LASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGY 181
+G G+FG +Y T + +G AIK+ + + Q E + + G + + +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVG---IPTIRWC 73
Query: 182 CVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHR 241
+ +++ E + SL +L R + + L +A + IEY+H IHR
Sbjct: 74 GAEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNF---IHR 129
Query: 242 DLKSANILLDHFMRAK---VADFGLSKE 266
D+K N L+ + + DFGL+K+
Sbjct: 130 DVKPDNFLMGLGKKGNLVYIIDFGLAKK 157
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 33/150 (22%), Positives = 60/150 (40%), Gaps = 15/150 (10%)
Query: 125 LGQGAFGPVYKAT-MPSGGVAAIKVLASDSH--QGEKEFQTEVSLLGRLHHRNLVNLIGY 181
+G G FG + + + AIK+ S Q E++ L + + +
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDG---IPQVYYF 73
Query: 182 CVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHR 241
++ E + SL +L +R + + L IA+ + +EY+H + I+R
Sbjct: 74 GPCGKYNAMVLELLGP-SLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNL---IYR 129
Query: 242 DLKSANILLDHFMRAK-----VADFGLSKE 266
D+K N L+ + DF L+KE
Sbjct: 130 DVKPENFLIGRPGNKTQQVIHIIDFALAKE 159
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 38/148 (25%), Positives = 71/148 (47%), Gaps = 13/148 (8%)
Query: 125 LGQGAFGPVYKAT-MPSGGVAAIKV--LASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGY 181
+G G+FG +Y T + + AIK+ + + Q E + L G + N+ +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTG---IPNVRWF 71
Query: 182 CVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHR 241
V+ +L+ + + SL +L R L+ + L +A + + +E++H + +HR
Sbjct: 72 GVEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF---LHR 127
Query: 242 DLKSANILLDHFMRAK---VADFGLSKE 266
D+K N L+ RA + DFGL+K+
Sbjct: 128 DIKPDNFLMGLGRRANQVYIIDFGLAKK 155
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 32/163 (19%), Positives = 59/163 (36%), Gaps = 26/163 (15%)
Query: 125 LGQGAFGPVYKA----TMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLV---- 176
+G G FG +Y A +KV ++ E + + + + +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 177 -------NLIGY---CVDKGKY-MLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISH 225
G Y ++ E + L + + LQ+ + +
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQKI-SGQNGTFKKSTVLQLGIRMLD 162
Query: 226 GIEYLHEGAVPPVIHRDLKSANILLDHFMRAKV--ADFGLSKE 266
+EY+HE +H D+K+AN+LL + +V AD+GLS
Sbjct: 163 VLEYIHENEY---VHGDIKAANLLLGYKNPDQVYLADYGLSYR 202
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 1e-07
Identities = 61/352 (17%), Positives = 108/352 (30%), Gaps = 109/352 (30%)
Query: 125 LGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGY-- 181
LG G F V+ + + A+KV+ S H E E+ LL + + + N
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-LDEIRLLKSVRNSD-PNDPNREM 102
Query: 182 ---CVD-------KGKYM-LIYEFMSNGSLSNLI-YSEERVLNWEERLQIALDISHGIEY 229
+D G ++ +++E + + L I S + L +I + G++Y
Sbjct: 103 VVQLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDY 161
Query: 230 LHEGAVPPVIHRDLKSANILL--------------------------------------- 250
LH +IH D+K NILL
Sbjct: 162 LHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGN 219
Query: 251 ----------DHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIF 300
++ K+AD G + + T Y + + + +DI+
Sbjct: 220 FLVNPLEPKNAEKLKVKIADLGNAC--WVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIW 277
Query: 301 SFGVIIFELITAIH---PHQNLMEYVN---LASM----------------------SQDG 332
S + FEL T + PH + +A + ++ G
Sbjct: 278 STACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKG 337
Query: 333 ----VDEI----LDKQLVGACNI--QEVRELARIGHKCLHKTPRKRPSIGEV 374
+ ++ L + LV +E L P KR + E
Sbjct: 338 DLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAEC 389
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 39/225 (17%), Positives = 77/225 (34%), Gaps = 53/225 (23%)
Query: 124 ILGQGAFGPVYKA--TMPSGGVAAIKVLASDS---HQGEKEFQTEVSLLGRLHHR----- 173
LG+G FG V + A+K++ + + E+++L ++ +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA----RLEINVLKKIKEKDKENK 81
Query: 174 -NLVNLIGYCVDKGKY-----ML---IYEFMSNGSLSNLIYSEERVLNWEERLQIALDIS 224
V + + G +L +EF+ + R +A +
Sbjct: 82 FLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVR--------HMAYQLC 133
Query: 225 HGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLK----GTY 280
H + +LHE + H DLK NIL + + + S EE + ++ G+
Sbjct: 134 HALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKN-TSIRVADFGSA 189
Query: 281 GYID---PAYIST-----------NKFTMKSDIFSFGVIIFELIT 311
+ ++T + D++S G I+FE
Sbjct: 190 TFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYR 234
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 42/224 (18%), Positives = 81/224 (36%), Gaps = 51/224 (22%)
Query: 124 ILGQGAFGPVYKA--TMPSGGVAAIKVLASDS---HQGEKEFQTEVSLLGRLHHR----- 173
LG+GAFG V + G A+K++ + ++E+ +L L+
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA----RSEIQVLEHLNTTDPNST 76
Query: 174 -NLVNLIGYCVDKGKYMLIYEFMSNGSLSNLI-------YSEERVLNWEERLQIALDISH 225
V ++ + G +++E + S + I + + + +A I
Sbjct: 77 FRCVQMLEWFEHHGHICIVFELLGL-STYDFIKENGFLPFRLDHIRK------MAYQICK 129
Query: 226 GIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLK----GTYG 281
+ +LH + H DLK NIL + + + ++E N +K G+
Sbjct: 130 SVNFLHSNKL---THTDLKPENILFVQSDYTEAYNPKIKRDE-RTLINPDIKVVDFGSAT 185
Query: 282 YID---PAYIST-----------NKFTMKSDIFSFGVIIFELIT 311
Y D +ST ++ D++S G I+ E
Sbjct: 186 YDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYL 229
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 4e-06
Identities = 46/221 (20%), Positives = 88/221 (39%), Gaps = 41/221 (18%)
Query: 124 ILGQGAFGPVYKAT-MPSGGVAAIKVLASDS---HQGEKEFQTEVSLLGRL-----HHRN 174
+G G FG V + + A+KV+ + + E +L ++ ++ N
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA----KIEADILKKIQNDDINNNN 97
Query: 175 LVNLIGYCVDKGKYMLIYEFMSNGSLSNLI-YSEERVLNWEERLQIALDISHGIEYLHEG 233
+V G + LI+E + SL +I + + E+ ++I + YL +
Sbjct: 98 IVKYHGKFMYYDHMCLIFEPLGP-SLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK- 155
Query: 234 AVPPVIHRDLKSANILLDH-----FMRAKVADFGLSKEEVFDGRNSGLK----GTYGYID 284
+ H DLK NILLD + K +++ +++G+K G +
Sbjct: 156 --MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKS 213
Query: 285 ---PAYIST-----------NKFTMKSDIFSFGVIIFELIT 311
+ I+T + + SD++SFG ++ EL T
Sbjct: 214 DYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT 254
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 41.4 bits (96), Expect = 5e-04
Identities = 41/262 (15%), Positives = 78/262 (29%), Gaps = 96/262 (36%)
Query: 240 HRDLKSANI------LLDHFMRAKVADFG-----------LSKEEV-------------- 268
H D ++ +L F A V +F LSKEE+
Sbjct: 6 HMDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTL 65
Query: 269 --FD-----GRN-------SGLKGTYGYI---------DPA-----YIST-NKFTMKSDI 299
F L+ Y ++ P+ YI ++ + +
Sbjct: 66 RLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQV 125
Query: 300 FS-FGVIIFELITAIHPH-QNL--MEYVNLASMSQDGVDEILDKQ-LVG-ACNIQEVREL 353
F+ + V + + L + V + + G K + C +V+
Sbjct: 126 FAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSG------KTWVALDVCLSYKVQ-- 177
Query: 354 ARIGHKCLHKTPRKRP------SIGEV--TQALLKIKQRHLAKQDTMSFADGEFSRAVS- 404
K ++ + +L++ Q+ L + D + + S +
Sbjct: 178 ------------CKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKL 225
Query: 405 RIEDQQVELSKLAEVKERHEEC 426
RI Q EL +L + K +E C
Sbjct: 226 RIHSIQAELRRLLKSK-PYENC 246
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 426 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.84 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.71 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.41 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.27 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.17 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.97 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.69 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.65 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.56 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.46 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.42 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.39 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.22 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.2 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.03 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.0 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.75 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.59 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.3 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.26 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.24 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.19 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.13 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.11 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 97.04 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.86 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.81 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.72 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 96.63 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 96.52 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.24 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 96.13 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.44 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 94.78 | |
| 2l34_A | 33 | TYRO protein tyrosine kinase-binding protein; immu | 94.62 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 94.34 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 93.06 | |
| 2k9y_A | 41 | Ephrin type-A receptor 2; receptor tyrosine kinase | 91.88 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 90.21 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 89.52 | |
| 2knc_B | 79 | Integrin beta-3; transmembrane signaling, protein | 88.33 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 86.69 | |
| 2klu_A | 70 | T-cell surface glycoprotein CD4; cell membrane, di | 86.29 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 84.9 | |
| 2k9j_B | 43 | Integrin beta-3; transmembrane complex, cell adhes | 82.43 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-60 Score=447.88 Aligned_cols=256 Identities=25% Similarity=0.432 Sum_probs=212.9
Q ss_pred HHHHHHhhhhcccccCCCeeEEEEEeC------CCcEEEEEEeccCCc-cChHHHHHHHHHHhcCCCCceeeEEeEEEeC
Q 014352 113 DIQKATQNFTNILGQGAFGPVYKATMP------SGGVAAIKVLASDSH-QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDK 185 (426)
Q Consensus 113 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 185 (426)
++..++++|.+.||+|+||+||+|.+. +++.||||++..... ...++|.+|+.++++++|||||+++|+|.++
T Consensus 22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~ 101 (308)
T 4gt4_A 22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD 101 (308)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC
Confidence 344455678899999999999999863 457899999976532 3356899999999999999999999999999
Q ss_pred CeEEEEEEecCCCChhHHhhhc---------------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEe
Q 014352 186 GKYMLIYEFMSNGSLSNLIYSE---------------ERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILL 250 (426)
Q Consensus 186 ~~~~lv~e~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill 250 (426)
+.+++|||||++|+|.++|... ...++|..++.|+.|||.||.|||+++ |+||||||+||||
T Consensus 102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl 178 (308)
T 4gt4_A 102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLV 178 (308)
T ss_dssp SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEE
Confidence 9999999999999999999543 245899999999999999999999998 9999999999999
Q ss_pred cCCCcEEEeeecCccccccC---CCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHh
Q 014352 251 DHFMRAKVADFGLSKEEVFD---GRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLA 326 (426)
Q Consensus 251 ~~~~~~kl~Dfgl~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~ 326 (426)
++++.+||+|||+++..... .......||++|||||++.++.|+.++|||||||+||||+| |..||.+........
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~ 258 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE 258 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH
T ss_pred CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 99999999999999854322 22345679999999999999999999999999999999998 899998754433222
Q ss_pred hccccchhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 014352 327 SMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLK 380 (426)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 380 (426)
.+ ......+.+...+..+.+|+.+||+.||++||||.+|+++|+.
T Consensus 259 ~i---------~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a 303 (308)
T 4gt4_A 259 MI---------RNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA 303 (308)
T ss_dssp HH---------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HH---------HcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 21 1122223344556789999999999999999999999999874
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-60 Score=445.28 Aligned_cols=256 Identities=26% Similarity=0.454 Sum_probs=213.1
Q ss_pred HHhhhhcccccCCCeeEEEEEeC------CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEE
Q 014352 117 ATQNFTNILGQGAFGPVYKATMP------SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYML 190 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 190 (426)
..+.+.+.||+|+||+||+|++. ++..||||+++.......++|.+|+++|++++|||||+++|+|.+++.+++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 34567789999999999999864 467899999987665556789999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhcc------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEE
Q 014352 191 IYEFMSNGSLSNLIYSEE------------RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKV 258 (426)
Q Consensus 191 v~e~~~~gsL~~~l~~~~------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 258 (426)
|||||++|+|.++|+..+ ..++|.+++.++.|++.||.|||+++ |+||||||+|||+++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 999999999999996532 46999999999999999999999998 999999999999999999999
Q ss_pred eeecCccccccCC---CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchh
Q 014352 259 ADFGLSKEEVFDG---RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVD 334 (426)
Q Consensus 259 ~Dfgl~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 334 (426)
+|||+|+...... ......||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.........+.
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~----- 244 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT----- 244 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-----
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-----
Confidence 9999998543222 1233568999999999999999999999999999999999 899998754432222211
Q ss_pred hhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHH
Q 014352 335 EILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQR 384 (426)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 384 (426)
.......+...+.++.+|+.+||+.||++|||+.+|++.|+.+.+.
T Consensus 245 ----~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 245 ----QGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp ----HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----cCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 1111223334557899999999999999999999999999988764
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-59 Score=446.41 Aligned_cols=254 Identities=27% Similarity=0.450 Sum_probs=208.2
Q ss_pred hhhhcccccCCCeeEEEEEeC------CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEE
Q 014352 119 QNFTNILGQGAFGPVYKATMP------SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIY 192 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 192 (426)
+.+.+.||+|+||+||+|++. ++..||||+++.......++|.+|+++|++++|||||+++|+|.+.+.++|||
T Consensus 43 ~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~ 122 (329)
T 4aoj_A 43 IVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVF 122 (329)
T ss_dssp EEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred eEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 456788999999999999864 46789999998766555678999999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhcc--------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEE
Q 014352 193 EFMSNGSLSNLIYSEE--------------RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKV 258 (426)
Q Consensus 193 e~~~~gsL~~~l~~~~--------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 258 (426)
|||++|+|.++++... .+++|.+++.|+.|+|.||.|||+++ |+||||||+|||+++++.+||
T Consensus 123 Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~Ki 199 (329)
T 4aoj_A 123 EYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKI 199 (329)
T ss_dssp ECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEE
T ss_pred EcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcEEE
Confidence 9999999999996532 46999999999999999999999998 999999999999999999999
Q ss_pred eeecCccccccCC---CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchh
Q 014352 259 ADFGLSKEEVFDG---RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVD 334 (426)
Q Consensus 259 ~Dfgl~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 334 (426)
+|||+++...... ......||+.|||||++.+..|+.++|||||||+||||+| |+.||........+..+.
T Consensus 200 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~----- 274 (329)
T 4aoj_A 200 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT----- 274 (329)
T ss_dssp CCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHH-----
T ss_pred cccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHH-----
Confidence 9999998543222 2234679999999999999999999999999999999999 899998654433222111
Q ss_pred hhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHH
Q 014352 335 EILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQR 384 (426)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 384 (426)
.......+...+.++.+|+.+||+.||++||||.||+++|+.+.+.
T Consensus 275 ----~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 275 ----QGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp ----HTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ----cCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 1111222334557899999999999999999999999999998763
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-59 Score=439.19 Aligned_cols=255 Identities=24% Similarity=0.453 Sum_probs=203.2
Q ss_pred hhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCc--cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecC
Q 014352 119 QNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSH--QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMS 196 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 196 (426)
+.+.+.||+|+||+||+|++.+ .||||+++.... ...+.|.+|+.+|++++|||||+++|++.+ +.++||||||+
T Consensus 38 l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~ 114 (307)
T 3omv_A 38 VMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCE 114 (307)
T ss_dssp CCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCS
T ss_pred eEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCC
Confidence 4577899999999999999754 489999875432 234679999999999999999999998865 56899999999
Q ss_pred CCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC---CCc
Q 014352 197 NGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD---GRN 273 (426)
Q Consensus 197 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~---~~~ 273 (426)
+|+|.++|+.....+++.+++.|+.|+|.||.|||+++ |+||||||+|||+++++.+||+|||+|+..... ...
T Consensus 115 gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~ 191 (307)
T 3omv_A 115 GSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQV 191 (307)
T ss_dssp SCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC----------
T ss_pred CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCcceee
Confidence 99999999877778999999999999999999999998 999999999999999999999999999854322 223
Q ss_pred ccCccccCccCcccccc---CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHH
Q 014352 274 SGLKGTYGYIDPAYIST---NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEV 350 (426)
Q Consensus 274 ~~~~gt~~y~aPE~~~~---~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (426)
....||+.|||||++.+ .+|+.++|||||||+||||+||+.||.+......+........ ..+.. ...+...+
T Consensus 192 ~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~---~~p~~-~~~~~~~~ 267 (307)
T 3omv_A 192 EQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGY---ASPDL-SKLYKNCP 267 (307)
T ss_dssp --CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTC---CCCCS-TTSCTTSC
T ss_pred cccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCC---CCCCc-ccccccch
Confidence 45689999999999964 4689999999999999999999999976433222111111100 00100 11223345
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 014352 351 RELARIGHKCLHKTPRKRPSIGEVTQALLKIKQ 383 (426)
Q Consensus 351 ~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 383 (426)
..+.+|+.+||+.||++||||.+|+++|+.++.
T Consensus 268 ~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 268 KAMKRLVADCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp HHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 789999999999999999999999999998764
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-57 Score=428.99 Aligned_cols=247 Identities=24% Similarity=0.361 Sum_probs=209.7
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCC
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSN 197 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 197 (426)
|++.+.||+|+||+||+|++. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++.+|||||||+|
T Consensus 76 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g 155 (346)
T 4fih_A 76 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 155 (346)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred cEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCC
Confidence 566678999999999999976 7899999999766555667789999999999999999999999999999999999999
Q ss_pred CChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC-CCcccC
Q 014352 198 GSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD-GRNSGL 276 (426)
Q Consensus 198 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-~~~~~~ 276 (426)
|+|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+..... ......
T Consensus 156 g~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~ 230 (346)
T 4fih_A 156 GALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL 230 (346)
T ss_dssp EEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCC
T ss_pred CcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCCccccc
Confidence 999999854 45999999999999999999999999 999999999999999999999999999865433 334567
Q ss_pred ccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHH
Q 014352 277 KGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARI 356 (426)
Q Consensus 277 ~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 356 (426)
+||+.|||||++.+..|+.++|||||||++|||++|..||.+......+..+...... ........+.++.+|
T Consensus 231 ~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~-------~~~~~~~~s~~~~dl 303 (346)
T 4fih_A 231 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP-------RLKNLHKVSPSLKGF 303 (346)
T ss_dssp CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCC-------CCSCGGGSCHHHHHH
T ss_pred ccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC-------CCCccccCCHHHHHH
Confidence 8999999999999999999999999999999999999999765443332222111100 011122345689999
Q ss_pred HHHcccCCCCCCCCHHHHHHH
Q 014352 357 GHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 357 ~~~cl~~~p~~RPs~~evl~~ 377 (426)
+.+||+.||++|||+.|++++
T Consensus 304 i~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 304 LDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp HHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHcCCChhHCcCHHHHhcC
Confidence 999999999999999999875
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-56 Score=416.09 Aligned_cols=246 Identities=23% Similarity=0.396 Sum_probs=198.6
Q ss_pred hhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC--ccChHHHHHHHHHHhcCCCCceeeEEeEEEe----CCeEEEEE
Q 014352 120 NFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS--HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVD----KGKYMLIY 192 (426)
Q Consensus 120 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~ 192 (426)
.+.+.||+|+||+||+|.+. ++..||+|.+.... ....+.|.+|+++|++++|||||++++++.+ .+.+||||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 45568999999999999975 68899999986542 2234579999999999999999999999875 34689999
Q ss_pred EecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecC-CCcEEEeeecCccccccCC
Q 014352 193 EFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDH-FMRAKVADFGLSKEEVFDG 271 (426)
Q Consensus 193 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgl~~~~~~~~ 271 (426)
|||++|+|.+++... ..+++..+..++.||+.||.|||+++ ++|+||||||+|||++. ++.+||+|||+|+... ..
T Consensus 109 Ey~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~-~~ 185 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR-AS 185 (290)
T ss_dssp ECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC-TT
T ss_pred eCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCC-CC
Confidence 999999999999654 56999999999999999999999986 56999999999999984 7999999999997532 33
Q ss_pred CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhh-ccccchhhhhhhhhcccCCHHHH
Q 014352 272 RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLAS-MSQDGVDEILDKQLVGACNIQEV 350 (426)
Q Consensus 272 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 350 (426)
.....+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+......+.. +....... .. +...+
T Consensus 186 ~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~----~~----~~~~~ 256 (290)
T 3fpq_A 186 FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA----SF----DKVAI 256 (290)
T ss_dssp SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG----GG----GGCCC
T ss_pred ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCC----CC----CccCC
Confidence 4456789999999999865 699999999999999999999999975332222111 11111111 11 11123
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 351 RELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 351 ~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
.++.+|+.+||+.||++|||+.|++++
T Consensus 257 ~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 257 PEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 568899999999999999999999875
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-57 Score=430.29 Aligned_cols=248 Identities=21% Similarity=0.355 Sum_probs=202.8
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc--cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEe
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH--QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEF 194 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 194 (426)
+|.+.+.||+|+||+||+|+.. +|+.||||++..... ...+.+.+|+++|++|+|||||++++++.+++.+|+||||
T Consensus 25 ~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy 104 (350)
T 4b9d_A 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDY 104 (350)
T ss_dssp CEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 3677889999999999999975 789999999976532 2345789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC-C
Q 014352 195 MSNGSLSNLIYSEE-RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG-R 272 (426)
Q Consensus 195 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-~ 272 (426)
|+||+|.++|.... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+...... .
T Consensus 105 ~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 181 (350)
T 4b9d_A 105 CEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL 181 (350)
T ss_dssp CTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHH
T ss_pred CCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCccc
Confidence 99999999996544 45789999999999999999999999 9999999999999999999999999998643322 2
Q ss_pred cccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHH
Q 014352 273 NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRE 352 (426)
Q Consensus 273 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (426)
....+||+.|||||++.+..|+.++|||||||++|||+||+.||.+......+..+.... . ...+...+.+
T Consensus 182 ~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~--------~-~~~~~~~s~~ 252 (350)
T 4b9d_A 182 ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGS--------F-PPVSLHYSYD 252 (350)
T ss_dssp HHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC--------C-CCCCTTSCHH
T ss_pred ccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC--------C-CCCCccCCHH
Confidence 345679999999999999999999999999999999999999998654333222221111 1 1122334578
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 353 LARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 353 l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
+.+|+.+||+.||++|||+.|++++
T Consensus 253 ~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 253 LRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHccCChhHCcCHHHHhcC
Confidence 9999999999999999999999875
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-56 Score=421.48 Aligned_cols=252 Identities=23% Similarity=0.257 Sum_probs=207.1
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCC
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSN 197 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 197 (426)
+.+.+.||+|+||+||+|++. +|+.||||++..... +.+|+.+|++++|||||++++++.+++.+|||||||+|
T Consensus 60 ~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g 134 (336)
T 4g3f_A 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEG 134 (336)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred eEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCC
Confidence 455678999999999999975 789999999975432 24799999999999999999999999999999999999
Q ss_pred CChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCC-cEEEeeecCccccccCC-----
Q 014352 198 GSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFM-RAKVADFGLSKEEVFDG----- 271 (426)
Q Consensus 198 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgl~~~~~~~~----- 271 (426)
|+|.++|... +.+++..+..++.|++.||.|||+++ |+||||||+|||++.++ .+||+|||+|+......
T Consensus 135 g~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~ 210 (336)
T 4g3f_A 135 GSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSL 210 (336)
T ss_dssp CBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC---------
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccce
Confidence 9999999654 46999999999999999999999999 99999999999999987 59999999998643322
Q ss_pred -CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhh-cccCCHHH
Q 014352 272 -RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQL-VGACNIQE 349 (426)
Q Consensus 272 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 349 (426)
.....+||+.|||||++.+..|+.++|||||||++|||+||+.||.+....... ..+..... ....+...
T Consensus 211 ~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~--------~~i~~~~~~~~~~~~~~ 282 (336)
T 4g3f_A 211 LTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC--------LKIASEPPPIREIPPSC 282 (336)
T ss_dssp ---CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCH--------HHHHHSCCGGGGSCTTS
T ss_pred ecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH--------HHHHcCCCCchhcCccC
Confidence 123457999999999999999999999999999999999999999753221111 11111110 11123345
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHhhh
Q 014352 350 VRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRHLA 387 (426)
Q Consensus 350 ~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~~ 387 (426)
+..+.+++.+||+.||++|||+.|++++|.........
T Consensus 283 s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~ 320 (336)
T 4g3f_A 283 APLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGG 320 (336)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTS
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhh
Confidence 57899999999999999999999999999888765543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-57 Score=432.96 Aligned_cols=261 Identities=27% Similarity=0.455 Sum_probs=212.9
Q ss_pred HHHHHhhhhcccccCCCeeEEEEEeCC------CcEEEEEEeccCCcc-ChHHHHHHHHHHhcCCC-CceeeEEeEEEeC
Q 014352 114 IQKATQNFTNILGQGAFGPVYKATMPS------GGVAAIKVLASDSHQ-GEKEFQTEVSLLGRLHH-RNLVNLIGYCVDK 185 (426)
Q Consensus 114 l~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~ 185 (426)
|....+.+.+.||+|+||+||+|.+.+ ++.||||.+...... ..+.|.+|+++|.+++| ||||+++|+|.+.
T Consensus 61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~ 140 (353)
T 4ase_A 61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 140 (353)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence 444567788999999999999998643 247999999765433 34579999999999965 8999999999765
Q ss_pred -CeEEEEEEecCCCChhHHhhhcc---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEE
Q 014352 186 -GKYMLIYEFMSNGSLSNLIYSEE---------------RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANIL 249 (426)
Q Consensus 186 -~~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil 249 (426)
+.+++|||||++|+|.++|+... ..+++..++.++.|||.||.|||+++ |+||||||+|||
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~NIL 217 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNIL 217 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCcccee
Confidence 56899999999999999996532 34899999999999999999999999 999999999999
Q ss_pred ecCCCcEEEeeecCccccccCC---CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHH
Q 014352 250 LDHFMRAKVADFGLSKEEVFDG---RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNL 325 (426)
Q Consensus 250 l~~~~~~kl~Dfgl~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~ 325 (426)
+++++.+||+|||+|+...... ......||+.|||||++.+..|+.++|||||||+||||+| |..||.+......
T Consensus 218 l~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~- 296 (353)
T 4ase_A 218 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE- 296 (353)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH-
T ss_pred eCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH-
Confidence 9999999999999998543322 2234678999999999999999999999999999999998 9999976321111
Q ss_pred hhccccchhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHh
Q 014352 326 ASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRH 385 (426)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~ 385 (426)
+...+........+...+.++.+++.+||+.||++|||+.+|+++|+.+.+..
T Consensus 297 -------~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 297 -------FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp -------HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred -------HHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 11122222222333445578999999999999999999999999999987654
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-55 Score=429.94 Aligned_cols=247 Identities=24% Similarity=0.365 Sum_probs=210.1
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCC
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSN 197 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 197 (426)
|++.+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++.+|||||||+|
T Consensus 153 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~g 232 (423)
T 4fie_A 153 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 232 (423)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred cEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCC
Confidence 556678999999999999975 7899999999876666667899999999999999999999999999999999999999
Q ss_pred CChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC-CCcccC
Q 014352 198 GSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD-GRNSGL 276 (426)
Q Consensus 198 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-~~~~~~ 276 (426)
|+|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+|+..... ......
T Consensus 233 G~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~ 307 (423)
T 4fie_A 233 GALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL 307 (423)
T ss_dssp EEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCCC
T ss_pred CcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCcccccc
Confidence 999999854 35999999999999999999999999 999999999999999999999999999865433 334567
Q ss_pred ccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHH
Q 014352 277 KGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARI 356 (426)
Q Consensus 277 ~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 356 (426)
+||+.|||||++.+..|+.++|||||||++|||++|..||.+......+..+...... . .......+.++.+|
T Consensus 308 ~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~-----~--~~~~~~~s~~~~dl 380 (423)
T 4fie_A 308 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP-----R--LKNLHKVSPSLKGF 380 (423)
T ss_dssp EECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC-----C--CSCTTSSCHHHHHH
T ss_pred ccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC-----C--CcccccCCHHHHHH
Confidence 8999999999999999999999999999999999999999765443332222111100 0 11122345678999
Q ss_pred HHHcccCCCCCCCCHHHHHHH
Q 014352 357 GHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 357 ~~~cl~~~p~~RPs~~evl~~ 377 (426)
+.+||+.||++|||+.|++++
T Consensus 381 i~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 381 LDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp HHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHcCCChhHCcCHHHHhcC
Confidence 999999999999999999875
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-55 Score=407.49 Aligned_cols=245 Identities=25% Similarity=0.363 Sum_probs=192.4
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc---cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEE
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH---QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYE 193 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 193 (426)
.|.+.+.||+|+||+||+|+.. +++.||+|++..... ...+.+.+|+++|++++|||||++++++.+++.+|+|||
T Consensus 14 ~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 93 (275)
T 3hyh_A 14 NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE 93 (275)
T ss_dssp CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEe
Confidence 4778889999999999999975 789999999975432 234578999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCc
Q 014352 194 FMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRN 273 (426)
Q Consensus 194 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 273 (426)
|+ +|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+........
T Consensus 94 y~-~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~ 168 (275)
T 3hyh_A 94 YA-GNELFDYIVQR-DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFL 168 (275)
T ss_dssp CC-CEEHHHHHHHS-CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred CC-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCCCcc
Confidence 99 67999998654 46999999999999999999999999 999999999999999999999999999865555555
Q ss_pred ccCccccCccCccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHH
Q 014352 274 SGLKGTYGYIDPAYISTNKF-TMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRE 352 (426)
Q Consensus 274 ~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (426)
....||+.|||||++.+..| +.++|||||||++|||+||+.||.+.........+... .. ..+...+.+
T Consensus 169 ~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~--------~~--~~p~~~s~~ 238 (275)
T 3hyh_A 169 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNG--------VY--TLPKFLSPG 238 (275)
T ss_dssp ------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--------CC--CCCTTSCHH
T ss_pred CCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--------CC--CCCCCCCHH
Confidence 66789999999999998886 57999999999999999999999764332222111111 00 112234467
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 353 LARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 353 l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
+.+++.+||+.||++|||+.|++++
T Consensus 239 ~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 239 AAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred HHHHHHHHccCChhHCcCHHHHHcC
Confidence 8999999999999999999999886
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-56 Score=420.63 Aligned_cols=262 Identities=22% Similarity=0.353 Sum_probs=197.5
Q ss_pred hhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCC----eEEEEEEe
Q 014352 119 QNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKG----KYMLIYEF 194 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~lv~e~ 194 (426)
+.+.+.||+|+||+||+|++ +|+.||||++..... ....+..|+..+.+++|||||+++++|.+++ .++|||||
T Consensus 5 i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey 82 (303)
T 3hmm_A 5 IVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 82 (303)
T ss_dssp EEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred EEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecC
Confidence 45678999999999999998 688999999865321 1223345666677899999999999998754 57999999
Q ss_pred cCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCC-----CCCeeecCCCCCCEEecCCCcEEEeeecCcccccc
Q 014352 195 MSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGA-----VPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF 269 (426)
Q Consensus 195 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 269 (426)
|++|+|.++|+. ..++|..++.++.|++.||+|||++. .++|+||||||+|||++.++.+||+|||+++....
T Consensus 83 ~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 160 (303)
T 3hmm_A 83 HEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 160 (303)
T ss_dssp CTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred CCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccC
Confidence 999999999954 35899999999999999999999871 23599999999999999999999999999975433
Q ss_pred CC-----CcccCccccCccCccccccC------CCCcchhhHHHHHHHHHHHhCCCCCCchHHHHH-Hhhcc--ccchhh
Q 014352 270 DG-----RNSGLKGTYGYIDPAYISTN------KFTMKSDIFSFGVIIFELITAIHPHQNLMEYVN-LASMS--QDGVDE 335 (426)
Q Consensus 270 ~~-----~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~-~~~~~--~~~~~~ 335 (426)
.. ......||+.|||||++.+. .++.++|||||||+||||+||..||........ ..... ......
T Consensus 161 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~ 240 (303)
T 3hmm_A 161 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240 (303)
T ss_dssp TTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHH
T ss_pred CCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHH
Confidence 22 12345799999999999764 367899999999999999999887643211100 00000 000011
Q ss_pred ----hhhhhhccc-----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHH
Q 014352 336 ----ILDKQLVGA-----CNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQR 384 (426)
Q Consensus 336 ----~~~~~~~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 384 (426)
+....+... ...+.+..+.+|+.+||+.||++||||.||++.|+++.+.
T Consensus 241 ~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 241 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 111111111 1234667899999999999999999999999999998764
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-56 Score=415.64 Aligned_cols=246 Identities=26% Similarity=0.337 Sum_probs=207.7
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC---ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEe
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS---HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEF 194 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 194 (426)
|++.+.||+|+||+||+|+.. +++.||+|++.... ....+.+.+|+++|++++|||||++++++.+++.+|+||||
T Consensus 34 y~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy 113 (311)
T 4aw0_A 34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 113 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence 778899999999999999975 78899999996532 23346789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC---C
Q 014352 195 MSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD---G 271 (426)
Q Consensus 195 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~---~ 271 (426)
|+||+|.+++... +.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+..... .
T Consensus 114 ~~gG~L~~~i~~~-~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~ 189 (311)
T 4aw0_A 114 AKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 189 (311)
T ss_dssp CTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCC
T ss_pred CCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcc
Confidence 9999999999654 45999999999999999999999999 999999999999999999999999999864322 2
Q ss_pred CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHH
Q 014352 272 RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVR 351 (426)
Q Consensus 272 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (426)
.....+||+.|||||++.+..|+.++|||||||++|||++|..||.+......+..+... .+ ..+...+.
T Consensus 190 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~--------~~--~~p~~~s~ 259 (311)
T 4aw0_A 190 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKL--------EY--DFPEKFFP 259 (311)
T ss_dssp CBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--------CC--CCCTTCCH
T ss_pred cccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--------CC--CCCcccCH
Confidence 345678999999999999999999999999999999999999999764433222222111 11 11223456
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014352 352 ELARIGHKCLHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 352 ~l~~l~~~cl~~~p~~RPs~~evl~~L 378 (426)
++.+|+.+||+.||++|||+.|++.+-
T Consensus 260 ~~~dli~~lL~~dp~~R~t~~e~~~~~ 286 (311)
T 4aw0_A 260 KARDLVEKLLVLDATKRLGCEEMEGYG 286 (311)
T ss_dssp HHHHHHHHHSCSSGGGSTTSGGGTCHH
T ss_pred HHHHHHHHHccCCHhHCcChHHHcCCH
Confidence 789999999999999999999976543
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-55 Score=411.33 Aligned_cols=246 Identities=26% Similarity=0.374 Sum_probs=198.0
Q ss_pred HhhhhcccccCCCeeEEEEEeC----CCcEEEEEEeccCCc--cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEE
Q 014352 118 TQNFTNILGQGAFGPVYKATMP----SGGVAAIKVLASDSH--QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLI 191 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 191 (426)
.|++.+.||+|+||+||+|+.. +++.||+|++..... .....+.+|+++|++++|||||++++++.+++.+|+|
T Consensus 25 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 104 (304)
T 3ubd_A 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLI 104 (304)
T ss_dssp GEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEE
T ss_pred ccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 3778899999999999999852 467899999975422 2234688999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccccc-C
Q 014352 192 YEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF-D 270 (426)
Q Consensus 192 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~-~ 270 (426)
||||+||+|.+++... +.+++.++..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+.... .
T Consensus 105 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 180 (304)
T 3ubd_A 105 LDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 180 (304)
T ss_dssp ECCCTTCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred EEcCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence 9999999999999654 46999999999999999999999999 99999999999999999999999999985433 2
Q ss_pred CCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHH
Q 014352 271 GRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEV 350 (426)
Q Consensus 271 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (426)
......+||+.|||||++.+..|+.++|||||||++|||+||+.||.+......+..+.... ...+...+
T Consensus 181 ~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~----------~~~p~~~s 250 (304)
T 3ubd_A 181 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK----------LGMPQFLS 250 (304)
T ss_dssp CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC----------CCCCTTSC
T ss_pred ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCC----------CCCCCcCC
Confidence 33456789999999999999999999999999999999999999998654333222221111 11122345
Q ss_pred HHHHHHHHHcccCCCCCCCCH-----HHHHHH
Q 014352 351 RELARIGHKCLHKTPRKRPSI-----GEVTQA 377 (426)
Q Consensus 351 ~~l~~l~~~cl~~~p~~RPs~-----~evl~~ 377 (426)
.++.+|+.+||+.||++|||+ +|++++
T Consensus 251 ~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 251 PEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp HHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred HHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 678999999999999999985 566543
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-53 Score=396.34 Aligned_cols=244 Identities=27% Similarity=0.400 Sum_probs=188.3
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc-cChHHHHHHHHHHhcCCCCceeeEEeEEEeCC----------
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH-QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKG---------- 186 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---------- 186 (426)
|++.+.||+|+||+||+|+.. +++.||||++..... ...+.+.+|+++|++++|||||++++++.+.+
T Consensus 7 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~ 86 (299)
T 4g31_A 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSP 86 (299)
T ss_dssp EEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------
T ss_pred CEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCC
Confidence 667789999999999999975 788999999875432 23457899999999999999999999987654
Q ss_pred --eEEEEEEecCCCChhHHhhhcc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeec
Q 014352 187 --KYMLIYEFMSNGSLSNLIYSEE--RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFG 262 (426)
Q Consensus 187 --~~~lv~e~~~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 262 (426)
.+|+|||||++|+|.+++.... ...++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 87 ~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~DFG 163 (299)
T 4g31_A 87 KVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFG 163 (299)
T ss_dssp CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCC
T ss_pred CcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEccCc
Confidence 3799999999999999996543 23566778899999999999999999 9999999999999999999999999
Q ss_pred CccccccCC-------------CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHH-Hhhc
Q 014352 263 LSKEEVFDG-------------RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVN-LASM 328 (426)
Q Consensus 263 l~~~~~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~-~~~~ 328 (426)
+|+...... .....+||+.|||||++.+..|+.++|||||||++|||++ ||....+... +...
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~ 240 (299)
T 4g31_A 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDV 240 (299)
T ss_dssp CC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHH
T ss_pred cceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHH
Confidence 997543221 1234579999999999999999999999999999999996 7765433211 1111
Q ss_pred cccchhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 329 SQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
.....+.. .......+.+++.+||+.||++|||+.|++++
T Consensus 241 ~~~~~p~~---------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 241 RNLKFPPL---------FTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HTTCCCHH---------HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hcCCCCCC---------CcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11111110 11233457789999999999999999999864
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=412.54 Aligned_cols=251 Identities=23% Similarity=0.329 Sum_probs=212.9
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecC
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMS 196 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 196 (426)
.|.+.+.||+|+||+||+|+.. +|+.||+|++........+.+.+|+.+|++++|||||++++++.+.+.+|+|||||+
T Consensus 158 ~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~ 237 (573)
T 3uto_A 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 237 (573)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecC
Confidence 5778899999999999999975 789999999987655556778999999999999999999999999999999999999
Q ss_pred CCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCC--CcEEEeeecCccccccCCCcc
Q 014352 197 NGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHF--MRAKVADFGLSKEEVFDGRNS 274 (426)
Q Consensus 197 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~--~~~kl~Dfgl~~~~~~~~~~~ 274 (426)
||+|.++|......+++.++..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+++.........
T Consensus 238 gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~ 314 (573)
T 3uto_A 238 GGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK 314 (573)
T ss_dssp CCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEE
T ss_pred CCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCCCcee
Confidence 99999999766667999999999999999999999999 9999999999999854 889999999998765555555
Q ss_pred cCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHH
Q 014352 275 GLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELA 354 (426)
Q Consensus 275 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 354 (426)
..+||+.|||||++.+..|+.++|||||||++|||++|..||.+......+..+..... .+........+.++.
T Consensus 315 ~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~------~~~~~~~~~~s~~~~ 388 (573)
T 3uto_A 315 VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDW------NMDDSAFSGISEDGK 388 (573)
T ss_dssp EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCC------CCCSGGGTTSCHHHH
T ss_pred eeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCC------CCCcccccCCCHHHH
Confidence 67899999999999999999999999999999999999999987544433322211110 001111122346788
Q ss_pred HHHHHcccCCCCCCCCHHHHHHH
Q 014352 355 RIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 355 ~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
+|+.+||+.||.+|||+.|+++|
T Consensus 389 dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 389 DFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHccCChhHCcCHHHHhcC
Confidence 99999999999999999999875
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-50 Score=391.07 Aligned_cols=255 Identities=21% Similarity=0.286 Sum_probs=200.5
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc--cChHHHHHHHHHHhcCCCCceeeEEeEEEe------CCeE
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH--QGEKEFQTEVSLLGRLHHRNLVNLIGYCVD------KGKY 188 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~~ 188 (426)
+|.+.+.||+|+||+||+|+.. +|+.||||++..... ...+.+.+|+++|++++|||||++++++.. .+.+
T Consensus 55 ~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~ 134 (398)
T 4b99_A 55 EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSV 134 (398)
T ss_dssp SEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCE
T ss_pred CeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEE
Confidence 4677889999999999999975 789999999975432 223568899999999999999999998764 3578
Q ss_pred EEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccc
Q 014352 189 MLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEV 268 (426)
Q Consensus 189 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 268 (426)
|+|||||+ |+|.+++... +.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 135 ~ivmE~~~-g~L~~~i~~~-~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 135 YVVLDLME-SDLHQIIHSS-QPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp EEEEECCS-EEHHHHHTSS-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred EEEEeCCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 99999995 6899998554 56999999999999999999999999 9999999999999999999999999998543
Q ss_pred c-----CCCcccCccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccc---cchhhh---
Q 014352 269 F-----DGRNSGLKGTYGYIDPAYISTN-KFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQ---DGVDEI--- 336 (426)
Q Consensus 269 ~-----~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~---~~~~~~--- 336 (426)
. .......+||+.|||||++.+. .++.++||||+||++|||++|+.||.+......+..+.. ......
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~ 289 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQA 289 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-
T ss_pred cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 2 1233467899999999998775 568999999999999999999999986544333222110 000000
Q ss_pred --------hhhhhccc--CC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 337 --------LDKQLVGA--CN-----IQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 337 --------~~~~~~~~--~~-----~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
....+... .+ ...+.++.+|+.+||..||++|||+.|++++
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 290 VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp ----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000000 00 1124678899999999999999999999986
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=382.61 Aligned_cols=251 Identities=20% Similarity=0.281 Sum_probs=194.3
Q ss_pred HhhhhcccccCCCeeEEEEEeC----CCcEEEEEEeccCCccChHHHHHHHHHHhcC-CCCceeeEEeEEEeCCeEEEEE
Q 014352 118 TQNFTNILGQGAFGPVYKATMP----SGGVAAIKVLASDSHQGEKEFQTEVSLLGRL-HHRNLVNLIGYCVDKGKYMLIY 192 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 192 (426)
.|.+.+.||+|+||+||+|+.+ +++.||+|.+.... ....+.+|+++|+++ +|||||++++++.+.+.+|+||
T Consensus 22 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvm 99 (361)
T 4f9c_A 22 VFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAM 99 (361)
T ss_dssp TCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEE
T ss_pred cEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEE
Confidence 4677889999999999999753 46789999986543 345788999999998 6999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCC-CcEEEeeecCccccccCC
Q 014352 193 EFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHF-MRAKVADFGLSKEEVFDG 271 (426)
Q Consensus 193 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgl~~~~~~~~ 271 (426)
||+++|+|.+++. .+++.++..++.|++.||.|||+++ |+||||||+|||++.+ +.+||+|||+|+......
T Consensus 100 E~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~ 172 (361)
T 4f9c_A 100 PYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK 172 (361)
T ss_dssp ECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECTTCS
T ss_pred eCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcc
Confidence 9999999999983 4899999999999999999999999 9999999999999877 799999999997432111
Q ss_pred -----------------------------CcccCccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCchHH
Q 014352 272 -----------------------------RNSGLKGTYGYIDPAYISTN-KFTMKSDIFSFGVIIFELITAIHPHQNLME 321 (426)
Q Consensus 272 -----------------------------~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~ 321 (426)
.....+||+.|||||++.+. .|+.++||||+||++|||++|+.||.....
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~ 252 (361)
T 4f9c_A 173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASD 252 (361)
T ss_dssp CGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCC
Confidence 12345799999999999775 589999999999999999999999954221
Q ss_pred H-HHHhhcc--------------------------ccchhhhhhhh------------------hcccCCHHHHHHHHHH
Q 014352 322 Y-VNLASMS--------------------------QDGVDEILDKQ------------------LVGACNIQEVRELARI 356 (426)
Q Consensus 322 ~-~~~~~~~--------------------------~~~~~~~~~~~------------------~~~~~~~~~~~~l~~l 356 (426)
. ..+..+. ........... .........+.++.+|
T Consensus 253 ~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DL 332 (361)
T 4f9c_A 253 DLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDL 332 (361)
T ss_dssp HHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHH
T ss_pred HHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHH
Confidence 1 1111000 00000000000 0000111234578899
Q ss_pred HHHcccCCCCCCCCHHHHHHH
Q 014352 357 GHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 357 ~~~cl~~~p~~RPs~~evl~~ 377 (426)
+.+||+.||++|||++|++++
T Consensus 333 l~~lL~~dP~~R~ta~eaL~H 353 (361)
T 4f9c_A 333 LDKLLDLNPASRITAEEALLH 353 (361)
T ss_dssp HHHHTCSCTTTSCCHHHHHTS
T ss_pred HHHHCcCChhHCcCHHHHhcC
Confidence 999999999999999999875
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-49 Score=398.41 Aligned_cols=246 Identities=26% Similarity=0.339 Sum_probs=198.6
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC---ccChHHHHH---HHHHHhcCCCCceeeEEeEEEeCCeEEEE
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS---HQGEKEFQT---EVSLLGRLHHRNLVNLIGYCVDKGKYMLI 191 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~---e~~~l~~l~h~niv~~~~~~~~~~~~~lv 191 (426)
|.+.+.||+|+||+||+|+.. +|+.||+|++.... ......+.+ ++.+++.++|||||++++++.+.+.+|+|
T Consensus 191 f~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylV 270 (689)
T 3v5w_A 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI 270 (689)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred eEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEE
Confidence 556688999999999999975 78999999996431 122233333 46677788999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC
Q 014352 192 YEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG 271 (426)
Q Consensus 192 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 271 (426)
||||+||+|.++|... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+|+.... .
T Consensus 271 mEy~~GGdL~~~l~~~-~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~~~-~ 345 (689)
T 3v5w_A 271 LDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK-K 345 (689)
T ss_dssp ECCCCSCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS-C
T ss_pred EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeecCC-C
Confidence 9999999999999654 45999999999999999999999999 99999999999999999999999999986432 3
Q ss_pred CcccCccccCccCccccc-cCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhh--cccCCHH
Q 014352 272 RNSGLKGTYGYIDPAYIS-TNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQL--VGACNIQ 348 (426)
Q Consensus 272 ~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 348 (426)
.....+||+.|||||++. +..|+.++|+|||||++|||++|.+||.+..... ..++..... ....+..
T Consensus 346 ~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~---------~~~i~~~i~~~~~~~p~~ 416 (689)
T 3v5w_A 346 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD---------KHEIDRMTLTMAVELPDS 416 (689)
T ss_dssp CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC---------HHHHHHHHHHCCCCCCTT
T ss_pred CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---------HHHHHHhhcCCCCCCCcc
Confidence 345678999999999996 4579999999999999999999999997532110 011111111 1122334
Q ss_pred HHHHHHHHHHHcccCCCCCCCC-----HHHHHHHH
Q 014352 349 EVRELARIGHKCLHKTPRKRPS-----IGEVTQAL 378 (426)
Q Consensus 349 ~~~~l~~l~~~cl~~~p~~RPs-----~~evl~~L 378 (426)
.+.++.+|+.+||+.||.+|++ +.||++|-
T Consensus 417 ~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~Hp 451 (689)
T 3v5w_A 417 FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESP 451 (689)
T ss_dssp SCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSG
T ss_pred CCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCc
Confidence 5578999999999999999998 68887653
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-48 Score=366.96 Aligned_cols=260 Identities=28% Similarity=0.463 Sum_probs=215.3
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecC
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMS 196 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 196 (426)
.+.+.+.||+|+||+||+|.+. ++..||+|.+........+.|.+|++++++++||||+++++++.+.+..++||||++
T Consensus 11 ~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 90 (310)
T 3s95_A 11 DLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIK 90 (310)
T ss_dssp GEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred HeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecC
Confidence 4667789999999999999975 688999999876655556789999999999999999999999999999999999999
Q ss_pred CCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCc---
Q 014352 197 NGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRN--- 273 (426)
Q Consensus 197 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~--- 273 (426)
+|+|.+++......+++.+++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 91 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 167 (310)
T 3s95_A 91 GGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEG 167 (310)
T ss_dssp TCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC--------
T ss_pred CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccccccc
Confidence 99999999876777999999999999999999999999 999999999999999999999999999753322111
Q ss_pred ------------ccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhh
Q 014352 274 ------------SGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQL 341 (426)
Q Consensus 274 ------------~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (426)
....||+.|+|||.+.+..++.++||||||+++|||++|..|+........ ..........+..
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~---~~~~~~~~~~~~~- 243 (310)
T 3s95_A 168 LRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTM---DFGLNVRGFLDRY- 243 (310)
T ss_dssp ------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCT---TSSBCHHHHHHHT-
T ss_pred cccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHH---HHhhhhhcccccc-
Confidence 145799999999999999999999999999999999999999865321110 0011111222222
Q ss_pred cccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHhhh
Q 014352 342 VGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRHLA 387 (426)
Q Consensus 342 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~~ 387 (426)
.+...+..+.+++.+||+.||++|||+.++++.|+.+......
T Consensus 244 ---~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~ 286 (310)
T 3s95_A 244 ---CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG 286 (310)
T ss_dssp ---CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred ---CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccC
Confidence 2223345789999999999999999999999999999876544
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-48 Score=366.53 Aligned_cols=263 Identities=36% Similarity=0.647 Sum_probs=219.6
Q ss_pred hhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCCC
Q 014352 119 QNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNG 198 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 198 (426)
|.+.+.||+|+||.||+|++.+++.||+|++........+.+.+|+.++++++||||+++++++.+.+..++||||+++|
T Consensus 41 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 120 (321)
T 2qkw_B 41 FDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENG 120 (321)
T ss_dssp CSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTC
T ss_pred cCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCC
Confidence 45567899999999999998889999999987766555678999999999999999999999999999999999999999
Q ss_pred ChhHHhhhcc---CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC---CC
Q 014352 199 SLSNLIYSEE---RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD---GR 272 (426)
Q Consensus 199 sL~~~l~~~~---~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~---~~ 272 (426)
+|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++..... ..
T Consensus 121 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 197 (321)
T 2qkw_B 121 NLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHL 197 (321)
T ss_dssp BTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCC
T ss_pred cHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence 9999996543 35899999999999999999999998 999999999999999999999999999753221 12
Q ss_pred cccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHH-------HhhccccchhhhhhhhhcccC
Q 014352 273 NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVN-------LASMSQDGVDEILDKQLVGAC 345 (426)
Q Consensus 273 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~ 345 (426)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ............+++......
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (321)
T 2qkw_B 198 STVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKI 277 (321)
T ss_dssp BCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCS
T ss_pred ccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhcccc
Confidence 2345689999999999999999999999999999999999999865321100 001112222333444444555
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHH
Q 014352 346 NIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQR 384 (426)
Q Consensus 346 ~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 384 (426)
....+..+.+++.+||+.||++|||+.+++++|+.+.+.
T Consensus 278 ~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 278 RPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp CHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred CHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 677888999999999999999999999999999988753
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-47 Score=357.59 Aligned_cols=248 Identities=24% Similarity=0.356 Sum_probs=207.3
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecC
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMS 196 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 196 (426)
+|.+.+.||+|+||+||+|... +++.||+|++........+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus 21 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 100 (297)
T 3fxz_A 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (297)
T ss_dssp TBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred ceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCC
Confidence 3566789999999999999864 788999999976655566789999999999999999999999999999999999999
Q ss_pred CCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC-CCccc
Q 014352 197 NGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD-GRNSG 275 (426)
Q Consensus 197 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-~~~~~ 275 (426)
+|+|.+++... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++...... .....
T Consensus 101 ~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 175 (297)
T 3fxz_A 101 GGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175 (297)
T ss_dssp TCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred CCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccCC
Confidence 99999998543 5899999999999999999999998 999999999999999999999999998754332 23345
Q ss_pred CccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHH
Q 014352 276 LKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELAR 355 (426)
Q Consensus 276 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 355 (426)
..||+.|+|||.+.+..++.++||||||+++|||++|..||...........+...... ....+...+..+.+
T Consensus 176 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~ 248 (297)
T 3fxz_A 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP-------ELQNPEKLSAIFRD 248 (297)
T ss_dssp CCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC-------CCSCGGGSCHHHHH
T ss_pred ccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-------CCCCccccCHHHHH
Confidence 67999999999999999999999999999999999999999764433222211111000 01112234467899
Q ss_pred HHHHcccCCCCCCCCHHHHHHH
Q 014352 356 IGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 356 l~~~cl~~~p~~RPs~~evl~~ 377 (426)
++.+||+.||++|||+.+++++
T Consensus 249 li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 249 FLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHccCChhHCcCHHHHhhC
Confidence 9999999999999999999875
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-48 Score=375.43 Aligned_cols=258 Identities=26% Similarity=0.444 Sum_probs=213.6
Q ss_pred HHHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc-cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEE
Q 014352 116 KATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH-QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYE 193 (426)
Q Consensus 116 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 193 (426)
...+.+.+.||+|+||.||+|.+. ++..||+|.+..... ...+.|.+|++++++++||||+++++++...+..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 345667889999999999999986 788999999875432 223468899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC--
Q 014352 194 FMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG-- 271 (426)
Q Consensus 194 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-- 271 (426)
|+++|+|.+++...+..+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 193 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~ 269 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA 269 (377)
T ss_dssp CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence 99999999999877667999999999999999999999999 9999999999999999999999999997532211
Q ss_pred -CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHH
Q 014352 272 -RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQE 349 (426)
Q Consensus 272 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (426)
......++..|+|||.+.+..++.++||||||+++|||++ |..||......... ..+........+...
T Consensus 270 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~---------~~~~~~~~~~~~~~~ 340 (377)
T 3cbl_A 270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTR---------EFVEKGGRLPCPELC 340 (377)
T ss_dssp CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHH---------HHHHTTCCCCCCTTC
T ss_pred ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH---------HHHHcCCCCCCCCCC
Confidence 1122335778999999998999999999999999999998 99999764332221 111222222223334
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHh
Q 014352 350 VRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRH 385 (426)
Q Consensus 350 ~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~ 385 (426)
+..+.+++.+||+.||++|||+.++++.|+.+.+++
T Consensus 341 ~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~~ 376 (377)
T 3cbl_A 341 PDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH 376 (377)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhhc
Confidence 567999999999999999999999999999987653
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=368.95 Aligned_cols=258 Identities=24% Similarity=0.440 Sum_probs=211.1
Q ss_pred HHHhhhhcccccCCCeeEEEEEeC--------CCcEEEEEEeccCCcc-ChHHHHHHHHHHhcC-CCCceeeEEeEEEeC
Q 014352 116 KATQNFTNILGQGAFGPVYKATMP--------SGGVAAIKVLASDSHQ-GEKEFQTEVSLLGRL-HHRNLVNLIGYCVDK 185 (426)
Q Consensus 116 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 185 (426)
...|.+.+.||+|+||.||+|.+. ++..||+|++...... ..+.+.+|+.+++++ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 345677889999999999999852 3457999999765322 235789999999999 899999999999999
Q ss_pred CeEEEEEEecCCCChhHHhhhcc---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEe
Q 014352 186 GKYMLIYEFMSNGSLSNLIYSEE---------------RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILL 250 (426)
Q Consensus 186 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill 250 (426)
+.+++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 99999999999999999996543 34899999999999999999999998 9999999999999
Q ss_pred cCCCcEEEeeecCccccccCC---CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHh
Q 014352 251 DHFMRAKVADFGLSKEEVFDG---RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLA 326 (426)
Q Consensus 251 ~~~~~~kl~Dfgl~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~ 326 (426)
+.++.+||+|||+++...... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||........
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~-- 314 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-- 314 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH--
Confidence 999999999999997543221 2234557889999999999999999999999999999999 9999975322111
Q ss_pred hccccchhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHh
Q 014352 327 SMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRH 385 (426)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~ 385 (426)
...+........+...+..+.+++.+||+.||++|||+.++++.|+.+....
T Consensus 315 -------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 315 -------FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp -------HHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -------HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 1111111122223344568999999999999999999999999999987643
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=366.42 Aligned_cols=260 Identities=25% Similarity=0.431 Sum_probs=212.8
Q ss_pred HHHHHhhhhcccccCCCeeEEEEEeC----CCcEEEEEEeccCC-ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeE
Q 014352 114 IQKATQNFTNILGQGAFGPVYKATMP----SGGVAAIKVLASDS-HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKY 188 (426)
Q Consensus 114 l~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 188 (426)
+...+|.+.+.||+|+||.||+|.+. .+..||||.+.... ....+.|.+|+.++++++||||+++++++.+.+..
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 125 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA 125 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence 44456778899999999999999974 34469999997653 23345799999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccc
Q 014352 189 MLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEV 268 (426)
Q Consensus 189 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 268 (426)
++||||+++|+|.+++......+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 126 MIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 9999999999999999776677999999999999999999999998 9999999999999999999999999997543
Q ss_pred cCCC----cccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcc
Q 014352 269 FDGR----NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVG 343 (426)
Q Consensus 269 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (426)
.... .....+|+.|+|||.+.+..++.++||||||+++|||++ |..||...........+ ......
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~---------~~~~~~ 273 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV---------EEGYRL 273 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH---------HTTCCC
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH---------HcCCCC
Confidence 2211 123346778999999999999999999999999999999 99999764433222111 111112
Q ss_pred cCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHh
Q 014352 344 ACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRH 385 (426)
Q Consensus 344 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~ 385 (426)
..+...+..+.+++.+||+.||++|||+.++++.|+.+....
T Consensus 274 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 274 PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 223344568999999999999999999999999999987643
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=352.18 Aligned_cols=254 Identities=28% Similarity=0.480 Sum_probs=214.1
Q ss_pred HhhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCC
Q 014352 118 TQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSN 197 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 197 (426)
.|.+.+.||+|+||.||+|.+.+++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 89 (269)
T 4hcu_A 11 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 89 (269)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred hceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCC
Confidence 466778999999999999999888899999997654 3457899999999999999999999999999999999999999
Q ss_pred CChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC--CCccc
Q 014352 198 GSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD--GRNSG 275 (426)
Q Consensus 198 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~--~~~~~ 275 (426)
++|.+++......+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++...... .....
T Consensus 90 ~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 166 (269)
T 4hcu_A 90 GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 166 (269)
T ss_dssp CBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTS
T ss_pred CcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccccccccC
Confidence 9999999777777999999999999999999999999 999999999999999999999999999753322 12234
Q ss_pred CccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHH
Q 014352 276 LKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELA 354 (426)
Q Consensus 276 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 354 (426)
..+|+.|+|||.+.+..++.++||||||+++|+|++ |..||...........+. .......+...+..+.
T Consensus 167 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~ 237 (269)
T 4hcu_A 167 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS---------TGFRLYKPRLASTHVY 237 (269)
T ss_dssp TTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH---------TTCCCCCCTTSCHHHH
T ss_pred cccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh---------cCccCCCCCcCCHHHH
Confidence 557788999999999999999999999999999999 999997643332221111 1111122223346799
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHHHHHHHH
Q 014352 355 RIGHKCLHKTPRKRPSIGEVTQALLKIKQR 384 (426)
Q Consensus 355 ~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 384 (426)
+++.+||+.||++|||+.+++++|+.+.+.
T Consensus 238 ~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 238 QIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 999999999999999999999999998764
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=360.49 Aligned_cols=267 Identities=27% Similarity=0.423 Sum_probs=212.8
Q ss_pred HHHHhhhhcccccCCCeeEEEEEe-----CCCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeC--Ce
Q 014352 115 QKATQNFTNILGQGAFGPVYKATM-----PSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDK--GK 187 (426)
Q Consensus 115 ~~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~ 187 (426)
...+|.+.+.||+|+||+||+|++ .+++.||+|++........+.+.+|+.++++++||||+++++++... ..
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 87 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence 345577888999999999999984 36789999999876555557899999999999999999999998653 56
Q ss_pred EEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccc
Q 014352 188 YMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEE 267 (426)
Q Consensus 188 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 267 (426)
.++||||+++|+|.+++......+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~ 164 (295)
T 3ugc_A 88 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVL 164 (295)
T ss_dssp CEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred eEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence 89999999999999999776667999999999999999999999998 999999999999999999999999999754
Q ss_pred ccCC----CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhcccc-------chhhh
Q 014352 268 VFDG----RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQD-------GVDEI 336 (426)
Q Consensus 268 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~-------~~~~~ 336 (426)
.... ......++..|+|||.+.+..++.++||||||+++|||++|..|+............... .....
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (295)
T 3ugc_A 165 PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 244 (295)
T ss_dssp -----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred cCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHH
Confidence 3221 123345777899999999999999999999999999999999998765432111100000 01111
Q ss_pred hhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHH
Q 014352 337 LDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQR 384 (426)
Q Consensus 337 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 384 (426)
+........+...+..+.+++.+||+.||++|||+.++++.|+.+.+.
T Consensus 245 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 245 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 112222223344567899999999999999999999999999998764
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-47 Score=361.81 Aligned_cols=245 Identities=24% Similarity=0.376 Sum_probs=206.0
Q ss_pred hhhhcccccCCCeeEEEEEe-CCCcEEEEEEeccCC--ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEec
Q 014352 119 QNFTNILGQGAFGPVYKATM-PSGGVAAIKVLASDS--HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 195 (426)
|.+.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 17 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 96 (328)
T 3fe3_A 17 YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYA 96 (328)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECC
Confidence 66778999999999999997 488999999987542 223456889999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCccc
Q 014352 196 SNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSG 275 (426)
Q Consensus 196 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 275 (426)
++|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..........
T Consensus 97 ~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 172 (328)
T 3fe3_A 97 SGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA 172 (328)
T ss_dssp TTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGGGT
T ss_pred CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCCCcccc
Confidence 999999999655 45899999999999999999999998 99999999999999999999999999986555555567
Q ss_pred CccccCccCccccccCCCC-cchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHH
Q 014352 276 LKGTYGYIDPAYISTNKFT-MKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELA 354 (426)
Q Consensus 276 ~~gt~~y~aPE~~~~~~~~-~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 354 (426)
..||+.|+|||.+.+..++ .++|||||||++|||++|..||.+.........+. .... ..+...+..+.
T Consensus 173 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~--------~~~~--~~p~~~s~~~~ 242 (328)
T 3fe3_A 173 FCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVL--------RGKY--RIPFYMSTDCE 242 (328)
T ss_dssp TSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--------HCCC--CCCTTSCHHHH
T ss_pred ccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--------hCCC--CCCCCCCHHHH
Confidence 7899999999999888875 79999999999999999999997643322111111 1110 11222346788
Q ss_pred HHHHHcccCCCCCCCCHHHHHHH
Q 014352 355 RIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 355 ~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
+++.+||+.||.+|||+.+++++
T Consensus 243 ~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 243 NLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp HHHHHHCCSSTTTSCCHHHHTTC
T ss_pred HHHHHHCCCChhHCcCHHHHhcC
Confidence 99999999999999999999976
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=355.09 Aligned_cols=259 Identities=23% Similarity=0.347 Sum_probs=212.0
Q ss_pred CCCChhHHHHHHh------------hhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCC
Q 014352 107 PRYAYKDIQKATQ------------NFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHR 173 (426)
Q Consensus 107 ~~~~~~~l~~~~~------------~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ 173 (426)
+.++.+++..+.. ...+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 3466677666553 33468999999999999986 7899999999876666677899999999999999
Q ss_pred ceeeEEeEEEeCCeEEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCC
Q 014352 174 NLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHF 253 (426)
Q Consensus 174 niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~ 253 (426)
||+++++++...+..++||||+++++|.+++.. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.+
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~ 177 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLD 177 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTT
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCC
Confidence 999999999999999999999999999999853 45999999999999999999999998 9999999999999999
Q ss_pred CcEEEeeecCccccccC-CCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccc
Q 014352 254 MRAKVADFGLSKEEVFD-GRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDG 332 (426)
Q Consensus 254 ~~~kl~Dfgl~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~ 332 (426)
+.+||+|||++...... .......||+.|+|||++.+..++.++||||||+++|||++|..||...........+....
T Consensus 178 ~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 257 (321)
T 2c30_A 178 GRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP 257 (321)
T ss_dssp CCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS
T ss_pred CcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC
Confidence 99999999998754332 22345679999999999999999999999999999999999999997643322221111110
Q ss_pred hhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 333 VDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
.. .. ......+..+.+++.+||+.||++|||+.+++++
T Consensus 258 ~~-----~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 258 PP-----KL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp CC-----CC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CC-----Cc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 00 0111234678999999999999999999999875
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-47 Score=357.44 Aligned_cols=260 Identities=31% Similarity=0.495 Sum_probs=203.9
Q ss_pred HHhhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCcc--ChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEe
Q 014352 117 ATQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQ--GEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEF 194 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 194 (426)
..+.+.+.||+|+||+||+|+. +++.||+|++...... ..+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 37 ~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 115 (309)
T 3p86_A 37 CDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEY 115 (309)
T ss_dssp GGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEEC
T ss_pred hHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEec
Confidence 4567788999999999999987 6788999998765422 235788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhcc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC-
Q 014352 195 MSNGSLSNLIYSEE--RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG- 271 (426)
Q Consensus 195 ~~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~- 271 (426)
+++|+|.+++.... ..+++..++.++.|++.||.|||+++ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 116 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 194 (309)
T 3p86_A 116 LSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFL 194 (309)
T ss_dssp CTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC----------
T ss_pred CCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccccccc
Confidence 99999999996543 24899999999999999999999986 459999999999999999999999999997533221
Q ss_pred CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHH
Q 014352 272 RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVR 351 (426)
Q Consensus 272 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (426)
......||+.|+|||.+.+..++.++||||||+++|||++|..||............. ........+...+.
T Consensus 195 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~--------~~~~~~~~~~~~~~ 266 (309)
T 3p86_A 195 SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVG--------FKCKRLEIPRNLNP 266 (309)
T ss_dssp -------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHH--------HSCCCCCCCTTSCH
T ss_pred ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--------hcCCCCCCCccCCH
Confidence 2345679999999999999999999999999999999999999997654332221110 00011112233446
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHhh
Q 014352 352 ELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRHL 386 (426)
Q Consensus 352 ~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~ 386 (426)
.+.+++.+||+.||++|||+.++++.|+.+.+...
T Consensus 267 ~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~ 301 (309)
T 3p86_A 267 QVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301 (309)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence 79999999999999999999999999998876543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-47 Score=360.97 Aligned_cols=275 Identities=36% Similarity=0.653 Sum_probs=222.6
Q ss_pred CCCCChhHHHHHH--hhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCcc-ChHHHHHHHHHHhcCCCCceeeEEeEE
Q 014352 106 IPRYAYKDIQKAT--QNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQ-GEKEFQTEVSLLGRLHHRNLVNLIGYC 182 (426)
Q Consensus 106 ~~~~~~~~l~~~~--~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~ 182 (426)
+..+++.++.... |.+.+.||+|+||.||+|...+++.||+|++...... ....+.+|+.++++++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 3456667766544 4556899999999999999888999999998765322 334789999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCChhHHhhhcc---CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEe
Q 014352 183 VDKGKYMLIYEFMSNGSLSNLIYSEE---RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVA 259 (426)
Q Consensus 183 ~~~~~~~lv~e~~~~gsL~~~l~~~~---~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 259 (426)
.+.+..++||||+++|+|.+++.... ..+++..+..++.|++.||.|||++..++|+||||||+|||++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 99999999999999999999996543 359999999999999999999999922229999999999999999999999
Q ss_pred eecCccccccCC--CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHH--------H-hhc
Q 014352 260 DFGLSKEEVFDG--RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVN--------L-ASM 328 (426)
Q Consensus 260 Dfgl~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~--------~-~~~ 328 (426)
|||+++...... ......||+.|+|||.+.+..++.++||||||+++|||++|..||........ . ...
T Consensus 177 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 256 (326)
T 3uim_A 177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256 (326)
T ss_dssp CCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT
T ss_pred cCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh
Confidence 999997543222 22345699999999999988999999999999999999999999964221100 0 111
Q ss_pred cccchhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 014352 329 SQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLK 380 (426)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 380 (426)
.........+...........+..+.+++.+||+.||.+|||+.+++++|+.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp SSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred hchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 2223344445555556677888999999999999999999999999999975
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=353.59 Aligned_cols=255 Identities=25% Similarity=0.412 Sum_probs=213.1
Q ss_pred HHHhhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEec
Q 014352 116 KATQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 116 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 195 (426)
...|.+.+.||+|+||.||+|.+.++..||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 34567788999999999999999888889999997654 34567999999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC--Cc
Q 014352 196 SNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG--RN 273 (426)
Q Consensus 196 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~--~~ 273 (426)
++++|.+++......+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++....... ..
T Consensus 86 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 162 (268)
T 3sxs_A 86 SNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS 162 (268)
T ss_dssp TTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEEC
T ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhhcc
Confidence 999999999877777999999999999999999999998 9999999999999999999999999987543222 12
Q ss_pred ccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHH
Q 014352 274 SGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRE 352 (426)
Q Consensus 274 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (426)
....+|+.|+|||.+.+..++.++||||||+++|||++ |..||.............. ......+...+..
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~ 233 (268)
T 3sxs_A 163 VGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQ---------GHRLYRPHLASDT 233 (268)
T ss_dssp CSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT---------TCCCCCCTTSCHH
T ss_pred cCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHc---------CCCCCCCCcChHH
Confidence 33456778999999999899999999999999999999 9999976443322211111 1111112223467
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 014352 353 LARIGHKCLHKTPRKRPSIGEVTQALLKIKQ 383 (426)
Q Consensus 353 l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 383 (426)
+.+++.+||+.||++|||+.+++++|+.+.+
T Consensus 234 l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 234 IYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp HHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 8999999999999999999999999988754
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=352.56 Aligned_cols=256 Identities=27% Similarity=0.422 Sum_probs=211.8
Q ss_pred HHHhhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEec
Q 014352 116 KATQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 116 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 195 (426)
...|.+.+.||+|+||.||++.+.++..||+|++.... ...+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 34567788999999999999999888899999997654 34578999999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC--CCc
Q 014352 196 SNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD--GRN 273 (426)
Q Consensus 196 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~--~~~ 273 (426)
++++|.+++......+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++...... ...
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 178 (283)
T 3gen_A 102 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 178 (283)
T ss_dssp TTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHST
T ss_pred CCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccccccc
Confidence 999999999776667999999999999999999999998 999999999999999999999999999753222 122
Q ss_pred ccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHH
Q 014352 274 SGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRE 352 (426)
Q Consensus 274 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (426)
....+|+.|+|||.+.+..++.++||||||+++|||++ |..||...........+. .......+...+..
T Consensus 179 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~ 249 (283)
T 3gen_A 179 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA---------QGLRLYRPHLASEK 249 (283)
T ss_dssp TSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH---------TTCCCCCCTTCCHH
T ss_pred cCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHh---------cccCCCCCCcCCHH
Confidence 34456788999999999999999999999999999998 999997644332222111 11111122223467
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHHHHHHHHH
Q 014352 353 LARIGHKCLHKTPRKRPSIGEVTQALLKIKQR 384 (426)
Q Consensus 353 l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 384 (426)
+.+++.+||+.||++|||+.+++++|..+..+
T Consensus 250 l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 250 VYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp HHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 99999999999999999999999999988764
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-47 Score=368.31 Aligned_cols=258 Identities=24% Similarity=0.426 Sum_probs=203.7
Q ss_pred HHHhhhhcccccCCCeeEEEEEeC----CCcEEEEEEeccCCc-cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEE
Q 014352 116 KATQNFTNILGQGAFGPVYKATMP----SGGVAAIKVLASDSH-QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYML 190 (426)
Q Consensus 116 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 190 (426)
...+.+.+.||+|+||.||+|++. ++..||||.+..... ...+.|.+|+.++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 345677789999999999999864 566799999976532 234579999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC
Q 014352 191 IYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD 270 (426)
Q Consensus 191 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 270 (426)
||||+++|+|.+++......+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 124 v~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 200 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200 (373)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence 99999999999999776667999999999999999999999998 999999999999999999999999999754322
Q ss_pred CC----cccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccC
Q 014352 271 GR----NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGAC 345 (426)
Q Consensus 271 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (426)
.. .....++..|+|||++.+..++.++||||||+++|||++ |..||......... ..+........
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~---------~~i~~~~~~~~ 271 (373)
T 2qol_A 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI---------KAVDEGYRLPP 271 (373)
T ss_dssp -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHH---------HHHHTTEECCC
T ss_pred CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH---------HHHHcCCCCCC
Confidence 11 122345778999999999999999999999999999998 99999754332211 11222222223
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHh
Q 014352 346 NIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRH 385 (426)
Q Consensus 346 ~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~ 385 (426)
+...+..+.+++.+||+.||++||++.++++.|+.+....
T Consensus 272 ~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 272 PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred CccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 3345578999999999999999999999999999997654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=371.18 Aligned_cols=252 Identities=28% Similarity=0.454 Sum_probs=208.6
Q ss_pred HHhhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCC-eEEEEEEec
Q 014352 117 ATQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKG-KYMLIYEFM 195 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~ 195 (426)
..+.+.+.||+|+||.||+|.+. ++.||||+++... ..+.|.+|+.+|++++||||+++++++.+.+ ..++||||+
T Consensus 193 ~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~ 269 (450)
T 1k9a_A 193 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 269 (450)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred HHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence 34556788999999999999985 6789999997653 4568999999999999999999999988765 799999999
Q ss_pred CCCChhHHhhhccC-CCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCcc
Q 014352 196 SNGSLSNLIYSEER-VLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNS 274 (426)
Q Consensus 196 ~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 274 (426)
++|+|.+++...+. .+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..... ..
T Consensus 270 ~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~~ 344 (450)
T 1k9a_A 270 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--QD 344 (450)
T ss_dssp TTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC------
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc--cc
Confidence 99999999976553 4799999999999999999999998 999999999999999999999999999853322 22
Q ss_pred cCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHH
Q 014352 275 GLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVREL 353 (426)
Q Consensus 275 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 353 (426)
...++..|+|||.+.+..++.++||||||+++|||++ |..||....... ....+........+...+..+
T Consensus 345 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---------~~~~i~~~~~~~~p~~~~~~l 415 (450)
T 1k9a_A 345 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---------VVPRVEKGYKMDAPDGCPPAV 415 (450)
T ss_dssp --CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT---------HHHHHHTTCCCCCCTTCCHHH
T ss_pred CCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---------HHHHHHcCCCCCCCCcCCHHH
Confidence 3467889999999999999999999999999999998 999997532211 111122222223334455789
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHHHHHHHHh
Q 014352 354 ARIGHKCLHKTPRKRPSIGEVTQALLKIKQRH 385 (426)
Q Consensus 354 ~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~ 385 (426)
.+++.+||+.||++|||+.++++.|+.+....
T Consensus 416 ~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~ 447 (450)
T 1k9a_A 416 YDVMKNCWHLDAATRPTFLQLREQLEHIRTHE 447 (450)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred HHHHHHHcCCChhHCcCHHHHHHHHHHHHHhh
Confidence 99999999999999999999999999987643
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-46 Score=358.88 Aligned_cols=250 Identities=27% Similarity=0.373 Sum_probs=207.0
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCcc------ChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEE
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQ------GEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYML 190 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 190 (426)
.|.+.+.||+|+||.||+|+.. +|..||+|++...... ..+.+.+|+.+|++++||||+++++++.+.+..++
T Consensus 13 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 92 (361)
T 2yab_A 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVL 92 (361)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEE
Confidence 4677889999999999999976 6889999999765322 24678999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCC----cEEEeeecCccc
Q 014352 191 IYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFM----RAKVADFGLSKE 266 (426)
Q Consensus 191 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfgl~~~ 266 (426)
||||+++|+|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++ .+||+|||++..
T Consensus 93 v~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~ 168 (361)
T 2yab_A 93 ILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (361)
T ss_dssp EEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred EEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence 9999999999999954 356999999999999999999999998 99999999999998877 799999999986
Q ss_pred cccCCCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCC
Q 014352 267 EVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACN 346 (426)
Q Consensus 267 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (426)
...........||+.|+|||++.+..++.++||||||+++|+|++|..||.+......+..+...... ++... .
T Consensus 169 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~--~~~~~----~ 242 (361)
T 2yab_A 169 IEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYD--FDEEF----F 242 (361)
T ss_dssp CCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC--CCHHH----H
T ss_pred cCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC--CCchh----c
Confidence 55444455678999999999999999999999999999999999999999764433222221111000 00000 0
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 347 IQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 347 ~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
...+..+.+++.+||..||++|||+.+++++
T Consensus 243 ~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 243 SQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1223578899999999999999999999864
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=359.23 Aligned_cols=252 Identities=19% Similarity=0.268 Sum_probs=208.5
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecC
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMS 196 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 196 (426)
.|.+.+.||+|+||.||+|... ++..+|+|.+.... .....+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 6 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 84 (321)
T 1tki_A 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS 84 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred ceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCC
Confidence 4667789999999999999976 67889999987543 334578899999999999999999999999999999999999
Q ss_pred CCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecC--CCcEEEeeecCccccccCCCcc
Q 014352 197 NGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDH--FMRAKVADFGLSKEEVFDGRNS 274 (426)
Q Consensus 197 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~--~~~~kl~Dfgl~~~~~~~~~~~ 274 (426)
+|+|.+++......+++..+..++.|++.||.|||+++ |+||||||+|||++. ++.+||+|||+++.........
T Consensus 85 g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~ 161 (321)
T 1tki_A 85 GLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR 161 (321)
T ss_dssp CCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEE
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCccc
Confidence 99999999766667999999999999999999999998 999999999999997 7899999999998654444445
Q ss_pred cCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHH
Q 014352 275 GLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELA 354 (426)
Q Consensus 275 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 354 (426)
...||+.|+|||++.+..++.++||||||+++|+|++|..||...........+...... .+... ....+.++.
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~----~~~~s~~~~ 235 (321)
T 1tki_A 162 LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYT--FDEEA----FKEISIEAM 235 (321)
T ss_dssp EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC--CCHHH----HTTSCHHHH
T ss_pred cccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCC--CChhh----hccCCHHHH
Confidence 567999999999999988999999999999999999999999764433222211111100 00000 012346789
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHHH
Q 014352 355 RIGHKCLHKTPRKRPSIGEVTQALL 379 (426)
Q Consensus 355 ~l~~~cl~~~p~~RPs~~evl~~L~ 379 (426)
+++.+||+.||++|||+.|++++-.
T Consensus 236 ~li~~~L~~dp~~Rpt~~e~l~hp~ 260 (321)
T 1tki_A 236 DFVDRLLVKERKSRMTASEALQHPW 260 (321)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred HHHHHHcCCChhHCcCHHHHhcChh
Confidence 9999999999999999999998754
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=355.15 Aligned_cols=252 Identities=25% Similarity=0.384 Sum_probs=208.0
Q ss_pred HHHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCcc------ChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeE
Q 014352 116 KATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQ------GEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKY 188 (426)
Q Consensus 116 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 188 (426)
...|.+.+.||+|+||.||+|... ++..||+|++...... ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 356788899999999999999976 6889999998754321 356799999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCC----cEEEeeecCc
Q 014352 189 MLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFM----RAKVADFGLS 264 (426)
Q Consensus 189 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfgl~ 264 (426)
++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++ .+||+|||++
T Consensus 90 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp EEEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 999999999999999954 356999999999999999999999998 99999999999999887 7999999999
Q ss_pred cccccCCCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhccc
Q 014352 265 KEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGA 344 (426)
Q Consensus 265 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (426)
+............||+.|+|||++.+..++.++||||||+++|+|++|..||........+..+...... ......
T Consensus 166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~-- 241 (326)
T 2y0a_A 166 HKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE--FEDEYF-- 241 (326)
T ss_dssp EECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCC--CCHHHH--
T ss_pred eECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCC--cCcccc--
Confidence 8655444455677999999999999999999999999999999999999999764333222211110000 000000
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 345 CNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 345 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
...+..+.+++.+||+.||++|||+.+++++
T Consensus 242 --~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 242 --SNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp --TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred --ccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1123578899999999999999999999975
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-46 Score=352.11 Aligned_cols=252 Identities=21% Similarity=0.244 Sum_probs=202.4
Q ss_pred ChhHHHHHHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCcc--ChHHHHHHHHHHhcC-CCCceeeEEeEEEeC
Q 014352 110 AYKDIQKATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQ--GEKEFQTEVSLLGRL-HHRNLVNLIGYCVDK 185 (426)
Q Consensus 110 ~~~~l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 185 (426)
...++....|.+.+.||+|+||+||+|... +++.||||++...... ....+..|+..+.++ +||||++++++|.+.
T Consensus 50 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~ 129 (311)
T 3p1a_A 50 RPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG 129 (311)
T ss_dssp SSSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred CccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeC
Confidence 345667778888999999999999999986 7889999998654322 223445555555555 899999999999999
Q ss_pred CeEEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcc
Q 014352 186 GKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSK 265 (426)
Q Consensus 186 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 265 (426)
+..++||||+ +++|.+++...+..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 130 ~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~ 205 (311)
T 3p1a_A 130 GILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLV 205 (311)
T ss_dssp TEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCE
T ss_pred CEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeee
Confidence 9999999999 67999999777778999999999999999999999998 9999999999999999999999999997
Q ss_pred ccccCCCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccC
Q 014352 266 EEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGAC 345 (426)
Q Consensus 266 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (426)
............||+.|+|||++.+ .++.++||||||+++|||++|..|+.....+..+.. .... +...
T Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~---~~~~----~~~~--- 274 (311)
T 3p1a_A 206 ELGTAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQ---GYLP----PEFT--- 274 (311)
T ss_dssp ECC------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHHHTT---TCCC----HHHH---
T ss_pred ecccCCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHhc---cCCC----cccc---
Confidence 6554444556679999999999876 789999999999999999999777665444332221 1111 1111
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 346 NIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 346 ~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
...+..+.+++.+||+.||++|||+.+++++
T Consensus 275 -~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 275 -AGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp -TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -cCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 1223679999999999999999999999864
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=364.89 Aligned_cols=263 Identities=25% Similarity=0.423 Sum_probs=215.2
Q ss_pred HHHHHHhhhhcccccCCCeeEEEEEeC--------CCcEEEEEEeccCCcc-ChHHHHHHHHHHhcC-CCCceeeEEeEE
Q 014352 113 DIQKATQNFTNILGQGAFGPVYKATMP--------SGGVAAIKVLASDSHQ-GEKEFQTEVSLLGRL-HHRNLVNLIGYC 182 (426)
Q Consensus 113 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~ 182 (426)
++...++.+.+.||+|+||.||+|... .+..||+|++...... ..+.+.+|+++++++ +||||+++++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 445567788899999999999999852 2357999999765322 235788999999999 999999999999
Q ss_pred EeCCeEEEEEEecCCCChhHHhhhcc---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCC
Q 014352 183 VDKGKYMLIYEFMSNGSLSNLIYSEE---------------RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSAN 247 (426)
Q Consensus 183 ~~~~~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~N 247 (426)
.+.+..++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+|
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~N 221 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARN 221 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcce
Confidence 99999999999999999999996543 35899999999999999999999998 9999999999
Q ss_pred EEecCCCcEEEeeecCccccccC---CCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHH
Q 014352 248 ILLDHFMRAKVADFGLSKEEVFD---GRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYV 323 (426)
Q Consensus 248 ill~~~~~~kl~Dfgl~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~ 323 (426)
||++.++.+||+|||+++..... .......+|+.|+|||++.+..++.++||||||+++|||++ |..||.......
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~ 301 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 301 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999999754322 22334567889999999999999999999999999999999 999997643322
Q ss_pred HHhhccccchhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHhhh
Q 014352 324 NLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRHLA 387 (426)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~~ 387 (426)
.... +........+...+..+.+++.+||+.||++|||+.++++.|+.+......
T Consensus 302 ~~~~---------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 356 (382)
T 3tt0_A 302 LFKL---------LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSN 356 (382)
T ss_dssp HHHH---------HHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCS
T ss_pred HHHH---------HHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 1111 111111122233456799999999999999999999999999999875544
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-46 Score=355.29 Aligned_cols=246 Identities=24% Similarity=0.356 Sum_probs=205.3
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccC---CccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEE
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASD---SHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYE 193 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 193 (426)
.+.+.+.||+|+||.||+++.. +++.||+|++... .......+.+|+.++++++||||+++++++.+.+.+++|||
T Consensus 6 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E 85 (337)
T 1o6l_A 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME 85 (337)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEe
Confidence 3567789999999999999976 7889999999653 12334578899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccccc-CCC
Q 014352 194 FMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF-DGR 272 (426)
Q Consensus 194 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~-~~~ 272 (426)
|+++|+|..++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.... ...
T Consensus 86 ~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~ 161 (337)
T 1o6l_A 86 YANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 161 (337)
T ss_dssp CCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred CCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccCCCc
Confidence 99999999998654 45899999999999999999999998 99999999999999999999999999985332 233
Q ss_pred cccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHH
Q 014352 273 NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRE 352 (426)
Q Consensus 273 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (426)
.....||+.|+|||++.+..++.++||||||+++|||++|..||...........+.. ... ..+...+..
T Consensus 162 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~--------~~~--~~p~~~s~~ 231 (337)
T 1o6l_A 162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM--------EEI--RFPRTLSPE 231 (337)
T ss_dssp BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--------CCC--CCCTTSCHH
T ss_pred ccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHc--------CCC--CCCCCCCHH
Confidence 4567899999999999999999999999999999999999999976433222111111 000 112234467
Q ss_pred HHHHHHHcccCCCCCCC-----CHHHHHHH
Q 014352 353 LARIGHKCLHKTPRKRP-----SIGEVTQA 377 (426)
Q Consensus 353 l~~l~~~cl~~~p~~RP-----s~~evl~~ 377 (426)
+.+++.+||+.||++|| ++.+++++
T Consensus 232 ~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 232 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 89999999999999999 89999876
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-46 Score=352.10 Aligned_cols=261 Identities=24% Similarity=0.295 Sum_probs=208.6
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC-ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCC--eEEEEEE
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS-HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKG--KYMLIYE 193 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e 193 (426)
+|.+.+.||+|+||+||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++...+ ..++|||
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 89 (319)
T 4euu_A 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIME 89 (319)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEE
T ss_pred CEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEe
Confidence 3667789999999999999976 58899999997543 233567889999999999999999999998765 7899999
Q ss_pred ecCCCChhHHhhhcc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEe----cCCCcEEEeeecCcccc
Q 014352 194 FMSNGSLSNLIYSEE--RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILL----DHFMRAKVADFGLSKEE 267 (426)
Q Consensus 194 ~~~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfgl~~~~ 267 (426)
|+++++|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||+++..
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~ 166 (319)
T 4euu_A 90 FCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (319)
T ss_dssp CCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCEEC
T ss_pred CCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCceec
Confidence 999999999996544 23899999999999999999999998 9999999999999 78888999999999865
Q ss_pred ccCCCcccCccccCccCccccc--------cCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHH----HHhhccccchhh
Q 014352 268 VFDGRNSGLKGTYGYIDPAYIS--------TNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYV----NLASMSQDGVDE 335 (426)
Q Consensus 268 ~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~----~~~~~~~~~~~~ 335 (426)
..........||+.|+|||++. +..++.++||||||+++|||++|..||....... .+..+.......
T Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~ 246 (319)
T 4euu_A 167 EDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246 (319)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTT
T ss_pred CCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcc
Confidence 5555555677999999999986 5788999999999999999999999996422110 000000000000
Q ss_pred -------h------hhhhh--cccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 014352 336 -------I------LDKQL--VGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKI 381 (426)
Q Consensus 336 -------~------~~~~~--~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 381 (426)
. ....+ ...........+.+++.+||+.||++|||+.|++++....
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp CCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred cchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 0 00011 1123356777899999999999999999999999998754
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=364.07 Aligned_cols=251 Identities=24% Similarity=0.359 Sum_probs=209.7
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecC
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMS 196 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 196 (426)
.|.+.+.||+|+||.||+|... ++..+|+|++..........+.+|+.+|++++||||+++++++.+.+..++||||++
T Consensus 52 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 131 (387)
T 1kob_A 52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 131 (387)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCC
Confidence 4777889999999999999975 788999999976654455678999999999999999999999999999999999999
Q ss_pred CCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecC--CCcEEEeeecCccccccCCCcc
Q 014352 197 NGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDH--FMRAKVADFGLSKEEVFDGRNS 274 (426)
Q Consensus 197 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~--~~~~kl~Dfgl~~~~~~~~~~~ 274 (426)
+|+|.+++......+++..+..++.|++.||.|||+++ |+||||||+|||++. ++.+||+|||+++.........
T Consensus 132 gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~ 208 (387)
T 1kob_A 132 GGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK 208 (387)
T ss_dssp CCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEE
T ss_pred CCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCCccee
Confidence 99999999766667999999999999999999999998 999999999999974 4679999999998654444444
Q ss_pred cCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHH
Q 014352 275 GLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELA 354 (426)
Q Consensus 275 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 354 (426)
...||+.|+|||++.+..++.++|||||||++|||++|..||........+..+..... ..........+..+.
T Consensus 209 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~------~~~~~~~~~~s~~~~ 282 (387)
T 1kob_A 209 VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDW------EFDEDAFSSVSPEAK 282 (387)
T ss_dssp EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCC------CCCSSTTTTSCHHHH
T ss_pred eeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC------CCCccccccCCHHHH
Confidence 56799999999999999999999999999999999999999986543322222111100 011111123446789
Q ss_pred HHHHHcccCCCCCCCCHHHHHHH
Q 014352 355 RIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 355 ~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
+++.+||+.||++|||+.+++++
T Consensus 283 ~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 283 DFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHcCCChhHCcCHHHHhhC
Confidence 99999999999999999999875
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=355.32 Aligned_cols=260 Identities=25% Similarity=0.415 Sum_probs=202.7
Q ss_pred HhhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCC----eEEEEEE
Q 014352 118 TQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKG----KYMLIYE 193 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~lv~e 193 (426)
.|.+.+.||+|+||+||+|++. ++.||||++.... .....+..|+.++++++||||+++++++.... .+++|||
T Consensus 25 ~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e 102 (322)
T 3soc_A 25 PLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITA 102 (322)
T ss_dssp EEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred hchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEe
Confidence 4667789999999999999985 7889999986543 22345667899999999999999999998754 4799999
Q ss_pred ecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcC----------CCCCeeecCCCCCCEEecCCCcEEEeeecC
Q 014352 194 FMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEG----------AVPPVIHRDLKSANILLDHFMRAKVADFGL 263 (426)
Q Consensus 194 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~----------~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 263 (426)
|+++|+|.+++.. ..+++..++.++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~DFg~ 177 (322)
T 3soc_A 103 FHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIADFGL 177 (322)
T ss_dssp CCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEccCCc
Confidence 9999999999954 3489999999999999999999998 7 99999999999999999999999999
Q ss_pred ccccccCC---CcccCccccCccCccccccC-----CCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHh----hcccc
Q 014352 264 SKEEVFDG---RNSGLKGTYGYIDPAYISTN-----KFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLA----SMSQD 331 (426)
Q Consensus 264 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~----~~~~~ 331 (426)
++...... ......||+.|+|||++.+. .++.++||||||+++|||++|+.||.+........ .....
T Consensus 178 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 257 (322)
T 3soc_A 178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP 257 (322)
T ss_dssp CEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSC
T ss_pred ccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCC
Confidence 97543222 22345799999999999763 45678899999999999999999996532110000 00000
Q ss_pred chhhhhh----hhhccc-----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHH
Q 014352 332 GVDEILD----KQLVGA-----CNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQR 384 (426)
Q Consensus 332 ~~~~~~~----~~~~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 384 (426)
....+.. ...... .....+..+.+++.+||+.||++|||+.++++.|+.+.+.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 258 SLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred chhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 1111111 000000 1224556799999999999999999999999999998764
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=361.38 Aligned_cols=248 Identities=26% Similarity=0.346 Sum_probs=202.4
Q ss_pred hcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCCCCh
Q 014352 122 TNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSL 200 (426)
Q Consensus 122 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 200 (426)
.+.||+|+||.||+|... ++..||+|++........+.+.+|+.++++++||||+++++++.+.+..++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 457999999999999875 7889999999876555567899999999999999999999999999999999999999999
Q ss_pred hHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEe--cCCCcEEEeeecCccccccCCCcccCcc
Q 014352 201 SNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILL--DHFMRAKVADFGLSKEEVFDGRNSGLKG 278 (426)
Q Consensus 201 ~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill--~~~~~~kl~Dfgl~~~~~~~~~~~~~~g 278 (426)
.+++......+++..+..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||+++............|
T Consensus 174 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~g 250 (373)
T 2x4f_A 174 FDRIIDESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFG 250 (373)
T ss_dssp HHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCCS
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccccC
Confidence 9999776667999999999999999999999998 9999999999999 5678899999999986554444455679
Q ss_pred ccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHHHH
Q 014352 279 TYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGH 358 (426)
Q Consensus 279 t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 358 (426)
|+.|+|||++.+..++.++|||||||++|||++|..||........+..+...... .........+..+.+++.
T Consensus 251 t~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~------~~~~~~~~~~~~~~~li~ 324 (373)
T 2x4f_A 251 TPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWD------LEDEEFQDISEEAKEFIS 324 (373)
T ss_dssp SCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC------SCSGGGTTSCHHHHHHHH
T ss_pred CCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC------CChhhhccCCHHHHHHHH
Confidence 99999999999999999999999999999999999999765443322221111000 000001123467899999
Q ss_pred HcccCCCCCCCCHHHHHHHH
Q 014352 359 KCLHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 359 ~cl~~~p~~RPs~~evl~~L 378 (426)
+||+.||.+|||+.+++++-
T Consensus 325 ~~L~~dp~~Rps~~e~l~hp 344 (373)
T 2x4f_A 325 KLLIKEKSWRISASEALKHP 344 (373)
T ss_dssp TTSCSSGGGSCCHHHHHHSH
T ss_pred HHcCCChhhCCCHHHHhcCc
Confidence 99999999999999999853
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=364.86 Aligned_cols=262 Identities=25% Similarity=0.381 Sum_probs=212.3
Q ss_pred HHHHHhhhhcccccCCCeeEEEEEeC------CCcEEEEEEeccCC-ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCC
Q 014352 114 IQKATQNFTNILGQGAFGPVYKATMP------SGGVAAIKVLASDS-HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKG 186 (426)
Q Consensus 114 l~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 186 (426)
+....+.+.+.||+|+||.||+|.+. ++..||||++.... ......+.+|+.++++++||||+++++++.+.+
T Consensus 68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 147 (367)
T 3l9p_A 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 147 (367)
T ss_dssp CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 34456778889999999999999853 45689999986543 233457889999999999999999999999999
Q ss_pred eEEEEEEecCCCChhHHhhhcc------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCC---cEE
Q 014352 187 KYMLIYEFMSNGSLSNLIYSEE------RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFM---RAK 257 (426)
Q Consensus 187 ~~~lv~e~~~~gsL~~~l~~~~------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~k 257 (426)
..++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++ .+|
T Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEE
Confidence 9999999999999999996543 35899999999999999999999999 99999999999999555 599
Q ss_pred EeeecCccccccC---CCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccch
Q 014352 258 VADFGLSKEEVFD---GRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGV 333 (426)
Q Consensus 258 l~Dfgl~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~ 333 (426)
|+|||+++..... .......||+.|+|||.+.+..++.++|||||||++|||++ |..||...........+
T Consensus 225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i----- 299 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV----- 299 (367)
T ss_dssp ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH-----
T ss_pred ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-----
Confidence 9999999743222 22334567899999999999999999999999999999998 99999764333222111
Q ss_pred hhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHhhh
Q 014352 334 DEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRHLA 387 (426)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~~ 387 (426)
........+...+..+.+++.+||+.||++|||+.+++++|+.+.+....
T Consensus 300 ----~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~~ 349 (367)
T 3l9p_A 300 ----TSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 349 (367)
T ss_dssp ----HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHH
T ss_pred ----HcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChhh
Confidence 11111122233446799999999999999999999999999999765543
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=349.22 Aligned_cols=259 Identities=23% Similarity=0.359 Sum_probs=201.1
Q ss_pred HHHHhhhhcccccCCCeeEEEEEeCC----CcEEEEEEeccCCc-cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEE
Q 014352 115 QKATQNFTNILGQGAFGPVYKATMPS----GGVAAIKVLASDSH-QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYM 189 (426)
Q Consensus 115 ~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 189 (426)
...+|.+.+.||+|+||.||+|.+.. +..||+|.+..... ...+.+.+|+.++++++||||+++++++. .+..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 34567788999999999999998743 44699999876432 23457899999999999999999999984 45789
Q ss_pred EEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccccc
Q 014352 190 LIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF 269 (426)
Q Consensus 190 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 269 (426)
+||||+++++|.+++......+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168 (281)
T ss_dssp EEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccCc
Confidence 999999999999999776667999999999999999999999998 99999999999999999999999999975432
Q ss_pred CC--CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCC
Q 014352 270 DG--RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACN 346 (426)
Q Consensus 270 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (426)
.. ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||...........+ ........+
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i---------~~~~~~~~~ 239 (281)
T 1mp8_A 169 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI---------ENGERLPMP 239 (281)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH---------HTTCCCCCC
T ss_pred ccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHH---------HcCCCCCCC
Confidence 22 1223456789999999999999999999999999999997 99999754322211111 111111122
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHhh
Q 014352 347 IQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRHL 386 (426)
Q Consensus 347 ~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~ 386 (426)
...+..+.+++.+||+.||++|||+.++++.|+.+.+...
T Consensus 240 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 279 (281)
T 1mp8_A 240 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 279 (281)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhc
Confidence 3345679999999999999999999999999999976543
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=375.40 Aligned_cols=257 Identities=27% Similarity=0.448 Sum_probs=213.0
Q ss_pred HHHHHHhhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEE
Q 014352 113 DIQKATQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIY 192 (426)
Q Consensus 113 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 192 (426)
++....+.+.+.||+|+||.||+|.+.++..||||.+.... ...+.|.+|+.+|++++||||+++++++. .+..++||
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~ 261 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIIT 261 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred eechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEE
Confidence 34455677788999999999999999888899999997654 45678999999999999999999999986 56789999
Q ss_pred EecCCCChhHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC-
Q 014352 193 EFMSNGSLSNLIYSEE-RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD- 270 (426)
Q Consensus 193 e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~- 270 (426)
||+++|+|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 262 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~ 338 (454)
T 1qcf_A 262 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE 338 (454)
T ss_dssp CCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred eecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence 9999999999996543 46899999999999999999999998 999999999999999999999999999854321
Q ss_pred -CCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHH
Q 014352 271 -GRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQ 348 (426)
Q Consensus 271 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (426)
.......+|..|+|||.+....++.++||||||+++|||+| |..||.+......... +........+..
T Consensus 339 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~---------i~~~~~~~~~~~ 409 (454)
T 1qcf_A 339 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA---------LERGYRMPRPEN 409 (454)
T ss_dssp HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH---------HHHTCCCCCCTT
T ss_pred eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH---------HHcCCCCCCCCC
Confidence 11233456789999999999999999999999999999999 9999976433222111 111222222334
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 014352 349 EVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQ 383 (426)
Q Consensus 349 ~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 383 (426)
.+..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 410 ~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 410 CPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 55789999999999999999999999999987643
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=344.38 Aligned_cols=272 Identities=33% Similarity=0.602 Sum_probs=219.8
Q ss_pred CCCCChhHHHHHHhhhh--------cccccCCCeeEEEEEeCCCcEEEEEEeccCC----ccChHHHHHHHHHHhcCCCC
Q 014352 106 IPRYAYKDIQKATQNFT--------NILGQGAFGPVYKATMPSGGVAAIKVLASDS----HQGEKEFQTEVSLLGRLHHR 173 (426)
Q Consensus 106 ~~~~~~~~l~~~~~~~~--------~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~ 173 (426)
.+.|++.++.+.+.+|. +.||+|+||.||+|.. +++.||+|++.... ....+.+.+|+.++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 45688899999988775 4599999999999997 67789999986542 12245789999999999999
Q ss_pred ceeeEEeEEEeCCeEEEEEEecCCCChhHHhhhc--cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEec
Q 014352 174 NLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSE--ERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLD 251 (426)
Q Consensus 174 niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~ 251 (426)
||+++++++.+.+..++||||+++++|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+||+++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~ 167 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLD 167 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEC
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEc
Confidence 9999999999999999999999999999998643 356999999999999999999999998 99999999999999
Q ss_pred CCCcEEEeeecCccccccCCC---cccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHh--
Q 014352 252 HFMRAKVADFGLSKEEVFDGR---NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLA-- 326 (426)
Q Consensus 252 ~~~~~kl~Dfgl~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~-- 326 (426)
.++.+||+|||++........ .....||+.|+|||.+.+ .++.++||||||+++|+|++|..||..........
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~ 246 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI 246 (307)
T ss_dssp TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHH
T ss_pred CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHH
Confidence 999999999999875432211 234578999999998865 57899999999999999999999997532211000
Q ss_pred ----hccccchhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 014352 327 ----SMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQ 383 (426)
Q Consensus 327 ----~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 383 (426)
..........+++.+ ...+...+..+.+++.+||+.||.+|||+.+++++|+.+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 247 KEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 001111222233222 23456677889999999999999999999999999998753
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=361.97 Aligned_cols=250 Identities=25% Similarity=0.377 Sum_probs=200.9
Q ss_pred HHHHHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC---ccChHHHHHHHHHHhcC-CCCceeeEEeEEEeCCeE
Q 014352 114 IQKATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS---HQGEKEFQTEVSLLGRL-HHRNLVNLIGYCVDKGKY 188 (426)
Q Consensus 114 l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 188 (426)
+....|.+.+.||+|+||.||+|+.. +++.||+|++.... ....+.+..|..++..+ +||||+++++++.+.+.+
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 34445777889999999999999976 68899999987542 22345678899999988 799999999999999999
Q ss_pred EEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccc
Q 014352 189 MLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEV 268 (426)
Q Consensus 189 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 268 (426)
|+||||+++|+|..++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 100 ~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 9999999999999999654 45999999999999999999999998 9999999999999999999999999998532
Q ss_pred c-CCCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCH
Q 014352 269 F-DGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNI 347 (426)
Q Consensus 269 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (426)
. .......+||+.|+|||++.+..++.++|||||||++|||++|..||...........+... .. ..+.
T Consensus 176 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--------~~--~~p~ 245 (353)
T 3txo_A 176 CNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND--------EV--VYPT 245 (353)
T ss_dssp C---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--------CC--CCCT
T ss_pred cCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcC--------CC--CCCC
Confidence 2 23345568999999999999999999999999999999999999999764433222221111 11 1122
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCH------HHHHHH
Q 014352 348 QEVRELARIGHKCLHKTPRKRPSI------GEVTQA 377 (426)
Q Consensus 348 ~~~~~l~~l~~~cl~~~p~~RPs~------~evl~~ 377 (426)
..+..+.+++.+||+.||++||++ .+++++
T Consensus 246 ~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 246 WLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred CCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 244678999999999999999998 777764
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=355.27 Aligned_cols=256 Identities=25% Similarity=0.402 Sum_probs=204.6
Q ss_pred HHHhhhhcccccCCCeeEEEEEeC-CCc----EEEEEEeccCC-ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEE
Q 014352 116 KATQNFTNILGQGAFGPVYKATMP-SGG----VAAIKVLASDS-HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYM 189 (426)
Q Consensus 116 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 189 (426)
...|.+.+.||+|+||+||+|++. ++. .||+|.+.... ....+.+.+|+.++++++||||++++++|.+.+ .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 344677789999999999999964 444 35888875442 234568999999999999999999999998764 78
Q ss_pred EEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccccc
Q 014352 190 LIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF 269 (426)
Q Consensus 190 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 269 (426)
+|+||+++|+|.+++......+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 999999999999999877778999999999999999999999998 99999999999999999999999999975432
Q ss_pred CCC---cccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccC
Q 014352 270 DGR---NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGAC 345 (426)
Q Consensus 270 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (426)
... .....+|+.|+|||++.+..++.++||||||+++|||++ |..||...... .....+........
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---------~~~~~~~~~~~~~~ 240 (327)
T 3poz_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---------EISSILEKGERLPQ 240 (327)
T ss_dssp TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---------GHHHHHHTTCCCCC
T ss_pred CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH---------HHHHHHHcCCCCCC
Confidence 221 223456889999999999999999999999999999999 99999753221 11222222222223
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHH
Q 014352 346 NIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQR 384 (426)
Q Consensus 346 ~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 384 (426)
+...+..+.+++.+||+.||++|||+.+++++|+.+...
T Consensus 241 ~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 241 PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp CTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred CccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 334556799999999999999999999999999998653
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-46 Score=359.70 Aligned_cols=266 Identities=19% Similarity=0.250 Sum_probs=207.4
Q ss_pred HHHhhhhcccccCCCeeEEEEEeCC------CcEEEEEEeccCCccC-----------hHHHHHHHHHHhcCCCCceeeE
Q 014352 116 KATQNFTNILGQGAFGPVYKATMPS------GGVAAIKVLASDSHQG-----------EKEFQTEVSLLGRLHHRNLVNL 178 (426)
Q Consensus 116 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~niv~~ 178 (426)
...|.+.+.||+|+||.||+|.+.. +..||+|++....... ...+..|+..+..++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 3457778899999999999998764 3679999987653211 1123456667778899999999
Q ss_pred EeEEEeC----CeEEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEec--C
Q 014352 179 IGYCVDK----GKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLD--H 252 (426)
Q Consensus 179 ~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~--~ 252 (426)
++++... ...++||||+ +++|.+++......+++..++.++.|++.||.|||+++ |+||||||+|||++ .
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKN 189 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEESSC
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEecCC
Confidence 9998875 4589999999 99999999777678999999999999999999999998 99999999999999 8
Q ss_pred CCcEEEeeecCccccccCCC--------cccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHH
Q 014352 253 FMRAKVADFGLSKEEVFDGR--------NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVN 324 (426)
Q Consensus 253 ~~~~kl~Dfgl~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~ 324 (426)
++.+||+|||+++....... .....||+.|+|||++.+..++.++||||||+++|||++|..||.+......
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~ 269 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK 269 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence 89999999999975432211 1334599999999999999999999999999999999999999985321111
Q ss_pred Hhh----ccccchhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHhhhc
Q 014352 325 LAS----MSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRHLAK 388 (426)
Q Consensus 325 ~~~----~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~ 388 (426)
... ........+++..+.. ...+..+.+++..||+.||++||++.++++.|+.+.......
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~ 334 (364)
T 3op5_A 270 YVRDSKIRYRENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSK 334 (364)
T ss_dssp HHHHHHHHHHHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHhhhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCC
Confidence 110 0112223333332211 123467899999999999999999999999999998765443
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=347.20 Aligned_cols=260 Identities=24% Similarity=0.354 Sum_probs=206.8
Q ss_pred HHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccC---hHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEE
Q 014352 117 ATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQG---EKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIY 192 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 192 (426)
.+|.+.+.||+|+||.||+|... ++..||+|.+....... .+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 35677889999999999999975 78899999986543332 356889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC-
Q 014352 193 EFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG- 271 (426)
Q Consensus 193 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~- 271 (426)
||+++++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 91 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 166 (294)
T 4eqm_A 91 EYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL 166 (294)
T ss_dssp ECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred eCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence 999999999999654 46999999999999999999999998 9999999999999999999999999997543222
Q ss_pred -CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHH
Q 014352 272 -RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEV 350 (426)
Q Consensus 272 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (426)
......||+.|+|||.+.+..++.++||||||+++|||++|..||.................... . .......+
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-~----~~~~~~~~ 241 (294)
T 4eqm_A 167 TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNV-T----TDVRKDIP 241 (294)
T ss_dssp --------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCH-H----HHSCTTSC
T ss_pred cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCc-c----hhcccCCC
Confidence 22345699999999999999999999999999999999999999986543322111111111111 0 11122234
Q ss_pred HHHHHHHHHcccCCCCCCC-CHHHHHHHHHHHHHHh
Q 014352 351 RELARIGHKCLHKTPRKRP-SIGEVTQALLKIKQRH 385 (426)
Q Consensus 351 ~~l~~l~~~cl~~~p~~RP-s~~evl~~L~~~~~~~ 385 (426)
..+.+++.+||+.||++|| ++.++.+.|..+....
T Consensus 242 ~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 242 QSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp HHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred HHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 6799999999999999998 8999998888765433
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-46 Score=349.37 Aligned_cols=266 Identities=26% Similarity=0.413 Sum_probs=211.9
Q ss_pred HHHHHhhhhcccccCCCeeEEEEEe-----CCCcEEEEEEeccCC-ccChHHHHHHHHHHhcCCCCceeeEEeEEEeC--
Q 014352 114 IQKATQNFTNILGQGAFGPVYKATM-----PSGGVAAIKVLASDS-HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDK-- 185 (426)
Q Consensus 114 l~~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-- 185 (426)
+.+..+.+.+.||+|+||.||+|++ .+++.||+|++.... ....+.+.+|+.++++++||||+++++++...
T Consensus 18 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 97 (302)
T 4e5w_A 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG 97 (302)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred hhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence 3344577788999999999999983 367899999997543 23346789999999999999999999999876
Q ss_pred CeEEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcc
Q 014352 186 GKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSK 265 (426)
Q Consensus 186 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 265 (426)
+..++||||+++|+|.+++......+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.
T Consensus 98 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 98 NGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred ceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccc
Confidence 6689999999999999999777777999999999999999999999998 9999999999999999999999999997
Q ss_pred ccccCC----CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccc--c----chhh
Q 014352 266 EEVFDG----RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQ--D----GVDE 335 (426)
Q Consensus 266 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~--~----~~~~ 335 (426)
...... ......||..|+|||.+.+..++.++||||||+++|||++|..|+.............. . ....
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN 254 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence 543322 22345688889999999999999999999999999999999999765433221110000 0 0111
Q ss_pred hhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 014352 336 ILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIK 382 (426)
Q Consensus 336 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 382 (426)
.+........+...+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 255 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 255 TLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 11122222233445678999999999999999999999999998874
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=348.36 Aligned_cols=253 Identities=32% Similarity=0.560 Sum_probs=204.0
Q ss_pred HHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccCh-------HHHHHHHHHHhcCCCCceeeEEeEEEeCCeE
Q 014352 117 ATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGE-------KEFQTEVSLLGRLHHRNLVNLIGYCVDKGKY 188 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 188 (426)
.+|.+.+.||+|+||.||+|++. +++.||+|++........ +.+.+|+.++++++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 44677889999999999999975 788999999865432221 57889999999999999999999987654
Q ss_pred EEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCc-----EEEeeecC
Q 014352 189 MLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMR-----AKVADFGL 263 (426)
Q Consensus 189 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~-----~kl~Dfgl 263 (426)
++||||+++|+|.+.+......+++..++.++.|++.||.|||+++ ++|+||||||+||+++.++. +||+|||+
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~ 175 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL 175 (287)
T ss_dssp EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCCTT
T ss_pred eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCCCc
Confidence 7999999999999999777778999999999999999999999976 45999999999999988776 99999999
Q ss_pred ccccccCCCcccCccccCccCcccc--ccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhh
Q 014352 264 SKEEVFDGRNSGLKGTYGYIDPAYI--STNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQL 341 (426)
Q Consensus 264 ~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (426)
++... .......||+.|+|||.+ ....++.++||||||+++|||++|..||........ ...........
T Consensus 176 ~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~------~~~~~~~~~~~ 247 (287)
T 4f0f_A 176 SQQSV--HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI------KFINMIREEGL 247 (287)
T ss_dssp CBCCS--SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH------HHHHHHHHSCC
T ss_pred ccccc--ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH------HHHHHHhccCC
Confidence 97432 234456799999999998 455678999999999999999999999965321100 00001111111
Q ss_pred cccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 014352 342 VGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLK 380 (426)
Q Consensus 342 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 380 (426)
....+...+..+.+++.+||+.||++|||+.++++.|+.
T Consensus 248 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 248 RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 222233445689999999999999999999999999875
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=351.82 Aligned_cols=258 Identities=18% Similarity=0.208 Sum_probs=208.6
Q ss_pred HhhhhcccccCCCeeEEEEEe-CCCcEEEEEEeccCCccChHHHHHHHHHHhcC-CCCceeeEEeEEEeCCeEEEEEEec
Q 014352 118 TQNFTNILGQGAFGPVYKATM-PSGGVAAIKVLASDSHQGEKEFQTEVSLLGRL-HHRNLVNLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~ 195 (426)
.|.+.+.||+|+||.||+|.. .+++.||+|++.... ..+.+..|+.+++++ +||||+++++++...+..++||||+
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (330)
T 2izr_A 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL 87 (330)
T ss_dssp TEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC
T ss_pred CeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC
Confidence 356778999999999999996 478899999987543 234688999999999 9999999999999999999999999
Q ss_pred CCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCc-----EEEeeecCccccccC
Q 014352 196 SNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMR-----AKVADFGLSKEEVFD 270 (426)
Q Consensus 196 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~-----~kl~Dfgl~~~~~~~ 270 (426)
+++|.+++......+++..++.++.|++.||.|||+++ |+||||||+|||++.++. +||+|||+++.....
T Consensus 88 -~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~ 163 (330)
T 2izr_A 88 -GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDP 163 (330)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCT
T ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecC
Confidence 99999999766677999999999999999999999998 999999999999999887 999999999854322
Q ss_pred CC--------cccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhc
Q 014352 271 GR--------NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLV 342 (426)
Q Consensus 271 ~~--------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (426)
.. .....||+.|+|||++.+..++.++||||||+++|||++|..||.......... ....+......
T Consensus 164 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~-----~~~~i~~~~~~ 238 (330)
T 2izr_A 164 ETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKE-----RYQKIGDTKRA 238 (330)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHH-----HHHHHHHHHHH
T ss_pred CCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHH-----HHHHHHhhhcc
Confidence 21 245679999999999999999999999999999999999999997532110000 00000000000
Q ss_pred ccC---CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHhhh
Q 014352 343 GAC---NIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRHLA 387 (426)
Q Consensus 343 ~~~---~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~~ 387 (426)
... ....+ .+.+++..||+.||.+||++.++++.|+.+..+...
T Consensus 239 ~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~ 285 (330)
T 2izr_A 239 TPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGY 285 (330)
T ss_dssp SCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred CCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence 000 00122 799999999999999999999999999988776533
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=376.45 Aligned_cols=257 Identities=29% Similarity=0.473 Sum_probs=214.2
Q ss_pred HHHHHHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEE
Q 014352 113 DIQKATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLI 191 (426)
Q Consensus 113 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 191 (426)
++....+.+.+.||+|+||.||+|.+. ++..||||.+.... ...+.|.+|+.+|++++||||++++++|...+..++|
T Consensus 216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 294 (495)
T 1opk_A 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 294 (495)
T ss_dssp BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEE
Confidence 445556778889999999999999986 47889999997654 3467899999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC
Q 014352 192 YEFMSNGSLSNLIYSEE-RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD 270 (426)
Q Consensus 192 ~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 270 (426)
|||+++|+|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 295 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 371 (495)
T 1opk_A 295 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371 (495)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred EEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence 99999999999997543 56899999999999999999999998 999999999999999999999999999854322
Q ss_pred C--CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCCH
Q 014352 271 G--RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNI 347 (426)
Q Consensus 271 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (426)
. ......++..|+|||.+.+..++.++||||||+++|||++ |..||...... .....+........+.
T Consensus 372 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~---------~~~~~~~~~~~~~~~~ 442 (495)
T 1opk_A 372 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---------QVYELLEKDYRMERPE 442 (495)
T ss_dssp CEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---------GHHHHHHTTCCCCCCT
T ss_pred ceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH---------HHHHHHHcCCCCCCCC
Confidence 1 1233456789999999999999999999999999999999 99999753221 1122222233333344
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 014352 348 QEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIK 382 (426)
Q Consensus 348 ~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 382 (426)
..+..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 443 ~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 443 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred CCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 45578999999999999999999999999988653
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=357.34 Aligned_cols=255 Identities=22% Similarity=0.331 Sum_probs=209.0
Q ss_pred HHHHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc--cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEE
Q 014352 115 QKATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH--QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLI 191 (426)
Q Consensus 115 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 191 (426)
....|.+.+.||+|+||.||+|... ++..||+|++..... ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3566888899999999999999975 688999999976532 2235688999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCC---cEEEeeecCccccc
Q 014352 192 YEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFM---RAKVADFGLSKEEV 268 (426)
Q Consensus 192 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfgl~~~~~ 268 (426)
|||+++|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++ .+||+|||++....
T Consensus 107 ~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp ECCCCSCBHHHHHTTC-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred EecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 9999999999998544 46899999999999999999999998 99999999999998654 59999999998655
Q ss_pred cCCCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHH
Q 014352 269 FDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQ 348 (426)
Q Consensus 269 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (426)
.........||+.|+|||++.+..++.++|||||||++|+|++|..||...........+..... .........
T Consensus 183 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~------~~~~~~~~~ 256 (362)
T 2bdw_A 183 DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY------DYPSPEWDT 256 (362)
T ss_dssp TCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC------CCCTTGGGG
T ss_pred CCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC------CCCcccccC
Confidence 44444567899999999999999999999999999999999999999976433222211111100 000011122
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 014352 349 EVRELARIGHKCLHKTPRKRPSIGEVTQALL 379 (426)
Q Consensus 349 ~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 379 (426)
.+..+.+++.+||+.||++|||+.+++++-.
T Consensus 257 ~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 287 (362)
T 2bdw_A 257 VTPEAKSLIDSMLTVNPKKRITADQALKVPW 287 (362)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCHHHHTTSHH
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence 3467899999999999999999999998744
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-46 Score=347.96 Aligned_cols=265 Identities=29% Similarity=0.466 Sum_probs=217.5
Q ss_pred CCChhHHHHHHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCC
Q 014352 108 RYAYKDIQKATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKG 186 (426)
Q Consensus 108 ~~~~~~l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 186 (426)
.+...++....+.+.+.||+|+||.||+|.+. ++..||+|.+.... ...+.+.+|+.++++++||||+++++++.+.+
T Consensus 4 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 82 (288)
T 3kfa_A 4 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 82 (288)
T ss_dssp TCCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred chhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 33334455566778899999999999999986 57889999987543 34567899999999999999999999999999
Q ss_pred eEEEEEEecCCCChhHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcc
Q 014352 187 KYMLIYEFMSNGSLSNLIYSEE-RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSK 265 (426)
Q Consensus 187 ~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 265 (426)
..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.
T Consensus 83 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~ 159 (288)
T 3kfa_A 83 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSR 159 (288)
T ss_dssp SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGG
T ss_pred CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccce
Confidence 9999999999999999996633 56899999999999999999999998 9999999999999999999999999997
Q ss_pred ccccCCC--cccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhc
Q 014352 266 EEVFDGR--NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLV 342 (426)
Q Consensus 266 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (426)
....... .....+|+.|+|||.+.+..++.++||||||+++|+|++ |..||....... ....+.....
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~---------~~~~~~~~~~ 230 (288)
T 3kfa_A 160 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---------VYELLEKDYR 230 (288)
T ss_dssp TSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---------HHHHHHTTCC
T ss_pred eccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---------HHHHHhccCC
Confidence 5432221 233456788999999999999999999999999999999 999987532211 1112222222
Q ss_pred ccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHh
Q 014352 343 GACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRH 385 (426)
Q Consensus 343 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~ 385 (426)
...+...+..+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus 231 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 231 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 2233344578999999999999999999999999999887654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=352.05 Aligned_cols=256 Identities=24% Similarity=0.308 Sum_probs=199.8
Q ss_pred HhhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCcc--ChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEec
Q 014352 118 TQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQ--GEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 195 (426)
+|.+.+.||+|+||+||+|+..+++.||+|++...... ....+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 22 ~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 101 (311)
T 3niz_A 22 KYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFM 101 (311)
T ss_dssp EEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECC
T ss_pred hhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCC
Confidence 36677899999999999999988999999998754322 2357889999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC-CCcc
Q 014352 196 SNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD-GRNS 274 (426)
Q Consensus 196 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-~~~~ 274 (426)
++ +|.+++......+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..... ....
T Consensus 102 ~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 177 (311)
T 3niz_A 102 EK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYT 177 (311)
T ss_dssp SE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---
T ss_pred CC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCccccc
Confidence 75 888888776677999999999999999999999998 999999999999999999999999999754322 2334
Q ss_pred cCccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhcc-------ccchhh------hhhhh
Q 014352 275 GLKGTYGYIDPAYIST-NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMS-------QDGVDE------ILDKQ 340 (426)
Q Consensus 275 ~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~-------~~~~~~------~~~~~ 340 (426)
...||+.|+|||.+.+ ..++.++||||||+++|||++|..||........+..+. ...... .....
T Consensus 178 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (311)
T 3niz_A 178 HEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRT 257 (311)
T ss_dssp CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCC
T ss_pred CCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcc
Confidence 4578999999999876 568999999999999999999999997533221111110 000000 00000
Q ss_pred hc--cc-----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 341 LV--GA-----CNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 341 ~~--~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
.. .. .....+.++.+++.+||+.||++|||+.|++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 258 FQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp CCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred cccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 00 00 011233578899999999999999999999874
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=359.74 Aligned_cols=254 Identities=24% Similarity=0.374 Sum_probs=201.4
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc---cChHHHHHHHHHHhcC-CCCceeeEEeEEEeCCeEEEEE
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH---QGEKEFQTEVSLLGRL-HHRNLVNLIGYCVDKGKYMLIY 192 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 192 (426)
.+.+.+.||+|+||.||+++.. +++.+|+|++..... ...+.+..|..++.++ +||||+++++++.+.+.+++||
T Consensus 53 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~ 132 (396)
T 4dc2_A 53 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI 132 (396)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred HcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEE
Confidence 3667789999999999999976 678899999975422 2234578899999887 8999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccc-cCC
Q 014352 193 EFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEV-FDG 271 (426)
Q Consensus 193 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~-~~~ 271 (426)
||+++|+|..++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++... ...
T Consensus 133 E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~ 208 (396)
T 4dc2_A 133 EYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 208 (396)
T ss_dssp ECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred EcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecccCCC
Confidence 999999999998654 45999999999999999999999999 9999999999999999999999999998532 233
Q ss_pred CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccch-hhhhhhhhcccCCHHHH
Q 014352 272 RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGV-DEILDKQLVGACNIQEV 350 (426)
Q Consensus 272 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 350 (426)
.....+||+.|+|||++.+..++.++|||||||++|||++|..||................. ..+.... ...+...+
T Consensus 209 ~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--~~~p~~~s 286 (396)
T 4dc2_A 209 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--IRIPRSLS 286 (396)
T ss_dssp CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC--CCCCTTSC
T ss_pred ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc--cCCCCcCC
Confidence 45567899999999999999999999999999999999999999964211100000000000 0111111 11223345
Q ss_pred HHHHHHHHHcccCCCCCCCCH------HHHHHH
Q 014352 351 RELARIGHKCLHKTPRKRPSI------GEVTQA 377 (426)
Q Consensus 351 ~~l~~l~~~cl~~~p~~RPs~------~evl~~ 377 (426)
..+.+++.+||+.||++||++ .+++++
T Consensus 287 ~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 287 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp HHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred HHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 678999999999999999995 566654
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=341.85 Aligned_cols=254 Identities=28% Similarity=0.470 Sum_probs=213.0
Q ss_pred HhhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCC
Q 014352 118 TQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSN 197 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 197 (426)
.+.+.+.||+|+||.||+|.+.+++.||+|.+.... ...+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (267)
T 3t9t_A 9 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEH 87 (267)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTT
T ss_pred heeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCC
Confidence 466778999999999999999888899999997654 3457899999999999999999999999999999999999999
Q ss_pred CChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC--CCccc
Q 014352 198 GSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD--GRNSG 275 (426)
Q Consensus 198 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~--~~~~~ 275 (426)
++|.+++......+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++...... .....
T Consensus 88 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 164 (267)
T 3t9t_A 88 GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 164 (267)
T ss_dssp CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTS
T ss_pred CcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccccccccc
Confidence 9999999776677999999999999999999999998 999999999999999999999999998754221 12234
Q ss_pred CccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHH
Q 014352 276 LKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELA 354 (426)
Q Consensus 276 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 354 (426)
..++..|+|||.+.+..++.++||||||+++|||++ |..||...........+.. ......+...+..+.
T Consensus 165 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~---------~~~~~~~~~~~~~l~ 235 (267)
T 3t9t_A 165 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST---------GFRLYKPRLASTHVY 235 (267)
T ss_dssp TTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT---------TCCCCCCTTSCHHHH
T ss_pred ccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhc---------CCcCCCCccCcHHHH
Confidence 557789999999999999999999999999999999 8999976433222111111 111112223346789
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHHHHHHHH
Q 014352 355 RIGHKCLHKTPRKRPSIGEVTQALLKIKQR 384 (426)
Q Consensus 355 ~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 384 (426)
+++.+||+.||++|||+.+++++|+.+.+.
T Consensus 236 ~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 236 QIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 999999999999999999999999998763
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-46 Score=350.86 Aligned_cols=261 Identities=27% Similarity=0.472 Sum_probs=213.1
Q ss_pred HHHHHhhhhcccccCCCeeEEEEEe------CCCcEEEEEEeccCCc-cChHHHHHHHHHHhcC-CCCceeeEEeEEEeC
Q 014352 114 IQKATQNFTNILGQGAFGPVYKATM------PSGGVAAIKVLASDSH-QGEKEFQTEVSLLGRL-HHRNLVNLIGYCVDK 185 (426)
Q Consensus 114 l~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 185 (426)
+...+|.+.+.||+|+||.||+|++ .++..||+|++..... ...+.+.+|+.+++++ +||||+++++++...
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 99 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence 3445677888999999999999985 2567899999976543 2346789999999999 999999999999999
Q ss_pred CeEEEEEEecCCCChhHHhhhccC-----------------CCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCE
Q 014352 186 GKYMLIYEFMSNGSLSNLIYSEER-----------------VLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANI 248 (426)
Q Consensus 186 ~~~~lv~e~~~~gsL~~~l~~~~~-----------------~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Ni 248 (426)
+..++||||+++|+|.+++..... .+++..++.++.|++.||.|||+++ |+||||||+||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Ni 176 (313)
T 1t46_A 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNI 176 (313)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceE
Confidence 999999999999999999965432 4899999999999999999999998 99999999999
Q ss_pred EecCCCcEEEeeecCccccccCCC---cccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHH
Q 014352 249 LLDHFMRAKVADFGLSKEEVFDGR---NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVN 324 (426)
Q Consensus 249 ll~~~~~~kl~Dfgl~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~ 324 (426)
+++.++.+||+|||++........ .....+|+.|+|||.+.+..++.++||||||+++|||++ |..||........
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 256 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH
Confidence 999999999999999975433222 233457889999999999999999999999999999999 9999975322111
Q ss_pred HhhccccchhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHh
Q 014352 325 LASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRH 385 (426)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~ 385 (426)
....+........+...+..+.+++.+||+.||.+|||+.+++++|+.+..+.
T Consensus 257 --------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 257 --------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp --------HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred --------HHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 11111222222222334567999999999999999999999999999887654
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=351.66 Aligned_cols=255 Identities=20% Similarity=0.324 Sum_probs=206.0
Q ss_pred HHHHHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccC-----CccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCe
Q 014352 114 IQKATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASD-----SHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGK 187 (426)
Q Consensus 114 l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 187 (426)
+....|.+.+.||+|+||+||+|... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 100 (351)
T 3c0i_A 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGM 100 (351)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 34567888999999999999999875 7889999998532 12245679999999999999999999999999999
Q ss_pred EEEEEEecCCCChhHHhhhcc---CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCc---EEEeee
Q 014352 188 YMLIYEFMSNGSLSNLIYSEE---RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMR---AKVADF 261 (426)
Q Consensus 188 ~~lv~e~~~~gsL~~~l~~~~---~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Df 261 (426)
.++||||+++|+|.+.+.... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++. +||+||
T Consensus 101 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Df 177 (351)
T 3c0i_A 101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGF 177 (351)
T ss_dssp EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecC
Confidence 999999999999998875432 35899999999999999999999998 999999999999987655 999999
Q ss_pred cCccccccCCC-cccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhh
Q 014352 262 GLSKEEVFDGR-NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQ 340 (426)
Q Consensus 262 gl~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (426)
|++........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||........ ..+...... ..+.
T Consensus 178 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~i~~~~~~--~~~~ 254 (351)
T 3c0i_A 178 GVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLF-EGIIKGKYK--MNPR 254 (351)
T ss_dssp TTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHH-HHHHHTCCC--CCHH
T ss_pred cceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHH-HHHHcCCCC--CCcc
Confidence 99976443322 3456799999999999999999999999999999999999999976432211 111000000 0000
Q ss_pred hcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014352 341 LVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 341 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 378 (426)
. ....+..+.+++.+||+.||++|||+.+++++-
T Consensus 255 ~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp 288 (351)
T 3c0i_A 255 Q----WSHISESAKDLVRRMLMLDPAERITVYEALNHP 288 (351)
T ss_dssp H----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred c----cccCCHHHHHHHHHHCCCChhHCcCHHHHhcCh
Confidence 0 012346789999999999999999999999864
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=342.96 Aligned_cols=252 Identities=29% Similarity=0.512 Sum_probs=196.7
Q ss_pred HhhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCcc----ChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEE
Q 014352 118 TQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQ----GEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYE 193 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 193 (426)
.+.+.+.||+|+||.||+|.+. +..+|+|++...... ..+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 8 ~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (271)
T 3dtc_A 8 ELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVME 86 (271)
T ss_dssp SEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEE
T ss_pred heeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEE
Confidence 4567789999999999999984 788999998754322 24678899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecC--------CCcEEEeeecCcc
Q 014352 194 FMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDH--------FMRAKVADFGLSK 265 (426)
Q Consensus 194 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~--------~~~~kl~Dfgl~~ 265 (426)
|+++++|.+++. ...+++..++.++.|++.||.|||+++..+|+||||||+||+++. ++.+||+|||++.
T Consensus 87 ~~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~ 164 (271)
T 3dtc_A 87 FARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164 (271)
T ss_dssp CCTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC--
T ss_pred cCCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccc
Confidence 999999999984 456999999999999999999999988666899999999999986 7789999999997
Q ss_pred ccccCCCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccC
Q 014352 266 EEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGAC 345 (426)
Q Consensus 266 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (426)
..... ......||+.|+|||.+.+..++.++||||||+++|+|++|..||............. ........
T Consensus 165 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--------~~~~~~~~ 235 (271)
T 3dtc_A 165 EWHRT-TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVA--------MNKLALPI 235 (271)
T ss_dssp ------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHH--------TSCCCCCC
T ss_pred ccccc-cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhh--------cCCCCCCC
Confidence 54322 2334578999999999999999999999999999999999999997644332221111 11111122
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 014352 346 NIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKI 381 (426)
Q Consensus 346 ~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 381 (426)
+...+..+.+++.+||+.||++|||+.+++++|+.+
T Consensus 236 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 236 PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 233446799999999999999999999999999753
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=356.97 Aligned_cols=253 Identities=24% Similarity=0.344 Sum_probs=195.3
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecC
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMS 196 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 196 (426)
+|.+.+.||+|+||+||+++.. +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 21 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 99 (361)
T 3uc3_A 21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYAS 99 (361)
T ss_dssp TEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred cEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCC
Confidence 4677889999999999999986 78899999997644 234678899999999999999999999999999999999999
Q ss_pred CCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCc--EEEeeecCccccccCCCcc
Q 014352 197 NGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMR--AKVADFGLSKEEVFDGRNS 274 (426)
Q Consensus 197 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~--~kl~Dfgl~~~~~~~~~~~ 274 (426)
+|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++. +||+|||+++.........
T Consensus 100 ~~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~ 175 (361)
T 3uc3_A 100 GGELYERICNA-GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 175 (361)
T ss_dssp SCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC----------
T ss_pred CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccccCCCC
Confidence 99999998654 45999999999999999999999999 999999999999987766 9999999998544444445
Q ss_pred cCccccCccCccccccCCCCcc-hhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHH
Q 014352 275 GLKGTYGYIDPAYISTNKFTMK-SDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVREL 353 (426)
Q Consensus 275 ~~~gt~~y~aPE~~~~~~~~~~-~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 353 (426)
...||+.|+|||++.+..++.+ +||||||+++|+|++|+.||........... ....+.............+..+
T Consensus 176 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~s~~~ 251 (361)
T 3uc3_A 176 STVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRK----TIQRILSVKYSIPDDIRISPEC 251 (361)
T ss_dssp -----CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHH----HHHHHHTTCCCCCTTSCCCHHH
T ss_pred CCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHH----HHHHHhcCCCCCCCcCCCCHHH
Confidence 6679999999999988888766 8999999999999999999976432111100 0111111111111112234678
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHHH
Q 014352 354 ARIGHKCLHKTPRKRPSIGEVTQALL 379 (426)
Q Consensus 354 ~~l~~~cl~~~p~~RPs~~evl~~L~ 379 (426)
.+++.+||+.||++|||+.+++++-.
T Consensus 252 ~~li~~~L~~dP~~Rps~~ell~hp~ 277 (361)
T 3uc3_A 252 CHLISRIFVADPATRISIPEIKTHSW 277 (361)
T ss_dssp HHHHHHHSCSCTTTSCCHHHHHTSHH
T ss_pred HHHHHHHccCChhHCcCHHHHHhCcc
Confidence 99999999999999999999998744
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=360.13 Aligned_cols=260 Identities=28% Similarity=0.472 Sum_probs=208.2
Q ss_pred HHHHhhhhcccccCCCeeEEEEEe------CCCcEEEEEEeccCCcc-ChHHHHHHHHHHhcC-CCCceeeEEeEEEeCC
Q 014352 115 QKATQNFTNILGQGAFGPVYKATM------PSGGVAAIKVLASDSHQ-GEKEFQTEVSLLGRL-HHRNLVNLIGYCVDKG 186 (426)
Q Consensus 115 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 186 (426)
....|.+.+.||+|+||.||+|.+ .+++.||||++...... ..+.+.+|++++.++ +||||+++++++.+.+
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 99 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 99 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCC
Confidence 344577788999999999999974 24578999999765322 235789999999999 7999999999998865
Q ss_pred -eEEEEEEecCCCChhHHhhhccC--------------------------------------------------------
Q 014352 187 -KYMLIYEFMSNGSLSNLIYSEER-------------------------------------------------------- 209 (426)
Q Consensus 187 -~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 209 (426)
..++||||+++|+|.+++.....
T Consensus 100 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (359)
T 3vhe_A 100 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179 (359)
T ss_dssp SCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------------
T ss_pred CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhc
Confidence 48999999999999999965432
Q ss_pred ---------CCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC---CcccCc
Q 014352 210 ---------VLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG---RNSGLK 277 (426)
Q Consensus 210 ---------~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---~~~~~~ 277 (426)
.+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...... ......
T Consensus 180 ~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 256 (359)
T 3vhe_A 180 EAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 256 (359)
T ss_dssp ----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CE
T ss_pred ccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccC
Confidence 1889999999999999999999998 9999999999999999999999999997543222 223456
Q ss_pred cccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHH
Q 014352 278 GTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARI 356 (426)
Q Consensus 278 gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 356 (426)
||+.|+|||++.+..++.++||||||+++|||++ |..||........ ....+........+...+..+.++
T Consensus 257 ~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~l~~l 328 (359)
T 3vhe_A 257 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--------FCRRLKEGTRMRAPDYTTPEMYQT 328 (359)
T ss_dssp ECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH--------HHHHHHHTCCCCCCTTCCHHHHHH
T ss_pred CCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH--------HHHHHHcCCCCCCCCCCCHHHHHH
Confidence 8899999999999999999999999999999998 9999975321111 111111111112223344679999
Q ss_pred HHHcccCCCCCCCCHHHHHHHHHHHHHHh
Q 014352 357 GHKCLHKTPRKRPSIGEVTQALLKIKQRH 385 (426)
Q Consensus 357 ~~~cl~~~p~~RPs~~evl~~L~~~~~~~ 385 (426)
+.+||+.||++|||+.+++++|+.+....
T Consensus 329 i~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 329 MLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 99999999999999999999999987643
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-46 Score=350.84 Aligned_cols=257 Identities=26% Similarity=0.458 Sum_probs=210.0
Q ss_pred HHHhhhhcccccCCCeeEEEEEe------CCCcEEEEEEeccCCc-cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeE
Q 014352 116 KATQNFTNILGQGAFGPVYKATM------PSGGVAAIKVLASDSH-QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKY 188 (426)
Q Consensus 116 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 188 (426)
...|.+.+.||+|+||.||+|.. .++..||+|++..... ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 44567788999999999999986 2457899999975432 2336788999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHhhhcc-----------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCC
Q 014352 189 MLIYEFMSNGSLSNLIYSEE-----------------------RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKS 245 (426)
Q Consensus 189 ~lv~e~~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~ 245 (426)
++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccch
Confidence 99999999999999996532 24889999999999999999999998 99999999
Q ss_pred CCEEecCCCcEEEeeecCccccccCC---CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHH
Q 014352 246 ANILLDHFMRAKVADFGLSKEEVFDG---RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLME 321 (426)
Q Consensus 246 ~Nill~~~~~~kl~Dfgl~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~ 321 (426)
+||+++.++.+||+|||+++...... ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999999997543222 1234457888999999999999999999999999999999 9999975322
Q ss_pred HHHHhhccccchhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHH
Q 014352 322 YVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQR 384 (426)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 384 (426)
... ...+........+...+..+.+++.+||+.||++|||+.+++++|+.+..+
T Consensus 259 ~~~---------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 259 ERL---------FNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp GGH---------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHH---------HHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 111 111111111222334456899999999999999999999999999988653
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=353.80 Aligned_cols=261 Identities=24% Similarity=0.436 Sum_probs=211.4
Q ss_pred HHHHHhhhhcccccCCCeeEEEEEeC--------CCcEEEEEEeccCCc-cChHHHHHHHHHHhcC-CCCceeeEEeEEE
Q 014352 114 IQKATQNFTNILGQGAFGPVYKATMP--------SGGVAAIKVLASDSH-QGEKEFQTEVSLLGRL-HHRNLVNLIGYCV 183 (426)
Q Consensus 114 l~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 183 (426)
+....|.+.+.||+|+||.||+|.+. ++..||+|++..... ...+.+.+|+.+++++ +||||+++++++.
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 44456778899999999999999863 456899999976532 2345788999999999 8999999999999
Q ss_pred eCCeEEEEEEecCCCChhHHhhhcc---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCE
Q 014352 184 DKGKYMLIYEFMSNGSLSNLIYSEE---------------RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANI 248 (426)
Q Consensus 184 ~~~~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Ni 248 (426)
+.+..++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+||
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NI 188 (334)
T 2pvf_A 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNV 188 (334)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGE
T ss_pred cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceE
Confidence 9999999999999999999996543 24899999999999999999999998 99999999999
Q ss_pred EecCCCcEEEeeecCccccccCC---CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHH
Q 014352 249 LLDHFMRAKVADFGLSKEEVFDG---RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVN 324 (426)
Q Consensus 249 ll~~~~~~kl~Dfgl~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~ 324 (426)
+++.++.+||+|||+++...... ......+|+.|+|||++.+..++.++||||||+++|||++ |..||........
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 268 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 268 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHH
Confidence 99999999999999997543222 2234457889999999998899999999999999999999 9999976432221
Q ss_pred HhhccccchhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHhh
Q 014352 325 LASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRHL 386 (426)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~ 386 (426)
... +........+...+..+.+++.+||+.||++|||+.++++.|+.+.....
T Consensus 269 ~~~---------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~ 321 (334)
T 2pvf_A 269 FKL---------LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321 (334)
T ss_dssp HHH---------HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHH---------HhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence 111 11111112223344679999999999999999999999999999976543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-46 Score=355.41 Aligned_cols=257 Identities=28% Similarity=0.500 Sum_probs=209.3
Q ss_pred HHHhhhhcccccCCCeeEEEEEeC------CCcEEEEEEeccCCcc-ChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeE
Q 014352 116 KATQNFTNILGQGAFGPVYKATMP------SGGVAAIKVLASDSHQ-GEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKY 188 (426)
Q Consensus 116 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 188 (426)
...|.+.+.||+|+||.||+|+.. ++..||+|++...... ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus 46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 125 (343)
T 1luf_A 46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 125 (343)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCce
Confidence 345667789999999999999874 3478999999765322 245789999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHhhhcc-----------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCC
Q 014352 189 MLIYEFMSNGSLSNLIYSEE-----------------------RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKS 245 (426)
Q Consensus 189 ~lv~e~~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~ 245 (426)
++||||+++|+|.+++.... ..+++.+++.++.|++.||.|||+++ |+||||||
T Consensus 126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp 202 (343)
T 1luf_A 126 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLAT 202 (343)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred EEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCc
Confidence 99999999999999996532 56899999999999999999999998 99999999
Q ss_pred CCEEecCCCcEEEeeecCccccccC---CCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHH
Q 014352 246 ANILLDHFMRAKVADFGLSKEEVFD---GRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLME 321 (426)
Q Consensus 246 ~Nill~~~~~~kl~Dfgl~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~ 321 (426)
+|||++.++.+||+|||+++..... .......+|+.|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 203 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 282 (343)
T 1luf_A 203 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 282 (343)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred ceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCCh
Confidence 9999999999999999998753222 22234568899999999999999999999999999999999 9999976433
Q ss_pred HHHHhhccccchhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHH
Q 014352 322 YVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQR 384 (426)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 384 (426)
......+... .....+...+..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 283 ~~~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 283 EEVIYYVRDG---------NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp HHHHHHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred HHHHHHHhCC---------CcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 2222111111 11112233446799999999999999999999999999987643
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=349.07 Aligned_cols=261 Identities=26% Similarity=0.497 Sum_probs=197.5
Q ss_pred hHHHHHHhhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCc--cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEE
Q 014352 112 KDIQKATQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSH--QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYM 189 (426)
Q Consensus 112 ~~l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 189 (426)
.|+...+|.+.+.||+|+||+||+|++.+ .+|+|++..... ...+.+.+|+.++++++||||+++++++ ..+..+
T Consensus 19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~ 95 (289)
T 3og7_A 19 WEIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLA 95 (289)
T ss_dssp CBCCTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCE
T ss_pred CccCccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccE
Confidence 34555667788999999999999998643 489999875532 2235789999999999999999999965 455689
Q ss_pred EEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccccc
Q 014352 190 LIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF 269 (426)
Q Consensus 190 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 269 (426)
+||||+++++|.+++......+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.....
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 96 IVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp EEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred EEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccc
Confidence 999999999999999777777999999999999999999999998 99999999999999999999999999874332
Q ss_pred ---CCCcccCccccCccCccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcc
Q 014352 270 ---DGRNSGLKGTYGYIDPAYIS---TNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVG 343 (426)
Q Consensus 270 ---~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (426)
........||+.|+|||.+. +..++.++||||||+++|||++|..||................. ..+. ..
T Consensus 173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~---~~~~-~~ 248 (289)
T 3og7_A 173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGS---LSPD-LS 248 (289)
T ss_dssp -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTS---CCCC-TT
T ss_pred ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccc---cCcc-hh
Confidence 12223457899999999986 66788999999999999999999999976432221111100000 0000 00
Q ss_pred cCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 014352 344 ACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIK 382 (426)
Q Consensus 344 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 382 (426)
......+..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 249 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 249 KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 111234467999999999999999999999999998764
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=351.30 Aligned_cols=266 Identities=25% Similarity=0.383 Sum_probs=214.1
Q ss_pred HHhhhhcccccCCCeeEEEEEe-----CCCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEe--CCeEE
Q 014352 117 ATQNFTNILGQGAFGPVYKATM-----PSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVD--KGKYM 189 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~ 189 (426)
..|.+.+.||+|+||.||+|++ .++..||+|++........+.+.+|++++++++||||+++++++.. .+..+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 4567788999999999999984 3678999999987655556679999999999999999999999874 46789
Q ss_pred EEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccccc
Q 014352 190 LIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF 269 (426)
Q Consensus 190 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 269 (426)
+||||+++++|.+++......+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 179 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPL 179 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred EEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence 999999999999999776667999999999999999999999998 99999999999999999999999999975432
Q ss_pred CC----CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhcccc------chhhhhhh
Q 014352 270 DG----RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQD------GVDEILDK 339 (426)
Q Consensus 270 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~------~~~~~~~~ 339 (426)
.. ......+|..|+|||.+.+..++.++||||||+++|+|++|..||............... .....+..
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (327)
T 3lxl_A 180 DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEE 259 (327)
T ss_dssp TCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHT
T ss_pred CCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhc
Confidence 22 223456788899999999999999999999999999999999998765433211111110 11112222
Q ss_pred hhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHh
Q 014352 340 QLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRH 385 (426)
Q Consensus 340 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~ 385 (426)
......+...+..+.+++.+||+.||++|||+.+++++|+.+....
T Consensus 260 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 260 GQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred ccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 2223334455678999999999999999999999999999886543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=370.70 Aligned_cols=256 Identities=28% Similarity=0.450 Sum_probs=208.3
Q ss_pred HHHHHhhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEE
Q 014352 114 IQKATQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYE 193 (426)
Q Consensus 114 l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 193 (426)
+....+.+.+.||+|+||.||+|.+.++..||||++.... ...+.|.+|+.+|++++||||+++++++.+ +..++|||
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e 258 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 258 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred cChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence 4445567788999999999999999888889999997654 345789999999999999999999999876 67899999
Q ss_pred ecCCCChhHHhhhc-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC-
Q 014352 194 FMSNGSLSNLIYSE-ERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG- 271 (426)
Q Consensus 194 ~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~- 271 (426)
|+++|+|.+++... +..+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 259 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 335 (452)
T 1fmk_A 259 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 335 (452)
T ss_dssp CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred hhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence 99999999999653 356999999999999999999999998 9999999999999999999999999997543221
Q ss_pred -CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHH
Q 014352 272 -RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQE 349 (426)
Q Consensus 272 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (426)
......++..|+|||.+.+..++.++||||||+++|||++ |..||.+......... +........+...
T Consensus 336 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~---------i~~~~~~~~~~~~ 406 (452)
T 1fmk_A 336 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ---------VERGYRMPCPPEC 406 (452)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH---------HHTTCCCCCCTTS
T ss_pred ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH---------HHcCCCCCCCCCC
Confidence 1233456789999999999999999999999999999999 9999976433222211 1111222233445
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 014352 350 VRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQ 383 (426)
Q Consensus 350 ~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 383 (426)
+..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 407 ~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 407 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 5789999999999999999999999999987653
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=352.53 Aligned_cols=254 Identities=26% Similarity=0.395 Sum_probs=202.9
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcE----EEEEEeccCC-ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEE
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGV----AAIKVLASDS-HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLI 191 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 191 (426)
.|.+.+.||+|+||.||+|.+. ++.. ||+|.+.... ......+.+|+.++++++||||+++++++.+ +..++|
T Consensus 14 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v 92 (325)
T 3kex_A 14 ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQLV 92 (325)
T ss_dssp TEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SSEEEE
T ss_pred HceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-CccEEE
Confidence 3566789999999999999975 4443 7888875443 2233567889999999999999999999864 568999
Q ss_pred EEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC
Q 014352 192 YEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG 271 (426)
Q Consensus 192 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 271 (426)
|||+++|+|.+++......+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 169 (325)
T 3kex_A 93 TQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 169 (325)
T ss_dssp EECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCT
T ss_pred EEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccCccc
Confidence 9999999999999776667999999999999999999999998 9999999999999999999999999998643322
Q ss_pred ---CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCCH
Q 014352 272 ---RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNI 347 (426)
Q Consensus 272 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (426)
......+|..|+|||.+.+..++.++||||||+++|||++ |..||........ ...+........+.
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---------~~~~~~~~~~~~~~ 240 (325)
T 3kex_A 170 KQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV---------PDLLEKGERLAQPQ 240 (325)
T ss_dssp TCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH---------HHHHHTTCBCCCCT
T ss_pred ccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH---------HHHHHcCCCCCCCC
Confidence 2234567889999999999999999999999999999999 9999975322111 11111111112222
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHH
Q 014352 348 QEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQR 384 (426)
Q Consensus 348 ~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 384 (426)
..+..+.+++.+||+.||.+|||+.+++++|+.+...
T Consensus 241 ~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 241 ICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp TBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred cCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 2345688999999999999999999999999998644
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=353.32 Aligned_cols=258 Identities=28% Similarity=0.491 Sum_probs=207.5
Q ss_pred HHHhhhhcccccCCCeeEEEEEe------CCCcEEEEEEeccCC-ccChHHHHHHHHHHhcC-CCCceeeEEeEEEeCCe
Q 014352 116 KATQNFTNILGQGAFGPVYKATM------PSGGVAAIKVLASDS-HQGEKEFQTEVSLLGRL-HHRNLVNLIGYCVDKGK 187 (426)
Q Consensus 116 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 187 (426)
...+.+.+.||+|+||.||+|.. .++..||+|++.... ....+.+.+|+.++.++ +||||+++++++...+.
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 123 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence 34577788999999999999986 245579999997543 23346789999999999 89999999999999999
Q ss_pred EEEEEEecCCCChhHHhhhccC----------------------CCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCC
Q 014352 188 YMLIYEFMSNGSLSNLIYSEER----------------------VLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKS 245 (426)
Q Consensus 188 ~~lv~e~~~~gsL~~~l~~~~~----------------------~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~ 245 (426)
.++||||+++|+|.+++..... .+++..++.++.|++.||.|||+++ |+||||||
T Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp 200 (344)
T 1rjb_A 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 200 (344)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCh
Confidence 9999999999999999965432 3799999999999999999999998 99999999
Q ss_pred CCEEecCCCcEEEeeecCccccccCCC---cccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHH
Q 014352 246 ANILLDHFMRAKVADFGLSKEEVFDGR---NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLME 321 (426)
Q Consensus 246 ~Nill~~~~~~kl~Dfgl~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~ 321 (426)
+|||++.++.+||+|||++........ .....+|+.|+|||.+.+..++.++||||||+++|||+| |..||.....
T Consensus 201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 280 (344)
T 1rjb_A 201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280 (344)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence 999999999999999999975433322 233457889999999999999999999999999999998 9999975322
Q ss_pred HHHHhhccccchhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHH
Q 014352 322 YVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQR 384 (426)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 384 (426)
... ....+........+...+..+.+++.+||+.||.+|||+.+++++|+.+...
T Consensus 281 ~~~--------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 281 DAN--------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp SHH--------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred HHH--------HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 111 1111122222222333456899999999999999999999999999988654
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=340.33 Aligned_cols=259 Identities=17% Similarity=0.204 Sum_probs=209.9
Q ss_pred HhhhhcccccCCCeeEEEEEe-CCCcEEEEEEeccCCccChHHHHHHHHHHhcC-CCCceeeEEeEEEeCCeEEEEEEec
Q 014352 118 TQNFTNILGQGAFGPVYKATM-PSGGVAAIKVLASDSHQGEKEFQTEVSLLGRL-HHRNLVNLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~ 195 (426)
.|.+.+.||+|+||.||+|.. .+++.||+|++.... ....+.+|+.+++++ +|+|++++++++.+....++||||+
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (298)
T 1csn_A 11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 88 (298)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred ceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec
Confidence 466778999999999999996 478899999986543 345688999999999 7999999999999999999999999
Q ss_pred CCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCc-----EEEeeecCccccccC
Q 014352 196 SNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMR-----AKVADFGLSKEEVFD 270 (426)
Q Consensus 196 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~-----~kl~Dfgl~~~~~~~ 270 (426)
+++|.+++...+..+++..+..++.|++.||.|||+++ |+||||||+||+++.++. +||+|||+++.....
T Consensus 89 -~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~ 164 (298)
T 1csn_A 89 -GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 164 (298)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred -CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccccccc
Confidence 99999999776677999999999999999999999998 999999999999987776 999999999754332
Q ss_pred C--------CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHH---HHHHhhccccchhhhhhh
Q 014352 271 G--------RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLME---YVNLASMSQDGVDEILDK 339 (426)
Q Consensus 271 ~--------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~---~~~~~~~~~~~~~~~~~~ 339 (426)
. ......||+.|+|||.+.+..++.++||||||+++|||++|..||..... ......+..... ....+
T Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~ 243 (298)
T 1csn_A 165 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ-STPLR 243 (298)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH-HSCHH
T ss_pred cccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc-CccHH
Confidence 2 12456799999999999999999999999999999999999999976321 111100000000 00000
Q ss_pred hhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHhhh
Q 014352 340 QLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRHLA 387 (426)
Q Consensus 340 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~~ 387 (426)
.. ....+..+.+++.+||+.||++|||+.++++.|+.+......
T Consensus 244 ~~----~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~ 287 (298)
T 1csn_A 244 EL----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 287 (298)
T ss_dssp HH----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred HH----HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCC
Confidence 00 112346799999999999999999999999999999875443
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=361.28 Aligned_cols=252 Identities=22% Similarity=0.319 Sum_probs=205.1
Q ss_pred HHHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCcc--ChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEE
Q 014352 116 KATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQ--GEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIY 192 (426)
Q Consensus 116 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 192 (426)
...|.+.+.||+|+||+||+|... +++.+|+|++...... ..+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 456888899999999999999875 7889999998765322 2356889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEec---CCCcEEEeeecCcccccc
Q 014352 193 EFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLD---HFMRAKVADFGLSKEEVF 269 (426)
Q Consensus 193 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfgl~~~~~~ 269 (426)
||+++|+|.+.+... ..+++..+..++.|++.||.|||+++ |+||||||+|||++ .++.+||+|||++.....
T Consensus 90 E~~~gg~L~~~i~~~-~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~ 165 (444)
T 3soa_A 90 DLVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165 (444)
T ss_dssp CCCBCCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred EeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence 999999999998654 45999999999999999999999999 99999999999998 467899999999975433
Q ss_pred CC-CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHH
Q 014352 270 DG-RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQ 348 (426)
Q Consensus 270 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (426)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+..... .........
T Consensus 166 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~------~~~~~~~~~ 239 (444)
T 3soa_A 166 EQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAY------DFPSPEWDT 239 (444)
T ss_dssp TCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC------CCCTTTTTT
T ss_pred CCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCC------CCCcccccc
Confidence 22 23456799999999999999999999999999999999999999976443322222111110 001111123
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 349 EVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 349 ~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
.+..+.+++.+||+.||++|||+.+++++
T Consensus 240 ~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 240 VTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 45679999999999999999999999875
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=350.55 Aligned_cols=266 Identities=27% Similarity=0.448 Sum_probs=213.5
Q ss_pred HHHhhhhcccccCCCeeEEEEEe-----CCCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCC--eE
Q 014352 116 KATQNFTNILGQGAFGPVYKATM-----PSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKG--KY 188 (426)
Q Consensus 116 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~ 188 (426)
...+.+.+.||+|+||.||++++ .+++.||+|++........+.+.+|+.++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 34567788999999999999984 367899999998765555578999999999999999999999987653 68
Q ss_pred EEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccc
Q 014352 189 MLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEV 268 (426)
Q Consensus 189 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 268 (426)
++||||+++++|.+++......+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++....
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~ 196 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLP 196 (326)
T ss_dssp EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence 9999999999999999776667999999999999999999999998 9999999999999999999999999997543
Q ss_pred cCCC----cccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHH-Hhhcccc------chhhhh
Q 014352 269 FDGR----NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVN-LASMSQD------GVDEIL 337 (426)
Q Consensus 269 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~-~~~~~~~------~~~~~~ 337 (426)
.... .....++..|+|||.+.+..++.++||||||+++|||++|..|+........ ....... ...+.+
T Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (326)
T 2w1i_A 197 QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 276 (326)
T ss_dssp SSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred ccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHh
Confidence 3221 2234577789999999988899999999999999999999999875432211 1000000 011122
Q ss_pred hhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHH
Q 014352 338 DKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQR 384 (426)
Q Consensus 338 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 384 (426)
........+...+..+.+++.+||+.||++|||+.++++.|+.+.+.
T Consensus 277 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 277 KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 22112222334557899999999999999999999999999998764
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=344.00 Aligned_cols=252 Identities=26% Similarity=0.377 Sum_probs=208.2
Q ss_pred HHHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCcc------ChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeE
Q 014352 116 KATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQ------GEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKY 188 (426)
Q Consensus 116 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 188 (426)
...|.+.+.||+|+||.||+|... ++..||+|.+...... ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 456888899999999999999976 6889999998764322 346799999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCC----cEEEeeecCc
Q 014352 189 MLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFM----RAKVADFGLS 264 (426)
Q Consensus 189 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfgl~ 264 (426)
++||||+++++|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+||+++.++ .+||+|||++
T Consensus 91 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp EEEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred EEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 999999999999999954 346899999999999999999999998 99999999999999888 7999999999
Q ss_pred cccccCCCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhccc
Q 014352 265 KEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGA 344 (426)
Q Consensus 265 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (426)
.............||+.|+|||.+.+..++.++||||||+++|+|++|..||........+..+...... .+....
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~~-- 242 (321)
T 2a2a_A 167 HEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYD--FDEEFF-- 242 (321)
T ss_dssp EECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC--CCHHHH--
T ss_pred eecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccc--cChhhh--
Confidence 8655444445667999999999999999999999999999999999999999764433222211111000 001111
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 345 CNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 345 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
...+..+.+++.+||+.||++|||+.+++++
T Consensus 243 --~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 243 --SHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp --TTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred --cccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1123578999999999999999999999875
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=351.10 Aligned_cols=248 Identities=22% Similarity=0.338 Sum_probs=199.7
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc-cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecC
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH-QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMS 196 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 196 (426)
|.+.+.||+|+||+||+|... +++.||+|++..... ...+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 9 y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 88 (323)
T 3tki_A 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 88 (323)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred ceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCC
Confidence 567789999999999999976 788999999865432 223578899999999999999999999999999999999999
Q ss_pred CCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC---CCc
Q 014352 197 NGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD---GRN 273 (426)
Q Consensus 197 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~---~~~ 273 (426)
+|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++...... ...
T Consensus 89 ~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 164 (323)
T 3tki_A 89 GGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164 (323)
T ss_dssp TEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred CCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCccccc
Confidence 99999998543 45999999999999999999999998 999999999999999999999999999753322 223
Q ss_pred ccCccccCccCccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHH
Q 014352 274 SGLKGTYGYIDPAYISTNKF-TMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRE 352 (426)
Q Consensus 274 ~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (426)
....||+.|+|||++.+..+ +.++||||||+++|||++|..||......... ....................
T Consensus 165 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~ 237 (323)
T 3tki_A 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-------YSDWKEKKTYLNPWKKIDSA 237 (323)
T ss_dssp CSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-------HHHHHTTCTTSTTGGGSCHH
T ss_pred CCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-------HHHHhcccccCCccccCCHH
Confidence 45679999999999987775 77899999999999999999999753221000 00011111111111233467
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 353 LARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 353 l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
+.+++.+||+.||++|||+.|++++
T Consensus 238 ~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 238 PLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHHHHccCChhhCcCHHHHhhC
Confidence 8899999999999999999999875
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=340.51 Aligned_cols=258 Identities=26% Similarity=0.386 Sum_probs=211.4
Q ss_pred hhhhc-ccccCCCeeEEEEEeC---CCcEEEEEEeccCCc-cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEE
Q 014352 119 QNFTN-ILGQGAFGPVYKATMP---SGGVAAIKVLASDSH-QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYE 193 (426)
Q Consensus 119 ~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 193 (426)
+.+.+ .||+|+||.||+|.+. ++..||+|++..... ...+.+.+|+.++++++||||+++++++ ..+..++|||
T Consensus 11 ~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e 89 (287)
T 1u59_A 11 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVME 89 (287)
T ss_dssp EEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEE
T ss_pred hhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEE
Confidence 34444 8999999999999853 567899999976532 2346789999999999999999999999 5567899999
Q ss_pred ecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC--
Q 014352 194 FMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG-- 271 (426)
Q Consensus 194 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-- 271 (426)
|+++++|.+++......+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 166 (287)
T 1u59_A 90 MAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY 166 (287)
T ss_dssp CCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE
T ss_pred eCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeeccCcce
Confidence 99999999999766677999999999999999999999998 9999999999999999999999999997543222
Q ss_pred --CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHH
Q 014352 272 --RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQ 348 (426)
Q Consensus 272 --~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (426)
......+|+.|+|||.+.+..++.++||||||+++|||++ |..||........... +........+..
T Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~---------i~~~~~~~~~~~ 237 (287)
T 1u59_A 167 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF---------IEQGKRMECPPE 237 (287)
T ss_dssp ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHH---------HHTTCCCCCCTT
T ss_pred eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHH---------HhcCCcCCCCCC
Confidence 1233456889999999998899999999999999999998 9999976433221111 111111122334
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHhhhcc
Q 014352 349 EVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRHLAKQ 389 (426)
Q Consensus 349 ~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~~ 389 (426)
.+..+.+++.+||+.||++|||+.+++++|+.+........
T Consensus 238 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~ 278 (287)
T 1u59_A 238 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 278 (287)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTC
T ss_pred cCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcc
Confidence 45789999999999999999999999999999988776643
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=353.58 Aligned_cols=247 Identities=22% Similarity=0.326 Sum_probs=203.8
Q ss_pred HhhhhcccccCCCeeEEEEEe-CCCcEEEEEEeccCC---ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEE
Q 014352 118 TQNFTNILGQGAFGPVYKATM-PSGGVAAIKVLASDS---HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYE 193 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 193 (426)
.|.+.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 10 ~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 89 (336)
T 3h4j_B 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIE 89 (336)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred CEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEE
Confidence 366778999999999999997 478899999986432 1223578899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCc
Q 014352 194 FMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRN 273 (426)
Q Consensus 194 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 273 (426)
|+ +|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.........
T Consensus 90 ~~-~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~ 164 (336)
T 3h4j_B 90 YA-GGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFL 164 (336)
T ss_dssp CC-CEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTT
T ss_pred CC-CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCCccc
Confidence 99 78999988654 45999999999999999999999998 999999999999999999999999999865555555
Q ss_pred ccCccccCccCccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHH
Q 014352 274 SGLKGTYGYIDPAYISTNKF-TMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRE 352 (426)
Q Consensus 274 ~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (426)
....||+.|+|||.+.+..+ +.++||||||+++|+|++|..||...........+.. . ....+...+..
T Consensus 165 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~---------~-~~~~p~~~s~~ 234 (336)
T 3h4j_B 165 KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNS---------C-VYVMPDFLSPG 234 (336)
T ss_dssp CCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCS---------S-CCCCCTTSCHH
T ss_pred ccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHc---------C-CCCCcccCCHH
Confidence 66789999999999988776 6899999999999999999999975321111000000 0 00112223467
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHHHH
Q 014352 353 LARIGHKCLHKTPRKRPSIGEVTQALL 379 (426)
Q Consensus 353 l~~l~~~cl~~~p~~RPs~~evl~~L~ 379 (426)
+.+++.+||+.||.+|||+.|++++-.
T Consensus 235 ~~~li~~~L~~dP~~Rpt~~eil~hp~ 261 (336)
T 3h4j_B 235 AQSLIRRMIVADPMQRITIQEIRRDPW 261 (336)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHTTCHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHhChh
Confidence 899999999999999999999998754
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-45 Score=346.04 Aligned_cols=244 Identities=24% Similarity=0.362 Sum_probs=204.3
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC---ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEE
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS---HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYE 193 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 193 (426)
.|.+.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 7 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e 86 (318)
T 1fot_A 7 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD 86 (318)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEe
Confidence 3667789999999999999976 78899999986542 2234578899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCc
Q 014352 194 FMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRN 273 (426)
Q Consensus 194 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 273 (426)
|+++|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++... ...
T Consensus 87 ~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~--~~~ 160 (318)
T 1fot_A 87 YIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVP--DVT 160 (318)
T ss_dssp CCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECS--SCB
T ss_pred CCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecC--Ccc
Confidence 99999999999654 45899999999999999999999998 9999999999999999999999999997542 233
Q ss_pred ccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHH
Q 014352 274 SGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVREL 353 (426)
Q Consensus 274 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 353 (426)
....||+.|+|||++.+..++.++||||||+++|||++|..||...........+. .... ..+...+..+
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~--------~~~~--~~p~~~~~~~ 230 (318)
T 1fot_A 161 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL--------NAEL--RFPPFFNEDV 230 (318)
T ss_dssp CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--------HCCC--CCCTTSCHHH
T ss_pred ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--------hCCC--CCCCCCCHHH
Confidence 45679999999999999999999999999999999999999997643322222111 1111 1122334678
Q ss_pred HHHHHHcccCCCCCCC-----CHHHHHHH
Q 014352 354 ARIGHKCLHKTPRKRP-----SIGEVTQA 377 (426)
Q Consensus 354 ~~l~~~cl~~~p~~RP-----s~~evl~~ 377 (426)
.+++.+||+.||++|| ++.+++++
T Consensus 231 ~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 231 KDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp HHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 9999999999999999 88888865
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=350.11 Aligned_cols=255 Identities=24% Similarity=0.405 Sum_probs=205.3
Q ss_pred HHHHhhhhcccccCCCeeEEEEEeC-CC-------cEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCC
Q 014352 115 QKATQNFTNILGQGAFGPVYKATMP-SG-------GVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKG 186 (426)
Q Consensus 115 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 186 (426)
....|.+.+.||+|+||.||+|... ++ ..||+|.+........+.+.+|+.++++++||||+++++++.+.+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD 85 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence 3445777889999999999999865 33 469999997665556678999999999999999999999999999
Q ss_pred eEEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCc--------EEE
Q 014352 187 KYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMR--------AKV 258 (426)
Q Consensus 187 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~--------~kl 258 (426)
..++||||+++|+|.+++......+++..++.++.|++.||.|||+++ |+||||||+|||++.++. +||
T Consensus 86 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 86 ENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred CCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceeee
Confidence 999999999999999999777666999999999999999999999999 999999999999998887 999
Q ss_pred eeecCccccccCCCcccCccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCC-CCCCchHHHHHHhhccccchhhh
Q 014352 259 ADFGLSKEEVFDGRNSGLKGTYGYIDPAYIST-NKFTMKSDIFSFGVIIFELITAI-HPHQNLMEYVNLASMSQDGVDEI 336 (426)
Q Consensus 259 ~Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~ 336 (426)
+|||++.... ......||+.|+|||.+.+ ..++.++||||||+++|||++|. +||............
T Consensus 163 ~Dfg~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~-------- 231 (289)
T 4fvq_A 163 SDPGISITVL---PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY-------- 231 (289)
T ss_dssp CCCCSCTTTS---CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH--------
T ss_pred ccCccccccc---CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh--------
Confidence 9999986432 2234458899999999987 77899999999999999999955 455432221111100
Q ss_pred hhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHhh
Q 014352 337 LDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRHL 386 (426)
Q Consensus 337 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~ 386 (426)
.. ....+...+..+.+++.+||+.||++|||+.+++++|+.+.....
T Consensus 232 -~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~ 278 (289)
T 4fvq_A 232 -ED--RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL 278 (289)
T ss_dssp -HT--TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC----
T ss_pred -hc--cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence 00 001111123468899999999999999999999999998865443
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=340.52 Aligned_cols=251 Identities=22% Similarity=0.373 Sum_probs=205.6
Q ss_pred HhhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCc--cChHHHHHHHHHHhcCCCCceeeEEeEEEeC--CeEEEEEE
Q 014352 118 TQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSH--QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDK--GKYMLIYE 193 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e 193 (426)
.|.+.+.||+|+||.||+|++. +..+|+|++..... ...+.+.+|+.++++++||||+++++++.+. +..++|||
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 89 (271)
T 3kmu_A 11 QLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITH 89 (271)
T ss_dssp GCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEE
T ss_pred HhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeec
Confidence 4667789999999999999984 78899999976532 2335789999999999999999999999887 77899999
Q ss_pred ecCCCChhHHhhhccC-CCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCC
Q 014352 194 FMSNGSLSNLIYSEER-VLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGR 272 (426)
Q Consensus 194 ~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 272 (426)
|+++|+|.+++..... .+++..++.++.|++.||.|||+++ ++++||||||+||+++.++.++|+|||++... .
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~----~ 164 (271)
T 3kmu_A 90 WMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSF----Q 164 (271)
T ss_dssp CCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT----S
T ss_pred ccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeee----c
Confidence 9999999999976543 5899999999999999999999976 55999999999999999999999999887532 2
Q ss_pred cccCccccCccCccccccCCCCc---chhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHH
Q 014352 273 NSGLKGTYGYIDPAYISTNKFTM---KSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQE 349 (426)
Q Consensus 273 ~~~~~gt~~y~aPE~~~~~~~~~---~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (426)
.....||+.|+|||.+.+..++. ++||||||+++|||++|..||............ .........+...
T Consensus 165 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~--------~~~~~~~~~~~~~ 236 (271)
T 3kmu_A 165 SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKV--------ALEGLRPTIPPGI 236 (271)
T ss_dssp CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHH--------HHSCCCCCCCTTC
T ss_pred ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHH--------HhcCCCCCCCCCC
Confidence 23456899999999998765544 899999999999999999999764433221111 1111111222334
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 014352 350 VRELARIGHKCLHKTPRKRPSIGEVTQALLKIK 382 (426)
Q Consensus 350 ~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 382 (426)
+..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 237 ~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 237 SPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 567999999999999999999999999999875
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=374.59 Aligned_cols=253 Identities=26% Similarity=0.391 Sum_probs=206.4
Q ss_pred ccccCCCeeEEEEEeC---CCcEEEEEEeccCCc-cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCCCC
Q 014352 124 ILGQGAFGPVYKATMP---SGGVAAIKVLASDSH-QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGS 199 (426)
Q Consensus 124 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 199 (426)
.||+|+||.||+|.+. ++..||||+++.... ...+.|.+|+++|++++||||+++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 6999999999999864 456799999976532 345789999999999999999999999976 56899999999999
Q ss_pred hhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCC----ccc
Q 014352 200 LSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGR----NSG 275 (426)
Q Consensus 200 L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~----~~~ 275 (426)
|.+++......+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++....... ...
T Consensus 422 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 498 (613)
T 2ozo_A 422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 498 (613)
T ss_dssp HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----------
T ss_pred HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccC
Confidence 99999776777999999999999999999999998 99999999999999999999999999985432211 122
Q ss_pred CccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHH
Q 014352 276 LKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELA 354 (426)
Q Consensus 276 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 354 (426)
..+++.|+|||++.+..++.++|||||||++|||++ |..||......... ..+........+...+..+.
T Consensus 499 ~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~---------~~i~~~~~~~~p~~~~~~l~ 569 (613)
T 2ozo_A 499 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM---------AFIEQGKRMECPPECPPELY 569 (613)
T ss_dssp ---CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHH---------HHHHTTCCCCCCTTCCHHHH
T ss_pred CCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH---------HHHHcCCCCCCCCcCCHHHH
Confidence 345689999999999999999999999999999998 99999764332211 11222222233344557899
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHHHHHHHHhhhcc
Q 014352 355 RIGHKCLHKTPRKRPSIGEVTQALLKIKQRHLAKQ 389 (426)
Q Consensus 355 ~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~~ 389 (426)
+++.+||+.||++|||+.++++.|+.+........
T Consensus 570 ~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~ 604 (613)
T 2ozo_A 570 ALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 604 (613)
T ss_dssp HHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSC
T ss_pred HHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcccc
Confidence 99999999999999999999999999876654433
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=348.27 Aligned_cols=259 Identities=26% Similarity=0.436 Sum_probs=206.2
Q ss_pred HHhhhhcccccCCCeeEEEEEeCCC-----cEEEEEEeccCCc-cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEE
Q 014352 117 ATQNFTNILGQGAFGPVYKATMPSG-----GVAAIKVLASDSH-QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYML 190 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 190 (426)
..+.+.+.||+|+||.||+|.+... ..||+|.+..... .....+.+|+.++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 3455678999999999999986432 3599999976532 233568899999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC
Q 014352 191 IYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD 270 (426)
Q Consensus 191 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 270 (426)
||||+++|+|.+++......+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 124 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 200 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 200 (333)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence 99999999999999776677999999999999999999999998 999999999999999999999999999754322
Q ss_pred C----CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccC
Q 014352 271 G----RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGAC 345 (426)
Q Consensus 271 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (426)
. ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||...........+ ........
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~---------~~~~~~~~ 271 (333)
T 1mqb_A 201 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI---------NDGFRLPT 271 (333)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH---------HTTCCCCC
T ss_pred cccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHH---------HCCCcCCC
Confidence 1 1123346788999999999999999999999999999999 99999754332221111 11111122
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHhhh
Q 014352 346 NIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRHLA 387 (426)
Q Consensus 346 ~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~~ 387 (426)
+...+..+.+++.+||+.||++||++.++++.|+.+......
T Consensus 272 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~ 313 (333)
T 1mqb_A 272 PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 313 (333)
T ss_dssp CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchh
Confidence 233456799999999999999999999999999998865544
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=343.77 Aligned_cols=255 Identities=24% Similarity=0.318 Sum_probs=199.9
Q ss_pred hhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCcc--ChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecC
Q 014352 119 QNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQ--GEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMS 196 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 196 (426)
|.+.+.||+|+||+||+|...+++.+|+|++...... ..+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (288)
T 1ob3_A 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD 83 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred chhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecC
Confidence 5667899999999999999988999999998654322 23678899999999999999999999999999999999997
Q ss_pred CCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC-CCccc
Q 014352 197 NGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD-GRNSG 275 (426)
Q Consensus 197 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-~~~~~ 275 (426)
+ +|.+++......+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..... .....
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 159 (288)
T 1ob3_A 84 Q-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH 159 (288)
T ss_dssp E-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred C-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccccccc
Confidence 5 999998766677999999999999999999999998 999999999999999999999999998754322 22344
Q ss_pred CccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccc-------cchhh-----hhhhhhc
Q 014352 276 LKGTYGYIDPAYIST-NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQ-------DGVDE-----ILDKQLV 342 (426)
Q Consensus 276 ~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~-------~~~~~-----~~~~~~~ 342 (426)
..||+.|+|||.+.+ ..++.++||||||+++|||++|..||........+..+.. ..... ..++...
T Consensus 160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T 1ob3_A 160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239 (288)
T ss_dssp --CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCC
T ss_pred ccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccc
Confidence 578999999999976 4589999999999999999999999976543322211100 00000 0000000
Q ss_pred -------ccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 343 -------GACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 343 -------~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
.......+..+.+++.+||+.||++|||+.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp CCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00111234678899999999999999999999864
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=348.66 Aligned_cols=247 Identities=23% Similarity=0.370 Sum_probs=197.0
Q ss_pred HHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc-cChHHHHHHHHHHhcCCCCceeeEEeEEEeCC--------
Q 014352 117 ATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH-QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKG-------- 186 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-------- 186 (426)
..|.+.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 45677889999999999999986 788999999975432 23467999999999999999999999986643
Q ss_pred -------------------------------------------------eEEEEEEecCCCChhHHhhhcc--CCCCHHH
Q 014352 187 -------------------------------------------------KYMLIYEFMSNGSLSNLIYSEE--RVLNWEE 215 (426)
Q Consensus 187 -------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~--~~l~~~~ 215 (426)
..++||||+++|+|.+++.... ...++..
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 2799999999999999996543 3456778
Q ss_pred HHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC-------------CCcccCccccCc
Q 014352 216 RLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD-------------GRNSGLKGTYGY 282 (426)
Q Consensus 216 ~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-------------~~~~~~~gt~~y 282 (426)
++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..... .......||+.|
T Consensus 166 ~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred HHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 8999999999999999998 999999999999999999999999999754332 122345799999
Q ss_pred cCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHHHHHccc
Q 014352 283 IDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLH 362 (426)
Q Consensus 283 ~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~ 362 (426)
+|||.+.+..++.++||||||+++|||++|..|+........ ........ .........+.+++.+||+
T Consensus 243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~~~~--~~~~~~~~---------~~~~~~~~~~~~li~~~l~ 311 (332)
T 3qd2_B 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIIT--DVRNLKFP---------LLFTQKYPQEHMMVQDMLS 311 (332)
T ss_dssp SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHHHHH--HHHTTCCC---------HHHHHHCHHHHHHHHHHHC
T ss_pred cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHHHHH--HhhccCCC---------cccccCChhHHHHHHHHcc
Confidence 999999999999999999999999999999877543221111 00000000 0112234567899999999
Q ss_pred CCCCCCCCHHHHHHH
Q 014352 363 KTPRKRPSIGEVTQA 377 (426)
Q Consensus 363 ~~p~~RPs~~evl~~ 377 (426)
.||++|||+.+++++
T Consensus 312 ~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 312 PSPTERPEATDIIEN 326 (332)
T ss_dssp SSGGGSCCHHHHHHS
T ss_pred CCCCcCCCHHHHhhc
Confidence 999999999999874
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=354.41 Aligned_cols=246 Identities=22% Similarity=0.349 Sum_probs=202.6
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC---ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEE
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS---HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYE 193 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 193 (426)
.|.+.+.||+|+||.||++... ++..||+|++.... ....+.+.+|+.+|++++||||+++++++.+.+..++|||
T Consensus 16 ~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e 95 (384)
T 4fr4_A 16 HFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVD 95 (384)
T ss_dssp GEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEe
Confidence 4677889999999999999976 67899999986432 2334678899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCc
Q 014352 194 FMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRN 273 (426)
Q Consensus 194 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 273 (426)
|+++|+|..++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 96 ~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~ 171 (384)
T 4fr4_A 96 LLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI 171 (384)
T ss_dssp CCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTCCB
T ss_pred cCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCCCce
Confidence 9999999999964 345999999999999999999999999 999999999999999999999999999865555555
Q ss_pred ccCccccCccCcccccc---CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhh--hhcccCCHH
Q 014352 274 SGLKGTYGYIDPAYIST---NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDK--QLVGACNIQ 348 (426)
Q Consensus 274 ~~~~gt~~y~aPE~~~~---~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 348 (426)
....||+.|+|||++.+ ..++.++|||||||++|||++|..||...... ........ ......+..
T Consensus 172 ~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~---------~~~~~~~~~~~~~~~~p~~ 242 (384)
T 4fr4_A 172 TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSST---------SSKEIVHTFETTVVTYPSA 242 (384)
T ss_dssp CCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTS---------CHHHHHHHHHHCCCCCCTT
T ss_pred eccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCc---------cHHHHHHHHhhcccCCCCc
Confidence 67789999999999964 45899999999999999999999999642111 00011000 001112233
Q ss_pred HHHHHHHHHHHcccCCCCCCCC-HHHHHH
Q 014352 349 EVRELARIGHKCLHKTPRKRPS-IGEVTQ 376 (426)
Q Consensus 349 ~~~~l~~l~~~cl~~~p~~RPs-~~evl~ 376 (426)
.+..+.+++.+||+.||.+||+ +.++++
T Consensus 243 ~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 243 WSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred CCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 4568999999999999999998 666664
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=348.61 Aligned_cols=252 Identities=25% Similarity=0.417 Sum_probs=196.2
Q ss_pred HHhhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhc--CCCCceeeEEeEEEeC----CeEEE
Q 014352 117 ATQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGR--LHHRNLVNLIGYCVDK----GKYML 190 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~----~~~~l 190 (426)
..|.+.+.||+|+||+||+|++ +++.||||++... ....+..|.+++.. ++||||+++++++... ...++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l 83 (301)
T 3q4u_A 8 RDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL 83 (301)
T ss_dssp GGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred CcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence 3466788999999999999998 6888999998643 34556667777666 7999999999987653 45899
Q ss_pred EEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHH--------cCCCCCeeecCCCCCCEEecCCCcEEEeeec
Q 014352 191 IYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLH--------EGAVPPVIHRDLKSANILLDHFMRAKVADFG 262 (426)
Q Consensus 191 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 262 (426)
||||+++|+|.+++.. ..+++..++.++.|++.||.||| +.+ |+||||||+|||++.++.+||+|||
T Consensus 84 v~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg 158 (301)
T 3q4u_A 84 ITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIADLG 158 (301)
T ss_dssp EECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECCCT
T ss_pred ehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEeeCC
Confidence 9999999999999943 45899999999999999999999 777 9999999999999999999999999
Q ss_pred CccccccCCC-----cccCccccCccCccccccC------CCCcchhhHHHHHHHHHHHhC----------CCCCCchHH
Q 014352 263 LSKEEVFDGR-----NSGLKGTYGYIDPAYISTN------KFTMKSDIFSFGVIIFELITA----------IHPHQNLME 321 (426)
Q Consensus 263 l~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~S~Gvvl~el~tg----------~~p~~~~~~ 321 (426)
+++....... .....||+.|+|||.+.+. .++.++||||||+++|||++| ..||.....
T Consensus 159 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~ 238 (301)
T 3q4u_A 159 LAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP 238 (301)
T ss_dssp TCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCC
Confidence 9975332221 2334799999999999876 455799999999999999999 777754211
Q ss_pred H----HHHhh-ccccchhhhhhhhhc-ccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 014352 322 Y----VNLAS-MSQDGVDEILDKQLV-GACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKI 381 (426)
Q Consensus 322 ~----~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 381 (426)
. ..... ...... .+... .......+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 239 NDPSFEDMRKVVCVDQQ----RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SSCCHHHHHHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCcchhhhhHHHhccCC----CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 0 00000 000000 00000 011234567899999999999999999999999999876
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=345.86 Aligned_cols=256 Identities=25% Similarity=0.329 Sum_probs=191.2
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc-cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEec
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH-QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 195 (426)
.|.+.+.||+|+||.||+|... ++..||+|++..... ...+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 85 (317)
T 2pmi_A 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFM 85 (317)
T ss_dssp -------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECC
T ss_pred ceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEec
Confidence 3566778999999999999875 688999999875532 23467889999999999999999999999999999999999
Q ss_pred CCCChhHHhhhcc-----CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC
Q 014352 196 SNGSLSNLIYSEE-----RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD 270 (426)
Q Consensus 196 ~~gsL~~~l~~~~-----~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 270 (426)
+ |+|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 86 ~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 161 (317)
T 2pmi_A 86 D-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP 161 (317)
T ss_dssp C-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred C-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence 7 59999886532 45899999999999999999999998 999999999999999999999999999754322
Q ss_pred -CCcccCccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccc------cc-hhhh-----
Q 014352 271 -GRNSGLKGTYGYIDPAYIST-NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQ------DG-VDEI----- 336 (426)
Q Consensus 271 -~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~------~~-~~~~----- 336 (426)
.......||+.|+|||.+.+ ..++.++|||||||++|||++|..||........+..+.. .. ....
T Consensus 162 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (317)
T 2pmi_A 162 VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPK 241 (317)
T ss_dssp CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTT
T ss_pred cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhh
Confidence 23345678999999999976 4689999999999999999999999976543322211100 00 0000
Q ss_pred ------------hhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 337 ------------LDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 337 ------------~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
+...+........+..+.+++.+||+.||++|||+.+++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 242 YNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp CCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 00000001111234579999999999999999999999875
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-45 Score=342.54 Aligned_cols=247 Identities=23% Similarity=0.343 Sum_probs=195.6
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCcc--------------------------ChHHHHHHHHHHhcC
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQ--------------------------GEKEFQTEVSLLGRL 170 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------------------------~~~~~~~e~~~l~~l 170 (426)
.|.+.+.||+|+||.||+|... +++.||+|++...... ..+.+.+|+++++++
T Consensus 14 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 93 (298)
T 2zv2_A 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKL 93 (298)
T ss_dssp TEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTC
T ss_pred ceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhC
Confidence 3667789999999999999875 6789999998654311 124688999999999
Q ss_pred CCCceeeEEeEEEe--CCeEEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCE
Q 014352 171 HHRNLVNLIGYCVD--KGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANI 248 (426)
Q Consensus 171 ~h~niv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Ni 248 (426)
+||||+++++++.+ .+..++||||+++++|.+++. ...+++..+..++.|++.||.|||+++ |+||||||+||
T Consensus 94 ~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Ni 168 (298)
T 2zv2_A 94 DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNL 168 (298)
T ss_dssp CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGE
T ss_pred CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHE
Confidence 99999999999987 568999999999999988763 356999999999999999999999998 99999999999
Q ss_pred EecCCCcEEEeeecCccccccCC-CcccCccccCccCccccccCC---CCcchhhHHHHHHHHHHHhCCCCCCchHHHHH
Q 014352 249 LLDHFMRAKVADFGLSKEEVFDG-RNSGLKGTYGYIDPAYISTNK---FTMKSDIFSFGVIIFELITAIHPHQNLMEYVN 324 (426)
Q Consensus 249 ll~~~~~~kl~Dfgl~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~ 324 (426)
|++.++.+||+|||+++...... ......||+.|+|||.+.+.. ++.++||||||+++|||++|..||........
T Consensus 169 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 248 (298)
T 2zv2_A 169 LVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCL 248 (298)
T ss_dssp EECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred EECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHH
Confidence 99999999999999997543322 234567999999999997765 37889999999999999999999976432211
Q ss_pred HhhccccchhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 325 LASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
...+. ............+..+.+++.+||+.||++|||+.+++++
T Consensus 249 ~~~~~--------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 249 HSKIK--------SQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp HHHHH--------HCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred HHHHh--------cccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 11110 0111111112344679999999999999999999999865
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-45 Score=339.52 Aligned_cols=255 Identities=24% Similarity=0.362 Sum_probs=205.3
Q ss_pred HhhhhcccccCCCeeEEEEEeCC----CcEEEEEEeccCC-ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEE
Q 014352 118 TQNFTNILGQGAFGPVYKATMPS----GGVAAIKVLASDS-HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIY 192 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 192 (426)
.+.+.+.||+|+||.||+|.+.+ +..||+|.+.... ....+.+.+|+.++++++||||+++++++.++ ..++||
T Consensus 13 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v~ 91 (281)
T 3cc6_A 13 DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWIIM 91 (281)
T ss_dssp GEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEEEE
T ss_pred ceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEEEE
Confidence 46677899999999999998643 2369999987653 23346789999999999999999999998654 568999
Q ss_pred EecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC-
Q 014352 193 EFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG- 271 (426)
Q Consensus 193 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~- 271 (426)
||+++++|.+++......+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 92 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 168 (281)
T 3cc6_A 92 ELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY 168 (281)
T ss_dssp ECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC-----
T ss_pred ecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccccccc
Confidence 999999999999777777999999999999999999999998 9999999999999999999999999987543222
Q ss_pred -CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHH
Q 014352 272 -RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQE 349 (426)
Q Consensus 272 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (426)
......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......... ..+........+...
T Consensus 169 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~---------~~~~~~~~~~~~~~~ 239 (281)
T 3cc6_A 169 YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI---------GVLEKGDRLPKPDLC 239 (281)
T ss_dssp ----CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHH---------HHHHHTCCCCCCTTC
T ss_pred cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHH---------HHHhcCCCCCCCCCC
Confidence 1234457889999999999999999999999999999998 99999643221111 111111111122234
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHh
Q 014352 350 VRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRH 385 (426)
Q Consensus 350 ~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~ 385 (426)
+..+.+++.+||+.||++|||+.+++++|+.+.+..
T Consensus 240 ~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 275 (281)
T 3cc6_A 240 PPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME 275 (281)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence 467999999999999999999999999999987654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=335.20 Aligned_cols=252 Identities=21% Similarity=0.301 Sum_probs=208.2
Q ss_pred HHHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEe
Q 014352 116 KATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEF 194 (426)
Q Consensus 116 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 194 (426)
...|.+.+.||+|+||.||+|... ++..+|+|.+........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 345778899999999999999976 5678999999776556677899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEe---cCCCcEEEeeecCccccccCC
Q 014352 195 MSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILL---DHFMRAKVADFGLSKEEVFDG 271 (426)
Q Consensus 195 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfgl~~~~~~~~ 271 (426)
+++++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+||++ +.++.+||+|||++.......
T Consensus 88 ~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~ 163 (277)
T 3f3z_A 88 CTGGELFERVVHK-RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163 (277)
T ss_dssp CCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence 9999999988654 45899999999999999999999999 9999999999999 788999999999998655455
Q ss_pred CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHH
Q 014352 272 RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVR 351 (426)
Q Consensus 272 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (426)
......||+.|+|||.+.+. ++.++||||||+++|||++|..||...........+...... ..... ....+.
T Consensus 164 ~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~-----~~~~~~ 236 (277)
T 3f3z_A 164 MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFT-FPEKD-----WLNVSP 236 (277)
T ss_dssp CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-CCHHH-----HTTSCH
T ss_pred chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC-CCchh-----hhcCCH
Confidence 55567799999999998754 899999999999999999999999764433222211111000 00000 002346
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014352 352 ELARIGHKCLHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 352 ~l~~l~~~cl~~~p~~RPs~~evl~~L 378 (426)
.+.+++.+||+.||++|||+.+++++-
T Consensus 237 ~~~~li~~~l~~dp~~R~s~~~~l~h~ 263 (277)
T 3f3z_A 237 QAESLIRRLLTKSPKQRITSLQALEHE 263 (277)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHTTSH
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 789999999999999999999998753
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=347.95 Aligned_cols=259 Identities=25% Similarity=0.390 Sum_probs=196.1
Q ss_pred HHHhhhhcccccCCCeeEEEEEeCCCc----EEEEEEeccCC--ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeE-
Q 014352 116 KATQNFTNILGQGAFGPVYKATMPSGG----VAAIKVLASDS--HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKY- 188 (426)
Q Consensus 116 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~----~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~- 188 (426)
...|.+.+.||+|+||.||+|.+..+. .||+|++.... ....+.+.+|+.++++++||||+++++++...+..
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 345777889999999999999875332 79999987652 23346799999999999999999999999877654
Q ss_pred -----EEEEEecCCCChhHHhhhcc-----CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEE
Q 014352 189 -----MLIYEFMSNGSLSNLIYSEE-----RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKV 258 (426)
Q Consensus 189 -----~lv~e~~~~gsL~~~l~~~~-----~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 258 (426)
++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~kl 178 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCV 178 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEE
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEEE
Confidence 99999999999999985432 25899999999999999999999998 999999999999999999999
Q ss_pred eeecCccccccCC---CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchh
Q 014352 259 ADFGLSKEEVFDG---RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVD 334 (426)
Q Consensus 259 ~Dfgl~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 334 (426)
+|||+++...... ......+++.|+|||.+.+..++.++||||||+++|||++ |..||...........
T Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~------- 251 (323)
T 3qup_A 179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNY------- 251 (323)
T ss_dssp CCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH-------
T ss_pred eeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHH-------
Confidence 9999997543222 1223456788999999999999999999999999999999 9999976332211111
Q ss_pred hhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHhh
Q 014352 335 EILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRHL 386 (426)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~ 386 (426)
+........+...+..+.+++.+||+.||++|||+.++++.|+.+.....
T Consensus 252 --~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~ 301 (323)
T 3qup_A 252 --LIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301 (323)
T ss_dssp --HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred --HhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence 11111112233445679999999999999999999999999999976543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=349.86 Aligned_cols=249 Identities=26% Similarity=0.363 Sum_probs=204.8
Q ss_pred HHhhhhcccccCCCeeEEEEEe-CCCcEEEEEEeccCCccC---hHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEE
Q 014352 117 ATQNFTNILGQGAFGPVYKATM-PSGGVAAIKVLASDSHQG---EKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIY 192 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 192 (426)
..|...+.||+|+||.||+|+. .+++.||||++....... .+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4466778999999999999996 478899999997543222 246889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCC
Q 014352 193 EFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGR 272 (426)
Q Consensus 193 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 272 (426)
||+. |+|.+++......+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.... .
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~---~ 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA---P 206 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSS---S
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecC---C
Confidence 9997 6898888766677999999999999999999999998 9999999999999999999999999997543 2
Q ss_pred cccCccccCccCccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHH
Q 014352 273 NSGLKGTYGYIDPAYIS---TNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQE 349 (426)
Q Consensus 273 ~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (426)
.....||+.|+|||++. ...++.++||||||+++|||++|..||.+......+..+.... .........
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~ 278 (348)
T 1u5q_A 207 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE--------SPALQSGHW 278 (348)
T ss_dssp BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC--------CCCCCCTTS
T ss_pred CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC--------CCCCCCCCC
Confidence 34567999999999984 5678999999999999999999999997644332222111111 111112223
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 014352 350 VRELARIGHKCLHKTPRKRPSIGEVTQALLK 380 (426)
Q Consensus 350 ~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 380 (426)
+..+.+++.+||+.||++|||+.+++++..-
T Consensus 279 ~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~ 309 (348)
T 1u5q_A 279 SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 309 (348)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHTTCHHH
T ss_pred CHHHHHHHHHHcccChhhCcCHHHHhhChhh
Confidence 4678899999999999999999999987553
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=344.68 Aligned_cols=263 Identities=26% Similarity=0.399 Sum_probs=211.4
Q ss_pred hhhcccccCCCeeEEEEEeC-----CCcEEEEEEeccCCc-cChHHHHHHHHHHhcCCCCceeeEEeEEEeC--CeEEEE
Q 014352 120 NFTNILGQGAFGPVYKATMP-----SGGVAAIKVLASDSH-QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDK--GKYMLI 191 (426)
Q Consensus 120 ~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv 191 (426)
.+.+.||+|+||+||++.+. +++.||+|++..... ...+.+.+|++++++++||||+++++++.+. ...++|
T Consensus 34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 113 (318)
T 3lxp_A 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV 113 (318)
T ss_dssp EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence 67789999999999998653 678899999976532 2345789999999999999999999999884 678999
Q ss_pred EEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC
Q 014352 192 YEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG 271 (426)
Q Consensus 192 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 271 (426)
|||+++|+|.+++... .+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 114 ~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 188 (318)
T 3lxp_A 114 MEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 188 (318)
T ss_dssp ECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECCTTC
T ss_pred EecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccccccccc
Confidence 9999999999999543 4899999999999999999999999 9999999999999999999999999997543322
Q ss_pred ----CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHH-Hhhccc-----cchhhhhhhhh
Q 014352 272 ----RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVN-LASMSQ-----DGVDEILDKQL 341 (426)
Q Consensus 272 ----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~-~~~~~~-----~~~~~~~~~~~ 341 (426)
......+|..|+|||.+.+..++.++||||||+++|||++|..||........ ...... ......+....
T Consensus 189 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (318)
T 3lxp_A 189 EYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGE 268 (318)
T ss_dssp SEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTC
T ss_pred cccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhccc
Confidence 12345678889999999999999999999999999999999999976443211 111111 11122222222
Q ss_pred cccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHhhh
Q 014352 342 VGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRHLA 387 (426)
Q Consensus 342 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~~ 387 (426)
....+...+..+.+++.+||+.||++|||+.++++.|+.+.+....
T Consensus 269 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~ 314 (318)
T 3lxp_A 269 RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG 314 (318)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC
T ss_pred CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhcc
Confidence 2333444567899999999999999999999999999999876544
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=356.21 Aligned_cols=256 Identities=28% Similarity=0.466 Sum_probs=197.8
Q ss_pred hhhhcccccCCCeeEEEEEeC--CC--cEEEEEEeccCCc-cChHHHHHHHHHHhcCCCCceeeEEeEEEe-CCeEEEEE
Q 014352 119 QNFTNILGQGAFGPVYKATMP--SG--GVAAIKVLASDSH-QGEKEFQTEVSLLGRLHHRNLVNLIGYCVD-KGKYMLIY 192 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~ 192 (426)
+.+.+.||+|+||.||+|.+. ++ ..||+|.+..... ...+.|.+|+.++++++||||+++++++.. .+..++||
T Consensus 91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~ 170 (373)
T 3c1x_A 91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 170 (373)
T ss_dssp EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence 455678999999999999864 22 3689998865432 334679999999999999999999998765 45789999
Q ss_pred EecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC-
Q 014352 193 EFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG- 271 (426)
Q Consensus 193 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~- 271 (426)
||+++|+|.+++......+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 171 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 247 (373)
T 3c1x_A 171 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 247 (373)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred ECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccccccc
Confidence 999999999999777677899999999999999999999998 9999999999999999999999999997532221
Q ss_pred ----CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCC
Q 014352 272 ----RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACN 346 (426)
Q Consensus 272 ----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (426)
......+|+.|+|||.+.+..++.++||||||+++|||++ |.+||........ ...+........+
T Consensus 248 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~---------~~~~~~~~~~~~p 318 (373)
T 3c1x_A 248 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---------TVYLLQGRRLLQP 318 (373)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH---------HHHHHTTCCCCCC
T ss_pred ccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH---------HHHHHcCCCCCCC
Confidence 1233457789999999999999999999999999999999 6777764321111 1111111111122
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHhh
Q 014352 347 IQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRHL 386 (426)
Q Consensus 347 ~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~ 386 (426)
...+..+.+++.+||+.||++|||+.++++.|+.+.....
T Consensus 319 ~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 319 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 2344679999999999999999999999999999987554
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=353.42 Aligned_cols=247 Identities=27% Similarity=0.404 Sum_probs=203.8
Q ss_pred HHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC---ccChHHHHHHHHHHhcC-CCCceeeEEeEEEeCCeEEEE
Q 014352 117 ATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS---HQGEKEFQTEVSLLGRL-HHRNLVNLIGYCVDKGKYMLI 191 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 191 (426)
..|.+.+.||+|+||.||+|+.. +++.||+|++.... ....+.+..|..++..+ +||||+++++++.+.+.+|+|
T Consensus 17 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv 96 (345)
T 1xjd_A 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 96 (345)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEE
Confidence 34667789999999999999986 68899999997542 23345678899999876 899999999999999999999
Q ss_pred EEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccccc-C
Q 014352 192 YEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF-D 270 (426)
Q Consensus 192 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~-~ 270 (426)
|||+++|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.... .
T Consensus 97 ~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 172 (345)
T 1xjd_A 97 MEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 172 (345)
T ss_dssp EECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhcccCC
Confidence 9999999999999654 45899999999999999999999998 99999999999999999999999999975332 2
Q ss_pred CCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHH
Q 014352 271 GRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEV 350 (426)
Q Consensus 271 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (426)
.......||+.|+|||++.+..++.++|||||||++|||++|..||...........+.... ...+...+
T Consensus 173 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~----------~~~p~~~s 242 (345)
T 1xjd_A 173 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN----------PFYPRWLE 242 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC----------CCCCTTSC
T ss_pred CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCC----------CCCCcccC
Confidence 33456789999999999999999999999999999999999999997643332222111110 01122234
Q ss_pred HHHHHHHHHcccCCCCCCCCHH-HHHHH
Q 014352 351 RELARIGHKCLHKTPRKRPSIG-EVTQA 377 (426)
Q Consensus 351 ~~l~~l~~~cl~~~p~~RPs~~-evl~~ 377 (426)
..+.+++.+||+.||++||++. +++++
T Consensus 243 ~~~~~li~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 243 KEAKDLLVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp HHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred HHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence 6789999999999999999997 66643
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-45 Score=347.14 Aligned_cols=258 Identities=26% Similarity=0.476 Sum_probs=208.4
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcE--EEEEEeccCC-ccChHHHHHHHHHHhcC-CCCceeeEEeEEEeCCeEEEEE
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGV--AAIKVLASDS-HQGEKEFQTEVSLLGRL-HHRNLVNLIGYCVDKGKYMLIY 192 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~--vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 192 (426)
.|.+.+.||+|+||.||+|+.. ++.. +|+|.+.... ....+.+.+|+.+++++ +||||+++++++.+.+..++||
T Consensus 26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 105 (327)
T 1fvr_A 26 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI 105 (327)
T ss_dssp GCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEE
Confidence 4667889999999999999875 5554 4899887542 23346789999999999 8999999999999999999999
Q ss_pred EecCCCChhHHhhhcc---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEE
Q 014352 193 EFMSNGSLSNLIYSEE---------------RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAK 257 (426)
Q Consensus 193 e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 257 (426)
||+++|+|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+|
T Consensus 106 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~k 182 (327)
T 1fvr_A 106 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAK 182 (327)
T ss_dssp CCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEE
T ss_pred ecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeEE
Confidence 9999999999996543 46899999999999999999999998 99999999999999999999
Q ss_pred EeeecCccccccCCCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhh
Q 014352 258 VADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEI 336 (426)
Q Consensus 258 l~Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 336 (426)
|+|||+++............+++.|+|||.+.+..++.++||||||+++|||++ |..||...........+..
T Consensus 183 L~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~------ 256 (327)
T 1fvr_A 183 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ------ 256 (327)
T ss_dssp ECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG------
T ss_pred EcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhc------
Confidence 999999875433333444567889999999998889999999999999999998 9999976433222211111
Q ss_pred hhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHhhh
Q 014352 337 LDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRHLA 387 (426)
Q Consensus 337 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~~ 387 (426)
......+...+..+.+++.+||+.||++|||+.+++++|+.+......
T Consensus 257 ---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 304 (327)
T 1fvr_A 257 ---GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 304 (327)
T ss_dssp ---TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred ---CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcC
Confidence 111122233446799999999999999999999999999999876544
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=349.65 Aligned_cols=254 Identities=24% Similarity=0.374 Sum_probs=201.4
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccC---hHHHHHHHHHHhcC-CCCceeeEEeEEEeCCeEEEEE
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQG---EKEFQTEVSLLGRL-HHRNLVNLIGYCVDKGKYMLIY 192 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 192 (426)
.|.+.+.||+|+||.||+++.. +++.||+|++....... .+.+.+|..++.++ +||||+++++++.+.+.+++||
T Consensus 10 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~ 89 (345)
T 3a8x_A 10 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI 89 (345)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred heEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEE
Confidence 3567789999999999999976 67899999997653222 34578899999988 8999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccccc-CC
Q 014352 193 EFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF-DG 271 (426)
Q Consensus 193 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~-~~ 271 (426)
||+++|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.... ..
T Consensus 90 e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~ 165 (345)
T 3a8x_A 90 EYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 165 (345)
T ss_dssp CCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTC
T ss_pred eCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccCCCC
Confidence 999999999999654 45999999999999999999999998 99999999999999999999999999985322 23
Q ss_pred CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccch-hhhhhhhhcccCCHHHH
Q 014352 272 RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGV-DEILDKQLVGACNIQEV 350 (426)
Q Consensus 272 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 350 (426)
......||+.|+|||++.+..++.++|||||||++|||++|..||................. ..+.... ...+...+
T Consensus 166 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~--~~~p~~~s 243 (345)
T 3a8x_A 166 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--IRIPRSLS 243 (345)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC--CCCCTTSC
T ss_pred cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC--CCCCCCCC
Confidence 34567899999999999999999999999999999999999999964211000000000000 0111111 11223345
Q ss_pred HHHHHHHHHcccCCCCCCCCH------HHHHHH
Q 014352 351 RELARIGHKCLHKTPRKRPSI------GEVTQA 377 (426)
Q Consensus 351 ~~l~~l~~~cl~~~p~~RPs~------~evl~~ 377 (426)
..+.+++.+||+.||++||++ .+++++
T Consensus 244 ~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 244 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp HHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred HHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 678999999999999999996 566654
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=337.98 Aligned_cols=252 Identities=26% Similarity=0.418 Sum_probs=210.1
Q ss_pred hHHHHHHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEe------
Q 014352 112 KDIQKATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVD------ 184 (426)
Q Consensus 112 ~~l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------ 184 (426)
.......|.+.+.||+|+||.||+|... +++.||+|.+.... ..+.+|++++++++||||+++++++..
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (284)
T 2a19_B 6 DKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE 81 (284)
T ss_dssp CHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred cchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence 4455667888899999999999999986 78899999987542 467889999999999999999998864
Q ss_pred ----------CCeEEEEEEecCCCChhHHhhhc-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCC
Q 014352 185 ----------KGKYMLIYEFMSNGSLSNLIYSE-ERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHF 253 (426)
Q Consensus 185 ----------~~~~~lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~ 253 (426)
....++||||+++|+|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+||+++.+
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~ 158 (284)
T 2a19_B 82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDT 158 (284)
T ss_dssp -------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEET
T ss_pred cccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCC
Confidence 34589999999999999999654 356999999999999999999999998 9999999999999999
Q ss_pred CcEEEeeecCccccccCCCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccch
Q 014352 254 MRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGV 333 (426)
Q Consensus 254 ~~~kl~Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~ 333 (426)
+.+||+|||++.............||+.|+|||.+.+..++.++||||||+++|||++|..|+........ .
T Consensus 159 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~--~------ 230 (284)
T 2a19_B 159 KQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFT--D------ 230 (284)
T ss_dssp TEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHHHH--H------
T ss_pred CCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHHHH--H------
Confidence 99999999999865544445566799999999999999999999999999999999999998754322111 0
Q ss_pred hhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHH
Q 014352 334 DEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQR 384 (426)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 384 (426)
..... .+...+..+.+++.+||+.||++|||+.+++++|+.+...
T Consensus 231 --~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 231 --LRDGI----ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp --HHTTC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred --hhccc----ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 00111 1112335688999999999999999999999999988654
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=349.08 Aligned_cols=245 Identities=22% Similarity=0.293 Sum_probs=205.0
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC---ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEE
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS---HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYE 193 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 193 (426)
.|.+.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+.+++|||
T Consensus 42 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 121 (350)
T 1rdq_E 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEc
Confidence 3667789999999999999976 78899999986532 2234678899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCc
Q 014352 194 FMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRN 273 (426)
Q Consensus 194 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 273 (426)
|+++|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++... ...
T Consensus 122 ~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~--~~~ 195 (350)
T 1rdq_E 122 YVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT 195 (350)
T ss_dssp CCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECS--SCB
T ss_pred CCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceecc--CCc
Confidence 99999999999654 45899999999999999999999999 9999999999999999999999999998543 233
Q ss_pred ccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHH
Q 014352 274 SGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVREL 353 (426)
Q Consensus 274 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 353 (426)
....||+.|+|||++.+..++.++|||||||++|||++|..||...........+... .. ..+...+..+
T Consensus 196 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--------~~--~~p~~~~~~~ 265 (350)
T 1rdq_E 196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG--------KV--RFPSHFSSDL 265 (350)
T ss_dssp CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--------CC--CCCTTCCHHH
T ss_pred ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcC--------CC--CCCCCCCHHH
Confidence 4567999999999999999999999999999999999999999764333222211111 10 1122344678
Q ss_pred HHHHHHcccCCCCCCCC-----HHHHHHHH
Q 014352 354 ARIGHKCLHKTPRKRPS-----IGEVTQAL 378 (426)
Q Consensus 354 ~~l~~~cl~~~p~~RPs-----~~evl~~L 378 (426)
.+++.+||+.||++||+ +.+++++-
T Consensus 266 ~~li~~lL~~dp~~R~~~~~~~~~ei~~h~ 295 (350)
T 1rdq_E 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHK 295 (350)
T ss_dssp HHHHHHHSCSCTTTCTTSSTTTTHHHHTSG
T ss_pred HHHHHHHhhcCHHhccCCccCCHHHHHhCc
Confidence 99999999999999998 88887653
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=351.24 Aligned_cols=249 Identities=24% Similarity=0.314 Sum_probs=188.6
Q ss_pred HHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEec
Q 014352 117 ATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 195 (426)
..|.+.+.||+|+||.||+|+.. ++..||+|++.... ..+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 53 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 130 (349)
T 2w4o_A 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELV 130 (349)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred CcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeC
Confidence 34667789999999999999986 57889999997543 3457889999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecC---CCcEEEeeecCccccccCCC
Q 014352 196 SNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDH---FMRAKVADFGLSKEEVFDGR 272 (426)
Q Consensus 196 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfgl~~~~~~~~~ 272 (426)
++|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++. ++.+||+|||+++.......
T Consensus 131 ~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~ 206 (349)
T 2w4o_A 131 TGGELFDRIVEK-GYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL 206 (349)
T ss_dssp CSCBHHHHHTTC-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC----------
T ss_pred CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCcccc
Confidence 999999998654 45899999999999999999999998 999999999999975 88999999999986544444
Q ss_pred cccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHH-HhhccccchhhhhhhhhcccCCHHHHH
Q 014352 273 NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVN-LASMSQDGVDEILDKQLVGACNIQEVR 351 (426)
Q Consensus 273 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (426)
.....||+.|+|||++.+..++.++|||||||++|||++|..||........ ...+..... ..........+.
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~------~~~~~~~~~~~~ 280 (349)
T 2w4o_A 207 MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEY------YFISPWWDEVSL 280 (349)
T ss_dssp ------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCC------CCCTTTTTTSCH
T ss_pred cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCC------ccCCchhhhCCH
Confidence 4556799999999999999999999999999999999999999965432211 111100000 000111123456
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 352 ELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 352 ~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
.+.+++.+||+.||++|||+.+++++
T Consensus 281 ~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 281 NAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 78999999999999999999999875
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=338.73 Aligned_cols=250 Identities=25% Similarity=0.343 Sum_probs=198.2
Q ss_pred HHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC-ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEe
Q 014352 117 ATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS-HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEF 194 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 194 (426)
..|.+.+.||+|+||.||++... ++..+|+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 45778899999999999999975 67899999987653 33457899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhc---cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEe---cCCCcEEEeeecCccccc
Q 014352 195 MSNGSLSNLIYSE---ERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILL---DHFMRAKVADFGLSKEEV 268 (426)
Q Consensus 195 ~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfgl~~~~~ 268 (426)
+++|+|.+++... ...+++..+..++.|++.||.|||+++ |+||||||+||++ +.++.+||+|||++....
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999988543 367999999999999999999999998 9999999999999 456789999999998654
Q ss_pred cCCCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHH
Q 014352 269 FDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQ 348 (426)
Q Consensus 269 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (426)
.........||+.|+|||.+. ..++.++||||||+++|||++|..||................ ..... ....
T Consensus 179 ~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~------~~~~~-~~~~ 250 (285)
T 3is5_A 179 SDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKE------PNYAV-ECRP 250 (285)
T ss_dssp --------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC------CCCCC---CC
T ss_pred CcccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCC------ccccc-ccCc
Confidence 444455677999999999986 568999999999999999999999997643222111100000 00000 0011
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 349 EVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 349 ~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
.+..+.+++.+||+.||++|||+.|++++
T Consensus 251 ~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 251 LTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp CCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 34678899999999999999999999864
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=350.47 Aligned_cols=258 Identities=25% Similarity=0.480 Sum_probs=209.0
Q ss_pred HHhhhhcccccCCCeeEEEEEeCC-C-----cEEEEEEeccCCc-cChHHHHHHHHHHhcC-CCCceeeEEeEEEeCCeE
Q 014352 117 ATQNFTNILGQGAFGPVYKATMPS-G-----GVAAIKVLASDSH-QGEKEFQTEVSLLGRL-HHRNLVNLIGYCVDKGKY 188 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 188 (426)
..+.+.+.||+|+||.||+|.... + ..||+|.+..... ...+.+.+|+.+++++ +||||+++++++.+.+..
T Consensus 46 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 125 (333)
T 2i1m_A 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPV 125 (333)
T ss_dssp TSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCce
Confidence 446677899999999999998742 2 3799999976543 2345789999999999 899999999999999999
Q ss_pred EEEEEecCCCChhHHhhhc-------------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCc
Q 014352 189 MLIYEFMSNGSLSNLIYSE-------------ERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMR 255 (426)
Q Consensus 189 ~lv~e~~~~gsL~~~l~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~ 255 (426)
++||||+++|+|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.
T Consensus 126 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~ 202 (333)
T 2i1m_A 126 LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHV 202 (333)
T ss_dssp EEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGGGE
T ss_pred EEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCCCe
Confidence 9999999999999999653 235799999999999999999999998 999999999999999999
Q ss_pred EEEeeecCccccccCCC---cccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhcccc
Q 014352 256 AKVADFGLSKEEVFDGR---NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQD 331 (426)
Q Consensus 256 ~kl~Dfgl~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~ 331 (426)
+||+|||++........ .....+|+.|+|||.+.+..++.++||||||+++|||++ |..||........
T Consensus 203 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~------- 275 (333)
T 2i1m_A 203 AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK------- 275 (333)
T ss_dssp EEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH-------
T ss_pred EEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH-------
Confidence 99999999975433221 233457889999999999999999999999999999998 9999875321111
Q ss_pred chhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHh
Q 014352 332 GVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRH 385 (426)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~ 385 (426)
....+........+...+..+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus 276 -~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 328 (333)
T 2i1m_A 276 -FYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED 328 (333)
T ss_dssp -HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -HHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence 11111222222222233467999999999999999999999999999887654
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=355.51 Aligned_cols=257 Identities=18% Similarity=0.266 Sum_probs=201.5
Q ss_pred HhhhhcccccC--CCeeEEEEEeC-CCcEEEEEEeccCCc--cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEE
Q 014352 118 TQNFTNILGQG--AFGPVYKATMP-SGGVAAIKVLASDSH--QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIY 192 (426)
Q Consensus 118 ~~~~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 192 (426)
+|.+.+.||+| +||.||+|+.. +++.||+|++..... ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 26 ~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 105 (389)
T 3gni_B 26 CYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT 105 (389)
T ss_dssp GEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEE
Confidence 46778899999 99999999986 788999999975432 22356888999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhc-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC-
Q 014352 193 EFMSNGSLSNLIYSE-ERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD- 270 (426)
Q Consensus 193 e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~- 270 (426)
||+++|+|.+++... ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||.+......
T Consensus 106 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~ 182 (389)
T 3gni_B 106 SFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHG 182 (389)
T ss_dssp ECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECEETT
T ss_pred EccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeecccc
Confidence 999999999999654 256999999999999999999999999 999999999999999999999999987643211
Q ss_pred -------CCcccCccccCccCcccccc--CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhh
Q 014352 271 -------GRNSGLKGTYGYIDPAYIST--NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQL 341 (426)
Q Consensus 271 -------~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (426)
.......||+.|+|||++.+ ..++.++|||||||++|||++|..||.+...................+...
T Consensus 183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (389)
T 3gni_B 183 QRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTST 262 (389)
T ss_dssp EECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------------
T ss_pred ccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccc
Confidence 11233478999999999987 679999999999999999999999997533222211111111110000000
Q ss_pred ------------------------------------cccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 342 ------------------------------------VGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 342 ------------------------------------~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
....+...+..+.+|+.+||+.||++|||+.+++++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 263 IPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp -------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 000112234679999999999999999999999976
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=337.13 Aligned_cols=255 Identities=27% Similarity=0.437 Sum_probs=210.1
Q ss_pred HHhhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecC
Q 014352 117 ATQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMS 196 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 196 (426)
.++.+.+.||+|+||.||+|...++..||+|.+.... ...+.+.+|++++++++||||+++++++.+ +..++||||++
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~ 90 (279)
T 1qpc_A 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME 90 (279)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred HhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCC
Confidence 4567788999999999999999888899999987543 346789999999999999999999999864 46899999999
Q ss_pred CCChhHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC--Cc
Q 014352 197 NGSLSNLIYSEE-RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG--RN 273 (426)
Q Consensus 197 ~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~--~~ 273 (426)
+++|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++....... ..
T Consensus 91 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 167 (279)
T 1qpc_A 91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR 167 (279)
T ss_dssp TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECC
T ss_pred CCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcccccc
Confidence 999999996543 36999999999999999999999998 9999999999999999999999999997543222 12
Q ss_pred ccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHH
Q 014352 274 SGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRE 352 (426)
Q Consensus 274 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (426)
....++..|+|||.+.+..++.++||||||+++|||++ |..||...........+ ........+...+..
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~ 238 (279)
T 1qpc_A 168 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPDNCPEE 238 (279)
T ss_dssp TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH---------HTTCCCCCCTTCCHH
T ss_pred cCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHH---------hcccCCCCcccccHH
Confidence 34456789999999998899999999999999999999 99999764332221111 111111122234467
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHh
Q 014352 353 LARIGHKCLHKTPRKRPSIGEVTQALLKIKQRH 385 (426)
Q Consensus 353 l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~ 385 (426)
+.+++.+||+.||++|||+.++++.|+.+....
T Consensus 239 l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 271 (279)
T 1qpc_A 239 LYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (279)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence 999999999999999999999999999987643
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=346.60 Aligned_cols=242 Identities=22% Similarity=0.331 Sum_probs=203.8
Q ss_pred HHHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCcc--------ChHHHHHHHHHHhcCCCCceeeEEeEEEeCC
Q 014352 116 KATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQ--------GEKEFQTEVSLLGRLHHRNLVNLIGYCVDKG 186 (426)
Q Consensus 116 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 186 (426)
...|.+.+.||+|+||.||+|... ++..||+|++...... ....+.+|+.++++++||||+++++++.+.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 456778889999999999999864 7889999999765321 2346778999999999999999999999999
Q ss_pred eEEEEEEecCCC-ChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcc
Q 014352 187 KYMLIYEFMSNG-SLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSK 265 (426)
Q Consensus 187 ~~~lv~e~~~~g-sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 265 (426)
..++||||+.+| +|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 178 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRH-PRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAA 178 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEEEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecccce
Confidence 999999999777 999998544 45999999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCcccCccccCccCccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhccc
Q 014352 266 EEVFDGRNSGLKGTYGYIDPAYISTNKF-TMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGA 344 (426)
Q Consensus 266 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (426)
............||+.|+|||.+.+..+ +.++||||||+++|||++|..||....+... ... .
T Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--------------~~~--~ 242 (335)
T 3dls_A 179 YLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVE--------------AAI--H 242 (335)
T ss_dssp ECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTT--------------TCC--C
T ss_pred ECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHh--------------hcc--C
Confidence 6554444556679999999999988877 7899999999999999999999976322110 000 0
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 345 CNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 345 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
.+...+..+.+++.+||+.||++|||+.+++++
T Consensus 243 ~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 243 PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111234678999999999999999999999986
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=345.26 Aligned_cols=247 Identities=25% Similarity=0.384 Sum_probs=195.4
Q ss_pred HHhhhhcccccCCCeeEEEEEe----CCCcEEEEEEeccCC----ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeE
Q 014352 117 ATQNFTNILGQGAFGPVYKATM----PSGGVAAIKVLASDS----HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKY 188 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 188 (426)
..|.+.+.||+|+||.||+++. .++..||+|++.... ......+.+|+.++++++||||+++++++...+..
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 3467788999999999999987 478899999997642 12334678899999999999999999999999999
Q ss_pred EEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccc
Q 014352 189 MLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEV 268 (426)
Q Consensus 189 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 268 (426)
++||||+++|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 97 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 97 YLILEYLSGGELFMQLERE-GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172 (327)
T ss_dssp EEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred EEEEeCCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence 9999999999999999654 45899999999999999999999998 9999999999999999999999999987533
Q ss_pred cC-CCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCH
Q 014352 269 FD-GRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNI 347 (426)
Q Consensus 269 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (426)
.. .......||+.|+|||.+.+..++.++||||||+++|||++|..||...........+. ... ...+.
T Consensus 173 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~--------~~~--~~~p~ 242 (327)
T 3a62_A 173 HDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKIL--------KCK--LNLPP 242 (327)
T ss_dssp ------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH--------HTC--CCCCT
T ss_pred cCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHH--------hCC--CCCCC
Confidence 22 22345679999999999999999999999999999999999999997643322221111 111 01122
Q ss_pred HHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 014352 348 QEVRELARIGHKCLHKTPRKRP-----SIGEVTQA 377 (426)
Q Consensus 348 ~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~~ 377 (426)
..+..+.+++.+||+.||++|| ++.+++++
T Consensus 243 ~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 243 YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp TSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred CCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 3346789999999999999999 77788765
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=344.89 Aligned_cols=261 Identities=25% Similarity=0.314 Sum_probs=202.1
Q ss_pred HHHHHHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc-----cChHHHHHHHHHHhcCC---CCceeeEEeEEE
Q 014352 113 DIQKATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH-----QGEKEFQTEVSLLGRLH---HRNLVNLIGYCV 183 (426)
Q Consensus 113 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~---h~niv~~~~~~~ 183 (426)
++...+|.+.+.||+|+||+||+|+.. +++.||+|++..... .....+.+|+.++++++ ||||+++++++.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~ 84 (308)
T 3g33_A 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA 84 (308)
T ss_dssp -----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred cccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence 445567888899999999999999964 788999999864321 12346778888877764 999999999998
Q ss_pred eCC-----eEEEEEEecCCCChhHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEE
Q 014352 184 DKG-----KYMLIYEFMSNGSLSNLIYSEE-RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAK 257 (426)
Q Consensus 184 ~~~-----~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 257 (426)
... ..++||||++ |+|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 85 TSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp ECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEE
T ss_pred ccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEE
Confidence 765 5799999996 59999986554 34899999999999999999999999 99999999999999999999
Q ss_pred EeeecCccccccCCCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccc-------
Q 014352 258 VADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQ------- 330 (426)
Q Consensus 258 l~Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~------- 330 (426)
|+|||+++............||+.|+|||.+.+..++.++|||||||++|||++|..||........+..+..
T Consensus 161 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (308)
T 3g33_A 161 LADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE 240 (308)
T ss_dssp ECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred EeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 9999999865544555667899999999999999999999999999999999999999976544332221110
Q ss_pred cchhh---hhhhhhcc-------cCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 331 DGVDE---ILDKQLVG-------ACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 331 ~~~~~---~~~~~~~~-------~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
..... .....+.. ......+..+.+++.+||+.||++|||+.+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 241 DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp TTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 00000 00000000 0011234678999999999999999999999875
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=332.86 Aligned_cols=253 Identities=25% Similarity=0.386 Sum_probs=204.0
Q ss_pred HHHHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc------cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCe
Q 014352 115 QKATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH------QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGK 187 (426)
Q Consensus 115 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 187 (426)
....|.+.+.||+|+||.||++... +++.+|+|.+..... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T 3bhy_A 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD 82 (283)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCe
Confidence 3456788899999999999999986 688999999875432 135679999999999999999999999999999
Q ss_pred EEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCC----cEEEeeecC
Q 014352 188 YMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFM----RAKVADFGL 263 (426)
Q Consensus 188 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfgl 263 (426)
.++||||+++++|.+++... ..+++..+..++.|++.||.|||+++ ++||||||+||+++.++ .+||+|||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 83 VVLILELVSGGELFDFLAEK-ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 99999999999999999543 46899999999999999999999998 99999999999999877 799999999
Q ss_pred ccccccCCCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcc
Q 014352 264 SKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVG 343 (426)
Q Consensus 264 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (426)
+.............||+.|+|||.+.+..++.++||||||+++|+|++|..||...........+...... ......
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~- 235 (283)
T 3bhy_A 159 AHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYD--FDEEYF- 235 (283)
T ss_dssp CEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC--CCHHHH-
T ss_pred ceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccC--Ccchhc-
Confidence 98654444445567999999999999999999999999999999999999999764433222211111000 000010
Q ss_pred cCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 344 ACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 344 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
...+..+.+++.+||+.||++|||+.+++++
T Consensus 236 ---~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 236 ---SNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp ---TTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred ---ccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 1123578999999999999999999999985
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=339.01 Aligned_cols=255 Identities=24% Similarity=0.276 Sum_probs=199.2
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccC--hHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEec
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQG--EKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 195 (426)
|.+.+.||+|+||+||+|... +++.||+|++....... ...+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 83 (292)
T 3o0g_A 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecC
Confidence 566789999999999999975 68899999997654322 357889999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC-CCcc
Q 014352 196 SNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD-GRNS 274 (426)
Q Consensus 196 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-~~~~ 274 (426)
++ +|.+.+......+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..... ....
T Consensus 84 ~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 159 (292)
T 3o0g_A 84 DQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS 159 (292)
T ss_dssp SE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCC
T ss_pred CC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcccccc
Confidence 75 677766665677999999999999999999999998 999999999999999999999999999754322 2334
Q ss_pred cCccccCccCccccccCC-CCcchhhHHHHHHHHHHHhCCCCCC-chHHHHHHhhcc-------ccchhhhhh-------
Q 014352 275 GLKGTYGYIDPAYISTNK-FTMKSDIFSFGVIIFELITAIHPHQ-NLMEYVNLASMS-------QDGVDEILD------- 338 (426)
Q Consensus 275 ~~~gt~~y~aPE~~~~~~-~~~~~Dv~S~Gvvl~el~tg~~p~~-~~~~~~~~~~~~-------~~~~~~~~~------- 338 (426)
...||+.|+|||.+.+.. ++.++||||||+++|||++|..||. .......+..+. .........
T Consensus 160 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 239 (292)
T 3o0g_A 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239 (292)
T ss_dssp SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCC
T ss_pred CCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccccc
Confidence 567899999999997765 8999999999999999999888853 221111111100 000000000
Q ss_pred -----hhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 339 -----KQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 339 -----~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
...........+..+.+++.+||+.||++|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000000112344678899999999999999999999874
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-45 Score=349.49 Aligned_cols=246 Identities=24% Similarity=0.368 Sum_probs=203.4
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC---ccChHHHHHHHHHHhcC-CCCceeeEEeEEEeCCeEEEEE
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS---HQGEKEFQTEVSLLGRL-HHRNLVNLIGYCVDKGKYMLIY 192 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 192 (426)
.|.+.+.||+|+||.||+|+.. +++.||+|++.... ....+.+..|..++..+ +||||+++++++.+.+.+|+||
T Consensus 21 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~ 100 (353)
T 2i0e_A 21 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 100 (353)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEE
T ss_pred HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEE
Confidence 4667789999999999999986 57889999987542 23345688999999988 7999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccccc-CC
Q 014352 193 EFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF-DG 271 (426)
Q Consensus 193 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~-~~ 271 (426)
||+++|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.... ..
T Consensus 101 E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 176 (353)
T 2i0e_A 101 EYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV 176 (353)
T ss_dssp ECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccccCCc
Confidence 999999999999654 45999999999999999999999998 99999999999999999999999999985332 23
Q ss_pred CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHH
Q 014352 272 RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVR 351 (426)
Q Consensus 272 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (426)
......||+.|+|||++.+..++.++|||||||++|||++|..||...........+.. ... ..+...+.
T Consensus 177 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~--------~~~--~~p~~~s~ 246 (353)
T 2i0e_A 177 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME--------HNV--AYPKSMSK 246 (353)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--------CCC--CCCTTSCH
T ss_pred ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHh--------CCC--CCCCCCCH
Confidence 34567899999999999999999999999999999999999999976433222211111 111 11223446
Q ss_pred HHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 014352 352 ELARIGHKCLHKTPRKRPS-----IGEVTQA 377 (426)
Q Consensus 352 ~l~~l~~~cl~~~p~~RPs-----~~evl~~ 377 (426)
.+.+++.+||+.||++||+ +.+++++
T Consensus 247 ~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 247 EAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp HHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred HHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 7899999999999999995 4777765
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=336.55 Aligned_cols=252 Identities=23% Similarity=0.348 Sum_probs=206.4
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc--cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEe
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH--QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEF 194 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 194 (426)
.|.+.+.||+|+||.||+|... ++..||+|++..... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 86 (284)
T 3kk8_A 7 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 86 (284)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEec
Confidence 3667789999999999999975 688999999865432 2235688999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCc---EEEeeecCccccccCC
Q 014352 195 MSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMR---AKVADFGLSKEEVFDG 271 (426)
Q Consensus 195 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfgl~~~~~~~~ 271 (426)
+++++|.+.+... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++. +||+|||++.......
T Consensus 87 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (284)
T 3kk8_A 87 VTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 162 (284)
T ss_dssp CCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC
T ss_pred CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc
Confidence 9999999988654 45899999999999999999999998 999999999999987655 9999999997655444
Q ss_pred CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHH
Q 014352 272 RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVR 351 (426)
Q Consensus 272 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (426)
......||+.|+|||.+.+..++.++||||||+++|+|++|..||...........+...... .........+.
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~ 236 (284)
T 3kk8_A 163 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD------YPSPEWDTVTP 236 (284)
T ss_dssp BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC------CCTTTTTTSCH
T ss_pred cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhcccc------CCchhhcccCH
Confidence 445678999999999999999999999999999999999999999764433222211111100 00111122346
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 014352 352 ELARIGHKCLHKTPRKRPSIGEVTQALL 379 (426)
Q Consensus 352 ~l~~l~~~cl~~~p~~RPs~~evl~~L~ 379 (426)
.+.+++.+||+.||++|||+.+++++-.
T Consensus 237 ~~~~li~~~l~~dp~~Rps~~~~l~h~~ 264 (284)
T 3kk8_A 237 EAKSLIDSMLTVNPKKRITADQALKVPW 264 (284)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTTSHH
T ss_pred HHHHHHHHHcccChhhCCCHHHHhcCcc
Confidence 7899999999999999999999998643
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=373.74 Aligned_cols=255 Identities=28% Similarity=0.451 Sum_probs=211.5
Q ss_pred HHHHHhhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEE
Q 014352 114 IQKATQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYE 193 (426)
Q Consensus 114 l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 193 (426)
+....+.+.+.||+|+||.||+|.+.++..||||++.... ...+.|.+|+++|++++||||+++++++.+ +..++|||
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e 341 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 341 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred cchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence 4455567788999999999999999888889999997654 345789999999999999999999999876 67899999
Q ss_pred ecCCCChhHHhhhc-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC--
Q 014352 194 FMSNGSLSNLIYSE-ERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD-- 270 (426)
Q Consensus 194 ~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-- 270 (426)
|+++|+|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 342 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 418 (535)
T 2h8h_A 342 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 418 (535)
T ss_dssp CCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred hhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence 99999999999653 356999999999999999999999998 999999999999999999999999999754321
Q ss_pred CCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHH
Q 014352 271 GRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQE 349 (426)
Q Consensus 271 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (426)
.......++..|+|||.+.+..++.++||||||+++|||++ |..||.+......... +........+...
T Consensus 419 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~---------i~~~~~~~~~~~~ 489 (535)
T 2h8h_A 419 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ---------VERGYRMPCPPEC 489 (535)
T ss_dssp HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHH---------HHTTCCCCCCTTC
T ss_pred ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---------HHcCCCCCCCCCC
Confidence 11233456789999999999999999999999999999999 9999976433222211 1111222233344
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 014352 350 VRELARIGHKCLHKTPRKRPSIGEVTQALLKIK 382 (426)
Q Consensus 350 ~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 382 (426)
+..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 490 ~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~ 522 (535)
T 2h8h_A 490 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522 (535)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 568999999999999999999999999998664
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=350.83 Aligned_cols=262 Identities=18% Similarity=0.227 Sum_probs=198.8
Q ss_pred HHHHHHhhhhcccccCCCeeEEEEEeC----CCcEEEEEEeccCCcc-----------ChHHHHHHHHHHhcCCCCceee
Q 014352 113 DIQKATQNFTNILGQGAFGPVYKATMP----SGGVAAIKVLASDSHQ-----------GEKEFQTEVSLLGRLHHRNLVN 177 (426)
Q Consensus 113 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~niv~ 177 (426)
++....|.+.+.||+|+||.||+|... ++..+|+|++...... ....+.+|+..+..++||||++
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~ 112 (345)
T 2v62_A 33 DMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPL 112 (345)
T ss_dssp CTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCC
T ss_pred cccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcce
Confidence 344456778899999999999999975 5678999998765321 1234667888999999999999
Q ss_pred EEeEEEe----CCeEEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCC
Q 014352 178 LIGYCVD----KGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHF 253 (426)
Q Consensus 178 ~~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~ 253 (426)
+++++.. ....++||||+ +++|.+++.... .+++..++.++.|++.||.|||+++ |+||||||+|||++.+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 113 FYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESS
T ss_pred eecccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccC
Confidence 9999988 67899999999 999999996554 6999999999999999999999998 9999999999999988
Q ss_pred C--cEEEeeecCccccccCC--------CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHH-H
Q 014352 254 M--RAKVADFGLSKEEVFDG--------RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLME-Y 322 (426)
Q Consensus 254 ~--~~kl~Dfgl~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~-~ 322 (426)
+ .+||+|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|..||..... .
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 267 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP 267 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence 7 99999999997543221 11445799999999999999999999999999999999999999954211 1
Q ss_pred HHHhhcc---ccchhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 014352 323 VNLASMS---QDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIK 382 (426)
Q Consensus 323 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 382 (426)
....... .......+.... .....+..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 268 VAVQTAKTNLLDELPQSVLKWA---PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HHHHHHHHHHHHTTTHHHHHHS---CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred HHHHHHHHhhcccccHHHHhhc---cccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 1110000 000111111100 01133467999999999999999999999999987653
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=340.47 Aligned_cols=255 Identities=28% Similarity=0.459 Sum_probs=202.2
Q ss_pred hhhhcccccCCCeeEEEEEeCCC----cEEEEEEeccCCc-cChHHHHHHHHHHhcCCCCceeeEEeEEEe-CCeEEEEE
Q 014352 119 QNFTNILGQGAFGPVYKATMPSG----GVAAIKVLASDSH-QGEKEFQTEVSLLGRLHHRNLVNLIGYCVD-KGKYMLIY 192 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~ 192 (426)
|.+.+.||+|+||.||+|.+.++ ..+|+|.+..... ...+.+.+|+.++++++||||+++++++.. ++..++||
T Consensus 27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 106 (298)
T 3f66_A 27 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 106 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred hhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEE
Confidence 56678999999999999986422 2589999875432 233578999999999999999999998654 46789999
Q ss_pred EecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC-
Q 014352 193 EFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG- 271 (426)
Q Consensus 193 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~- 271 (426)
||+++|+|.+++......+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 107 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 183 (298)
T 3f66_A 107 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 183 (298)
T ss_dssp ECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGG
T ss_pred eCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccccccch
Confidence 999999999999776777999999999999999999999998 9999999999999999999999999997533221
Q ss_pred ----CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCC
Q 014352 272 ----RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACN 346 (426)
Q Consensus 272 ----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (426)
......+|+.|+|||.+.+..++.++||||||+++|||++ |.+||........ ...+........+
T Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~ 254 (298)
T 3f66_A 184 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---------TVYLLQGRRLLQP 254 (298)
T ss_dssp CBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH---------HHHHHTTCCCCCC
T ss_pred hccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH---------HHHHhcCCCCCCC
Confidence 2234567889999999999999999999999999999999 5556654221111 1111111111112
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHh
Q 014352 347 IQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRH 385 (426)
Q Consensus 347 ~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~ 385 (426)
...+..+.+++.+||+.||++|||+.++++.|+.+....
T Consensus 255 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 255 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 233467999999999999999999999999999987744
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=338.18 Aligned_cols=256 Identities=27% Similarity=0.419 Sum_probs=205.5
Q ss_pred hhhcccccCCCeeEEEEEeC-CC---cEEEEEEeccCCc-cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeE-EEEEE
Q 014352 120 NFTNILGQGAFGPVYKATMP-SG---GVAAIKVLASDSH-QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKY-MLIYE 193 (426)
Q Consensus 120 ~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~-~lv~e 193 (426)
...+.||+|+||+||+|.+. ++ ..+|+|.+..... ...+.+.+|+.++++++||||+++++++.+.+.. ++|||
T Consensus 24 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e 103 (298)
T 3pls_A 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLP 103 (298)
T ss_dssp EEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEC
T ss_pred ccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEe
Confidence 34578999999999999863 22 2699999875432 2346788999999999999999999999876655 99999
Q ss_pred ecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC---
Q 014352 194 FMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD--- 270 (426)
Q Consensus 194 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~--- 270 (426)
|+.+|+|.+++......+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 104 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 180 (298)
T 3pls_A 104 YMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDREYY 180 (298)
T ss_dssp CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGG
T ss_pred cccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccCCccc
Confidence 99999999999776777999999999999999999999998 999999999999999999999999999743221
Q ss_pred --CCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCC-CCchHHHHHHhhccccchhhhhhhhhcccCCH
Q 014352 271 --GRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHP-HQNLMEYVNLASMSQDGVDEILDKQLVGACNI 347 (426)
Q Consensus 271 --~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (426)
.......+|+.|+|||.+.+..++.++||||||+++|+|++|..| |....... ....+........+.
T Consensus 181 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~---------~~~~~~~~~~~~~~~ 251 (298)
T 3pls_A 181 SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD---------LTHFLAQGRRLPQPE 251 (298)
T ss_dssp CSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG---------HHHHHHTTCCCCCCT
T ss_pred ccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH---------HHHHhhcCCCCCCCc
Confidence 223345678999999999999999999999999999999996555 43321111 111111111122223
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHhhh
Q 014352 348 QEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRHLA 387 (426)
Q Consensus 348 ~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~~ 387 (426)
..+..+.+++.+||+.||.+|||+.++++.|+.+......
T Consensus 252 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~ 291 (298)
T 3pls_A 252 YCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291 (298)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred cchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 3456799999999999999999999999999999876543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=362.36 Aligned_cols=247 Identities=24% Similarity=0.351 Sum_probs=195.6
Q ss_pred HHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccC---CccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEE
Q 014352 117 ATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASD---SHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIY 192 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 192 (426)
..|.+.+.||+|+||.||+|... +++.||+|++... .......+.+|+.++++++||||+++++++.+.+.+++||
T Consensus 148 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 227 (446)
T 4ejn_A 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM 227 (446)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEE
T ss_pred HHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEE
Confidence 34667789999999999999975 7889999998753 2223356788999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeecCCCCCCEEecCCCcEEEeeecCcccccc-C
Q 014352 193 EFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHE-GAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF-D 270 (426)
Q Consensus 193 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~-~ 270 (426)
||+++|+|.+++... ..+++..+..++.|++.||.|||+ .+ |+||||||+|||++.++.+||+|||+++.... .
T Consensus 228 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 303 (446)
T 4ejn_A 228 EYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG 303 (446)
T ss_dssp CCCSSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred eeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceeccCCC
Confidence 999999999998654 469999999999999999999998 88 99999999999999999999999999975322 2
Q ss_pred CCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHH
Q 014352 271 GRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEV 350 (426)
Q Consensus 271 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (426)
.......||+.|+|||++.+..++.++|||||||++|||++|..||.+.........+... .. ..+...+
T Consensus 304 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--------~~--~~p~~~~ 373 (446)
T 4ejn_A 304 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--------EI--RFPRTLG 373 (446)
T ss_dssp ---CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--------CC--CCCTTSC
T ss_pred cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhC--------CC--CCCccCC
Confidence 3345678999999999999999999999999999999999999999764332221111111 00 1122234
Q ss_pred HHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 014352 351 RELARIGHKCLHKTPRKRP-----SIGEVTQA 377 (426)
Q Consensus 351 ~~l~~l~~~cl~~~p~~RP-----s~~evl~~ 377 (426)
..+.+++.+||+.||++|| |+.+++++
T Consensus 374 ~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 374 PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 6789999999999999999 99999875
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=360.21 Aligned_cols=247 Identities=26% Similarity=0.363 Sum_probs=205.6
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC---ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEE
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS---HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYE 193 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 193 (426)
.|.+.+.||+|+||.||+|+.. +|+.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 17 ~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E 96 (476)
T 2y94_A 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVME 96 (476)
T ss_dssp TEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 3667789999999999999976 78999999986532 1234578899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCc
Q 014352 194 FMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRN 273 (426)
Q Consensus 194 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 273 (426)
|+++|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.........
T Consensus 97 ~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~~ 172 (476)
T 2y94_A 97 YVSGGELFDYICKN-GRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL 172 (476)
T ss_dssp CCSSEEHHHHTTSS-SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTTCCB
T ss_pred CCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccccccc
Confidence 99999999999543 46999999999999999999999998 999999999999999999999999999865544445
Q ss_pred ccCccccCccCccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHH
Q 014352 274 SGLKGTYGYIDPAYISTNKF-TMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRE 352 (426)
Q Consensus 274 ~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (426)
....||+.|+|||.+.+..+ +.++|||||||++|||++|..||...........+ .+... ..+...+..
T Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i--------~~~~~--~~p~~~s~~ 242 (476)
T 2y94_A 173 RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKI--------CDGIF--YTPQYLNPS 242 (476)
T ss_dssp CCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHH--------HTTCC--CCCTTCCHH
T ss_pred cccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHH--------hcCCc--CCCccCCHH
Confidence 56789999999999988776 68999999999999999999999753222111111 11111 112223457
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHHH
Q 014352 353 LARIGHKCLHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 353 l~~l~~~cl~~~p~~RPs~~evl~~L 378 (426)
+.+++.+||+.||++|||+.+++++-
T Consensus 243 ~~~Li~~~L~~dP~~Rpt~~eil~hp 268 (476)
T 2y94_A 243 VISLLKHMLQVDPMKRATIKDIREHE 268 (476)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHTCH
T ss_pred HHHHHHHHcCCCchhCcCHHHHHhCH
Confidence 89999999999999999999999863
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=344.72 Aligned_cols=255 Identities=26% Similarity=0.402 Sum_probs=203.5
Q ss_pred HHhhhhcccccCCCeeEEEEEeC-CCc----EEEEEEeccC-CccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEE
Q 014352 117 ATQNFTNILGQGAFGPVYKATMP-SGG----VAAIKVLASD-SHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYML 190 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 190 (426)
..|.+.+.||+|+||.||+|.+. +++ .||+|.+... .....+.+.+|+.++++++||||+++++++.... .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 34667789999999999999964 444 3577777544 2344578999999999999999999999998765 789
Q ss_pred EEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC
Q 014352 191 IYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD 270 (426)
Q Consensus 191 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 270 (426)
|+||+++|+|.+++......+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 94 v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~ 170 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC-------
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEccCc
Confidence 99999999999999877777999999999999999999999998 999999999999999999999999999754322
Q ss_pred C---CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCC
Q 014352 271 G---RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACN 346 (426)
Q Consensus 271 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (426)
. ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||....... ....+........+
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---------~~~~~~~~~~~~~~ 241 (327)
T 3lzb_A 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---------ISSILEKGERLPQP 241 (327)
T ss_dssp ---------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---------HHHHHHTTCCCCCC
T ss_pred cccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---------HHHHHHcCCCCCCC
Confidence 2 1233456788999999999999999999999999999999 999997632221 12222222222233
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHH
Q 014352 347 IQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQR 384 (426)
Q Consensus 347 ~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 384 (426)
...+..+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus 242 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 242 PICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 34556799999999999999999999999999999754
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=359.93 Aligned_cols=252 Identities=21% Similarity=0.281 Sum_probs=203.6
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC---ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEE
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS---HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYE 193 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 193 (426)
.+.+.+.||+|+||+||+|+.. +++.||+|++.... ......+.+|..++..++||||++++++|.+.+.+|+|||
T Consensus 75 ~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~E 154 (437)
T 4aw2_A 75 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMD 154 (437)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEEC
T ss_pred heEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEe
Confidence 3566789999999999999986 57889999986531 1223358899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCC-
Q 014352 194 FMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGR- 272 (426)
Q Consensus 194 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~- 272 (426)
|+++|+|.+++......+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 155 y~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 231 (437)
T 4aw2_A 155 YYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 231 (437)
T ss_dssp CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE
T ss_pred cCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCc
Confidence 99999999999775667999999999999999999999999 99999999999999999999999999975433322
Q ss_pred -cccCccccCccCccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCC
Q 014352 273 -NSGLKGTYGYIDPAYIS-----TNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACN 346 (426)
Q Consensus 273 -~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (426)
.....||+.|+|||++. ...++.++|||||||++|||++|..||...........+..... ...+ ....
T Consensus 232 ~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~----~~~~-p~~~ 306 (437)
T 4aw2_A 232 QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE----RFQF-PTQV 306 (437)
T ss_dssp ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH----HCCC-CSSC
T ss_pred ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccc----cccC-Cccc
Confidence 23467999999999997 56789999999999999999999999976443322221111000 0000 1111
Q ss_pred HHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 014352 347 IQEVRELARIGHKCLHKTPRK--RPSIGEVTQA 377 (426)
Q Consensus 347 ~~~~~~l~~l~~~cl~~~p~~--RPs~~evl~~ 377 (426)
...+..+.+++.+||..+|++ ||++.|++++
T Consensus 307 ~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 307 TDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp CCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred ccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 224567899999999888888 9999999876
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-45 Score=343.78 Aligned_cols=254 Identities=27% Similarity=0.448 Sum_probs=196.8
Q ss_pred HhhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCC
Q 014352 118 TQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSN 197 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 197 (426)
.+.+.+.||+|+||.||+|++. +..||+|.+... ...+.|.+|++++++++||||+++++++.+ ..++||||+++
T Consensus 9 ~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~ 83 (307)
T 2eva_A 9 EIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEG 83 (307)
T ss_dssp GEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTT
T ss_pred HeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCC
Confidence 4667789999999999999984 678999998643 335678999999999999999999998774 47999999999
Q ss_pred CChhHHhhhcc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCc-EEEeeecCccccccCCCcc
Q 014352 198 GSLSNLIYSEE--RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMR-AKVADFGLSKEEVFDGRNS 274 (426)
Q Consensus 198 gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~-~kl~Dfgl~~~~~~~~~~~ 274 (426)
|+|.+++.... ..+++..++.++.|++.||.|||+.+..+|+||||||+||+++.++. +||+|||++..... ...
T Consensus 84 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~--~~~ 161 (307)
T 2eva_A 84 GSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT--HMT 161 (307)
T ss_dssp CBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----------
T ss_pred CCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc--ccc
Confidence 99999996544 24789999999999999999999932223999999999999998886 79999999874322 223
Q ss_pred cCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHH
Q 014352 275 GLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELA 354 (426)
Q Consensus 275 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 354 (426)
...||+.|+|||.+.+..++.++||||||+++|||++|+.||......... .................+..+.
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~l~ 234 (307)
T 2eva_A 162 NNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR-------IMWAVHNGTRPPLIKNLPKPIE 234 (307)
T ss_dssp ---CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH-------HHHHHHTTCCCCCBTTCCHHHH
T ss_pred cCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH-------HHHHHhcCCCCCcccccCHHHH
Confidence 456899999999999999999999999999999999999999743111000 0000000111111223346789
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHHHHHHHHh
Q 014352 355 RIGHKCLHKTPRKRPSIGEVTQALLKIKQRH 385 (426)
Q Consensus 355 ~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~ 385 (426)
+++.+||+.||++|||+.++++.|+.+....
T Consensus 235 ~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 265 (307)
T 2eva_A 235 SLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265 (307)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred HHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence 9999999999999999999999999987654
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=338.91 Aligned_cols=262 Identities=25% Similarity=0.402 Sum_probs=202.7
Q ss_pred hhHHHHHHhhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcC--CCCceeeEEeEEEeC---
Q 014352 111 YKDIQKATQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRL--HHRNLVNLIGYCVDK--- 185 (426)
Q Consensus 111 ~~~l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~~~~~~~~~--- 185 (426)
..+.....|.+.+.||+|+||.||+|++. +..||+|++... ....+..|.+++..+ +||||+++++++...
T Consensus 31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp HHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred cccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 34455677888999999999999999985 889999998643 234455566666554 899999999999887
Q ss_pred -CeEEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcC--------CCCCeeecCCCCCCEEecCCCcE
Q 014352 186 -GKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEG--------AVPPVIHRDLKSANILLDHFMRA 256 (426)
Q Consensus 186 -~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~--------~~~~ivH~dlk~~Nill~~~~~~ 256 (426)
...++||||+++|+|.+++.. ..+++..++.++.|++.||.|||++ + |+||||||+|||++.++.+
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~ 181 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNGTC 181 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTSCE
T ss_pred CCceEEEEeccCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCCCE
Confidence 789999999999999999954 3589999999999999999999998 6 9999999999999999999
Q ss_pred EEeeecCccccccCCC-----cccCccccCccCccccccCCCCcc------hhhHHHHHHHHHHHhC----------CCC
Q 014352 257 KVADFGLSKEEVFDGR-----NSGLKGTYGYIDPAYISTNKFTMK------SDIFSFGVIIFELITA----------IHP 315 (426)
Q Consensus 257 kl~Dfgl~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~------~Dv~S~Gvvl~el~tg----------~~p 315 (426)
||+|||++........ .....||+.|+|||++.+..++.+ +||||||+++|||++| ..|
T Consensus 182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p 261 (337)
T 3mdy_A 182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP 261 (337)
T ss_dssp EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence 9999999964332221 124579999999999988776665 9999999999999999 556
Q ss_pred CCchHHHHHHhhccccchhhhh-hhhhcccC-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHh
Q 014352 316 HQNLMEYVNLASMSQDGVDEIL-DKQLVGAC-----NIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRH 385 (426)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-----~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~ 385 (426)
|........ ........+ ........ ....+..+.+++.+||+.||++|||+.+++++|+.+.+..
T Consensus 262 ~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 262 YHDLVPSDP----SYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp TTTTSCSSC----CHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred HhhhcCCCC----chhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 543211000 000000000 00111111 1256778999999999999999999999999999998754
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=336.74 Aligned_cols=252 Identities=28% Similarity=0.462 Sum_probs=201.2
Q ss_pred HHhhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeC-CeEEEEEEec
Q 014352 117 ATQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDK-GKYMLIYEFM 195 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~ 195 (426)
..|.+.+.||+|+||.||++.. ++..||+|++.... ..+.+.+|+.++++++||||+++++++.+. +..++||||+
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 97 (278)
T 1byg_A 21 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 97 (278)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred hhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence 3467788999999999999988 47889999987543 456789999999999999999999997654 4789999999
Q ss_pred CCCChhHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCcc
Q 014352 196 SNGSLSNLIYSEE-RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNS 274 (426)
Q Consensus 196 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 274 (426)
++++|.+++.... ..+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++..... ...
T Consensus 98 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~--~~~ 172 (278)
T 1byg_A 98 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS--TQD 172 (278)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccc--ccc
Confidence 9999999996544 34899999999999999999999998 99999999999999999999999999875332 223
Q ss_pred cCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHH
Q 014352 275 GLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVREL 353 (426)
Q Consensus 275 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 353 (426)
...+++.|+|||.+.+..++.++||||||+++|||++ |..||........... +........+...+..+
T Consensus 173 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~l 243 (278)
T 1byg_A 173 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR---------VEKGYKMDAPDGCPPAV 243 (278)
T ss_dssp ---CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH---------HTTTCCCCCCTTCCHHH
T ss_pred CCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---------HhcCCCCCCcccCCHHH
Confidence 3467889999999999999999999999999999998 9999975322111111 11111112233345679
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHHHHHHHHh
Q 014352 354 ARIGHKCLHKTPRKRPSIGEVTQALLKIKQRH 385 (426)
Q Consensus 354 ~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~ 385 (426)
.+++.+||+.||++|||+.++++.|+.+....
T Consensus 244 ~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 244 YEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 99999999999999999999999999997654
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=343.28 Aligned_cols=257 Identities=24% Similarity=0.366 Sum_probs=204.1
Q ss_pred HHhhhhcccccCCCeeEEEEEe-CCCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEe----CCeEEEE
Q 014352 117 ATQNFTNILGQGAFGPVYKATM-PSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVD----KGKYMLI 191 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv 191 (426)
.+|.+.+.||+|+||.||++.. .+++.||+|++........+.+.+|+.++++++||||+++++++.. ....++|
T Consensus 29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 108 (317)
T 2buj_A 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLL 108 (317)
T ss_dssp EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEE
T ss_pred eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEE
Confidence 4567788999999999999997 4788999999876555556789999999999999999999999873 3478999
Q ss_pred EEecCCCChhHHhhh---ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccc
Q 014352 192 YEFMSNGSLSNLIYS---EERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEV 268 (426)
Q Consensus 192 ~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 268 (426)
|||+++|+|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++....
T Consensus 109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 185 (317)
T 2buj_A 109 LPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQAC 185 (317)
T ss_dssp EECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEESC
T ss_pred EEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhcc
Confidence 999999999999865 3467999999999999999999999998 9999999999999999999999999886432
Q ss_pred cCCC----------cccCccccCccCccccccCC---CCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhh
Q 014352 269 FDGR----------NSGLKGTYGYIDPAYISTNK---FTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDE 335 (426)
Q Consensus 269 ~~~~----------~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 335 (426)
.... .....||+.|+|||.+.+.. ++.++||||||+++|||++|..||...... ......
T Consensus 186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~ 258 (317)
T 2buj_A 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK-------GDSVAL 258 (317)
T ss_dssp EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHT-------TSCHHH
T ss_pred cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcc-------cchhhH
Confidence 1111 12235799999999997654 688999999999999999999998642211 011111
Q ss_pred hhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 014352 336 ILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQ 383 (426)
Q Consensus 336 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 383 (426)
..............+..+.+++.+||+.||.+|||+.+++++|+.+..
T Consensus 259 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 259 AVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp HHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred HhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 111111112223345679999999999999999999999999987753
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=351.76 Aligned_cols=266 Identities=24% Similarity=0.293 Sum_probs=211.0
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC-ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCC--eEEEEEE
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS-HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKG--KYMLIYE 193 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e 193 (426)
+|.+.+.||+|+||+||+|.+. +++.||+|++.... ....+.+.+|++++++++||||+++++++...+ ..++|||
T Consensus 10 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e 89 (396)
T 4eut_A 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIME 89 (396)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEC
T ss_pred ceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEe
Confidence 3667789999999999999976 58899999997543 233467889999999999999999999998765 7899999
Q ss_pred ecCCCChhHHhhhcc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEe----cCCCcEEEeeecCcccc
Q 014352 194 FMSNGSLSNLIYSEE--RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILL----DHFMRAKVADFGLSKEE 267 (426)
Q Consensus 194 ~~~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfgl~~~~ 267 (426)
|+++|+|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||+++..
T Consensus 90 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~ 166 (396)
T 4eut_A 90 FCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (396)
T ss_dssp CCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCEEC
T ss_pred cCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCceEc
Confidence 999999999996543 23899999999999999999999998 9999999999999 77888999999999865
Q ss_pred ccCCCcccCccccCccCcccccc--------CCCCcchhhHHHHHHHHHHHhCCCCCCchHHH----HHHhhccccchhh
Q 014352 268 VFDGRNSGLKGTYGYIDPAYIST--------NKFTMKSDIFSFGVIIFELITAIHPHQNLMEY----VNLASMSQDGVDE 335 (426)
Q Consensus 268 ~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~----~~~~~~~~~~~~~ 335 (426)
..........||+.|+|||++.+ ..++.++||||||+++|||++|..||...... ..+..+.......
T Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~ 246 (396)
T 4eut_A 167 EDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246 (396)
T ss_dssp CCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTT
T ss_pred cCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcc
Confidence 54444556779999999999865 56778999999999999999999999642210 0000000000000
Q ss_pred h-------------hhhhhc--ccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHhh
Q 014352 336 I-------------LDKQLV--GACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRHL 386 (426)
Q Consensus 336 ~-------------~~~~~~--~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~ 386 (426)
. ....+. ..........+.+++.+||+.||++|||+.++++.+..+.....
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~~ 312 (396)
T 4eut_A 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRMV 312 (396)
T ss_dssp CCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCEE
T ss_pred cchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhceE
Confidence 0 000111 12235677789999999999999999999999999998876543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=342.36 Aligned_cols=254 Identities=21% Similarity=0.339 Sum_probs=195.1
Q ss_pred HhhhhcccccCCCeeEEEEEe-CCCcEEEEEEeccCCccC---hHHHHHHHHHHhcCCCCceeeEEeEEEeCC----eEE
Q 014352 118 TQNFTNILGQGAFGPVYKATM-PSGGVAAIKVLASDSHQG---EKEFQTEVSLLGRLHHRNLVNLIGYCVDKG----KYM 189 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~ 189 (426)
+|.+.+.||+|+||.||+|+. .+++.||+|++....... ...+.+|+.++++++||||+++++++.... ..+
T Consensus 13 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 92 (311)
T 3ork_A 13 RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 92 (311)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccE
Confidence 466778999999999999997 478899999997654333 246889999999999999999999987654 349
Q ss_pred EEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccccc
Q 014352 190 LIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF 269 (426)
Q Consensus 190 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 269 (426)
+||||+++++|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 93 lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 168 (311)
T 3ork_A 93 IVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIAD 168 (311)
T ss_dssp EEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-----
T ss_pred EEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcccccc
Confidence 999999999999999654 45999999999999999999999998 99999999999999999999999999975432
Q ss_pred CC----CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccC
Q 014352 270 DG----RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGAC 345 (426)
Q Consensus 270 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (426)
.. ......||+.|+|||.+.+..++.++||||||+++|||++|..||................... + ...
T Consensus 169 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~---~---~~~ 242 (311)
T 3ork_A 169 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP---P---SAR 242 (311)
T ss_dssp -------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC---H---HHH
T ss_pred cccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCC---c---ccc
Confidence 21 2234568999999999999999999999999999999999999997644332211111110000 0 000
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH-HHHHH
Q 014352 346 NIQEVRELARIGHKCLHKTPRKRPSIGEVTQ-ALLKI 381 (426)
Q Consensus 346 ~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~-~L~~~ 381 (426)
....+..+.+++.+||+.||++||+..+++. .+..+
T Consensus 243 ~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 243 HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 1123467899999999999999997666554 44444
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-45 Score=355.93 Aligned_cols=250 Identities=22% Similarity=0.302 Sum_probs=202.5
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC---ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEE
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS---HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYE 193 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 193 (426)
.|.+.+.||+|+||.||+|+.. ++..||+|++.... ......+.+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus 70 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E 149 (410)
T 3v8s_A 70 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVME 149 (410)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 3556688999999999999976 68899999986521 1223468899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC--
Q 014352 194 FMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG-- 271 (426)
Q Consensus 194 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-- 271 (426)
|+++|+|.+++.. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 150 ~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~ 224 (410)
T 3v8s_A 150 YMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 224 (410)
T ss_dssp CCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEE
T ss_pred CCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeEeeccCCcc
Confidence 9999999999854 35899999999999999999999998 9999999999999999999999999997543322
Q ss_pred CcccCccccCccCccccccCC----CCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCH
Q 014352 272 RNSGLKGTYGYIDPAYISTNK----FTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNI 347 (426)
Q Consensus 272 ~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (426)
......||+.|+|||++.+.. ++.++|||||||++|||++|..||...........+.... ..+..+...
T Consensus 225 ~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~------~~~~~p~~~ 298 (410)
T 3v8s_A 225 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK------NSLTFPDDN 298 (410)
T ss_dssp ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH------HHCCCCTTC
T ss_pred cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcc------ccccCCCcc
Confidence 234678999999999997765 7899999999999999999999997643322222111100 001111112
Q ss_pred HHHHHHHHHHHHcccCCCCC--CCCHHHHHHHH
Q 014352 348 QEVRELARIGHKCLHKTPRK--RPSIGEVTQAL 378 (426)
Q Consensus 348 ~~~~~l~~l~~~cl~~~p~~--RPs~~evl~~L 378 (426)
..+..+.+++.+||+.+|.+ ||++.|++++-
T Consensus 299 ~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp 331 (410)
T 3v8s_A 299 DISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 331 (410)
T ss_dssp CCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSG
T ss_pred cccHHHHHHHHHHccChhhhCCCCCHHHHhcCc
Confidence 34567899999999999988 99999999863
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=359.88 Aligned_cols=254 Identities=26% Similarity=0.359 Sum_probs=206.7
Q ss_pred HHHHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC--ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEE
Q 014352 115 QKATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS--HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLI 191 (426)
Q Consensus 115 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 191 (426)
...+|.+.+.||+|+||+||+|... +++.||+|++.... ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 4466888999999999999999976 78899999986432 23456789999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEec---CCCcEEEeeecCccccc
Q 014352 192 YEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLD---HFMRAKVADFGLSKEEV 268 (426)
Q Consensus 192 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfgl~~~~~ 268 (426)
|||+++|+|.+.+... ..+++..+..++.|++.||.|||+++ |+||||||+|||++ .++.+||+|||+++...
T Consensus 100 ~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 100 GELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp ECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred EEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 9999999999988654 45999999999999999999999999 99999999999995 45679999999998655
Q ss_pred cCCCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHH
Q 014352 269 FDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQ 348 (426)
Q Consensus 269 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (426)
.........||+.|+|||++.+ .++.++|||||||++|+|++|..||.+......+..+...... ........
T Consensus 176 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~------~~~~~~~~ 248 (486)
T 3mwu_A 176 QNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYA------FDLPQWRT 248 (486)
T ss_dssp CC----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC------SCSGGGGG
T ss_pred CCCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC------CCCcccCC
Confidence 4444556779999999999976 5999999999999999999999999765443332222111100 00011123
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 014352 349 EVRELARIGHKCLHKTPRKRPSIGEVTQALL 379 (426)
Q Consensus 349 ~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 379 (426)
.+..+.+++.+||+.||.+|||+.+++++-.
T Consensus 249 ~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~ 279 (486)
T 3mwu_A 249 ISDDAKDLIRKMLTFHPSLRITATQCLEHPW 279 (486)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHHCHH
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHhcCHh
Confidence 3467899999999999999999999998743
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=342.62 Aligned_cols=259 Identities=27% Similarity=0.470 Sum_probs=207.9
Q ss_pred HHHhhhhcccccCCCeeEEEEEe------CCCcEEEEEEeccCCcc-ChHHHHHHHHHHhcC-CCCceeeEEeEEEeCC-
Q 014352 116 KATQNFTNILGQGAFGPVYKATM------PSGGVAAIKVLASDSHQ-GEKEFQTEVSLLGRL-HHRNLVNLIGYCVDKG- 186 (426)
Q Consensus 116 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~- 186 (426)
...|.+.+.||+|+||.||+|.+ .+++.||+|++...... ..+.+.+|+.++.++ +||||+++++++...+
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 105 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 105 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCC
Confidence 44577788999999999999974 25578999999765432 235788999999999 7999999999988764
Q ss_pred eEEEEEEecCCCChhHHhhhccC---------------CCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEec
Q 014352 187 KYMLIYEFMSNGSLSNLIYSEER---------------VLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLD 251 (426)
Q Consensus 187 ~~~lv~e~~~~gsL~~~l~~~~~---------------~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~ 251 (426)
..++||||+++|+|.+++..... .+++..++.++.|++.||.|||+++ |+||||||+||+++
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~ 182 (316)
T 2xir_A 106 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLS 182 (316)
T ss_dssp CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEEC
Confidence 58999999999999999965432 2789999999999999999999998 99999999999999
Q ss_pred CCCcEEEeeecCccccccCCC---cccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhh
Q 014352 252 HFMRAKVADFGLSKEEVFDGR---NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLAS 327 (426)
Q Consensus 252 ~~~~~kl~Dfgl~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~ 327 (426)
.++.+||+|||+++....... .....+|+.|+|||.+.+..++.++||||||+++|||++ |..||.........
T Consensus 183 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~-- 260 (316)
T 2xir_A 183 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF-- 260 (316)
T ss_dssp GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH--
T ss_pred CCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHH--
Confidence 999999999999975432221 234557889999999999999999999999999999998 99999653211110
Q ss_pred ccccchhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHh
Q 014352 328 MSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRH 385 (426)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~ 385 (426)
...+........+...+..+.+++.+||+.||.+|||+.+++++|+.+.+..
T Consensus 261 ------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 261 ------CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp ------HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ------HHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 1111111111122234467999999999999999999999999999987654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=346.61 Aligned_cols=249 Identities=21% Similarity=0.356 Sum_probs=196.8
Q ss_pred HhhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCcc--ChHHHHHHHHHHhcCCC--CceeeEEeEEEeCCeEEEEEE
Q 014352 118 TQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQ--GEKEFQTEVSLLGRLHH--RNLVNLIGYCVDKGKYMLIYE 193 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e 193 (426)
.|.+.+.||+|+||.||++...+++.||+|++...... ..+.+.+|+.++.+++| |||+++++++.+.+..++|||
T Consensus 10 ~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e 89 (343)
T 3dbq_A 10 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME 89 (343)
T ss_dssp EEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred EEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe
Confidence 36677899999999999999988999999998754322 23578999999999976 999999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC--
Q 014352 194 FMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG-- 271 (426)
Q Consensus 194 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-- 271 (426)
+ .+++|.+++... ..+++.++..++.|++.||.|||+++ |+||||||+|||++ ++.+||+|||+++......
T Consensus 90 ~-~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 163 (343)
T 3dbq_A 90 C-GNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 163 (343)
T ss_dssp C-CSEEHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC------
T ss_pred C-CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCccccc
Confidence 4 588999999654 56899999999999999999999998 99999999999997 5789999999997543322
Q ss_pred -CcccCccccCccCcccccc-----------CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhh
Q 014352 272 -RNSGLKGTYGYIDPAYIST-----------NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDK 339 (426)
Q Consensus 272 -~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 339 (426)
......||+.|+|||++.+ ..++.++||||||+++|||++|..||........ .....+++
T Consensus 164 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-------~~~~~~~~ 236 (343)
T 3dbq_A 164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS-------KLHAIIDP 236 (343)
T ss_dssp ------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-------HHHHHHCT
T ss_pred ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHH-------HHHHHhcC
Confidence 1235679999999999865 6789999999999999999999999975322111 01112222
Q ss_pred hhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 014352 340 QLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALL 379 (426)
Q Consensus 340 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 379 (426)
......+......+.+++.+||+.||.+|||+.+++++..
T Consensus 237 ~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~ 276 (343)
T 3dbq_A 237 NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 276 (343)
T ss_dssp TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred CcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcc
Confidence 2222222223357899999999999999999999998754
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-44 Score=337.10 Aligned_cols=260 Identities=23% Similarity=0.374 Sum_probs=199.5
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc---cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEE
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH---QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYE 193 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 193 (426)
.|.+.+.||+|+||.||+|... ++..||+|++..... .....+.+|+.++++++||||+++++++...+..++|||
T Consensus 33 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 112 (310)
T 2wqm_A 33 NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 112 (310)
T ss_dssp GEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEe
Confidence 4677889999999999999974 788999999975332 233568899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhh---ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC
Q 014352 194 FMSNGSLSNLIYS---EERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD 270 (426)
Q Consensus 194 ~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 270 (426)
|+++++|.+++.. ....+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++......
T Consensus 113 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~ 189 (310)
T 2wqm_A 113 LADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 189 (310)
T ss_dssp CCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC---------
T ss_pred cCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecCC
Confidence 9999999999854 2456899999999999999999999998 999999999999999999999999998754322
Q ss_pred C-CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHH-HHHhhccccchhhhhhhhhcccCCHH
Q 014352 271 G-RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEY-VNLASMSQDGVDEILDKQLVGACNIQ 348 (426)
Q Consensus 271 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (426)
. ......|++.|+|||.+.+..++.++||||||+++|+|++|..||...... ..+. ..+............
T Consensus 190 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-------~~~~~~~~~~~~~~~ 262 (310)
T 2wqm_A 190 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLC-------KKIEQCDYPPLPSDH 262 (310)
T ss_dssp ---------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHH-------HHHHTTCSCCCCTTT
T ss_pred CccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHH-------HHhhcccCCCCcccc
Confidence 2 223456899999999999999999999999999999999999998643210 0000 000011111111123
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHhhh
Q 014352 349 EVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRHLA 387 (426)
Q Consensus 349 ~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~~ 387 (426)
.+..+.+++.+||+.||++|||+.++++.|+++......
T Consensus 263 ~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~ 301 (310)
T 2wqm_A 263 YSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301 (310)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred cCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence 446799999999999999999999999999999876544
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=335.67 Aligned_cols=256 Identities=27% Similarity=0.430 Sum_probs=204.5
Q ss_pred Hhhhhc-ccccCCCeeEEEEEeC---CCcEEEEEEeccCCccC--hHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEE
Q 014352 118 TQNFTN-ILGQGAFGPVYKATMP---SGGVAAIKVLASDSHQG--EKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLI 191 (426)
Q Consensus 118 ~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 191 (426)
++.+.+ .||+|+||.||+|.+. ++..||+|++....... .+.+.+|+.++++++||||+++++++ ..+..++|
T Consensus 17 ~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv 95 (291)
T 1xbb_A 17 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLV 95 (291)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEE
T ss_pred hhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEE
Confidence 455666 8999999999999642 46789999997653222 46789999999999999999999999 56678999
Q ss_pred EEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC
Q 014352 192 YEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG 271 (426)
Q Consensus 192 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 271 (426)
|||+++++|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 96 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (291)
T 1xbb_A 96 MEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 171 (291)
T ss_dssp EECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred EEeCCCCCHHHHHHhC-cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceeeccCC
Confidence 9999999999999654 45899999999999999999999998 9999999999999999999999999997543222
Q ss_pred C----cccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCC
Q 014352 272 R----NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACN 346 (426)
Q Consensus 272 ~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (426)
. .....+++.|+|||.+.+..++.++||||||+++|||++ |..||........... +........+
T Consensus 172 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~---------~~~~~~~~~~ 242 (291)
T 1xbb_A 172 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM---------LEKGERMGCP 242 (291)
T ss_dssp SEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH---------HHTTCCCCCC
T ss_pred CcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH---------HHcCCCCCCC
Confidence 1 123346788999999998889999999999999999999 9999976433222111 1111111223
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHhhh
Q 014352 347 IQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRHLA 387 (426)
Q Consensus 347 ~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~~ 387 (426)
...+..+.+++.+||+.||++|||+.++++.|+.+......
T Consensus 243 ~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~ 283 (291)
T 1xbb_A 243 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 283 (291)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhh
Confidence 34456899999999999999999999999999998765544
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=339.27 Aligned_cols=258 Identities=27% Similarity=0.413 Sum_probs=198.4
Q ss_pred HHHhhhhcccccCCCeeEEEEEeC----CCcEEEEEEeccCCcc--ChHHHHHHHHHHhcCCCCceeeEEeEEEeCC---
Q 014352 116 KATQNFTNILGQGAFGPVYKATMP----SGGVAAIKVLASDSHQ--GEKEFQTEVSLLGRLHHRNLVNLIGYCVDKG--- 186 (426)
Q Consensus 116 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--- 186 (426)
...|.+.+.||+|+||.||+|.+. ++..||+|.+...... ..+.+.+|+.++++++||||+++++++.+.+
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 112 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG 112 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccC
Confidence 445677889999999999999864 3347999998755322 2356899999999999999999999998754
Q ss_pred --eEEEEEEecCCCChhHHhhh-----ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEe
Q 014352 187 --KYMLIYEFMSNGSLSNLIYS-----EERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVA 259 (426)
Q Consensus 187 --~~~lv~e~~~~gsL~~~l~~-----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 259 (426)
..++||||+++|+|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+
T Consensus 113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl~ 189 (313)
T 3brb_A 113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVA 189 (313)
T ss_dssp --CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEEC
T ss_pred CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEEe
Confidence 35999999999999999843 2356999999999999999999999998 9999999999999999999999
Q ss_pred eecCccccccCC---CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhh
Q 014352 260 DFGLSKEEVFDG---RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDE 335 (426)
Q Consensus 260 Dfgl~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 335 (426)
|||++....... ......+++.|+|||.+.+..++.++||||||+++|||++ |..||...........
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~-------- 261 (313)
T 3brb_A 190 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDY-------- 261 (313)
T ss_dssp SCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH--------
T ss_pred ecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHH--------
Confidence 999997543221 2233457889999999999999999999999999999999 8899875332211111
Q ss_pred hhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHh
Q 014352 336 ILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRH 385 (426)
Q Consensus 336 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~ 385 (426)
+........+...+..+.+++.+||+.||++|||+.+++++|+.+....
T Consensus 262 -~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 262 -LLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp -HHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -HHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 1111111122334467999999999999999999999999999987643
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=345.64 Aligned_cols=262 Identities=25% Similarity=0.393 Sum_probs=207.5
Q ss_pred HHHHHhhhhcccccCCCeeEEEEEe------CCCcEEEEEEeccCC-ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCC
Q 014352 114 IQKATQNFTNILGQGAFGPVYKATM------PSGGVAAIKVLASDS-HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKG 186 (426)
Q Consensus 114 l~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 186 (426)
+....|.+.+.||+|+||.||+|++ .++..||+|.+.... ......+.+|+.++++++||||+++++++.+.+
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 106 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence 3345577888999999999999984 256689999997543 233457899999999999999999999999999
Q ss_pred eEEEEEEecCCCChhHHhhhcc------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecC---CCcEE
Q 014352 187 KYMLIYEFMSNGSLSNLIYSEE------RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDH---FMRAK 257 (426)
Q Consensus 187 ~~~lv~e~~~~gsL~~~l~~~~------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~k 257 (426)
..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+|||++. +..+|
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEE
T ss_pred CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEE
Confidence 9999999999999999997543 35899999999999999999999998 999999999999994 45699
Q ss_pred EeeecCccccccCC---CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccch
Q 014352 258 VADFGLSKEEVFDG---RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGV 333 (426)
Q Consensus 258 l~Dfgl~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~ 333 (426)
|+|||++....... ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||...........+
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~----- 258 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV----- 258 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH-----
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHH-----
Confidence 99999987432221 2234567889999999999999999999999999999998 99999754332221111
Q ss_pred hhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHhhh
Q 014352 334 DEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRHLA 387 (426)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~~ 387 (426)
........+...+..+.+++.+||+.||.+|||+.+++++|+.+......
T Consensus 259 ----~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~ 308 (327)
T 2yfx_A 259 ----TSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 308 (327)
T ss_dssp ----HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHH
T ss_pred ----hcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHHH
Confidence 11111112223446789999999999999999999999999999775544
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=333.96 Aligned_cols=260 Identities=21% Similarity=0.284 Sum_probs=205.5
Q ss_pred HHhhhhcccccCCCeeEEEEEe-CCCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEE-EeCCeEEEEEEe
Q 014352 117 ATQNFTNILGQGAFGPVYKATM-PSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYC-VDKGKYMLIYEF 194 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~lv~e~ 194 (426)
.+|.+.+.||+|+||.||+|+. .+++.||+|++.... ....+..|+.++++++|++++..+..+ ...+..++||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEc
Confidence 4577788999999999999997 478899999876543 234688999999999988877766655 566788999999
Q ss_pred cCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEe---cCCCcEEEeeecCccccccCC
Q 014352 195 MSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILL---DHFMRAKVADFGLSKEEVFDG 271 (426)
Q Consensus 195 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfgl~~~~~~~~ 271 (426)
+ +++|.+++......+++..+..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||+++......
T Consensus 87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~ 162 (296)
T 4hgt_A 87 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp C-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence 9 99999999766677999999999999999999999999 9999999999999 788999999999997543322
Q ss_pred --------CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcc
Q 014352 272 --------RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVG 343 (426)
Q Consensus 272 --------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (426)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ..............
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~~~~~~~~~~~~ 237 (296)
T 4hgt_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK-----RQKYERISEKKMST 237 (296)
T ss_dssp TCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSS-----SSHHHHHHHHHHHS
T ss_pred cCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhh-----hhhhhhhhcccccc
Confidence 12356799999999999999999999999999999999999999975321100 00011111111110
Q ss_pred c---CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHhhh
Q 014352 344 A---CNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRHLA 387 (426)
Q Consensus 344 ~---~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~~ 387 (426)
. .....+..+.+++.+||+.||++|||+.++++.|+.+..+...
T Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~ 284 (296)
T 4hgt_A 238 PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred hhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCC
Confidence 0 0011246799999999999999999999999999999876654
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=340.55 Aligned_cols=264 Identities=22% Similarity=0.373 Sum_probs=208.8
Q ss_pred CChhHHHHHHhhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhc--CCCCceeeEEeEEEeCC
Q 014352 109 YAYKDIQKATQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGR--LHHRNLVNLIGYCVDKG 186 (426)
Q Consensus 109 ~~~~~l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~ 186 (426)
+...+.....|.+.+.||+|+||.||+|+. +++.||+|++... ....+..|.+++.. ++||||+++++++...+
T Consensus 34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~ 109 (342)
T 1b6c_B 34 LLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN 109 (342)
T ss_dssp HHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred eeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence 344566677888999999999999999998 5889999998643 34567888888887 78999999999998875
Q ss_pred ----eEEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHH--------cCCCCCeeecCCCCCCEEecCCC
Q 014352 187 ----KYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLH--------EGAVPPVIHRDLKSANILLDHFM 254 (426)
Q Consensus 187 ----~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~~~~ivH~dlk~~Nill~~~~ 254 (426)
..++||||+++|+|.+++.. ..+++..++.++.|++.||.||| +.+ |+||||||+|||++.++
T Consensus 110 ~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~ 184 (342)
T 1b6c_B 110 GTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNG 184 (342)
T ss_dssp SSCCCEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTS
T ss_pred CccceeEEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCC
Confidence 78999999999999999954 35899999999999999999999 777 99999999999999999
Q ss_pred cEEEeeecCccccccCC-----CcccCccccCccCccccccCC------CCcchhhHHHHHHHHHHHhC----------C
Q 014352 255 RAKVADFGLSKEEVFDG-----RNSGLKGTYGYIDPAYISTNK------FTMKSDIFSFGVIIFELITA----------I 313 (426)
Q Consensus 255 ~~kl~Dfgl~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~S~Gvvl~el~tg----------~ 313 (426)
.+||+|||++....... ......||+.|+|||.+.+.. ++.++||||||+++|||++| .
T Consensus 185 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~ 264 (342)
T 1b6c_B 185 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 264 (342)
T ss_dssp CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccc
Confidence 99999999997543332 224557999999999997653 33689999999999999999 6
Q ss_pred CCCCchHHH----HHH-hhccccchhhhhhhhhcc-cCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHh
Q 014352 314 HPHQNLMEY----VNL-ASMSQDGVDEILDKQLVG-ACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRH 385 (426)
Q Consensus 314 ~p~~~~~~~----~~~-~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~ 385 (426)
.||...... ..+ ....... ..+.+.. .........+.+++.+||+.||++|||+.+++++|+.+.+..
T Consensus 265 ~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 265 LPYYDLVPSDPSVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp CTTTTTSCSSCCHHHHHHHHTTSC----CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred cCccccCcCcccHHHHHHHHHHHH----hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence 777542110 000 0000000 0011110 012356678999999999999999999999999999997643
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=343.64 Aligned_cols=257 Identities=25% Similarity=0.397 Sum_probs=208.7
Q ss_pred HHHhhhhcccccCCCeeEEEEEeC------CCcEEEEEEeccCCc-cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeE
Q 014352 116 KATQNFTNILGQGAFGPVYKATMP------SGGVAAIKVLASDSH-QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKY 188 (426)
Q Consensus 116 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 188 (426)
...|.+.+.||+|+||.||+|.+. ++..||+|.+..... .....+.+|+.++++++||||+++++++.+.+..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 103 (322)
T 1p4o_A 24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 103 (322)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCcc
Confidence 345777889999999999999764 367899999875432 2334688999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHhhhcc---------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEe
Q 014352 189 MLIYEFMSNGSLSNLIYSEE---------RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVA 259 (426)
Q Consensus 189 ~lv~e~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 259 (426)
++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+
T Consensus 104 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~kl~ 180 (322)
T 1p4o_A 104 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG 180 (322)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred EEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEEEC
Confidence 99999999999999996532 45789999999999999999999998 9999999999999999999999
Q ss_pred eecCccccccCC---CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhh
Q 014352 260 DFGLSKEEVFDG---RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDE 335 (426)
Q Consensus 260 Dfgl~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 335 (426)
|||+++...... ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||...........+....
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~--- 257 (322)
T 1p4o_A 181 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG--- 257 (322)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC---
T ss_pred cCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCC---
Confidence 999997543222 1233457889999999999999999999999999999999 899987643322221111111
Q ss_pred hhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHH
Q 014352 336 ILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQR 384 (426)
Q Consensus 336 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 384 (426)
....+...+..+.+++.+||+.||++|||+.+++++|+.+...
T Consensus 258 ------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~ 300 (322)
T 1p4o_A 258 ------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300 (322)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred ------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence 1112233446799999999999999999999999999876443
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=337.10 Aligned_cols=252 Identities=24% Similarity=0.392 Sum_probs=204.6
Q ss_pred HHHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEe
Q 014352 116 KATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEF 194 (426)
Q Consensus 116 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 194 (426)
..+|.+.+.||+|+||.||+++.. +++.||+|++........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 456778899999999999999976 7889999999866544556789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEe---cCCCcEEEeeecCccccccCC
Q 014352 195 MSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILL---DHFMRAKVADFGLSKEEVFDG 271 (426)
Q Consensus 195 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfgl~~~~~~~~ 271 (426)
+++++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+||++ +.++.+||+|||++..... .
T Consensus 88 ~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~-~ 162 (304)
T 2jam_A 88 VSGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN-G 162 (304)
T ss_dssp CCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC-B
T ss_pred CCCccHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC-C
Confidence 9999999998554 45899999999999999999999998 9999999999999 7889999999999875332 2
Q ss_pred CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHH
Q 014352 272 RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVR 351 (426)
Q Consensus 272 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (426)
......||+.|+|||.+.+..++.++||||||+++|||++|..||...........+..... ..........+.
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~------~~~~~~~~~~~~ 236 (304)
T 2jam_A 163 IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYY------EFESPFWDDISE 236 (304)
T ss_dssp TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCC------CCCTTTTTTSCH
T ss_pred ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC------CCCccccccCCH
Confidence 23345689999999999999999999999999999999999999976433222111111100 001111123446
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014352 352 ELARIGHKCLHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 352 ~l~~l~~~cl~~~p~~RPs~~evl~~L 378 (426)
.+.+++.+||+.||++|||+.+++++-
T Consensus 237 ~~~~li~~~l~~dp~~Rps~~~~l~h~ 263 (304)
T 2jam_A 237 SAKDFICHLLEKDPNERYTCEKALSHP 263 (304)
T ss_dssp HHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHhcCc
Confidence 799999999999999999999999764
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=370.97 Aligned_cols=248 Identities=28% Similarity=0.436 Sum_probs=201.5
Q ss_pred cccccCCCeeEEEEEeC---CCcEEEEEEeccCCc--cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCC
Q 014352 123 NILGQGAFGPVYKATMP---SGGVAAIKVLASDSH--QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSN 197 (426)
Q Consensus 123 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 197 (426)
+.||+|+||.||+|.+. ++..||||+++.... ...+.+.+|+++|++++|||||++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 37999999999999653 457899999976432 234689999999999999999999999865 568999999999
Q ss_pred CChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC----Cc
Q 014352 198 GSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG----RN 273 (426)
Q Consensus 198 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~----~~ 273 (426)
|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 454 g~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 529 (635)
T 4fl3_A 454 GPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 529 (635)
T ss_dssp EEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred CCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence 999999954 456999999999999999999999998 9999999999999999999999999997543221 12
Q ss_pred ccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHH
Q 014352 274 SGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRE 352 (426)
Q Consensus 274 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (426)
....+|+.|+|||++.+..++.++|||||||++|||++ |..||.+........ .+........+...+..
T Consensus 530 ~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~---------~i~~~~~~~~p~~~~~~ 600 (635)
T 4fl3_A 530 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA---------MLEKGERMGCPAGCPRE 600 (635)
T ss_dssp -----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH---------HHHTTCCCCCCTTCCHH
T ss_pred cCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH---------HHHcCCCCCCCCCCCHH
Confidence 33456788999999999999999999999999999998 999997644332211 12222222333445578
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHHHHHHHHH
Q 014352 353 LARIGHKCLHKTPRKRPSIGEVTQALLKIKQR 384 (426)
Q Consensus 353 l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 384 (426)
+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 601 l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 601 MYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 99999999999999999999999999987654
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=336.20 Aligned_cols=246 Identities=26% Similarity=0.411 Sum_probs=182.6
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC---ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEe
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS---HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEF 194 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 194 (426)
|.+.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 13 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 92 (278)
T 3cok_A 13 FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEM 92 (278)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEec
Confidence 567789999999999999974 78899999986432 12236789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC-CCc
Q 014352 195 MSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD-GRN 273 (426)
Q Consensus 195 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-~~~ 273 (426)
+++++|.+++......+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++...... ...
T Consensus 93 ~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 169 (278)
T 3cok_A 93 CHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH 169 (278)
T ss_dssp CTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC------
T ss_pred CCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCcc
Confidence 9999999999776677999999999999999999999998 999999999999999999999999998754322 222
Q ss_pred ccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHH
Q 014352 274 SGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVREL 353 (426)
Q Consensus 274 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 353 (426)
....||+.|+|||.+.+..++.++||||||+++|||++|..||.............. ... ..+...+..+
T Consensus 170 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------~~~--~~~~~~~~~~ 239 (278)
T 3cok_A 170 YTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL--------ADY--EMPSFLSIEA 239 (278)
T ss_dssp ----------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCS--------SCC--CCCTTSCHHH
T ss_pred eeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh--------ccc--CCccccCHHH
Confidence 345789999999999999999999999999999999999999975321111111100 000 1112234678
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHH
Q 014352 354 ARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 354 ~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
.+++.+||+.||++|||+.+++++
T Consensus 240 ~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 240 KDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHcccCHhhCCCHHHHhcC
Confidence 999999999999999999999864
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=353.60 Aligned_cols=250 Identities=22% Similarity=0.294 Sum_probs=201.9
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC---ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEE
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS---HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYE 193 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 193 (426)
.+.+.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|..++.+++||||+++++++.+.+.+|+|||
T Consensus 62 ~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE 141 (412)
T 2vd5_A 62 DFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVME 141 (412)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEEC
T ss_pred hEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEc
Confidence 3566789999999999999985 78999999986432 1223458899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCC-
Q 014352 194 FMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGR- 272 (426)
Q Consensus 194 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~- 272 (426)
|+++|+|.+++...+..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 142 ~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~ 218 (412)
T 2vd5_A 142 YYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV 218 (412)
T ss_dssp CCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE
T ss_pred CCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhheeccCCCcc
Confidence 99999999999776667999999999999999999999998 99999999999999999999999999976443322
Q ss_pred -cccCccccCccCccccc-------cCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhc-c
Q 014352 273 -NSGLKGTYGYIDPAYIS-------TNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLV-G 343 (426)
Q Consensus 273 -~~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 343 (426)
.....||+.|+|||++. ...++.++|||||||++|||++|+.||...........+.... .... .
T Consensus 219 ~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~------~~~~~p 292 (412)
T 2vd5_A 219 RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYK------EHLSLP 292 (412)
T ss_dssp ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH------HHCCCC
T ss_pred ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcc------cCcCCC
Confidence 23467999999999997 4578999999999999999999999997643332221111100 0000 0
Q ss_pred cCCHHHHHHHHHHHHHcccCCCCCC---CCHHHHHHH
Q 014352 344 ACNIQEVRELARIGHKCLHKTPRKR---PSIGEVTQA 377 (426)
Q Consensus 344 ~~~~~~~~~l~~l~~~cl~~~p~~R---Ps~~evl~~ 377 (426)
..+...+.++.+++.+||. +|++| |++.+++++
T Consensus 293 ~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 293 LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp ----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 0112244679999999999 99998 689998775
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=340.83 Aligned_cols=243 Identities=24% Similarity=0.330 Sum_probs=179.3
Q ss_pred cccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCC-CCceeeEEeEEEeCCeEEEEEEecCCCCh
Q 014352 123 NILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLH-HRNLVNLIGYCVDKGKYMLIYEFMSNGSL 200 (426)
Q Consensus 123 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL 200 (426)
+.||+|+||.||+|... +++.||+|++... ....+.+|+.+++++. ||||+++++++.+.+..++||||+++|+|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 67999999999999975 6889999998643 3467889999999997 99999999999999999999999999999
Q ss_pred hHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCC---cEEEeeecCccccccC-CCcccC
Q 014352 201 SNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFM---RAKVADFGLSKEEVFD-GRNSGL 276 (426)
Q Consensus 201 ~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfgl~~~~~~~-~~~~~~ 276 (426)
.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++ .+||+|||+++..... ......
T Consensus 94 ~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 169 (325)
T 3kn6_A 94 FERIKKK-KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTP 169 (325)
T ss_dssp HHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC--------
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCccccc
Confidence 9999654 56999999999999999999999998 99999999999998765 8999999999754322 223456
Q ss_pred ccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhccc---CC---HHHH
Q 014352 277 KGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGA---CN---IQEV 350 (426)
Q Consensus 277 ~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~---~~~~ 350 (426)
.||+.|+|||.+.+..++.++||||||+++|||++|..||........ .....+.......+. .. ...+
T Consensus 170 ~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-----~~~~~~~~~~i~~~~~~~~~~~~~~~s 244 (325)
T 3kn6_A 170 CFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLT-----CTSAVEIMKKIKKGDFSFEGEAWKNVS 244 (325)
T ss_dssp --------------CCCCHHHHHHHHHHHHHHHHHSSCTTC------------CCCHHHHHHHHTTTCCCCCSHHHHTSC
T ss_pred CCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccc-----cccHHHHHHHHHcCCCCCCcccccCCC
Confidence 789999999999999999999999999999999999999976432110 000111111111110 00 1235
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 351 RELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 351 ~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
..+.+++.+||+.||++|||+.+++++
T Consensus 245 ~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 245 QEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred HHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 679999999999999999999999865
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=343.74 Aligned_cols=256 Identities=25% Similarity=0.354 Sum_probs=190.4
Q ss_pred HHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCC-CCceeeEEeEEEe--------CC
Q 014352 117 ATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLH-HRNLVNLIGYCVD--------KG 186 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~--------~~ 186 (426)
.+|.+.+.||+|+||.||+|.+. +++.||+|++........+.+.+|+.++.++. ||||+++++++.. ..
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~ 107 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA 107 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence 35677889999999999999975 78899999987665555667899999999996 9999999999953 34
Q ss_pred eEEEEEEecCCCChhHHhhh--ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCc
Q 014352 187 KYMLIYEFMSNGSLSNLIYS--EERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLS 264 (426)
Q Consensus 187 ~~~lv~e~~~~gsL~~~l~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 264 (426)
.+++||||+. |+|.+++.. ....+++..++.++.|++.||.|||+++ ++|+||||||+|||++.++.+||+|||++
T Consensus 108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 185 (337)
T 3ll6_A 108 EFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGSA 185 (337)
T ss_dssp EEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTTC
T ss_pred eEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCccc
Confidence 5899999995 699998854 3456999999999999999999999976 45999999999999999999999999999
Q ss_pred cccccCCC-------------cccCccccCccCcccc---ccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhc
Q 014352 265 KEEVFDGR-------------NSGLKGTYGYIDPAYI---STNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASM 328 (426)
Q Consensus 265 ~~~~~~~~-------------~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~ 328 (426)
........ .....||+.|+|||.+ .+..++.++||||||+++|||++|..||.........
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~--- 262 (337)
T 3ll6_A 186 TTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIV--- 262 (337)
T ss_dssp BCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------------
T ss_pred eeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhh---
Confidence 75432211 1134589999999998 5677899999999999999999999999753322111
Q ss_pred cccchhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHhh
Q 014352 329 SQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRHL 386 (426)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~ 386 (426)
...............+.+++.+||+.||++|||+.+++++|+.+.....
T Consensus 263 ---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~ 311 (337)
T 3ll6_A 263 ---------NGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN 311 (337)
T ss_dssp ------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred ---------cCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence 1111111111222458899999999999999999999999999987543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=344.22 Aligned_cols=253 Identities=23% Similarity=0.298 Sum_probs=198.6
Q ss_pred HHHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccC-----CccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEE
Q 014352 116 KATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASD-----SHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYM 189 (426)
Q Consensus 116 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 189 (426)
..+|.+.+.||+|+||.||+|... ++..||+|++... .....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 456888899999999999999975 7788999998643 2233467899999999999999999999999999999
Q ss_pred EEEEecCCCChhHHhhhc---------------------------------------cCCCCHHHHHHHHHHHHHHHHHH
Q 014352 190 LIYEFMSNGSLSNLIYSE---------------------------------------ERVLNWEERLQIALDISHGIEYL 230 (426)
Q Consensus 190 lv~e~~~~gsL~~~l~~~---------------------------------------~~~l~~~~~~~i~~~i~~~l~~L 230 (426)
+||||+++|+|.+++... ...+++..+..++.|++.||.||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 999999999999998421 11235677888999999999999
Q ss_pred HcCCCCCeeecCCCCCCEEecCCC--cEEEeeecCccccccCC-----CcccCccccCccCcccccc--CCCCcchhhHH
Q 014352 231 HEGAVPPVIHRDLKSANILLDHFM--RAKVADFGLSKEEVFDG-----RNSGLKGTYGYIDPAYIST--NKFTMKSDIFS 301 (426)
Q Consensus 231 H~~~~~~ivH~dlk~~Nill~~~~--~~kl~Dfgl~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S 301 (426)
|+++ |+||||||+||+++.++ .+||+|||+++...... ......||+.|+|||.+.+ ..++.++||||
T Consensus 185 H~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws 261 (345)
T 3hko_A 185 HNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261 (345)
T ss_dssp HHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHH
T ss_pred HHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHH
Confidence 9998 99999999999998776 89999999997543211 1245679999999999965 67899999999
Q ss_pred HHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 302 FGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 302 ~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
||+++|||++|..||...........+...... .........+..+.+++.+||+.||.+|||+.+++++
T Consensus 262 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h 331 (345)
T 3hko_A 262 AGVLLHLLLMGAVPFPGVNDADTISQVLNKKLC------FENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQH 331 (345)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC------TTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHS
T ss_pred HHHHHHHHHHCCCCCCCCChHHHHHHHHhcccc------cCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 999999999999999765443322221111100 0000111234678999999999999999999999875
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=332.70 Aligned_cols=247 Identities=26% Similarity=0.387 Sum_probs=201.3
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC---ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEE
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS---HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYE 193 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 193 (426)
.|.+.+.||+|+||.||+|... ++..||+|++.... ......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (279)
T 3fdn_A 10 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE 89 (279)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEe
Confidence 3667789999999999999876 66789999986432 1234578899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCc
Q 014352 194 FMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRN 273 (426)
Q Consensus 194 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 273 (426)
|+++|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++..... ...
T Consensus 90 ~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~-~~~ 164 (279)
T 3fdn_A 90 YAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRR 164 (279)
T ss_dssp CCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC------
T ss_pred cCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCc-ccc
Confidence 99999999998654 45899999999999999999999998 99999999999999999999999998864332 223
Q ss_pred ccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHH
Q 014352 274 SGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVREL 353 (426)
Q Consensus 274 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 353 (426)
....||+.|+|||.+.+..++.++||||||+++|+|++|..||...........+.. .....+...+..+
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~ 234 (279)
T 3fdn_A 165 TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR----------VEFTFPDFVTEGA 234 (279)
T ss_dssp ---CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH----------TCCCCCTTSCHHH
T ss_pred cccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHh----------CCCCCCCcCCHHH
Confidence 456789999999999999999999999999999999999999976433222111110 0111122234678
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHHH
Q 014352 354 ARIGHKCLHKTPRKRPSIGEVTQALL 379 (426)
Q Consensus 354 ~~l~~~cl~~~p~~RPs~~evl~~L~ 379 (426)
.+++.+||+.||++|||+.+++++-.
T Consensus 235 ~~li~~~l~~~p~~Rps~~e~l~h~~ 260 (279)
T 3fdn_A 235 RDLISRLLKHNPSQRPMLREVLEHPW 260 (279)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHHHCHH
T ss_pred HHHHHHHhccChhhCCCHHHHhhCcc
Confidence 89999999999999999999998754
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=349.86 Aligned_cols=246 Identities=22% Similarity=0.290 Sum_probs=190.2
Q ss_pred cccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHh-cCCCCceeeEEeEEEe----CCeEEEEEEecC
Q 014352 123 NILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLG-RLHHRNLVNLIGYCVD----KGKYMLIYEFMS 196 (426)
Q Consensus 123 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~----~~~~~lv~e~~~ 196 (426)
+.||+|+||+||++... ++..||||++.. ...+.+|+.++. ..+||||+++++++.. .+.+|+||||++
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~ 142 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 142 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCC
Confidence 68999999999999975 788999999863 345778888874 4589999999999876 567899999999
Q ss_pred CCChhHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecC---CCcEEEeeecCccccccCCC
Q 014352 197 NGSLSNLIYSEE-RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDH---FMRAKVADFGLSKEEVFDGR 272 (426)
Q Consensus 197 ~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfgl~~~~~~~~~ 272 (426)
+|+|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+|||++. ++.+||+|||+++.......
T Consensus 143 gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~ 219 (400)
T 1nxk_A 143 GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 219 (400)
T ss_dssp SEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTCEECC----
T ss_pred CCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccccccCCCCc
Confidence 999999997643 46999999999999999999999998 999999999999998 78899999999986544444
Q ss_pred cccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhh--cccCCHHHH
Q 014352 273 NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQL--VGACNIQEV 350 (426)
Q Consensus 273 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 350 (426)
.....||+.|+|||++.+..++.++|||||||++|||++|..||....... ........+....+ ........+
T Consensus 220 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----~~~~~~~~i~~~~~~~~~~~~~~~s 295 (400)
T 1nxk_A 220 LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA----ISPGMKTRIRMGQYEFPNPEWSEVS 295 (400)
T ss_dssp -------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCS----SCCSHHHHHHHTCCCCCTTTTTTSC
T ss_pred cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccc----ccHHHHHHHHcCcccCCCcccccCC
Confidence 556789999999999999999999999999999999999999996532110 00000011111111 111112345
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 014352 351 RELARIGHKCLHKTPRKRPSIGEVTQALLK 380 (426)
Q Consensus 351 ~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 380 (426)
..+.+++.+||+.||++|||+.+++++-.-
T Consensus 296 ~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 325 (400)
T 1nxk_A 296 EEVKMLIRNLLKTEPTQRMTITEFMNHPWI 325 (400)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhcCccc
Confidence 679999999999999999999999987553
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=347.81 Aligned_cols=241 Identities=25% Similarity=0.366 Sum_probs=191.9
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc---cChHHHHHHHHH-HhcCCCCceeeEEeEEEeCCeEEEEE
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH---QGEKEFQTEVSL-LGRLHHRNLVNLIGYCVDKGKYMLIY 192 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~lv~ 192 (426)
.|.+.+.||+|+||.||+++.. ++..+|+|++..... .....+..|..+ ++.++||||+++++++.+.+.+|+||
T Consensus 39 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~ 118 (373)
T 2r5t_A 39 DFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVL 118 (373)
T ss_dssp GEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEE
T ss_pred heEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEE
Confidence 4677889999999999999976 678899999976432 223456667776 56789999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccccc-CC
Q 014352 193 EFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF-DG 271 (426)
Q Consensus 193 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~-~~ 271 (426)
||+++|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.... ..
T Consensus 119 E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~ 194 (373)
T 2r5t_A 119 DYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS 194 (373)
T ss_dssp ECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCC
T ss_pred eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccccCCC
Confidence 999999999999654 45899999999999999999999999 99999999999999999999999999985332 23
Q ss_pred CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHH
Q 014352 272 RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVR 351 (426)
Q Consensus 272 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (426)
......||+.|+|||++.+..++.++|||||||++|||++|..||...........+ +.... ..+...+.
T Consensus 195 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i--------~~~~~--~~~~~~~~ 264 (373)
T 2r5t_A 195 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI--------LNKPL--QLKPNITN 264 (373)
T ss_dssp CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHH--------HHSCC--CCCSSSCH
T ss_pred ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHH--------Hhccc--CCCCCCCH
Confidence 445678999999999999999999999999999999999999999764332222111 11111 11223346
Q ss_pred HHHHHHHHcccCCCCCCCCHH
Q 014352 352 ELARIGHKCLHKTPRKRPSIG 372 (426)
Q Consensus 352 ~l~~l~~~cl~~~p~~RPs~~ 372 (426)
.+.+++.+||+.||.+||++.
T Consensus 265 ~~~~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 265 SARHLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp HHHHHHHHHTCSSGGGSTTTT
T ss_pred HHHHHHHHHcccCHHhCCCCC
Confidence 789999999999999999985
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=332.04 Aligned_cols=259 Identities=21% Similarity=0.284 Sum_probs=206.5
Q ss_pred HhhhhcccccCCCeeEEEEEe-CCCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEE-EeCCeEEEEEEec
Q 014352 118 TQNFTNILGQGAFGPVYKATM-PSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYC-VDKGKYMLIYEFM 195 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~lv~e~~ 195 (426)
.|.+.+.||+|+||.||+|+. .+++.||+|++.... ....+.+|+.++++++|++++..+.++ ...+..++||||+
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 87 (296)
T 3uzp_A 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 87 (296)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred EEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec
Confidence 366778999999999999997 478899999987543 234689999999999988877666655 5667889999999
Q ss_pred CCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEe---cCCCcEEEeeecCccccccCCC
Q 014352 196 SNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILL---DHFMRAKVADFGLSKEEVFDGR 272 (426)
Q Consensus 196 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfgl~~~~~~~~~ 272 (426)
+++|.+++......+++..++.++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||++........
T Consensus 88 -~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (296)
T 3uzp_A 88 -GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred -CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccc
Confidence 89999999766677999999999999999999999998 9999999999999 4889999999999975433221
Q ss_pred --------cccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhccc
Q 014352 273 --------NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGA 344 (426)
Q Consensus 273 --------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (426)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||....... .......+........
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT-----KRQKYERISEKKMSTP 238 (296)
T ss_dssp CCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS-----SSSHHHHHHHHHHHSC
T ss_pred ccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchh-----hhhhhhhhcccccCCc
Confidence 245679999999999999999999999999999999999999997532110 0000011111111100
Q ss_pred ---CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHhhh
Q 014352 345 ---CNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRHLA 387 (426)
Q Consensus 345 ---~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~~ 387 (426)
.....+..+.+++.+||+.||++|||+.++++.|+.+......
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 284 (296)
T 3uzp_A 239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence 0112346799999999999999999999999999999876654
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=335.45 Aligned_cols=254 Identities=24% Similarity=0.378 Sum_probs=203.3
Q ss_pred HHHHHHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEE
Q 014352 113 DIQKATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLI 191 (426)
Q Consensus 113 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 191 (426)
+.....|.+.+.||+|+||.||+|... ++..||+|.+.... ..+.+.+|+.++++++||||+++++++...+..++|
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV 102 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence 334555777889999999999999976 68899999987643 346789999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC-
Q 014352 192 YEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD- 270 (426)
Q Consensus 192 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~- 270 (426)
|||+++++|.+++......+++..+..++.+++.||.|||+.+ ++|+||||+||+++.++.+||+|||++......
T Consensus 103 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 103 MEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp EECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred eecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 9999999999999766677999999999999999999999998 999999999999999999999999999754332
Q ss_pred CCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHH
Q 014352 271 GRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEV 350 (426)
Q Consensus 271 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (426)
.......||+.|+|||.+.+..++.++||||||+++|+|++|..||................... ...+...+
T Consensus 180 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~ 252 (314)
T 3com_A 180 AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPT-------FRKPELWS 252 (314)
T ss_dssp SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-------CSSGGGSC
T ss_pred cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcc-------cCCcccCC
Confidence 22345678999999999999999999999999999999999999997643332221111100000 00112234
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014352 351 RELARIGHKCLHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 351 ~~l~~l~~~cl~~~p~~RPs~~evl~~L 378 (426)
..+.+++.+||+.||.+|||+.+++++-
T Consensus 253 ~~l~~li~~~l~~dp~~Rpt~~~ll~~~ 280 (314)
T 3com_A 253 DNFTDFVKQCLVKSPEQRATATQLLQHP 280 (314)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHTTSH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHhCH
Confidence 6789999999999999999999998753
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=349.89 Aligned_cols=249 Identities=21% Similarity=0.354 Sum_probs=197.5
Q ss_pred HhhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCc--cChHHHHHHHHHHhcCC--CCceeeEEeEEEeCCeEEEEEE
Q 014352 118 TQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSH--QGEKEFQTEVSLLGRLH--HRNLVNLIGYCVDKGKYMLIYE 193 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e 193 (426)
.|.+.+.||+|+||.||++...+++.||||++..... ...+.+.+|+.+|++++ ||||+++++++...+.+++|||
T Consensus 57 ~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E 136 (390)
T 2zmd_A 57 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME 136 (390)
T ss_dssp EEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred ceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe
Confidence 3677789999999999999988899999999875432 23467899999999996 5999999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC--
Q 014352 194 FMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG-- 271 (426)
Q Consensus 194 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-- 271 (426)
+.+++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++ ++.+||+|||+++......
T Consensus 137 -~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 210 (390)
T 2zmd_A 137 -CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 210 (390)
T ss_dssp -CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred -cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence 5688999999654 46899999999999999999999998 99999999999996 5899999999998543222
Q ss_pred -CcccCccccCccCcccccc-----------CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhh
Q 014352 272 -RNSGLKGTYGYIDPAYIST-----------NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDK 339 (426)
Q Consensus 272 -~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 339 (426)
......||+.|+|||++.+ ..++.++|||||||++|||++|..||........ ....+++.
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~-------~~~~~~~~ 283 (390)
T 2zmd_A 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS-------KLHAIIDP 283 (390)
T ss_dssp ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-------HHHHHHCT
T ss_pred ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHH-------HHHHHhCc
Confidence 2245679999999999865 4689999999999999999999999975322111 01112222
Q ss_pred hhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 014352 340 QLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALL 379 (426)
Q Consensus 340 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 379 (426)
......+......+.+++.+||+.||++|||+.+++++-.
T Consensus 284 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~ 323 (390)
T 2zmd_A 284 NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 323 (390)
T ss_dssp TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred cccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcC
Confidence 2211112222457899999999999999999999998743
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=357.77 Aligned_cols=252 Identities=25% Similarity=0.350 Sum_probs=202.7
Q ss_pred HHHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC--ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEE
Q 014352 116 KATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS--HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIY 192 (426)
Q Consensus 116 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 192 (426)
...|.+.+.||+|+||+||+|+.. ++..+|+|++.... ......+.+|+.++++++||||+++++++.+.+..++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 456888899999999999999976 78899999987653 233567899999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCC---CcEEEeeecCcccccc
Q 014352 193 EFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHF---MRAKVADFGLSKEEVF 269 (426)
Q Consensus 193 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfgl~~~~~~ 269 (426)
||+++|+|.+.+... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.. +.+||+|||++.....
T Consensus 116 e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 116 ECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp ECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred ecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 999999999988654 45899999999999999999999998 9999999999999764 4599999999986555
Q ss_pred CCCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHH
Q 014352 270 DGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQE 349 (426)
Q Consensus 270 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (426)
........||+.|+|||++. ..++.++|||||||++|+|++|..||........+..+...... .........
T Consensus 192 ~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~------~~~~~~~~~ 264 (494)
T 3lij_A 192 QKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYT------FDSPEWKNV 264 (494)
T ss_dssp TBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC------CCSGGGTTS
T ss_pred CccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC------CCchhcccC
Confidence 45556678999999999986 56999999999999999999999999865443222221111100 000011123
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014352 350 VRELARIGHKCLHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 350 ~~~l~~l~~~cl~~~p~~RPs~~evl~~L 378 (426)
+..+.+++.+||+.||.+|||+.+++++-
T Consensus 265 s~~~~~li~~~L~~dp~~R~s~~e~l~hp 293 (494)
T 3lij_A 265 SEGAKDLIKQMLQFDSQRRISAQQALEHP 293 (494)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHTCH
T ss_pred CHHHHHHHHHHCCCChhhCccHHHHhcCc
Confidence 46789999999999999999999999763
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=343.75 Aligned_cols=254 Identities=21% Similarity=0.353 Sum_probs=205.3
Q ss_pred HHHHHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCcc--------ChHHHHHHHHHHhcC-CCCceeeEEeEEE
Q 014352 114 IQKATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQ--------GEKEFQTEVSLLGRL-HHRNLVNLIGYCV 183 (426)
Q Consensus 114 l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 183 (426)
.....|.+.+.||+|+||.||+|+.. +|+.||||++...... ..+.+.+|+.+++++ +||||+++++++.
T Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 170 (365)
T 2y7j_A 91 EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE 170 (365)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence 33456777789999999999999985 7899999998765321 134578899999999 7999999999999
Q ss_pred eCCeEEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecC
Q 014352 184 DKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGL 263 (426)
Q Consensus 184 ~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 263 (426)
..+..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 171 ~~~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~DfG~ 246 (365)
T 2y7j_A 171 SSSFMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGF 246 (365)
T ss_dssp BSSEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred eCCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEecCc
Confidence 999999999999999999999644 45999999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCCcccCccccCccCcccccc------CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhh
Q 014352 264 SKEEVFDGRNSGLKGTYGYIDPAYIST------NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEIL 337 (426)
Q Consensus 264 ~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 337 (426)
+.............||+.|+|||++.+ ..++.++||||||+++|||++|..||........+..+...... ..
T Consensus 247 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-~~ 325 (365)
T 2y7j_A 247 SCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQ-FS 325 (365)
T ss_dssp CEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC-CC
T ss_pred ccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC-CC
Confidence 986554445556789999999999863 35889999999999999999999999764333222111111000 00
Q ss_pred hhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 338 DKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 338 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
.+. ....+..+.+++.+||+.||++|||+.+++++
T Consensus 326 ~~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 326 SPE-----WDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HHH-----HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred Ccc-----cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 000 01123568999999999999999999999874
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=355.61 Aligned_cols=254 Identities=24% Similarity=0.261 Sum_probs=194.7
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC--ccChHHHHHHHHHHhcCCCCceeeEEeEEEeC------CeE
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS--HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDK------GKY 188 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~ 188 (426)
+|.+.+.||+|+||+||+|... +++.||||++.... ....+.+.+|+.+|+.++||||+++++++... ...
T Consensus 63 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~ 142 (464)
T 3ttj_A 63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 142 (464)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred CeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeE
Confidence 4667789999999999999875 68899999997542 22345788999999999999999999999654 457
Q ss_pred EEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccc
Q 014352 189 MLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEV 268 (426)
Q Consensus 189 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 268 (426)
|+||||+++ +|.+.+. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 143 ~lv~E~~~~-~l~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 215 (464)
T 3ttj_A 143 YLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215 (464)
T ss_dssp EEEEECCSE-EHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred EEEEeCCCC-CHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence 999999976 5666663 23899999999999999999999998 9999999999999999999999999998655
Q ss_pred cCCCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccc---cc-----------h-
Q 014352 269 FDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQ---DG-----------V- 333 (426)
Q Consensus 269 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~---~~-----------~- 333 (426)
.........||+.|+|||++.+..|+.++|||||||++|||++|+.||.+......+..+.. .. .
T Consensus 216 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~ 295 (464)
T 3ttj_A 216 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 295 (464)
T ss_dssp -CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHH
T ss_pred CCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhh
Confidence 44455667899999999999999999999999999999999999999986443222211100 00 0
Q ss_pred --------------hhhhhhhhcccCC---HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014352 334 --------------DEILDKQLVGACN---IQEVRELARIGHKCLHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 334 --------------~~~~~~~~~~~~~---~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 378 (426)
...+......... ......+.+|+.+||+.||++|||+.|++++-
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp 357 (464)
T 3ttj_A 296 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 357 (464)
T ss_dssp HHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred hHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcCh
Confidence 0000000000000 11256789999999999999999999999863
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=338.55 Aligned_cols=256 Identities=21% Similarity=0.319 Sum_probs=196.7
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccC--hHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEe
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQG--EKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEF 194 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 194 (426)
+|.+.+.||+|+||+||+|... +++.||+|++....... .+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (311)
T 4agu_A 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEY 83 (311)
T ss_dssp CEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEe
Confidence 3567789999999999999986 68899999986553222 35688999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC-CCc
Q 014352 195 MSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD-GRN 273 (426)
Q Consensus 195 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-~~~ 273 (426)
+++++|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++...... ...
T Consensus 84 ~~~~~l~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 159 (311)
T 4agu_A 84 CDHTVLHELDRY-QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY 159 (311)
T ss_dssp CSEEHHHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred CCCchHHHHHhh-hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCccccc
Confidence 999999888754 455999999999999999999999998 999999999999999999999999999754322 223
Q ss_pred ccCccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccc---cchh---hhhh-hh-----
Q 014352 274 SGLKGTYGYIDPAYIST-NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQ---DGVD---EILD-KQ----- 340 (426)
Q Consensus 274 ~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~---~~~~---~~~~-~~----- 340 (426)
....||+.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.........+.. .... .... ..
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
T 4agu_A 160 DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGV 239 (311)
T ss_dssp ------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTC
T ss_pred CCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccC
Confidence 45678999999999976 6789999999999999999999999976543322211100 0000 0000 00
Q ss_pred -hc---ccC-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 341 -LV---GAC-----NIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 341 -~~---~~~-----~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
.. ... ....+..+.+++.+||+.||++|||+.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 240 KIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp CCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00 000 01234568999999999999999999999875
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=348.53 Aligned_cols=260 Identities=20% Similarity=0.263 Sum_probs=204.9
Q ss_pred HHhhhhcccccCCCeeEEEEEeCC---------CcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceee----------
Q 014352 117 ATQNFTNILGQGAFGPVYKATMPS---------GGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVN---------- 177 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~---------- 177 (426)
..|.+.+.||+|+||.||+|.... ++.||+|++... +.+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 356778899999999999999763 778999998653 46889999999999999987
Q ss_pred -----EEeEEEe-CCeEEEEEEecCCCChhHHhhhc-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEe
Q 014352 178 -----LIGYCVD-KGKYMLIYEFMSNGSLSNLIYSE-ERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILL 250 (426)
Q Consensus 178 -----~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill 250 (426)
+++++.. .+..++||||+ +++|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+|||+
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl~ 192 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFV 192 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEEE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEE
Confidence 6777776 67889999999 99999999764 367999999999999999999999998 9999999999999
Q ss_pred cCCC--cEEEeeecCccccccCC--------CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchH
Q 014352 251 DHFM--RAKVADFGLSKEEVFDG--------RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLM 320 (426)
Q Consensus 251 ~~~~--~~kl~Dfgl~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~ 320 (426)
+.++ .+||+|||+++...... ......||+.|+|||.+.+..++.++||||||+++|||++|..||....
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 9998 89999999997543221 1234579999999999999999999999999999999999999997642
Q ss_pred -HHHHHhhccccchhhhhhhhhcccC--CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHhhh
Q 014352 321 -EYVNLASMSQDGVDEILDKQLVGAC--NIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRHLA 387 (426)
Q Consensus 321 -~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~~ 387 (426)
............ ... ...+...+ ....+..+.+++.+||+.||++|||+.++++.|+.+......
T Consensus 273 ~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~ 340 (352)
T 2jii_A 273 PNTEDIMKQKQKF-VDK-PGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRV 340 (352)
T ss_dssp TCHHHHHHHHHHH-HHS-CCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred cCHHHHHHHHHhc-cCC-hhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCC
Confidence 111111000000 000 00000000 012246799999999999999999999999999999876543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=354.18 Aligned_cols=252 Identities=23% Similarity=0.330 Sum_probs=192.1
Q ss_pred HHHHHHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc--------cChHHHHHHHHHHhcCCCCceeeEEeEEE
Q 014352 113 DIQKATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH--------QGEKEFQTEVSLLGRLHHRNLVNLIGYCV 183 (426)
Q Consensus 113 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~~~~~~~ 183 (426)
......|.+.+.||+|+||.||+|... ++..||+|++..... .....+.+|+.+|++++||||+++++++.
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 344566888899999999999999875 678999999865321 11235889999999999999999999975
Q ss_pred eCCeEEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCC---cEEEee
Q 014352 184 DKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFM---RAKVAD 260 (426)
Q Consensus 184 ~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~D 260 (426)
.+..++||||+++|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++ .+||+|
T Consensus 211 -~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~D 285 (419)
T 3i6u_A 211 -AEDYYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 285 (419)
T ss_dssp -SSEEEEEEECCTTCBGGGGTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred -cCceEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEee
Confidence 45689999999999999988544 46999999999999999999999998 99999999999997544 599999
Q ss_pred ecCccccccCCCcccCccccCccCcccccc---CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhh
Q 014352 261 FGLSKEEVFDGRNSGLKGTYGYIDPAYIST---NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEIL 337 (426)
Q Consensus 261 fgl~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 337 (426)
||+++............||+.|+|||++.+ ..++.++||||||+++|+|++|..||........ ....+
T Consensus 286 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--------~~~~i 357 (419)
T 3i6u_A 286 FGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--------LKDQI 357 (419)
T ss_dssp SSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--------HHHHH
T ss_pred cccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--------HHHHH
Confidence 999986554444556789999999999853 6788999999999999999999999975321111 01111
Q ss_pred hhhhcccC---CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 338 DKQLVGAC---NIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 338 ~~~~~~~~---~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
........ ....+..+.+++.+||+.||++|||+.+++++
T Consensus 358 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 358 TSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp HTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 11000000 01234678999999999999999999999875
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=340.38 Aligned_cols=260 Identities=22% Similarity=0.332 Sum_probs=206.3
Q ss_pred CChhHHHHHHhhhh-cccccCCCeeEEEEEeC-CCcEEEEEEeccCC--ccChHHHHHHHHHHhcCC-CCceeeEEeEEE
Q 014352 109 YAYKDIQKATQNFT-NILGQGAFGPVYKATMP-SGGVAAIKVLASDS--HQGEKEFQTEVSLLGRLH-HRNLVNLIGYCV 183 (426)
Q Consensus 109 ~~~~~l~~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~ 183 (426)
|...+.....|.+. +.||+|+||.||+|... +++.||+|++.... ......+.+|+.++.++. ||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 44445556666665 78999999999999976 68899999987542 233567899999999994 699999999999
Q ss_pred eCCeEEEEEEecCCCChhHHhhhc-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecC---CCcEEEe
Q 014352 184 DKGKYMLIYEFMSNGSLSNLIYSE-ERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDH---FMRAKVA 259 (426)
Q Consensus 184 ~~~~~~lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~ 259 (426)
+.+..++||||+++|+|.+++... ...+++..+..++.|++.||.|||+++ |+||||||+|||++. ++.+||+
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~ 176 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIV 176 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEEC
T ss_pred eCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEe
Confidence 999999999999999999998543 356999999999999999999999998 999999999999998 7899999
Q ss_pred eecCccccccCCCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhh
Q 014352 260 DFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDK 339 (426)
Q Consensus 260 Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 339 (426)
|||+++............||+.|+|||.+.+..++.++||||||+++|||++|..||...........+.... .
T Consensus 177 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~------~ 250 (327)
T 3lm5_A 177 DFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVN------V 250 (327)
T ss_dssp CGGGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC------C
T ss_pred eCccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcc------c
Confidence 9999986554444456679999999999999999999999999999999999999997644332221111100 0
Q ss_pred hhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 340 QLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 340 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
..........+..+.+++.+||+.||++|||+.+++++
T Consensus 251 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 251 DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred ccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 01111112344678999999999999999999999865
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=348.93 Aligned_cols=259 Identities=22% Similarity=0.322 Sum_probs=205.0
Q ss_pred HHHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc-cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEE
Q 014352 116 KATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH-QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYE 193 (426)
Q Consensus 116 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 193 (426)
...|.+.+.||+|+||.||++... ++..||+|++..... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 345667789999999999999986 788999999876532 234578999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCC
Q 014352 194 FMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEG-AVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGR 272 (426)
Q Consensus 194 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 272 (426)
|+++++|.+++... ..+++..+..++.+++.||.|||++ + |+||||||+|||++.++.+||+|||++..... ..
T Consensus 112 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-~~ 186 (360)
T 3eqc_A 112 HMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SM 186 (360)
T ss_dssp CCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-HC
T ss_pred CCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccccc-cc
Confidence 99999999999654 4589999999999999999999995 7 99999999999999999999999999874422 22
Q ss_pred cccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhcc-----------------------
Q 014352 273 NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMS----------------------- 329 (426)
Q Consensus 273 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~----------------------- 329 (426)
.....||+.|+|||.+.+..++.++||||||+++|||++|..||.............
T Consensus 187 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (360)
T 3eqc_A 187 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNK 266 (360)
T ss_dssp ----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------------
T ss_pred ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccc
Confidence 345679999999999999999999999999999999999999997533221100000
Q ss_pred -------ccchhhhhhhhh----cccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 014352 330 -------QDGVDEILDKQL----VGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALL 379 (426)
Q Consensus 330 -------~~~~~~~~~~~~----~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 379 (426)
.....+..+... ........+..+.+++.+||+.||++|||+.+++++-.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 327 (360)
T 3eqc_A 267 FGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 327 (360)
T ss_dssp -------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred cccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChH
Confidence 000011111111 11111223567999999999999999999999998754
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=348.92 Aligned_cols=257 Identities=25% Similarity=0.352 Sum_probs=190.9
Q ss_pred HHHHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC--ccChHHHHHHHHHHhcCC-CCceeeEEeEEEeCC--eE
Q 014352 115 QKATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS--HQGEKEFQTEVSLLGRLH-HRNLVNLIGYCVDKG--KY 188 (426)
Q Consensus 115 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~--~~ 188 (426)
...+|.+.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++++. ||||+++++++...+ .+
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 3445778889999999999999875 78899999986542 223456788999999997 999999999998654 78
Q ss_pred EEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccc
Q 014352 189 MLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEV 268 (426)
Q Consensus 189 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 268 (426)
|+||||++ ++|..++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 87 ~lv~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 160 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFV 160 (388)
T ss_dssp EEEEECCS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred EEEecccC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence 99999997 599998854 46899999999999999999999999 9999999999999999999999999997532
Q ss_pred c----------------------CCCcccCccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHH
Q 014352 269 F----------------------DGRNSGLKGTYGYIDPAYIST-NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNL 325 (426)
Q Consensus 269 ~----------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~ 325 (426)
. ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+......+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~ 240 (388)
T 3oz6_A 161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQL 240 (388)
T ss_dssp SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 1 111234579999999999976 67899999999999999999999999764433222
Q ss_pred hhccc---------------cchhhhhhh----------------------hhcccCCHHHHHHHHHHHHHcccCCCCCC
Q 014352 326 ASMSQ---------------DGVDEILDK----------------------QLVGACNIQEVRELARIGHKCLHKTPRKR 368 (426)
Q Consensus 326 ~~~~~---------------~~~~~~~~~----------------------~~~~~~~~~~~~~l~~l~~~cl~~~p~~R 368 (426)
..+.. ......+.. ..........+..+.+|+.+||+.||++|
T Consensus 241 ~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R 320 (388)
T 3oz6_A 241 ERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKR 320 (388)
T ss_dssp HHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGS
T ss_pred HHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccC
Confidence 21110 000000000 00000011234578999999999999999
Q ss_pred CCHHHHHHH
Q 014352 369 PSIGEVTQA 377 (426)
Q Consensus 369 Ps~~evl~~ 377 (426)
||+.|++++
T Consensus 321 ~t~~e~l~H 329 (388)
T 3oz6_A 321 ISANDALKH 329 (388)
T ss_dssp CCHHHHTTS
T ss_pred CCHHHHhCC
Confidence 999999987
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=329.81 Aligned_cols=250 Identities=22% Similarity=0.336 Sum_probs=202.3
Q ss_pred HHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc-cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEe
Q 014352 117 ATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH-QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEF 194 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 194 (426)
..|.+.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 45778889999999999999976 788999999865432 2346789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC---C
Q 014352 195 MSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD---G 271 (426)
Q Consensus 195 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~---~ 271 (426)
+++++|.+++.. ...+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++...... .
T Consensus 87 ~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 162 (276)
T 2yex_A 87 CSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (276)
T ss_dssp CTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred cCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence 999999999854 345899999999999999999999998 999999999999999999999999998754322 2
Q ss_pred CcccCccccCccCccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHH
Q 014352 272 RNSGLKGTYGYIDPAYISTNKF-TMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEV 350 (426)
Q Consensus 272 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (426)
......||+.|+|||.+.+..+ +.++||||||+++|||++|..||......... .................+
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~ 235 (276)
T 2yex_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-------YSDWKEKKTYLNPWKKID 235 (276)
T ss_dssp CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH-------HHHHHTTCTTSTTGGGSC
T ss_pred cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH-------HHHhhhcccccCchhhcC
Confidence 2345678999999999987765 77999999999999999999999753221000 000000000001112234
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 351 RELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 351 ~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
..+.+++.+||+.||++|||+.+++++
T Consensus 236 ~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 236 SAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 678899999999999999999999864
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=337.07 Aligned_cols=250 Identities=26% Similarity=0.443 Sum_probs=200.5
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecC
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMS 196 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 196 (426)
.|.+.+.||+|+||.||+|... ++..+|+|++........+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus 20 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 99 (302)
T 2j7t_A 20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCP 99 (302)
T ss_dssp TEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCT
T ss_pred ceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCC
Confidence 4667789999999999999986 688999999977665666789999999999999999999999999999999999999
Q ss_pred CCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC-CCccc
Q 014352 197 NGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD-GRNSG 275 (426)
Q Consensus 197 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-~~~~~ 275 (426)
+++|.+++......+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++...... .....
T Consensus 100 ~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 176 (302)
T 2j7t_A 100 GGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS 176 (302)
T ss_dssp TEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC---
T ss_pred CCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccccccccc
Confidence 99999999776677999999999999999999999998 999999999999999999999999987532211 12234
Q ss_pred CccccCccCcccc-----ccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHH
Q 014352 276 LKGTYGYIDPAYI-----STNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEV 350 (426)
Q Consensus 276 ~~gt~~y~aPE~~-----~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (426)
..||+.|+|||.+ .+..++.++||||||+++|+|++|..||................... ...+...+
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~ 249 (302)
T 2j7t_A 177 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPT-------LLTPSKWS 249 (302)
T ss_dssp --CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-------CSSGGGSC
T ss_pred ccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcc-------cCCccccC
Confidence 5689999999998 46778999999999999999999999997644332221111111000 01122234
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 351 RELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 351 ~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
..+.+++.+||+.||++|||+.+++++
T Consensus 250 ~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 250 VEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp HHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred HHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 678999999999999999999999864
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=335.94 Aligned_cols=249 Identities=25% Similarity=0.388 Sum_probs=205.2
Q ss_pred HHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc---cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEE
Q 014352 117 ATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH---QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIY 192 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 192 (426)
.+|.+.+.||+|+||.||++... +++.+|+|++..... ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 34667789999999999999976 678899999865432 23456889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC-C
Q 014352 193 EFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD-G 271 (426)
Q Consensus 193 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-~ 271 (426)
||+++++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++...... .
T Consensus 95 e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 170 (294)
T 2rku_A 95 ELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 170 (294)
T ss_dssp ECCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred ecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecccCcc
Confidence 999999999988544 46999999999999999999999998 999999999999999999999999999754322 2
Q ss_pred CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHH
Q 014352 272 RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVR 351 (426)
Q Consensus 272 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (426)
......||+.|+|||.+.+..++.++||||||+++|+|++|..||...........+... . ...+.....
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--------~--~~~~~~~~~ 240 (294)
T 2rku_A 171 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN--------E--YSIPKHINP 240 (294)
T ss_dssp CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT--------C--CCCCTTSCH
T ss_pred ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc--------c--CCCccccCH
Confidence 234467899999999999999999999999999999999999999764332221111110 0 011122345
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 014352 352 ELARIGHKCLHKTPRKRPSIGEVTQALL 379 (426)
Q Consensus 352 ~l~~l~~~cl~~~p~~RPs~~evl~~L~ 379 (426)
.+.+++.+||+.||++|||+.+++++-.
T Consensus 241 ~~~~li~~~l~~~p~~Rps~~~ll~~~~ 268 (294)
T 2rku_A 241 VAASLIQKMLQTDPTARPTINELLNDEF 268 (294)
T ss_dssp HHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred HHHHHHHHHcccChhhCcCHHHHhhChh
Confidence 7889999999999999999999998643
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=362.45 Aligned_cols=250 Identities=25% Similarity=0.401 Sum_probs=205.2
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC---ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEe
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS---HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEF 194 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 194 (426)
+.+.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+.+|++++||||+++++++.+.+.+++||||
T Consensus 186 f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy 265 (576)
T 2acx_A 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 265 (576)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEc
Confidence 555678999999999999975 78899999986532 23345688999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCc
Q 014352 195 MSNGSLSNLIYSEE-RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRN 273 (426)
Q Consensus 195 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 273 (426)
+++|+|.+++...+ ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 266 ~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~~ 342 (576)
T 2acx_A 266 MNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI 342 (576)
T ss_dssp CCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCE
T ss_pred CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecccCccc
Confidence 99999999986544 35899999999999999999999998 999999999999999999999999999865444444
Q ss_pred ccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHH
Q 014352 274 SGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVREL 353 (426)
Q Consensus 274 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 353 (426)
....||+.|+|||++.+..++.++|||||||++|||++|..||........ ...+...+. ......+...+..+
T Consensus 343 ~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~-----~~~i~~~i~-~~~~~~p~~~s~~~ 416 (576)
T 2acx_A 343 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-----REEVERLVK-EVPEEYSERFSPQA 416 (576)
T ss_dssp ECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC-----HHHHHHHHH-HCCCCCCTTSCHHH
T ss_pred cccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh-----HHHHHHHhh-cccccCCccCCHHH
Confidence 566899999999999999999999999999999999999999975321000 000001111 01111223345689
Q ss_pred HHHHHHcccCCCCCCC-----CHHHHHHH
Q 014352 354 ARIGHKCLHKTPRKRP-----SIGEVTQA 377 (426)
Q Consensus 354 ~~l~~~cl~~~p~~RP-----s~~evl~~ 377 (426)
.+++.+||+.||.+|| ++.|++++
T Consensus 417 ~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 417 RSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp HHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred HHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 9999999999999999 78888875
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=334.04 Aligned_cols=255 Identities=23% Similarity=0.357 Sum_probs=195.2
Q ss_pred hhh-hcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcC-CCCceeeEEeEEEeCCeEEEEEEec
Q 014352 119 QNF-TNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRL-HHRNLVNLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 119 ~~~-~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~ 195 (426)
|.+ .+.||+|+||.||+|... +++.||+|++..........+.+|+.++.++ +||||+++++++.+.+..++||||+
T Consensus 14 y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 93 (316)
T 2ac3_A 14 YQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKM 93 (316)
T ss_dssp CEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcC
Confidence 444 357999999999999965 7889999999876555567899999999985 7999999999999999999999999
Q ss_pred CCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCc---EEEeeecCccccccCC-
Q 014352 196 SNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMR---AKVADFGLSKEEVFDG- 271 (426)
Q Consensus 196 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfgl~~~~~~~~- 271 (426)
++|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++. +||+|||++.......
T Consensus 94 ~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 169 (316)
T 2ac3_A 94 RGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD 169 (316)
T ss_dssp TTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------
T ss_pred CCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCc
Confidence 999999999654 45899999999999999999999998 999999999999998776 9999999987432211
Q ss_pred -------CcccCccccCccCcccccc-----CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHh---hccccchhhh
Q 014352 272 -------RNSGLKGTYGYIDPAYIST-----NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLA---SMSQDGVDEI 336 (426)
Q Consensus 272 -------~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~---~~~~~~~~~~ 336 (426)
......||+.|+|||.+.+ ..++.++||||||+++|||++|..||.......... .........+
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 249 (316)
T 2ac3_A 170 CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNML 249 (316)
T ss_dssp ------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHH
T ss_pred cccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHH
Confidence 1223459999999999875 558899999999999999999999997532100000 0000000000
Q ss_pred hhhhhcc--cCC----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 337 LDKQLVG--ACN----IQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 337 ~~~~~~~--~~~----~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
....... ..+ ...+..+.+++.+||+.||++|||+.+++++
T Consensus 250 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 250 FESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0000000 011 1134678999999999999999999999975
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=338.38 Aligned_cols=257 Identities=25% Similarity=0.387 Sum_probs=198.0
Q ss_pred HHHhhhhcccccCCCeeEEEEEeC--CCc--EEEEEEeccCCc---cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeE
Q 014352 116 KATQNFTNILGQGAFGPVYKATMP--SGG--VAAIKVLASDSH---QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKY 188 (426)
Q Consensus 116 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 188 (426)
...|.+.+.||+|+||+||+|++. ++. .||+|++..... ...+.+.+|+.++++++||||+++++++.+.+ .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 345777889999999999999863 333 689999875422 23467889999999999999999999998765 8
Q ss_pred EEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccc
Q 014352 189 MLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEV 268 (426)
Q Consensus 189 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 268 (426)
++|+||+++++|.+++......+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++....
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccccc
Confidence 8999999999999999776677999999999999999999999998 9999999999999999999999999987543
Q ss_pred cCCC----cccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcc
Q 014352 269 FDGR----NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVG 343 (426)
Q Consensus 269 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (426)
.... .....+|..|+|||.+.+..++.++||||||+++|+|++ |..||...........+... ....
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~--------~~~~ 244 (291)
T 1u46_A 173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE--------GERL 244 (291)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTS--------CCCC
T ss_pred ccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHcc--------CCCC
Confidence 2221 223457788999999998889999999999999999999 99999764433222211111 1111
Q ss_pred cCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHH
Q 014352 344 ACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQR 384 (426)
Q Consensus 344 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 384 (426)
..+...+..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 245 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 245 PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 11223456799999999999999999999999999887543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=342.91 Aligned_cols=249 Identities=25% Similarity=0.394 Sum_probs=205.4
Q ss_pred HHHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc---cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEE
Q 014352 116 KATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH---QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLI 191 (426)
Q Consensus 116 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 191 (426)
..+|.+.+.||+|+||.||++... +++.+|+|++..... ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 345677889999999999999976 678999999865422 2345688999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC-
Q 014352 192 YEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD- 270 (426)
Q Consensus 192 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~- 270 (426)
|||+++++|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 120 ~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 195 (335)
T 2owb_A 120 LELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 195 (335)
T ss_dssp ECCCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EecCCCCCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence 9999999999988544 46999999999999999999999998 999999999999999999999999999754322
Q ss_pred CCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHH
Q 014352 271 GRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEV 350 (426)
Q Consensus 271 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (426)
.......||+.|+|||.+.+..++.++||||||+++|||++|..||...........+... .. ..+....
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--------~~--~~~~~~~ 265 (335)
T 2owb_A 196 ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN--------EY--SIPKHIN 265 (335)
T ss_dssp CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT--------CC--CCCTTSC
T ss_pred ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC--------CC--CCCccCC
Confidence 2234567999999999999999999999999999999999999999764322211111110 00 1112233
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014352 351 RELARIGHKCLHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 351 ~~l~~l~~~cl~~~p~~RPs~~evl~~L 378 (426)
..+.+++.+||+.||++|||+.+++++-
T Consensus 266 ~~~~~li~~~l~~dp~~Rps~~ell~~~ 293 (335)
T 2owb_A 266 PVAASLIQKMLQTDPTARPTINELLNDE 293 (335)
T ss_dssp HHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 5788999999999999999999999864
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=334.44 Aligned_cols=254 Identities=20% Similarity=0.299 Sum_probs=198.7
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccC---hHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEE
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQG---EKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYE 193 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 193 (426)
.|.+.+.||+|+||.||+|... +++.||+|++....... .+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 2h34_A 35 PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMR 114 (309)
T ss_dssp CEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEE
Confidence 4677889999999999999975 78899999987653322 3578899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC--
Q 014352 194 FMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG-- 271 (426)
Q Consensus 194 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-- 271 (426)
|+++++|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 115 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 190 (309)
T 2h34_A 115 LINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT 190 (309)
T ss_dssp CCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC----------
T ss_pred ecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccccccc
Confidence 99999999999654 45899999999999999999999998 9999999999999999999999999987543221
Q ss_pred CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHH
Q 014352 272 RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVR 351 (426)
Q Consensus 272 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (426)
......||+.|+|||.+.+..++.++||||||+++|||++|..||...........+.... .. ....+...+.
T Consensus 191 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~------~~~~~~~~~~ 263 (309)
T 2h34_A 191 QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAI-PR------PSTVRPGIPV 263 (309)
T ss_dssp ------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCC-CC------GGGTSTTCCT
T ss_pred cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCC-CC------ccccCCCCCH
Confidence 2234568999999999999999999999999999999999999998654321111111000 00 0111223345
Q ss_pred HHHHHHHHcccCCCCCCC-CHHHHHHHHHHHH
Q 014352 352 ELARIGHKCLHKTPRKRP-SIGEVTQALLKIK 382 (426)
Q Consensus 352 ~l~~l~~~cl~~~p~~RP-s~~evl~~L~~~~ 382 (426)
.+.+++.+||+.||++|| |+.++++.|+...
T Consensus 264 ~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l 295 (309)
T 2h34_A 264 AFDAVIARGMAKNPEDRYVTCGDLSAAAHAAL 295 (309)
T ss_dssp HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTC
T ss_pred HHHHHHHHhccCCHHHHHHhHHHHHHHHHHHH
Confidence 789999999999999999 9999999988664
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=328.44 Aligned_cols=247 Identities=23% Similarity=0.391 Sum_probs=197.0
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC--ccChHHHHHHHHHHhcCCCCceeeEEeEEEe----CCeEEEE
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS--HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVD----KGKYMLI 191 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv 191 (426)
+.+.+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.++++++||||+++++++.. ....++|
T Consensus 28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 107 (290)
T 1t4h_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence 456678999999999999875 67789999987542 2234578999999999999999999999876 3568999
Q ss_pred EEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEec-CCCcEEEeeecCccccccC
Q 014352 192 YEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLD-HFMRAKVADFGLSKEEVFD 270 (426)
Q Consensus 192 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfgl~~~~~~~ 270 (426)
|||+++|+|.+++... ..+++..+..++.|++.||.|||+++ ++|+||||||+||+++ .++.+||+|||++.... .
T Consensus 108 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~-~ 184 (290)
T 1t4h_A 108 TELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR-A 184 (290)
T ss_dssp EECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC-T
T ss_pred EEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccccc-c
Confidence 9999999999999654 55899999999999999999999976 4599999999999998 78999999999996432 2
Q ss_pred CCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhh-ccccchhhhhhhhhcccCCHHH
Q 014352 271 GRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLAS-MSQDGVDEILDKQLVGACNIQE 349 (426)
Q Consensus 271 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 349 (426)
.......||+.|+|||.+. ..++.++||||||+++|+|++|..||........... ........ . .+...
T Consensus 185 ~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----~----~~~~~ 255 (290)
T 1t4h_A 185 SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA----S----FDKVA 255 (290)
T ss_dssp TSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG----G----GGGCC
T ss_pred cccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCcc----c----cCCCC
Confidence 2334567999999999886 4589999999999999999999999975332221111 11111010 1 11112
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 350 VRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 350 ~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
+..+.+++.+||+.||.+|||+.+++++
T Consensus 256 ~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 256 IPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 3578999999999999999999999864
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=354.82 Aligned_cols=255 Identities=26% Similarity=0.389 Sum_probs=210.5
Q ss_pred HHHHHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC---ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEE
Q 014352 114 IQKATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS---HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYM 189 (426)
Q Consensus 114 l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 189 (426)
+...+|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 102 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 34567888899999999999999976 78899999986543 234567999999999999999999999999999999
Q ss_pred EEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEe---cCCCcEEEeeecCccc
Q 014352 190 LIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILL---DHFMRAKVADFGLSKE 266 (426)
Q Consensus 190 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfgl~~~ 266 (426)
+||||+.+|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 103 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIISR-KRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp EEECCCCSCBHHHHHHTC-SCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 999999999999998654 45999999999999999999999998 9999999999999 5678999999999976
Q ss_pred cccCCCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCC
Q 014352 267 EVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACN 346 (426)
Q Consensus 267 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (426)
...........||+.|+|||.+.+ .++.++|||||||++|+|++|..||........+..+...... ......
T Consensus 179 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~------~~~~~~ 251 (484)
T 3nyv_A 179 FEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYT------FELPQW 251 (484)
T ss_dssp BCCCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC------CCSGGG
T ss_pred cccccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC------CCCccc
Confidence 544444455679999999999876 6999999999999999999999999875444333222111100 000111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 014352 347 IQEVRELARIGHKCLHKTPRKRPSIGEVTQALL 379 (426)
Q Consensus 347 ~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 379 (426)
...+..+.+++.+||+.||.+|||+.+++++-.
T Consensus 252 ~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~ 284 (484)
T 3nyv_A 252 KKVSESAKDLIRKMLTYVPSMRISARDALDHEW 284 (484)
T ss_dssp GGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHH
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhhChh
Confidence 234467899999999999999999999998754
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=332.59 Aligned_cols=250 Identities=26% Similarity=0.417 Sum_probs=207.7
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC-ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecC
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS-HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMS 196 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 196 (426)
|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 24 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 103 (303)
T 3a7i_A 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 103 (303)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred HHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCC
Confidence 566789999999999999875 78899999997653 2345689999999999999999999999999999999999999
Q ss_pred CCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC-Cccc
Q 014352 197 NGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG-RNSG 275 (426)
Q Consensus 197 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-~~~~ 275 (426)
+++|.+++.. ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++....... ....
T Consensus 104 ~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 178 (303)
T 3a7i_A 104 GGSALDLLEP--GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT 178 (303)
T ss_dssp TEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBCC
T ss_pred CCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccccccCc
Confidence 9999999843 46899999999999999999999998 9999999999999999999999999997543322 2345
Q ss_pred CccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHH
Q 014352 276 LKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELAR 355 (426)
Q Consensus 276 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 355 (426)
..||+.|+|||.+.+..++.++||||||+++|+|++|..||...........+.. ......+...+..+.+
T Consensus 179 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~l~~ 249 (303)
T 3a7i_A 179 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK---------NNPPTLEGNYSKPLKE 249 (303)
T ss_dssp CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---------SCCCCCCSSCCHHHHH
T ss_pred cCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhc---------CCCCCCccccCHHHHH
Confidence 6789999999999999999999999999999999999999976433322211111 1111112233467999
Q ss_pred HHHHcccCCCCCCCCHHHHHHHHHHHH
Q 014352 356 IGHKCLHKTPRKRPSIGEVTQALLKIK 382 (426)
Q Consensus 356 l~~~cl~~~p~~RPs~~evl~~L~~~~ 382 (426)
++.+||+.||++|||+.+++++..-..
T Consensus 250 li~~~l~~dp~~Rps~~~ll~~~~~~~ 276 (303)
T 3a7i_A 250 FVEACLNKEPSFRPTAKELLKHKFILR 276 (303)
T ss_dssp HHHHHCCSSGGGSCCHHHHTTCHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHhhChhhhc
Confidence 999999999999999999998765443
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=333.02 Aligned_cols=246 Identities=24% Similarity=0.355 Sum_probs=204.5
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC---ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEE
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS---HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYE 193 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 193 (426)
.|.+.+.||+|+||.||+|... ++..||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 15 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 94 (284)
T 2vgo_A 15 DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLE 94 (284)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEE
Confidence 4677789999999999999976 67789999986432 1234678999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCc
Q 014352 194 FMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRN 273 (426)
Q Consensus 194 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 273 (426)
|+++|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++..... ...
T Consensus 95 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~-~~~ 169 (284)
T 2vgo_A 95 FAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS-LRR 169 (284)
T ss_dssp CCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS-SCB
T ss_pred eCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc-ccc
Confidence 99999999999654 45899999999999999999999998 99999999999999999999999999865432 233
Q ss_pred ccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHH
Q 014352 274 SGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVREL 353 (426)
Q Consensus 274 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 353 (426)
....|++.|+|||.+.+..++.++||||||+++|+|++|..||...........+.. .. ...+...+..+
T Consensus 170 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~--------~~--~~~~~~~~~~~ 239 (284)
T 2vgo_A 170 RTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVN--------VD--LKFPPFLSDGS 239 (284)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT--------TC--CCCCTTSCHHH
T ss_pred ccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhc--------cc--cCCCCcCCHHH
Confidence 456789999999999999999999999999999999999999976433222111111 00 01122334678
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHH
Q 014352 354 ARIGHKCLHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 354 ~~l~~~cl~~~p~~RPs~~evl~~L 378 (426)
.+++.+||+.||.+|||+.+++++-
T Consensus 240 ~~li~~~l~~~p~~Rps~~~ll~h~ 264 (284)
T 2vgo_A 240 KDLISKLLRYHPPQRLPLKGVMEHP 264 (284)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHTCH
T ss_pred HHHHHHHhhcCHhhCCCHHHHhhCH
Confidence 9999999999999999999999864
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-44 Score=344.62 Aligned_cols=257 Identities=24% Similarity=0.315 Sum_probs=202.7
Q ss_pred HHHHHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCC-----CCceeeEEeEEEeCCe
Q 014352 114 IQKATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLH-----HRNLVNLIGYCVDKGK 187 (426)
Q Consensus 114 l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~~~~~~~~~~~ 187 (426)
+....|.+.+.||+|+||+||+|+.. ++..||+|++... ....+.+..|+.+++++. ||||+++++++...+.
T Consensus 32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~ 110 (360)
T 3llt_A 32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDH 110 (360)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTE
T ss_pred EecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCe
Confidence 34456778899999999999999974 7889999998743 233456788999999986 9999999999999999
Q ss_pred EEEEEEecCCCChhHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecC--------------
Q 014352 188 YMLIYEFMSNGSLSNLIYSEE-RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDH-------------- 252 (426)
Q Consensus 188 ~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~-------------- 252 (426)
.++||||+ +++|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.
T Consensus 111 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~~~~~~~~ 186 (360)
T 3llt_A 111 MCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVT 186 (360)
T ss_dssp EEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEEEEEEECTT
T ss_pred eEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccccccchhccc
Confidence 99999999 899999996654 45899999999999999999999998 999999999999975
Q ss_pred -----------CCcEEEeeecCccccccCCCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHH
Q 014352 253 -----------FMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLME 321 (426)
Q Consensus 253 -----------~~~~kl~Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~ 321 (426)
++.+||+|||+++... .......||+.|+|||++.+..++.++|||||||++|||++|..||.....
T Consensus 187 ~~~~~~~~~~~~~~~kl~DFG~a~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 264 (360)
T 3llt_A 187 DGKKIQIYRTKSTGIKLIDFGCATFKS--DYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEH 264 (360)
T ss_dssp TCCEEEEEEESCCCEEECCCTTCEETT--SCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccccCCCCEEEEeccCceecC--CCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcH
Confidence 7889999999997532 233456789999999999999999999999999999999999999976433
Q ss_pred HHHHhhc---cccchhhhhhhhh-----------------cc------------cC-C---HHHHHHHHHHHHHcccCCC
Q 014352 322 YVNLASM---SQDGVDEILDKQL-----------------VG------------AC-N---IQEVRELARIGHKCLHKTP 365 (426)
Q Consensus 322 ~~~~~~~---~~~~~~~~~~~~~-----------------~~------------~~-~---~~~~~~l~~l~~~cl~~~p 365 (426)
...+..+ ............. .. .+ + ......+.+++.+||+.||
T Consensus 265 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 344 (360)
T 3llt_A 265 MEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDP 344 (360)
T ss_dssp HHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSG
T ss_pred HHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCCh
Confidence 2221111 0000000000000 00 00 0 0012568899999999999
Q ss_pred CCCCCHHHHHHH
Q 014352 366 RKRPSIGEVTQA 377 (426)
Q Consensus 366 ~~RPs~~evl~~ 377 (426)
++|||+.|++++
T Consensus 345 ~~Rpta~elL~h 356 (360)
T 3llt_A 345 TLRPSPAELLKH 356 (360)
T ss_dssp GGSCCHHHHTTS
T ss_pred hhCCCHHHHhcC
Confidence 999999999864
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=341.02 Aligned_cols=251 Identities=21% Similarity=0.238 Sum_probs=204.5
Q ss_pred HHHHhhhhcccccCCCeeEEEEE------eCCCcEEEEEEeccCCccChHHHHHHHHHHhcCC---CCceeeEEeEEEeC
Q 014352 115 QKATQNFTNILGQGAFGPVYKAT------MPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLH---HRNLVNLIGYCVDK 185 (426)
Q Consensus 115 ~~~~~~~~~~lg~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~ 185 (426)
....|.+.+.||+|+||+||+|. ..++..||+|++... ...++..|++++.+++ |+||+++++++...
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 34456777899999999999994 346789999998754 3557888888888886 99999999999999
Q ss_pred CeEEEEEEecCCCChhHHhhh----ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecC---------
Q 014352 186 GKYMLIYEFMSNGSLSNLIYS----EERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDH--------- 252 (426)
Q Consensus 186 ~~~~lv~e~~~~gsL~~~l~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~--------- 252 (426)
+..++||||+++|+|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+|||++.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC----
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccc
Confidence 999999999999999999964 3456999999999999999999999998 999999999999998
Q ss_pred --CCcEEEeeecCcccccc---CCCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhh
Q 014352 253 --FMRAKVADFGLSKEEVF---DGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLAS 327 (426)
Q Consensus 253 --~~~~kl~Dfgl~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~ 327 (426)
++.+||+|||+++.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---- 292 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE---- 292 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE----
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc----
Confidence 89999999999964321 223345679999999999999999999999999999999999999985421110
Q ss_pred ccccchhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCC-CCHHHHHHHHHHHHHHh
Q 014352 328 MSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKR-PSIGEVTQALLKIKQRH 385 (426)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R-Ps~~evl~~L~~~~~~~ 385 (426)
. .+...+... ...+.+.+++..|++.+|.+| |++.++.+.|+.+....
T Consensus 293 ---~----~~~~~~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 293 ---C----KPEGLFRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp ---E----EECSCCTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred ---e----eechhcccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 0 001111111 123567788899999999999 78899999998887654
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=341.04 Aligned_cols=256 Identities=24% Similarity=0.407 Sum_probs=198.3
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccC--hHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEe
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQG--EKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEF 194 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 194 (426)
+|.+.+.||+|+||.||+|+.. +++.||+|++....... .+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 105 (331)
T 4aaa_A 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEF 105 (331)
T ss_dssp GEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEec
Confidence 4667789999999999999976 58899999986543222 34578999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC-CCc
Q 014352 195 MSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD-GRN 273 (426)
Q Consensus 195 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-~~~ 273 (426)
+++++|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++...... ...
T Consensus 106 ~~~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 181 (331)
T 4aaa_A 106 VDHTILDDLELF-PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY 181 (331)
T ss_dssp CSEEHHHHHHHS-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred CCcchHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCcccc
Confidence 999888887643 345999999999999999999999998 999999999999999999999999999754322 223
Q ss_pred ccCccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccc---cch---hhhhh--------
Q 014352 274 SGLKGTYGYIDPAYISTN-KFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQ---DGV---DEILD-------- 338 (426)
Q Consensus 274 ~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~---~~~---~~~~~-------- 338 (426)
....||+.|+|||.+.+. .++.++||||||+++|+|++|..||........+..+.. ... ...+.
T Consensus 182 ~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (331)
T 4aaa_A 182 DDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGV 261 (331)
T ss_dssp --CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTC
T ss_pred CCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccc
Confidence 456789999999999775 789999999999999999999999976543322211100 000 00000
Q ss_pred --hhhcccC-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 339 --KQLVGAC-----NIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 339 --~~~~~~~-----~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
+...... ....+..+.+++.+||+.||++|||+.|++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 262 RLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp CCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred cCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000000 11235679999999999999999999999975
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=341.30 Aligned_cols=251 Identities=22% Similarity=0.334 Sum_probs=200.7
Q ss_pred HHHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcC-CCCceeeEEeEEEeCCeEEEEEE
Q 014352 116 KATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRL-HHRNLVNLIGYCVDKGKYMLIYE 193 (426)
Q Consensus 116 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 193 (426)
...|.+.+.||+|+||.||+|... +++.||+|++..... .+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 345778899999999999999976 688999999976432 345688888887 79999999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCC----CcEEEeeecCcccccc
Q 014352 194 FMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHF----MRAKVADFGLSKEEVF 269 (426)
Q Consensus 194 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfgl~~~~~~ 269 (426)
|+++|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||+..+ +.+||+|||+++....
T Consensus 97 ~~~gg~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~ 172 (342)
T 2qr7_A 97 LMKGGELLDKILRQ-KFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172 (342)
T ss_dssp CCCSCBHHHHHHTC-TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred CCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence 99999999998554 46999999999999999999999998 9999999999998543 3599999999985433
Q ss_pred C-CCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHH---HHHHhhccccchhhhhhhhhcccC
Q 014352 270 D-GRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLME---YVNLASMSQDGVDEILDKQLVGAC 345 (426)
Q Consensus 270 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 345 (426)
. .......||+.|+|||++.+..++.++|||||||++|||++|..||..... ......+.... .......
T Consensus 173 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~------~~~~~~~ 246 (342)
T 2qr7_A 173 ENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGK------FSLSGGY 246 (342)
T ss_dssp TTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCC------CCCCSTT
T ss_pred CCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCC------cccCccc
Confidence 2 233456789999999999888899999999999999999999999975211 00000000000 0011111
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 014352 346 NIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLK 380 (426)
Q Consensus 346 ~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~ 380 (426)
....+..+.+++.+||+.||++|||+.+++++-.-
T Consensus 247 ~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~ 281 (342)
T 2qr7_A 247 WNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWI 281 (342)
T ss_dssp TTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHH
T ss_pred cccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCee
Confidence 22345679999999999999999999999987554
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=328.33 Aligned_cols=244 Identities=20% Similarity=0.293 Sum_probs=200.0
Q ss_pred HHHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc--cChHHHHHHHHHHhcC-CCCceeeEEeEEEeCCeEEEE
Q 014352 116 KATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH--QGEKEFQTEVSLLGRL-HHRNLVNLIGYCVDKGKYMLI 191 (426)
Q Consensus 116 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 191 (426)
...|.+.+.||+|+||.||+|... +++.||+|++..... .....+.+|+..+.++ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 456778899999999999999986 788999999876432 2345788999999999 999999999999999999999
Q ss_pred EEecCCCChhHHhhhcc---CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCC---------------
Q 014352 192 YEFMSNGSLSNLIYSEE---RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHF--------------- 253 (426)
Q Consensus 192 ~e~~~~gsL~~~l~~~~---~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~--------------- 253 (426)
|||+++++|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 99999999999996542 56899999999999999999999998 9999999999999844
Q ss_pred ----CcEEEeeecCccccccCCCcccCccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhc
Q 014352 254 ----MRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTN-KFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASM 328 (426)
Q Consensus 254 ----~~~kl~Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~ 328 (426)
..+||+|||++..... .....||+.|+|||.+.+. .++.++||||||+++|+|++|.+|+........+...
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~ 243 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISS---PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQG 243 (289)
T ss_dssp ---CCCEEECCCTTCEETTC---SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHHHHHTT
T ss_pred cCCceEEEEcccccccccCC---ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHHHHHcC
Confidence 4799999999875432 2334589999999999766 5668999999999999999999887654333222111
Q ss_pred cccchhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 329 SQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
. ....+...+..+.+++.+||+.||++|||+.+++++
T Consensus 244 ~------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 244 R------------LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp C------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred C------------CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 0 011122234678999999999999999999999875
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=336.70 Aligned_cols=250 Identities=24% Similarity=0.349 Sum_probs=187.0
Q ss_pred HHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccC-h-HHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEE
Q 014352 117 ATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQG-E-KEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYE 193 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~-~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 193 (426)
..|.+.+.||+|+||.||+|... +++.||+|++....... . +.+.++...++.++||||+++++++.+.+..++|||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e 86 (290)
T 3fme_A 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICME 86 (290)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEE
T ss_pred HhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEe
Confidence 34667789999999999999974 78899999997653222 2 234555566888999999999999999999999999
Q ss_pred ecCCCChhHHhhh---ccCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCeeecCCCCCCEEecCCCcEEEeeecCcccccc
Q 014352 194 FMSNGSLSNLIYS---EERVLNWEERLQIALDISHGIEYLHEG-AVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF 269 (426)
Q Consensus 194 ~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 269 (426)
|++ |+|.+++.. ....+++..+..++.|++.||.|||++ + |+||||||+||+++.++.+||+|||++.....
T Consensus 87 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 87 LMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp CCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred hhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 997 588887754 346799999999999999999999997 8 99999999999999999999999999976544
Q ss_pred CCCcccCccccCccCcccc----ccCCCCcchhhHHHHHHHHHHHhCCCCCCchH-HHHHHhhccccchhhhhhhhhccc
Q 014352 270 DGRNSGLKGTYGYIDPAYI----STNKFTMKSDIFSFGVIIFELITAIHPHQNLM-EYVNLASMSQDGVDEILDKQLVGA 344 (426)
Q Consensus 270 ~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 344 (426)
........||+.|+|||.+ .+..++.++||||||+++|||++|..||.... ....+. ..........
T Consensus 163 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~--------~~~~~~~~~~ 234 (290)
T 3fme_A 163 DVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLK--------QVVEEPSPQL 234 (290)
T ss_dssp -------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHH--------HHHHSCCCCC
T ss_pred cccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHH--------HHhccCCCCc
Confidence 4444456799999999996 56678999999999999999999999997421 111111 1111111111
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014352 345 CNIQEVRELARIGHKCLHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 345 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 378 (426)
.....+..+.+++.+||+.||++|||+.+++++-
T Consensus 235 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp 268 (290)
T 3fme_A 235 PADKFSAEFVDFTSQCLKKNSKERPTYPELMQHP 268 (290)
T ss_dssp CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSH
T ss_pred ccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCc
Confidence 1223446799999999999999999999999853
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=344.19 Aligned_cols=255 Identities=22% Similarity=0.318 Sum_probs=195.4
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccC-hHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecC
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQG-EKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMS 196 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 196 (426)
|.+.+.||+|+||+||+|... +++.||+|++....... ...+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 4 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (324)
T 3mtl_A 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD 83 (324)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred eEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc
Confidence 566789999999999999976 78899999987543222 2245679999999999999999999999999999999997
Q ss_pred CCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC-CCccc
Q 014352 197 NGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD-GRNSG 275 (426)
Q Consensus 197 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-~~~~~ 275 (426)
|+|.+++...+..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..... .....
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 159 (324)
T 3mtl_A 84 -KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN 159 (324)
T ss_dssp -EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC---------
T ss_pred -cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCcccccc
Confidence 5999999777777999999999999999999999998 999999999999999999999999998754322 22344
Q ss_pred CccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccc-------cchhhhhhh------hh
Q 014352 276 LKGTYGYIDPAYIST-NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQ-------DGVDEILDK------QL 341 (426)
Q Consensus 276 ~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~-------~~~~~~~~~------~~ 341 (426)
..||+.|+|||.+.+ ..++.++||||||+++|||++|..||.+......+..+.. ......... ..
T Consensus 160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (324)
T 3mtl_A 160 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNY 239 (324)
T ss_dssp ---CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCC
T ss_pred ccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccccc
Confidence 578999999999876 5689999999999999999999999976443322211100 000000000 00
Q ss_pred cc-------cCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 342 VG-------ACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 342 ~~-------~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
.. .........+.+++.+||+.||++|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 240 PKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp CCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00 0011234578899999999999999999999975
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=340.04 Aligned_cols=257 Identities=26% Similarity=0.384 Sum_probs=183.9
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC-ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEec
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS-HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 195 (426)
.|.+.+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 95 (303)
T 2vwi_A 16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLL 95 (303)
T ss_dssp CCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECC
T ss_pred hhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhc
Confidence 4567789999999999999864 78899999986543 233457889999999999999999999999999999999999
Q ss_pred CCCChhHHhhh-------ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccc
Q 014352 196 SNGSLSNLIYS-------EERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEV 268 (426)
Q Consensus 196 ~~gsL~~~l~~-------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 268 (426)
++++|.+++.. ....+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++....
T Consensus 96 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 172 (303)
T 2vwi_A 96 SGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLA 172 (303)
T ss_dssp TTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHHHCC
T ss_pred cCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchheec
Confidence 99999999864 2356899999999999999999999998 9999999999999999999999999986432
Q ss_pred cCC------CcccCccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhh
Q 014352 269 FDG------RNSGLKGTYGYIDPAYIST-NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQL 341 (426)
Q Consensus 269 ~~~------~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (426)
... ......||+.|+|||.+.+ ..++.++||||||+++|||++|..||.........................
T Consensus 173 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (303)
T 2vwi_A 173 TGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQ 252 (303)
T ss_dssp ---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC---
T ss_pred cCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccccc
Confidence 211 1234568999999999865 568999999999999999999999997643322111110111000000000
Q ss_pred cccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 342 VGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 342 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
........+..+.+++.+||+.||++|||+.+++++
T Consensus 253 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 253 DKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp --CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred cchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 001111234578999999999999999999999874
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=355.05 Aligned_cols=252 Identities=27% Similarity=0.337 Sum_probs=203.2
Q ss_pred HHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc-------------cChHHHHHHHHHHhcCCCCceeeEEeEE
Q 014352 117 ATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH-------------QGEKEFQTEVSLLGRLHHRNLVNLIGYC 182 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~niv~~~~~~ 182 (426)
..|.+.+.||+|+||+||+|... ++..+|+|++..... ...+.+.+|+.++++++||||+++++++
T Consensus 36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 115 (504)
T 3q5i_A 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF 115 (504)
T ss_dssp GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 34677889999999999999976 678999999875431 2245788999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCC---cEEEe
Q 014352 183 VDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFM---RAKVA 259 (426)
Q Consensus 183 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~ 259 (426)
.+.+..++||||+++|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++ .+||+
T Consensus 116 ~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~ 191 (504)
T 3q5i_A 116 EDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIV 191 (504)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSEEEC
T ss_pred EcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccEEEE
Confidence 9999999999999999999998654 45999999999999999999999998 99999999999999876 69999
Q ss_pred eecCccccccCCCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhh
Q 014352 260 DFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDK 339 (426)
Q Consensus 260 Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 339 (426)
|||++.............||+.|+|||.+. ..++.++|||||||++|+|++|..||.+......+..+....... +.
T Consensus 192 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~--~~ 268 (504)
T 3q5i_A 192 DFGLSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYF--DF 268 (504)
T ss_dssp CCTTCEECCTTSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--CH
T ss_pred ECCCCEEcCCCCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC--Cc
Confidence 999998655544556678999999999987 468999999999999999999999998654433222221111000 00
Q ss_pred hhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 014352 340 QLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALL 379 (426)
Q Consensus 340 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 379 (426)
. .....+..+.+++.+||+.||.+|||+.+++++-.
T Consensus 269 ~----~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 304 (504)
T 3q5i_A 269 N----DWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRW 304 (504)
T ss_dssp H----HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred c----ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHh
Confidence 0 00123467899999999999999999999987643
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=328.94 Aligned_cols=246 Identities=25% Similarity=0.358 Sum_probs=194.8
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC---ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEE
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS---HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYE 193 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 193 (426)
.|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 91 (276)
T 2h6d_A 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVME 91 (276)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEe
Confidence 4667789999999999999986 78899999986532 2234578899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCc
Q 014352 194 FMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRN 273 (426)
Q Consensus 194 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 273 (426)
|+++++|.+++... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++.........
T Consensus 92 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 167 (276)
T 2h6d_A 92 YVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL 167 (276)
T ss_dssp CCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----
T ss_pred ccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCCcce
Confidence 99999999999654 45899999999999999999999998 999999999999999999999999999765444334
Q ss_pred ccCccccCccCccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHH
Q 014352 274 SGLKGTYGYIDPAYISTNKF-TMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRE 352 (426)
Q Consensus 274 ~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (426)
....||+.|+|||.+.+..+ +.++||||||+++|+|++|..||...........+... . ...+......
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---------~-~~~~~~~~~~ 237 (276)
T 2h6d_A 168 RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG---------V-FYIPEYLNRS 237 (276)
T ss_dssp ---------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC---------C-CCCCTTSCHH
T ss_pred ecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC---------c-ccCchhcCHH
Confidence 45678999999999988765 58999999999999999999999754322211111100 0 0111223467
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 353 LARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 353 l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
+.+++.+||+.||++|||+.+++++
T Consensus 238 l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 238 VATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHccCChhhCCCHHHHHhC
Confidence 8999999999999999999999986
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=330.63 Aligned_cols=245 Identities=26% Similarity=0.351 Sum_probs=196.2
Q ss_pred cccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCCCChh
Q 014352 123 NILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLS 201 (426)
Q Consensus 123 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 201 (426)
..||+|+||.||+|... ++..||+|.+........+.+.+|+.++++++||||+++++++...+..++||||+++++|.
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS 107 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence 47999999999999974 67899999998765555678999999999999999999999999999999999999999999
Q ss_pred HHhhhcc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecC-CCcEEEeeecCccccccC-CCcccCc
Q 014352 202 NLIYSEE--RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDH-FMRAKVADFGLSKEEVFD-GRNSGLK 277 (426)
Q Consensus 202 ~~l~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgl~~~~~~~-~~~~~~~ 277 (426)
+++.... ..+++..+..++.|++.||.|||+++ |+|+||||+||+++. ++.+||+|||++...... .......
T Consensus 108 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 184 (295)
T 2clq_A 108 ALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT 184 (295)
T ss_dssp HHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----CCCC
T ss_pred HHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCCCcccccC
Confidence 9996653 34678889999999999999999998 999999999999997 899999999999754322 2234567
Q ss_pred cccCccCccccccCC--CCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHH
Q 014352 278 GTYGYIDPAYISTNK--FTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELAR 355 (426)
Q Consensus 278 gt~~y~aPE~~~~~~--~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 355 (426)
||+.|+|||.+.+.. ++.++||||||+++|+|++|..||.......... ............+...+..+.+
T Consensus 185 ~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~ 257 (295)
T 2clq_A 185 GTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAM-------FKVGMFKVHPEIPESMSAEAKA 257 (295)
T ss_dssp CCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHH-------HHHHHHCCCCCCCTTSCHHHHH
T ss_pred CCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHH-------HhhccccccccccccCCHHHHH
Confidence 899999999997653 8899999999999999999999996432111000 0000001111222334567899
Q ss_pred HHHHcccCCCCCCCCHHHHHHH
Q 014352 356 IGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 356 l~~~cl~~~p~~RPs~~evl~~ 377 (426)
++.+||+.||++|||+.+++++
T Consensus 258 li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 258 FILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp HHHHTTCSSTTTSCCHHHHHTS
T ss_pred HHHHHccCChhhCCCHHHHhcC
Confidence 9999999999999999999864
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=340.95 Aligned_cols=255 Identities=23% Similarity=0.289 Sum_probs=191.5
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccC--hHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEe
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQG--EKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEF 194 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 194 (426)
+|.+.+.||+|+||+||+|... +++.||+|++....... .+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 35 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 114 (329)
T 3gbz_A 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEY 114 (329)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEec
Confidence 4677889999999999999865 78899999997553222 34678999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEec-----CCCcEEEeeecCcccccc
Q 014352 195 MSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLD-----HFMRAKVADFGLSKEEVF 269 (426)
Q Consensus 195 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~-----~~~~~kl~Dfgl~~~~~~ 269 (426)
++ |+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++ .++.+||+|||+++....
T Consensus 115 ~~-~~L~~~~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~ 189 (329)
T 3gbz_A 115 AE-NDLKKYMDKN-PDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI 189 (329)
T ss_dssp CS-EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-
T ss_pred CC-CCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCccccCC
Confidence 97 4999998654 45999999999999999999999998 99999999999994 555699999999975432
Q ss_pred C-CCcccCccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccc------c-chhhhh---
Q 014352 270 D-GRNSGLKGTYGYIDPAYISTN-KFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQ------D-GVDEIL--- 337 (426)
Q Consensus 270 ~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~------~-~~~~~~--- 337 (426)
. .......||+.|+|||++.+. .++.++|||||||++|||++|..||........+..+.. . ......
T Consensus 190 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (329)
T 3gbz_A 190 PIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALP 269 (329)
T ss_dssp ----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred cccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhh
Confidence 2 223445689999999999774 489999999999999999999999976544322221100 0 000000
Q ss_pred --hhhh---cc-----cCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 338 --DKQL---VG-----ACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 338 --~~~~---~~-----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
.... .. .........+.+++.+||+.||++|||+.|++++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 270 DWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp TCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 0000 00 0000123678899999999999999999999864
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=345.10 Aligned_cols=252 Identities=19% Similarity=0.255 Sum_probs=196.8
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeC-----------
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDK----------- 185 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~----------- 185 (426)
+|.+.+.||+|+||+||+|... ++..||+|++..... ...+|+.+++.++||||+++++++...
T Consensus 8 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~ 83 (383)
T 3eb0_A 8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPP 83 (383)
T ss_dssp TEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-----------
T ss_pred eEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccccccccc
Confidence 4677889999999999999874 788999999865432 234799999999999999999998543
Q ss_pred ---------------------------CeEEEEEEecCCCChhHHhhh---ccCCCCHHHHHHHHHHHHHHHHHHHcCCC
Q 014352 186 ---------------------------GKYMLIYEFMSNGSLSNLIYS---EERVLNWEERLQIALDISHGIEYLHEGAV 235 (426)
Q Consensus 186 ---------------------------~~~~lv~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~ 235 (426)
...++||||++ |+|.+.+.. ....+++..+..++.|++.||.|||+++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g- 161 (383)
T 3eb0_A 84 DDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG- 161 (383)
T ss_dssp --------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT-
T ss_pred cccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCc-
Confidence 34889999997 588877753 3467999999999999999999999998
Q ss_pred CCeeecCCCCCCEEec-CCCcEEEeeecCccccccCCCcccCccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCC
Q 014352 236 PPVIHRDLKSANILLD-HFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTN-KFTMKSDIFSFGVIIFELITAI 313 (426)
Q Consensus 236 ~~ivH~dlk~~Nill~-~~~~~kl~Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~ 313 (426)
|+||||||+|||++ .++.+||+|||+++............+|+.|+|||.+.+. .++.++|||||||++|||++|.
T Consensus 162 --i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~ 239 (383)
T 3eb0_A 162 --ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239 (383)
T ss_dssp --EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSS
T ss_pred --CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCC
Confidence 99999999999998 6889999999999865555555667789999999998765 4899999999999999999999
Q ss_pred CCCCchHHHHHHhhccc----cchhhhh--hh-------------hhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 014352 314 HPHQNLMEYVNLASMSQ----DGVDEIL--DK-------------QLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEV 374 (426)
Q Consensus 314 ~p~~~~~~~~~~~~~~~----~~~~~~~--~~-------------~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev 374 (426)
.||.+......+..+.. .....+. ++ ......+...+..+.+++.+||+.||++|||+.|+
T Consensus 240 ~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~ 319 (383)
T 3eb0_A 240 PLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEA 319 (383)
T ss_dssp CSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred CCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 99986543332222110 0000000 00 00000112234678999999999999999999999
Q ss_pred HHH
Q 014352 375 TQA 377 (426)
Q Consensus 375 l~~ 377 (426)
+++
T Consensus 320 l~h 322 (383)
T 3eb0_A 320 MAH 322 (383)
T ss_dssp HTS
T ss_pred hcC
Confidence 865
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=353.16 Aligned_cols=238 Identities=17% Similarity=0.167 Sum_probs=187.3
Q ss_pred hhhhcccccCCCeeEEEEEe-CCCcEEEEEEeccCC---ccChHHHHHHH---HHHhcCCCCceeeEE-------eEEEe
Q 014352 119 QNFTNILGQGAFGPVYKATM-PSGGVAAIKVLASDS---HQGEKEFQTEV---SLLGRLHHRNLVNLI-------GYCVD 184 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~---~~l~~l~h~niv~~~-------~~~~~ 184 (426)
|.+.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+ +++++++||||++++ +++.+
T Consensus 75 y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~ 154 (377)
T 3byv_A 75 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKD 154 (377)
T ss_dssp EEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEEC
T ss_pred EEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhc
Confidence 55678999999999999996 478999999997432 22346788999 555666899999998 66665
Q ss_pred CC-----------------eEEEEEEecCCCChhHHhhhccC------CCCHHHHHHHHHHHHHHHHHHHcCCCCCeeec
Q 014352 185 KG-----------------KYMLIYEFMSNGSLSNLIYSEER------VLNWEERLQIALDISHGIEYLHEGAVPPVIHR 241 (426)
Q Consensus 185 ~~-----------------~~~lv~e~~~~gsL~~~l~~~~~------~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~ 241 (426)
.+ ..++||||+ +|+|.+++..... .+++..++.++.|++.||.|||+++ |+||
T Consensus 155 ~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHr 230 (377)
T 3byv_A 155 PQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHT 230 (377)
T ss_dssp TTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred cCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 53 278999999 6899999965432 2335888899999999999999998 9999
Q ss_pred CCCCCCEEecCCCcEEEeeecCccccccCCCcccCccccCccCccccccC-----------CCCcchhhHHHHHHHHHHH
Q 014352 242 DLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTN-----------KFTMKSDIFSFGVIIFELI 310 (426)
Q Consensus 242 dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~S~Gvvl~el~ 310 (426)
||||+|||++.++.+||+|||+++... .......| +.|+|||++.+. .++.++|||||||++|||+
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ell 307 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRDG--ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW 307 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETT--CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCCCEEEEechhheecC--CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHH
Confidence 999999999999999999999998532 23345567 999999999887 8999999999999999999
Q ss_pred hCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 311 TAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 311 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
+|+.||......... ..+.. .....+..+.+++.+||+.||++|||+.+++++
T Consensus 308 tg~~Pf~~~~~~~~~--------~~~~~------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 308 CADLPITKDAALGGS--------EWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp HSSCCC------CCS--------GGGGS------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred HCCCCCcccccccch--------hhhhh------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 999999653321111 11111 011223678999999999999999999999974
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=341.23 Aligned_cols=258 Identities=24% Similarity=0.298 Sum_probs=199.9
Q ss_pred HHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccC-----hHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEE
Q 014352 117 ATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQG-----EKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYML 190 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 190 (426)
.+|.+.+.||+|+||.||+|... +++.||+|++....... .+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 10 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (346)
T 1ua2_A 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISL 89 (346)
T ss_dssp ---CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEE
T ss_pred cccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEE
Confidence 44677889999999999999975 68899999987542211 2468899999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC
Q 014352 191 IYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD 270 (426)
Q Consensus 191 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 270 (426)
||||+++ +|..++......+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 90 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (346)
T 1ua2_A 90 VFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 165 (346)
T ss_dssp EEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred EEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence 9999976 899988776677999999999999999999999999 999999999999999999999999999754322
Q ss_pred -CCcccCccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccc----cchhhh------hh
Q 014352 271 -GRNSGLKGTYGYIDPAYISTN-KFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQ----DGVDEI------LD 338 (426)
Q Consensus 271 -~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~----~~~~~~------~~ 338 (426)
.......||+.|+|||.+.+. .++.++||||||+++|||++|..||........+..+.. .....+ .+
T Consensus 166 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 245 (346)
T 1ua2_A 166 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 245 (346)
T ss_dssp CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcc
Confidence 233456789999999999654 589999999999999999999999976544322221110 000000 00
Q ss_pred h---hhcccCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014352 339 K---QLVGACN-----IQEVRELARIGHKCLHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 339 ~---~~~~~~~-----~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 378 (426)
. ......+ ...+..+.+++.+||+.||++|||+.|++++-
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 246 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred cccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 0 0000000 12346799999999999999999999999864
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=337.74 Aligned_cols=256 Identities=25% Similarity=0.341 Sum_probs=199.3
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCcc--ChHHHHHHHHHHhcCCCCceeeEEeEEEe--------CC
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQ--GEKEFQTEVSLLGRLHHRNLVNLIGYCVD--------KG 186 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~--------~~ 186 (426)
+|.+.+.||+|+||.||+|+.. +++.||+|++...... ....+.+|+.++++++||||+++++++.. .+
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 97 (351)
T 3mi9_A 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKG 97 (351)
T ss_dssp GEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------C
T ss_pred ceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCc
Confidence 4677889999999999999984 7889999998655322 24578899999999999999999999987 34
Q ss_pred eEEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccc
Q 014352 187 KYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKE 266 (426)
Q Consensus 187 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 266 (426)
..++||||+++ +|.+.+......+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 98 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 173 (351)
T 3mi9_A 98 SIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARA 173 (351)
T ss_dssp EEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred eEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchhccc
Confidence 68999999975 888888666667999999999999999999999998 99999999999999999999999999975
Q ss_pred ccc-----CCCcccCccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccc-------cch
Q 014352 267 EVF-----DGRNSGLKGTYGYIDPAYIST-NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQ-------DGV 333 (426)
Q Consensus 267 ~~~-----~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~-------~~~ 333 (426)
... ........||+.|+|||.+.+ ..++.++||||||+++|||++|..||...........+.. ...
T Consensus 174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 253 (351)
T 3mi9_A 174 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 253 (351)
T ss_dssp CCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred ccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhc
Confidence 432 122344578999999999876 4589999999999999999999999986543322211100 000
Q ss_pred hhhhhhhhc--------ccCCH-H------HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 334 DEILDKQLV--------GACNI-Q------EVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 334 ~~~~~~~~~--------~~~~~-~------~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
...-..... ..... . ....+.+++.+||+.||++|||+.|++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 254 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 000000000 00000 0 13468899999999999999999999986
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=354.01 Aligned_cols=250 Identities=25% Similarity=0.384 Sum_probs=201.3
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC---ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEe
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS---HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEF 194 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 194 (426)
+.+.+.||+|+||.||+|+.. +++.||+|++.... ......+..|+.++++++||||+++++++.+.+.+|+||||
T Consensus 187 f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~ 266 (543)
T 3c4z_A 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTI 266 (543)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEe
Confidence 334567999999999999985 78999999986532 12345788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhc---cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC
Q 014352 195 MSNGSLSNLIYSE---ERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG 271 (426)
Q Consensus 195 ~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 271 (426)
++||+|.+++... ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 267 ~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~ 343 (543)
T 3c4z_A 267 MNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ 343 (543)
T ss_dssp CTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred ccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccCCC
Confidence 9999999998654 246999999999999999999999998 9999999999999999999999999998644332
Q ss_pred C-cccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHH
Q 014352 272 R-NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEV 350 (426)
Q Consensus 272 ~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (426)
. .....||+.|+|||++.+..++.++|||||||++|||++|..||...........+ ...+.... ...+...+
T Consensus 344 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~----~~~i~~~~--~~~p~~~s 417 (543)
T 3c4z_A 344 TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL----KQRVLEQA--VTYPDKFS 417 (543)
T ss_dssp CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHH----HHHHHHCC--CCCCTTSC
T ss_pred cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHH----HHHHhhcc--cCCCcccC
Confidence 2 33458999999999999999999999999999999999999999753210000000 00111111 11223345
Q ss_pred HHHHHHHHHcccCCCCCCCCH-----HHHHHH
Q 014352 351 RELARIGHKCLHKTPRKRPSI-----GEVTQA 377 (426)
Q Consensus 351 ~~l~~l~~~cl~~~p~~RPs~-----~evl~~ 377 (426)
..+.+++.+||+.||++||++ .+++++
T Consensus 418 ~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 418 PASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp HHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred HHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 678999999999999999975 666653
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-44 Score=331.77 Aligned_cols=252 Identities=25% Similarity=0.378 Sum_probs=200.0
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc--cChHHHHHHHHHHhcCCCCceeeEEeEEEe--CCeEEEEE
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH--QGEKEFQTEVSLLGRLHHRNLVNLIGYCVD--KGKYMLIY 192 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~ 192 (426)
.|.+.+.||+|+||.||++... +++.||+|.+..... ...+.+.+|+.++++++||||+++++++.+ .+..++||
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 86 (279)
T 2w5a_A 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM 86 (279)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEE
T ss_pred heeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEE
Confidence 3567789999999999999976 788999999975432 234578999999999999999999998865 56899999
Q ss_pred EecCCCChhHHhhhcc---CCCCHHHHHHHHHHHHHHHHHHHcCC--CCCeeecCCCCCCEEecCCCcEEEeeecCcccc
Q 014352 193 EFMSNGSLSNLIYSEE---RVLNWEERLQIALDISHGIEYLHEGA--VPPVIHRDLKSANILLDHFMRAKVADFGLSKEE 267 (426)
Q Consensus 193 e~~~~gsL~~~l~~~~---~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 267 (426)
||+++++|.+++.... ..+++..++.++.|++.||.|||+++ ..+|+||||||+||+++.++.+||+|||+++..
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~ 166 (279)
T 2w5a_A 87 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL 166 (279)
T ss_dssp ECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC
T ss_pred eCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheee
Confidence 9999999999996532 45999999999999999999999975 234999999999999999999999999998754
Q ss_pred ccCCC-cccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCC
Q 014352 268 VFDGR-NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACN 346 (426)
Q Consensus 268 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (426)
..... .....||+.|+|||.+.+..++.++||||||+++|+|++|..||...........+... .....+
T Consensus 167 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~---------~~~~~~ 237 (279)
T 2w5a_A 167 NHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG---------KFRRIP 237 (279)
T ss_dssp ---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT---------CCCCCC
T ss_pred ccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhc---------ccccCC
Confidence 32211 22346899999999999999999999999999999999999999764332211111111 111122
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014352 347 IQEVRELARIGHKCLHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 347 ~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 378 (426)
...+..+.+++.+||+.||++|||+.++++++
T Consensus 238 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 238 YRYSDELNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred cccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 23446799999999999999999999999864
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=364.91 Aligned_cols=246 Identities=24% Similarity=0.363 Sum_probs=204.4
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC---ccChHHHHHHHHHHhcC-CCCceeeEEeEEEeCCeEEEEE
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS---HQGEKEFQTEVSLLGRL-HHRNLVNLIGYCVDKGKYMLIY 192 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 192 (426)
.|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+..|..++..+ +||||+++++++.+.+.+|+||
T Consensus 342 ~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~ 421 (674)
T 3pfq_A 342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 421 (674)
T ss_dssp TEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEE
T ss_pred ceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEE
Confidence 4566788999999999999976 67889999987531 23345678899999988 7999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccccc-CC
Q 014352 193 EFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF-DG 271 (426)
Q Consensus 193 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~-~~ 271 (426)
||+++|+|..++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.... ..
T Consensus 422 E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~ 497 (674)
T 3pfq_A 422 EYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV 497 (674)
T ss_dssp ECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECCCTTC
T ss_pred eCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeeccccCCc
Confidence 999999999999655 45999999999999999999999998 99999999999999999999999999985332 23
Q ss_pred CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHH
Q 014352 272 RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVR 351 (426)
Q Consensus 272 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (426)
......||+.|+|||++.+..|+.++||||||+++|||++|..||.+.........+.... ...+...+.
T Consensus 498 ~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~----------~~~p~~~s~ 567 (674)
T 3pfq_A 498 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN----------VAYPKSMSK 567 (674)
T ss_dssp CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSC----------CCCCTTSCH
T ss_pred ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC----------CCCCccCCH
Confidence 4456789999999999999999999999999999999999999998654332222221111 112223456
Q ss_pred HHHHHHHHcccCCCCCCCCH-----HHHHHH
Q 014352 352 ELARIGHKCLHKTPRKRPSI-----GEVTQA 377 (426)
Q Consensus 352 ~l~~l~~~cl~~~p~~RPs~-----~evl~~ 377 (426)
++.+|+.+||+.||++||++ .+|+++
T Consensus 568 ~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 568 EAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp HHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred HHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 79999999999999999998 666654
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=329.69 Aligned_cols=250 Identities=23% Similarity=0.317 Sum_probs=203.4
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc---------cChHHHHHHHHHHhcCC-CCceeeEEeEEEeCC
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH---------QGEKEFQTEVSLLGRLH-HRNLVNLIGYCVDKG 186 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~ 186 (426)
.|.+.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+.+++++. ||||+++++++...+
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (298)
T 1phk_A 18 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT 97 (298)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred ccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCC
Confidence 3667789999999999999986 678999999975431 11346789999999995 999999999999999
Q ss_pred eEEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccc
Q 014352 187 KYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKE 266 (426)
Q Consensus 187 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 266 (426)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++..
T Consensus 98 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 173 (298)
T 1phk_A 98 FFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQ 173 (298)
T ss_dssp EEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecccchhh
Confidence 999999999999999999654 46899999999999999999999998 99999999999999999999999999986
Q ss_pred cccCCCcccCccccCccCccccc------cCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhh
Q 014352 267 EVFDGRNSGLKGTYGYIDPAYIS------TNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQ 340 (426)
Q Consensus 267 ~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (426)
...........||+.|+|||.+. ...++.++||||||+++|||++|..||...........+..... .
T Consensus 174 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~------~ 247 (298)
T 1phk_A 174 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY------Q 247 (298)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC------C
T ss_pred cCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCc------c
Confidence 54444455667999999999885 45688999999999999999999999976433322211111100 0
Q ss_pred hcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 341 LVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 341 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
.........+..+.+++.+||+.||++|||+.+++++
T Consensus 248 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 248 FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 0001112345679999999999999999999999863
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=336.51 Aligned_cols=251 Identities=24% Similarity=0.342 Sum_probs=196.8
Q ss_pred HHHHHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc--------cChHHHHHHHHHHhcCCCCceeeEEeEEEe
Q 014352 114 IQKATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH--------QGEKEFQTEVSLLGRLHHRNLVNLIGYCVD 184 (426)
Q Consensus 114 l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 184 (426)
.....|.+.+.||+|+||.||+|... +++.||||++..... .....+.+|+.++++++||||+++++++..
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 86 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 86 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence 44567888999999999999999975 678999999865421 122358899999999999999999999876
Q ss_pred CCeEEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCc---EEEeee
Q 014352 185 KGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMR---AKVADF 261 (426)
Q Consensus 185 ~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Df 261 (426)
.+ .++||||+++++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++. +||+||
T Consensus 87 ~~-~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 87 ED-YYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp SS-EEEEEECCTTEETHHHHSTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred Cc-eEEEEecCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccC
Confidence 54 89999999999999988543 56899999999999999999999998 999999999999987665 999999
Q ss_pred cCccccccCCCcccCccccCccCccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhh
Q 014352 262 GLSKEEVFDGRNSGLKGTYGYIDPAYIS---TNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILD 338 (426)
Q Consensus 262 gl~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 338 (426)
|++.............||+.|+|||++. ...++.++||||||+++|+|++|..||........+ ...+.
T Consensus 162 g~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--------~~~~~ 233 (322)
T 2ycf_A 162 GHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL--------KDQIT 233 (322)
T ss_dssp TTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCH--------HHHHH
T ss_pred ccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHH--------HHHHH
Confidence 9997543332233456899999999973 567899999999999999999999999753221110 01110
Q ss_pred hhhccc---CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 339 KQLVGA---CNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 339 ~~~~~~---~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
...... .....+..+.+++.+||+.||++|||+.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 234 SGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp HTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 000000 001234678999999999999999999999864
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=344.92 Aligned_cols=257 Identities=24% Similarity=0.332 Sum_probs=194.3
Q ss_pred HHhhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCccC-----------hHHHHHHHHHHhcCCCCceeeEEeEEEeC
Q 014352 117 ATQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQG-----------EKEFQTEVSLLGRLHHRNLVNLIGYCVDK 185 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 185 (426)
..|.+.+.||+|+||.||+|...++..||+|++....... .+.+.+|+.++++++||||+++++++...
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 101 (362)
T 3pg1_A 22 SPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHF 101 (362)
T ss_dssp CSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEEC
T ss_pred cceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEec
Confidence 3466678999999999999998889999999986543221 25789999999999999999999998653
Q ss_pred -----CeEEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEee
Q 014352 186 -----GKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVAD 260 (426)
Q Consensus 186 -----~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 260 (426)
...++||||++ |+|.+++......+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 102 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~D 177 (362)
T 3pg1_A 102 EEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICD 177 (362)
T ss_dssp CTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred cCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEEcCCCCEEEEe
Confidence 36899999997 6898888776677999999999999999999999998 99999999999999999999999
Q ss_pred ecCccccccCCCcccCccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccc----cch--
Q 014352 261 FGLSKEEVFDGRNSGLKGTYGYIDPAYIST-NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQ----DGV-- 333 (426)
Q Consensus 261 fgl~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~----~~~-- 333 (426)
||+++............||+.|+|||.+.+ ..++.++||||||+++|+|++|..||........+..+.. ...
T Consensus 178 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 257 (362)
T 3pg1_A 178 FNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIED 257 (362)
T ss_dssp TTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred cCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHH
Confidence 999985544445556679999999999876 6789999999999999999999999986443322211100 000
Q ss_pred ---------hhhhhhhhcc-------cCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 334 ---------DEILDKQLVG-------ACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 334 ---------~~~~~~~~~~-------~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
...+...... .........+.+++.+||+.||++|||+.+++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 258 VVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 0000000000 0011224568999999999999999999999975
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=333.65 Aligned_cols=251 Identities=19% Similarity=0.299 Sum_probs=199.4
Q ss_pred HHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCC-CCceeeEEeEEEe--CCeEEEEE
Q 014352 117 ATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLH-HRNLVNLIGYCVD--KGKYMLIY 192 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~--~~~~~lv~ 192 (426)
..|.+.+.||+|+||.||+|... +++.||+|++... ..+.+.+|+.++++++ ||||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 34677889999999999999864 7889999998743 4567899999999997 9999999999988 56789999
Q ss_pred EecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCC-cEEEeeecCccccccCC
Q 014352 193 EFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFM-RAKVADFGLSKEEVFDG 271 (426)
Q Consensus 193 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgl~~~~~~~~ 271 (426)
||+++++|.+++. .++...+..++.|++.||.|||+++ |+||||||+|||++.++ .+||+|||+++......
T Consensus 113 e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 185 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185 (330)
T ss_dssp ECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred eccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence 9999999999883 3889999999999999999999999 99999999999999776 89999999998655444
Q ss_pred CcccCccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCchHH-HHHHhhc----cccchhhhhhh------
Q 014352 272 RNSGLKGTYGYIDPAYIST-NKFTMKSDIFSFGVIIFELITAIHPHQNLME-YVNLASM----SQDGVDEILDK------ 339 (426)
Q Consensus 272 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~----~~~~~~~~~~~------ 339 (426)
......||..|+|||.+.+ ..++.++||||||+++|||++|..||..... ...+..+ ........++.
T Consensus 186 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 265 (330)
T 3nsz_A 186 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 265 (330)
T ss_dssp CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccc
Confidence 5556679999999999877 6789999999999999999999999843211 1110000 00000000000
Q ss_pred -----------------hhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 340 -----------------QLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 340 -----------------~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
..........+..+.+++.+||+.||++|||+.+++++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 266 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp THHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00001111235789999999999999999999999975
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=364.57 Aligned_cols=260 Identities=23% Similarity=0.359 Sum_probs=209.0
Q ss_pred HHHHHHhhhhcccccCCCeeEEEEEeCC----CcEEEEEEeccCCc-cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCe
Q 014352 113 DIQKATQNFTNILGQGAFGPVYKATMPS----GGVAAIKVLASDSH-QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGK 187 (426)
Q Consensus 113 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 187 (426)
++...++.+.+.||+|+||.||+|.+.. +..||+|.+..... ...+.+.+|+.++++++||||+++++++. .+.
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~ 464 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 464 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCc
Confidence 3445667788999999999999998742 45799999875432 22367899999999999999999999985 456
Q ss_pred EEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccc
Q 014352 188 YMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEE 267 (426)
Q Consensus 188 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 267 (426)
.++||||+++|+|.+++......+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 465 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred eEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 89999999999999999766667999999999999999999999998 999999999999999999999999999754
Q ss_pred ccCCC--cccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhccc
Q 014352 268 VFDGR--NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGA 344 (426)
Q Consensus 268 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (426)
..... .....+|+.|+|||.+.+..++.++||||||+++|||++ |..||.+.........+.. .....
T Consensus 542 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~---------~~~~~ 612 (656)
T 2j0j_A 542 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN---------GERLP 612 (656)
T ss_dssp CC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHH---------TCCCC
T ss_pred CCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc---------CCCCC
Confidence 32221 223456789999999999999999999999999999997 9999976443322211111 11111
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHh
Q 014352 345 CNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRH 385 (426)
Q Consensus 345 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~ 385 (426)
.+...+..+.+++.+||+.||++|||+.++++.|+.+....
T Consensus 613 ~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~ 653 (656)
T 2j0j_A 613 MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653 (656)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 22334567999999999999999999999999999987643
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=345.38 Aligned_cols=257 Identities=21% Similarity=0.302 Sum_probs=205.5
Q ss_pred HhhhhcccccCCCeeEEEEEe-CCCcEEEEEEeccCCccChHHHHHHHHHHhcCCC-CceeeEEeEEEeCCeEEEEEEec
Q 014352 118 TQNFTNILGQGAFGPVYKATM-PSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHH-RNLVNLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~ 195 (426)
.|.+.+.||+|+||.||+|.+ .++..||||++.... ....+..|+++++.++| +++..+..++...+..++||||+
T Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~ 85 (483)
T 3sv0_A 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (483)
T ss_dssp TEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred cEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC
Confidence 466778999999999999997 478899999876543 23468899999999987 56666667777888899999999
Q ss_pred CCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEe---cCCCcEEEeeecCccccccCCC
Q 014352 196 SNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILL---DHFMRAKVADFGLSKEEVFDGR 272 (426)
Q Consensus 196 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfgl~~~~~~~~~ 272 (426)
+++|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++.......
T Consensus 86 -g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (483)
T 3sv0_A 86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (483)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred -CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcc
Confidence 89999999766677999999999999999999999998 9999999999999 6889999999999975433221
Q ss_pred --------cccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHH---HHHhhccccchhhhhhhhh
Q 014352 273 --------NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEY---VNLASMSQDGVDEILDKQL 341 (426)
Q Consensus 273 --------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~ 341 (426)
.....||+.|+|||.+.+..++.++|||||||++|||++|..||...... ..+..+........+. .+
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~-~l 240 (483)
T 3sv0_A 162 HQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIE-AL 240 (483)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHH-HH
T ss_pred ccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHH-HH
Confidence 22567999999999999999999999999999999999999999763221 1111110100000000 00
Q ss_pred cccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHh
Q 014352 342 VGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRH 385 (426)
Q Consensus 342 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~ 385 (426)
.. ..+.++.+++..||+.||++||++.+|++.|+.+....
T Consensus 241 ~~----~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 241 CR----GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp HT----TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred hc----CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 01 12367999999999999999999999999999997654
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=338.20 Aligned_cols=255 Identities=24% Similarity=0.253 Sum_probs=192.1
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc--cChHHHHHHHHHHhcCCCCceeeEEeEEEeCC------eE
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH--QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKG------KY 188 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~~ 188 (426)
.|.+.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+.+++.++||||+++++++...+ ..
T Consensus 26 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 105 (371)
T 2xrw_A 26 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV 105 (371)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEE
T ss_pred heeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccce
Confidence 3667789999999999999875 688999999875432 22356889999999999999999999997654 78
Q ss_pred EEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccc
Q 014352 189 MLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEV 268 (426)
Q Consensus 189 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 268 (426)
++||||+++ +|.+.+. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 106 ~lv~e~~~~-~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 178 (371)
T 2xrw_A 106 YIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178 (371)
T ss_dssp EEEEECCSE-EHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred EEEEEcCCC-CHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence 999999975 7888774 34899999999999999999999998 9999999999999999999999999998654
Q ss_pred cCCCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhcccc---chhhh---------
Q 014352 269 FDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQD---GVDEI--------- 336 (426)
Q Consensus 269 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~---~~~~~--------- 336 (426)
.........||+.|+|||++.+..++.++|||||||++|||++|..||.+......+..+... ...+.
T Consensus 179 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 258 (371)
T 2xrw_A 179 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR 258 (371)
T ss_dssp -----------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHH
T ss_pred cccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHH
Confidence 433445567999999999999999999999999999999999999999765433222211100 00000
Q ss_pred -----------------hhhhhcccC---CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 014352 337 -----------------LDKQLVGAC---NIQEVRELARIGHKCLHKTPRKRPSIGEVTQALL 379 (426)
Q Consensus 337 -----------------~~~~~~~~~---~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 379 (426)
+........ .......+.+++.+||+.||++|||+.+++++-.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 321 (371)
T 2xrw_A 259 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 321 (371)
T ss_dssp HHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred HHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcc
Confidence 000000000 0123567999999999999999999999998753
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=345.41 Aligned_cols=253 Identities=20% Similarity=0.269 Sum_probs=194.7
Q ss_pred HhhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCe------EEEE
Q 014352 118 TQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGK------YMLI 191 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~------~~lv 191 (426)
+|.+.+.||+|+||+||+|+...+..+|+|++..... ...+|+.+++.++||||+++++++...+. +++|
T Consensus 41 ~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv 116 (394)
T 4e7w_A 41 AYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV 116 (394)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEE
T ss_pred eEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEE
Confidence 3667789999999999999987777788888765432 22469999999999999999999976443 7899
Q ss_pred EEecCCCChhHHhh--hccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEec-CCCcEEEeeecCccccc
Q 014352 192 YEFMSNGSLSNLIY--SEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLD-HFMRAKVADFGLSKEEV 268 (426)
Q Consensus 192 ~e~~~~gsL~~~l~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfgl~~~~~ 268 (426)
|||++++.+..... .....+++..+..++.|++.||.|||+++ |+||||||+|||++ .++.+||+|||+++...
T Consensus 117 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~ 193 (394)
T 4e7w_A 117 LEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI 193 (394)
T ss_dssp EECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccccc
Confidence 99998754433321 22466999999999999999999999998 99999999999999 79999999999998655
Q ss_pred cCCCcccCccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccc----cchh--hhhhhhh
Q 014352 269 FDGRNSGLKGTYGYIDPAYISTN-KFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQ----DGVD--EILDKQL 341 (426)
Q Consensus 269 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~----~~~~--~~~~~~~ 341 (426)
.........||+.|+|||.+.+. .++.++|||||||++|||++|..||.+......+..+.. .... ....+..
T Consensus 194 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~ 273 (394)
T 4e7w_A 194 AGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNY 273 (394)
T ss_dssp TTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGG
T ss_pred CCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhh
Confidence 55555567889999999998765 589999999999999999999999986543322221110 0000 0000000
Q ss_pred -------------cccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 342 -------------VGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 342 -------------~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
........+..+.+++.+||+.||++|||+.+++++
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 274 MEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp SSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 000111234679999999999999999999999976
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-43 Score=333.97 Aligned_cols=261 Identities=21% Similarity=0.362 Sum_probs=194.3
Q ss_pred HhhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHH--HhcCCCCceeeEEeEEEe-----CCeEEE
Q 014352 118 TQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSL--LGRLHHRNLVNLIGYCVD-----KGKYML 190 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~--l~~l~h~niv~~~~~~~~-----~~~~~l 190 (426)
.|.+.+.||+|+||.||+|+. +++.||+|++... ....+..|.++ +..++||||+++++.+.. ...+++
T Consensus 14 ~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~l 89 (336)
T 3g2f_A 14 NLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLL 89 (336)
T ss_dssp SEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred HhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEE
Confidence 356778999999999999987 6789999998643 23445555554 455899999999986653 235789
Q ss_pred EEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcC---------CCCCeeecCCCCCCEEecCCCcEEEeee
Q 014352 191 IYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEG---------AVPPVIHRDLKSANILLDHFMRAKVADF 261 (426)
Q Consensus 191 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---------~~~~ivH~dlk~~Nill~~~~~~kl~Df 261 (426)
||||+++|+|.+++... ..++..++.++.|++.||.|||++ + |+||||||+|||++.++.+||+||
T Consensus 90 v~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL~DF 164 (336)
T 3g2f_A 90 VMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVISDF 164 (336)
T ss_dssp EECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEEECCC
T ss_pred EEecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEEEeec
Confidence 99999999999999543 358999999999999999999998 7 999999999999999999999999
Q ss_pred cCccccccC---------CCcccCccccCccCcccccc-------CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHH
Q 014352 262 GLSKEEVFD---------GRNSGLKGTYGYIDPAYIST-------NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNL 325 (426)
Q Consensus 262 gl~~~~~~~---------~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~ 325 (426)
|+++..... .......||+.|+|||++.+ ..++.++||||||+++|||++|..||.........
T Consensus 165 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~ 244 (336)
T 3g2f_A 165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY 244 (336)
T ss_dssp TTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCC
T ss_pred cceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHH
Confidence 999754321 11234569999999999976 35667899999999999999998776432110000
Q ss_pred hh------ccccch---hhhhh-----hhhcc--cCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHhhh
Q 014352 326 AS------MSQDGV---DEILD-----KQLVG--ACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRHLA 387 (426)
Q Consensus 326 ~~------~~~~~~---~~~~~-----~~~~~--~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~~ 387 (426)
.. ...... ...+. +.+.. ......+..+.+++.+||+.||++|||+.++++.|+.+......
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~ 322 (336)
T 3g2f_A 245 QMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWER 322 (336)
T ss_dssp CCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC
T ss_pred HHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHh
Confidence 00 000000 00000 01111 11223567899999999999999999999999999999864433
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=346.91 Aligned_cols=251 Identities=12% Similarity=0.080 Sum_probs=181.9
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc---cChHHHHHHH---HHHhcCCCCceeeEE-------eEEEe
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH---QGEKEFQTEV---SLLGRLHHRNLVNLI-------GYCVD 184 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~---~~l~~l~h~niv~~~-------~~~~~ 184 (426)
|.+.+.||+|+||.||+|.+. +++.||+|++..... ...+.+.+|+ ..|+. +||||++++ +++..
T Consensus 64 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~~ 142 (371)
T 3q60_A 64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVAV 142 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEEE
T ss_pred eeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehheec
Confidence 556789999999999999975 788999999987543 2234577784 45555 799988755 44443
Q ss_pred C-----------------CeEEEEEEecCCCChhHHhhhccCCCCHHHH------HHHHHHHHHHHHHHHcCCCCCeeec
Q 014352 185 K-----------------GKYMLIYEFMSNGSLSNLIYSEERVLNWEER------LQIALDISHGIEYLHEGAVPPVIHR 241 (426)
Q Consensus 185 ~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~------~~i~~~i~~~l~~LH~~~~~~ivH~ 241 (426)
. ...++||||++ |+|.+++...+..+.+..+ +.++.|++.||.|||+++ |+||
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---ivHr 218 (371)
T 3q60_A 143 QSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHG 218 (371)
T ss_dssp TTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---EEET
T ss_pred CCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---CccC
Confidence 3 33899999998 8999999776655677777 788899999999999999 9999
Q ss_pred CCCCCCEEecCCCcEEEeeecCccccccCCCcccCccccCccCcccccc--CCCCcchhhHHHHHHHHHHHhCCCCCCch
Q 014352 242 DLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYIST--NKFTMKSDIFSFGVIIFELITAIHPHQNL 319 (426)
Q Consensus 242 dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~ 319 (426)
||||+|||++.++.+||+|||+++.... ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 219 Dikp~NIll~~~~~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 296 (371)
T 3q60_A 219 HFTPDNLFIMPDGRLMLGDVSALWKVGT--RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV 296 (371)
T ss_dssp TCSGGGEEECTTSCEEECCGGGEEETTC--EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBC
T ss_pred cCCHHHEEECCCCCEEEEecceeeecCC--CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 9999999999999999999999985421 2224557799999999987 77999999999999999999999999764
Q ss_pred HHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 320 MEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
..... ........................+..+.+++.+||+.||++|||+.+++++
T Consensus 297 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 297 TPGIK-GSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp CTTCT-TCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred Ccccc-cchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 22110 0000000000001111111112345689999999999999999999999864
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=349.57 Aligned_cols=255 Identities=22% Similarity=0.333 Sum_probs=182.1
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc--cChHHHHHHHHHHhcCCCCceeeEEeEEEeC-----CeEE
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH--QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDK-----GKYM 189 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~ 189 (426)
+|.+.+.||+|+||+||+|... +++.||||++..... ...+.+.+|+.+|++++||||+++++++... +.+|
T Consensus 54 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 133 (458)
T 3rp9_A 54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELY 133 (458)
T ss_dssp TEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred CeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEE
Confidence 4677889999999999999875 788999999865422 2345788999999999999999999998543 5689
Q ss_pred EEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccccc
Q 014352 190 LIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF 269 (426)
Q Consensus 190 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 269 (426)
+||||+ +++|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 134 lv~e~~-~~~L~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 208 (458)
T 3rp9_A 134 VVLEIA-DSDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDY 208 (458)
T ss_dssp EEECCC-SEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred EEEecc-ccchhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchhccC
Confidence 999998 5699998854 456999999999999999999999998 99999999999999999999999999975432
Q ss_pred CC----------------------------CcccCccccCccCcccc-ccCCCCcchhhHHHHHHHHHHHh---------
Q 014352 270 DG----------------------------RNSGLKGTYGYIDPAYI-STNKFTMKSDIFSFGVIIFELIT--------- 311 (426)
Q Consensus 270 ~~----------------------------~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~S~Gvvl~el~t--------- 311 (426)
.. ......||+.|+|||++ .+..++.++|||||||++|||++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~ 288 (458)
T 3rp9_A 209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH 288 (458)
T ss_dssp CTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSG
T ss_pred ccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccc
Confidence 11 12345789999999986 56679999999999999999999
Q ss_pred --CCCCCCchHHH--------------------HHHhhc---cccchhhhhh-----------hhhc-------ccCCHH
Q 014352 312 --AIHPHQNLMEY--------------------VNLASM---SQDGVDEILD-----------KQLV-------GACNIQ 348 (426)
Q Consensus 312 --g~~p~~~~~~~--------------------~~~~~~---~~~~~~~~~~-----------~~~~-------~~~~~~ 348 (426)
|+++|.+.... ..+..+ ......+.+. ..+. ......
T Consensus 289 ~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (458)
T 3rp9_A 289 ADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPA 368 (458)
T ss_dssp GGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTT
T ss_pred ccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCC
Confidence 55666442210 000000 0000000000 0000 000112
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 349 EVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 349 ~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
.+..+.+|+.+||..||++|||+.|++++
T Consensus 369 ~s~~~~dLl~~mL~~dP~~R~t~~e~L~H 397 (458)
T 3rp9_A 369 SSADAIHLLKRMLVFNPNKRITINECLAH 397 (458)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 35678999999999999999999999986
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=344.54 Aligned_cols=263 Identities=20% Similarity=0.204 Sum_probs=202.8
Q ss_pred CCChhHHHHHHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCC--------CCceeeE
Q 014352 108 RYAYKDIQKATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLH--------HRNLVNL 178 (426)
Q Consensus 108 ~~~~~~l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~~ 178 (426)
.+...++...+|.+.+.||+|+||+||+|+.. +++.||+|++.... ...+.+.+|+.++++++ |+||+++
T Consensus 28 ~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~ 106 (397)
T 1wak_A 28 LVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDPNREMVVQL 106 (397)
T ss_dssp SSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCE
T ss_pred EEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC-cchHHHHHHHHHHHHHhhcCCCCCCcceeeee
Confidence 34445555567888899999999999999865 67899999987432 33467889999999885 7889999
Q ss_pred EeEEE----eCCeEEEEEEecCCCChhHHhhhc-cCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCeeecCCCCCCEEecC
Q 014352 179 IGYCV----DKGKYMLIYEFMSNGSLSNLIYSE-ERVLNWEERLQIALDISHGIEYLHEG-AVPPVIHRDLKSANILLDH 252 (426)
Q Consensus 179 ~~~~~----~~~~~~lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~ivH~dlk~~Nill~~ 252 (426)
++++. .....++||||+ +++|.+.+... ...+++..+..++.|++.||.|||++ + |+||||||+|||++.
T Consensus 107 ~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~ 182 (397)
T 1wak_A 107 LDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSV 182 (397)
T ss_dssp EEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECC
T ss_pred ecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEec
Confidence 99987 456789999999 55666666443 36699999999999999999999998 8 999999999999997
Q ss_pred CC-------------------------------------------------cEEEeeecCccccccCCCcccCccccCcc
Q 014352 253 FM-------------------------------------------------RAKVADFGLSKEEVFDGRNSGLKGTYGYI 283 (426)
Q Consensus 253 ~~-------------------------------------------------~~kl~Dfgl~~~~~~~~~~~~~~gt~~y~ 283 (426)
++ .+||+|||++..... ......||+.|+
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~--~~~~~~gt~~y~ 260 (397)
T 1wak_A 183 NEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQTRQYR 260 (397)
T ss_dssp CHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB--CSCSCCSCGGGC
T ss_pred cchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc--cCccCCCCCccc
Confidence 75 799999999975432 334567899999
Q ss_pred CccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHH------HHHHh---hccccchhhhhh-h--------------
Q 014352 284 DPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLME------YVNLA---SMSQDGVDEILD-K-------------- 339 (426)
Q Consensus 284 aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~------~~~~~---~~~~~~~~~~~~-~-------------- 339 (426)
|||++.+..++.++|||||||++|||++|..||..... ...+. ..........+. .
T Consensus 261 aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 340 (397)
T 1wak_A 261 SLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLK 340 (397)
T ss_dssp CHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBS
T ss_pred CChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccc
Confidence 99999999999999999999999999999999964211 00000 000000000000 0
Q ss_pred ------------h--hcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 340 ------------Q--LVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 340 ------------~--~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
. -....+......+.+|+.+||+.||++|||+.+++++
T Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 341 HITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp SCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 0 0012245567789999999999999999999999875
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=346.19 Aligned_cols=194 Identities=27% Similarity=0.404 Sum_probs=163.6
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc--cChHHHHHHHHHHhcCCCCceeeEEeEEEeC-----CeEE
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH--QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDK-----GKYM 189 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~ 189 (426)
.|.+.+.||+|+||.||+|... ++..||||++..... ...+.+.+|+.+|++++||||+++++++... +..|
T Consensus 27 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 106 (432)
T 3n9x_A 27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELY 106 (432)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred CEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEE
Confidence 3667789999999999999975 678899999975422 2345788999999999999999999999876 5789
Q ss_pred EEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccccc
Q 014352 190 LIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF 269 (426)
Q Consensus 190 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 269 (426)
+||||++ |+|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 107 lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 181 (432)
T 3n9x_A 107 IVLEIAD-SDLKKLFKT-PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181 (432)
T ss_dssp EEEECCS-EEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred EEEecCC-cCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence 9999996 599999854 456999999999999999999999999 99999999999999999999999999985432
Q ss_pred CC-----------------------CcccCccccCccCcccc-ccCCCCcchhhHHHHHHHHHHHhCCCCC
Q 014352 270 DG-----------------------RNSGLKGTYGYIDPAYI-STNKFTMKSDIFSFGVIIFELITAIHPH 316 (426)
Q Consensus 270 ~~-----------------------~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~S~Gvvl~el~tg~~p~ 316 (426)
.. ......||+.|+|||++ ....++.++|||||||++|||++|..||
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp -----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 21 12456799999999986 5667999999999999999999865554
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-43 Score=332.46 Aligned_cols=247 Identities=28% Similarity=0.474 Sum_probs=195.3
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcC-CCCceeeEEeEEEe------CCeEEE
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRL-HHRNLVNLIGYCVD------KGKYML 190 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~------~~~~~l 190 (426)
|.+.+.||+|+||.||+|+.. +++.||+|++.... .....+.+|+.+++++ +||||+++++++.. .+..++
T Consensus 26 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~l 104 (326)
T 2x7f_A 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWL 104 (326)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEE
T ss_pred EEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEE
Confidence 567789999999999999975 78899999987543 3456789999999999 79999999999987 467899
Q ss_pred EEEecCCCChhHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccccc
Q 014352 191 IYEFMSNGSLSNLIYSEE-RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF 269 (426)
Q Consensus 191 v~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 269 (426)
||||+++|+|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.....
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 181 (326)
T 2x7f_A 105 VMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 181 (326)
T ss_dssp EEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCTTTC----
T ss_pred EEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeCcCceecCc
Confidence 999999999999996543 56899999999999999999999998 99999999999999999999999999875432
Q ss_pred C-CCcccCccccCccCccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcc
Q 014352 270 D-GRNSGLKGTYGYIDPAYIS-----TNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVG 343 (426)
Q Consensus 270 ~-~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (426)
. .......||+.|+|||.+. +..++.++||||||+++|+|++|..||...........+.... ...
T Consensus 182 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------~~~ 253 (326)
T 2x7f_A 182 TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP--------APR 253 (326)
T ss_dssp ---------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC--------CCC
T ss_pred CccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc--------ccc
Confidence 2 2234457899999999986 5678999999999999999999999997644332221111110 011
Q ss_pred cCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 344 ACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 344 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
......+..+.+++.+||+.||.+|||+.+++++
T Consensus 254 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 254 LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 1112234678999999999999999999999875
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=337.90 Aligned_cols=259 Identities=22% Similarity=0.247 Sum_probs=190.5
Q ss_pred HHHHHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCe-----
Q 014352 114 IQKATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGK----- 187 (426)
Q Consensus 114 l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~----- 187 (426)
.....|.+.+.||+|+||.||+|+.. ++..||||++.... .....+.++++.++.++||||+++++++...+.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 98 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRD 98 (360)
T ss_dssp HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTC
T ss_pred hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccc
Confidence 33445777889999999999999975 68899999986543 233456788888999999999999999976443
Q ss_pred --EEEEEEecCCCChhHHhh---hccCCCCHHHHHHHHHHHHHHHHHHH--cCCCCCeeecCCCCCCEEecC-CCcEEEe
Q 014352 188 --YMLIYEFMSNGSLSNLIY---SEERVLNWEERLQIALDISHGIEYLH--EGAVPPVIHRDLKSANILLDH-FMRAKVA 259 (426)
Q Consensus 188 --~~lv~e~~~~gsL~~~l~---~~~~~l~~~~~~~i~~~i~~~l~~LH--~~~~~~ivH~dlk~~Nill~~-~~~~kl~ 259 (426)
.++||||+++ +|...+. .....+++..+..++.|++.||.||| +++ |+||||||+|||++. ++.+||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~kl~ 174 (360)
T 3e3p_A 99 IYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLKLC 174 (360)
T ss_dssp EEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEEEC
T ss_pred eeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEEEe
Confidence 7899999976 5555443 23456899999999999999999999 877 999999999999997 8999999
Q ss_pred eecCccccccCCCcccCccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccc---cchhh
Q 014352 260 DFGLSKEEVFDGRNSGLKGTYGYIDPAYISTN-KFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQ---DGVDE 335 (426)
Q Consensus 260 Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~---~~~~~ 335 (426)
|||+++............||+.|+|||.+.+. .++.++||||||+++|||++|..||........+..+.. ....+
T Consensus 175 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 254 (360)
T 3e3p_A 175 DFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSRE 254 (360)
T ss_dssp CCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred eCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHH
Confidence 99999866555555567789999999998655 489999999999999999999999986543322221110 00000
Q ss_pred hhh-------------------hhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 336 ILD-------------------KQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 336 ~~~-------------------~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
.+. ...........+..+.+++.+||+.||++|||+.|++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 255 VLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000 000111122245789999999999999999999999976
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=325.18 Aligned_cols=255 Identities=25% Similarity=0.364 Sum_probs=206.7
Q ss_pred hHHHHHHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC--ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeE
Q 014352 112 KDIQKATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS--HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKY 188 (426)
Q Consensus 112 ~~l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 188 (426)
......+|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..
T Consensus 17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (287)
T 2wei_A 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (287)
T ss_dssp THHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence 3445567888999999999999999976 78899999986542 23456789999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCC---CcEEEeeecCcc
Q 014352 189 MLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHF---MRAKVADFGLSK 265 (426)
Q Consensus 189 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfgl~~ 265 (426)
++|+||+++++|.+++... ..+++..++.++.|++.||.|||+++ ++||||||+||+++.+ +.+||+|||++.
T Consensus 97 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp EEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 9999999999999988654 45899999999999999999999998 9999999999999764 469999999987
Q ss_pred ccccCCCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccC
Q 014352 266 EEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGAC 345 (426)
Q Consensus 266 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (426)
............+|+.|+|||.+.+ .++.++||||||+++|+|++|..||...........+...... .....
T Consensus 173 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~------~~~~~ 245 (287)
T 2wei_A 173 CFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYA------FDLPQ 245 (287)
T ss_dssp TBCCCSSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC------CCSGG
T ss_pred eecCCCccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC------CCchh
Confidence 6544444445568999999999875 4899999999999999999999999764433222211111100 00000
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 346 NIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 346 ~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
....+..+.+++.+||+.||++|||+.+++++
T Consensus 246 ~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 246 WRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp GTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred hhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 11234678999999999999999999999985
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=338.94 Aligned_cols=249 Identities=28% Similarity=0.361 Sum_probs=199.5
Q ss_pred HhhhhcccccCCCeeEEEEEe----CCCcEEEEEEeccCC----ccChHHHHHHHHHHhcC-CCCceeeEEeEEEeCCeE
Q 014352 118 TQNFTNILGQGAFGPVYKATM----PSGGVAAIKVLASDS----HQGEKEFQTEVSLLGRL-HHRNLVNLIGYCVDKGKY 188 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 188 (426)
.|.+.+.||+|+||.||+++. .+++.||||++.... ....+.+.+|+.++.++ +||||+++++++...+..
T Consensus 55 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 134 (355)
T 1vzo_A 55 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKL 134 (355)
T ss_dssp GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEE
T ss_pred ceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceE
Confidence 467788999999999999987 378899999986532 12345677899999999 699999999999999999
Q ss_pred EEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccc
Q 014352 189 MLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEV 268 (426)
Q Consensus 189 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 268 (426)
++||||+++|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 135 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 135 HLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFV 210 (355)
T ss_dssp EEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred EEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence 9999999999999999654 45899999999999999999999998 9999999999999999999999999987532
Q ss_pred cC--CCcccCccccCccCcccccc--CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhh--c
Q 014352 269 FD--GRNSGLKGTYGYIDPAYIST--NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQL--V 342 (426)
Q Consensus 269 ~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 342 (426)
.. .......||+.|+|||++.+ ..++.++||||||+++|||++|..||....... ....+..... .
T Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--------~~~~~~~~~~~~~ 282 (355)
T 1vzo_A 211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN--------SQAEISRRILKSE 282 (355)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC--------CHHHHHHHHHHCC
T ss_pred cCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc--------hHHHHHHHHhccC
Confidence 22 12234579999999999975 357899999999999999999999996421110 0011111111 1
Q ss_pred ccCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHH
Q 014352 343 GACNIQEVRELARIGHKCLHKTPRKRP-----SIGEVTQAL 378 (426)
Q Consensus 343 ~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~~L 378 (426)
...+...+..+.+++.+||+.||++|| |+.+++++.
T Consensus 283 ~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 283 PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 122333456789999999999999999 999998765
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=344.59 Aligned_cols=253 Identities=22% Similarity=0.298 Sum_probs=194.9
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeC------CeEEE
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDK------GKYML 190 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~~l 190 (426)
.|.+.+.||+|+||.||+|++. +++.||||++.... ..+.+|+++|++++||||+++++++... ..+++
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 3666789999999999999985 68899999986542 2344799999999999999999998652 13679
Q ss_pred EEEecCCCChhHHhhh---ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCC-CcEEEeeecCccc
Q 014352 191 IYEFMSNGSLSNLIYS---EERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHF-MRAKVADFGLSKE 266 (426)
Q Consensus 191 v~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgl~~~ 266 (426)
||||+++ +|.+.+.. ....+++..+..++.|++.||.|||+++ |+||||||+|||++.+ +.+||+|||+++.
T Consensus 131 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 131 VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred ehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 9999976 67666542 3467999999999999999999999998 9999999999999965 5689999999986
Q ss_pred cccCCCcccCccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccc----cchhhh--hhh
Q 014352 267 EVFDGRNSGLKGTYGYIDPAYISTN-KFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQ----DGVDEI--LDK 339 (426)
Q Consensus 267 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~----~~~~~~--~~~ 339 (426)
...........||+.|+|||++.+. .++.++|||||||++|||++|+.||.+......+..+.. .....+ ..+
T Consensus 207 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~ 286 (420)
T 1j1b_A 207 LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 286 (420)
T ss_dssp CCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCS
T ss_pred cccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhCh
Confidence 5444445567799999999999765 799999999999999999999999986543322221110 000000 000
Q ss_pred hh--------cc-----cCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014352 340 QL--------VG-----ACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 340 ~~--------~~-----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 378 (426)
.+ .. ......+.++.+|+.+||+.||++|||+.|++++-
T Consensus 287 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp 338 (420)
T 1j1b_A 287 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 338 (420)
T ss_dssp CCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred hhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCH
Confidence 00 00 01112346799999999999999999999998753
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=337.56 Aligned_cols=256 Identities=24% Similarity=0.389 Sum_probs=199.5
Q ss_pred HhhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCC--ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEec
Q 014352 118 TQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDS--HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 195 (426)
.+.+.+.||+|+||.||+|...+ .+|+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 34 ~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~ 111 (319)
T 2y4i_B 34 QLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLC 111 (319)
T ss_dssp CEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCC
T ss_pred HeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecc
Confidence 46677899999999999999754 38899886542 222356788999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccccc------
Q 014352 196 SNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF------ 269 (426)
Q Consensus 196 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~------ 269 (426)
++++|.+++......+++..++.++.|++.||.|||+++ |+||||||+||+++ ++.+||+|||++.....
T Consensus 112 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~ 187 (319)
T 2y4i_B 112 KGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRR 187 (319)
T ss_dssp CSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC----------
T ss_pred cCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcccccccccccc
Confidence 999999999776667999999999999999999999998 99999999999998 68999999999764321
Q ss_pred CCCcccCccccCccCcccccc---------CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhh
Q 014352 270 DGRNSGLKGTYGYIDPAYIST---------NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQ 340 (426)
Q Consensus 270 ~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (426)
........||+.|+|||.+.+ ..++.++||||||+++|||++|..||...........+.....
T Consensus 188 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~------- 260 (319)
T 2y4i_B 188 EDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMK------- 260 (319)
T ss_dssp CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCC-------
T ss_pred ccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCC-------
Confidence 122234568999999999864 4578999999999999999999999976443322211111110
Q ss_pred hcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHhhh
Q 014352 341 LVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRHLA 387 (426)
Q Consensus 341 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~~ 387 (426)
........+..+.+++.+||+.||++|||+.++++.|+.+..+...
T Consensus 261 -~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~ 306 (319)
T 2y4i_B 261 -PNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRR 306 (319)
T ss_dssp -CCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC------
T ss_pred -CCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 0011112335689999999999999999999999999988765433
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=344.26 Aligned_cols=254 Identities=25% Similarity=0.318 Sum_probs=200.3
Q ss_pred HHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcC------CCCceeeEEeEEEeCCeEE
Q 014352 117 ATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRL------HHRNLVNLIGYCVDKGKYM 189 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~~~~~~~~~~~~~ 189 (426)
.+|.+.+.||+|+||.||+|... +++.||||++.... ...+.+.+|+.+++.+ +|+||+++++++...+..+
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 175 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC 175 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence 35777889999999999999875 67899999997532 2345677888888776 6789999999999999999
Q ss_pred EEEEecCCCChhHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCc--EEEeeecCccc
Q 014352 190 LIYEFMSNGSLSNLIYSEE-RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMR--AKVADFGLSKE 266 (426)
Q Consensus 190 lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~--~kl~Dfgl~~~ 266 (426)
+||||+. ++|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++. +||+|||++..
T Consensus 176 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~ 251 (429)
T 3kvw_A 176 MTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCY 251 (429)
T ss_dssp EEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeeccccee
Confidence 9999996 69999886654 45999999999999999999999998 999999999999999887 99999999975
Q ss_pred cccCCCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccc---cchhhhh------
Q 014352 267 EVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQ---DGVDEIL------ 337 (426)
Q Consensus 267 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~---~~~~~~~------ 337 (426)
.. .......||+.|+|||++.+..++.++|||||||++|||++|..||........+..+.. .....++
T Consensus 252 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~ 329 (429)
T 3kvw_A 252 EH--QRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRA 329 (429)
T ss_dssp TT--CCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTH
T ss_pred cC--CcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhh
Confidence 32 234456799999999999999999999999999999999999999976543322211100 0000000
Q ss_pred ----hhh---------------------------hcc---c------CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 338 ----DKQ---------------------------LVG---A------CNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 338 ----~~~---------------------------~~~---~------~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
+.. ... . ........+.+|+.+||+.||++|||+.|++++
T Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~H 409 (429)
T 3kvw_A 330 KNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRH 409 (429)
T ss_dssp HHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCC
Confidence 000 000 0 000113568999999999999999999999975
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=326.49 Aligned_cols=248 Identities=28% Similarity=0.428 Sum_probs=193.4
Q ss_pred HHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEe-----------
Q 014352 117 ATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVD----------- 184 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----------- 184 (426)
..|.+.+.||+|+||.||+|+.. ++..||+|.+.... ...+.+.+|+.++++++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH-HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 45777889999999999999975 78899999986432 234678899999999999999999998865
Q ss_pred --CCeEEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeec
Q 014352 185 --KGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFG 262 (426)
Q Consensus 185 --~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 262 (426)
.+..++||||+++|+|.+++......+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg 161 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFG 161 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCC
T ss_pred ccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEeeCc
Confidence 35689999999999999999776667889999999999999999999998 9999999999999999999999999
Q ss_pred CccccccC---------------CCcccCccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHH-
Q 014352 263 LSKEEVFD---------------GRNSGLKGTYGYIDPAYISTN-KFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNL- 325 (426)
Q Consensus 263 l~~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~- 325 (426)
++...... .......||+.|+|||.+.+. .++.++||||||+++|||++ ||.........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~ 238 (303)
T 1zy4_A 162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNIL 238 (303)
T ss_dssp CCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred chhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHH
Confidence 98753211 122345689999999999764 68999999999999999998 55433222111
Q ss_pred hhccccchhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 326 ASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
..+... ........+...+..+.+++.+||+.||.+|||+.+++++
T Consensus 239 ~~~~~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 239 KKLRSV------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHST------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred Hhcccc------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 111000 0111122233344678999999999999999999999964
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=338.87 Aligned_cols=251 Identities=25% Similarity=0.342 Sum_probs=193.4
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc--cChHHHHHHHHHHhcCCCCceeeEEeEEEeCC------eEE
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH--QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKG------KYM 189 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~~~ 189 (426)
|.+.+.||+|+||.||+|... +|+.||+|++..... ...+.+.+|+.++++++||||+++++++...+ .+|
T Consensus 27 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~ 106 (367)
T 1cm8_A 27 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFY 106 (367)
T ss_dssp EEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCE
T ss_pred EEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEE
Confidence 566789999999999999975 788999999865432 22356889999999999999999999998753 469
Q ss_pred EEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccccc
Q 014352 190 LIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF 269 (426)
Q Consensus 190 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 269 (426)
+||||+ +++|.+++.. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 107 lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~- 179 (367)
T 1cm8_A 107 LVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQAD- 179 (367)
T ss_dssp EEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecccccc-
Confidence 999999 7899999854 45899999999999999999999999 9999999999999999999999999998543
Q ss_pred CCCcccCccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccc---cchhhhhh-------
Q 014352 270 DGRNSGLKGTYGYIDPAYIST-NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQ---DGVDEILD------- 338 (426)
Q Consensus 270 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~---~~~~~~~~------- 338 (426)
.......+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||.+......+..+.. ....+...
T Consensus 180 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~ 258 (367)
T 1cm8_A 180 -SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 258 (367)
T ss_dssp -SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHH
T ss_pred -cccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHH
Confidence 23445678999999999877 6899999999999999999999999976443322211100 00000000
Q ss_pred ----hhhc-------ccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 339 ----KQLV-------GACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 339 ----~~~~-------~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
..+. .......+..+.+++.+||+.||++|||+.+++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 259 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 0000 01112234678999999999999999999999985
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=331.40 Aligned_cols=256 Identities=24% Similarity=0.338 Sum_probs=199.8
Q ss_pred HhhhhcccccCCCeeEEEEEe--CCCcEEEEEEeccCCc--cChHHHHHHHHHHhcC---CCCceeeEEeEEE-----eC
Q 014352 118 TQNFTNILGQGAFGPVYKATM--PSGGVAAIKVLASDSH--QGEKEFQTEVSLLGRL---HHRNLVNLIGYCV-----DK 185 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~~~~~~~-----~~ 185 (426)
.|.+.+.||+|+||.||+|.. .++..||+|++..... .....+.+|+.+++.+ +||||+++++++. ..
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~ 91 (326)
T 1blx_A 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 91 (326)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSE
T ss_pred ceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCC
Confidence 366778999999999999997 3678899999865322 2234567788777766 8999999999987 45
Q ss_pred CeEEEEEEecCCCChhHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCc
Q 014352 186 GKYMLIYEFMSNGSLSNLIYSEE-RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLS 264 (426)
Q Consensus 186 ~~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 264 (426)
...++||||++ |+|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 92 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~Dfg~~ 167 (326)
T 1blx_A 92 TKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLA 167 (326)
T ss_dssp EEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred ceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEecCccc
Confidence 67899999997 69999986543 45899999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccc----cchhh-----
Q 014352 265 KEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQ----DGVDE----- 335 (426)
Q Consensus 265 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~----~~~~~----- 335 (426)
+............||+.|+|||.+.+..++.++||||||+++|||++|..||........+..+.. .....
T Consensus 168 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 247 (326)
T 1blx_A 168 RIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 247 (326)
T ss_dssp CCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTC
T ss_pred ccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCcccc
Confidence 865444444566789999999999999999999999999999999999999986543322211110 00000
Q ss_pred -----hhh---hhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 336 -----ILD---KQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 336 -----~~~---~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
.+. ...........+..+.+++.+||+.||++|||+.+++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 248 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp SSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000 000001112244678999999999999999999999864
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=337.80 Aligned_cols=255 Identities=20% Similarity=0.338 Sum_probs=201.9
Q ss_pred HhhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCccCh-----------------HHHHHHHHHHhcCCCCceeeEEe
Q 014352 118 TQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGE-----------------KEFQTEVSLLGRLHHRNLVNLIG 180 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-----------------~~~~~e~~~l~~l~h~niv~~~~ 180 (426)
.|.+.+.||+|+||.||+|.. ++..||+|.+........ +.+.+|+.++++++||||+++++
T Consensus 32 ~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 110 (348)
T 2pml_X 32 DYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEG 110 (348)
T ss_dssp TEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSE
T ss_pred ceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 466778999999999999999 899999999865422111 78999999999999999999999
Q ss_pred EEEeCCeEEEEEEecCCCChhHH------hhhc-cCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeecCCCCCCEEecC
Q 014352 181 YCVDKGKYMLIYEFMSNGSLSNL------IYSE-ERVLNWEERLQIALDISHGIEYLHE-GAVPPVIHRDLKSANILLDH 252 (426)
Q Consensus 181 ~~~~~~~~~lv~e~~~~gsL~~~------l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlk~~Nill~~ 252 (426)
++.+.+..++||||+++|+|.++ +... ...+++..+..++.|++.||.|||+ ++ |+||||||+||+++.
T Consensus 111 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~~~ 187 (348)
T 2pml_X 111 IITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILMDK 187 (348)
T ss_dssp EEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEECT
T ss_pred EEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEEcC
Confidence 99999999999999999999998 5432 4679999999999999999999999 88 999999999999999
Q ss_pred CCcEEEeeecCccccccCCCcccCccccCccCccccccC-CCCc-chhhHHHHHHHHHHHhCCCCCCchHH-HHHHhhcc
Q 014352 253 FMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTN-KFTM-KSDIFSFGVIIFELITAIHPHQNLME-YVNLASMS 329 (426)
Q Consensus 253 ~~~~kl~Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~Dv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~ 329 (426)
++.+||+|||++...... ......||..|+|||.+.+. .++. ++||||||+++|||++|..||..... ......+.
T Consensus 188 ~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~ 266 (348)
T 2pml_X 188 NGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIR 266 (348)
T ss_dssp TSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHT
T ss_pred CCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh
Confidence 999999999999754322 34456799999999999887 6666 99999999999999999999976432 11111111
Q ss_pred ccchhhh------hhh---hhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 330 QDGVDEI------LDK---QLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 330 ~~~~~~~------~~~---~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
....... ... ..........+..+.+++.+||+.||++|||+.+++++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 267 TKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp SCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1100000 000 00000012244678999999999999999999999874
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=341.75 Aligned_cols=254 Identities=24% Similarity=0.341 Sum_probs=181.7
Q ss_pred hhh-hcccccCCCeeEEEEEeC---CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEe--CCeEEEEE
Q 014352 119 QNF-TNILGQGAFGPVYKATMP---SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVD--KGKYMLIY 192 (426)
Q Consensus 119 ~~~-~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~ 192 (426)
|.+ +++||+|+||+||+|++. ++..||+|++.... ....+.+|+.+|++++||||+++++++.. ....++||
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~ 99 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 99 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence 444 458999999999999965 57789999987542 34578899999999999999999999965 57899999
Q ss_pred EecCCCChhHHhhhcc--------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEe----cCCCcEEEee
Q 014352 193 EFMSNGSLSNLIYSEE--------RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILL----DHFMRAKVAD 260 (426)
Q Consensus 193 e~~~~gsL~~~l~~~~--------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~D 260 (426)
||++ |+|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|
T Consensus 100 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 100 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp ECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred eCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 9996 58888774321 24899999999999999999999999 9999999999999 7788999999
Q ss_pred ecCccccccC----CCcccCccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCchHHHH---------HHh
Q 014352 261 FGLSKEEVFD----GRNSGLKGTYGYIDPAYISTN-KFTMKSDIFSFGVIIFELITAIHPHQNLMEYV---------NLA 326 (426)
Q Consensus 261 fgl~~~~~~~----~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~---------~~~ 326 (426)
||+++..... .......||+.|+|||++.+. .++.++|||||||++|||++|..||....... .+.
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~ 255 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 255 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHH
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHH
Confidence 9999754322 223456789999999999874 58999999999999999999999996432210 000
Q ss_pred hc------cc-cchhh---------h---hhhhhcccCCH---------HHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014352 327 SM------SQ-DGVDE---------I---LDKQLVGACNI---------QEVRELARIGHKCLHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 327 ~~------~~-~~~~~---------~---~~~~~~~~~~~---------~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 378 (426)
.+ .. ..... . +.......+.. .....+.+|+.+||+.||.+|||+.|++++-
T Consensus 256 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp 335 (405)
T 3rgf_A 256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP 335 (405)
T ss_dssp HHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 00 00 00000 0 00000000000 0135688999999999999999999999863
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=329.74 Aligned_cols=252 Identities=25% Similarity=0.379 Sum_probs=178.2
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCcc-ChHHHHHHHH-HHhcCCCCceeeEEeEEEeCCeEEEEEEec
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQ-GEKEFQTEVS-LLGRLHHRNLVNLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 195 (426)
+.+.+.||+|+||.||+|... +++.||+|++...... ....+..|+. +++.++||||+++++++...+..++||||+
T Consensus 24 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~ 103 (327)
T 3aln_A 24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM 103 (327)
T ss_dssp EEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred hhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeec
Confidence 456678999999999999985 7889999999765322 2334555655 777889999999999999999999999999
Q ss_pred CCCChhHHhhh----ccCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC
Q 014352 196 SNGSLSNLIYS----EERVLNWEERLQIALDISHGIEYLHEG-AVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD 270 (426)
Q Consensus 196 ~~gsL~~~l~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 270 (426)
++ +|.+++.. ....+++..+..++.|++.||.|||++ + |+||||||+||+++.++.+||+|||+++.....
T Consensus 104 ~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 179 (327)
T 3aln_A 104 ST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS 179 (327)
T ss_dssp SE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC----
T ss_pred CC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceecccc
Confidence 75 88887743 246689999999999999999999998 8 999999999999999999999999999765444
Q ss_pred CCcccCccccCccCcccc----ccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHH-HhhccccchhhhhhhhhcccC
Q 014352 271 GRNSGLKGTYGYIDPAYI----STNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVN-LASMSQDGVDEILDKQLVGAC 345 (426)
Q Consensus 271 ~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 345 (426)
.......||+.|+|||.+ .+..++.++||||||+++|||++|..||........ +........ +.+....
T Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-----~~~~~~~ 254 (327)
T 3aln_A 180 IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDP-----PQLSNSE 254 (327)
T ss_dssp --------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCC-----CCCCCCS
T ss_pred cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCC-----CCCCCcc
Confidence 344445799999999998 566789999999999999999999999976432211 111111110 0111111
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 014352 346 NIQEVRELARIGHKCLHKTPRKRPSIGEVTQALL 379 (426)
Q Consensus 346 ~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 379 (426)
....+..+.+++.+||+.||++|||+.+++++-.
T Consensus 255 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~ 288 (327)
T 3aln_A 255 EREFSPSFINFVNLCLTKDESKRPKYKELLKHPF 288 (327)
T ss_dssp SCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHH
T ss_pred cccCCHHHHHHHHHHhhCChhhCcCHHHHHhChH
Confidence 1223467999999999999999999999998643
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=325.70 Aligned_cols=248 Identities=23% Similarity=0.346 Sum_probs=196.3
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC----ccChHHHHHHHHHHhcCCCCceeeEEeEEE--eCCeEEE
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS----HQGEKEFQTEVSLLGRLHHRNLVNLIGYCV--DKGKYML 190 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~l 190 (426)
.|.+.+.||+|+||.||++... ++..+|+|++.... ......+.+|+.++++++||||+++++++. +.+..++
T Consensus 6 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (305)
T 2wtk_C 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYM 85 (305)
T ss_dssp CBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEE
T ss_pred ceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEE
Confidence 3667789999999999999975 67899999986532 223467899999999999999999999984 4467899
Q ss_pred EEEecCCCChhHHhhhc-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccccc
Q 014352 191 IYEFMSNGSLSNLIYSE-ERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF 269 (426)
Q Consensus 191 v~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 269 (426)
||||++++ |.+++... ...+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.....
T Consensus 86 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 86 VMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161 (305)
T ss_dssp EEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence 99999876 77776543 456999999999999999999999998 99999999999999999999999999975432
Q ss_pred C---CCcccCccccCccCccccccCCC--CcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhccc
Q 014352 270 D---GRNSGLKGTYGYIDPAYISTNKF--TMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGA 344 (426)
Q Consensus 270 ~---~~~~~~~gt~~y~aPE~~~~~~~--~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (426)
. .......||+.|+|||.+.+... +.++||||||+++|||++|..||...........+... . ..
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~--------~--~~ 231 (305)
T 2wtk_C 162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG--------S--YA 231 (305)
T ss_dssp TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC--------C--CC
T ss_pred cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcC--------C--CC
Confidence 1 12234568999999999976543 77999999999999999999999764332221111110 0 01
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 014352 345 CNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALL 379 (426)
Q Consensus 345 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 379 (426)
.+...+..+.+++.+||+.||++|||+.+++++-.
T Consensus 232 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 266 (305)
T 2wtk_C 232 IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSW 266 (305)
T ss_dssp CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHH
T ss_pred CCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcc
Confidence 12223467889999999999999999999998643
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=330.64 Aligned_cols=256 Identities=22% Similarity=0.314 Sum_probs=202.4
Q ss_pred HHHHhhhhcccccCCCeeEEEEEe-C-CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCC------ceeeEEeEEEeCC
Q 014352 115 QKATQNFTNILGQGAFGPVYKATM-P-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHR------NLVNLIGYCVDKG 186 (426)
Q Consensus 115 ~~~~~~~~~~lg~G~~g~Vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~------niv~~~~~~~~~~ 186 (426)
...+|.+.+.||+|+||.||+|.. . +++.||+|++.... ...+.+.+|+.++++++|+ +++++++++...+
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~ 90 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence 344577888999999999999986 3 67899999987532 3346788999999988665 4999999999999
Q ss_pred eEEEEEEecCCCChhHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecC-------------
Q 014352 187 KYMLIYEFMSNGSLSNLIYSEE-RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDH------------- 252 (426)
Q Consensus 187 ~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~------------- 252 (426)
..++||||+ +++|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.
T Consensus 91 ~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 91 HICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred cEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence 999999999 889999986554 46899999999999999999999998 999999999999987
Q ss_pred ------CCcEEEeeecCccccccCCCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHh
Q 014352 253 ------FMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLA 326 (426)
Q Consensus 253 ------~~~~kl~Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~ 326 (426)
++.+||+|||+++... .......||+.|+|||.+.+..++.++||||||+++|||++|..||..........
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 244 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDD--EHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLA 244 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETT--SCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHH
T ss_pred ccccccCCCceEeeCcccccCc--cccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 6689999999997532 23345679999999999999999999999999999999999999997643322111
Q ss_pred hc---cccchhhhh--------------------------hhh-----hcccCCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 014352 327 SM---SQDGVDEIL--------------------------DKQ-----LVGACNIQEVRELARIGHKCLHKTPRKRPSIG 372 (426)
Q Consensus 327 ~~---~~~~~~~~~--------------------------~~~-----~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ 372 (426)
.+ .......+. ... ............+.+++.+||+.||++|||+.
T Consensus 245 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ 324 (339)
T 1z57_A 245 MMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLR 324 (339)
T ss_dssp HHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred HHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHH
Confidence 10 000000000 000 00112234567899999999999999999999
Q ss_pred HHHHH
Q 014352 373 EVTQA 377 (426)
Q Consensus 373 evl~~ 377 (426)
|++++
T Consensus 325 ell~h 329 (339)
T 1z57_A 325 EALKH 329 (339)
T ss_dssp HHTTS
T ss_pred HHhcC
Confidence 99864
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=328.64 Aligned_cols=254 Identities=23% Similarity=0.295 Sum_probs=192.7
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEE-------------
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCV------------- 183 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~------------- 183 (426)
+|.+.+.||+|+||.||+|... +++.||+|.+........+.+.+|+.++++++||||+++++++.
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 91 (320)
T 2i6l_A 12 RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSL 91 (320)
T ss_dssp TEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----C
T ss_pred ceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccc
Confidence 4567789999999999999986 58899999987665555577899999999999999999999873
Q ss_pred -eCCeEEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEec-CCCcEEEeee
Q 014352 184 -DKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLD-HFMRAKVADF 261 (426)
Q Consensus 184 -~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Df 261 (426)
+.+..++||||++ |+|.+++.. ..+++..+..++.|++.||.|||+++ |+||||||+||+++ +++.+||+||
T Consensus 92 ~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~Df 165 (320)
T 2i6l_A 92 TELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDF 165 (320)
T ss_dssp CSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEECCC
T ss_pred cccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEEccC
Confidence 3467899999997 699999843 45899999999999999999999998 99999999999997 5679999999
Q ss_pred cCccccccC----CCcccCccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhcccc-----
Q 014352 262 GLSKEEVFD----GRNSGLKGTYGYIDPAYIST-NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQD----- 331 (426)
Q Consensus 262 gl~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~----- 331 (426)
|+++..... .......+|..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+...
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 245 (320)
T 2i6l_A 166 GLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVH 245 (320)
T ss_dssp TTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCC
T ss_pred ccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCc
Confidence 999754321 12234567899999998865 67899999999999999999999999865433222111100
Q ss_pred --chhh-------hhhhhhccc------CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 332 --GVDE-------ILDKQLVGA------CNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 332 --~~~~-------~~~~~~~~~------~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
...+ .+....... .....+..+.+++.+||+.||++|||+.+++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 246 EEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 0000 000000000 011234679999999999999999999999875
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=335.58 Aligned_cols=251 Identities=23% Similarity=0.332 Sum_probs=181.8
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc--cChHHHHHHHHHHhcCCCCceeeEEeEEEeC------CeE
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH--QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDK------GKY 188 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~ 188 (426)
+|.+.+.||+|+||.||+|... +++.||||++..... ...+.+.+|+.++++++||||+++++++... ...
T Consensus 30 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 109 (367)
T 2fst_X 30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 109 (367)
T ss_dssp TEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred ceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeE
Confidence 3667789999999999999864 788999999865422 2345788999999999999999999998754 567
Q ss_pred EEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccc
Q 014352 189 MLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEV 268 (426)
Q Consensus 189 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 268 (426)
++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 110 ~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 110 YLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTA 183 (367)
T ss_dssp EEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC--------
T ss_pred EEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence 9999999 7899998854 46999999999999999999999998 9999999999999999999999999997533
Q ss_pred cCCCcccCccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccc---------------cc
Q 014352 269 FDGRNSGLKGTYGYIDPAYIST-NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQ---------------DG 332 (426)
Q Consensus 269 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~---------------~~ 332 (426)
.......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.+......+..+.. ..
T Consensus 184 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~ 261 (367)
T 2fst_X 184 --DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 261 (367)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHH
T ss_pred --ccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence 22345679999999999877 6789999999999999999999999976543322211100 00
Q ss_pred hhhhhhhhhcc--cCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 333 VDEILDKQLVG--ACN-----IQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 333 ~~~~~~~~~~~--~~~-----~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
....+. .+.. ... ......+.+|+.+||+.||++|||+.+++++
T Consensus 262 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 262 ARNYIQ-SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHHHH-TSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHh-ccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 000000 0000 000 1123568999999999999999999999986
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=331.78 Aligned_cols=255 Identities=23% Similarity=0.288 Sum_probs=197.5
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCcc-ChHHHHHHHHHHhcCCCCceeeEEeEEEeC-----CeEEE
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQ-GEKEFQTEVSLLGRLHHRNLVNLIGYCVDK-----GKYML 190 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~l 190 (426)
+|.+.+.||+|+||.||+|... ++..||+|++...... ..+.+.+|++++++++||||+++++++... ...++
T Consensus 28 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i 107 (364)
T 3qyz_A 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYI 107 (364)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred cEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEE
Confidence 3667789999999999999875 7788999999754322 235788999999999999999999999765 36899
Q ss_pred EEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC
Q 014352 191 IYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD 270 (426)
Q Consensus 191 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 270 (426)
||||++ |+|.+++.. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 108 v~e~~~-~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 181 (364)
T 3qyz_A 108 VQDLME-TDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181 (364)
T ss_dssp EEECCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EEcccC-cCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEecCCC
Confidence 999997 599998854 45899999999999999999999998 999999999999999999999999999754322
Q ss_pred CC----cccCccccCccCccccc-cCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhcc---ccchhhhhh----
Q 014352 271 GR----NSGLKGTYGYIDPAYIS-TNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMS---QDGVDEILD---- 338 (426)
Q Consensus 271 ~~----~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~---~~~~~~~~~---- 338 (426)
.. .....||+.|+|||.+. +..++.++||||||+++|||++|..||.+......+..+. .....+.+.
T Consensus 182 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 261 (364)
T 3qyz_A 182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 261 (364)
T ss_dssp GCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCC
T ss_pred CCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 21 24457999999999875 4558999999999999999999999997643222211110 000000000
Q ss_pred -------hhhc--ccC-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014352 339 -------KQLV--GAC-----NIQEVRELARIGHKCLHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 339 -------~~~~--~~~-----~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 378 (426)
.... ... ....+..+.+++.+||+.||++|||+.+++++-
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 315 (364)
T 3qyz_A 262 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 315 (364)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred hhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 0000 000 012346789999999999999999999999763
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=326.29 Aligned_cols=249 Identities=22% Similarity=0.362 Sum_probs=195.3
Q ss_pred HHhhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCc--cChHHHHHHHHHHhcCC--CCceeeEEeEEEeCCeEEEEE
Q 014352 117 ATQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSH--QGEKEFQTEVSLLGRLH--HRNLVNLIGYCVDKGKYMLIY 192 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv~ 192 (426)
..|.+.+.||+|+||.||++...+++.||+|++..... ...+.+.+|+.++.+++ ||||+++++++.+.+..++||
T Consensus 28 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 107 (313)
T 3cek_A 28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 107 (313)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEE
T ss_pred ceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEE
Confidence 34677789999999999999988899999999875432 23467899999999997 599999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC-
Q 014352 193 EFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG- 271 (426)
Q Consensus 193 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~- 271 (426)
| +.+++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||+++ +.+||+|||++.......
T Consensus 108 e-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~ 181 (313)
T 3cek_A 108 E-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTT 181 (313)
T ss_dssp C-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC------
T ss_pred e-cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccccccccCccc
Confidence 9 5588999999654 46899999999999999999999998 999999999999975 899999999997543222
Q ss_pred --CcccCccccCccCcccccc-----------CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhh
Q 014352 272 --RNSGLKGTYGYIDPAYIST-----------NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILD 338 (426)
Q Consensus 272 --~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 338 (426)
......||+.|+|||.+.+ ..++.++||||||+++|||++|..||........ ......+
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-------~~~~~~~ 254 (313)
T 3cek_A 182 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS-------KLHAIID 254 (313)
T ss_dssp --------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-------HHHHHHC
T ss_pred cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH-------HHHHHHh
Confidence 1234568999999999875 4788999999999999999999999975322111 0111112
Q ss_pred hhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014352 339 KQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 339 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 378 (426)
.......+...+..+.+++.+||+.||++|||+.+++++-
T Consensus 255 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 255 PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred cccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence 2111111222246789999999999999999999999864
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=325.54 Aligned_cols=246 Identities=23% Similarity=0.377 Sum_probs=193.5
Q ss_pred hhHHHHHHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCcc------ChHHHHHHHHHHhcC----CCCceeeEE
Q 014352 111 YKDIQKATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQ------GEKEFQTEVSLLGRL----HHRNLVNLI 179 (426)
Q Consensus 111 ~~~l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l----~h~niv~~~ 179 (426)
..+.....|.+.+.||+|+||.||+|... +++.||+|++...... ....+..|+.++.++ +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 34455667888999999999999999874 7889999999655321 223466799999888 899999999
Q ss_pred eEEEeCCeEEEEEEe-cCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEec-CCCcEE
Q 014352 180 GYCVDKGKYMLIYEF-MSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLD-HFMRAK 257 (426)
Q Consensus 180 ~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~k 257 (426)
+++...+..++|+|| +.+++|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+||+++ .++.+|
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 180 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEK-GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAK 180 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEE
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEE
Confidence 999998999999999 7899999999654 45999999999999999999999998 99999999999999 889999
Q ss_pred EeeecCccccccCCCcccCccccCccCccccccCCCC-cchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhh
Q 014352 258 VADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFT-MKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEI 336 (426)
Q Consensus 258 l~Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 336 (426)
|+|||++..... .......||..|+|||++.+..+. .++||||||+++|||++|+.||.........
T Consensus 181 l~dfg~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~----------- 248 (312)
T 2iwi_A 181 LIDFGSGALLHD-EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEA----------- 248 (312)
T ss_dssp ECCCSSCEECCS-SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHT-----------
T ss_pred EEEcchhhhccc-CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHHhhh-----------
Confidence 999999975432 234456799999999999877764 5899999999999999999999764332110
Q ss_pred hhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 337 LDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 337 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
.. ..+......+.+++.+||+.||++|||+.+++++
T Consensus 249 ---~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 249 ---EL--HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp ---CC--CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ---cc--CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 1112234578899999999999999999999975
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=328.49 Aligned_cols=242 Identities=22% Similarity=0.350 Sum_probs=199.5
Q ss_pred HHHHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCcc------ChHHHHHHHHHHhcCC--CCceeeEEeEEEeC
Q 014352 115 QKATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQ------GEKEFQTEVSLLGRLH--HRNLVNLIGYCVDK 185 (426)
Q Consensus 115 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~ 185 (426)
...+|.+.+.||+|+||.||+|... +++.||+|++...... ....+..|+.++++++ ||||+++++++...
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~ 120 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence 3455778899999999999999864 7889999998754322 2245778999999996 59999999999999
Q ss_pred CeEEEEEEecCC-CChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEec-CCCcEEEeeecC
Q 014352 186 GKYMLIYEFMSN-GSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLD-HFMRAKVADFGL 263 (426)
Q Consensus 186 ~~~~lv~e~~~~-gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfgl 263 (426)
+..++|+|++.+ ++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++ .++.+||+|||+
T Consensus 121 ~~~~lv~e~~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~Dfg~ 196 (320)
T 3a99_A 121 DSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS 196 (320)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred CcEEEEEEcCCCCccHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence 999999999976 8999998654 46899999999999999999999998 99999999999999 789999999999
Q ss_pred ccccccCCCcccCccccCccCccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhc
Q 014352 264 SKEEVFDGRNSGLKGTYGYIDPAYISTNKF-TMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLV 342 (426)
Q Consensus 264 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (426)
++.... .......||+.|+|||++.+..+ +.++||||||+++|||++|..||.......... .
T Consensus 197 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~--------------~- 260 (320)
T 3a99_A 197 GALLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQ--------------V- 260 (320)
T ss_dssp CEECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHCC--------------C-
T ss_pred cccccc-ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhhccc--------------c-
Confidence 975432 23345679999999999987766 678999999999999999999997643321100 0
Q ss_pred ccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 343 GACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 343 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
..+...+..+.+++.+||+.||++|||+.+++++
T Consensus 261 -~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 261 -FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp -CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -cccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111223578899999999999999999999864
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=329.90 Aligned_cols=254 Identities=23% Similarity=0.271 Sum_probs=196.1
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc-cChHHHHHHHHHHhcCCCCceeeEEeEEEeC-----CeEEE
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH-QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDK-----GKYML 190 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~l 190 (426)
.|.+.+.||+|+||.||+|... +++.||||.+..... .....+.+|+.++++++||||+++++++... ...++
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 91 (353)
T 2b9h_A 12 DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYI 91 (353)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEE
T ss_pred ceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEE
Confidence 3567789999999999999976 688999999965432 2235678999999999999999999998764 67899
Q ss_pred EEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC
Q 014352 191 IYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD 270 (426)
Q Consensus 191 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 270 (426)
||||++ ++|.+++.. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 92 v~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (353)
T 2b9h_A 92 IQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165 (353)
T ss_dssp EECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccccccc
Confidence 999997 599998854 45899999999999999999999998 999999999999999999999999999753321
Q ss_pred C-----------CcccCccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccc--------
Q 014352 271 G-----------RNSGLKGTYGYIDPAYIST-NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQ-------- 330 (426)
Q Consensus 271 ~-----------~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~-------- 330 (426)
. ......||+.|+|||.+.+ ..++.++||||||+++|||++|..||.+......+..+..
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T 2b9h_A 166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD 245 (353)
T ss_dssp --------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCST
T ss_pred cccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchh
Confidence 1 1123468999999998754 7789999999999999999999999976443221111000
Q ss_pred --------cchhhhhhhhh-ccc-----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 331 --------DGVDEILDKQL-VGA-----CNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 331 --------~~~~~~~~~~~-~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
....+.+.... ... .....+..+.+++.+||+.||++|||+.+++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 246 NDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp TTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000000000 000 011234678999999999999999999999975
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=328.95 Aligned_cols=257 Identities=19% Similarity=0.299 Sum_probs=200.8
Q ss_pred HHHHHhhhhcccccCCCeeEEEEEeC-CC-cEEEEEEeccCCccChHHHHHHHHHHhcCCCCc------eeeEEeEEEeC
Q 014352 114 IQKATQNFTNILGQGAFGPVYKATMP-SG-GVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRN------LVNLIGYCVDK 185 (426)
Q Consensus 114 l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~~~~~~~~~ 185 (426)
....+|.+.+.||+|+||.||+|... ++ ..||+|++.... ...+.+.+|+.++++++|++ ++.+++++...
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred eecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 33456788899999999999999875 34 689999987532 33457888999999987665 99999999999
Q ss_pred CeEEEEEEecCCCChhHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEe--------------
Q 014352 186 GKYMLIYEFMSNGSLSNLIYSEE-RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILL-------------- 250 (426)
Q Consensus 186 ~~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill-------------- 250 (426)
+..++||||+ +++|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+|||+
T Consensus 95 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 95 GHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred CeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccccc
Confidence 9999999999 567777765543 56999999999999999999999998 9999999999999
Q ss_pred -----cCCCcEEEeeecCccccccCCCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHH
Q 014352 251 -----DHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNL 325 (426)
Q Consensus 251 -----~~~~~~kl~Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~ 325 (426)
+.++.+||+|||+++... .......||+.|+|||.+.+..++.++||||||+++|||++|..||........+
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 248 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDH--EHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL 248 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETT--SCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ccccccCCCcEEEeecCcccccc--ccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 667899999999997532 2334567999999999999999999999999999999999999999764332211
Q ss_pred hhc---cccchhhhh--------------------------hhh-----hcccCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 014352 326 ASM---SQDGVDEIL--------------------------DKQ-----LVGACNIQEVRELARIGHKCLHKTPRKRPSI 371 (426)
Q Consensus 326 ~~~---~~~~~~~~~--------------------------~~~-----~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 371 (426)
..+ .......+. ... ............+.+++.+||+.||++|||+
T Consensus 249 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 328 (355)
T 2eu9_A 249 VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITL 328 (355)
T ss_dssp HHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCH
Confidence 110 000000000 000 0011223445689999999999999999999
Q ss_pred HHHHHH
Q 014352 372 GEVTQA 377 (426)
Q Consensus 372 ~evl~~ 377 (426)
.+++++
T Consensus 329 ~e~l~h 334 (355)
T 2eu9_A 329 AEALLH 334 (355)
T ss_dssp HHHTTS
T ss_pred HHHhcC
Confidence 999864
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=330.80 Aligned_cols=251 Identities=24% Similarity=0.307 Sum_probs=194.5
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCcc--ChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeE------
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQ--GEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKY------ 188 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~------ 188 (426)
+|.+.+.||+|+||.||+|... +++.||+|++...... ..+.+.+|+.++++++||||+++++++...+..
T Consensus 43 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 122 (371)
T 4exu_A 43 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF 122 (371)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCC
T ss_pred cEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeE
Confidence 3566788999999999999875 7889999999764322 235788999999999999999999999877654
Q ss_pred EEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccc
Q 014352 189 MLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEV 268 (426)
Q Consensus 189 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 268 (426)
++||||+. ++|.+++. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 123 ~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 195 (371)
T 4exu_A 123 YLVMPFMQ-TDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHAD 195 (371)
T ss_dssp EEEEECCC-EEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred EEEEcccc-ccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence 99999997 58888773 34899999999999999999999998 9999999999999999999999999997542
Q ss_pred cCCCcccCccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccc---cchhhh--------
Q 014352 269 FDGRNSGLKGTYGYIDPAYIST-NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQ---DGVDEI-------- 336 (426)
Q Consensus 269 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~---~~~~~~-------- 336 (426)
.......||+.|+|||.+.+ ..++.++||||||+++|+|++|..||.+......+..+.. ....+.
T Consensus 196 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 273 (371)
T 4exu_A 196 --AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 273 (371)
T ss_dssp ------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHH
T ss_pred --cCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhh
Confidence 23345678999999999977 7889999999999999999999999986443222211100 000000
Q ss_pred ---hhhhhccc-------CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 337 ---LDKQLVGA-------CNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 337 ---~~~~~~~~-------~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
........ .....+..+.+++.+||+.||++|||+.+++++
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 274 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 00000000 011234679999999999999999999999976
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=322.56 Aligned_cols=250 Identities=24% Similarity=0.351 Sum_probs=180.8
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccC--hHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEe
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQG--EKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEF 194 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 194 (426)
.|.+.+.||+|+||.||+|... +++.||+|++....... .+.+.++..+++.++||||+++++++.+.+..++||||
T Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 105 (318)
T 2dyl_A 26 DLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMEL 105 (318)
T ss_dssp GEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC
T ss_pred cccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEec
Confidence 3566789999999999999985 78899999997653222 23345556678888999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCc
Q 014352 195 MSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEG-AVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRN 273 (426)
Q Consensus 195 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 273 (426)
+ ++.+..+.......+++..+..++.|++.||.|||++ + |+||||||+||+++.++.+||+|||++.........
T Consensus 106 ~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 181 (318)
T 2dyl_A 106 M-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK 181 (318)
T ss_dssp C-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred c-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccCCccc
Confidence 9 5566666655556799999999999999999999995 8 999999999999999999999999999755444444
Q ss_pred ccCccccCccCccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCchHHH-HHHhhccccchhhhhhhhhcccCCH
Q 014352 274 SGLKGTYGYIDPAYIS-----TNKFTMKSDIFSFGVIIFELITAIHPHQNLMEY-VNLASMSQDGVDEILDKQLVGACNI 347 (426)
Q Consensus 274 ~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (426)
....||+.|+|||.+. ...++.++||||||+++|||++|..||...... ..+......... .. ....
T Consensus 182 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-----~~--~~~~ 254 (318)
T 2dyl_A 182 DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPP-----LL--PGHM 254 (318)
T ss_dssp -----CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCC-----CC--CSSS
T ss_pred cccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCC-----CC--CccC
Confidence 5567999999999994 567889999999999999999999999753211 111111000000 00 0111
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014352 348 QEVRELARIGHKCLHKTPRKRPSIGEVTQAL 378 (426)
Q Consensus 348 ~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L 378 (426)
..+..+.+++.+||+.||.+|||+.+++++-
T Consensus 255 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~ 285 (318)
T 2dyl_A 255 GFSGDFQSFVKDCLTKDHRKRPKYNKLLEHS 285 (318)
T ss_dssp CCCHHHHHHHHHHTCSCTTTSCCHHHHTTSH
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhhCH
Confidence 2346789999999999999999999999864
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=324.24 Aligned_cols=251 Identities=22% Similarity=0.273 Sum_probs=172.9
Q ss_pred hhhh-cccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEe----CCeEEEEE
Q 014352 119 QNFT-NILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVD----KGKYMLIY 192 (426)
Q Consensus 119 ~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~ 192 (426)
|.+. +.||+|+||.||+|... +++.||+|++... .....+....++.++||||+++++++.. ....++||
T Consensus 30 y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~ 105 (336)
T 3fhr_A 30 YQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIM 105 (336)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred eEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEE
Confidence 5553 46999999999999986 7889999998643 2222333344667799999999999876 44589999
Q ss_pred EecCCCChhHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecC---CCcEEEeeecCccccc
Q 014352 193 EFMSNGSLSNLIYSEE-RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDH---FMRAKVADFGLSKEEV 268 (426)
Q Consensus 193 e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfgl~~~~~ 268 (426)
||+++|+|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+|||++. ++.+||+|||+++...
T Consensus 106 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~ 182 (336)
T 3fhr_A 106 ECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT 182 (336)
T ss_dssp ECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-
T ss_pred eccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccceecc
Confidence 9999999999997654 46999999999999999999999998 999999999999986 4559999999997543
Q ss_pred cCCCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHH
Q 014352 269 FDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQ 348 (426)
Q Consensus 269 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (426)
........||+.|+|||.+.+..++.++||||||+++|+|++|..||.................. ............
T Consensus 183 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 259 (336)
T 3fhr_A 183 -QNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL--GQYGFPNPEWSE 259 (336)
T ss_dssp ----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------------CCCTTTSTT
T ss_pred -ccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhc--cccccCchhhcc
Confidence 22334567899999999999889999999999999999999999999754332111100000000 000011111123
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 014352 349 EVRELARIGHKCLHKTPRKRPSIGEVTQALL 379 (426)
Q Consensus 349 ~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 379 (426)
.+..+.+++.+||+.||.+|||+.+++++-.
T Consensus 260 ~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 290 (336)
T 3fhr_A 260 VSEDAKQLIRLLLKTDPTERLTITQFMNHPW 290 (336)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 4567999999999999999999999998654
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=332.30 Aligned_cols=255 Identities=23% Similarity=0.340 Sum_probs=199.3
Q ss_pred HHHHHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCC-----------CCceeeEEeE
Q 014352 114 IQKATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLH-----------HRNLVNLIGY 181 (426)
Q Consensus 114 l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~ 181 (426)
+...+|.+.+.||+|+||.||+|+.. +++.||+|++.... ...+.+.+|+.++++++ ||||++++++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~ 94 (373)
T 1q8y_A 16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 94 (373)
T ss_dssp ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence 34456788899999999999999974 78899999987432 23457889999998886 8999999999
Q ss_pred EEeCC----eEEEEEEecCCCChhHHhhhc-cCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCeeecCCCCCCEEec----
Q 014352 182 CVDKG----KYMLIYEFMSNGSLSNLIYSE-ERVLNWEERLQIALDISHGIEYLHEG-AVPPVIHRDLKSANILLD---- 251 (426)
Q Consensus 182 ~~~~~----~~~lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~ivH~dlk~~Nill~---- 251 (426)
+...+ ..++||||+ +++|.+++... ...+++..+..++.|++.||.|||++ + |+||||||+|||++
T Consensus 95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 95 FNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEET
T ss_pred hhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCC
Confidence 88654 789999999 88999998653 35599999999999999999999998 8 99999999999995
Q ss_pred --CCCcEEEeeecCccccccCCCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHH------H
Q 014352 252 --HFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEY------V 323 (426)
Q Consensus 252 --~~~~~kl~Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~------~ 323 (426)
..+.+||+|||++.... .......||+.|+|||++.+..++.++||||||+++|||++|..||...... .
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 248 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYD--EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 248 (373)
T ss_dssp TTTEEEEEECCCTTCEETT--BCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred CcCcceEEEcccccccccC--CCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence 34479999999997543 2334557899999999999999999999999999999999999999753211 0
Q ss_pred HHhhc---cccch-------------------------------hhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCC
Q 014352 324 NLASM---SQDGV-------------------------------DEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRP 369 (426)
Q Consensus 324 ~~~~~---~~~~~-------------------------------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP 369 (426)
.+..+ ..... ...... ....+......+.+++.+||+.||++||
T Consensus 249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTE--KYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHH--TTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhh--cccCCcchHHHHHHHHHHHhccCccccC
Confidence 00000 00000 000000 1123456678899999999999999999
Q ss_pred CHHHHHHH
Q 014352 370 SIGEVTQA 377 (426)
Q Consensus 370 s~~evl~~ 377 (426)
|+.+++++
T Consensus 327 t~~ell~h 334 (373)
T 1q8y_A 327 DAGGLVNH 334 (373)
T ss_dssp CHHHHHTC
T ss_pred CHHHHhhC
Confidence 99999875
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=327.44 Aligned_cols=256 Identities=22% Similarity=0.272 Sum_probs=198.1
Q ss_pred HHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCC-CC-----ceeeEEeEEEeCCeEE
Q 014352 117 ATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLH-HR-----NLVNLIGYCVDKGKYM 189 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~~~~~~~~~~~~~ 189 (426)
.+|.+.+.||+|+||+||+|... +++.||||++.... .....+..|+.++..++ |+ +|+++++++...+..+
T Consensus 54 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 132 (382)
T 2vx3_A 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC 132 (382)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEE
T ss_pred eeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceE
Confidence 35677889999999999999876 67889999997432 23456778888888875 44 4999999999999999
Q ss_pred EEEEecCCCChhHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEec--CCCcEEEeeecCccc
Q 014352 190 LIYEFMSNGSLSNLIYSEE-RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLD--HFMRAKVADFGLSKE 266 (426)
Q Consensus 190 lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~--~~~~~kl~Dfgl~~~ 266 (426)
+||||++ |+|.+++.... ..+++..+..++.|++.||.|||++. .+|+||||||+|||++ .++.+||+|||+++.
T Consensus 133 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~ 210 (382)
T 2vx3_A 133 LVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 210 (382)
T ss_dssp EEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEEEeccCcee
Confidence 9999996 59999997654 56999999999999999999999531 2399999999999995 478899999999975
Q ss_pred cccCCCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccc---cchhh--------
Q 014352 267 EVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQ---DGVDE-------- 335 (426)
Q Consensus 267 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~---~~~~~-------- 335 (426)
.. .......||+.|+|||++.+..++.++|||||||++|||++|..||........+..+.. .....
T Consensus 211 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 288 (382)
T 2vx3_A 211 LG--QRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKA 288 (382)
T ss_dssp TT--CCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTH
T ss_pred cc--cccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHH
Confidence 42 233456799999999999999999999999999999999999999986443322211100 00000
Q ss_pred --hhhhh----------------------------h-------------cccCCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 014352 336 --ILDKQ----------------------------L-------------VGACNIQEVRELARIGHKCLHKTPRKRPSIG 372 (426)
Q Consensus 336 --~~~~~----------------------------~-------------~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ 372 (426)
.++.. + ...........+.+|+.+||+.||++|||+.
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~ 368 (382)
T 2vx3_A 289 RKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPY 368 (382)
T ss_dssp HHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHH
T ss_pred HHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHH
Confidence 00000 0 0001123446799999999999999999999
Q ss_pred HHHHH
Q 014352 373 EVTQA 377 (426)
Q Consensus 373 evl~~ 377 (426)
|++++
T Consensus 369 e~L~h 373 (382)
T 2vx3_A 369 YALQH 373 (382)
T ss_dssp HHTTS
T ss_pred HHhcC
Confidence 99875
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=333.62 Aligned_cols=245 Identities=25% Similarity=0.339 Sum_probs=186.9
Q ss_pred hhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcC-CCCceeeEEeEEEeCCeEEEEEEecCC
Q 014352 119 QNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRL-HHRNLVNLIGYCVDKGKYMLIYEFMSN 197 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 197 (426)
+.+.+.||+|+||+||.....+++.||||++.... ...+.+|+.+|+++ +||||+++++++.+.+..++||||++
T Consensus 26 y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~- 101 (432)
T 3p23_A 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA- 101 (432)
T ss_dssp EEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-
T ss_pred EecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-
Confidence 55667899999999665555688999999986543 23467899999999 79999999999999999999999996
Q ss_pred CChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecC-----CCcEEEeeecCccccccC--
Q 014352 198 GSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDH-----FMRAKVADFGLSKEEVFD-- 270 (426)
Q Consensus 198 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~-----~~~~kl~Dfgl~~~~~~~-- 270 (426)
|+|.+++......+.......++.|++.||.|||+++ |+||||||+|||++. ...+||+|||+++.....
T Consensus 102 g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~ 178 (432)
T 3p23_A 102 ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH 178 (432)
T ss_dssp EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-----
T ss_pred CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCc
Confidence 5999999766655666667889999999999999999 999999999999953 335889999999754322
Q ss_pred --CCcccCccccCccCccccc---cCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhccc
Q 014352 271 --GRNSGLKGTYGYIDPAYIS---TNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGA 344 (426)
Q Consensus 271 --~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (426)
.......||+.|+|||++. ...++.++|||||||++|||++ |..||.................. ...
T Consensus 179 ~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~-------~~~ 251 (432)
T 3p23_A 179 SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLD-------CLH 251 (432)
T ss_dssp -------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCT-------TSC
T ss_pred ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCcc-------ccC
Confidence 2234567999999999997 4567889999999999999999 99998653222111111000000 001
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 345 CNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 345 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
........+.+++.+||+.||++|||+.+++++
T Consensus 252 ~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 252 PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 122345568899999999999999999999854
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=326.40 Aligned_cols=250 Identities=23% Similarity=0.316 Sum_probs=193.6
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCcc--ChHHHHHHHHHHhcCCCCceeeEEeEEEeCCe------EE
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQ--GEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGK------YM 189 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~------~~ 189 (426)
|.+.+.||+|+||.||+|... +|+.||||++...... ..+.+.+|+.++++++||||+++++++...+. .+
T Consensus 26 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 105 (353)
T 3coi_A 26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFY 105 (353)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCE
T ss_pred EEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEE
Confidence 556788999999999999975 7889999999764322 23568899999999999999999999987653 49
Q ss_pred EEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccccc
Q 014352 190 LIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF 269 (426)
Q Consensus 190 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 269 (426)
+||||++ ++|.+++. ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++...
T Consensus 106 lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~- 177 (353)
T 3coi_A 106 LVMPFMQ-TDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHAD- 177 (353)
T ss_dssp EEEECCS-EEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred EEecccc-CCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccccCCC-
Confidence 9999997 58888773 34899999999999999999999998 9999999999999999999999999997532
Q ss_pred CCCcccCccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccc---------------cch
Q 014352 270 DGRNSGLKGTYGYIDPAYIST-NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQ---------------DGV 333 (426)
Q Consensus 270 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~---------------~~~ 333 (426)
.......+|+.|+|||.+.+ ..++.++||||||+++|||++|..||.+......+..+.. ...
T Consensus 178 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 256 (353)
T 3coi_A 178 -AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAA 256 (353)
T ss_dssp -------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHH
T ss_pred -CCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHH
Confidence 22345678999999999876 6789999999999999999999999976433222111100 000
Q ss_pred hhhhhhhh------cccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 334 DEILDKQL------VGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 334 ~~~~~~~~------~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
...+.... ........+..+.+++.+||+.||++|||+.+++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 257 KSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00000000 001112345689999999999999999999999875
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=332.70 Aligned_cols=245 Identities=23% Similarity=0.298 Sum_probs=184.3
Q ss_pred hhcccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcC-CCCceeeEEeEEEeCCeEEEEEEecCCCC
Q 014352 121 FTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRL-HHRNLVNLIGYCVDKGKYMLIYEFMSNGS 199 (426)
Q Consensus 121 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gs 199 (426)
..+.||+|+||+||.+...+|+.||||++... ..+.+.+|+.+++++ +||||+++++++.+.+..++||||++ |+
T Consensus 19 ~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gs 94 (434)
T 2rio_A 19 SEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LN 94 (434)
T ss_dssp EEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EE
T ss_pred ccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CC
Confidence 34689999999998776668999999998653 245678899999876 89999999999999999999999995 69
Q ss_pred hhHHhhhccCC------CCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCC-------------CcEEEee
Q 014352 200 LSNLIYSEERV------LNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHF-------------MRAKVAD 260 (426)
Q Consensus 200 L~~~l~~~~~~------l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~-------------~~~kl~D 260 (426)
|.+++...... .++..++.++.|++.||.|||+++ |+||||||+|||++.+ +.+||+|
T Consensus 95 L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~D 171 (434)
T 2rio_A 95 LQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD 171 (434)
T ss_dssp HHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECC
T ss_pred HHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEEEcc
Confidence 99999654321 123345779999999999999998 9999999999999754 4899999
Q ss_pred ecCccccccCC-----CcccCccccCccCcccccc-------CCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhh
Q 014352 261 FGLSKEEVFDG-----RNSGLKGTYGYIDPAYIST-------NKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLAS 327 (426)
Q Consensus 261 fgl~~~~~~~~-----~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~ 327 (426)
||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++ |..||.........
T Consensus 172 FG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~-- 249 (434)
T 2rio_A 172 FGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN-- 249 (434)
T ss_dssp CTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHHH--
T ss_pred cccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHHH--
Confidence 99998543322 1234579999999999965 678999999999999999999 99999753221110
Q ss_pred ccccchhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 328 MSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
+...... .+..........+..+.+++.+||+.||.+|||+.+++++
T Consensus 250 i~~~~~~---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 250 IIRGIFS---LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp HHHTCCC---CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HhcCCCC---cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 0000000 0001111234566789999999999999999999999864
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=344.01 Aligned_cols=266 Identities=26% Similarity=0.318 Sum_probs=205.2
Q ss_pred HHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC-ccChHHHHHHHHHHhcCCCCceeeEEeEEEe------CCeE
Q 014352 117 ATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS-HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVD------KGKY 188 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~~ 188 (426)
..|.+.+.||+|+||.||+|... ++..||+|++.... ....+.+.+|+.++++++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 45778899999999999999874 68899999987642 2234578999999999999999999998765 6678
Q ss_pred EEEEEecCCCChhHHhhhcc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCc---EEEeeecC
Q 014352 189 MLIYEFMSNGSLSNLIYSEE--RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMR---AKVADFGL 263 (426)
Q Consensus 189 ~lv~e~~~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfgl 263 (426)
++||||+++|+|.+++.... ..+++..+..++.+++.||.|||+.+ |+||||||+||+++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccccc
Confidence 99999999999999996543 35899999999999999999999998 999999999999997665 99999999
Q ss_pred ccccccCCCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccc----------cch
Q 014352 264 SKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQ----------DGV 333 (426)
Q Consensus 264 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~----------~~~ 333 (426)
+.............||+.|+|||.+.+..++.++||||||+++|||++|..||........+..... ...
T Consensus 171 a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l 250 (676)
T 3qa8_A 171 AKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDL 250 (676)
T ss_dssp CCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCC
T ss_pred ccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhh
Confidence 9866555555567899999999999999999999999999999999999999975322221111000 000
Q ss_pred hhh--hhhh--hcccCCHHHHHHHHHHHHHcccCCCCCCCCHHH-----HHHHHHHHHHHh
Q 014352 334 DEI--LDKQ--LVGACNIQEVRELARIGHKCLHKTPRKRPSIGE-----VTQALLKIKQRH 385 (426)
Q Consensus 334 ~~~--~~~~--~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e-----vl~~L~~~~~~~ 385 (426)
... +... .........+..+.+++.+||+.||++|||+.+ ..+.++.+....
T Consensus 251 ~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k 311 (676)
T 3qa8_A 251 TGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK 311 (676)
T ss_dssp SSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred ccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence 000 0000 011223446788999999999999999999988 455666665433
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=309.87 Aligned_cols=236 Identities=10% Similarity=0.088 Sum_probs=185.0
Q ss_pred HHHHHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccC---hHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEE
Q 014352 114 IQKATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQG---EKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYM 189 (426)
Q Consensus 114 l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 189 (426)
+...+|.+.+.||+|+||.||+|... +++.||+|++....... .+.+.+|+.++.+++||||+++++++.+.+..|
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 44456778889999999999999986 58899999997654332 257899999999999999999999999999999
Q ss_pred EEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccccc
Q 014352 190 LIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF 269 (426)
Q Consensus 190 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 269 (426)
+||||+++++|.+++.. . ....+...++.|++.||.|||+++ |+||||||+|||++.++.+||+++|
T Consensus 108 lv~e~~~g~~L~~~l~~--~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADT--S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp EEEECCCEEEHHHHHTT--C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred EEEEecCCCCHHHHHhc--C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-------
Confidence 99999999999999843 2 355678889999999999999999 9999999999999999999998443
Q ss_pred CCCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHH
Q 014352 270 DGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQE 349 (426)
Q Consensus 270 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (426)
|++| ++.++||||||+++|||++|+.||........+.............. .......
T Consensus 175 ------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 232 (286)
T 3uqc_A 175 ------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEP---ADIDRDI 232 (286)
T ss_dssp ------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCH---HHHCTTS
T ss_pred ------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCCh---hhcccCC
Confidence 3333 68999999999999999999999976322111100000000000000 0011123
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHh
Q 014352 350 VRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRH 385 (426)
Q Consensus 350 ~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~ 385 (426)
+..+.+++.+||+.||++| |+.++++.|+.+....
T Consensus 233 ~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 233 PFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp CHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred CHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 4679999999999999999 9999999999886543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=348.19 Aligned_cols=249 Identities=21% Similarity=0.318 Sum_probs=198.0
Q ss_pred CChhHHHHHHhhhhcccccCCCeeEEEEEeC--CCcEEEEEEeccCCc-cChHHHHHHHHHHhcCCCCceeeEEeEEEeC
Q 014352 109 YAYKDIQKATQNFTNILGQGAFGPVYKATMP--SGGVAAIKVLASDSH-QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDK 185 (426)
Q Consensus 109 ~~~~~l~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 185 (426)
+...++...+|.+.+.||+|+||.||+|.+. +++.||||++..... .....+.+|+.++++++||||+++++++...
T Consensus 72 ~~~g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 151 (681)
T 2pzi_A 72 LNPGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHT 151 (681)
T ss_dssp SCTTCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEE
T ss_pred CCCCCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeec
Confidence 3444555567888899999999999999975 688999999865432 2335688999999999999999999999886
Q ss_pred Ce-----EEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEee
Q 014352 186 GK-----YMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVAD 260 (426)
Q Consensus 186 ~~-----~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 260 (426)
+. .|+||||+++++|.+++.. .+++..++.++.|++.||.|||+++ |+||||||+|||++.+ .+||+|
T Consensus 152 ~~~~~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~D 224 (681)
T 2pzi_A 152 DRHGDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLID 224 (681)
T ss_dssp CTTSCEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECC
T ss_pred CCCCCceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEe
Confidence 65 7999999999999988743 6999999999999999999999999 9999999999999985 899999
Q ss_pred ecCccccccCCCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhh
Q 014352 261 FGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQ 340 (426)
Q Consensus 261 fgl~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (426)
||+++.... .....||+.|+|||++.+.. +.++||||||+++|+|++|..||..... .....
T Consensus 225 FG~a~~~~~---~~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~---------~~~~~----- 286 (681)
T 2pzi_A 225 LGAVSRINS---FGYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYV---------DGLPE----- 286 (681)
T ss_dssp CTTCEETTC---CSCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEEC---------SSCCT-----
T ss_pred cccchhccc---CCccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccc---------ccccc-----
Confidence 999975432 24567999999999997654 8999999999999999999988764210 00000
Q ss_pred hcccCCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHHHHHHH
Q 014352 341 LVGACNIQEVRELARIGHKCLHKTPRKRP-SIGEVTQALLKIKQR 384 (426)
Q Consensus 341 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-s~~evl~~L~~~~~~ 384 (426)
..........+.+++.+||+.||++|| ++.++.+.|..+...
T Consensus 287 --~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 329 (681)
T 2pzi_A 287 --DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLRE 329 (681)
T ss_dssp --TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHH
T ss_pred --cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHH
Confidence 000112335789999999999999999 466677777666443
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=323.86 Aligned_cols=237 Identities=19% Similarity=0.191 Sum_probs=178.6
Q ss_pred hhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCcc---ChHHHHHHHHHHhcCCC-Cce---------e---------
Q 014352 120 NFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQ---GEKEFQTEVSLLGRLHH-RNL---------V--------- 176 (426)
Q Consensus 120 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h-~ni---------v--------- 176 (426)
...+.||+|+||+||+|.+. +++.||||++...... ..+.|.+|+.+++.++| +|. +
T Consensus 81 ~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (413)
T 3dzo_A 81 VRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDP 160 (413)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECC
T ss_pred EEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccC
Confidence 34578999999999999964 7889999998744322 24678999999999987 211 1
Q ss_pred ---eEEeEEEe-----CCeEEEEEEecCCCChhHHhh------hccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecC
Q 014352 177 ---NLIGYCVD-----KGKYMLIYEFMSNGSLSNLIY------SEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRD 242 (426)
Q Consensus 177 ---~~~~~~~~-----~~~~~lv~e~~~~gsL~~~l~------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~d 242 (426)
.++.++.. ....+++|+++ +++|.+++. .....+++..++.++.|++.||.|||+++ |+|||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---iiHrD 236 (413)
T 3dzo_A 161 QKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTY 236 (413)
T ss_dssp C---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred CCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCC
Confidence 11111111 12457777766 679999884 22455888899999999999999999999 99999
Q ss_pred CCCCCEEecCCCcEEEeeecCccccccCCCcccCccccCccCcccc----------ccCCCCcchhhHHHHHHHHHHHhC
Q 014352 243 LKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYI----------STNKFTMKSDIFSFGVIIFELITA 312 (426)
Q Consensus 243 lk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Dv~S~Gvvl~el~tg 312 (426)
|||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||++|||++|
T Consensus 237 iKp~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg 313 (413)
T 3dzo_A 237 LRPVDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA 313 (413)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHS
T ss_pred cccceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHC
Confidence 9999999999999999999998754322 345567 999999999 556688999999999999999999
Q ss_pred CCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 313 IHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 313 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
+.||........ ....+. . ....+..+.+++.+||+.||++|||+.+++++
T Consensus 314 ~~Pf~~~~~~~~--------~~~~~~----~--~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 314 DLPNTDDAALGG--------SEWIFR----S--CKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp SCCCCTTGGGSC--------SGGGGS----S--CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCCCCCcchhhh--------HHHHHh----h--cccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 999975322111 111111 0 01223679999999999999999999888765
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=298.96 Aligned_cols=227 Identities=22% Similarity=0.301 Sum_probs=177.1
Q ss_pred cccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHH-hcCCCCceeeEEeEEEe----CCeEEEEEEecC
Q 014352 123 NILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLL-GRLHHRNLVNLIGYCVD----KGKYMLIYEFMS 196 (426)
Q Consensus 123 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~----~~~~~lv~e~~~ 196 (426)
+.||+|+||.||++... ++..||+|++.. ...+.+|+.++ +.++||||+++++++.. ....++||||++
T Consensus 24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~ 98 (299)
T 3m2w_A 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 98 (299)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCC
T ss_pred cccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecC
Confidence 67999999999999974 788999999853 34677888888 56699999999999987 667899999999
Q ss_pred CCChhHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecC---CCcEEEeeecCccccccCCC
Q 014352 197 NGSLSNLIYSEE-RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDH---FMRAKVADFGLSKEEVFDGR 272 (426)
Q Consensus 197 ~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfgl~~~~~~~~~ 272 (426)
+|+|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+||+++. ++.+||+|||++....
T Consensus 99 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~---- 171 (299)
T 3m2w_A 99 GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT---- 171 (299)
T ss_dssp SCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECT----
T ss_pred CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccccccc----
Confidence 999999997654 46999999999999999999999999 999999999999998 7889999999986421
Q ss_pred cccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHH
Q 014352 273 NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRE 352 (426)
Q Consensus 273 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (426)
+..++.++||||||+++|||++|..||..................... ..........+..
T Consensus 172 -----------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 232 (299)
T 3m2w_A 172 -----------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY--EFPNPEWSEVSEE 232 (299)
T ss_dssp -----------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCC--SSCHHHHTTSCHH
T ss_pred -----------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccc--cCCchhcccCCHH
Confidence 244678999999999999999999999764432221111111000000 0000000123467
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 014352 353 LARIGHKCLHKTPRKRPSIGEVTQALLK 380 (426)
Q Consensus 353 l~~l~~~cl~~~p~~RPs~~evl~~L~~ 380 (426)
+.+++.+||+.||++|||+.+++++-.-
T Consensus 233 ~~~li~~~l~~dP~~Rps~~e~l~hp~~ 260 (299)
T 3m2w_A 233 VKMLIRNLLKTEPTQRMTITEFMNHPWI 260 (299)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred HHHHHHHHcccChhhCCCHHHHhcChhh
Confidence 9999999999999999999999987543
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=307.76 Aligned_cols=245 Identities=17% Similarity=0.197 Sum_probs=186.9
Q ss_pred HHHHHhhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCc--------cChHHHHHHHHHHhcCC---------CCcee
Q 014352 114 IQKATQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSH--------QGEKEFQTEVSLLGRLH---------HRNLV 176 (426)
Q Consensus 114 l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~---------h~niv 176 (426)
+....|.+.+.||+|+||+||+|+. +++.||||++..... ...+.+.+|+.++++++ ||||+
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred cccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 3456688889999999999999998 779999999976532 22367889999998885 88888
Q ss_pred eEEeEEE------------------------------eCCeEEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHH
Q 014352 177 NLIGYCV------------------------------DKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHG 226 (426)
Q Consensus 177 ~~~~~~~------------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~ 226 (426)
++.+++. +.+..++||||+++|++.+.+.. ..+++..+..++.|++.|
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHH
Confidence 8887653 26789999999999977776633 558999999999999999
Q ss_pred HHHHH-cCCCCCeeecCCCCCCEEecCCC--------------------cEEEeeecCccccccCCCcccCccccCccCc
Q 014352 227 IEYLH-EGAVPPVIHRDLKSANILLDHFM--------------------RAKVADFGLSKEEVFDGRNSGLKGTYGYIDP 285 (426)
Q Consensus 227 l~~LH-~~~~~~ivH~dlk~~Nill~~~~--------------------~~kl~Dfgl~~~~~~~~~~~~~~gt~~y~aP 285 (426)
|.||| +++ |+||||||+|||++.++ .+||+|||+++.... ....||+.|+||
T Consensus 174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~----~~~~gt~~y~aP 246 (336)
T 2vuw_A 174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD----GIVVFCDVSMDE 246 (336)
T ss_dssp HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET----TEEECCCCTTCS
T ss_pred HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC----CcEEEeecccCh
Confidence 99999 888 99999999999999887 899999999985432 234799999999
Q ss_pred cccccCCCCcchhhHHHHHH-HHHHHhCCCCCCchHHHHHHh-hccccchhhhhhhhhcccCCHHHHHHHHHHHHHcccC
Q 014352 286 AYISTNKFTMKSDIFSFGVI-IFELITAIHPHQNLMEYVNLA-SMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHK 363 (426)
Q Consensus 286 E~~~~~~~~~~~Dv~S~Gvv-l~el~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~ 363 (426)
|++.+.. +.++||||||++ .+++++|..||.+........ .+.... ..............+.++.+|+.+||+.
T Consensus 247 E~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~s~~~~dli~~~L~~ 322 (336)
T 2vuw_A 247 DLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQM---TFKTKCNTPAMKQIKRKIQEFHRTMLNF 322 (336)
T ss_dssp GGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTC---CCSSCCCSHHHHHHHHHHHHHHHHGGGS
T ss_pred hhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhh---ccCcccchhhhhhcCHHHHHHHHHHhcc
Confidence 9998776 899999998777 777889999986421100000 000000 0000000111234667899999999997
Q ss_pred CCCCCCCHHHHH-HH
Q 014352 364 TPRKRPSIGEVT-QA 377 (426)
Q Consensus 364 ~p~~RPs~~evl-~~ 377 (426)
| |+.|++ ++
T Consensus 323 d-----sa~e~l~~H 332 (336)
T 2vuw_A 323 S-----SATDLLCQH 332 (336)
T ss_dssp S-----SHHHHHHHC
T ss_pred C-----CHHHHHhcC
Confidence 6 888888 54
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.8e-33 Score=281.59 Aligned_cols=184 Identities=16% Similarity=0.115 Sum_probs=129.8
Q ss_pred ccccCCCeeEEEEE-eCCCcEEEEEEeccCCc----------cChHHHHHHHHHHhcC-CCCceeeEEeEEEeCCeEEEE
Q 014352 124 ILGQGAFGPVYKAT-MPSGGVAAIKVLASDSH----------QGEKEFQTEVSLLGRL-HHRNLVNLIGYCVDKGKYMLI 191 (426)
Q Consensus 124 ~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~----------~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 191 (426)
..+.|++|.+..++ .-.|+.+++|++..... ...++|.+|+++|+++ .|+||+++++++.+++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 46777777776654 33678899999975521 1224699999999999 799999999999999999999
Q ss_pred EEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC-
Q 014352 192 YEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD- 270 (426)
Q Consensus 192 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~- 270 (426)
|||++|++|.++|... .+++.. .|+.||+.||.|+|+++ ||||||||+|||++.+|.+||+|||+++.....
T Consensus 321 MEyv~G~~L~d~i~~~-~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAG-EEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC 393 (569)
T ss_dssp EECCCSEEHHHHHHTT-CCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred EecCCCCcHHHHHHhC-CCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence 9999999999999654 446654 47899999999999999 999999999999999999999999999854332
Q ss_pred CCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCC
Q 014352 271 GRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHP 315 (426)
Q Consensus 271 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p 315 (426)
......+||+.|||||++.+ .+..++|+||+|++++++.++..|
T Consensus 394 ~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 394 SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 23345679999999999976 467789999999998887665433
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.5e-29 Score=252.87 Aligned_cols=181 Identities=17% Similarity=0.207 Sum_probs=144.3
Q ss_pred hcccccCCCeeEEEEEeCCCcEEEEEEeccCCccC--------hHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEE
Q 014352 122 TNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQG--------EKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYE 193 (426)
Q Consensus 122 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 193 (426)
.+.||+|+||.||+|.. .+..+++|......... .+.+.+|++++++++||||+++..++...+..++|||
T Consensus 341 ~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp -------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 35899999999999965 56677888764432111 2347899999999999999966666667778899999
Q ss_pred ecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCC-
Q 014352 194 FMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGR- 272 (426)
Q Consensus 194 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~- 272 (426)
|+++++|.+++.. +..++.|++.||.|||+++ |+||||||+|||++. .+||+|||+++.......
T Consensus 420 ~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~ 485 (540)
T 3en9_A 420 YINGKLAKDVIED---------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDK 485 (540)
T ss_dssp CCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCHHHH
T ss_pred CCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCcccc
Confidence 9999999999954 4679999999999999999 999999999999999 999999999986433211
Q ss_pred -------cccCccccCccCcccccc--CCCCcchhhHHHHHHHHHHHhCCCCCC
Q 014352 273 -------NSGLKGTYGYIDPAYIST--NKFTMKSDIFSFGVIIFELITAIHPHQ 317 (426)
Q Consensus 273 -------~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gvvl~el~tg~~p~~ 317 (426)
.....||+.|||||++.. ..|+...|+||..+-.++-+.++.+|.
T Consensus 486 ~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 486 AVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 135679999999999976 668888999999999999888877763
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.9e-25 Score=207.91 Aligned_cols=141 Identities=15% Similarity=0.148 Sum_probs=114.0
Q ss_pred hhcccccCCCeeEEEEEeCCCcEEEEEEeccCCcc------------------ChHHHHHHHHHHhcCCCCceeeEEeEE
Q 014352 121 FTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQ------------------GEKEFQTEVSLLGRLHHRNLVNLIGYC 182 (426)
Q Consensus 121 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~e~~~l~~l~h~niv~~~~~~ 182 (426)
+.+.||+|+||.||+|...+|+.||+|.+...... ....+.+|+.++++++ | +++.+++
T Consensus 94 ~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~ 170 (282)
T 1zar_A 94 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVY 170 (282)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEE
T ss_pred ecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEE
Confidence 45789999999999999977899999998643211 2346889999999999 4 5555554
Q ss_pred EeCCeEEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeec
Q 014352 183 VDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFG 262 (426)
Q Consensus 183 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 262 (426)
.. +..++||||+++|+|.+ +.. .....++.|++.||.|||+++ |+||||||+|||++ ++.+||+|||
T Consensus 171 ~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~~~vkl~DFG 237 (282)
T 1zar_A 171 AW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFP 237 (282)
T ss_dssp EE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-TTEEEECCCT
T ss_pred ec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-CCcEEEEECC
Confidence 43 45699999999999998 421 123469999999999999999 99999999999999 9999999999
Q ss_pred CccccccCCCcccCccccCccCccccc
Q 014352 263 LSKEEVFDGRNSGLKGTYGYIDPAYIS 289 (426)
Q Consensus 263 l~~~~~~~~~~~~~~gt~~y~aPE~~~ 289 (426)
+++. +..++|||++.
T Consensus 238 ~a~~------------~~~~~a~e~l~ 252 (282)
T 1zar_A 238 QSVE------------VGEEGWREILE 252 (282)
T ss_dssp TCEE------------TTSTTHHHHHH
T ss_pred CCeE------------CCCCCHHHHHH
Confidence 9863 34578999874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=2.1e-21 Score=178.38 Aligned_cols=134 Identities=21% Similarity=0.233 Sum_probs=103.5
Q ss_pred hhhcccccCCCeeEEEEEe-CCCcE--EEEEEeccCCccC------------------------hHHHHHHHHHHhcCCC
Q 014352 120 NFTNILGQGAFGPVYKATM-PSGGV--AAIKVLASDSHQG------------------------EKEFQTEVSLLGRLHH 172 (426)
Q Consensus 120 ~~~~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~~------------------------~~~~~~e~~~l~~l~h 172 (426)
.+.+.||+|+||.||+|.. .+|+. ||||+++...... ...+..|+.+|.+++|
T Consensus 50 ~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 129 (258)
T 1zth_A 50 AMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKE 129 (258)
T ss_dssp EEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHH
T ss_pred hhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHh
Confidence 4567899999999999998 68888 9999875432110 1257889999999988
Q ss_pred Cce--eeEEeEEEeCCeEEEEEEecCC-C----ChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHH-cCCCCCeeecCCC
Q 014352 173 RNL--VNLIGYCVDKGKYMLIYEFMSN-G----SLSNLIYSEERVLNWEERLQIALDISHGIEYLH-EGAVPPVIHRDLK 244 (426)
Q Consensus 173 ~ni--v~~~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~~~~ivH~dlk 244 (426)
+++ ..++++ +..++||||+.+ | +|.+.... .++.....++.|++.||.||| +.+ |+|||||
T Consensus 130 ~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~g---ivHrDlk 198 (258)
T 1zth_A 130 AGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAE---LVHADLS 198 (258)
T ss_dssp TTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSC---EECSSCS
T ss_pred CCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCC---EEeCCCC
Confidence 754 344432 256899999942 4 66665422 224456789999999999999 888 9999999
Q ss_pred CCCEEecCCCcEEEeeecCccc
Q 014352 245 SANILLDHFMRAKVADFGLSKE 266 (426)
Q Consensus 245 ~~Nill~~~~~~kl~Dfgl~~~ 266 (426)
|+|||++. .++|+|||++..
T Consensus 199 p~NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 199 EYNIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp TTSEEESS--SEEECCCTTCEE
T ss_pred HHHEEEcC--cEEEEECccccc
Confidence 99999998 999999999974
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.71 E-value=2.4e-18 Score=164.66 Aligned_cols=135 Identities=12% Similarity=0.109 Sum_probs=97.9
Q ss_pred hhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCcc--------------ChHH--------HHHHHHHHhcCCCCcee
Q 014352 119 QNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQ--------------GEKE--------FQTEVSLLGRLHHRNLV 176 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------~~~~--------~~~e~~~l~~l~h~niv 176 (426)
|.+.+.||+|+||.||+|...+|+.||||+++..... .... ...|...|.++.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 5667899999999999999989999999997542110 0111 13466677777554442
Q ss_pred eEEeEEEeCCeEEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCC--
Q 014352 177 NLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFM-- 254 (426)
Q Consensus 177 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-- 254 (426)
...-+... ..+|||||++|++|..+... +....++.|++.+|.|||+.+ ||||||||.|||+++++
T Consensus 177 vp~p~~~~--~~~LVME~i~G~~L~~l~~~-------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 177 VPEPIAQS--RHTIVMSLVDALPMRQVSSV-------PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp CCCEEEEE--TTEEEEECCSCEEGGGCCCC-------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEECS
T ss_pred CCeeeecc--CceEEEEecCCccHhhhccc-------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCCCc
Confidence 21111122 23799999999888765421 123467899999999999998 99999999999998876
Q ss_pred --------cEEEeeecCcc
Q 014352 255 --------RAKVADFGLSK 265 (426)
Q Consensus 255 --------~~kl~Dfgl~~ 265 (426)
.+.|+||+-+-
T Consensus 245 ~d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp SCTTSEEEEEEECCCTTCE
T ss_pred ccccccccceEEEEeCCcc
Confidence 38999999765
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.41 E-value=9.3e-13 Score=120.71 Aligned_cols=140 Identities=15% Similarity=0.047 Sum_probs=108.3
Q ss_pred hhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCC-CCceeeEEeEEEeCCeEEEEEEecCC
Q 014352 119 QNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLH-HRNLVNLIGYCVDKGKYMLIYEFMSN 197 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~ 197 (426)
+.+...++.|+++.||+.... ++.+++|............+.+|+.+++.+. +.++.++++++...+..|+||||++|
T Consensus 16 ~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 94 (263)
T 3tm0_A 16 YRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADG 94 (263)
T ss_dssp SEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSS
T ss_pred ceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCC
Confidence 344566788888999999864 6788999986532223446889999999884 67788999999988899999999999
Q ss_pred CChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCC-------------------------------------------
Q 014352 198 GSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGA------------------------------------------- 234 (426)
Q Consensus 198 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------------------------------------------- 234 (426)
.+|.+.+. +......++.+++++|..||+..
T Consensus 95 ~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (263)
T 3tm0_A 95 VLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPR 168 (263)
T ss_dssp EEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHH
T ss_pred eehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHH
Confidence 99987641 11223467889999999999811
Q ss_pred -------------CCCeeecCCCCCCEEecCCCcEEEeeecCcc
Q 014352 235 -------------VPPVIHRDLKSANILLDHFMRAKVADFGLSK 265 (426)
Q Consensus 235 -------------~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 265 (426)
.+.++|+|++|.||+++++..+.|+||+.+.
T Consensus 169 ~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 169 ELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1348999999999999876666799999764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.27 E-value=1.1e-11 Score=113.10 Aligned_cols=128 Identities=17% Similarity=0.120 Sum_probs=96.7
Q ss_pred ccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCc--eeeEEeEEEeCCeEEEEEEecCCCChhHH
Q 014352 126 GQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRN--LVNLIGYCVDKGKYMLIYEFMSNGSLSNL 203 (426)
Q Consensus 126 g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~gsL~~~ 203 (426)
+.|..+.||+....+|..+++|..... ....+..|+.+++.+.+.+ +.+++++...++..++||||++|.+|.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~-- 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-- 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence 455669999998777778899987643 2346788999999886545 456888888877899999999998884
Q ss_pred hhhccCCCCHHHHHHHHHHHHHHHHHHHcCC-------------------------------------------------
Q 014352 204 IYSEERVLNWEERLQIALDISHGIEYLHEGA------------------------------------------------- 234 (426)
Q Consensus 204 l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------------------------------------------------- 234 (426)
... .+ ...++.+++..|..||+..
T Consensus 104 ~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 176 (264)
T 1nd4_A 104 SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKA 176 (264)
T ss_dssp TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHH
T ss_pred cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHH
Confidence 211 12 1256677888888888743
Q ss_pred ------CCCeeecCCCCCCEEecCCCcEEEeeecCcc
Q 014352 235 ------VPPVIHRDLKSANILLDHFMRAKVADFGLSK 265 (426)
Q Consensus 235 ------~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 265 (426)
.+.++|+|++|.||+++.++.+.|+||+.+.
T Consensus 177 ~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 177 RMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp TCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1129999999999999887667799999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.17 E-value=9.2e-11 Score=112.52 Aligned_cols=140 Identities=19% Similarity=0.293 Sum_probs=104.7
Q ss_pred cccccCCCeeEEEEEeCCCcEEEEEEec--cCC-ccChHHHHHHHHHHhcCC--CCceeeEEeEEEeC---CeEEEEEEe
Q 014352 123 NILGQGAFGPVYKATMPSGGVAAIKVLA--SDS-HQGEKEFQTEVSLLGRLH--HRNLVNLIGYCVDK---GKYMLIYEF 194 (426)
Q Consensus 123 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~---~~~~lv~e~ 194 (426)
+.|+.|.++.||+....+ ..+++|+.. ... ......+.+|..+++.+. +..+.+++.++.+. +..++||||
T Consensus 44 ~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~ 122 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF 122 (359)
T ss_dssp EECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred EEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence 468999999999998754 567788765 322 123457889999999887 45678889888776 447999999
Q ss_pred cCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCC----------------------------------------
Q 014352 195 MSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGA---------------------------------------- 234 (426)
Q Consensus 195 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---------------------------------------- 234 (426)
++|..+.+.. -..++...+..++.+++..|..||+..
T Consensus 123 v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (359)
T 3dxp_A 123 VSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDS 199 (359)
T ss_dssp CCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHH
T ss_pred cCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHH
Confidence 9998875422 123678888889999999999999731
Q ss_pred ---------------CCCeeecCCCCCCEEecCCCc--EEEeeecCccc
Q 014352 235 ---------------VPPVIHRDLKSANILLDHFMR--AKVADFGLSKE 266 (426)
Q Consensus 235 ---------------~~~ivH~dlk~~Nill~~~~~--~kl~Dfgl~~~ 266 (426)
.+.++|+|+++.||+++.++. +.|.||+.+..
T Consensus 200 ~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 200 LMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 245999999999999997753 68999998863
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.97 E-value=3.4e-10 Score=105.94 Aligned_cols=181 Identities=21% Similarity=0.232 Sum_probs=117.8
Q ss_pred ccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCC-CCc--eeeEEeEEEeCC---eEEEEEEecCC
Q 014352 124 ILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLH-HRN--LVNLIGYCVDKG---KYMLIYEFMSN 197 (426)
Q Consensus 124 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~~~~~~~~~~---~~~lv~e~~~~ 197 (426)
.++.|.+..||+.. ..+++|+.... .....+.+|.++|+.+. +.. +.+++......+ ..|+||++++|
T Consensus 27 ~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G 100 (304)
T 3sg8_A 27 ISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG 100 (304)
T ss_dssp EEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred ecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence 58899999999863 34778875432 23457889999998873 332 334444433332 34889999999
Q ss_pred CChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCC-------------------------------------------
Q 014352 198 GSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGA------------------------------------------- 234 (426)
Q Consensus 198 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------------------------------------------- 234 (426)
.+|..... ..++..++..++.+++..|..||+..
T Consensus 101 ~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 177 (304)
T 3sg8_A 101 VPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFY 177 (304)
T ss_dssp EECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHH
T ss_pred eECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHH
Confidence 88875432 23667777788888888888888611
Q ss_pred ------------CCCeeecCCCCCCEEecC--CCcEEEeeecCccccccCCCcccCccccCc---cCccccc----c-CC
Q 014352 235 ------------VPPVIHRDLKSANILLDH--FMRAKVADFGLSKEEVFDGRNSGLKGTYGY---IDPAYIS----T-NK 292 (426)
Q Consensus 235 ------------~~~ivH~dlk~~Nill~~--~~~~kl~Dfgl~~~~~~~~~~~~~~gt~~y---~aPE~~~----~-~~ 292 (426)
.+.++|+|++|.||+++. ...+.|+||+.+........ ......+ ..|+... . +.
T Consensus 178 ~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D---l~~~~~~~~~~~~~~~~~~l~~Y~~ 254 (304)
T 3sg8_A 178 RDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND---FISLMEDDEEYGMEFVSKILNHYKH 254 (304)
T ss_dssp HHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH---HHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred HHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH---HHHHHhhccccCHHHHHHHHHHcCC
Confidence 134899999999999998 45678999998764211000 0000000 1222110 0 01
Q ss_pred C---------CcchhhHHHHHHHHHHHhCCCCC
Q 014352 293 F---------TMKSDIFSFGVIIFELITAIHPH 316 (426)
Q Consensus 293 ~---------~~~~Dv~S~Gvvl~el~tg~~p~ 316 (426)
. ....+.|++|.++|.+.+|..+|
T Consensus 255 ~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 255 KDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 1 12368999999999999998775
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.56 E-value=3.8e-07 Score=83.43 Aligned_cols=134 Identities=14% Similarity=0.080 Sum_probs=94.5
Q ss_pred ccccCCCe-eEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCC-CCceeeEEeEEEeCCeEEEEEEecCCCCh
Q 014352 124 ILGQGAFG-PVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLH-HRNLVNLIGYCVDKGKYMLIYEFMSNGSL 200 (426)
Q Consensus 124 ~lg~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL 200 (426)
.+..|..| .||+.... ++..+++|+-.. .....+..|...|+.+. +--+.++++++.+.+..++|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 34555554 68988765 455678887543 23457888999998774 33366888899999999999999999888
Q ss_pred hHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCC----------------------------------------------
Q 014352 201 SNLIYSEERVLNWEERLQIALDISHGIEYLHEGA---------------------------------------------- 234 (426)
Q Consensus 201 ~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---------------------------------------------- 234 (426)
.+..... ......+..+++..|.-||+..
T Consensus 108 ~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (272)
T 4gkh_A 108 FQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKE 182 (272)
T ss_dssp HHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHH
T ss_pred cccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHH
Confidence 7654221 1122345556666666666411
Q ss_pred ---------CCCeeecCCCCCCEEecCCCcEEEeeecCcc
Q 014352 235 ---------VPPVIHRDLKSANILLDHFMRAKVADFGLSK 265 (426)
Q Consensus 235 ---------~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 265 (426)
.+.++|+|+.+.||+++.++.+-|+||+.+.
T Consensus 183 l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 183 MHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1237999999999999987777899999875
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.46 E-value=1.1e-06 Score=82.16 Aligned_cols=133 Identities=23% Similarity=0.244 Sum_probs=88.0
Q ss_pred ccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCCCC---ceeeEEeEEE-eCCeEEEEEEecCCCC
Q 014352 124 ILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHR---NLVNLIGYCV-DKGKYMLIYEFMSNGS 199 (426)
Q Consensus 124 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~-~~~~~~lv~e~~~~gs 199 (426)
.++.|....||+. ++.+++|+... ......+..|.++|+.+.+. .+.+++.++. ..+..++||||++|.+
T Consensus 26 ~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~ 99 (306)
T 3tdw_A 26 SLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI 99 (306)
T ss_dssp EEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred ecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence 5788888899988 44567787422 22345788999999998642 3556666664 3455789999999988
Q ss_pred hhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcC----------------------------------------------
Q 014352 200 LSNLIYSEERVLNWEERLQIALDISHGIEYLHEG---------------------------------------------- 233 (426)
Q Consensus 200 L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---------------------------------------------- 233 (426)
|..... ..++......++.+++..|..||+.
T Consensus 100 l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~ 176 (306)
T 3tdw_A 100 LGEDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRF 176 (306)
T ss_dssp CHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHH
T ss_pred Cchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHH
Confidence 866321 1123333344444444444444432
Q ss_pred -----------CCCCeeecCCCCCCEEecC---CCc-EEEeeecCcc
Q 014352 234 -----------AVPPVIHRDLKSANILLDH---FMR-AKVADFGLSK 265 (426)
Q Consensus 234 -----------~~~~ivH~dlk~~Nill~~---~~~-~kl~Dfgl~~ 265 (426)
..+.++|+|+++.||+++. ++. +.|+||+.+.
T Consensus 177 ~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~ 223 (306)
T 3tdw_A 177 QSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA 223 (306)
T ss_dssp HHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred HHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence 2234799999999999997 455 5899999775
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.42 E-value=4.3e-07 Score=86.68 Aligned_cols=79 Identities=5% Similarity=-0.017 Sum_probs=54.4
Q ss_pred ccc-ccCCCeeEEEEEeC-------CCcEEEEEEeccCC---ccChHHHHHHHHHHhcCC-C--CceeeEEeEEEeC---
Q 014352 123 NIL-GQGAFGPVYKATMP-------SGGVAAIKVLASDS---HQGEKEFQTEVSLLGRLH-H--RNLVNLIGYCVDK--- 185 (426)
Q Consensus 123 ~~l-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h--~niv~~~~~~~~~--- 185 (426)
+.| +.|....+|+.... +++.+++|...... ......+..|..+++.+. + -.+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 357 78888999998764 25677888764322 112346788888888874 2 3466788877655
Q ss_pred CeEEEEEEecCCCChh
Q 014352 186 GKYMLIYEFMSNGSLS 201 (426)
Q Consensus 186 ~~~~lv~e~~~~gsL~ 201 (426)
+..++||||++|.++.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 3468999999987664
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.22 E-value=5.3e-06 Score=80.31 Aligned_cols=74 Identities=16% Similarity=0.089 Sum_probs=48.4
Q ss_pred cccccCCCeeEEEEEeC-CCcEEEEEEeccCCc-------cChHHHHHHHHHHhcCCC--Cc-eeeEEeEEEeCCeEEEE
Q 014352 123 NILGQGAFGPVYKATMP-SGGVAAIKVLASDSH-------QGEKEFQTEVSLLGRLHH--RN-LVNLIGYCVDKGKYMLI 191 (426)
Q Consensus 123 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h--~n-iv~~~~~~~~~~~~~lv 191 (426)
+.+|.|.++.||++... +++.+++|....... .....+..|.++++.+.. |. +.+++.+ +.+..++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 46899999999999764 467889998653211 123456778888887732 33 3455543 34456899
Q ss_pred EEecCCC
Q 014352 192 YEFMSNG 198 (426)
Q Consensus 192 ~e~~~~g 198 (426)
|||+++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.20 E-value=1.1e-05 Score=76.14 Aligned_cols=137 Identities=16% Similarity=0.218 Sum_probs=78.5
Q ss_pred ccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCC-----CCceeeEE-e--EEEeCCeEEEEEEec
Q 014352 124 ILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLH-----HRNLVNLI-G--YCVDKGKYMLIYEFM 195 (426)
Q Consensus 124 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~~~-~--~~~~~~~~~lv~e~~ 195 (426)
.|+.|..+.||+....++ .+++|+.... ...+..|..++..|. .|.++... | +....+..+++|+|+
T Consensus 39 ~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i 113 (346)
T 2q83_A 39 VIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI 113 (346)
T ss_dssp ECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred eccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence 466677899999987555 4788987642 234445555555442 34444311 1 123456789999999
Q ss_pred CCCChh--------------HHhhhccC-------------CCCHHHHH-------------------------------
Q 014352 196 SNGSLS--------------NLIYSEER-------------VLNWEERL------------------------------- 217 (426)
Q Consensus 196 ~~gsL~--------------~~l~~~~~-------------~l~~~~~~------------------------------- 217 (426)
+|.++. ..++.... .-.|....
T Consensus 114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 193 (346)
T 2q83_A 114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID 193 (346)
T ss_dssp CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence 986542 11121110 01232110
Q ss_pred HHHHHHHHHHHHHHc----------CCCCCeeecCCCCCCEEecCCCcEEEeeecCcc
Q 014352 218 QIALDISHGIEYLHE----------GAVPPVIHRDLKSANILLDHFMRAKVADFGLSK 265 (426)
Q Consensus 218 ~i~~~i~~~l~~LH~----------~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 265 (426)
.+...+..++.+|++ ...+.++|+|+++.||+++.++.+.|+||+.+.
T Consensus 194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 011123345666653 012459999999999999888899999999764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.03 E-value=3.9e-05 Score=71.47 Aligned_cols=135 Identities=16% Similarity=0.167 Sum_probs=90.4
Q ss_pred cccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCC---CCceeeEEeEEEeCCeEEEEEEecCCCC
Q 014352 123 NILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLH---HRNLVNLIGYCVDKGKYMLIYEFMSNGS 199 (426)
Q Consensus 123 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~gs 199 (426)
+.|+.|.+..+|+... +++.+++|+.... ....+..|...|+.|. ...+.+++.++...+..++||||+++.+
T Consensus 42 ~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~ 117 (312)
T 3jr1_A 42 EKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSK 117 (312)
T ss_dssp EEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred EEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCC
Confidence 3588999999999986 4567788886532 3557888999888873 3567888888887888999999999876
Q ss_pred hhH-----------HhhhccC---------------------CCCHHHHH---HHH----------------HHHHHH-H
Q 014352 200 LSN-----------LIYSEER---------------------VLNWEERL---QIA----------------LDISHG-I 227 (426)
Q Consensus 200 L~~-----------~l~~~~~---------------------~l~~~~~~---~i~----------------~~i~~~-l 227 (426)
+.. .|+.... .-+|.... ++. ..+... .
T Consensus 118 ~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~ 197 (312)
T 3jr1_A 118 NKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVA 197 (312)
T ss_dssp CCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHH
T ss_pred CCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHH
Confidence 521 1222111 01454322 111 112212 2
Q ss_pred HHHHc-CCCCCeeecCCCCCCEEecCCCcEEEeeec
Q 014352 228 EYLHE-GAVPPVIHRDLKSANILLDHFMRAKVADFG 262 (426)
Q Consensus 228 ~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 262 (426)
..|.. ...+.++|+|+.+.|++++.++ +.|.||.
T Consensus 198 ~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 198 DTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 23432 2346799999999999999887 8899974
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.00 E-value=3.3e-05 Score=71.20 Aligned_cols=74 Identities=19% Similarity=0.256 Sum_probs=54.4
Q ss_pred cccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCCC---CceeeEEeEEEeCCeEEEEEEecCCCC
Q 014352 123 NILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHH---RNLVNLIGYCVDKGKYMLIYEFMSNGS 199 (426)
Q Consensus 123 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~~~~~~~~~~~~~lv~e~~~~gs 199 (426)
+.+|.|..+.||+.+..+|+.+++|+...........|..|...|+.|.- -.+.+++++ + .-++||||++++.
T Consensus 21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLAMEWVDERP 96 (288)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEEEECCCCCC
T ss_pred EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEEEEeecccC
Confidence 46899999999999999999999998765544445578899999887742 134455543 2 2378999998765
Q ss_pred h
Q 014352 200 L 200 (426)
Q Consensus 200 L 200 (426)
.
T Consensus 97 ~ 97 (288)
T 3f7w_A 97 P 97 (288)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.75 E-value=0.00014 Score=70.73 Aligned_cols=72 Identities=13% Similarity=0.154 Sum_probs=43.9
Q ss_pred cccccCCCeeEEEEEeCCCcEEEEEEeccCCc------c---ChHHHHHHHHHHh-cCCCCceeeEEeEEEeCCeEEEEE
Q 014352 123 NILGQGAFGPVYKATMPSGGVAAIKVLASDSH------Q---GEKEFQTEVSLLG-RLHHRNLVNLIGYCVDKGKYMLIY 192 (426)
Q Consensus 123 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------~---~~~~~~~e~~~l~-~l~h~niv~~~~~~~~~~~~~lv~ 192 (426)
+.||.|..+.||+... +++.+++|....... . ....+..|+..+. ......+.+++.+. .+..++||
T Consensus 40 ~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv~ 116 (420)
T 2pyw_A 40 KEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIGM 116 (420)
T ss_dssp EECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEEE
T ss_pred EEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEEE
Confidence 3689999999999975 456788994332110 0 2223444443332 22234566666665 45679999
Q ss_pred Eec-CC
Q 014352 193 EFM-SN 197 (426)
Q Consensus 193 e~~-~~ 197 (426)
||+ ++
T Consensus 117 e~l~~g 122 (420)
T 2pyw_A 117 RYLEPP 122 (420)
T ss_dssp CCCCTT
T ss_pred eecCCc
Confidence 999 76
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.59 E-value=0.00044 Score=59.90 Aligned_cols=99 Identities=16% Similarity=0.123 Sum_probs=67.3
Q ss_pred CChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCcccCc
Q 014352 198 GSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLK 277 (426)
Q Consensus 198 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 277 (426)
-||.++|...+.+++.++++.++.|.+.+|.-+-.+..+ ..+=+.|..|++..+|.+...+ +.+. .
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------~ 98 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD-----------A 98 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc-----------c
Confidence 489999988899999999999999999998776221111 1223347899999999988764 2111 1
Q ss_pred cccCccCccccccCCCCcchhhHHHHHHHHHHHh
Q 014352 278 GTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT 311 (426)
Q Consensus 278 gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t 311 (426)
....+.|||... ...+.+.=|||+|+++|.-+-
T Consensus 99 ~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 99 GEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp --------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred cccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 122456787763 345678899999999999886
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.30 E-value=0.002 Score=60.41 Aligned_cols=31 Identities=32% Similarity=0.352 Sum_probs=26.7
Q ss_pred CCeeecCCCCCCEEecCC----CcEEEeeecCccc
Q 014352 236 PPVIHRDLKSANILLDHF----MRAKVADFGLSKE 266 (426)
Q Consensus 236 ~~ivH~dlk~~Nill~~~----~~~kl~Dfgl~~~ 266 (426)
..++|||+.+.||+++.+ +.+.|.||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 459999999999999875 6799999998763
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.26 E-value=0.00049 Score=63.64 Aligned_cols=70 Identities=9% Similarity=0.132 Sum_probs=42.3
Q ss_pred cccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCce-eeEEeEEEeCCeEEEEEEec-CCCCh
Q 014352 123 NILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNL-VNLIGYCVDKGKYMLIYEFM-SNGSL 200 (426)
Q Consensus 123 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~-~~gsL 200 (426)
+.|+.|....+|+. +.+++|+....... .-....|..+++.+...++ .+++++ +.+.-++++||+ ++.+|
T Consensus 24 ~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 24 LERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQTM 95 (301)
T ss_dssp EEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEEC
T ss_pred eEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCccC
Confidence 46888999999998 44678877543211 1223567777776642223 345544 333457899999 66554
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.24 E-value=0.00058 Score=66.62 Aligned_cols=71 Identities=15% Similarity=0.239 Sum_probs=48.0
Q ss_pred ccccCCCeeEEEEEeCC--------CcEEEEEEeccCCccChHHHHHHHHHHhcCCCCce-eeEEeEEEeCCeEEEEEEe
Q 014352 124 ILGQGAFGPVYKATMPS--------GGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNL-VNLIGYCVDKGKYMLIYEF 194 (426)
Q Consensus 124 ~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~ 194 (426)
.|+.|....+|+....+ +..+++|+.... .....+..|..+++.|...++ .++++.+.+ .+|+||
T Consensus 80 ~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~ 153 (429)
T 1nw1_A 80 RIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY 153 (429)
T ss_dssp EECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred EeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEE
Confidence 57788889999998753 467888887432 122456689998888753333 566665432 389999
Q ss_pred cCCCCh
Q 014352 195 MSNGSL 200 (426)
Q Consensus 195 ~~~gsL 200 (426)
++|.+|
T Consensus 154 l~G~~l 159 (429)
T 1nw1_A 154 IPSRPL 159 (429)
T ss_dssp CCEEEC
T ss_pred eCCccc
Confidence 986444
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.19 E-value=0.0013 Score=62.84 Aligned_cols=137 Identities=16% Similarity=0.210 Sum_probs=79.3
Q ss_pred ccccCCCeeEEEEEeCC--------CcEEEEEEeccCCccChHHHHHHHHHHhcCCCCc-eeeEEeEEEeCCeEEEEEEe
Q 014352 124 ILGQGAFGPVYKATMPS--------GGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRN-LVNLIGYCVDKGKYMLIYEF 194 (426)
Q Consensus 124 ~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~ 194 (426)
.|..|-...+|+....+ +..+++|+... .......+.+|.++++.|.-.+ ..++++++.+ .+||||
T Consensus 57 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~ 131 (379)
T 3feg_A 57 PVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQY 131 (379)
T ss_dssp EC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEEC
T ss_pred EcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEE
Confidence 56677788899988642 46788888533 2224556778999988774222 3456665543 289999
Q ss_pred cCCCChhHH-----------------hhhcc----CCCC--HHHHHHHHHHHHH-------------------HHHH---
Q 014352 195 MSNGSLSNL-----------------IYSEE----RVLN--WEERLQIALDISH-------------------GIEY--- 229 (426)
Q Consensus 195 ~~~gsL~~~-----------------l~~~~----~~l~--~~~~~~i~~~i~~-------------------~l~~--- 229 (426)
++|.+|..- |+... +... |.++.++..++.. .+..
T Consensus 132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~ 211 (379)
T 3feg_A 132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK 211 (379)
T ss_dssp CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence 998655311 11111 1122 3344444433311 1222
Q ss_pred -HHcC-CCCCeeecCCCCCCEEecCC----CcEEEeeecCcc
Q 014352 230 -LHEG-AVPPVIHRDLKSANILLDHF----MRAKVADFGLSK 265 (426)
Q Consensus 230 -LH~~-~~~~ivH~dlk~~Nill~~~----~~~kl~Dfgl~~ 265 (426)
|... ....++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 3222 22348999999999999876 789999999875
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.13 E-value=0.0014 Score=60.96 Aligned_cols=139 Identities=15% Similarity=0.157 Sum_probs=77.4
Q ss_pred ccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCC-----CCceeeEE-e--EEEeCCeEEEEEEec
Q 014352 124 ILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLH-----HRNLVNLI-G--YCVDKGKYMLIYEFM 195 (426)
Q Consensus 124 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~~~-~--~~~~~~~~~lv~e~~ 195 (426)
.|+.|....+|+....++ .+++|..... .....+..|..++..|. -|.++... | +....+..+++++|+
T Consensus 29 ~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l 105 (322)
T 2ppq_A 29 GIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL 105 (322)
T ss_dssp EECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred ccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeC
Confidence 467788889999987665 4678887652 12345667777776663 23333210 1 112345678999999
Q ss_pred CCCChhH----H----------hhhcc----CC----C---CHHHHHH------------HHHHHHHHHHHHHcC----C
Q 014352 196 SNGSLSN----L----------IYSEE----RV----L---NWEERLQ------------IALDISHGIEYLHEG----A 234 (426)
Q Consensus 196 ~~gsL~~----~----------l~~~~----~~----l---~~~~~~~------------i~~~i~~~l~~LH~~----~ 234 (426)
+|..+.. . ++... .+ . .|...+. +...+...+.++... .
T Consensus 106 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~ 185 (322)
T 2ppq_A 106 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDL 185 (322)
T ss_dssp CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSS
T ss_pred CCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccC
Confidence 8865421 0 12110 00 1 1222110 001134455555531 1
Q ss_pred CCCeeecCCCCCCEEecCCCcEEEeeecCcc
Q 014352 235 VPPVIHRDLKSANILLDHFMRAKVADFGLSK 265 (426)
Q Consensus 235 ~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 265 (426)
...++|+|+.+.||+++.+..+.|+||+.+.
T Consensus 186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 186 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 2348999999999999987666899999765
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.11 E-value=0.0022 Score=59.86 Aligned_cols=138 Identities=12% Similarity=0.133 Sum_probs=78.9
Q ss_pred ccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCc--eeeEEeE-----EEeCCeEEEEEEecC
Q 014352 124 ILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRN--LVNLIGY-----CVDKGKYMLIYEFMS 196 (426)
Q Consensus 124 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~-----~~~~~~~~lv~e~~~ 196 (426)
.++ |....||+....+|+.+++|...... .....+..|..++..+.... +.+++.. ....+..+++|+|++
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~ 110 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 110 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence 356 77789999877667678899886432 23456777888887764212 3334332 222456688999998
Q ss_pred CCChh-----HH---------hhhcc--------CCCCHHHH----HHH---------------HHHHHHHHHHHHc---
Q 014352 197 NGSLS-----NL---------IYSEE--------RVLNWEER----LQI---------------ALDISHGIEYLHE--- 232 (426)
Q Consensus 197 ~gsL~-----~~---------l~~~~--------~~l~~~~~----~~i---------------~~~i~~~l~~LH~--- 232 (426)
|.++. .. ++... ..+++... ..+ ...+...+..+..
T Consensus 111 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 190 (328)
T 1zyl_A 111 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR 190 (328)
T ss_dssp CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhh
Confidence 75432 10 11100 11222211 001 0011112222221
Q ss_pred -CCCCCeeecCCCCCCEEecCCCcEEEeeecCcc
Q 014352 233 -GAVPPVIHRDLKSANILLDHFMRAKVADFGLSK 265 (426)
Q Consensus 233 -~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 265 (426)
.....++|+|+++.||+++ + .+.|+||+.+.
T Consensus 191 ~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 191 EDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp SCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred hcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 1223489999999999999 4 89999998765
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=97.04 E-value=6.9e-05 Score=45.31 Aligned_cols=28 Identities=18% Similarity=0.159 Sum_probs=20.6
Q ss_pred CCCCeEEEEeehHHHHHHHHHHHHHHHh
Q 014352 3 HKSDLVIIGICVGLALGILIATLVFFGL 30 (426)
Q Consensus 3 ~~~~~~ii~i~~g~~~~~~~~~~~~~~~ 30 (426)
.+|.++|+||++|+++++++++++.+++
T Consensus 7 ~ls~GaIAGiVvG~v~gv~li~~l~~~~ 34 (38)
T 2k1k_A 7 GLTGGEIVAVIFGLLLGAALLLGILVFR 34 (38)
T ss_dssp TCCHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCCCceeeeehHHHHHHHHHHHHHHHH
Confidence 4677888999999988877766555443
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.86 E-value=0.0041 Score=60.97 Aligned_cols=72 Identities=18% Similarity=0.164 Sum_probs=45.6
Q ss_pred ccccCCCeeEEEEEeCC-CcEEEEEEeccCCccChHHHHHHHHHHhcCCCCce-eeEEeEEEeCCeEEEEEEecCCCCh
Q 014352 124 ILGQGAFGPVYKATMPS-GGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNL-VNLIGYCVDKGKYMLIYEFMSNGSL 200 (426)
Q Consensus 124 ~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~gsL 200 (426)
.|+.|-...+|+....+ +..+++|+..... ...-+...|..++..|...++ .++++++. + .+|+||++|.+|
T Consensus 115 ~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 115 IINGGITNILIKVKDMSKQAKYLIRLYGPKT-DEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EECC--CEEEEEEEETTTTEEEEEEEECC-C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EcCCCeEeEEEEEEECCCCceEEEEECCCCh-hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 57778889999998765 4677888764322 111122578888888865545 46676662 2 259999987554
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.81 E-value=0.0016 Score=62.09 Aligned_cols=72 Identities=8% Similarity=0.087 Sum_probs=42.4
Q ss_pred ccccCCCeeEEEEEeCC---------CcEEEEEEeccCCccChHHHHHHHHHHhcCCCCc-eeeEEeEEEeCCeEEEEEE
Q 014352 124 ILGQGAFGPVYKATMPS---------GGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRN-LVNLIGYCVDKGKYMLIYE 193 (426)
Q Consensus 124 ~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e 193 (426)
.++.|....+|+....+ +..+++|+...... ...+...|..+++.+...+ ..++++.. . -++|||
T Consensus 40 ~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~e 114 (369)
T 3c5i_A 40 QILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIEE 114 (369)
T ss_dssp EC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred EeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEEE
Confidence 57788888999998654 25778887654321 1113467888887774333 33566543 2 268999
Q ss_pred ecCCCCh
Q 014352 194 FMSNGSL 200 (426)
Q Consensus 194 ~~~~gsL 200 (426)
|++|.++
T Consensus 115 ~i~G~~l 121 (369)
T 3c5i_A 115 WLYGDPL 121 (369)
T ss_dssp CCCSEEC
T ss_pred EecCCcC
Confidence 9987544
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.72 E-value=0.018 Score=54.01 Aligned_cols=30 Identities=17% Similarity=0.259 Sum_probs=26.8
Q ss_pred CCeeecCCCCCCEEecCCCcEEEeeecCcc
Q 014352 236 PPVIHRDLKSANILLDHFMRAKVADFGLSK 265 (426)
Q Consensus 236 ~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 265 (426)
..++|+|+.+.||+++.++.+.|.||+.+.
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~ 235 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPM 235 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCe
Confidence 459999999999999988889999998765
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.63 E-value=0.00063 Score=42.38 Aligned_cols=10 Identities=30% Similarity=0.564 Sum_probs=4.4
Q ss_pred eehHHHHHHH
Q 014352 12 ICVGLALGIL 21 (426)
Q Consensus 12 i~~g~~~~~~ 21 (426)
|++|++++++
T Consensus 13 IA~gVVgGv~ 22 (44)
T 2ks1_B 13 IATGMVGALL 22 (44)
T ss_dssp STHHHHHHHH
T ss_pred EEeehhHHHH
Confidence 4444444333
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.52 E-value=0.00063 Score=42.25 Aligned_cols=9 Identities=33% Similarity=0.637 Sum_probs=3.8
Q ss_pred eehHHHHHH
Q 014352 12 ICVGLALGI 20 (426)
Q Consensus 12 i~~g~~~~~ 20 (426)
|++|+++++
T Consensus 12 IA~gVVgGv 20 (44)
T 2l2t_A 12 IAAGVIGGL 20 (44)
T ss_dssp HHHHHHHHH
T ss_pred EEEeehHHH
Confidence 444444433
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=96.13 E-value=0.0011 Score=41.13 Aligned_cols=7 Identities=57% Similarity=0.838 Sum_probs=4.8
Q ss_pred EEEeehH
Q 014352 9 IIGICVG 15 (426)
Q Consensus 9 ii~i~~g 15 (426)
|+++++|
T Consensus 14 Ia~~vVG 20 (44)
T 2jwa_A 14 IISAVVG 20 (44)
T ss_dssp HHHHHHH
T ss_pred hHHHHHH
Confidence 6666777
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.44 E-value=0.021 Score=55.33 Aligned_cols=72 Identities=14% Similarity=0.143 Sum_probs=45.6
Q ss_pred ccccCCCeeEEEEEeCC--------CcEEEEEEeccCCccChHHHHHHHHHHhcCCCCc-eeeEEeEEEeCCeEEEEEEe
Q 014352 124 ILGQGAFGPVYKATMPS--------GGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRN-LVNLIGYCVDKGKYMLIYEF 194 (426)
Q Consensus 124 ~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~ 194 (426)
.+..|-...+|+....+ +..+++|+..... ...-+..+|..+++.+.-.+ ..++++.+ .+ ++|+||
T Consensus 77 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I~ef 151 (424)
T 3mes_A 77 QIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF--PE--GRIEEF 151 (424)
T ss_dssp EECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEEEC
T ss_pred EcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEEEEE
Confidence 56777788999998753 5678888864322 11123457888887774222 34555433 22 789999
Q ss_pred cCCCCh
Q 014352 195 MSNGSL 200 (426)
Q Consensus 195 ~~~gsL 200 (426)
++|.+|
T Consensus 152 I~G~~l 157 (424)
T 3mes_A 152 IDGEPL 157 (424)
T ss_dssp CCSEEC
T ss_pred eCCccC
Confidence 998654
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.78 E-value=0.024 Score=35.24 Aligned_cols=31 Identities=19% Similarity=0.000 Sum_probs=17.7
Q ss_pred CCeEEEEeehHHHHHHHHHHHHHHHhhhhhc
Q 014352 5 SDLVIIGICVGLALGILIATLVFFGLRWYKK 35 (426)
Q Consensus 5 ~~~~ii~i~~g~~~~~~~~~~~~~~~~~~r~ 35 (426)
..++|++.++|.+++++++++++++++++|+
T Consensus 9 ~~~~IA~gVVgGv~~~~ii~~~~~~~~RRr~ 39 (44)
T 2ks1_B 9 KIPSIATGMVGALLLLLVVALGIGLFMRRRH 39 (44)
T ss_dssp CSSSSTHHHHHHHHHHHHHHHHHHHHHHTTT
T ss_pred CcceEEeehhHHHHHHHHHHHHHHHHhhhhH
Confidence 3455677777666666666655555444433
|
| >2l34_A TYRO protein tyrosine kinase-binding protein; immunoreceptor, transmembrane assembly, DAP12, protein bindi; NMR {Homo sapiens} PDB: 2l35_B | Back alignment and structure |
|---|
Probab=94.62 E-value=0.0057 Score=35.49 Aligned_cols=28 Identities=25% Similarity=0.242 Sum_probs=22.0
Q ss_pred CCCCCeEEEEeehHHHHHHHHHHHHHHH
Q 014352 2 VHKSDLVIIGICVGLALGILIATLVFFG 29 (426)
Q Consensus 2 ~~~~~~~ii~i~~g~~~~~~~~~~~~~~ 29 (426)
+.+|.++++||++|.+++++++++++++
T Consensus 2 ~~L~~gaIaGIVvgdi~~t~~i~~~vy~ 29 (33)
T 2l34_A 2 STVSPGVLAGIVVGDLVLTVLIALAVYF 29 (33)
T ss_dssp CCCCTHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred cccCcceEEeEeHHHHHHHHHHHHHHhh
Confidence 4678889999999999888776666554
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.34 E-value=0.029 Score=34.81 Aligned_cols=32 Identities=19% Similarity=0.094 Sum_probs=18.4
Q ss_pred CCeEEEEeehHHHHHHHHHHHHHHHhhhhhcc
Q 014352 5 SDLVIIGICVGLALGILIATLVFFGLRWYKKH 36 (426)
Q Consensus 5 ~~~~ii~i~~g~~~~~~~~~~~~~~~~~~r~~ 36 (426)
..++|++.++|.+++++++++++++++++|++
T Consensus 8 ~~~aIA~gVVgGv~~v~ii~~~~~~~~RRRr~ 39 (44)
T 2l2t_A 8 RTPLIAAGVIGGLFILVIVGLTFAVYVRRKSI 39 (44)
T ss_dssp SSHHHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred CcceEEEeehHHHHHHHHHHHHHHHHhhhhhh
Confidence 34556777777666666666555554444433
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=93.06 E-value=0.32 Score=41.91 Aligned_cols=119 Identities=12% Similarity=0.146 Sum_probs=82.5
Q ss_pred CCCCceeeEEeEEEeCCeEEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEE
Q 014352 170 LHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANIL 249 (426)
Q Consensus 170 l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil 249 (426)
..||+.+.. .+-.+.+.+.+.++.-+. ...+- .-+.++...+++++..|+....++++ -+|--|.|+|++
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~--~~~f~--~ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL~ 111 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYDINDN--HTPFD--NIKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDELF 111 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEECCCTT--SEEGG--GGGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGEE
T ss_pred ccCCcccce-EEEEcccEEEEEEEcCcc--cCCHH--HHHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceEE
Confidence 378999876 455666666666665432 22221 11347889999999999988866665 478899999999
Q ss_pred ecCCCcEEEeeecCccccccCCCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCch
Q 014352 250 LDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNL 319 (426)
Q Consensus 250 l~~~~~~kl~Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~ 319 (426)
++.++.+++.-.|+... ++|. .++...=.-.+=+++..+++++..|..+
T Consensus 112 f~~~~~p~i~~RGik~~----------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~l 160 (215)
T 4ann_A 112 FTRDGLPIAKTRGLQNV----------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFDAL 160 (215)
T ss_dssp ECTTSCEEESCCEETTT----------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHHH
T ss_pred EcCCCCEEEEEccCccC----------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHHH
Confidence 99999999988776432 2221 1233333457788899999999888654
|
| >2k9y_A Ephrin type-A receptor 2; receptor tyrosine kinase, membrane protein, dimeric transmembrane domain, ephrin receptor, ATP-binding, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=91.88 E-value=0.069 Score=32.78 Aligned_cols=15 Identities=20% Similarity=0.587 Sum_probs=8.8
Q ss_pred EEeehHHHHHHHHHH
Q 014352 10 IGICVGLALGILIAT 24 (426)
Q Consensus 10 i~i~~g~~~~~~~~~ 24 (426)
.+|++|+++++++++
T Consensus 13 ~~I~~~vv~Gv~ll~ 27 (41)
T 2k9y_A 13 LAVIGGVAVGVVLLL 27 (41)
T ss_dssp THHHHHHHHHHHHHH
T ss_pred EEEEeehhHHHHHHH
Confidence 445666666666555
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=90.21 E-value=0.6 Score=40.34 Aligned_cols=120 Identities=8% Similarity=0.072 Sum_probs=81.0
Q ss_pred CCCCceeeEEeEEEeCCeEEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHH-HHHcCCCCCeeecCCCCCCE
Q 014352 170 LHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIE-YLHEGAVPPVIHRDLKSANI 248 (426)
Q Consensus 170 l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~-~LH~~~~~~ivH~dlk~~Ni 248 (426)
..||++ -..+-.+.+.+.+.++.-+++.=...+ +.++...+++++..++.... ++++ -+|--|.|+|+
T Consensus 47 ~~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i----~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~NL 115 (219)
T 4ano_A 47 EVDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI----RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPENL 115 (219)
T ss_dssp GSCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH----HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGGE
T ss_pred ccCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH----HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCceE
Confidence 368888 344446677777777765443223333 34788899999998887666 5554 57889999999
Q ss_pred EecCCCcEEEeeecCccccccCCCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHH
Q 014352 249 LLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLME 321 (426)
Q Consensus 249 ll~~~~~~kl~Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~ 321 (426)
++|.++.+++.-.|+-.. ++|.- .+...=.-.+=+++..++.++..|....+
T Consensus 116 ~f~~~~~p~i~hRGi~~~----------------lpP~e-----~~ee~fl~qyKali~all~~K~~Fe~l~~ 167 (219)
T 4ano_A 116 MFNRALEPFFLHVGVKES----------------LPPDE-----WDDERLLREVKATVLALTEGEYRFDEYLK 167 (219)
T ss_dssp EECTTCCEEESCCEETTT----------------BSSCS-----CCHHHHHHHHHHHHHHHTTCSSCHHHHHH
T ss_pred EEeCCCcEEEEEcCCccc----------------CCCCC-----CCHHHHHHHHHHHHHHHHcCCCCHHHHHh
Confidence 999999999988776432 33321 12222234677888889998888765433
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=89.52 E-value=0.19 Score=48.18 Aligned_cols=29 Identities=31% Similarity=0.400 Sum_probs=24.7
Q ss_pred eeecCCCCCCEEe------cCCCcEEEeeecCccc
Q 014352 238 VIHRDLKSANILL------DHFMRAKVADFGLSKE 266 (426)
Q Consensus 238 ivH~dlk~~Nill------~~~~~~kl~Dfgl~~~ 266 (426)
++|+|+.+.|||+ +++..+.++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4567799999998763
|
| >2knc_B Integrin beta-3; transmembrane signaling, protein structure, cell A cleavage on PAIR of basic residues, disease mutation, disul bond, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.33 E-value=0.065 Score=38.20 Aligned_cols=25 Identities=16% Similarity=0.104 Sum_probs=16.7
Q ss_pred EEEEeehHHHHHHHHHHHHHHHhhh
Q 014352 8 VIIGICVGLALGILIATLVFFGLRW 32 (426)
Q Consensus 8 ~ii~i~~g~~~~~~~~~~~~~~~~~ 32 (426)
-+.+|+.|+++++++++++++++++
T Consensus 9 n~~~Iv~gvi~gilliGllllliwk 33 (79)
T 2knc_B 9 DILVVLLSVMGAILLIGLAALLIWK 33 (79)
T ss_dssp CSHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CchhhHHHHHHHHHHHHHHHHHHHH
Confidence 3456677877777777776666554
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=86.69 E-value=0.078 Score=51.94 Aligned_cols=60 Identities=7% Similarity=0.029 Sum_probs=17.5
Q ss_pred hcccccCCCeeEEEEEeCC-CcEEEE------EEeccCCc--cChHHHHHHHHHHhcCCCCceeeEEeEEEe
Q 014352 122 TNILGQGAFGPVYKATMPS-GGVAAI------KVLASDSH--QGEKEFQTEVSLLGRLHHRNLVNLIGYCVD 184 (426)
Q Consensus 122 ~~~lg~G~~g~Vy~~~~~~-~~~vav------K~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 184 (426)
.+.|| ||.||+|.+.. ...||+ |....... .....|.+|..++.+++|||+++.+++...
T Consensus 147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 34565 99999999864 357788 66554321 122467889999999999999999988654
|
| >2klu_A T-cell surface glycoprotein CD4; cell membrane, disulfide bond, HOST- virus interaction, immune response, immunoglobulin domain, lipoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=86.29 E-value=0.35 Score=32.37 Aligned_cols=26 Identities=27% Similarity=0.441 Sum_probs=12.9
Q ss_pred eehHHHHHHHHHH-HHHH-Hhhhhhccc
Q 014352 12 ICVGLALGILIAT-LVFF-GLRWYKKHD 37 (426)
Q Consensus 12 i~~g~~~~~~~~~-~~~~-~~~~~r~~~ 37 (426)
|++|.++++++++ +.+| ++.|++|++
T Consensus 12 ivlGg~~~lll~~glcI~ccvkcrhRrr 39 (70)
T 2klu_A 12 IVLGGVAGLLLFIGLGIFFSVRSRHRRR 39 (70)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHSSCCSS
T ss_pred HHHhHHHHHHHHHHHHHHHhhHHHHHHH
Confidence 6776666555443 4444 443443333
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=84.90 E-value=0.74 Score=28.42 Aligned_cols=7 Identities=14% Similarity=-0.002 Sum_probs=3.3
Q ss_pred eehHHHH
Q 014352 12 ICVGLAL 18 (426)
Q Consensus 12 i~~g~~~ 18 (426)
|++|+++
T Consensus 14 Ia~~vVG 20 (44)
T 2jwa_A 14 IISAVVG 20 (44)
T ss_dssp HHHHHHH
T ss_pred hHHHHHH
Confidence 4445444
|
| >2k9j_B Integrin beta-3; transmembrane complex, cell adhesion, cleavage on basic residues, disease mutation, glycoprotein, pyrrolidone carboxylic acid; NMR {Homo sapiens} PDB: 2rmz_A 2rn0_A 2l91_A | Back alignment and structure |
|---|
Probab=82.43 E-value=0.48 Score=29.28 Aligned_cols=26 Identities=15% Similarity=0.110 Sum_probs=15.7
Q ss_pred EEEeehHHHHHHHHHHHHHHHhhhhh
Q 014352 9 IIGICVGLALGILIATLVFFGLRWYK 34 (426)
Q Consensus 9 ii~i~~g~~~~~~~~~~~~~~~~~~r 34 (426)
+.+|+.|+++++++++++++++++..
T Consensus 9 ~~~Iv~gvi~~ivliGl~lLliwk~~ 34 (43)
T 2k9j_B 9 ILVVLLSVMGAILLIGLAALLIWKLL 34 (43)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EeehHHHHHHHHHHHHHHHHHHHHHH
Confidence 34556677777777766665555443
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 426 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-68 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-66 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-66 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-65 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-64 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-62 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-62 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-61 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-61 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-60 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-60 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-60 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-59 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-59 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-58 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-58 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-58 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-57 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-57 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-57 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-57 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 8e-57 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-56 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-56 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-56 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-56 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-54 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-54 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-54 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-52 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-51 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 8e-51 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-50 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-49 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-49 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 9e-49 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-47 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-45 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-45 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-45 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-44 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 7e-44 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-43 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-43 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-43 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-42 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 7e-42 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-41 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-40 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 8e-40 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 8e-40 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 9e-40 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-39 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-37 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 8e-37 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-36 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-33 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 6e-33 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 8e-33 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-30 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-29 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-24 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-19 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (549), Expect = 4e-68
Identities = 66/271 (24%), Positives = 127/271 (46%), Gaps = 18/271 (6%)
Query: 121 FTNILGQGAFGPVYKATMPSGGVAAIKVL--ASDSHQGEKEFQTEVSLLGRLHHRNLVNL 178
+G G+FG VYK A+K+L + + Q + F+ EV +L + H N++
Sbjct: 12 VGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69
Query: 179 IGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPV 238
+GY + ++ ++ SL + ++ E + + IA + G++YLH +
Sbjct: 70 MGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSI 125
Query: 239 IHRDLKSANILLDHFMRAKVADFGLSK---EEVFDGRNSGLKGTYGYIDPAYIST---NK 292
IHRDLKS NI L + K+ DFGL+ + L G+ ++ P I N
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185
Query: 293 FTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRE 352
++ +SD+++FG++++EL+T P+ N+ + M G ++ C +
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC----PKA 241
Query: 353 LARIGHKCLHKTPRKRPSIGEVTQALLKIKQ 383
+ R+ +CL K +RP ++ ++ + +
Sbjct: 242 MKRLMAECLKKKRDERPLFPQILASIELLAR 272
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (537), Expect = 2e-66
Identities = 73/276 (26%), Positives = 122/276 (44%), Gaps = 24/276 (8%)
Query: 106 IPRYAYKDIQKATQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVS 165
+PR K +++ LG G FG V+ A+K L F E +
Sbjct: 10 VPRETLKLVER--------LGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEAN 60
Query: 166 LLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERV-LNWEERLQIALDIS 224
L+ +L H+ LV L + Y +I E+M NGSL + + + + L + L +A I+
Sbjct: 61 LMKQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 225 HGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSK--EEVFDGRNSGLKGTYGY 282
G+ ++ E IHRDL++ANIL+ + K+ADFGL++ E+ G K +
Sbjct: 120 EGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 176
Query: 283 IDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLV 342
P I+ FT+KSD++SFG+++ E++T M + + G +
Sbjct: 177 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC- 235
Query: 343 GACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQAL 378
EL ++ C + P RP+ + L
Sbjct: 236 -------PEELYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 211 bits (538), Expect = 4e-66
Identities = 73/300 (24%), Positives = 133/300 (44%), Gaps = 33/300 (11%)
Query: 106 IPRYAYKDIQKATQNFT-----------NILGQGAFGPVYKATMPSGG----VAAIKVLA 150
I + ++D +A + F ++G G FG V + G AIK L
Sbjct: 4 IDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLK 63
Query: 151 SD-SHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEER 209
S + + ++F +E S++G+ H N+++L G M+I EFM NGSL + + +
Sbjct: 64 SGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG 123
Query: 210 VLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF 269
+ + + I+ G++YL + +HRDL + NIL++ + KV+DFGLS+
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180
Query: 270 DGRNS------GLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYV 323
D + G K + P I KFT SD++S+G++++E+++
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER-------- 232
Query: 324 NLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQ 383
M+ V +++ + L ++ C K RP G++ L K+ +
Sbjct: 233 PYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 1e-65
Identities = 69/266 (25%), Positives = 123/266 (46%), Gaps = 14/266 (5%)
Query: 120 NFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLI 179
F +G G FG V+ + AIK + + E++F E ++ +L H LV L
Sbjct: 8 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLY 66
Query: 180 GYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVI 239
G C+++ L++EFM +G LS+ + ++ + E L + LD+ G+ YL E VI
Sbjct: 67 GVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVI 123
Query: 240 HRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNS--GLKGTYGYIDPAYISTNKFTMKS 297
HRDL + N L+ KV+DFG+++ + D S G K + P S ++++ KS
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 183
Query: 298 DIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIG 357
D++SFGV+++E+ + + G + + +I
Sbjct: 184 DVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLA--------STHVYQIM 235
Query: 358 HKCLHKTPRKRPSIGEVTQALLKIKQ 383
+ C + P RP+ + + L +I +
Sbjct: 236 NHCWKERPEDRPAFSRLLRQLAEIAE 261
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 2e-64
Identities = 69/264 (26%), Positives = 115/264 (43%), Gaps = 14/264 (5%)
Query: 120 NFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLI 179
F LG G FG V AIK++ + E EF E ++ L H LV L
Sbjct: 7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLY 65
Query: 180 GYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVI 239
G C + +I E+M+NG L N + ++ L++ D+ +EYL +
Sbjct: 66 GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFL 122
Query: 240 HRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNS--GLKGTYGYIDPAYISTNKFTMKS 297
HRDL + N L++ KV+DFGLS+ + D S G K + P + +KF+ KS
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 182
Query: 298 DIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIG 357
DI++FGV+++E+ + + E + + L ++ I
Sbjct: 183 DIWAFGVLMWEIYSLGKM--------PYERFTNSETAEHIAQGLRLYRPHLASEKVYTIM 234
Query: 358 HKCLHKTPRKRPSIGEVTQALLKI 381
+ C H+ +RP+ + +L +
Sbjct: 235 YSCWHEKADERPTFKILLSNILDV 258
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 2e-62
Identities = 74/281 (26%), Positives = 122/281 (43%), Gaps = 17/281 (6%)
Query: 101 PSASGIPRYAYKDIQKATQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEF 160
P G+ + A+ +I + + LGQG FG V+ T AIK L + F
Sbjct: 2 PQTQGLAKDAW-EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAF 59
Query: 161 QTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEE-RVLNWEERLQI 219
E ++ +L H LV L + ++ E+MS GSL + + E + L + + +
Sbjct: 60 LQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM 118
Query: 220 ALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSK--EEVFDGRNSGLK 277
A I+ G+ Y+ +HRDL++ANIL+ + KVADFGL++ E+ G K
Sbjct: 119 AAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK 175
Query: 278 GTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEIL 337
+ P +FT+KSD++SFG+++ EL T M + + G
Sbjct: 176 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 235
Query: 338 DKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQAL 378
+ L + +C K P +RP+ + L
Sbjct: 236 PPEC--------PESLHDLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 4e-62
Identities = 74/265 (27%), Positives = 123/265 (46%), Gaps = 18/265 (6%)
Query: 121 FTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIG 180
+G+G FG V G A+K + +D+ + F E S++ +L H NLV L+G
Sbjct: 11 LLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLG 67
Query: 181 YCVD-KGKYMLIYEFMSNGSLSNLIYSEER-VLNWEERLQIALDISHGIEYLHEGAVPPV 238
V+ KG ++ E+M+ GSL + + S R VL + L+ +LD+ +EYL
Sbjct: 68 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNF 124
Query: 239 IHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSD 298
+HRDL + N+L+ AKV+DFGL+KE K + P + KF+ KSD
Sbjct: 125 VHRDLAARNVLVSEDNVAKVSDFGLTKE--ASSTQDTGKLPVKWTAPEALREKKFSTKSD 182
Query: 299 IFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGH 358
++SFG++++E+ + + ++ + G V E+ +
Sbjct: 183 VWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCP-----PAVYEVMK--- 234
Query: 359 KCLHKTPRKRPSIGEVTQALLKIKQ 383
C H RPS ++ + L IK
Sbjct: 235 NCWHLDAAMRPSFLQLREQLEHIKT 259
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 198 bits (505), Expect = 2e-61
Identities = 80/281 (28%), Positives = 133/281 (47%), Gaps = 16/281 (5%)
Query: 107 PRYAYKDIQKATQNFTNILGQGAFGPVYKATMPSGGVA-AIKVLASDSHQGEKEFQTEVS 165
P Y ++++ + LG G +G VY+ + A+K L D+ + E EF E +
Sbjct: 7 PNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAA 65
Query: 166 LLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEER-VLNWEERLQIALDIS 224
++ + H NLV L+G C + + +I EFM+ G+L + + R ++ L +A IS
Sbjct: 66 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQIS 125
Query: 225 HGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG--RNSGLKGTYGY 282
+EYL + IHRDL + N L+ KVADFGLS+ D ++G K +
Sbjct: 126 SAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 182
Query: 283 IDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLV 342
P ++ NKF++KSD+++FGV+++E+ T + V E+L+K
Sbjct: 183 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY--------PGIDLSQVYELLEKDYR 234
Query: 343 GACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQ 383
++ + C P RPS E+ QA + Q
Sbjct: 235 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 4e-61
Identities = 67/271 (24%), Positives = 125/271 (46%), Gaps = 21/271 (7%)
Query: 123 NILGQGAFGPVYKATMPSGG-----VAAIKVLASDSHQGEK-EFQTEVSLLGRLHHRNLV 176
++G G FG VYK + + AIK L + + ++ +F E ++G+ H N++
Sbjct: 13 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 72
Query: 177 NLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVP 236
L G M+I E+M NG+L + ++ + + + + I+ G++YL
Sbjct: 73 RLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN---M 129
Query: 237 PVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRN----SGLKGTYGYIDPAYISTNK 292
+HRDL + NIL++ + KV+DFGLS+ D SG K + P IS K
Sbjct: 130 NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK 189
Query: 293 FTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRE 352
FT SD++SFG++++E++T +S V + ++ +
Sbjct: 190 FTSASDVWSFGIVMWEVMTYGERPYW--------ELSNHEVMKAINDGFRLPTPMDCPSA 241
Query: 353 LARIGHKCLHKTPRKRPSIGEVTQALLKIKQ 383
+ ++ +C + +RP ++ L K+ +
Sbjct: 242 IYQLMMQCWQQERARRPKFADIVSILDKLIR 272
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (503), Expect = 1e-60
Identities = 62/301 (20%), Positives = 119/301 (39%), Gaps = 42/301 (13%)
Query: 114 IQKATQNFT--NILGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQG-EKEFQTEVSLLGR 169
++ +F + LG G G V+K + PSG V A K++ + + E+ +L
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 170 LHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEY 229
+ +V G G+ + E M GSL ++ R + + ++++ + G+ Y
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTY 119
Query: 230 LHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYIS 289
L E ++HRD+K +NIL++ K+ DFG+S ++ D + GT Y+ P +
Sbjct: 120 LREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSG-QLIDSMANSFVGTRSYMSPERLQ 176
Query: 290 TNKFTMKSDIFSFGVIIFELITAIHP-------HQNLMEYVNLASMSQDGVDEILDKQLV 342
++++SDI+S G+ + E+ +P LM + + +
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236
Query: 343 GACNIQEVRELARIGH---------------------------KCLHKTPRKRPSIGEVT 375
+ + R I KCL K P +R + ++
Sbjct: 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 296
Query: 376 Q 376
Sbjct: 297 V 297
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 2e-60
Identities = 73/281 (25%), Positives = 128/281 (45%), Gaps = 22/281 (7%)
Query: 120 NFTNILGQGAFGPVYKATMPSGG----VAAIKVLASDSHQGE-KEFQTEVSLLGRLHHRN 174
+F ++G+G FG VY T+ A+K L + GE +F TE ++ H N
Sbjct: 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89
Query: 175 LVNLIGYCVD-KGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEG 233
+++L+G C+ +G +++ +M +G L N I +E ++ + L ++ G+++L
Sbjct: 90 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS- 148
Query: 234 AVPPVIHRDLKSANILLDHFMRAKVADFGLSK-----EEVFDGRNSGLKGTYGYIDPAYI 288
+HRDL + N +LD KVADFGL++ E +G K ++ +
Sbjct: 149 --KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 206
Query: 289 STNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQ 348
T KFT KSD++SFGV+++EL+T P + ++ G + +
Sbjct: 207 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC------- 259
Query: 349 EVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRHLAKQ 389
L + KC H RPS E+ + I + +
Sbjct: 260 -PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 299
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 5e-60
Identities = 78/314 (24%), Positives = 145/314 (46%), Gaps = 36/314 (11%)
Query: 107 PRYAYKDIQKATQNFTNILGQGAFGPVYKATMPSGG---VAAIKVLASD-SHQGEKEFQT 162
P + DI+ F +++G+G FG V KA + G AAIK + S ++F
Sbjct: 5 PVLDWNDIK-----FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAG 59
Query: 163 EVSLLGRL-HHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIY---------------S 206
E+ +L +L HH N++NL+G C +G L E+ +G+L + + S
Sbjct: 60 ELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANS 119
Query: 207 EERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKE 266
L+ ++ L A D++ G++YL + IHRDL + NIL+ AK+ADFGLS+
Sbjct: 120 TASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRG 176
Query: 267 EVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLA 326
+ + + + ++ ++ + +T SD++S+GV+++E+++ M L
Sbjct: 177 QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 236
Query: 327 SMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRHL 386
G EV +L R +C + P +RPS ++ +L ++ +
Sbjct: 237 EKLPQGYRLEKPLNCD-----DEVYDLMR---QCWREKPYERPSFAQILVSLNRMLEERK 288
Query: 387 AKQDTMSFADGEFS 400
+T + ++
Sbjct: 289 TYVNTTLYEKFTYA 302
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 2e-59
Identities = 64/259 (24%), Positives = 112/259 (43%), Gaps = 17/259 (6%)
Query: 125 LGQGAFGPVYKATMPSGG-VAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCV 183
LG GAFG VYKA +AA KV+ + S + +++ E+ +L H N+V L+
Sbjct: 20 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 79
Query: 184 DKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDL 243
+ ++ EF + G++ ++ ER L + + + YLH+ +IHRDL
Sbjct: 80 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDL 136
Query: 244 KSANILLDHFMRAKVADFGLSKEEV-FDGRNSGLKGTYGYIDPAYISTN-----KFTMKS 297
K+ NIL K+ADFG+S + R GT ++ P + + K+
Sbjct: 137 KAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKA 196
Query: 298 DIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIG 357
D++S G+ + E+ PH L L +++ + ++ +
Sbjct: 197 DVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWS----SNFKDFLK-- 250
Query: 358 HKCLHKTPRKRPSIGEVTQ 376
KCL K R + ++ Q
Sbjct: 251 -KCLEKNVDARWTTSQLLQ 268
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (490), Expect = 3e-59
Identities = 67/290 (23%), Positives = 117/290 (40%), Gaps = 23/290 (7%)
Query: 112 KDIQKATQNFTNI---LGQGAFGPVYKATMPSGG---VAAIKVLASDSHQGE-KEFQTEV 164
K + N LG G FG V + AIKVL + + + +E E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 165 SLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDIS 224
++ +L + +V LIG C + L+ E G L + + + ++ +S
Sbjct: 61 QIMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 119
Query: 225 HGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSK----EEVFDGRNSGLKGTY 280
G++YL E +HRDL + N+LL + AK++DFGLSK ++ + S K
Sbjct: 120 MGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176
Query: 281 GYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQ 340
+ P I+ KF+ +SD++S+GV ++E ++ M+ + + + G +
Sbjct: 177 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPE 236
Query: 341 LVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRHLAKQD 390
EL + C RP V Q + +K +
Sbjct: 237 C--------PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 278
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 1e-58
Identities = 60/296 (20%), Positives = 123/296 (41%), Gaps = 36/296 (12%)
Query: 125 LGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVD 184
+G+G FG V++ G A+K+ +S + + E+ L H N++ I
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNK 68
Query: 185 KG----KYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAV----- 235
+ L+ ++ +GSL + + + E +++AL + G+ +LH V
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 126
Query: 236 PPVIHRDLKSANILLDHFMRAKVADFGL-----SKEEVFDGRNSGLKGTYGYIDPAYIST 290
P + HRDLKS NIL+ +AD GL S + D + GT Y+ P +
Sbjct: 127 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 186
Query: 291 N------KFTMKSDIFSFGVIIFELITAIHPHQNLMEY-----------VNLASMSQDGV 333
+ + ++DI++ G++ +E+ +Y ++ M +
Sbjct: 187 SINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVC 246
Query: 334 DEILDKQLVGAC-NIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRHLAK 388
++ L + + + +R +A+I +C + R + + + L ++ Q+ K
Sbjct: 247 EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIK 302
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 4e-58
Identities = 62/262 (23%), Positives = 109/262 (41%), Gaps = 19/262 (7%)
Query: 121 FTNILGQGAFGPVYKATMPSGGVA-AIKVLASD--SHQGEKEFQTEVSLLGRLHHRNLVN 177
F +G+G+F VYK V A L + + F+ E +L L H N+V
Sbjct: 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72
Query: 178 LIGYCVD----KGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEG 233
K +L+ E M++G+L + +V+ + I G+++LH
Sbjct: 73 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLK-RFKVMKIKVLRSWCRQILKGLQFLHTR 131
Query: 234 AVPPVIHRDLKSANILL-DHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNK 292
PP+IHRDLK NI + K+ D GL+ + GT ++ P K
Sbjct: 132 T-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL-KRASFAKAVIGTPEFMAPEMYE-EK 188
Query: 293 FTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRE 352
+ D+++FG+ + E+ T+ +P+ + GV ++ I EV+E
Sbjct: 189 YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVA----IPEVKE 244
Query: 353 LARIGHKCLHKTPRKRPSIGEV 374
+ C+ + +R SI ++
Sbjct: 245 IIE---GCIRQNKDERYSIKDL 263
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 6e-58
Identities = 68/261 (26%), Positives = 111/261 (42%), Gaps = 21/261 (8%)
Query: 121 FTNILGQGAFGPVYKATMPSGG-VAAIKVL---ASDSHQGEKEFQTEVSLLGRLHHRNLV 176
LG+G FG VY A + A+KVL + E + + EV + L H N++
Sbjct: 10 IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 69
Query: 177 NLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVP 236
L GY D + LI E+ G++ + + + + ++++ + Y H
Sbjct: 70 RLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHS---K 125
Query: 237 PVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMK 296
VIHRD+K N+LL K+ADFG S R + L GT Y+ P I K
Sbjct: 126 RVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMIEGRMHDEK 184
Query: 297 SDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNI-QEVRELAR 355
D++S GV+ +E + P + A+ Q+ I + + + R+L
Sbjct: 185 VDLWSLGVLCYEFLVGKPPFE--------ANTYQETYKRISRVEFTFPDFVTEGARDLIS 236
Query: 356 IGHKCLHKTPRKRPSIGEVTQ 376
+ L P +RP + EV +
Sbjct: 237 ---RLLKHNPSQRPMLREVLE 254
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 189 bits (482), Expect = 1e-57
Identities = 64/275 (23%), Positives = 109/275 (39%), Gaps = 30/275 (10%)
Query: 107 PRYAYKDIQKATQNFTNILGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGE---KEFQT 162
P + D+++ +G G+FG VY A + + V AIK ++ Q ++
Sbjct: 13 PEKLFSDLRE--------IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIK 64
Query: 163 EVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALD 222
EV L +L H N + G + + L+ E+ + L ++ L E +
Sbjct: 65 EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP-LQEVEIAAVTHG 123
Query: 223 ISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGY 282
G+ YLH +IHRD+K+ NILL K+ DFG + + GT +
Sbjct: 124 ALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSAS---IMAPANSFVGTPYW 177
Query: 283 IDPAYIST---NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDK 339
+ P I ++ K D++S G+ EL P N+ L ++Q+ +
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSG 237
Query: 340 QLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEV 374
+ R CL K P+ RP+ +
Sbjct: 238 HWS-----EYFRNFVD---SCLQKIPQDRPTSEVL 264
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 1e-57
Identities = 72/291 (24%), Positives = 125/291 (42%), Gaps = 43/291 (14%)
Query: 121 FTNILGQGAFGPVYKATMPSGG------VAAIKVLASDSHQGEKE-FQTEVSLLGRL-HH 172
F +LG GAFG V AT A+K+L + E+E +E+ ++ +L H
Sbjct: 41 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 100
Query: 173 RNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEER----------------------V 210
N+VNL+G C G LI+E+ G L N + S+ V
Sbjct: 101 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 160
Query: 211 LNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD 270
L +E+ L A ++ G+E+L +HRDL + N+L+ H K+ DFGL+++ + D
Sbjct: 161 LTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 217
Query: 271 GR---NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLAS 327
+ ++ P + +T+KSD++S+G++++E+ + Y +
Sbjct: 218 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP-----YPGIPV 272
Query: 328 MSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQAL 378
+ +++ E+ I C RKRPS +T L
Sbjct: 273 DAN--FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 189 bits (480), Expect = 1e-57
Identities = 72/310 (23%), Positives = 136/310 (43%), Gaps = 44/310 (14%)
Query: 107 PRYAYKDIQKATQNFTNILGQGAFGPVYKATMP------SGGVAAIKVLASDSHQG-EKE 159
P+ + + + +G+GAFG V++A P + A+K+L ++ + +
Sbjct: 3 PKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD 62
Query: 160 FQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEER---------- 209
FQ E +L+ + N+V L+G C L++E+M+ G L+ + S
Sbjct: 63 FQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 122
Query: 210 -------------VLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRA 256
L+ E+L IA ++ G+ YL E +HRDL + N L+ M
Sbjct: 123 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVV 179
Query: 257 KVADFGLSK---EEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAI 313
K+ADFGLS+ + + ++ P I N++T +SD++++GV+++E+ +
Sbjct: 180 KIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 239
Query: 314 HPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGE 373
M + + + + D ++ AC EL + C K P RPS
Sbjct: 240 LQPYYGMAHEEV-------IYYVRDGNIL-ACPENCPLELYNLMRLCWSKLPADRPSFCS 291
Query: 374 VTQALLKIKQ 383
+ + L ++ +
Sbjct: 292 IHRILQRMCE 301
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (477), Expect = 6e-57
Identities = 78/314 (24%), Positives = 130/314 (41%), Gaps = 30/314 (9%)
Query: 114 IQKATQ-NFTNILGQGAFGPVYKAT-MPSGGVAAIKVL-----ASDSHQGEKEFQTEVSL 166
I K T+ +LG GAFG VYK +P G I V + S + KE E +
Sbjct: 5 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 64
Query: 167 LGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHG 226
+ + + ++ L+G C+ LI + M G L + + + + + L + I+ G
Sbjct: 65 MASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 123
Query: 227 IEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRN---SGLKGTYGYI 283
+ YL + ++HRDL + N+L+ K+ DFGL+K + + G K ++
Sbjct: 124 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 180
Query: 284 DPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVG 343
I +T +SD++S+GV ++EL+T + + + IL+K
Sbjct: 181 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD--------GIPASEISSILEKGERL 232
Query: 344 ACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIK---QRHLAKQ-----DTMSFA 395
++ I KC RP E+ K+ QR+L Q S
Sbjct: 233 PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPT 292
Query: 396 DGEFSRAVSRIEDQ 409
D F RA+ ED
Sbjct: 293 DSNFYRALMDEEDM 306
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 8e-57
Identities = 62/254 (24%), Positives = 119/254 (46%), Gaps = 14/254 (5%)
Query: 125 LGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCV 183
+GQGA G VY A + +G AI+ + ++ E+ ++ + N+VN + +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 184 DKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDL 243
+ ++ E+++ GSL++++ E ++ + + + +E+LH VIHRD+
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDI 142
Query: 244 KSANILLDHFMRAKVADFGLSKEEVFDG-RNSGLKGTYGYIDPAYISTNKFTMKSDIFSF 302
KS NILL K+ DFG + + + S + GT ++ P ++ + K DI+S
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSL 202
Query: 303 GVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLH 362
G++ E+I P+ N L ++ +G E+ + + + R+ +CL
Sbjct: 203 GIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLS----AIFRDFLN---RCLD 255
Query: 363 KTPRKRPSIGEVTQ 376
KR S E+ Q
Sbjct: 256 MDVEKRGSAKELLQ 269
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 1e-56
Identities = 66/268 (24%), Positives = 118/268 (44%), Gaps = 20/268 (7%)
Query: 120 NFTNILGQGAFGPVYKATMPSGG-VAAIKVL--ASDSHQGEKEFQTEVSLLGRLHHRNLV 176
+G G++G K S G + K L S + ++ +EV+LL L H N+V
Sbjct: 7 EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIV 66
Query: 177 NLIGYCVDK--GKYMLIYEFMSNGSLSNLIYS---EERVLNWEERLQIALDISHGIEYLH 231
+D+ ++ E+ G L+++I E + L+ E L++ ++ ++ H
Sbjct: 67 RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 126
Query: 232 E--GAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNS-GLKGTYGYIDPAYI 288
V+HRDLK AN+ LD K+ DFGL++ D + GT Y+ P +
Sbjct: 127 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQM 186
Query: 289 STNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQ 348
+ + KSDI+S G +++EL + P LA ++G + +
Sbjct: 187 NRMSYNEKSDIWSLGCLLYELCALMPPFTA-FSQKELAGKIREGKFRRIPYRYS-----D 240
Query: 349 EVRELARIGHKCLHKTPRKRPSIGEVTQ 376
E+ E+ + L+ RPS+ E+ +
Sbjct: 241 ELNEIIT---RMLNLKDYHRPSVEEILE 265
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 1e-56
Identities = 73/289 (25%), Positives = 124/289 (42%), Gaps = 38/289 (13%)
Query: 121 FTNILGQGAFGPVYKATM------PSGGVAAIKVLASDSHQGEKE-FQTEVSLLGRL-HH 172
F LG GAFG V +AT + A+K+L +H E+E +E+ +L L +H
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 173 RNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIY-----------------SEERVLNWEE 215
N+VNL+G C G ++I E+ G L N + +E L+ E+
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 216 RLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRN-- 273
L + ++ G+ +L IHRDL + NILL H K+ DFGL+++ D
Sbjct: 147 LLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 274 -SGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDG 332
+ ++ P I +T +SD++S+G+ ++EL + M +
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK------- 256
Query: 333 VDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKI 381
+++ + E+ I C P KRP+ ++ Q + K
Sbjct: 257 FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 2e-56
Identities = 69/265 (26%), Positives = 117/265 (44%), Gaps = 22/265 (8%)
Query: 123 NILGQGAFGPVYKATMPSGGVA---AIKVLASDSHQGE--KEFQTEVSLLGRLHHRNLVN 177
LG G FG V K V A+K+L ++++ E E +++ +L + +V
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 178 LIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPP 237
+IG C + +ML+ E G L+ + + + +++ +S G++YL E
Sbjct: 73 MIGIC-EAESWMLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEE---SN 127
Query: 238 VIHRDLKSANILLDHFMRAKVADFGLSK----EEVFDGRNSGLKGTYGYIDPAYISTNKF 293
+HRDL + N+LL AK++DFGLSK +E + + K + P I+ KF
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 187
Query: 294 TMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVREL 353
+ KSD++SFGV+++E + M V +L+K C RE+
Sbjct: 188 SSKSDVWSFGVLMWEAFSYGQK--------PYRGMKGSEVTAMLEKGERMGCPAGCPREM 239
Query: 354 ARIGHKCLHKTPRKRPSIGEVTQAL 378
+ + C RP V L
Sbjct: 240 YDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 4e-56
Identities = 60/273 (21%), Positives = 106/273 (38%), Gaps = 22/273 (8%)
Query: 121 FTNILGQGAFGPVYKATMPS----GGVAAIKVLASD---SHQGEKEFQTEVSLLGRLHHR 173
LG G+FG V + + A+K L D + +F EV+ + L HR
Sbjct: 12 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 71
Query: 174 NLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEG 233
NL+ L G + M + E GSL + + + + A+ ++ G+ YL
Sbjct: 72 NLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES- 129
Query: 234 AVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG----RNSGLKGTYGYIDPAYIS 289
IHRDL + N+LL K+ DFGL + + K + + P +
Sbjct: 130 --KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187
Query: 290 TNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQE 349
T F+ SD + FGV ++E+ T + + + +I +
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI-------LHKIDKEGERLPRPEDC 240
Query: 350 VRELARIGHKCLHKTPRKRPSIGEVTQALLKIK 382
+++ + +C P RP+ + LL+ +
Sbjct: 241 PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 181 bits (461), Expect = 4e-54
Identities = 60/255 (23%), Positives = 119/255 (46%), Gaps = 12/255 (4%)
Query: 125 LGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCV 183
LG GAFG V++ +G V K + + + + E+S++ +LHH L+NL
Sbjct: 37 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 96
Query: 184 DKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDL 243
DK + +LI EF+S G L + I +E+ ++ E + G++++HE ++H D+
Sbjct: 97 DKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDI 153
Query: 244 KSANILLDHF--MRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFS 301
K NI+ + K+ DFGL+ + D T + P + +D+++
Sbjct: 154 KPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWA 213
Query: 302 FGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCL 361
GV+ + L++ + P + L ++ + + D+ + + E ++ + L
Sbjct: 214 IGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE--FDEDAFSSVS-PEAKDFIK---NLL 267
Query: 362 HKTPRKRPSIGEVTQ 376
K PRKR ++ + +
Sbjct: 268 QKEPRKRLTVHDALE 282
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 181 bits (460), Expect = 5e-54
Identities = 60/254 (23%), Positives = 108/254 (42%), Gaps = 12/254 (4%)
Query: 124 ILGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYC 182
LG GAFG V++ T +G A K + + ++ + E+ + L H LVNL
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 183 VDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRD 242
D + ++IYEFMS G L + E ++ +E ++ + G+ ++HE +H D
Sbjct: 93 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLD 149
Query: 243 LKSANILL--DHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIF 300
LK NI+ K+ DFGL+ GT + P +D++
Sbjct: 150 LKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMW 209
Query: 301 SFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKC 360
S GV+ + L++ + P + L ++ + +D + ++ ++ R K
Sbjct: 210 SVGVLSYILLSGLSPFGGENDDETLRNVKSCDWN--MDDSAFSGIS-EDGKDFIR---KL 263
Query: 361 LHKTPRKRPSIGEV 374
L P R +I +
Sbjct: 264 LLADPNTRMTIHQA 277
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 5e-54
Identities = 61/275 (22%), Positives = 114/275 (41%), Gaps = 19/275 (6%)
Query: 121 FTNILGQGAFGPVYKATMPSGG----VAAIKVLASDSHQGEKE-FQTEVSLLGRLHHRNL 175
+G+G FG V++ S AIK + + +E F E + + H ++
Sbjct: 11 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 70
Query: 176 VNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAV 235
V LIG + + +I E + G L + + + L+ + A +S + YL
Sbjct: 71 VKLIGVITENPVW-IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES--- 126
Query: 236 PPVIHRDLKSANILLDHFMRAKVADFGLSK--EEVFDGRNSGLKGTYGYIDPAYISTNKF 293
+HRD+ + N+L+ K+ DFGLS+ E+ + S K ++ P I+ +F
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 186
Query: 294 TMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVREL 353
T SD++ FGV ++E++ ++ ++ ++G + + L
Sbjct: 187 TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCP-----PTLYSL 241
Query: 354 ARIGHKCLHKTPRKRPSIGEVTQALLKIKQRHLAK 388
KC P +RP E+ L I + A+
Sbjct: 242 MT---KCWAYDPSRRPRFTELKAQLSTILEEEKAQ 273
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 5e-52
Identities = 56/260 (21%), Positives = 107/260 (41%), Gaps = 17/260 (6%)
Query: 121 FTNILGQGAFGPVYKAT-MPSGGVAAIKVL-ASDSHQGEKEFQTEVSLLGRLHHRNLVNL 178
LG+GA+G V A + A+K++ + + + E+ + L+H N+V
Sbjct: 9 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 68
Query: 179 IGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPV 238
G+ + L E+ S G L + I + + + + + G+ YLH +
Sbjct: 69 YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAGVVYLHG---IGI 124
Query: 239 IHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLK---GTYGYIDPAYISTNKF-T 294
HRD+K N+LLD K++DFGL+ ++ R L GT Y+ P + +F
Sbjct: 125 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 184
Query: 295 MKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELA 354
D++S G+++ ++ P + S ++ + + + L
Sbjct: 185 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKID----SAPLALL 240
Query: 355 RIGHKCLHKTPRKRPSIGEV 374
K L + P R +I ++
Sbjct: 241 H---KILVENPSARITIPDI 257
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 4e-51
Identities = 66/273 (24%), Positives = 106/273 (38%), Gaps = 25/273 (9%)
Query: 115 QKATQNFT--NILGQGAFGPVYKAT-MPSGGVAAIKVLASD---SHQGEKEFQTEVSLLG 168
+K ++F ILG+G+F V A + + AIK+L E ++
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 169 RLHHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIE 228
RL H V L D K + NG L I + +I +E
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTAEIVSALE 122
Query: 229 YLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRN---SGLKGTYGYIDP 285
YLH +IHRDLK NILL+ M ++ DFG +K + + + GT Y+ P
Sbjct: 123 YLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 179
Query: 286 AYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGAC 345
++ SD+++ G II++L+ + P + EY+ +I+ +
Sbjct: 180 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF--------QKIIKLEYDFPE 231
Query: 346 NI-QEVRELARIGHKCLHKTPRKRPSIGEVTQA 377
+ R+L K L KR E+
Sbjct: 232 KFFPKARDLVE---KLLVLDATKRLGCEEMEGY 261
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 8e-51
Identities = 48/255 (18%), Positives = 101/255 (39%), Gaps = 13/255 (5%)
Query: 125 LGQGAFGPVYKATMPSGG-VAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCV 183
LG+G FG V++ S K + + + E+S+L HRN+++L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFE 71
Query: 184 DKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDL 243
+ ++I+EF+S + I + LN E + + +++LH + H D+
Sbjct: 72 SMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDI 128
Query: 244 KSANILLDH--FMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFS 301
+ NI+ K+ +FG +++ L Y P + + +D++S
Sbjct: 129 RPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWS 188
Query: 302 FGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCL 361
G +++ L++ I+P + ++ D++ + E + + L
Sbjct: 189 LGTLVYVLLSGINPFLAETNQQIIENIMNAEYT--FDEEAFKEIS-IEAMDFVD---RLL 242
Query: 362 HKTPRKRPSIGEVTQ 376
K + R + E Q
Sbjct: 243 VKERKSRMTASEALQ 257
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 169 bits (429), Expect = 5e-50
Identities = 60/259 (23%), Positives = 110/259 (42%), Gaps = 9/259 (3%)
Query: 120 NFTNILGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQG-EKEFQTEVSLLGRLHHRNLVN 177
+F ++LG GAF V A + + AIK +A + +G E + E+++L ++ H N+V
Sbjct: 12 DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVA 71
Query: 178 LIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPP 237
L G LI + +S G L + I E+ + ++ + ++YLH+ +
Sbjct: 72 LDDIYESGGHLYLIMQLVSGGELFDRIV-EKGFYTERDASRLIFQVLDAVKYLHDLGIVH 130
Query: 238 VIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKS 297
+ LD + ++DFGLSK E S GT GY+ P ++ ++
Sbjct: 131 RDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAV 190
Query: 298 DIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIG 357
D +S GVI + L+ P + + + + + D + ++ R
Sbjct: 191 DCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYE--FDSPYWDDIS-DSAKDFIR-- 245
Query: 358 HKCLHKTPRKRPSIGEVTQ 376
+ K P KR + + Q
Sbjct: 246 -HLMEKDPEKRFTCEQALQ 263
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 3e-49
Identities = 74/307 (24%), Positives = 127/307 (41%), Gaps = 45/307 (14%)
Query: 106 IPRYAYKDIQKATQNFTNILGQGAFGPVYKATM------PSGGVAAIKVLASDSHQGE-K 158
PR K LG+GAFG V +A + A+K+L + E +
Sbjct: 10 FPRDRLK--------LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHR 61
Query: 159 EFQTEVSLLGR-LHHRNLVNLIGYCVDKG-KYMLIYEFMSNGSLSNLIYSE--------- 207
+E+ +L HH N+VNL+G C G M+I EF G+LS + S+
Sbjct: 62 ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKV 121
Query: 208 ------ERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADF 261
+ L E + + ++ G+E+L IHRDL + NILL K+ DF
Sbjct: 122 APEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDF 178
Query: 262 GLSK---EEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQN 318
GL++ ++ R + ++ P I +T++SD++SFGV+++E+ +
Sbjct: 179 GLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 238
Query: 319 LMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQAL 378
++ L + E+ + C H P +RP+ E+ + L
Sbjct: 239 GVKIDEE-------FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 291
Query: 379 LKIKQRH 385
+ Q +
Sbjct: 292 GNLLQAN 298
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 6e-49
Identities = 66/289 (22%), Positives = 129/289 (44%), Gaps = 39/289 (13%)
Query: 121 FTNILGQGAFGPVYKATMPS--------GGVAAIKVLASDSHQGE-KEFQTEVSLLGRL- 170
LG+GAFG V A A+K+L SD+ + + + +E+ ++ +
Sbjct: 17 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76
Query: 171 HHRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLI---------------YSEERVLNWEE 215
H+N++NL+G C G +I E+ S G+L + ++ E L+ ++
Sbjct: 77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136
Query: 216 RLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSK---EEVFDGR 272
+ A ++ G+EYL IHRDL + N+L+ K+ADFGL++ + +
Sbjct: 137 LVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 273 NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDG 332
+ + ++ P + +T +SD++SFGV+++E+ T + +
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP--------GVPVEE 245
Query: 333 VDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKI 381
+ ++L + EL + C H P +RP+ ++ + L +I
Sbjct: 246 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 9e-49
Identities = 66/283 (23%), Positives = 122/283 (43%), Gaps = 32/283 (11%)
Query: 121 FTNILGQGAFGPVYKAT------MPSGGVAAIKVL-ASDSHQGEKEFQTEVSLLGRLHHR 173
+ LGQG+FG VY+ AIK + + S + EF E S++ +
Sbjct: 24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 83
Query: 174 NLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERV---------LNWEERLQIALDIS 224
++V L+G ++I E M+ G L + + S + + +Q+A +I+
Sbjct: 84 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 143
Query: 225 HGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSK---EEVFDGRNSGLKGTYG 281
G+ YL+ +HRDL + N ++ K+ DFG+++ E + +
Sbjct: 144 DGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 200
Query: 282 YIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQ 340
++ P + FT SD++SFGV+++E+ T A P+Q L L + + G+ + D
Sbjct: 201 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDN- 259
Query: 341 LVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQ 383
L + C P+ RPS E+ ++ + +
Sbjct: 260 --------CPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 161 bits (407), Expect = 4e-47
Identities = 57/275 (20%), Positives = 117/275 (42%), Gaps = 25/275 (9%)
Query: 121 FTNILGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGE---KEFQTEVSLLGRLHHRNLV 176
ILG G V+ A + A+KVL +D + F+ E L+H +V
Sbjct: 11 LGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 70
Query: 177 NLIGYCVDKGK----YMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHE 232
+ + ++ E++ +L +++++E + + +++ D + + H+
Sbjct: 71 AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQALNFSHQ 129
Query: 233 GAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRN----SGLKGTYGYIDPAYI 288
+IHRD+K ANI++ KV DFG+++ G + + + GT Y+ P
Sbjct: 130 ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186
Query: 289 STNKFTMKSDIFSFGVIIFELITAIHPHQNLMEY-VNLASMSQDGVDEILDKQLVGACNI 347
+ +SD++S G +++E++T P V + +D + + + A
Sbjct: 187 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSA--- 243
Query: 348 QEVRELARIGHKCLHKTPRKRP-SIGEVTQALLKI 381
+L + K L K P R + E+ L+++
Sbjct: 244 ----DLDAVVLKALAKNPENRYQTAAEMRADLVRV 274
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 2e-45
Identities = 62/259 (23%), Positives = 106/259 (40%), Gaps = 24/259 (9%)
Query: 121 FTNILGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKEFQT----EVSLLGRLHHRNL 175
+LG+G+FG V+ A + AIK L D + + + + L H L
Sbjct: 6 LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 65
Query: 176 VNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAV 235
++ K + E+++ G L I S + + A +I G+++LH
Sbjct: 66 THMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLHS--- 121
Query: 236 PPVIHRDLKSANILLDHFMRAKVADFGLSKE-EVFDGRNSGLKGTYGYIDPAYISTNKFT 294
+++RDLK NILLD K+ADFG+ KE + D + + GT YI P + K+
Sbjct: 122 KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYN 181
Query: 295 MKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEV--RE 352
D +SFGV+++E++ P +E+ + +E
Sbjct: 182 HSVDWWSFGVLLYEMLIGQSPFHG------------QDEEELFHSIRMDNPFYPRWLEKE 229
Query: 353 LARIGHKCLHKTPRKRPSI 371
+ K + P KR +
Sbjct: 230 AKDLLVKLFVREPEKRLGV 248
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 159 bits (402), Expect = 2e-45
Identities = 65/268 (24%), Positives = 106/268 (39%), Gaps = 24/268 (8%)
Query: 123 NILGQGAFGPVYKATMPSGG-VAAIKVL---ASDSHQGEKEFQTEV---SLLGRLHHRNL 175
I+G+G FG VY G + A+K L QGE E SL+ +
Sbjct: 10 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 69
Query: 176 VNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAV 235
V + K I + M+ G L + S+ V + + A +I G+E++H
Sbjct: 70 VCMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEADMRFYAAEIILGLEHMHN--- 125
Query: 236 PPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNK-FT 294
V++RDLK ANILLD +++D GL+ + + GT+GY+ P + +
Sbjct: 126 RFVVYRDLKPANILLDEHGHVRISDLGLAC-DFSKKKPHASVGTHGYMAPEVLQKGVAYD 184
Query: 295 MKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEV--RE 352
+D FS G ++F+L+ P + EI L A + + E
Sbjct: 185 SSADWFSLGCMLFKLLRGHSPFRQ---------HKTKDKHEIDRMTLTMAVELPDSFSPE 235
Query: 353 LARIGHKCLHKTPRKRPSIGEVTQALLK 380
L + L + +R +K
Sbjct: 236 LRSLLEGLLQRDVNRRLGCLGRGAQEVK 263
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 155 bits (393), Expect = 5e-45
Identities = 62/269 (23%), Positives = 114/269 (42%), Gaps = 27/269 (10%)
Query: 123 NILGQGAFGPVYKAT-MPSGGVAAIKVL---------ASDSHQGEKEFQTEVSLLGRLH- 171
ILG+G V + P+ A+K++ A + + + EV +L ++
Sbjct: 9 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68
Query: 172 HRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLH 231
H N++ L + L+++ M G L + + + L+ +E +I + I LH
Sbjct: 69 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT-LSEKETRKIMRALLEVICALH 127
Query: 232 EGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTN 291
+ ++HRDLK NILLD M K+ DFG S + + + GT Y+ P I +
Sbjct: 128 K---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECS 184
Query: 292 ------KFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGAC 345
+ + D++S GVI++ L+ P + + + + M G + +
Sbjct: 185 MNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMIMSGNYQFGSPEWDDYS 243
Query: 346 NIQEVRELARIGHKCLHKTPRKRPSIGEV 374
V++L + L P+KR + E
Sbjct: 244 --DTVKDLVS---RFLVVQPQKRYTAEEA 267
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 155 bits (393), Expect = 1e-44
Identities = 61/266 (22%), Positives = 108/266 (40%), Gaps = 24/266 (9%)
Query: 121 FTNILGQGAFGPVYKAT-MPSGGVAAIKVL---ASDSHQGEKEFQTEVSLLGRLHHRNLV 176
LG G+FG V+ +G A+KVL + + E +L + H ++
Sbjct: 8 ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFII 67
Query: 177 NLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVP 236
+ G D + +I +++ G L +L+ +R N + A ++ +EYLH
Sbjct: 68 RMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKF-YAAEVCLALEYLHS---K 123
Query: 237 PVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMK 296
+I+RDLK NILLD K+ DFG +K L GT YI P +ST +
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAKY--VPDVTYTLCGTPDYIAPEVVSTKPYNKS 181
Query: 297 SDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEV--RELA 354
D +SFG++I+E++ P + + +K L ++
Sbjct: 182 IDWWSFGILIYEMLAGYTPFYD------------SNTMKTYEKILNAELRFPPFFNEDVK 229
Query: 355 RIGHKCLHKTPRKRPSIGEVTQALLK 380
+ + + + +R + +K
Sbjct: 230 DLLSRLITRDLSQRLGNLQNGTEDVK 255
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 7e-44
Identities = 68/261 (26%), Positives = 116/261 (44%), Gaps = 21/261 (8%)
Query: 125 LGQGAFGPVYKAT-MPSGGVAAIKVL------ASDSHQGEKEFQTEVSLLGRLHHRNLVN 177
LG G F V K +G A K + +S ++ + EVS+L + H N++
Sbjct: 18 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 178 LIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPP 237
L +K +LI E ++ G L + + +E L EE + I +G+ YLH
Sbjct: 78 LHEVYENKTDVILILELVAGGELFDFLAEKES-LTEEEATEFLKQILNGVYYLHS---LQ 133
Query: 238 VIHRDLKSANILLDHF----MRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKF 293
+ H DLK NI+L R K+ DFGL+ + F + GT ++ P ++
Sbjct: 134 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPL 193
Query: 294 TMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVREL 353
+++D++S GVI + L++ P + LA++S E D+ ++
Sbjct: 194 GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA-VNYEFEDEYFSNTS--ALAKDF 250
Query: 354 ARIGHKCLHKTPRKRPSIGEV 374
R + L K P+KR +I +
Sbjct: 251 IR---RLLVKDPKKRMTIQDS 268
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 1e-43
Identities = 65/322 (20%), Positives = 121/322 (37%), Gaps = 36/322 (11%)
Query: 124 ILGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRL-HHRNLVNLIGY 181
+LG G G V + + A+K+L Q + + EV L R ++V ++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDV 73
Query: 182 C----VDKGKYMLIYEFMSNGSLSNLIYSE-ERVLNWEERLQIALDISHGIEYLHEGAVP 236
+ +++ E + G L + I ++ E +I I I+YLH +
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINI- 132
Query: 237 PVIHRDLKSANILLDHFM---RAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKF 293
HRD+K N+L K+ DFG +KE + T Y+ P + K+
Sbjct: 133 --AHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKY 190
Query: 294 TMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNI-QEVRE 352
D++S GVI++ L+ P + M + + +EV+
Sbjct: 191 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKM 250
Query: 353 LARIGHKCLHKTPRKRPSIGEV------------TQALLKIKQRHLAKQDTMSFADGEFS 400
L R L P +R +I E Q L + ++ E +
Sbjct: 251 LIR---NLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMT 307
Query: 401 RAVS--RIEDQQVELSKLAEVK 420
A++ R++ +Q+++ K+ +
Sbjct: 308 SALATMRVDYEQIKIKKIEDAS 329
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 6e-43
Identities = 66/294 (22%), Positives = 115/294 (39%), Gaps = 34/294 (11%)
Query: 114 IQKATQNFT--NILGQGAFGPVYKAT--MPSGGVAAIKVL--ASDSHQGEKEFQTEVSLL 167
+ +A Q + +G+GA+G V+KA G A+K + + EV++L
Sbjct: 2 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61
Query: 168 GRL---HHRNLVNLIGYCVD-----KGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQI 219
L H N+V L C + K L++E + + L E + E +
Sbjct: 62 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 121
Query: 220 ALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGT 279
+ G+++LH V+HRDLK NIL+ + K+ADFGL++ F + + T
Sbjct: 122 MFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVT 178
Query: 280 YGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQ---------NLMEYVNLASMSQ 330
Y P + + + D++S G I E+ + +++ + L
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
Query: 331 DGVDEILDKQLVGACNIQEVRELAR--------IGHKCLHKTPRKRPSIGEVTQ 376
D L +Q + + Q + + + KCL P KR S
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 7e-43
Identities = 56/262 (21%), Positives = 100/262 (38%), Gaps = 31/262 (11%)
Query: 124 ILGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKE------FQTEVSLLGRLH--HRN 174
+LG G FG VY + AIK + D E EV LL ++
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 175 LVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGA 234
++ L+ + ++LI E +E L E + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN-- 128
Query: 235 VPPVIHRDLKSANILLD-HFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKF 293
V+HRD+K NIL+D + K+ DFG + D + GT Y P +I +++
Sbjct: 129 -CGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVYSPPEWIRYHRY 186
Query: 294 -TMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRE 352
+ ++S G+++++++ P + +EI+ Q+ + E
Sbjct: 187 HGRSAAVWSLGILLYDMVCGDIPFE--------------HDEEIIRGQVFFRQRVSS--E 230
Query: 353 LARIGHKCLHKTPRKRPSIGEV 374
+ CL P RP+ E+
Sbjct: 231 CQHLIRWCLALRPSDRPTFEEI 252
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 149 bits (378), Expect = 1e-42
Identities = 56/278 (20%), Positives = 96/278 (34%), Gaps = 19/278 (6%)
Query: 125 LGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCV 183
+G G+FG +Y T + +G AIK+ + + E + + + I +C
Sbjct: 15 IGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCG 72
Query: 184 DKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDL 243
+G Y ++ + SL +L R + + L +A + IEY+H IHRD+
Sbjct: 73 AEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDV 129
Query: 244 KSANIL---LDHFMRAKVADFGLSK--------EEVFDGRNSGLKGTYGYIDPAYISTNK 292
K N L + DFGL+K + + N L GT Y +
Sbjct: 130 KPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE 189
Query: 293 FTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRE 352
+ + D+ S G ++ P Q L + ++ V E
Sbjct: 190 QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPS--E 247
Query: 353 LARIGHKCLHKTPRKRPSIGEVTQALLKIKQRHLAKQD 390
A + C +P + Q + R D
Sbjct: 248 FATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYD 285
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 7e-42
Identities = 61/278 (21%), Positives = 104/278 (37%), Gaps = 30/278 (10%)
Query: 123 NILGQGAFGPVYKATMPSGG-VAAIKVLASDSHQGEKE-----FQTEVSLLGRLHHRNLV 176
+ LG+G F VYKA + + AIK + K+ E+ LL L H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 177 NLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVP 236
L+ K L+++FM +I VL L G+EYLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEV-IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ---H 119
Query: 237 PVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGR-NSGLKGTYGYIDPAYISTNK-FT 294
++HRDLK N+LLD K+ADFGL+K R + T Y P + + +
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYG 179
Query: 295 MKSDIFSFGVIIFELITAIHPHQ------------------NLMEYVNLASMSQDGVDEI 336
+ D+++ G I+ EL+ + ++ ++ S+ +
Sbjct: 180 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239
Query: 337 LDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEV 374
+ +L + P R + +
Sbjct: 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 147 bits (371), Expect = 1e-41
Identities = 46/282 (16%), Positives = 98/282 (34%), Gaps = 25/282 (8%)
Query: 125 LGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCV 183
+G+G+FG +++ T + + AIK + + E L + + Y
Sbjct: 13 IGEGSFGVIFEGTNLLNNQQVAIKFE--PRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFG 70
Query: 184 DKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDL 243
+G + ++ + SL +L+ R + + A + ++ +HE +++RD+
Sbjct: 71 QEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDI 127
Query: 244 KSANILLD-----HFMRAKVADFGLSK--------EEVFDGRNSGLKGTYGYIDPAYIST 290
K N L+ + V DFG+ K + + L GT Y+
Sbjct: 128 KPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG 187
Query: 291 NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQ--DGVDEILDKQLVGACNIQ 348
+ + + D+ + G + + P Q L N + + ++L
Sbjct: 188 REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFP-- 245
Query: 349 EVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRHLAKQD 390
E + H + P + K+ +R +D
Sbjct: 246 --EEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTED 285
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 3e-40
Identities = 64/262 (24%), Positives = 103/262 (39%), Gaps = 23/262 (8%)
Query: 121 FTNILGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKE---FQTEVSLLGRLHHRNLV 176
+ +LG+G FG V +G A+K+L + + E TE +L H L
Sbjct: 9 YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 68
Query: 177 NLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVP 236
L + + E+ + G L + S ERV E +I +EYLH
Sbjct: 69 ALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVSALEYLHS---R 124
Query: 237 PVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSG-LKGTYGYIDPAYISTNKFTM 295
V++RD+K N++LD K+ DFGL KE + DG GT Y+ P + N +
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGR 184
Query: 296 KSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEV--REL 353
D + GV+++E++ P N + + + L+ E
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYN------------QDHERLFELILMEEIRFPRTLSPEA 232
Query: 354 ARIGHKCLHKTPRKRPSIGEVT 375
+ L K P++R G
Sbjct: 233 KSLLAGLLKKDPKQRLGGGPSD 254
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 8e-40
Identities = 58/277 (20%), Positives = 106/277 (38%), Gaps = 29/277 (10%)
Query: 123 NILGQGAFGPVYKAT-MPSGGVAAIKVL--ASDSHQGEKEFQTEVSLLGRLHHRNLVNLI 179
+G+G +G VYKA +G V A+K + +++ E+SLL L+H N+V L+
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 180 GYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVI 239
+ K L++EF+ + S + + G+ + H V+
Sbjct: 68 DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS---HRVL 124
Query: 240 HRDLKSANILLDHFMRAKVADFGLSKEEVFDGR--NSGLKGTYGYIDPAYISTNKFTMKS 297
HRDLK N+L++ K+ADFGL++ R + + + ++
Sbjct: 125 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 184
Query: 298 DIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVR------ 351
DI+S G I E++T E L + + + + G ++ + +
Sbjct: 185 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR-TLGTPDEVVWPGVTSMPDYKPSFPKW 243
Query: 352 --------------ELARIGHKCLHKTPRKRPSIGEV 374
+ + + LH P KR S
Sbjct: 244 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 141 bits (357), Expect = 8e-40
Identities = 59/275 (21%), Positives = 106/275 (38%), Gaps = 27/275 (9%)
Query: 123 NILGQGAFGPVYKATMPSGGVAAIKVL--ASDSHQGEKEFQTEVSLLGRLHHRNLVNLIG 180
+G+G +G VYKA G A+K + + E+S+L L H N+V L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 181 YCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIH 240
K + +L++E + L E L L + +GI Y H+ V+H
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCEGG-LESVTAKSFLLQLLNGIAYCHD---RRVLH 123
Query: 241 RDLKSANILLDHFMRAKVADFGLSKEEVFDGRN--SGLKGTYGYIDPAYISTNKFTMKSD 298
RDLK N+L++ K+ADFGL++ R + + + + K++ D
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTID 183
Query: 299 IFSFGVIIFELITAIHPHQ------------------NLMEYVNLASMSQDGVDEILDKQ 340
I+S G I E++ N + N+ + + + + +
Sbjct: 184 IWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEP 243
Query: 341 LVGACNIQEVRELAR-IGHKCLHKTPRKRPSIGEV 374
L ++ + E + K L P +R + +
Sbjct: 244 LPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 9e-40
Identities = 59/305 (19%), Positives = 109/305 (35%), Gaps = 37/305 (12%)
Query: 102 SASGIPRYAYKDIQKATQNFTNILGQGAFGPVYKATMPSGG-VAAIKVLASDSHQGEKEF 160
+ P Q+ + T ++G G+FG VY+A + G + AIK + D ++
Sbjct: 5 TVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFK 60
Query: 161 QTEVSLLGRLHHRNLVNLIGYCVDKGK------YMLIYEFMSNGSLSNLIY--SEERVLN 212
E+ ++ +L H N+V L + G+ L+ +++ + ++ L
Sbjct: 61 NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLP 120
Query: 213 WEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDH-FMRAKVADFGLSKEEVFDG 271
+ + Y+H + HRD+K N+LLD K+ DFG +K+ V
Sbjct: 121 VIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177
Query: 272 RNSGLKGTYGYIDPAYI-STNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQ 330
N + Y P I +T D++S G ++ EL+ L + +
Sbjct: 178 PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 237
Query: 331 DGVDEILDKQLVGACNIQEVR-------------------ELARIGHKCLHKTPRKRPSI 371
++ N E + E + + L TP R +
Sbjct: 238 VLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTP 297
Query: 372 GEVTQ 376
E
Sbjct: 298 LEACA 302
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 5e-39
Identities = 65/337 (19%), Positives = 129/337 (38%), Gaps = 42/337 (12%)
Query: 123 NILGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGE-KEFQTEVSLLGRLHHRNLVNLIG 180
+ +G+GA+G V A + AIK ++ HQ + E+ +L R H N++ +
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73
Query: 181 YCVDKGKYMLIYEFMSNGSLSNLIYS--EERVLNWEERLQIALDISHGIEYLHEGAVPPV 238
+ ++ + +Y + + L+ + I G++Y+H V
Sbjct: 74 IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANV 130
Query: 239 IHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTY----GYIDPAYISTNKFT 294
+HRDLK +N+LL+ K+ DFGL++ D ++G Y Y P + +K
Sbjct: 131 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 190
Query: 295 MKS-DIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVREL 353
KS DI+S G I+ E+++ Y++ + + + L N++ L
Sbjct: 191 TKSIDIWSVGCILAEMLSNRPIFPG-KHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 249
Query: 354 ARIGH----------------------KCLHKTPRKRPSIGEVTQALLK---IKQRHLAK 388
+ H K L P KR + + L ++Q +
Sbjct: 250 LSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQ----ALAHPYLEQYYDPS 305
Query: 389 QDTMSFADGEFSRAVSRIEDQQVELSKLAEVKERHEE 425
+ ++ A +F + + ++++ E
Sbjct: 306 DEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPG 342
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 6e-37
Identities = 54/277 (19%), Positives = 94/277 (33%), Gaps = 29/277 (10%)
Query: 123 NILGQGAFGPVYKAT-MPSGGVAAIKVL--ASDSHQGEKEFQTEVSLLGRLHHRNLVNLI 179
+G+G +G V+KA + + A+K + D E+ LL L H+N+V L
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 180 GYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVI 239
K L++EF S L+ E + G+ + H V+
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLK-KYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS---RNVL 123
Query: 240 HRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKG--TYGYIDPAYISTNKFTMKS 297
HRDLK N+L++ K+A+FGL++ R + + ++
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSI 183
Query: 298 DIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELARIG 357
D++S G I EL A P + + + ++Q + + +
Sbjct: 184 DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYP 243
Query: 358 H--------------------KCLHKTPRKRPSIGEV 374
L P +R S E
Sbjct: 244 ATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (339), Expect = 8e-37
Identities = 66/291 (22%), Positives = 114/291 (39%), Gaps = 43/291 (14%)
Query: 123 NILGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQG--EKEFQTEVSLLGRLHHRNLVNLI 179
+GQG FG V+KA +G A+K + ++ + E+ +L L H N+VNLI
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 180 GYCVD--------KGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLH 231
C KG L+++F + L + E ++ + +G+ Y+H
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRVMQMLLNGLYYIH 134
Query: 232 EGAVPPVIHRDLKSANILLDHFMRAKVADFGLSK-----EEVFDGRNSGLKGTYGYIDPA 286
++HRD+K+AN+L+ K+ADFGL++ + R + T Y P
Sbjct: 135 R---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 191
Query: 287 YISTNK-FTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQ----------DGVDE 335
+ + + D++ G I+ E+ T Q E LA +SQ VD
Sbjct: 192 LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDN 251
Query: 336 ILDKQLVGACNIQEVRELARIGH------------KCLHKTPRKRPSIGEV 374
+ + Q+ + R+ K L P +R +
Sbjct: 252 YELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 134 bits (339), Expect = 1e-36
Identities = 61/252 (24%), Positives = 96/252 (38%), Gaps = 24/252 (9%)
Query: 124 ILGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKE---FQTEVSLLGRLHHRNLVNLI 179
LG G+FG V SG A+K+L K+ E +L ++ LV L
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 180 GYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVI 239
D ++ E+++ G + + + R + A I EYLH +I
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHARFYAAQIVLTFEYLHS---LDLI 163
Query: 240 HRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDI 299
+RDLK N+L+D +V DFG +K GR L GT + P I + + D
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWTLCGTPEALAPEIILSKGYNKAVDW 221
Query: 300 FSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEV--RELARIG 357
++ GV+I+E+ P D +I +K + G +L +
Sbjct: 222 WALGVLIYEMAAGYPPFFA------------DQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 358 HKCLHKTPRKRP 369
L KR
Sbjct: 270 RNLLQVDLTKRF 281
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 2e-33
Identities = 56/302 (18%), Positives = 104/302 (34%), Gaps = 43/302 (14%)
Query: 109 YAYKDIQKATQNFTN------ILGQGAFGPVYKAT-MPSGGVAAIKVL--ASDSHQGEKE 159
+ +++ K +G GA+G V A +G AIK L S K
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 160 FQTEVSLLGRLHHRNLVNLIGYCVDKGK------YMLIYEFMSNGSLSNLIYSEERVLNW 213
E+ LL + H N++ L+ + L+ FM + L
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGK---LMKHEKLGE 120
Query: 214 EERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRN 273
+ + + G+ Y+H +IHRDLK N+ ++ K+ DFGL++ +
Sbjct: 121 DRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR-QADSEMT 176
Query: 274 SGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLME-----------Y 322
+ + ++ ++T DI+S G I+ E+IT +
Sbjct: 177 GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 236
Query: 323 VNLASMSQDGVDEILDKQLVGACNIQEVRELARIGH----------KCLHKTPRKRPSIG 372
A Q + + G +++ + + + K L +R + G
Sbjct: 237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAG 296
Query: 373 EV 374
E
Sbjct: 297 EA 298
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 124 bits (312), Expect = 6e-33
Identities = 48/306 (15%), Positives = 104/306 (33%), Gaps = 52/306 (16%)
Query: 111 YKDIQKATQNFTNI--------LGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKEFQ 161
Y D + + N LG+G + V++A + + +K+L +K+ +
Sbjct: 21 YWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIK 77
Query: 162 TEVSLLGRL-HHRNLVNLIGYCVD--KGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQ 218
E+ +L L N++ L D L++E ++N L + L +
Sbjct: 78 REIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRF 133
Query: 219 IALDISHGIEYLHEGAVPPVIHRDLKSANILLDH-FMRAKVADFGLSKEEVFDGRNSGLK 277
+I ++Y H ++HRD+K N+++DH + ++ D+GL++ +
Sbjct: 134 YMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV 190
Query: 278 GTYGYIDP-AYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEI 336
+ + P + + D++S G ++ +I P + + + +
Sbjct: 191 ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 250
Query: 337 LDKQLVGACNIQEVRELARIGH----------------------------KCLHKTPRKR 368
+ NI+ I K L + R
Sbjct: 251 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSR 310
Query: 369 PSIGEV 374
+ E
Sbjct: 311 LTAREA 316
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 8e-33
Identities = 70/267 (26%), Positives = 112/267 (41%), Gaps = 25/267 (9%)
Query: 123 NILGQGAFGPVYKA----TMPSGGVAAIKVL----ASDSHQGEKEFQTEVSLLGRL-HHR 173
+LG GA+G V+ +G + A+KVL + + +TE +L +
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 174 NLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEG 233
LV L + K LI ++++ G L + ER E +I +E+LH+
Sbjct: 90 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER-FTEHEVQIYVGEIVLALEHLHK- 147
Query: 234 AVPPVIHRDLKSANILLDHFMRAKVADFGLSKE--EVFDGRNSGLKGTYGYIDPAYISTN 291
+I+RD+K NILLD + DFGLSKE R GT Y+ P +
Sbjct: 148 --LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGG 205
Query: 292 K--FTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNI-Q 348
D +S GV+++EL+T P E + A +S+ IL + +
Sbjct: 206 DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR----RILKSEPPYPQEMSA 261
Query: 349 EVRELARIGHKCLHKTPRKRPSIGEVT 375
++L + + L K P+KR G
Sbjct: 262 LAKDLIQ---RLLMKDPKKRLGCGPRD 285
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 4e-30
Identities = 58/292 (19%), Positives = 99/292 (33%), Gaps = 48/292 (16%)
Query: 124 ILGQGAFGPVYKAT-MPSGGVAAIKVL--ASDSHQGEKEFQTEVSLLGRLHHRNLVNLIG 180
+G GA G V A AIK L + K E+ L+ ++H+N+++L+
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 181 YCVDKGK------YMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGA 234
+ L+ E M + + E + + GI++LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----DHERMSYLLYQMLCGIKHLHS-- 137
Query: 235 VPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFT 294
+IHRDLK +NI++ K+ DFGL++ + T Y P I +
Sbjct: 138 -AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 196
Query: 295 MKSDIFSFGVIIFELITAIHP---HQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVR 351
DI+S G I+ E++ + ++ + E + K N E R
Sbjct: 197 ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 256
Query: 352 -----------------------------ELARIGHKCLHKTPRKRPSIGEV 374
+ + K L P KR S+ +
Sbjct: 257 PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 3e-29
Identities = 55/303 (18%), Positives = 110/303 (36%), Gaps = 41/303 (13%)
Query: 107 PRYAYKDIQKATQNFTN------ILGQGAFGPVYKAT-MPSGGVAAIKVL--ASDSHQGE 157
P + +++ K +G GA+G V A +G A+K L S
Sbjct: 2 PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 61
Query: 158 KEFQTEVSLLGRLHHRNLVNLIGYCVDK-----GKYMLIYEFMSNGSLSNLIYSEERVLN 212
K E+ LL + H N++ L+ + + + L+N++ + + L
Sbjct: 62 KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLT 119
Query: 213 WEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGR 272
+ + I G++Y+H +IHRDLK +N+ ++ K+ DFGL++ +
Sbjct: 120 DDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-M 175
Query: 273 NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQ--NLMEYVNLASMSQ 330
+ + ++ + DI+S G I+ EL+T + ++ + L
Sbjct: 176 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 235
Query: 331 DGVDEILDKQLVGACNIQEVRELARIG-------------------HKCLHKTPRKRPSI 371
L K++ ++ L ++ K L KR +
Sbjct: 236 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 295
Query: 372 GEV 374
+
Sbjct: 296 AQA 298
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 102 bits (253), Expect = 1e-24
Identities = 43/211 (20%), Positives = 82/211 (38%), Gaps = 23/211 (10%)
Query: 125 LGQGAFGPVYKAT-MPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCV 183
LG G F V+ A M + A+K++ D + + E+ LL R++ +
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSMGA 79
Query: 184 ---------------DKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIE 228
+ ++++E + L+ + E R + QI+ + G++
Sbjct: 80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139
Query: 229 YLHEGAVPPVIHRDLKSANILLD----HFMRAKVADFGLSKEEVFDGRNSGLKGTYGYID 284
Y+H +IH D+K N+L++ ++ L +D + T Y
Sbjct: 140 YMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS 197
Query: 285 PAYISTNKFTMKSDIFSFGVIIFELITAIHP 315
P + + +DI+S +IFELIT
Sbjct: 198 PEVLLGAPWGCGADIWSTACLIFELITGDFL 228
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 82.5 bits (203), Expect = 4e-19
Identities = 37/197 (18%), Positives = 64/197 (32%), Gaps = 22/197 (11%)
Query: 123 NILGQGAFGPVYKATMPSGGVAAIKVLASDS----------HQGEKEFQTEVSLLGRLHH 172
++G+G V+ G +K G+ F R
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 173 RNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYSE-ERVLNWEERLQIALDISHGIEYLH 231
R L L G V K +Y + N L LI ++ + E ++ I + +
Sbjct: 66 RALQKLQGLAVPK-----VYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120
Query: 232 EGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTN 291
++H DL N+L+ + DF S E +G L+ I + +
Sbjct: 121 H---RGIVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGWREILERDVRNIITYF--SR 174
Query: 292 KFTMKSDIFSFGVIIFE 308
+ + DI S I +
Sbjct: 175 TYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 426 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.55 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.18 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.73 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.84 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.47 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.69 | |
| d1cjaa_ | 342 | Actin-fragmin kinase, catalytic domain {Physarum p | 87.3 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-57 Score=415.47 Aligned_cols=253 Identities=27% Similarity=0.479 Sum_probs=204.3
Q ss_pred hhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCCC
Q 014352 119 QNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNG 198 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 198 (426)
+++.+.||+|+||+||+|.+.+++.||||++.... ...++|.+|++++++++|||||+++|+|.+++..++||||+++|
T Consensus 7 ~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g 85 (263)
T d1sm2a_ 7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHG 85 (263)
T ss_dssp EEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred cEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCC
Confidence 45678999999999999999888899999997643 45678999999999999999999999999999999999999999
Q ss_pred ChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC--CcccC
Q 014352 199 SLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG--RNSGL 276 (426)
Q Consensus 199 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~--~~~~~ 276 (426)
+|.+++......+++..++.++.|++.||.|||+++ |+||||||+|||+++++.+||+|||+++...... .....
T Consensus 86 ~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~ 162 (263)
T d1sm2a_ 86 CLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 162 (263)
T ss_dssp BHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC----------------
T ss_pred cHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCceeecce
Confidence 999999777778999999999999999999999998 9999999999999999999999999998543322 22345
Q ss_pred ccccCccCccccccCCCCcchhhHHHHHHHHHHHhC-CCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHH
Q 014352 277 KGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITA-IHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELAR 355 (426)
Q Consensus 277 ~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 355 (426)
.||+.|+|||++.+..|+.++|||||||++|||+|+ .+||........... +........+...+.++.+
T Consensus 163 ~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~---------i~~~~~~~~p~~~~~~l~~ 233 (263)
T d1sm2a_ 163 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED---------ISTGFRLYKPRLASTHVYQ 233 (263)
T ss_dssp --CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHH---------HHHTCCCCCCTTSCHHHHH
T ss_pred ecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHH---------HHhcCCCCCccccCHHHHH
Confidence 789999999999999999999999999999999995 555554322221111 1111112222334467999
Q ss_pred HHHHcccCCCCCCCCHHHHHHHHHHHHHH
Q 014352 356 IGHKCLHKTPRKRPSIGEVTQALLKIKQR 384 (426)
Q Consensus 356 l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 384 (426)
++.+||+.||++|||+++++++|+++.+.
T Consensus 234 li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 234 IMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 99999999999999999999999998753
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-56 Score=419.65 Aligned_cols=253 Identities=27% Similarity=0.470 Sum_probs=201.5
Q ss_pred hhhcccccCCCeeEEEEEeC-CC---cEEEEEEeccCCc-cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEe
Q 014352 120 NFTNILGQGAFGPVYKATMP-SG---GVAAIKVLASDSH-QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEF 194 (426)
Q Consensus 120 ~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 194 (426)
.+.+.||+|+||+||+|.+. ++ ..||||.+..... ...+.|.+|+++|++++|||||+++|+|.+++..++||||
T Consensus 29 ~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey 108 (299)
T d1jpaa_ 29 KIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEF 108 (299)
T ss_dssp EEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred EEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEe
Confidence 34568999999999999875 22 2688998865433 3346799999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCC--
Q 014352 195 MSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGR-- 272 (426)
Q Consensus 195 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~-- 272 (426)
|++|+|.+++......+++.+++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 109 ~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~ 185 (299)
T d1jpaa_ 109 MENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP 185 (299)
T ss_dssp CTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------------
T ss_pred cCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccCCCCcc
Confidence 9999999999777777999999999999999999999998 99999999999999999999999999985432221
Q ss_pred ----cccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCCH
Q 014352 273 ----NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNI 347 (426)
Q Consensus 273 ----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (426)
.....||+.|||||.+.+..++.++|||||||++|||+| |..||.+......... +........+.
T Consensus 186 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~---------i~~~~~~~~~~ 256 (299)
T d1jpaa_ 186 TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINA---------IEQDYRLPPPM 256 (299)
T ss_dssp ----------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH---------HHTTCCCCCCT
T ss_pred eeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHH---------HHcCCCCCCCc
Confidence 123457899999999999999999999999999999998 8999976543322211 11222223344
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHH
Q 014352 348 QEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQR 384 (426)
Q Consensus 348 ~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 384 (426)
..+..+.+++.+||+.||++|||+.+|++.|+++.+.
T Consensus 257 ~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 257 DCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 4567899999999999999999999999999988653
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-57 Score=418.03 Aligned_cols=256 Identities=26% Similarity=0.469 Sum_probs=203.3
Q ss_pred HhhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCC--ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEec
Q 014352 118 TQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDS--HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 195 (426)
.+.+.+.||+|+||+||+|++++ .||||++.... ....+.|.+|+.+|++++|||||++++++.+ +.+++||||+
T Consensus 9 ~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~ 85 (276)
T d1uwha_ 9 QITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWC 85 (276)
T ss_dssp CCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred cEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecC
Confidence 35567899999999999998643 58999987543 2334679999999999999999999998765 5689999999
Q ss_pred CCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC---CC
Q 014352 196 SNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD---GR 272 (426)
Q Consensus 196 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~---~~ 272 (426)
++|+|.+++......+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+..... ..
T Consensus 86 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~ 162 (276)
T d1uwha_ 86 EGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQ 162 (276)
T ss_dssp CEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC---------
T ss_pred CCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccCCccc
Confidence 999999999777777999999999999999999999998 999999999999999999999999999754322 22
Q ss_pred cccCccccCccCcccccc---CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHH
Q 014352 273 NSGLKGTYGYIDPAYIST---NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQE 349 (426)
Q Consensus 273 ~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (426)
.....||+.|||||++.+ ..|+.++|||||||++|||+||+.||.+......+........ ..+. ....+...
T Consensus 163 ~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~---~~p~-~~~~~~~~ 238 (276)
T d1uwha_ 163 FEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGY---LSPD-LSKVRSNC 238 (276)
T ss_dssp ---CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTS---CCCC-GGGSCTTC
T ss_pred ccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCC---CCCc-chhccccc
Confidence 345679999999999864 3589999999999999999999999976433222111111000 0000 01122334
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 014352 350 VRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQ 383 (426)
Q Consensus 350 ~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 383 (426)
++.+.+++.+||+.||++|||+.+++++|+.+.+
T Consensus 239 ~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 239 PKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 5689999999999999999999999999998875
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.8e-56 Score=416.49 Aligned_cols=258 Identities=29% Similarity=0.453 Sum_probs=213.4
Q ss_pred HHHHHHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEE
Q 014352 113 DIQKATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLI 191 (426)
Q Consensus 113 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 191 (426)
+|....+.+.+.||+|+||+||+|++. +++.||||++..+. ...++|.+|+++|++++|||||+++++|.+++..++|
T Consensus 13 ei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (287)
T d1opja_ 13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 91 (287)
T ss_dssp BCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred EecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEE
Confidence 344456777889999999999999986 68889999987654 3467899999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhc-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC
Q 014352 192 YEFMSNGSLSNLIYSE-ERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD 270 (426)
Q Consensus 192 ~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 270 (426)
|||+++|+|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 92 ~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (287)
T d1opja_ 92 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168 (287)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred eecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCC
Confidence 9999999999998654 467999999999999999999999998 999999999999999999999999999864333
Q ss_pred CC--cccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHH
Q 014352 271 GR--NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQ 348 (426)
Q Consensus 271 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (426)
.. .....||+.|+|||++.+..|+.++|||||||++|||++|..|+........+ ...+........+..
T Consensus 169 ~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~--------~~~i~~~~~~~~~~~ 240 (287)
T d1opja_ 169 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV--------YELLEKDYRMERPEG 240 (287)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH--------HHHHHTTCCCCCCTT
T ss_pred CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHH--------HHHHhcCCCCCCCcc
Confidence 22 23345889999999999999999999999999999999977765432221111 122222222333344
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 014352 349 EVRELARIGHKCLHKTPRKRPSIGEVTQALLKIK 382 (426)
Q Consensus 349 ~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 382 (426)
.+..+.+|+.+||+.||++|||+.++++.|+.+.
T Consensus 241 ~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 241 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 5578999999999999999999999999887654
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-55 Score=403.03 Aligned_cols=249 Identities=28% Similarity=0.430 Sum_probs=212.5
Q ss_pred hhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCCC
Q 014352 119 QNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSNG 198 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 198 (426)
+.+.+.||+|+||+||+|++++++.||||+++... ...++|.+|+.++++++||||++++|+|.+++.+++||||+++|
T Consensus 6 ~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g 84 (258)
T d1k2pa_ 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANG 84 (258)
T ss_dssp CCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTE
T ss_pred CEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCC
Confidence 45678999999999999999888899999998654 35678999999999999999999999999999999999999999
Q ss_pred ChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC--CcccC
Q 014352 199 SLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG--RNSGL 276 (426)
Q Consensus 199 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~--~~~~~ 276 (426)
+|..++......+++..++.++.|+++||.|||+++ |+||||||+|||+++++.+||+|||+++...... .....
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 161 (258)
T d1k2pa_ 85 CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS 161 (258)
T ss_dssp EHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCS
T ss_pred cHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCceeeccc
Confidence 999998777778999999999999999999999998 9999999999999999999999999997543322 22346
Q ss_pred ccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHH
Q 014352 277 KGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELAR 355 (426)
Q Consensus 277 ~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 355 (426)
.||+.|+|||.+.+..++.++||||||+++|||+| |+.||...........+ ........+...+..+.+
T Consensus 162 ~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i---------~~~~~~~~p~~~~~~l~~ 232 (258)
T d1k2pa_ 162 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI---------AQGLRLYRPHLASEKVYT 232 (258)
T ss_dssp CCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH---------HTTCCCCCCTTCCHHHHH
T ss_pred CCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHH---------HhCCCCCCcccccHHHHH
Confidence 68999999999999999999999999999999998 89999865443222211 111122223334468999
Q ss_pred HHHHcccCCCCCCCCHHHHHHHHHH
Q 014352 356 IGHKCLHKTPRKRPSIGEVTQALLK 380 (426)
Q Consensus 356 l~~~cl~~~p~~RPs~~evl~~L~~ 380 (426)
++.+||+.||++|||+.+++++|.+
T Consensus 233 li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 233 IMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred HHHHHccCCHhHCcCHHHHHHHhhC
Confidence 9999999999999999999999854
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-56 Score=408.84 Aligned_cols=254 Identities=27% Similarity=0.431 Sum_probs=208.0
Q ss_pred HHHhhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEec
Q 014352 116 KATQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 116 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 195 (426)
...+.+.+.||+|+||+||+|.+++++.||||++.... ...+.|.+|+.++++++|||||++++++.+ +..++||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 34567788999999999999999888899999997543 456789999999999999999999998765 5679999999
Q ss_pred CCCChhHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC--C
Q 014352 196 SNGSLSNLIYSEE-RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG--R 272 (426)
Q Consensus 196 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~--~ 272 (426)
++|+|.+++.... ..+++..++.++.||++||.|||+++ |+||||||+|||+++++.+||+|||+++...... .
T Consensus 90 ~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~ 166 (272)
T d1qpca_ 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (272)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred CCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCcccc
Confidence 9999999875443 46999999999999999999999998 9999999999999999999999999998643322 2
Q ss_pred cccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCC-CCchHHHHHHhhccccchhhhhhhhhcccCCHHHHH
Q 014352 273 NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHP-HQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVR 351 (426)
Q Consensus 273 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (426)
.....||+.|||||++.+..++.++|||||||++|||+||..| +........... +........+...+.
T Consensus 167 ~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~---------i~~~~~~~~p~~~~~ 237 (272)
T d1qpca_ 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN---------LERGYRMVRPDNCPE 237 (272)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH---------HHTTCCCCCCTTCCH
T ss_pred ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHH---------HHhcCCCCCcccChH
Confidence 3456789999999999999999999999999999999996555 443222211111 111122222334456
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 014352 352 ELARIGHKCLHKTPRKRPSIGEVTQALLKIKQ 383 (426)
Q Consensus 352 ~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 383 (426)
++.+++.+||+.||++|||+.+|++.|+.+-.
T Consensus 238 ~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 238 ELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 79999999999999999999999999987643
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-55 Score=409.24 Aligned_cols=255 Identities=26% Similarity=0.392 Sum_probs=209.2
Q ss_pred hhhc-ccccCCCeeEEEEEeC---CCcEEEEEEeccCCc-cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEe
Q 014352 120 NFTN-ILGQGAFGPVYKATMP---SGGVAAIKVLASDSH-QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEF 194 (426)
Q Consensus 120 ~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 194 (426)
.+.+ .||+|+||+||+|.+. ++..||||++..... ...+.|.+|+++|++++|||||+++|++.+ +.+++||||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~ 89 (285)
T d1u59a_ 11 LIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEM 89 (285)
T ss_dssp EEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEEC
T ss_pred EECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEe
Confidence 3445 4999999999999864 345799999976543 234679999999999999999999999865 468999999
Q ss_pred cCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC---
Q 014352 195 MSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG--- 271 (426)
Q Consensus 195 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~--- 271 (426)
+++|+|.+++......+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 90 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 166 (285)
T d1u59a_ 90 AGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY 166 (285)
T ss_dssp CTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEE
T ss_pred CCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccccccccc
Confidence 9999999998776677999999999999999999999998 9999999999999999999999999998543322
Q ss_pred -CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHH
Q 014352 272 -RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQE 349 (426)
Q Consensus 272 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (426)
......||+.|+|||++.+..++.++|||||||++|||+| |..||.+........ .+........+...
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~---------~i~~~~~~~~p~~~ 237 (285)
T d1u59a_ 167 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA---------FIEQGKRMECPPEC 237 (285)
T ss_dssp CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHH---------HHHTTCCCCCCTTC
T ss_pred ccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHH---------HHHcCCCCCCCCcC
Confidence 2234568999999999999999999999999999999998 899997643322111 11122222333445
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHhhh
Q 014352 350 VRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRHLA 387 (426)
Q Consensus 350 ~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~~ 387 (426)
+.++.+|+.+||+.||++||||.+|++.|+.+.....+
T Consensus 238 ~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~ 275 (285)
T d1u59a_ 238 PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 275 (285)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhh
Confidence 57899999999999999999999999999877654444
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-55 Score=406.87 Aligned_cols=248 Identities=24% Similarity=0.356 Sum_probs=208.5
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecC
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMS 196 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 196 (426)
+|.+.+.||+|+||+||+|... +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+.+|+||||++
T Consensus 21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~ 100 (293)
T d1yhwa1 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (293)
T ss_dssp TBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred ccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecC
Confidence 3667789999999999999974 789999999976655566789999999999999999999999999999999999999
Q ss_pred CCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC-CCccc
Q 014352 197 NGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD-GRNSG 275 (426)
Q Consensus 197 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-~~~~~ 275 (426)
+|+|.+++.. ..+++.++..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..... .....
T Consensus 101 gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~ 175 (293)
T d1yhwa1 101 GGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175 (293)
T ss_dssp TCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred CCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccccccc
Confidence 9999998754 45999999999999999999999999 999999999999999999999999999864332 23456
Q ss_pred CccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHH
Q 014352 276 LKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELAR 355 (426)
Q Consensus 276 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 355 (426)
..||+.|+|||++.+..|+.++|||||||++|||++|..||.+......+..+...... ....+...+..+.+
T Consensus 176 ~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~-------~~~~~~~~s~~~~~ 248 (293)
T d1yhwa1 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP-------ELQNPEKLSAIFRD 248 (293)
T ss_dssp CCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC-------CCSSGGGSCHHHHH
T ss_pred cccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC-------CCCCcccCCHHHHH
Confidence 67999999999999999999999999999999999999999764433322211111100 01112234567999
Q ss_pred HHHHcccCCCCCCCCHHHHHHH
Q 014352 356 IGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 356 l~~~cl~~~p~~RPs~~evl~~ 377 (426)
++.+||+.||++|||+.|++++
T Consensus 249 li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 249 FLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp HHHHHTCSSTTTSCCHHHHTTC
T ss_pred HHHHHccCChhHCcCHHHHhcC
Confidence 9999999999999999999865
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-55 Score=409.32 Aligned_cols=249 Identities=26% Similarity=0.413 Sum_probs=208.2
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCC
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSN 197 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 197 (426)
|++.+.||+|+||+||+|++. ++..||+|++........+.+.+|+++|++++|||||++++++.+++..++||||+++
T Consensus 14 Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~ 93 (288)
T d2jfla1 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred eEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCC
Confidence 566788999999999999975 7889999999876656667899999999999999999999999999999999999999
Q ss_pred CChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC-CCcccC
Q 014352 198 GSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD-GRNSGL 276 (426)
Q Consensus 198 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-~~~~~~ 276 (426)
|+|.+++......+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+..... ......
T Consensus 94 g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~~ 170 (288)
T d2jfla1 94 GAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF 170 (288)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTCC
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCccccccc
Confidence 9999998777778999999999999999999999999 999999999999999999999999999754322 223456
Q ss_pred ccccCccCccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHH
Q 014352 277 KGTYGYIDPAYIS-----TNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVR 351 (426)
Q Consensus 277 ~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (426)
.||+.|||||++. +..|+.++|||||||++|||+||+.||.+......+..+...... ....+...+.
T Consensus 171 ~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~-------~~~~~~~~s~ 243 (288)
T d2jfla1 171 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPP-------TLAQPSRWSS 243 (288)
T ss_dssp CSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCC-------CCSSGGGSCH
T ss_pred ccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCC-------CCCccccCCH
Confidence 7999999999983 556899999999999999999999999764332222211111100 0111233456
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 352 ELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 352 ~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
++.+++.+||+.||++|||+.|++++
T Consensus 244 ~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 244 NFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 89999999999999999999999864
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-55 Score=408.54 Aligned_cols=255 Identities=26% Similarity=0.431 Sum_probs=204.1
Q ss_pred hhhhcccccCCCeeEEEEEeCCC-----cEEEEEEeccCCcc-ChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEE
Q 014352 119 QNFTNILGQGAFGPVYKATMPSG-----GVAAIKVLASDSHQ-GEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIY 192 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 192 (426)
+.+.++||+|+||+||+|.+.++ ..||||++...... ...+|.+|+.++++++|||||+++|++.+.+..++||
T Consensus 9 ~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~ 88 (283)
T d1mqba_ 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIIT 88 (283)
T ss_dssp EEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred eEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEE
Confidence 45567899999999999987533 36999998755332 3357899999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC-
Q 014352 193 EFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG- 271 (426)
Q Consensus 193 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~- 271 (426)
||+.+|++.+++......+++.+++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 89 e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~ 165 (283)
T d1mqba_ 89 EYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 165 (283)
T ss_dssp ECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred EecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcccCCCc
Confidence 999999999998777778999999999999999999999998 9999999999999999999999999998543221
Q ss_pred ---CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCC-chHHHHHHhhccccchhhhhhhhhcccCCH
Q 014352 272 ---RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQ-NLMEYVNLASMSQDGVDEILDKQLVGACNI 347 (426)
Q Consensus 272 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (426)
......||+.|||||++.+..++.++|||||||++|||++|..|+. .......+ ..+........+.
T Consensus 166 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~---------~~i~~~~~~~~~~ 236 (283)
T d1mqba_ 166 ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM---------KAINDGFRLPTPM 236 (283)
T ss_dssp --------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---------HHHHTTCCCCCCT
T ss_pred cceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHH---------HHHhccCCCCCch
Confidence 2234568999999999999999999999999999999999665543 32221111 1122222223334
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHh
Q 014352 348 QEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRH 385 (426)
Q Consensus 348 ~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~ 385 (426)
..+..+.+|+.+||+.||++|||+.+|++.|+.+.+..
T Consensus 237 ~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p 274 (283)
T d1mqba_ 237 DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274 (283)
T ss_dssp TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred hhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence 45578999999999999999999999999999887643
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-55 Score=404.19 Aligned_cols=248 Identities=22% Similarity=0.337 Sum_probs=201.1
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc-cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecC
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH-QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMS 196 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 196 (426)
|++.+.||+|+||+||+|+.. +++.||||++..... ...+.+.+|+++|++++|||||++++++.+++..|+||||++
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~ 86 (271)
T d1nvra_ 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 86 (271)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccC
Confidence 667789999999999999975 788999999875432 234578999999999999999999999999999999999999
Q ss_pred CCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC---CCc
Q 014352 197 NGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD---GRN 273 (426)
Q Consensus 197 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~---~~~ 273 (426)
+|+|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||+++++.+||+|||+|+..... ...
T Consensus 87 gg~L~~~l~~-~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~ 162 (271)
T d1nvra_ 87 GGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 162 (271)
T ss_dssp TEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred CCcHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCccccc
Confidence 9999999954 356999999999999999999999999 999999999999999999999999999854322 234
Q ss_pred ccCccccCccCccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHH
Q 014352 274 SGLKGTYGYIDPAYISTNKF-TMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRE 352 (426)
Q Consensus 274 ~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (426)
....||+.|||||++.+..+ +.++|||||||++|||++|+.||.......... ................+.+
T Consensus 163 ~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~-------~~~~~~~~~~~~~~~~s~~ 235 (271)
T d1nvra_ 163 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-------SDWKEKKTYLNPWKKIDSA 235 (271)
T ss_dssp CCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH-------HHHHTTCTTSTTGGGSCHH
T ss_pred cceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHH-------HHHhcCCCCCCccccCCHH
Confidence 55789999999999988876 578999999999999999999996532211100 0011111111112233467
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 353 LARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 353 l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
+.+++.+||+.||++|||+.|++++
T Consensus 236 ~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 236 PLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHHHHcCCChhHCcCHHHHhcC
Confidence 8899999999999999999999764
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-55 Score=401.29 Aligned_cols=244 Identities=27% Similarity=0.394 Sum_probs=206.7
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC---ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEe
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS---HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEF 194 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 194 (426)
|.+.+.||+|+||+||+|+.. +++.||+|++.... ....+.+.+|+.++++++|||||++++++.+++..++||||
T Consensus 8 y~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy 87 (263)
T d2j4za1 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY 87 (263)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEee
Confidence 677889999999999999985 78899999986432 23356789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCcc
Q 014352 195 MSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNS 274 (426)
Q Consensus 195 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 274 (426)
+++|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++... .....
T Consensus 88 ~~~g~L~~~l~~~-~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~-~~~~~ 162 (263)
T d2j4za1 88 APLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRT 162 (263)
T ss_dssp CTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCC-CCCCE
T ss_pred cCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecC-CCccc
Confidence 9999999999654 45999999999999999999999999 9999999999999999999999999997543 23345
Q ss_pred cCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHH
Q 014352 275 GLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELA 354 (426)
Q Consensus 275 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 354 (426)
...||+.|||||++.+..++.++|||||||++|||++|+.||........+..+.... ...+...+.++.
T Consensus 163 ~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~----------~~~p~~~s~~~~ 232 (263)
T d2j4za1 163 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE----------FTFPDFVTEGAR 232 (263)
T ss_dssp ETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC----------CCCCTTSCHHHH
T ss_pred ccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC----------CCCCccCCHHHH
Confidence 5679999999999999999999999999999999999999997644332222211111 011223446789
Q ss_pred HHHHHcccCCCCCCCCHHHHHHH
Q 014352 355 RIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 355 ~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
+++.+||+.||++|||+.|++++
T Consensus 233 ~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 233 DLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHTC
T ss_pred HHHHHHccCCHhHCcCHHHHHcC
Confidence 99999999999999999999875
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-54 Score=399.17 Aligned_cols=247 Identities=28% Similarity=0.435 Sum_probs=199.4
Q ss_pred cccccCCCeeEEEEEeC---CCcEEEEEEeccCCcc--ChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecCC
Q 014352 123 NILGQGAFGPVYKATMP---SGGVAAIKVLASDSHQ--GEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMSN 197 (426)
Q Consensus 123 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 197 (426)
+.||+|+||+||+|.+. .++.||||++...... ..+.|.+|+++|++++|||||+++++|.+ +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 36999999999999864 3457999999754322 23579999999999999999999999865 467899999999
Q ss_pred CChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC----Cc
Q 014352 198 GSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG----RN 273 (426)
Q Consensus 198 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~----~~ 273 (426)
|+|.+++.. ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 92 g~L~~~l~~-~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 167 (277)
T d1xbba_ 92 GPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167 (277)
T ss_dssp EEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred CcHHHHHhh-ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence 999999854 456999999999999999999999998 9999999999999999999999999998543222 22
Q ss_pred ccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHH
Q 014352 274 SGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRE 352 (426)
Q Consensus 274 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (426)
....||+.|||||.+.+..++.++|||||||++|||+| |..||.+......... +........+...+.+
T Consensus 168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~---------i~~~~~~~~p~~~~~~ 238 (277)
T d1xbba_ 168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM---------LEKGERMGCPAGCPRE 238 (277)
T ss_dssp ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH---------HHTTCCCCCCTTCCHH
T ss_pred cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHH---------HHcCCCCCCCcccCHH
Confidence 34568999999999999999999999999999999998 8999986543322211 1112222233345578
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 014352 353 LARIGHKCLHKTPRKRPSIGEVTQALLKIKQ 383 (426)
Q Consensus 353 l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 383 (426)
+.+|+.+||+.||++|||+.+|++.|+..-.
T Consensus 239 ~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 239 MYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 9999999999999999999999998877644
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-54 Score=394.74 Aligned_cols=246 Identities=23% Similarity=0.397 Sum_probs=197.9
Q ss_pred hhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC--ccChHHHHHHHHHHhcCCCCceeeEEeEEEe----CCeEEEEE
Q 014352 120 NFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS--HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVD----KGKYMLIY 192 (426)
Q Consensus 120 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~ 192 (426)
.+.+.||+|+||+||+|++. ++..||+|.+.... ....+.|.+|+++|++++|||||++++++.+ .+.+++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 45668999999999999976 67899999986542 2234578999999999999999999999875 34689999
Q ss_pred EecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEec-CCCcEEEeeecCccccccCC
Q 014352 193 EFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLD-HFMRAKVADFGLSKEEVFDG 271 (426)
Q Consensus 193 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfgl~~~~~~~~ 271 (426)
||+++|+|.+++... ..+++..+..++.|++.||.|||+++ ++|+||||||+|||++ +++.+||+|||+++... ..
T Consensus 92 E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~-~~ 168 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR-AS 168 (270)
T ss_dssp ECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC-TT
T ss_pred eCCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceecc-CC
Confidence 999999999999654 46999999999999999999999976 5699999999999997 57899999999997532 23
Q ss_pred CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHh-hccccchhhhhhhhhcccCCHHHH
Q 014352 272 RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLA-SMSQDGVDEILDKQLVGACNIQEV 350 (426)
Q Consensus 272 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 350 (426)
......||+.|||||++.+ .++.++|||||||++|||++|+.||........+. .+....... .. +...+
T Consensus 169 ~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~----~~----~~~~~ 239 (270)
T d1t4ha_ 169 FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA----SF----DKVAI 239 (270)
T ss_dssp SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG----GG----GGCCC
T ss_pred ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCc----cc----CccCC
Confidence 3456789999999999865 69999999999999999999999997533222211 111111111 11 11123
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 351 RELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 351 ~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
.++.+++.+||+.||++|||+.|++++
T Consensus 240 ~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 240 PEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 568899999999999999999999874
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-54 Score=400.63 Aligned_cols=250 Identities=25% Similarity=0.392 Sum_probs=194.0
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCcc--ChHHHHHHHHHHhcCCCCceeeEEeEEEe--CCeEEEEEE
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQ--GEKEFQTEVSLLGRLHHRNLVNLIGYCVD--KGKYMLIYE 193 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e 193 (426)
|++.+.||+|+||+||+|+.. +|+.||+|.+...... ..+.+.+|+++|++++|||||++++++.+ .+.+|+|||
T Consensus 6 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmE 85 (269)
T d2java1 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME 85 (269)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEE
T ss_pred CEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEe
Confidence 667789999999999999875 7889999998765322 23568899999999999999999999865 456899999
Q ss_pred ecCCCChhHHhhh---ccCCCCHHHHHHHHHHHHHHHHHHHcCCC--CCeeecCCCCCCEEecCCCcEEEeeecCccccc
Q 014352 194 FMSNGSLSNLIYS---EERVLNWEERLQIALDISHGIEYLHEGAV--PPVIHRDLKSANILLDHFMRAKVADFGLSKEEV 268 (426)
Q Consensus 194 ~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~--~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 268 (426)
|+++|+|.+++.. ....+++..++.++.|++.||.|||+++. .+|+||||||+|||++.++.+||+|||+++...
T Consensus 86 y~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~ 165 (269)
T d2java1 86 YCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN 165 (269)
T ss_dssp CCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-
T ss_pred cCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecc
Confidence 9999999999854 24579999999999999999999998641 349999999999999999999999999998644
Q ss_pred cCC-CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCH
Q 014352 269 FDG-RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNI 347 (426)
Q Consensus 269 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (426)
... ......||+.|||||++.+..|+.++|||||||++|||+||..||...........+.. .. ....+.
T Consensus 166 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~--------~~-~~~~~~ 236 (269)
T d2java1 166 HDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE--------GK-FRRIPY 236 (269)
T ss_dssp ----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH--------TC-CCCCCT
T ss_pred cCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHc--------CC-CCCCCc
Confidence 322 33457899999999999999999999999999999999999999976433322211111 11 111223
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 348 QEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 348 ~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
..++++.+++.+||+.||.+|||+.|++++
T Consensus 237 ~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 237 RYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 345689999999999999999999999864
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-54 Score=411.37 Aligned_cols=252 Identities=28% Similarity=0.511 Sum_probs=205.2
Q ss_pred HHhhhhcccccCCCeeEEEEEeCC-C-----cEEEEEEeccCC-ccChHHHHHHHHHHhcC-CCCceeeEEeEEEeCCeE
Q 014352 117 ATQNFTNILGQGAFGPVYKATMPS-G-----GVAAIKVLASDS-HQGEKEFQTEVSLLGRL-HHRNLVNLIGYCVDKGKY 188 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 188 (426)
..+.+.+.||+|+||+||+|++.. + ..||+|.+.... ......+.+|+.+|.++ +|||||++++++.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 456788899999999999998643 2 268999986543 23346789999999998 899999999999999999
Q ss_pred EEEEEecCCCChhHHhhhcc----------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCC
Q 014352 189 MLIYEFMSNGSLSNLIYSEE----------------------RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSA 246 (426)
Q Consensus 189 ~lv~e~~~~gsL~~~l~~~~----------------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~ 246 (426)
++||||+++|+|.++|.... ..+++..++.++.|++.||.|||+++ |+||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCchh
Confidence 99999999999999996542 35899999999999999999999998 999999999
Q ss_pred CEEecCCCcEEEeeecCccccccCCC---cccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHH
Q 014352 247 NILLDHFMRAKVADFGLSKEEVFDGR---NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEY 322 (426)
Q Consensus 247 Nill~~~~~~kl~Dfgl~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~ 322 (426)
|||++.++.+||+|||+|+....... .....||+.|||||++.+..++.++|||||||++|||+| |..||.+....
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999986443332 234568999999999999999999999999999999998 89999763322
Q ss_pred HHHhhccccchhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 014352 323 VNLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALL 379 (426)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~ 379 (426)
..+ ..++........+...+.++.+|+.+||+.||++|||++||+++|.
T Consensus 274 ~~~--------~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 274 ANF--------YKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp HHH--------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHH--------HHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 111 1222222222333445578999999999999999999999999985
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.4e-54 Score=404.55 Aligned_cols=251 Identities=24% Similarity=0.365 Sum_probs=191.9
Q ss_pred HHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc-cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEe
Q 014352 117 ATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH-QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEF 194 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 194 (426)
..|++.+.||+|+||+||+|+.. +++.||||++..... .....+.+|+.+|++++|||||++++++.+++.+|+||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~ 88 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL 88 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 44778899999999999999975 788999999975532 2345688999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEec---CCCcEEEeeecCccccccCC
Q 014352 195 MSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLD---HFMRAKVADFGLSKEEVFDG 271 (426)
Q Consensus 195 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfgl~~~~~~~~ 271 (426)
++||+|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++ +++.+||+|||+++......
T Consensus 89 ~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~ 164 (307)
T d1a06a_ 89 VSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 164 (307)
T ss_dssp CCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred cCCCcHHHhhhc-ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence 999999999965 456999999999999999999999999 99999999999995 57899999999998655455
Q ss_pred CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHH
Q 014352 272 RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVR 351 (426)
Q Consensus 272 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (426)
......||+.|||||++.+..|+.++|||||||++|||++|..||.+.........+..... ..........+.
T Consensus 165 ~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~------~~~~~~~~~~s~ 238 (307)
T d1a06a_ 165 VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEY------EFDSPYWDDISD 238 (307)
T ss_dssp --------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCC------CCCTTTTTTSCH
T ss_pred eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCC------CCCCccccCCCH
Confidence 55667899999999999999999999999999999999999999976443322221111110 011111223456
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 352 ELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 352 ~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
++.+++.+||+.||++|||+.|++++
T Consensus 239 ~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 239 SAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 79999999999999999999999875
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-54 Score=399.97 Aligned_cols=252 Identities=27% Similarity=0.434 Sum_probs=203.4
Q ss_pred HHhhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecC
Q 014352 117 ATQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMS 196 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 196 (426)
..+.+.+.||+|+||+||+|+++++..||||++.... ...+.|.+|+.++++++|||||+++++|.+ +..++||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence 4577889999999999999999888889999997543 456789999999999999999999999854 56899999999
Q ss_pred CCChhHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC--Cc
Q 014352 197 NGSLSNLIYSEE-RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG--RN 273 (426)
Q Consensus 197 ~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~--~~ 273 (426)
+|+|..++.... ..++|.+++.++.||+.||.|||+++ |+||||||+|||+|.++.+||+|||+++...... ..
T Consensus 95 ~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 171 (285)
T d1fmka3 95 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 171 (285)
T ss_dssp TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred CCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCceee
Confidence 999999986543 56999999999999999999999998 9999999999999999999999999998543222 23
Q ss_pred ccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCc-hHHHHHHhhccccchhhhhhhhhcccCCHHHHHH
Q 014352 274 SGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQN-LMEYVNLASMSQDGVDEILDKQLVGACNIQEVRE 352 (426)
Q Consensus 274 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (426)
....||+.|+|||++.++.++.++||||||+++|||+||..|+.. ......+.. +........+...+.+
T Consensus 172 ~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~---------i~~~~~~~~~~~~~~~ 242 (285)
T d1fmka3 172 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ---------VERGYRMPCPPECPES 242 (285)
T ss_dssp ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH---------HHTTCCCCCCTTSCHH
T ss_pred ccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHH---------HHhcCCCCCCcccCHH
Confidence 346789999999999999999999999999999999997666533 222211111 1112222333445578
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 014352 353 LARIGHKCLHKTPRKRPSIGEVTQALLKIK 382 (426)
Q Consensus 353 l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 382 (426)
+.+++.+||+.||++|||+.+|++.|+...
T Consensus 243 l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 243 LHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred HHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 999999999999999999999998887644
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-53 Score=401.38 Aligned_cols=246 Identities=25% Similarity=0.349 Sum_probs=203.7
Q ss_pred HHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccC---hHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEE
Q 014352 117 ATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQG---EKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIY 192 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 192 (426)
..|...+.||+|+||+||+|+.. +++.||||++....... .+.+.+|+++|++++|||||++++++.+++..|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 34677789999999999999975 78899999987654322 246889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCC
Q 014352 193 EFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGR 272 (426)
Q Consensus 193 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 272 (426)
|||++|+|..++. ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++... .
T Consensus 95 E~~~~g~l~~~~~-~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~---~ 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA---P 167 (309)
T ss_dssp ECCSEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSS---S
T ss_pred EecCCCchHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccC---C
Confidence 9999999976654 4456999999999999999999999999 9999999999999999999999999998543 2
Q ss_pred cccCccccCccCcccccc---CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHH
Q 014352 273 NSGLKGTYGYIDPAYIST---NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQE 349 (426)
Q Consensus 273 ~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (426)
.....||+.|||||++.+ ..|+.++|||||||++|||++|..||.+......+..+... ......+...
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~--------~~~~~~~~~~ 239 (309)
T d1u5ra_ 168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--------ESPALQSGHW 239 (309)
T ss_dssp BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS--------CCCCCSCTTS
T ss_pred CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC--------CCCCCCCCCC
Confidence 345679999999999864 46899999999999999999999999765443322221111 1111122234
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 350 VRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 350 ~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
+..+.+++.+||+.||++|||+.|++++
T Consensus 240 s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 240 SEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 5679999999999999999999999875
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=8.2e-54 Score=408.75 Aligned_cols=251 Identities=23% Similarity=0.329 Sum_probs=212.1
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecC
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMS 196 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 196 (426)
.|++.+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+.+|+|||||+
T Consensus 27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 106 (350)
T d1koaa2 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 106 (350)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 5778899999999999999975 788999999977655556778999999999999999999999999999999999999
Q ss_pred CCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecC--CCcEEEeeecCccccccCCCcc
Q 014352 197 NGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDH--FMRAKVADFGLSKEEVFDGRNS 274 (426)
Q Consensus 197 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~--~~~~kl~Dfgl~~~~~~~~~~~ 274 (426)
+|+|.+++......+++..+..++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+++.........
T Consensus 107 gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~ 183 (350)
T d1koaa2 107 GGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK 183 (350)
T ss_dssp SCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEE
T ss_pred CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccccccc
Confidence 99999999766667999999999999999999999999 999999999999964 6789999999998765555556
Q ss_pred cCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHH
Q 014352 275 GLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELA 354 (426)
Q Consensus 275 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 354 (426)
...||+.|||||++.+..++.++|||||||++|||++|+.||.+......+..+..... ..........+..+.
T Consensus 184 ~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~------~~~~~~~~~~s~~~~ 257 (350)
T d1koaa2 184 VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDW------NMDDSAFSGISEDGK 257 (350)
T ss_dssp EECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC------CSCCGGGGGCCHHHH
T ss_pred eecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC------CCCcccccCCCHHHH
Confidence 67899999999999999999999999999999999999999976543332222211110 000111122346789
Q ss_pred HHHHHcccCCCCCCCCHHHHHHH
Q 014352 355 RIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 355 ~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
+++.+||+.||++|||+.|++++
T Consensus 258 ~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 258 DFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp HHHHHHCCSSGGGSCCHHHHHHS
T ss_pred HHHHHHccCChhHCcCHHHHhcC
Confidence 99999999999999999999875
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=9.4e-54 Score=408.65 Aligned_cols=251 Identities=24% Similarity=0.359 Sum_probs=213.5
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecC
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMS 196 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 196 (426)
.|++.+.||+|+||+||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++.+|+|||||+
T Consensus 30 ~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 109 (352)
T d1koba_ 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 109 (352)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 3778889999999999999975 789999999987655556678899999999999999999999999999999999999
Q ss_pred CCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEec--CCCcEEEeeecCccccccCCCcc
Q 014352 197 NGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLD--HFMRAKVADFGLSKEEVFDGRNS 274 (426)
Q Consensus 197 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~--~~~~~kl~Dfgl~~~~~~~~~~~ 274 (426)
+|+|.+++......+++.++..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++.........
T Consensus 110 gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~ 186 (352)
T d1koba_ 110 GGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK 186 (352)
T ss_dssp CCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEE
T ss_pred CChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCCcee
Confidence 99999988776667999999999999999999999999 99999999999998 57899999999998765555556
Q ss_pred cCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHH
Q 014352 275 GLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELA 354 (426)
Q Consensus 275 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 354 (426)
...||+.|+|||++.+..++.++|||||||++|||+||..||.+......+..+.... ...........+.++.
T Consensus 187 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~------~~~~~~~~~~~s~~~~ 260 (352)
T d1koba_ 187 VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCD------WEFDEDAFSSVSPEAK 260 (352)
T ss_dssp EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCC------CCCCSSTTTTSCHHHH
T ss_pred eccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC------CCCCcccccCCCHHHH
Confidence 6789999999999999999999999999999999999999998754433322221111 0111112233456789
Q ss_pred HHHHHcccCCCCCCCCHHHHHHH
Q 014352 355 RIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 355 ~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
+|+.+||+.||.+|||+.|++++
T Consensus 261 ~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 261 DFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHccCChhHCcCHHHHhcC
Confidence 99999999999999999999875
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-54 Score=408.29 Aligned_cols=256 Identities=23% Similarity=0.324 Sum_probs=203.6
Q ss_pred HHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCcc-ChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEe
Q 014352 117 ATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQ-GEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEF 194 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 194 (426)
..|++.+.||+|+||+||+|+.. +|+.||+|++...... ....+.+|+.+|++++|||||+++++|.+.+.+++||||
T Consensus 6 d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy 85 (322)
T d1s9ja_ 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 85 (322)
T ss_dssp GGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 34667789999999999999975 7889999999765332 245789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCc
Q 014352 195 MSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEG-AVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRN 273 (426)
Q Consensus 195 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 273 (426)
+++|+|.+++.+. ..+++..+..++.|++.||.|||++ + |+||||||+|||++.++.+||+|||+|+.... ...
T Consensus 86 ~~gg~L~~~l~~~-~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~-~~~ 160 (322)
T d1s9ja_ 86 MDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMA 160 (322)
T ss_dssp CTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-HTC
T ss_pred CCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC-Ccc
Confidence 9999999999655 4599999999999999999999974 7 99999999999999999999999999985433 233
Q ss_pred ccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhh----cc--------------------
Q 014352 274 SGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLAS----MS-------------------- 329 (426)
Q Consensus 274 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~----~~-------------------- 329 (426)
....||+.|||||++.+..|+.++|||||||++|||++|+.||........... ..
T Consensus 161 ~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (322)
T d1s9ja_ 161 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSY 240 (322)
T ss_dssp ---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------------
T ss_pred ccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccccc
Confidence 456899999999999999999999999999999999999999965321100000 00
Q ss_pred ------ccchhhhhhhhhcc----cCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 330 ------QDGVDEILDKQLVG----ACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 330 ------~~~~~~~~~~~~~~----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
.....+..+..... ......+.++.+++.+||+.||++|||+.|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 241 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp -----CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 00000011100000 0111234678999999999999999999999986
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-54 Score=396.28 Aligned_cols=258 Identities=23% Similarity=0.363 Sum_probs=202.4
Q ss_pred HHHhhhhcccccCCCeeEEEEEeCC----CcEEEEEEeccCCccC-hHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEE
Q 014352 116 KATQNFTNILGQGAFGPVYKATMPS----GGVAAIKVLASDSHQG-EKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYML 190 (426)
Q Consensus 116 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 190 (426)
...+++.+.||+|+||.||+|++.. +..||||.+....... .+.|.+|+.+|++++|||||++++++. .+..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 3457788999999999999998642 3468899886543332 357999999999999999999999986 467899
Q ss_pred EEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC
Q 014352 191 IYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD 270 (426)
Q Consensus 191 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 270 (426)
||||+++|+|.+++......+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161 (273)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheeccCC
Confidence 99999999999998777778999999999999999999999999 999999999999999999999999999854322
Q ss_pred C--CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCCH
Q 014352 271 G--RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNI 347 (426)
Q Consensus 271 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (426)
. ......||+.|+|||++.+..++.++|||||||++|||+| |.+||...........+ ........+.
T Consensus 162 ~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i---------~~~~~~~~~~ 232 (273)
T d1mp8a_ 162 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI---------ENGERLPMPP 232 (273)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH---------HTTCCCCCCT
T ss_pred cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHH---------HcCCCCCCCC
Confidence 2 2344568999999999999999999999999999999998 89998764332221111 1111122333
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHhh
Q 014352 348 QEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRHL 386 (426)
Q Consensus 348 ~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~ 386 (426)
..+..+.+|+.+||+.||++|||+.+|+++|+.+.+...
T Consensus 233 ~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~k 271 (273)
T d1mp8a_ 233 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 271 (273)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhh
Confidence 455789999999999999999999999999998876543
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-53 Score=396.19 Aligned_cols=247 Identities=26% Similarity=0.342 Sum_probs=204.8
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC---ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEe
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS---HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEF 194 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 194 (426)
|++.+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|+++|++++|||||++++++.+++.+|+||||
T Consensus 10 y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy 89 (288)
T d1uu3a_ 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 89 (288)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECC
T ss_pred CEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEc
Confidence 678899999999999999975 78899999986432 22346789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC---C
Q 014352 195 MSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD---G 271 (426)
Q Consensus 195 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~---~ 271 (426)
+++|+|.+++... +.+++..+..++.|++.||.|||+++ |+||||||+|||+++++.+||+|||+++..... .
T Consensus 90 ~~gg~L~~~~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~ 165 (288)
T d1uu3a_ 90 AKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 165 (288)
T ss_dssp CTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred cCCCCHHHhhhcc-CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccCCccc
Confidence 9999999988654 45999999999999999999999999 999999999999999999999999999864322 2
Q ss_pred CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHH
Q 014352 272 RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVR 351 (426)
Q Consensus 272 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (426)
......||+.|||||++.+..|+.++|||||||++|||++|..||...........+.... . ..+...+.
T Consensus 166 ~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~--------~--~~p~~~s~ 235 (288)
T d1uu3a_ 166 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE--------Y--DFPEKFFP 235 (288)
T ss_dssp ----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC--------C--CCCTTCCH
T ss_pred ccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCC--------C--CCCccCCH
Confidence 2345679999999999999999999999999999999999999998654433222211111 0 11223446
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 014352 352 ELARIGHKCLHKTPRKRPSIGEVTQALL 379 (426)
Q Consensus 352 ~l~~l~~~cl~~~p~~RPs~~evl~~L~ 379 (426)
++.+|+.+||+.||++|||++|++.+..
T Consensus 236 ~~~~li~~~L~~dP~~R~t~~e~~~~~~ 263 (288)
T d1uu3a_ 236 KARDLVEKLLVLDATKRLGCEEMEGYGP 263 (288)
T ss_dssp HHHHHHHTTSCSSGGGSTTSGGGTCHHH
T ss_pred HHHHHHHHHccCCHhHCcCHHHHcCCHH
Confidence 7899999999999999999999876544
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-53 Score=392.09 Aligned_cols=249 Identities=29% Similarity=0.469 Sum_probs=200.2
Q ss_pred hhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEe-CCeEEEEEEecCC
Q 014352 119 QNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVD-KGKYMLIYEFMSN 197 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~ 197 (426)
+.+.+.||+|+||.||+|++ .|..||||+++.+ ...+.|.+|++++++++||||++++|+|.+ .+.+++||||+++
T Consensus 9 ~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~ 85 (262)
T d1byga_ 9 LKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 85 (262)
T ss_dssp EEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTT
T ss_pred eEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCC
Confidence 56778999999999999998 5778999999754 345689999999999999999999999865 4568999999999
Q ss_pred CChhHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCcccC
Q 014352 198 GSLSNLIYSEE-RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNSGL 276 (426)
Q Consensus 198 gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~ 276 (426)
|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+|++|||+++... ......
T Consensus 86 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~--~~~~~~ 160 (262)
T d1byga_ 86 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS--STQDTG 160 (262)
T ss_dssp EEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-------------
T ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecC--CCCccc
Confidence 99999996543 45899999999999999999999998 9999999999999999999999999998543 233445
Q ss_pred ccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHHH
Q 014352 277 KGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELAR 355 (426)
Q Consensus 277 ~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 355 (426)
.+|..|+|||++.+..++.++||||||+++|||+| |+.||......... ..+........+...+.++.+
T Consensus 161 ~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~---------~~i~~~~~~~~~~~~~~~~~~ 231 (262)
T d1byga_ 161 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV---------PRVEKGYKMDAPDGCPPAVYE 231 (262)
T ss_dssp -CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH---------HHHTTTCCCCCCTTCCHHHHH
T ss_pred cccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHH---------HHHHcCCCCCCCccCCHHHHH
Confidence 68899999999999999999999999999999998 68887653222111 111222222333344578999
Q ss_pred HHHHcccCCCCCCCCHHHHHHHHHHHHHH
Q 014352 356 IGHKCLHKTPRKRPSIGEVTQALLKIKQR 384 (426)
Q Consensus 356 l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 384 (426)
++.+||+.||++|||+.+++++|+.++..
T Consensus 232 li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 232 VMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 99999999999999999999999998753
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-53 Score=394.99 Aligned_cols=251 Identities=25% Similarity=0.376 Sum_probs=208.6
Q ss_pred HHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc------cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEE
Q 014352 117 ATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH------QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYM 189 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 189 (426)
.+|++.+.||+|+||+||+|+.. +|+.||||++..... ...+.+.+|+.+|++++|||||++++++.+.+.+|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 35778899999999999999975 788999999865421 23467999999999999999999999999999999
Q ss_pred EEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCC----cEEEeeecCcc
Q 014352 190 LIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFM----RAKVADFGLSK 265 (426)
Q Consensus 190 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfgl~~ 265 (426)
+|||||++|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++ .+|++|||++.
T Consensus 90 iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEcCCCccccchhccc-cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhhhh
Confidence 999999999999999654 46999999999999999999999999 99999999999998876 49999999998
Q ss_pred ccccCCCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccC
Q 014352 266 EEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGAC 345 (426)
Q Consensus 266 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (426)
............||+.|+|||++.+..++.++|||||||++|||++|..||.+......+..+...... .....
T Consensus 166 ~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~--~~~~~---- 239 (293)
T d1jksa_ 166 KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE--FEDEY---- 239 (293)
T ss_dssp ECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCC--CCHHH----
T ss_pred hcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC--CCchh----
Confidence 765555566678999999999999999999999999999999999999999865443332222111100 00000
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 346 NIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 346 ~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
+...+..+.+++.+||+.||++|||+.|++++
T Consensus 240 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 240 FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01233578899999999999999999999864
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-52 Score=396.21 Aligned_cols=253 Identities=26% Similarity=0.404 Sum_probs=205.1
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCc----EEEEEEeccC-CccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEE
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGG----VAAIKVLASD-SHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIY 192 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 192 (426)
|++.+.||+|+||+||+|.+. +|+ .||+|.+... .....+.|.+|+.++++++|||||+++|+|.++ ..++++
T Consensus 11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~ 89 (317)
T d1xkka_ 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT 89 (317)
T ss_dssp EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEE
T ss_pred CEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEE
Confidence 667789999999999999875 443 5889988654 334457899999999999999999999999875 567889
Q ss_pred EecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC-
Q 014352 193 EFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG- 271 (426)
Q Consensus 193 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~- 271 (426)
||+.+|+|.+.+......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 90 e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~ 166 (317)
T d1xkka_ 90 QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 166 (317)
T ss_dssp ECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC
T ss_pred EeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecccccc
Confidence 999999999999887788999999999999999999999998 9999999999999999999999999998543322
Q ss_pred --CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHH
Q 014352 272 --RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQ 348 (426)
Q Consensus 272 --~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (426)
......||+.|+|||++.++.++.++|||||||++|||+| |..||.+.... .+...+........+..
T Consensus 167 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~---------~~~~~i~~~~~~~~p~~ 237 (317)
T d1xkka_ 167 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---------EISSILEKGERLPQPPI 237 (317)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG---------GHHHHHHHTCCCCCCTT
T ss_pred cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH---------HHHHHHHcCCCCCCCcc
Confidence 2234568999999999999999999999999999999998 78888753221 11222222222233344
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHH
Q 014352 349 EVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQR 384 (426)
Q Consensus 349 ~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 384 (426)
.+..+.+++.+||+.||++|||+.+++++|..+...
T Consensus 238 ~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 238 CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred cCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 557899999999999999999999999999988653
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-52 Score=391.96 Aligned_cols=256 Identities=27% Similarity=0.448 Sum_probs=206.2
Q ss_pred hhhcccccCCCeeEEEEEeCCC----cEEEEEEeccCC-ccChHHHHHHHHHHhcCCCCceeeEEeEEEeC-CeEEEEEE
Q 014352 120 NFTNILGQGAFGPVYKATMPSG----GVAAIKVLASDS-HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDK-GKYMLIYE 193 (426)
Q Consensus 120 ~~~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e 193 (426)
+|.++||+|+||+||+|++.++ ..||||.+.... ....+.|.+|+++|++++|||||+++|++.+. +..++|||
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 4567899999999999987432 268999987543 23346799999999999999999999998764 68999999
Q ss_pred ecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC--
Q 014352 194 FMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG-- 271 (426)
Q Consensus 194 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-- 271 (426)
||++|+|.+++......+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 110 ~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred EeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 99999999999877777889999999999999999999998 9999999999999999999999999998543322
Q ss_pred ---CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHH
Q 014352 272 ---RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQ 348 (426)
Q Consensus 272 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (426)
......||+.|+|||.+.+..++.++||||||+++|||+||..||......... ...+........+..
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~--------~~~i~~g~~~~~p~~ 258 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI--------TVYLLQGRRLLQPEY 258 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------C--------HHHHHTTCCCCCCTT
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHH--------HHHHHcCCCCCCccc
Confidence 123356899999999999999999999999999999999988887643221111 111111111122223
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHhh
Q 014352 349 EVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRHL 386 (426)
Q Consensus 349 ~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~ 386 (426)
.++.+.+++.+||+.||++|||+.||+++|+.+.....
T Consensus 259 ~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~ 296 (311)
T d1r0pa_ 259 CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 296 (311)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred CcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhh
Confidence 44679999999999999999999999999999976533
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.6e-53 Score=396.15 Aligned_cols=253 Identities=28% Similarity=0.488 Sum_probs=207.1
Q ss_pred HhhhhcccccCCCeeEEEEEeC------CCcEEEEEEeccCCccC-hHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEE
Q 014352 118 TQNFTNILGQGAFGPVYKATMP------SGGVAAIKVLASDSHQG-EKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYML 190 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 190 (426)
.+++.+.||+|+||+||+|++. +++.||||++....... .++|.+|+.+|++++||||++++++|.+.+..++
T Consensus 14 ~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~ 93 (301)
T d1lufa_ 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCL 93 (301)
T ss_dssp GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEE
T ss_pred HcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEE
Confidence 4567789999999999999864 34689999987654332 4579999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhcc-----------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCC
Q 014352 191 IYEFMSNGSLSNLIYSEE-----------------------RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSAN 247 (426)
Q Consensus 191 v~e~~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~N 247 (426)
+|||+++|+|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+|
T Consensus 94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlKp~N 170 (301)
T d1lufa_ 94 LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRN 170 (301)
T ss_dssp EEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred EEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEcccc
Confidence 999999999999985422 24899999999999999999999998 9999999999
Q ss_pred EEecCCCcEEEeeecCccccccC---CCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCC-CCCCchHHHH
Q 014352 248 ILLDHFMRAKVADFGLSKEEVFD---GRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAI-HPHQNLMEYV 323 (426)
Q Consensus 248 ill~~~~~~kl~Dfgl~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~-~p~~~~~~~~ 323 (426)
||+|.++.+||+|||+++..... .......||+.|+|||.+.+..|+.++|||||||++|||++|. +||.+.....
T Consensus 171 ILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e 250 (301)
T d1lufa_ 171 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250 (301)
T ss_dssp EEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred eEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHH
Confidence 99999999999999999754322 2233467889999999999999999999999999999999985 5776544332
Q ss_pred HHhhccccchhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 014352 324 NLASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIK 382 (426)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 382 (426)
....+... .....+...+.++.+|+.+||+.||++||||.||++.|+++.
T Consensus 251 ~~~~v~~~---------~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 251 VIYYVRDG---------NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp HHHHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHHHHHcC---------CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 22221111 112223344568999999999999999999999999998764
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-52 Score=393.06 Aligned_cols=256 Identities=27% Similarity=0.475 Sum_probs=207.1
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCc--EEEEEEeccC-CccChHHHHHHHHHHhcC-CCCceeeEEeEEEeCCeEEEEEE
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGG--VAAIKVLASD-SHQGEKEFQTEVSLLGRL-HHRNLVNLIGYCVDKGKYMLIYE 193 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 193 (426)
+++.+.||+|+||+||+|++. ++. .||||.+... .....+.|.+|+++|+++ +|||||+++++|.+.+.+++|||
T Consensus 12 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~e 91 (309)
T d1fvra_ 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE 91 (309)
T ss_dssp CEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEE
Confidence 556789999999999999976 443 4788887644 233456799999999999 79999999999999999999999
Q ss_pred ecCCCChhHHhhhc---------------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEE
Q 014352 194 FMSNGSLSNLIYSE---------------ERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKV 258 (426)
Q Consensus 194 ~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 258 (426)
|+++|+|.++|+.. ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||
T Consensus 92 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~kl 168 (309)
T d1fvra_ 92 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKI 168 (309)
T ss_dssp CCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEE
T ss_pred ecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCceEE
Confidence 99999999999643 256999999999999999999999998 999999999999999999999
Q ss_pred eeecCccccccCCCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCC-CCCCchHHHHHHhhccccchhhhh
Q 014352 259 ADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAI-HPHQNLMEYVNLASMSQDGVDEIL 337 (426)
Q Consensus 259 ~Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~ 337 (426)
+|||+++............||..|+|||.+.+..++.++|||||||++|||++|. +||...........+.
T Consensus 169 ~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~-------- 240 (309)
T d1fvra_ 169 ADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-------- 240 (309)
T ss_dssp CCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG--------
T ss_pred ccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHH--------
Confidence 9999998655444455667999999999999999999999999999999999976 4676543322222111
Q ss_pred hhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHhh
Q 014352 338 DKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRHL 386 (426)
Q Consensus 338 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~ 386 (426)
.......+...+.++.+|+.+||+.||++||||.+|+++|+++.+...
T Consensus 241 -~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~ 288 (309)
T d1fvra_ 241 -QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288 (309)
T ss_dssp -GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred -hcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence 111222233455789999999999999999999999999999976543
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-52 Score=383.98 Aligned_cols=252 Identities=25% Similarity=0.391 Sum_probs=197.1
Q ss_pred HhhhhcccccCCCeeEEEEEeC--CC--cEEEEEEeccCCc---cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEE
Q 014352 118 TQNFTNILGQGAFGPVYKATMP--SG--GVAAIKVLASDSH---QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYML 190 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 190 (426)
.+++.+.||+|+||.||+|++. ++ ..||||++..... ...+.|.+|+.+|++++|||||+++|++.++ ..++
T Consensus 9 d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~l 87 (273)
T d1u46a_ 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMKM 87 (273)
T ss_dssp GEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCEE
T ss_pred HeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chhe
Confidence 3667789999999999999864 22 3689999875432 2235799999999999999999999999764 6789
Q ss_pred EEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC
Q 014352 191 IYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD 270 (426)
Q Consensus 191 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 270 (426)
||||+++|+|.+++......+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 88 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~ 164 (273)
T d1u46a_ 88 VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 164 (273)
T ss_dssp EEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred eeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhcccC
Confidence 99999999999998877778999999999999999999999998 999999999999999999999999999864332
Q ss_pred CC----cccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHHhhccccchhhhhhhhhcccC
Q 014352 271 GR----NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNLASMSQDGVDEILDKQLVGAC 345 (426)
Q Consensus 271 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (426)
.. .....|+..|+|||.+.+..++.++||||||+++|||+| |..||.+.........+... ......
T Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~--------~~~~~~ 236 (273)
T d1u46a_ 165 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE--------GERLPR 236 (273)
T ss_dssp CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTS--------CCCCCC
T ss_pred CCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhC--------CCCCCC
Confidence 22 234567889999999999999999999999999999998 89999765443332222111 111122
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 014352 346 NIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKI 381 (426)
Q Consensus 346 ~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~ 381 (426)
+...+..+.+++.+||+.||++|||+.+|++.|.+.
T Consensus 237 ~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 237 PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 233456799999999999999999999999888754
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-51 Score=389.86 Aligned_cols=245 Identities=24% Similarity=0.344 Sum_probs=206.3
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC---ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEe
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS---HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEF 194 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 194 (426)
|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.+|++++||||+++++++.+.+.+|+||||
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey 86 (337)
T d1o6la_ 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 86 (337)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceec
Confidence 667889999999999999975 78999999997532 23346788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccccc-CCCc
Q 014352 195 MSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF-DGRN 273 (426)
Q Consensus 195 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~-~~~~ 273 (426)
+++|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.+|.+||+|||+|+.... ....
T Consensus 87 ~~gg~L~~~~~~~-~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~~ 162 (337)
T d1o6la_ 87 ANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM 162 (337)
T ss_dssp CTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCB
T ss_pred cCCCchhhhhhcc-cCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccCCccc
Confidence 9999999998654 45899999999999999999999999 99999999999999999999999999986433 2344
Q ss_pred ccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHH
Q 014352 274 SGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVREL 353 (426)
Q Consensus 274 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 353 (426)
...+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.........+.... ...+...+.++
T Consensus 163 ~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~----------~~~p~~~s~~~ 232 (337)
T d1o6la_ 163 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE----------IRFPRTLSPEA 232 (337)
T ss_dssp CCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC----------CCCCTTSCHHH
T ss_pred ccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCC----------CCCCccCCHHH
Confidence 56789999999999999999999999999999999999999997644332221111110 11223345678
Q ss_pred HHHHHHcccCCCCCCCC-----HHHHHHH
Q 014352 354 ARIGHKCLHKTPRKRPS-----IGEVTQA 377 (426)
Q Consensus 354 ~~l~~~cl~~~p~~RPs-----~~evl~~ 377 (426)
.+|+.+||+.||.+||+ +.+++++
T Consensus 233 ~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 233 KSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHHHhhccCCchhhcccccccHHHHHcC
Confidence 99999999999999995 7888875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-52 Score=389.74 Aligned_cols=258 Identities=28% Similarity=0.460 Sum_probs=198.3
Q ss_pred HHHhhhhcccccCCCeeEEEEEeC------CCcEEEEEEeccCCc-cChHHHHHHHHHHhcC-CCCceeeEEeEEEeC-C
Q 014352 116 KATQNFTNILGQGAFGPVYKATMP------SGGVAAIKVLASDSH-QGEKEFQTEVSLLGRL-HHRNLVNLIGYCVDK-G 186 (426)
Q Consensus 116 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-~ 186 (426)
...+.+.+.||+|+||.||+|.+. +++.||||++..... ...+.+..|..++.++ +|+||+.+++++.+. +
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 345778899999999999999863 235899999875432 2345678888888777 689999999998765 4
Q ss_pred eEEEEEEecCCCChhHHhhhcc---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEec
Q 014352 187 KYMLIYEFMSNGSLSNLIYSEE---------------RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLD 251 (426)
Q Consensus 187 ~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~ 251 (426)
.+++|||||++|+|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+|||++
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeEC
Confidence 6899999999999999996432 34899999999999999999999998 99999999999999
Q ss_pred CCCcEEEeeecCccccccCC---CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCC-CCCCchHHHHHHhh
Q 014352 252 HFMRAKVADFGLSKEEVFDG---RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAI-HPHQNLMEYVNLAS 327 (426)
Q Consensus 252 ~~~~~kl~Dfgl~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~-~p~~~~~~~~~~~~ 327 (426)
+++.+||+|||+|+...... ......||+.|||||.+.+..++.++|||||||++|||+||. .||........
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~--- 245 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--- 245 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH---
T ss_pred CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH---
Confidence 99999999999997543222 234567999999999999999999999999999999999974 57764321111
Q ss_pred ccccchhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHH
Q 014352 328 MSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQR 384 (426)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 384 (426)
....+........+...+.++.+++.+||+.||++|||+.|++++|+.+.+.
T Consensus 246 -----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 246 -----FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp -----HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----HHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 1111222222223334456799999999999999999999999999988654
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3e-51 Score=386.01 Aligned_cols=243 Identities=23% Similarity=0.350 Sum_probs=204.8
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC---ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEe
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS---HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEF 194 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 194 (426)
|++.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+.+|++++|||||++++++.+++.+|+||||
T Consensus 6 y~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 85 (316)
T d1fota_ 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY 85 (316)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeee
Confidence 667889999999999999975 78999999986432 23346789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCcc
Q 014352 195 MSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRNS 274 (426)
Q Consensus 195 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 274 (426)
++||+|..++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++... ....
T Consensus 86 ~~gg~l~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~--~~~~ 159 (316)
T d1fota_ 86 IEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVP--DVTY 159 (316)
T ss_dssp CCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECS--SCBC
T ss_pred cCCcccccccccc-ccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEec--cccc
Confidence 9999999988544 45889999999999999999999999 9999999999999999999999999998643 2344
Q ss_pred cCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHH
Q 014352 275 GLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELA 354 (426)
Q Consensus 275 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 354 (426)
...||+.|||||++.+..|+.++|||||||++|||++|+.||.+.........+... . ...+...+.++.
T Consensus 160 ~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--------~--~~~p~~~s~~~~ 229 (316)
T d1fota_ 160 TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA--------E--LRFPPFFNEDVK 229 (316)
T ss_dssp CCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC--------C--CCCCTTSCHHHH
T ss_pred cccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcC--------C--CCCCCCCCHHHH
Confidence 678999999999999999999999999999999999999999764433222221111 1 111223446789
Q ss_pred HHHHHcccCCCCCCC-----CHHHHHHH
Q 014352 355 RIGHKCLHKTPRKRP-----SIGEVTQA 377 (426)
Q Consensus 355 ~l~~~cl~~~p~~RP-----s~~evl~~ 377 (426)
+++.+||+.||.+|| |+++++++
T Consensus 230 ~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 230 DLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp HHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 999999999999996 89999875
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-52 Score=387.42 Aligned_cols=257 Identities=26% Similarity=0.441 Sum_probs=206.7
Q ss_pred HHHHhhhhcccccCCCeeEEEEEeCC--------CcEEEEEEeccCCcc-ChHHHHHHHHHHhcC-CCCceeeEEeEEEe
Q 014352 115 QKATQNFTNILGQGAFGPVYKATMPS--------GGVAAIKVLASDSHQ-GEKEFQTEVSLLGRL-HHRNLVNLIGYCVD 184 (426)
Q Consensus 115 ~~~~~~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 184 (426)
....+.+.+.||+|+||.||+|+..+ +..||||++...... ...++.+|...+.++ +|||||+++++|.+
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 34467788999999999999998532 247999999765432 336788899999888 79999999999999
Q ss_pred CCeEEEEEEecCCCChhHHhhhcc---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEE
Q 014352 185 KGKYMLIYEFMSNGSLSNLIYSEE---------------RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANIL 249 (426)
Q Consensus 185 ~~~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil 249 (426)
++..++||||+++|+|.+++.... ..+++.+++.++.|++.||.|||+++ |+||||||+|||
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiL 167 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 167 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeeccccee
Confidence 999999999999999999996442 35899999999999999999999999 999999999999
Q ss_pred ecCCCcEEEeeecCccccccCC---CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHHH
Q 014352 250 LDHFMRAKVADFGLSKEEVFDG---RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVNL 325 (426)
Q Consensus 250 l~~~~~~kl~Dfgl~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~ 325 (426)
++.++.+||+|||+++...... ......+|+.|+|||.+.++.|+.++||||||+++|||++ |.+||.+.......
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~ 247 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 247 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHH
Confidence 9999999999999998654332 2334678999999999999999999999999999999998 78888764433222
Q ss_pred hhccccchhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 014352 326 ASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQ 383 (426)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 383 (426)
. .+........+...+..+.+++.+||+.||++|||+.||++.|+++..
T Consensus 248 ~---------~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 248 K---------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp H---------HHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H---------HHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 1 122222222333445679999999999999999999999999998854
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.1e-51 Score=379.83 Aligned_cols=255 Identities=21% Similarity=0.330 Sum_probs=201.4
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccC---hHHHHHHHHHHhcCCCCceeeEEeEEEeCC----eEE
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQG---EKEFQTEVSLLGRLHHRNLVNLIGYCVDKG----KYM 189 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~ 189 (426)
+|.+.+.||+|+||+||+|... +++.||||++......+ ...|.+|++++++++||||+++++++...+ ..|
T Consensus 8 rY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~ 87 (277)
T d1o6ya_ 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 87 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred eeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEE
Confidence 4677889999999999999974 78899999997654333 346899999999999999999999988754 379
Q ss_pred EEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccccc
Q 014352 190 LIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF 269 (426)
Q Consensus 190 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 269 (426)
+||||++||+|.+++... +.+++.++..++.|++.||.|||+++ |+||||||+|||++.++..+++|||.+.....
T Consensus 88 lvmE~~~g~~L~~~~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 88 IVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIAD 163 (277)
T ss_dssp EEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred EEEECCCCCEehhhhccc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhhhcc
Confidence 999999999999988554 46999999999999999999999999 99999999999999999999999998864322
Q ss_pred C----CCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccC
Q 014352 270 D----GRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGAC 345 (426)
Q Consensus 270 ~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (426)
. .......||+.|||||++.+..++.++|||||||++|||+||..||................. ......
T Consensus 164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~------~~~~~~ 237 (277)
T d1o6ya_ 164 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP------IPPSAR 237 (277)
T ss_dssp ---------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC------CCGGGT
T ss_pred ccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCC------CCCchh
Confidence 2 123456799999999999999999999999999999999999999986543322221111110 001111
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHHHHH
Q 014352 346 NIQEVRELARIGHKCLHKTPRKRP-SIGEVTQALLKIK 382 (426)
Q Consensus 346 ~~~~~~~l~~l~~~cl~~~p~~RP-s~~evl~~L~~~~ 382 (426)
....+..+.+++.+||+.||++|| |++++++.|.++.
T Consensus 238 ~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 238 HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp SSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 223446799999999999999999 8999999888774
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.4e-51 Score=379.48 Aligned_cols=250 Identities=23% Similarity=0.319 Sum_probs=206.6
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccC---------hHHHHHHHHHHhcCC-CCceeeEEeEEEeCC
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQG---------EKEFQTEVSLLGRLH-HRNLVNLIGYCVDKG 186 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---------~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~ 186 (426)
.|++.+.||+|+||+||+|+.. +++.+|||++....... .+.+.+|+.++++++ ||||+++++++.+++
T Consensus 4 ~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 83 (277)
T d1phka_ 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT 83 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred cCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCc
Confidence 3667889999999999999974 78899999987653221 135789999999997 999999999999999
Q ss_pred eEEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccc
Q 014352 187 KYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKE 266 (426)
Q Consensus 187 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 266 (426)
..|+||||+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 84 ~~~ivmE~~~~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 159 (277)
T d1phka_ 84 FFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQ 159 (277)
T ss_dssp EEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred ceEEEEEcCCCchHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchheeE
Confidence 999999999999999999654 46999999999999999999999999 99999999999999999999999999987
Q ss_pred cccCCCcccCccccCccCcccccc------CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhh
Q 014352 267 EVFDGRNSGLKGTYGYIDPAYIST------NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQ 340 (426)
Q Consensus 267 ~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (426)
...........||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.........+..... .
T Consensus 160 ~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~------~ 233 (277)
T d1phka_ 160 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY------Q 233 (277)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC------C
T ss_pred ccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCC------C
Confidence 655555566789999999999853 3568899999999999999999999987544333222111110 0
Q ss_pred hcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 341 LVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 341 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
.........+.++.+++.+||+.||++|||+.|++++
T Consensus 234 ~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 234 FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1111122345689999999999999999999999764
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-51 Score=386.73 Aligned_cols=250 Identities=19% Similarity=0.274 Sum_probs=207.8
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecC
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMS 196 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 196 (426)
+|.+.+.||+|+||+||+|... +++.||+|++.... .....+.+|+++|++++|||||++++++.+++.+|+|||||+
T Consensus 6 rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~ 84 (321)
T d1tkia_ 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS 84 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCC
Confidence 3677889999999999999975 78899999997653 234568899999999999999999999999999999999999
Q ss_pred CCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCC--CcEEEeeecCccccccCCCcc
Q 014352 197 NGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHF--MRAKVADFGLSKEEVFDGRNS 274 (426)
Q Consensus 197 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~--~~~kl~Dfgl~~~~~~~~~~~ 274 (426)
||+|.+++...+..+++.++..++.|++.||.|||+++ |+||||||+|||++.+ ..+||+|||+++.........
T Consensus 85 gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~ 161 (321)
T d1tkia_ 85 GLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR 161 (321)
T ss_dssp CCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEE
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccCCccc
Confidence 99999999766667999999999999999999999999 9999999999999854 579999999998654444445
Q ss_pred cCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHHH
Q 014352 275 GLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRELA 354 (426)
Q Consensus 275 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 354 (426)
...+|+.|+|||.+.+..++.++|||||||++|+|++|..||........+..+...... ++... ....+.++.
T Consensus 162 ~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~--~~~~~----~~~~s~~~~ 235 (321)
T d1tkia_ 162 LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYT--FDEEA----FKEISIEAM 235 (321)
T ss_dssp EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC--CCHHH----HTTSCHHHH
T ss_pred ccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--CChhh----ccCCCHHHH
Confidence 667999999999999999999999999999999999999999765443322222111100 00000 012345789
Q ss_pred HHHHHcccCCCCCCCCHHHHHHH
Q 014352 355 RIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 355 ~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
+++.+||+.||.+|||+.|++++
T Consensus 236 ~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 236 DFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHccCChhHCcCHHHHhcC
Confidence 99999999999999999999986
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-51 Score=385.09 Aligned_cols=260 Identities=27% Similarity=0.464 Sum_probs=212.1
Q ss_pred HHHHHhhhhcccccCCCeeEEEEEe------CCCcEEEEEEeccCCcc-ChHHHHHHHHHHhcC-CCCceeeEEeEEEeC
Q 014352 114 IQKATQNFTNILGQGAFGPVYKATM------PSGGVAAIKVLASDSHQ-GEKEFQTEVSLLGRL-HHRNLVNLIGYCVDK 185 (426)
Q Consensus 114 l~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 185 (426)
+....+++.+.||+|+||.||+|++ .++..||||++...... ....|.+|+.+++++ +|||||+++++|.+.
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 4445677889999999999999985 24468999999765433 345789999999999 699999999999999
Q ss_pred CeEEEEEEecCCCChhHHhhhcc-----------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCE
Q 014352 186 GKYMLIYEFMSNGSLSNLIYSEE-----------------RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANI 248 (426)
Q Consensus 186 ~~~~lv~e~~~~gsL~~~l~~~~-----------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Ni 248 (426)
+..++|||||++|+|.+++.... ..+++..+..++.||+.||.|||+++ ++||||||+||
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NI 176 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNI 176 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccc
Confidence 99999999999999999986432 25899999999999999999999999 99999999999
Q ss_pred EecCCCcEEEeeecCccccccCC---CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCchHHHHH
Q 014352 249 LLDHFMRAKVADFGLSKEEVFDG---RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELIT-AIHPHQNLMEYVN 324 (426)
Q Consensus 249 ll~~~~~~kl~Dfgl~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~ 324 (426)
+++.++.+|++|||+++...... ......||+.|+|||.+.+..++.++||||||+++|||+| |.+||.......
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~- 255 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS- 255 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH-
T ss_pred cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH-
Confidence 99999999999999998543322 2234678999999999999999999999999999999999 555554422111
Q ss_pred HhhccccchhhhhhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHH
Q 014352 325 LASMSQDGVDEILDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQR 384 (426)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 384 (426)
....++........+...+..+.+|+.+||+.||++|||+.+|+++|+++..+
T Consensus 256 -------~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 256 -------KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp -------HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------HHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 12223333333333344557899999999999999999999999999877553
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-51 Score=381.43 Aligned_cols=261 Identities=22% Similarity=0.370 Sum_probs=196.7
Q ss_pred hhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHH--HHHHHHHhcCCCCceeeEEeEEEeCC----eEEEEE
Q 014352 119 QNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEF--QTEVSLLGRLHHRNLVNLIGYCVDKG----KYMLIY 192 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~--~~e~~~l~~l~h~niv~~~~~~~~~~----~~~lv~ 192 (426)
+.+.+.||+|+||.||+|++ +|+.||||++.... .+.+ ..|+..+.+++|||||+++++|.+.+ .+++||
T Consensus 5 ~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 5 IVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp EEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred EEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 45667899999999999997 67899999986432 3333 34555566789999999999998754 589999
Q ss_pred EecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCC-----CCCeeecCCCCCCEEecCCCcEEEeeecCcccc
Q 014352 193 EFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGA-----VPPVIHRDLKSANILLDHFMRAKVADFGLSKEE 267 (426)
Q Consensus 193 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 267 (426)
||+++|+|.++|... .++|..++.++.+++.||.|||+.. .++|+||||||+||||+.++.+||+|||+++..
T Consensus 81 Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~ 158 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp ECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred ecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence 999999999999653 5899999999999999999999741 134999999999999999999999999999854
Q ss_pred ccCC-----CcccCccccCccCccccccCC------CCcchhhHHHHHHHHHHHhCCCCCCchHHHHH-Hhhcc--ccch
Q 014352 268 VFDG-----RNSGLKGTYGYIDPAYISTNK------FTMKSDIFSFGVIIFELITAIHPHQNLMEYVN-LASMS--QDGV 333 (426)
Q Consensus 268 ~~~~-----~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~-~~~~~--~~~~ 333 (426)
.... ......||+.|+|||++.+.. ++.++|||||||+||||+||..|+........ ..... ....
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T d1vjya_ 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchH
Confidence 3322 233567999999999987643 56789999999999999999888743211100 00000 0000
Q ss_pred h----hhhhhhhccc-----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHh
Q 014352 334 D----EILDKQLVGA-----CNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRH 385 (426)
Q Consensus 334 ~----~~~~~~~~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~ 385 (426)
. ...+...... ...+....+.+++.+||+.||++|||+.||++.|+++.+..
T Consensus 239 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp HHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence 0 1111111111 12345567999999999999999999999999999998654
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.3e-50 Score=385.09 Aligned_cols=244 Identities=23% Similarity=0.291 Sum_probs=205.9
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC---ccChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEE
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS---HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYE 193 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 193 (426)
.|++.+.||+|+||.||+|++. +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+.+..++|||
T Consensus 42 ~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e 121 (350)
T d1rdqe_ 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccc
Confidence 4677889999999999999975 78999999986432 2234578899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCCCc
Q 014352 194 FMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDGRN 273 (426)
Q Consensus 194 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 273 (426)
|+.+|+|..++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++... ...
T Consensus 122 ~~~~g~l~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~--~~~ 195 (350)
T d1rdqe_ 122 YVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT 195 (350)
T ss_dssp CCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECS--SCB
T ss_pred cccccchhhhHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecc--ccc
Confidence 99999999998655 45999999999999999999999999 9999999999999999999999999998643 334
Q ss_pred ccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHHH
Q 014352 274 SGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVREL 353 (426)
Q Consensus 274 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 353 (426)
....||+.|||||++.+..++.++|||||||++|||+||..||.+.........+.... ...+...+.++
T Consensus 196 ~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~----------~~~p~~~s~~~ 265 (350)
T d1rdqe_ 196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK----------VRFPSHFSSDL 265 (350)
T ss_dssp CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC----------CCCCTTCCHHH
T ss_pred ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCC----------CCCCccCCHHH
Confidence 46789999999999999999999999999999999999999998654333222211111 11122345678
Q ss_pred HHHHHHcccCCCCCC-----CCHHHHHHH
Q 014352 354 ARIGHKCLHKTPRKR-----PSIGEVTQA 377 (426)
Q Consensus 354 ~~l~~~cl~~~p~~R-----Ps~~evl~~ 377 (426)
.+++.+||+.||.+| ||+.+++++
T Consensus 266 ~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp HHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 999999999999999 489999874
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-51 Score=383.73 Aligned_cols=255 Identities=24% Similarity=0.380 Sum_probs=207.9
Q ss_pred HHhhhhcccccCCCeeEEEEEeC------CCcEEEEEEeccCCc-cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEE
Q 014352 117 ATQNFTNILGQGAFGPVYKATMP------SGGVAAIKVLASDSH-QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYM 189 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 189 (426)
..+++.+.||+|+||+||+|.+. ++..||||++..... .....|.+|+.++++++|||||+++++|...+..+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 45667789999999999999863 356899999975432 22346899999999999999999999999999999
Q ss_pred EEEEecCCCChhHHhhhcc---------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEee
Q 014352 190 LIYEFMSNGSLSNLIYSEE---------RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVAD 260 (426)
Q Consensus 190 lv~e~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 260 (426)
+||||+++|+|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEee
Confidence 9999999999999985432 34789999999999999999999998 99999999999999999999999
Q ss_pred ecCccccccCCC---cccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCC-CCCCchHHHHHHhhccccchhhh
Q 014352 261 FGLSKEEVFDGR---NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAI-HPHQNLMEYVNLASMSQDGVDEI 336 (426)
Q Consensus 261 fgl~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~ 336 (426)
||+++....... .....||+.|+|||.+.+..++.++||||||+++|||+||. +||.+......+..+...
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~----- 251 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG----- 251 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT-----
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC-----
Confidence 999985433222 23456899999999999999999999999999999999984 777654433322222111
Q ss_pred hhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 014352 337 LDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQ 383 (426)
Q Consensus 337 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 383 (426)
. ....+...+..+.+++.+||+.||++|||+.+|+++|++..+
T Consensus 252 ---~-~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 252 ---G-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp ---C-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred ---C-CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 1 112223344679999999999999999999999999876543
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=384.88 Aligned_cols=249 Identities=22% Similarity=0.293 Sum_probs=198.5
Q ss_pred hhhh-cccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcC-CCCceeeEEeEEEe----CCeEEEE
Q 014352 119 QNFT-NILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRL-HHRNLVNLIGYCVD----KGKYMLI 191 (426)
Q Consensus 119 ~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~----~~~~~lv 191 (426)
|.+. +.||+|+||+||+|+.. +++.||||++.. ...+.+|+.++.++ +|||||++++++.+ .+.+|+|
T Consensus 13 y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~iv 87 (335)
T d2ozaa1 13 YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV 87 (335)
T ss_dssp EEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEE
Confidence 5554 46999999999999974 788999999853 34677899987654 89999999999876 3568999
Q ss_pred EEecCCCChhHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecC---CCcEEEeeecCcccc
Q 014352 192 YEFMSNGSLSNLIYSEE-RVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDH---FMRAKVADFGLSKEE 267 (426)
Q Consensus 192 ~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfgl~~~~ 267 (426)
||||+||+|.+++...+ ..+++.++..++.|++.||.|||+++ |+||||||+|||++. ++.+||+|||+++..
T Consensus 88 mEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~ 164 (335)
T d2ozaa1 88 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 164 (335)
T ss_dssp EECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccceeeec
Confidence 99999999999997643 56999999999999999999999999 999999999999986 567999999999876
Q ss_pred ccCCCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCH
Q 014352 268 VFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNI 347 (426)
Q Consensus 268 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (426)
..........||+.|||||++.+..|+.++|||||||++|+|+||+.||.+.........+....... ...+......
T Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~--~~~~~~~~~~ 242 (335)
T d2ozaa1 165 TSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG--QYEFPNPEWS 242 (335)
T ss_dssp CCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSC--SSSCCTTHHH
T ss_pred cCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcC--CCCCCCcccc
Confidence 55556667789999999999999999999999999999999999999997533211111110000000 0000001112
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 348 QEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 348 ~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
..+.++.+|+.+||+.||++|||+.|++++
T Consensus 243 ~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 243 EVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp HSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 345679999999999999999999999886
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.9e-50 Score=385.45 Aligned_cols=245 Identities=26% Similarity=0.349 Sum_probs=197.4
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC---ccChHHHHH---HHHHHhcCCCCceeeEEeEEEeCCeEEEE
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS---HQGEKEFQT---EVSLLGRLHHRNLVNLIGYCVDKGKYMLI 191 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~---e~~~l~~l~h~niv~~~~~~~~~~~~~lv 191 (426)
|.+.+.||+|+||.||+|+.. +|+.||||++.... ......+.+ ++.+++.++|||||++++++.+.+.+|+|
T Consensus 6 y~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~iv 85 (364)
T d1omwa3 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI 85 (364)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred CeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEE
Confidence 567789999999999999975 78999999986432 122233444 47778888999999999999999999999
Q ss_pred EEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC
Q 014352 192 YEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG 271 (426)
Q Consensus 192 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 271 (426)
|||+++|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+.... .
T Consensus 86 mE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~-~ 160 (364)
T d1omwa3 86 LDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK-K 160 (364)
T ss_dssp ECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEECSS-S
T ss_pred EEecCCCcHHHHHHhc-ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeecCC-C
Confidence 9999999999999654 45899999999999999999999999 99999999999999999999999999985432 3
Q ss_pred CcccCccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhh--cccCCHH
Q 014352 272 RNSGLKGTYGYIDPAYIST-NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQL--VGACNIQ 348 (426)
Q Consensus 272 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 348 (426)
......||+.|+|||++.. ..|+.++|||||||++|||+||+.||...... ....+..... ....+..
T Consensus 161 ~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~---------~~~~~~~~~~~~~~~~~~~ 231 (364)
T d1omwa3 161 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK---------DKHEIDRMTLTMAVELPDS 231 (364)
T ss_dssp CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS---------CHHHHHHHSSSCCCCCCSS
T ss_pred cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH---------HHHHHHHhcccCCCCCCCC
Confidence 3456689999999999964 56899999999999999999999999753211 0011111111 1111223
Q ss_pred HHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 014352 349 EVRELARIGHKCLHKTPRKRPS-----IGEVTQA 377 (426)
Q Consensus 349 ~~~~l~~l~~~cl~~~p~~RPs-----~~evl~~ 377 (426)
.+.++.+++.+||+.||++||| +++++++
T Consensus 232 ~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 232 FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp SCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred CCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 4567999999999999999999 6888764
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-50 Score=380.64 Aligned_cols=244 Identities=27% Similarity=0.407 Sum_probs=201.4
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC---ccChHHHHHHHHHHh-cCCCCceeeEEeEEEeCCeEEEEEE
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS---HQGEKEFQTEVSLLG-RLHHRNLVNLIGYCVDKGKYMLIYE 193 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~~~~~~lv~e 193 (426)
|.+.+.||+|+||+||+|+.. +++.||||++.... ....+.+..|..++. .++|||||++++++.+++.+|+|||
T Consensus 4 y~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmE 83 (320)
T d1xjda_ 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME 83 (320)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEe
Confidence 667889999999999999975 78899999996532 223345667777665 6899999999999999999999999
Q ss_pred ecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC-CC
Q 014352 194 FMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD-GR 272 (426)
Q Consensus 194 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-~~ 272 (426)
|+++|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..... ..
T Consensus 84 y~~~g~L~~~i~~~-~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~ 159 (320)
T d1xjda_ 84 YLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK 159 (320)
T ss_dssp CCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred ecCCCcHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccccccc
Confidence 99999999999654 45899999999999999999999999 999999999999999999999999999854332 33
Q ss_pred cccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccCCHHHHHH
Q 014352 273 NSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGACNIQEVRE 352 (426)
Q Consensus 273 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (426)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.........+.... ...+...+..
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~----------~~~p~~~s~~ 229 (320)
T d1xjda_ 160 TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN----------PFYPRWLEKE 229 (320)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC----------CCCCTTSCHH
T ss_pred ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC----------CCCCccCCHH
Confidence 445689999999999999999999999999999999999999997644332222211110 1112233467
Q ss_pred HHHHHHHcccCCCCCCCCHH-HHHH
Q 014352 353 LARIGHKCLHKTPRKRPSIG-EVTQ 376 (426)
Q Consensus 353 l~~l~~~cl~~~p~~RPs~~-evl~ 376 (426)
+.+|+.+||+.||++|||+. ++++
T Consensus 230 ~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 230 AKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp HHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred HHHHHHHhcccCCCCCcCHHHHHHh
Confidence 89999999999999999995 7765
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-50 Score=377.34 Aligned_cols=251 Identities=24% Similarity=0.310 Sum_probs=194.9
Q ss_pred cccccCCCeeEEEEEeC-CCcEEEEEEeccCCccC-----hHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEecC
Q 014352 123 NILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQG-----EKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFMS 196 (426)
Q Consensus 123 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 196 (426)
++||+|+||+||+|+.. +|+.||||++....... .+.+.+|+.+|++++|||||++++++.+++..|+||||+.
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~ 83 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 83 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence 57999999999999975 78999999986543221 2468899999999999999999999999999999999998
Q ss_pred CCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC-Cccc
Q 014352 197 NGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG-RNSG 275 (426)
Q Consensus 197 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-~~~~ 275 (426)
++++..+. .....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...... ....
T Consensus 84 ~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~ 159 (299)
T d1ua2a_ 84 TDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH 159 (299)
T ss_dssp EEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCC
T ss_pred chHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcccccc
Confidence 87766555 44566899999999999999999999999 9999999999999999999999999997543322 3345
Q ss_pred CccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccc-------cchhhhh---h-hhh--
Q 014352 276 LKGTYGYIDPAYISTN-KFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQ-------DGVDEIL---D-KQL-- 341 (426)
Q Consensus 276 ~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~-------~~~~~~~---~-~~~-- 341 (426)
..||+.|+|||++.+. .|+.++|||||||++|||++|..||.+..+...+..+.. ....... . ...
T Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (299)
T d1ua2a_ 160 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239 (299)
T ss_dssp SCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCC
T ss_pred eecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhcc
Confidence 6799999999998654 679999999999999999999999976544332221110 0000000 0 000
Q ss_pred cccCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 342 VGACN-----IQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 342 ~~~~~-----~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
....+ ...+.++.+|+.+||+.||++|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 00000 1234678999999999999999999999875
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-49 Score=368.45 Aligned_cols=239 Identities=23% Similarity=0.366 Sum_probs=196.7
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCcc------ChHHHHHHHHHHhcCC--CCceeeEEeEEEeCCeE
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQ------GEKEFQTEVSLLGRLH--HRNLVNLIGYCVDKGKY 188 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~ 188 (426)
+|.+.+.||+|+||+||+|+.. +++.||||++...... ....+.+|+.+|++++ |||||++++++.+++..
T Consensus 5 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~ 84 (273)
T d1xwsa_ 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF 84 (273)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEE
T ss_pred eEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeE
Confidence 4778889999999999999975 7899999998654211 1234678999999986 89999999999999999
Q ss_pred EEEEEecCC-CChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecC-CCcEEEeeecCccc
Q 014352 189 MLIYEFMSN-GSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDH-FMRAKVADFGLSKE 266 (426)
Q Consensus 189 ~lv~e~~~~-gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgl~~~ 266 (426)
++||||+.+ +++.+++.. ...+++.++..++.|++.||.|||+++ |+||||||+|||++. ++.+||+|||+++.
T Consensus 85 ~lv~e~~~~~~~l~~~~~~-~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 85 VLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp EEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEeccCcchHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcccccee
Confidence 999999976 577777754 456999999999999999999999999 999999999999985 47999999999975
Q ss_pred cccCCCcccCccccCccCccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcccC
Q 014352 267 EVFDGRNSGLKGTYGYIDPAYISTNKF-TMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVGAC 345 (426)
Q Consensus 267 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (426)
.. ........||+.|+|||++.+..+ +.++|||||||++|||++|..||....+.... .. ..
T Consensus 161 ~~-~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i~~~--------------~~--~~ 223 (273)
T d1xwsa_ 161 LK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG--------------QV--FF 223 (273)
T ss_dssp CC-SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHC--------------CC--CC
T ss_pred cc-cccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHHhhc--------------cc--CC
Confidence 43 334456789999999999987776 56789999999999999999999864322110 00 01
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 346 NIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 346 ~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
+...+.++.+++.+||+.||++|||+.|++++
T Consensus 224 ~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 224 RQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 11234678999999999999999999999864
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-49 Score=370.98 Aligned_cols=256 Identities=24% Similarity=0.277 Sum_probs=198.5
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc--cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEec
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH--QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 195 (426)
|.+.+.||+|+||+||+|++. +++.||+|++..... .....+.+|+++|++++|||||++++++.+++.+|+||||+
T Consensus 4 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~ 83 (298)
T d1gz8a_ 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 83 (298)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeec
Confidence 556789999999999999974 789999999965432 23467899999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccC-CCcc
Q 014352 196 SNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFD-GRNS 274 (426)
Q Consensus 196 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-~~~~ 274 (426)
.++.+..........+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..... ....
T Consensus 84 ~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~ 160 (298)
T d1gz8a_ 84 HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT 160 (298)
T ss_dssp SEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTT
T ss_pred CCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCcccce
Confidence 765444444444567999999999999999999999999 999999999999999999999999999754332 3344
Q ss_pred cCccccCccCccccccCC-CCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhcc------ccc-hhhhh-hh----hh
Q 014352 275 GLKGTYGYIDPAYISTNK-FTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMS------QDG-VDEIL-DK----QL 341 (426)
Q Consensus 275 ~~~gt~~y~aPE~~~~~~-~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~------~~~-~~~~~-~~----~~ 341 (426)
...||+.|+|||.+.... ++.++|||||||++|+|++|+.||.+......+..+. ... ..... .. ..
T Consensus 161 ~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (298)
T d1gz8a_ 161 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 240 (298)
T ss_dssp CCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTS
T ss_pred eecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccccccc
Confidence 567999999999887665 4789999999999999999999997644332221110 000 00000 00 00
Q ss_pred ccc-------CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 342 VGA-------CNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 342 ~~~-------~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
... .....+.++.+++.+||+.||++|||+.|++++
T Consensus 241 ~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp CCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 000 001234678999999999999999999999875
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-49 Score=372.34 Aligned_cols=257 Identities=24% Similarity=0.319 Sum_probs=200.4
Q ss_pred HhhhhcccccCCCeeEEEEEeC-C-CcEEEEEEeccCCc--cChHHHHHHHHHHhcC---CCCceeeEEeEEEe-----C
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-S-GGVAAIKVLASDSH--QGEKEFQTEVSLLGRL---HHRNLVNLIGYCVD-----K 185 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~-----~ 185 (426)
+|++.+.||+|+||+||+|+.. + ++.||||++..... .....+.+|+.+|+.| +||||++++++|.. .
T Consensus 8 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~ 87 (305)
T d1blxa_ 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 87 (305)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSE
T ss_pred CEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccC
Confidence 4777889999999999999974 4 56799999865422 2234566788877665 79999999999864 2
Q ss_pred CeEEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcc
Q 014352 186 GKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSK 265 (426)
Q Consensus 186 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 265 (426)
...+++|||+.++++..........+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 88 ~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 88 TKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp EEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred ceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchhhhh
Confidence 4689999999988776666556677999999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccc----cch--------
Q 014352 266 EEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQ----DGV-------- 333 (426)
Q Consensus 266 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~----~~~-------- 333 (426)
............||+.|+|||++.+..|+.++|||||||++|||++|+.||........+..+.. ...
T Consensus 165 ~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 244 (305)
T d1blxa_ 165 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 244 (305)
T ss_dssp CCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCS
T ss_pred hhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccccccc
Confidence 65555556678899999999999999999999999999999999999999986543322221100 000
Q ss_pred --hhhhhhh---hcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 334 --DEILDKQ---LVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 334 --~~~~~~~---~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
....... .........+..+.+|+.+||+.||++|||+.|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 245 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp SCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred chhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000000 0001112234678899999999999999999999875
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=8.6e-49 Score=365.16 Aligned_cols=256 Identities=23% Similarity=0.292 Sum_probs=198.4
Q ss_pred HhhhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCc--cChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEec
Q 014352 118 TQNFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSH--QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 195 (426)
+|++.+.||+|+||+||+|++.+|+.||||++..... ...+.+.+|+.+|++++|||||++++++.+.+..++++||+
T Consensus 3 ~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~ 82 (286)
T d1ob3a_ 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL 82 (286)
T ss_dssp SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred CceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEee
Confidence 3566789999999999999999999999999976532 22467999999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC-Ccc
Q 014352 196 SNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG-RNS 274 (426)
Q Consensus 196 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-~~~ 274 (426)
.++.+..+. .....++...+..++.|++.||+|||+++ |+||||||+|||++.++.+|++|||++....... ...
T Consensus 83 ~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 158 (286)
T d1ob3a_ 83 DQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT 158 (286)
T ss_dssp SEEHHHHHH-TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred hhhhHHHHH-hhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCccccc
Confidence 876665554 44567999999999999999999999998 9999999999999999999999999987543322 234
Q ss_pred cCccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccc-------cchhhhh-----hhhh
Q 014352 275 GLKGTYGYIDPAYISTN-KFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQ-------DGVDEIL-----DKQL 341 (426)
Q Consensus 275 ~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~-------~~~~~~~-----~~~~ 341 (426)
...+++.|+|||.+.+. .++.++|||||||++|||++|+.||.+..+...+..+.. ....... ....
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T d1ob3a_ 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238 (286)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred eecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccccc
Confidence 45689999999998654 568999999999999999999999976443322211100 0000000 0000
Q ss_pred -------cccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 342 -------VGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 342 -------~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
........+..+.+++.+||+.||++|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 001112234678899999999999999999999864
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=366.86 Aligned_cols=252 Identities=22% Similarity=0.274 Sum_probs=194.9
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEeC------CeEEEE
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVDK------GKYMLI 191 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~~lv 191 (426)
|+..++||+|+||+||+|++. +++.||||++..... .+.+|+++|++++||||+++++++... ..+++|
T Consensus 22 Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 97 (350)
T d1q5ka_ 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 97 (350)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred cEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEE
Confidence 556678999999999999975 789999999976432 234799999999999999999998653 247899
Q ss_pred EEecCCCChhHHhh--hccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCC-cEEEeeecCccccc
Q 014352 192 YEFMSNGSLSNLIY--SEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFM-RAKVADFGLSKEEV 268 (426)
Q Consensus 192 ~e~~~~gsL~~~l~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgl~~~~~ 268 (426)
|||++++.+..+.. .....+++..+..++.|++.||+|||+++ |+||||||+|||++.++ .+||+|||+++...
T Consensus 98 ~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 98 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp EECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred EeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhcc
Confidence 99998764444332 23456999999999999999999999998 99999999999999775 89999999998665
Q ss_pred cCCCcccCccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccc---cchhhhhhh-----
Q 014352 269 FDGRNSGLKGTYGYIDPAYIST-NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQ---DGVDEILDK----- 339 (426)
Q Consensus 269 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~---~~~~~~~~~----- 339 (426)
.........||+.|+|||.+.+ ..++.++|||||||++|||++|+.||........+..+.. ....+....
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~ 254 (350)
T d1q5ka_ 175 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 254 (350)
T ss_dssp TTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC--
T ss_pred CCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccch
Confidence 5555566789999999998765 5789999999999999999999999976443322221110 000000000
Q ss_pred -----------hhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 340 -----------QLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 340 -----------~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
..........+.++.+|+.+||+.||++|||+.|++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 255 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp -CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00001112234678999999999999999999999975
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.5e-47 Score=356.53 Aligned_cols=257 Identities=21% Similarity=0.253 Sum_probs=199.7
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCcee-eEEeEEEeCCeEEEEEEec
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLV-NLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~ 195 (426)
+|.+.+.||+|+||+||+|++. +++.||||++.... ...++..|++++++++|+|++ .+.++..+.+..++||||+
T Consensus 8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~ 85 (299)
T d1ckia_ 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 85 (299)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc
Confidence 4677889999999999999974 78899999987643 234688999999999877655 5556667778899999999
Q ss_pred CCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecC---CCcEEEeeecCccccccCC-
Q 014352 196 SNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDH---FMRAKVADFGLSKEEVFDG- 271 (426)
Q Consensus 196 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfgl~~~~~~~~- 271 (426)
+++|...+......+++..+..++.|++.||+|||+++ |+||||||+|||++. +..+||+|||+|+......
T Consensus 86 -~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (299)
T d1ckia_ 86 -GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 161 (299)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred -CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence 56787777666778999999999999999999999999 999999999999864 5579999999998543322
Q ss_pred -------CcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhhcc-
Q 014352 272 -------RNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQLVG- 343 (426)
Q Consensus 272 -------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 343 (426)
......||+.|||||.+.+..++.++|||||||++|||+||..||............. .........
T Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~-----~~~~~~~~~~ 236 (299)
T d1ckia_ 162 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE-----RISEKKMSTP 236 (299)
T ss_dssp CCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HH-----HHHHHHHHSC
T ss_pred ccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHH-----HhhcccCCCC
Confidence 2234679999999999999999999999999999999999999997643322111100 000000000
Q ss_pred --cCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHh
Q 014352 344 --ACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRH 385 (426)
Q Consensus 344 --~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~ 385 (426)
......+.++.+++..||+.||++||++.++.+.|+.+..+.
T Consensus 237 ~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 237 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 001123367899999999999999999999999988876544
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=8.6e-47 Score=352.37 Aligned_cols=258 Identities=17% Similarity=0.216 Sum_probs=206.3
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCCC-CceeeEEeEEEeCCeEEEEEEec
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHH-RNLVNLIGYCVDKGKYMLIYEFM 195 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~ 195 (426)
+|.+.+.||+|+||+||+|++. +++.||||++.... ....+.+|++.++.++| +|++.+++++......++||||+
T Consensus 6 ~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~ 83 (293)
T d1csna_ 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 83 (293)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec
Confidence 4678889999999999999975 78899999886543 33467889999999975 89999999999999999999999
Q ss_pred CCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecC-----CCcEEEeeecCccccccC
Q 014352 196 SNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDH-----FMRAKVADFGLSKEEVFD 270 (426)
Q Consensus 196 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~-----~~~~kl~Dfgl~~~~~~~ 270 (426)
+++|.+++......+++.++..++.|++.||.|||+++ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 84 -~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~ 159 (293)
T d1csna_ 84 -GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 159 (293)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred -CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEcccC
Confidence 68999999777778999999999999999999999999 999999999999974 578999999999754322
Q ss_pred --------CCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHH---HHhhccccchhhhhhh
Q 014352 271 --------GRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYV---NLASMSQDGVDEILDK 339 (426)
Q Consensus 271 --------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~ 339 (426)
.......||+.|||||.+.+..++.++||||||+++|||+||..||.+..... ....+.... .....+
T Consensus 160 ~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~-~~~~~~ 238 (293)
T d1csna_ 160 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK-QSTPLR 238 (293)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH-HHSCHH
T ss_pred ccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhcc-CCCChH
Confidence 12234679999999999999999999999999999999999999997432111 100000000 000001
Q ss_pred hhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHHhh
Q 014352 340 QLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQALLKIKQRHL 386 (426)
Q Consensus 340 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~ 386 (426)
.+.. ..++++.+++..|++.+|++||+++.+.+.|+.+.++..
T Consensus 239 ~l~~----~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~ 281 (293)
T d1csna_ 239 ELCA----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 281 (293)
T ss_dssp HHTT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HhcC----CCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcC
Confidence 1111 123578999999999999999999999999988765543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.7e-46 Score=355.10 Aligned_cols=250 Identities=18% Similarity=0.289 Sum_probs=197.2
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCC-CCceeeEEeEEEeC--CeEEEEEE
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLH-HRNLVNLIGYCVDK--GKYMLIYE 193 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~e 193 (426)
.|.+.+.||+|+||+||+|+.. +++.||||++... ..+.+.+|+.+|++++ ||||+++++++... ..+++|||
T Consensus 36 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e 112 (328)
T d3bqca1 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112 (328)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence 5778889999999999999974 7889999998653 3567899999999995 99999999999754 56899999
Q ss_pred ecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCC-cEEEeeecCccccccCCC
Q 014352 194 FMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFM-RAKVADFGLSKEEVFDGR 272 (426)
Q Consensus 194 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgl~~~~~~~~~ 272 (426)
|+++++|..+. +.++...+..++.|++.||.|||+++ |+||||||+|||++.++ .+||+|||+++.......
T Consensus 113 ~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~ 185 (328)
T d3bqca1 113 HVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 185 (328)
T ss_dssp CCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC
T ss_pred ecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccCCCc
Confidence 99999997764 45899999999999999999999999 99999999999998655 699999999987655555
Q ss_pred cccCccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCchHHHHH----Hhhc-------------cccc--
Q 014352 273 NSGLKGTYGYIDPAYISTN-KFTMKSDIFSFGVIIFELITAIHPHQNLMEYVN----LASM-------------SQDG-- 332 (426)
Q Consensus 273 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~----~~~~-------------~~~~-- 332 (426)
.....+|+.|+|||.+.+. .++.++||||+||++||+++|+.||........ .... ....
T Consensus 186 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 265 (328)
T d3bqca1 186 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 265 (328)
T ss_dssp CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCG
T ss_pred ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCc
Confidence 6677899999999998765 479999999999999999999999864321110 0000 0000
Q ss_pred -hhhh--------hhhhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 333 -VDEI--------LDKQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 333 -~~~~--------~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
.... .............+.++.+|+.+||+.||++|||++|++++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 266 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp GGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000 00000011112234678999999999999999999999874
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=359.87 Aligned_cols=256 Identities=25% Similarity=0.338 Sum_probs=193.8
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCcc--ChHHHHHHHHHHhcCCCCceeeEEeEEEeCC------eE
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQ--GEKEFQTEVSLLGRLHHRNLVNLIGYCVDKG------KY 188 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~~ 188 (426)
+|.+.+.||+|+||+||+|... +|+.||||++...... ..+.+.+|+++|++++|||||+++++|...+ .+
T Consensus 19 ~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 98 (346)
T d1cm8a_ 19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF 98 (346)
T ss_dssp SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred cEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceE
Confidence 4667789999999999999975 7899999999754322 2356889999999999999999999998654 57
Q ss_pred EEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccc
Q 014352 189 MLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEV 268 (426)
Q Consensus 189 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 268 (426)
++||||+ +++|..++.. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+|++|||+++..
T Consensus 99 ~lv~e~~-~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~- 171 (346)
T d1cm8a_ 99 YLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQA- 171 (346)
T ss_dssp EEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred EEEEecc-cccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccceecc-
Confidence 9999999 5678777643 45999999999999999999999999 999999999999999999999999999854
Q ss_pred cCCCcccCccccCccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccc---cchhh---------
Q 014352 269 FDGRNSGLKGTYGYIDPAYIST-NKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQ---DGVDE--------- 335 (426)
Q Consensus 269 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~---~~~~~--------- 335 (426)
........||+.|+|||.+.+ ..++.++||||+||++|||++|+.||.+......+..... .....
T Consensus 172 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (346)
T d1cm8a_ 172 -DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250 (346)
T ss_dssp -CSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHH
T ss_pred -CCccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchh
Confidence 334456789999999999876 4568999999999999999999999976543322211100 00000
Q ss_pred --hhhhhhc-------ccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHH
Q 014352 336 --ILDKQLV-------GACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA--LLKI 381 (426)
Q Consensus 336 --~~~~~~~-------~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~--L~~~ 381 (426)
....... .......+..+.+|+.+||..||++|||+.|++++ ++.+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 251 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred hhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 0000000 01112234578899999999999999999999986 4444
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-46 Score=354.09 Aligned_cols=257 Identities=25% Similarity=0.313 Sum_probs=193.3
Q ss_pred HHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCC--ccChHHHHHHHHHHhcCCCCceeeEEeEEEe--------C
Q 014352 117 ATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDS--HQGEKEFQTEVSLLGRLHHRNLVNLIGYCVD--------K 185 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--------~ 185 (426)
.+|.+.+.||+|+||+||+|++. +|+.||||++.... ......+.+|+.+|++++||||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 34677889999999999999975 78999999986542 2334678899999999999999999999865 3
Q ss_pred CeEEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcc
Q 014352 186 GKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSK 265 (426)
Q Consensus 186 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 265 (426)
+..++||||+.++.+.... .....++...+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 90 ~~~~iv~e~~~~~~~~~~~-~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp -CEEEEEECCCEEHHHHHT-CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ceEEEEEeccCCCccchhh-hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecceee
Confidence 4689999999876665443 44556899999999999999999999998 9999999999999999999999999997
Q ss_pred ccccC-----CCcccCccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccc-------cc
Q 014352 266 EEVFD-----GRNSGLKGTYGYIDPAYISTN-KFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQ-------DG 332 (426)
Q Consensus 266 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~-------~~ 332 (426)
..... .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||.+.........+.. ..
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 245 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence 43321 122345799999999998765 689999999999999999999999976433322111100 00
Q ss_pred --------hhhhhhhhhcccCCH-------HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 333 --------VDEILDKQLVGACNI-------QEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 333 --------~~~~~~~~~~~~~~~-------~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
............... .....+.+|+.+||+.||++|||+.|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp STTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 000000000000011 113467789999999999999999999976
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-46 Score=356.02 Aligned_cols=254 Identities=22% Similarity=0.272 Sum_probs=191.7
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCc-cChHHHHHHHHHHhcCCCCceeeEEeEEEeCC----eEEEEE
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSH-QGEKEFQTEVSLLGRLHHRNLVNLIGYCVDKG----KYMLIY 192 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~lv~ 192 (426)
|.+.+.||+|+||+||+|+.. +|+.||||++..... ...+.+.+|+.+|++++||||+++++++.... ..++++
T Consensus 10 Y~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~ 89 (345)
T d1pmea_ 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLV 89 (345)
T ss_dssp EEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred eEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEE
Confidence 667789999999999999864 889999999975432 22457889999999999999999999997653 234455
Q ss_pred EecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC-
Q 014352 193 EFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG- 271 (426)
Q Consensus 193 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~- 271 (426)
+|+.+|+|.+++.. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 90 ~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~ 164 (345)
T d1pmea_ 90 THLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 164 (345)
T ss_dssp EECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred EeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence 66779999999954 35999999999999999999999999 9999999999999999999999999997543221
Q ss_pred ---CcccCccccCccCcccc-ccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhc----cccch----------
Q 014352 272 ---RNSGLKGTYGYIDPAYI-STNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASM----SQDGV---------- 333 (426)
Q Consensus 272 ---~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~----~~~~~---------- 333 (426)
......||+.|+|||.+ .+..++.++||||+||++|||++|+.||............ .....
T Consensus 165 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (345)
T d1pmea_ 165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244 (345)
T ss_dssp BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhh
Confidence 23456799999999998 4456789999999999999999999999764322111110 00000
Q ss_pred -hhhhh-hhhcccCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 334 -DEILD-KQLVGACN-----IQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 334 -~~~~~-~~~~~~~~-----~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
..... .......+ ...+.++.+++.+||+.||.+|||+.|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000 00000000 1123568899999999999999999999986
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=345.05 Aligned_cols=256 Identities=23% Similarity=0.258 Sum_probs=200.0
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCcc--ChHHHHHHHHHHhcCCCCceeeEEeEEEeCCeEEEEEEe
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQ--GEKEFQTEVSLLGRLHHRNLVNLIGYCVDKGKYMLIYEF 194 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 194 (426)
+|++.+.||+|+||+||+|++. +++.||||+++..... ....+.+|+.+|++++||||+++++++.+.+..++|+++
T Consensus 3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~ 82 (292)
T d1unla_ 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeee
Confidence 3667789999999999999975 7889999999755432 246789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCccccccCC-Cc
Q 014352 195 MSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVFDG-RN 273 (426)
Q Consensus 195 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-~~ 273 (426)
+.+++|..++. ..+.+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.++...... ..
T Consensus 83 ~~~~~l~~~~~-~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~ 158 (292)
T d1unla_ 83 CDQDLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY 158 (292)
T ss_dssp CSEEHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCC
T ss_pred ccccccccccc-cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCCccc
Confidence 99988888764 4456899999999999999999999999 9999999999999999999999999998654332 33
Q ss_pred ccCccccCccCccccccCC-CCcchhhHHHHHHHHHHHhCCCCCCchHHHHH-Hhh---cccc----ch---hhhhh---
Q 014352 274 SGLKGTYGYIDPAYISTNK-FTMKSDIFSFGVIIFELITAIHPHQNLMEYVN-LAS---MSQD----GV---DEILD--- 338 (426)
Q Consensus 274 ~~~~gt~~y~aPE~~~~~~-~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~-~~~---~~~~----~~---~~~~~--- 338 (426)
....++..|+|||.+.+.. ++.++|||||||++|||++|+.||........ +.. .... .. ....+
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T d1unla_ 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccc
Confidence 3456788999999987665 68999999999999999999999743221111 000 0000 00 00000
Q ss_pred ------hhhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 339 ------KQLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 339 ------~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
...........+..+.+|+.+||+.||.+|||++|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000001112334678899999999999999999999875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-45 Score=352.67 Aligned_cols=252 Identities=24% Similarity=0.256 Sum_probs=188.0
Q ss_pred hhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCcc--ChHHHHHHHHHHhcCCCCceeeEEeEEEe------CCeEE
Q 014352 119 QNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQ--GEKEFQTEVSLLGRLHHRNLVNLIGYCVD------KGKYM 189 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~~~ 189 (426)
|.+.+.||+|+||+||+|.+. +|+.||||++...... ....+.+|+.+|++++|||||++++++.. .+.+|
T Consensus 19 Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~ 98 (355)
T d2b1pa1 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY 98 (355)
T ss_dssp EEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEE
T ss_pred eEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeE
Confidence 667789999999999999976 7899999999765322 23468899999999999999999999964 36789
Q ss_pred EEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccccc
Q 014352 190 LIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF 269 (426)
Q Consensus 190 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 269 (426)
+||||+.++ +...+. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+|++|||+++....
T Consensus 99 iv~Ey~~~~-l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~ 171 (355)
T d2b1pa1 99 LVMELMDAN-LCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_dssp EEEECCSEE-HHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEeccchH-HHHhhh---cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhhcccc
Confidence 999999765 444442 45899999999999999999999999 99999999999999999999999999886665
Q ss_pred CCCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhcc--------------c-----
Q 014352 270 DGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMS--------------Q----- 330 (426)
Q Consensus 270 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~--------------~----- 330 (426)
........+|+.|+|||++.+..++.++||||+||++|||++|+.||.+.........+. .
T Consensus 172 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 251 (355)
T d2b1pa1 172 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 251 (355)
T ss_dssp ---------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHH
T ss_pred ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHH
Confidence 556667789999999999999999999999999999999999999996533221111100 0
Q ss_pred ----------cchhhhhhhhhcccC---CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 331 ----------DGVDEILDKQLVGAC---NIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 331 ----------~~~~~~~~~~~~~~~---~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
............... ....+.++.+|+.+||+.||++|||++|++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000111111111111 12346788999999999999999999999976
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=349.06 Aligned_cols=247 Identities=28% Similarity=0.354 Sum_probs=197.9
Q ss_pred hhhhcccccCCCeeEEEEEeC----CCcEEEEEEeccCC----ccChHHHHHHHHHHhcCCC-CceeeEEeEEEeCCeEE
Q 014352 119 QNFTNILGQGAFGPVYKATMP----SGGVAAIKVLASDS----HQGEKEFQTEVSLLGRLHH-RNLVNLIGYCVDKGKYM 189 (426)
Q Consensus 119 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~ 189 (426)
|++.+.||+|+||+||+|... +|+.||||++.... ....+.+.+|+++|++++| |||+++++++.+.+..+
T Consensus 26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~ 105 (322)
T d1vzoa_ 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 105 (322)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred eEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCcee
Confidence 778889999999999999852 57899999986432 1234568899999999976 89999999999999999
Q ss_pred EEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccccc
Q 014352 190 LIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF 269 (426)
Q Consensus 190 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 269 (426)
++|||+.+|+|.+++.... .++......++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 106 ~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~ 181 (322)
T d1vzoa_ 106 LILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 181 (322)
T ss_dssp EEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred eeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchhhhcc
Confidence 9999999999999986554 4778888999999999999999999 99999999999999999999999999975332
Q ss_pred --CCCcccCccccCccCccccccC--CCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccccchhhhhhhhh--cc
Q 014352 270 --DGRNSGLKGTYGYIDPAYISTN--KFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQDGVDEILDKQL--VG 343 (426)
Q Consensus 270 --~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 343 (426)
........|++.|+|||.+.+. .++.++|||||||+||||++|..||........ ...+..... ..
T Consensus 182 ~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~--------~~~i~~~~~~~~~ 253 (322)
T d1vzoa_ 182 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--------QAEISRRILKSEP 253 (322)
T ss_dssp GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--------HHHHHHHHHHCCC
T ss_pred cccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--------HHHHHHhcccCCC
Confidence 2223456799999999999654 468899999999999999999999975322111 111111111 11
Q ss_pred cCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 014352 344 ACNIQEVRELARIGHKCLHKTPRKRPS-----IGEVTQA 377 (426)
Q Consensus 344 ~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~evl~~ 377 (426)
..+...+.++.+++.+||+.||++||| ++|++++
T Consensus 254 ~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 254 PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 222345678999999999999999995 7888764
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-45 Score=347.27 Aligned_cols=253 Identities=22% Similarity=0.281 Sum_probs=192.5
Q ss_pred HhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCcc--ChHHHHHHHHHHhcCCCCceeeEEeEEEeC-----CeEE
Q 014352 118 TQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQ--GEKEFQTEVSLLGRLHHRNLVNLIGYCVDK-----GKYM 189 (426)
Q Consensus 118 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~ 189 (426)
+|.+.+.||+|+||+||+|+.. +|+.||||++...... ..+.+.+|+.+|++++|||||++++++... ...+
T Consensus 19 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~ 98 (348)
T d2gfsa1 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 98 (348)
T ss_dssp TEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCC
T ss_pred CeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceE
Confidence 3667789999999999999975 7899999999765322 234688999999999999999999998643 3346
Q ss_pred EEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeeecCcccccc
Q 014352 190 LIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADFGLSKEEVF 269 (426)
Q Consensus 190 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 269 (426)
++++|+.+|+|.+++.. +.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+|++|||++....
T Consensus 99 ~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~- 172 (348)
T d2gfsa1 99 YLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTD- 172 (348)
T ss_dssp EEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----CCT-
T ss_pred EEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhcccC-
Confidence 67778889999999843 45999999999999999999999999 9999999999999999999999999987532
Q ss_pred CCCcccCccccCccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCchHHHHHHhhccc---cchhh----------
Q 014352 270 DGRNSGLKGTYGYIDPAYISTN-KFTMKSDIFSFGVIIFELITAIHPHQNLMEYVNLASMSQ---DGVDE---------- 335 (426)
Q Consensus 270 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~---~~~~~---------- 335 (426)
.......||+.|+|||.+.+. .++.++|||||||++|+|++|..||.+.........+.. ....+
T Consensus 173 -~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 251 (348)
T d2gfsa1 173 -DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251 (348)
T ss_dssp -GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHH
T ss_pred -cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhh
Confidence 334456799999999987665 468899999999999999999999976433222111100 00000
Q ss_pred -hhhhhhcc--cC-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014352 336 -ILDKQLVG--AC-----NIQEVRELARIGHKCLHKTPRKRPSIGEVTQA 377 (426)
Q Consensus 336 -~~~~~~~~--~~-----~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~ 377 (426)
........ .. ....+..+.+|+.+||+.||++|||+.|++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp HHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 00000000 00 01234568899999999999999999999985
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7e-40 Score=314.92 Aligned_cols=255 Identities=22% Similarity=0.261 Sum_probs=189.1
Q ss_pred HHhhhhcccccCCCeeEEEEEeC-CCcEEEEEEeccCCccChHHHHHHHHHHhcCC-----------CCceeeEEeEEEe
Q 014352 117 ATQNFTNILGQGAFGPVYKATMP-SGGVAAIKVLASDSHQGEKEFQTEVSLLGRLH-----------HRNLVNLIGYCVD 184 (426)
Q Consensus 117 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~~~~ 184 (426)
.+|.+.+.||+|+||+||+|+.. +|+.||||+++.... ..+.+.+|+.++++++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 34788899999999999999974 789999999975432 2456788999988875 5789999988764
Q ss_pred --CCeEEEEEEecCCCChhHHh--hhccCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeecCCCCCCEEecCCCc----
Q 014352 185 --KGKYMLIYEFMSNGSLSNLI--YSEERVLNWEERLQIALDISHGIEYLHE-GAVPPVIHRDLKSANILLDHFMR---- 255 (426)
Q Consensus 185 --~~~~~lv~e~~~~gsL~~~l--~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~---- 255 (426)
....+++++++..+...... ......+++..+..++.|++.||.|||+ .+ |+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 35667777776554433322 2334668999999999999999999998 77 999999999999987653
Q ss_pred --EEEeeecCccccccCCCcccCccccCccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCchHHHHH------Hh-
Q 014352 256 --AKVADFGLSKEEVFDGRNSGLKGTYGYIDPAYISTNKFTMKSDIFSFGVIIFELITAIHPHQNLMEYVN------LA- 326 (426)
Q Consensus 256 --~kl~Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~------~~- 326 (426)
++++|||.+.... .......||+.|+|||.+.+..++.++|+||+||++++|++|+.||........ +.
T Consensus 169 ~~~kl~dfg~s~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~ 246 (362)
T d1q8ya_ 169 IQIKIADLGNACWYD--EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246 (362)
T ss_dssp EEEEECCCTTCEETT--BCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred ceeeEeecccccccc--cccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence 9999999987543 334566799999999999999999999999999999999999999964321100 00
Q ss_pred --hccccchhhh----------h-----------------hh--hhcccCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 014352 327 --SMSQDGVDEI----------L-----------------DK--QLVGACNIQEVRELARIGHKCLHKTPRKRPSIGEVT 375 (426)
Q Consensus 327 --~~~~~~~~~~----------~-----------------~~--~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl 375 (426)
.......... . .. ..........+..+.+|+.+||..||.+|||++|++
T Consensus 247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L 326 (362)
T d1q8ya_ 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 326 (362)
T ss_dssp HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 0000000000 0 00 001122345677899999999999999999999998
Q ss_pred HH
Q 014352 376 QA 377 (426)
Q Consensus 376 ~~ 377 (426)
++
T Consensus 327 ~H 328 (362)
T d1q8ya_ 327 NH 328 (362)
T ss_dssp TC
T ss_pred cC
Confidence 75
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=4.9e-25 Score=191.21 Aligned_cols=163 Identities=17% Similarity=0.215 Sum_probs=118.2
Q ss_pred hhhcccccCCCeeEEEEEeCCCcEEEEEEeccCCcc------------------ChHHHHHHHHHHhcCCCCceeeEEeE
Q 014352 120 NFTNILGQGAFGPVYKATMPSGGVAAIKVLASDSHQ------------------GEKEFQTEVSLLGRLHHRNLVNLIGY 181 (426)
Q Consensus 120 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~e~~~l~~l~h~niv~~~~~ 181 (426)
.+++.||+|+||+||+|+..+|+.||||+++..... ....+..|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 356899999999999999888999999987542110 01234568889999999999988765
Q ss_pred EEeCCeEEEEEEecCCCChhHHhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCCEEecCCCcEEEeee
Q 014352 182 CVDKGKYMLIYEFMSNGSLSNLIYSEERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHFMRAKVADF 261 (426)
Q Consensus 182 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 261 (426)
. ..+++|||+++..+.. ++......++.|++.+|.|||+++ |+||||||+|||++++ .++|+||
T Consensus 83 ~----~~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp E----TTEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEECCC
T ss_pred c----CCEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEEEC
Confidence 3 2379999998865533 333445678999999999999999 9999999999999965 5899999
Q ss_pred cCccccccCCCcccCccccCccCc------cccccCCCCcchhhHHHHHHH
Q 014352 262 GLSKEEVFDGRNSGLKGTYGYIDP------AYISTNKFTMKSDIFSFGVII 306 (426)
Q Consensus 262 gl~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~~~Dv~S~Gvvl 306 (426)
|++......... .|... +.+ ...|+.++|+||..--+
T Consensus 147 G~a~~~~~~~~~-------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 147 PQSVEVGEEGWR-------EILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TTCEETTSTTHH-------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred CCcccCCCCCcH-------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 998743211110 11110 111 35678889999975433
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.55 E-value=2.1e-07 Score=82.45 Aligned_cols=131 Identities=17% Similarity=0.090 Sum_probs=89.6
Q ss_pred CCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCC-CCceeeEEeEEEeCCeEEEEEEecCCCChhHHhhh
Q 014352 128 GAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLH-HRNLVNLIGYCVDKGKYMLIYEFMSNGSLSNLIYS 206 (426)
Q Consensus 128 G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 206 (426)
++.+.||+... +++.+++|+...........+.+|...+..+. +--+.+++.+..+++..++||++++|.++......
T Consensus 25 ~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~ 103 (263)
T d1j7la_ 25 MSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED 103 (263)
T ss_dssp CSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTT
T ss_pred CCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccc
Confidence 33468999875 45556778876544344456788888887764 33356778888888899999999999888655421
Q ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHcCC----------------------------------------------------
Q 014352 207 EERVLNWEERLQIALDISHGIEYLHEGA---------------------------------------------------- 234 (426)
Q Consensus 207 ~~~~l~~~~~~~i~~~i~~~l~~LH~~~---------------------------------------------------- 234 (426)
.. . ...++.++++.+..||+..
T Consensus 104 ~~---~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 177 (263)
T d1j7la_ 104 EQ---S---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTE 177 (263)
T ss_dssp CS---C---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHS
T ss_pred cc---c---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhc
Confidence 11 1 2234455555666666411
Q ss_pred ----CCCeeecCCCCCCEEecCCCcEEEeeecCcc
Q 014352 235 ----VPPVIHRDLKSANILLDHFMRAKVADFGLSK 265 (426)
Q Consensus 235 ----~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 265 (426)
.+.++|+|+.|.||++++++.+-|.||+.+.
T Consensus 178 ~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 178 KPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1237999999999999987667799999775
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.18 E-value=5.1e-06 Score=72.80 Aligned_cols=130 Identities=17% Similarity=0.121 Sum_probs=84.3
Q ss_pred ccccCCC-eeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCCC--CceeeEEeEEEeCCeEEEEEEecCCCCh
Q 014352 124 ILGQGAF-GPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHH--RNLVNLIGYCVDKGKYMLIYEFMSNGSL 200 (426)
Q Consensus 124 ~lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~gsL 200 (426)
.+..|.. +.||+....++..+++|...... ...+..|...++.+.. -.+.+++.+..+++..++||++++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3445543 67999998788778889865432 3356778888876643 3356778888888889999999988665
Q ss_pred hHHhhhccCCCCHHHHHHHHHHHHHHH---------------------------------------------------HH
Q 014352 201 SNLIYSEERVLNWEERLQIALDISHGI---------------------------------------------------EY 229 (426)
Q Consensus 201 ~~~l~~~~~~l~~~~~~~i~~~i~~~l---------------------------------------------------~~ 229 (426)
.... .... ..+.+++..| ..
T Consensus 94 ~~~~------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (255)
T d1nd4a_ 94 LSSH------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR 164 (255)
T ss_dssp TTSC------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred cccc------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHH
Confidence 3311 0000 0111222222 22
Q ss_pred HHcCC----CCCeeecCCCCCCEEecCCCcEEEeeecCcc
Q 014352 230 LHEGA----VPPVIHRDLKSANILLDHFMRAKVADFGLSK 265 (426)
Q Consensus 230 LH~~~----~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 265 (426)
+.... .+.++|+|+.|.||+++++..+-|+||+.+.
T Consensus 165 l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 165 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 22211 1237999999999999987667899999775
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.73 E-value=8.5e-05 Score=69.34 Aligned_cols=76 Identities=17% Similarity=0.105 Sum_probs=47.1
Q ss_pred cccccCCCeeEEEEEeC-CCcEEEEEEeccCC-------ccChHHHHHHHHHHhcCC-C--CceeeEEeEEEeCCeEEEE
Q 014352 123 NILGQGAFGPVYKATMP-SGGVAAIKVLASDS-------HQGEKEFQTEVSLLGRLH-H--RNLVNLIGYCVDKGKYMLI 191 (426)
Q Consensus 123 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~~~~~e~~~l~~l~-h--~niv~~~~~~~~~~~~~lv 191 (426)
+.||.|....||+.... +++.+++|.-.... .........|.+.|+.+. + ..+.+++.+ +++..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 35899999999999865 45678888654311 112233456777776652 2 345555554 44556899
Q ss_pred EEecCCCCh
Q 014352 192 YEFMSNGSL 200 (426)
Q Consensus 192 ~e~~~~gsL 200 (426)
||++++..+
T Consensus 110 mE~L~~~~~ 118 (392)
T d2pula1 110 MEDLSHLKI 118 (392)
T ss_dssp ECCCTTSEE
T ss_pred EeccCCccc
Confidence 999976543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.84 E-value=0.0074 Score=54.06 Aligned_cols=68 Identities=10% Similarity=0.140 Sum_probs=45.9
Q ss_pred eeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCce--eeEE-----eEEEeCCeEEEEEEecCCCC
Q 014352 131 GPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNL--VNLI-----GYCVDKGKYMLIYEFMSNGS 199 (426)
Q Consensus 131 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~~~-----~~~~~~~~~~lv~e~~~~gs 199 (426)
-.||+....+|+.+++|+.+... .+.+++..|...+..|...++ +..+ ......+..+.++++++|..
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 47999999899989999987543 346678889888877742221 1111 12234567889999997643
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.47 E-value=0.0047 Score=57.10 Aligned_cols=72 Identities=15% Similarity=0.237 Sum_probs=48.0
Q ss_pred cccccCCCeeEEEEEeCCC--------cEEEEEEeccCCccChHHHHHHHHHHhcCCCCce-eeEEeEEEeCCeEEEEEE
Q 014352 123 NILGQGAFGPVYKATMPSG--------GVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNL-VNLIGYCVDKGKYMLIYE 193 (426)
Q Consensus 123 ~~lg~G~~g~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e 193 (426)
+.|+.|-.=.+|+....++ ..+.+++... . .......+|..+++.+.-.++ .++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-P-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-C-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-c-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 3678888899999986543 4566666542 2 234456688888888753344 467776643 58999
Q ss_pred ecCCCCh
Q 014352 194 FMSNGSL 200 (426)
Q Consensus 194 ~~~~gsL 200 (426)
|++|.+|
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.69 E-value=0.06 Score=47.40 Aligned_cols=30 Identities=27% Similarity=0.253 Sum_probs=26.6
Q ss_pred CCeeecCCCCCCEEecCCCcEEEeeecCcc
Q 014352 236 PPVIHRDLKSANILLDHFMRAKVADFGLSK 265 (426)
Q Consensus 236 ~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 265 (426)
.+++|+|+.+.||+++.+...-|.||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 348999999999999998777899999875
|
| >d1cjaa_ d.144.1.3 (A:) Actin-fragmin kinase, catalytic domain {Physarum polycephalum [TaxId: 5791]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Actin-fragmin kinase, catalytic domain domain: Actin-fragmin kinase, catalytic domain species: Physarum polycephalum [TaxId: 5791]
Probab=87.30 E-value=0.66 Score=39.93 Aligned_cols=133 Identities=14% Similarity=0.094 Sum_probs=73.3
Q ss_pred ccCCCeeEEEEEeCCCcEEEEEEeccCCccChHHHHHHHHHHhcCCCCceeeEEeEEEe---------------------
Q 014352 126 GQGAFGPVYKATMPSGGVAAIKVLASDSHQGEKEFQTEVSLLGRLHHRNLVNLIGYCVD--------------------- 184 (426)
Q Consensus 126 g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--------------------- 184 (426)
..+|.+-|+-+.. ++..+++|.-. ....+-+-.++...-.+.-|...-+. .+..
T Consensus 77 s~~Gs~Gv~FV~~-e~gaiVlK~s~---tta~E~y~~eLAr~LGvpvPqmRvI~-~~~~E~~~~~~~~l~~~e~d~~I~s 151 (342)
T d1cjaa_ 77 SEKGTEGLFFVET-ESGVFIVKRST---NIESETFCSLLCMRLGLHAPKVRVVS-SNSEEGTNMLECLAAIDKSFRVITT 151 (342)
T ss_dssp CCSTTSCEEEEEE-SSCEEEEECCT---THHHHHHHHHHHHHHTCCCCCEEEEE-SSSHHHHHHHHHHHHHCSSSCHHHH
T ss_pred eecCCceEEEEEc-CCceEEEecCC---chHHHHHHHHHHHHhCCCCCceEEec-CCCHHHHHHHHHHhcCCChhHHHHH
Confidence 3334444555554 45567788632 23335566666666677778765443 1110
Q ss_pred --CCeEEEEEEecCCCChhHHhhhc-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCC-CCCCEEecCCC-cEEEe
Q 014352 185 --KGKYMLIYEFMSNGSLSNLIYSE-ERVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDL-KSANILLDHFM-RAKVA 259 (426)
Q Consensus 185 --~~~~~lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl-k~~Nill~~~~-~~kl~ 259 (426)
.....++|||.+|.+|.+.-... ........... +-.++--=.+++.....|+.+|+- .+.||+++.++ .+..+
T Consensus 152 el~~A~~liMeYvpG~~l~e~~~~~a~~~fs~~~l~~-LGkIiaFDifInN~DR~PL~Wrn~GN~~Niml~~n~~~~~~I 230 (342)
T d1cjaa_ 152 LANQANILLMELVRGITLNKLTTTSAPEVLTKSTMQQ-LGSLMALDVIVNNSDRLPIAWTNEGNLDNIMLSERGATVVPI 230 (342)
T ss_dssp HTTCSEEEEEECCCEEESTTCCSSSHHHHSCHHHHHH-HHHHHHHHHHHTCCSSSCSSSCSCCCGGGEEEESBTTCEEEC
T ss_pred HHhcccceeeeccCCccccccccccchhhhcHHHHHH-hhhHHHHHHHHcCCccccccccCCCCccceEEecCCcEEEEe
Confidence 23478999999987765542110 01122222211 111222334677776667777743 78999998876 56677
Q ss_pred eecCc
Q 014352 260 DFGLS 264 (426)
Q Consensus 260 Dfgl~ 264 (426)
|=|..
T Consensus 231 Ds~i~ 235 (342)
T d1cjaa_ 231 DSKII 235 (342)
T ss_dssp SCCCC
T ss_pred cCCcc
Confidence 75443
|